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Infectious cost of leisure (Keynote lecture) 
IKZO] Infectious cost of leisure 
s. Unal 
Ankara, TR 
Most people equate leisure time with joy of living, and dismiss any idea of 
&ease or accident. Travellers’ dseases are among the most frequent leisure- 
time ailments (Life is risky, and travel even more so). Although the 
incidence varies &om country to country, travellers’ diarrhoea, sexually 
transmitted diseases (STD) and viral hepatitis are the major problems for 
travellers. In addition to the Ezctors like historical, natural and social 
characteristics and security status of the countries, the incidence of the above 
mentioned travel related infections in that particular region contributes to 
the decision. Turkey is an attractive country for tourism. In the perspective 
of travellers’ safety, the incidence of STD is low (1000/65 000 000 000 
known HIV(+) cases, June 2000) and the risk for travellers’ diarrhoea is 
shfling fiom moderate to low as the number of appropriate accommodation 
facihties increases rapidly. The incidence of hepatitis A is slowing down 
parallel to the development in the infrastructure. Hepatitis B vaccine is 
available for the last 12 years and it is included in the national new born 
vaccination program for 3 years. The infectious cost of leisure appears to be 
low in Turkey as well as all the other travel expenses. Yes, it is the time to 
visit Turkey. 
The need for a new revolution in RTI prescribing? (Arranged by GlaxoSmithKline) 
15221 Pharmacokinetialpharmacodynamics - the key to change? 
M. Jacobs 
Cleveland, USA 
The correlation of the outcome of infections in human and experimental 
animal studies with pharmacokinetic (PK) and pharmacodynamic (PD) 
parameters has allowed clinical outcomes to be correlated with susceptibdity 
data. This also provides an evidence-based approach to predicting the 
clinical outcome of agents for which clinical data are not available. Data 
fiom animal models and from human studies, such as bacteriologic outcome 
of acute otitis media, community acquired pneumonia and acute 
exacerbations of chronic bronchitis, show that bacteriologic and chical 
outcome can be correlated with PK/PD parameters. The PK/PD parameter 
for time-dependent agents, such as beta-lactams and most macrolides, that 
correlates with bacteriological eradication is the unbound serum concentra- 
tion that is present for 40-50% of the dosing interval. For concentration- 
dependent agents, such as quinolones, aminoglycosides and azithromycin, 
the PK/PD parameters that correlate with bacteriological eradication are the 
peak unbound serum concentration to MIC (peakMIC) ratio and the 
unbound area-under-the-curve to MIC (AUC:MIC) ratio. The dosing 
regimens and resulting serum concentration protiles that achieve these 
parameters can therefore be used to develop PK/PD breakpoints for 
interpreting in vitro susceptibility results based on MIC determination. This 
allows dosing regimens to be designed to exceed the minimum PWPD 
parameters needed to eradicate the required spectrum of pathogens. Various 
groups have recognized the value of PK/PD relationships for predicting the 
clinical efficacy of antibiotics, and have developed guidelines or MIC 
breakpoints based on PK/PD parameters. Examples include recent Center 
for Disease Control and Prevention (CDC) Drug Resistant Streptococcus 
pneumoniae Therapeutic Working Group guidelines for the treatment of 
otitis media and pneumonia, Sinus and Allergy Health Partnershp 
guidelines for sinusitis, and the National Committee for Clinical Laboratory 
Standards’ recent susceptibihty breakpoints for some oral beta-lactams 
against Streptococcus pneumoniae. Similar development of breakpoints for a 
wider range of antibacterial agents, diseases and dosing regimens is now 
needed. Antibacterial agents should be selected based on their ability to 
achieve rapid bactericidal activity and optlmal PK/PD parameters to 
treat infections adequately and minimize the development and spread of 
resistant mutants 
15231 Resistance and clinical failure -the emerging link? 
A. A. Medeiros 
Rhode Island, USA 
In pneumococcal meningitis there is conclusive evidence that resistance in 
S. pneumoniae compromises clinical outcome. However, the nature of 
community-acquired respiratory tract infections (RTIs) means that the 
clinical impact of increasing resistance is more difficult to determine. 
Clinical efficacy of antibiotics is related to bacteriological outcome, which is 
influenced by the pharmacodynamic activity (potency and pharmacolu- 
netics) of the agent being employed against the lnfecting pathogen. For 
example, in Streptocorns pneumoniae-related acute otitis meka (AOM), the 
bacteriological failure rate of some cephalosporins increases as the MIC 
against the pathogen increases (Dagan ef al. Pediatric Infectious Disease Journal 
1996; 15: 980-85). Surveillance of clinical isolates from community- 
acquired RTIs shows that there is a trend towards increasing prevalence of 
resistant pathogens, and that MICs are increasing for a range of antihiotics. 
Emerging data suggest that resistance is compromising the efficacy of 
routinely used agents such as beta-lactams, macrolides and fluoroquinolones. 
For example, there have been reports of clinical and bacteriological failure 
of macrolides due to resistance in S. pneumoniae (Garau et al. ICMAS, 2000, 
abstract 7.09). In adktion, the older fluoroquinolones, which have relatively 
high MICs against S. pneumoniae, have been associated with treatment 
failures in patients with pneumococcal pneumonia. The results firom a 
number of published clinical t r ia ls  appear to suggest that resistance has not 
significantly compromised the clinical outcome of routinely used agents. 
However, these published studies often exclude &om the analysis patients 
most likely to be infected with resistant pathogens, or the studies were 
conducted prior to the current extent of resistance. Recent retrospective 
analyses and increasing sporadic reports of clinical failures due to resistance 
may be more reflective ofthe real situation and show the ‘tip of the iceberg’. 
These reports suggest a need to reassess current empirical therapeutic 
recommendations for the treatment of community-acquired RTIs suspected 
to be of pneumococcal etiology. 
Antibiotic resistance - European unity or diversity? 
R. Reinert 
Aachen, D 
Epidemiological survedance data are essential for monitoring the prevalence 
of antibiotic resistance, assessing the impact of antibiotic use on resistance 
trends and guidmg appropriate empirical antibiotic therapy strategies. 
Data from surveillance programmes monitoring resistance in the key 
community-acquired respiratory aact pathogens-Streptococcus pneumoniae, 
Haemophilus infuenzae and Mormelfa catanhalis-show that the pattern of 
resistance to commonly used antibiotics varies across Europe. Latest data 
from the Alexander Project, a worldwide surveillance programme, show a 
continued high prevalence of penicillin-nonsusceptible S. pneumoniae (MIC 
> /=0.12 mg/L) in some regions of Europe, particularly centres in Spain 
(47%) and France (62%). Of further concern is the recent emergence of 
strains exhibiting penicillin MICs 2 8 mg/L. In contrast, the prevalence of 
penicillin-nonsusceptible S. pneumoniae strains does not exceed 10% in 
centres in Germany and the Czech Republic. An increasmgly high 
prevalence of macrolide-resistant S. pneumoniae (erythromycin MIC 2 1 
mg/L) is also reported in a number of European countries, such as Belgium 
(26%) and Italy (31%). In many cases the prevalence is higher than that of 
penicdlin resistance. An ongoing study on invasive pneumococcal disease 
across Germany has also documented a dramatic increase in the prevalence 
of macrolide resistance in 2000, to more than 15% and 25% in adults and 
children, respectively. Data from the Alexander Project show an increased 
prevalence of beta-lactamase-producing H. infuenzae strains in recent years. 
In France, almost one-third of H. inflcrenzae isolates now produce beta- 
lactamase. In M .  catarrhalis, beta-lactamase-producing strains dominate with 
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the prevalence exceeding 90% in many European countries. Analysis of 
MIC90 data for a range of antibiotics shows that some agents, such as 
amoxic&+clavulanate, have maintained good activity against S .  
pneumoniae, including penicillin-nonsusceptible strains, compared with 
cefaclor and macrolides. The combination of amoxicillin plus clawlanate 
is highly active against H. infumzae and M. ratanhalis, including beta- 
lactamase-producing strains. In contrast, the higher MIC90 of macrolides 
against H. inzumrae indicates their relatively low intrinsic activity, 
suggesting they are less suitable empirical therapy choices for RTIs. These 
tindings emphasize the need for continued epidemiological monitoring of 
antibiotic resistance, both globally and locally. 
1525 Forward together? Strategies for appropriate use of 
antibiotics 
J. Anon 
Pittsburgh, USA 
Antibiotic resistance in pathogenic bacteria has become an important issue 
in community medicine. This has brought a need to reassess current 
antibiotic prescribing habits for community-acquired respiratory tract 
infections (RTIs) to maximize clinical benefits for patients and minimize 
the selection and spread of resistant pathogens. To aid appropriate antibiotic 
therapy choices, a number of goals have been identified: (1) Unnecessary 
and inappropriate use of antibiotics contributes towards resistance and 
therefore should be avoided. (2) When antibiotic therapy is deemed 
necessary, the goal should be to rapidly eradicate bacteria, or to achieve 
maximal reduction of bacterial load, at the site of infection. (3) Emerging 
scientific criteria for evaluating the bacteriological and clinical efficacy of 
antibiotics should be applied-pbcokinetic (PK) and pharmamdynamic 
(PD) parameters are currently the most valuable predictors of efficacy. These 
considerations can provide the basis for rational, evidence-based antibiotic 
prescribing guidelines for RTIs. This is illustrated in recent guidelines for 
the treatment of acute bacterial rhinosinusitis (ABRS), published by the 
Sinus and Allergy Health Partnership (Sinus and Allergy Health Partnership. 
OlohyngdopHead and Neck Surgery 2000; 123(supplement): Sl-S32). 
Using mathematical modelling of ABRS, based on pathogen epidemiology 
and susceptibility patterns, spontaneous resolution rates and PK/PD 
predicted bacteriological efficacy, antibiotics are categorized according to 
their expected clinical efficacy in adults and children with ABRS. 
Treatment recommendations are then based upon these clinical predictions. 
A further example of systematic, evidence-based treatment guidelines is seen 
in the Centers for Disease Control and Prevention’s (CDC’s) guidelines for 
acute otitis media (Dowell ef  al. Pediafrir Infectious DiseaceJoumal 1999; 18: 
1-9). Based on the PWPD profiles of agents against the major pathogen in 
this infection-Streptocorms pneumoniae-the guidelines recommend the use of 
amoxicillin, with a high-dose option being recommended for patients at risk 
of infection with drug-resistant strains of the organism. This evidence-based 
approach has the potential to be adapted locally, through website 
availability, by policy makers, guideline committees and prescribers. 
New developments in PCR-based diagnosis 
vl A novel single-tube real-time RT-PCR assay for 
enterovirus detection and quantification in cerebrospinal fluid 
and other clinical samples 
W. A. Versuepen, S .  Kuhn, M. Kockx, M. E. Van De Vyvere, A. H. Mertens 
Antwetpen, B 
Objective: A rapid and sensitive PCR-based diagnostic method for 
Enteroviral infections may have a strong impact on early diagnosis and 
management ofviral meningitis. Our aim was to develop a closed-tube real- 
time RT-PCR assay for Enterovirus detection in cerebrospinal fluid. 
Methods: Viral RNA was extracted from either viral culture supernatant. 
stabilized Enterovirus RNA standard, or clinical cerebrospinal fluid samples 
using the QiaAmp viral RNA extraction kit. Reaction conditions and 
cycling parameters of a single-tube Taqman RT-PCR were optimized on a 
ABI Prism 7700 SDS using a fluorogenic probe and primers dxected to 
conserved sequences located in the 5’ nontranslated region of the 
Enterovirus genome. 
Results: Quantitative detection of the Enterovirus genome was demon- 
strated in FWA extracts from a tenfold dilution series of viral culture 
supernatant spanning 5 logs. The detection lunit at 95% confidence &om the 
stabilized Enterovirus RNA standard was 11.8 genome equivalents per 
reaction, corresponding in our current extraction protocol to 592 genome 
equivalents per mL cerebrospinal fluid. No cross-reaction with Herpes 
simplex virus type 1 and 2, or Varicella zoster virus was observed. From a 
total of 45 cerebrospinal fluid samples &om patients suspected of viral 
meningitis, 14 tested positive both by viral culture and Taqman RT-PCR 
assay. Two samples were positive by TaqMan RT-PCR only, whereas none 
of the PCR-negative samples was positive by viral Culture. The assay was 
furthermore applicable to RNA extracted from other chical samples such 
as eye swabs and myocardial biopsies. Owing to the elirmnation of 
postamplification detection steps, the assay was completed within 2.5 h 
while requiring considerably less hands-on t h e ,  and its conduct was 
associated with a minimal carry-over risk. 
Conclusions: Preliminary data suggest that our novel single-tube Enter- 
ovirus real-time RT-PCR assay provides a reliable alternative to viral 
culture. It compares favorably to previously described RT-PCR assays for 
Enterovirus detection in clinical samples by combining high sensitivity and 
low carry-over risk with hgh  sample throughput, high speed and low 
hands-on time. It is therefore particularly well suited for implementation in 
a routine molecular diagnostic laboratory. 
vl Multiplex rapid cycle PCR with microwell format probe 
hybridbation for the detection d macrolick resistance mechanisms 
in Streptococcus pneumoniae and Stteptocuccus pyogenes 
D. J. Farrell, I. Morrissey, S .  Bakker, D. Felrmngham 
London, UK 
Macrolide resistance in SPN and SPY predominantly occurs by two 
mechanisms: (1) target modification by an rRNA E m  methylase ( e d  
and/or ermA(TR)), or (2) efflux mediated by MeE4. Typically, isolates with 
me€4 have low macrolide MICs and retain susceptibility to clindamycin 111. 
In adhtion, only those isolates with ermB appear to show resistance to 
ketolides 121. The acquisition of both a methylase and an e5ux mechanism 
in the same strain is also possible. Mutations within domain V of 23s rRNA 
and ribosomal proteins L4 and L22 can also came macrolide resistance [3]. 
There is a clinical need therefore to determine resistance mechanisms and 
the distribution of the mechanism types in isolates from surveillance studies. 
Our aim was to develop a rapid cycle multiplex PCR with a probe/ 
microwell detection format to detect e d ,  ermTR, en&, ermC and 
mefA, in both SPN and SPY, that would allow cost-effective and time- 
e5cient hgh volume screening-in particular, to support surveillance 
studies. To validate the method, we tested 139 macrolide resistant isolates 
from recent surveillance studies in Great Britain, Northern Ireland and the 
Republic of Ireland2. A high correlation (137/139 strains tested) was 
obtained between our test and a modification of a previously published 
multiplex method using gel-based detection [l]. For 83 strains of macrolide 
resistant SPN, 51 (61.4%) were positive for mefA, 29 (34.9%) e d ,  2 
(2.4%) mefA + e d ,  and 1 (1.2%) negative for all mechanisms tested (L4 
and L22 riboprotein mutations have been excluded and 23s rRNA 
mutations are currently under investigation). For 56 macrolide resistant 
SPY, 33 (58.9%) were positive for ermA(TR), 18 (32.1%) me% and 5 
(8.9%) err&. Interestingly, the two results that differed when using gel 
detection after multiplex PCR were the two with dual resistance 
mechanisms. In our hdds  therefore the probe detection method was 
better able to characterize isolates with 2 mechanisms ofmacrolide resistance 
than the gel detection method. The method is hghly suited for rapid, 
accurate, standardized, high-volume screening of macrolide resistance 
determinants in these species. 
References 
1. SutcWe et al. AAC 1996; 40: 2562. 
2. Momssey et al. Absmact 2149, 40th ICAAC. 20M) 
3. Tait-Kamradt er a/. AAC 2MK); 44: 2118. 
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jo32/ A prospective study on PCR inhibitor removal by silica 
membranes 
B. Boeddinghaus, T. A. Wichelhaus, V. Brade, T. Bittner 
FrankJtrdM, D 
Objective: PCR is a powerful diagnostic tool due to its sensitivity and broad 
applicability. Unfortunately, clinical specimen frequently contain various 
substances which may inhibit the PCR completely. This study was aimed at 
evaluating the ability of silica membrane to remove a variety of inhibitors 
simultaneously. 
Methods: Amplicor M. tuberculosis(MTB) test kit (Roche Diagnostic 
Systems, Branchburg, USA) is especially susceptible to inhibition, because it 
comprises no cleaning of the extracted DNA. Therefore, it is suitable for 
studying the effectiveness of inhibitor removal. A protocol was established 
to combine Amplicor M. tuberculosis kit with the QIAamp DNA Mini kit 
(Qiagen. Hilden, Germany). Firstly, we evaluated the sensitivity of this 
combination for M. bovis BCG and human blood as inhibitor. Secondly, 
we investigated the effectiveness of this protocol with clinical specimen in a 
prospective study for 14 months. A total of 655 probes were investigated by 
culture and by PCR. Materials included sputum, tracheavbronchial aspirate, 
pleural fluid, gastric fluid, aspirates, cerebrospinal fluid, and lymph nodes. 
Results: On evaluation of the sensitivity with cell dilutions both procedures, 
the original Amplicor protocol as well as the modified sllica membrane 
protocol, showed a detection limit as low as 4 CFUdPCR. When 
dlscrepancies due to e.g. therapy were resolved for microscopic positive 
materials the PCR showed a sensitivity of 0.97, a specsty of 1.0, a positive 
predictive value of 1.0 and a negative predictive value of 0.998 without 
(n=  573) and a sensitivity of 1.0, a specifity of 1.0, a positive predictive 
value of 1.0 and a negative predictive value of 1.0 with (n=82) the 
silica membranes. By contrast, the inhibition rate was reduced from 
12.52% to 1.07% by using silica membrane columns during the Amplicor 
lut procedure. 
Conclusions: We conclude that binding of DNA to silica membrane with 
this protocol is rapid, easy to handle, and therefore also cost-effective. Due 
to its remaining sensitivity, this method is suitable for the removal of a 
variety of PCR inhibitors at once. As for the diagnosis of TB, chis method 
provides an effective means to overcome the 6equent inhibition seen with 
the Amplicor MTB kit and to establish diagnosis of TB with a broadened 
spectrum of materials. 
(033( Clinical utility of broad-spectrum PCR on direct 
specimens: a 3-years experience 
K. Jaton, M. Altwegg, F. Bally, A. Wenger, J. Bille 
Lausanne, Zurich, CH 
Background: Among the procedures currently used in clinical microbiol- 
ogy, culture is s t d  the most sensitive method for detecting bacteria. 
However, in some situations (use of prophylactic and early empirical 
antibiotics, slow or nongrowing organisms, diflicult-to-idenhfy bacteria), 
the broad-spectrum PCR approach (bsPCR) can be very useful to detect 
and/or identify bacteria in tissues or other normally sterile body fluids. 
Objectives: To determine in a prospective study the utility of a bsPCR 
approach in highly selected situations where bacterial infection is suspected 
but culture remains negative. 
Methods: The bsPCR approach is based on 165 rRNA gene amplification, 
followed by duect sequencing of the amplified product and comparison to 
reference sequences. So far 70 culture negative selected specimens from 47 
patients @ts) were submitted to bsPCR. 44 tissue biopsies or deep seated 
collections from 26 pts; 17 resected heart valves from 13 pts; 6 liver biopsies 
from 5 pts; 3 CSF &om 3 pts. The results were then compared to other 
laboratory findings (in particular microscopy), histopathology and clinical 
outcome (in particular change in antibiotherapy). Consensus opinion about 
the imphcation and the contribution of bsPCR was settled for each case. 
Results: For 18 out of 47 pts (38%) corresponding to 19/70 (27%) 
specimens, bsPCR was positive and for 17 pts a bacteria could be identified 
(9 Streptocorms sp., 1 each of Streptobacillur monilformis, Haemophilus 
paraphrophilus, Tropheryma tuhippelii, Campylobacter sp., Adnetobacter sp., 
Raktonia sp.. Propionibacterium arnes, Enterobactetiaceae). According to the 
consensus opinion, the detection or/and identification of the bacteria was 
found clinically usef3l for 11 ofthem: 6/13 pts with a suspected endocarditis 
(46%) and 5/26 pts (19%) with tissue biopsies or deep seated collections. 
None of the 6 liver biopsies (5 pts) nor the 3 CSF (3 pts) were found 
positive by bsPCR. 
Conclusion: The results of this ongoing study suggest that the bsPCR 
approach is useful in well defined clinical situations and in our experience it 
was found to be conclusive for 11 out of 47 patients (23%) investigated 
10341 Validation of real-time quantitative PCR for human 
intestinal mucosal biopsies 
X. W. Huijsdens, R. K. Linskens, M. Mak, S .  G. M. Meuwissen, 
C. M. J. E. Vandenbroucke-Grauls, P. H. M. Savelkoul 
Amsterdam, NL 
Background: The human intestinal tract harbors a large and complex 
community of microbes and is involved in maintaining human health by 
preventing the colonization by pathogens and producing nutrients for the 
colonic mucosa. Conventional bacteriological methods like culture, 
microscopy and identification are used for the analysis and/or quantification 
of the intestinal microflora, but each of the methods has its own limitations, 
like a high detection limit, the unability to detect noncultivable and 
unknown bacteria, technical difficulties, time consuming and hardly 
reproducible due to the multitude of species to be identified and quantified, 
and the difference in growth rates and conditions among the different 
species. To overcome some of these problems and as a consequence to get a 
better understanding of the actual in vivo compostion of the gut flora, we 
evaluated the use of real-time quantitative PCR to q u w  and quantify the 
adherent intestinal mucosa. 
Methods: For evaluation of the approach, primer/probe combinations were 
designed, dtrected at 16s rDNA of two bacteria present in the gut, E. roli 
and Bucteroides vulgatus. Sensitivity and specificity of these primedprobe 
combinations were determined in a ABI Prism 7700 Sequence Detector. 
Specificity, a key factor in quantifying only the bacteria of interest, was 
dete-ed in the presence of eght other intestinal bacted species. Mucod 
biopsies from the sigmoid region of 25 healthy persons were obtained. 
Results: Sensitivity was very high, one E. coli and nine B. uulgatus cells could 
be detected. Specificity experiments showed no influence of the other 
intestinal bacterial species. Reproducibihty of the Herent experiments was 
over 99%. Analysis of the mucosal samples showed no PCR inhibition. 
Conclusion: Real-time quantitative PCR is applicable to study the adherent 
intestinal microflora in mucosaI biopsies. For this assay no cultivation is 
necessary, the actual in oiuo situation of the gut microflora can be studied. 
The method is highly sensitive, specific and reproducible. Research of the 
mucosal microflora will be crucial in understanding the role of the 
microflora in gut health, but also of great importance in clinical use, e.g. 
inflammatory bowel diseases like Crohn’s dlsease and ulcerative colitis. 
1035) Clustering of serologically defined Proteus vulgaris 
strain collection by PCR-based fingerprinting methods 
T. Cieslikowski, M. Rzeznik, W. Kaca 
Lndr, PL 
Objectives: The established formerly on the set of P. mira6ilis reference 
strains correlation between their serological and genetic properties, was 
tested on the group of the P. vulgaris strains included to the same 
serologically defined Kaufham-Perch strains collection. 
Methods: PCR fingerprint differentiation based on microsatelitte 
(GACA)CPCR. and repetitive sequence (rep-PCR)-BOXAlR-PCR. 
Results: Two types of PCR tests were applied for the investigation of 
diversity of 31 P. ~ ~ l g e r i ~  reference strains. These serologically defined strains 
were representing 23 different serotypes. For 13 strains it was one out of the 
five: 01, 04 ,  019  (3 strains for each), 0 2 ,  011 (2 strains for each); while 
the rest of the strains were representing singular diverse serotypes only. The 
computer-assisted analysis of the fingerprints (UPGMA band pattern analysis, 
calculated by use of Applied Maths’ program ‘Gel-Compare’) resulted in 
sigtllficantly similar clustering of the investigated strains. The both of the 
performed fingerprints result in a similar way of clustering. At 70% 
homology level about six clusters of a similar content were formed in each 
of them. In both clustering procedures the 0 2  and the 011 strains were 
similarly distinguished, displaying a high homology level (about 80% for 0 2  
and 90% for 0 1  1). The two out of three 01-strains, i.e. PrK 1/57 and PrK 
2/57 as well the PrK 35/57 (019) were gathered together in both the tests. 
The 04-specific cluster was distinguished in BOXAIR test at 70% 
homology level including all representative strains (PrK 9/57, PrK 10/57 
and PrK 11/57), while (GACA)4-based test was less sensitive (less then 50% 
interstrain homology in that cluster). Also some P. uulgaric strains 
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representing different serotypes as 031, 032, 045, 0 4 7  and 0 3 9  were 
forming the same clusters in both of the above tests. The typing of P. vulgaris 
strains fingerprints ehbi ted  some similarity of clustering with the strain 
antigenic properties for most of serotypes represented by more than one strain, 
i.e. 01, 02 ,  0 4  011 and (only in BOXAlR test) 019. As it was observed 
previomly in the case of P.  mirubilis reference collection (10th ECCMID, 
Clinical Microbiofogy and In j i ion  6, suppl.1, 2000, p. 44, MoP135). 
Conclusion: The presented correlation suggests the possibllity of such a 
PCR-based differentiation of P. vulgaris strains that allows referring the 
clustenng results to the appropriate strain serotype. 
10361 Real-time PCR for detection of Helicobacter py/ori 235 
rRNA gene mutations associated with clarithromycin resistance 
V. Avesani, M. Delmee, P. Deprez,. J.-L. Vaerman, Y. Glupczynski 
Brussels, B 
Aim: To develop and evaluate a real-time PCR assay for the rapid detection 
of macrolide-resistance associated mutations in H. pylon (Hp) isolates. 
Methods: A fluorogenic PCR assay (SYBR Green 1) was developed to 
analyze strain sequence in the 23s rDNA gene. Four pairs of primers were 
designed one for the susceptible gene and one for each of the three known 
mutations (A2142G. A2142C, and A2143G) associated with clarithromydn 
resistance. Strain DNA samples were tested for amplification with each of these 
primer sets in parallel in four separate PCR tubes. Each PCR reaction was 
pedormed starting &om the same amount of template DNA. After 40 PCR 
cycles, the cycle threshold values (CT) were determined. Selected clinical Hp 
s h a i n s  isolated h m  73 patients were tested. Results were compared with those 
obtained by DNA sequencing, PCR-Lipa and detennination of MIC values by 
E-test (darithromycin susceptibility breakpoint = 1 pg/mL). 
Results: Four strains (one susceptible and three displaying each of the three 
described mutations as confirmed by sequencing and PCR-reverse 
hybridization line probe assay) were used to set up the method. Each test 
was repeated 4 times. The CT ranged &om 16 to 21 for primers tested for 
corresponding sequences, 26-40 for primers against non specific ones and 
36-40 for blank.. For each strain, the difference of CT for specific and non 
specific reactions was in the range of 7-17. A value of 7 was chosen as the 
minimum decrease in CT value indicating a positive result. Nineteen 
susceptible strains were correctly identified: CT  range of 17-19 with S 
primers and of 25-35 for the 3 resistance primers. 30 out of 31 strains 
displaying a single (homozygote) mutation (18 A2142G, 13 A2143G) were 
correctly identified as well. In 19 out of 23 isolates presenting multiple 
resistance mutations or heterozygote patterns (wild type susceptible 
sequence + one of the resistant mutation), real time PCR detected correctly 
the two genes. In the remaining four, it detected only one resistant gene. 
Conclusion: Real time PCR is a rapid method (less than two hours) which 
we show here to be accurate for detection of clarithromycin resistance in 
HP isolates. Further studies are needed to assess the value of this assay for 
detection of H. pylon 23s mutations associated with clarithromycin 
resistance directly tiom gastric biopsy specimens. 
10371 Nuclisens basic kit NASBA with ‘real time‘ detection for 
accelerated laboratory diagnosis of enterovirus infections 
J. D. Fox, S .  Han, P. Sillekens, M. van de Wiel-van de Meer, H. Foolen 
Cardiff, VK; Boxtel, NL 
Objective: The aim of this study was to develop molecular diagnosuc assays 
for the detection of enteroviruses in a variety of clinical specimens using 
nucleic acid sequence based amplification (NASBA). 
HIV/AIDS 
Method% Primers and probes were derived fiom the 5’ noncoding region of 
the enterovirus genome (pan-enterovirus assay) and the P3-C region 
(poliovirus specific assay). For nucleic acid extraction and subsequent FWA 
amplification and detection, reagents fiom the NucliSens Basic Kit were 
used. Reference picomavirus strains and clinical samples were analyzed. 
Results: Initially, the assays utilised degenerate primers and ‘end-point’ 
detection of amplified products by electrochemiluminescence. The 
sensitivity of the pan-enterovirus assay, determined on cultures of a range 
of enteroviruses, was about 1 TCID50. The specificity of the assay was 
loo%, as determined by examination of reference strains including 
genetically closely related rhinoviruses. Prospectively analyzed clinical 
samples revealed concordant results for NASBA and ‘in-house’ RT-PCR. 
The pan-enterovirus assay format was made more user-friendly by 
incorporating a molecular beacon for ‘real time’ detection and an internal 
control RNA to monitor isolation, amplification and detection. None of 
these changes had a major impact on the sensitivity and specificity of the 
assay. The assay based on the poliovirus P3-C region picked up all 
poliovirus strains tested with a detection limit of approximately 0.01 
TCID50. The assay did not pick up nonpoliovirus picomaviruses. 
Conclusions: The pan-enterovirus NASBA, in NucliSens Basic Kit format, 
is a clinically useful assay applicable to a wide range of clinical specimens. 
Use ofan internal control RNA and ‘real time’ detection enlarges the utility 
of the assay in a routine diagnostic setting. A poliovirus specific NASBA can 
be utilised on positive samples as a simple method for differentiation of 
polioviruses &om other enteroviruses. 
10381 Development and evaluation of nuclisens basic kit 
NASBA for diagnosis of viral respiratory tract infections 
J. D. Westmoreland, A. Fox, M. L. Rahman, D. Neale 
Curd@ UK 
Introduction and aim: Molecular assays provide advantages over culture and 
antigen detection methods for dagnosis ofRNA respiratory tract infections, 
particularly where acellular samples are taken for surveillance or where a 
sensitive, rapid diagnosis will greatly assist patient management. The aim of 
this study was to develop and evaluate nucleic acid sequence based 
amplification (NASBA) for diagnostic detection of respiratory syncytial virus 
(RSV) and influenza viruses in clinical samples. 
Methods: Respiratory samples tested by ‘conventional‘ procedures, together 
with cultured material and in vitro synthesized RNAs, were used for 
development and evaluation of the new molecular-based amplification 
methods. A series of primers and probes were designed within the RSV 
fusion protein and influenza A and B nucleoproteins for this study. For 
nucleic acid extraction and subsequent RNA amplification and detection, 
reagents from the NucliSens Basic Kit were used. Analysis of amplified 
products utilised either electrochemiluminescence (end-point detection) or 
molecular beacons (‘real-time’ detection). RT-PCR was undertaken for 
cloning, in vifro production of synthetic RNA and for comparison with 
NASBA protocols. 
Results: The feasibility of using rapid molecular-based assays for detection of 
viral genomic RNA in respiratory samples was demonstrated. NASBA was 
at least as sensitive as RT-PCR for detection of RSVA, RSVB, influenza A 
and intluenza B sequences. The use of the ‘kit-based’ format provided a 
cost-effective and convenient method for molecular diagnosis of these 
respiratory infections. 
Conclusion: We have shown the feasibility of using NASBA for diagnosis of 
respiratory tract infections. Rapid, molecular-based assays d make an 
impact on diagnosis of such infections over the next few years. 
~. 
AIDS. The human CD4+ T cell line CEM can be-infected by HSV-1. 
Upon HSV-1 infection, virtually all cells (CEMHSV) expressed the latency 
associated transcripts, while only a fiaction was productively infected. 
Treatment of CEMHSV cells with acyclovir (ACV) resulted in inhibition of 
A. C. Calistri, L. Parolin, C. Benetti, G.  Salata, I .  Palli 
Paduu, I 
Herpes simplex viruses (HSV) cause severe clinical manifestations in HIV-1 
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infectious HSV-1 production but &d not eradicate the state of HSV 
persistence. We used CEMHSV as an in uifro model to study molecular 
interactions occurring between HIV-1 and HSV-1, including LTR 
transactivation, apoptosis and pseudotyping, that might be relevant to the 
pathogenesis of AIDS. Superinfection of CEMHSV with HIV-1 led to a 
double chronic infection of these cells (CEMHIV/HSV) with a delay in 
HIV-1 replication; we demonstrated that this delay is due to HSV-induced 
apoptosis. The apoptosis effect was overcome by treatment with ACV, and 
CEMHSV treated with ACV supported HIV-1 replication as did normal 
CEM cells. In addition, CEMHIVIHSV cells produced HIV-1 pseudo- 
typed by HSV-1 envelope, which was able to infect CD4 negative cells. 
Vero, Cf2-Th and 293T cell lines were productively infected by 
pseudotyped HIV-I, even at very low multiplicity of infection. This 
infection was sensitive to HSV-1 neutralizing antibodies and to AZT 
treatment. With the help of HIV-1 env and gag mutants we are 
characterizing the retroviral sequences relevant to the pseudotyping 
phenomenon. Our data seem to indicate that the eiiv gene is partially 
dispensable. In conclusion, we present a cellular model which supports 
evidence for a direct HIV-l/HSV-l interaction in CD4+ T lymphocytes. A 
chronic carrier state of the two viruses in lymphocytes and HIV-1 
pseudotyping are two phenomena that may be relevant to AIDS 
pathogenesis and could explain hgh viral load in the absence of circulating 
CD4+ cells in late stage disease. Ths phenomenon could be further 
investigated at the molecular level to ascertain the alleged role of HSV-1 as a 
cofactor in promoting HIV-1 infection in uivo. 
Disseminated M. avium infection in the Swiss HIV cohort 
study: declining incidence, improved survival and interruption of 
maintenance therapy 
M. Rossi, M. Flepp, V. Schiffer, A. Telenti, N. EglotT, H. Bucher, P. 
Vemazza, E. Bernasconi, M. Rickenbach, H. Furrer and the Swiss H.I.V. 
Cohort Study 
Beme, Zurich, Geneva, Lausanne, Barel, St. Gallen, Lugano, CH 
Objective: To study the influence of the avadable potent antiretroviral 
combination therapy (ART) on incidence and m o d t y  of disseminated M .  
avium infection in the Swiss HIV Cohort Study (SHCS). To study the safety 
of discontinuing maintenance therapy against M. auium in patient on ART. 
Design: Setting: A national multicentre cohort study with seven centres. 
Methods: Patients with a nadir CD4 count below 50 cells per microlitte 
were considered at risk for disseminated M .  aoium dection and contributed 
to total follow-up time for calculating the incidence. Survival analysis was 
performed by using Kaplan Meier and Cox proportional hazards methods. 
Safety of discontinuation of maintenance therapy was evaluated by chart review. 
Results: From 1990 to 1999 398 patients were diagnosed with disseminated 
M. auium infection. Total follow-up time of patients at risk was 11101 
person-years. In the time period of available ART incidence of disseminated 
M .  auium infection was sigtllficantly reduced (1.3 vs. 4.3 events per 100 
person-years, P < 0,001). Being diagnosed with disseminated M. auium 
infection after 1995 was the most powerful predictor of better survival 
(adjusted hazard ratio for death. 0.27; 95% confidence interval 0.18-0.39; P 
< 0.001). None of 24 patients discontinuing maintenance therapy while on 
ART experienced recurrence of disseminated M. auium infection during a 
total follow-up of 52 person-years. The incidence shows an upper 95% 
confidence limit of 5.7 per 100 person-years. 
Conclusion: Introducing ART has markedly reduced the risk of 
disseminated MAC infection for HIV-infected individuals with a history 
of very low CD4 counts. Survival after diagnosis of disseminated MAC 
infection has improved after antiretroviral combination therapy became 
available. In patients surviving MAC disease and responding to ART 
discontinuation of maintenance therapy against M .  avium may be safe. 
10411 Treatment of tuberculosis among HIV-infected patients 
in the era of highly active antiretroviral therapy: clinical 
experience with rifabutin 
M Santin, M. J Barberi, F Alcade, D. Podzamczer, G Rufi 
Barcelona, E 
Background: Treatment of TB among HIV-Infected pahents can be dfficult 
because of interactions of nfamycins wrh protease inhibitors (PIS) and non- 
nucleoside analogues (NNAs) Based on pharmacolunetic data, regmens 
that include RFB instead of rifampin were previously recommended as the 
preferable alternative in these circumstances. However, little is known about 
the results in clinical practice. 
Methods: Retrospective study of the 51 cases of TB between September-96 
and December-99 in a university t eachq  hospital, with predominant 
intravenous drug abusers (IVDA). 
Results: Mean age of patients was 36 year, male 76%. IVDA 73%, mean 
CD4 count 110 cells/mL (5-395). 63% had dmeminated disease. Thirty 
patients (59%) completed a full course of treatment and 10 (20%) were lost 
to follow-up before the completion of treatment. Drug regimens were: a 
rifamycin and isoniazid for 6-12 months, supplemented by pyrazinami- 
de ethambutol for the first 2 months in 21 cases (70%), and 9 (30%) other 
regimens. Nineteen patients (39%4 were given RFB (150 */day) with PIS 
(11 IDV, 7 NFV and 1 both). Except for 2 patients with no adherence to 
antiretroviral therapy, patients treated with RFB and follow-up data 
achieved HIV-RNA levels < 500 copies/mL (b-DNA). Overall, after 21.5 
patient-years of observation, there was 1 relapse (4.6 per 100 patient-years), 
none among those treated with RFB. RFB was discontinued in 1 patient 
because of allergy. 
Conclusions: Our results suggest that RFB-containing regimens are 
effective and safe for the treatment of TB in HIV-infected patients taking 
PIS. Short-term response of the virological markers seems to be good. 
However, prospective studies are needed to evaluate long-term evolution of 
HIV disease in patients taking RFB concomitantly with PIS or "As. 
Fl Efficacy of highly active antiretroviral therapy (HAART) 
and prevalance of cornorbid conditions in older male veterans 
M. Seenivasan, S. Hegde, L. Lunvick 
New York, USA 
Background The number of HW infected persons over 55 years is 
increasing despite mitllmal data on the efficacy of HAART in this 
population. 
Objective: To study the viral suppression and immune reconstitution associated 
with HAART in male veterans age > 55 and assess cornorbid conditions. 
Methods: A retrospective review of clinic chaas of the VA NY Harbor 
Health care system was performed for patients recieving HAART at the 
time of review and for > 24 months. 95 HIV infected patients > 55(group 
0) at the time of study (range 55-79, median 62) were identitied fitting the 
criteria. 18 (19%) were > 70 years, and 35 (37%)6069 years. Change in 
HIV viral load (VL.) and CD4 cell count were reviewed for the first two 
year of HAART and compared with 83 patients < 45-year-old (group Y) 
(range 32-45, median 44). Group differences in proportion were analysed 
using Fischer's exact test for 2 x 2 tables and with Chi-square test for 2 x 3 
tables. Differences in median scores were tested using the Wilcoxon test. 
Results: The groups were comparable with respect to available basehe VL 
(Group 0 n=48, median 36 550 copies; group Y n=38 median 53 702, P- 
value=0.137) and baseline CD4 (0 median 200,Y median=148, P- 
value=0.121). In the O group 48/95 (51%) were treatment naive prior to 
HAART vs. 55/83 (66%), P-value = 0.048. VL resposes at 24 months were 
divided into three groups: full (sustained undetectable VL), pamal (achieved 
undectable VL with subsequent rebound) and nonresponder (persistently 
detectable VL). The change in CD4 at 1 & 2 years were compared. See Table 1 : 
Ulder Y ounger I pvalue I 
The difference in viral suppression between the groups were not statistically 
significant. The CD4 replehon at 1 PC 2 years was siwcantly lower, 
however, in older when compared to the younger group. Older patients 
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had significantly higher prevalences of hypertension (P < 0.001), cancer 
(P=0.016), and cardiovascular disease (P=0.002) but not diabetes 
(P~0.246).  hepatitis C (P= 0.233), Central nervous system problems 
(P=0.124) and COPD (P=O.124). 
Conclusion: Although immune reconstitution seems to decrease with 
increasing age,HAART remaim lughly e5cacious in the elderly in 
producing viral suppression. An aggressive approach is warranted in treating 
the elderly HN-infected with HAART. A n  association of an excess of 
comorbidity calls for a careful selection of antivirals and a multidisciplutvy 
approach in treatment. 
10431 3-year durability of response with an Efavirenz (EFV)- 
containing regimen: 144 week follow-up of study 006 
J. Arribas, S. Staszewski, M. Nelson, C. Barros Aguado, R. Rubio Garcia, 
D. Podzamczer, D. Farina, N. M. Ruiz, S. Villano, D. J. Manion 
Madrid, E; Frankfurt, D; London, UK; Barcelona, E; Wilmington, USA 
Methods: DPC Study 006 (N=1266) is a multicentre, open label, 
randomized trial comparing EFV + ZDV + 3TC, indinavir (IDV) + 
ZDV + 3TC and EFV + IDV in PI-, NNRTI- and 3TC-nave HIV + 
subjects with baseline (BL) viral load (VL) > = 10 000 copies/mL (cpm), 
CD4 > = 50 cells/mm3. The Initial Cohort (N= 450) was enrolled by 9/97 
and the Extended Cohort (N=1266) by 9/98. Response rates were 
determined by observed (on treatment, OBS) and intent-to-treat: 
noncompleter equals to failure (1TT:NC = F) analyses (N= 450). Kaplan- 
Meier estimates were performed on the time to treatment failure (TTF), 
durability of response (DOR) and durability of virological response 
@OVR)(N= 1266). 
Results: Male: 3%; Caucasian: 60%, BL VL: 4.78 log10 cpm; C D 4  341 
cells/mm3. The responder rates at week 144 (N= 450) are listed in the table. 
Similar results were seen in the subset of patients with baseline VL > 100 
000 cpm. S i r  increases in CD4 count were noted for all regimens. For 
the EFV + ZDV + 3TC arm, 9% discontinued study for adverse events 
and 8% were virological failures through 144 weeks. Between weeks 72 and 
144 in the EFV + ZDV + 3TC arm, there was no increase in virological 
failures, 2% of patients discontinued for adverse events and 10% 
discontinued for reasons other than safety or virological failure. Based on 
the Extended Cohort (N= 1266), EFV + ZDV + 3TC was superior to IDV 
+ ZDV + 3TC by TTF, DOR and DOVR (P=O.OOOl, 0.0001 and 
0.0005, respectively). 
RePoderRRatesatWeek144(N=450) 
FFV+7DV+3TC EFV+IDV lDVtZDV +3T 
k 1 5 4  N=148 N=148 
OBS 4 O c p m  97% 89% 95% 
6 0  cpm 91 x 91% 86% 
ITT:NC=F 4 0 0  cpm 55% 34% 34% 
6 0 c p m  *52% 35% 30 % 
* E0.05 EFV+ZDV+STC over IDV+ZDV+3TC 
Conclusion: EFV + ZDV + 3TC continues to provide greater and more 
durable viral suppression than IDV + ZDV + 3TC through 3 years of 
follow-up. 
10441 Successful substitution of protease inhibitors with 
efavirenr in patients with undetectable plasma HIV-1 RNA 
levels-48-week results of a prospective, randomized 
multicentre, open-label study (DMP 266-027) 
C. Katlama, S. Staszewski, N. Clumeck, K. Arasteh, P. Dellamonica, J. M. 
Molina, J. L. Vilde, J. Maa, N. M. Ruiz, S. Villano 
Paris, F; Frankfurt, D; Bwssels, B; Berlin, D; Nice, F; Wilrnington, USA 
Background: Simple, potent antiretrod (ARV) regimens that enhance 
adherence and are well tolerated are needed. Substitution of complicated ARV 
regimens with efivirenz (EFV)-based therapy may provide these benefits. 
Methods: Randormzed, mdhcentre, open-label study. Pauents receiving a 
regunen contammg PI(s) + NRTIs wth plasma HIV-1 RNA levels < 50 
copies/mL were enrolled Pahents were randomed to subshtute the PI(s) 
ulth EFV 600 mg QD or to conhnue wth  the exlshng PI regnnen (NRTIs 
were -tuned) Enrolment to a thtrd arm @,Fv + PI[s]) was dtscontmued 
because of poor acceptance by patlents and providers Vmologml fulure was 
defined as a confumed plasma HIV-1 RNA level > 50 copies/mL 
Resulk 165 pahents were randormzed (mean age 40 years, 89% male, mean 
durahon of PI treatment 23 months [range 2-58 months], mean basehe 
CD4 count 514 cells/mm3) Outcome at Week 48 for EFV subsatuhon and 
PI connnuauon groups are hsted III the table 
Outcome atWeck48forEFVsubstltutlon andPI contllluadcm groups was as follows 
RFVtNBTI. PI+N'RTI. 
-9) P 6 5 )  
Met mtcnafor viro1ogre fdwe 2 (2 9?h) 6 (9 FA) 
Vmd suomesaon mamtsuncd* 
N&F # 67/69 47/65 
(97 1%) (72 3 Yo) 
67/68 47f51 
(98 5?*) (92 2%) 
Mean chaoge (cells/mm3) m CD4 c o a t  6 0  +7 1 
Discmtinuedfran s t u d y  # 2 ( 2  %) 14 (21 5%) 
Wtthcinnt ccmsent 0 4 
Adverse cxpencnoe 0 5 
other 2 5 
XFIlsmaIW-1 R N A l A s  4 0  copiesFmL 
# Statlspcdly simficant between ~~roup6 @-value CO 05) 
Conclusions: EFV substitution of a PI, in a suppressive PI-containing 
regimen, successfdly maintains full ARV control (plasma HIV-1 RNA 
levels < SO copies/mL) and contmued increases m CD4 counts. 
10451 Relationship between carotid intima media thickness, 
hyperlipidaemia and lipodystrophy in HN-infected patients 
A. Vaidie, Y. Douadi, B. Vidal, A. C. Gauvin, J. M. Race, F. X. Lescure, A. 
Smail, J. L. Schmit 
Amiens, F 
Background As HIV infected patients are likely to develop accelerated 
atherosclerosis in relation to metabolic risk factors induced by antiretroviral 
drugs, physicians need to evaluate the risk of vascular disease for their 
patients. Carotid intima media thickness (CIMT) measurement may be a 
useful tool in this context. 
Methods: global assessment of risk factors for vascular disease was performed 
in 50 unselected patients, i.e. past of personal or family history of 
cardiovascular events, smolung habits, blood pressure, abdominal circum- 
ference, total cholesterol (TC) HDL, LDL cholesterol, &ting and post 
charge glycaemia. High resolution B ultrasound cervical imaging with 
CIMT measure was performed; lipo&trophy was recorded. Univariate and 
multivariate analysis of these Werents parameters was performed. 
Results: 37 men and 13 women were included, mean age 42 years (23-66), 
mean CD4507f 311/mm3, mean viral load 2.62 1.13 log/mL (50% < 
1.7). Patients groups of treatment: 2 naive, 18 under protease inhibitors PI), 
30 under mtherapies without PI (13 PI naive and 17 PI experienced). 
Twenty-three patients had lipodystrophy. Dyslipidemia was present in 64% 
of the patients: 54% hypercholesterolemia > 5.2 mmol/L, 40% 
hypertriglyceridemia > 1.95 mmol/L), abnormal glucose metabolism in 
36%. Mean CIMT was 0.55 0 3 mm, 16% of the patients had abnormal 
elevated values according to age and sex. There was a statistical association 
between PI treatment, lipids abnormalities and lipodystrophy. Lipodystro- 
phy was associated with PI duration of treatment and hypercholesterolemia. 
Increased CIMT was linked with lipodystrophy (univariate analysis) and to 
abdominal circumference (multivariate analysis). 
Conclusion: CIMT measurement may be proposed in a routine basis to 
assess the vascular risk of HIV infected patients, especially when 
lipodystrophy develops. 
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Lyme borreliosis 
(0471 Diagnosis of Lyme arthritis by PCR and serology 
0. Pkter, M.-C. Mottiez, A,-F. Rodriguez 
S o n ,  CH 
Aim: Evaluation of the usefulness of serology and PCR in the diagnosis of 
Lyme arthritis. 
Methods: Screening serological tests were performed with an enzyme- 
linked fluorescent assay (ELFA) VIDAS Lyme @3ioM&ieux). ELFA positive 
results were confirmed by home-made immunoblots for IgG to 4 Borrelia 
species: B. burgdorferi sensu stticto (ss), B.  afielii, B. garinii and B. valaisiana. 
PCR was performed with primers drected to the OspA gene of B. 
burgdorferi sensu lato. Positive samples were confirmed by hybridization in a 
ELISA format assay and amplicons were typed at the species level using 
single-strand conformation polymorphism. 
Results: Synovial fluids from 91 patients were submitted to PCR for Lyme 
borreliosis (LB) and serology was done on serum samples or synovial fluids 
fiom the same patients. Results are summarized in the Table. Out of 21 
probable Lyme arthritis, 15 (71%) were detected by PCR and 16 (76%) 
were detected by serology. Concordance between the two tests was only 
50% (n = 10). Among these, 7 PCR amplicons were typed, 4 were B.  a/zelii, 
2 B. burgdo@ ss and 1 was a mixture of B.  azelii-B. burgdorferi ss. Only one 
discrepant result with serological typing was observed. However, the 6 
cases** with highly positive serology and negative PCR were typed as B .  
burgdo@ ss in 5 cases and in one B.  afzelii by serology. Among the 5 
positive PCR cases with a negative serology, weak amplifications were 
observed and so far we have been able to type only two of them, one as B. 
afielii and one as B. garinii. 
Conclusions: PCR for LB in synovial fluids was unsuccessful for the 
majority of B.  burgdotfn ss infections, although this Borrelia species is 
correctly amplified when using cultured isolates (n=55). A possible 
explanation would be a stronger attachment of this Borrelia species to 
synovial tissues, resulting in fewer Borrelia in the liquid. T h  observation 
suggests that for PCR, a synovial biopsy may represent a better sample for B.  
burgdotfen' ss, as already reported by other authors. Nevertheless, the 
coupling of PCR with serology seems necessary for a correct diagnosis of 
Lyme arthritis. 
jo48/ Seroprevalence of the asymptomatic infection with 
Borrelia burgdoderi in forestry workers in Romania 
A. Hristea, S. Hristescu, C. Ciufecu, A. Vasile 
Bucharest, RO 
In order to assess the seroprevalence of the asymptomatic dection with 
Bonelia burgdoferi and to find out the factors that d u e n c e  it, we conducted 
in 1999 a cross-sectional, observational study. We have studied 2666 serums 
coming from 1048 forestry workers from 7 districts of Romania, 40 sites for 
lot no. 1 and 1598 serums coming from healthy blood donors from 13 
dxtricts, 22 sites for lot no. 2. We used a two-step testing strategy All the 
serums were tested for IgG anti Bonelia burgdorferi by a commercially 
available passive hemagglutination assays (PHA) Lymag Diagast, and the 373 
serums with positive results were tested for syphilis antibodies (TPHA 
Syphagen) in order to exclude the cross reactions. We excluded fiom the 
next step, a IgG Western blot testing (Gull Laboratories, using a Bonelia 
gan'nii isolate) 15 serums positive for syphdis and 24 serums which did not 
fulfill the quality conditions. Ofthe 334 serums tested by Western blot, 168 
tested positive, 99 in the lot no. 1 and 69 in the lot no. 2. Anamnestic data 
on age, gender, profession, work placelresidence, duration of employment 
(for the forestry workers), animal presence in the environment of the 
subjects and tick bites history were collected fiom a questionnaire. The data 
obtained from serological study were matched with those obtained from the 
questionnaire. The seroprevalence of the asymptomatic infection with 
Borrelia burgdo@ in the forestry workers group was of 9.3% (varying 
between 32% and 2.8%) and in the donors group was of 4.3% (varying 
between 8.7% and 1.4%). The seroprevalence was higher in the forestry 
workers group for the population with tick bites history (10.7% vs. 4.3% P 
< 0.05). As for the blood donors, the seroprevalence was higher for the 
population that had animals in their environment (15.9% vs. 2.9% P < 
0.05). We did not note a statistically sigdcant difference in seroprevalence 
according to age, sex and duration of employment. The highest 
seroprevalence (32%) was registered in a district in the Western part of 
the country (Arad), where a previous study of entomology showed the 
highest density of I. ricinus ticks. To our knowledge this is the first study on 
the seroprevalence of IgG anti Bonelia burgdo$i' in Romania. Further 
studles are necessary to find out the incidence and the prevalence of Lyme 
borreliosis, especially in the area we found the highest seroprevalence in 
forestry workers. 
10491 Comparison of strains isolated from patients reinfected 
with Borrelia burgdotferi sensu lato 
E. Ruzic-Sabljic, V. Maraspin, S .  Lotric-Furlan, J. Cimperman, F. Strle 
Ljubljana, SLO 
Objectives: Lyme borreliosis is the most common tick-transmitted disease in 
Europe. It  is caused by borrelial strains designated as Borrelia burgdo@ 5mu Into. 
Reinfections manifested clinically with erythema mi- (pathognomonic 
borrelial s k i n  lesion and the most frequent d e s t a t i o n  of Lyme borreliosis) 
have been reported previously but were rarely evaluated microbioligically. 
Herein we present analysis and comparison of the borrelial strains isolated from 
our patients who developed e+ema migrans two times. 
Methods: Skin biopsy specimens were inoculated into the MKF' medium 
and incubated at 33 "C. Analysis of isolated Boneliae (18 strains &om nine 
patients) was performed by SDS-PAGE for protein profiles, and PFGE for 
identification of species and plasmid profiles. 
Results: In seven patients Boneliae isolated fiom the initial and subsequent 
skin lesion were in accordance regarding to species: in all seven patients 
both strains were B. ufzelii. However, B. dzeli i  strain pairs Wered in 
plasmid profiles. In two patients with disacordant species findings B. a/zelii 
was isolated from the initial skin lesions and B. garinii from the subsequent 
erythema migrans. All nine strain pairs differed concerning protein profiles 
but in most cases these differences were not very pronounced. 
Conclusions: Comparison of the skin isolates from nine Slovenian patients 
who developed erythema m i g r a n s  two times revealed Herences between 
the isolates from the initial and subsequent skin lesion concerning borrelial 
species and/or plasmid profiles as well as protein profiles. None of the 
Borrelia pair isolates was completly identical. 
losol Modulation of cytokine release in ex vivo stimulated 
blood from borreliosis patients 
I. Diterich, L. Hker ,  D. Hassler, A. Wendel, T. Harmng 
Konsfanz, Kraichtal, I) 
It is still unclear how Bonelia buqdoji'  s.1. can persist in the host in the 
presence of an active immune system and generally lead to a chronic 
infection ifnot treated with antibiotics. A possible modulation of the host's 
immune response such as a shift or a suppression, represents an attractive 
hypothesis to explain the survival of the pathogen. In order to investigate 
direct interactions between the pathogen and the immune cells, blood from 
healthy controls was exposed in vitro to live or heat-killed Borrelia, or to 
Borrelia lysate. A common unique pattern of cytolune release was induced 
Compared to Herent  bacterial endotoxins, a reduced release of the pro- 
inilammatory cytokines TNF-alpha and IFN-gamma vs. an enhanced 
secretion of the anti-inflammatory mematon IL-10 and G-CSF was found, 
as measured by ELISA. To further characterize the influence of an ongoing 
BorreIia infection we compared the ex vivo cytokine release capacity ofblood 
from 71 patients suffering from late stage borreliosis to 24 healthy controls. 
In blood from borreliosis patients a significant reduction in the release of the 
pro-idammatory cytokines TNF-alpha and IFN-gamma (28 i 5% and to 
31 f 5% (p * O.OOl), respectively), in response to stimulation with 
endotoxin (LPS) was observed. In contrast the IL-10 production was not 
affected. White blood cell counts were normal in both groups. After 
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stimulation with Borrelia antigen TNF-alpha formation was also decreased to 
31 f 14% and IFN-gamma to 8 3% (p * 0.001) compared to the 
cytokine response of blood from healthy controls, indicating that also the 
specitic cytokine response to Borrelia was attenuated. We propose to 
consider anti-idammatory changes such as elevated endogenous formation 
of IL-10 of the blood cytokine response capacity elicited by Borrelia as a 
condition that rmght fivor invasion and persistence of the spirochete in the host. 
[I Colorimetric susceptibility testing of ABT 773-a novel 
ketolide-against 17 isolates of the Borrelia burgdorferi sensu 
lato complex 
K. P. Hunfeld, E. Kekoukh, T. A. Wichelhaus, P. Kraiczy, M. Molitor, V. 
Bra& 
Fmnkfirt, Bornheim-Herset, D 
Objective: To analyze the in vitro effectiveness of new ketolides against the 
Borrelia (B.) burgdoferi complex including species pathogenic for humans and 
other previously designated genospecies. 
Methods: In the present study a standardized colorimetric microdilution 
method was applied to investigate the minimal inhibitory concentrations 
(MICs) of the new ketolide ABT 773 against 17 isolates of the B.  Burgdotfen 
complex: B. burgdot@ senw strirro (N=5), B. garinii (N=5),  B. afi.!ii 
(N=5), B.  bissettii (N= 1). and B.  valaisiana (N= 1). MICs were read after 
72 h of incubation. Moreover, time-kill studies were performed by 
application of conventional cell counts in combination with dark-field 
microscopy and the minimal borreliacidel concentrations (MBCs) were 
determined by subculture experiments. 
Results: Colorimetric MIC determination was found to be in excellent 
agreement with the results of conventional cell counts. MICs of ABT 773 
uniformly ranged from <0.0019 pg/mL to 0.0019 pg/mL in all isolates 
tested (MIC 90: 0.0019 pg/mL). The MBC 90 as revealed by our 
subculture experiments was found to be 0.25 pg/mL. The MBC 90 
correlated very well with the results of our time-lull studies demonstrating 
that higher drug concentrations of 0.125-0.5 pg/mL are required to reach a - two to three log10 unit reduction of the final inoculum. 
Conclusions: Our study demonstrates excellent in vitro effectiveness of ABT 
773 awnst the members of the B.  burgdoferi complex and suggests a possible 
suitability of new ketolidesalone or in combination with well established 
antimicrobials-for the stage-dependent therapy of Lyme-disease. 
Herpes virus infections in solid organ transplant recipients 
josz] Selective cloning of Borrelia burgdorferi antigens by 
phage display technology 
M. Mueller, M. Weichel, R. Crameri, T. Hartung 
Konstanz, D ,  Davos, CH 
Borrelia burgdotfen senm lato are the causative agents of Lyme borreliosis, the 
most common tick-borne infectious cksease in Europe. For the diagnosis of 
Lyme borreliosis, serological tests with whole borrelia lysate as antigen are 
used. The serodiagnosis could be improved, when more antigens are known 
and recombinant available. Unlike in the USA, there are three strains of 
Bowlia burgdotferi sensu lato in Europe which are pathogenic to humans. 
Therefore, the B. burgdorferi vaccine, recently developed in the USA, is of 
limited value for use in Europe. 
We have identified antigenic proteins of B. burgdotferi which might 
quahfy for serodiagnosis as well as for vaccine development using phage 
display surface technology. This technique allows rapid isolation even 
of rare gene products from complex genomic or c-DNA libraries by 
affinity selection. 
Therefore, the genomic DNA of all three European B. burgdorferi sensu 
lato strains was digested and ligated in the phagemid vector pJuFoII. The 
gene products were displayed on the surface of the h e n t o u s  phage M13. 
Then the large libraries were screened and enriched for clones displaying 
gene products which bound to IgG of a serum pool fiom patients known to 
suffer fiom Lyme borreliosis. Analysis of the relevant inserts of the phage 
genome revealed three new DNA-sequences as well as two already known 
antigenic protein sequence involved in Lyme disease. After amplifymg the 
complete coding sequences by PCR, they were ligated into a statement 
vector (PQE30). Constructs were verified by sequence analysis and 
transformed into Escherichia coli (strain BL21) for the production of 
recombinant proteins. The ELlSA with &ity purified proteins showed 
significantly higher signals with patients’ sera than with sera from healthy 
controls. These data suggest, that the identified proteins represent antigenic 
structures involved in Lyme borreliosis, which represent candidates for 
vaccine development as well as for serodiagnosis. Furthermore the phage 
display technology represents a powerful instrument to identify new 
antigens of bacteria by using patient sera for affinity selection. 
15531 The pathological role of newly detected herpesviruses in 
transplant recipients 
A. Linde 
Solna, S 
Human herpesviruses 6 and 7 are ubiquitous beta-herpesviruses. They 
normally infect early in life, and CD4+ lymphocytes are regarded to be the 
main target cells for both. HHV-6 causes the majority of clinical exanthema 
subitum ( E S )  in childhood. The main complications of HHV-6 in immune- 
competent children are febrile seizures and encephalitis. Some cases of ES 
may be caused by HHV-7, otherwise very little of disease has been ascribed 
to this virus. HHV-6 is frequently reactivated after transplantation, and 
encephalitis marked by cognitive dysfunctions may be a major complication. 
Febnle illness with or without exanthema, and rare cases of pneumonia have 
also been described. In liver transplantation it may cause hepatitis, and graft 
failure and rejections in renal transplantation. Delayed engrahent and an 
increased risk of cytomegalovirus (CMV) disease after HHV-6 reactivation 
are hkely allogeneic stem cell transplantation. Laboratory verification of 
symptomatic HHV-6 or HHV-7 infections in the immune-compromised 
host is difficult. Serology is uncertain due to the immune-suppression and 
IgM to other herpes-viruses may cross-react with HHV-6. Virus isolation 
and genome-amplification from blood and other materials are both efficient 
for demonstration of virus, but presence is not equal to symptomatic 
infection. Quantification of genes may improve diagnostics, but other 
causes of disease in the immune-suppressed must be excluded before 
demonstration of HHV-6 or HHV-7 genes can be regarded as diagnostic for 
disease. Human herpesvirus-8 (HV-8) is a gamma-herpesvirus. In some 
parts of Africa around 50% are infected by HHV-8, but the seroprevalence 
is lower in other regions. The exact rate is not yet settled due to divergmg 
serology results, but it may be around 10% in most Western countries. 
HHV-8 is strongly related to Kaposis’ sarcoma ( K S ) .  Seroconversion to 
HHV-8 and development of KS after a l l  kinds transplantation has been 
reported, but whether it is due to transfer of the infection with the graft, 
on reactivation is not clear. Origin Afiica or the Middle East, and use 
of antithymocyte immune-globulin have been risk factors for KS. In 
Hungary, totally 8 per-mill of renal graft recipients were reported to 
acquired KS after transplantation. Remission of KS after reduced immune- 
suppression is common. Serological identification of transplant recipients 
at risk of KS, and monitoring by quantitative genome amplification is a 
future possibility. 
(5541 HHV-7 as a pathogen and cofactor for CMV disease 
following transplantation 
V. Emery 
London, UK 
Human herpesvirus type is the most recent addition to the betaherpesvirus 
m y .  Infection with HHV-7 is almost universal with primary infection 
being associated with febrile illnes in childhood. Following organ 
transplantation, HHV-7 can be detected by sensitive methods such as 
PCR. The pathological significance of HHV-7 detection has been 
investigated in many studies. HHV-7 has been associated with graft-vs.- 
host disease following bone marrow transplantation and in renal transplant 
recipients HHV-7 appears to predlspose patients to CMV disease. Recent 
data &om my laboratory has indlcated that this association may be due to 
HHV-7 increasing the frequency of acute rejection episodes which 
following managment with antirejection therapy exacerbate the patholo- 
gical consequences of CMV infection. The presentation will critically 
review the contribution of HHV-7 to the morbidity of patients following 
organ transplantation. 
15551 HHV8: from virus to disease 
P. Erb 
Basel, CH 
The human herpesvirus 8 (HHV8) or Kaposi’s sarcoma-associated 
herpesvlrus (KSHV) 1s a recently idennfied w u s  belongmg to the 
gamma-herpesvmes. The v m s  is present in all forms of Kaposi’s sarcoma, 
in p n m q  effusion lymphoma (PEL) and in the plasma cell type of 
mulhcentnc Castleman’s dlsease (MCD) Epidenuologcal data demonstrate 
that the seroprevalence for HHV8 parallels the nsk of developing Kaposis’s 
sarcoma Moreover, HHV8 infecuon preceeds the development of Kaposi’s 
sarcoma Immunosuppression is thought to be an miportant cofactor in the 
pathogenesis of HHVS-associated malignancies. Indeed, Kapois’s sarcoma, 
PEL and MCD occur more frequently in patients infected with HIV 
infection. Kaposi’s sarcoma, epithelial skm tumors and malignant lympho- 
mas are also significantly increased after solid organ transplantation. 
However, HHV8 DNA has been only detected in Kaposi’s sarcoma lesions 
but not in other tumors associated with solid organ transplantation. The 
precise route of transmission of HHV8 is not yet fuUy understood, although 
ample evidence exists that sexual transmission is common. Because Kaposi’s 
sarcoma is associated with HHVS infection and the incidence of Kaposi’s 
sarcoma is markedly increased after solid organ transplantation, it is possible 
that HHV8 is transmitted by the transplant &om HHV8-positive donors 
to HHV8-negative recipients. Alternatively, reactivation of HHV8 
infection in the recipient, facilitated by the immunosuppression, could lead 
to Kaposi’s sarcoma formation. Evidence is now available that both 
pathways, transmission by infected transplants or HHVS reactivation, lead to 
Kaposi’s sarcoma development in transplant recipients. In geographical 
region in which the virus is endemic reactivation seems to be more often 
the cause of Kaposi’s sarcoma formation than in nonendemic areas in 
which transmission by infected transplants is more common. The exact 
mechanism of tumor formation by HHVS is still unresolved, although 
genes associated with cell proliferation, transformation, angiogenesis and 
apoptosir prevention have been identilied in the virus genome. Recently, 
evidence has been provided that primary HHVS infection and HHV8 
reactivation are also associated with non-neoplastic complications in 
immunosuppressed patients. 
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Extended-spectnrrn beta-lactamase and carbapenernase: biology, detection and epidemiology-Joint symposium with ICAAC 
/s57\ Detection of ESBL and carbapenemase 
P. Hawkey 
Leeds, UK 
The last 10 years have seen a rapid expansion not only in the number of 
different molecular groups of ESBL but also the number of different 
mutations present in these genes. It is also apparent that the kequency of 
isolation of bacteria carrying these genes bas risen rapidly in China, for 
instance 40-50% of Klebsiellae are ESBL producers. More recently a new 
threat has appeared in the form of transmissible Class B zinc dependent 
carbapenemases (ZDC), of which two principal families exist, IMP and 
VIM. ESBL and ZDC can be difficult to detect because ofvariations both in 
the level of expression (differences in promoter strength and cassette order, 
respectively) and the influence of different mutations. Whdst it could be 
argued that provided a clinically relevant result is obtained by susceptibility 
testing, the presence of ESBL is irrelevant. This ignores the possibility of 
expression being up-regulated and the need for accurate epidemiological 
data. The TEM and SHV ESBL are normally inhibited by clavulanic acid, 
therefore current phenotypic tests rely on distortion of inhibition zones 
when clawlanate containing discs are placed close to cefotaxime or 
ceftazidime discs. The E-test ESBL is generally more sensitive but has a high 
unit cost. Combination discs such as Mast DD allow comparison of zone 
diameters and only involve the use of one or two extra discs in routine 
testing. Automated systems are now offering combination wells with 
clavulanic acid. A promising approach for detecting ZDC is that using a disc 
approximation test with one disc containing the chelating agent 2- 
mercaptoacetic acid resulting in a zone enlargement similar to the ESBL 
dlsc approximation test. Review of the molecular methods for detecting 
these genes is not possible in the time available but undoubtedly in the long 
term, microarray technology using immobilised oligonucleotide probes 
offers a powerful if expensive solution to identify a l l  the current and future 
ESBL‘ZDC genes. 
15591 Emerging carbapenemases in aerobic bacteria 
P. Nordmann, L. Poirel 
Paris, F 
Although a series of naturally occuring carbapenemases have been described 
in a variety of bacterial species (i.e. Bacillus weus, Chryseobaderium 
meningosepticum, C. indologenes, Sfenotrophomonas maltophilia, . . . ), acquired 
carbapenemases have been reported in Gram negative species. These 
enzymes have the broadest specaum of substrate profile among the p- 
lactamases. The carbapenemases of Ambler class B group, also known as 
metallo-enzymes, are the most frequently encountered in clinical micro- 
biology. IMP-1, first described in 1990 inJapan, has spread among different 
Gram-negative species in this country through plasmid and integron 
location of its gene. IMP-1 derivatives (IMP-2 and IMP-3) have been 
reported in ShigeNaflexnen‘ and Acimtobactm spp. The second group of class B 
carbapenemases includes VIM-1 and VIM-2 that share only 35% amino acid 
identity with IMP-1. They have been reported in P. aeruginosa and 
enterobacterial isolates in France, Greece, Italy, and Korea. VIM-1 and 
VIM-2 enzymes are mostly plasmid-encoded. Each of the class B 
carbapenemase genes are reported as class 1 integron-located, rarely as class 
3 integron-located. Some class D enzymes (also known as oxacihnases) 
possessing carbapenem-hydrolyzing activities have been described recently 
(OXA-23-and OM-27)  in Acinetobacter spp. In addition, a few clavulanic 
acid-inhibited class A p-lactamases possess a substrate profile extended to 
carbapenems. NMC-A, IMI-1, and SME-I/-2 enzymes have been isolated 
in Enterobacfer cloacae and Senatia marcescens. The activity of these enzymes 
does not include extended-spectrum cephalosporins except aztreonam and 
their genes are chromosomdy encoded. Finally, a variant of the class A 
extended-spectrum beta-lactamase GES-1 was recently found in P. 
aeruginosa that hydrolyzed imipenem. Since its gene is plasmid-and 
integron-located, GES-2 may represent an additional threat. IMP-1, 
VIM-1, VIM-2 and GES-2 p-lactamases in clinical isolates involved in 
Werent outbreaks underlines their potential of spread. As these p- 
lactamases were mostly found in P. aeruginosa that express a natural high 
level of resistance to p-lactams, their prevalence may limit the antibiotic 
efficiency dramatically. 
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Pmpionibacterium acne5 in human infections-Symposium organised by the EWPARAB 
15751 Identification of propionibacteria 
A. Rodloff 
Leipig, D 
The genus Propionibacteria consists of Gram-positive asporogenous 
obligately or facultatively anaerobic rods. Their DNA displays G + C 
contents of between 59 and 75%, which are similar to those of 
Bifidobacterium, Actinomyces, and Mobiluncus, However, their cell walls 
may contain meso-DAP, LL-DAP, or lysine in place of diaminopimelic 
acid. Microscopically, they appear as pleomorphic coryneform rods that 
may have metachromatic granules. As suggested by their name, Propioni- 
bacteria produce large quantities of propionate. They are nonmotile and 
ferment glucose, while nitrate and catalase formation as well as fermentation 
of other carbohydrates are species dependent. The phenotypic identification 
of Propionibacterium spp. is still problematic and alternative methods 
have been investigated lately, i.e., a technique based on the amphfication 
of 16s rRNA genes using PCR and subsequent restriction endonuclease 
digestion has been described. Alternatively, RAPD-PCR and restriction 
endonuclease digestion has been employed successfdly. Finally, results 
of a preliminary study employing matrix assisted laser desorptionl 
ionization-time of flight mass spectrometry for identification purposes will 
be reported. 
(5781 Antibiotic resistance and clinical significance of the two- 
faced PropionibacieriUm acnes 
E. Nagy 
Szeged, H 
Propionibucterium spp. are well-known consituents of the normal flora at 
different body sites, with a predominance of some species on the skin, or in 
the mouth, gut and vagina. They are usually regarded as strict anaerobic 
bacteria, as anaerobiosis is required to isolate them &om biological materials, 
despite the fact that they possess one or more oxygen-detoxidfying enzymes. 
Their role, and especially the role of P. Q M ~ S  in various infectious processes, 
other than acne, was long neglected, compared to the pathogenic role of 
other anaerobic bacteria. Ths is probably the reason why very few data are 
available on their resistance, except for isolates obtained from acne patients. 
In this review, the pathogenic role of P. acnes in various infections (e.g. oral 
diseases, infections of the eye, includmg endophtalmitis, systemic infections 
of immune-compromised patients, and arthritis) is discussed. Isolates 
obtained from normal flora and &om different sources other than normal 
flora have been screened for resistance to beta-lactam, macrolides, temcych, 
dindamycin and metronidazole. Differences in resistance to Merent antibiotics 
were observed accordmg to the origin of the strains. However, it has been 
shown that Proplaibacten'um spp. are resistant to metronidazole, it has only 
recently been proved that several isolates may hahour the nimA gene. The 
systemic, longterm usage of antibiotics has an important impact on the 
resistance of normal floral bacteria, including propionibacteria. On the other 
hand, resistance genes gained by these bacteria may serve as a reservoir for 
other anaerobic bacteria living at the same site. 
Experimental infection: advances in understanding microbial pathogenesis and diseaeSymporium organised by the ENSEI 
15831 Experimental meningitis: searching strategies to prevent 
brain damage 
S. L. Leib 
h, CH 
Bacterial meningitis is associated with persisting neurological sequelae in 
approximately one third of the surviving patients. An experimental model of 
bacterial meningitis in infant rats has been developed to investigate the 
pathophysiologic mechanisms leadmg to neuronal injury as a consequence 
of the disease. Eleven days old Sprague Dawley rats are infected by direct 
intracistemal inoculation of a suspension of Streptococcus agalactiae or 
Streptococcus pneumoniae. The clinical, hstopathological and long-term 
neuropsychological consequences of the disease model are closely reflect 
by bacterial meningitis in humans. Cortical neuronal injury is characterized 
by areas of neuronal loss in a pattern suggestive of underlying vascular 
injury, while neuronal damage in the hippocampus shows apoptotic 
neuronal death in the dentate gyms. Studies in the model system have 
idenatied some of the pathophysiologic mechanisms and mediators leading 
to brain injury. Cerebral ischemia has been documented to be instrumental 
in cortical injury while the exact roles of cytokines, reactive oxygen species, 
and matrix metalloproteinases need to be further clarified. However, 
pathophysiological concepts derived &om this model revealed promising 
targets for pharmacological intervention to prevent brain damage and led to 
the evaluation of new therapeutic modalities such as antagonists of 
endothelins, anticytokine agents, antioxidants and matrix metalloproteinase 
inhibitors. Current research in the model evaluates, whether the 
neuroprotective agents identified so far have the potential to attenuate 
learning disabilties as a long-term consequence of bacterial meningitis. 
js841 A new model of pneumococcal pneumonia 
P. Chavanet 
Dzjon, F 
Pneumococcal pneumonia remains a wolrdwild health public problem due 
to its frequency, morbi-mortality and the increasing prevalence of antibiotic 
resistance. Thus, there is a need to explore further the pathophysiology and 
the relation between bacterio-clinical response and antibiotic treatment. 
However, clinical trials are difiicult to do for infections due to these resistant 
pneumococci. So, we developed a new model of pneumococcal pneumonia 
due to resistant strains in immunocompetent rabbits. Also, we simulate the 
human pharmacolunetics of tested antibiotic. The pathological findings 
(macroscopic and microscopic examination) as the pulmonar permeability 
were not Herent the strains were resistant or not to penicillin, macrolides 
or fluoroquinolones. The evolution of the experimental pneumonia was the 
same that observed in humans. The simulation of human antibiotic PK 
often fit a open two compartment model; the results show that human-like 
treatment is possible for beta-lactam, macrolide (erythromycin), ketolide 
and new fluoroquinolones. We observed that antibiotic PK seem different 
in infected anim&.With these treatment, we observed that the in vitro 
break-point (MIC) can be, in few cases, poorly conmbutive; however, we 
were able to precise in uiuo breakpoints; for example, human-like treatment 
amoxicillin 1 g x 3/d is very active even vs. pneumonia due to strain with 
MIC = 4 mg/L; on the opposite, we obsewed that a new fluoroquinolone 
was not active on pneumonia due to strain with MIC at the upper limit 
breakpoint; in this latter case 1/100 of the residual bacteria were mutants. 
Thus, this new model can be contributive to explore both the pulmonar 
pathophysiology of resistant pneumococci strains and the power and limits 
of antibiotic treatments. 
15851 A new human-like model of tuberculosis 
P.-J. Cardona 
Badalona, E 
The experimental murine model of tuberculosis is the most used to study 
this disease. Interestingly, the histopathology in t h ~ s  animal has at least one 
paramount difference compared with observed in humans: the lack of 
intragranulomatous necrosis. This fact reflects important implications in the 
nature of the immunological response in mice against Mpbactm'rrm 
tuberculosis making it more 'tolerant' and thus, triggering a low inflammatory 
response and a low degree of delayed hypersensitivity. This weak response 
causes a continuous spreading of new granulomas in the pulmonary 
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parenchyma, instead of isolating the initial ones, that always ends in the 
death of the host [l]. The lack of intragranulomatous necrosis has another 
‘practical’ consequence in the study of new prophylaxis and treatments 
against tuberculosis: the lack of an extracellular bacilli. This population is 
very important because it is considered one of the focus of latency in M. 
tuberculosis [2]. The Shwartman reaction 131 has been considered a feasible 
hypothesis that might exphn the origin of intcwanulomatous necrosis in 
humans. Continuous high levels of Tumor necrosis factor-a in the 
tuberculous granulomas have similarities with the ‘prepared sites’ induced 
by Shwartzman [4]. Again, the sudden increase of M. tuberculosis in these 
lesions before acquisition of specific immunity and thus the local 
concentration of endotoxins from their cell wall resembles the local 
inoculation of endotoxins done by the same author [5]. A new model of 
murine tuberculosis with intragranulomatous necrosis has been obtained [5] 
through the intranasal inoculation of lipopolysaccharide in mice infected 
aerogenically with a d e n t  strain of M. tuberculosis. These results lend 
support to Shwartzman reaction as the origin of the intragranulomatous 
necrosis in M. tubermlosis infection and provide a useful tool to improve 
experimental murine models in tuberculosis. 
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Managing bacterial resistance: surveillance, strategies and solutions (Arranged by Astra Zeneca) 
/5871 Global surveillance studies: looking back to move forward 
R.  N. Jones 
Iowa, USA 
In the last decade several nations have initiated programmes of surveillance 
and global investigations have emerged generally funded by the pharma- 
ceutical industry (Alexander Project, MYSTIC, SENTRY) using reference 
methods and comprehensive prospective, longitudmal protocols. Lookmg 
back on the results from these programmes, problems have been identified, 
but few have been acted upon at a local/regional/global level. Established 
resistance emergencies exist on a broad scale or in some global regions such 
as: multidmg (MD) resistant Staphylocorrus aureus (MRSA), vancomycin- 
resistant enterococci, MD Pserrdomonas aenrginosa, drug-resistant Streptococcus 
pneumoniae, third-generation cephalosporin-resistant EntprobactniaEeae (ESBL or 
AmpC mechanisms), and a greater prevalence of inherently resistant species 
(Sto?ohopkomona malfoph~l~u, Acinetobacter spp.). Prior experience dictates that 
broad strategies maybe necessaty, which usually include infection control and/ 
or formulary policy alterations. These options may vary by species or type of 
resistance mecharusm. To minimise future interregional problems (e.g. ESBL 
genomes passed from fidmichiu coli or Kkbsiella spp.), care must be taken to 
gain knowledge of geographic areas where a problem of resistance has been 
common. Furthermore, formulary interventions may produce additional 
unexpected selective pressures for other drug classes. Co-resistance will also 
impact formulary changes, driven by multiple resistances carried on a single 
gene cassette. Current surveillance progmnmes must be able to focus rapidly 
control procedures against emerging resistance for the participant and 
disseminate information to the practitioners-at-large. The better programmes 
will remain wide in scope of sampled bacteria, monitor all relevant drug classes, 
use reference quantitative susceptibhty tests, and support results with molecular 
epidemiology with resistance mechanism testing. The numbers of global 
programmes of this type are very few and more national level programmes are 
urgently needed to limit the spread of antimicrobial resistance genes. 
Successes at local or national level should be shared to further guide 
appropriate intervention strategies and techniques. Results fiom the 
MYSTIC and other prognmmes will be used to demonstrate surveillance 
techniques as applied to vGous regions and patient populations. 
15881 Unveiling the mystery of European resistance patterns- 
new data from the MYSTIC programme 
P. K. Chadwick 
Sdfird, UK 
The Meropenem Yearly Susceptibility Test Collection (MYSTIC) is a 
global bacterial resistance surveillance progranune. Surveillance data are 
being collected &om countries in Europe, North and South America, South 
Africa, the Middle East, and Asia. MYSTIC is a multicentre, longitudinal 
project collecting and testing antimicrobial susceptibdities of clinical isolates 
over a period of at least 5 years. Isolates (both Gram-positive and Gram- 
negative aerobes) are collected &om intensive care units, haematology/ 
oncology units, cystic fibrosis units and nonspeciahst centres. Annual 
analysis of the MYSTIC database allows resistance to a range of broad- 
spectrum antimicrobial agents, including meropenem, to be compared. 
Meropenem is prescribed in all participating centres and there is potential 
for resistance pattems and mechanisms to be matched with antibiotic usage 
data. In the European arm of MYSTIC, a total of 31 centres in 10 countries 
have provided data between 1 and 3 years. Analysis of the European 
susceptibility data shows that regional and national differences exist. The 
lowest incidence of antimicrobial resistance has been observed in Germany. 
In contrast, high rates of AmpC beta-lactamase, ESBL-producing and 
aminoglycoside-resistant Entarobacmiuceae have been observed in Italy, 
Poland, Russia and Turkey. An increase in quinolone resistance among 
Enterobacteriaceae was observed in Italy during the second and third years of 
the project. Meropenem and imipenem remain the most potent agents 
tested and no changes in susceptibility to the carbapenems have been 
observed in the countries surveyed for more than one year. The MYSTIC 
programme will contribute to the monitoring of resistance patterns to 
broad-spectrum antimicrobial agents on a global scale and will support the 
development strategies to minimire the spread of resistance. 
15891 Strategies for maximising power, minimising resistance 
G. L. Drusano 
New York, USA 
The time that free drug concentrations remain above the minimum 
d b i t o r y  concentration (MIC) of the causative pathogen is the controlling 
principle for optimising therapy with the beta-lactams. For carhapenems, 
the maximal bactericidal effect is attained by having free drug concentrations 
exceed the pathogen MIC for 40% of the dosing interval. Meropenem is a 
carbapenem antibiotic with an ultra-broad spectrum of activity and is a 
suitable choice for empirical monotherapy in the hospital environment. The 
recommended dosage regime of 0.5 g every 8 h provides adequate cover 
against the majority of clinically relevant pathogens, with the exception of 
Pseudomonas aenrginosa where 1 g every 8 h is more appropriate. Global rates 
of resistance with meropenem are generally very low, with a slightly higher 
incidence in P.  aenrginosa. Resistance mediated by deletion of the OMP D2 
porin usually results in a 2-4 fold increase in MIC for meropenem. However, 
these elevated meropenem MICs often remain below the brea!qoint and do 
not necessarily result in clinical Mure. In faa, the concentdon-time profile of 
meropenem may influence the probability of a positive clinical outcome and 
the probability of resistance emerging. We performed a 1000-subject Monte- 
Car10 pharmacokinetic simulation for meropenem, evaluating doses of 1 g and 
1.5 g, and infusion times of 1 and 3 h. Data b m  the model suggest that 
emergence of resistance in P. mginosa  could be suppressed by increasing the 
dose and irhsion duration of meropenem. Attainment of maximal bacterial 
cell lull increased from 86.6% with meropenem 1 g / l  h infusion, to 96% 
with a 1-g/3 h infusion, and to 97.4% with a 1.5-g/3 h infusion. The 
favourable tolerability profile of meropenem allows flexibility of dosage up 
to 6 g/day. The relevance of these data will be tested in a clinical trial. 
15901 Combating serious infection-today‘s solutions, 
tomorrow‘s challenges 
E. Rubinstein 
Tel Aviv, Il 
Serious infections, namely sepsis and hospital-acquired pneumonia, mainly 
occur in sick patients of advanced age with a multitude of underlying 
diseases. Patients are often dependent on external assistance for failing vital 
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functions. These infections, which are associated with invasive devices in a 
hostile environment and surrounded by antibiotic pressures, are often 
aggressively persistent and caused by resistant organisms. Among the major 
pathogens causing these infections are methicillin-resistant Staphylocoms 
aureus (MRSA) and multiresistant Gram-negative bacteria. Today’s 
measures include the use of newly developed antibiotics as well as the 
rational use of established agents. As most newer agents belong to only a few 
chemical families, there is a constant race between antibiotic development 
and emerging bacterial resistance. The race is usually won by the bacteria, at 
least in the longer term. What do we need for the future? Rapid methods 
for idennfylng bacteria and their susceptibility profiles to allow the use of 
well-targeted antibiotics. Rapid bedside methods to identify infections at 
In vitro studies of antimicrobial drugs 
their first stage, before damage can ensue Development of more achve and 
safe agents that d only -ally affect the envlronment Methods to 
decrease bactenal adherence to plasm, tubes, rubber, shcon, etc , and also 
to sputum, bone, shn, and mucod su&ces Greater knowledge of how to 
accelerate bactenal apoptosis, muupdate ‘quorum sensing’, and understand 
mterrelationshps between bactenal species A htherto unfulfilled dream is 
to be able to boost the body’s own defence system-to control cytohne 
release, lnnammatory response, and whte blood cell produchon and 
mgrahon-m order to Lmt  the mfecaon once It IS estabhhed. Modem 
technology and unproved biologcd understandmg may render some of 
these mshes m e  in a not too distant future 
Chlamydia pneumoniae replicates at low level in 
presence of new quinolones but not macrolides in vitro 
J. Gieffers, H. Fiillgraf, W. Solbach, M. Maass 
Lubeck, D 
The new quinolones modoxacin, levofloxacin, and trovafloxacin are 
effective against a wide range of respiratory pathogens, but data on their in 
vitro activity against Chlamydia pneumoniae are surprisingly controversial and 
treatment failures have been reported. In vitro activities of new macrolides, 
however, are consistent. Both substance groups are currently used in clinical 
trials on antichlamydial therapy in coronary sclerosis. In order to find the 
base for the inconsistent results reported with quinolones we applied a RT- 
PCR assay to detect chlamydial mRNA as a marker of viability (5 
respiratory and vascular isolates) in parallel to the conventional MIC 
determination by immunofluorescence (IF) staining (17 respiratory and 
vascular isolates). For azithromycin and roxithromycin, IF-staining and RT- 
PCR gave comparable results: MIC values differed by no more than one 
dilutional step. For the three quinolones, however, the conventional MIC- 
values were not reflected by RT-PCR mRNA detection decreased at 
quinolone concentrations in the range of the conventional MIC but then 
constantly reemerged at concentrations above the achievable serum levels. 
This phenomenon was reproduced for all quinolones and strains tested. 
Apparently, quinolones permit chlamydial replication at a low level that 
can be detected in the RT-PCR assay but not by conventional MIC 
testing. Thus, conventional susceptibihty testing appean reliable for 
macrolides but is not valid for quinolones. The clinical implications of 
this finding are yet unknown. Treatment studies and animal models will 
further contribute to clarification of the clinical value of quinolones in C. 
pneumoniae infections. 
Mutation prevention concentration of fluoroquinolones 
against penicillin nonsuxeptible clinical isolates of 
Streptococcus pneumoniae 
J. M. Blondeau, G. Hansen, X. Zhao, K. Drlica 
Saskatoon, CDN, New York, USA 
Within a bacterial population, resistant mutants are present despite the 
observation of the population being susceptible by routine susceptibihty 
testing. The mutant prevention concentration (MPC) defines the 
antimicrobial (AM) concentration required to prevent the selection of first 
step resistant mutants when AM agents are tested against a large inoculum of 
bacteria (10 to the power of 10 cells). This observation is critical for long- 
term survival of AM compounds. Working with fluoroquinolones, we 
tested 43 clinical isolates of penicillin nonsusceptible Streptocoaur pneumoniae 
(SP) by MPC. Using an agar dilution methodology, antibiotic containing 
plates were inoculated with 10 to the power of 10 cells of SP. Following 
incubation, plates were read at 24 and 48 h. The MPC was recorded as the 
lowest concentration preventing growth. Isolates with high MPC values had 
the quinolone resistance determining region sequenced. Analysis by MPC 
revealed the following MPC50, MPC90 and range results, respectively, for 
the 4 fluoroquinolones tested gatifloxacin 1, 4, 0.5-8 pg/mL; gemifloxacin 
0.25, 1, 0.063-64 pg/mL; levofloxacin 2, 8, 1-512 pg/mL; moxifloxacin 
0.5, 1, 0.12564 pg/mL. The MIC90 values for the 4 compounds, 
respectively, are as follows: 0.5, 0.031-0.063, 1, 0.25 pg/mL. The modal 
MPC values for the 4 compounds, respectively, were as follows: 1, 0.25, 2, 
0.5 pg/mL.. Gemifloxacin and moxifloxacin were the two most active 
compounds while levofloxacin was the least active. Ongoing sequence 
analysis is essential for explaining organisms with high MPC values. Our 
data suggests that gatifloxacin, gemifloxacin and moxifloxacin are less likely 
to select for fluoroquinolone resistant SP than is levofloxacin. Use of 
gatifloxacin, gemifloxacin and moxifloxacin will select for resistant SP less 
frequently than levofloxacin and provides a strong argument for the use of 
these compounds in treating mfection with SP. MPC is an important 
parameter for preserving the integrity of fluoroquinolones for treating SP 
infection. 
vi Evaluation of levofloxacin activity against Streptococcus 
pneumoniae isolated from 12 countries 
M. E. Jones, R. S. Blosser, J. A. Karlowsky, I. A. Critchley, C. 
Thornsbeny, D. F. Sahm 
Utrecht, NL; Hemdon, Brentwood, USA 
Objective: S .  pneurnoniae (SP) bas a history of developing high rates of 
resistance to beta-lactams, macrolides, and other agents in several countries. 
Therefore, careful and timely monitoring of the activities of newer agents, 
such as fluoroqninolones (FQs), developed for use against SP, is needed. 
This study examined the activity of levofloxacin (LEVO) against recent 
isolates of SP f?om around the world. 
Methods: During the 1999-2000 respiratory season, 5080 isolates of SP 
were collected tiom 12 countries on five continents. LEVO activity was 
evaluated by analysis of resistance rates and MIC distributions. MICs were 
generated and interpreted according to NCCLS guidelines. 
Results: No LEVO-resistant isolates (MIC > 4 mg/L) were detected in 
Brazil, South Afiica, or the United Kingdom. Among isolates from other 
countries, resistance rates were Germany (0.2%), France (0.4%). Thailand 
(0.5%), South Korea (0.9%), Mexico (1.5%), Spain (1.6%), Italy (3.1%), 
China (3.3%), and Hong Kong (8.0%). Regardless of the country of origin, 
LEVO MIC dtstributions were always narrowly grouped between 0.25 and 
1 mg/L. Importantly, the LEVO MIC dtstributions among isolates from 
countries with higher resistance rates (ie. Italy, China, Hong Kong) did not 
show any upward population shift in MICs relative to isolate populations 
&om the other countries studied. Rather, the greater resistance rates 
observed in these three countries were due to a relatively high incidence of 
clonal strains coming from one (Italy, China) or two institutions (Hong 
Kong). Additionally, analysis of LEVO resistance rates relative to penicillin 
resistance on a per country basis demonstrated that LEVO resistance did not 
correlate with penicillin resistance rates. For example, while penican 
resistance rates among isolates kom France, Thailand, and South Korea 
were 29, 38, and 70%, respectively, the commensurate LEVO resistance 
rates were 0.4, 0.5, and 0.9%. 
Conclusion: As evidenced by the MIC dtstribution analysis performed on 
isolates &om several countries, LEVO continues to maintain potent activity 
against SP worldwide, and no upward shifts in population MIC dstributions 
were observed. This pattern was even noted in countries where higher 
LEVO resistance rates were observed and associated with emergence of 
clonal resistant strains. Therefore, LEVO resistance among SP continues to 
be due to sporadic events rather than to an upward shift in LEVO MICs 
among SP populations. 
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/0981 Revised method for susceptibility testing of 
Haemophilus influenzae 
P. Karpinoja, A. Nissinen, H. Sarkkmen 
taht i ,  Jyviskylu, FIN 
The susceptibility of H. influenzae against different antimicrobial agents has 
remained very stable in Finland during the past few years. In the F I W S  
study (1 999, www.mmm.fi/enghsh/veterinary/publications), the fresuency 
of ampicillin resistant H. influenzae varied between 18 and 25% (1995-98), 
m d y  due to betalactamase production. During the same period over 99% 
of the strains were susceptible to cefuroxime, 82% against sulfa- 
hiniethoptim and 98% to tetracycline. Chromosomal resistance towards 
ampicdin has been rare. Among the 875 strains collected &om Finnish 
clinical microbiology laboratories between 1988 and 1990, only two isolates 
(0.2%) of BLNAR strains were detected. The NCCLS-recommendation for 
the disc dission method in the susceptibility testing of H. injuenzae 
includes the use of HTM-medium, paper discs of 6 mm diameter, 
incubation in 5% C 0 2  atmosphere and following concentrations of 
antimicrobial agents (in micrograms): ampicillin 10, amoxich-clawla- 
nate, cefaclor, cefuroxime and tetracycline 30, and sulfa-triniethoprim 25. 
To validate the NCCLS method for a national FiRe standard, five H. 
influenzae strains (from the ATCC collection and the quality control 
distributions of the UKNEQAS) were tested in 27 Finnish clinical 
microbiology laboratories. The method recommended by the NCCLS 
was used and, additionally 2 pg ampicillin and 3 pg amoxicdlin-clavulanate 
discs were included in the study, as suggested earlier for ampicillin (Zerva et 
al. 1996. J Clin Microbiol 34: 1970-74). The results of these susceptibility 
tests were analyzed using the WHONET4-computer program. On the basis 
of these results, a national recommendation for the susceptibility testing of 
H. influenzae was published in October 2000. The resolution of the 
BLNAR strains was found to be considerably better using the lower 
concentrations of ampicikn and amoxicillin-clavulanic acid and their use is 
recommended. Also the recommended breakpoints for tetracycline are 
slightly hfferent from the NCCLS-standard. The pleminary stndard will be 
further validated using a collection of consecutive H. influenzae isolates. 
Acknowledgement: Ths  study was done in co-operation with the FiRe 
network (Finnish Study Group for Antimicrobial Resistance). 
Direct antimicrobial susceptibility testing of enteric 
bacteria from positive blood cultures using VlTEK I 
R. Skov, D. Hansen, A. Jensen, N. Nsrskov-Lauritsen, B. Bruun 
Copenhagen, DK 
Objectives: To evaluate the accuracy and speed of the VITEK I for 
antimicrobial susceptibility testing (AST) of Enterobacteriaceae and P. 
aerqinosa inoculated directly from positive blood cultures using the GNS- 
GA card. 
Material and methods: Eight months of consecutive blood cultures (Bactec 
9240 system) positive with large Gram negative bacilli by microscopy were 
included (one culture per bacteremic episode). The bacteria were harvested 
by differential centrifkgation of 5 mL blood culture broth and inoculated 
into the GNI + identification card and the GNS-GA card. Only 
Enterobuctenaceae and P. neruginosa were evaluated. Strains with no or poor 
identiiication were excluded as the VITEK susceptibility algorithm is species 
specific. The following antibiotics were evaluated ampican, cefuroxime, 
ceftriaxone, ceftazidime, ciprofloxacin, gentamicin and tobramycin. AST 
using disk &sion was used for comparison. In case of disagreement, an E- 
test was performed and used as gold standard. Discrepancies are reported as 
very major, major or minor errors. 
Results: A total of 169 episodes were included. 141 (83%) episodes were 
evaluable for AST (E. coli (86), Klebsiella spp. (26). Proteus spp. (7), Salmoneh 
spp. (6), Enterobacter spp. (4), Citrobacter spp. (2), Sewatia spp. (1) and Ps. 
aeruginosa (9). In 126 episodes the identification was correct, whereas in 15 
cases (all E. coQ the strains were misidentified. In general, the resistance was 
low: AMP (52%), CEFUR (ll%), CTX (3%), CTZ (1%). CIP (1%). GEN 
(1%). and TOBRA (1%). In one episode the expert system cautioned about 
the AST found for a Serratia isolate resulting in a total of 980 evaluable 
dmg/bug combinations (140 episodes). VITEK gave correct results for 973 
(99%) of these combinations. Four misidentified strains gave a major error 
for AMP. Three strains gave a minor error: one Klebsiella spp. for CEFUR 
and two P.  aeruginosa for CTX and CTZ, respectively. Median (range) time 
for AST was: 6 h (3-14 h). 85% were completed withm 6 h. 
Conclusion: VITEK I suscephbhty testmg performed dwectly from blood 
cultures of entenc bactena is both accurate and fast, makmg it possible to 
report results on the same day as blood cultures are positive 
Performances of 2 techniques to detect low-level 
methicillin resistant coagulase negative staphylococci (LMRCNS): 
cephems disk diffusion in agar, Vitek 2 R automated system 
A. Felten, B. Grandry, P. H. Lagrange, I. Casin 
Paris, F 
The recommended disk-difhsion 0xacill.m ( O m )  tests fail to detect 
heterogenous methiciuln resistant S. aureus (HMRSA) and a great number 
of MRCNS also. In a previous study, detection of HMRSA was shown to 
be enhanced with a diffusion test in agar using cefoxitin (FOX) and 
lamoxactam (MOX) disks (30 pg), and the convenient critical inhibition 
diameters (CID) were set up. The same method was evaluated to detect 
LMRCNS and was compared to the Vitek 2 system (bioMCrieux-France). 
We tested 143 clinical CNS isolated at St-Louis Hospital. Detection of the 
mecA gene by PCR was the reference for methicillin resistance. FOX, 
MOX and OXA (5 pig) disks were laid on Mueller Hinton agar plates 
seeded with a miltion bacteria/mL, and inhibition hameters were measured 
afrer varying conhtions ofincubation: 18 h at 37 “C (FOX, MOX), 48 h at 
30 OC (OXA). OXA-MICs were measured simultaneously by E-test. The 
Vitek 2 which combines OXA-MIC in broth and ‘oxascreen’ was tested on 
136 isolates. Identification was performed by API ID 32 Staph strips and by 
the Vitek 2. All tests were read blindly. One-hundred-and-two staphylo- 
cocci carried the mecA gene. OXA-disk revealed only 81 MRCNS over 
102 (79%) with CID < 20 mm. FOX-disk detected 95 MRCNS with CID 
< 27 mm (93%), and MOX-disk 98 MRCNS with CID < 22 mm (96%). 
Vitek 2 showed OXA-MIC > 2 mg/L and/or growth on ‘oxascreen ’’ for 
87 over 95 mecA-positive isolates (92%). By E-test, 86% of mecA-positive 
isolates had OXA-MIC > 1 mg/L. The 41 mecA-negative isolates were 
classdied as methicillin-susceptible by all above tests with their respective 
criteria (100% specificity). The mecA gene was found in 100% of S. 
haemolyticus (15 isolates), S.  sciuri (2) and S. chromogenes (2). 87% of S. 
epidemzidis (69), 55% of S. hominis (18) and S .  warnen’ (11). S. hominis 
accounted for most f&e negative MRCNS 2 with MOX and FOX, 6 with 
Vitek 2. According to their sensitivities and specscities, MOX-disk, FOX- 
disk and Vitek 2 are valuable tools to detect LMRCNS w i t h  18 h. 
Lamoxactam, respectively, 96% and 100% sensitive on MRCNS and 
MRSA for CID < 22 mm, is more accurate than oxacillin to detect 
methicillin-resistance in the genus Staphylococcus. 
v] Comparison of NCCLS and BSAC methods for 
susceptibility testing of ketolides, macrolides and arolides 
against aerobic Gram-positive pathogens 
A. King, I. Phillips 
London, UK 
Objective: To compare results obtained by NCCLS and BSAC methods for 
in tifro activity of ABT-773, telithromycin, clarithromycin, erythromycin 
and azithromycin. 
Methods: MICs were determined by an agar dilution method on Mueller- 
Hinton agar and on Isotonic agar adjusted to contain 50 mg/L free calcium. 
Both media were supplemented with 5% horse blood for fastidious 
organisms. The organism included were clinical isolates from St. Thomas’ 
Hospital selected to include representative numbers of species associated 
with infection and further selected to include, where possible, those known 
to have specific resistance mechanism$. Interpretative criteria were as given 
in either NCCLS or BSAC guidelines. The effect of added blood and 
incubation with added carbon dioxide was assessed for the control S. aureus. 
Results: There was no sigdicant difference between the results on 
Mueller-Hinton agar and Isotonic agar for the 476 aerobic Gram-positive 
isolates with the majority of results equal or withm one doubhg dhtion. 
The exception was with enterococci where results tended to be lower on 
Isotonic agar. Differences in breakpoints between NCCLS and BSAC did 
have an effect on the interpretation of results for some of the agents. Where 
the low NCCLS breakpoint was equal to the BSAC breakpoint-ABT-773, 
telithromycin and erythromycin-there was little difference in designation of 
susceptible isolates. However where the low NCCLS breakpoint Uered  
&om BSAC-clarithrornycin and azithromycin-there was a notable 
difference in interpretation for isolates with results close to the breakpoints. 
14 Abstracts 
The majority of NCCLS intermekate strains were interpreted as resistant by 
the BSAC method that has no intermediate category. The addition ofblood 
to the media had minimal effect on results for the control strain but added 
caxbon dioxide increased results two-fold for most agents and often four- 
fold for azithromycin. 
Conclusion: The effect of media on results was minimal. Discrepancies in 
interpretation between NCCLS and BSAC occurred when the low 
breakpoints Wered. The adktion of carbon dioxide increased results for 
the control strain. 
vl The in vitro activity of daptomycin against 564 Gram- 
positive aerobic clinical isolates 
A. King, I. Phillips 
London, UK 
Objectives: To assess the in uitro activity of daptomycin in comparison with 
that of vancomycin and penicillin against a wide range of Gram-positive 
aerobic bacteria, and to compare the NCCLS and BSAC methods. 
Methods: Daptomycin, penicdlin and vancomycin were tested as powders 
of known potency-. MICs were determined by an agar dilution method on 
Mueller-Hinton agar (NCCLS) or Isotonic agar adjusted to contain 50 mg/ 
L free calcium (BSAC). Both me&a were supplemented with 5% hone 
blood for fastidious organisms. The organisms (n=564) were all clinical 
Epidemiological issues 
isolates from St. Thomas’ Hospital and were selected to include 
representative numbers of species associated with infection and were 
further selected to include, where possible, isolates with known resistance 
mechanisms including methicillin, vancomycin and erythromycin. 
Results: All 172 staphylococci, including methicillin-susceptible and 
methcillin-resistant S .  wrm, S .  epidmidis and S. hemolyticus had 
daptomycin MICs 0.03-0.5 mg/L). 99 of the 100 enterococci, includmg 
37 vancomycin-resistant isolates, had daptomycin MICs 0.25-2 mg/L while 
one vancomycin-resistant isolate had an MIC of 4 mg/L. All 108 beta- 
haemolytic streptococci, including S .  pyogmes and S.  agalactiae, had 
daptomycin MICs of 0.016-0.25 mg/L and 101 alpha-haemolytic 
streptococci, including S. pneumoniue, and ‘viridans’ streptococci had 
daptomycin MICs of 0.016-2 mg/L. Miscellaneous vancomycin-resistant 
isolates includmg Lartobacillus spp., Laaocorrus spp., Larconostor spp.. P e d i o c m  
spp. and isolates of Efimocom casse[rflauus and E. gdfimnrm had daptomycin 
MICs values of 0.03-2 mg/L. The seven isolates of LiFteria monorytogenec had 
daptomycin MICs sirmlar to those of enterococci (0.25-4 mg/L). There was 
little Werence between the results on Mueller-Hinton agar and on Isotonic 
agar The merent results occasionally obtained on Isotonic agar tended to be 
one dilution higher than those on Mueller-Hinton. 
Conclusion: Daptomycin was active (MICs Q 2 mg/L) against all the 
isolates tested with the exception of one isolate each of E. faenurn and L. 
monoryfogen~s (MICs=4 mg/L). Based on our results, daptomycin MICs 
were independent of methicjllin and vancomycin MICs. Results of Phase 111 
climcal trials will provide the clinical sigdicance of daptomycin potency. 
v) Meningococcal invasive disease in the Czech Republic 
in the 1990s 
P. Kriz, B. Kriz, M. Musilek, J. Kalmusova, M. Bobak 
Prugue, CZ; London, UK 
Objectives: New meningococcal clone ET-15/37 emerged in the Czech 
Republic in 1993 and caused increased morbidity and fatality rates in 
invasive meningococcal disease. The objective of the current research is to 
examine microbial and host factors that can influence the risk of invasive 
meningococcal disease. 
Methods: The data came from an active sunredance programme established 
in 1993. Strains of Neisseriu meningitidis isolated from patients with invasive 
meningococcal disease were compared with strains from healthy carriers 
with reference to their phenotypes, genotypes and virulence factors. The 
role of factors related to the host were investigated in a population based 
case-control study, using a questionnaire. 
Results: The incidence of invasive meningococcal disease increased since 
1993 due to Neisseria meningitidis C:2a:P1.2, P1.5 belonging to the ET-15/ 
37 complex. The incidence peaked in 1995 (2.21100 000) and then 
declined (to 1.0/100 000 in 1999). The case fatality rate of invasive 
meningococcal disease was 13%, mainly because of high fatality rate (20%) 
of cases with the ET-15/37 complex. Analysis ofphenotypes and genotypes 
indicated that strains belonging to the complex ET-15/37 (phenotype 
C:2a:P1.2, P1.5 being the most prevalent) represented 22-7196 of the 
patient strains in the period 1993-2000. T h i s  percentage has been 
decreasing since 1997 and will soon reach the nonepidemic situation from 
before 1993. Investigation of strains on cell cultures revealed significantly 
higher adherence and lower phagocytosis in meningococci isolated from 
patients compared to those isolated from healthy camers. Assessment of the 
host factors showed that invasive meningococcal disease in children was 
strongly associated with low matemal education and parental smoking; for 
the latter the rate ratios were 3.5 for matemal smoking, 3.2 for smoking of 
father and 2.7 for every 20 cigarettes smoked at home on an average day. 
Conclusions: The increase in morbidity and fatality rates in invasive 
meningococcal disease that emerged in the Czech Republic since 1993 can 
largely be attributed to the meningococcal strain belonging to the ET-15/37 
complex. These meningococci show high virulence and high Lality. The 
risk of developing an invasive disease is strongly influenced by the host 
factors, such as passive smoking and socioeconomic conditions. 
10105/ Outbreak of ECHO virus type 30 presenting as aseptic 
meningitis in toddlers and schoolchildren 
D. Marsan, M. Melmann, N. Schwerk, G. Orth, H. Schu l t e -Wisse r ,  
S. Diedrich, E. Schreyer, T. Menn, C. H. Wirsing von Konig 
Krefeld, Berlin, D 
Objective: To describe the epidemiology and clinical features of an outbreak 
with ECHO virus type 30 infections in the lower Rhine region in 
Germany. 
Methods: Between September and November 2000, an outbreak compris- 
ing a total of 42 cases presenting with meningitis was investigated. The 
children’s hospital is the only institution for children within a catchment 
area of approximately 300 000 people. Clinical symptoms, course and 
outcome in patients were monitored. The public health authorities 
investigated all tvniles and scrutinized contacts in schools, kindergartens, 
and nursery schools. Laboratory diagnosis of cases was done by using an 
enterovirus RT-nPCR, and the identity of the isolates was determined by 
culture or by genome sequencing. Enterovirus serology with an ELISA was 
additionally performed. 
Results: The outbreak occured in a characteristic fashion, starting with 10 
cases per week in late September, followed by seven cases per week in 
October, and decreased to a mean of four cases a week until mid- 
November. The age distribution among children ranged from 1 to 13 years. 
The outbreak occured in a s m a l l  geographic area, with no or very few cases 
being seen in neighbouring children’s hospitals. A total of 11 cases could be 
attributed to i n t r a f d a l  spread, and four cases occured in adults. All other 
cases were presumably acquired in school, kindergarten or nursery school. 
Single cases occured in most institutions, and in only two hdergartens 
were two consecutive cases found. Most of the patients presented with 
typical symptoms such as €ever, headache and vomiting. Some cases, 
however, showed severe and encephalitic symptoms. CSF pleocytosis was 
up to 1600 cells/pL with a predominance of polymorphonuclear 
leukocytes. The cases were diagnosed by RT-nPCR of CSF. Serology of 
CSF and serum samples did not conmbute significantly to the diagnosis. All 
children and adults recovered without obvious sequelae. 
Conclusion: An outbreak of ECHO virus type 30 aseptic meninigitis was 
investigated. This outbreak mostly followed known patterns of enteroviral 
diseases. The clinical presentation of cases, however, was so diverse and 
partly SO severe that RT-nPCR of CSF used as a first-line diagnostic tool 
was of si&cant help in identifiying cases rapidly, thus limiting antibiotic 
use, and reducing parental concern about the prognosis. 
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Nasopharyngeal carriage of Haemophilus influenzae 
related to day care attendance: a molecular epidemiological study 
P. G. H. Peerbooms, M. N.  Engelen, A. vanBelkum, R. A. Couhnho 
Amsterdam, Rotterdam, N L  
Early 1999 nasopharyngeal samples were obtained from 259 chddren 
attending day care (DCC) in Amsterdam and 276 children being cared for at 
home in order to study the influence of day care on the prevalence of 
carriage of Streptococcus pneumoniue, Haemophilus influenzae and Moraxella 
cafanhalis and on the prevalence of antibiotic resistance in these isolates. 
DCC children were sampled a second time after 4 weeks to study the 
persistence of the carrier state. H. influenme was isolated from 97 out of 259 
DCC chddren (37%) and from 30 out of 276 children in the control group 
(1 1%, P < 0.01%). Only 4 strains in the day care group and one strain in the 
control group belonged to H. influenzae type b. In the second sample H. 
influenzae was isolated fiom 96 out of 254 sampled DCC chddren (38%). 
Only 40 children harbored H .  influenzae in their nasopharynx in both 
samples. N o  increased antibiotic resistance related to day care attendance 
was found in contrast to the results in other counmes. In order to get 
additional information on the dynamics of colonization of the nasopharynx 
with H .  influenzae we decided to genotype all isolates. By using pulsed field 
gel electrophoresis as a reference method we showed that we could type H. 
influenzae with equal discriminatory power by using RAPD with 3 different 
primers (AP3, ERIC2 and RAPD1). We applied this typing method to 271 
30 isolates fiom the control group and 187/193 isolates from the day care 
group, which were still viable on subculturing; RAPD patterns were 
compared only for isolates from children in the same day care center. Based 
on RAPD typing we found that in the control group only 2 strains yielded 
identical RAPD patterns, while in the first samples of the day care group 36 
strains belonged to a cluster (of 2-4) strains with identical RAPD-patterns. 
When both samples from the day care group were used for cluster analysis 
93 out of 187 strains belonged to a cluster (of 2-8 strains). An identical 
RAPD-profile was only found in 4/40 chddren with 2 positive samples, 
illustrating that colonization with H. injluenzae is highly transient. The 
results of this study demonstrate that extensive child to chdd transmission of 
bacteria colonizing the nasopharynx takes place within day care centers. 
Though antibiotic resistance in H .  injluenzoe is not yet a major problem in 
The Netherlands, introduction of resistant strains into this population might 
lead to a rapid dissemination. 
Risk evaluation of Enterococcus faecium as a feed 
additive 
B. Lund, C. Edlund 
Stockholm, S 
Objective: To evaluate if an ingested, probtotic derived, Enteroroccusfecium 
could survive transit through the human gastrointestinal tract with or 
without simultaneous vancomycin administration, and to clarify if the same 
probiotic strain could, in vitro, gain vancornycin-resistant determinants. 
Methods: 20 healthy volunteers, 20-30-year-old, male:female ratio 1: 1, 
recieved 150 mL of the fermented rmlk product once daily, which 
corresponded to a daily dose of 4 . 5 ~  10"-7.5~ lo9 CFU E. faecium. 
Half of the volunteers were randomised to concomittant orally recieve 125 
mg vancomycin four times daily. Faecal samples were collected before, 
directly after (day 10) and three weeks after treatment (day 31). 
Approximately five random E. faecium colonies, when present, were picked 
&om each faecal sample on day 10 and 31. A total of 177 E. faecium 
isolates were after SmaI digestion analyzed with pulsed-field gel electro- 
phoresis (PFGE) together with the probiotic E. faecium strain. An in uitro 
filter mating method was performed using the food strain with induced 
rifampicin and streptomycin resistance as recipient and two vanA positive 
E. faecium strains (one type strain, CCUG 36804, and one clinical isolate, 
SMI 141) as donors. Transconjugants were detected with antibiotic 
containing mema. The conjugation event was confirmed with PCR 
and PFGE. 
Results: A total of 71 E. faecium isolates from day 10 were analyzed with 
PFGE. Of these 27 were considered identical, 9 genetically related and 35 
genetically unrelated to the foodstrain. A total of 106 E.faecium isolates &om 
day 31 were analyzed, all were considered genetically unrelated to the 
foodstrain. In eight out of 10 volunteers in the probiotic group, the 
foodstrain was recovered in faeces on day 10. In the probiotic and 
vancomycin group the foodstrain was not recovered in faeces. The rates of 
conjugation with CCUG 36804 and SMI 141 as donors were 4.0 x 1 K 6  
and 1.8 x 10W5 per recipient CFU, respectively. 
Conclusions: The probiotic E. faecium can survive transit through the 
gastrointestinal tract of humans. The colonization of the probiotic E.  fecium 
in the intestine seems transient. The E.  faecium foodstrain can under in uitro 
conditions easily pick up the vanA gene cluster. 
101081 Management of community acquired pneumonia: 
comparing a European hospital with American medical centers 
A. Blickenstorfer, C. Ruef 
Zurich, CH 
Objectives: To benchmark a European hospital with academic health 
centers in the USA regarding the management of community-acquired 
pneumonia (CAP). 
Methods: Prospective benchmarking study among participating member 
hospitals of the University Healthsystem Consortium (UHC) including the 
University Hospital of Zurich (UHZ). Standardized collection of data 
regarding severity of CAP, underlymg diseases, use of diagnostic and 
therapeutic interventions and length of stay (LOS). Comparison of UHZ 
data with the entire UHC database (39 participating hospitals). 
Results: A total of 1463 patients with CAP were entered into the study. 
UHZ conaibuted 35 patients. No significant differences were found 
regarding the frequency of underlying diseases (asthma, COPD, cardiac or 
cerebrovascular disease, diabetes or neoplastic diseases) between UHZ and 
UHC, whereas intravenous drug use was more prevalent among UHZ 
patients (P=O.O2; chi-square test). A significantly higher proportion of 
patients at UHZ (68%) were classified in PORT classes 1-111, whlch are 
associated with a better outcome, than in the UHC cohort (49% P=O.O2). 
This is reflected by a significantly lower rate of ICU admissions of patients at 
UHZ (P=0.003). Median LOS of patients with CAP at UHZ was 11.9 
days and differed significantly &om LOS of the U H C  cohort (5.5 days, P < 
0.05). Relatively long LOS of 8 days were even noted for patients in PORT 
classes I or 11. Antibiotic therapy was given at UHZ for a mean of 14 days 
(including outpatient treatment in some patients). At UHZ antibiotics were 
administered intravenously for a mean of 8 days. The first dose was 
admimstered with a mean delay of 256 min at UHZ (UHC: 426 min). 
Blood cultures were performed significantly quicker at UHZ (mean delay 
115 min) compared to U H C  (mean delay 348 min; P < 0.05). 
Conclusions: Ths benchmarking study shows that the management of CAP 
at UHZ is associated with a longer LOS, longer duration of parented 
antibiotic therapy and a higher proportion of patients in risk classes, which 
would permit outpatient treatment, compared to hospitals with a 
comparable academic mission in the USA. In order to be able to respond 
to increasing economic pressures in Europe, it might be helpful to adapt 
positive management aspects from so-called best-performers, which can be 
identified by such studies, to the local European situation without giving up 
already existing good practices. 
vl Hospitalization of community-acquired pneumonia 
E. Coma, J. Guardiola, P. Domingo, P. Giralt, 0. Torres, F. Sanchez, S .  
Benito, M. Gurgui, G. Vizquez-Mata 
Barcelona, E 
Background: The P O R T  scoring system was described for Fine et al. in 
1997, they stratified the patients in 5 class with specific mortahty rates and 
defined the need of hospitalization, but others concurrent disease process 
may influenced in this decision. 
Objectives: To analyze our experience with the PORT scoring and to 
evaluate his impact about de need ofhopitalization. To correlate the PORT 
scoring with the others indexes: Charlson (Comorbhty) and Barthel 
(Autonomy). 
Methods: From January 2000 to May 2000, patients with CAP were 
prospectively included in this study. CAP was defined as the presence of 
symptoms of lower respiratory tract infection, along with a new infiltrate 
on chest radiography and no emerging alternative diagnosis during 
follow-up. Data collection will be carried out accordmg to a standarized 
protocol that includes epidemiologic, clinical and treatment variables. 
Complementary tests that include venous access and blood sampling, 
radiology, and microbiologist studies. Clinical control after 15 and 30 days. 
The PORT scoring, Charlson index and Barthel index were calculed in 
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all the patients. All the information will be registered in a specifically 
designed database. 
Results: During the period january-may 2000, 132 patients were included in 
the study. The microbiologic diagnosis were obtained in the 50% of the 
cases. The average age was 62 years (Range: 15-94) and 39% were females. 
10 patients proceded of a nursing home. The emergence room patients 
destine was: 39 (29%) outcome, 79 (60%) hospitalized in the Internal 
Medicine Departement, and 14 (11%) hospitalized in the intensive care 
units, 4 cases of this needed mechanical ventilation. Of the patients who are 
hospitalized, 13 (14%) to pertain to score I, 16 (17%) to score 11, 27 (30%) to 
score 111, 19 (20%) to score IV, and 18 (19%) to score V. The analysis of the 
patients to pertain to score I detect differences statystically significant 
betwen the patients who are hospitalized or not, the hospitalized patients 
with score I had a Charlson index > 1 and de outcome patients had a 
Charlson index < 1 (P < 0.1). The total mortality rate was 7.6%, and the 
relationated was 4.6%. 
Conclusions: 1. The Fine scoring is a useful system for identifie the risk 
patients in the emergence room. 2. The Charlson index is a complementary 
clasification who included a scoring of comorbidities that not are included 
in the PORT scoring. 
Community-acquired multiresistant bacteria in a 
French teaching hospital 
F. X. Lescure, M. EveiUard, Y. Douadi, F. Eb 
Amiens, F 
Because of the length of the multiresistant bactena (MRB) camage, patients 
are usually shll colonized at the time of hospital discharge. However, few 
data concerning the MRB acquisition in the community are available, 
especially in Europe. Our objective was to estimate if MRB had recently 
become endemic in our regional community, according to microbiological 
samples obtained in our hospital. The study was conducted from January 
1999 to June 2000 in a French 1800-bed university hospital. A case was 
defined as a patient colonised or infected by a MRB. Cases identified among 
outpatients and non transferred inpatients within the 48 h following 
admission were considered as ‘potenhdy community acquired’ (PCA). 
Concerning each outpatient, the existence of a previous hospitahzation 
within the last 5 years was noted. Three indicators were followed (i) the 
cumulative incidence of MRB in outpatients; (ii) the cumulative incidence; 
and (iii) the proportion of MRB isolated in nontransferred inpatients withn 
the 48 h following a h s s i o n .  Their evolution was studied by periods of 6 
months with the chi-sqare for trend test. During the study, 67 outpatients 
carrying a MRB (60 methcfin-resistant Slaphylococcus aweus (MRSA) and 
6 extended-spectrum beta-lactamase producting Enterobacteriaceae (ESBLE)) 
were identified. The incidence (i) was 2.0/10 000 admissions. The 
proportion of MRB isolated in inpatients non transferred &om another 
institution within the 48 h following admission was 18.0% and the 
cumulative incidence was 17.9/10 000 admissions. These three indicators of 
PCA MRB increased significantly during the 18-month study period ( P  < 
0.001 for (i), P=0.07 for (ii) and P < 0.03 for (iii)). Thirty-seven 
outpatients (55%) including 4 ESBLE carriers had not been hospitalized 
within the last 5 years. Among outpatients wich had been hospitalized, the 
median delay fiom the last day of hospitalization to the day of MRB 
isolation was 4 months. It seems that, in our region, the isolation of PCA 
MRB increased during the last 18 months. Some recent studies have 
reported obvious cases of community MRSA transmissions or de nouo 
community MRSA acquisition. The isolation of MRB in outpatients seems 
to be a useful hospital-based indicator of the level of MRB community 
acquisition. This increasing incidence of PCA MRB could have some 
implications on empirical treatments concerning suspected S. aurew 
infections in patients coming from their home. 
Viral infections in transplant recipients 
/01121 Prospective monitoring of Epstein-Barr virus load in 
blood and saliva samples from kidney transplant recipients 
C. Frias, R. Lauzurica, B. Bay&, A. Hernandez, J. Bonet, R. Romero, 
V. Ausina 
Badalona, E 
Background: Epstein-Barr virus (EBV) infection is associated with the 
development of post-transplant lymphoproliferative disorders (PTLD). 
Objectives: We sought to assess the EBV viral load (VL.) value in clinical 
samples fiom kidney transplant patients (KT) to premct the risk of PTLD. 
Patients and methods: Blood and saliva samples from 64 adult (KT) patients 
were collected: just before transplantation, every 15 days between 1 and 3 
months, at 4, 5, 6, 9 and 12 months after transplantation, and once a year. 
EBV VL was assessed by semiquantitative PCR. 
Results: Sixty-four KT patients were prospectively monitored. The mean 
follow-up period was 20.4 months (range 3-36 months). A total of 1069 
samples: 622 blood and 447 saliva were tested. In 36 patients EBV VL was 
under 50 EBV DNA copies/75.000 PBMC in all samples tested. In 28 
patients, even though mean VL values were between 25 and 50 EBV DNA 
copies/75.000 PBMC throughout the study period, high VL values were 
detected incidentally without apparent clinical features. Results of EBV VL 
in PBMC were: 1-50 EBV DNA copies (91% blood samples tested), 5& 
100 EBV DNA copies (5.3%), 100-500 EBV DNA copies (2.7%) and 
> 500 EBV DNA copies (1%). EBV VL in saliva was hghly variable among 
patients. EBV shedding in saliva proggresively increased from the second 
week after transplantation up to the third and sixth month. There was no 
relationship between EBV VL in blood and saliva samples. Up to now, no 
KT patient has developped any PTLD. 
Conclusions: According to our data, EBV VL in saliva is not likely to be 
useful in EBV VL monitoring. We believe that patients with high EBV VL 
are at risk of developping PTLD, though up to now none has developed 
PTLD. Obviously, a long-term follow-up of those patients should allow to 
support these hipothesis. 
10113 Epstein-Barr virus serology and viral load in blood and 
saliva samples of kidney transplant patients with 
cytomegalovirus infection 
C. Frias, R. Lauzurica, B. Bay&, A. Hernandez, J. Bonet, R. Romero, 
V. Ausina 
Badalona, E 
Background: CMV has been described as a risk factor for the development 
of post-transplant lymphoproliferative msorders (PTLPD) associated with 
EBV. 
Objectives: To correlate CMV infection (primoinfection or reactivahon) 
with EBV status in blood and saliva. 
Patients and methods: Serum, blood and saliva samples from 11 kidney 
transplant (KT) with CMV infection were collected before, during and after 
CMV infection.Serum samples were tested for EBV-specific antibodies: IgG 
(VCA), IgG (EBNA) titer, IgM (VCA), and IgG FA) .  EBV viral load in 
PBMC and saliva was assessed by semiquantitative PCR. 
Results: A total of 177 samples (59 sera, 59 blood and 59 saliva) were 
analyzed. Of these 11 patients 8 bad CMV primoinfection and 3 
reactivation, with clinical disease in all but one. In 5/11 KT (45%), there 
was evidence of EBV serological reactivation at the time of CMV infection 
(3 primoinfections and 2 reactivations). In 2/6 KT without EBV serological 
reactivation, EBV viral load in blood increased at the time of CMV 
infection. No increase in EBV viral load either in blood or saliva was 
observed in any KT with EBV reactivation. Therapy with ganciclovir 
(GCV) had an effect on EBV viral load in saliva but not in blood. 
Conclusions: In KT patients with CMV infection, EBV serological 
reactivation rate is twice that of general transplant population. In those 
patients, there do not seem to be remarkable variations in EBV viral load in 
blood or saliva samples. EBV viral load in saliva is affected by GCV therapy. 
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101141 Epstein-Barr virus reactivation in kidney transplant 
recipients: significance of serological study 
C. Frias, R. Lauzurica, B. Bay&, A. Hernandez, J. Bonet, R. Romero, V. Ausina 
Badalona, E 
Background: The association between Epstein-Barr wrus (EBV) infectlon 
and the development of post-transplant lymphoproliferative disorders 
(PTLD) is well established. Nevertheless, there are few data regarding the 
evolution of EBV serological markers and their true clinical significance in 
kidney transplant (KT) recipients. 
Objectives: To prospectively analyze several EBV serological markers. To 
establish the reactivation rate m this subset of patients, their clinical value 
and correlation with kidney transplantation data. 
Patients and methods: Seventy KT patients were studied. In patients with 
clinical features (fever of infectious origin or acute rejection), serum samples 
collected before, during and after these, were analyzed. In KT patients 
without clinical features, serum samples collected during the first three 
months after transplantation were tested. IgG (VCA), IgG (EBNA) titer, 
IgM (VCA) and IgG (EA) were the EBV serological markers analized. A 
total of 287 serum samples were tested. 
Results: In 15/70 (20.1%) KT patients, EBV serological reactivation was 
diagnosed. It was asymptomatic in 6 KT (40%), while in the remaining nine 
at that time there was: fever (13.3%), leukopenia (6.6%), fever + leukopenia 
(6.6%), kidney function impairment (KFI) alone (6.6%), fever + KFI + 
leukopenia (6.6%), KFI (6.6%) and fever + leukopenia + renal insuficiency 
+ transanlinasec increase (6.6%). N o  differences in the epidemiological data 
or in immunosuppression were observed between the KT patients with and 
without EBV reactivation. 
Conclusions: In our KT transplant population, the EBV serological 
reactivation rate is 20.1%, and no risk factors for it have been found. 
Clinical significance of serological markers is discussed. 
I 01 15 1 Importance of concurrent beta-herpesvirus infection in 
the development of postrenal-transplantation complications 
upon antirejection therapy 
S. Chapenko, I. Folkmane, D.  Amerika, R. Rozental, M. Murovska 
Riga, LET 
Introduction: Infectious complications are a major cause of morbidity and 
mortality after renal transplantation (RT). Among the most commonly 
identified pathogens infecting transplant recipients are human beta- 
herpesviruses: CMV, HHV-6, HHV-7. These viruses establish latency in 
the host at the time of primary infection and are capable to be reactivated 
during intense immunosuppression. The aim of this research was to analyze 
the incidence, activation and involvement of beta-herpesviruses in post- 
transplantation complications upon treatment by different types of 
antirejection therapy. 
Patients and methods: The study included 50 transplant recipients. The 
recipients were grouped into four groups according treatment after RT. 
Group I (12 = 25) received Aza-based triple therapy (Aza + P + CyA), group 
I1 (n=25)-MMF-based triple therapy (MMF + P + CyA), from them 
group I11 ( n  = 4)-high doses of steroids, group IV ( n  = 9)-antithymocyte 
globulin (ATG) in addition to high doses of steroids. Viral infections were 
hagnosed by serological analysis; by polymerase chain reaction analysis of 
DNA from peripheral blood mononuclear cells and plasma/serum, DNA 
&om cultured cells and culture medium concentrate; by virus isolation in 
cell cultures. 
Results: The prevalence of CMV, HHV-6, HHV-7 latent infection before 
RT was SO%, 32%, 62%, respectively. The concurrent viral infection was 
prevalent in patients before (54%) and after (60%) RT. After RT clinical 
complications were revealed in 22 out of 50 recipients and the concurrent 
viral infection was detected in 77% of them. The risk of active beta- 
herpesviruses infections and complications was 5.5-fold higher in recipients 
of group I1 in comparison with group I. 6/9 (67%) of the group IV 
recipients developed severe infectious complications and 89% of them had 
concurrent beta-herpesvirus infection. 
Conclusion: The concurrent beta-herpesvirus infection is the major risk 
factor for the development of post-transplantation complications especially 
when ATG-and MMF-based immunosuppressive therapy is applied. 
V l T h e  COBAS amplicor CMV monitor test in monitoring 
cytomegalovirus DNA load after transplantation 
V. Ghisetti, A. Barbui 
Torino, I 
Cytomegalovirus (CMV) continues to be a major problem after 
transplantation. Viral load in blood as detected by quantitative polymerase 
chain reaction is an important risk factor for disease progression. A 
prospective study was performed on leukocytes (PBL) collected from solid 
organ transplanted patients undergoing CMV monitoring after transplanta- 
tion, from January to June 2000. Results of viral load (CMV-DNA) 
detected by the COBAS AMPLICOR CMV Monitor were compared to 
the pp65 antigen test. 1118 PBL samples were analyzed (297 patients; 273 
(24%) were pp65 antigenemia positive and 329 (29%) were positive by 
COBAS. The overall concordance between the two test was 85.5% (956/ 
1118 concordant samples). Analysis of the discordant samples outlined that 
1) 53 samples (4.8%) were pp65+/COBAS-, 38% of them were from 
patients who did not eventually develop CMV infection (pp65 levels < 3 
PBL+/200 000 examined) while 33/53 (62%) were from patients who did 
eventually have CMV infection (pp65 level < 10 PBL+/200 000); (2) 109 
samples were COBAS+/pp65-, 25 of them (21%) were sporadic low-positive 
samples (below 1000 copied106 PBL) from patients who did not develop CMV 
infection while in 84 samples CMV-DNA was positive before pp65 anhgen test 
(a mean of 13 days).The specificity and sensitivity of the COBAS assay for CMV- 
DNA in detecting an ongoing CMV infection were 96.8% and 90.2%. with a 
92.4% and 95.8% PPV and NPV, respectively. Prospective analysis of sequenaal 
PBL samples showed a sgdcandy hgher viral load in those patients who 
developed a severe CMV infiction requiring anti-CMV therapy (n = 16/34) than 
did in those patients who experienced an "ymptomatic mfection (n = 18/34) and 
were not treated (20 262 + 15 101 vs. 4785 + 6454 copies/l06 PBL, 
P =  0.0003). Data evaluation accordmg to the pretransphtation CMV serostam 
showed a CMV-DNA pattern resembling the one of pp65 antigen test, the wal 
load being agmficantly higher in seronegative patients receiving a graft from a 
seropositive donor than in seropositive patients before surgery (28 668 + 21 
816 vs. 9201 + 9708 copies/l06 PBL, P =  0.002). Our  study shows that the 
COBAS assay is a sensitive and specific method to detect and quantify 
CMV-DNA in blood from transplanted patients,its trend correlating with 
the antigenemia.The viral load in our experience is an earlier marker of an 
ongoing CMV infection, thus providing an important clinical marker of the 
evolution of CMV infection. 
10117 Quantitative CMV PCR in allogeneic stem-cell 
transplant patients 
L. Cardefioso, P. De La Obra, C. Sanz-Rodriguez, J.-M. Femindez 
Rafiada, E. Lomas, M. L6pez-Brea, R. De La Camara 
Madrid, E 
Objective: To assess the value of quantitative PCR assay in CMV 
management in allogeneic SCT patients. 
Methods: A total of 454 blood samples &om 35 patients were tested by both 
the CMV antigenemia and quantitative CMV PCR (COBAS AMPLICOR 
Roche Diagnostics). All patients were monitored until day I20 post-SCT 
with weekly antigenemia and seropositive or seronegative with seropositive 
donor a surveillance bronchoalveolar lavage (BAL). CMV seropositive 
patients received high dose of acyclovir as prophylaxis until day + 30 post- 
SCT. A median of 13 samples (range 4 2 7 )  from each patient were 
collected. Thirty-six surveillance BALs were studied by shell-vial 
cennifugacion and conventional culture. Antigenemia results were used 
for patient management. Plasma samples were frozen (-70 "C) and tested 
retrospectively. P C R  was considered positive when more or equal 400 
DNA-copies/mL were detected. Antigenemia was considered positive 
when one or more positive cells were detected (in 2 x lo5). 
Results: Thrty-one patients were CMV seropositive (or negative with a 
seropositive donors) and 4 were CMV seronegative with a negative donor. 
All these 4 patients had negative antigenemia and PCR, and none 
developed CMV disease. O f  the 31 seropositive patients, I 1  were 
antigenemia/BAL -negative during all the follow up period. Four out of 
these patients had a positive PCR (3 of these where receiving antiviral 
therapy). Twenty out of 31 seropositive-patients had CMV infection. In 16 
patients both the antigenemia and P C R  were positive, at a median of 63.4 
days (range 41-97) and 57.8 days (range 41-81), respectively. Four 
asymptomatic patients had CMV infection detected on BAL at a median of 
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109 days (range 96-135). AU these were antigenemia negative, but 3 had a 
positive PCR at a median of 85.6 days (range 73-102). Six patients 
developed CMV disease at a median of 81.3 days, 4 of who died. AU these 
patients had a positive PCR at a median 70.5 days and a positive 
antigenemia/BAL at a median 80 days. 
Conclusion: Quantitative P C R  detected all CMV infection episodes, 
and also earlier than antigenemia or surveilance BAL, by 5.6 days and 24 
days, respectively. PCR assay detected CMV disease 11 days before 
conventional methods. 
Tuberculosis: epidemiology and pathogenesis 
Immunology of rnycobacteriosis 
R. Appelberg 
Porfo, P 
Mycobacterial infections represent major burdens in Public Health with M .  
tubernrlosis being one of the most deadly human pathogens. Also, M. avium 
complex species cause important human and animal infections. Immunity to 
mycobacteria is mostly, if not exclusively, dependent on cell-mediated 
mechanisms regulated by innate and acquired systems. The recent 
availability of genetically engineered mice and the identification of 
mutations in humans leading to increased susceptibility to infection have 
boosted our understanding of such mechanisms of immunity and led us to 
identify major distinctions in the responses to M .  tuberculosis or M .  avium 
complex. IL-12 is the major inducer of protective immunity and works 
partly through the priming of gamma interferon responses. However, 
IFNgamma-independent pathways are emerging. The final effector 
responses of the activated macrophage include the production of nitric 
oxide but clearly other mechanisms are involved namely against M. avium. 
Among the latter, apoptosis, granulysin, as well as other as yet unidentified 
mechanisms, are being intensively studied. The role of the Nranipl protein 
is controversial but it is clear that Nrampl plays a role in resistance to M. 
avium infections in the mouse model. Its mode of action appears to involve 
the transport of dwalent cations such as iron raising the possibility that 
nutrient deprivation might be a way to resmct mycobacterial growth inside 
the phagocytes. 
Carriage of Streptococcus pneumoniae in the era of antibiotic resistance and new vaccines 
Streptococcus pneumoniae and the human nasopharynx 
J. Weiser 
Philadelphia, USA 
Streptomtcus yneumoitiae is a commensal resident of the mucosal surface of the 
human nasopharynx that is also able to infect its host both within and 
beyond the respiratory tract. Its ability to survive in these different host 
environments correlates with differences in expression of multiple virulence 
determinants. Insight into these phenotypic differences has been gained by 
observations of variations in colony morphology. Isolates of S. pneumoniae 
are not uniform populations. There is phase variation between at least two 
phenotypes that may be distinguished by hfferences in colony morphology. 
Transparent pneumococci are efficient at colonization of the nasopharynx 
in an animal model of camage. Opaque pneumococci of the same isolate 
are rapidly cleared from the mucosal surface but are more virulent 
compared to the transparent form in a model of invasive infection. The 
more virulent opaque variant expresses greater quantities of capsular 
poysaccharide per cell. The increased amounts of capsular polysaccharide 
inhibit adherence and colonization, but prevent clearance involving 
antibody, complement and phagocytes. In addition, the opaque form is 
able to dramatically increase the expression of capsular polysaccharide under 
anaerobic growth conditions. The diminished oxygen levels in the 
consolidated lung therefore may contribute to virulence by stimulating 
increased production of capsular polysaccharide. Transparent pneumococci, 
in contrast, express higher amounts of phosphorylcholine (Chop), a 
component of its teichoic acid. Chop anchors many surface proteins 
(referred to as choline binding proteins) that are affected by opacity 
phenotype. These include CbpA, whch functions in adherence and 
transcytosis, and PspA, an important target of humoral immunity. Chop also 
mediates the direct interaction of the pneumococcus with the receptor for 
platelet activating factor. Additional factors other than smaller capsules and 
adhesins may contribute to the ability of transparent pneumococci to 
colonize its host. For example, transparent pneumococcus produces > 0.5 
m hydrogen peroxide through the activity of pyruvate oxidase, S p a ,  
when grown under aerobic condtions. Levels of H202 generated by the 
pneumococcus inhibit and in many cases kill other members of the 
respiratory tract flora. 
New technologies for the prevention of catheter-related sepsis 
Flq New technologies for the prevention of catheter- 
related sepsis 
T. S. J. Elliott 
Birmingham, UK 
Intravascular catheters continue to be a major source of sepsis ranging 
&om localized phlebitis at the site of catheter insertion to septicaemia. 
New developments for the prevention of catheter-related sepsis offer an 
exciting potential to reduce these infecnons. These include the use of 
antiseptic and antibiotic coated catheters, the development of polymers 
with antiadhesive surfaces and the potential use for low voltage electric 
current. The antiseptic coated catheters include the use of chlorhexidine 
with silver sulphadazine and benzalkonium chloride. Antibiotic coated 
catheters have also utilised a range of antimicrobials including doxycycline 
with rifampicin. teicoplanin and several cephalosporins. The results of 
several chnical trials suggest that the application of antimicrobial coated 
catheters will significantly reduce both bacterial colonization and 
subsequent sepsis. Improvements in polymer formulations have also been 
made. These include catheters with ultra-smooth surfaces and the use of 
antiadhesive coatings, for example Hydromer(R). These developments 
have also reduced the ability of microorganisms to adhere to the surface 
of catheters. The use of electrical current is currently experimental but 
it also appears to offer an exciting potential for the prevention of 
catheter-related sepsis. The use of electrical current includes both 
microbial repulsion coupled with bactericidal activity. This technology 
has only been tested in in oitro models and awaits in viuo assessment. 
These new approaches for the prevention of catheter-related sepsis will 
be reviewed. Ths will include both in vitro laboratory results and 
in uivo clinical trials. The clinical application of these new catheters will 
also be discussed. 
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Hydatid disease and Leishmaniasis in Europe 
Fl Diagnosis, screening and laboratory monitoring of 
echinococcosis 
B. Gottstein 
Beme, CH 
‘Cystic hydatid disease’ (CHD) exhibits the presence of delineated spherical 
cysts, most frequently in the liver (60%) and the lungs (20%). Imaging 
diagnostic features of CHD include separation of the parasite cyst layers 
fiom the surrounding host capsule, daughter cysts and collapsed cysts, 
occasionally peripheral calcifications. An international classification system 
of ultrasonographc CHD images has been elaborated and will be published 
by W H O  in 2001. CT, where available, is superior to US for extrahepatic 
CHD, while MRI adds magnostic benefit for cysts at a c u l t  sites. US is 
very helpful in following treated patients, successfully treated cysts 
becoming hyperechogenic. Immunodiagnostic tests for antibody or 
circulating antigen detection are used to support the clinical diagnosis of 
CHD. Diagnostic sensitivity of IHAT and ELISA is relatively high for 
hepatic cases (8598%) and low for pulmonary cyst locahzation (5040%). 
As specificity is low, secondary confirmation tests are required such as 
immunoblotting. Anti-Ag5 MAbs and PCR are used for the identification 
of CHD upon diagnostic fine needle aspiration biopsies (FNAB). AHD 
develops primarily in the liver, metastases may form in the lungs, brain and 
other sites. The lesion appears as a mspersed mass of fibrous tissue with a 
conglomerate of small vesicles. The lesion often contains internal focal zones 
of calcification. Recent findings have documented the occurrence of a 
resistant form of AHD with ‘died-out’ lesions; conversely, immunodefi- 
ciency predisposes for fatal AHD. Clinical symptoms of AHD include 
hepatomegaly cholestasis-jaundice, secondary bhary cirrhosis, liver abscess, 
portal hypertension and Budd-Chari syndrome. US, C T  and MRI are of 
primary diagnostic value. Immunohistochemistry (e.g. MabGl1) and P C R  
are used to identify surgically resected samples and FNAB; parasite viability 
may be assessed by respective RT-PCR. In vivo, following therapeutical 
interventions may be offered by magnetic resonance spectrometry (MRS) 
or positron emission tomography (PET). Immuno&agnosis is more reliable 
for AHD than CHD. Purified E.  multilocularis antigens (such as Em2, Em18 
or recII/3-10/EM10) e h b i t  &agnostic sensitivities ranging between 91 
and loo%, with overall specificities of 98-100%. Discrimination rate 
between AHD and C H D  approximates 95%. The currently optimal 
epidemiological tool for large-scale screening of early AHD relies upon 
specific immunodiagnosis complemented by US. 
Adventures of microorganisms in vessels 
151411 Clinical trials in the treatment of visceral HIV-related 
leishmaniasis 
F. Laguna 
Madrid, E 
Visceral leishmaniasis (VL) is a common opportunistic infection in HIV- 
mfected patients living in endemic countries. Despite a large number of 
HIV-infected patients with VL have been reported, their therapy remains 
controversial. Early retrospective reports suggested that treatment with 
pentavalent antimonial salts was effective. However these patients were not 
uniformly treated, in most cases parasitological cure was not confirmed and 
toxicity was not prospectively evaluated. In this setting an open, 
prospective, multicentre, randomized trial was carried out to compare 
meglumine antimoniate with amphotericin B for the treatment of first 
episodes of VL in HIV-infected patients. In an intention to treat analysis, 
65.9% and 62.2% of patients were respectively cured. There were not 
significant Werences in toxicity, m o d t y  and relapses between both arms. 
In last years the development of lipid-associated formulations of 
amphotericin B, which have a low toxicity and a high efficacy in 
immunocompetent patients has been a great advance in the treatment of 
VL. These formulations have different efficacy in the treatment of VL in 
diverse world areas. Liposomal amphotericin B has proved to be very 
effective as treatment of VL HIV-related in no comparative trials. To test 
the dosage of amphotericin B lipid complex (ABLC) in VL-HIV co- 
infected patients we planned a open, prospective, multicentre and 
randomized trial to compare two doses of ABLC (3 mg/kg per day for 5 
days and 3 mg/kg per day for 10 days) vs. meglumine antimoniate (20 mg 
Sb/kg per day for 28 days). Both doses of ABLC showed an efficacy similar 
to meglumine antimoniate with a lower flequency of adverse events and 
better tolerability. There is a need for new drugs for HIV-infected patients 
with VL. Ideally these drugs would be inexpensive, with low toxicity and 
orally administered. We must to compare the efficacy and cost-effectiveness 
of these drugs in prospective randomized clinical trials, both for treatment 
and secondary prophylaxis. 
rS.1451 Has cytomegalovirus any role in the development of 
coronary arterial disease? 
M. Degr6 
Oslo, N 
A common viral or/and bacterial infection may be the 6rst step in a 
complex process of development of atherosclerosis and coronary disease. It 
may represent an insult initiating an Injury which leads to development of 
fatty streaks composed of lipid-laden smooth muscle cells, endothelial cells, 
macrophages and T cells. Cytomegalovirus (CMV) is one of the candidates 
that may participate in such a process. Both clinical and experimental studies 
have been presented by several groups, that support such a hypothgesis. In 
some seroepidemiological studies an association was found between 
coronary heart disease, especially in transplant recipients and evidence for 
HCMV infection, while other studies failed to confirm t h s  association. 
S d r  association was found for persistent infection, proven by culture, or 
presence of HCMV DNA in the lesions. HCMV infects human endothelial 
cells, including aortic cells and may cause either lytic infection or persistent 
infection. Severd cellular functions may be altered in HCMV infected 
endothelial cells, including regulation of HLA Class I1 antigen expression, 
production and secretion of multifunctional cytokines, as TNF-alpha, 
mterleukin-1, 3, 6, and growth factors GM-CSF, SCF and TBF-beta. 
Cellular expression of important adhesion molecules, like VCAM-1, 
ICAM-1 and E-selectin is also influenced by HCMV infection in in vitro 
models. Atherosclerotic plaques can be produced by CMV infection in 
murine model. 
/51461 Chlamydia pneumoniae: can infection cause 
infarction? 
M. Maass 
b e b e c k ,  D 
Atherosclerosis is a chronic inflammatory condition characterized by 
mesenchymal cell proliferation. The etiology is unclear but may involve 
vascuIar infection. C. pneumoniae has been implicated in atherogenesis as 
viable bacteria have been detected in atheromatous plaques and restenotic 
venous bypass grafts relating the pathogen to primary atherosclerosis and to 
graft restenosis. Due to the lack of a genetic recombination system for 
chlamydiae the atherogenetic relevance remains difficult to assess. Animal 
models in&cate rhlamydiae to induce a vascular innammation that resembles 
atherosclerosis. In vim, C. pneumoniae infection initiates expression of 
procoagulant proteins and prodammatory mediators in endothelium and 
smooth muscle cells by activating the transcriptional factor NF-KB. 
Infection of vascular cells also results in 1L-8 and MCP-1 production, 
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synthesis of soluble growth factors, and up-regulation of HSP60. Infected 
macrophages produce various matrix-metalloproteinases. All these are 
known in vivo characteristics of atherosclerosis that have not been well 
explained yet. Thus, acceleration of arteriosclerosis by vascular chlamydial 
infection appears plausible. Recently chlamydial components have been 
shown to induce foam cell formation and oxidative stress in host cellsa 
potential link between infection and the dysregulated lipid metabolism of 
atherosclerosis. The proinflammatory activity of chlamydial infection is 
reduced by statins indtcating an unexpected beneficial effect of lipid- 
lowering drugs. C. pneumoniae apparently uses blood monocytes as transport 
system for systemic dissemination. In monocytes the pathogen enters a 
nonreplicative but viable state characterized by continuous production of 
mRNA transcripts. Release of proinflammatory mediators by circulating or 
transendothelially migrating infected monocytes might promote chronic 
inflammation and atherogenesis. Interestingly, persistent chlamydiae in 
monocytes appear to be reflactory to conventional antichlamydial treatment 
thus posing a challenge to the large antimicrobial treatment trials in 
atherosclerosis that have been initiated recently. The persistent state is likely 
to have a key role in the pathogenesis of chronic chlamydial infections and 
requires further examination on a molecular level. 
/5148] The Ehrlichiae and the blood vessel 
P. Brouqui 
Marseille, F 
Ehrlickiae are strict intracellular bacteria which parasite c e h  of the reticulo 
endothelial system. They all clustered in the alpha subgroup of 
proteobacteria closely related to the rickettsia. They are infectious agent 
of animals and humans and are transmitted by vectors mainly arthropods but 
also by hehninthes. Depending on the organism they parasite endothelial 
cells, circulating monocytes, polymorphonuclear cells, lymphocytes, plate- 
lets or even red blood cells. As for example, ’heartwater’ is a disease of cattle 
transmitted by Arnblyomma ticks and caused by Cowdna ruminantium, 
whch i s  found in endothelial cells of the blood vessels of the animal. 
Ehrfickia ch@emis is a human pathogen described in the USA and transmitted 
by the tick Ambfyomma americanum and which parasite only monocytes, whde 
Ekriickia phgoqtophila, another human pathogen, parasite strictly granulocytes. 
Anaphma marginale is causing hemolytlc anemia in caale by targeting the red 
blood cells of these mammals. Ehrfichia phtys has been recently reported to 
cause diseases in dog and cat by invadmg the platelets of their host. 
Although in vitro these bacteria may be adapted to different cell lines, in vivo 
bacteria are rarely found in cells other than the primary target cell. The 
spechcity of the targeting is suggested in vitro by the fact that depending on 
the maturity of the HL60 cells (a promyelocytic cell line) they allowed 
either monocytic ehrlicbia (E. ckazeenxis) or granulocytic ehrlichia (E. 
phagocytopkih) to grow. More research is needed to understand why this 
group of bacteria preferably invades cells of the reticuloendothelial system. 
Meet the experts 
vl Gideon: a computer program for simulation and 
informatics in infectious diseases and clinical microbiology 
S. Berger 
Tel Aviv, II 
Over 300 generic infectious diseases are distributed haphazardly in time and 
space; and are challenged by over 250 drugs and vaccines. 1500 species of 
pathogenic bacteria, viruses, parasites and fungi have been described. 
Printed media can no longer follow the dynamics of diseases, outbreaks and 
epidemics ‘in real time.’ Although the advent of electronic media has given 
us unlimited information access, the search for meaningful data is confusing 
and time-consuming. A computer software program (GIDEON-Global 
Infectious Diseases and Epidemiology Network) was developed for disease 
simulation and informatics in the fields of Geographic and Travel Medicine. 
GIDEON is currently used by 1500 sites in 45 countries: health ministries, 
military installations, travel clinics, libraries and student teaching modules, 
clinical departments, laboratories and missionary agencies. The program 
consists of four modules. The first generates a Bayesian ranked differential 
diagnosis based on signs, symptoms, laboratory tests, country or origin and 
incubahon periodand can be used for diagnostic support and simulation of 
all infectious diseases in all countries. The second module presents the 
epidemiology of individual diseases, including their global background and 
status in each of 205 countries and regions. All past and current outbreaks 
are described in detail, and a web-based version under development will 
allow for daily updating on line. The user may also access a list of mseases 
compatible with any combination of agent, vector, vehicle, reservoir and 
country (i.e. list all of the mosquito-borne viruses of Brazil which have an 
avian reservoir). The third module is an interactive encyclopaedia whch 
incorporates the pharmacology, usage, testing standards and global trade 
names of all anti-infective drugs and vaccines. The fourth module is 
designed to identlfy or characterize all species of bacteria, mycobacteria and 
yeasts. The data base includes 50-100 taxa which may not appear in standard 
texts and laboratory data bases for several months. Additional options allow 
the user to add data relevant to his  own institution, electronic patient charts, 
material from the internet, important telephone numbers, drug prices, 
antimicrobial resistance patterns, etc. This form of custom data is partiCUlarly 
useful when running GIDEON on institutional networks. The data in 
GIDEON are derived &om: all peer-reviewed journals in the fields of 
Infectious Diseases, Paediatrics, Internal Medicine, Tropical Medicine, 
Travel Medicine, Antimicrobial Pharmacology and Clinical Microbiology; 
a monthly electronic literature search based on all relevant keywords; all 
avadable health ministry reporn (both printed and electronic); standard 
texts; and abstracts of major meetings. The program wdl be demonstrated 
using computer projection. Further detads regarding the program are 
available at http://www.cyinfo.com 
Managing serious infection: interactive grand rounds (Arranged by Astra Zeneca) 
w] Nosocomial pneumonia in the intensive care unit: 
making the first choice the right choice? 
F. Colardyn 
Ghent, B 
Mortality is h g h  in patients with vendator-associated pneumonia (VAP). 
Chances of survival are more dependent upon the severity of the patient’s 
disease than the impact of intervention, as is the case for patients with acute 
respiratory distress syndrome and Gram-negative bacteraemia. Conse- 
quently, one may question the need for antibiotic therapy in treating 
patients with VAP. Indeed, as early as 1980, the value of combination 
therapy in this setting was debated. However, as infection triggers and 
sustains inflammation, and inflammation leads to tissue destruction, 
antibiotic treatment is doubtless necessary. Although the speciality societies 
provide recommendations on the use of antibiotics in this setting, these are 
not evidence-based. The physician is therefore left with a range of 
uncertainties. Empirical antibiotic treatment represents an enormous 
challenge: what is (are) the causative agent($? What are the resistance 
patterns? What percentage needs to be covered? Bacterial resistance to 
antibiotics decreases the success rate, so the risk of resistance must be 
minimized. Colonization precedes infection in over 60% of cases, and 
surveillance cultures can improve the opportunities for targeted antibiotic 
therapy. Idammation is a host response and not a specific sign of infection. 
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Differentiating early onset VAP (e.g. caused by S .  pneumoniae) from late- 
onset VAP (e.g. Enterobacteriaceae, P. aenrginosa) will help to define the 
antibiotic spectrum, especially if resistance has already been decreased (e.g. 
susceptible strain of P. ueruginosa). Finally, dady evaluation of antibiotic use 
may lead to shorter treatment courses or iden@ those cases where 
antibiotic treatment should be changed. In summary, the choice of Grst 
antibiotic is important for various reasons, including resistance, inflamma- 
tion and outcome, and a case history will be discussed that emphasises the 
difficulties faced in providing adequate and appropriate therapy. 
15157 Serious surgical infection: a suitable case for 
monotherapy? 
S. Geroulanos 
Athens, GR 
Severe sepsis in surgery patients is associated with serious operative and 
postoperative complications and usually leads to a longer hospital stay and an 
increased risk of mortality. Successful treatment of patients with serious 
postsurgical infection often demands a series of complex decisions to be 
made. While good epidemiological knowledge of local resistance patterns 
can aid the selection of appropriate empirical therapy, a major challenge is to 
decide on appropriate first-line therapy. Can monotherapy with a broad- 
spectrum agent provide aerobic and anaerobic cover equivalent to 
combination therapy? Additional decisions are needed in the postoperative 
period. Should patients be switched from one antibiotic regimen to 
another? When should treatment be stopped all together? If reintervention 
is required, what is the appropriate antimicrobial therapy? If so, should it be 
with the same antibiotic and for a similar regimen and duration? To 
illustrate the demanding environment of treating patients with serious 
surgical infection, we will discuss the case of a 29-year-old man who was 
adrmtted to the intensive care unit and subsequently underwent 11 surgical 
interventions, including splenectomy. In this complicated case, antibiotics 
were stopped and started several times, and each decision was extremely 
dfficult and challenging to make. This case provides an ideal example for 
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discussing the indications and contra-indications concerned with commen- 
cing, continuing and discontinuing antimicrobial therapy, given either as 
mono- or combination therapy. 
151581 Fever in neutropenic cancer patients: the value of risk- 
based treatment strategies? 
W. V. Kern 
Ulm, D 
Combinations of intravenous beta-lactams plus an aminoglycoside have 
been used traditionally as standard empirical therapy for fever in neutropenic 
patients. According to published studies, monotherapy with selected broad 
spectrum beta-lactam agents, such as Pseudomonas-active cephalosporins 
and the carbapenems, provide an effective alternative, even in high-risk 
febnle neutropenia, while oral therapy with ciprofloxacin plus amoxicillin/ 
clavulanic acid may be an acceptable option for low-risk patients. The 
assessment of individual and local epidemiological factors concerning 
bacterial resistance, issues related to tolerability and cost, as wetl as risk 
definition and prediction, are critical in assigning the most appropriate 
therapeutic strategy. In settings with extensive use of third-generation 
cephalosporins, for example, agents such as ceftazidime may have become 
less effective over the years. Discussion of cost issues should include 
expenditures for the management of adverse events, as well as time to 
defervescence and duration of therapy. Predictions of clinical risk at the 
onset of fever have not been (and perhaps cannot easily be) standardized. 
Variables such as age, clinical status, site of the mfection, intensity of prior 
chemotherapy, expected further duration of neutropenia, significant 
comorbidities, and others need to be considered. Patients considered low- 
risk may be unable to swallow oral medications and require an initial 
parented regimen. In patients with extensive mucositis, for example, a drug 
with adequate coverage of oral streptococci and anaerobes may be the 
preferred choice and be associated with a lower need for treatment 
modification. A case hstory will be presented that hghlights the complex 
decision tree involved in treating patients with febrile neutropenia. 
101631 Early detection of serum antibody titers to 
Mycoplama pneumoniae in patients hospitalized for 
community-acquired pneumonia 
M. Allewelt, A. Roth, H. Mauch, H. Lode 
Berlin, D 
Serum antibody titers are generally considered helpful in determining the 
etiology of pneumonia only in retrospect. In patients hospitalized for 
community-acquired pneumonia (CAP), significant single serum titers to 
M. pneumortiue are often found on admission. W e  retrospectively analyzed 
serum titers of patients with CAP caused by M .  pneumoniae and correlated 
these data with the time of hospitalization. From January 1998 to 
November 2000, 73 patients were identified with elevated serum titers 
(I@, IgG, and IgA) to M.  pneumoniae by particle-immunoassay (PIA). 
Titers of 1:160 were considered borderline, > 1:160 indicated significant 
titers. 42 subjects (57.5%) were female, mean age was 28.1 years (SD 16.8 
year, range 1-87 year). 45 patients (61.6%) had pneumonia confirmed by 
chest X-ray and on clinical grounds. In 39 individuals (53.4%), no other 
etiology but M. pneumoniae was identified. In 6 patients (8.2%) other 
causative agents were also isolated. In 16 pneumonia patients (35.6%), 
presence of M. pneumoniae-DNA was confirmed by PCR using pharyngeal 
or bronchio-alveolar lavage fluid. In 9 patients (12.3%) pneumonia was 
excluded, 6 patients (8.2%) suffered from infectious disease other than 
pneumonia, and on 12 patients (16.4%), no conclusive information on 
disease could be obtained. In 29 subjects (64.4%) with confhned 
pneumonia, serum samples with borderline or significant titers were 
obtained on admission or the following day, in a total of 36 CAP patients 
(80.0%) w i t h  the first 4 days of hospitahzation. For 20 of these (55.6%), 
consecutive serum samples were available, producing a 4-fold or greater 
increase in 12 subjects (60.0%). Despite the limitahons of serum antibody 
testing, our data suggests that in the vast majority of hospitahzed patients 
with a final diagnosis of CAP caused by M .  pneumoniue, serum antibody 
levels suggestive for M. pneumoniae infection are already detectable on 
admission or shortly thereafter. Immedate testing might therefore speed up 
confirmation of the etiology of CAP, and might help in the initial choice of 
antibiotic therapy. 
101641 An interlaboratory comparison for the detection of 
Mycoplama pneumoniae in respiratory samples by the 
polymerase chain reaction 
D. Ursi, M. Ieven, G. T. Noordhoek, M. Ritder, H. Zandleven, M. 
Altwegg 
Edegem, B; Leeuwarden, NL; Zurich, CH 
Objective: The objective of thw study was to organise an interlaboratory 
exchange of DNA extracted from respiratory samples for the detection of 
Mpplasmu pneumoniae by PCR in order to evaluate the quality performance 
of the four different assays applied inat three laboratories. 
Materials and methods: A total of 78 respiratory specimens (22 sputa and 
56 throat swabs) from 43 patients participating in a treatment study of adults 
with community-acquired pneumonia or acute exacerbation of chronic 
obstructive pulmonary disease were selected for this study. They comprised 
all PCR-positive specimens available and an equal number of PCR- 
negative ones based on the results obtained with the test system then used in 
laboratory 1 (method A). DNA extraction from all these clinical samples was 
then performed in laboratory 1 using a commercial DNA extraction kit 
(QIAGEN). The extracts were aliquoted in three parts and two were 
shipped in frozen condition to the other laboratories. The three laboratones 
applied their own ‘in house’ PCR protocol for amplification and detection, 
with laboratory 1 using a different detection format but identical primers 
(method B). 
Results: Thirty-nine specimens from 19 patients met the criterium of at least 
two positive independent PCR results to be considered as true positives. 
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undetermined (UD) or not done (ND) and shows the calculated specificity 
(SPEC) and sensitivity (SENS) of the assays. The percentage of concordance 
in the three centres was 84%. 
Serion ELISAs ImmunoWell 
from Virion EIAs from 
GenBio 
Yo, w., 
Pl-enriched EMS from 
Labsystems 
Yo) 
Conclusion: This study demonstrated that the exchange of samples between 
laboratories is very useful, especially when 'in house' PCR tests are applied. 
By interlaboratory quality controls the sensitivity, specificity and pitfalls of a 
procedure can be estimated. In this study, none of the participating centres 
was free of false positive P C R  results indicating the importance of including 
a sufficient number of negative controls in amplification runs to detect 
possible sample-to-sample carry-over, especially when a high proportion of 
positive samples is to be expected. 
Specificity 
PV pos 
PV neg 
Effici ency 
93 64 95 
74 27 80 
100 100 100 
94 68 96 
Sensitivity 97 94 100 
Specificity 100 79 96 5 
PVPOS 100 59 3 91 4 
OQ Q 07 6 1 nn 
Plat elia 
from Sanofi 
Pasteur 
I I I 
Sensitmty I 100 I 100 I 100 
Immuno Well P 1 - e m  ched 
EIAs from EIAs from 
GenBi o Labsystems 
Discussion and conclusion: There is currently no gold standard for M .  
pneumoniae serology. In the absence of such our study, however, showed a 
good agreement between the methods to detect acute M. pneumoniae 
infection. O n  the contrary, a big difference in the specificity of the methods 
was revealed. ImmunoWell IgM EIA was clearly less specific. In conclusion, 
the new EIAs employing P1-enriched antigen were found highly 
appropriate for routine diagnosis of acute M .  pneumoniae infection. 
101661 Comparison of 11 commercial tests for IgG 
serodiagnosis of previous or persistent Chlamydia pneumoniae 
infection 
C. Hermann, K. Graf, T. Hartung 
Konstanz, D 
Persistent infection with Chlamydia pneumoniae (C.P.) has been suggested to 
be implicated in the pathogenesis of chronic and destructive diseases like 
asthma, sarcoidosis, lung cancer, Alzheimer's disease and atherosclerosis. To 
date, the microimmunofluorescence (MIF) test represents the gold standard 
for serological routine diagnosis. However, carrying out a MIF requires 
experience and there is s t i l l  lack of standardization. Partially automated 
ELISA and EIA have been developed, which are more standardized and less 
subjective. The different commercially available serological tests differ in 
sensitivity and specificity dependmg primanly on the antigen used. A 
reliable C.p. diagnostic is crucial for prospective studies, investigation of the 
association of chronic disease with previous or persistent C.p. infections, 
and for treatment of patients. Therefore, we evaluated 11 different tests, to 
assess IgG antibodies in serum samples of 80 healthy volunteers. 10 tests 
were species specific (4 MIF, 3 EIA, 3 ELISA) and one was a genus-specific 
rELISA. The MIFs use purified elementarybodies from C.P., which are 
freed from cross-reactive LPS. The ELISA/EIA employ complete, LPS- 
containing C.p. antigens or various LPS-fiee C.p. preparations. An 
exception represents the rELISA, which uses a chemically defined, 
Chlamydia-specific LPS & p e n t .  For interpretation of the results, we 
defined an internal standard a sample had to be positive in at least 6 of the 
species-specific assays to be judged as positive; a sample was considered 
negative, if it was positive in less than 3 assays. Based on this internal 
standard we found 66% of the samples positive, whde 8% were false positive 
in some tests. The correlation between the different MIF ranged from 82- 
99% and from 78-96% between the MIF and the Merent  ELISA/EIA. 
Comparison of the IgG titea, measured by MIF, showed a good agreement: 
( p =  0.78-0.96). This analysis revealed that some ELISA/EIA and rELISA 
fail to detect samples with low IgG titer. The positive predictive values of 
the species specific tests varied tiom 98 to 100% and the negative predictive 
values from 60-99%. These results indicate that serological assays have to be 
carefully selected for epedemiological and therapy studies. 
/01671 Role of corticotherapy in the persistence of urinary 
antigen of Legionella pneumophila and in the evolution of 
Legionella pneumonia 
N. Sopena, M. L. Pedro-Botet, E. Reynaga, M. Garcia, J. Dominguez, L. 
Matas, M. S a b 6  
Badalona, E 
Introduction: Urinary antigen has become the main tool for the diagnosis 
of Legionella pneumonia. The excretion of this antigen may persist fiom a 
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few weeks to several months after pneumonia, although the related 
factors are not well known. Cellular immunity plays an important role 
in the containing and eradication of Legionella. Corticotherapy may 
influence the evolution of pneumonia and the duration of Legionella urinar 
antigen excretion. 
Objectives: To know the influence of corticotherapy in the persistence of 
antigenuria of Legionella pneumophila and in the evolution of pneumonia. 
Methods: We studied 62 patients with pneumonia caused by Legionella 
pneumophila serogroup 1 dagnosed by positive urinary antigen (enzimoim- 
munoassay &om Binax, Portland, Maine), who were followed monthly 
until negativity of the test. Seventeen patients had been treated with 
corticoids before and/or after the diagnosis, while the other 45 had not. No 
differences in the demographc characteristics and risk factors were observed 
between the two groups, although patients with corticotherapy more 
hequently received chemotherapy (29.4% vs. 6.6%, P= 0.02). 
Results: The antigenuria persisted for one or more months in 14 (82.3%) 
patients on corticotherapy vs. 18 (40%) patients fiom the other group 
(P=O.O07), and two or more months in 10 (58.8%) and 5 (ll.l%), 
respectively (P' 0.0002). Patients with corticotherapy acheved apyrexia 
later than the others (time to apyrexia 3 48 h 52.9% vs. 17.8%, respectively, 
P=OO.8). No differences were observed in either the rate of nosocomial 
acquisition or bilateral pneumonia. There were no statistically significant 
differences in the evolution (complications and mortahty) between the two 
groups, although recurrence (2 cases) was only seen in the goup treated 
with corticoids. 
Conclusion: Patients with Legionella pneumonia on corticotherapy have a 
longer persistence of antigenuria and a more prolonged time to apyrexia 
after initiation of antibiotics. However, the outcome of patients with 
Legionella pneumonia does not appear to be influenced by comcoids use. 
101681 Diagnosis of atypical pneumonia by PCR-based assay: 
simultaneous detection of legionella (non)-pneumophila, 
Chlamydia pneumoniae and Mycoplasma pneumoniae 
A. van der Zee, C. de Jong, H.  Verbakel, P. Schneeberger, W. Dorigo- 
Zetsma, M. Peeters 
Tilburg, Dee Bosch, Bilthooen, NL 
Atypical pneumonia often lacks specific symptoms and can be due to 
Legionella (non)-pneumophila, Chlamydia pneumoniae and Mycoplasma pneu- 
moniae. Conventional diagnosis (serology, culture) of these bacteria has been 
very difficult and was often hampered by low sensitivity. We developed a 
highly sensitive PCR-based assay with three sets of compatible primers 
specific for each of the three above mentioned microorganisms. In a single- 
tube multiplex P C R  it is now possible to detect simultaneously the presence 
of one of three major causative agents of atypical pneumonia. To  allow 
vahdation of the multiplex PCR assay we investigated a large number of 
samples hom well-documented patients with pneumonia and compared the 
results of multiplex PCR with the results obtained with different separate 
PCR's for Legionella (non)-pneumophila, Chlamydia pneumoniae and Myco- 
plasma piaeumoniae. 
Usefulness of sputum culture for the diagnosis of 
bacterial community-acquired pneumonia in HIV infected patients 
E. Cordero, J. Pachbn, A. Rivero, J. A. Girbn, J. G6mez-Mateos, M. D. 
Merino, M. Torres-Tortosa, M. Gon.dez-Serrano, L. Aliaga, A. Collado, J. 
Hemindez-Quero, A. Barrera, E. Nuiio 
Sevilla, Mhlaga, Ciidiz, Huelva, Algeciras, LA Linen de la Concepci6n, Granada, 
Almenh, Jerez de la Frontera, V&z-Mhlaga, E 
Introduction: The use of sputum culture in immunocompetent patients 
with community-acquired pneumonia (CAP) has been controversial. In HIV 
infected patients the usefulness of this technique has not been evaluated. 
Objectives: To determine the usefdness of Sputum culture for the 
etiological diagnosis of bacterial CAP in HIV infected patients. 
Methods: A prospective, observational, hospital-based study of consecutive 
cases of bacterial CAP was carried out in 12 hospitak in Andalucia 
(Southem Spain). Only good quality sputum samples were cultured (< 10 
squamous cells and > 25 leukocytes/low-power field). Definitions: (a) 
Definite bacterial CAP: fever and/or respiratory symptoms, a new 
pulmonary infiltrate and an etiological diagnosis. A bacteria was considered 
as the cause of CAP when it was isolated as a single or multiple pathogen in 
sterile fluids, or when it was the only organism isolated in respiratory 
samples. @) Presumed bacterial CAP: fever and/or respiratory symptoms 
and cure with antibacterial treatment (different to cotrimoxazole), or 
prescription of only bacterial treatment in those patients who died. 
Results: 355 cases of bacterial CAP were included. An etiological 
diagnosis was obtained in 190 cases (53.2%). The most fiequent 
etiologies were Streptoroms pneumoniae (74 cases), Pseudomonas aeruginosa 
(34 cases), Haemophilus infuenrae (26 cases), Rhodococcus equi (12 cases) 
and Staphylococcus uureus (11 cases). Sputum was cultured in 313 cases 
(88.1%), being diagnostic in 108 patients (35.6%). The diagnostic 
yield of other samples were: blood cultures 22.7% (75/329), bronchoal- 
veolar lavage 36.6% (11/30), protected specimen brush 33.3% (6/18), 
transbronquial biopsy 33.3% (2/6), bronquial aspirates 34.6% (9/26), 
transthoracic needle aspiration 61.1% (11118) and pleural 5uid 34.6% 
(9/26). Considering the gold-standard for the dngnosis of bacterial CAP 
the isolates in sterile samples, sputum cultures identified the same 
microorganism that sterile samples in 26 of the 27 (96.3%) patients in 
who both samples were diagnostic. The relationship between microbiologic 
tindings in sputum samples and in those obtained by bronchoscopic 
techniques were concordant in 7 of the 8 cases in which both were 
positive (87.5%). 
Conclusions: These results suggest that sputum culture is an useful technique in 
the diagnosis of CAP in HlV-dected patients. Moreover, it may performed in 
an important propomon of cases given its availability and easy performance. 
101701 Procalcitonin measurement in bacterial and viral 
respiratory tract infections in children 
C. Prat, J. Dominguez, C. Rodrigo, M. Gimknez, M. Azuara, C. Ramil, V. 
Ausina 
Badalona, E 
Objective: T o  evaluate the usefulness of procalcitonin (PCT) measurement 
to distinguish between respiratory tract infections of bacterial vs. viral origin 
in children. 
Methods: Were eligible for the study entry children admitted to Pediatric 
Emergency Department presenting clinical signs of respiratory tract 
infection. Blood cultures, serum and urine samples, and nasopharyngeal 
aspirates were collected. A serum sample was stored at -20 "C for PCT 
measurement. Bacterial pneumonia was diagnosed in 26 patients. The 
etiology was S .  pneumoniae in 14 patients (blood culture isolation in 3 
patients and urinary antigen detection by counterimmunoelectrophoresis in 
all of them), Mycoplama pneumoniae in 8 and Chlamydia sp. in 4 patients 
(specific antibodies detection in serum). Viral bronchiolitis or pneumonia 
was diagnosed in 20 patients by direct immunofluorescence on nasophar- 
yngeal aspirate (11 Influenza A, 8 Respiratory Sincitial Virus and 1 
Adenovirus). PCT was measured by immunoluminometric assay (Lumitest 
PCT Brahms Diagnostica) 
Results: The mean PCT value for respiratory tract infection was 1.033 ng/ 
mL (range 0.1544.85). The mean PCT value for bacterial respiratory tract 
infection was 9.08 ng/mL (0.268-38.2). When differentiating pneumo- 
coccal pneumonia t?om other bacterial etiologies, the mean PCT values 
were 13.23 ng/mL (0.53-38.2) and 4.01 ng/mL(0.268-20.7), respectively. 
Sensitivity and specificity of PCT in distinguishing between bacterial and 
viral respiratory tract infection, using 2 ng/tnL. as the cut-off, were 79.16% 
and 90%, respectively. Sensitivity of PCT in distinguishing pneumococcal 
etiology was 92.85%. 
Conclusion: Procalcitonin is a useful marker to distinguish between bacterial 
and viral respiratory tract infection at the onset of symptoms and it can 
help to distinguish pneumococcal pneumonia from the other usual 
etiologies in children. 
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Epidemiology of antimicrobial resistance 
Incidence of invasive penicillin nonsusceptible 
streptococcus pneumoniae and methicillin-resistant 
Staphylococcus aureus in The Netherlands: data from the EARSS 
project (1 999) 
W. G. Goettsch, A. J. de Neeling, the Dutch EARSS Laboratories 
Bilthoven, NL 
Objective: To provide an estimate of the incidence of susceptible and 
nonsusceptible invasive S. pneumoniae and S. aureus infections in The 
Netherlands within the framework of European Antimicrobial Resistance 
Surveillance System (EARSS). 
Design: Prospective incidence survey in medical microbiological labora- 
tories in The Netherlands in 1999. 
Methods: Data on the hospital and community coverage of the participating 
laboratories were collected fiom different sources in order estimate EARSS 
coverage and to calculate incidences of resistant pathogens. Susceptibility 
data on S. pneumoniae and S. aureus were electronically extracted from 
local laboratories. 
Results: Data on the catchment population were estimated using adherence 
data fiom hospitals, which were served by the EARSS laboratories. Data on 
the hospital coverage (in patient-days) were derived from a Dutch Hospital 
Institute (Prismant). These data indicated that the E A R S  project covered 
approximately 40% of the Dutch population and hospitals. In 1999 
susceptibility data on 1259 invasive S. aureus isolates and 767 invasive S. 
pneumoniae isolates were collected &om 21 laboratories. Resistance to 
oxacillin in S. aureus was low, only 4 (0.3%) isolates were MRSA (mecA 
positive). Penicillin resistance in S. pneumoniae was minimal; only 9 of 767 
(1.2%) isolates were PNSP. These strains had all MICs of 1 mg/L or lower. 
The incidence of invasive S.  pneumoniae infections was 117 cased10 000 
000 person-years; the incidence of invasive PNSP infections was 1 case/l 
000 000 person-years. The incidence of invasive S. nureus infections was 
0.25 cases/ 1000 patient-days; the incidence of invasive MRSA infections 
was 0.0006 cases/1000 patient-days. 
Conclusions: U n d  recently mostly data on the prevalence or percentage of 
resistance in The Netherlands were presented. In this study, we calculated 
the incidence of invasive PNSP and MRSA infections in The Netherlands 
in 1999, which was still very low. In a next step these incidence data will be 
coupled to clinical diagnosis and outcome data in order to assess the public 
health iniplications of these resistant cases. 
/0172/ Prevalence of antimicrobial resistance in enterococci in 
Australian teaching hospitals 
J. Bell, L. Femandes, G. Coombs, C. Femandes 
Adelaide, Sydney, Perth, A U S  
Objectives: Two national surveys, in 1995 and in 1999, were undertaken hy 
the Austrahan Group on Antimicrobial Resistance (AGAR). The objectives 
were to study the prevalence of antimicrobial resistance in Enterococcus 
species to ampicdin, vancomycin and aminoglycosides, to determine species 
distribution and to define the minimum set of tests required for accurate 
identification. 
Methods: Participating laboratories collected 100 consecutive clinically 
significant isolates during each period and performed their routine 
identification and susceptibility tests. All non-E. fuecalis and strains that 
tested as resistant to ampicillin, vancomycin or high-level aminoglycosides 
were forwarded to one of two coordinating centres who performed MIC 
testing by agar dilution, verified their identity by detailed biochemical tests 
and confirmed identity and genotype by PCR. 
Results: Eighteen laboratories participated. Several observations were made 
between the two studies. Accurate speciation of non-E.faecalis continues to 
be a problem with commercial identification systems. There was an increase 
in the proportion ofE.-fieciurn isolated in 1999-(9.7%) compared with 1995 
(5.1%). Minor changes were noted in the proportions of strains isolated 
from blood and other sterile sites and €rom wound infections. No 
vancomycin resistance was detected in 1995, however, 6 (0.3%) strains 
were resistant in the 1999 survey. Five were E.faecium (2 vanA, 3 vanB) and 
I vanB E. juecalis. One E. jaeculir isolate in 1995 produced beta-lactamase; 
none in 1999. O f  interest was a significant increase in high-level 
aminoglycoside resistance in both E. faecalis and E. faecium. Ampicillin 
resistance in E .  faedum also increased kom 57% in 1995 to 77% in 1999. 
Conclusions: The emergence of vancomycin resistant enterococci has 
highhghted the need for accurate speciation and susceptibility testing. 
Significant changes have occurred in Australian isolates since 1995 which 
emphasises the need for continual surveillance. 
0173 I Multiresistant Salmonella enterica semvar 
typhimurium phage type U302 associated with foreign travel 
R. A. Walker, E. A. Lindsay, L. R. Ward, E. J. Threlfall 
London, UK 
In recent years multiresistant (MR) Salmonella enterica serovar Typhimurium 
definitive phage type (DT) 104 (MR DT104) and related multiresistant 
phage types, including U302 (MR U302), have caused numerous infections 
in many parts of the world. In common with M R  DT104, M R  U302 are 
typically resistant to a m p i c h  (A), chloramphenicol (C), streptomycin (S), 
sulphonamides (Su) and tetracyclines (T) (ACSSuT). Since 1995 the 
Laboratory of Enteric Pathogens (LEP) has received 50 human M R  U302 
isolates with additional resistance to gentamicin (G) and trimethoprim (Tm) 
(ACGSSuTTm). 46% of these isolates were from patients with a history of 
foreign travel, particularly to the Iberian Peninsula. The aim of this study 
was to use molecular techniques to determine the relatedness of these 50 
strains to one another and epidemic MR DT104. All isolates was screened 
using P C R  for the presence of selected genes conferring resistance to 
ampicillin (blaCAR€-2 and blaTEM), chloramphenicol (cmlA, catl, catIII), 
streptomycin (aadA2). sulphonamides (sull), tetracyclines (tetA, tetB, tetG), 
trimethoprim (dhfrI) and gentamicin (aac(3)IV). In addition strains were 
investigated by P C R  for the presence of class 1 integrons, a group of DNA 
elements able to incorporate antibiotic resistance genes. Furthermore 
isolates were characterised by plasmid profiling and pulsed-field gel 
electrophoresis (PFGE). Of the strains examined 43/50 were positive for 
blaTEM, aadA2, sull, tetA and aac(3)IV. The remaining seven strains had 
various resistance gene profiles. Only three isolates had a protile that 
included the five resistance genes (blaCARB-2, cmlA, aadA2, sull, tetG) 
normally associated with M R  DT104. Class 1 integrons were present in 49 
strains and five integron profdes (IP) were identified. The IP-I profile, 
which consisted of a 0.2 and 1.85kb integron was identified in 80% of 
isolates. All isolates possessed a large plasmid > 95kb. The 95kb serovar 
specific plasmid normally associated with M R  DT104 was absent from all 
strains tested. All isolates produced PFGE patterns that could be 
distinguished from the predominant M R  DT104 PFGE profde and 45 
stram formed a distinct group with closely related PFGE profiles. These 
results show that the majority of MR U302 resistant to ACGSSuTTm 
constitute a lineage that can be Merentiated from MR DT104 by several 
&&rent molecular methods. Such isolates were associated with foreign 
travel and may therefore have emerged outside of the UK. 
101741 Current trends in fluoroquinoione resistance among 
fscherichia coli in Spain: year 2000 results from the TSN-Spain 
database 
R. Canton, E. Bouza, C. Garcia-Riestra, J .  A. Garcia-Rodriguez, M. 
Gobemado, J .  Linares, E. J. Perea, E. Perez-Trallero, J. J .  Picazo, J. A. 
Karlowsky, D. C. Mayfield, R. N.  Master, D.  F. Sahm, M. E. Jones 
Madrid, Santiago, Salamanca, Valencia, Barcelona, Seville, San Sebastian, E; 
Herndon, U S A ;  Utrecht, NL 
Objectives: T o  evaluate the recently created TSN-Spain (TSN-ES) 
database, we examined the current status of E. coli (EC) resistance to 
fluoroquinolones (FQs) and the prevalence of concurrent resistance to other 
antibiotics among FQ-resistant (R) EC, in Spain. 
Methods: TSN uses internet technology to collect routine, daily clinical 
microbiology data fiom 16 laboratories in Spain. AU data undergoes 
stringent quality control before being merged into the database. Patterns of 
antibiotic resistance were determined using M R L  proprietary software. Data 
fiom January 1999 to October 2000 were interpreted using NCCLS criteria. 
Results: The preliminary TSN-ES database contained results from 23 523 
EC isolates. Rates of FQ resistance per hospital ranged from 12.4% to 
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33.1%. Overall rates of resistance to ciprofloxacin (CIP) and ofloxacin were 
17.3 and 16.3%, respectively, for isolates from blood 15.8 and 18.7% for 
lower respiratory tract (LRT) isolates; and 18.9 and 17.3% for urinary 
isolates. Using CIP as a marker, FQ resistance among urinary isolates was 
demonstrated to be associated with resistance to other antibiotics. For EC 
susceptible (S) and resistant (R) to amoxicillin-clavulanate, the rates of FQ 
resistance were 15.6 and 38.8%. Likewise for cephalothin-S and -R isolates, 
the rates of FQ resistance were 13.4 and 41.3%; for fosfomycin-S and -R 
isolates, 20.4 and 72.7% were FQ-R; for nitrofurantoin-S and -R isolates, 
15.1 and 46.3% were FQ-R; and for trimethoprim-sulfamethoxazole-S and 
-R isolates, 8.4 and 42.3% were FQ-R, respectively. A similar association 
between resistance to a FQ and resistance to other agents was observed for 
isolates derived from blood and the LRT. FQ resistance increased with 
patient age, with 4.9% of isolates from patients aged < 17 years, 15.4% of 
isolates from patients 18-64 years, and 24.5% of isolates from patients aged 
>65 yean being FQ-R. EC from males (22.2%) were more FQ-R than 
isolates from females (16.7%). 
Conclusion: TSN-ES demonstrated that FQ resistance among EC in Spain is 
highly prevalent (range 15.8-18.9%) for all sites of infection and comparable 
to data presented in previous publications. Of particular note, was the rate of 
FQ resistance (4.9%) among paediamcs and the FQ resistance rates among 
isolates resistant to other antibiotics. We conclude that an electronic 
surveillance system can comprehensively track aspects of emerging resistance 
in clinically important pathogens, such as EC. 
lmipenem resistant Acinetobacter baumannii with 
carbapenem hydrolyzing beta-lactamase in a Korean Hospital 
M. N. Kim, S. J. Ryu, Y.  J. Pya, C. H. Pai 
Seoul, KOR 
Objectives: A. baumannii accounts for 4-5% of total isolates from clinical 
specimens in Asan Medical Center; r. 1500 strains per year. Since late 1998, 
imipenem (IMP) resistance has emerged in A. baumannii and the rate of IMP 
resistance has been steeply increased to 20% in 2000. We purposed to 
elucidate the risk factors of transmission and resistance mechanism of IMP 
resistant A .  baumannii (Irab). 
Methods: For a period from Jan 1999 to Mar 2000, 38 patients growing 
IRAB were retrospectively reviewed for demographic findings, wards, 
hospital stays, underlying diseases, invasive procedures, and histories of 
infections and antibiotic treatments. I F U B  isolates were tested for idendcation 
and antimicrobial susceptibility tests with McroScan Type 21 panel (Dade- 
Bebring, USA); 22 IRAB isolates were tested for MIC to IMP by Etest (As 
BIODISK, Sweden), and typed with pulsed field gel electrophoresis of genomic 
DNA cut with SmaI and ApaI, respectively. tsoelecaic focusing (LEF) of 
bacterial lysates was carried out on PhastGel @H 3-9, Pharmacia Biotech, 
Sweden) and beta-lactamase bands were visualized with nitrocefin. 
Carbapenem hydrolyzing activity was assayed with cloverleaf method using 
10 pg imipenem disk (BBL, USA) and E. coli ATCC 25922. 
Results: Six patients were colonized with IRAB and 32 patients had 35 
infections of IRAB, including as pneumonia (to), wound infection (15), sepsis 
(3), cholecystitis (4), ascites (2). and pleurisy (1). All were nosocomial and 19 
patients (6Ph) had hktory of stay in the intensive care unit. All patients were 
treated with IMP or broad spectrum cephem or ciprofloxacin. IRAB was 
preceded by susceptible one in 15 patients, 14 ofwhom were treated by IMP. All 
isolates tested (22 isolates) had IMP MIC of > 16 mg/L and showed carbapenem 
hydrolyzing activities. IEF analysis revealed multiple beta-lactamases with PI 
varying from 4.5 to >9.0 except one. 11 isolates were resistant to all 
antimicrobials of Type 21 panel and 10 of those showed same PFGE pattern 
and had four beta-lactamases of pI 4.5, 5.4, 6.3, and >9.0. 
Conclusion: IRAB infections were associated with use of broad spectrum 
antibiotics and ICU stay. There was an evidence suggesting the clonal 
spread of multiresistant IRAB and carbapenem-hydrolyzing beta-lactamase 
contributed to the IMP resistance. 
101761 The identification of VIM carbapenemases in 
Pseudomonas aeruginosa clinical isolates since 1992 in Athens, 
Greece 
I. Galani, P. Grecka, H. Giamarellou 
Maroussi Attikis, GR 
Introduction: The development of hgh-level resistance to carbapenems is a 
well established reality in Greece which, however, cannot be attributed to 
the overwhelming presence of metalloenzymes such as IMP-1 (P. Grecka et 
al. Abstr. 82031 8th ICI, Boston, MA. 1998). 
Objective: After the report in 1999 of the isolation of a novel class of 
carbapenemases (VIM), we investigated its presence in 23 carbapenem- 
resistant (CR). P.  aeruginosa isolates coming from different tertiary hospitals 
in the metropolitan area of Athens, different patients and different sources 
(pus, urine, sputum) collected during the 1992-95 period along with 35 C R  
strains isolated in the Univenity Infectious Diseases Department since 
January 2000. 
Methods: MICs of Imipenem (IMP) and Meropeneni (MER) were 
determined by the nucrodilution technique, the serotyping of the strains by 
the application of the Difco commercial kit, PFGE profiles were analyzed 
after treatment of the isolates by Spe-1 whereas the blaVlM gene in purified 
total DNA (Quiamp DNA Minikit) was amplified by P C R  using the pair of 
primers described by Poirel et al. (AAC, 2000). 
Results: In four of the 23 strains with MIC levels of IMP 2 128/mL and 
MER 2 8 micro/mL with different PFGE profiles and which belonged to 
the 05 (2 strains), 01 and 012 serotypes the presence of blaVIM was crearly 
shown. Among the recently collected mutants only one,with MICs of IMP 
and MER 64 pg/mL and 16 pg/mL exhibited P C R  product compatible 
with the presence of the aforementioned gene. 
Conclusions: It is evident that the presence of the blaVIM gene (i) is 
established in Greece in the area of Athens well, (ii) should be 
retrospectively investigated in a l l  C R  P. aeruginosa isolates and (iii) can be 
speculated along with other mechanisms of beta lactam resistance in cases of 
strains with high level resistance to carbapenem. 
[01771 Comparability of microbiological susceptibility test 
results from 23 European countries and Israel: the European 
antimicrobial resistance surveillance system (EARSS)/NEQAS 
study 
U. Buchholz, S. Bronzwaer, J. Snell, P. Courvalin, G. Comaglia, J. de 
Neeling, J. Kool, J. Degener 
Bilthoven, NL; London, UK; Pans, F; Verona, I; Groningen, NL 
Introduction: EARSS is a n  expanding network of national surveillance 
systems collecting data on antimicrobial resistance. At present, Streptococcus 
pneumoniae (SPN) and Staphylococcus aureus (SAU), are surveyed. For the 
interpretation of susceptibility tests a European guideline does not exist, 
which might confound international comparability of antimicrobial 
susceptibility testing. We used a QA scheme to assess the comparability 
of susceptibihty test results among European laboratories participating 
in EARSS. 
Methods: Test strains were characterized by three reference laboratories. In 
September 2000, UK NEQAS distributed a set of three SPN strains and two 
SAU strains. To test the ability to identify glycopeptide resistance in 
staphylococci, one S. huemolyticus strain (SH) resistant to teicoplanin was also 
included. Laboratories reported the guideline followed, the interpretation of 
the susceptibility test result and the minimal inhibitory concentration (MIC) 
if tested. Results were scored for correct interpretation of susceptibility/ 
nonsusceptibility of penicillin in SPN and oxacillin in SAU. 
Results: Overall, 433 (90%) of 482 laboratories from 23 (100%) countries 
reported back. The NCCLS guideline was the most frequently followed, by 
48% of laboratories from 19 countries. Any other guideline was not 
followed by more than 5% of laboratories. Concordance for detection of 
penicihn resistance in the three SPN strains was 96% (country-spec& 
standard deviation (CSD] = 5%; guideline-specific standard deviation 
[GSD] =2%), 90% (CSD= 10%; GSD= 13%) and 87% (CSD=29%; 
GSD = 18%). Concordance for detection of oxacillin resistance in the 
SAU strains was 100% (CSD=l%; GSD=2%) and 78% (CSD= 17%; 
GSD = 13%). Concordance for detection of teicoplanin resistance in the SH 
strain was 82% (CSD = 24%; GSD = 27%). Quantitative methods yielding 
an MIC were more concordant than non-MIC methods for the SPN strains 
(94% vs. 79%) and in detection of teicoplanin resistance in the SH strain 
(91% vs. 71%). For SAU, MIC-methods were sirmlar to non-MIC methods 
(88% and 89%). 
Conclusions: In this EARSS study, NCCLS guideline is the most widely 
followed. For surveillance purposes and the strains tested, comparability 
among European countries and across guidelines is satisfactory. However, 
penicillin nonsusceptibility in SPN strains as well as glycopeptide 
nonsusceptibility in staphylococci need to be confirmed by determination 
of an MIC. 
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101781 Analysis of primary resistance to clarithromycin of 
Helicobacter py/ori strains isolated from children 
E. Rozynek, K. Dzierzanowska-Fangrat, D. Celinska-Cedro, P. Jozwiak, 
D. Dzierzanowska 
Warsaw, PL 
Objectives: The aim of our study was to correlate the results of in vitru 
activity of clarithromycin against clinical isolates of Helicobacter pylon' 
determined by agar dilution procedure with genetic resistance pattern. 
Materials and methods: Fifty strains of H .  pylon' isolated from gastric biopsy 
specimens obtained from children before treatment were tested. Isolated 
strains were kozen at -70 "C in Brucella broth with 25% glycerol. The base 
medium for the agar dilution test was Mueller-Hinton agar containing 7% 
horse blood. The range ofclarithromycin concentrations was 0.003 mg/L to 
256 mg/L. Bacterial inoculum used for testing was adjusted to a density 
Pathogenesis of Gram-negative bacterial infections 
equivalent to a no. 2 McFarland standard. Antibiotic containing plates were 
inoculated using a standard replicator. All plates were incubated for 3 days 
under microaerophilic conditions at 37 "C. T o  evaluate the mechanisms of 
primary resistance of H. pylon' to clarithromycin the pattern of point 
mutations in the peptidyltransferase region of the 23s rRNA was analyzed 
by use of PCR-RFLP techmque. Amplified DNA hgments were 
incubated with restriction enzymes BsaI and BbsI enabling to detect A-G 
mutations at positions 2143 and 2142, respectively. 
Results: Twenty-one strains (42%) of H .  pylon' had clarithromycin MIC 
values >256 mg/L, and most of them showed A-G point mutations at 
position 2143. Four resistant strains had neither A2143G nor A2142G 
mutations. 
Conclusions: The primary resistance to clarithromycin was mainly 
associated with point mutation A-G at  position 2143. Approximately 
14% of tested strains had different mechanisms of resistance to clarithro- 
mycin, other than A2143G and A2142G mutations. 
vl Salutary physiological response to 
immunoneutralization of calcitonin precursors in septic pigs 
E. S. Nylen, R. H. Snider, K. L. Becker, B. Muller, K. Wagner, J. C.  Whne 
Wahingfon,  USA; Easel, CH 
Objective: Procalcitonin (ProCT) and its component peptides (collectively 
termed calcitonin precursors [CTpr]) are important markers and mediators 
of sepsis. Previously, we have shown that septic hamsters malufest enhanced 
survival when given an antiserum reactive to CTpr. In this study, we sought 
to evaluate the effect of immunoneutralization of CTpr on metabolic and 
physiologic parameters of sepsis in a porcine model. 
Methods: Sepsis was induced in 12 Yorkshire p~gs by intraperitoneal 
instillation of a suspension of cecal content (1 g/kg) and Eschen'chia coli 
(2 x 10" cfu). One hour prior to induction of sepsis, 5 pigs received an 
intravenous infusion of purified antiserum to the 57 amino acid 
aminotetminal peptide of porcine ProCT (N-ProCT), while control 
atumals received nothing. All animals had physiologic data (urine output, 
core temperature, arterial pressure, heart rate, cardlac index, and stroke 
index) and metabolic data (blood urea nitrogen, serum creatinine, arterial 
lactate, pH, ionized calcium and serum phosphate), collected or recorded 
hourly until death or euthanasia (15 h). 
Results: In this large animal model of lethal peritonitis, serum CTpr were 
significantly elevated. Antiserum administration resulted in a significant 
attenuation of a majority of the measured physiologic and metabolic 
derangements induced by sepsis. Treated ammals also experienced a 
statistically significant increase of short-term survival. 
Conclusion: This is the first time that data &om a large animal model with 
clinically relevant sepsis have demonstrated the salutary effect of 
immunoneutralization of CTpr upon physiological parameters, supporting 
the notion that the endogenous CTpr response is toxic. Furthermore, 
immunological blockade of CTpr may offer a novel therapeutic approach to 
human sepsis. 
/]/The effects of ibuprofen on the physiology and 
survival of rabbit endotoxic shock 
I. Celik, A. Akbulut, S. Kilic, A. Rahman, P. Vural, M. Canbaz, S .  Felek 
Elazig, TR 
Despite the phenomenal increases in the diagnosis and the treatment of 
diseases, a sigdicant rate of morbidity and mortality s t i U  exist for septic 
shock. Many phamiacological agents are investigated for the purpose of 
reduction of high mortality rates in septicemia. In the present study, 
intluence of ibuprofen on the vital functions and suMval during endotoxic 
shock were investigated. A total of 28 rabbits were allocated into 4 groups 
randomly. The first group received only saline and served as the control 
animals. The rest of the animals were injected with endotoxin intravenously 
at 2 mg/kg dose. To the third group, 30 min following endotoxin 
administration ibuprofen a t  30 nig/kg dosage was given whereas in the 
fourth group animals, ibuprofen was administered 30 min before endotoxin 
administration. Animals were monitered through femoral arteria and 
venules. Total blood count, thromboxane B2 and blood gase content 
determinations were carried out at 0, 30, 60, 90, 120, 180 and 240 min 
following endotoxic shock. For prostaglandin E2 determinations, urine 
samples were collected at the time points as noted above. The undesirable 
effects of endotoxic shock on respiration number, heart rate, blood pressure, 
blood pH, and plasma HCOJ were alleviated by ibuprofen a b s t r a t i o n .  
However, ibuprofen did not better the negative effects of endotoxic shock 
on body temperature, hematocrit value, white blood cell count and the 
number of thrombocytes. In animals from group ni., TxB2 values were 
significantly lower than the rest of the animals and the increase in TxB2 
values started later than the others. In all ibuprofen adnunistered animals, 
PGE2 levels were decreased for a t  least 90 min and started to increase 
thereafter. W e  the average survival in group I1 ammals was 192.9 + 46.9 
min, in animals from group 111, and IV were 339.1 + 33.5 min ( P =  0.026) 
and 383.0 + 39.6 min (P=O.009), respectively. In conclusion, the results of 
the present study indicate that ibuprofen increase the survival in a n i m a l s  
with endotoxic shock. 
/01811 Relation of endotoxin and cytokine levels to antibiotic- 
induced morphological changes of €. co/i in neutropenic mice, 
comparing 4 different beta-lactam antibiotics 
J. Buijs, A. DofferhoE, J. Mouton, J. van der MeeI 
Kerkrade, Nijmegen, NL 
Objectives: Aztreonam and ceftazidime bind to penicdlin-binding protein 
(PBP)-3 on E. coli cell walls, leading to proliferation without septation and 
fomiation of long bacterial strands, i.e. filaments. Imipenem and 
meropenem bind to PBP-2, causing formation of large rounded cells, i.e. 
spheroplasts. In vitro, lysis of filaments is associated with excessive 
endotoxin-liberation tiom the cell-wall in comparison to normal bacteria 
and spheroplasts. We hypothesized that beta-lactarn-induced morphological 
changes of E. coli irr v i m  may lead to stimulation of the cytokine-cascade 
with a worse clinical outcome of Gram-negative infections. 
Methods: Fifteen neutropenic Swiss mice were challenged with 0.94 x lo7 
CFU of E. coli ATCC 25922 in the left thigh muscle. Two hours after 
inoculation they were treated with aztreonam, ceftazidime, imipenem, 
meropenem or saline 0.9% intravenously in groups of three. Antibiotic 
dosages were adjusted to 200 x MIC peak-level (0.05 mg, 0.05 mg, 0.005 
mg and 0.05 mg, respectively). Four hours after treatment, all mice were 
sacrificed for bacterial cell counts (CFUs) in muscle, spleen and liver, 
morphological stuhes of the bacteria (HE- and fluorescence-studies), 
collection of plasma for TNF-alpha, IL-6 and endotoxin-levels. 
Results: In the 4 treatment groups, reduction of CFUs in muscle, liver and 
spleen was comparable to controls. Mice treated with aztreonam or 
ceftazidime showed massive filament-formation in histological sections. 
Thigh muscles of imipenem and meropenem treated mice showed 
spheroplast-formation. whereas in controls Gram-negative rod$ were seen. 
In the treated groups, significant higher TNF-levels were found ( P =  0.007), 
particularly in the filament-group. Circulating IL-6-levels demonstrated a 
high correlation ( P =  0.01 level) with TNF-concentrations. Endotoxin- 
levels tended to be lower in the antibiotic treated mice. 
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Conclusion: Use of beta-lactam antibiotics in E .  coli-sepsis in mice causes 
filament-and spheroplast-formation and higher circulating TNF-levels, 
particularly in the filament-group. Antibiotic-induced morphological 
changes of bacteria may be related to an adverse clinical outcome of sepsis, 
and should be prevented by an adequate choice of antimicrobial agent and 
dosing-regimen, paying special attention to the antibiotics PBP-specifity. 
101821 Beta-lactam induced bacterial filaments in a murine 
thigh model: a study of cytokine patterns and morphology after 
a second dose of antibiotics 
J .  Buijs, A. Dofferhoff, J. Mouton, J. van der Meer 
Kerkrade, Nijmegeri, NL 
Objectives: In Gram-negative bacteria, beta-lactam-antibiotics like ceftazi- 
dime may induce formation of filaments, i.e. large strands ofbacteria that are 
capable of dividing but not septating. Previous in uifro studies demonstrated 
excessive endotoxin release after filament lysis. We studied the in uiuo 
consequences of this phenomenon by exposing ceftazidime-induced 
bacterial filaments to a second dose of antibiotics. We hypothesized, that 
this might provoke excessive endotoxin-release from the filament cell wall, 
leading to production of pro-inflammatory cytokines such as TNF-alpha 
and IL-6 and negative effects on the host. 
Methods: Twmty-two neutropenic Swiss mice were challenged with a 
dose of 1.60 x lo7 and 0.73 x lo7 E. roli ATCC 25922 in the left thigh 
muscle. Two hours after inoculation, ceftazidime 20 mg/kg (peak level 
200 x MIC) was given intravenously in the tail vein to induce bacterial 
filament-formation. Four hours later, a second dose of ceftazidime 20 mg/ 
kg or tobramycin 20 mg/kg or saline for control was given. After 0.5 and 1 
h, mice were sacrificed for morphology studies, bacterial cell-counts (CFUs) 
in muscle, liver and spleen, and plasma was collected to measure TNF and 
IL-6 concentrations. 
Results: Compared to controls, filaments were shorter in the tobramycin- 
group, but longer in the ceftazidime-group. Half an hour after the second 
dose of ceftazidime, IL-6 levels were significant elevated compared to 
controls (P < 0.05), despite lower CFUs of E. coli in h g h  muscle in these 
mice. One hour after the second dose, IL-6 concentrations were still hlgher 
in the treated mce.  In the groups treated with tobraniycin, IL-6 levels also 
appeared higher, but statistically not significant (P=O.30). TNF was below 
the detection limit of 0.20 ng/mL in most mice, with no significant 
difference between groups. 
Conclusions: Challenge of bacterial tilaments with a second gift of 
antibiotics, particularly cetiazidime, may provoke signlficant elevations of 
pro-inflammatory cytokines such as 1L-6. Our in uiuo data support the 
hypothesis that bacterial filaments may lead to excessive endotoxin-liberation 
&om the cell-wall. Therefore, antibiotic-induced filament-formation by Gram- 
negative bacteria is an undesirable effect of antibiotic therapy, and therapeutic 
strategies should aim at preventing this phenomenon. 
1 0183 1 Differential tumor necrosis factor-a expression from 
human monocytes in v/tro, in response to different components 
of P. aeruginosa, through an NFKb dependent mechanism 
G. Lagoumintzis, M. Christofidou, G. Dimitracopoulos, F. Paliogianni 
Patras, GR 
P.  aeruginosa, an oppurtunistic pathogen, is capable of establishing both 
chronic and acute infections in immunocompromized hosts. TNF-a release 
is a cmcial event in the pathophysiology of these infections. To understand 
P. aencgiiiosa-xnonoqe interaction required for TNF-a synthesis, and the 
molecular mechanisms involved in ths  induction, we have treated human 
monocytes with P. aeruginosn purified LPS (5 ng-50 pg/ rd) ,  Slime(5-50 
pg/mL), Exotoxin A (2.5 pg/mL), Heat N e d  or viable bacteria (10 
bactena/monocyte) and measured TNF-a production for 2-24 h. E. coli 
LPS, a potent inducer of TNF-a production was used as positive control of 
monocyte activation. P. aeruginosa slime was found to have TNF-a 
inducing activity similar to that of E. coli LPS or viable P. aeruginora cells 
cocultured with monocytes, which was approximately four-fold greater 
than the activity induced by P. aeruginosa LPS. Exotoxin A and heat N e d  
bacteria did not induce any TNF-a production. To  clarify the molecular 
mechanisms underlying these effects we checked Tyrosine Phosphorylation, 
by Immunoblotting. N o  differrences were observed under the different 
conmtions of stimulation. NFKb transcriptional activity, the most important 
for TNF-a production, was analyzed by EMSA under the same 
experimental conditions (2-12 b). NFKb activation by P. aemginosa slime, 
viable cells and E. culi LPS was equal whereas P. aeruginosa LPS and 
Exotoxin A caused less than 50% of the above mentioned induction. These 
findings indicate that P. aeruginosa slime is essential for TNF-a production 
through an NFKb dependent mechanism and may mediate many of the 
pathophysiology caused by P. neruginosa infection. 
vl Anti-inflammatory modulation of eicosanoid release 
by granulocyte colony-stimulating factor 
S. von Aulock, E.-M. Boneberg, T. Haming 
Konstanz, D 
Recombinant granulocyte colony-stimulating factor (G-CSF, filgrastini) has 
been administered to more than 2 d o n  patients so far. T h s  
hematopoietic growth factor is mostly used to combat neutropoenia. As it 
additionally modulates cytokine release in an anti-inflammatory manner, 
trials on its potential to prevent or reduce severity of postoperative 
infections are ongoing. Common side-effects of G-CSF treatment are bone 
pain and headache. As these are aspirin-sensitive, we examined whether G- 
CSF treatment also modulates eicosanoid response in addition to cytokme 
response. T o  test whether modulation of eicosanoid formation can be 
studied in whole blood incubations ex uiuo, three healthy volunteers were 
given 500 mg acetyl-salicylic acid (ASA) p.0. LPS-induced PGE2 and TxB2 
release were attenuated up to 6 h after drug intake, while LTB4 and TNFa 
release were not affected. In the context of a treatment study in healthy 
volunteers who received 480 pg G-CSF S.C. once or twice, 24 h apart, or 
placebo, the ex uiuo LPS-inducible eicosanoid release was determined in 
whole blood. Net LPS-inducible LTB4 and TxB2 release doubled 8 h after 
G-CSF treatment. PGE2 formation increased 10-fold 8 h afier G-CSF 
injection and returned to pretreatment values 24 h after the injection. As 
LPS-induced TNF-alpha release was decreased in the presence of PGE2 in 
uitro, we investigated whether anti-inflammatory G-CSF effects might be 
mediated via PGEZ release. However, when G-CSF was administered to 
volunteers under ASA therapy, the decrease in ex uiuo release of pro- 
inflammatory cytokines remained unaected. We conclude that the anti- 
inflammatory actions of G-CSF are realized not only by modulation of the 
cytokme response, but also by augmentation of the capacity to fomi the 
immunosuppressant eicosanoid PGE2. Furthemiore, the shon-term boost 
in hyperalgesic PGEZ formation might be linked to the well-known ASA- 
sensitive bone pain often associated with G-CSF treatment. 
101851 Analysis of pathogenicity markers in wild and mutant 
strains of Yersinia enterocolitica 0 8  
H. M. Najdenski, E. N. Golkocheva, A. M. Vesselinova 
Sofa, BG 
Live replicating bacteria are being considered as atractive antigen delivery 
vectors. A variety of attenuated S. typhimurium, Y. eiitevocolitica, M.  
tuberculosis, and L. mortocytogenes mutant strains have been evaluated as 
potential canier vaccines to present heterologous antigens to the immune 
sistems of host.An attractive alternative for creation of attenuated bacterial 
strains is the mutation of genes that code for virulence associated factors. 
The Mn-cofactored superoxide dumutase (sodA) Y. ent. 0:8 mutant, which 
is deficient in resistance to exogenous oxygen radicals produced by 
phagocytes was constructed in the Max Von Pettenkofer Institute for 
Hygiene and Medical Microbiology (Munich, Germany). Assessment of the 
capacity of both wild and mutant strains to produce in uitro Yersiilia outer 
membrane proteins (Yaps) D, E, H, V, as well as their resistance to survive 
in polymorphonuclear leucocytes (PMNL) and to resist the bactericidal 
activity of normal sera from pig and rabbit was the aim of this study. Y. 
enterocoliticn strain WA-314, serotype 0:8, pYV + and its mutant derivative 
WA-314 sodA were used. Serum bactericidal activity was perfomled by the 
method of Pai & De Stefan0 (Inffmmun, 1982, 35, 605-1) with two fold 
ddution of normal rabbit and pig sera. Serum activity was defined as 
bactericidal titer where 50% reduction of the original bacterial inoculum 
during 120 min of incubation was established. K A n g  ability of PMNL was 
camed out according to the method of Vissar et al. (Inf Immun. 1995, 63, 
257tbY). Isolation of excreted proteins, SDS-PAGE and immunoblotting 
were studied as described by Heesemann et al. (Inffmmun, 1984, 46, 105- 
Results: Serum bactericidal activity did not differ in both wild and mutant 
strains-bactericidal titers of 1:4 and 1:16 were observed in rabbit, 
10; Iflfrmmun, 1986, 54, 561-7). 
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respectively, pig sera. Kdling test was camed out with PMNL (as the first 
protective cells against potential bacterial invader) isolated from healthy 
rabbits and pigs. Intracellular survival of mutant strain in PMNL was 
strongly -shed in comparison with the wild one, especially in the pig 
leucocytes. Analysis of protein secretion revealed that all four tested Yops- 
YopD, YopE, YopH and YopV-were produced in vitru by the wdd and its 
isogenic mutant strain in detectable quantities. Evolving a strategy to survive 
and multiply intracellularly, this mutant strain might be an advantageous 
candidate for a carrier vaccine strain. 
/0186/ Complement opsonization of E. coli: a potential new 
mechanism for increased bacterial pathogenicity 
T. Springall, S. H. Sacks, H.  Wan, Y. Hong, N. S. Sheerin 
London,  UK 
Bacterial infection of the kidney (pyelonephntis) has been estimated to 
hospitahze up to 100 000 patients per year in the USA and has been 
implicated as the cause in 15-20% of children reaching end stage renal 
failure. Over 80% of these infections are due to E. coli. Most pathogenic 
strains are also serum resistant, implicating the complement system as an 
important factor in host defence. However, previous work using a iiiunne 
model ofpyelonephritis has shown that mice deficient in C3 have a reduced 
renal infection compared to wild type controls despite comparable bladder 
infection. In uitru, C3 was found to augment internalization of bacteria into 
mouse renal epithelial cells but not to affect bacterial bindmg. To investigate 
whether a similar process takes place in humans the effect of C3 on bacterial 
internalization was assessed by incubating monolayers of human proximal 
tubular cells with pyelonephritic E. coli J96 in the presence of normal (NHS) 
or heat inactivated (HINHS) human serum for 3 h. The monolayers were 
then incubated with lipid insoluble gentamicin to kill the extracellular 
bacteria. After washing, the cells were lysed and plated onto CLED agar. 
The bacterial counts showed that up to 2 log-fold more bacteria were 
internalized in the presence of NHS compared to HINHS. Confocal 
microscopy revealed that the bacteria were located within vacuoles inside 
the cells. This effect was not due to complement mediated cell damage as 
cells that had been preincubated in serum did not then internalize bacteria in 
the absence of serum. Neither was this an effect of binding, which was not 
affected by C3 as demonstrated by FACS analysis. C3 was also shown to 
increase E. roii internalization into other cell types including bladder, 
glomerular epithelium and colonic cell lines. The same effect was also seen 
using another human pyelonephritic isolate GR-12. A preliminary study on 
urinary tract isolates has shown that not all urinary tract bacteria are 
internalized more effectively in the presence of C3. However, early results 
reveal a trend in the ability of bacteria to intemahze on incubation with C3 
and the presence of infection. In summary, we have shown that bacterial 
internalization into renal proximal tubular epithelial, glomerular epithelial, 
bladder and colonic cells is augmented by C3. Furthermore, colonization by 
bacteria whch are able to internalize in the presence of C3 may increase the 
likelihood of infection. 
Update on Clostridium difficile infection-Symposium organised by the ESGCD 
151911 Laboratory diagnosis of C. difficie disease 
M. Delmee 
Brussels, B 
There are several methods for the detection of Clostriditrm dr$cile (CD) and 
its toxin from hecal specimens. Toxin detection by a tissue culture 
cytotoxin assay followed by neutralization with spec& antiserum is often 
considered the ‘gold standard when new detection methods are evaluated. 
However, this approach lacks sensitivity and has not detected up to 30% of 
patients with confirmed CD associated disease (CDAD). Multiple enzyme 
immunoassays (EIA) have been introduced by various manufacturers for the 
detection of toxin A alone or for both toxins A and B. Some of these are 
designed to give a result within less than 1 h. Comparative studies of EIA 
kits reported that the sensitivity and specificity ranged from 34 to 100% and 
88 to loo%, respectively. Culture is performed on a commercially available 
selective media called CCFA. CD colony morphology is typical when 
viewed under a dissecting microscope. Definitive identification is best 
obtained by gas liquid chromatography. Addition of sodium taurocholate to 
CCFA or alcohol or heat pretreatment of faeces have been shown to 
increase the rate of recovery. Culture is very sensitive hut, when used alone 
without toxin testing, it leads to low specificity and misdiagnosis of CDAD 
when high rates of asymptomatic camage exist. Toxigenic culture tests CD 
isolates for toxin production. It has higher sensitivity and equivalent 
specificity compared to the cytotoxicity assay. In this procedure, colonies 
isolated on selective media are tested for in-vitro toxin production either by 
a cytotoxicity assay (after subculture in broth) or by direct EIA for toxin A. 
The latter can be eady pe*ormed directly on colonies within a few minutes. In 
the routine laboratory, the following scheme is recommended for the diagnosis 
of CDAD: culture and direct toxin detection are performed on faecal 
specimens. In case both are negative or both are positive, the results are 
considered definitive. In case, the culture is positive and faecal toxin negative, 
toxigenic cultures are performed on isolated colonies. In the rare event of 
positive faecal toxin and negative culture, culture is repeated with the addition 
of sodium taurocholate or alcohol or heat pretreatment. 
151921 Pathogenicity of C. difficile 
I. R.  Poxton 
EdinbuqJq UK 
It is now well established that the major virulence factors of C. d@cile are 
the two toxins A and B. However, the organism possesses an array of other 
putative virulence determinants that may be important for localization 
within the colon, and in evasion of the immune response. Why are certain 
types of C. d@rile more commonly found causing disease that others? Is it 
simply a reflection of their abundance in the hospital environment, or is it 
due to the complement of virulence determinants that they carry? Our 
current knowledge of the modes of action of Toxins A and B will be 
reviewed at the cellular and molecular levels, while the contributions of the 
putative other factors will be discussed in light of current epidemiological 
and immunological data. 
151941 How to detect C. difficile variant strains in a routine 
laboratory 
M. Rupnik 
Ljubljana, SLO 
Clost t idium d@ciie is important pathogen associated with postantibiotic gut 
infections. Its virulence correlates well with the production of two large 
toxins belonging to the group of large clostridial cytotoxins (LCT): TcdA 
and TcdB. Certain C. d @ d e  strains can also produce a third toxin, named 
binary toxin. C. d f i d e  strains can be divided into 15 toxinotypes according 
to the changes in genes coding for toxins TcdA and TcdB. Changes in toxin 
genes are conserved also on protein level and variant toxins TcdA and TcdB 
could differ from reference ones in properties of catalytic domains, 
cytopathic effect and probably in receptor binding. Our studies on culture 
collections indicate that variant strains are widespread and can represent 
approximately 10% of the population. Clinical importance of variant C. 
d f i c i l e  strains with changed toxin genes is unknown because they would not 
be recognised as variants with the diagnostic methods currently used. 
Variant strains can produce both toxins, only TcdB (A-B+ strains) or none 
of the toxins (A-B- strains). In routme laboratories only A-B+ variant 
strains will be rrcognised if the correct tests are used. To recognize other 
variant C. d f i c i l e  strains, we suggest the use of either of the two different 
PCRs. With amplification of repehtive regions of TcdA gene and 
subsequent restriction analysis 14 out of 15 known toxinotypes can be 
detected. The drawback of the method is that It is time-consuming. Second 
possibility is amplification of genes for binary tomn, which are found only in 
variant strains. With this PCR 10 of 15 toxinotypes can be recognized. Five 
toxinotypes which are not recognized have only slightly changed toxin 
genes for TcdA and TcdB or are A-B+ strains (toxinotype VIII) and can be 
detected because of changed toxin production. The introduction of 
detection of variant C. d f i c i l e  strains into routine laboratories would 
provide information on their prevalence in different hospitals, their possible 
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connection with some patient population or some form of disease and relatively small. This precludes the use of many standard statistical 
information on the prevalence of binary toxin producing strains. techniques that require asymptotic assumptions. Moreover, many of these 
standard methods fail to utilize the spatio-temporal nature of the data that 
are key to drawing inferences about nosocomial epidemics. Stochastic 
models that can deal with small numbers of events are promising methods 
for the understanding of C. dtg;cik epidemiology. Bayesian techniques allow 
inferences to be drawn about hidden states of patient ‘susceptibility’ and 
‘resistance’. This is illustrated with an example of a reverse jump Markov 
chain Monte Carlo model based on the herd immunity hypothesis of C. 
&id le  
/51961 Mathematical modelling of C. diffide infection 
J. M. Starr, A. Campbell, H. Martin, J. McCoubrey, I. R. Poxton, G. Gibson 
Edinburgh, Glasgotu, UK 
Cfostridium d @ d e  diarrhoea is a major cause of morbidity and mortality 
in hospitals. However, the number of cases in any single outbreak is 
Epidemiology and clinical aspects of foreign body infections-Symposium organised by the ESGNI 
152071 Prevention of infection in orthopaedic implants-an 
impossible goal? 
R. C. Spencer 
Bristol, UK 
Small numbers of bacteria, including those of ‘low pathogenicity’ can cause 
infections following orthopaedic implant operations. The consequences can 
be extremely serious for the patients, leadmg to loss of the prosthesis and 
prolonger disability. Revision arthroplasty for infection is both time- 
consuming and costly, eroding the already meagre resources for use in 
primary prosthetic operations. Reduction in infection rates depends on: 1. 
operating theatre design, including air quality, UV radiation; 2. surgical 
technique and discipline including theatre attire and numbers of theatre 
personnel; 3. aseptic discipline; 4. correct usage of antibiotic prophylaxis; 5. 
host factors, e.g. obesity, age, immunosuppression. This presentation will 
critically examine the effectiveness of practical, preventive measures for use 
in reducing the incidence of such deep seated infections. 
152081 Clinical management and prevention of infection in 
vascular grafts 
P. R. Vogt 
Giesseti, D 
Purpose: To evaluate in situ repair with cryopreserved arterial allografts in 
the surgical treatment of aortic infection and to discuss technical 
improvements achieved during a 10-year period further improving its early 
and late results. 
Methods: Between 1990 and 1999, 49 patients, 21 (43%) with mycotic 
aneurysm and 28 (57%) with prosthetic graft infection of the thoracic and 
abdominal aorta, including pelvic and groin vessels underwent it! situ repair 
using cryopreserved arterial allografts. There were 17 patients (35%) with 
aortobronchial, aortoesophageal or aortoenteric fistulae. 
Results: The 30-day mortahty rate was 6%). Allograft-related technical 
problems occurred in 8 patients (16%) in this series and seven out of eight 
technical problems (87%) occurred in the first 10 patients (80%). With 
technical adaptations, early mortality even dropped to 2.6% for the last 39 
patients ( P  = 0.002). Compared to conventional surgical techniques, e.g. 
prosthetic in situ repair or extra-anatomic prosthetic reconstruction, the use 
of cryopreserved arterial allografts decreased the 30-day mortality and 
perioperative morbidity with regard to the incidence of postoperative sepsis, 
acute renal failure, the need for prolonged mechanical ventilation and 
secondary surgical wound closure. Duration of intensive care stay, 
hospitalization and antibiotic treatment were significantly reduced. There 
was one recurrence of infection, and three allograft related late deaths withm 
a maximal follow-up of 8.5 years. 
Conclusion: In ritu repair using cryopreserved arterial allografts achieves 
excellent early and late results in the treatment of aortic infection. However, 
distinct allograft related technical problems had to be overcome to improve 
the outcome of patients with major vascular infections. 
Issues in clinical trials on antifungal agents-Joint symposium with EORTC-IFICG 
5210 Spiralling empiricism 
G. Maschmeyer 
Berliir, D 
Clinical studies on antifungal treatment (AFT) in immunocompronlised 
hosts are hampered by the lack of standardized case definitions, the d%culty 
to establish the proof of an invasive fungal infection (IFI) ante mortem, and 
the heterogeneity of criteria used for response assessment. Since AFT must 
be started as early as possible in order to improve prognosis, and isolation of 
pathogenic fungi from otherwise sterile body sites may indicate an already 
far advanced IFI, trials showing favorable results ofAFT kequently are based 
upon possible, but unproven IFI. This may cause an overestimation of AFT 
efficacy. However, even highly effective AFT is unlikely to achieve 
complete resolution of 1FI while patients are still profoundly immunosup- 
pressed, e.g. neutropenic. This inversely may result in an underestimation of 
AFT efficacy. This dilemma results in the paradigm of very early institution 
ofpre-emptive AFT in high-risk febrile neutropenic patients, i.e. those with 
lung diltrates and those not promptly responding to empirical broad- 
spectrum antibacterial treatment. Takmg into account the substantial 
toxicity of amphotericin B deoxycholate, the extreme expenses associated 
with less toxic amphotericin lipid compounds, and the yet undefined 
efficacy of new azoles and candins in invasive aspergdosis, the introduction 
and vhdation of new diagnostic techniques for early identification of IF1 as 
well as standardization of case definitions and of criteria for response 
assessment in patients with IF1 appears essential. 
15211 Problems in clinical trial design 
B. De Pauw 
Nijmegen, NL 
For several reasons clinical trials on invasive fungal infections are difficult to 
conduct. (A) Due to diagnostic limitations, especially in patients who are 
treated for a malignant disease, it remains problematic to establish the 
diagnosis in an early phase. (B) The study populanon is inevitably 
heterogeneous with respect to: underlying dlseases (niahgnant, nonmalig- 
nant, transplan-related); state of the underlying disease (remission vs. 
progressive); use of possibly interfering comedication like corticosteroids, 
cyclosporin; coexistence of other, nonfungal infectious coniplications. (C) 
Number of patients in a given centre is low-multicentre studies are 
inevitable and that will result in compromises in design and subjective 
interpretations of outcome. (D) Uniformly accepted diagnostic criteria are 
still pending. (E) There is no agreement on the criteria for outcome: 
survival, disappearance of symptoms, defevervescence, etc. (F) Funding is 
virtually completely dependent on pharmaceutical companies that have 
their own scenario and reasons to influence in-and exclusion criteria. (G) 
Questions on drug comparisons have become to prevail over strategic 
questions like the necessity for prophylaxis, optimal moment to start 
empirical antifungals and the influence of (new) diagnostic procedures. It is 
therefore the question whether the classic randomized controlled (double 
blind) trials are stdl the instrument of choice to assess the options and 
limitations of antifungal strategies. 
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vl Why standardization of definition is necessary 
S. Ascioglu 
Ankara, TR 
Invasive fungal infections (IFIs) are still a &agnostic and therapeutic 
challenge due to remaining uncertainties in treatment options and 
diagnostic strategies. Although clinical research is accumulating in the 
medical literature, quality of research should be improved also. There are 
methodological challenges in the areas of research on diagnostic strategies 
and clinical trials mostly. One of the main obstacles in clinical research is the 
use of different definitions of IFIs. Differences in definitions, nomenclature, 
and diagnostic criteria complicate comparison of results and collaboration 
between centers. Therefore EORTC/IFICG launched a project to reach a 
consensus on definitions of invasive fungal infections in immunocompro- 
mised cancer patients. The purpose of this effort was to improve the ability 
to compare protocols, therapeutic interventions and eliminate confusion in 
communication for both clinicians and researchers by standardizing the 
definitions. A task force was created in 1997 to systematically review the 
literature, describe problems related to heterogeneity of study populations, 
and abstract previously used definitions of IFI. The task force was composed 
of 12 members of IFICG and later with the invited members of NIAID/ 
MSG formed a consensus committee. As a result ofjoint efforts of the 
committee members, a new classification based on the level of certainty for 
the diagnosis of IF1 was devised. This proposal includes both diagnostic 
criteria for proven IF1 and also classification criteria for probable and 
possible diseases. Three elements formed the basis of these definitions: host 
factors, clinical features and microbiological results. We have chosen 
a format that is easy and flexible to apply to individual patients in daily 
clinical practice. 
Clinical relevance of quantitative amplification and genotyping in diagnosis and management of viral infection 
/52141 The use of HIV viral load assays in patient 
management 
S. Skidmore 
Birmingham, UK 
Our understanding of HIV disease progression has been greatly enhanced by 
the ability to quantify plasma viral RNA. The levels observed have a useful 
dynamic range, correlate with clinical stage and fall following effective 
antiretroviral therapy. Viral load measurements, undertaken by a variety of 
commercial assays, were therefore rapidly incorporated into patient 
management protocols. Regular testing enables clinicians to monitor the 
infection and also the response to drugs. In conjunction with CD4 T cell 
counts it gives an indication ofwhen to initiate therapy and when treatment 
is failing, either due to the development of viral resistance or lack of 
compliance. Many studies have been reported detading the response to new 
drugs or different combinations of existing drugs. In addition, studies have 
used viral load testing to predict the outcome of both untreated and treated 
infection. Substantial increases in disease progression rates have been shown 
to be associated with hgher baseline viral levels and also the rate of increase 
is significantly faster in those who develop AIDS. Following studies on 
patients undergoing treatment, it has recently been shown that plasma 
viraema is the factor most highly correlated with the duration of treatment 
required to suppress below 50 copies/mL. HIV viral load measurements are 
not only assessed in blood but can be used to investigate the amount of virus 
present in other body fluids and compaments, e.g. lymph nodes, whch 
may serve as viral reservoirs. It has been documented that even when virus is 
undetectable in blood it can still be found in other sites. Therefore the 
effectiveness of therapy must be confirmed hy multisite analysis. Although at 
the moment it may seem unachievable, the ultimate goal of therapy is the 
eradication of the virus and there will be a continuing use for viral load 
testing to assess new approaches to treatment. However this will need to be 
allied to the development of even more sensitive assays. 
Update on Heliobacter py/ori infection-Symposium organised by the EHPWP 
15219; Gastric permeability: a new dimension in 
pathophysiology of H. pylori infection 
T. Matysiak 
Park, F 
In the past, gastric permeability was neglected since stomach was considered 
mainly as a secretory organ with very little absorptive capacity. However, 
recent studies have shown that absorption of macromolecules takes place in 
the stomach and can be influenced by H. pylon infection. The epithelial 
bamer is composed of two elements: epithelial cells and intercellular tight 
junctions which correspond to two different pathways of the trans-epithelial 
transport: transcellular and paracellular, respectively. The Ussing chamber 
technique has allowed to demonstrate that H. pylon' is capable of altering 
both pathways in vitro. Treatment of epithelial cell monolayers with H. pylon or 
with the VacA cytotoxin, increases the paracellular permeability, as assessed by a 
decrease of the transepithelial resistance and increase of the mannitol flues 
across the layers. The mechanisms probably involve modifications of 
cytoskeleton and inteLerence with protein b a s e  C activity. In vivo, in H. 
pylon-positive patients, gastric permeability to sucrose is also increased as 
compared to noninfected subjects and correlates with the intensity of PMN 
mfiltration. More importantly, H. pylon altea the epithelial permeability to 
macromolecules, i.e. it incream the tramcellular pmage of intact proteins across 
the epithelial layer in vim, and in uivo, as demonstrated in a model of H. felis 
infected mice and in the study of h u n m  gastric biopsies obtained from H. 
pylon-positive patients. The increase of gastric permeability to proteins by H. 
pylon', could lead, by an excessive stimulation of mucosal immune system, to 
the persistence of gastric inflammation after H. pylon' eradication, and in 
some subjects, to allergic sensitisation. The increase of paracellular 
permeability could facilitate the penetration of acid and pepsin into gastric 
mucosa and favour the gastric ulcerogenesis. 
[ 5220 I Are some strains of H. pylori more cancerogenic than 
others? 
F. MCgraud 
Bordeaux, F 
Helicobncterpylori is the first bacterial infection to be associated with cancer in 
humans, i.e. gastric carcinoma and gastric lymphoma. A chain of events, the 
so-called Correa sequence, has been described, which leads fkom chronic 
gastritis toward dysplasia and carcinoma. Environmental factors and host 
genetic factors are most likely involved in this evolution but differences in 
H. pylon strains may also be responsible. Indeed, many studies have shown 
an important microdiversity in the H. pylon' genoma, while the differences 
concerning macrodiversity are not as striking. The first difference linked to 
strain pathogenicity is the presence of a pathogenicity island (PAI), namely 
cag PAI, coding for a CagA protein which can be injected in the epithelial 
cell by a type IV secretory apparatus, indeed also coded by the PAL This 
mechanism leads to changes in the cell machinery including IL-8 mduction 
through an NF-kappa-B pathway. The resulting increased inflammation has 
been associated with more severe diseases including gastric carcinoma. A 
study of 102 cases and controls by Queiroz et al. in Brazil found an OR of 
25.9 [95% CI: 5.8-75.31 for the association, while other studies in areas of 
high Cag PA1 prevalence did not. We recently looked at a highly variable 
region of H. pylon genome, named the plasticity region. When comparing 
strains fkoni cases and controls, 3 genes were found to be linked to 
carcinoma. These genes are now being explored in depth. Although it has 
not yet been proven, one should not exclude the possibility that the rare 
evolution fkom chronic gastritis to carcinoma may he strain driven, and 
due to a direct carcinogenic property rather than an indirect consequence 
of inflammation. 
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/52231 Status of H. pylori resistance in the east of Europe 
L. Boyanova 
Soja,  B G  
Objective: To evaluate the primary, secondary and combined resistance to 
five antimicrobial agents of 2285 Helicobaderpylon' isolates &om 11 countries 
in the east of Europe. 
Methods: Data were available for Bulgaria, Croatia, Czech Republic, 
Estonia, Greece, Hungary, Lithuania, Poland, Russia, Slovenia, and Turkey. 
Susceptibility testing was performed by E-test (5 countries), agar dilution (6 
countries) and disk diffusion (3 countries) methods. Resistance breakpoints 
were: metronidazole (MTZ) 8 mg/L, clarithromycin (CLA) 1 mg/L, 
amoxicillin (AMX) 0.5 mg/L, tetracycline (TET) 4 mg/L, and ciproflox- 
acin (CIP) 1 or 4 mg/L in most countries. Primary and secondary resistance 
rates were assessed among 1994 and 291 strains, respectively. Results 
obtained for 282 children and 176 adults in three countries since 1998, 
were compared. 
Results: Overall mean primary resistance rates since 1998 were: MTZ 
38.6% (9.5% CI: 36-41.2%), CLA 9.7% (8.1-11.3%), Ah4X 0.9% (0.3- 
1.5%), TET 2% (1-3%), CIP 3.9% (2-5.8%), and MTZ + CLA 6.3% (4.5- 
8.1%). Differences in resistance to MTZ or CLA between North vs. South 
and between Central vs. Eastern European countries were not significant. In 
1998-2000, AMX resistance was detected in Bulgaria, Greece, and Turkey. 
From 1996/1997 to 1998/2000, overall MTZ resistance in five countries 
studied, increased from 30.5 to 37.1% ( P  < 0.02). while CLA resistance 
increased slightly from 8.9 to 10.9% ( P  > 0.20). In Poland, Greece and 
Bulgaria, mean MTZ resistance was hgher in adults vs. children (42.9 vs. 
31.2%, P < 0.02), ths  trend not being found for CLA and AMX. In five 
centres, mean post-treatment resistance rates (9.5% CI) were: MTZ 47.5% 
(38.6-56.4%), CLA 15.5% (9.9-21.1%), and AMX 1.7% (0-4%). Mean 
rates of secondary resistance were 35% (95% CI: 23.7-45.7%) for MTZ and 
6.5% (2.4-10.6%) for CLA. 
Conclusions: In the east of Europe, primary H. pylon' resistance to MTZ is 
considerable (40%), and that to CLA is similar to slightly higher (10%) 
compared to data in the west of Europe. Primary and post-treatment 
resistance rates vary enormously among and within countnes and centres. 
Primary resistance to AMX, TET, and CIP was detected in several 
countries. Slovenia and Lithuania maintain low resistance rates of H .  pylon' 
to all drugs tested. 
Rickettsia1 diseases: new trends and current concepts-Symposium organised by the EUWOG 
(5228/ Tick-borne lymphadenopathy (TIBOLA) 
A. Lakos 
Budapest, H 
Background: In April 1996, we started to prospectively collect data on 
patients with a hitherto unknown disease, what we nomnated TIBOLA 
(tick-borne lymphadenopathy). In 1997, one single case was reported from 
France, describing a patient with an inoculation lesion to the scalp and 
cervical lymph nodes following a dermacentor tick bite. In that case, 
Rickettsia slovaca was proved as pathogen. From 1996 to 2000 we collected 
data on 86 TIBOLA patients. 
Methods: Epidemiological and clinical data of these 86 patients were 
statistically analyzed. All patients were tested for borrelia and 73 cases for R. 
slouaca antibodies by imniunoblot. Fine needle lymphnode and/or skin 
biopsy was done in 16 patients. Genomic amplification was performed by 
PCK from these biopsy samples (D. Raoult, Marseille, France). 
Results: 76 patients described an 'extremely big' tick, and/or recognized 
demacentor rick from a collection of several species indigenous in 
Hungary. Tick bite was usually (96%) located on the scalp region. The 
time from the recognition of the tick bite to the first syniptom varied 
between 0 and 55 (mean 9) days. A characteristic local reaction was seen in 
70 (82%) patients. It is a necrotic papula 3 mm-3 cm in diameter at the site 
of the tick bite. The eruption starts with a small vesicle then a honey-like 
discharge appears. One to four weeks later, the erupaon dries out and a 
crust covers the region. The eschar can be surrounded by a circular 
erythema (18 cases). In some cases, the eruption seems to heal but flares up 
again a few days or weeks later. After heahng of the eruption, alopecia 
remains at the site (30 cases). The other main symptoms are the enlarged and 
sometimes painful lymph nodes in the region of the tick bite, 
characteristically in the occipital region and/or behind the sternocleido- 
mastoideal muscle. The infection occurs most commonly in young children 
(age range: 2-57 years, mean: 12.6 years, 63% less than 10 years of age). A 
female predominance was registered (50/36). Longer and stronger hair 
seemed to be a predisposing factor for acquiring TIBOLA. The disease bas a 
strong seasonality with a peak in April and a dropout in August and 
September. One of the patients showed neurological involvement and 
healed without any sequelae. The disease can be chronic: lymphadenopathy 
as well as the local reaction may last for years. One of our patients still had 
lymphadenopathy 4 years after her first symptoms. Genomic amplification 
from the biopsy sample of this enlarged lymphnode revealed R. slovaca. 
Doxycycline treatment can shorten the usually benign illness. 19/73 (26%) 
patients showed a characteristic IgG antibody reaction in R. slovaca 
h i m o b l o t .  Four of them produced seroprogression even after the clinical 
improvement, R. slouara PCR gave positive results from skin or lymphnode 
biopsy samples in 10/16 (62%) patients. 
Conclusion: We described a new and frequent tick-borne infection, most 
probably caused by R. slouaca. 
Acknowledgement: We are indebted to D. Raoult (Marseille, France) for 
rickettsia P C R  and for providing us with R. slovaca antigen. 
Tick-borne diseases in Spain 
J .  A. Oteo Revuelta 
Logrotio, E 
In Spain, southern Europe, a broad variety of hard-ticks exist. Its geographic 
characteristics and climatic conditions do it. Moreover clinical spectrum of 
tick-borne diseases depend of the presence of a determinate tick specie, 
presence of the reservoir and of the susceptibility of the individual. In this 
way we observed important differences between north and south areas. Do 
not exist ofFiciai statistics, and only Mediterranean Spotted Fever (MSF) 
caused by Rickettsia conorii is an obligatory declaration illness. This tick- 
borne disease is present in all of the country, principally in Mediterranean 
areas, south and in the middle of the Iberic Peninsula. All years the 
physicians declare a lot of cases of this condition in the summer. Its possible 
that other spotted fever rickettsials as BAR-29 may be caused of MSF. 
Other tick-borne disease present is Lyme disease (LD). Up to date, different 
genoespecies of Borrelia burgdorferi has been isolated. LD is endemic in the 
north of the Spain were Ixodes ricinus presents a high prevalence of 8. 
burgdo+ri sl. when we investigated its presence by PCR. B. garirtii has been 
also isolated from patients with erythema migrans (EM). Similar to the other 
areas of Europe LD (EM and Banwarth's syndrome) is frequent in the last 
spring, summer and first of autumn. We have recently described the first 
confirmed case of human granulocityc ehrlichiosis in the north, were the 
prevalence of I. ricinus infected by ehrlichias of the Ehrlichia phagocytophila 
genogroup is high. In the last years we are seen a 'new tick borne disease' 
transmitted by Demacerztor marginatus and caused by Rirkettsia slouara. The 
clinical picture consist in a point of necrosis (tache noire) in the point of the 
tick bite, with a rounded erythema like EM, and regional painful 
lymphadenopathy. By personal communications of others physicians, I 
can say this tick-borne disease exist in all the country. Other tick-borne 
diseases like babesiosis, tularemia and tick paralysis has been also described 
in Spain. 
[5230/ Imported African tick bite fever 
M. Jensenius 
Oslo, N 
African tick bite fever (ATBF) is an acute flu-like illness frequently 
accompanied by aphtous stomatitis, multiple inoculation escbars and regional 
lymphadenitis. ATBF is caused by Rickettsia Gfricae, a recently identified 
spotted fever group (SFG) rickettsia, and is transmitted by ungulate ticks of 
the Amblyomma genus in rural sub-Saharan Africa. Serosurveys conducted in 
endemic areas have yielded impressive results, and R. afn'cae is currently 
regarded as the most widespread of all SFG rickettsiae known to be 
pathogenic to man. Parallelled with the rapidly expanding safari tourism to 
southern Africa during the last decade, ATBF has emerged as an important 
cause of imponed fever in many European countries. Studies conducted 
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recently in Norway indicate that up to 8% of short-term travellers to rural 
Afiica are infected by R. ajiicae and that half of these develop symptoms 
compatible with ATBF. Most cases are infected in South Afiica, Swaziland, 
Botswana and Zimbabwe, i.e. countries where many popular game reserves 
and national parks are highly endemic for R. Cfiicae infection. Reported 
cases of travel-related ATBF comprise a wide spectrum of travellers, such as 
leisure safari tourists, game hunters, sports competitors, students, Glm staff 
members, deployed soldiers and foreign aid workers. Noteworthy, a 
significant proportion of cases are grouped in clusters that may affect up to 
80% of exposed subjects. In conclusion, ATBF is a new and rapidly 
increasing cause of imported flu-like illness in Europe, and must now be 
considered along with diseases like malaria, relapsing fever and typhoid fever 
when evaluating febrile returnees &om rural Ahca. 
Mechanisms of resistance in bacteria 
102361 A novel integron-associated ESBL (IBC-1) from 
Enterobacter cloacae 
A. Mavroidi, P. Giakkoupi, D. Sofianou, A. Tsakris, N. J. Legakis, E 
Tzelepi, L. S. Tzouvelelus 
Athens, Tlressaloniki, GR 
A transferable betdactamase produced by a clinical isolate of Enterobacter 
doacap was studied. The bra gene was camed by a 80-kb conjugative 
plasmid. Nucleotide sequence analysis showed that It was part of a gene 
cassette camed by a class 1 integron. The encoded enzyme (IBC-1) was a 
novel class A beta-lactamase that hydrolyzed oxyimino-cephalosponns 
including ceftazidime and was inhibited by clavulanate, tazobactam and 
imipenem. The enzyme consisted of 287 amino acid residues, including 
Ser-237, cysteines at positions 69 and 237a, and Arg-244 which may be 
implicated in its interaction with beta-lactams. In amino acid sequence 
companrons, IBC- 1 displayed the highest similarity with the chromosomal 
penicillinase of Yersinia enrerocoolitica, a carbenicillinase from Proteus mirabih, 
the species-specific enzymes of Klebsiella uxytoca and the carbapenemase 
Sme-1 . However a phylogenetic association with established beta-lactamase 
clusters could not be conclusively shown. This finding underlines the 
diversity of bla genes in the bacterial gene pool as well as the importance of 
integrons and mobile elemena in the spread of these resistance determinants. 
10237 Carbapenem-hydrolysing VIM-2 rnetallo-beta- 
lactamase in Pseudomonas aeruginosa from Greece 
A. Mavroidi, A. Tsakris, E. Tzelepi, S. Poumaras, N. J. Legakis, L. S 
Tzouvelekis 
Atlreits, 77iessaloniki, GR 
A clinical strain of Pseudomonas aewgiitosa exhibiting high-level resistance to 
imipenem and meropenem was studied. It was isolated recently from a 
hospitalized patient at AHEPA University Hospital of Thessaloniki. MICs 
of carbapenems and other beta-lactams were measured by an agar dilution 
method. Beta-lactamases were characterized by isoelectric focusing and 
hydrolysis studies. PCR fragments obtained using blaVIM-specific primers 
were cloned in an TA plasmid vector and expressed in E. coli JM109 cells. 
DNA sequencing was perfomied with Sequenase 2.0. The carbapenem- 
resistant P.  aemgiiiosa strain produced a beta-lactamase with a pl of 5.6. The 
enzyme was inhibited in situ by EDTA. Its substrate specificity was similar 
with those reported for VIM-type carbapenemases. The respective gene was 
located in the chromosome, it was part of a class 1 integron and the coding 
region was identical with blaVIM-2. This finding shows that VIM-type 
metallo-enzyme-producing P. aeruginora strains have also emerged in 
Greek hospitals. 
10238/ Identification of a new carbapenemase, IMP-5, in an 
Acinetobacter baumannii clinical isolate 
G. J. Da Silva, M. Correia, C. Vital, G. Ribeiro, R. LeitLo, J. C .  Sousa, A. 
Duane, L. Peixe 
Coimbra, Lisboa, Porto, P 
Objective: Molecular characterization of a carhapenem-hydrolyzing beta- 
lactamase from an Acinetobacter baumniznii nosocomial isolate collected at the 
University Hospitals of Coimbra. 
Methods: The MICs for beta-lactam antibiotics were determined by the E- 
test method. Beta-lactamase activity in crude cell extracts was assayed 
spectrophotometrically. Search for blaIMP-1-like gene was performed by 
PCR amplification with specific primers. The PCR products were cloned 
to the pCK2.1-TOP0 vector. DNA sequence5 were determined on both 
strands by the dideoxy-chain termination method. 
Results: The A .  baumannii isolate was highly resistant to imipenem and 
meropenem (MICs > 32 mg/L), to ceftazidime, ceftriaxone, cefepime 
(MICs > 256 mg/L) and to cefpirome (MIC=96 mg/L). Aztreonani 
presented a MIC of 64 mg/L. Crude extract hydrolyzed imipeneni (specific 
activity of 205.5 niU/mg of protein) and enzyme activity was inhibited in 
the presence of EDTA. The nucleotide and deduced amino acid sequences 
were analyzed and compared to other available sequences. The sequenced 
gene revealed a new allelic variant of blaIMP, named blaIMP-5, which 
encodes a polypeptide of 246 amino acids. The IMP-5 beta-lactamase 
exhibits 93% of amino acidic sequence identity with IMP-1 and only 87% 
with IMP-2. 
Conclusions: These features are rather interesting, considering that IMP-2 
was found in an A .  baumannii strain isolated in Europe and IMP-5 is more 
sindar to those found in the Japanese isolates. To  our knowledge this is 
the second IMP metallo-beta-lactamase found in Europe, and the first 
in Portugal. Therefore, this study contrihutes to the observation that the 
blaIMP genes are more disseminated than initially thought, beginning 
to appear in South European hospitals, a cause of concern considering 
the difficulties of treating nosocomial infection by multiresistant A. 
bauinannii strains. 
10239 Sequencing of the gyrA QRDRs of six Bacteroides 
fragilis group type strains and comparison with those of 37 
quinolone resistant faecal isolates 
H. Oh, N. El-Amin, C. Edlund 
Stockholm, S 
Introduction: Since the mapping of the gyrA of Esrhericbia mli, this gene has 
been seqenced in numerous aerobic bacteria. Mutations within positions 
67-1 06 of gyrA, the quinolone-resistance-determining-region (QRDR), 
considerably contribute to QK in aerobic microorganisms. It has also been 
shown that resistant mutants of Bacteroides.fiagiZis ATCC 25285 had amino 
acid exchanges in the gyrA QRDR compared to the parent type strain. 
Objectives: To sequence and compare the gyrA QRDR of 37 faecal 
Bacteroides-fiagilis group isolates with varying quinolone resistance levels and 
their respective type ATCC strains. 
Materials and methods: The isolates were identified to species level by 
morphological and biochemical tests. The QRDR of gyrA was sequenced 
in 37 isolates (5 B.fragilis, 1 B. ouatu5, 4 B. thetaiotaomicron, 6 B. unijormis and 
21 B. vulgatus) and six type strains: B. distasonis ATCC 8503, B. ovatus 
ATCC 8483, B.  thetaiotaomicron ATCC 29741, B. uniformis ATCC 8492 
and B. vulgatus ATCC 8482. 
Results: The painvise scores among the sequenced ATCC strains matched 
with B.fragilis ATCC 25285 and E.  coli, as follows: B. distasonis ATCC 8503 
94% and 73%, B. uvatus ATCC 8483 63% and 43%, B. thetaiotaomicron 
ATCC 2974 63% and 46%, B. unijormis ATCC 8492 90% and 71%, B. 
vulgatu5 ATCC 8482 92% and 73%, respectively. The QKDR of B. ovatuS 
ATCC 8483 and B. thetaiotaomicron ATCC 2974 had lower homology with 
B.JiaRilis ATCC 25285 than the other reference strains, but a homology of 
90% with each other. Ser82 was conserved in all studied B. jagilis group 
type strains, but at position 86 Phe, Gly or Tyr was present. When 
comparing the clinical strains with their respective type ATCC strain, 
homologies varied from 63 to 98%. Two susceptible isolates lacked 
mutations in the QRDR, while all 35 quinolone resistant strains harboured 
1-11 amino acid exchanges in this region. Mutations in hotspot positions 
(82 and 86) were found in all highly quinolone resistant strains, resistant to 
moxifloxacin and clinafloxacin. 
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Conclusion: The homology among the QRDR sequences of the seven B. 
fragilis group ATCC strains was mostly high, however, B. ovatus ATCC 
8483 and B. tketaioitaomirron ATCC 29741 had unexpectedly low homology 
with B.frogilis ATCC 25285. Mutations in the Q R D R  where found in 35 
faecal strains and these were strongly correlated with quinolone resistance. 
Mutations in positions 82 and 86 were found in all strains resistant to newer 
quinolones with enhanced antianaerobic activity. 
v] The molecular characterization of resistance to 
ciprofloxacin, levofloxacin, sparfloxacin and moxifloxacin in 
Staphylococcus saprophyticus 
F. M’Zali, K. Kerr, P. Hawkey, J. Ambler 
Leeds, UK; Wuppertal, D 
Objectives: Although E. cooli are the single most common cause of lower 
urinary tract infection in all patient groups, S. supropkyticus, has been shown 
to be the second most common cause of these infections in sexually active 
young women. Earlier work in our laboratory suggested that there were 
noticeable differences in the propensity of individual quinolones to select for 
resistant mutants of S. sapropkyticus. The aim of this study therefore was to 
determine the sequence of the quinolone resistance determining regions of 
gyrA, grlA, gyrB and grlB genes in both wild type bacteria and their 
corresponding resistant mutants generated in uitro. 
Methods: 12 unrelated, nonclonal (by PFGE) clinical isolates of S. 
supropkyticus susceptible to ciprofloxacin (MIC 02-0.4 mg/L) were 
examined. Mutants were selected in-vitro by a standard stepwise selection 
method. Polymerase Chain Reaction using specific primers, was used to 
amplify the gyrA, grlA, gyrB and grlB genes of the clinical isolates and their 
in vitro generated mutants. 
Results: The mechanism(s) associated with quinolone resistance, as 
determined by the sequences of these genes in the mutants were different 
in respect of ciprofloxacin, levofloxacin, sparfloxacin and moxifloxacin 
although glA mutations were the most prevalent. 
Aspergillosis: diagnostic and treatment issues 
Conclusion: T h s  study is the first to use a large collection of f d y  quinolone 
sensitive S. sapropkyticus and shows that ciprofloxacin, levofloxacin, 
sparfloxacin and modoxacin have preferential molecular targets in S. 
sapprophyticus. 
102411 Fluoroquinolone resistance in Streptococcus 
pneumoniae has the least effect on moxifloxacin 
T. G. Dorai-John, C. J. Thomson, S .  G. B. Amyes 
Edinburgh, Newbury, UK 
The emergence ofpenicillin resistant pneumococci is rapidly posing a threat 
to the current beta-lactam treatment option. The introduchon of novel 
broad-specttum fluoroquinolones such as moxifloxacin and gatifloxacin 
provides an alternative. Classically resistance to the fluoroquinolones arises 
through genetic mutations within the type I1 topoisomerases (DNA gyrase 
and topoisomerase IV). Recently, efflux has been described as a mechanism 
of resistance. To  investigate the evolution of fluoroquinolone resistance 
within clinical isolates of penicdh-intermediate pneumococci, stepwise 
mutants were raised by serial exposure to moxifloxacin. Selection of 
resistance revealed no genetic changes withm the Q R D R  of the target 
genes in all firs-step mutants although four-to eight-fold increases to 
ciprofloxacin and a two-fold increase to moxifloxacin was observed. Further 
challenge resulted in a 4-32-fold increase to ciprofloxacin and a four-fold 
increase to modoxacin.  Subsequent changes involved a mutation of Ser79 
to Phe in parC. Other mutational changes were observed within the ParE 
subunit but were not associated with fluoroquinolone resistance. All the 
mutants retained an emux phenotype with norfloxacin and ciprofloxacin. 
The penicillin susceptibility of the mutants remained the same as the parent 
strain. These results suggest that moxifloxacin is able to induce genetic 
mutations within the QRDR,  although the phenotypically these changes 
affect the activity of comparator quinolones more than moxifloxacin. 
10243-1 The diagnosis of invasive aspergillosis: is early early 
enough? 
R. J. Manuel, S .  Ainscough, H. G. Prentice, L. A. Berger, T. Yeghen, M. 
N. Potter, C. C. Kibbler 
London, UK 
Invasive aspergasis (IA) remains a life-threatening infection in irnmuno- 
compromised patients and is the most important cause of fungal death in 
cancer patients; in bone marrow transplant recipients the mortality rate is 
stiU greater than 90%. The purpose of this study was to investigate methods 
for the early diagnosis of IA in patients with haematological malignancy, and 
to examine the best strategy for sampling. The study compared clinical, 
microbiological and histopathological data with newer diagnostic techni- 
ques such as antigen detection (Pastorex latex agglutination and sandwich 
ELISA tests), high resolution computed tomography (CT) scanning and the 
polymerase chain reaction (PCR) (Einsele et al. 1997). The research 
involved both a retrospective and a prospective study. The initial 
retrospective study was performed over 24 months. During ths  time, 38 
bronchoalveolar lavage (BAL) fluid and 178 serum samples were collected 
from 38 febrile neutropenic and bone marrow transplant (BMT) patients. 
BAL and serum samples from 12 immunocompetent and 20 asymptomatic 
HIV+ patients were used as controls. The results suggest the sandwich 
ELISA provides a simple, effective and rapid screening test, and that the 
higher negative predictive value of PCR may allow for better use of 
empirical antifungal therapy. Regular prospective monitoring of sequential 
serum samples with BAL and C T  scanning in high risk immunocompro- 
mised patients allows for the earlier diagnosis of IA. Based on the above 
results, a one-year prospective study was performed. However, the 
prospective study showed that effective prophylaxis with itraconazole is 
superior to pre-emptive therapy, even at an early stage of infection. 
Acknowledgements: RJM supported by grants from Janssen-Cilag and 
Nexstar PLC. Reagents purchased with funds from Special Trustees of 
Royal Free Hospital. 
jo244] Screening for Aspergillus spp. by a PCR of whole blood 
samples from patients with haernatological disorders 
C. Lass-Florl, E. Gunsihus, H. Einsele, M. Dierich 
Innsbnrck, AT; Tiibingen, D 
We performed a screening for Aspetgillus spp. by polymerase chain reaction 
of whole blood samples in patients with haematological disorders. In a two- 
year study, 121 patients admitted to the University Hospital of Innsbruck for 
cancer chemotherapy without clinical signs of fungal infection were 
prospectively screended for Aspergillus spp. In 28 of 121 (23%) patients 
Aspergus DNAemia was detected. Of these patients 16 (57%) were 
positive only once for Aspergdus DNA but positivity was never associated 
with invasive aspergdosis. PCR positive episodes were short and resolved 
without antifungal treatment. Five patients (1 8%) had intermittent PCR 
positive results. Seven (25%) patients presented at least two consecutive 
positive P C R  results, one of these patients developed invasive aspergllosis 
and another two were hghly suspected of having aspergdlosis. Based on the 
criteria of EORTC case definitions sensitivity and specificity of serial PCR 
monitoring were 75% and 96%. Positive PCR results became negative 
shortly after commencement ofantifungal treatment but the changes did not 
correlate with clinical responsiveness to treatment in three patients. Our 
results indicate the potential usefullness of PCR for screening for Aspe@us 
spp. in patients at risk yet without antifungal treatment. 
Activity of antifungal drugs against filamentous fungi 
in different nutrient media 
J. Meletiadis, E. A. H. Kramer, J. W. Mouton, J. F. G. M. Meis, P. E. Venveij 
Nijmegen, NL 
Background: Given that filamentous fungi grow at different growth rates in 
various nutrient media, the in vitm activity of antifungal drugs may vary 
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depending on the nutrient media. The MICs of amphotericin B (AB), 
itraconazole (IT) and terbinafine (TB) against 5 strains of AspergilZus 
jiumigatus, Rhizopus oryzae and Scedosponum prolijcans were determined in 
antibiotic medium 3 (AM3), yeast nitrogen base medium (YNB), liquid 
Sabouraud (SAB) and RPMI-1640 (RPMI). 
Methods: Conidia and spores suspensions were adjusted spectrophotome- 
trically and suspensions of lo4 CFU/mL in double strength AM3, YNB, 
SAB and RPMI were inoculated in two fold serial water dilutions of AB 
(16-0.015 mg/L), TB and IT (32-0.03 mg/L) in a 96 flatbottoni 
microtitration plates. The plates were incubated at 37 "C for 72 h and 
the MICs were determined visually after 24, 48 and 72 h of incubation. 
Then 0.1 mL of clear wells were subcultured onto Sabouraud agar plates and 
the MFCs were determined as the drug concentration at which less than 5 
colonies grew. The geometric mean of the MICs (GM-MICs) were calculated 
for each species and nutrient medium, and the differences of second 
logarithm of the MICs were analyzed by ANOVA (repeated measures test). 
Results: No statistical significant differences between the four nunient 
media were found for IT against A.fumigatus (P  > 0.05) although the GM- 
MICs after 72 h was lower for AM3. For AB significant differences were 
found for MICs after 24 and 48 h for all species. The GM-MICs in AM3 
(6.1 mg/L) and SAB (7 mg/L) were hgher than in RPMI (2.6 mg/L) and 
YNB (3.5 mg/L) €or A ,  jumigatur and the GM-MICs in YNB (4.6 mg/L) 
were higher than in the other media for R. oryzae ( 2 4  mg/L). For TB 
significant differences were found for A. jumigatus and R. oryzae with the 
GM-MICs to be higher in RPMI (18.4 mg/L) and in YNB (7 mg/L), 
respectively. No statistical significant differences were found for MFCs of all 
the drugs tested against all species except the case of TB against A..fumigatus. 
Conclusions: The activity of IT was not dependent on the nutrient media in 
contrast with AB and TB whch were more active in richer and poorer 
media, respectively. 
Acknowledgements: This study was supported by the EC-TMR-EURO- 
FUNG network (ERBFMXR-CT970145). 
102461 Effect of different concentrations of Tween 20 in the 
antifungal susceptibility testing of Aspergillus fumigatus 
A. Gomez-Lopez, A. Aberkane, E. Petnkkou, J. Mosquera, J.-L 
Rodriguez-Tudela 
Majadahonda, E 
Background: Inoculum preparation for hydrophobic fungi, as AF, is 
facilitated by adding Tween 20 (TW). The NCCLS M38-P document 
recommends to prepare inoculum suspensions by a spectrophotometric 
method and adding a 5% of TW, thus final inoculum contains a TW 
concentration of 0.025%. However, T W  can have an effect on AST ofAF. 
The objective of this study was to evaluate the combined influence of T W  
and inoculum size on AST of AF. 
Method A microdilution procedure was performed. Antifungal agents: 
Amphotericin B (AmB), Itraconazole (ITZ) and Voriconazole (VZ). Assay 
medium: RPMI 2% of glucose. Organisms: 7 clinical isolates of AF; 3 in uivo 
resistant to Itraconazole (RS), and 4 susceptible (SS). AF ATCC 9197 was used 
as q d t y  control. Inocula preparation: a hemacytometer count method was 
employed. Three Merent concentrations ofTW were utiliztd (0.25%, 0.025% 
and 0.005%). Two inoculum sizes were analyzed (10' and 10' CFLJ/mL). Each 
experinlent was repeated three times on three different days. 
Results: Table 1 sunmiarizes in ranges (mg/L) results obtained by each T W  
concentration/inoculum size combination. 
Rs An8 14 I4 0.52 0.52 0.51 0.52 
nz >a x >8 ;8 x >8 
w 0.2-2 0.7s.2 0.2?1 0.2-2 0 12-1 0.12-2 
ss .4nB 0.51 0.52 0.2-1 0.25-1 0.25-1 0.73-1 
IlZ 2-8 4% 0.25-1 0.52 0.W.Z O.IM.5 
w 0.51 0.54 0.51 0.52 0.25-1 0.52 
Conclusions: (1) Inoculum size (104 or 105) has no significant influence on 
AST of AF. (2) MICs obtained with higher T W  concentrations were 
proportionally more elevated than those obtained with lower concentra- 
tions, mainly for ITZ. (3) The utihzation of final inoculum with a T W  
concentration higher than 0.025% can falsely elevate MICs. (4) The use of 
higher inocula than that recommended by NCCLS must take into account 
the d u e n c e  of T W  concentration on AST of AF. 
(02471 &ole cross resistance in Aspergi//us fumigatus 
J. Mosquera, P. Wam, C. Moore, D.  Denning 
Manchester, UK 
Background: Itraconazole (ITZ) is currently the only oral treatment for the 
human pathogen Aspergillus, but new azoles are currently being studied. 
Standardization of azole in-uitro susceptibllity testing is in process. No study 
has presented consistent azole cross resistance results for more than a few 
Aspergillus strains. 
Objectives: To study azole cross resistance in Aspergillusfumigatus. 
Methods: 15 A hmigatus strains, obtained from different patients and with 
IT2 susceptibilities ranging from 0.12 to >8  mg/mL (14 higher than 0.25 
mg/niL and 10 of these higher than 1 m e l d ) ,  were tested in-vim against 
ITZ, Ravuconazole/BMS-207147 (RCZ), Posaconazole/SCH 56592 
(PCZ) and Voriconazole (VCZ). A validated microtire method whch is 
able to detect ITZ resistance in Aspergillusfumigatus (Denning et al. 1997.J 
Antirnimbial Chemofher 40: 401) was employed. Conditions were: RPMI- 
1640 + 2% glucose medium, inoculum counted in a haemocytometer, final 
inoculum size of 5 x 10' CFU/mL and microdilution plates incubated at 37 
"C for 46-50 h, read visually with a 100% inhibition of growth endpoint. 
The highest and lowest final inocula of the range proposed in the NCCLS 
M-38P document (0.4 x 10' and 5 x 10' CFU/md) were also cornpared, in 
order to analyze the effect of the inoculum. 
Results: All ITZ 'resistant' strains (MIC > 2 mg/mL at 0.4 x 10* and 
5 x 10' CFU/mL.) demonstrated cross resistance to PCZ, whereas no 
correlation in resistance was apparent with either R C Z  or VCZ. The 
inoculum had an effect on the MIC of some strains with all azoles. 
Conclusion: In contrast to susceptible isolates of Aspergillus in wtuch PCZ is 
the most active azole, in I T 2  resistant isolates MICs for all 3 drugs are 
variable suggesting several different mechanisms of resistance. The use of an 
inoculum range, as recommended in the NCCLS M-38P document, may 
contribute to lower reproducibility in azole MIC results. 
vl Efficacy of caspofungin as salvage therapy in invasive 
aspergillosis as compared to standard therapy in a historical cohort 
J. Maertens, J. Hiemem, I. Raad, M. Boogaerts, P. Saddier, R. Berman, M. 
Severino, A. Saah, C. A. Sable, J. Chodakewitz, T. F. Patterson, D. 
Denning, T. Walsh 
Leuoen, B; Orlando, Houston, West Point, San Antonio, USA; Marichester, UK; 
Bethesda, U S A  
Background: Caspohngin, an investigational echinocandin, has activity 
against AspergiZlus in v i m  and in animal models. Caspofungin was evaluated 
in a noncomparative IA salvage study (P019). An approldmate comparator 
group for efficacy was identified from a hstorical cohort (HC) through a 
retrospective medical chart review. 
Methods: In P019, S6 patients who were refractory or intolerant to other 
antifungal therapies received caspofungin 70 mg IV x 1, then 50 mg daily. 
The H C  enrolled 206 patients who received at least 1 week of standard 
andfUngal therapy. In both studies, patients had well-documented IA (probable 
pulmonary or definite disease at any site). A favorable response (complete or 
partial) required documented radiopphc and symptomatic improvement. 
Diagnosis and outcanie were confirmed by independent expert review. 
Multivariate analysis, adjusdng for prognostic factors identi6ed in the HCS 
population, was used for the comparison of efficacy between studies. 
Results: Most patients had BMTs (PO19 36%; H C  41%) or hematological 
malignancies (PO19 34%; H C  30%)). Most infections were pulmonary (PO19 
72%; H C  75%) or disseminated (PO19 18%; H C  20%). In P019, most 
patients (80%) were refractory to substantial prior therapy. Overall, the 
favorable response rate was 41% in PO19 and 17% in the HC. The 
unadjusted odds ratio (OR) for a favorable response (P019/HC) was 3.3 
(95% CI 1.7, 6.8). In a multivariate analysis adjusting for potential 
imbalances in disseminated IA, neutropenia, BMT, and corticosteroid use, 
the OR was 3.4 (1.6, 7.5). 
Conclusions: (1) In a nonrandomized comparison, the efficacy of 
caspohngin in PO19 was greater than the efficacy of standard therapy in 
the HC. (2) Patient characteristics were well balanced between studies. (3) 
Multivariate analysis strongly supported efficacy of caspofungin in the 
treatment of IA. 
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102491 Isolation of an MRP-like (multidrug resistance protein) 
gene in Plasmodium falciparum 
F. Nogueira, D. Lopes, C.  Casimiro, M. Carrolo, V. Rosirio, J .  Gil 
Lisbon, P 
Aii~noquinoleine antimalarial drug resistance (AMDR) in Wasniudilrm 
~falciparum is probably a phenomena of multigenic nature. We have been 
isolating chloroquine-resistant parasites from different geographical loca- 
tions, not associated with the current ‘resistance genes’ (pfcrt and p h d r l ) ,  
suggesting the existence of other contributing markers. This was particularly 
frequent in samples of South-east Asian (Thailand) ongin. The MRP 
(Multidrug Resistance Protein) type of Al3C proteins are the main group of 
oxidized gluthatione trans-membrane transporters in several organisms, 
being also able to use phase I1 conjugates of xenobiotics (e.g. dmgs) as 
substrates. We have hypothesized that these kind of transporters exist in P. 
fhlciparum. Using the K1 parasite clone (Thailand), we performed a 
degenerated primer based PCR approach, using conserved ABC Walker 
related regions sequences as targets. Through EST-RACE protocols, we 
have isolated a cDNA, coding for a candidate MRP protein. In our studies, 
we have detected expression of such gene in different isolates of P.falciparum 
in their erythrocytic cycle. Levels of expression are being investigated under 
chloroquine pressure. 
102501 Placental malaria infection in a rural West African 
population: impact on foetal outcome 
J .  B. Okoko, M. Ota, W. A. S. Banya, L. K. Yamuah, A. Avieka, K. P. J. 
W. McAdam, K. Osinusi 
Banjul, WAG; Ibadan, WAN 
Introduction: In sub-Saharan Afncan countnes endemic for malaria, almost 
half of all primigravidae will be parasitaemia at their first antenatal visit. The 
implications of these infections, for the mother and baby are considerable 
and constitute one of Ahca’s major public health problems. This 
observational study was camed out to evaluate the prevalence of placental 
malaria infection among rural Gamblan women and to determine its inipact 
on foetal outcome in a population where few women take antimalaria 
chemoprophylaxis. 
Methods: Over a 6-month period (July-December 1998), 313 mother- 
newborn pairs (singletons only) were consecutively recruited into the study. 
Placental blood and tissue were collected for placental malaria diagnosis. 
Clinical assessment of babies and follow up until discharge was also carried 
out; based on birthweight and baby’s birthweight, live babies were classified 
as term, normal birth weight (Tern-NBW), term, low birthweight (Term- 
LBW), preterm, normal birth weight (Pretem-NBW) and preterm, low 
birthweight (Preterm-LBW) . 
Results: The overall prevalence of placental malaria infection was 51.1% 
by placental histology and 37.1% by blood smear. Primigravid women 
were more susceptible to placental malaria than the multigravidae (65.3% 
vs. 44.7% P=0.01). Thirty-five (1 1.2%) of the study babies were 
stillbirths, giving a stillbirth rate of 111/1000 while 75 (24%) were low 
birth weight babies (birth weight < 2.5 kg). Placental malaria was 
significantly associated with preterm delivery (P  < 0.01). intrauterine 
growth retardation and two-fold risk of stillbirth delivery (OR = 2.22, 95% 
CI. 1.04, 4.20). Similarly, placental malaria infection was associated with 
reduction of mean birthweight of babies by 320 gm ( P  < 0.001) while the 
risk of mothers with parasiazed placentae delivering low birthweight babies 
was four times more than the group with nonparasitized placentae 
(OR=4.42, 95% CI. 2.10, 9.27). Chronic and active -on -chronic 
placental malaria infections are as important as active infection in this 
Gambian population. 
Conclusion: The findings of this study showed that there is an overall 
poor fetal outcome associated with placental malaria infection in the 
Gambia, Thus, adequate treatment of malaria infection in pregnancy 
and/or antimalaria prophylaxis dunng pregnancy is critical in malaria 
endemic regions. 
102511 Short course of liposomal amphotericin B for the 
treatment of visceral leishmaniasis in immunocompetent 
children: study of 32 cases 
C. Figueras, M. J. Garcia, F. Asensi, R. Velasco, A. Canals, L. Ciria, R. 
Cullell, J .  De la Cruz, C. Fortuny, M. J.  Mellado, F. Muiiiz, L. Santos, T. 
Vallmanya, J. Pontes 
Barrelma, Madn’d, Valeiwia, ToZedu, Alicanfe, Palma de Mailom, Tamagnnn, 
Ja&, Denia, Ldrida, E 
Introduction: Leishmania i+ztLim visceral leishmaniasis remains endemic in 
Southern Europe. Pentavalent antimonial compounds have been the 
mainstay of therapy but clinical treatment failures and important adverse 
effects have been reported in the last years. Davidson et al. published the 
first clinical use of liposomal amphotericin B (Ambisome (R)) for 
leishmaniasis in 1991, and in 1996 established the efficacy of short courses 
of Ambisome (R). 
Objectives: To asses the efficacy and safety of Anibisome (R): 4 nig/kg as a 
maximum dose on days 1. 2, 3,  4, 5 and 10 for the treatment of infantile 
visceral leishmaniasis (VL) . 
Methods: From January 1997 to September 2000 we treated in a 
prospective multicenter study of 13 children’s hospitals of Spain, 32 
immunocompetent infected children (14 males), aged 7-84 months (median 
26.03 months), who had not previously undertaken any leishmaniasis 
treatment. Ambisome (R) 4 mg/kg dose on days 1, 2, 3, 4, 5 and 10 was 
admnistered in 28 chddren and 3 mg/kg dose following the same schedule 
in the other 4 ones. All patients had signs of clinically active VL. Blood 
samples for laboratory assesments were taken on days 1, 4, 10, 21 and on 
months 3-6 and 12, and a bone marrow aspirate (BMA) and/or serological 
test (IFA or ELISA) were performed on days 1 and 21. On day 1 visible 
parasites on BMA were observed in 27 children (87.1%), and in the cases 
where no parasites were detected (n = 4) or BMA was not undertaken 
(n = 1) antibodies against leishmania were positive. All patient were 
followed up during the 6rst 21 days, 24 for 3 months, 19 for 6 months 
and 16 for up to one year. 
Results: All the children (100%) had rapid clinical response and the BMA 
was normal on 21 day in the 24 patients (100%) in which this was 
undertaken. In the other 8 chddren efficacy of treatment was assessed by the 
clinical response. During the follow up period, relapses did not occur 111 any 
case (0%). No adverse events (0%) were observed. 
Conclusion: The treatment of VL in children with a short course of 
Anibisome (R) with a total dose of 24 mg/kg, is in our study hlghly efficace 
and safe. In addition, we highhght the advantage of reducing the hospital 
stay with this short course treatment, achieving a quality of life 
improvement of the children and relatives and a possible reduction in the 
general hospital costs caused by a longer stay. 
1 0252 1 Single dose of ambisome: efficacy and safety in the 
treatment of Indian visceral leishmaniasis 
S. Sundar, T. K. Jha, C. P. Thakur, M. Mishra, R. Buffels 
Paris, F 
Introduction: Visceral leishmaniasis (VL) is endemic in India. Refractoriness 
to pentavalent antimony (Sb) treatments has been growing during last 15 
years. More than half the v7, patients either do not respond or relapse after 
Sb therapy. In our previous multicenter trial with Liposomal amphotericin 
B (AmBisome‘R), a cumulative dose of 7.5 mg/kg of the drug, given over 5 
days, induced definite cure in 93% of our VL patients. In this tnal, we 
studied the safety and efficacy of a single dose of AnlBisonie of 7.5 mg/kg 
and sent home after 24 h observation. Clinical, parasitological and 
laboratory evaluation were done on day 30. The final clinical and laboratory 
evaluation was done after 280 days, spleen or bone marrow aspirate was only 
required if signs and symptoms indicated a possible relapse 
Results: 203 immunocompetent patients (102 children of < 12 years) with 
parasitologically proven VL were enrolled at four centen. Most (92%) ofthe 
patients were newly diagnosed. At day 30 evaluation, 196 of 200 (96%) 
were cured, three patients did not turn up, and thus only 200 patients were 
evaluable. Eight patients had positive spleen aspirate but, during follow-up, 
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only three patients required h g h  dose AmElisome treatment. One patient 
died due to disease progression. At final evaluation of cure, six months after 
treatment, 182 (90%) patients were considered cured. Only two patients 
(1%) were lost to follow up. One other patient died due to unrelated 
disease. Five patients (2%) did not respond to the treatment and 12 patients 
(6%) relapsed after initial cure. Two patients died. Fever (9%), vomiting 
(3.5%) and chills (3%) were the most frequent side-effects. All patients not 
responding or relapsing afier the single-dose treatment responded to a 
cumulative dose of 25 mg/kg AmBisome treatment. 
Conclusion: These results suggest that single dose 7.5 mg/kg M i s o m e  
treatment is effective and safe in treatment of VL in India, with significant 
reduction in hospital cost, and occupancy. 
lamblia: 95,8%, 99,7%, 99.0%. and 88.5%. respectively; for E. hisfofytical 
dispaar: 77,2%, 97,8%, 99,6%, and 95,7%, respectively, and for C. patvum: 
84.0%, 98.4%. 99.8%. and 95.5%. No cross-reactivity with other gut 
parasites was detected. 
Conclusions: The test results of this study show that the Triage test can be 
used as a rapid, sensitive, and specific diagnostic screening tool for the 
detection of G. lamblia, E.  histofytica/dispar, and C. parvum antigens in 
human stool samples. However, in case of a negative test results and/or 
persistent symptomatology a conventional parasitological stool examination 
including a permanent stained smear for a preserved stool sample should be 
performed additionally. 
102551 Study of the intestinal protozoal infections in children 
N. Andreeva, R. Kurdova, V. Bladoeva, D. Popov, A. Stoianova, M. Spassova 
Sofia, BG 
10253) First results of zentel chemotherapy of echinococcosis 
in childhood 
V. Stanev, N. Chatalbashev, P. Tashev, A. Karadmov, N. Andreeva, A. 
Massarlieva, V. Blagoeva 
Sofia, BG 
Introduction: In the last decade the number of cases of echinococcosis in 
childhood has been on the rise. An increase in the morbidity rate of multiple 
and multiorgan echinococcosis has also been reported. This fact places 
physicians in a dilemma-they have to choose between chemotherapy and 
repeated surgical treatment of echinococcosis which sometimes cames a 
significant risk of long-term sequels. 
Objective: The present study was aimed at establishing the efficacy of 
albendazole treatment in cases of echinococcosis in childhood. 
Materials and methods: The study included a total of 27 chddren. Nine of 
them presented with recurrent liver cysts, 12 with multiorgan (lung and 
liver) echinococcosis, 4 with lung cysts (2 of them had multiple bilateral 
lesions), 2 had pnmary hepatic echinococcosis. The efficacy of chemother- 
apy was evaluated based on US and C T  scanning in the course of treatment 
and during the follow-up period (ranging between 3 months and 3 years). 
Results: A positive response was reported in 92.5% of the cases-complete 
disappearance of the cysts in 2 cases (16%); as well as a marked reduction in 
the cyst size, increased density of the cyst fluid and multiple calcifications in 
the cyst wall. 
Conclusion: The results of the study show that albendazole can be 
recommended for treatment of echinococcosis in cases in which surgery is 
contraindicated. 
Objective: The present study is aimed at establishing the prevalence rate and 
structure of protozoal infections due to opportunistic agents in immuno- 
compromised children and in children with normal immune response. 
Materials and methods: The study includes a total of 484 patients47 
children with malignant diseases (leukaemia, Hodgkin's and non-Hodgkin's 
lymphoma, Ewing- and osteosarcoma, meduloblastoma and soft tissue 
sarcoma), undergoing intense chemotherapeutic regimens, 325 children 
without gastrointestinal complaints treated as outpatients and 11 2 clinically 
healthy children from day-care centers. Fresh stool samples are collected 
from each patient and are tested twice: 1. by microscopy of saline wet and 
iodine stained slides and by Ziehl-Nielsen stained slides; 2. by culturing in 
Pavlova's medium. 
Results: Opportunistic protozoal infections are established in all study 
groups-their prevalence rates are as follows: 38.3% (lughest) in chddren with 
malignant diseases (immunocompromised), 13.5% in the outpatients and 
17.8% (lowest) in children from rural day-care centers. Cryptospon'dium spp. 
is also detected in all groups with infestations rates being: 14.9%, 0.6% and 
3.7%, respectively. B. hominis is present in 19.1%. 8.6% and 8.9% of the 
children, respectively, G. lambliu-17.0%, 8.3% and 9.8%, respectively. 
Conclusions: In immunocompromised chddren a high incidence of 
asymptomatic intestinal opportunistic infections is established. They, if 
not properly diagnosed and adequately treated are not only epidemilogically 
dangerous but present a serious risk of heavy even fatal diarrhoeal 
conditions. 
102541 Evaluation of the triage parasite panel test in the 
laboratory diagnosis of intestinal protozoal infections 
102561 A community-based ascaris control program in 
Hamadan, West Iran: a success story 
T. G. Mank, T.  Goo1 
Haarlem, Amsterdam, N L  
Objective: To assess the test accuracy of the Triage Parasite Panel test in the 
laboratory diagnosis of G. Lmblia, E. histolytica/dispar, and Crypfospon'dium 
parvum infections in routine clinical practice. 
Methods: Panel performance was evaluated with the use of known positive 
samples and samples randomly selected from routine clinical practice in 
Haarlem. Test results of the Triage test were compared with that of a 
'construct gold standard' including permanent staining techniques, mod. 
acid-fast stains, Formalin Ether concentration, a panel of EIA tests, and 
PCR techniques. The panel of EIA tests comprised the Prospect Giardia, 
Cryptosporidium, and E. histolytica/dispar test kits from Alexon, and the E. 
histolytica/dispar test, the E. histolytica test, and the G. lamblia and 
Cryptosporidium test kits from Techlab. Samples with discrepant test 
results were re-tested using the same methods. T o  study cross-reactivity 193 
fecal samples containing other gut protozoa and helminths were examined. 
The Triage test was performed without knowledge of the test results from 
all other parasitological examinations. 
Results: In this study, the Triage test was pexformed from 642 fresh, or fresh 
frozen, fecal samples (patients); 548 samples were randomly selected from 
routine clinical practice and 94 samples were known positives (E. histolytica/ 
dispar: SO, G. lamhlia: 25, C. paroum: 19). In 15 samples the test results of the 
Triage device were equivocal, all these samples were extremely mucous. 
After resolution of discrepant results, the sensitivity, negative predictive 
value, specificity, and positive predictive value were as follows: for G. 
M. Fallah, A. Mirarab, F. Jamalian, A. Ghaderi 
Hamadan, IR 
Mass treatment of ascariasis in developing countries particularly those with 
high endemicity has been considered as a highly effective method for 
control of this soil-transmitted helminth. Among the prevailing common 
intestinal parasitic infections, Ascaris lumbn'coides is the most dominant 
parasite in Hamadan, west of Iran. A pretreatment stool examination of 
10570 individuals was done using formdim-ether sedimentation method 
for initial prevalence rate determination, and a modified Stoll techtuque for 
egg quantitation for the baseline. The prevalence rate of Ascaris infections 
ranges 40.4-75.6% in hamadan district and Toyserkan area, respectively. 
After the stool survey was completed, blanket treatment using albendazole, 
400 mg single dose was given to all population, except children lower 24 
month age and pregnant women. Treatment repeated with three mo 
intervals for 2 years in the all rural areas except 2 cities, nahavand and 
Malayer which had lower infection rate, 13% and and 4%, respectively. A 
sharp decline of infecton rate were observed in the all parts of study region 
and the program bring down the Ascaris infection rate to 6%. Mean 
prevalence rate were 53.3 before beginning of program. Sharp decline were 
observed in all rural areas including center of province, Hamadan. 
Treatment coverage were 93% to 97% in different villages. No any decline 
were observed in the prevalence of intestinal protozoan parasites such as 
Giardia Iamblia. This study indicated, regular mass treatment, in spite of lack 
of other preventive measures, can considered as a good and effective 
measure in the control of ascariasis. 
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152581 Optimal use of antibiotic resistance surveillance systems 
D. L. Monnet 
Copenhagen, DK 
From local microbiology laboratory databases to international studies and 
multicentric survedlance system, there are numerous sources of antibiotic 
susceptibility data. Besides national and regional initiatives, a recent review 
identified more than 20 multinational projects in this field ( I n t J  Antimicrob 
Agents 2000; 15: 91-101).These projects are using different methodologies 
depending on whether isolates, paper questionnaires or electronic dam are 
collected at a central level. Various sources of data and system designs 
provide us with very different kinds of information that must be judiciously 
used to answer specific questions on antibiotic resistance. For example, data 
obtained by centralized testing of isolates are most suited for breakpoint 
determination and identification of slight shifts in zone diameter/MIC 
distributions. O n  the other hand, central analysis of electronic susceptibility 
data obtained from local laboratories provides a reasonable and timely 
estimate of the prevalence of resistance. Based on this idea, a categorization 
of resistance surveillance systems has recently been proposed by the French 
National Observatory of the Epidemiology of Bacterial Resistance to 
Antimicrobials (http://www.onerba.org/). Optimal use of antibiotic 
survedlance systems therefore requires to choose the methodology which 
is best adapted to the system’s objectives. Additionally, practical and 
reasonable solutions must be found for collection of susceptibility data, 
elimination of duplicate isolates and determination of resistance levels using 
relevant measurement units. Finally, data must be used for more than just 
benchmarlung institutions or countries. Data should be plotted over time to 
idenufy short-term variations and long-term trends of resistance. Regional 
mstribution should be examined using geographical information systenu; to 
identify possible clusters. New methods such as data mining could be used 
to identify unexpected emerging patterns. When relevant, the relationship 
with implementation of control interventions and variations in antibiotic 
use levels should be examined. Interpreted results of this surveillance should 
be forwarded in a timely fashion to those who make decisions at the local 
level, e.g. prescribe antibiotics empirically or implement control interven- 
tions, or at the national or multinational level, e.g. define breakpoints, revise 
indications for specific antibiotics or define national antibiotic policies. 
Fl What does the infection control specialist expect from 
the clinical microbiologist? 
U. Frank 
Freiburg, D 
Close collaboration between the infection control specialst and the clinical 
microbiologist is desirable. Both should be members of an Infection Control 
Committee that is responsible for all surveillance activities relating to the 
prevention of preventable infections. A prerequisite for collaboration is that 
the microbiologist should have knowledge of infection control practice, and 
although the infection control specidst should possess understanding of 
microbiology, he will usually only have a limited familiarity with 
microbiological techniques. The rapid development and application of 
new technologies in the diagnostic laboratory require ongoing commu- 
nication between the laboratory and infection control personnel. Colla- 
boration begins with precise instructions from the laboratory on the 
collection, storage and transport of microbiological material. Next, 
microbiological results must be interpreted properly, i.e. accurate 
identificahon of nosocomial pathogens may serve to clarify issues of 
colonization vs. infection. In outbreak situations, when epidenllological 
investigations are necessary, the microbiologist must assess the appropriate- 
ness of various microbiological approaches to the given infection, i.e. he 
must answer the question as to necessity and possibdity of microbiological 
investigations. Knowledge about the pathogen spectrum and resistance 
situation in the hospital is indispensable for the work of any infection 
control practitioner. The compilation of resistance statistics must be done 
regularly by the microbiological laboratory. Within the scope of nosocomial 
infection surveillance, the infection control personnel needs full access to 
microbiological data. O n  this basis isolation precautions and antibiotic 
guidelines can be discussed and drawn up by the Infection Control 
Committee. 
152601 Role of the microbiologist in guiding therapy 
J. Melo-Cristino 
Lisboa, P 
The correlation between consumption of antimicrobials and the emergence 
of resistance is complex and has proved difficult to establish. Besides 
antimicrobial use, other distinct contributing factors are also involved in the 
issue. Cross-transmission of resistance both in the community and hospital 
plays a major role. Despite this complexity, there is a substantial body of 
evidence that the use of antimicrobials is associated with the development of 
resistance in the hospital and in the conmunity. Actions of the clinical 
microbiologist in guiding antimicrobial therapy include: infomiation on 
which microbiological magnostic tests are indicated and how test results 
should be interpreted; accurate identification of bacterial pathogens; correct 
detection and identification of antimicrobial resistance: fast reporting of 
clinically relevant information; availabllity to discuss with clinicians issues 
related to antimicrobial therapy; education on appropriate antimicrobial use, 
disease prevention and infection control issues; selective reporting of 
antimicrobial susceptibhty tests of bacterial pathogens; timely information 
of local surveillance of antimicrobial resistance of key pathogens. 
Update on infections in cancer patients 
152611 Usual and unusual risk factors of infection in cancer 
patients 
V. Krcmery 
Bratislava, SK 
Within last 40 years of EORTC experience in prevention and management 
of febrile neutropenic (FN) several risk factors were identified cytotoxic 
agents resulting to mucosal damage, bone marrow suppression with 
neutropenia, corticosteroids, central venous catheters, underlying neoplastic 
disease, high volume radiotherapy, etc. Paradoxically, broad spectrum 
antibiotic prophylaxis may be at risk for development of infections due to 
microorganisms from comensual patient flora (e.g. uiridans streptococci, Bacillus 
cereus, arcanobarferia, Candidu and Trichosporon spp.). Among unusual risk 
factors, exposure to uncooked food and spices, vegetables and raw fish may 
result to infection 111 BMT and acute leukemic patients with long lasting and 
profound neutropenia (Prototheca, Fusarium spp., etc.). The role of specific 
antineoplastic therapy, e.g. combinations of certain anticancer agents 
(ARAC + MTIX, etc.) may be additional ‘unusual’ risk factors. Despite, 
there is a lot of data on risk factors for infection in cancer patients, many of 
them are unpreventable and related to aggressive therapy or underlying 
disease. There is no empiric broad spectrum therapy neither antibiotic 
prophylaxis to prevent from all types of infections in ths  partial population. 
152641 Different strategies in prevention of infection 
M. Akova 
Ankara, TR 
A variety of preventive methods for infection are being used in cancer 
patients with neutropenia. Although convincing data are lacking, several 
antibacterial and antifungal agents are used either systemically or orally as 
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nonabsorbable medications. In several studies trimethoprim sulfamethox- 
azole and quinolones were found to be the most effective antibiotics 
reducing infectious episodes with Gram-negative bacteria. However, no 
survival advantage could be demonstrated and increased incidence of 
infection with resistant Gram-negatives and alpha hemolytic streptococci 
was of major concern especially in those experiencing longer duration of 
neutropenia. The only exception for pharmacological prophylaxis is use of 
tluconazole in patients receiving bone marrow or hemopoietic stem cell 
transplantation (HSCT). Solid data are available for this indication but not 
for those with acute leukemia and solid tumors. Since the transmission of 
Fluoroquinolones today (Arranged by Grunenthal) 
infectious agents from the environmental sources to patients is via human 
carriers, strict handwashing technique for all health care personnel can 
reduce this transmission dramatically. Avoiding consumption of fresh h i t s  
and vegetables, and nonprocessed dairy products during neutropenic periods 
are suggested. Rooms with laminar flow are costly and their use is optional 
for HSCT recipients. HEPA-filtered rooms could be useful for protection 
against nosocomial aspergdlosis during prolonged neutropenia. All of these 
preventive strategies along with the others not mentioned here are used 
singly or in combination in Merent centers, however, prospective 
controlled studies should prove their efficacies. 
152701 Microbiological comparison of fluoroquinolones 
P. Appelbaum 
Hershey, USA 
The 3 major bacterial pathogens in community-acquired respiratoty 
infections such as pneumonia, sinusitis, acute exacerbations of chronic 
bronchitis and otitis media comprise S. pneumoniae, H .  influenzae and M .  
catanhalis. In community-acquired pneumonia, the 'atypical' group (C. 
pneumoniae, M .  pneumoniae and L. pneumophila) also play a role. There are 3 
groups of oral antimicrobial agents which may be used for these infections: 
p-lactams, macrolides and quinolones. Because of the high incidence of 
pneumococci resistant to penicillin G, macrolides and other agents 
throughout the world, amoxicillin is the appropriate oral penicillin for 
treatment of these strains; addition of clavulanate will also combat p- 
lactamase positive H .  injuenzae and M.  catarrhalis. Except for cefditoren, 
there are no oral cephalosporins with comparable activity against both 
penicillin resistant pneumococci and H .  influenzae. Of available compounds, 
cefuroxime, cefixime or cefpodoxime are possibilities but less active against 
pneumococci and/or H. influenzae than amoxicillin and cefditoren. None of 
the p-lactams are active on their own against the atypical group. The higher 
the penicillin MIC of a pneumococcus, the higher its macrolide MIC. 
Macrolide abuse exerts selective pressure for both macrolide and penicillin 
resistance. Additionally, it is doubtful whether the macrolides or azalides are 
active against H .  influetzzae (although they are active against M .  catarrhalir). 
They may, however, be combined with amoxicillin/clavulanate or 
cefditoren if infection with one of the atypical group is suspected. The 
broad-spectrum fluoroquinolones are very active against all six pathogens 
mentioned above. However, toxicity has led to the withdrawal of several of 
these from US and European markets. In the USA, oral broad-spectrum 
fluoroquinolones currently in use include levofloxacin (the 1-isomer of 
ofloxacin), gatifloxacin and moxifloxacin. MICs of gatifloxacin and 
moxitloxacin are lower than those of levofloxacin. Gatifloxacin has a 
possible advantage in being excreted unchanged in the urine, making 
hepatotoxicity (such as was the case with trovatloxacin) u d e l y .  When 
considering empiric therapy for community-acquired respiratory tract 
infections, it must be carefully borne in mind that antibiotic abuse will lead 
to resistance. 
vl Optimizing antimicrobial therapy by using PKlPD 
parameters 
M. R. Jacobs 
Cleveland, USA 
Antimicrobial resistance in bacterial respiratory tract pathogens is a rapidly 
evolving and increasing problem. Major factors that have contributed to 
resistance are inappropriate prescribing of antibiotics for viral infections and 
the use of antibiotics with poor activity. The treatment of respiratory tract 
infections (RTI) are significantly impacted by resistance in organisms such as 
Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. 
Resistance to beta-lactams, macrolides and sulfonamides among these 
respiratory pathogens continues to rise in many countries. Evidence-based 
guidelines based on clinical and bacteriological outcomes are imperative in 
order to treat patients effectively, to limit the spread of these pathogens, and 
to minimize further development of resistance. The current MIC 
susceptibility breakpoints for many oral antimicrobial agents were 
established when resistance rates were much lower and do not correlate 
well with clinical outcomes. Pharmacokinetidpharmacodynamic (PKIPD) 
parameters have recently been shown to have good correlation with clinical 
outcome and offer a more rational approach to predicting antimicrobial 
e5cacy and determining clinically relevant susceptibility breakpoints. 
Antimicrobials can be classified as time or concentration dependent. For 
time-dependent agents, such as beta-lactams and macrolides, the serum 
concentration should exceed the MIC of the pathogen for 40-50% of the 
dosing interval in order to acheve a successful outcome. For concentration- 
dependent agents, such as fluoroquinolones and azahdes, the AUC:MIC 
ratio should exceed 25 and/or the peakMIC ratio should exceed 10 in 
order to achieve a successful outcome in immunocompetent hosts. 
Additionally, the AUC:MIC ratio should exceed 100 to prevent emergence 
of resistant mutan& Based on PK/PD parameters, the most effective agents 
in treating RTI caused by S. pneumoniae, H .  iyflirenzae and M.  catarrhalis are 
amoxicillin/clavulanate and the newer fluoroquinolones, such as gahflox- 
acin, levofloxacin and moxifloxacin. 
Difficult-to-treat Gram-negative hospital infections 
/5277( Epidemiological surveillance of a sustained hospital 
endemic by A. baumannii: what can we learn? 
M. A. Dominguez 
Barrelono, E 
Since 1992 multiresistant A .  baumanrzii (MRAB) has been the most frequent 
nosocomial pathogen isolated in Hospital de Bellvitge, a 1000-bed teaching 
hospital for adults. Although an ongoing infection control program was 
implemented, MRAB spread throughout the hospital from 1992 to 1998, 
with more than 1400 patients colonized or infected, 75% of them during an 
ICU stay. A prospective surveillance was performed on more than 1500 
MRAB clinical and enviromental isolates to determine patterns of antibiotic 
resistance (PR), molecular characterization of involved clones, evolution of 
the epidemic clones, and MRAB reservoirs. From 1992 to 1996, MRAB 
isolates were uniformly resistant (R) to beta-lactams arid gentamycin, and 
susceptible (S) to sulbactam, carbapenems and colistin. O n  the basis of the 
variable susceptibilities to tobramycin, amikacin, tetracycline, and cipro- 
floxacin, three major P R  among MRAB could be defined PR-1, R to 
tobramycin, tetracycline, ciprofloxacin, and S/R to amikacin; PR-2, R to 
tobramycin and S to amikacin, tetracycline, and ciprofloxacin; and PR-3, R 
to tetracycline and ciprofloxacin and S to tobramycin and amikacin. 
Surveillance of MRAB isolates by molecular typing procedures (REP PCR, 
PFGE, and plasmid analysis) showed three main clonal types that 
corresponded to the three PRs: clone A, PR-1, detected in 63% of the 
isolates; clone B, PR-2 (6.7%); and clone C, PR-3 (4.6%). In January 1997, 
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MRAB isolates also resistant to carbapenems (CRAB) were first detected. 
InitiaUy CRAB isolates were S to sulbactam (MIC, 4 mg/L), intermediate 
to imipeneni (MIC, 8 mg/L), and belonged to a new genotype (clone D). 
In May 1997, a merent  CRAB clone (clone E) was identified, R to 
sulbactam (MIC > 64 mg/L), R to imipenem (MIC > 32 mg/L) and only 
S to colistin (MIC < 2 mg/L). Carbapenem resistance spread rapidly, and 
by the end of 1998 had exceeded 50%. A high proportion of patients (30- 
40%) were colonized at different body sites very early during ICU adrmssion. 
Fecal carriage of MRAB and the presence of a larger proportion of MRAB 
infected or colonized patients in the same ICU ward were idended as major 
risk factors for subsequent MRAB infections. Colonized patients and 
environmental contamination might act as the major epidemiological 
reservoirs for infection. Inadequate prevention of cross-transmission is the 
main determinant for MRAB persistence in Hospital de Bellvitge. 
152791 Pseudomonas aeruginosa: the multiresistance queen 
H. Giamarellou 
Athens, CR 
(VAP) where attributed mortality exceeds 30%. Except for the inherent 
multivimlence factors which render the bacterium by itself more 
pathogenic, the predominance of multiresistance strains in the nosocomial 
setting multiplies the dBiculties for therapeutic options. O n  the other hand 
the feasib5ty of P. aeruginosa to colonize the respiratory tract (either as 
a result on normal flora selective pressure exerted by pretherapies with 
broad spectrum antibiotics or by the hospital personnel transfer by 
hands) creates problenis in Merentiating real pathogens kom colonizers. 
Several European ICU studies revealed that overuse and nlisuse of 
carbapenems which should have a major role in ICU empirical therapy 
has led to the predominance of Pseudomonas strains encoding for broad 
spectrum carbapenemases (IMP-1, IMP-2, VIM-I, VIM-2) inactivating 
almost all beta-lactams (with exception to aztreonam) sharing as a rule 
cross-resistance with all other antipseudomonal antibiotics. Colimycin 
being active in uitro remains the only therapeutic solution, however, side- 
effects and poor hnetics compromise its use. Rational antibiotic policies 
including infectious diseases consultation and the application of rotation 
systems in antibiotic prescription, improved diagnostic approach in VAP 
and catheter related bacteremia, as well as appropriate hand-antiseptic use 
are the means that should be urgently and strictly applied in any ICU and 
tertiary hospitals. 
P. aeruginosa represents nowadays the predominant gram-negative isolate in 
ICU infections, particularly implicated in ventilator-associated pneumonia 
Immune response modification and the management of genital herpes (Arranged by 3M) 
/52951 Herpes: current disease trends 
A. Volpi 
Rome, I 
Genital herpes can be caused by either Herpes simplex virus type 1 (HSV-1) 
or HSV type 2 (HSV-2). Infection results from contact with virus present in 
secretions on oral or genital mucosal surfaces. Seroprevalence of genital 
HSV vanes considerably, however, infection is increasing worldwide. HSV- 
2, considered for decades as the primary causative agent for genital 
infections, is easily distinguishable from HSV-1 by antigenic and biological 
differences. Serologic assays that can distinguish between antibodes to 
HSV-1 and HSV-2 have recently been made readily available, allowing the 
study of type-spec& HSV prevalence. However, as serological tests cannot 
distinguish between genital and orolabial HSV-1 infections it is difficult to 
define what proportion of HSV-1 seropositive individuals have genital 
herpes. As a result, despite the increasing number of genital herpes cases 
diagnosed as HSV-1 positive, the prevalence of genital herpes continues to 
be reported as the prevalence of antibodies to HSV-2. According to the 
most recent studies prevalence of HSV-2 greatly varies according to several 
factors including geographical area, gender, age, race, education, previous 
memcal history, drug use, sexual preferences, occupation and/or socio- 
economic status. It appears lowest in healthy heterosexual ndes living In 
Southern Europe (3-7%) and highest among adults in Africa (5@95%) and 
men who have sex with men in Europe and USA (4@-95%). However, as a 
general rule, h g h  prevalence of HSV-2 infection in populations considered 
at risk seems to be an international trend. Worldwide, prevalence of 
infection in those at risk varies much less than in the general population, and 
remains hgh in countries with low population based frequencies. 
/5296j Clinical management of herpes today 
R. Whtley 
Birmingham, USA 
Herpes simplex viruses (HSV) cause recurrent genital herpes, a chronic 
dect ion of mucous membranes and one of the most prevalent sexually 
transmitted diseases worldwide. Both HSV-1 and HSV-2 cause genital 
infections; however, the majority of genital herpes (GH) cases have been 
attributed to HSV-2 infection. The fundamental biological property of HSV 
is its capacity to persist in neuronal cells. Recurrent HSV episodes are a 
consequence of reactivated viral replication of latent infection in the ganglia, 
which results in either asymptomatic viral excretion or recurrent lesions. 
The majority of cases remain subclinical, however, virus shedding can occur 
during asymptomatic infection. Prophylactic and therapeutic vaccmation 
studies have progressed slowly, despite major efforts. Current treatments for 
genital herpes aim to reduce the duration and severity of signs and 
symptoms of the disease. Acyclovir, a nucleoside analog, has been used 
successfully in the treatment of primary and recurrent infections, reducing 
the duration of viral shedding and accelerating lesion healing. Topical 
formulations of the drug have shown little efficacy. Both valaciclovir and 
famciclovir are also available for the treatment of recurrent genital herpes 
but neither are significantly superior to acyclovir. The Centers for Disease 
Control (CDC) and International Herpes Management Forum (IHMF) 
current guidelines recommend acyclovir, famciclovir or valaciclovir for the 
treatment of genital herpes. However, there are patient compliance issues 
associated with long-term suppressive therapy, includmg the long-term 
daiiy drug intake. Persistent infection and viral shedding, leading to 
transmission, remain the central problems of GH disease. This presentation 
wiU hrther discuss current treatment approaches and management guidehes 
for genital herpes infection, and address the need for new therapeutic options. 
15297 Unmet clinical needs of current approaches: what are 
the future solutions? 
S. Barton 
London, UK 
Genital herpes results from infection with HSV type 2 or type 1 virus, with 
geographical variation of the relative contribution of these two subtypes. 
HSV infection is rarely life threatening, however, specific patient groups do 
develop severe disease, for instance infants with neonatal encephalitis and 
disseminated disease. HSV in inmuno-compromised patients can also be 
extremely severe causing extensive lesions on the mucous membranes. 
Recurrent episodes become progressively less severe over the years 
suggesting the host’s immune response can control herpes infection. Disease 
clearance has also been associated with cell mediated immune responses, and 
HSV-specific T cell infltrates have been isolated horn resolving lesions. 
However, the efficacy of topical and systemic IFN treatments has been 
minimal, and attempts to develop prophylactic and therapeutic vaccines 
have been largely unsuccessful. A report of partial success with HSV-2 gD2 
subunit vaccine in combination with a potent adjuvant was recently 
presented, however, protection 6oni HSV disease was acquired only by 
women with no previous exposure to HSV. There is currently no predictor 
of frequency and severity of recurrent episodes, which are variable among 
patients, and commonly infected individuals suffer psychosocial and 
psychosexual niorbidity. Nucleoside analogs are currently recommended 
for both episodic and long-term, daily suppressive treatment of genital 
herpes. These potent antiviral drugs do not clear the virus from the system 
but directly inhibit viral replication. Typically, patients suffer a recurrent 
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episode of genital herpes if treatment is interrupted. Some patients use 
alternative therapies w h c h  can cause further tissue injury: an example of t h s  
will be given in the presentation. Also, the issues of viral shedding and 
disease transmission are not addressed by current therapy. Recently a new 
family of compounds called the immune response modifiers (IRMs) has 
been described. lRMs exhibit nonspecific antiviral activity by stimulating 
the T h l  immune response in the host, and have been used successfully in 
over 25 countries for the treatment of genital warts. Results of preclinical 
tests in the guinea pig model of primary and recurrent genital herpes, and in 
phase I 1  clinical trials, have shown that topically applied IRMs are effective 
in significantly delaying recurrent episodes. The implications of the 
potential development of l R M s  for the treatment of genital herpes will 
be discussed. 
152981 Immunotherapeutic treatment options 
St Paul, USA 
Immune response modifiers (IRMs) are a novel class of drug with potent 
immune modifying properties. Pre-clinical studies in mice and human 
PBMC have shown that IRMs can prevent growth and replication of a 
range of viral and tumour targets. Further investigation in vitro showed that 
I R M s  do not exhibit direct antiviral activity, but act indirectly by 
stimulating production of cytokines including IFN alpha, IFN gamma, 
TNF alpha and IL12 which stimulate a Thl  response. Irniquimod, the first 
IRM to be approved, is licensed for the treatment of genital warts. 
Investigation of the mode of action of imiquimod has shown that a 5% 
preparation applied to lesions induces cytokme production and triggers 
intiltration of CD4 and CD8 T cells, inducing a T h l  response locally at the 
site of application. Treatment also decreases expression of CDla antigen on 
the antigen presenting dendritic cells (DCs) in lesions, suggesting that IRMs 
stimulate migration of DCs to the draining lymph nodes where antigen 
presentation to naive T cells can occur. This may up-regulate the T cell 
response to specific antigen leading to long-term protection against disease 
recurrence. Imiquimod has also shown efficacy in treating primary or 
recurrent genital herpes (RGH) and can act as a vaccine adjuvant in 
conjunction with HSV-2 glycoprotein vaccine in the guinea pig model of 
R G H  infection. Immunisation with the vaccine reduced disease severity, 
however, when used in combination with an IRM 7&80% of disease 
recurrences were prevented. Resiquimod, a new compound belonging to 
R. Miller 
the I R M  family, is 100 times more potent than imiquimod and is also an 
effective treatment for R G H  in the guinea pig model. Resiquimod was 
found to be as effective as imiquimod with the added benefit of fewer 
applications. The ability of IRMs to generate and maintain effective cell 
mediated immunity against a specific pathogen, demonstrated by low disease 
recurrence rates of genital warts in 1RM treated individuals, should provide 
an improvement over existing treatments for genital herpes. This 
presentation will discuss the potential role IRMs could play in the 
treatment of RGH. 
vl Topical immunotherapy to decrease recurrences of 
genital herpes 
S. Spruance 
Salt Lake City, USA 
Resiquimod (R-848) is an immune response modifier that induces 
endogenous production of interferon-alpha, interleukin-12, and other 
cytokines. In the guinea-pig model of recurrent genital herpes (RGH), 
lesion kequency is reduced even after cessation of resiquimod therapy. To 
determine if topical application of resiquimod gel to genital herpes lesions in 
humans was tolerable and had post-treatment effects, immune competent 
adults with a history of 6 or more recurrences per year were sequentially 
randomised in cohorts of 12-3 weeks of treatment with resiquimod gel or 
vehicle (2:l). Study drug was applied to lesion(s) up to 24 h fiom onset and 
patients were observed for 6 months after treatment. Fifty-two patients were 
randomized. Dosing regimens studied, in order, were: 0.05% 1 x per week, 
0.05% 2 x per week, 0.01% 2 x per week and 0.01% 3 x per week. In the 
0.05% 2 x per week cohort, 3 of 12 patients (1 vehicle, 2 resiquimod) had 
dose-lirmting local adverse events; the other 3 regimens were well tolerated. 
Analyses suggest local adverse events may be increased in the latter half of 
the treatment period with 0.05% and more Gequent dosing. Kaplan Meier 
estimate of median time to h t  recurrence for the 41 patients who entered 
observation was 169 days for resiquimod patients (combined) compared to 
57 for vehicle (P=O.006). The proportion without a recurrence during 
observation was 32% (11134) for resiquimod patients vs. 6% (1/18) for 
vehicle (P' 0.039). Topical resiquimod 0.01% appears better tolerated than 
0.05% when dosed 2 x per week and the 0.01% regimens were associated 
with a post-treatment delay in recurrence. Further assessment of topical 
resiquimod 0.01% for R G H  is warranted. 
Staphylococci and streptococci pathogeneses and vaccines 
103oO/ Necrotizing pneumonia due to 5taphy/ococcus aureus 
strains producing the Panton Valentine leucotoxin 
Y. Gillet, B. Issartel, P. Vanhems, J. C. Fournet, M. Bes, G. Lina, F. 
Vandenesch, Y. Piemont, N. Brousse, D. Floret, J. Etienne 
Lyon, Paris, Strusbourg, F 
Introduction: Between 1986 and 1999, 8 cases of severe pneumonia due to 
Stuphylomccus aureus strains producing the Panton and Valentine leucotoxin 
(PVL) were referred to the French National Reference Centre for 
Staphylococcal Toxaemia. To determine the clinical features of these 
pneumonias, we conducted a prospective surveillance of community 
acquired pneumonia during the year 1999. Staphylococcal pneumonia 
was defined according to usual standards and clinical, biological and 
radiological data were collected. AU the strains were tested for the genes 
coding PVL. The cases associated with PVL positive strains were considered 
as study group and those associated with PVL negative strains were the 
controls. Nosocomial pneumonias were excluded. 
Results: 52 caes of S. aureux pneumonia were referred by 32 different 
hospitals; 16 of them were due to PVL positive strains. These pneumonia 
occurred in significantly younger patients (median age = 14.8 vs. 70.1), d 
previously healthy (40% of underlying diseases in the control group). 
Remarkable c h c a l  features were the presence of viral infection in the 
preceding days (75% vs. 9%), the fiequency of shock (81% vs. 53%), 
respiratory distress (75% vs. 53%) and the presence of hemoptysis (38% vs. 
3%). Biologically, leucopenia was present in 79% of cases. There were no 
significant differences regarding radiological findings. Mortality was higher 
in the PVL group (75% vs. 47%). Autopsy showed necrotic lesions of the 
tracheal and bronchial epithelium, alveolar septum destruction and difise 
haemorrhagic lesions. 
Discussion: Severe staphylococcal pneumonia with shock, leucopenia, 
hemoptysis and high mortality rate have been previously described in 
children and young adults as sporadic cases or cases associated with historic 
mfluenza pandemia. We established the relationship between this clinical 
syndrome and the PVL production by S. aureus isolates.We believe that viral 
infection constitutes the prerequisite altering the respiratory epithelium 
which secondarily allows S. aureus invasion; and the necrotizing action of 
the PVL leads to the massive haemorragic pneumonia. 
Conclusion: Staphyloccocal necrotizing pneumonia is a new entity with 
a probable underestimated fiequency. Further studies are needed to 
determine the prognosis factors, the exact role of S. UURUS camage and 
of preceding viral infections. The description of this new syndrome 
could lead to changes in the therapeutic management of staphylococcal 
pneumonia in chlldren. 
103011 Taqman real-time quantitative PCR is a powerful tool 
to study gene expression in vitro in staphylococci 
S. J. Vandecasteele, W. E. Peetermans, R. Merclot, J. Van Eldere 
Leuuen, B 
Objective: The aim of our study was to develop a rapid, accurate and 
reproducible tool to study gene expression under changing conditions. We 
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studied the expression of the hsp-60 (heat shock protein 60) and 4 
housekeeping genes of Staphylococcus epidemridis during heatshock to vahdate 
our techmque. 
Methods: We sequenced two housekeeping genes (gmk: guanylate kinase 
and tpi triosephosphate isomerase) and cloned these genes, the dhfr gene 
(hhydrofolaat reductase), the 16s rRNA gene and the hsp-60 gene &om a 
clinical S .  epidertnidis isolate. Instant RNA isolation was performed 
with mechanical disruption in the presence of an acid phenol based 
solution. RNA purification was performed with the RNeasy kit 
(Qiagen). cDNA synthesis was done with MMLV in the presence of 
RNasin (Promega). For Taqman P C R  runs, we used the PE Taqman 
PCR master mix. In each run a negative control and a standard dilution 
of the cloned gene with known quantity were included. For each 
RNA isolation, bacterial cell count (Burcker chaimher) and quantitative 
culture were done. The number of RNA copies was divided by the 
number of cells, to obtain the number of copies per cell. Heatshock 
was given in the exponential growth phase for 10 min at 37 "C (control) vs. 
47 "C (heatshock). 
Results: The expression of hsp-60 increased %fold after heatshock 
(P=1.8x10-13); expression of gmk declined slightly (0.7 fold- 
P= 0.009), and expression of 16s increased slightly (1.4 fold-&'= 0,001); 
the expression of tpi and dhfi did not change significantly. 
Discussion: Taqman real time quantitative PCR in combination with 
instant RNA isolation is a highly sensitive and reproducible technique 
to study gene expression in staphylococci. We could confirm a rapid 
up-regulation of the hsp-60 gene after heatshock, with a slight increase 
in 16s expression, and a slight decrease in gmk expression. Our technique 
seems very promising to study gene expression in bacteria. Future work 
wdl study gene expression in staphylococci during infection and 
stress conditions. 
103021 Expression of housekeeping genes during in vitro 
exponential and early stationary growth of staphylococci 
S .  J. Vandecasteele, W. E. Peetermans, R. Merckx, J. Van Eldere 
Leuven, B 
Objective: Taqman real time quantitative P C R  in combination with 
instant RNA isolation is a powerful tool to study gene expression in 
staphylococci. The aim of the current work was to determine the expression 
of five housekeeping genes during exponential and early stationary 
growth, in order to create a reference for further gene expression 
experiments. 
Methods: We sequenced two housekeeping genes (gmk: guanylate kmase 
and tpi triosephosphate isomerase) and cloned these genes, the dhfr gene 
(dihydrofolaat reductase), the 16s rRNA gene and the hsp-60 (heat shock 
protein) gene from a clinical S .  epidermidir isolate. Instant RNA isolation was 
performed with mechanical disruption in the presence of an acid phenol 
based solution. RNA purification was performed with the RNeasy kit 
(Qiagen). cDNA synthesis was done with MMLV in the presence of 
RNasin (Promega). For Taqman PCR runs, we used the PE Taqman P C R  
master mix. In each run a negative control and a standard dut ion  of the 
cloned gene with known quantity were included. For each RNA isolation, 
bacterial cell count (Burcker chaimber) and quantitative culture were done. 
The number of RNA copies was divided by the number of cells, to obtain 
the number of copies per cell. 
Results: The expression of all genes was much higher during early 
exponential phase than during late exponential and early stationary growth 
phase. After an initial rapid up-regulation of all genes, there was a marked 
decrease of the expression of all genes ( x 1/18 gmk, x 1/14 tpi, X 1/8.6 
dhfr, x 1/89 hsp and x 1/46 16s). During late exponential-early stationary 
phase, 16s rRNA increased slightly compared with the other genes. 
Expression of gmk dechnes faster than expression of other genes. All 
differences were statistically highly significant. 
Discussion: Taqman real time quantitative PCR is a sensitive and 
reproducible technique to study gene expression in staphylococci. After 
an initial increased expression of the housekeeping genes who were studied, 
there is a gradual decrease in gene expression during exponential bacterial 
growth, Expression of 16s shows a slight increase during early stationary 
phase, which may indicate a higher metabolic activity dunng change of 
growth phase. 
vl Streptococcus viridans septicemia: role of cytokine 
induction and in vitm effect of polyspecific immunoglobulins 
N. Ihendyane, E. Sparrelid, J. Andersson, P. Ljungman, 0. RingdCn, A 
Norrby-Teglund 
Stockholm, S 
Objective: 3 7 .  viridans is an important cause of severe sepsis in neutropenic 
patients. In this study, the cytokine inducing capacity of clinical Str. oiridans 
strains isolated from patients with severe sepsis (n = 6) was compared to that 
of isolates fiom patients with uncomplicated bacteremia (n = 5). We also 
tested whether intravenous polyspecific immunoglobulin (IVIG) could 
neutralize the pro-inflammatory activity of the isolates. 
Methods: Peripheral blood mononuclear cells (PBMC) from healthy 
individuals were stimulated with bacterial culture supernatants as well as 
heat-Ned bacteria, and tested for cytokine and mitogenic activity. The 
proliferative response was assessed after 72 h of culture by 3H-Thymidine 
incorporation, and cytokine responses after 24, 48, and 72 h by intracellular 
immunohistochemical staining. The capacity of different IVIG preparations, 
containing various levels of IgA, IgM, and IgG, to inluhit the cytokine 
production induced by culture supernatants or heat killed bacteria was 
determined in cell culture experiments. 
Results: None of the isolates induced a significant proliferative response, and 
culture supernatan6 and heat-killed bacteria generated equally low 
responses. Cytokine analyses revealed high frequencies of ILlheta- and 
IL8-producing cells, reaching as high as 26% in some cultures, whereas only 
low or no production of TNFalpha, TNFheta, and IFNgamma could he 
detected. There was no significant diference in cytokine induction by 
isolates from severe and nonsevere cases. In contrast to previous results with 
Str. pyogenes, only very low inhibition of the isolates was acheved by the Ig- 
preparations. 
Conclusion: The study showed that Str. viridans isolates are powertid 
inducers of pro-inflammatory cytokines, and the results suggest that the 
response is induced by both surface associated molecules as well as secreted 
factors. However, the isolates did not induce a significant production of T 
cell cytokines, which was consistent with very low mitogenic activity. This 
lack of induction of T cell cytokine may partly explain why IVIG did not 
inhibit these isolates, whereas a strong inhibition is seen for Str. pyogenes, 
which also induces h g h  T cell cytokine production. 
F] Horizontal gene transfer and host specificity of beta- 
hemolytic streptococci 
C. Franken, C. M. Brandt, J. Weber-Heynemann, S .  Martin, R. Lutticken, 
B. Spellerberg 
Aachen, D 
Objectives: Beta-hemolytic streptococci are important human and animal 
pathogens, genetic traits that are closely associated with the ability to infect 
human hosts remain, however, unclear. Our laboratory previously identified 
the surface protein Lmh, whch mehates the adherence of S. agalactiae to 
human laminin. The purpose of ths  study was to charactenze the adjacent 
nucleotide region, to investigate if this region is present in other heta- 
hemolytic streptococci and to investigate if the presence of this region is 
associated with the pathogenic potential of a streptococcal strain. 
Methods: The genetic locus adjacent to lmb was sequenced in S. agalactiae 
strain 090R.  Unknown nucleotide regions were obtained from a Lambda 
phage library, amplified by PCR and sequenced on an ABI 310 DNA 
sequencer. The plasmid pGh5 was used for targeted mutagenesis of h h .  
Results: Nucleotide sequencing revealed that the lmb gene is localized on a 
putative composite transposon of 16kb that is flanked by two copies of a 
novel insertion sequence element (ISSag2). This putative transposon harbors 
the C5a peptidase gene scpB and the lmb locus. Analysis of the distribution 
of scpB, lmb and the flanking ISSag2 element among 128 strains of beta- 
hemolytic streptococci revealed that all of the human, hut only 20% of the 
animal isolates contained scpB and Imb, or their homologues. Both of these 
genes are 98% identical with the respective genes of S .  pyogenes, while the 
comparison of the nucleotide sequence identities of other known genes in 
S. agalactiae and S .  pyogenes displayed identities ranging from 71 to 93%. To 
test the hypothesis that the putative transposon can be mobilized from the 
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bacterial chromosome, an erythromycin resistance marker was incorporated 
into the Imb gene of S.  agafactiae. Screening for mutant strains with 
a regained susceptibility for erythromycin, identified strains with a 
deletion comprising the entire nucleotide region of scpB, hnb and one 
copy of ISSag2. 
Conclusions: We hypothesize that a horizontal gene transfer is responsible 
for the exchange of these genes and that the ability of beta-hemolytic 
streptococci to infect or colonize human hosts is dependent on their presence. 
103051 Differential induction of cytokines by beta-hemolytic 
group A, B, C, and G streptococci 
A. Norrby-Teglund, N.  Ihendyane, N. Svensson, D. Low 
Stockholm, Skbvde, S; Toronto, CDN 
Objective: Beta-hemolytic streptococci (BHS) are important causes of sepsis 
and septic shock in patients. Although group A streptococcus (GAS) is most 
conunonly associated with these infections, they may also be caused by 
group B, C, and G (GBS, GCS, and GGS). The imiunopathogenesis of 
GAS is quite extensively studied. however, much less is known about the 
other BHS. In this study, the cytokine inducing capacity of clinical GBS 
( i t -4 ) .  GCS ( n =  l), and GGS (PI= 1) strains isolated from patients with 
severe sepsis or STSS was determined and compared to that of GAS STSS 
isolates ( n =  10). 
Methods: Peripheral blood mononuclear cells (PBMC) from healthy 
individuals were stimulated with bacterial culture supematants as well as 
heat-killed bactena, and tested for cytokine and mitogenic activity. 
The proliferative response was assessed after 72 h of culture by 3H- 
Thymidine incorporation, and cytokine responses after 24 and 72 h by 
intracellular immunohistochemical staming using cytokine specific mono- 
clonal antibodies. 
Results: A distinct difference could be noted between the various isolates in 
their ability to induce proliferative responses. AU 10 GAS isolates induced 
very powerful proliferative responses whereas no or only very low 
proliferative responses were induced by the GBS, GCS, or GGS strains. 
Cytokine analyses revealed very high frequencies of ILlbeta- and 1L8- 
producing cells, reaching up to 30% in some cultures, following stimulation 
with all the different streptococcal strains. In contrast, a strong production 
(5-30% cytokine producing cells) of the T cell cytokines TNF-beta and 
IFN-gamma were only induced by the GAS isolates and not by the GBS, 
GCS, or GBS strains. Although some variation existed between culture 
supematant and heat-killed bacteria, the overall cytokine induction profile 
of an isolate was sindar in both type and amount of cytokines. 
Conclusion: The study showed that BHS are potent inducers of pro- 
itiflammatory cytokine responses, and this is most likely an important event 
in the pathogenesis of sepsis. However, there are clear distinctions between 
GAS isolates and GBS, GCS, and GGS, especially with regards to their 
ability to induce T cell activation. This may be attributed to differences in 
the production of superantigens between the BHS strains. 
[03061 Better clinical outcome and improvement of survival 
time with extracorporeal phagocytosis assistance in a pig-model 
of sepsis 
M. Sauer, S. Klohr, M. Suraj, J. Altrichter, J. Stange, S. Mitziier 
Rostork, D 
Objectives: One major reason for the development of a systemic infection is 
the dysfunction of the host immune system including phagocytosis. So we 
investigated the possibility to establish an extracorporeal phagocytosis 
assistance system for the treatment of sepsis. The presented study shows 
results of phagocytosis assistance in a pig-model of Gram-positive sepsis. 
Methods: Human hematopoetic precursor cells have been expanded and 
stimulated to differrntiate towards functional granulocytic cells. In an 
animal-model of sepsis, described by Lee et al. 1998, 21 female immature 
landscape-swines (weight: 8.5-10.5 kg) were given 8 x 10' cfu/kg living 
Staph. aureus and for 7 days clinical parameters and survival time 
were monitored. After a 1-h infusion of bacteria the pigs were treated for 
6 h by an extracorporeal plasmaperfusion model containing a membrane- 
based bioreactor (Nylon, pore-size: 20 pm) with 2.5 x 10' cells. 
Plasmaseperation was carried out by centrifugation. Group I was treated 
without cells (Untreated-Group = UG, ti = 7), group I1 with cells (Treated- 
Group = TG, n = 7) and group 111 with cells, but without bacteria (Control- 
Group = CG, n = 7). 
Results: All animals of the UG died, but two animals of the TG and all 
animals of CG survived the whole time (Log Rank test: TG-UG P =  0.075). 
The other clinical parameters showed significant benefit for the cell-treated 
animals (TG) compared with the UG (see Table 1). 
Conclusion: Cell-based extracorporeal immune support may improve the 
outcome in severe infection. 
03071 Results from an efficacy study of Nabi '' StaphVAX" 
(Stapby/ococcus aureus polysaccharide conjugate vaccine) in 
hemodialysis patients 
A. Fattom, G. Honvith, S. Fuller, S. Black, H. Shinefield, R. Naso 
Rorkville, Oakland, USA 
Introduction: Capsular polysaccharides (CP) types 5 and 8 comprise 85-90% 
of all clinical isolates of S. aureus in the USA and Europe. Nabi '' 
StaphVAX is a S. uure-us bivalent glycoconjugate vaccine that includes CP 
type 5 and 8 conjugated to a nontoxic recombinant exoprotein A (rEPA) 
from Pseudowonas aeruginosa. Rat and mouse models of infection have 
shown that immunizauon with StaphVAX" or with antibodies to 
StaphVAX 'I provided significant protection against S. aureus induced 
mortality, bacteremia, endocarditis and organ seeding. A single dose of 
StaphVAX" was found to elicit maximal immune response in healthy, adult 
volunteers within two weeks after vaccination, and titers persisted for well 
over one year. Patients w t h  end stage renal diwase (ESRD) on hemodialysis 
are at high risk for S. aureus bacteremia (estimated at 0.05 infections/patient 
year). A vaccine dose of 100 pg of StaphVAX" was required to elicit a 
response in ESRD patients, as measured by percent responders and peak 
antibody titers, comparable to that achieved in healthy adult volunteers. 
Methods: StaphVAX", administered as a single i.m. injection, was 
evaluated in a double-bhnded, randomized, placebo controlled efficacy 
trial in 1800 hemodialysis patients. The trial began in April 1998 and ended 
in April 2000. 
Results: There were no significant safety issues that warranted study 
modification. Approximately 38% of vaccinees, and 20% of placebo 
recipients reported reactogenicity to the intrarsuscular injection. Reacto- 
genicity events were generally mild to moderate and most resolved without 
intervention within 2 days. Through approximately 10 months postvacci- 
nation, there were 26 S aureus bacteremias in the placebo group and 11 
bacteremias in the group that received StaphVAX " , a 57% reduction in 
bacteremia. By 12 months postvaccination, the reduction in S. aureus 
bacteremia was 26%. GMT of StaphVAXR -induced antibodies at 6 months 
and 12 months postvaccination were approximately 50% and 33% of peak 
titers (measured in this study at 42 days postvaccination). A population- 
based assessment suggests that vaccine efficacy in this patient group is related 
to a minimum circulating antibody titer of approximately 100 pg/mL. 
Conclusion: These data indicate that StaphVAX '' was well tolerated, and 
can sigmficantly reduce the incidence of S. uureus bacteremia in this at-risk 
adult population through approximately 10 months postvaccination. 
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Hepatitis B and C 
Rationale for offering universal hepatitis B 
immunization to babies born in the UK 
M. Joyes, M. Kerawala, T. Huber, B. Patel, P. Lee, Y. Drabu 
Lmdori ,  UK 
Introduction: Hepatitis B virus (HBV) infection is globally endemic and a 
major public health problem. The outcome of HBV disease i< age- 
dependent. Infection during early years induces a carrier state leading to 
serious long-tenn sequelae of chronic liver disease and the risk of primary 
hepatocellular carcinoma. 
Objectives: Although, some Western European countries have implenien- 
ted a National Programme for routine childhood hepatitis B inmiunization, 
universal vaccination is not in place in UK. The current guidelines issued by 
UK Department of Health recoinmend universal antenatal screening for 
HBV and immunisation of babies born to infected mothers. The aim of this 
study is to identify those babies at a potential risk of acquiring hepatitis B 
&om their family environment. 
Methods: The blood samples were tested using Biokit bioelisa HBsAg and 
anti-HBc for the presence of hepatitis B surface antigen (HBsAg) and 
hepatitis B core (anti-HBc), respectively. 
Results: A total of 3148 women attending our antenatal clinic in 1998 were 
screened routmely for HBsAg. A high seroprevalence was noted in these 
pregnant women; 63/3148 (2%). Alternate HBsAg negative sera were tested 
for antibody to anti-HBc. A significant proportion of women were anti- 
HBc positive; 146/1425 (10%). 
Conclusions: Our data suggests that HBsAg screening may not be sufficient 
to identify the full risk of hepatitis B within the household environment. 
This study highlights an additional 10% of babies that would potentially 
benefit &om hepatitis B immunization. Therefore, we suggest that uIllversal 
immunization against hepatitis B would be a more appropriate preventative 
measure in areas of high or intemiediate prevalence arras of the UK. In 
conclusion, there is a need to modify the UK policy. 
103091 Sporadic breakthrough infections in newborns of 
HBsAg positive mothers vaccinated against hepatitis B 
L. Roznovsky, I .  Lochnian, A. Zjevikova, L. Lukacova, I. Orsagova, L. 
Pliskova, A. Kloudova 
Ostrava, Hradec Kralove, CZ 
Objectives: Breakthrough infections (viral hepatitis B and asymptomatic 
appearance of anti-HBc) and ananinestic anti-HBs response were 
investigated in children of HBsAg positive mothers vaccinated against 
hepatitis D. 
Methods: Combined passive-active immunization against hepatitis B of 496 
new-barns was commenced in 1988. AU mothers were HBsAg positive 
during pregnancy, 24 of them were also HBeAg positive. The children 
received hepatitis B immunoglobulin at birth and three 10-pg doses of 
plasma-derived or recombinant vaccine at interval 0, 1, 6 months (only 
15 children of HBeAg positive mothers at interval 0, 1 and 2 months). 
Basic vaccination was finished in 454 children, serological investig ation 
after Vaccination was performed in 433 children. Blood samples were 
tested by ELISA for HBsAg, anti-HBs, anti-HBc, anti-HBe. The presence 
of hepatitis B virus (HBV) DNA was determined by polymerase 
chain reaction. 
Results: No perinatal transmission of hepatitis B virus was proved in 
children. Only one child became an HBsAg carrier, this followed mild, 
acute hepatitis B in the beginning of the second year of his life. The child 
was infected with variants of HBsAg with substitutions at residues 137 and 
139. Asymptomatic infections were observed in two girls in the fourth and 
sixth year of life. The new appearance of anti-HBc in 13 chldren in the first 
three years was considered as clinical inqignificant. The increase of anti-HBs 
without revaccination was observed in 32 children, mostly in the first four 
years of life. 
Conclusions: Only one hepatitis B, two asymptomatic infections and 32 
anamnestic anti-HBs responses were observed in 496 children vaccinated 
against hepatitis B during 12-year monitoring. 
Acknowledgement: This work was supported by Ministry o f  Health, Czech 
Republic, IGA No. NI6047-3/2000. 
(03101 The long-term outcome of interferon-alpha treatment 
in chronic hepatitis B 
K. Demir, S. Kaymakoglu, I .  Tuncer, D.  Dincer, S. Turkoglu, H.  C. Umit, 
S. Badur, F. Besisik, U. Cevikbas, Y. Cakaloglu, A. Okten 
Istanbul, TR 
Forty-six chronic hepatitis B pts, who were HBV-DNA positive (24 of 
them being HBeAg positive and 22 HBeAg negative) and were in their 
precirrhotic stage, were included in this study. This retrospective study 
investigated the outcome of the treatment with IFN-alfa at various 
doses (4.5, 5 or 10 M\, tiw for six months) in these pts. AU pts were also 
followed-up for at least 24 months [mean, 3312 months (range, 24-78 
months)] during which period they received no medical treatment. 
Among the pts with HBeAg(+) primary response (PR) was found to be 
16.7%. recurrence 0% and sustained response (SR) 54.2%. Among the 
patients with HBeAg(-) P R  was found to be 72.7%, recurrence 31.2% 
and SR 59.1%, there was no significant difference in SR between the 
two groups. For the HBeAg(+) and (-) groups SR relationship with 
gender, age, serum ALT, AST levels, HBV-DNA levels, anti-HBe 
seroconversion, histologic activity indexes, histologic stage and the 
administered total doses of IFN-alfa were investigated in a multivariant 
analysis. Among those with HBeAg(+) AL.T levels, low HBV-DNA levels, 
and seroconversion of anti-HBe during treatment were predictive for SR. 
Among the HBeAg(-) pts only young age was predictive for SR. With 
the patients all together among those who had HBV-DNA levels over 
1000 pg/mL SR rate was 22.2% and among those with HBV-DNA levels 
below 1000 pg/mC SR rate was 68% (P=O.025). SR rate was found to 
be 78.5% among those treated with 10 MU a-IFN and 46.9% among 
those treated with 4.5-5 MU a-IFN (P' 0.059). SR rate was higher among 
cases with stages I and 11 than the cases w t h  stage I11 of the disease. 
However this difference was significant only among HBeAg(-) group 
(P= 0.036). Among all pts no side-effects developed requiring ternhation 
of treatment. In conclusion interferon IFN-alfa is more effective in chronic 
hepatitis patients with lower levels of HBV-DNA and at earlier stages. IFN- 
alfa should not be administered alone to ptc with high levels of viremia 
(> 1000 pg/mL), because SR in such patients is very low. SR is siimlar for 
HBeAg(+) and HDeAg(-) groups. Higher doses of IFN-alfa appear to be 
more successful. 
/03111 Long-term efficacy of alpha-2b interferon plus 
ribavirin in naive patients with C chronic hepatitis: an Italian 
multicenter experience 
G. Barbarini, G. Barbara, G. Di Lorenzo, G. Belloni, L. Ferrari, P. Paiano, 
P.  Del Poggio, D. Bacca, L. Fruttaldo, F. Mongib, R. Francavilla, G. 
Scotto, B. Grisorio, G. Calleri, M. Annese, A. Barelli, P. Rocchetto, G. 
Rizzo, I. Poltronieri, A. Pellicelli, F. Cadario 
Pauia, I 
Background and aims: A combination of interferon alpha and ribavirin has 
been suggested to reach a greater rate of sustained response in patients with 
C chronic hepatitis. In this study we assessed the long-term efficacy of the 
combination therapy in the treatment of selected Italian naive chronic 
hepatitis patients compared to interferon alpha nionotherapy. 
Methods: We enrolled 428 naive patients who were randondy assigned to 
receive either recombinant interferon alpha 2b plus ribavirin for 24 weeks 
or interferon alpha 2b alone for 48 weeks. The primary end-point of the 
study was the rate of sustained virological response. Serum HCV-RNA 
levels were determined before treatment; during treatment at weeks 12 and 
24 in patients receiving the combination therapy; at weeks 12, 24, 36 and 48 
in patients receiving monotherapy; after therapy at weeks 12, 24 and 48 in 
patients of both groups. 
Results: Sustained virological response was observed in 43% of the patients 
treated with combination therapy and in 14% of the patients treated with 
monotherapy. Logistic regression analysis showed that sustained response 
was associated with a HCV viral load of 3 Millions copies or less. with a 
Knodell score of 10 or less and with an estimated duration of disease of 10 
years or less. 
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Conclusions: A 24-weeks treatment course with interferon alpha2b and 
ribavirin offers a greater chance of sustained virological response compared 
to treatment with interferon alpha2b alone for 48 weeks and may be 
indicated as initial therapy in such patients 
103121 Interferon alpha alone and interferon plus ribavirin in 
patients with chronic hepatis C nonresponders to previous 
course of interferon alpha 
F. Cartabellotta, R. Vassallo, A. D’Angelo 
Palenno, I 
Objective: To study, in a nonrandomized trial, the effects of monotherapy 
with interferon alpha (IFN) vs. IFN + ribavirin, in patients with hepatitis 
chronic C who where nonresponder to previous course of IFN. 
Material and methods: we recruited 38 patients (22M, 16F) mean age 49.6 
years (range 18-63 year), with biopsy proven chronic hepatitis C ,  ALT 
2 x N  and HCVRNA positive with predominantly genotype l b  (85%). 
Group A: 12 patients received monotherapy with IFN 6 MU T W  for six 
months. Group B: 26 patients received IFN 6 MU T W  + ribavirin 1200 
mg/day for the same period. ALT levels and adverse effects were measured 
every month, and HCVRNA levels were measured at study entry at the end 
of treatment and after 6 months of follow-up. 
Results: In group A a t  the end of treatment 3/12 (25%) patients had 
normalized serum ALT level and only 1/12 had completed response 
(HCVRNA negative); in group B 11/26 (42%) patients had normalised 
ALT and 9/26 (35%) had completed response. At follow-up no patients of 
group A had sustained response; in group B 3 patients (12%) were still 
negative for HCVRNA and had normal ALT. Only in two patients of 
group B, therapy was suspended because of anaemia; flu-like syndrome was 
recorded with non 6equency d&erence in the two groups. 
Conclusion: These results, in a little sample, suggest that patients with 
chronic hepatitis C unreponsive to IFN alpha monotherapy could benefit 
6om combination therapy with IFN alpha + ribavirin. 
v1 Low prevalence of hepatitis C infection in hernodialysis 
units: effect of isolation? 
0. Harmankaya, B. Cetin, A. Eran, E. Seber, K. KiiGukler, A. Obek 
Istanbul, TR 
Objectives: Hepatitis B and C virus infections are commonly seen 
in chronic hemodialysis patients. The use of hepatitis B vaccine has 
favourably affected the occurrence of hepatitis B among patients on 
chronic hemodialysis. Although the availability and use of erythropoietin 
have reduced blood transfusions, the frequency of HCV infection has 
not declined. HCV infection has become the most important cause of 
chronic liver disease in dialysis patients. There is a wide range in 
the prevalence of HCV infection among different countries (449%). 
The nosocomial transmission of HCV infection by sharing dialysis 
machines in the hemodialysis unit is controversial. The aim of this 
study was to estimate the prevalance of HCV infection in hemodialysis 
patients and to emphasize the positive effect of dedicated machines and 
isolated areas. 
Methods: Blood samples from 168 patients with chronic renal failure 
treated in our hemodialysis unit were tested for anti-HCV antibodies 
by ELISA. Anti-HCV positive patients were tested for HCV-RNA by 
PCR Transaminases (AST, ALT) were also determined. In our hemodialysis 
unit we use dedicated machines and isolated areas for anti-HCV 
positive patients. 
Results: Between March 1992 and August 2000, eight of 168 patients on 
chronic hemodalysis have become anti-HCV positive after 9 4 months 
(4,7%). These patients were also found HCV-RNA positive. Four of these 
patients have become anti-HCV positive shortly after they have undergone 
hemodialysis in other dialysis centers. 
Conclusion: The relatively low prevalence of HCV infection in our H D  
unit strongly suggests that isolation of anti-HCV positive patients and 
careful attention to hygiene and sterilization of dialysis machines decrease 
the transmission of HCV infection. 
103141 Are distinct hepatitis C variants associated with 
cryoglobulins? 
C. Casino, D. B. Smith, C. Di Giacomo, G. Marinucci, C. Mancini, P. 
Simmonds 
Rome, I; Edinburgh, UK 
Objectives: Numerous studies have demonstrated that the infection with 
hepatitis C virus is involved in the pathogenesis of most mixed 
cryoglobulinemia. It  has been suggested that anti-HVR antibody is one 
of the antibodies responsible for the formation of immunocomplex. We 
have investigated the question whether anti-HVR antibodies have 
neutralizing activity by studying virus EWE2 sequences &om six HCV- 
infected cryoglobulinemic individuals. The aim of our study was to 
undertake a detailed re-investigation of HCV population diversity within 
infected individuals using approaches that minimise the methodological 
difficulties that impaired previous studies on HCV variability. 
Methods: The HVR sequences of HCV isolates in serum and cryopreci- 
pitate were compared in 6 patients with cryoglobulinemia using limiting 
dilution RT PCR, direct sequencing of PCR products, phylogenetic 
analysis and statistical tests. All individuals were infected with HCV subtype lb. 
Results: In our study, a mean of 28 sequences were analyzed for each patient 
in cryoprecipitate and serum. Phylogenenc analysis of HVR nucleotide 
sequences (positions 11 14-1246) &om cryoglobulinemic patients fded  to 
provide bootstrap support for a compartment-specific distribution of 
variants in three patients. Phylogenetic analysis of the same genomic region 
of HCV isolates of the other three patients revealed common grouping for 
variants exclusively present in serum (patients n.6 and 8) or in the 
cryoprecipitate (patient n.3). However, the statistical analysis provided a 
weak significance (P= 0.046) only for patient n.8. 
Conclusion: Our findings suggest that mutations in the HVR don’t play an 
important role in escape phenomena from the host immunosuweillance 
system, since the same variants were often found in serum and 
cryoprecipitate and when we could see by the bootstrap analysis of the 
phylogenetic trees a sort of comparcimentaLzation of the viral variants, it 
was not supported by a statistical significance. It seems that antibodies to the 
HCV antigen other than HVR or nonspecific antibody response to HVR 
are responsible for the formation of cryoglobulins. Our findings imply that 
the investigation of the HVR variability in different tissues in a single 
individual requires the phylogenetic analysis and a statistical confimiation of 
genetic compartmentalization in order to exclude that the obtained 
distribution of vanants is a casual event. 
vl Serotyping of hepatitis C v i m  infection in haemodialysis 
patients: comparison with standardized genotyping assay 
E. Elsawy, M. Sobh, F. Elchenawi, I. Hassan, M. Ghoneim 
Mansoura, ET 
Studies on HCV genotype prevalence in haemodialysis patients are quite 
few, despite the relevant importance of this subject. The aims of this study 
were to investigate the prevalence of HCV genotypes and serotypes in anti- 
HCV positive haemodialysis patients and determine the concordance 
between genotyping and serotyping methods. We included in this study 62 
haemodialysis patients 39 males, 23 females with an average duration of 
dialysis treatment of 26 months (range 2-71). HCV RNA was detemned 
using Amplicor HCV (Roche) and genotypes using a line probe assay 
(InnoLipa I1 Innogenetics). HCV serotyping was performed with 
competitive ELISA assay (Murex HCV serotyping 1-6 assay). AU 62 serum 
samples tested were HCV RNA positive by PCR and could thus be typed 
by the InnoLipa I1 HCV. Genotype 4 (52 patients) was the predominant 
one, followed by type 1 (10 patients). Accordmg to serotyping procedure, 
the most prevalent HCV serotype was type 4 (41 pabents) followed by 
serotype 1 (6 patients). We detected multiple serotypes in 4 patients (serotypes 1 
+ 4) and 11 patients with untypeable strains (8 with non type specific reactions 
and 3 with non reactive results). The overall sensitivity of serotyping assay was 
82% for the study pahents. According to the genotyping results, the sensitivity 
of serotyping was 60 and 86.5% for the determination of HCV types 1 and 4, 
respectively. There was a 100% concordance between results of serotyping and 
genotyping in the identi6cation of HCV type 1 while 91% concordance in 
HCV type 4. The present analysis indicates that serological typing method may 
be of great value in microbiology laboratories that require a simple assay for 
identification of HCV genotypes, although the sensitivity of ths  assay may 
be limited by the himunocompetence of infected haemodialysis patients. 
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Nosocomial infections 
103161 Does closed aspiration system reduce nosocomial 
pneumonia? 
A. Yildirim, B. Ertugrul, I. Ozkan Akinci, F. Ulger, A. Atahan Cagatay, C. 
Ertekin, H. Eraksoy, N. Cakar 
Istanbul, TR 
Introduction: Pneumonia is the most frequent nosocomial infection 
occurring in ventilated patient. In this study we explored the efficacy of 
closed aspiration system (CAS) on epidemiological pattern of nosocomial 
pneumonia (NP). 
Methods: Fifty ICU patients in a randomized controlled manner were 
included as study group (with CAS) or control group (without CAS). 
Adrmssion criteria were; expected time on mechanical vendation more 
then 48 h and intubation in the same unit within 24 h of admission. Patients 
who had positive endotracheal culture and pneumonia on adrmssion or who 
had immunosuppressive or high dose corticosteroid therapy before ICU 
admission were excluded. NP diagnosed with infiltration on chest X-ray, 
fever (>38.5"C), leukocytosis (> 12 000), variations of tracheal secretion 
and positive tracheal culture. Endotracheal aspirate culture was obtained on 
admission, then repeated twice a week if necessary or according to clinical 
decision. Leukocyte count, and chest X-ray obtained everyday. All 
endotracheal cultures evaluated quantitatively. Observation of the patients 
began with the adrmssion to ICU and ended till extubation, transfer or 
death. APACHE 11, SOFA, and Glasgow coma score (GCS) on admission 
and before discharge were recorded for each patients. T-test and Kruskal- 
Wallis tests used for statistical evaluation. 
Results: Ages, gender, duration of ICU, GCS, APACHE 11, SOFA, 
duration of mechanical ventilation were similar between groups. NP 
diagnosed in 4 patients (1 8%) of CAS group, and 10 patients (40%) of non- 
CAS group. 3 methicdh-resistant Staphylococcus auyeus (MRSA) and 1 
methcillin-sensitive Staphylococcus aureus (MSSA) recognized as pathogen 
bacteria in CAS group and 3 MRSA, 3 methicfin-resistant coagulase- 
negative staphylococci (MRCNS), 3 Acinetobacter spp. and 1 P. aemginosa 
were pathogen bacteria causing NP. The bacteria in endotracheal aspirate 
culture were also isolated in blood culture of CAS group, on the other hand 
only 5 patients' blood culture were positive with same pathogen in non- 
CAS group. NP were diagnosed on 7 (k0.75) day after ICU admission in 
CAS group and 9 (k1.4) day of non-CAS group, but there was not 
statistical significance between groups. 
Conclusion: The contamination risk and nosocomial pneumonia incidence 
were decreased by dosed aspiration system in this group and number of patients. 
[0317j Molecular investigation of Stenotrophomonas mahphilia 
isolates during two outbreaks in an intensive care unit 
0. Ronveaux, M. Fajo, J. van Broeck, Jc Autrique, S. Verschuren, A. 
Piroton, J. Wautelet, M. Delnlee, E. Leens 
Brussels, Ottignies, B 
Background: Two S. maltophilia outbreaks were detected in one intensive 
care unit (ICU) in January and May 2000, respectively. Each of these 
involved five patients representing an attack rate of 7.0 and 5.8/100 ICU 
admissions, respectively, compared to an average before and between 
outbreaks of 1.2/100 ICU adrmssiom. Due to potential water contanination 
problem with Pseudomonac aemginosu, routine water samples had been taken 
since November 1999. In three occasions (March, April and May 2000). S. 
maltophilia was isolated &om ICU rooms' outlet water (5 positive samples). 
Methods: To assess the relatedness between the strains, molecular 
investigation was performed using pulse-field gel electrophoresis (PFGE) 
after mgestion with XbaI. All available strains isolated from January to May 
in the ICU (n = 9 clinical and 1 environmental) were PFGE-typed together 
with 19 clinical strains isolated in other units from January to October. 
Epidemiological descriptive investigation was conducted to explore 
hypotheses of transmission. 
Results: S. maltophilia clinical isolates (ICU strains) were cultured from 
bronchial aspiration (5), blood (2). mouth/throat (2) and pus (1). Tap water 
was used to bath patients and rinse medical material such as bronchoscopes 
after disinfection. The same PFGE pattern (2a) was observed on isolates 
from 2 patients in January (both on January 17) and 2 patients in May (May 
8 and May 24). Another PFGE pattern ( l l a )  was isolated in 2 patients (May 
5 and May 8). The water sample was also found positive with the 2a pattern 
(May 12, in the same room than one patient positive on January 17 and 
another positive on May 8). All the remaining strains generated different 
PFGE patterns (n=24). The outbreaks were controlled by installmg 
disposable filters at the ICU outlets. This measure has proven very expensive 
in the long term. Recently filters were removed and a continuous chlorine 
injection pump (NaC10 concentration 0.25 p.p.m./L) was installed along 
with regular flush at outlet level. 
Conclusion: The two outbreaks were partly caused by one strain with a 
distinct PFGE pattern. Arguments to support that water environment might 
have played a role as a reservoir for transmission include (1) water found 
positive with the outbreak strain in one room (2) two patients with the same 
strain occupied this room at Merent  points of time (the two outbreaks) and 
(3) patients' exposure to tap water. 
103181 Waterborne outbreak with Pseudomonas aeruginosa 
in reverse isolation unit 
A. Widmer, A. Gratwohl, J. Passweg, R. Frei 
Basel, CH 
Background: The incidence of Pseudomonas aeruginosa infections in 
immunocompromised patients decreased in the last decade. We observed 
an outbreak, when the reverse isolation unit (RIU) unit was reopened after 
major renovation in 1999. A new centralized water treatment system with 
nanofiltration and continuous flow was installed. Shower heads and tubing 
were weekly disinfected, and remained water drained dter each shower. 
Methods: An epidemiological investigation was begun after identification of 
a cluster of P. aeruginosa after reopening. Samples of water from all faucets, 
showers and filters were taken at regular intervals. Screening of patients 
included swabs taken from the throat and perineal area and hands from 
health care workers (HCWs). 
Results: 9 patients with advanced hematological disease were identified as 
cases: 7 patients had evidence for bloodstream infections (BSIs) with P. 
aeruginosa, two additional patients were colonized. P. oemginosa was 
predominantly isolated from water of faucets and showers in 14/14 
(100%) patient rooms between 7/99 and 9/99, and again in Spring 2000. 
Isolates of 7 patients were available for typing: 4 had identical pattern by 
pulsed field gel electrophoresis. Two isolates from two infected patients 
matched the pattern from water isolates. Epidemic investigations did not 
reveal any other common procedure, infusion or catheter as source. Hand 
cultures (n=50)  from HCWs were negative. The filters of the water 
treatment system were replaced and a sanitization program installed. 
Cultures of water from all patient rooms and screening cultures from 
patients subsequently remained negative. However, recolonization was 
observed at the point of use. 
Conclusion: This outbreak in the RIU was due to contaminated drinking 
water. Replacement of the defective filter, regular sanitization and 
disinfection of shower heads stopped the outbreak emphasizing the 
importance of safe water supply for severely immunocompromised patients. 
103191 Three consecutive outbreaks of Serratia marcescens in 
a neonatal intensive care unit 
F. Fleisch, U. Zinmermann, R. Zbinden, D. Mieth, D. Nadal, C. Ruef 
Zurich, CH 
Objectives: To investigate a series of three outbreaks of Serratia marcescens 
(Sm) in the neonatal intensive care unit (NICU) of the University Hospital 
of Zurich. 
Methods: Retrospective analysis of epidemiological and microbiological 
data, prospective study of the prevalence and incidence of colonization of 
neonates and environmental sources by Sm. Genotyping of strains by 
pulsed-field gel electrophoresis (PFGE). Analysis of risk factors for 
colonization/infection by Sm. 
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Results: Sm infection was detected in 4 children transferred from the NICU 
to the University Children’s Hospital. All isolates showed identical banding 
patterns by PFGE (Strain A). The ensuing retrospective investigation 
detected 20 Sm mfections between 1/98 and 4/99 in the NICU. In a 
prospective prevalence survey in 7/99, 11 of 20 neonates were found to be 
colonized by Sm. Sm was isolated from several bodes of liquid theophylline 
(used on multiple patients) and from several sinks. Despite the replacement 
of these bottles, disinfection of sinks and reinforced infection control, 
additional patients with Srn colonization were detected. In 12/99 and 1/ 
2000, a prospective collection of stools and gastric samples showed that 
colonization occurred within 24 h after delivery in some babies. These 
isolates showed a new banding pattern (Strain B). The observation of the 
emergence of a new clone suggested a common source as the reason of the 
epidemc. Investigating all used milk bottles in the NU in 6/2000, we found 
Sm in 6 of 19 bottles (31.6%). These isolates showed a new banding pattern 
in the PFGE (Strain C). The same banding pattern was found in strains 
isolated from blood cultures &om two neonates with fatal sepsis. 
Reprocessing of bottles was changed to thermal dtsinfection in Central 
Stenlization. Reinforcement of strict infection control practices was 
repeated. To  evaluate the effectiveness of this procedure a further 
prevalence study was performed in 10/2000. None of the 19 investigated 
neonates were found to be colonized by Sm. 
Conclusions: Transmissions of Serrafia marcesrens within NlCUs can be 
multifactorial and epidemiological investigations are useful to detect 
risk factors for S. marresrens acquisition. Consecutive outbreaks suggest 
that new strains were reintroduced into the unit as a result of infection 
control deficits. 
An outbreak of vancomycin-resistant enterococci in an 
hematology ward: impact of infection control and cohorting of 
patients and nursing staff 
C. M.  J. E. Vandenbroucke-Grauls, D. J. Austen, H. H. M. Meester, A. 
Kaiser, M. J. M. Bonten 
Amsterdam, NL; London, UK; Ufrecht, NL 
Between November 1998 and August 1999, an outbreak of vancomycin- 
resistant Enteromccusfaecium (VRE) occurred on the hematology unit of the 
University Hospital Vrije Universiteit. VRE was actually eradicated from 
the ward by stringent infection control measures and cohorting of patients 
and nursing staff During the outbreak period patient admissions, discharges, 
cohorting (including staff cohorting), and infection control measures were 
recorded. Microbiological surveillance (including genotypic strain typing) of 
all patients was performed throughout the outbreak period and continued 
thereafter. A simple mathematical model (based on the Ross-Macdonald 
model) on the dynamics of bacterial colonisation was consmcted. Admksions, 
&charges, patient colonisation status (uncolonised, colonized but undetected, 
and colonized), and three dection control measures: hand disinfection, 
cohorting of nurses and creation of a cohort of ‘newly admitted patients’ (who 
had never before been admitted to the hematology unit) were the main 
variables included in the model. By multiple stochastic analyses we determined 
the quantitative effects of these three aspects of infection control. Without 
infection control, the model predicted an endemic situation with 40% of VRE 
carriage among patients. Hand disinfection alone reduced the percentage of 
colonised patients to an endenllc level of +_20%, but was insufficient to halt the 
outbreak. Cohordng of s d  led to a funher decrease of the endemic 
colonisation rate, but endemicity was maintained by readmission of colonised 
but undetected VRE carriers. When all three infection control measures 
were included, the model predicted full eradication of VRE from the ward. 
The model simulations showed perfect agreement with the observed data. 
We conclude that mathematical modelling provides a very useful tool to 
evaluate quantitatively the impact of different infection control measures on 
the spread of VRE in a single hospital ward. 
v] Increasing rote of Enterococcus spp. as a cause of 
urinary tract infection: a seven-day survey at Pisa General 
Hospital 
M. Meini, C. Gigh, B. Innocenti, P. Leonetti, A. Lofaro, S. Gori, V. 
Carsini, S .  Bamini, M. Bonadio 
Pisa. I 
Aim of the study: To assess the prevalence and the current in v im sensitivity 
patterns to antibiotics of uropathogens causing urinary tract infection (UTI) 
in a n  italian teaching hospital. 
Methods: A 7-day survey of all urine culture results at Pisa General Hospital 
during the first week of March 2000 was performed. 
Results: Out of 996 urine cultures performed during the study period, 164 
(16.5%) showed significant bacteriuria (> lo5 CFU/mL). These results 
were obtained from 141 patients (98 females and 43 males). Seventy-five 
were out-patients and 66 were hospitalized patients (58 in medical units and 
8 in surgical or intensive care units). Overall causative microorganisms were: 
E. coli 78 (47.6%). Enferucoccus spp. 32 (19.5%), KES group 16 (9.7%), Pruteus 
spp. 11 (6.7%), Pseudumonns spp. 8 (4.9%), Citrobacter spp. 7 (4.3%), Candida 
albirans 6 (3.6%), others Gram positive cocci 5 (3%), Providencia spp. 1 
(0.6%). In uitro resistance rate of E.  coli strains to cotrimoxazole, ampicillin 
and ciprofloxacin was 32%, 43.6% and 14.1%, respectively. S i x  (18.7%) 
enterococci (E.  faecalis 5, E. gallinunrm 1) were resistant to vancomycin and 
teicoplanin. Enferococrus spp. was cause of UTI in 24.4% of hospitalized 
patients and in 30% of patients with indwelling bladder catheters. Candida 
albicuns was responsible for UTI in 20% of hospitalized patients with 
indwellig bladder catheter. E. coli strains isolated in hospital setting showed a 
resistance rate to coaimoxazole, ampicillin and ciprofloxacin of 51.6%, 
67.7% and 22.6%, respectively. 
Conclusions: The present study underlines the important role of enterococci 
as a cause of UTI especially in hospitalized patients with indwelling 
bladder catheter. In addition, enterococcal glycopeptide resistance repre- 
sents a growing problem at Pisa hospital and this phenomenon needs to be 
strictly controlled. 
/0322 Harmony: infection control device-related guidelines 
B. Cookson on behalf of the HARMONY Infection Control Group 
Lundon, UK 
Objectives: To learn from each others’ EU national guideline and 
local policy development processes and use the 1998 UK Clinical Audit 
Project (CAP) ‘bottom-up’ detailed guidelines for central venous catheter 
(CVC) and urinary catheters (UTC) to help develop an opinion 
ascertainment tool in participating counmes that would enable analysis of 
comments, audit data and new statements and see how applicable and useful 
this may be. 
Methods: The nine countries helped develop the approach. ESCMID 
interactions were part of the study design. A published qualitative assessment 
approach (Murphy et al. 1998) was used for scorings. These and references, 
additional statements, audit and comments were entered in WORDTM via 
E m d  and exported into EXCELTM for calculations. Analyses were fed- 
back within two months. All data were considered by a multidisciplinary 
steering group including world experts in the field and the new statements 
and explanations fed-back to all participants withn six months and shortly 
will be on the HARMONY website (www.phls.co.uk/Intemational/ 
Harmony/Harmony. htm). 
Results: National guidelines were available in all countries but varied 
enormously in design, funding or presence of designated centres, evidence 
base and process for interactions with healthcare workers. It was evident that 
there was much duplication of effort regarding systematic reviews. Most 
consider the CDC statements as a basis. 48 hospitals in s i x  countries 
participated and over 100 multidisciplinary healthcare workers considered 
each ofthe two device guidelines. The steering group were astonished at the 
degree of consensus for the device statements. The mode and average scores 
were predominately in agreement or strong agreement. No one country was 
an outlier in disagreements. Less than 4% of hospitals disagreed with most 
statements, the two exceptions being for CVC (13.4%). and UTC (23%1), 
maintenance-related statements. The approach enabled participants to add 
comments (281), audit data (110) and references (77) far consideration by 
the steering group, who wrote 13 (14%) new statements and modified 47 
(52%) and fed back these as stated above. 
Conclusions: This is the first study of its type and has shown the enormous 
potential for this approach to provide a rapid and flexible tool that can 
facilitate guideline and local policy development in member states. It needs 
further development in more hospitals and more countries and will shortly 
interact with the national guideline statements and evidence categorisations 
via this and other ESCMID initiatives. 
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/0323/ Presence of the ica and aap gene in clinical 
Staphylococus epidermidis isolates: diagnostic value and 
implications for pathogenesis of S. epiderrnidis foreign body 
infections 
S. J. Vandecasteele, W. E. Peetermans, R. Merckx, B. J. A. Rijnden, 
J. Van Eldere 
Leuven, B 
Objective: The aim of our study was to evaluate the diagnostic value of two 
markers of biofilm production (icaA and aap gene) in clinical S. epidemidis 
isolates recovered from patients with, respectively, catheter colonization and 
invasive bloodstream infection. 
Methods: We compared 59 clinical S. epidemidis isolates with 29 skin 
isolates. Ofthe clinical isolates, 25 were catheter related (CR)( > 1000 CFU 
per catheter without sepsis) and 34 were sepsis related (SR)(SIRS with 2 
blood cultures positive f catheter colonization). Gene detection was 
performed with PCR with the following primers: 5’-CACGTGCTC- 
TATGCTGGATG and 5’-CCGTTGGATATTGCCTCTGT‘ (icaA) 
and 5’-ATACAACTGGTGCAGATGGTTG and 5’-GTAGCCGTC- 
CAAGTTTTACCAG’ (aap). 
Results: The ica and the aap gene were significantly more prevalent in C R  
isolates (92% aapf, P=O.O02; 80% ica+, P=0.002) than in SR isolates 
(68% aap+, Pz0 .3 ;  59% ica+; P=O.13) and control strains (52% aap+; 38% 
ica+). All the C R  strains, 79% of the SR stains and 66% of the skin isolates 
had at least one gene (aap or ica) involved in biofilm production. The 
number of CFUs on the catheters of C R  strains (median 1 x 10‘) was 
significantly lower (P= 0.004) than the number of CFUs on the catheters of 
SR strains (median 3.9 x lo5). 
Discussion: In view of the h g h  incidence of biofilm associated genes in skin 
isolates and in view of their clear association with catheter colonization but 
not with bloodsteam invasion we conclude that genetic markers of biofilm 
formation are not useful to distinguish between ‘clinically relevant strains’ 
and contamination. Our  findmgs suggest a correlation between biofilm 
formation and the ability to colonize a foreign body. Bloodstream infection 
is less correlated with the presence of genes involved in b i o h  formation. 
Addtional and yet unknown virulence factors may he necessary for S. 
epidemidis to cause invasive bloodstream infection. Two thrds of the skin 
isolates have at least one of the b i o h  associated genes (ica or aap). This 
may suggest that a h g h  proportion of the slun S. epidermidis strains are 
potential foreign body colonizers. 
Quality control in molecular diagnostics in microbiology; organisation, pitfalls and solutions - Symposium organised by 
the ESGMD with ESCV and QCCA 
153331 The European Union quality control concerted action 
programme: present status and future plans 
A. M. van Loon 
Utrecht, NL 
The EU-QCCA IS a nonprofit organization, managed by professionals in 
the field, with the aim to establish an external quality control programme for 
assessment and evaluation of existing and evolving nucleic acid amplification 
procedures in diagnostic virology. The strategy of the programme includes 
(i) the preparation and distribution of proficiency panels: (i) the 
organisation of postdistribution workshop (electronically, on a website); 
and (iii) the preparation of reference materials (standards, run-controls). So 
far, emphasis has been put on the preparation and distribution ofproficiency 
panels. Until April 2001, a total of 13 proficiency panels has been dismbuted, or 
are planned. These include panels for detection and/or quantitation of 
enteroviruses (3), herpes simplex virus (2), cytomegalovirus, human immuno- 
deficiency virus (2), hepatitis B virus (2). hepatitis C virus (2) and Chlamydia 
trarhomatis. The number of participants ranged between 46 and 105, and 
increases with nearly each dismbution. Whereas for detection of enteroviruses 
or HSV nearly all participants used in-house methods, commercial assays were 
used mostly for detection of HIV and Chlamydia trachomafix For HBV and 
HCV most participants used in-house methods for qualitative determinations 
and commercial assays for quantitation. In contrast to &dings in the early/mid 
90 s, the percentage of fake-positive results had clearly decreased, and was 
usually in the order of 1-3%, indicating that laboratories are better managing 
contamination risks. The sensitivity of in-house methods for detection of 
enteroviruses and HSV Mered considerably; up to 1000-fold. Therefore, there 
is clear need for more standardisation and quality control. The EU-QCCA 
programme is now running in its 3rd year, and sponsoring by the EU will stop 
by the end of 2001. Various parties, including both European professional 
societies-ESCMLD and ESCVand industry have requested the EU-QCCA to 
continue and to develop the programme further. Therefore, plans are now 
being developed for continuation of the EU-QCCA. It is clear that the scope 
of the programme needs to be extended. More pathogens (and not only viruses) 
have to be included, and molecular typing also has to be addressed in addition 
to detection and quantitation. Furthermore, more attention will be given to 
the development of international standards and run-controls. An annual 
progranune will be developed that includes at least 15-18 different 
pathogens, among others Mycobacterium tuberculosis and Epstein-Barr 
virus. ESMID and ESCV are endorsing the progranmie as well as the major 
molecular diagnostic companies. Further support w d  be needed from the 
EU. However, the programme will only be viable when there is active 
participation by membership of ESCMID and ESCV. 
153341 ESCV-ESGMD quality control concerted action for 
detection of C. trachomatis in urine samples 
G. T. Noordhoek, G. Hoddevik, R. P. Verkooyen 
Leeuwarden, NL; Oslo, N; Rotterdam, NL 
The first European quality control concerted action (EU-QCCA) on 
laboratory performance for detection of Chlamydia frachomatis by nucleic 
acid amplification tests (NAATs) was organized by a working party in whch 
members from the European Society for Clinical Virology (ESCV) and the 
European Society for Clinical Microbiology and Infectious Diseases 
(ESCMID) collaborated. The aim of the study was to assess the quahty 
performance oflaboratories for detection of C. trachomaris in a panel ofunne 
samples that resembled samples from symptomatic and asymptomatic 
infected patients. The panel consisted of 10 coded specimens with 
lyophilized urines, 3 negative samples, 2 strong positive samples and 5 
weak positive samples. Before shipment, extensive quality control was 
performed on the influence of freeze-drying on the detectahility of C. 
trachomatiz with different commercial detection systems, on the dilution 
factor and the stability of the samples. The panel was sent to 104 participants 
in 22 countties, together with a questionnaire on the methods used. Ninety- 
six participants responded with 102 data sets. Seventy-four data sets (72.5%) 
had correct results on all samples, and 17 data sets (16.7%) had one false 
negative or false positive result. Eleven data sets (10.8%) scored 80% or less, 
with 2 or more incorrect results. Only 2 data sets reported a false positive on 
a negative sample. Of 204 strong positive samples 199 (97.5%) were 
correctly reported and of 507 weak positive samples 468 (92.3%) were 
successful. In 43.1% of data sets the Roche Cobas-Amplicor test was 
performed, 30.4% data sets reported with Abbott LCx, 8.8% with Roche 
Amplicor Manual, 8.8% perfornied in house PCR, 4.9% data sets reported 
Becton Dickmson ProbeTEC and 3.9% performed GenProbe TMA. 
The mean successful scores of these tests were 96.9%, 94.8% 95.6%. 95%. 
97.8% and 92.5%, respectively. This was the first international quality 
control study on detection of C. trachomatis in clinical saniples. The pilot 
studies and the results from the final panel showed that lyophilized urines are 
very suitable for this purpose. Problems of the organisation of QC-studies 
and pitfalls of assays \rill be discussed. For future intra laboratory quality 
control studies in Europe, a professiond noncommercial organisation is 
needed that is supported by the European societies for medical 
microbiology and virology. 
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15335/ EU-QCCA proficiency panels for qualitative and 
quantitative detection of HCV-RNA, HIV-RNA and HBV-DNA in 
diagnostic virology 
J. Schirm, A. M. van Loon, E. Valentine-Thon, J. Reid, P. E. Klapper, 
G. M. Cleator 
Croningen, Utrecht, NL; Bremen, D; Dundee, Manrhesrer, UK 
The programme of the European Union Concerted Action for Quality 
Control of Nucleic Acid Amplification in Diagnostic Virology (EU- 
QCCA) includes proficiency panels for the qualitative and quantitative 
detection of HCV-RNA, HBV-DNA and HIV-RNA. In May 1999 and 
February 2000 panels for each of these viruses were sent to laboratories in 
more than 20 countries. All panels consisted of 2 negative samples and 6 
positive samples with various concentrations and virus genotypes. The 
majority of labs used commercial assays for qualitative or quantitative 
examination of the samples; Roche assays were used most fiequently The 
1999-and 2000-HCV panels were tested by 57 and 81 laboratories, 
respectively, submitting 45 qualitative and 35 quantitative data sets in 1999, 
and 75 qualitative and 45 quantitative data sets in 2000. The HBV panels 
were tested by 42 and 51 laboratories, respectively, submitting 20 qualitative 
and 37 quantitative data sets in 1999, and 25 qualitative and 47 quanhtative 
data sets in 2000. The HIV panels were tested by 50 and 67 laboratories, 
respecuvely, submitting 5 qualitative and 58 quantitative data sets in 1999, 
and 6 qualitative and 72 quantitative data sets in 2000. The false-positive 
rate was well below 3% in all panels, excluding the first HBV-DNA panel 
(5.3%). The false-negative rates were difficult to determine and to compare 
because of large variation in detection limits of various assays, and also 
because the 2000-panels contained more low-positive samples than the 
1999-panels. However, when lunited to clearly positive samples, the false- 
negative rates were very low (less than 3%). Analysis of quantitative results 
showed considerable variation in viral loads due to variabihty within and 
between assays of various manufacturers. In general, the coefficients of 
variation of viral loads obtained by Bayer-bDNA assays were significantly 
lower than those obtained by other assays. Agreement between results from 
assays of different manufacturers was generally good to acceptable, although 
the bDNA gave consistently higher wal loads for the HCV-RNA samples than 
the other assays. In reverse, the HIV viral loads were consistently lower with 
bDNA assays as compared to other test system.. Our results indicate that 
considerable improvements in molecular detection and quantitation of HIV, 
HCV and HBV have been achieved in recent years, particularly through the 
use of commercial assays. However, further standardization is still needed. 
153361 Validation of and quality control on molecular 
methods for the detection of respiratory specimens 
D Ursi 
Edegem, B 
Detection of Myrobactenurn tuberculosis for confirmation of smear positive 
sputum samples by the Gen-Probe tranrcnphon-mediated amphfication or 
the Roche PCR test are the only FDA approved molecular amphficauon 
Rare filamentous fungal infections in Europe 
tests for respiratory specimens. For the detection of other respiratory 
pathogens, numerous ‘in house’ PCR assays were developed. These tests 
must be submitted to extensive validation before their introduction in the 
molecular diagnostic laboratory. Validation must be performed at several 
levels, including sample preparation, amplification and detection. Since 
respiratory samples often contain amplification inhibitory substances, special 
attention should be paid to the efficiency of the reaction with these samples. 
Once a test is validated, it should be evaluated further in organized 
proficiency testing programs. However, for PCR detection of respiratory 
pathogens there is no organized proficiency testing program in Europe. 
Therefore, there is a growing tendency to organize interlaboratory 
exchange of clinical samples to compare results and evaluate individual 
assays. This will be illustrated by an interlaboratory comparison for the 
detection of Mytoplasma pneumoniae in respiratory samples by PCR. 
153371 Quality control on the molecular detection of herpes 
simplex virus 
A. Linde 
Solna, S 
Within the programme of the European Union Concerted Action for 
Quality Control of Nucleic Acid Amplification in Diagnostic Virology, 
external quaLty control panels for herpes simplex types 1 and 2 (HSVl and 
2) were distributed in 1999 and 2000. Each panel included 12 samples, 
containing either HSV1, 2, varicella-zoster or no virus. The vials contained 
stenle-filtered, fieeze-dried culture supernatants, or medium alone. The 
amount of HSV genomes included in the panel ranged from 200 to 20 
million; a range found by real-time PCR in CSF from 30 patients with HSV 
encephalitis. The panels were produced at the Swedish Institute for 
Infectious Disease Control (SMI). Five external reference laboratones pre- 
examined the panel in qualitative P C R  and two in quantitative PCR. 
Quantification had also been made by parallel h t ra t iOt I  of preparations with 
known number of virions estimated by electron microscopy, and of 
preparations with purified HSVl and 2 genomes and known amount of 
DNA. Repeated analyses for stability were performed at SMI. The panels 
were dismbuted to around 70 laboratories in both years, and 76 and 78 data 
sets were returned in 19Y9 and 2000, respectively. The results were scored, 
and 70% and 68% recorded satisfactory results or better (more than or equal 
to 9 points) in 1999 and 2000, respectively. False positive results were 
recorded in 8% and 18% for the two years. There was no correlation as to 
which laboratories that performed good or bad the tirst and second year. 
There were seven mfferent groups of methods reported for both sample 
treatment and genome amplification. Performance in relation to methods 
could not be fully evaluated since there were very few users for the many 
methods, but single PCR gave satisfactory results or better in 52% of the 
data sets and nested PCR in 80% of data sets in 2000, a difference tending 
towards significance (P= 0.07). The results show that many laboratories 
have very good or satisfactory HSV nucleic acid amplification performance, 
but the lack of sensitivity and spechcity, resulting in a performance score of 
less than 9 in 30% of the laboratories indicates that improvement of 
methodology and further external quality control is necessary. 
15339 Animal models, the critical bridge between the 
mycologist and the clinician 
1. R. Graybill 
Sun Antonio, USA 
Development of novel antifungal drugs begins in the chermstry laboratory 
and ends at the pahent’s bedside. By the time the drug arrives in the clinic, it 
must be shown safe and effective. Therefore, during preclinical develop- 
ment several cntical bridges must be crossed, including determination of 
activity in vitro and then i~ vivo testing for activity and safety against specific 
mycoses. In viim testing is almost always done in small laboratory animals 
before human studies are commenced. While the chemist can ready 
determine whether a compound is active in the test tube, the animal model 
is more rigorous than in vitro testing, because it allows as variables: 
absorption and delivery to the site of infection, clearance of drug, 
interaction with other drugs which may affect toxicity and/or clearance, 
reproduchon of the host immune defect associated with invasive infection, 
evaluation of some drug toxicities and infection via the route occurring in 
natural infection. Animal models may also be used to evaluate interaction of 
immune modulators and antifungal drugs. Various animals are used, but the 
most common for initial studies are mice, rats and rabbits. Animal models 
can show dear in vivo activity where in v i m  testing has failed to demonstrate 
this . . . the most recent example of this is in showing the efficacy 
echinocandins in aspergdlosis. In ths  symposium we shall consider various 
examples of where animal models have been critcally important in speeding 
the development of various antifungal drugs, such as the lipid vehcles of 
amphotericin B, the new triazoles posaconazole and voriconazole and the 
echinocandins. We shall also consider other examples where animal models 
were critical in arresting the development of antifungal dmgs before (d- 
omithyl amphotericin methyl ester) or during (genaconazole, ZD0870) 
clinical trials. 
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153581 Draft recommendations ESGAP subgroup 3 
I. M. Gould 
Aberdeen, UK 
Subgroup 3 of ESGAP has drafted preliminary Minimum Standards for 
Antibiotic Stewardship. These are intended to ensure harmonized 
improvement in quahty of antibiotic prescribing. Those that pertain to 
regulators and the pharmaceutical industry will be discussed with illustrative 
examples. They include an Antibiotic Policy and Formulary (limited list) 
should be created locally after widespread consultation and its implementa- 
tion ensured by audit cycles. It should be regularly updated in the light of 
local resistance problems and availability of new drugs. Restricted lists ofkey 
agents should be implemented. Single dose surgical prophylaxis should be 
Quality of antibiotic usage 
encouraged. A drugs and therapeutic committee should consider timely 
introduction of new agents and review of the old agents. Laboratories 
should regularly make local sensitivity patterns widely know and routinely 
should only report on those agents, which appear, on their formulary and 
policy. Fachties should exist for regular review of new and old agents to 
ensure appropriate licensing of antibiotics. OTC availability of antibiotics 
should be banned and quality control of generic antibiotics ensured. Black 
market availability should be addressed by providing better access to doctors. 
Fast-track development of key agents and prolonged patient life of narrow- 
spectrum, limited use antibiotics should be encompassed. Ethical promotion 
of all antibiotics should be encouraged. Discounting to pharmacists should 
be discouraged. Promotional activities should be notified to Health 
Authorities and Health Care institutions in advance for prior agreement. 
[0359 A European study on the relationship of antibiotic use 
and antimicrobial resistance 
S. L. A. M. Bronzwaer, 0. Cars, U. Buchholz, S. Molstad, W. Goensch, I. 
K. Veldhuijzen, J. L. Kool, M. J. W.  Sprenger, J. E. Degener and EARSS 
Participants 
Bilthouen, NL; Stockholm, Malmo, S; Groningen, N L  
Introduction: Antimicrobial resistance (AMR) is a growing problem 
worldwide. In Europe, AMR has been monitored since 1998 by the European 
Antimicrobd Resistance Surveillance System (EARS) with Streptocorn 
pneumuniae as one of the inmcator organisms. We examined the relationship 
between penicdh nonsusceptibility of invasive S .  pneumoniae (PNSP) isolates 
and the sales of relevant antibiotics (AB) among 12 European countries. 
Methods: Information was collected on 1998/1999 resistance data of S.  
pneumoniae to penicillin using surveillance data from EARSS in 13 European 
countries, and on outpatient sales over 1997 for beta-lactam antibiotics and 
macrolides, using data purchased from IMS Health Global Services from 15 
European countries. In 12 countries, information was avdable for both 
AMR and AB sales. Using an ecological study design we modelled the linear 
relationship of the log-odds of resistance of S. pneumoniae to penicillin (as 
percentage of total isolates reported) and AB sales data (in defined daily doses). 
Results: The proportion of PNSP isolates is higher in southem compared to 
northern European countries. Similarly, sales for beta-lactam AB and 
nucrolides are higher in southern European countries. We found a linear 
relationship between the usage of beta-lactam AB and the proportion of 
PNSP isolates with a Spearman coefficient of determination of 0.62 (P- 
value=0.002), as well as between the usage of macrolides and the 
proportion of PNSP isolates with a Spearman coefficient of determination 
of 0.46 (P-value=0.02). 
Conclusions: This study shows that it is possible on the European level to 
observe an association of AMR (of S. pneumoniae to penicillin) and AB 
usage (of beta-lactam AB and macrolides). At present, several countries are 
planning or implementing national control efforts to improve appropriate 
use of AB. It is essential to monitor AMR and AB sales prospectively to 
assess the effectiveness of those interventions. 
(03601 Hospital misuse of broad-spectrum antibiotics (MA): 
need for better agreement between experts 
G. Zanetti, P. Francioli, J. D. Baumgartner, A. Cometta, P. Eckert, R 
Polikar, R. Schneider, B. Bumand 
Lausanne, CH 
Background: Intravenous BSA are responsible for a burden of cost and 
selective pressure for bacterial resistance in hospitals. Although frequent, 
misuse is difficult to assess because BSA are often prescribed ernpincally in 
complex acute settings. We report experts’ judgement of appropriateness of 
BSA use in a teaching, university-affiliated hospltal, and interexpert 
agreement about these judgements. 
Methods: A panel of experts independently evaluated 90 courses of 
intravenous BSA in 78 patients using a standardized chart abstraction. The 
panel always included 2 infectious diseases specialists, and a specialist in 
either surgery, medicine, or intensive care, depending on the provenance of 
the patient. BSA under study were imipenem, ceftazidime, cefepime, 
piperacillin/tazobactam, and IV ciprofloxacin. Assessments were based on a 
majority of at least 2/3 experts. We used kappa statistics to measure 
interexpert concordance. 
Results: Misuse was reported in 59/90 (66%, interexpert range 57-70%) 
courses of antibiotic therapy. This proportion was similar in surgery, 
medicine, and intensive care units. Disapproval concerned prescription in 
41/59 cases (68%), and the course of therapy in 18 cases. 35% of the days 
with antibiotics were considered unjustified. The most frequent reasons for 
disapproval of prescriptions were an absence of pertinent indication for an 
antibiotic (15 cases) and an inadequate antibacterial spectrum (10 cases). 
BSA prescriptions were more frequently inappropriate if empirical in the 
absence of a severe septic syndrome (adjusted OR 15.7, 95% CI 4.0-61.2). 
or if another antibiotic had previously been given for the same indication 
(adjusted OR 4.1, 95% C1 1.4-12.3). Experts’ opinion did not depend on 
their specialty. Kappa coe6cients for interexperts concordance were 0.55 
for assessment of the indication to antibiotic therapy, 0.40 for the choice of 
the antibiotic, 0.27 for an interim assessment at day 3-5 of antibiotic 
therapy, and 0.43 for the end of treatment. 
Conclusion: There is a need for an institutional effort towards better and 
more restrictive use of intravenous BSA. However, interexperts agreement 
was only fair to moderate in this study, which highlights the need for 
stronger evidences on appropriateness of BSA use. 
)03611 Audit of the use of restricted-list antibiotics in a 
Scottish teaching hospital 
A. Mackenzie, M. Lelekis, R. Laing, I. Gould 
Aberdeen, UK 
Objectives: To audit patterns of, justification for, and outcome of the use of 
Restricted List Antibiotics (KLAs) in relation to the hospital formulary in a 
large Scottish teaching hospital. 
Methods: A prospective examinahon of the mehcal notes and informal 
interviews with clinical and pharmacy staff regarding a l l  RLA prescriptions 
in all ward? in Aberdeen Royal Infirmary during a five week period, June/ 
July 2000. Adherence with the formulary and appropriateness (as judged 
independently by 2 Infectious Diseases Physicians (IDP) and 1 Medical 
Microbiologist (MM)) was determined for each prescription. 
Results: Eighty-four patients in 21 wards received 128 RLAs: 26 (20%) 
prescriptions in the Intensive Therapy Unit (ITU), 24 (19%) in the 
Infection Unit, 21 (16%) in the Respiratory Unit and 11 (9%) in other 
Wards. The commonest prescribed RLAs were piperacillin/tazobactam 31 
(24%). teicoplanin 29 (23%), ceftazidime 19 (15%), and imipenem 9 (7%). 
The documented reason for 58 (45%) prescriptions was advice from an IDP 
or MM, not stated 37 (29%), rmcrobiology data 16 (13%), treatment failure 
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on another regimen 14 (11%) and intolerance of other regimen 3 (2%). 
One-hundred-and-seven (84%) prescriptions adhered to the formulary, of 
whch 79 (74%) were judged appropriate, 22 (20%) inappropriate, 5 (5%) no 
agreement and 1 was not evaluable. Six (29%) of the 21 nonadherent 
prescriptions were appropriate and 15 (71%) were inappropriate. The RLA 
treatment course was completed in 57 (45%) prescriptions, 70 (59%) did not 
complete the course and 1 was not evaluable. The reasons for not 
completing the course (n = 70) were intravenous-to-oral switch 33 (47%), 
change to another antibiotic after IDP/MM advice or microbiology data 15 
(21%). empirical change 9 (13%), change because of treatment failure 5 
(7%), drug toxicity 4(6%) and patient died 4 (6%). 
Conclusion: Fifty-five per cent of RLA prescriptions were in the ITU, 
Infection Unit and Respiratory Unit. There was a good level of adherence 
to the formulary. Those prescriptions which adhered to the formulary were 
significantly more likely to be appropriate that those that did not. Less than 
half of the RLA treatment courses were completed, mostly because of 
intravenous-to-oral switch to another antibiotic. 
103621 Antibiotic prescribing in children with community- 
acquired respiratory tract infections in the situation of growing 
resistance to macrolides 
V. Jindrak, J. Henysova, V. Vanis, 2. Zemanova, P. Urbaskova 
Prague, CZ 
Objectives: Resistance of respiratory tract pathogens in community is still 
very low in the Czech Republic. Rapidly growing resistance Streptococcus 
pyogenes to erythromycin was observed &om 1995, probably as a 
consequence of increasing macrolide consumption in primary pediatric care. 
Methods: The antibiotic prescribing of 23 paediatricians on the background 
of all cases of acute respiratory tract illness during 4 weeks in November 
1999 in two districts of Prague was analysed. The audit of prescribing was 
performed using standardized questionnaEe. Consulting with clinical 
microbiologist, selective reporting of laboratory results and audits of 
antibiotic prescribing, we used to improve this practice. Results were 
compared with the first audit, performed in 1998. 
Results: There were found 3022 cases of acute respiratory tract illness. More 
than 80% of respiratory infections were probably of viral aetiology. The 
most of children visited the paediamcian for common cold (46.4%). 
followed by acute laryngotracheitis (21 .8%), acute bronchtis (1 1.4%) and 
influenza (5.3%). Probably bacterial disease was identified in less than 15% of 
cases; acute tonsillopharyngitis (7.8%), sinusitis (2.9%), otitis media (0.9%) 
and pneumonia (1.6%). Total number of cases treated with antibiotics was 
726 (24%). One half of prescriptions was performed for acute bronchitis 
(32%), acute laryngotracheitis (16.4%) and comnion cold (3.9%). Acute 
tonsillopharyngitis was the second most important cause for prescribing 
antibiotics (28.7%). Surprisingly, infections potentially caused by viruses 
were kequently associated with prescribing broad-spectrum antibiotics, 
anunopenicillins with beta-lactamase inhibitors and macrolides. Eleven 
practitioners taking part in both audits significantly improved their 
prescribing practice. They increased prescribing penicillin for acute 
tonsillopharyngitis (52-82%), and decreased usage of macrolides (33- 
12%). Totally, they increased prescribing of basic drugs (amoxicilhn), and 
decreased prescribing broad-spectrum antibiotics. Resistance S.  pyogenes to 
erythromycin in our region, growing exponentially &om 1994, was 
stabilised at the same level (9%) from 1998 to 1999. 
Conclusions: Close cooperation between general practitioners and clinical 
microbiologists at the regional level can be successful to improve prescribing 
practices, including control of antimicrobial resistance in community. 
vl Major differences in levels and patterns of 
antimicrobial consumption in primary care between Belgium and 
Denmark, 1997 
E. Hendrickx, H. Goossens, D.  Monnet, T. Sorensen 
Brussels, Antwerp, B; Copenhagen, DK 
Objective: To compare antibiotic use by primary care patients in Belgium 
and Denmark and to relate it to health care structure. 
Methods: Since 1996 in Belgium, data on reimbursed drugs for insured 
ambulatory patients (87.4% of the population in 1997) are sent to the 
National Institute of Sickness and Disability Insurance for monitoring use in 
W H O  Defined Daily Doses (DDD). Since 1994 in Denmark, data on each 
prescription delivered to ambulatory patients is transmitted to the Danish 
Medicines Agency and then converted into WHO DDDs. Population data 
were obtained fkom the Belgian National Institute for Statistics and Statistics 
Denmark. Data on health care structure were obtained from the WHO 
HFA statistical database. 
Results: In 1997, antibiotic use (ATC J O l )  in primary care in Belgium and 
Denmark amounted to 23.80 and 11.35 DDD/I000 inh.-days, respectively. 
For cephalosporins, penicdhns with beta-lactamase inhibitor and fluor- 
oquinolones, Belgium used 265, 209 and 8 times more than Denmark, 
respectively. Use of narrower spectrum penicillins fJOlCE, JOICF) was 
higher in Denmark (4.9 vs. 0.5 DDD/1000 inh.-days). In Belgium, general 
practitioners (GP) are paid according to a fee-for-service which is partially 
reimbursed. Patients do not have to enrol with a GP and can consult 
specialists for primary care. In Denmark, most people (96.4% in 1991) enrol 
with a GP who acts as the referring physician for access to specialists. The 
GP is paid according to a fee-for-service which is f d y  subsidized. With 
5.48 and 5.26 GP contacts per patient in 1997 for Belgium and Denmark, 
respectively, GPs are equally accessible in both countries. But, Belgium had 
153 full time practising GPs per 100 000 inh. in 1997, while Denmark only 
had 64. Also, Belgian patients only pay 15-25% of the cost of antibiotics and 
never more than 9.3 Euro, whereas in 1997 in Denmark, patients paid the 
full cost of cephalosporins, tetracyclines, aminoglycosides, chloramphenicol, 
and cotrimoxazole, and 50% of the cost of other antibiotics. 
Conclusion: Antibiotic use in primary care in Belgium was more than mice 
the consumption in Denmark in 1997. Several differences in the health care 
structure could explain this difference. For example, unregulated access to 
primary care and a high GP/patient ratio could be responsible for more 
competition between GPs in Belgium. Also, a lower contribution of 
patients to antibiotic costs could make the prescription of expensive drugs 
more acceptable. 
10364 Does the microbiological data influence the physician's 
antimicrobial choice for susceptible pathogens? 
J. Cobo, J. Oliva, J. Sanz, J. M. Aguado, J. L. del Pozo, M. E. Moreno, J. de 
Miguel, J. Martinez-Beltrin, E. Loza, J. Cuadros, M. C. Pazos, R. Garcia, 
S. Moreno 
Madrid, E 
Introduction: The reported scarce use of the microbiological data (MD) in 
the selection of antimicrobial therapy could be in part explained by the 
presence of various concomitant infections in the patient, various isolated 
pathogens in the culture or by a doubtful value of the clinical sample. 
Objective: To study changes in antimicrobial therapy after the MD receipt 
of sole 'susceptible pathogens' in valid clinical samples from hospitalized 
penicilh nonallergic patients without other concomitant infections. 
Methods: Observational, multicentric study. For every hospital we planed 
to select 5 consecutive cases of E. coli ampicillin-S (urine), E. Jaecalis 
ainpicdhn-S (unne), S .  nureus oxacillin-S (blood), S.  pneumoniae penicifiin-S 
(blood), S. pyogenes (blood), S.  agulactiue (urine or blood). We defined as 
optimal therapy the selection of penicillin, ampicillin or amoxicillin for E. 
jaecalis, S .  pneumonie and S. agalartiae; cefazolin or cloxacillin for S. aureus; 
penicillin or clindamycin for S. pyogeties and ampicihn or amoxicillin for E. roli. 
Results: We evaluate 100 cases (19 E. coli, 18 E.faeca/is, 19 S. aureus, 17 S.  
pneumoniae, 14 S. ppgenes and 13 S.  agalactiae). Any change in antimicrobial 
therapy after the MD receipt was detected only in 34%. Excessive 
antimicrobial spectrum still occurred after MD receipt in 85%. In only 15 
cases physicians selected the optimal therapy (in 6 cases from the beginning 
and in 9 cases after the MD receipt). By multivariate analysis optimal therapy 
was associated with, nosocomial infection, oral communication from 
Microbiological Service and Infectious Diseases consultation. 
Conclusion: Even in ideal situations for narrow spectrum antimicrobial 
choice most physicians ignore the MD, missing opportunities for a more 
rational antibiotic use. New strategies are needed to improve the efficiency 
of the MD. 
103651 Evaluation of an antimicrobial control program based 
on nonenforced infectious diseases specialist recommendations 
J. Cobo, J. Oliva, M. Soler, J. Martinez-Beltrin, R. Cant&, L. Pedraza, 
M.D. Prieto, V. Pintado, S. Moreno 
Madrid, E 
Introduction: Antimicrobial control programs (ACP) are necessary in 
hospitals, but controversy exists about the type of intervention that would 
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be most convenient. Enforced ACP, such as Infectious Diseases Specialist 
(IDS) approval for selected antimicrobials, are useful although sometimes 
they are not well accepted by prescribers. 
Objective: To evaluate the impact of an ACP based on nonenforced IDS 
recommendations. 
Methods: Cases were identified by means of computerised registers of 
Pharmacy Service that were recordered over 54 beds of two Services 
(Endocrinology and Vascular Surgery) according to established criteria. 
Written recommendations were indicated in medical chart. We measured 
antimicrobials use, MRSA and Clostridium dficile incidence, re-adrmssions 
and mortality. We compared the intervention period with the same period 
of the previous year. After finishing ACP we performed an anonymous 
health care workers (HCW) opinion survey. 
Results: We evaluated 101 courses of treatment in 3.5 months. Seventy- 
seven recommendations were made: discontinue antimicrobial therapy 
(39%). switch to oral therapy (31%); reduce antimicrobial specrmm (24%) 
and increase the antimicrobial spectrum (6%). Compliance with reconi- 
mendations reached 85%. Total defined daily doses (DDU)/lOO patients- 
days were sirmlar in both periods, but oral use increased from 12.5 to 18.6 
DDD/100 patients-days and parented use decreased from 25.9 to 22.3 
DDD/100 patients-days. Expense in antimicrobials decreased 19.4% (4485 
euros). We conservatively estimate savings of 30 250 euros by extendmg the 
program to the rest of the hospital during one year. There was a decrease in 
the use of carbapenms, intravenous fluoroquinolons, intravenous clinda- 
mycin, vancomycin and aminoglycosides, and an increase in oral 
fluoroquinolons use. We found a reduction of both MRSA (3.7% to 
0.8%; P < 0.05) and C.  d!@cile incidence (1.2% to 0%; P=0.05). There 
were no differences between both periods regarding mortahty and re- 
admissions. None of the respondent HCW felt criticized, 53% felt helped 
and 100% recommended to extend the ACP to other areas in the hospital. 
Conclusions: An educational ACP based on nonenforced recommendations 
made by the IDS is very well accepted. It allows significant savings by 
reduction in parented a h s t r a t i o n  and specific antimicrobials use 
without sacrifying patient safety, and it would even contribute to reduce 
the incidence of several nosocomial pathogens. 
Epidemiology and diagnosis of MRSA 
103661 Impact of rapid reporting on clinical outcome 
G. M. Scott, L. Banks, P. Folan, G. Webb 
h n d o n ,  Basingstoke, UK 
The objective of t h s  study was to show whether more rapid tests for 
antibiotic resistance detection, could change the clinical outcome. In this 
p r e h n a r y  experiment, reliabhty of the results of early and late methods 
was assessed. At UCLH, an automated blood cuiture system (Bactec 9240) 
and an automated Identification and Susceptibility Testing system 
(VITEK") are used routinely in microbiology. Laboratory working 
practices dictated that a positive result had to be obtained before the end 
of the working day for the information to be able to be communicated to 
clinicians. Otherwise results read the following day would be avulable at the 
same time as conventional culture and disc a s i o n  methods. In order to 
achieve this, only those cultures whch cued positive first thng  in the 
morning were included. A Gram-stain was performed on the blood culture 
as usual. Mixed cultures on Gram stain were excluded. Positive samples 
were centrifuged to remove red blood cells. The pellet was then suspended 
in saline and inoculated into an appropriate identification and sensitivity 
VITEK card. For the conventional method, positive cultures were 
inoculated on to Isosensitest agar for direct sensitivity tests (LIST) by the 
modified Stokes' method and into appropriate API galleries for overnight 
identification. In this preliminary phase, over 400 positive blood cultures 
were studied. One quarter of the isolates were Gram negative. The median 
time to identification and DST was 7-9 h 93 isolates gave concordant 
identification by the two methods, 16 were not identified by VITEK and 12 
differed in their identification. Antibiotic sensitivity tests for cefuroxime, 
ceftazidime, piperach-tazobactam, meropenem. ciprofloxacin and genta- 
micin were, overall, 94% concordant. Discrepant results were resolved by 
multiple tests on the isolate. There were 55 isolates of Staphylococcus aureux 
and the concordance for DST for methicdh by both methods was 96%, the 
VITEK failing to give an answer for two isolates. The noise created by the 
179 coagulase negative staphylococci pointed to the need for rapid 
identhcation of S. aureus. The VITEK method was accurate for 10/13 
enterococci and 3 strains of Candida spp. We can predict that ID and AST 
by VITEK is sufficiently sensitive, quick and accurate to have an effect in 
terms of antibiotic recommendations in a significant proportion of patients. 
/0367) Rapid molecular typing of methicillin-resistant 
Staphylococcus aureus by PCR-RFLP 
T. A. Wichelhaus, K.-P. Hunfeld, B. Boeddinghaus, P. Kraiczy, V. 
Schaefer, V. Brade 
Frankfurt/M, D 
Introduction: Typing of methicillin-resistant Staphylococcus uureus (MRSA) 
within the context of epidemiological investigation of nosocomial infections 
is of paramount importance for assessing the relatedness of isolates as well as 
demonstrating the chain of infections and, consequently, for the 
implementation of appropriate infection control measures. 
Objective: This study was aimed at establishing a new, rapid, and reliable 
genotypic fingerprinting technique for MRSA-typing in routine epide- 
miological surveillance. 
Methods: The method is based on polymerase chain reaction restriction 
fragment length polymorphism (PCR-RFLP) following HaeII digestion of 
simultaneously amplified parts of the protein A gene, the coagdase gene, and 
the hypervariable region adjacent to mecA. A total of 40 MRSA initial isolates 
was analyzed including 14 isolates from 5 countries, the 6 German epidemic 
strains, 16 isolates fiom the Frankfhrt metropolitean area which were known to 
be heterogenous by pulsed-field gel electrophoresis (PFGE), and 4 isolates 
obtained during an epidemic, all of whch displayed an identical genotype. 
Results: Restriction analysis by PCR-RFLP pennitted discrimination of 10 
out of 14 international isolates, all 6 German epidemic strains, and 15 out of 
16 national isolates. It also confirmed the homogenous character of the 4 
outbreak isolates. 
Conclusions: This new and rapid PCR-RFLP typing method is a valuable 
tool in routine epidemiologicai surveillance. Its outstanding characteristics 
are ease of performance and interpretation, while at the same time 
guaranteeing good discriminatory power, reproducibility, and typeability. 
10368) Using an internet-based surveillance system, TSN- 
database France, to examine patterns of antibiotic resistance 
among 199%2000 clinical isolates of 5raphy/ococcus aureus 
E. Lecaillon, H. Monteil, B. Pangon, A. Philippon, A. Le Coustumier, M. 
Weber, J. A. Karlowsky, K. N. Master, D. C. Mayfield D. F. Sahm, M. E. Jones 
Perpignan, S t rasboq ,  Versailles, Pans, Cahors, Nancy, F; Hemdon, USA; 
Utrecht, NL 
Objectives: To demonstrate the potential of a national real-time electronic 
surveillance network, we determined the current prevalence of oxacillin- 
resistant S .  aureus (ORSA), and compared the antimicrobial susceptibility 
profiles of ORSA with oxacillin-susceptible S. aureus (OSSA) using TSN- 
Database France (TSN-FR). 
Methods: TSN uses internet technology to collect routine clinical 
microbiological data from participant microbiology laboratories on a daily 
basis. Data undergoes stringent quality control before it is merged into the 
database. Patterns of antimicrobial resistance in S. aureus were characterized 
using a variety of patient parameters. Data from January 1999 to October 
2000 were examined using SFM defined breakpoints. 
Results: TSN-FR currently contains 6103 675 susceptibility test results 
from 33 hospitals, including data from 24 905 S aureus isolates. The 
prevalence of ORSA varied by hospital from 10% (26/261) to 45% (558/ 
1240), with a mean of 31.3%. Prevalence varied by age of patients: 12-17 
years (10.3%), 18-64 years (18.1%), and >65 years (41.8%). ORSA rates 
were constant (27-30%) regardless of patient gender or whether isolates 
were derived from blood, pneumonia, or soft tissue specimens. ORSA were 
more often cross-resistant to other antibiotics than OSSA, especially to 
ofloxacin (OKSA, 77.0% vs. OSSA, 4.8%), erythroniycin (74.9% vs. 
16.9%), gentamcin (17.3% vs. 0.6%), and rifampin (20.4% vs. 0.6%). 
Among ORSA, resistance remained low but was s t i U  higher than in OSSA 
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for pristinamycin (6.6% vs. 0.5%) and cotrimoxazole (1.3% vs. 0.2%). 
ORSA isolated from patients aged 0-17 years were less cross-resistant to 
other compounds, most noticeably to pristinamycin (1.9%) and ofloxacin 
(52.5%). than isolates derived from patients aged > 17 years. 
Conclusions: TSN-FR demonstrated that the current prevalence of 
ORSA in France vaned significantly among the current 33 participant 
hospitals (range, 1045%; mean 31.3%). A comprehensive surveillance 
system such as TSN-FR, which utilizes large volumes of real-time, 
otherwise unavailable clinical laboratory data for key pathogens and 
antibiotics, enables clinical microbiologists to track and study resistance 
via a new internet-based technology and to compare its findings with those 
of previously published studies. 
103691 Molecular epidemiology and antimicrobial 
susceptibility of methicillin-resistant Staphy/ococcus aureus 
isolated from blood cultures in Belgian hospitals in 1999 
0. Denis, A. Deplano, C. Nonho& R. De Ryck, N. Maes, S. Kottiers, E. 
Hendrickx, M. J. Struelens 
Brussels, B 
Objectives: To determine the molecular epidemiology and antimicrobial 
susceptibility ofMRSA blood isolates collected in 1999 in Belgian hospitals 
and to compare these results with those of a previous national survey of 
MRSA isolated from various types of clinical samples in 1997. 
Materials and methods: As a part of the European Antimicrobial Resistance 
Survedlance System S .  aureus survey, 147 non duplicate MRSA strains 
isolated from blood cultures were collected from patients admitted to 32 
hospitals in 1999. Isolates were identified by phenotypic tests (coagulase and 
oxascreen agar plates) and duplex PCR for nuc and mecA genes. Strains 
were typed by macroreshiction analysis (SmaI) resolved by pulsed field gel 
electrophoresis (PFGE). Macroreshiction patterns were classified in groups 
(patterns showing < 7  fragment Serence) ,  types (patterns showing <3 
fragment difference) and subtypes (each type variants). MICs of 16 
antimicrobials were determined by agar ddution methods according to 
NCCLS recommendanons. 
Results: The 147 MRSA strains were classified by PFGE analysis in 5 
epidemic groups (found in 2 or more hospitals) named group A (38%), B 
(35%), C (4%), E (I%), H (1%) and 5 sporadic groups (21%). The three 
widespread groups A, B and C were found in 20 (63%), 21 (66%) and 6 
(19%) Belgian hospitals, respectively. As compared with the survey of 1997, 
the proportion of MRSA strains susceptible to gentamicin increased (59% 
vs. 47%). This evolution correlated with (i) increased proportion of group B 
strains; (ii) emergence of aminoglycoside susceptible strains of new types 
related to group A. MRSA strains (n=3) susceptible to other non beta- 
lactam antimicrobials tested belonged to 3 distinct groups. N o  MRSA with 
decreased susceptibhty to vancomycin was observed. MRSA strains ( n  = 3) 
with high level resistance to mupirocin belonged to epidemic groups B 
( n  = 2) and C (n = 1). 
Conclusions: The clonal distribution of MRSA strains in Belgium showed a 
diversification of the ‘old’ group A lineage. Since 1997, new aminoglyco- 
side-susceptible variants types have emerged. Gentamicin susceptible group 
B strains have expanded as well during the period 1997-99. Further surveys 
of S. aureus from non bacteremia mfections are needed to assess the true 
incidence of resistance to mupirocin and of decreased susceptibility to 
glycopeptides. 
103701 Characterization of an epidemic clone of 
heterogeneous vancomycin resistant Staphy/ococcus aureus 
strains in a teaching hospital in France 
N .  L. van der Mee-Marquet, C. Barc, L. Mereghetti, J. Mesny, J. 
Loulergue, R. Quentin 
Tours, F 
Since the emergence of methicdhn-resistant Staphylococcus aureus (MKSA) 
strains with reduced susceptibility to vancomycin (MIC = 8 pg/mL) poses a 
potentially serious threat to public health, we have investigated the 
prevalence of heterogeneous vancomycin resistance in o w  hospital and have 
initiated a screening program to identify MRSA strains with reduced 
susceptibhty to vancomycin. 372 epidemiologically unrelated MRSA 
collected from January 1999 to March 2000 from our hospital were 
screened for susceptibility to vancomycin following different steps. The first 
step used the results provided by the Vitek automated system (bioMirieux, 
France) and as recommended by the Sociiti Franpise de Microbiologie 
(2000), 100 of the 372 clinical strains were categorized as intermediate or 
resistant with teicoplanin and suspected of heteroresistance for vancomycin. 
None of the 372 clinical strains were found intermediate with vancomycin. 
In a second step, the MICs of glycopeptides were determined with the 100 
suspected strains. Using the NCCLS criteria, none of the 100 strains showed 
a MICs value of vancomycin > 4  p g / d  and 21 strains showed a MICs 
value of vancomycin of 4 pg/mL. These 21 strains were selected for further 
investigation. S.  aureus isolates are heteroresistant for vancomycin since they 
contain minority subpopulations that can grow on agar medium containing 
> 4 pg vancomycin per mL. Screening for detection of heteroresistant for 
vancomycin S. aureuj on brain heart lnfusion agar plates containing 4 mg of 
vancomycin per line was carried out with the 21 isolates (vancomycin agar 
screen). 15 strains did grow on the plates. S. aureus isolates are 
heteroresistant for vancomycin since they contain minority subpopulations 
that are characterized by MICs of vancomycin of 8 p g / d  Thus, the MICs 
of vancomycin was determined for multiple isolates from each of the 15 
strains. Of the 15 strains, one (S62) produced subclones for which the 
vancomycin MIC was 8 pg/mL. Sections of strain S62 examined by 
electron microscopy showed a thicker cell wall than did vancomycin 
susceptible strains. Clonal identity between the 15 heterogeneous 
intermediate vancomycin-resistant S. aureus isolates was confirmed by 
phage typing using the international set of phages and PFGE (SmaI). Our 
results underlined the existence in our hospital of an epidemic phenomenon 
characterized by MRSA strains with reduced vancomycin susceptibility 
(heterogeneous vancomycin resistance). 
103711 Mortality related to methicillin-resistant 
5taphy/ococcus aureus bacteremia as compared to methicillin- 
sensitive 5. aureus bacteremia: a meta-analysis 
S. E. Cosgrove, M. J. Schwaber, E. N. Perencevich, G. Sakoulas, A. W. 
Karchmer, Y. Carmeli 
Boston, USA 
Objectives: To examine the impact of methcillin-resistance on mortality in 
S. aureux bacteremia (SAB). 
Methods: We identified all studies of SAB published between 1/80 arid 
8/00 using MEDLINE (search terms: ’aureus’ and ‘bacteremia’ ‘endocardi- 
tis’ ‘outcome’ or ‘mortality’). Inclusion and exclusion criteria were 
established a priori. 223 papers were identified for review and were included 
if they identified the number of patients (pts) with MRSA and MSSA 
bacteremia and their respective mortality rates. Studies were excluded if 
they were not in Enghsh, pts were exclusively children, cases described 
occurred before 1975, or pts were described in another included study. 
W e  extracted the following data: country, period of study, number of 
pts,% nosocomial cases, age, adjustment for severity of illness and 
comorbidities, source of bacteremia, and crude and adjusted odds ratios 
(ORs) and 95% confidence intervals (CIS) for in-hospital mortality for pts 
with MRSA vs. MSSA bacteremia. We used the DerSimonian and Laird 
random-effects model to obtain pooled estimates and tested for hetero- 
geneity in the results using the Q statistic. Publication bias was examined 
using a funnel plot. 
Results: 31 cohort studies reporting on a total of 2421 pts with SAB (1371 
MSSA and 1050 MRSA) met our criteria: 24 studies found no significant 
difference in mortality between MRSA and MSSA bacteremia, and 7 found 
significantly hgher mortality associated with MRSA bacteremia. When the 
results of all studies were combined, a significant increase in mortality due to 
MRSA bacteremia compared to MSSA bacteremia was found [pooled OR 
1.93, 95% CI 1.56, 2.38; P < 0.0011; no significant heterogeneity was 
evident. We found no evidence of publication bias. 10 of the studies 
adjusted for potential confounders. Analysis of these studies also showed 
MRSA bacteremia to be associated with significantly higher mortality 
[pooled OR 2.08, 95% C1 1.5, 2.87; P < 0.001]; no significant 
heterogeneity was evident. When we examined the momhty specifically 
attributable to SAB, we found similar results [pooled OR 2.16, 95% CI 
1.39, 3.34; P < 0.0011. 
Conclusions: When results of studies are combined, MRSA bacterenlia is 
associated with significantly higher mortality than MSSA bacteremia. The 
association remains significant when adjusting for potential confounding and 
when examining mortality specifically attributable to SAJ3. Most individual 
studles were s m a l l  and lacked the power to detect this association. 
Clinical Microbiology and Infection, Volume 7, Supplement 1, 2001 53 
1 0372 1 Endemic heteroresistant glycopeptide-intermediate 
Staphylococcus aureus (hGISA) comprising unrelated clonal 
types and not associated with vancomycin therapy 
P. Gueudet, E. Lecaillon, M. Wootton, A. P. MacGowan, T. R. Walsh, M. 
E. Jones 
Perpignan, F; Bristol, U K ;  Utrecht, NL 
Objectives: The detection of oxacillin-resistant S. aureus (SA) (ORSA) 
refractory to glycopeptides is a serious clinical issue. The current study reports 
on the prevalence of hGISA strains at Hospital Markhal JofEe, France. 
Methods: All ORSA detected during 1999 at Hosp. Marhchal Joffre were 
screened for vancomycin (VAN) resistance @HI supplemented with 4 mg/ 
L VAN: SFM recommended method). Isolates were retested using E-test (2 
McFarland inocula on BHI) and population analysis profile-area under the 
curve (PAP-AUC) analysis with hGISA SA Mu3 as a comparator. 
Results: In all, 858 nonrepeat SA were isolated during 1999; 367 (43%) 
isolates, from 257 patients, were ORSA (mean incidence 11.9/1000 
admssions). Of these, 188 (51.3%) grew on VAN screen agar (6.1/1000 
admwons). These were isolated from patients in medical, surgical, long- 
temi care, ICU, and outpatient facilities (mean patient age 70 years; mean 
delay to acquisition 24.5 days) and from diverse infection sites. 28 isolates 
(7.6%) possessed E-test VAN MICs 2 8 mg/L; all others had VAN MICs 
< 8 mg/L. Of these 28 isolates, 10 were stably and heterogeneously 
'resistant' to both VAN and teicoplanin (MIC > 8 ing/L). PAP-AUC 
showed 12 isolates (from a group of 58 randomly selected isolate5 from the 
initial 188, and included all 28 isolates with VAN MICs 2 8 mg/L by E- 
test) to have PAP-AUC ratios 20.90 but < l .3 (i.e. hGISA, not GISA). All 
7 isolates defined as hGISA by both E-test and PAP-AUC comprised 1 
PFGE clone (< 3 bands dfference). Additionally, two distinct PFGE types 
were detected among the other five hGISA identified using PAP-AUC. 
The 12 hGISA were derived from 12 patients (9 male, 3 female; age range 
31-80 years; mean 63 years), the majority of whom had severe underlying 
hsease. None were on glycopeptide therapy prior to hGISA isolation. 
Conclusions: This is the first report of endemic hGISA comprising 3 or 
more clonal types. The isolation of hGISA seems not to be associated with 
patient-specific glycopeptide therapies. Whilst screen tests can overestimate 
the incidence of glycopeptide-refractory isolates, subsequent 'macro' E-test 
MIC and PAP-AUC analysis are able to better confirm hGISA/GISA status, 
although these methods do not always agree. 
group C, 4/5 strains were susceptible to MLS and one strain contained the 
ermC gene. In group D (n=23), all strains possessed the ermA gene. 
Conclusions: Belgian MRSA strains resistant to MLS generally harbored 
ermA or ermC methyhe gene and rarely macrolides efflux system msrA. There 
was a very good correlation between PFGE clonal groups and MLS redstance 
phenotype: groups A and D/ermA, group B/ermC and group C/susceptibility. 
/03741 Evaluation of the EVIGENE MRSA Detection Kit for 
detection of methiciliin resistance in staphylococci from agar plates 
A. B. Poulsen, R. Skov, F. Espersen, L. Pallesen 
Copenhagen, DK 
Introduction: Reliable phenotypic testing of methicillin resistance in 
staphylococci has proved difficult. In thls study we evaluated the DNA 
probe based EVIGENE MRSA Detection Kit for detection of niethlcillin 
resistance in both S. aweus and non-S. nureus isolates and for differentiation 
between S. aureus and non-S. aureus species. 
Materials and methods: Two hundred and seventy-five epidemiologically 
unrelated S. aureus bacteremic strains and 242 non-S. aureus strains were 
categorized by multiplex PCR for the presence of the 16s rRNA gene, the 
mecA gene and the nuc gene. All of the strains were examined by the 
EVIGENE MRSA Detection Kit. The h t  is a microwell plate based gene 
probe hybridization kit detecting the 16s rRNA gene (Positive control), the 
mecA gene and the nuc gene (thermostable nuclease). The kit uses no 
amplification of the target sequences, and a positive reaction results in a 
yellow color readable by the unaided eye. 
Results: All of the 275 S. aureus strains gave readable and correct results for 
both the mecA and the nuc gene in the EVIGENE MRSA Detection Kit 
when compared to PCR. Two hundred and thirtynine (98.7%) of the 
non-S. aureus strains gave readable results in the EVIGENE MRSA 
Detection Kit. For these strains 100% agreement with PCR results were 
found. Three strains produced a signal in the positive control well 
(staphylococcal 16s rRNA gene) below the cut-off of the kit and by 
definition could thus not be interpreted. 
Conclusion: The EVIGENE MRSA Detection Kit gave 100% sensitivity 
and specificity in readable strains for detection of methicillin resistance in S. 
aureuz and non-S. actreus and can provide genotypic mecA classification of 
staphylococci in routine laboratories. The kit simultaneously provides a 
differentiation between S. aureus and non-S. aureuz isolates. 
/03731 Distribution of macrolides-lincosamides-streptogramins 
resistance genes among methicillin-resistant Staphy/ococcus 
aureus isolated from blood cultures in Belgium during 1999 
J. Magdalena, 0. Denis, A. Deplano, C. Nonho& E. Hendrickx, M. J. Struelens 
Brussels, B 
Objective: To determine the macrolides-lincosanudes-streptogramins genes 
(MLS) distribution among MRSA isolated from blood cultures in patients 
admitted to Belgian hospitals in 1999. 
Materials and methods: As part of the European Antimicrobial Resistance 
Surveillance System S. uureuz survey, 145 nonduplicate MRSA isolated 
from blood cultures were collected from 31 Belgian hospitals in 1999. 
Isolates were identified by conventional methods (coagulase and Oxascreen 
agar plates) and by 16s rRNA-mecA-nuc triplex PCR. The prevalence of 
MLS resistance determinants including ribosomal methylase encoded by 
ermA and ermC, macrolide efflux pump encoded by msrA and msrB, and 
streptogramin A inactivating enzyme encoded by vatB were evaluated by 
PCR. Susceptibility to erythromycin and clindamycin was determined by 
agar dilution MIC. Inducible/constitutive MIS resistance phenotype was 
evaluated by double disk diffision with erythromycin and clindamycin. 
MRSA strains were typed by PFGE after SmaI restriction. 
Results: MLS resistance due to ermA and ermC was found, respectively, in 
76 strains (53%) and 35 strains (24%). The msrB gene was detected in one 
strain which contained the ermA gene. No msrA gene was detected. 
Resistance to streptogramin A encoded by vatB was not detected. Thuty-four 
isolates (23%) susceptible to MLS did not show any MLS resistance tested 
genes. The ermA gene was always associated with constitutive MLS resistance 
phenotype and ermC with inducible phenotype. Strains were classified by 
PFGE analysis in four major groups, group A (38%), B (35%), C (3.5%) and D 
(16%) and 6 ininor groups (7.5%). In group A (n=55), MLS resistance was 
mainly due to the presence of the ermA (80%) or emiC (7%) gene and 13% of 
isolates were susceptible to MLS. In group B (n 51), 57% of strains contained 
the ermC gene and 6% the ermA gene and 37% of strains were susceptible. In 
103751 Detection of methicillin resistance in staphylococci 
directly from blood cultures using the WIGENE MRSA Detection Kit 
A. B. Poulsen, R. Skov, F. Espersen, L. Pallesen 
Copenhagen, DK 
Introduction: The EVIGENE MRSA Detection Kit has been evaluated and 
found in 100% agreement with PCR detection of the niecA gene. In the 
present study we preliminarily evaluated the kit for its ability to detect the 
mecA gene and the S. uureu.5 nuclease (nuc) gene in staphylococci directly 
from positive blood cultures. 
Materials and methods: A total of 131 Staphylococcal strains (S. actreus and 
non-S. uureus) with mecA and nuc status previously characterized by PCR 
were tested. The collection consisted of 51 MRSA, 21 MSSA, 31 niethicillin- 
resistant non-S. aureus and 28 methicillin-sensitive non-S. auretcc. For each 
strain 2-4 CFU was inoculated into an aerobic BacTec blood culture bottle 
containing approximately seven mL of whole blood and incubated. When 
detected positive by the BacTec system 1 mL of blood culture was mixed with 
5 mL of sterile water to lyse the red blood ceh. The mixture was transferred to 
25 mL of Mueller-Hinton broth to increa$e the number of bacteria. The 
culture was incubated at 37 "C while gently shaking for 3 h. 10 mL of the 
culture was centnfuged at 45008 for 10 nun and the bacterial pellet was used as 
starting material in the kit using the standard procedure. 
Results: After the additional incubation all readable tests gave correct mecA 
results. Eight (14%) of the 59 non-S. aureus strains tested gave a signal in the 
positive control well below the cut-off and could thus not be interpreted. 
One MRSA strain produced a very faint nuc signal. Furthemiore in 4 of the 
MRSA strains the nuc signal was close to the cut-off value of the kit, but 
still clearly positive when read by the eye. 
Conclusion: This study demonstrates that after an additional enrichment step 
the EVIGENE MRSA Detection Kit can be used on samples taken directly 
from positive blood cultures making same-day determination of nlethicillin 
resistance on staphylococci possible. 
54 Abstracts 
Mycobacterium tuberculosis: rapid diagnosis and resistance 
10376( A rapid diagnostic test for the detection of 
Mycobacterium tuberculosis in sputum specimen+results of a 
preliminary study 
G. Revathi, K. Radia, D. Patel, R. Ngantia 
Nairobi, EAK 
Objective: To evaluate a rapid test (Fast plaque M. tuberculosis assay-Biotec 
UK) for detection of M.  tuberculosis in sputum samples. Principle of the test: 
Fast plaque MTB assay is based on the fact that a bacteriophage specific for 
TB bacilli rapidly infects and multiplieq within viable TB bacilli present in 
the clinical samples. The phage can be detected and quantified within 48-72 
h on culture plates supporting growth of special indicator cells. 
Methods: 100 sputum specimens received in the laboratory for mycobac- 
terial investigation were subjected to Z N  staining, mycobacterial culture 
(Bactec 460 by standard protocol) and Fast plaque assay as per 
manufacturer's instructions. 
Results: 13 positive MTB cultures were obtained from 73 smear negative 
sputum samples. All of them (13) tested positive in Fast plaque assay. Two 
smear positive specimens with positive plaque assay were culture negative. 
Out of 27 smear positive sputa, 16 cultures were positive for MTB. All of 
them (216) tested positive with Fast plaque assay. None of the specimens 
which grew nontubercular mycobacteria in cultures (8 in number) were 
positive in plaque assay. 
Conclusions: 1. Fast plaque assay appears to have a good potential for rapid 
detection ofMTB in sputum samples. 2. It is cheaper than MTB PCR assay 
for the purpose of isolating infectious patients by identifying MTB within 
2-3 days in their sputa samples. 3. Large number of specimens need to be 
evaluated to assess the limitations of this test with various ciinical specimens 
in addition to sputa. 
103771 Evaluation of a rapid TB diagnostic test, FASTPlaqueTB, 
in South Africa 
A. Heydendrych, R. Brookes, H. Albert, R. Mole, E. Harley, E. Subotzky, 
R. Henry, V. Azevedo 
Cape Town, Johannesburg, ZA; @sm'ch, UK 
The FASTPlaqueTB (also known as PhageTek MB) test utilizes Phage 
Amplification technology in which phage (viruses reactive for MTB) are 
used as a reporter for the presence of viable TB bacilli in a specimen. The 
result is easy to interpret, requires no specialist equipment and is available 
within 2 days. We evaluated the use of FASTPlaqueTB for the diagnosis of 
TB from sputum specimens from new TB suspects in 12 clinics in Cape 
Town, South Africa (HIV prevalence 610%). Interim analysis (n = 751) of 
the trial compared the results &om the FASTPlaqueTB test with 
concentrated auranline smear microscopy and solid culture (LJ) . FASTPla- 
queTB gave excellent specificity (99.8%) and positive predictive value 
(0.98) compared to culture, indicating that a positive result indicated a true 
TB positive case. An overall sensitivity of 73% was achieved compared with 
culture, with the advantage of results achieved within 2 days compared with 
up to 8 weeks for culture. FASTPlaqueTB detected an additional 41% of 
the TB cases that were missed by smear microscopy (concentrated). This test 
can be used to rapidly confirm the diagnosis of TB and to detect additional 
TB cases that would be missed by smear microscopy. FASTPlaqueTB is 
suitable for widespread use due to its manual format and rapid reporting of 
results. Additional trials are ongoing in Turkey. 
v] Evaluation and comparison of molecular techniques 
for epidemiological typing of M. tuberculosis 
A. Piana, I. Maida, G. Sotgiu, P. Castiglia, I. Mura, E. Muresu 
Sassan', I 
Objective: Several techniques can be used in the epidemiology of tubercular 
pathology, and today, also molecular biology methods. These methods 
allow the identifLing of bacterial genoma sequences responsible for 
expressing virulence factors and to define the genomic facies of bacteria 
derived from different geographic area. The aim of this work is to determine 
the genotypic aspects of M. tuberculosis in North Sardinia area. 
Methods: 30 strains of M. tuberculosis isolated from patients in North-West 
Sardinia, were tested using PCR-ribotyping, PCR based RAPD and PFGE. 
The patterns have been processed by WGMA (Unweighted Pair-Group 
Method of Average) method. Identical or very similar strains can be 
congregate using t h s  analysis. 
Results: The PCR ribotyping highlights an amplification product size of 
520 bp for all microorganisms. The digestion of P C R  products, by 
restriction enzymes HaeIII and PvuII, generates four Werent patterns. 
P C R  based RAPD fingerprinting shows a greater polymorphism among 
mycobacteria also isolated in apparently similar strains using the previous 
method. The RAF'D assembles the isolated in 5 different patterns, 
characterised by 6-16 bands with molecular weight of 100-1200 bp. The 
genomic profiles obtained by PFGE are characterized by several bands with 
a molecular weight of 36-360 Kb. The 30 strains have been inserted in 3 
patterns with different genomic aspects. Molecular weights obtained by 
PFGE and the coefficients of dissimilarity among strains were computed by 
UPGMA method and a phenogram was set. 
Discussion: The use of molecular biology techniques, together with statistic 
methods, can be very helpll in the study of mycobacterial infection 
epidemiology. These techniques can permit an easy and early idenhlication of 
specific clones that can be responsible of sporadic/endemic or epidemic bacteria 
infections; so a correct preventive and therapeutic approach can be possible. 
I 0379 1 Detection of drug resistance using mycobacteriophages 
in Mycobacterium tuberculosis clinical isotates 
N. Gali, J. Dominguez, S. Blanco, P. Pedroso, J. Lonca, J. M. Mauterola, V 
Ausina 
Badalona, E 
Objectives: To evaluate a rapid, simple and low-cost assay to detect 
susceptibility of M. tuberculosis (MTB) clinical isolates to isoniazid, 
rifampicin and streptomycin by using mycobacteriophage D29. 
Methods: The assay is based on the ability of viable mycobacteria to be 
infected by lyac phage D29 after being exposured to drugs (24 h for 
rifampicin and streptomycin, and 72 h for isoniazid). Any phage outside the 
bacilli are chemically inactivated, while those inside are protected and 
replicate within the cells, causing their lysis and the release of a new 
mycobacteriophage progeny. The phages are detected by the formation of 
plaques in a lawn of the fast-grower M .  smegmatis after incubating for 24 h at 
37°C. The phage assay was evaluated testing 44 MTB clinical isolates: 18 
isoniazid-resistant, 9 isoniazid and rifampicin-resistant, 5 isoniazid and 
streptomycin-resistant and 12 sensitive strains. Results were compared to an 
'in uitro' susceptibility testing method (BACTEC). The Minimal Inhibitory 
Concentration (MIC) was also determined for the 32 isoniazid resistant 
strains: 15 low MIC (0.25-1 pg/mL) and 17 high MIC ( > 2  pg/mL). 
Results: Rifampicin results were in concordance with those obtained by 
BACTEC in 43 out of 44 clinical strains (97.7%), while in the case of 
streptomycin 3 discordant results were found (93.2% concordance). When 
testing isoniazid, 8 strains of 44 were misclassified in comparison to 
BACTEC (84.1% concordance): one sensitive strain was determined as 
resistant by the phage method; 7 resistant strains were classified as sensitive. 
These 7 discordant resistant isolates presented low MICs while all high MIC 
isoniazid-resistant strains were also resistant by the phage technique (17/17). 
Conclusions: The susceptibility phage-based technique has proven high 
concordance when testing rifampicin and streptomycin. To our knowledge, 
isoniazid results depend on the resistance level of the strains, since all 
isoniazid-resistant isolates presenting high MICs were classified correctly by 
the phage method, in comparison to the lower concordance of resistant 
strains with MlCs of 0.25-1 pg/mL. 
10380 Prevalence of Ser315Thr substitution within the katG 
gene in isoniazid-resistant clinical isolates of Mycobacterium 
tuberculosis from the Middle East 
S .  Ahmad, A. T. Abal, E. Mokaddas, G. F. Araj, E. Fares, A. S. Mustafa 
S a f f ,  KW; Beirut, LB; Dubai 
Clinical Microbiology and Infection, Volume 7, Supplement 1, 2001 55 
Objectives: To deternune the prevalence of the mutation Ser315Thr 
within catalase/peroxidase encoded by the katG gene that causes high 
level resistance to isoniazid (INH), in INH-resistant clinical isolates 
of M. tuberrulosis recovered from patients in three Middle Eastern 
countries. 
Methods: A PCR-RFLP method that allows the detection of the presence 
of Ser315Thr substitution within the katG gene was used to determine the 
prevalence of this mutation in INH-resistant clinical isolates of M. 
tuberculosis. A total of 17, 12 and 55 INH-resistant isolates were analyzed, 
recovered from TB patients from Beirut (Lebanon), Dubai (UAE) and 
Kuwait, respectively. Additionally 7 and 13 INH-susceptible isolates 
obtained fiom TB patients from Lebanon and Kuwait, respectively, were 
also analyzed. 
Results: The results showed that 6 of 17 (35%) INH-resistant M .  tuberculosis 
isolates from Lebanon, 6 of 12 (SO%) from UAE and 43 of 55 (78%) from 
Kuwait contained Ser315Thr substitution within the katG gene. None of 
the INH-susceptible strains contained the Ser315Thr substitution within the 
katG gene. Correlating the ethnic origin of the TB patients with the 
prevalence of Ser315Thr substitution showed that 65-80% of the INH- 
resistant M. tuberculosis isolates recovered from patients of South Asian or 
South-east Asian countries contained this substitution. 
Conclusions: The high prevalence (82%) of Ser315Thr substitution in INH- 
resistant M.  tuberculosis strains from patients of South Asian origin suggests 
that PCR-RFLP can be utilized to rapidly detect INH-resistant clinical M. 
tuberculosis isolates in majority of patients belonging to this ethnic grouping. 
Acknowledgement: Supported by Kuwait University Research Adminis- 
tration grant MI 116. 
103811 Distribution of rpoB mutations and genetic 
relationship of rifampin-resistant clinical Mycobacterium 
tuberculosis isolates from Germany 
M. Heep, B. Brandstatter, U.  Rieger, N. Lehn, E. Richter, S. Riisch- 
Gerdes, S .  Niemann 
Regensburg, Borstel, D 
Objectives: To evaluate the prevalence of rpoB mutations and the genetic 
relationship of rifampin (RIF) resistant clinical M. tuberculosis isolates from 
Germany. 
Methods: The distribution of rpoB mutations among 80 RIF resistant M. 
tubermlosis strains isolated in Germany during 1997 has been determined by 
direct sequencing of rpoB PCR fragments. The genetic relationship of the 
strains analyzed has been determined by IS6110 DNA fingerprinting and 
additionally by spoligotyping. 
Results: Of the 80 RIF resistant strains, 73 (91%) were multidrug-resistant 
(MDR). The most frequent rpoB mutations were changes in codon 456 (52 
isolates, 65%), followed by changes in codon 441 (13 isolates, 16%) and 
codon 451 (11 isolates, 14%). The newly described V176F mutation in the 
beginning of the rpoB gene was detected in one isolate of the study 
population and in 5 of 18 RIF resistant strains without Cluster I mutation 
from 6 previously published studies. In three isolates a mixture of resistant 
and susceptible subpopulations (heteroresistance) prohibited the detection of 
rpoB mutations in the initial analysis, however, in these isolates Cluster I 
mutations have been verified after a passage on RIF-containing media. 
IS61 10 DNA fingerprinting of 76 strains revealed 8 clusters comprising 27 
MDR strains with identical RFLP patterns that mainly also showed identical 
rpoB inntations and identical or similar drug-resistance patterns. Twenty- 
two (approx. 29%) of the 76 strains proved to belong to the W-strain/ 
Beijing farmly, all of whch were MDR. 
Conclusions: Our  results indicate that the V176F mutation should be 
included in molecular tests for prediction of RIF resistance in M. tuberculosis. 
Heteroresistance caused by a mixture of mycobactenal subpopulations with 
different susceptibilities to RIF may influence the efficiency of molecular 
tests for detection of resistance mutations. The amount of clustered strains 
determined indicates that transmission of MDR M.  tuberrulosis isolates may 
occur in Germany. At least the rpoB mutations found in the clustered strains 
in this study seem not to affect the virulence of M. tuberculosis isolates in a 
way that transmission is not possible. Strains of the Beijing family, 
presumably mainly imported from countries of the former SU, represent a 
h g h  proportion of MDR resistant M .  tuberculosis strains isolated in 
Germany. 
1 0382 1 Pyrazinamide biotransformation study in 
pyrazinamide resistant Mycobacterium tuberculosis 
M. Mestdagh, P.-A. Fonteyne, F. Portaels, E. Van den Eeckhout 
Cent, Antwerp, B 
Although pyrazinamide (PZA) has now been implemented in regimens for 
almost 50 years, its target remained unidentified until recently. PZA is 
assumed to be a prodrug, conversed intracellularly by the bacterial 
pyrazinamidase (PZase) to the toxic pyrazinoic acid (POA). Single 
mutations of the pncA gene encoding this amidase are considered the 
major cause of PZA resistance in tubercle bacdi. However, for some PZA 
resistant M. tuberculmis strains no pncA mutations could be detected. Thus, 
additional resistance mechanisms remain to be elucidated. To check the 
hypothesis of transport disorders, we studied PZA uptake in a set of PZA 
resistant M. tuberculosis strains. Bacteria resuspended in modtied Mid- 
dlebrook 7H10 broth at pH 5.8 were incubated with [carbonyl-l4C] PZA 
at 37 "C. At set time points, aliquots were removed to measure radioactivity 
associated with the cells by scintillation counting. From the remainder of 
each test suspension, 5-pL aliquots of the supematants were spotted onto a 
silica G gel 60 plate with glass backing (Whatman). Thin Layer 
Chromatography plates were developed in I-butanol: 10% ammonia 
(S:l). After air drying, the plates were exposed to X-ray tilm for 
autoradiography. 5-pL aliquots of the pellets were analyzed in the same 
way. The results obtained for the two M. bovis strains, and for M. tuberculosis 
H37Ra, and M.  tuberculosis H37Rv, corresponded well with previous 
findings under slightly merent  test conditions. Of the 11 PZA resistant M. 
6uberculosis clinical isolates tested, nine did not show uptake of [carbonyl- 
14C] PZA. Five ofthem contained pncA mutations, whde a wild type pncA 
sequence was present in the other four. Of the two remaining PZA resistant 
isolates taking up [carbonyl-14C] PZA, transforming it into [carbonyl-l4C] 
POA, and accumulating it intracellularly, one had a pncA mutation, 
whereas the second one contained the wild type pncA sequence. For 11 
PZA resistant M. tuberculosis isolates, PZA biotransformation was studied. 
Nine strains, five of which containing pncA mutations, did not take up 
[carbonyl-l4C] PZA. Two strains showed uptake, converted [carbonyl- 
14CJ PZA into [carbonyl-l4C] pyrazinoic acid, and accumulated it. PZA 
resistance correlated better with lack of PZA uptake than with mutation of 
pncA. To check for eventual efflux systems, strains are now being tested by 
incubating with [carbonyl-I4C] POA, and results will be included at the 
end of 2000. 
103831 Molecular analysis of a high molecular mass class A 
penicillin-binding protein of Mycobacterium tuberculosis 
S. Bhakta, J. Basu 
Culcutla, IND 
The annotated genome of Mycobarterium tuberculosis indicates the presence 
of several penicillin-binding proteins. Based on sequence sindarity 
searches, two of these genes were predicted to encode two multimodular 
high molecular mass penicillin-binding proteins (PBPs) of class A. The 
gene encoding one of these proteins was cloned and overexpressed in 
Escherichin coli. The His-tagged PBP, designated PBPl was purified by 
affinity chromatography after solubihzation from the membranes using 
Zwittergent 3-12. The punfied protein bound penican  with high affinity, 
indicating that M. tuberculosis contains at least one penicillin-sensitive 
target. Efforts were undertaken to overproduce a recombinant protein that 
retained penicillin-binding ability, but was at the same time soluble. 
Genetically manipulated mutants with successive truncations from the N- 
terminal end were constructed. The class A multimodular PBPs consist 
of an N-terminal nonpenicillin-binding module with four conserved 
sequence motifs, and a C-terminal penicillin-binding module with another 
four conserved sequence motifs. It was observed that at least the first 
two of the conserved motifs of the N-terminal module could be deleted 
resulting in  a mutant with penicillin-binding ability equivalent to that 
of the full-length PBP. The mutant was also soluble. This soluble 
derivative should prove to be a valuable tool in attempts to crystallize and 
generate structural information on the class A high molecular mass PBPs, 
and to design beta-lactams capable of interacting with high affinity with 
this target. 
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(53841 Quality assurance and EUCAST 
D. F. J. Brown 
Cambridge, UK 
Quality assurance of antimicrobial susceptibility tests i s  essential to ensure 
the quahty of test methods. The European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) seeks to highhght the Merent  but 
complementary approaches which should form an effective programme for 
quality assurance of antimicrobial susceptibility testing. Routine internal 
quality control with a range of largely susceptible control strains is an 
essential part of quality assurance as it facilitates monitoring of test 
performance. In addition to checking that control MICs or zone diameters 
are within published ranges, more complex performance rules or statistical 
tests may be used. If control tests indicate unacceptable performance the 
source of the error should be investigated and rectified. An understanding of 
the limitations of methods and potential sources of error assists in the 
recognition, resolution and avoidance of errors. Awareness of atypical results 
may also provide waming of possible erroneous results. Expert systems are 
valuable in combining knowledge of incompatible results, atypical results 
and interpretative reading. External quality assessment schemes provide an 
independent assessment of performance, and exercises in which routine tests 
are repeated with the identity of the organisms blinded may detect problems 
not seen with other control methods. An extended set of strains of known 
susceptibility in reference methods would be useful for comparison of 
methods and for providing access to strains with known resistances, which 
may be a useful addltion to the routine sets of control strains. 
/53861 The HARMONY approach to quality assurance 
€3. D. Cookson and the HARMONY Antimicrobial Susceptibility Testing 
Group 
London, UK 
Objectives: To review the EU national antimicrobial susceptibility testing 
quality assurance (ASTQA) schemes and, as a demonstration project, 
examine the feasibility of developing bottom-up quality assurance groups to 
facilitate the sharing of QA experiences and so improve the continuous 
quality improvement process. 
Methods: World experts in ASTQA helped develop the questionnaires. 
The national ASTQA tool was less problematic. However, the piloting of 
the local hospital ASTQA tool was much more of a problem. The initial 
tool was not sufficiently prescriptive and hospitals were unclear as to what 
was envisaged. We thus re-designed the approach to provide many more 
fields for data entry and examples given of where there might be useful 
discussions. The analyzes were to be sent to each country’s co-ordinator and 
then the group were to discuss their finmngs early in 2001. 
Results: The national questionnaires showed increasing interest in external 
QA testing. The distributions of the INSPEAR and EARSS projects 
coincided with the questionnaires. Some counnies were able to develop the 
ASTQA local tool in their own hospital and found it very helpful. 
However, there was not the time for them to do anything with other 
hospitals. Greece, the United Kingdom and Germany have so far used the 
local tool in several hospitals and results are currently being analyzed. 
Germany in particular wishes to extend the system to even more hospitals. 
The group plan to meet in 2001 to review how the tool might be modified 
and whether it would be of use to other countries. The tool in its current 
Bacterial toxins and pathogenicity 
form is already accessible on the HARMONY website (http:/I 
www.phls.co.uk/Intemational/Harmony/Harmony.htm). 
Conclusions: There is an increased interest in external quality assurance in 
the EU. However, there are few countries attempting to exchange local 
ASTQA experiences and much potential for improving this situation. 
153871 External quality assessment in Europe 
J. S .  Snell 
London, UK 
Comparability of results of antimicrobial susceptibility testing between 
laboratories is essential for resistance surveillance studm. The use of 
different methods in different countries may cause problems with 
international comparisons of resistant rates. Success rates with organisms- 
antimicrobial agents known to be difficult to test were examined using data 
&om laboratories in several countries participating in the UK National 
External Quality Assessment Scheme for Microbiology. With penicillin 
resistance in pneuniococci, vancomycin and high level gentamicin resistance 
in enterococci, ampicillin, coamoxyclav and chloramphenicol resistance in 
H .  influenzap and methcillin resistance in staphylococci there were 
differences between countries in success rates for detection of resistant 
strains. This study suggests that differences between countries in rates of 
resistance for some organism-antimicrobial agent combinations should be 
interpreted with caution when based on results of susceptibility testing by 
different methods. International EQA is useful in the demonstration and 
clarification of such differences. 
153891 Quality assurance of susceptibility testing through the 
use of expert systems 
M. Peyret 
Hazelwood,  USA 
In the past 15 years, several expert systems have been developed to validate 
automated susceptibility test results. Simple systems will check for natural 
resistance only but the most advanced systems will attempt to identify 
phenotypes. A phenotype is defined as the expression of a specific 
mechanism of susceptibtlity or resistance to a given drug class within a 
particular species. The quality of the phenotype identification, which will 
depend of the drug tested, is of epidemiological value, since it enables rapid 
anticipation of resistance mechanisms encountered in large series of results. 
It is also of interest for quality assurance of bacterial antibiotic susceptibility 
testing: an unknown phenotype would draw the biologst’s attention, since 
such a phenotype may either result from a technical error or reveal a new 
mechanism of resistance. Based upon the phenotype identified, corrections 
of results may be proposed for some drugs; indeed results may also be 
extrapolated for drugs not tested. Multiplying the number of antibiotics and 
resistance mechanisms, and therefore the number of phenotypes, produces a 
large pool of information difficult to memorize and is clearly impractical for 
everyday practice. Expert systems, capable of handling simple logic for 
determining the resistance phenotype, have been proposed as useful tools to 
help the biologist in this situation. In the clinical laboratory, an expert 
system has the advantage of always being available; its reasoning and 
responses are also reproducible. 
)5393: Vaccine issued from genetic detoxification on genetic detoxification. Here we show how t h i s  approach was applied 
successfullv to oertussis. heat-labile and cholera toxins. Pertussis toxin (PT) I L  > ,  
V. Masignani, M. Pizza, R. Rappuoli 
Siena, I 
A number of vaccine formulations have been based on the use of chemically 
detoxified toxins. However, this kmd of attenuation has a number of 
drawbacks. To overcome these problems, we have used an approach based 
i s  a complex protein composed of five subunits organized in an AB5 
structure. The A domain i s  an enzyme with ADP-nbosylating activity, 
whereas the B domain i s  a non toxic oligomer, which binds the receptor 
located on the surface of eukaryotic cells and facilitates the translocation of 
the enzymatically active subunit across the cell membrane. On the basis of 
the homology with the enzymatic moiety of other bacterial toxins with the 
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same mechanism of action, and using computer modelling analysis, the 
amino acids located within the NAD-binding and catalytic cavity have been 
identified and changed by site-directed mutagenesis. The mutated toxins 
have been characterized for their biochemical and immunological proper- 
ties. Among them, a double-mutant toxin (PT-9W129G) resulted to be 
completely free of enzymatic activity and toxicity. Moreover, when used to 
immunize mice, the toxin induced high levels of antibodies able to 
neutralize the toxin in vifro and in vivo. This PT derivative has been used for 
the construction of an acellular vaccine against pertussis, which is presently 
licensed in several countries. A similar approach has been used for the 
ingegnerization of cholera toxin (CT) and E. coli heat-labile enterotoxin 
(LT). These proteins are the most powerful immunogens and mucosal 
adjuvants recognized to date. However, their h g h  toxicity has so far 
precluded their application in humans. Computer modelling analysis has 
once again been the starting point to identlfy residues important for the 
toxic actiwty and site-directed mutagenesis has been applied to obtain 
nontoxic derivatives of C T  and LT still active as mucosal adjuvants. By h s  
approach, more than 50 different molecules have been generated and tested 
for their immunological properties. Among them, two mutants of LT have 
been identified as the best immunogens and adjuvants in the animal model. 
Clinical mals with these molecules are undergoing. In conclusion, the 
genetic detoxification of bacterial toxins allows the identification of 
molecules useful as components of a new generation vaccines. 
Emerging and resurgent infectious diseases 
(54041 Q fever - resurgent or underestimated threat? 
J. K. Kazar 
Bratislava, SK 
Q fever is a zoonosis caused by Coxiella burnetii that occurs practically 
everywhere providing it is properely diagnosed. Its seemingly absence in 
some regions can be explained by unawareness and inaccessibility of 
diagnostic methods and/or reagents. Since C. bumefii is a very resistant 
microorganism and in nature it is maintained and disseminated by horizontal 
and vertical transmission (ticks, wild and domestic animals), foci of infection 
may persist for years or even decades. However, C. bumetii can also be 
introduced to another country by infected domestic animals and 
contaminated animal or plant products. As a consequence, in some areas 
Q fever can be considered as underestimated rather than resurgent infectious 
disease. Humans are not infected by a tick bite, but contract infecnon 
usually by aerogenic route in contact with domestic animals or when 
processing their products. The alimentary route, namely by ingestion of 
contaminated rmlk or mdk products is also possible, but controversial. 
Though acute form of Q fever, presenting with a variety of symptoms, is 
usually self-limited febnle illness, chronic Q fever, manifesting mostly as 
endocarditis, is a serious and often fatal Illness. Thus, Q fever can pose under 
certain conditions a public health problem and a real threat, so that it 
deserves more and continuous attention &om both clinicians and public 
health authorities. Diagnosis of Q fever relies on serological examination, 
PCR detection of the agent in clinical specimens and its isolation in cell 
cultures, respectively. Preventive measures require control of the importa- 
hOn and transport of domestic animals, adequate disinfection and control of 
animal products of concepnon and boiling or proper pasteurization of nntk. 
Vaccination of domestic animals or humans at risk with an efficient phase I 
or phase I-derived vaccine is also possible. 
/5405 Rabies in Europe 
L. Sihvonen 
Helsinki, FIN 
The virus of rabies is a member of the genus Lyssavirus. Rabies virus can 
infect all warm-blooded animals, and in nearly all instances the infection 
ends in death. Rabies virus is not stable in the enviroment. Usually the 
infection is transmitted only by the bite or scratch of a rabid a d .  In bat 
caves, where amounts of virus may be very hgh ,  infection can be 
transmitted via aerosol. Four host species can be destinguished in Europe as 
maintaining their own cycles: the red fox (Vulpes vulpes), the dog (Curtis 
familiaris), the arctic fox (Alopex lagopus) and the serotine bat (Eptesicus 
serotinus). Dog-mediated rabies is still most important in many parts of 
world, such as in Turkey, Africa and Asia. Prevention of rabies is best 
accomplished by vaccinating dogs and cats with the killed rabies vaccines. In 
Europe, an epidemic of wildlife-mediated rabies spread from a focus of 
Kalingrad during the second World War, and within a few decades it 
conquered most parts of continent. Red fox is the main resorvoir and plays a 
critical role in the maintenance and spread of rabies in Europe. In addition 
to red fox, raccoon dog (Nyctereutes prodcyonoides) is an other important 
vector in north-eastem Europe. The stepwise change fiom dog to wildlife 
rabies in the middle of the 1950s led to changes in control policies against 
rabies. In addition to the prevention of rabies in domestic animals by 
vaccination, the control of rabies in wildlife has become increasingly 
important. Rabies in wildhfe can theoretically be controlled either by an 
intensive reduction in population density or by mass vaccination of reservoir 
population. The oral immunization of foxes against rabies using modified 
live virus vaccines has offered a new perspective in rabies control. Crucial 
for the survival of rabies is that the virus is transmitted by an infected 
animal to susceptible animals during the short period of virus excretion. 
Rabies transmission ceases when the population density drops below a 
certain level, or when the herd immunity reaches the threshold. Oral 
vaccination of foxes started in Switzerland in the late 1970s and other 
countries followed later. Four countries in Europe have attained rabies-free 
status due to oral vaccination: Finland (1991), the Netherlands (1991), 
Italy (1997) and Switzerland (1998). There are more candidates a t  present. 
The peak of rabies cases in Europe was recorded in 1989 amounting to 
24 377. Due to increasing efforts with oral vaccination the number of cases 
has reduced to 6591 cases in 1999. Continuous surveillance and 
epidemiological screening is necessary to detect any new outbreaks of 
rabies at an early stage. 
Hospital infection control in the 21st century-Joint symposium with IFlC 
154081 Audit as a tool to optimize antibiotic prescription in 
hospitals and general practice 
H. J. Kolmos 
Odense, DK 
Education in antibiotic prescribing is an important part of an antibiotic 
policy. It should not only be aimed at prescribing physicians, but also at 
nurses and medical students, and maybe even patients. To  be effective, 
education must be an ongoing process, particularly because young staff 
members often change positions, and good prescribing habits tend to 
decline over time. Written guidelines are an important educational element, 
because they make the local antibiotic policy visible to staff members. 
Guidelines should as a minimum contain information on indications for 
therapy and prophylaxis, choice of drug, route of administration, dose of 
drug, and duration of treatment. Educational programmes and guidelines 
may have hmited effect on antibiotic prescribing, if used alone. However, if 
used as part of an audit circle, they may have a significant and sustained 
effect. An audit circle on antibiotic prescribing consists of four steps: 
elaboration of guidelines, registration of prescriptions, comparison of 
prescriptions with guidelines, and implementation of change in accordance 
with the guidelmes. The success of an audit is largely dependent on regular 
feedback of data to the prescribing physicians, and on their active 
involvement in all steps of the audit. Audits are time-consuming, and to 
be long-term viable, their design must he simple. Examples of audits 
applicable for hospitals and general practice will be presented. 
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154091 Experience of education in infection control countries with few resources, by networking between societies for the exchanw of experience and ideas and by educational activities. In infection 
Y 
A. Hambraeus 
Uppsala, S 
International Federation of Infection Control, IFIC (www.ific.narod.ru), is 
an umbrella organization of national societies of health care professionals in 
infection control and related fields. The goal of IFIC is to reduce or 
mininize nosocomial infections worldwide, w t h  particular attention to 
control a high level of knowledge is not sufficient to gain results, 
compliance to infection control measures is needed. To acheve this change 
of behavior is often necessary. In my talk I will give examples of merent  
kinds of approaches to education in infection control and 1 will present 
Some results &om an educational project perfmmed in cooperation with 
colleagues in St Petenburg and in Sweden. 
Rational use of antibiotics 
A public campaign for a more rational use of 
antibiotics 
I. Bauraind, H. Goossens, P. M. Tulkens, M. De Meyere, P. De Mol, L. Verbist 
Brussels, Autcr~erp, Gent, Liege, Louuain, B 
Following the recommendations of the EU Conference ‘The Microbial 
Threat’, a commission for the coordination of the antibiotic policy has been 
established at the federal level in Belgium. Ths commission has set up a 
workmg party to develop a 500 000 Euros programme to increase the 
sensibdity and awareness of the public to a more ranonal use of antibiotics. 
The aim was to reduce overconsumption of antibiotics in humans, based on 
studies demonstrating that Belgium had one of the highest antibiotic use per 
capita in EU. The campaign, aimed at both to the general public and the 
health professional, has been organised as follows. (1) A preliminary survey 
( n =  1014; covering equally the 15-34, 35-54, and above 54 years groups, 
geographic regions, and socio-economic categories) was performed to 
obtain direct information on the level of public awareness on antibiotic 
overconsumption and threat of bacterial resistance. (2) All health 
professionals were informed about bacterial resistance and its s igdcance 
(‘leading article’ published in a journal sent regularly to MDs and 
pharmacists [Folia Pharmacotherapeutica]; guidelines for primary health 
care and for hospitals, veterinary workgroups), (3) Launchmg information 
acuons for the public through (i) a press conference with pamcipation of the 
State authorities and university experts; (ii) a radio and TV campaign (spots) 
insisting on the necessity to use antibiotics with care and to address the issue 
of overconsumption with their doctor and pharmacist; (iii) the publication 
of a brochure [sent to all general practitioners and selected specialists, all 
pharmacists, and key professionals active in socio-medical activities (Social 
Security offices, Child care organisations, etc. . . .)  for displaying and 
distribution to patients] telling about (a) the nature of an infection, (b) the 
fact that mdd infections may not need antibiotic treatment, (c) the relation 
between an inappropriate use of antibiotics and the selection of resistant 
organisms, and (d) the necessity to spare antibiotics, whch are a precious 
good; (iv) two Web sites (antibiotiques.org [French], and red-antibioti- 
ca.org [Dutch]) with a similar information and the possibility to download 
the brochure and to &splay the TV video spots. The campaign was 
launched on 27 November 2000 and its materials will be displayed. 
Pfl] Is a less expensive broad-spectrum antibiotic less 
effective than a carbapenem for the treatment of secondary 
peritonitis? 
D. GennC, A. Menetrey, A. Jacqnet, P. Indino, C. S&n&chaud, H. H. 
Siegrist 
La Chaux-de-Fonds, CH 
Objective: Therapy of secondary peritonitis combines surgical intervention 
with antibiotic treatment. In order to cover intestinal pathogens, 
carbapenems are prescribed widely. Is it still possible to use a first line 
antibiotic with a less broad spectrum, such as amoxicillm/clavulanic (AMC) 
acid for empirical therapy? 
Methods: This is a retrospective study of all secondary peritonitis cases 
whch occurred at the Municipal Hospital of La Chaux-de-Fond?, 
Switzerland between 1998 and 2000. All micro-organisms isolated in 
peritoneal fluid were identified and their susceptibhty to imipenem (IPM) 
and AMC was determined. The therapeutic success rates of AMC and IPM 
were compared. The choice of the antibiotic was left to the surgeon. 
Therapeutic failure was defined by death, the necessity for repeated surgical 
intervention or clinical deterioration with persistent positive cultures despite 
initial antibiotic therapy. 
Results: We found 76 peritonitis cases (60 community-acquired, 16 
nosocomial) of which 34 (45%) were perforated appendicitis, 27 (36%) 
other mgestive perforations, 7 (9%) diverticulitis, 8 (10%) of miscellaneous 
aetiology. There were 39 female, 37 male, mean age was 53 years. Empirical 
treatments were: 52 (68%) AMC, 8 (10%) IPM, 16 (21%) different 
antibiotics for a median duration of 9 days. One hundred and fifty-six 
micro-organisms were cultured, 4 being yeasts. One hundred and forty-nine 
(98%) organisms were susceptible to IPM us, 124 (82%) susceptible to AMC 
( P  < 0.0001). Thirteen therapeutic failures occurred in 52 patients treated 
with Ah4C (25%) uz. 3/8 (38%) treated with IPM (P=0.43). Five patients 
out of 52 (10%) died under AMC vs. 1/8 (13%) under IPM (I“ 1.0). The 
proportion of organisms resistant to AMC in therapeutic failures was greater 
in n o s o c o d  peritonitis vs. community-acquired peritonitis (2/11 11s. 0/41, 
D= 0.041). 
Conclusion: Despite a better in uilro bacteriological activity, the clinical 
efficacy of IPM was identical to that of AMC. The use of AMC should be 
avoided in cases of secondary nosoconllal peritonitis, as the risk of 
encountering resistant micro-organisms is higher. AMC as a first-line 
antibiotic instead of LPM in secondary community-acquired peritonitis 
would save $757 per 9-day treatment regimen. 
v1 Pharmaco-economic considerations in selecting 
treatment for nosocomial bacteremias in Argentina 
H. LSpez, T. Zitto, G. Vidal, F. Geraci, H. Lorenzo 
Buenos Aires, RA 
Objective: A health economic study was camed out in Argentina, to 
investigate the cost-effectiveness of hnezolid 05. vancomycin for the 
treatment of patients with nosocomial bacteremias. 
Methods: We built a mathematical model of the nosocomial bacteremias 
incidence on public sector by using hospital discharge data collected by 
National Institute of Statistics and Census and the literature reports. In our 
model, direct medical cost attributable to bacteremias were estimated and 
two antibiotics in the bacteremias’s treatment were compared, linezolid (10 
days) us. vancomycin (14 days). We considered length of stay (LOS) 
potentially attributable to infection in 14 days for vancomycin and 7 days for 
linezolid. We used standard sources for the costs of health care based on 
local prices. 
Results: We estimated 4866 cases of nosocomial bacteremias by cocci gram 
positives niethicillin resistant. The direct medtcal costs wlth vancomyciii 
may be $17 146 032 and the direct costs with linezolid may be $9 120 830. 
Cost saving would be $8 025 202 on total bacteremias. 
Conclusion: Linezolid is an alternative proposal in the treatment of the 
bacteremias by cocci Gram positives methicillin resistant, its oral 
bioequivalence may shorten LOS and thip new drug could lead to 
cost saving 
v) Annual analysis of prescribed antibiotics in ambulatory 
practice within the area of Zabrze Town 
W. Drzastwa, E. Drzastwa, W .  Lukas, W .  Karczewska, I. Syzmczyk 
Zabrze, PL 
Introduction: Ambulatory treatment of infectious diseases has mainly the 
empirical character based on supposed etiology. It is still very difficult to 
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introduce the rule of guided therapy according to antibiogram and culture 
results in ambulatory practice. Factors reducing the efficacy of antibiotic 
therapy are: copathogenicity, inappropriate choice and irregular application 
of drugs, conscious relinquishment of their application, antibiotics 
refractoriness increase among most common bacteria, in case of too often 
applied macrolids and tetracyclines as first choice drugs. Recommendations 
deahng with rules of antibiotic administration has been prepared in Poland 
in 1997 and 1998. 
Objectives: The aim of this study was to estimate application of these 
recommendation among out-patients units physicians. 
Materials and methods: Analysis has included 49 267 recipes realized in 
randomly chosen chemist’s shop open 24 hour in 1999, in urban area (about 
280 000 inhabitants). Analysis has considered (1) recipe identification 
written by a doctor according to hidher place of employment (Primary 
Health Care [PHC], Specialist Outpatient Clinic); (2) fkequency of 
antibiotic recipes regardmg seasonal orders; (3) prescribed antibiotics 
analysis considering their attachment to the proper group. 
Results: Among 49 267 prescribed drugs, antibiotics have covered 3661 
recipes-7.42% of all ordered medicines (4.46% PHC doctors, 2.96% the 
specialists). The biggest amount of antibiotic recipes has been prescribed by 
PHC doctors during winter, the smallest amount in spring-summer season, 
whereas simdar fluctuations haven’t been observed in the group of 
specialists. Among antibiotics prescribed by PHC doctors penicilhns 
(44.45%), cephalosporins (23.4%) and macrolids (21.35%) have dominated. 
Tetracyclines have been ordered in 9.3% ofpatients and aminoglycosides in 
0.9%. Doctors working in specialist outpatient clinics equally often have 
ordered penicillins (42.3%) and macrolids (21.35%) whereas less fkequently 
cephalosporins (16.42%) and more tetracyclines (14.03%). Relatively high 
percentage of prescribed penicillins and cephalosporins (over 60%) is 
consistent with current recommendations in Poland. What trouble us is 
relatively frequent prescription of macrolids as first choice drugs, what can 
bring in future the increase of refractoriness to most common pathogens, 
similar to the situation in some western counmes. 
Conclusion: Obtained results indicate the necessity of frequent up-dating of 
antibiotics prescription rules and their efficient exacting. 
I P414 I Processes and outcomes of care for patients 
hospitalized with community-acquired lower respiratory tract 
infection 
A. M. Lovering, J. Sunderland, A. P. MacGowan 
Bristol, UK 
Objectives: To describe the processes of care in the period before hospital 
admission and the episode outcome for patients with community-acquired 
LRTI. 
Methods: In a I-year retrospective observational study patients admitted 
to a general hospital in Bristol, UK, with a LRTI were traced back to 
primary care where their medical records were reviewed. Processes of care 
before hospital admission were assessed as were hospital lengths of stay and 
patient mortality. 
Results: From a population of 100 534 there were 287 patients admitted to 
hospital with evidence in both the primary and secondary care records to 
support an admission for a community-acquired LRTI (28.5 admissions per 
10 000/year). 40% of the admissions were for community-acquired 
pneumonia. 70.4% of the hospitalized patients were seen in the 14 days 
before admission; 54.0% of the patients were seen for respiratory illness 
and 35.5% were prescribed antibiotics. The main antibiotics prescribed 
were amoxicdin 54%, clarithromycin 16%, ciprofloxacin 11% and 
coamoxiclav 10%. The median number of days of antimicrobial therapy 
before adrmssion was 4 days. Overall mortality was 17.1%, ranging &om 
< 7% in the younger (< 60 years) patients to > 30% in the older (> 80 
years) patients. The median length of stay was 7d with no sex-related 
daerences but there were significant differences related to age, ranging fkom 
< 5  days in the younger patients ( 1 6 0  years) to > 8  days in the older 
patients (> 80 years). 
Conclusions: In over half of the hospital admissions for LRTI, patients were 
seen in the 14 days before admission for respiratory problems; over a third 
were prescribed antibiotics. The majority of patients received four or more 
days of therapy before hospitalization. We conclude that there may be scope 
to reduce the burden on secondary care provision due to LRTI by altering 
patient management in primary care. 
vl Patients’ compliance and cost effectiveness of oral 
antibiotic treatment in hospitalized patients with skin and soft 
tissue infections 
U. Frank, P. Schaedlich, J. Brecht, E. Huppertz 
Freiburg, Berlin, Bad Soden, D 
Objective: To investigate the impact of patients’ compliance on cost 
effectiveness of the following oral antimicrobials in the treatment of 
haspitahzed patients with mild to moderate superficial skin and soft tissue 
infections from the perspective of hospitals in Germany: a m o x i c h /  
clavulanic acid 500/125 mg TID (AMC); cefpodoxime proxenl200 mg bid 
(CPD); cefuroxime axeti1500 mg BID. (CXM); ciprofloxacin 500 mg BID. 
(CIP); or roxithromycin 300 mg OD (ROX). 
Methods: An economic model was used to quantify the cost-effectiveness 
ratio (CER), cost per successfdy treated patient of each alternative, based 
on decision-tree technique synthesizing published data, the results of a 
hospital survey and expert knowledge. Costs were exclusively those 
incurred by hospitals. 
Results: There were 3 groups of CERs: E U R O  54 (ROX) with application 
once daily, EURO 99 (XM, CPD, CIP) with application twice daily, and 
EURO 136 (AMC) with application three times daily. The application- 
specific compliance rate had by far the greatest impact on each CER. This 
impact was about 1.5-3-fold of that of the clinical effectiveness and about 
1.9-4.7-fold of that of the acquisition cost per unit of each alternative. In 
the sensitivity analysis, the robusmess of the model was shown in a Monte 
Carlo simulation. After 10 000 computations each, the cost effectiveness 
acceptability curves of the alternatives again showed 3 distinct groups. Once 
daily application (ROX) with the highest compliance rate was most 
favourable followed by twice (CXM, CPD, CIP) and three times (AMC) 
daily application with moderate and low compliance, respectively. 
Conclusions: Patients’ compliance is the most important factor for cost 
effective oral antibiotic treatment in hospitalized patients with s h  and soft 
tissue infections. 
1p4161 Economic consequences of failing initial antibiotic therapy 
in hospitalized patients with serious intra-abdominal infection 
E. J. Dasbach, D. Yin, H. Teppler, G. W. Guides, R .  M. Gesser, B. A. Deyi 
Blue Bell, Whitehouse Station, West Point, USA 
Objective: The objective of this study was to compare the hospital length of 
stay and costs between patients who were or were not cured by initial 
antimicrobial therapy in a multicenter, double blind, randomized clinical 
trial evaluating the safety, tolerability, and efficacy of MK-0826 vs. 
ceftriaxone plus metronidazole in patients with serious complicated intra- 
abdominal infections of mdd-to-moderate severity. 
Methods: All clinical sites in the USA with 5 or more patients were 
requested to provide data on length of stay and total hospital costs 
retrospectively. A cure was defined as resolution of the index infection with 
no signs or symptoms of an mfectious complication having occurred and no 
addtianal antimicrobial therapy required between completion of study 
treatment and the 4-6 week follow-up visit. Regression models were 
estimated for both length of hospital stay and costs adjusting for the 
following covariates: age, gender, APACHE I1 severity score, primary 
diagnosis, primary infection site, and clinical cure status. Given the non- 
n o d t y  of the response variables, we fit the regression models and 
constructed 95% confidence intervals of the difference in means using a 
bootstrap resampling methodology. 
Results: O f  the 220 enrolled in the clinical trial, 126 (57%) patients were 
included in the retrospective data collection. Of those included, 65% were 
cured and 13% were not cured; 22% had missing clinical outconie data. 
Patients who were not cured were more llkely to be more severely d, have 
the colon as the primary infection site, and undergo a sigmoidectomy 
compared to those who were cured. Excluding patients with missing clinical 
outcome data, the mean length of stay and cost for those cured vs. those 
who hiled was 9.5 days and $18 013 (n=81) vs. 14.8 days and $28 798 
(n  = 16), respectively. The least-square mean differences in length of stay 
and cost were -5.3 days (95% CI: -9.8,-2.6) and -$I0 785 (95% CI: 4 1 9  
225, -$6519). 
Conclusion: Patients whose initial antibiotic therapy was not successful 
uthzed more hospital days and incurred greater costs than patients whose 
initial antibiotic therapy was successful. 
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[p4171 Assessment of whether the guidelines on 
management of pharyngitis in adults are applicable in general 
practice 
D. Peyramond, H. Portier, 1. Boucot, M.  Grappin, A. Boibieux, C.  Pribil 
Lyoti, Dijun, Marly le Roi, F 
Objectives: In order to analyze the impact of the revised therapeutic strategy 
for pharyngitis based on the use of Strep A rapid diagnostic tests (RDT), the 
GRAPH group evaluated whether the SPILF consensus guidelines for the 
treatment of pharyngitis in adults (>25 years) are applicable in general 
practice. This study was camed out using a representative sample of about 
100 general practitioners (GPs) from Bourgogne and Rhone Apes regions. 
Methods: Pragmatic study, of the ‘before-after’ type, aiming to evaluate 
changes in pratices after training. This study was camed out over three 
periods: period I ‘before’ and I11 ‘after’ when information was collected 
about GPs’ practices: period I1 when GPs underwent training which 
included information about the conclusions of the consensus conference and 
training on the use of Strep A RDT. 
Results: Between October 1998 and March 1999, information was 
collected about GPq’ practices in approximately 900 cases of pharyngitis 
in each period (I et 111). After just one training course, RDTs were 
performed in 93% of cases. with a positivity rate of 20.2%. The overall use 
ofantihiotics was reduced by more than 40% (42.6% in period I11 v5. 82.6% 
in period I,  P < 0.001). Furthermore, the analysis of antibiotics 
prescriptions profiles showed that amiuopenicillins were the most fiequent 
antibiotic prescribed while penicillin V war prescribed in less than 5% of 
cases. In terms of economic impact, the mean total cost of the treatment of 
an episode of pharyngitis was, respectively, 154.23Euros and 137Euros in 
period I and 111 (cost difference= 17.23Euros). 
Conclusions: The French current guidelines (SPILF, AFSSAPS) on the 
nianagement of pharyngitis are applicable in general practice and 
appropriately followed. 
/p4181 Telithromycin treatment of CAP is associated with 
lower usage of additional RTI-related antibiotics than high-dose 
amoxycillin in a randomized, double-blind, comparative trial 
J. Chang, J. Stewart, I. Brumpt, D. Conway 
Bridgewater, USA; Quebec, CDN 
The objective of this study was to compare respiratory tract infection 
(RT1)-related addihond antibiotic usage for subjects randomized to receive 
the new ketolide antimicrobial telithromycin (TEL; HMR 3647) or high- 
dose unoxycillin (AMX) for the treatment of mdd or moderate 
community-acquired pneumonia (CAP). In this parallel group, double- 
blind study, 404 adults aged 17 years or older (medan 42.0 years) with mild 
or moderate CAP were randomized to receive TEL 800 mg once daily for 
7-10 days ( t i =  199) or AMX 1000 nig three times daily for 10 days 
(11 = 205). Subjects were evaluated at baseline (Day 1). on-therapy (Days 3- 
S ) ,  end oftherapy (Days 11-13), post-therapy/test ofcure (Day$ 17-21) and 
late post-therapy (Days 31-36). Clinical and bacteriological outcomes were 
assessed at Days 17-21 and Days 31-36. The need for RTI-related 
additional antibiotics during and after treatment was also recorded. Clinical 
cure rates were excellent for patients treated with TEL, and compared well 
with high-dose AMX (94.6% [ n =  1491 vs. 90.1% [ n =  1521, respectively; 
95%CI-2.1-11.1%; per protocol population). Bacteriological outcome also 
favoured the TEL group: satisfactory for 90% (is. 87.5% of AMX-treated 
subjects. A total of 62 subjects in the 2 groups needed additional RTI- 
related antibiotics, either during or after study treatment. This requirement 
was more frequent in the AMX group (18.5% [38/205]) than in TEL- 
treated subjects (12.1% [24/199]). The greatest Werence in KTI-related 
antibiotic usage between the 2 groups was observed during the first 5 
treatment days: in this period twice as many AMX-treated subjects ( n =  16) 
received additional antibiotics compared with TEL-treated subjects (n = 8). 
This trend was also evident on Days 11-15 and Days 16-20. The major 
reasons for adcttional antibiotic usage were clinical failure or unresolved 
symptoms. TEL, given in an 800-mg once-daily regimen, provides a new, 
convenient oral treatment for CAP. It is at least as effective and well 
tolerated as high-dose AMX, with a comparable safety profile. The reduced 
need for supplementary antibiotics in patients receiving TEL, compared 
with those receiving AMX, potentially reduces treatment costs and the need 
for follow-up physician visits, and would be expected to result in cost 
savings in the overall management of CAP. 
w1 Sales of over-the-counter remedies as an early 
warning system for winter bed crises: a pilot study 
G. R. Davies, R. G. Finch 
Nutringham, UK 
Objectives: Winter pressures on acute medical services in the UK are 
increasing. Models are needed to predict demand. Since respiratory 
infections are thought to contribute sigruficantly to this increased workload 
and sales of over-the-counter cold remedies may reflect community activity 
of these infections we compared local acute medical admissions with 
national pharmaceutical and local retail sales. 
Methods: Retrospective analysis of electronic databases provided by 
Nottingham City Hospital NHS Trust, Reckitt Benckiser (national) and 
Boots’ the chemist (local electronic point of sale or EPOS). 
Results: Analysis of eight consecutive winter periods beginning in 1992/93 
showed that the peak in adult acute medical admissions always occurred in a 
10-day period from 29 December to 9 January. There were significantly 
more admissions at peak in 1996-99 as compared with 1992-95 (D < 0.01). 
Pharmaceutical and retail data were avadable for the winter periods 1998/9 
and 199/2000 only, neither of whch coincided with increased influenza 
activity nationally. Acute respiratory illnesses as defined by ICD-10 
discharge codmg did not contribute significantly to the increase in 
admissions at peak. Both National and local EPOS sales were positively 
correlated with admissions but the sales peak occurred 1 week after the peak 
in admissions in 1998/99 and 1 week before in 1999/2000. The rate of 
change of EPOS sales exceeded a threshold of 1000 units per week 2 weeks 
prior to peak admissions in both years. 
Conclusions: We did not confirm a strong relationship between acute 
respiratory illness and hospital admissions over the winter petiod in this study. 
Adnussiom are increasing and expected within a de6ned period of only 10 days 
each year. Local EPOS data may give up to two weeks warning of the peak in 
admissions and we are prospectively evaluating its usefulness a$ an early warning 
system for increased hospital activity over future winter periods. 
1-1 Cost of re-hospitalizations for Gram-positive infections 
among patients treated with intravenous vancomycin: an 
insurer’s perspective 
Y .  Carmeli, E. Mozaffari, J. R. Hendrickson 
Bostua, Kalamazoo, USA 
Objective: Hospital treated Gram-positive infections may require a 
continuation of home antibiotic after discharge. Often, given susceptibihty 
profile, intravenous (IV) vancomycin therapy is chosen. To better 
understand the expenditures incurred to an insurer, we measured the costs 
associated with this treatment and with re-hospitalization following the 
treatment 
Methods: We conducted a retrospective cohort study using a population- 
based claims database from a New England insurer. The insurer reimbursed 
claims to treat Gram-positive infections that occurred between January 1998 
and April 2000. We restricted our analysis to patients who were hospitalized 
with a diagnosis of Gram-positive infection (the major diagnoses were 
cellditis and septicemia) and later received IV vancomycin in the homecare 
setting. We measured the fiequency and reimbursement cost of re- 
hospitalization for Gram-positive infection during the 60-day period 
following patients’ initial hospital discharge. Costs were standardized to 
year 2000 dollars using the Consumer Price Index. 
Results: We identfied 94 patients that were hospitalized with a Gram- 
positive infection and were treated immediately after ctscharge with IV 
vancomycin in the homecare setting. 95% of the cohort were 20-64-year- 
old. The insurer reimbursed $188 000 for IV vancomycin administered in 
the homecare setting (mean = $2000). During the 60-day period following 
their initial hospital discharge, 10 patients (11%) experienced a t  least one re- 
hospitalization for a primary diagnosis of Gram-positive infection, which 
had a mean cost=$26 553; 95% CI ($3804 to $49 301). Three patients 
experienced a second re-hospitalization at an additlonal cost. The total 
reimbursement for re-hospitalizations for a Gram-positive infection (10 
patients, 13 admissions) was $306 000. Thus, an insurer could expect to 
reimburse an average of $5255 for treating the Gram-positive infections, 
$2000 related to homecare antibiotics and $3255 related to re-hospitalization. 
Conclusions: Patients hospitalized with Gram-positive infections that are 
treated with home IV vancomycin represent a population for which lugh 
expenditure should be expected. This high expenditure is related to both 
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high homecare treatment costs, and costs related to re-hospitalization. 
Strategies to reduce these costs should be directed at reducing the cost and 
coniplexity of homecare antibiotic treatment, and to prevent the need for 
re-haspitahtion. 
Ip421/ Biliary infectionHost-effectiveness analysis of 
ceftriaxone vs. standard antibiotic therapy 
T Zoepf, K Kullmann, R Jakobs, J. hemann 
Luduagshafn, Grenzad-  Wyhlen, D 
Objective: Ceftnaxone (RoLephin) gwen once daily is known to be witable 
for the treatment of bdiary tract infections The aim of ths  prospective 
multicenter observational study was to compare ceftnaxone 1 g once daily 
vs ‘standard therapy’ (a second-generation cephalocponn or broad- 
spectrum penicillin or anunopenicillm with a p-lactamase mhlbitor) gwen 
twice or three umes daily according to the chfferent pharniacokmeticc of 
these antibiohcs End points of the study were chnical efficacy, tolerance 
and economy in the treatment of blliary tract infections 
Methods: 902 adult patients of 75 centers with chnicdy apparent blliary 
tract infection requinng intravenous antibiotic therapy were treated either 
with ceftnaxone, or wth a standard therapy customary for the chfferent Lenten 
Ceftnaxone was used in 80% of the pahents as 1 g dady dose The patient data 
were subjected to matched-pars-analysis accordmg to the followmg 6 dfferent 
nsk cntena Male/female, stone &?ease/m&gnant dsease, obmuchve 
cholangm, cholecyshhs wthout chohgihs, endoscoopic intervenhon, first 
nidestahon of Mary tract infechon/recurrent idecnon M a t c h g  redted m 
173 p a n  u t h  a comparable nsk and interveiihod profile 
Results: The results are shown in the table 
Conclusions: Treatment with ceftnaxone 1 g once daily was as effective as 
standard therapy in bdiary tract infection. Because of a lower need for 
Loncomtant antibiotics, a shorter durahon of therapy with Ceftriaxone and 
lower cost for adrmmstration cefmaxone showed almost a 50%) cost 
reduction compared to standard therapy 
Resource use and cost of care for patients hospitalized 
with community-acquired pneumonia in France 
E. Van Ganse, D. Yin, C. Brambilla, P. Souquet, E. Alemao, F. Gormand, 
H. My, G. Pietri 
Lyon, F; Whitehouse Station, USA; Grenoble, F; Pisrutawuy, USA 
Objectives: Parenteral antibiotics are often used empirically to treat 
haspitahzed community-acquired pneumonia (CAP) patients before 
pathogens are identified. Change of initial therapy occurs often for various 
reasons. This study aims to estimate resource use and cost of care and to 
determine the effect of changing the initial empirical therapy on resource 
use and costs. 
Methods: Retrospective study was conducted in 7 hospitals from the 
Rhone-Alpes region (France), Adult patients hospitalized for CAP between 
January 1996 and June 2000 were identified from computerized patient 
records using ICD-10 codes. Medical records were reviewed to confirm 
diagnosis and to collect clinical and resource use information. Propensity 
score methods were used to adjust for baseline differences between patients 
who did and did not require a change of empirical therapy. Nonparametric 
test was used to determine statistical significant difference in length of stay 
(LOS) and cost. 
Results: 387 patients were enrolled. Mean age was 63.8 k 19.1 (range 18- 
102); 63.1% were male, 42.9% ofpatients were classified into Fine severity 
classes IV and V (Fine el al. NEJA4 1997). Pathogens were identified in 71 
(18%) of the patients; most common pathogens within 48 h were S. 
Pneumoniae (52%), Haemophilus species (12%), and Escherichia o l i  (10.6%). 
Most frequently used empiric parented antibiotics were anioxicillin/ 
clavulanate IV (30.5%), amoxicillin IV (1 7.8%) and ceftriaxone (17.6%). 
Mean number of antibiotic days and LOS were 6.0 f 4.2 and 10.6 f 6.5 
days, respectively. Average cost of antibiotics and hospitalization were EUK 
89 and EUK 3858 per patient. Ninety-three (24.0%) patients switched 
empirical antibiotic to another parented antibiotic or added other 
parented antibiotics. Compared with patients who did not change 
empirical therapy, patients requiring a change had more antibiotic days (5 
us. 7, P < 0.001), longer LOS (9 us. 11, P < 0.001) and higher costs of 
antibiotic (EUR 34 us. EUR 98, P < 0.001) and hospitalization (EUR 
3275 M. EUR 4003, P < 0.001). Differences in antibiotic days, LOS, and 
costs of antibiotics and hospitalization remained statistically significant after 
adjusting for age, Fine score, and comorbid conditions. 
Conclusions: Average costs ofantibiotics and hospitalization were EUR 89 and 
EUR 3,858, repectively, in the haspitahzed CAP patients. Change of empiric 
therapy was associated with more antibiotic days, longer LOS and higher COSR 
lp423 Cost and outcomes of care for patients hospitalized 
with community-acquired pneumonia in Northern Italy 
F. de Lalla, A. Traniarin, D. Yin 
Wcenza, I ;  Whitehouse Station, USA 
Objectives: To estimate the direct medical costs of care for hospitalized 
patients with communityacquired pneumonia (CAP) and to assess the rate 
of cure and time to defervescence in these pahents. 
Methods: A prospective observational study was conducted in 5 acute 
hospitals in Northem Italy. Adult patients hospitalized for CAP between 
January and August 2000 were enrolled. Excluded were patients with 
nosocomal pneumonia, fungal infection, and neutropenia. Clinical 
evaluation was done on day 3 and at discharge. Clinical outconies at 
discharge were assessed as cure (complete resolution of all acute signs and 
symptoms and resolution or improvement of chest X-ray results), 
improvement (significant but incomplete resolution of signs and symptoms 
and improvement of X-ray results) and fdure  (persistence or progression of 
sign., and symptoms, or development of new clinical findings consistent with 
active infection, or death due to infection). The following direct medical 
costs were assessed from the hospital perspective: antibiottc acquisition and 
administration (including materials and nursing time estimated by tinie- 
motion methods), laboratory and radiological procedures and hospitalization. 
Results: 175 patients were enrolled in the study. Mean age was 65.0 + 20.5 
years: 43.4% were female. The percent of positive cultures isolated from 
sputum, blood and pleural fluids were 83% (78 of 94 culture collected), 14% 
(8/57) and 67% (2/3), respectively. Most common pathogens were S. 
pneumoniae (59 isolates) and H. injuenzae (21 isolates). The average number 
ofantibiotic days and length ofstay were 7.4 k 5.0 and 12.7 k 5.7 days. At 
discharge, 128 (73.1%) patients were cured, 41 (23.4%) had improvement 
and 5 (2.9%) failed (one patient had unknown outcome). Average time to 
defervescence was 2.9 f 1.8 days. For each i.v. infusion, the average costs of 
materials and nursing time estimated by time-motion studies were EUK 
0.84 and EUR 4.21, respectively. For each hospitalization, the estimated per 
patient costs of antibiotic acquisition, administration, laboratory and 
radiology exammations, and hospitalization were EUR 185.4 f 199.3, 
EUR 93.7 & 87.3, EUR 204.59, EUK 3788.3 k 1710.7, respectively. 
Conclusion: Hospitalized CAP patients were estimated to stay in hospital for 
12.7 days in Northern Italy and cost E U R  3788.3 per hospitalization. 
Antibiotic acquisition and administration costs represent about 4.8% and 
2.5% of the hospitalization cost. 
1 Economic evaluation of linezolid for the treatment of 
cellulitis in the USA decision-modelling results 
A. G. Vinken, 2. Li, B. E. Rittenhouse, R. J .  Wilke, M. den Hartog, C .  
Goodnlan 
Hoofddoq, NL; Kalamazoo, Peapack, Falls Church, USA 
Introduction: Standard care treatment of infections has become more 
difficult and costly due to treatment failure associated with rising bacterial 
resistance. This makes new antibiotics, effective against resistant pathogens, 
potentially cost saving. Using decision-modelling techniques we compare 
the costs of treatment of cellulitis among hospitalized patients initiated with 
linezolid, a new antibiotic effective for susceptible and resistant Gram- 
positive bacterial infections, with oxacdlin and vancomycin, current 
standard care treatments for cellulitis. 
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Methods: The model employs the appropriate use principle for antibiotic 
treatment, which allows the initial treatment (one of linezolid, oxacillin, or 
vancomycin) to be switched or continued based on the culture and sensitivity 
test (C & S) results (see Table). When treatment fails, patients are switched to a 
2nd line therapy. E5cacy, length of antibiotic treatment, and length of stay 
(LOS) data were obtained from the hezolid clinical trials, other medical 
resource utilization (MRU) was obtained from an expert panel ( n =  10) of 
chcians for resistant and susceptihle infections separately. We ako surveyed 14 
infectious disease expexts on the level of inconclusive C 81 S results normally 
seen in cellulitis (80%). Direct medical costs of treatment have been determined 
&om the US hospital perspective using standard costing techques. 
Results: Treatment initiated on linezolid is less expensive than treatment 
initiated on vancomycin when the inconclusive pathogen rate is 60% or 
hgher, mainly due to the shorter LOS associated with Linezolid. Treatment 
initiated on linezolid becomes cost-saving compared to treatment initiated 
on oxacillin as resistance risk increases. At an 80% inconclusive pathogen 
rate, the costs of the two treatments break even at $6264 when the resistance 
risk is 17.1%, a level relevant for many individual patients and commonly seen 
in US hospitals. Prospective data will be needed to confirm these findings. 
lp4251 Efficacy and cost analysis for the treatment of secondary 
peritonitis-comparison of ceftriaxone vs. standard therapy 
U. Mittelkotter, F. Endter, H. Thielemann, R. Schmitz, P. Ihle, K. H 
Kullmann 
Wiirzburg, Berlin, Bergisch- Gladbach, Nordhausen, Grenrach- Wyhlen, D 
Objectives: Various classes of antibiotics including cephalosporins and broad 
spectrum penicillins in combination with metronidazole are suitable for 
PharrnacokineticdPharmacodynamics 
treatment of secondary peritonitis, The aim of this prospective multicenter 
observational study was to compare ceftriaxone (CRO) once daily in 
combination with metronidazole vs. ‘standard regimen 1 (SRI) (mezlo- 
cillin, piperacan, ampicillin/sulbactam, amoxycillin/clavulanic acid, cefo- 
tiam, cefazolin + metronidazole) and standard regimen 2 (SR2) 
(piperacillin/tazobactam, imipenem, meropenem) b i d .  or t.i.d. in the 
treatment of secondary peritonitis. Endpoints of the study were clinical and 
bacteriological efficacy, duration of hospitalization and treatment costs. 
Methods: A total of 357 patients in 59 sites were treated with either CRO 
(230 patients), SRl  or SR2 (127 patients). The patient data were subjected 
to matched-pairs-analysis according to 4 different catagories of ‘Mannhei- 
mer peritonitis index’. Matching resulted in homogenous pairs with respect 
to demographic data, surgical procedures and risk factors. 81 pairs were 
treated with CRO/SRl ,  46 with CRO/SR2, 103 patients could not be 
matched. Clinical efficacy was defined as abdomen cleaned up and infection 
cured with no change of the primary antibiotic treatment. Treatment costs 
included acquisition cost for primary and secondary antibiotics and 
application costs (workload). 
Results: The results are shown in the tablr. 
C R O  SRl CRO SR2 
A‘=81 .“81 N = 4 6  N=46 
Clinical efficacy (“9) 91.3 72.2 90.0 88.4 
Treatment cost (EUR) 592 538 465 734 
Dayq in intentive care unit 5.9 7.0 3.5 6.0 
Days in normal ward 11.3 11.8 12.5 12.6 
Microb. response (“9) XY.4 71.7 87.5 86.2 
Hospital allowance (EUR) 8715 9835 6Yi14 8286 
Conclusion: These results show that ceftriaxone was more effective compared 
to SR1 in the treatment of secondary peritonitis (P= 0004). But there was no 
difference in the c h i d  and microbiological outcome between cefinaxone and 
SR2. In terms of treatment costs ceftriaxone resulted in cost savings of 36.6% 
compared to SR2. Due to shorter stay in intensive care units and normal wards, 
there was also a tendency towards lower costs for the insurance companies. 
Ceftriaxone in combination with mehonidzole can be recommended as first 
line antimicrobial treatment of secondary peritonitis 
lp4261 Angioplasty increases target site concentrations of 
ciprofloxacin in patients with peripheral arterial occlusive 
disease of the lower limbs 
C. Joukhadar, E. Minar, N. Klein, H.  Stass, M. Hermann, M.  Muller 
Vienna, AT; Wuppertal, D 
Objective: Patients with peripheral arterial occlusive disease (PAOD) are 
prone to acute and chronic soft tissue infections, which are frequently 
treated with fluoroquinolones, such as ciprofloxacin. Current therapy 
guidelines do also recommend to optimize micro- and macro-circulatory 
blood now in the affected extremity in these patients. To date, however, it 
is still unclear whether an increase of blood flow affects antimicrobial drug 
concentrations at the site of inflammation. 
Patients and methods: Therefore, the present study aimed at investigating 
the influence of blood flow on interstitial ciprofloxacin concentrations in 
inflamed and healthy adipose tissue following a single intravenous infusion 
of 400 mg in 10 patients suffering from PAOD of the lower limbs. AU 
patients were scheduled to undergo invasive revascularization. Assessment of 
ciprofloxacin pharmacokinetics and measurements of arterial mean blood 
flow velocity were performed within 72 h before and after percutaneouq 
transluininal mgioplasty (PTA). ZIT vivo microdialysis was employed for the 
measurement of free, pharmacologically active drug concentrations at the 
relevant target site of infection, i.e. the interstitial space fluid of soft tissues. 
One microdialysis probe was inserted distal from the arterial stenosis into 
inflamed soft tissue and the second probe was inserted proximal from the 
stenosis into healthy adipose tissue. 
Results: Revascularization process did significantly increase arterial mean 
blood flow velocity as compared to baseline ( P  < 0.05). Before PTA, mean 
ciprofloxacin concentrations measured in inflamed tissues were significantly 
lower than compared to healthy adipose reference tissues ( P =  0.038). 
How-ever, following PTA this significant difference was not apparent as the 
time M. concentrations profiles were identical in inflamed and healthy 
adipose tissue (see Figure 1). 
Conclusion: We have shown that PTA increases mterstitial concentrations 
of ciprofloxacin in inflamed foot lesions in patients with PAOD. The results 
of the present study thus corroborate the view that blood flow is an 
important determinant for the penetration of ciprofloxacin and probably 
also for other fluoroquinolones into peripheral tissues. An increase in 
interstitial ciprofloxacin concentrations might have implications on 
microbiological and clinical outcome in these patients. 
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thiazolyl) (1 -carboy-I -methyletoxy)imino]acetyl-ethanal and pyridine 
(arising fiom the opening of the beta-lactam ring), and of the delta-2 
isomer of ceftazidime. Studies mimicking the simultaneous administration 
of ceftazidime and other drugs in a Y-shaped infusion device and using the 
practical conditions of their potential administration in clinics showed 
incompatibihties with vancomycin, nicardipine (a Ca2+ channel blocker), 
midazolam (a benzodiazepine), propofol (a general anaesthetic) and N- 
acetylcystein (a glutahone replenisher). Concentrated solutions (50 mg/ 
d) of erythromycin and clarithromycin caused the formation of a 
precipitate not seen with 5-fold more diluted preparations. Aminoglycosides 
(gentamicin, tobramycin, amikacin, and isepamcin), fluconazole, two 
general anaesthetics (ketamine and sufentanil), valproic acid (an antic- 
onvulsivant), hrosemide (a loop diuretic), uradipil (an alpha 1-adrenergic 
antagonist), and a standard aminoacid solution were found compatible. 
Thus, the present data may be used to validate the potential use of ceftazidime 
by continuous infusion at the pharmaceutical point of view and in the 
perspective of its application in patients hospitalized in Intensive Care Units. 
J ,  
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lp4271 Experimental and conformational analysis of the 
interactions between the antifungal butenafine and lipids 
M.-P. Mingeot-Leclercq, X. Gallet, F. Van Bambeke, C. Flore, J. Peuvot, 
K. Brasseur 
Brussels, Gembloux, B 
Butemhe (W4-tert-butylbenzyl-N-methyl-l-naphtalenemethyhe hydro- 
chloride) is an antifungal agent of the class of benzylamine derivatives. It has 
an excellent therapeutic efficacy and provides a remarkable long-tmie effect. 
In the present study, we investigate if these properties could be explained by 
an interaction of the drug with membrane lipids. For this, we calculated the 
conformation of neutral and protonated forms of butenafine in interaction 
with three monolayers of phospholipids (POPC [phtoyloleoylpho- 
sphatidylcholine], DPPC [dipalmitoylphosphatidylcholine] and DPPE 
[dipalmitoylphosphatidylethanolamine]) by computer-aided analysis. We 
also studied the effect of butenafine on membrane fluidity and permeability 
using liposomes made of cholesterol, phosphatidylcholine, sphingomyelin 
and phosphatidylinositol. The computer-aided conformational analysis 
showed that the neutral form of butenafine and the S enantiomer of the 
protonated form have globular structure and were folded in such way that 
aromatic Lycles were piled up in order to create a resonance effect between 
their electronic clouds. The distance between the aromatic cycles (approxi- 
mately 0.37 nm) is sufficient for creating a pouch favourable to ion binding 
(ionic diameter of potassium: 0.265 nni), suggesting that butemfine could 
induce the release of this cation &om hngal cells. In contrast, the enantiomer R 
displayed a flatter conformation in which the aromatic groups were almost in 
the same plane. The hydrophobic nature of the molecule also appeared clearly 
in these computer-aided analyses, the aromatic cycles being clustered into the 
hydrophobic phase whde the nitrogen atom being at the intehce. In parallel, 
we demonstrated that butenafine induces an increase in membrane fluidity of 
the acyl chains close to the hydrophilic/hydrophobic interface and deeper into 
the hydrophobic domain (assessed by measuring the fluorescence polarization of 
trimethylammoninm-diphenylhexatriene and diphenylhexaniene, respectively) 
as well as a fast and marked release of calcein, a fluorescent probe entrapped in 
liposomes. These results may represent an appropriate set of background data 
explaining key features of butenafine interactions with phospholipids 
shedding new light on the antifungal activity and unusual pharmacokinetic 
properties of this agent. 
(p4281 Stability and compatibility study of ceftazidime for 
administration by continuous infusion in intensive care patients 
H. Servais, P. M. Tulkens 
Brussels, B 
The stability and compatibility of ceftazidime has been examined in the 
context of its potential use in concentrated solutions for continuous infusion 
in patients suffering fiom severe nosocomial pneumonia and receiving other 
intravenous medications by the same route. Ceftazidime stability in 4 1 2 %  
solutions was found satisfactory (less than 10% degradation) for 24 h if kept 
at a temperature of 25 "C (77 O F )  maximum. Higher temperatures caused 
significant antibiotic breakdown with the liberation of [(2-amino-4- 
v1 Loading dose concept and use of metoclopramide 
premedication to reduce time to therapeutic drug levels with 
oral itraconazole 
M. Haack, A. Jenke, G. Ehninger, U. S. Schuler 
Dresden, D 
With the usual dosage oral administration of itraconazole (ITRA) has been 
shown to achieve therapeutic levels only after several days of treatment. 
Using the oral liquid formulation the concept of a loading dose (with 
4 x 200 mg for 2 days) was combined with the use of metoclopramide to 
enhance absorption. This was followed by a dosage of 2 x 200 mg per day. 
Patients with AML (n = 9) or NHL (n = 1) and need for a prophylactic 
antimycotic were eligible. Metoclopramide was administered in a dose of 12 
mg approximately 15 min before ITRA oral solution. Patients were not 
restrained &om eating during the study period. ITRA and hydroxy- 
itraconazole (HO-ITRA) was determined using a HPLC method. Samples 
were taken at 0, 14, 24, 38, 48, 62, 72, 86 and 96 h. The predetermined target 
concentration of >500 ng/mL was achieved in 9/10 patients after 6 doses. 
Only one female patient showed delayed absorption and reached 654 ng/mL 
only after >96 h. Steady state was reached in most patients after 48 h with 
trough levels around 800 ng/mL. CHO-ITRA levels were in the same range 
These results show, that with a loading dose of 4 x 200 mg for 2 days given 
immediately after oral metoclopramide, therapeutic drug levels are achievable in 
the majority of patients. This is an approach, which is not only important for 
antihngal prophylaxis, but might also be useful for situations of empirical 
treatment. In a patient without prophylaxis, the initiation during the first 
days of fever will produce therapeutic levels well within the time range 
usually considered necessary for the empirical antifungal treatment. 
A new method to determine the postantibiotic effect 
index 
H. K. Geiss, S. Dilger 
Heidelberg, D 
Introduction: The PAE is defined as the delay of growth of bacteria after a 
limited period of exposure to an antibiotic after which the effect of the 
antibiotic is removed. The PAE index is the time needed for the cell count 
to increase by a factor of 1 log after the removal of the antibiotic in 
comparison with an untreated control culture. 
Methods: Three different antibiotics (levofloxacin, moxitloxacm, and 
trovafloxacin) were tested. Test strains included 3 different H. influenzae, 
M .  catarrhnlis, S. pneumoniae and reference strains of E. mli (DSM 11250). S. 
aureus (ATCCC 5628), P .  intermedia (DSM 20706) and B. -fiagiZis (ATCC 
25285). After determining the individual MIC values, all strains were 
exposed to the 0.25-, 0.5-, 1-, 2-, 4- and 8-fold MIC concentration for 120 
nlin in a shakmg water bath at 37 "C. Antibiotics were removed by 
centnfugation (3500 rev/min for 10 min) and resuspending the bacterial 
pellet in antibiotic fiee nutrient broth. 100 pL of the bacterial suspension 
were added to an aerobic or anaerobic BACTEC blood culture bottle (BD 
Biosciences, Heidelberg, Germany) and incubated in the BACTEC 9120 
system. The BACTEC automated blood culture system determines bacterial 
growth by measuring the increase of fluorescence activity, concentration of 
C 0 2  and pressure and indicates the transition to exponential growth in the 
culture bottle. Therefore, calculation of the PAE index is possible by 
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subtracting the time when exponential growth of the antibiotic-exposed test 
strain is signalled from that of the untreated control strain. Controls included 
coiivenhonal cell counts &om the same inocula every 30 min for up to 8 h. 
Results: The comparison of the automated and conventional PAE indices 
were almost identical with differences of maximally 10 min. However, the 
intertest stabihty of the PAE values was greater with the new method, 
which was especially true with strains exhibiting a very long (> 200 min) 
PAE. All three antibiotics showed significant PAE indices with highest 
values for Bademides and Prevutella (4 x MIC: 700 and 1850 min, 
respectively), while the values for Haemuphilus (4 x MIC: 80-250 min), 
Moraxefla (1 x MIC: 2S170 nlln), and pneumococci (4 X MIC: 65-87 min) 
varied wdely depending on the strain tested. 
Conclusions: The advantages of this new automated method for testing the 
PAE index are: significant work load reduction; lower intertest variability; 
reliable testing of anaerobes; exact deternination of the PAE indices, even 
of values exceeding 4-6 h. 
distributed within the lower respiratory tract; sustained concentrations of 
the drug were detectable at the last sampling time (1 56 h) in lung tissue and 
bronchial washing, with levels of 2.52 f 0.54 mg/kg and 0.17 f 0.06 mg/ 
L at 500 mg daily and 3.52 f 0.19 mg/kg and 0.39 0.16 mg/L at 1000 
mg daily, respectively. The ratio of the area under the concentration-time 
curve (AUC) in lung tissue us. plasma AUC and bronchial washing AUC us. 
plasma AUC increased from 90.9 to 122.5 and 7.03-26.1 at 500 and 1000 
mg, respectively. In conclusion, the present results indicate that enhanced 
lung tissue exposure may be obtained with the administration of 
azithromycin for 3 days at 1000 mg with respect to 500 mg. In particular, 
the antibiotic transfer into bronchial secretion is increased at the higher dose 
administered, suggesting that the saturation of tissue reservoirs at 1000 mg is 
associated with enhanced drug accumulation into the bronchial fluid. This 
finding is of particular importance if one considers that bacterial growth 
occurs not only at the tissue level but also along the airways within the 
bronchial secretion. Therefore, the present study provides the pharmaco- 
kinetic evidence that an enhanced cure rate of respiratory infections may be 
achieved by increasing the dose of azithromycin 
I P431 I Pharmacokinetics of teicoplanin in patients 
undergoing chronic haemodialysis 
M. Papaioannou, M. Pappas, Ch. Stathakis, H. Giamarellou 
Maroussi Arrikis, GR 
Objective: To define the phamlacokinetics of teicoplanin (T) in patients 
with chronic renal failure (CKF) under CH, smce infections by resistant Gram- 
positive cocci against which T IS active are fiequent in the field of CKF. 
Methods: T was administered intravenously in five patients with CKF at 
doses of 5 and 10 nig/kg of body weight and blood samples were collected 
at specific time intervals. C H  was started 48 h after the end of the infusion 
and samples were collected both by the arterial (A) and by the venous (V) 
end one, two and four hours after the start of CH. Concentrations of T 
were determined by a nlicrobiologcal assay. 
Results: Mean concentrations of T just after, 2,24, 48,72 and 96 h after the 
end ofthe infusion ofthe 5 mg/kg dose were 56.22, 15.11, 4.40,4.17, 4.13 
and 3.34 nig/L, respectively, and after the end of the infusion of the 10 mg/ 
kg dose were 97.29, 35.36, 10.17, 6.39, 5.07 and 3.49 mg/L, respectively. 
Respective mean t1/2 and AUC of the 5 ing/kg dose were 01.37 hours and 
10.72 mg/L x h and of the 10 mg/kg dose 1.06 h and 578.02 mg/L X h. 
Concentrations of T after the dose of 5 mg/kg 1, 2 and 4 h on C H  at the A 
end were 3.86 f 1.72, 3.82 f 1.15 and 3.52 f 1.36 mg/L, respectively, 
and at the V end 3.74 f 1.13, 3.59 f 1.32 and 3.43 k 1.29 mg/L, 
respectively. Concentrations of T after the dose of 10 mg/kg 1 , 2  and 4 h on 
C H  at the A end were 6.00 f 1.41, 6.20 f 2.03 and 5.65 k 1.68 mg/L, 
respectively, and at the V end 5.40 f 1.67, 6.00 f 2.29 and 7.22 + 4.26 
nig/L, respectively. 
Conclusions: (a) Ahnistrat ion of T at an either dose of 5 or 10 mg/kg in 
patients with CRF results for more than 72 h at blood levels well above the 
MICs for resistant infective COCCI (b) C H  does not affect significantly the 
bioavailabiliry of T so that T should be administered each 96 h in patients 
with CRF under CH. 
v1 Lung tissue penetration and plasma pharmacokinetics of 
azithromycin after multiple oral doses of 500 and lo00 mg in adults 
R. Danesi, T. Malizia, C. Barbara, S. Fogli, A. Chella, C. A. Angeletti, M. 
Del Tacca, S.  Senesi, M. Campa 
Pisa, I 
Azithromycin is a semisynthetic azalide with expanded antinllcrobial 
spectrum as compared to erythromycin, including pathogens involved in 
respiratory tract infections. The pharniacokinetics of azithromycin is 
characterized by extensive intracellular uptake, with high tissue-to-plasma 
concentration ratios. Although clinical mals have demonstrated the efficacy 
of azithromycin 500 mg daily for 3 days in the treatment of respiratory tract 
infections, the emergence of resistant strains opens the question whether 
increasing the drug dose may result in enhanced tissue uptake and improved 
antibacterial efficacy. The present study was designed to compare the 
distribution of azithromycin in plasma, lung tissue and bronchial washing 
after oral administratian of 500 mg (standard dose) vs. 1000 mg dady for 3 
days. Samples of lung tissue and bronchial washing were collected during 
surgery a t  6, 12, 60, 108 and 156 h after the last dose, while blood samples 
were obtained before the first dose and 1, 4, 6, 12, 24, 48, 60, 72, 96, 108, 
120 and 156 h after the last dose of azithromycin; drug levels were analyzed 
by both microbiologrcal and HPLC assays. Azithromycin was widely 
Tonsillar tissue penetration and plasma 
pharmacokinetics of azithromycin after multiple oral doses of 10 
and 20 rng/kg in paediatric patients 
T. Malizia, C. Blandizzi, P. Bmschini. F. Baschiera, M. Del Tacca, M 
Campa, S. Senesi 
Azithromycin is a macrolide antibiotic currently employed in the treatment 
of paediatric infections of the upper respiratory tract, including pharyngitis, 
tonsdlitis and otitis media. Children with acute bacterial pharyngitis or 
tonsilhis treated with azithromycin 10 mg/kg daily for 3 days display 
clinical cure rates above 90%, although a recurrence of streptococcal 
infections has been reported in a variable number of cases, indicating a lower 
eradication rate of the pathogen involved. Since the efficacy of antibiotic 
therapy can be improved by increasing drug exposure of target tissues, the 
present study has been designed to compare azithromycin concentrations in 
specimens of tonsillar tissue and plasma obtained from paediatric patients 
treated with the macrolide at the dose of 10 mg/kg (standard dose) or 20 
mg/kg by oral route daily for 3 days. Five patients per dose level and time 
point were enrolled in a pharmacokinetic study that was approved by the 
Ethics Committee of Pisa University Hospital. Blood and tonsil samples 
were collected during surgical resection oftonsils at various time points (0.5, 
2.5, 4.5, 6.5 and 8.5 days) after the last drug dose. Plasma azithromycin 
levels were determined by both reverse-phase high performance liquld 
chromatography (HPLC) and microbiological assay using Micrococcus 
luteus NCTC 8440. Drug plasma levels 12 and 60 h after the last dose of 10 
us. 20 mg/kg were 0.26 f 0.03 us. 0.30 k 0.04 nig/L, and 0.19 L- 0.05 us. 
0.23 f 0.09 mg/L (microbiological assay). Sindar results were obtained by 
HPLC assay. Tonsillar concentrations after 12 h were 11.7 + 2.4 us. 
15.7 f 2.6 mg/kg (microbiological assay) and 8.8 + 1.6 us, 11.4 f 1.9 mg/ 
kg (HPLC assay). Tissue levels at 60 h were 13.3 f 2.9 us. 18.9 3.8 mg/ 
kg (microbiological assay) and 9.4 2.5 vs. 12.8 f 1.7 mg/kg (HPLC 
assay). Azithromycin concentrations in tonsil samples were significantly 
higher after administration of the 20 mg/kg regimen, the increment 
reaching up to 91.6% depending on the assay method employed, with 
respect to 10 mg/kg. In conclusion, this study indicates that a more 
favorable tissue penetration of azithromycin can be obtained when ths  
antibiotic is administered for 3 days at doses higher than 10 mg/kg daily. 
Furthermore, the present findings provide evidence that the increment in 
drug dose might result in improved eradication rate after treatment of upper 
respiratory tract infections in paediatnc patients. 
P i S A ,  I 
v) Oritavancin (LY333328): a dose-escalation safety and 
pharmacokinetics study in patients 
D. K. Braun, J. K. Chien, D. S. Farlow, D. L. Phillips, M. W. Wasilewski, 
M. L. Zeckel 
Indianapolis, USA 
Background Oritavancin is an investigational glycopeptide with bacter- 
icidal activity against gram-positive pathogens, including resistant strains. 
Methods: T h s  was an open-label pharmacokinetic (PK) and safety study of 
seven intravenous dosing regimens in patients (pts). Liquid chromatogra- 
phy/niass spectrophotometry was used to assay plasma samples from 29 pts. 
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PK estimates were obtained fiom all plasma concentration data fitted to a 
two-compartment model using population PK techniques. 
Results: Significant variabihty in Cmax and AUC (approximately 30%) 
were observed, but PK appeared linear with dose. Mean plasma clearance 
was 0.469 L/ h, steady-state volume of distribution was 96.6 L, and terminal 
half-life ranged between 156 and 304 h. 
Table 1 Pharmacokinetic Parameten bv Dosine Crouos 
972 S Z 9  789 I 6 7 1  739 I 8 7 5  596 793 616 
ti12 (h) 
Oritavancin CL V C  Vn  AUC24* ~ 
(Wk) N (L/ 11) (L) (L) pg h/mL N !3 
1.5 for 7 d 4 0.545 7.31 95.9 71.8 7.29 1Y2 
2.0 for 7 d 5 0.492 7.49 Y6.l 143 3.49 209 
3.0 for I d 4 (1.428 7.83 96.4 211 3.73 223 
3.0 for 3 d 4 0.566 9.52 98.1 175 4 I6 182 
3.0 for 7 d 4 0.404 8.61 97.2 I80 4.13 233 
6 0 for 1 d 4 0.442 8.07 96.6 375 3.84 220 
9.0 for 1 d 1 0.538 8.34 96.9 465 3.72 186 
*Predicted AUC24. 
Phlebitis (5 pts), headache (l), vaginitis (l), asthenia (I), diarrhea (l), 
hemorrhage (hematoma; I) ,  and red-neck syndrome, vasodilatation, and 
sweating (in 1 pt) were reported as adverse events possibly related to 
oritavancin. Reversible elevations in ALT and AST were noted. 
Conclusions: Oritavancin was well tolerated. PK was linear. 
I p435 I Pharmacodynamic approach for ceftazidirne treatment 
of acute exacerbation of chronic bronchitis 
S .  Lueck, M. Rau, A. Lubasch, M. Vogelbusch, S .  Wagner, H. Lode 
Berlin, D 
Background: Antibiotic pharmacodynamics is an evolving science that 
attenipts to study the interaction between bacteria and changing 
concentration of antibiotics. Parameters that link antibiotic phamiacokinetic 
parameters such as AUC peak antibiotic conc. with the bacterial MIC can 
be identified to predict the clinical and microbiological outcome. 
Methods: In a prospective multicenter randomized study two dosages of 
CTZ 3 x 2.0 g i.v./30 min (s.i.) vs. 2 x 2.0 g infusion/7 h (c-i.) per day were 
compared in the treatment of 80 patients AECB. 
Results: 21 (10 c.i., 11 s.i.) patients (19 m, 2 f., age 65, 1 f 10 years) in our 
institution had a complete serum kinetic program at baseline, in the middle and 
the end of the treatment period. Serum conc. were determined by bioassay (test 
train: E. roli ATCC 25922, C V  3.0). 16 pathogens (4 S. yneurrioriiae, 3 M. 
catorrhalis, 3 S. aureus, 2 H. influerizae, 2 P.  amginosa) were isolated, median 
MIC of strains: 1.65 (range: 0.05-8 mg/L). Median m a .  serum conc. during 
c.i. were 48 (range: 30.2-138.5 mg/L), median trough conc. were 13.9 (range: 
5.2-42.6 mg/L). Median rnax. conc. after s.i. were 161.0 (range: 122-297 mg/ 
L) median trough conc. were 10.5 (range: t1.O-27.7 mg/L). Medlan AUC/ 
24 h with c.i. were 836 (range: 438-1838 mg x h/L), median AUC/24 h for 
3 x 2.0 g s.i. were 1066 (range: 812-1502 mg x h/L). Median AUC divided by 
MIC for c.i. was 507, taking the w e s t  MIC (8.0 mg/L) it was still 105; the 
respective data for s.i. were 646 and 133. The clinical and bacteriological 
outcome in all 21 AECB patients was excellent. 
Conclusions: A modem pharmacodynamic approach in the treatment of 
AECB with CTZ (2 x 2.0 g as continuous infusion) is as effective, safe and 
less expensive than conventional therapy. 
Carbapenems 
)p436 MYSTIC results from Europe: evaluation of antimicrobial 
susceptibility of multidrug resistant Pseudomonas aeruginosa 
H. Goossens and the MYSTIC Study Group 
Edegem-Anfwerp, B 
Objectives: To evaluate the antimicrobial susceptibility of niultidrug 
resistant (MDR) Pseudomonas aeruginosa isolated as part of the MYSTIC 
(Meropmem Yearly Susceptibility Testing Information Collection) Pro- 
gramme in Europe, between 1997 and 2000. 
Methods: A total of 2467 P.  aeruginosa strains were isolated &om 31 centres 
in 10 European countries where meropenem was being prescribed. 
Susceptibility to meropenem and five other antibiotic agents was assessed 
using NCCLS methodology, except for 3 (Belgian) centres that used E-test 
strips (AB Biodisk). 
Results: Among 2467 isolates, 189 (7.7%) MDR strains were identified by 
exhibiting resistance against ceftazidinie (> 32 mg/L), and ciprofloxacin 
(> 4 mg/L) and gentanlicin (> 8 mg/L). Prevalence of MLX strains was 
as follows for the types of centres: ICUs, 9.6% (n=88); neutropenic units, 
9.2% ( n =  18); cystic fibrosis units, 6.7% 0 1 ~ 7 8 ) ;  and general units, 2.5% 
( n  = 5). The prevalence of MDR strains per country vaned between 2.2% 
(Swededone centre) and 41.8% (Turkey/two centres). Percentage 
resistance to meropenem, imipenem, amikacin, piperacillin + tazobactam 
and cefepime was 47.6, 64.6, 59.3, 65.6 and 83.6%, respectively. 
Cumulative percentage inhibition at a range of minimum inhibitory 
concentrations (MICs) is shown in Table 1. 
i 
Conclusion: Nearly all MDR P .  aeruginosa strains were also resistant to 
cefepime. Carbapenem and amikacin combination therapy appears to be the 
most useful therapeutic option for these MDR isolates. 
66 Abstracts 
Conclusion: Meropenem remained highly active in uitro against all 
Enterobactenareae and P. aeruginosa. Moreover, its activity was not influenced 
by beta-lactamase production. Based on these data, we noticed h g h  level of 
resistance against several antimicrobials and an alarming rate of ESBL 
producers which may restrict the therapeutic choice to the carbapenems in 
this selected group of patients. There was no observed reduction in 
meropenem activity over a 3-year observation period indicating that 
meropenem is not prone to determine bacterial resistance. 
m] Antimicrobial activity of selected agents against 
strains of Escherichia coli, KIebsiella spp. and Proteus mirabilis 
with resistance phenotypes consistent with an extended 
spectrum beta-lactamase: report from the MYSTIC programme in 
Europe (1997-2000) 
R. N. Jones, M. A. Pfaller and the MYSTIC Study Group 
louja City, USA 
Objectives: To determine the occurrence of extended spectrum beta- 
lactamase (ESBL) phenotypes among E. coli (EC), Mebsiella spp. (KS) and P .  
mirabilis (PM) isolates &om medical centers participating in the MYSTIC 
Programme in Europe (EU) between 1997 and 2000. 
Methods: A total of 2553 strains of E.  coli (1310), mebsielh spp. (934) and P.  
mirabilis (309) were isolated from patients in 31 centers in 10 countries. O f  
these, 538 strains were identified as potential ESBL phenotypes (ceftazidinie 
[CAZ] MIC at > 2  mg/L). Susceptibility tests were performed using the 
NCCLS agar dilution method us. meropenem (MEM), imipenem (IPM), 
cefepime (CPE), piperacihdtazobactam (TAZ), ciprofloxacin (CIP), 
gentamicin (GM) and tobramycin (TM). These strains were among 11 
345 aerobic bacteria studed by MYSTIC participants, each examining 100 
Gram-negative and 100 Grani-positive isolates per year. 
Results: KS isolates had the greatest percentage (32.8%) and the greatest 
number of ESBL-producing strains (n=306), followed by EC (14.4%; 
n =  189) and PM (13.9%; n =  43). Geographcally, more ESBL strains were 
observed in eastern EU (Russia, Poland, Czech Republic) and Turkey at 
43.9% of all isolates. Overall, 21.1% of these species isolates were suspect for 
ESBL production. The susceptibility/MIC90 potency rank order for ESBL 
strains ofEC was: MEM (100%/0.25 nig/L) > IPM (98/2) > CPE (92/8) 
> TAZ (69/64). For KS, the order was MEM (99%/1 mg/L) > IPM (98/ 
2) > CPE (72/32) = CIP (71/16). For PM, MEM (98%/2 mg/L) and TAZ 
(95%/16 mg/L) had greater spectrum and activity compared with other 
agents, especially IPM with 7% ofMICs at 2 16 mg/L. Co-resistances were 
very common among ESBL strains, including the fluoroquinolones and 
anlinoglycosides, compared with all strains tested (e.g. T M  resistance in KS 
ESBL-producers was 60% uz. 28% in nonproducers). Marked activity 
differences between ESBL-positive and all strain data (average %fold in 
MIC90s) were detected for five out of seven drugs tested. 
Conclusions: Carbapenems (MEM > IPM) remain very active against 
ESBL-producing strains of EC, KS and PM in EU medical centers over the 
period ofthe sample (1997-2000). Among PM, ESBL-producers are emerging as 
resistant to IPM activity. ESBL-producing strains must be continually monitored 
to direct infection control and guide empirical therapy selection. 
Antimicrobial susceptibility of inducible AmpC beta- 
lactamase producing Gram-negative bacilli from the European 
Meropenem Yearly Susceptibility Test Information Collection 
(MYSTIC) programme, 1997-2000 
M. A. Pfaller, R. N .  Jones and the MYSTIC Study Group 
loiva City, USA 
Objectives: To determine the in uitro activity of merapenem (MEM) and 
eight comparator antimicrobial agents against isolates of Enterobacter (EB), 
Citrobacrer (CB) and Serraria marcescens (SM) obtained in 1997-2000 from 31 
study centers in Europe. 
Methods: MICs of MEM, imipenem (IPM), cefotaxime (CTX), ceftazi- 
dune (CAZ), cefepinie (CW), piperacillin/tazobactam (TAZ), ciproflox- 
acin (CIP), gentanlicin (GM), and tobramycin (TM) were determined using 
NCCLS methodology. AmpC beta-lactame (AmpC) producing isolates of 
EB, CB, and SM were defined as those with CAZ MICs of 2 32 mg/L. 
Results: Among the 11 345 aerobic bacterial isolates, the etioiogic agent was 
FJ3 in 904, CB in 144, and SM in 288. Resistance to extended spectrum 
cephalosporins (CAZ, CTX; 1147%) and a beta-lactamase inhibitor 
combination (TAZ; 6 1 4 % )  among these isolates was elevated. Both MEM 
(MIC90,0.25 mg/L; > 99% susceptible) and IPM (MIC90,2 mg/L; > 99% 
susceptible) were active against virtually all isolates tested, including 369 
stably derepressed AmpC-producing CAZ-resistant strains of EB (305 
strains), CB (29 strains) and SM (35 strains). The overall rank order of 
spectrum (% susceptible) for the seven most potent agents tested against 
these AmpC-producing strains was MEM (98%) = IPM (98%) > CPE 
(89%) > GM (73%) > CIP (62%) > TM (60%) > TAZ (21%). 
Conclusion: The MYSTIC programme demonstrates the contemporary 
fkquency of AmpC-producing species of EB, CB, and SM among hospital 
strains in Europe and the potent activity of MEM and LPM against these CAZ- 
resistant pathogens. For control of these resirant pathogens, we suggest attention 
to microbiological recognition of phenotypes, to dection control practices, and 
to limiting the overuse of certain extended spechum beta-lactam agents. 
Activity of meropenem against Acinetobacter spp. 
isolated from the European MYSTIC programme, 1997-2000 
P Tumer and the MYSTIC Study Group 
Macclerfield, UK 
Objective: There is an increasing concern at the isolation of mulhresistant 
strains of Annetobacter ~ p p  from hospitalized patients These strams are 
typically resistant to many classes of antibiotics (cephalosponns, fluoroqui- 
nolones, amoglycosidec) and as such are &fficult to eradlcate 
Methods: A total of 360 stram of AonetobaaP, spp were lsolated m Europe as 
part of the ongomg MYSTIC (Meropenem Yearly Suscepnbhty Test 
h&omhon Collection) study, whch e m e d  the actlvlty of meropenem and 
five comparator anhbiohcs agamst Isolates o b m e d  &om meropenem-prescnbmg 
centfes m 10 countna between 1997 and 2000 Of these 360 Isolates, 294 were 
idended as A baumanir and the other 66 as a vanety of specles (21 A lm#r, 14 
Annetobacter spp , 10 A anitratus, 9 A junri, 7 A cakoaceticus and 5 A haemolyticus) 
Results: The mqonty of these isolates were resistant to the cephalosponns, 
beta-lactam/beta-lactamase inhibitor combinattons, tluoroquinolones and 
mnoglycosides Meropenem, however, conhnued to demonstrate good 
achvlty (see Table 1) 
~- - - ~  ___ - 
I ~ ~ ~ ~ ~ ~ ~ ~ f & ~ ~ # ~ ~ I ~ ~  I 
Conclusion: Meropenem ihlbited 2431294 stram of A baumanii and 63/ 
66 strains of other Acinetobacter spp at the suscephble breakpomt (< 4 mg/ 
L) These data would suggest that merapenem is a viable treatment against 
this hfficult to-treat group of organisms 
v1 Susceptibility of Gram negative bacilli to various 
antibiotics and carbapenem resistance 
C. Bicmen. G. Senol, N. Eris, N. Florat 
Irinir, TR 
Objectives: Gram-negative bacilli produce a variety of beta-lactamases. In 
order to manage an efficient infection control program, it is essential to 
survey the resistance of antibiotics; which is mostly due to beta-lactamases. 
Methodlresults: In this study, a total of 75 Grani-negative strains, such as; 
44 Pseudomonas spp., 9 Mebsiella spp., 8 Escherichia coli, 6 Enterobacter spp., 4 
Acinetobacter spp., 3 Gram-negative nonfermenter bacilli and one Proteus 
mirabilis were isolated during Septembedctober  2000, in the Bacteriology 
Laboratory at Training Hospital for Chest Diseases and Surgery, Izmir, 
Turkey. Susceptibilities of these strains were investigated for meropenem 
(MEM), imipenem (IMI), ceftriaxone (CRO), ceftazidme (CAZ), 
aztreonam (ATM), amoxicillin-klavunic acid (AMC), isepamicin (ISP), 
gentamicin (CN), levofloxacine(LEV), ciprofloxacine (CIP), piperacillin- 
tazobactam (TZP) and cefaperazon-sulbactam (CEF-PER) by Kirby-Bauer 
disc diffusion method according to NCCLS standards. Antimicrobial 
resistance proportions are given in Table 1. ESBLs were determined in 12 
Pseudomonas and 3 Enterobacter strains ( n  = 15; 20%) whereas inducible beta- 
lactamases were found in 15 Pseudomonas and one KIebsiella strains (n = 16; 
21.3%). In one Hebsiefla and one Enterobacter strains were detected both 
ESBL and inducible beta-lactamases together. Gram-negative strains, which 
were appeared to be intermediate and complete resistant to carbapenems by 
Clinical Microbiology and Infection, Volume 7,  Supplement 1, 2001 67 
disc a s i o n  method, were analyzed for MIC levels by agar dut ion and 
microdution methods for imipenem and meropenem, respectively. The MIC 
values for imipenem were determined as 4 pg/mL in 18 strains whereas 16 pg/ 
mL for 12 strains. O n  the other hand, MIC values for meropenenl were found 
as 4 pg/mL in 12 strains and 16 M L / ~  in only two cases. 
Conclusion: Increasing production of beta-lactamases in Gram-negative 
bacilli and high resistance levels including carbapenem resistance indicates 
the widespread use of those antibiotics that leads to selection of resistant 
organisms and an endemic problem in some hospitals. 
vl Effect of carbapenems on various cell functions of 
Enterobacter cloacae 
V. Majtan, L. Majtanova 
Bratislava, SK 
Objectives: To study the effect of suprainhibitory concentrations (2 x and 
4 x MIC) of two carbapenems (imipenem, meropenem) on the metabolism 
(biosynthesis of macromolecules, respiration), cell-surface hydrophobicity 
and motility of a clinical isolate of Enterobacfer cloacae. 
Methods: The biosynthesis of macromolecules of bacterial strain after 16 h 
and 24 h cultivation was evaluated by the method of incorporation of 
radioactive precursors [14]C adenine and [14]C leucine to TCA insoluble 
fractions of cells. The respiration was determined polarographicdy. Cell 
hydrophobicity of the strain tested was determined by three methods: 
bacterial adherence to hydrocarbon (BATH), salt aggregation test (SAT) and 
bacterial adherence to nitrocelulose filter (NCF). The test of motility was 
performed on the semisolid swarming agar medium (0.35%). 
Results: Both carbapenems inhibited the incorporation of [14]C precursors at 
16 h cultivation of E. cloacae in the postantibiotic phase, but at 24 h regrowth 
the stimulation of proteosynthesis. indicated by the incorporation of [14]C 
leucine was found. The presence of the exogenous mtermediators of Krebs 
cycle expreively increased the respiratory activity of cells, namely in the case of 
2-oxoglutarate. The decrease of cell-surface hydrophobicity with all three 
methods was found at supradubitory concentrations of carbapenems while 
meropenem being more effective. Motility of E. cloacae was also inhibited. 
Conclusions: The results of this study extend the knowledge on the efficacy 
of antibiotics on certain virulence factors and metabolic activity of the 
clinically important pathogen E. cloarae 
vl In vitro activity of carbapenems (imipenem and 
meropenem) against Gram-negative pathogens isolated from 
Brazilian intensive care units 
C. Mendes, A. Hsiung, C. Oplustil, S. Sinto, A. Nicodemo, C. Kiffer 
Sao Paauto, 3R 
Carbapenem antibiotics are unique amongst beta-lactam antibiotics by 
retaining potent activity against organisms which, by virtue expression of 
beta-lactamases or other mechanisms, are resistant to third, and in some 
cases newer cephalosporins, and penicillin/beta-lactanlase inhibitor combi- 
nations. The selection of multiresistant bacteria has increased subsequent to 
the introduction of a large number of antibiotics with various mechanisms 
of action. The scale of this problem is best exemplified by the fact that most 
nosocomial infection involve multiresistant bacteria producing several types 
of enzymes such as extended spectrum beta-lactamases, derepression of 
chromossomal ampC beta-lactamases, plasmid coded ampC beta-lactarnases 
in members of Enterobacteriaceae, and multiresistant Pseudomonar aeruginosa 
and Arinetobacter baumannii. In this study, the in vifro activities of meropenem 
and imipenem, were monitored and compared against 177 recent clinical 
isolates of K. pneumoniae (n = 49), E. coli (n  = 48), A .  baumannii (n = 47). and 
P. aeruginosa (n=33) all isolated Ekom ICU patients. Minimal Inhibitory 
Concentrations (MICs) were determined by E-test methodology (A0 
BIODISK, Solna, Sweden), using standardized and controlled procedures. 
Although all K. pneumoniae and E. coli were fully susceptible to both 
carbapenems, meropenem consistently showed lower MICc. For P. amginora 
and A. baumannii, both agents had sirmlar performances, however, among the 
susceptible isolates, meropenem also steadily presented lower MICs. The 
MIC50 and MIC90 values and susceptibility distribution for the tested isolates 
are shown in Table 1. Based on current resistance trends among Gram-negative 
nosocomial pathogens, carbapenems may now be the only class of beta-lactam 
antibiotic, or possibly the only class of antibiotic, which can be used with 
confidence as empirical monotherapy in intensive care units. 
MIC, MIC, % SwepMe %Intermediate % Resrstsnt 
Lpeumdae Meropmem 0032 2 IW 
(n.49) lmipenem 021 2 100 
E coli Meropentm 0.016 2 I00 
(11.481 Imipenem 0.21 2 100 
P, aeri@nosa Meropmem 021 >32 81.8 18.2 
(n=3T) Imipenem 2 >32 78.8 3 18.2 
A bamaimu Meropmem 1 4 91.5 2.1 6 4  
( ~ 4 7 )  Imipmem 1 4 91.1 8 5  
v1 Antimicrobial susceptibility of nosocomial P. 
aeruginosa isolates against imipenem and meropenem with 
broth microdilution and €-test methods and comparison of the 
two methods 
S. Senbayrak-Akgay, A. Topkaya, S .  Akin-Ertem, P. Goktas, N. Oguzoglu 
Istanbul, TR 
Nosocomial infections are serious cause of morbidxy and mortahty. P. 
aenrginosa is easily become resistant against various antibiotics responsible for 
these infections. Carbapenems are suitable antimicrobial agents against to 
infections due to P. aeruginosa. In our hospital, antimicrobial susceptibility of 
50 nosocomial P. aeruginosa isolates against IMP and MEM was investigated 
with broth microdilution and E-test methods and was compared according 
to sensitivity of these two methods in this study. 25 (50%) isolates were 
found susceptible to IMP, 23 (46%) isolates were found susceptible to MEM 
and 19 (38%) isolates were found resistant to IMP, 24 (48%) isolates were 
found resistant to MEM with broth microdilution method. 27 (54%) isolates 
were found su\\ eptible to IMP, 23 (46%) isolates were found susceptible to 
MEM and 20 (40%) isolates were found resistant to IMP, 20 (40%) isolates 
were found resistant to MEM with E-test. There are no statistical difference 
against ratio of antimicrobial susceptibility and resistance of IMP and MEM 
with broth microdilution and E-test methods. MICs within the accuracy 
limits of f 1 dilution were regarded as essential agreements. Essential 
agreements between two methods were found to be 70% for IMP and 60% 
for MEM. E-test method can be used because of the practical difficulty of 
broth microdilution but it should be confirmed with broth microdilution if 
it was found resistant isolates with E-test method. 
/p4451 In vitro activity of imipenem and meropenem at sub- 
MIC concentrations, against multiresistant strains of 
Acinetobacter baumanii, by evaluation of morphological 
changes in cell surface 
M. Bernabeu-Wittel, C. Pichardo, A. Garcia-Curiel, D. Martin-Lozano, 
J. Pachon 
Sevilla, E 
Objectives: To evaluate in vitro activity of sub-MIC concentrations of 
imipenem (IMP) and meropenem (MRP) against two strains of multi- 
resistant A .  baumannii by assessment ofbacterial surface changes. Strain 1 was 
sensitive to both antimicrobials, and strain 2 was resistant to both. 
Methods: MIC was performed by broth dilution, and bactericidal activity by 
time-kd curves. Both strains were cultured in Miieller-Hintin Broth (MHB) 
until logarithmic growth was reached (time 0). Then 5 x 105 cfu of bacteria 
were subcultured in MHB with 0 (control), 0.25MIC. OSMIC, and lMIC 
concenmtions of both antimicrobials during 4 h. After this, Gram staining of 
three extensions €tom every dilution were performed. Control cultures in 
MHB of every dilution were performed at time 0 and immediately before 
performing extensions for gram staining. Bacterial surface changes definitions: 
Forms t 3  pm, cocobacilli, and baciUi were considered normal; Forms > 3  
pm, cocci, and spheroplasts were considered abnormal, Forms < 1 pni were 
not counted. Statistical analysis: chi square test, exact Fisher test. 
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Results: Strain 1 MIC was 1 g/L and 0.5 g/L against IMP and MRP, 
respectively; strain 2 MIC was 16 g/L against both antimicrobials. In time- 
kdl curves IMP showed more bactericidal activity than MRP against strain 
1, while MRP was more active against strain 2. With respect to strain 1: 
both antimicrobials produced significantly more altered fomis a t  0.25, 0.5, 
and IMIC, than controls; nevertheless, IMP produced more altered forms 
than MRP at 1 MIC (81% vs. 67.15% of altered fonns in gram staining, 
P=O.O7). With respect to strain 2: both antimicrobials produced also 
significantly more altered forms at 0.25, 0.5, and IMIC, than controls; 
nevertheless, this time, MRP produced significantly more altered forms at 
0.25MIC (86.2% us. 11.3%, P < 0.0001). OSMIC (94.4% us. 8.8%, P < 
O.OOOl),  and lMIC (95% us. SO%, P=O.OOS) than IMP. 
Conclusions: Carbapenems proniote sigtuticant changes in bacterial surface 
at sub-MIC concentrations; ths  effect could explain the prolonged 
postantibiotic effect of these antimicrobials compared with other beta- 
lactams. The quantitative differences in promoting these changes between 
IMP and MRP correlate well with results obtained in timekill curves. 
Antiseptics 
lp446 The time-dependent effect of various antiseptics on 
slime-positive and -negative staphylococci 
M. Yalinay Cirak, A. Aydin, 1. Fidan, S. Turet 
Ankara, TR 
The time-dependent effecn of various antiseptics on she-negative and 
-positive staphylococci were investigated in this study. Staphylococcus epidmnidis 
ATCC 35983; Staphylococm aureus ATCC 25923; 3 c h c a l  isolata 
Staphylocomu epidmnidis (slime-positive and COagLhe-negahVe), Staphylococrrrs 
aureuc (she-negative and coagulase-positive) and a slime-negative and 
coagulase-negative staphylococcal sa-ain were used as the test organisms. The 
tested andseptic agenn and dilutions were as follows: 1/1000, 1/2000, 1/4000, 
1/8000 and 1/16 OOO dilutions of 10% benzalchonium chloride, 1/25, 1/50, 11 
100, 1/200 and 1/400 dilutions of 4% chlorhexidine, 1/10, 1/20, 1/40, 1/80 
and 1/16Odilutionsofsodium hypochloride, 1/10, 1/20. 1/40, 1/80 and l/l60 
dilutions of 10% polyvinylpyrolidon iyod, 1000/0, 70%, 50%, 25% and 12.5% 
dilutions of 99.5% ethanol. All of the Staphylococcal saains were inoculated in 
all of the denoted concentrations of anasepacs. In order to evaluate the time 
dependent effect of the antiseptics followmg the time periods of 1, 3, 5, 10, 15, 
30,45 and 60 min, an ltioculum of 10 p.l &om the antiseptic and Staphylococcus 
inmres  were smeaked on to the blood agar for overnight incubation. 
According to our results, the suggested concentrations for application of 
benzalchonium chloride, chlorhexidine, sodium hypochloride and iodine are 
found to be completely effective on the tested staphylococcal strains. On the 
other hand, ethanol is not found to be effective in the concentrations suggested 
for routine applications as the growth ofclinical isolate Staphylomccus epidmnidis is 
detected at the time period of 1 min of the assay after the overnight incubation. 
Thus, the usage of ethanol must be overviewed especially for the intravenous 
nmpulations for current me. We recommend iodine instead of ethanol for the 
cleaning of cutaneom area for intravenous manipulations. Besides benzalcho- 
nium chloride, chlorhexidine and sodium hypochloride can be still used 
safely for the sterilization of staphylococcal strains. 
/p4471 An in vitro study on bactericidal activities of common 
antiseptics 
M. Mahzounieh 
Sltahrekord, IR 
Most iatrogenic septicemia begin with invasion of transcutaneous insertion 
tract by micro-organisms from the patient skin flora. Disinfecting of 
insertion site with a chenncal antiseptic such as ethanol, betadine, cetrinlide- 
cholorhexidine gluconate is regarded as one of the most important measures 
for prevention of intravascular device-related infection especially in NICU, 
ICU and immunocompromised patient. Phlebitis, local abscess, bacterenlia, 
osteomyelitis and arthritis are the most common serious complication of 
improper use of antiseptics. To asses the efficacy of six usual antiseptics, 
cetrinude-cholorhexidine, 10% betadine, 96% ethyl alcohol and 5% and 1% 
betadine (10%) in ethyl alcohol, phenol coefficient of them against S. aureus 
(PTCC 11 13), E. coli (PTCC 1338) and K.  pneumoniae (PTCC 1053) were 
determined by AOAC methods. Phenol coefficient of cetnmide-cholor- 
hexidine and betadine 10% were 66 and 47 on S. aureus, 51 and 30 on E.  mli 
and 16 and 12 on K. przemoniae, respectively. Other antiseptics had phenol 
coefficient less than 1.  there was significant difference among cetrimide- 
cholorhexidine, betadine 10% and other alcoholic forms of antiseptics 
(P' 0.05). Our finding suggest that cetrimide-cholorhexidine and betadine 
10% should be considered as a firs-line antiseptics against 3 bacterial strains. 
lp448) Hospital endemic strains and their susceptibility to 
betadine and chlorhexidine gluconicum 
K. Gizynski, A. Samet, A. Sledzinska, M. Bronk, J. Kur 
Gdaiisk, PL 
Objectives: Determination of activity of two antiseptics: betadine, 
chlorhexidmum gluconicum. 
Methods: Bactericidal activity of the betadine and chlorhexidinum 
gluconicum was tested following the recommendations of the Polish 
Institute of Hygene against the endemic strains of bacteria: Staphylococcus 
aureus (MRSA), Enterococcus faecalis, Enterococrus faerium, Pseudomoms 
aeruginosa, Acinetobacter baumannii, Enterobacrter cloacae, Senatia marcescens, 
Klebsiella pneumoniae, Escherichia coli. Tested concentrations were: 1 .O% and 
0.5% for betadine (stock solution 10%1), 0.5%; 0.05%; 0.02% for 
chlorhexidinum gluconicum (stock solution 20%). 
Results: Betadine demonstrated cidal activity against all tested bacteria in 1% 
concentration in 1 rnin. Chlorhexidinum gluconicum demonstrated such 
activity against most of the tested bacteria (Enterococcus Jecalis, Enterococcus 
Jaecium, Pseudomonas aeruginosa, Enterobacrter cloacae, Serratia marcescens, 
Klebsiella pneumoniae, Escherichia colt) in 0.5% concentration in 1 min, 
against Acinetobacter baumannii in 2 min. Chlorhexidinum gluconicum 
demonstrated lack of bactericidal activity against MRSA strains. 
Conclusions: Betadine demonstrated full activity against tested bacteria, 
while chlorhexidinum gluconicum showed the lack of activity against 
MRSA. The data also indicate the importance of testing of antiseptic agents 
against endemic strains. 
I pa9 I Biocidal effect of protamine and melittin in 
combination with chlorhexidine 
S. Kdjalg, P. Naaber, R. Mikelsaar, M. Mikelsaar 
Taru, EE 
Introduction: Due to the increasing bacterial resistance to antimicrobial 
drugs incl. disinfectants new effective chemicals are needed. Several cationic 
peptides have been found to express antibacterial activity and synergism 
between peptides and antibiotics has been shown. N o  data about interaction 
between cationic peptides and disinfectants are available. 
Objective: To evaluate the antimicrobial effect of two cationic peptides, 
protamine (PR) and melittin (MT) and find possible interaction between 
peptides and chlorhexidine (CH). 
Materials and methods: Antimicrobial activity of PR, MT and CH against 
22 clinical and 3 type strains (S. aureus ATCC 25923, E. coli ATCC 25922, 
P. aeruginosa ATCC 27853) were tested. Minimal Inhbitory (MIC) and 
minimal bactericidal concentration (MBC) were eshmated using niicro- 
(PR, MT) and macrodilution (CH) methods. Mueller-Hinton broth was 
used for MIC tests and subcultures from serial dilutions to blood agar for 
MBC tests. Synergistic effect of protamine to C H  susceptibility was studied 
at two concentrations (low: 51.2 mg/L and high: 512 mg/L) on 4 clinical 
strains (S. aureus and E. J e c a h ,  two isolates of each). 
Results: The investigated chemicals showed various antitmcrobial values 
towards studied Gram-positive and -negative strains. CH MIC varied from 
0.5 mg/L to 64 mg/L (mean 11.1 mg/L) and CH MtlC from 1 mg/L to 
128 mg/L (mean 28.6 nig/L). Both, M T  and PR showed lower 
antimicrobial capacity than traditional antiseptic CH. From investigated 
two peptides, MT possessed relatively lugher activity. Mean MT MIC was 
29.3 (7.8-62.5) mg/L and M T  MBC 89.8 (15.6-250) mg/L. However, P R  
MIC occurred &om 7.8 mg/L to higher than 256 mg/L and PR MBC 
Clinical Microbiology and Infection, Volume 7, Supplement 1, 2001 69 
higher than 256 mg/L. Strains used in synergistic effect study were 
nonsusceptible to 51.2 mg/L and 512 mg/L PR alone, except the growth ofone 
S. aumr strain was inhibited by 512 mg/L PR. Controversial MIC values were 
seen using P R  and CH combination. Concerning MBGvalues some synergistic 
effect of PR to C H  was seen, but it occurred strain specific. We found fourfold 
reduction of C H  MBC in two cases (one S.  aumu and one E.faecalis) using low 
PR concentration. High PR concentration lowered CH MIC 8-16 times, 
except one S. aureus strain or igdly sensitive to h& PR concentration. 
Conclusion: Investigated cationic peptides showed lower antimicrobial activity 
than chlorhexidine. Relatively better antibacterial effect of melittin makes it 
potentially useful for future experimental studies. Clinical usage of the protarnine 
is problematic due to high inhibitory and bactericidal concentrations. Our results 
about synergistic effect of procarnine and chlorhexidme may provide better 
understanding for putative antibacterial mechanism of chlorhexidine. 
Antibacterial efficacy of chlorhexidine as antiseptic for 
hands 
Z. Muszyfiski, I. Mirska 
Poznaii, PL 
Objectives: Antiseptics for hand disinfection should reduce the microbial 
counts on and in the skin and destroy the transient microflora. The above 
principle, however, does not define to what extent the quahtative and 
quantitative dermal flora should be reduced and how he effectiveness of 
antiseptics should be assessed. The aim of the study was to compare in uitro 
and in uiuo the efficacy of two alcohol-based antiseptics containing 60% n- 
propanol (A) and 70% 2-propanol + 0.5% chlorhexidine + 1.5% H202 (B). 
Methods: The tests were carried out in accordance with European standards 
(ES 12054/97, ES 1500/97). The reduction index (RF) of the tested 
bacteria count exposed to the antiseptic (t’ 30 s) and RF of bacterial counts 
on the participating volunteers’ hands, as well as Preudomonas aerugitiora 
ATTC 15442 counts applied onto the surface of latex gloves after washing 
hands with soap (60 s) and rubbing the antiseptic into the skm (1 x 3 mL, 
t = 30 s) was determined. Statistical analysis was performed using Student’s t 
and Wilcoxon tests. 
Results: Under in vitro conditions, both the investigated preparations 
reduced, in accordance with the standards, microbial cell counts by over 105 
(log RF > 5) Hygienic hand rub, as compared with washing with soap 
only, caused a significant ( P  < 0.05) reduction of total count of bacteria 
isolated from the skin. The degree of reduction, however, was low (log RF 
< 0.5), and the differences in the activity ofboth preparations did not reach 
statistical significance. Over 104 bacteria were isolated from the skin, 
including mainly coagulase(-) staphylococci, but also Gram(-) rods. 
Miscellaneous antimicrobials in vitro 
Conclusions: Alcohol-based antiseptics demonstrating bactericidal activity it7 
vitro, reduce to a large extent the transient microflora, but their application 
does not guarantee the microbiological purity of hands safe for the patient 
and cannot be used instead of putting gloves on. 
v] An investigation of the bactericidal effect of certain 
antiseptiddisinfectants against some hospital isolates of Gram- 
negative bacteria 
M. Ekizoglu, M. Ozalp, N. Sultan, D. Cur 
Ankara,  TR 
Objectives: The aim of this study was to assess the activity of a widely used 
antiseptic/disinfectant agents against hospital isolated Gram-negative 
bacteria by a quantitative suspension test. 
Methods: Chlorhexidine gluconate (Dermanios scrub, 4%). savlon (15% 
cetrimide and 1.5% chlorhexidine gluconate) and 5.25% sodium hypo- 
chlorite (household bleach) were tested against Pseudomonas amginosa 
(n  = 20), Klebsiella spp. ( n  = 20), Eschen’chia coli (ti = 17), Acinetobarter spp. 
(n = 15), Enterobacter cloacae (n = 3) and Sterzotrophomonas nraltophilia (17 = 2). 
Sodium hypochlorite solutions were prepared at 1: 50 (1000 ppm) and 
1:500 (100 ppm) dilutions, savlon was prepared at 1:100 dilution. 
Chlorhexidine gluconate was not diluted. Sodium hypochlorite at 1:500 
dilution was also checked using 15 min contact time. In the test, bacterial 
suspension (10 8 cfu/mL) was added to disinfectant solution in a certain 
concentration. After specified exposure period (5 min) reaction nlixture was 
added to neutralizing medium and removed to agar plates and inoculated by 
sudace-plating technique. The colony forming units were counted after 18- 
24 b. Disinfectants were replaced by sterile distilled water for control and 
whole procedure was repeated. The results in 2 5  log reduction or no 
growth were estimated as an indication of acceptable efficacy. 
Results: It was found that savlon and chlorhexidine gluconate at in-use 
concentrations were effective against all the isolates. However, sodium 
hypochlorite was ineffective against some Klebsiella spp. and Aritrerobacter 
spp. at 1:50 dilutions. When sodium hypochlorite concentration was 
decreased to 1:500 dilutions, this effect was significantly decreased against all 
of the isolates. Microbicidal effect increased with longer contact time (15 
min), but it was not enough to kill all examined bacteria. 
Conclusion: Our data demonstrate that savlon and chlorhexidine gluconate 
were convenient as antiseptic/disinfectant agents in hospitals. In addition, it 
was revealed that sodmm hypochlorite usage should be preferred at higher 
concentrations. For sodium hypochlorite, 15 min contact time was not 
enough for antimicrobial activity against bacteria. 
vl Multicenter study of the susceptibility of 400 
Haemophilus influenzae strains to 16 antibiotics isolated in 1999 
in Spain 
B. Aracil, J. Oteo, J. I. Alas, J. L. Gomez-Garces 
Mhrtoles, E 
Haemophilus infIuenzae IS a micro-organism responsible for infections of the 
respiratory tract such as otitis, sinusitis, pneumonia and acute infectious 
exacerbation of chronic bronchitis, and also of severe syPtemic infections 
such as meningitis and bacterenlia. Resistance of these phatogens to 
antibiotics has been increasing. Therefore the objetive of this study was to 
assess the susceptibility of 400 strains of Haentophilux ir!fluenrae isolated in 21 
Spanish laboratories in 1999. The number of strains collected was 
proportional to the number of inhabitants of each geographic area. In all 
strains production of beta-lactamase was investigated by the nitrocefin 
method. The susceptibility to 17 antibiotics was studied using the agar 
dilution method following the NCCLS criteria. We used ampicillin (Am), 
amoxicillidclavulanate (A/C), loracarbef (Lc), cefprozil (Cfp), cefaclor 
(Cfc), cefuroxime (Cfu), ceftibuten (Cft), cefpodoxime (Cpd), cefixime 
(Cfk), rifampin (Rf), tetracicline (Te), cloramphenicol (Cc), nalidixic acid 
(Na), ciprofloxacin (Cp), trovafloxacin (Tv), claritromycin (Cl), and 
azitromycin (Az). The susceptibility percentages and the MICYO (in mg/ 
L, in parentheses) of the antibiotics are shown: Am 74.2% (> 8), A/C 99.2% 
(G2/1), Lc 66,296 (32) ,  Cfp 70,294 (32), Cfc 76.2% (32),Cfu 95% (4), Cft 
100% (0.5). CdplOO% (0.25), C& 100% (O.l) ,  R f  99.8% (0.5). Te 98.2% 
(Ll), Cc 99.2% (l), Na 97.5% (2). Cp 100% (0.015), Tv 100% (0.03), CI 
74% (16), Az 100% (4). In some antibiotics, the geographic distribution of 
susceptibility rates is not homogeneous. 24.5% of the strains produced beta- 
lactamase and showed higher MICs for antibiotics such as Cfp and Cfc than 
non beta-lactamase producers. However Cfi, Cfu and Cfx had similar MIC$ 
in both beta-lactamase producers or non beta-lactamase producers. Five 
strains (1.25%) were beta-lactamase(-) but resistant to Am, probably by 
other mechanisms. All strains were susceptible to Az, with MIC < 4  mg/L 
and all were susceptible to Cp and Tv with MIC G0.5 mg/L. 
p4531 Comparison of the in vitro activity of commonly 
prescribed antibiotics against Haemophihs influenzae isolates in 
the Middle East 
A. Shibl, A. Al-Ajeel, T.  D. Chugh, W. Dibb, A. Elbashier, K. El Hag, Z. 
Memish, A. Osoba, K. Toreci, T. Yasin, E. Power 
Riyadli, SA; Sharjah; Kuwait C i t y ,  KW; Abu Dhabi; QatiJ SA; Muscat, 0; 
Jeddah, SA; Istanbul, TR; Brentford, UK 
Background: Surveillance of Haentophilux injluenzae isolates for resistance to 
the most commonly prescribed oral antibiotics can contribute to the 
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selection of appropriate empiric antibiotic therapy for indications where this 
pathogen is suspected. The present study determined the activity of 
anioxicillin/clavulanate (Amox/Clav) and other commonly prescribed 
antibiotics against isolates of H influenzae from 9 centres in the Middle 
Eastem region. 
Methods: Isolates were collected during 1996-98 fiom a variety of clinical 
sources and identified to the species level at each study centre. Susceptibility 
testing was performed according to NCCLS guidelines and the manuhc- 
turer's instructions using commercially available Etest strips. NCCLS 
interpretive criteria (MlOO S-10) were used to determine susceptibdity rates. 
Results: MIC9O (pg/mL)/% susceptible results are given in Table 1. 
NA = not applicable. 
A n t i t i d C  Saudkatia Turkw WE Onan Klrnait 
Pnplallin 4825 11957 2829 >2561796 321653 
maw 00161103 om100 oM)81100 ow100 0016/103 
cefaclor 41994 4957 4100 we64 ?@a74 
Uanthrcnyan 8'924 161870 81943 16'573 1W47 
aponmacln O O I ~ / I C O  O m 7 1  O O I ~ I O O  003/100 swim 
4/99 1 N4 N4 N4 N4 
Q/&Ia: +Lne 16.9 29 14.3 19.4 35.8 
Conclusion: Of all the agents, cefiriaxone and ciprofloxacin demonstrated 
best overall activity against H influenrae. Amox/clav showed best overall 
activity of the oral beta-lactams. The h g h  beta-lactamase rates in some 
countries suggest penicillins alone or beta-lactamase-labile cephalosporins 
should not be considered adequate empiric therapy where these organisms 
are likely to be encountered 
lp454/ Antimicrobial susceptibility of ffaemophifus influenzae 
isolates causing meningitis in Bulgaria (1995-2000) 
L. Setchanova, M. Sredkova, I. Hiadushka, T. Vajaurova, M. Kojouharova 
S&, BG 
Haemophilus irlfluenzae strains ( n  = 41) isolated fkom cerobrospinal fluid 
(CSF) were tested by the agar dilution method (Haemophilus test agar) for 
susceptibility to commonly prescribed antibiotics for the treatment of 
community-acquired meningitis. The majority of H intuenrae meningitis 
occur in children under five years of age (95%). All strains were serotype b 
and biotype I (73%) or biotype I1 (27%). In H influenzae strains ampicillin- 
resistance occurred in 44%, resistance to chloramphenicol in 39%, and 
resistance to nimethoprim/sulfamethoxazole in 25%. Based on these results 
we recommend a third generation cephalosporins (cefotaxime/ceftriaxone) 
for empirical therapy of childhood H influenzae meningitis. 
v1 Arcanobacterium haemolyticumr identification and 
susceptibility testing of nine antimicrobial agents 
M. Almuzara, C. de Mier, C. Barberis, J. Mattera, A. Famighetti, C.  Vay 
Buenos Aires, AR 
Objectives: To describe 19 strains of Arcanobacterium haemolyticum (Ah) 
isolated from human sources, its microbiological features and its 
antimicrobial susceptibility. 
Methods: Nineteen strains of (Ah) were isolated during a period of 2 years 
(1998-2000) in our clinical laboratory. Identification were camed out by 
conventional biochemical test following the scheme of Funke, and API 
CORYNE. Pyr test was performed using pyrrolidod-beta-naphthylamide 
disks following manufacturer recommendations (Lab. Britania, Argentina), 
Bacitracin susceptibility was determined using a suspension equivalent to 0.5 
Mc Farland and bacitracin disks were placed on Columbia agar with 5% 
sheep blood. Inhibition zones were read at 24 h incubation. Antimicrobial 
susceptibility tests were determined by agar dilution on Mueller-Hinton 
with 5% sheep blood at 35 "C, air condition, at 48 h 
Results: 13 strains were isolated tiom throat and colleagues from: DBT foot 
ulcers, bone, urethral discharge, peritonsillar abscess, pleural fluid and 
loquia. In none of the throat samples was isolated haemolytic streptococci 
simultaneously with (Ah). Three strains were isolated kom a mixed culture: 
one of them from pleural fluid of a patient with traumatic hemotorax, other 
fiom urethral discharge and the other fiom a loquia fiom spontaneous 
abortion. The biocodes obtained by API CORYNE were: 2010360, 
21 10360, 2130360, 2210360, 2230360, 2310360, 2510360, 2530360, 
6010360, 6110360, 6130360, 6330360 and 6530361. All the stains were 
positive for alpha mannosidase, pyrazinamidase and inverse CAMP, and 
negative for xylose and gelatin. All these tests allow its differentation from 
Arcanobacterium pyogenes. 13 strains gave positive Pyr test using disks whereas 
only 6 strain3 gave positive with Pyr test/API CORYNE. Bacitracin 
inhibition zones were between 8 and 14 mm. MIC ranges (ug/mL) were: 
penicillin 0.004-0.25, cephalothin 0.0044064, cefuroxime 0.032-0.5, 
erythromicin <0.004-0.25, azithromicyn <0.004, tetracycline <0.25-64, 
clindamycin 0.004-4.032, ciprofloxacin 0 .2545 and vancomycin 0.25-0.5. 
Conclusions: A Gram-positive rod that exhibit beta haemolysis on human 
blood, catalase-negative and a positive result for inverse CAMP test may be 
identhed as (Ah). Only tetracycline showed variable activity on the strains. 
jp456 The in vitro susceptibility of urinary tract pathogens to 
mecillinam, compared with other antimicrobial agents: a 
multicenter study 
J. M. Hubrechts, M. Lontie, M. Caudron 
Aalst, Leuven, Mons, B 
During a 8-month period (from January until August 2000), a multicenter 
approach was used in order to evaluate the general in vitro resistance level in 
Belgium of common uropathogens to mecillinam and other currently used 
antibiotics. All strains were isolated fioni ambulatory patienh (female, at 
least 16-year-old), suffering from urinary tract infection and were system- 
atically tested by one of the 3 participating centers. All Gram-negative 
strains, except P. aeruginosa,were included in the study. The folllowing 
antibiotics were routinely tested: cefazolin, cefuroxime, nitrofurantoine, 
ciprofloxacine or norfloxacine, cotrimoxazole, ampicillin or amoxycillin, 
amoxyciUin + clawlanic acid, fosfomycin and mecillinam. Two laboratories 
used a disk ditfusion test as described by Bauer et at. with paper disks on 
Mueller-Hinton Agar 11. Results were evaluated by using the zone diameter 
interpretative standards for Becton Dickinson paper disks (NCCLS Doc. 
M100-S9). Breakpoint values for qualitative interpretation of inhlbition 
zone diameters for mecillinam were based on the recommandations of Skov 
et al. (Statens Serum Institut, Copenhagen, Denmark). The third laboratory 
used the ATB-system (Bio-Merieux) in combination with Rosco neo- 
sensitabs for mecillinam (not available on the automated system). MICs for 
mecillinam were measured for 79 strains found 'resistant'. Epsilon-tests (AB- 
Biodisk) were performed on Mueller Hinton Agar 11. 1355 Gram-negative 
micro-organism were enrolled in the study. E. coli was by far the most 
common uropathogen (73.3%), followed by Proteus rnirabilis (10.9%). Except 
for Enterobacter sp. (4.5%) and Klebsiella sp. (4.3%) all other uropathogens 
showed kequencies far under 2%. The rates of resistance among E. coli 
strains (n = 993) were 23% for cotrimoxazole, 14.8% for cefazolin, 4.4% for 
cefuroxime, 3.8% for nitrofurantoine, 8.9% for ciprofloxacine, 9.9% for 
norfloxacine, 39% for ampicillin, 6.5% for amoxycillin-clav., 3.1% for 
fosfomycin and 4.7% for mecillinam. The rates of resistance among all 
Gram-negative strains ( n  = 1355) were 25.2% for cotrimoxazole, 16.7% for 
nitrofurantoine, 12.1% for ciprofloxacine, 13.1% for amoxycillin-clav. and 
9% for mecdhnam. Among the 122 mecdham-resistant strains, 79 could be 
collected for MIC-determination by E-test. 65 (82.3%) had a MIC of 32 
p g / d  or more. In view of these results we recommend routine laboratory 
testing of mecdinam for urinary samples. 
Y 
vl In vitro activity of antimicrobial agents against clinical 
isolates of Gram-negative rods 
T. Zar?ba, A. Dusqniska, D. Stankiewicz, S .  Tyski 
Warsaw, PL 
Objective: The aim of the study was to mvestigate the prevalence of Gram- 
negative rods among hospitalized patients and resistance of isolates to 
antimicrobial agents. 
Materials and methods: Four hundred and forty-seven consecutive Gram- 
negative isolates from a variety of specimens were obtained kom patients 
hospitalized in Regional Hospital in Warsaw during 2-month period in 
1999. Isolates were identified by standard biochemical tests and ID 32 GN 
(BioMerieux) ATB System. Antimicrobial susceptibllity testing was 
performed in accordance to NCCLS. The double-disk synergy test was 
used, to detect ESBL. 
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Results: During this study, Gram-negative strains accounted for 47% of the 
935 isolates recovered from clinical materials. The species distribution was as 
follow: E .  coli 200 (44%), P. aeruginosa 45 (lo%), P. mirabilis 40 (9%), 
Klebsiella sp. 30 (7%) and colleagues 132 (29%). e.g. Acinetobacter sp. 18, 
Enterobacter sp. 15, Sewatia sp. 11 and Morganella sp. 9 isolates. The most 
common materials were: urine (47%), wound swabs (19%). and tracheal 
aspirate/sputum (7%). Generally, most of strains isolated in hospital showed 
high rates of resistance to antimicrobial agents. More than half isolates of E. 
coli were resistant to ampicillin and 36% to tetracycline. The cephalosporins 
of second and third generations were active against over 95% of isolates. 
About 4.5% of isolates expressed ESBL production. Twenty-nine of 30 
(96%) Klebsiella sp. isolates were resistant to ampicillin. More than 35% were 
ESBL positive. About 40% were also resistant to tetracycline, 35% to 
gentamicin and 7% to amikacin. All Klebsiella sp. rods were sensitive to 
ciprofloxacin. Among P. mirabilis isolates the resistance varied from 2% to 
ciprofloxacin to 90% to tetracycline followed by ampicillin (70%), 
aminoghcosides (47%) and cotrimoxasole (40%). Eleven of 45 P. aeruginosa 
isolates were resistant to carbenicdhn, five of them were also resistant to 
imipenem. No isolate was sensitive to tetracycline or cotrimoxasole. About 
60% were sensitive to amikacin and ciprofloxacin. 
Conclusions: Gram-negative rods were responsible for almost half of 
infections. Most of them were recovered from urine and wounds. The 
resistance to tetracycline was the most frequent and concerned 58% of 
isolates of all indicated species. High rate of resistance (59%) to penicfins 
alone was also observed. Over 35% K.  pneumoniae isolates would be 
considered to ESBL producen in comparison to 4.5% of E. coli. 
I P458 I New potent analogues of fusidic acid 
A. S. Henriksen, T. Duvold 
Ballerup, DK 
Fusidic acid belongs to a famdy of naturally occurring fusidane antibiotics 
having in common a tetracyclic ring system with the unusual tratzs-syn-trarzs 
arrangement of rings A, B and C forcing ring B into a boat conformation. 
Fusidic acid, the most potent of the fusidane, was first isolated from Fusidium 
coccineum in 1960 [l] and has since 1962 been used clinically in treatment of 
both systemic and topical infections caused by staphylococci. Although 
fusimc acid is most active against staphylococci, it is also active against 
several other Gram-positive species. The clinical value of fusidc acid is also 
due to its excellent distribution in various tissues, low degree of toxicity and 
allergic reactions and the absence cross-resistance with other clinically used 
antibiotics. The structureactivity relationship (SAR) of fusidic acid 
analogues has been extensively studied [2] and a large number of analogues 
have been prepared. However, only a few of these analogues were equally 
active to fusidic acid and most of them had a similar antibacterial profile. A 
renewed interest in fusidic acid recently led us to design and synthesise a 
new series of fusidic acid analogues with unique structural features. These 
analogues have in common a more flexible side chain linked to the 
tetracyclic framework by a single bond. Some analogues in this series show 
potent antistaphylococcal activity besides interesting activities against several 
other problematic Gram-positive species. They also show altered physico- 
chemical properties which may be considered favourable for clinical use. 
References 
1 Godtfrrdsrn WO, Vaiigedal S .  Terraii~droii 1962; 18: ln29 
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w1 Resistance phenotypes at Enterobacteriaceae spp. 
involved in urinary tract infections: the task of the 
microbiologist in guiding antibiotherapy 
T. Turcu, C. Corcaci, V. Luca, R. Fintinaru, R. Scurtu, A. Teodor 
h i ,  RO 
Objectives: To determine incidence of UTI caused by multiresistant 
Enterobncteriaceue spp. and their resistance phenotypes in order to institute a 
correct antibiotherapy. 
Material and methods: 627 strains (482 E .  coli, 86 Klebsiella spp., 37 Enterobacter 
spp. and 22 Proteus spp.) isolated from patients with UTI between January and 
October 2000 were tested by disk &sion test (accordmg to NCCLS) for 15 
antibiotics in order to determine resistance phenotypes. 
Results: 19.7% E .  coli, 38.3% Klebsiella, 45.9% Eitterobacter and 59% Proteus 
were found uiultiresistant for more than 6-8 antibiotics. The most 
important resistance was detected against Ampicfin (AM): 78-90% and 
against Tnmethoprimsulfametoxazol (SxT) = 80-90%. There were also 
found important ~ e r e n c e s  of resistance between the isolated species we 
identified 33 phenotypes of resistance (for 6-8 markers): 11 of E. coli and 
Klebsiella, 6 of Enterobacfer and 5 of Profeus. The most common phenotypes 
were: E. coli: AM, AMC, CB, CTX, S, Gm, Na, Cip, C, Te, SxT, 24.2%. 
AM, AMC, CB, S, C, T,  F/M, SxT, 15.8%. Klebsiello: AM, AMC, CTX, S, 
Gm, Ak, Na, Cip, C, Te, F/M, SxT, 24.2%. Enterobarter and Proteus: AM, 
AMC, C, Tx, S, Gm, Na, Cip, C, Te, F/M, CI, SxT, 61.5%; AM, AMC, 
C,  Tx, S, Gm, Na, Cip, C, Te, FIM, C1, SxT, 52.9%. 
Conclusions: UTI antibiotherapy should always be guided by microbiolo- 
gical susceptibility tests. Multi-resistant strains, in growth in the last years 
represent 25.1% from enterobacteriareae implicated in UTI. The resistant 
phenotype strains determine problems of therapy, being sensible at 
carbapenems and some fluoroquinolones and cephalosporins 111. 
Ip4601 Susceptibility of 100 clinical isolates of Burkholderia 
cepacia complex to trimethoprim and trimethopriml 
sulfamethoxazole 
S. Mihaylova, M. Sredkova 
Pleven, BG 
Objective: To study the activity of TMP alone and combined with SMX 
against 100 clinical isolates of Bcc. 
Methods: One hundred isolates of Bcc collected from 1996 to 2000 were 
stuhed. They were obtained from 87 patients (55 males and 32 females). 
The organisms were found in 77 blood cultures, 16 central venous catheter 
tips, 2 tracheal aspirates, 2 drainages, 1 wound, 1 throat swab, and 1 
conjunctival swab. Ninety of the isolates were from ICU patients and 10 
were from non-ICU patients. The MICs of TMP and TMPISMX were 
determined by the agar dilution method accordmg to NCCLS recommen- 
dations. Epidemiological data for patients were taken Gom the register of 
our microbiological laboratory. 
Results: All isolates tested were susceptible to both TMP and TMP/SMX 
but the combination was more effective than TMP alone. The MICs of 
TMP for 50 and 90% of the organisms were 4 mg/L whereas MIC50 of 
TMP/SMX was fourfold less (1 mg/L) and MIC90 was twofold less (2 mg/ 
L). The MIC ranges of TMP and TMPISMX were < 0 . 2 5 4  mg/L and 
<0.25-2 mg/L, respectively. There were no differences in the MICs of 
isolates obtained from ICU patients and Gom non-ICU patients. 
Conclusions: Our data suggest that TMP alone and combined with SMX 
are effective drugs against Bcc isolates. Further in vivo studies are advisable in 
order to evaluate the possibility to be used TMP alone for treatment of mild 
Bcc infections. 
Ip461 Detection of antimicrobial susceptibility in Gram- 
negative rods isolated urine specimen by the Sceptor System 
M. Altindis, 0. Aktepe 
Afyon, TR 
Urinary tract infections (UTI) are one of the most frequently encountered 
infections in human. E.  coli is the leading pathogen of UTI with the other 
Gram(-) rods isolated commonly fron such infections. In this study, was 
investigated in vitro susceptibilities of Gram(-) rods isolated urine specimens 
in Microbiology laboratory. In a wide range of antibiotics covering beta- 
lactam compounds, aminoglycosides, imipenem from karbapenem and 
quinolones were tested according to NCCLS recommendations by 
Automated Microbiology System (Sceptor, BD). Distributions of 146 
isolates were as 90 (61.6%) E.coli, 23 (15.7%) Proteus sp.. 18 (12.3%) 
Klebsiella sp.. 3 (2.0%) Pseudomoms spp. and 12 (8.4%) other micro- 
organisms (Mopnella, Eizferobacfer, Cirrobacter and Provideticia). Antibiotic 
susceptibihty rates of E.  coli were found as Amikacin (AK) 87.8%. 
Ticarcdhdclavulanic Asid (TIC) 46.7%. Ciprofloxacin (CIP) 68.9%. 
Norfloxacin (NOR) 60%, Gentamicin (CN) 77.8%, Tobramicin (TOB) 
71.1%, Imipenem (IMP) 92.2% Ceftriaxone (CRO) 77.8%, Cefoperazone 
(CEP) 71.1% for Klebsiella spp. were found as CIP 72.2%, TIC 66.7%, C N  
77.8%, TOB 77.8%, AK 77.8%, IPM 83.3%, C R O  72.2%; for Proteus were 
found as CIP 60.9%, TIC 74.0%, C N  82.7%, TOB 74.0%, AK 82.7%, IMP 
78.2%, respectively. The most effective antibiotic to Pseudonioitas and other 
strains was found as IMP and C R O  (92.2% and 76.8%)). Under the sight of 
these results, third-generation cephalosporins and aminoglycosides are the 
first choice for the treatment of UTI, especially caused by E. coli. 
Interestingly quinolones has a low susceptibility rate than expected. We 
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Nr. Bacteria Sensitive Partial E ~ S .  Resistant 
crt. (frequency) Nr. Nr. 1 % Nr. I % 
1 E coli 42.7% 133 31,9 202 48,5 El 19.4 
2 Enterolacter 31 6*:0 73 237 105 34 130 42,2 
thought that the usage of IMP must be limited in such infections because 
the possibility resistant development, even though it is the most effective 
agents in all strains. 
Total 
416 
308 
(p4621 Sensitivity to amoxicilinlclavulanate of 973 bacterial 
strains isolated from different pathological elements 
V. Arama, M. Chlotan, E. Mitache, A. Iancu, E. Andrei, V. Molagic, M. 
Podani, 0. Stoica, R. Nastase, M. Ionescu 
Euharest, RO 
Objective: Reviewing of the sensitivity to Amoxicillin/Clavulamate (piM/ 
CL) for 973 bactenal species isolated &om different pathological elements 
during January 1999-December 1999. 
Methods and materials: We analyzed the results of 973 d&usimetric 
antibiogranls made for bacterial strains isolated in urine (66.9%), sputum 
(10.1%), pharynx (9%) and skin lesions (4.9%). 
Results: The bequency of isolated bacterial strains and their sensitivity 
profile are presented in Table 1. 
o,5% - - 40 60 
Conclusions: The extensive use of AM/CL during the last few years has 
significantly increased the percentage of resistant bacterial strainc which 
could no longer indicate AM/CL as a first intention in antimicrobial therapy 
in the future. 
[p4631 Aminoglycoside susceptibilities of Gram-negative 
bacteria in intensive care units 
a new aminoglycoside, resistance was found high except P. aenrginosa 
compared to others. But unfortunately aminoglycoside resistance in P. 
aenrginosa was high. It is a worrisome event that amikacin which is known to 
be a potent agent against P. aeruginosa has a susceptibility rate of only 43%. 
m] In vitro antimicrobial activity of natural products from 
eucalyptus growing in Greece and mechanism of action 
S. Pasi, E. Harvala, 0. Kretsi, E. Chinou, I. Chinou 
Athens, GR 
Objectives: As a part of a systematic research on the chemical composinon 
of Eucalyptus ramaldulensis (Myrtaceae), among the main uses of whch is the 
production of essential oils, which are used for medicinal and phannaceu- 
tical purposes, we report in this study the arttimicrobial activities of the essential 
oil and of pure isolated compounds of Eucalyptus growing in Greece, which 
have never been studied before. 
Methods: The antimicrobial activities of the essential oil and of pure isolated 
compounds of Greek Eucalyptus were determined, using the dilution 
technique, by measuring the MIC of them against two Gram-positive 
bacteria: S. aureus and S. epidemidis; four Gram-negative bacteria: E. coli, E. 
cloacae, K. pneumoniae and P. aeruginosa and three pathogenic fungi Candida 
albicans, Caridida tropicalis and Tomlopsis glabrata all of them strains of ATCC. 
Standard antibiotics were used in order to control the sensitivity of the 
test organisms. 
Results: Through the antimicrobial screening, the oil proved to be 
significantly active against all s i x  tested bacteria as well as the tested fungi 
(MIC values 0.3-6 mg/mL). The chenlical composition of the oil has been 
stuhed by GC/MS and the major compounds (alpha-pinene and 1,8 cineol) 
have been identified, isolated and were tested on the same cultures, under 
identical conhtions, to compare their activities with those of the oll. 
Conclusions: The results of the assays suggest that the activity of the oil can 
be attributed, to a considerable degree, to the existence of alpha-pinene and 
1,8 cineol which appeared to possess strong activities against all tested 
microbia. Furthermore, it was found that the antifungal activity of alpha- 
pinene was reversed by fatty acids and cellular constituents leaked from 
Candida albicans cells incubated with it, These results suggest that the 
antimicrobial activity of alpha-pinene in Eucalyptus is due to a change of 
membrane permeability arising &om membrane lipid alteration. 
A. Cagatay, M. Punar, S. Oncii, B. Ertugrul, H. Berk, H. Ozsiit, H. 
Eraksoy, S. Galany 
Istanbul, TR 
Objective: To determine aminoglycoside susceptibihties of Gram-negative 
bacteria in the Intensive Care Urut (ICU). 
Method: Between 1 January and 14 November 2000, 483 Gram-negative 
bacteria were isolated from 400 samples obtained as endotracheal aspirates, 
urine, blood, catheter and pus &om patients hospitalized in ICU. 
Aminoglycoside susceptibilities of isolates were determined with disk 
diffusion method according to NCCLS M2-A6, and isolates having 
intermediate sensitivity were categorized as resistant, 
Results: Escherichia coli (35%) was the most common pathogen detected in 
our patient group, which is followed by Pseudomonas aeruginosa (26%), 
Klebsiella pneumoniae (14%) Acinefobacter spp. (1 1%)). Giterobacter spp. (9%), 
Proteus vu@is (4%). and other Gram-negative enteric bacteria (1%). P. 
aeruginosa was found to be susceptible to gentamicin (25%), netilmicin 
(30%), tobramycin (42%), isepamicin (42%) and amikacin (43%) as 
percentage shown in parentheses. Most active aminoglycosides to 
An'rietobacter spp. were netilmicin (76%) tobramycin (47%) amikacin 
(33%). gentamicin (30%). and isepamicin (29%) in order of the susceptibility 
rate. Regarding the rest of the Gram-negative bacteria, the order of 
susceptibility rate was netilmicin (91%), anlikacin (85%), isepamicin 
(82.5%), and gentamicin (58%). Finally, overall susceptibilities of all isolates 
were 58% to gentamicin, 77% to tobramycin, 64%, 66% to isepamicin, 68% 
to amikacin, and 75% to netilmicin. 
Conclusion: The resistance pattern of parented aminoglycosides which are 
frequently preferred in combination antibiotherapy is largely dependent on 
their kequency of usage and the pathogens involved. In our study netilnucin 
was found rather effective. Tobramycin was also found to be effective as 
compared with its results of last year, which could be assumed to be due to 
the fact that it was not generally prescribed in ICU. Although isepamacin is 
1 P465 1 Antimicrobial activity of local anaesthetics 
0. N. Aydin, M. Eyigor, N. Aydin 
Aydin,  TR 
Objective: It is claimed that local anaesthetics have antimicrobial properties. 
Our aim was to investigate the antimicrobial effects of different 
concentrations of ropivacaine, bupivacaine, hdocaine and prilocaine on 
Escherichia Cali, Staphylucuccus aureus, Pseudomonas aefuginosa and Candida 
albicans. 
Methods: Micro-organisms were cultured on blood agar for 18-24 h at 
35 "C. The colonies were added to 2 mL of local anaesthetic dilutions and 
normal saline as controls. The densities of micro-organisms were prepared 
according to MacFarland 0.5. All local anaesthetic dilutions and controls 
were exposed to micro-organisms for 0, 0.5, 1, 2, 4 h at room temperature. 
The inoculums taken from suspensions were inoculated on blood agar and 
incubated for 18-24 h at 35 centigrade and then colonies were counted. 
Antimicrobial activity was considered to be active when there was 
significant difference in the colony count between the imtial and 
postinoculation values. 
Results: Ropivacaine did not inhibit any of the micro-organisms tested. 
Bupivacaine reduced the viable cells of P. aeruginosa at 0.5% and 0.25% 
dilutions. Lidocaine 5% and 2% and prilocaine 2.0% dilutions reduced the 
viable cells of all micro-organisms tested. Prilocaine 1 .O% reduced the viable 
cells of E. culi, S. aureus and P .  aeruxinosa. Lidocaine 1% reduced only the 
viable cells of P. aemgirtosa and pnlocaine 0.5% reduced only E. coli. 
Bupivacaine showed poor antimicrobial effectiveness. Lidocaine and 
pnlocaine had more powerful antimicrobial effects than the other two 
local anaesthetics. 
Conclusion: Only some of the local anaesthetics have antimicrobial effects. 
For this reason, we should provide strict aseptic conditions in local or 
regional anaesthesia practice. 
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lp4661 Natural and hemisynthetic coumarins as in vitm 
antibacterial agents 
P. Magiatis, E. Meliou, A.-L. Skaltsounis, S. Mitaku, E. Chinou, I .  Chinou 
Athens, GR 
Objectives: Conmarins constitute a major category of secondary plant 
products that are widely distributed in the plant kingdom. They are 
characterized by a variety of oxygenation patterns on the benzopyrone 
nucleus and display a remarkable array of biochemical and pharmacological 
actions. The antibacterial activity of a series of 19 natural and hemisynthetic 
coumarins is evaluated against seven bacteria. 
Methods: The antimicrobial activities of the tested compounds were 
determined, using the diffusion technique (disc method), by measuring the 
zone of inhibition of them against two Gram-positive bacteria: S. aureus, 
and S. epidermidis, five Gram-negative bacteria: E. coli, E. cloacae, K. 
pneumoniae, P. mirabilis and P. aeruginosa all of  them strains of ATCC. 
Standard antibiotics were used in order to control the sensitivity of the 
test organisms. 
Results: Through the antimicrobial screening, the 19 tested compound$ 
showed a broad diversity regarding growth inhibitory activity. Six 
compounds among the tested ones (xanthoxyletin and brominated 
derivatives, 5,7 dihydroxy and 6.7 dimethoxy coumarins) appeared to be 
significantly active against all seven tested bacteria (zones of inhibition 15- 
20 mm), two others showed moderate activity, while two of them expressed 
a specific activity only against the two Gram-positive bacteria (5,7 diacetoxy 
coumarin and 3-bromo-4-benzoyloxy seselin). Eight coumarins appeared 
completely inactive. 
Conclusions: The results of the assays suggest that the activity of the tested 
coumarins can be attributed, to a considerable degree, to the existence of 
oxygenated substituents to simple coumarins, while the methoxy derivatives 
of the angular pyranocoumarins showed increased activities. It is remarkable 
that all the brominated derivatives exhibited stronger activity in comparison 
with all the rest conmarins possessing another pattem of substitution. 
p 7 - 1  Antimicrobial screening of some medicinal plants of 
Central America 
A. Camporese, N. Morsellino, G. Mucignat, M. Balick, R. Arvigo, R 
Esposito, A. M. Eletto, A. Tubaro 
Porderione, I; New Yurk, USA; S.Ignacio, BZ; Fisciam, Trieste, I 
Chiefly due to deficient sanitary conditions, skin infections represent in 
developing countries a common risk as a consequence of deep and 
superficial wounds. Traditional medicines front this risk by the use of a 
number of plant preparations, which should possess antimicrobial activity. 
In order to verify the antimicrobial properties of some medicinal plants used 
by the Central American traditional medicine, eight herbal drugs collected 
in Belize were studied: Bursera simanrba (Burseraceae) bark, Aristolorhia trilobata 
(Aristolochiaceae) leaves, A. trilobata bark, Guazuma ulm@lia (Stercuhceae) 
bark, Hamelia patens (Rubiaceae) leaves, Piper amalago (Piperaceae) leaves, 
Syngonium podophyllum leaves (Arareae), S. podophyllum bark. From each 
drug, three different extracts have been obtained by sequential extraction 
with hexane, chloroform and methanol. The antimicrobial activity of the 
extracts was tested against standard strains of Esrherirhia coli ATCC 25922, 
Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 25923, 
Enterococcus faecalis ATCC 29212, Caridida albirans ATCC 10231. The 
minimal inhibitory concentration (MIC) was determined by means of a 
microdilution method using microtitre plates, as prescribed by standard 
NCCLS. Serial dilution of the extracts ranging from 10.0 mg/mL to 0.31 
mg/mL have been tested. At the 2.5 mg/mL concentration, corresponding 
to 0.25% and easily reached in the wound healing preparations, almost all 
the extracts were able to inhibit microbial growth of one or more of the 
tested strains to a certain extent. The best antimicrobial activity was shown 
by Piper amalago, all the extracts of wich inhibit the growth of S. aureus and 
C. albicam (MIC < 0.31 mg/mL for the methanol extract and MIC= 1.25 
mg/mL for the hexane and the chloroform extract). Interesting activity was 
shown also by Aristolochia trilobata: the hexane and the chloroform extract of 
the leaves inhibit the growth of S. aureus (MIC < 0.31 mg/mL and= 1.25 
mg/mL, respectively), whereas for the bark only the chloroform extract 
inhibits this strain (MICz0.625 mg/mL). The tested extracts are complex 
mixtures of a number of different substances, each of them is probably 
present at low concentration. Therefore, the observed activities can be 
considered of h g h  interest and suggest the further fractionation of the most 
active extracts in order to individuate the active principles responsible for 
the observed activity. 
1 Characterization of antimicrobial activity of selected 
nonantibiotic drugs 
H. Kruszewska, T.  Zar$ba, S. Tyslu 
Warsaw, PL 
A variety ofpharmaceutical preparations, which are applied in the treatment 
of noninfectious diseases have been shown some in vitro antimicrobial 
activity. These drugs are called ‘nonantibiotics’. The aim of this study was to 
detect and characterise the antimicrobial activity expressed by selected 
nonantibiotic drugs, analyzed during state control performed in Drug 
Institute in Poland. About one hundred pharmaceutical preparations were 
randomly chosen from different groups of drugs. The surveillance study was 
performed on standard microbial strains: Staphylococcus aureus ATCC 6538P, 
Escherichia coli ATCC 8739, Pseudomonas aeruginosa ATCC 15442, and 
Candida albicans ATCC 10231. The sterile blotting-paper disks were soaked 
with 10% (v/v or w/v) solution of tested drug in 0.08 M phosphate buffer 
pH 7 and placed onto Mueller-Hinton 2 Agar plates, inoculated with spread 
standardzed cells suspension (0.5 McFarland scale) of suitable strain. The 
inhibition of bacterial growth was observed as a halo around the disk 
containing the tested compound. Size of inhibition zone was correlated 
with the antimicrobial activity of drug. Minimal inhibitory concentrations 
were calculated when inhibition zone was observed. It was shown, that the 
following drugs inhibited growth at least one of the examined strains: 
alendronate sodium (Alenato 5 mg, tabl.), alverine (Meteospasmyl 20 nig, 
caps.), diclofenac (Olfen 75 amp.), diethyltoluamide and antazoline (Detosol 
10% and 0.5% \ o h . ) ,  etodolac (Febret 200 mg, caps.), losartan (Lorista 50 
mg, tabl.), mesalazine (Pentasa 1%, susp.), naproxen (Nalgesin 550 mg, 
tabl.), ribavirin (Rebetol 200 mg, caps.), sulodexine (Vessel due F, caps.), 
temozolomide (Temodal 100 mg, caps.), ticlopidine (Ticlid 250 mg, tabl.), 
tolfenamic acid (Migea rapid 200 mg, tabl.). Staphylororrus aureus was iri vitro 
susceptible to most of the drugs listed above. Ticlopidine showed the 
highest activity against S. aureus, E.  coli and C. albirans (MICs equal 0.45, 
0.45, 0.65 mg/n& respectively). P. aeruginosa was resistant to most analyzed 
drugs but alendronate and ribavirin in concentration: 10 and 3 mg/niL, 
respectively, inhibited growth of this micro-organism. Aleiidronate in 
concentration 5.5 mg/mL also inhibited growth of E. coli and C. albicans. 
Detected antimicrobial activity of these drugs einphasises a necessity of 
neutralisation of this activity during microbial purity examination in 
pharmaceutical industry. 
lp469 Survey of incidence of bacterial agents in urinary tract 
infection and sensitivity testing on E. coli isolated in Sari in 
1998-99 
M. Haghshenas, S. Mimiobini 
Sari, IR 
Urinary tract infection (UTI) is one of the public health problem in all 
countries and also in Iran. In the UTI, the bacteria have the main role and 
the more common of them is E .  coli which it’s prevalence differs in different 
countries and for its treatment antibiotics are used. This studying has been 
performed to detemene the prevalence of bacterial infection in UTI and 
sensitivity testing on E. coli isolated. After teaching the patients, their mid- 
urine samples was collected in a plastic sterilized container. All specimens 
were cultured less then 20 min after collection on MacKoncki Agar and 
Notrian Agar incubated at 37 “C for 24 h. After incubation period the 
bacterial colonies were counted, that the cultures more than 100 000. For 
identification of bacteria the culture media of TSI, SIM, MR-W, Si. 
Citrate lia and urea as well as the agents of MR and VP were used. For 
sensitivity testing the Kirby-Bauer method with antibiotics discs of antidote 
were used. The culture medium for sensitivity testing was Muller-Hinton 
agar. In this survey 2942 specimens were tested, 250 (8.8%) of them were 
positive for E. coli. For other bactena the results were as follows: 120 
(4.07%) Staphylococus, 80 (2.7%) Proteus, 88 (2.99%) Enterobarter, 20 (0.78%) 
Pseudomonas, 41 (1.29%) Klebsiella. Because of the high prevalence ofE.  r d i  
as causative agant of UTI and the sensitivity testing performed, it was the 
most sensitive to seftizoksim (84.94%) and less sensitive to cephalexin 
(20.27%). There for because of sensitivity of E. coli to cephtizoxim, nalidixic 
acid, gentamicin and nitrofurantoin It is advised for detecting and choosiiig 
best drugs for treatment antibiugram must be done. 
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vl Macrolide resistance determinants in different species 
of streptococci isolated in Austria 
C. Jebelean, A. Bocksrucker, L. Binder, M. Haditsch, R. Watschinger, H .  
Mittemiayer 
Linz, A 
Objectives: We investigated the macrolide resistance determinants in p- 
haemolytic streptococci groups A and B, as well as in pneumococci and 
viridans s~reptococci isolated in Upper Austria and other regions of Austria. 
Methods: 294 S. pizeumoniae, 389 S. pyogem, 373 S.  agakdae and 106 viridans 
streptococci saains were examined using the agar dilution method for susceptibility 
to eIythromycin (E), azithromycin, clarithromycin, roxithromycin and josamycin. 
E-resistant (E-r) strains were fuaher invetpted for the resistance phenotype and 
for the presence of macrolide resistance genes (mef, erm and ermTR) . 
Results: The prevalence of E-r was 10.5% in S .  pneumoniae, 11.3% in S. 
pyogenes, 15% in S .  agalactiae and 25% in viridans streptococci. The 14- and 15- 
membered niacrolides were not active on E-r strains. Only josamycin was 
active on the strains with an M-phenotype and also showed a low MIC on 
some strains with an MLSB-phenotype. We found the following 
phenotype/genotype distribution: out of 29 E-r S .  pneumoniae, 33.3% M/ 
mef and 65.6% MLSB/erni; out of 61 E-r S. yyogenes, 70.4% M/mef, 13% 
MLSB/erm, 11.4% inducible MLSB/ermTR and 4.9% e m  + me6 out of 
25 E-r viridans, 53.8% M and 44% MLSB phenotype. Using a PCR method, 
we could detect 12 ‘mef, 9 ‘erm’, and in four strains none of the genes we 
were searching for. Of the 26 E-r S. agalactiae strains, 54% carried the 
ermTR-, 31% the erm-and 15% the mef-gene. 
Conclusions: 1. The prevalence of macrolide resistance determinants differs 
in various streptococci species. 2. Josamycin, a 16-membered macrolide, 
was effective in vitro on a l l  streptococci with an M-phenotype, on some 
strains with inducible MLSB it showed a much lower MIC than 14- and 15- 
membered macrolides. 
/p4711 Macrolide resistance in Streptococcus pneumoniae 
isolated in Poland from children under 5 years of age 
K. Betlejewska, J. Fiett, M. Turzyhska, W. Hryniewicz 
Warsaw, PL 
Objectives: Erythromycin and other macrolide antibiotics show consider- 
able bactericidal activity against Streptococcus pneumoniae, important respira- 
tory pathogen. The mechanisms of macrolide resistance have been 
elucidated and involve target modification mediated by a methylase 
(encoded by e m  genes) which modifies an adenine in23 rRNA and efflux 
system encoded by mef genes. The present study was performed to 
investigate the niacrolide susceptibility and mechanisms of resistance among 
Strepfococcus pneumoniae isolated in Poland. 
Materials and methods: From 1 January 1997 to 31 December 1999 we 
collected 93 snains of Srwptucoccus prrarmoniae isolated &om respiratory tract 
infections tiom children under 5-year-old. Minimal inhibitory concentrations 
were determined by means of broth microdilution method accordmg to NCCLS 
guidelines for the following antibioacs: penicillin, etythromycin, nfmpin, 
bimethoprinl/sulfometoxazole, cefotaxime, cefniaxone, cefaclor, vancomycin 
clindamycin, linkomycin, doxycyche, chloramphenicol, teicoplanin, inupenem, 
meropenem, ciprofloxacin, moxifloxacin. AU strains were screened for MLSB 
and M phenotype by an agar disc dihiosion method. PCR identification of ermB 
and mefA was completed by SutcliEe method. Serotypes of S. pneumoniae were 
determined at the Statens Serum Imtitute, Copenhagen, Dennwk. 
Results: Twentyone isolates (22.6%) were susceptible to penicillin. 
Seventy-two isolates (77.4%) were nonsusceptible to penicillin (7- 
intermediate and 65 resistant to penicillin)]. All pneumococci were 
susceptible to vancomycin and rifampin. Forty-three percentages of isolates 
were resistant to amoxicdlin, cefotaxhe, cefhiaxone, meropenem, imipenem 
and erythroniycin. The highest percentage of resistance was observed for 
cefaclor (78%1), chloratnphenicol (70%), nimethopnm/sulfametho~zole (74%) 
and clindaniycin (31%)). Twenty-mne of 40 erythromycin-resistant isolates 
demonstrated a MLSB phenotype (27 en&+). Eleven of erythromycin- 
resistant snain demonstrated a M phenotype ( I  1 me--). The most common 
serotype waF 23F found in 40% of isoIates. 
Conclusions: Target site modification ( e m s )  resistance mechanisms was 
prevalent among the macrohde-resistant isolates of macrolide resistant 
Streptomccus pnrrrmoiiiae. 
lp4721 Characterization of erythromycin resistant S. pneumniae 
isolates recovered from 11 European medical centers 
R. R. Reinert, A. Al-Lahham, A. Ringelstein, R. Lutticken, F.  J. Schmitz 
Aachen, Diisseldoff, D 
Background: The resistance rate of Streptorocas pneumoniae to macrolides is a 
problem of increasing concern worldwide. The aim of this study is to 
characterize the erythromycin resistant pneumococcal strains (Erythromycin 
1 mg/L) collected €-om 1 1  European medical university centen in 1997. 
Methods: Eightyfour clinical strains of erythromycin resistant S. pneumonia 
(ERSP) were collected tiom 11 medical centen in 7 European countries. MICs 
to p e n i c h  (PEN), cefotaxime (CETA), amoxidm (AMOX), clindamycin 
(CLI), quinupristin-dabopristin (Q-D), vancomycin (VAN), teicoplanin (TEI), 
ciprofloxacin (CIP), roxithromycin (ROXI), danthromycin (CLA), spiramycin 
(SPI), azithromycin (MI) and telithromycin (TELI) were determined by the 
microdilution method (NCCLS). S& were serotyped by Nedeld Quellung 
reaction. Macrolide resistance genes (ermB and met??) were analyzed by PCR. 
Results: The resistance rate of the erythromycin resistant strains to other 
antibiotics was as follows: PEN (4.8%), CETA (4.8%), AMOX (9.5%), CLI 
(77.4%), ROXI (95.2%). CLA (90.5%), SPI (89.3%), AZI (90.5%). AU 
strains were sensitive for TELI, CIP, TEI, VAN, Q D  and SPAR. Serotypes 
14 (31%), 23F (24%) and 6B (17.9%) were the most prevalent. The 
percentage of ERSP strains with the efflux gene (meE f)  was 19.1% and 
with the MLSB type of resistance (ermB+) 78.8%. 
Conclusions: The MLSB phenotype is the predominant mechanism of 
maci~olide resistance in S .  pneumoniae in Europe. Careful usage of macrolides 
in therapy and continuous surveillance of resistance protile of S.  pneurnoniae 
are warranted. 
Incidence of M-phenotype (mefE) and MLSB-type 
(ermB) among erythromycin resistant 5. pneumoniae isolates 
recovered in Germany; 1992-99 
R. R. Reinen, A. A-Lahham, S. Haupts, R. Lutticken 
Aachen, D 
Background: Macrolide resistance among clinical isolates of Streptococcus 
pneunioniae is increasing worldwide. In the present study erythromycin 
resistant S .  pneumoniae strains (ERSP) (ERY 1 mg/L) isolated as part of an 
ongoing German nationwide surveillance study on invasive pneumococcal 
disease from 1992 through 1999 were characterized. 
Methods: A total of 191 ERSP were collected by 60 medical laboratories in 
Germany. MICs of penicillin (PEN), cefotaxime (CETA), erythromycin 
(ERY), clindamycin (CLI), quinupristin-dalfopristin (Q-D), tetracycline 
(TET), teicoplanin (TEI), vancomycin (VAN), sparfloxacin (SPA), and 
ciprofloxacin (CIP) were determined by the microdilution method as 
reconmended by the NCCLS. Serotyping was performed by the Neufeld 
Quellung reaction. All ERSP were characterized for macrolide resistance 
genes (ermB and meE) by PCR. 
Results: The resistance rate of the ERSP strains to other antibiotics was as 
follows: PEN (1.1%). CETA (0.5%), CLI (47.1%), TET (56.6%), SPA 
(0.5%) and CIP (1.6%). All strains were susceptible to TEI, VAN and Q-D. 
Serotypes 14 (22%) and 6B (22%) were the most prevalent. The percentage 
of ERSP strains with the efflux mechanism (meE+) was 52.4%) and with 
the MLSB type ( e n d + )  46.6%. Two strains (1.1%) were mefE and ermB 
negative and need further investigation. 
Conclusions: Both macrolide resistance mechanisms (meE and ermB) are 
widespread in Germany. Careful usage of macrolides in therapy and 
continuous surveillance of resistance are warranted. 
Mutations in 235 rRNA causing macrolide resistance in 
Streptococcus pneumoniae 
M. Pihlajamaki, J. Kataja, H. Seppala, P. Kotilainen, P. Huovinen, J. Jalava 
Turku, F I N  
Background and objectives: The two recognized mechanisms for 
erythromycin resistance in Streptococcus pneunioniae (pneumococcus) are 
target site modification by the erythromycin ribosome methylase [encoded by 
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the erm(B)gene] causing the MLSB -phenotype (resistance to erythromycin, 
clindamycin and streptogramin B) and macrolide efflux [encode by the 
mef(A)gene] causing the M-phenotype (resistance to erythromycin and other 
1 4  or 15-membered-ring macrolides). A novel phenotype in macrolide 
resistant pneumococci, with neither of these resistance genes, has also been 
found (Antiminob Agents Chernofh 2000: 44(8): 2118-25). Ths new 
phenotype refels to resistance to erythromycin and spiramycin and low level 
resistance to clindamycin. In this work we looked for the mutations in 23s 
rRNA, noted to confer erythromycin resistance in other species. 
Materials and methods: Minimal inhibitory concentration (MIC) values for 18 
antimicrobials were tested from 1300 penicillin nonsusceptible pneumococci 
collected from Finnish clinical microbiology laboratories. Of the 540 
macrolide-resistant isolates, phenotypes were determined by the mple disc 
method and by analysing the MIC data. The presence of the em@), mef(A), 
erm(A), erm(C), erm(TR) and mrs(A) genes was tested by PCR. Isolates 
presenting none of the resistance genes were tested for mutahons in the 
domain V of the 23s rRNA by using PCR and DNA sequencing. 
Results: Of the macrolide-resistant isolates, 70% expressed the MLSB - 
phenotype, all of which had the em@) gene. Twenty-five percent of the 
pneumococci expressed the M-phenotype and had the mef(A) gene. The novel 
phenotype was found in 14 isolates in whch none of the studied genes could be 
detected. The four alleles encodmg 23s rRNA has been sequenced from the 
strains. Adenine to cytosine mutation in position 2059 was detected in 11 strains, 
in 10 strains all four alleles were mutated. In the same position adenine to guanine 
mutation was detected in two alleles in two strains. One s h a i n  had cytosine to 
guanine mutation in the position 2611 in all four alleles. 
Conclusions: Mutations in the positions 2059 and 2611 of 23s rRNA confer 
resistance to macrolides in strains with the novel phenotype. Simdar 
mutations has previously been shown to occur in vim. It remains to be 
studied weather the use of macrolides in individual patients in able to gwe 
rise to these mutations. 
v] Fluoroquinolone resistance of mycoplasma is 
(non)specifically induced by interaction with HeLa cells 
K. Momynaliev, 0. Smirnova, V. Orlova, V. Ladygina, V. Govorun 
Moscow, RUS 
Objectives: Mycoplasmas are the smallest and simplest self-replicating 
prokaryotes. Due to their small genomes (0.58-1.35 Mb) these organism 
have limited metabolic options for replication and survival. Most of 
mycoplasmas are parasites, exhibiting strict host and tissue specificities. 
Tetracyclines, macrolides and fluoroquinolones are considered to be the 
most effective drugs against mycoplasmal infection. Fluoroquinolones are 
broad-spectrum antibiotics applied in the clinics for treatment of diseases 
caused both by gram-positive and gram-negative bacteria. Our aim was to 
find whether an interaction between mycoplasma and Hela cells non or 
specifically induced mycoplasma resistance to fluoroquinolone. 
Materials and methods: Growth conditions for HeLa cells, M. horninis H34, A .  
laidlaudi PG8 as well as antibiotic susceptibility were camed out according to 
standard procedure. Inoculation of cell cultures by mycoplasma was made as 
described by Taylor-Robinson (1991) and antibiotic was added at 4 or 48 h at 37 
"C. Infected HeLa cells were destroyed by osmotic shock and then mycoplasinas 
were pelleted by centrifugation. To monitor genomic changes we used the 
following methods: RAPD, Alu-PCR, SSCP gyrA, paK, DNA sequencing. 
Results: The MICs for M .  horninis and A. laidlawii after treatment with 
ciprofloxacin (CFX) at 48 h ofthe infected Hella ceUs were found vable 1). The 
survival of mycoplasma was depended from the time of the addition antibiotic. If 
CFX was added at 4 h of incubation, the MICs for M. hornonis and A. laidlawii 
were 1.0 and 0.5 pg/mL correspondqly. The presence of eucaryotic DNA in 
samples were determined by Alu-PCR. The RAPD-analysis showed the distinct 
differences between ' d d  type' and 'experimental' mycoplasma. Whereas no 
@cant aerences in quinolone resistance-determining region (QRDR) of 
gyrA, parC were observed between ' d d  type' and 'experimentat' mycoplasmas 
as showed by SSCP and DNA sequencing. 
Table 1 Survivnl of M .  Iroririnis and A faidlaivii after treannrnr of infectrd HeLd cells 
w r h  CFX (48 11) 
Conclusions: The biological relationships between mycoplasma and 
eucaryotic cells plays critical role in adaptation of mycoplasmas. It is 
important that interaction between mycoplasma and HeLa cells evoked 
genetic rearrangements. We suggest that quinolone resistance is associated 
with genomic and metabolic changes in mycoplasma, whch induced by 
interaction with HeLa cells, but not with mutation in QRDR. 
lp4761 Multiple mechanisms of resistance to fluoroquinolones 
in clinical isolates of Morganda morganii 
L. Martinez-Martinez, I. Garcia, A. Domenech-Sanchez, P. Joyanes, M. C. 
Conejo, V. J .  Benedi, A. Pascual 
Seuille, Palma de Mallorca, E 
Objectives: To evaluate the mechanism of fluoroquinolones (FQ) resistance 
in clinical isolates of M .  morganii (Mmo). 
Methods: Five strains of Mmo were studied Mmo CECT173 (Mmol) and 
4 clinical isolates, Mmo2 to h 0 5 .  MICs of nalidixic acid (NAL) and FQ 
were determined by microdilution. Outer membrane protein (OMP) 
profiles were determined by SDS-PAGE. Accumulation of norfloxacin 
(NOR) in bacteria treated or not with 0.1 m~ carbonylcianide m- 
chlorophenyl-hydrazone (CCCP) was measured by fluorometry. Mutations 
in gyrA or gyrB were inferred from decreased MICs of quinolones after 
transformation of Mmo strains with plasmids pBP517 (coding for wild-type 
gyrA &om E. (011) and pBP548 (coding for wild-type gyrB from E. coli). 
Results: MICs (mg/L) of NAL, ciprofloxacin (CIP) and N O R  were: < 0.5/ 
<0.06/<0.06 (Mmol), 64/32/128 (Mmo2), >1024/64/128 (Mmol), 
> 1024/1/2 (Mmo4) and > 1024/4/32 (Mmo5). OMP profiles were 
similar in all Muellex-Hinton broth, nutrient broth and nutrient broth + 
20% sucrose. Mmol to Mmo4 expressed 2 bands in the enterobacterial 
porin region ( 3 k 4 5  kDa), whde Mmo5 expressed only 1 band. Strain 
Mmo3 admtionally expressed a 50-kDa band. The accumulation of N O R  
was 2.1 (strain Mm02) and 5.9 times (strain Mmo3) higher in CCCP- 
treated cells than in not treated cells, while it was not affected in strains 
Mmol, Mmo4 and b 0 5 .  Transformants containing plasmids pBP517 and 
pBP548 were only obtained in strain Mmo2: wild type GyrA reduced the 
MICs of CIP 4 8  times and did not reduce the MIC of NAL; wild-type 
GyrB reduced the MIC of NAL 2-4 times and the MIC of CIP 8-16 times. 
Conclusion: Besides gyrA and gyrB mutations, energy-dependent accumu- 
lation of fluoroquinolones and altered OMP profiles have been observed in 
fluoroquinolone-resistant clinical isolates of M. morganii. 
vl Levofloxacin: low comparative potential for resistance 
development among 5treptococcus pneumoniae 
I .  N. Simpson, 1. Harding 
Upwell, UK 
Introduction: Fluoroquinolones appear to have differing potentials to select 
for resistance. Fluoroquinolone resistance in Streptococcus pizeumot~iue is 
generally due to mutations in the gyrA, gyrB, parC and parE genes, within 
the quinolone-resistance determining region (QRDR), resulting in changes 
to the subunits of the type I1 DNA topoisomerase gyrase and topoisomerase 
N enzymes. PmrA, a membrane associated protein, also mediates resistance 
by active efflux of fluoroquinolones. 
Objectives: To review the potential of S. pneurnoniae to develop resistance 
to levofloxacin and comparator fluoroquinolones. 
Results: At 4 x MIC, the frequency of levofloxacin-resistant mutants (< 10-', 
is much lower than obtained with sparfloxacin (> 2.2 x lo-'') or trovafloxacin 
(6.2 x lo-*)). Single-step ciprofloxaciii-resistance is g e n r d y  due to mutation at 
Ser79 of Patc whereas sparfloxacin-resistance is normally due to mutation at 
Ser83 of GyrA. The concept of target specificity is at variance with studies using 
isolated gyrase and topoisomerase enzymes, which indicate that all fluoroqui- 
nolones preferentially inhibit topoisomerase IV rather than gyrase. In serial 
passage experiments. a mean of < 15 passages is required to increase the MIC of 
ciprofloxacin, grepafloxaan, spartloxacin and trovafloxacin by 4-fold whereas a 
mean of 24 passages is required to achieve the same effect with Icvofloxacin. 
High-level resistance (> 4-fold increase in MIC) to ciprofloxacin, grepdox- 
acin, sparfloxacin and trovafloxacin is generally associated with changes in ParC 
and/or GyrA. Levofloxacin-resistance emerges more slowly and appears to 
necessitate mutations in ParE and GyrB to achieve high-level resistance. 
Efflux-mediated resistance accountS for 6/10 ciprofloxacin-resistant mutants 
but fewer than 3/20 mutants obtained by serial passage on levofloxacin and 
other newer fluoroquinolones. 
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Conclusion: Levofloxacin has low potential for the development of 
resistance in S. pneumoniae. Ths is confirmed by the low prevalence of 
resistance observed worldwide after many years of use and is an important 
consideration in the treatment of respiratory tract infections. 
Ip478J cost of norfloxacin resistance for urinary tract 
Escherichia coli 
P. Lindgren, D. Hughes 
Uppsala, S 
Objectives: To detemiine the development and the cost of Norfloxacin 
resistant mutations in urinary tract isolated Escherichia coli. 
Methods: Nortloxacin resistant (NFR) mutants were selected kom a sensitive E. 
coli urinary tract isolate ( d d  type) at low levels of Norfloxacin. These stclins are 
thus isogenic and M e r  only in the acquired resistance mutation. Resistance levels 
for Nodoxacin and other antibiotics were determined by E-test. Resistance 
mutations were identified by sequencing gyrA, gyrB, p d ,  parE and marOK. 
Costs of resistance were determined by measuring growth rate and competition 
of mutants against the antibiotic-sensitive wild type in urine. 
Results: Single mutations were found in either gyrA, gyrB or the mar0R 
region for all mutants tested. There is a clolse correspondance between the 
mutant gene responsible for NFR and the pattern of MIC values. Thus, 
gyrA niutants all have high MICs for nahdixic acid, whde mar0R 
mutations have increased MICs for chloramphenicol. The measured 
generation times of these mutants do not differ significantly from the 
sensitive wild type. However, most of the NFR-mutants show a reduced 
fitness in competitions experiments in urine against the sensitive wild-type. 
This shows that even for very low level resistance mutations there is a fitness 
cost. Interestingly, a few NFR-mutants have an increased fitness in 
competition compared to the sensitive E. coli isolate. 
Conclusion: In general, antibiotic resistant mutations are often associated 
with decreased fitness of the resistant bacteria. These selected NFR-mutants 
show that single mutations in the gyrA, gyrB or marOR genes most often 
reduce fitness. This has implications for the evolution of high-level 
resistance by the accumulation of multiple mutations. 
jp479/ In vitro plasmid transferring from multiple resistant to 
susceptible strains of Staphylococcus aureus by transformation 
N. Yigit, A. Ayyildiz, A. E. Aktas, I. Batat 
Erruritm, TR 
Staphylococci are important bacteria that conunonly come out as causative 
agents in many infections with both hospital and comniunity origin The major 
problem in these infections is that of antimicrobial resistance developing in the 
bacteria. It IS known that the fkquency of this resistance has reached to an 
important levels as a result of improper and widespread use of antibiotics. The 
progress of resistance is more frequent pamcularly in S. aweus strains. Since 
these nucro-organisna have multiple resistance genes, they are resistant to many 
anhbiotics along with the beta lactamines. Because the multiple resistant strains 
can colonize in the patients receiving antibiotics, spreading of these micro- 
organisms in hospital environment and subsequently leadmg to the nosocomial 
infections have become easier. In order to detennine if the drug resistance will 
transfer to susceptible bacteria, transformation procedure was conducted 
between 6 S. aurpus strains isolated &on1 several clinical samples, and found to 
be resistant to unipetiem, clindamycin, netilmycin, gentamkin, tobramycin and 
mupirocin, and 21 S. aureus strains determined as susceptible against the same 
drugs. At the end, 3 out of 6 donor bacteria found to be effective donor, that is 
they were capable transfemng the resistance they had. On the other hand, 9 out 
of 21 susceptible recipient strains became resistant after transformation. Three 
of these 9 transformed strains become resistant to gentanlicin, 3 to 
mupirocin, 1 to tobramycin and 2 to both gentainicin and tobramycin. It 
was obterved that none of the recipient bacteria became resistant to 
imipenem, clindamycin and netilmycin. 
Ip480/ Telithromycin interacts directly with the base of A752 
in domain I I  of 235 ribosomal RNA, in contrast to erythromycin 
and clarithromycin 
G. W. Novotny, N .  M. Andersen, S. Douthwaite 
Oderise, DK 
The macrolide erythromycin (ERY), its 6-0-methyl derivative, clarithromycin 
(CLA), and the ketolide telithromycin (TEL) bind to bacterial ribosomes 
primarily through interactions with nucleotides in domains I1 and V of 23s 
rRNA. The key determinant of drug binding is nucleotide A2058 in domain 
V, where all the drugs interact in a slrmkr manner. In domain 11, the drug 
interact at nucleotide A752. For ERY and CLA, the domain I1 interaction is 
made through the macrolide 3-~-cladinose moiety, whereas TEL interacts 
through its C11,12-carbamate extension. In chemical mod&ication experi- 
ments, TEL protects A752, whereas ERY and CLA enhance the accessibility of 
this base. The nature and strength of the interactions with A752 are thus 
distinctly Merent for the macrolides and TEL. T h i q  difference correlates with 
the ability of TEL to maintain some binding capacity to ribosomes that are 
mutated at A2058, the main contact site of the drugs, and may account for the 
high chical e5cacy of TEL apns t  ERY-resistant pneumococcal mfections. In 
the present study, we have induced mutations in bases within domains I1 and V 
of the Escherichia coli 23s rRNA to investigate further the sites of drug contact. 
Mutant 23s rRNA genes were introduced on a plasmid into an E .  coli strain 
from whch the chromosomal copies of the rRNA operons (rm) had been 
deleted. Growth is dependent on the plamid copy of rm, and the strain is thus 
homozygous with respect to the plasmid-coded rRNA genes. Mutagenesis of 
A2058, as expected, gave resistance to ERY and CLA, and lower resistance to 
TEL. The resistance patterm conferred by domain I1 mutations were more 
complex. Substitution of the adenine base at position 752 gave low resistance to 
TEL, but no change in the phenotype towards ERY or CLA. However, 
deletion of this nucleotide conferred resistance to all three drugs. These results 
are consistent with the idea that TEL interacts directly with the base of A752, 
probably through the drug C11,lZ-carbamate extension. The interactions of 
ERY and CLA with domain I1 are made at some other region of nucleotide 
752, and/or at an adjacent nucleotide. Thus, in contrast to TEL, the identity 
of the base at position 752 has no bearing on the binding of ERY and CLA. 
rim1 Genetic characterization of clinical isolates of 
Mycoplasma hominis resistant to tetracycline 
V. M. Govorun, K. T. Momynaliev, A. E. Soroka, T. A. Akopian, 
A. M.  Taraskina, A. M. Savicheva 
Moscou~, St Petenburg, RUS 
Objective: Study of structure of the tet(M) determinant in M.  hominis 
clinical isolates resistant to tetracycline and investigation of genetic changes 
in the isolates obtained from patients with chronic infection. 
Methods: Cultivation of M.  horninis, PCR, sequencing, RAPD-PCR. 
Results: 127 clinical isolates of M .  hominis were studied for the presence of 
TetM determinant. 13 of them were resistant to Tc and found to contain 
tet(M) gene, and comparison of nucleotide sequence has allowed to reveal the 
nucleotide tet(M) polymorphism in all 13 isolates. The mosaic structure of 11 of 
tet(M)-containing isolate is completely identical and that IS classified as the new 
type of allele. Also one more new allele variant of tet(M) was found in 2 other 
isolates. The fast and reproducible method for the M .  Iiominis strains molecular 
typing with arbitrary prinier W D )  was developed. The phenomenon of the 
genetic heterogeneity in the mycoplasnd population, which arises in the 
course of symptomatic antibacterial therapy, is described. The rnycoplasmal 
DNA was obtained &om the patients during the treatment period and for 3-6 
months later. Recurring of mycoplasnioses was revealed among the majonty of 
the patients, despite of the treatment canied out. The electrophoretic profile of 
amplification products remained unchangeable in 4 of 9 Tc(r) isolates of M. 
horninis. In other cases the results show that the RAPD fingerprinting method 
distinguishes genetically Merent Tc(r) strains of M. horninis. 
Conclusion: 11 of Tc(r) isolates of M .  hominis with new alleles variants of 
tet(M) could acquire the resistance gene from one host, while two isolates 
have done it from other resource. The sequence analysis showed that the 
evolution of M .  horninis resistance to Tc  implies acquirement of tet(M) 
genes from various hosts and recombination. We showed that RAPD could 
be used not only for distinguishing among M. hominis clinical isolates. 
RAPD revealed the significant changes in genome structure of M.  hominis 
cltnical isolates in the course of treatment with antibiotics. 
p m ]  Differential transcription of omp3B gene in a 
doxycycline-resistant clinical isolate and laboratory strain E of 
Chlamydia trachomatis 
0. Y. Misurina, E. V. Shipicina, K. T. Mominaliev, A. M. Savicheva, 
V. M. Govorun 
Moscow, St Petersbuq, RUS 
Objectives: In order to investigate the alteration ofthe growth rate or life cycle of 
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doxycyhe-resistant chca l  isolates Chlamydia harhomatis, transcription of 
omp3B gene for cystein-rich outer membrane protein OMP3B was analyzed. 
Methods: The clinical isolate of C .  trachomatis, resistant to 2.54 pg/mL and 
C. trachomatis laboratory strain E (MIC of doxycycline 0.04 pg/mL) was 
compared. McCoy cells were lnfected at approximately 1 MOI of 
doxycycline-resistant clinical isolate of C. trachomatis and C. trachomatis 
strain E. Total RNA extractions were performed at 24 and at 36 h after 
infection. The RT-PCR assays targeted the omp3B gene and 16s RNA 
gene. For PCR of omp3B gene only that quantities of cDNA was used, that 
gave equal brightness of electrophoresis bands after PCR of 16s RNA gene. 
Result and conclusion: The RT-PCR analysis has shown that the quantity 
of transcript of omp3B gene in doxycycline-resistant clinical isolates C. 
trachomatis substantially decreased compared to doxycycline-susceptible C. 
trachomatis strain E. To  confirm this results by an independent approach, 
quantitative RT-PCR and other assays are presently performed. 
(p4831 Expression of the carbapenemase gene (&A) in 
Bactemides fragilis without insertion sequence element promoters 
R. Edwards, F. Yazdani 
Nottingham, U K  
Carbapenem antibiotics show stability to beta-lactamases typically produced by 
Eucmoidesjagilis. However, approx. 5% of clinical isolates of B.ja$is possess the 
carbapenemase gene c6A. One in 10 of these show expression of c6A resulting in 
hgh levels of carbapenemase production and resistance. High expression of cfiA 
is reported to be associated with insertion sequence (IS) elements immediately 
upstream of the gene; 11 IS element types have so far been identified. However, 
we have encountered carbapenem resistance in B. jagilis without IS elements 
immediately upstream of &A. An isolate from a faecal sample, comiirmed by 
PCR to be cfiA positive, was shown to be resistant to meropenem (MIC 128 
mg/L) and imipeneni (MIC 64 mg/L), and gave a specific activity of 99 nmols 
meropenem hydrolysed/min/mg protem. Further examination by PCR using 
primers derived from a conserved region upstream of &A, and from within c6A 
itself, showed no insertion w i h  300 bp upstream of the gene. Sequencing of 
the upstreani PCR product revealed identity with the published DNA sequence 
found adjacent to 'silent' &A. Low level resistance (MIC of meropenem 16 mg/ 
L) has also been observed in shains without IS elements upstream of c6A. 
Therefore, & expression resulting in carbapenem resistance can o c m  in the 
absence of IS elements immeckately upstream of the gene, suggeshng the presence 
of efficient promoters within the cfiA gene of some stmins. 
v1 Prevalence of resistance in 5higellae in a Romanian 
clinical hospital for infectious diseases 
I .  Rebedea, D. Cocioaba, I. Mitache, S. Iacob, G. Coltan, C. Apostolescu 
Bucharesl, RO 
Background: Shigellosis is an increasing course of bacterial diarrhea. We 
determined the antimicrobial resistance of Shigella spp. isolated in our 
hospital, because an effective antimicrobial therapy can reduce the duration 
of illness, the severity and potential complications. 
Methods: 1306 strains of Shi&l!elln-l177 Sh. Flexneri and 132 Sh. Sonriei 
isolated !?om stool samples during 1999-2000-were tested for resistance to 
ampicillin, amoxicdm/clavulanat, tetracycline, nahdixic acid and fluor- 
oquinolone, colistin, himetoprim/sulfaniethoxazole and third-generation 
cephalosporins, by broth microdilution [NCCLS]. 
Results: High rates of resistance were found in both Sh. Flexneri and Sh. 
Soniiei, respectively, trimetoprim/sulfamethoxazole [50% and 40%], tetra- 
cycline [25% and 30%], colistin [70% and 60%], ampicillin (30% and 50%], 
nalidixic acid [60% and 30%]. A very low resistance was determined to 
fluoroquinolones, third-generation cephalosporins and amoxicillidclavdanat. 
Conclusions: Our results confirm that a lot of antimicrobial.. lost efficacy against 
Ship/lla spp. Fluoroquinolones, W-generation cephalosporins and amoxicillin/ 
clavulanat can be considered as dmgs of choice for treatment of Shgellosis. 
lp4851 Co-transfer of aminoglycosides and ceftazidime 
resistance in nosocomial Klebsiella pneumoniae strains 
S. Akhan, S. Giindes, B. Mutlu. H. Vahaboglu, A. Willke 
Kocaeli, TR 
Objectives: T o  asses the relationship between transferable ceftazidime 
resistance and the probability of cotransfer of aminoglycosides resistance. 
Methods: We studed on 30 nosocomial k7ebsiella isolates; those were 
transconjugated on agar media and the recipients were selected on M H  agars 
supplemented by rifampicin (100 mg/L) plus ceftazidune (8 mg/L). The 
recipient was Erchm'chia coli J53-2 (met pro Rifi). From these, we obtained 
13 transconjugates resistant to ceftazidime. Antibiotic susceptibhty tests 
were performed to amikacin, gentamicin, tobramicin, isepamicin, netilm- 
cin and ceftazidime on Mueller-Hinton (MH) agar (Oxoid) according to 
the recommendations of the National Committee for Clinical Laboratory 
Standards (NCCLS). 
Results: From the 13 K .  pneumoniae there were resistance to amikacin in 5, 
to gentamicin in 11, to tobramicin in 10, to isepamicin in 6 and to 
netilmicin in 9. Aminoglycosides resistance pattern transferred with 
ceftazidime resistance to the recipient E.  coli was in one tranconjugate to 
gentamicin and tobramicin together and in five only to tobramicin. 
Conclusions: It seems that the resistance to amikacin, iseparnicin and 
netilrmcin were not transferred with the transconjugation of ceftazidime. 
However, we found 1 gentamicin resistant transconjugate from 11 
gentamicin resistant isolates and 6 from 10 tobramicin resistant isolates. 
lp4861 Genetic basis of chloramphenicol resistance in 26 
Clostridium difficie strains 
M. Chosson, D. Decre, N. Hidn, B. Burghoffer, J.-C. Petit 
Paris, F 
Chloramphenicol (CMP) resistance is usually mediated by production of the 
chloramphenicol acetyltransferase (CAT), encoded by the catD gene in 
Clostridium d@cile. The 26 CMP-resistant C. dficile strains used in hs study 
were isolated from human feces. The CMP susceptibility was studied on 
prereduced Whs-Chalgren  medium. Serotyping was performed by the 
method of Delmke et a/. CAT activity was studied by a colorimetric 
technique. PCR amplifications were performed with specific primers for 
the catD, catQ, catB genes and the catD transposon. The probes used for 
Southern hybridization were prepared by PCR with primers hybridizing in 
catD, tnpX and tnpZ genes. For cloning, C. difldle genomic DNA was 
cleaved with MfeI, MboI, and HindIII. The fragments were ligated to 
appropriately cleaved pUC18 DNA. E.  coli transformants were selected on 
agar containing ampicillin and CMP. All CMP resistant isolates belonged to 
serogoup C,  except one nontypeable. P C R  and Southern blot analysis 
showed in 25 isolates the presence of the catD gene on a transposon related 
to Tn4451 of C. pefingens. Hybridization analysis c o n b e d  that at least 2 
copies of the catD gene were present for each strain. Furthermore, the 
transposon was shown to be present in duplicate in these 25 strains. The 
nontypable resistant isolate did not hybridize to either the catD probe or the 
probes from any of the other Cat hybrization class identified in Clostridia: 
catP, catQ and catB. CAT activity was not observed in this isolate, 
indicating the presence of another resistance mechanism. Up to now, 
attempts to clone a new resistance gene have failed, although we cloned the 
catD gene of a resistant isolate used as control. The fact that this strain 
presents an associated resistance to erythromycin and tetracycline could 
suggest an active efflux mechanism. Actually, genes encoding for an efflux 
protein described in bacteria of different genera are not present in genebanks 
of C. d@& genome. The investigation of resistance determinants of 
tetracyciine and erythromycin, which is currently being carried out in our 
laboratory, may yield additional insights into CMP resistance mechanism of 
this strain. 
v] Three ligase genes in vancomycin resistant 
Enterncoccus gallinarum, characterization of a D-Ala-D-Ala 
ligase flanking the vanC cluster 
0. H. Ambur, C. A. Arias, P. E. Reynolds 
Cambridge, UK;  Santa Fe de Bogota, CO 
Constitutive low level resistance to vancomycin in Enterococnrs gallinarum 
BM4174 (VanC phenotype) involves an altered pathway of peptidoglycan 
synthesis and the elimination of susceptible precursors. Substitution of D- 
alanyl-r)-alanine (synthesised by Ddl) by u-alanyl-o-serine (synthesized by 
VanC-I) at the terminus of late peptidoglycan precursors results in a sixfold 
decrease in affinity for vancomycin. An open reading kame was identified 
230 nucleotides downstream &om the vanC resistance cluster in E. 
gallinarum BM4174. This gene, designated ddl2, encoded a protein of 343 
amino acid residues with a calculated Mr 38430: Ddl2 displayed s igdcant  
sequence identity to the ligases, Ddl (32%) and VanC-I (33%) present in this 
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strain. The ddl2. gene was amplified by PCR and cloned into a vector that 
allows expression of the gene as a His-tagged protein. The Hi-tagged Ddl2 
was overexpressed in Escherichia coli and purified. In uitro assays of Ddl2 
activity were performed using various concentrations of [14C]D-Ala 
separately or together with D-Ser. The products were separated by thin 
layer chromatography and quantified by phosphorimaging. The enzymatic 
activity was determined as 0.5 mol D-Ala-D-Ala/min/mol enzyme at a 
substrate concentration of 10 nm D-Ala. No D-Ala-D-Ser was detected 
irrespective of the relative concentration of D-Ala and D-Ser, indicating 
lack of D-Ala:D-Ser ligase activity under the conditions of the assay. The 
vancomycin-dependent strain E. famlis BM4320 (VanB-phenotype) lacks Ddl 
activity due to a S3191 substitution, and is dependent for growth on induction 
of the resistance pathway for peptidoglycan synthesis by vancomycin. In order 
to inveshgate the in vivo activity of Ddl2, the ddl2 gene includmg the ribosomal 
binding site was cloned under the control of the P2 promoter in a shuttle 
vector, and introduced into E.faecalis BM4320. The transformed strain was no 
longer dependent on vancomycin indicadng that Ddl2 had complemented the 
defective Ddl in thls shain. Analysis of the peptidoglycan precursors in the 
transformed strain grown in the absence of vanconiycin indicated that 
precursors terminating in D-Ala-D-Lac had been replaced completely by 
those terminating in D-Ala-D-Ala. These results document the presence of 
three ligases with potential activity in the same organism. 
Non-PmrA mediated multidrug efflux in Streptococcus 
pneumoniae 
E. Pestova, J. J. Millichap, F. Siddiqui, G. A. Noskin, L. R. Peterson 
Northbrook, Chirap, U S A  
Active efflux is becoming widely recognized as an important initial step in 
the development of resistance to fluoroquinolone antimicrobial agents in S. 
pneurnoniae, the leading cause of serious community acquired respiratory 
tract infections, and meningitis. P m A  has been the only multidrug transport 
protein associated with fluoroquinolone resistance in S. pneumoniae, while 
the other bacterial species contain several distinct transporters with similar 
substrate specificities that are involved in fluoroquinolone resistance. In this 
study, we present evidence for alternative efflux mechanism(s) in S. 
pneumoniae that could contribute to fluoroquinolone resistance in this 
orgamsm. The gene encodmg for PmrA efflux protein was inactivated in S. 
pneurnorriae strains CPlOOO (wild-type) and a mutant (EBR) selected for 
resistance to ethdium bromide. While enhanced efflux in EBR was reduced 
to the wild type level, neither the reserpine effect on efflux, nor the ability 
to produce ethidium bromide resistant mutants was eliminated in the 
CPlOOO knockout. By exposing CPtOOO and EBR knockout strains to 2.0 
pg/mL (twice their MIC) of ethidium bromide, we have been able to select 
resistant mutants. Examination of the selected mutants revealed that they 
posses reserpine-sensitive cross-resistance to norfloxacin and ciprofloxacin, 
indicating the involvement of additional multidrug export proteins. 
Fluoroquinolone resistance profiles were determined for the selected 
mutants with norfloxacin, ciprofloxacin, levofloxacin and sparfloxacin still 
exhibiting sensitivity to reserpine in the knockout strains; only moxifloxacin 
retained its resistance to efflux in these series of experiments. 
jP4891 The reversion of resistance to fluconazole by four 
quimiosensitisers is independent of calcium 
C. Pina-Vaz, A. Gongalves Rodrigues, S. Costa-de-Oliveira, C.  Tavares, J. 
Martinez-de-Oliveira, P. Mardh, A. Freitas da Fonseca 
Porto, P; Land, S 
introduction: Efflux punips are assumed as important resistant mechanisms 
to azoles that by exporting the drugs reduce their toxicity. We tested 4 
compound5 as potential modulators of resistance of Candida spp. to 
fluconazole (Flu): verapamil (a calcium channel blocker), P-estradiol and 
progesterone (hormones), known inhibitors of efflux pumps on human 
neoplastic cells, and ibuprofen (Ibu). Ibu has a documented fungicidal acnvity at 
hgh concentrations but shows at lower doses a synergistic effect with Flu 
mainly on resistant strains, unrelated with the fungicidal mechanism [l]. We 
decided to study their capacity to revert resistance by blockade of efflux pumps 
and to examine the role of calcium in efflux pumps. 
Material and methods: Ten clinical isolates of Candida strains resistant (R) 
to Flu and 2 sensitive (S) were incubated with subinhibitory concentrations 
of verapad  (100 p ~ ) ,  P-estradiol (50 PM), progesterone (50 p ~ )  or Ibu 
(500 pg/nL). MIC values to Flu associated to each modulator were 
determined. Yeast cells exposed and not exposed to the modulators were 
stained with FUN-I (a fluorescent probe) and analyzed by FC. Similar 
experiments were prepared in the presence of calcium (5 m and 10 m) [2]. 
Results: MIC values decreased whenever Flu was associated with the 
dserent modulators, in most strains. However with C. knrsei (R) and (S) 
strains no significant MIC variations were registered. FC results showed that 
on strains with MIC values reduced by the modulators, FUN-1 staining 
increased, except for C. glabrata. A good correlation was found between the 
effect of the different compounds. Calcium did not interfere with the 
reversion of resistance. 
Conclusions: Most of the resistant strains tested seem to have efflux pumps 
that are blocked by the tested compounds, reverting the resistant phenotype. 
C. krurei seems to possess other mechanisms of resistance. FUN-I is a useful 
probe that can be used to detect efflux pumps in Candida spp. However, 
with C. glabrata the modulators blocked transport of FLU but not of FUN- 
1. The reversion of the resistance phenorype produced by the modulaton 
was not affected by calcium, supporting that efflux pumps are not mediated 
by calcium. The hormones and especially Ibu, associated with Flu, might be 
used in the c b c a l  management of candidosis. 
References: 
1. Pm-Vaz  et a1.J Mcd Minohioi XiOO; 49- 1-10. 
2. Rodriper A cr al Gm M i i r o  20Ml: 40: 145-8 
v1 Correlation between sulfonamide resistance genes in 
human and veterinary Escherichia coii strains from Denmark 
M. B. Kern,  T. Klemmensen, L. V. Pallesen, A. M. Seyfarth, N. Friniodt- 
M ~ l l e r  
Copenhagen, DK 
Background: Resistance towards SULs is reported as being caused by sulI 
and sulII genes (sulI located on integrons (class 1)). The purpose of the 
investigation was to study the relationship among SUL resistance markers in 
food animal and human clinical strains of E .  coli. 
Methods: 60 poultry (P), 20 cattle (C) and 64 swine (S) E .  coli isolates 
(isolated &om faeces in healthy food a d s ,  1998-99) were selected 
according to their MICs towards SUL. The strains were retested towards 
sulfamethizole by the agar-ddution method using Mueller-Hinton agar 
BBL-11. Data &om 297 human (H) E.  culi (106 SUL resistant strains) are 
presented in detail elsewhere. A multiplex PCR was established to detect 
16s rRNA, sulII, sulI and intIl genes in E .  coli. Another PCR was 
developed using single primers from the previous sulI and intIl PCR 
directed against each other. Some of the strains were tested with the 
GeneAmp XL PCR Kit. Fisher’s exact test test was used ( P  < 0.05). 
Results: Among the 144 veterinary (V) strains 56 had MICs between 16 and 
256 pg/mL of which 1 strain was sulII positive and the rest were sulI and 
sdII negative. Of the remaining 88 E. coh with MIC > 4096 pg/mL 39, 4 
and 15 strains originated &om P, C and S ,  respectively. The total 
distribution of sul-genes (MIC > 4096 pg/mL) in numbers of strains were 
as follows: 3 sul-negative, 28 sulI-positive, 50 sulII-positive and 7 sulI and 
sulII-positive. There was a significant difference in the distribution of sul- 
genes (sulI/sulII) among P (4134) and S (23117) (P  < 0.0001). Among the 
P strains there were significantly less sull positive strains than among the H 
strains (P  < 0.05). In S there were significantly more sulI positive, less sulII 
and less sulI + sdII strains than in the H isolates ( P  < 0.05). Forty-nine H 
and 35 V strains carried both the sulI and the intIl genes and the PCR 
showed that in all but one strain the sulI gene was present on the integron. 
Among the H SUL resistant strains there were coresistance with ampicillin 
(881102) which was uncommon in V isolates (15/88; P < 0.00005). 
Conclusion: We found a hgher frequency of SUL resistance in P and S than 
in C ( P  < 0.0001). There was a significant difference in the distribution of 
sul-genes among S and P. In relation to the H isolates the distribution of sul- 
genes differs more in S than in P. The coresistance of SUL and ampicillin 
that was common among H isolates was rarely observed in the V strains. 
Prevalence of class I integrons in Danish blood isolates 
of Enterobacteriaceae 
N. Ncrrskov-Lauritsen, H .  C.  Schcrnheyder 
Aarhus, Aalborg, DK 
Objective: To investigate the prevalence of class 1 integrons in blood isolates 
of Enterobacteriaceae and the possible association to phenotypic expression of 
antibiotic resistance. 
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Methods: Consecutive blood isolates 1996-98 from the County of 
Northern Jutland were investigated. Class 1 integrons (Icl) encode a 
sulphonamide (Sul) resistance gene, and isolates expressing Sul-resistance 
were investigated for presence of Icl by P C R  amplification of a hgment  of 
the 3’ conserved region. Antibiotic resistance was measured by a tablet 
difhsion assay (Rosco, Denmark). 
Results: During the 3-year period, a total of 1364 Enterobacteriuceae from 
1242 bacteriaemic episodes in 1134 patients were detected. Thirtysix 
isolates were not available, leaving 929 E. coli and 399 non-E. coli for study. 
E. coli: Resistance to Sul was expressed in 288 isolates (31%), and 125 of 
these were positive for Icl, corresponding to 13.5% of 929 E. mli. Icl- 
positive E. coli accounted for 30, 36, 38, and 50% of the E. coli isolates 
expressing resistance to ampicih,  streptomycin, tetracycline, and tri- 
methoprim, respectively. Compared with 163 Sul-resistant E. coli negative 
for Icl, presence of Icl was associated with resistance to trimethoprim (OR 
2.4, 95% CI 1.4-4.0), to tetracycline (OR 2.2, 95% CI 1.3-3.7), and to 
combined resistance to trimethoprim, tetracycline, plus streptomycin (OR 
2.0, 95% CI 1.1-3.5). Non-E. coli: Resistance to Sul was expressed in 56 
isolates (14%), and 23 ofthese were positive for Icl, corresponding to 5.8% 
of 399 non-E. coli. Icl-positive non-E. coli isolates accounted for 30,38, and 
39% of the non-E. coli expressing resistance to trimethoprime, tetracyche, 
and streptomycin, respectively. Compared with 33 Sul-resistant noncoli 
negative for Icl, presence of Icl was associated with resistance to 
tetracycline (OR 1.9, 95% CI 0.5-8.1) (excluding Proteus spp. from 
analysis), and to streptomycin (OR 11.7, 95% CI 2.5-70). 
Conclusions: Sulphonamide resistance was strongly associated with 
resistance to a range of antibiotics in Danish blood isolates of 
Enferobacteriaceue. Presence of a class 1 integron in the sulphonamide 
resistant strains was associated with resistance to trimethoprim and 
tetracyche in E. coli, and to streptomycin and trimethoprim in non-E. 
coli. Presence of class I integrons and acquired resistance to sulphonamide, 
tetracycline, or streptomycin, were 2-3 times more prevalent in E. coli than 
in other Enterobaderiaceae. 
v1 Involvement of the exopolysaccharide alginate in the 
resistance of Pseudomonas aeruginosa to aminoglycosides 
M. Ahangarzadeh Rezaee, Q. Behzadlyan-Nejad, S. Pirayeh, P. Owlia 
Tehran, IR 
Alginate, a copolymer of 0-acetylated beta 1,Clinked D-mannuronic acid 
and L-guluronic acid, has been.reported to function in the virulance and 
antibiotic resistance of Pseudomonas aeruginosu. In the present study, the in 
vitro activities of gentamicin, tobramycin and amikacin were tested by disk 
diffUsion method against 133 clinical isolates of Pseudomonar aeruginosa. 
Mucoid strains of Pseudomonas aeruginosa were isolated by capsule staining. 
The resualts indicated that amikacin, tobramycin and gentamicin were active 
agents, respectively. Statistical analysis of the results showed a sigdcant 
relationship between alginate in the mucoid strains of Pseudomow aemginosa 
and their resistance to amikacin, gentamicin and tobramycin. 
vl Antimicrobial resistance of Gram-negative bacilli 
isolated from in-patients 
B. Durmaz, C. Kuzucu, M. Ayan, L. Abut, T. Bayraktar 
Malatya, TR 
Objective: This study was performed to establish the degree of antimicrobial 
resistance to various broad-spectrum agents used to treat clinically relevant 
infections. 
Methods: During a four month period, 152 Gram-negative bacilli were 
isolated from inpatients. Of these micro-organisms, 19.7% were from 
intensive care units. Test isolates were consisted of Escherichia coli-43 strains, 
Acinetobacter spp.-32 strains, Pseudomonas aemginose31 strains, Klebsiella 
spp.-31 strains, Enterobacter spp.-10 strains and the other members of 
Enterobacferiaceae5 strains. The samples from which these strains were 
isolated fiom were 48 urine, 41 wounds, 35 blood, 22 tracheal aspirates, 2 
sputum, 1 catheter, 1 bronchoalveolar lavage, 1 throat and 1 cerebrospinal 
fluid. Antibiotic resistance rates to gentamicin (GN), amikacin (AK), 
isepamicine (ISP), cefotaxime (CTX), ceftriaxone (CRO), ceftazidime 
(CAZ), cefepime (CEF), imipenem (IMP), meropenem (MEM), piper- 
acillin/tazobactam (PTZ), amoxycillin/clavulanate (AMC), ampicillin/ 
sulbactam (SAM) and ticarcillin/clavulanic acid (TIM) were determined 
using disk diffusion method. 
Results: Among all micro-organisms tested, the percentage of resistant 
strains were 53 for GN, 27 for AK, 23 for ISP, 58 for CTX, 59 for CRO, 
34 for CAZ, 27 for CEF, 3 for IMP, 3 for MEM, 39 for PTZ, 56 for AMC, 
46 for TIM and 54 for SAM. These data showed the high level of 
percentage resistance in Gram-negative bacilli isolated from inpatients. 
Conclusion: In vitro antimicrobial susceptibility tests are necessary for 
aminoglycosides, third and fourth generation cephalosporinc and beta lactamase 
inhibitor combinations except for carbapenems such as imipenem, meropenem. 
wl Mechanisms of antifungal activity of copper (CuS04) 
on Candida species 
A. Gongalves Rodrigues, C. Pina-Vaz, S. Costa-de-Oliveira, C. Tavares, P. 
Mardh, J. Martinez-de-Oliveira, A. Freitas da Fonseca 
Porto, 0; Lund, S 
Introduction: Mucocutaneous candidosis is the most common clinical 
manifestation with Candida. The growing emergence of anhfungal resistance 
stresses the need of alternative and/or complementary medications. 
Objectives: To evaluate the mechanisms of antifungal activity of CuS04, 
estimated as the minimal inhibitory concentration (MIC) and minimal lethal 
concentration (MLC) on the most commonly pathogenic Candida species. 
Materials and methods: The fungistatic activity was studied with the 
fluorescent probe FUN-1 and observation under epifluorescence micro- 
scopy and flow cytometry; MIC was also determined according the NCCLS 
protocol M 27-A. The fungicidal activity was assayed by MLC and viabhty 
counts (CFU). Membrane alterations induced in the yeast cells were 
evaluated by quantification of intracellular K+ leakage and by staining with 
propidium iodide (PI) followed by flow cytometry. Fourteen clinical isolates 
of Candida (4 C. albicans, 3 C. parapsihis, 2 C. krusei, 2 C. glabrata, 2 C. 
tropicalis, 1 C. guilliemondit) were tested at serial concentrations of &SO4 
05H20,  ranging from 1 to 10 m, in RPMI 1640 medium. MIC for 
fluconazole and amphotericin B were also determined for each strain. 
Results: MIC was 2.5 rn for all tested strains, except for one strain of C. 
glabrata that had a MIC of 5 m. MIC corresponded to MLC in seven 
strains; MLC was 2 times higher the corresponding MIC in the remaining 
strains. N o  correlation was found between MIC or MLC and the 
susceptibility pattern to antifungals. The impairment of metabolic activity 
resulting from the lowest concentrations could be detected with FUN-1. 
The CuS04 concentrations associated to an extensive rate of killing induced 
permeability to PI and marked efflux of intracellular K+. 
Conclusions: At lower concentrations copper demonstrated a fungistatic 
activity, due to yeast metabolic impairment, while at hgher Concentrations 
(commonly used in mouth rinses) produced a fungicidal effect, due to direct 
damage to the cytoplasmic membrane of Candida species, either sensitive or 
resistant to antifungals. Our results support the use of aqueous copper 
solutions in the treatment of mucocutaneous candidosis. 
Phenotypical resistance of Candida spp. to 
amphotericin B conferred by pre-exposure to fluconazole: a flow 
cytometric approach 
C. Pina-Vaz, A. Gongalves Rodrigues, S. Costa-de-Oliveira, C. Tavares, 
J. Martinez-de-Oliveira, A. Freitas da Fonseca 
Porto, P 
Introduction: Studies evaluating interactions between azoles and Ampho- 
tericin B (Am B) provided codicting results. The use of azole prophylaxis as a 
measure to prevent invasive hngal infections in hgh-risk patients is widespread. 
However, in the presence of a fungal infection, treatment is initiated usually with 
Am B. Thus, we decided to study the effect of pre-exposure to Fluconazole (Flu) 
on the susceptibility pattern of clinical Candida isolates to Am B. Apart from the 
classical MIC and MLC deteminations we used a cytoniemc approach(5ow 
cytometry) as an alternative methodology. 
Material and methods: 5 clinical isolates of Candida susceptible (S) and 2 
resistant@) to Flu were incubated ovemight in Sabouraud broth with and 
without 50 mg/mL of Flu. The cells were washed and the MIC and MLC 
to Am B were determined according to the NCCLS protocol M27-A. 
Additionally the cells were incubated for 1 h with 0.5, 1 and 2 mg/mL of 
Am B and stained with JC-1 (Molecular Probes). The intensity of 
5ourescence (FL3/FL1) was evaluated with a Beckman flow cytometer. JC- 
1 is a useful probe to study membrane mithocondrial potential, that had 
been previously optimised to evaluate the susceptibility of Cundidu spp. to 
different antifungals [l]. CFU counts were also performed after Am B treatment. 
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Results: No difference was registered, respectively, between MIC and 
MLC to Am B in pre-exposed cells Flu were equal to untreated cells: 
however, a less potent fungicidal activity of Am B was assessed by CFU 
countS with pre-exposed cells to Flu. However with JC-1 staining less 
alterations of the mithocondnal potential were registered with the pre- 
strains to Flu. 
Conclusions: The pre-exposure to Flu conferred a more resistant phenotype 
to Am B which was not clearly evident when using classic methodologies of 
susceptibility tesang. Flow cytometry, in the particular case of Am B with JC-1, 
proved to be a sensitive technique to study interactions between antifungals. 
Reference: 
1. pma."az L., c ,,,, ,. ~,![*()"(); 6(s"pF[.I): 95, exposed cells, meaning an increased resistance to Am B, both on s and R 
Antimicrobial resistance: staphylococci 
lp4961 The relation between slime production and resistance 
to fusidic acid of Staphy/ococcus epidermidis isolated from blood 
cultures 
A. Karadenizli, M. Men$, S. GiilenG, S. Akhan, S. Giindes, A. Willke 
Kocaeli, TR 
S h e  production plays an important role in adherence of Staphylococcus 
epidermidis to plastic surfaces. Besides, it may protect microorganisms from 
the inhbitory effect ofantimicrobial agents. In this study, the abihty ofslime 
production in S. epidermidis strains isolated from blood cultures and the 
susceptibility of those strains against fusidic acid which is an effective 
antibiotic to staphylococci was planned to investigate. The relation between 
resistance to fusidic acid and slime factor production of those strains was also 
evaluated. Automatized Bloodculture System (Bactec 9050) was used for the 
isolation of strains. The identitication of the strains was done by Automatic 
Identification Systenls (Sceptor-Becton Dickenson). S h e  production was 
detected by a dye (Safranin 0) applied to all glass tubes after aspiration of 
cultures grown in trypticase soy broth for 48 h. And the results were 
evaluated qualitativeIy. The susceptibility to fusidic acid was tested by disk 
diffttsion method on Mueller-Hinton agar. The diameter ofzones 3 2 2  mm 
was accepted as susceptible, as recommended by the manufacturer. Sixty- 
four of totally 82 isolates (78.04%) was found to be susceptible and 18 
(21.95%) of them was resistant to fusidic acid. Twenty-three (28.04%) of 
them were s h e  (+) and 59 (71.95%) were slime (-). The relation between 
slime production and resistance to fusidic acid was analyzed by Fisher's 
Exact Test. As a result, there was no difference between both groups 
statistically (D > 0.05). 
(p4971 In vitro activity of quinpristin/dalfopristin (synercid), 
erythromycin, and clindamycin against coagulase-negative 
staphylococci (CONS) 
2. Hussain, C. Pletch, M. John 
London, CDN 
Background: CONS are frequent cause of nosocomially acquired bacter- 
emia. These organisms are commonly resistant to multiple antibiotic agents. 
Recently, SYN with greater activity against gram-positive bacteria has 
been marketed. 
Objectives: To determine iri oitro susceptibility of SYN agasinst CONS and 
compared it PO that of EKY and CLIN. 
Methods: 695 strains of CONS representing 16 different species and 
subspecies were inosdy clirucal isolates, collected over several years. MICs to 
SYN, ERY, and CLIN were determined by the agar dilution method as 
describred by the Nahond Committee for Clinical Laboratory Standards. 
The range of MIC tested was 0.25-16 mg/L of each antibiotic. 
Results: The MIC50 and MIC90 for SYN were 0.5 and 2.0 mg/L, 
respectively. Only 41/695 (5.9%) of isolates were resistant to SYN (MIC > 
4 mg/L). Resistance was species specific, 34/41 resistant strains belonged 
to the species S. auricularis, S.  mhnii, and S. sruiri. Resistance to ERY 
was common, and strains resistant to CLIN tended to have a higher MIC 
to SYN. 
Conclusions: I I I  uirro, SYN is more active than ERY and CLIN. Cross 
resistance among CONS between ERY and CLIN on  one hand and SYN 
on the other is uncomion. CONS species with frequent resistance to SYN 
are infrequent cause of hunian infections. 
lp4981 Antimicrobial resistance of 5. aureus in Vilnius 
University Children's Hospital 
I. Narkeviciute, G. Bematoniene, G. Murauskaite, J. Bernatoniene 
Vilnius, LIT 
Aim: To evaluate antimicrobial resistance of S. aureus isolated in Vilnius 
University Children's Hospital in 2000 and to compare these data with the 
results, obtained in 1997 and 1999. 
Materials and methods: A total of 1736 isolates of S. autt-US were obtained 
from mfferent clinical materials of hospitalized children (427 isolates in 
2000; 765 in 1999 and 544 in 1997 years). Antimicrobial susceptibility of S. 
aureus strains was performed using disk dihsion method according to the 
NCCLS guidelines. 
Results: The resistance of S .  aureus to some antimicrobial agents in 2000 
were follows: penicillin, 90.3%; methicillin, 6.9%; amoxiciUin/clavulanic 
acid, not tested; cefazolin, 2.0%; cefamandole, 0.5%; gentamicin, 6.0%; 
erythromycin, 23.7%; fusidic acid, 0.5%; vancomycin, 0%. The resistance of 
S. aureus in 1999 penicillin, 73.8% methi&, 4.4%; amoxiciUi~i/clavuknic 
acid, 0.8%; cefazolin, 1.2%; cefamandole, 0.5%; gentamicin, 3.8% eryrhro- 
mycin, 22.977 fusidic acid, 0%; vancoinycin, 0%. The resistance of S .  aurecu' in 
1997: penicdhn, 90.8%; methicilh, 2.0% amoxicillin/clavulamc acid, 0.5% 
cekolin, 0%; cefamandole, 0%; gentamicin, 2.1%; erythromycin, 24.4%; 
fusidic acid, not tested; vancomycin, 0%. 
Conclusions: The prevalence of methicdlin-resistant S. aureus strains is low 
in Lithuania. All S. aureus isolates were sensitive to vanconiycin. 
Approxiniately 25% of the strains showed resistance to erythromycin. The 
incidence of S. aureus resistance to some antimicrobial agents is increasing. 
Comparison of the in vitro efficacies of liposomal 
vancomycin with vancomycin and liposomal ofloxacin with 
Ofloxacin against Staphylococcus aureus 
A. Sanic, M. Uric, S. Erdogan, A. Y. Ozer, B. Durupinar 
Samsun, Ankara, TR 
Objectives: The efficacies of antinlicrobial agents in the treatment of 
infections depends upon the interactions of bacteria, antibiotic and 
phagocytes. The aim of this study was to detemGne whether liposome- 
encapsulation of vancomycin and ofloxacin, when compared with their free 
forms, can enhance the drug activity at the same concentrations against S. 
auietls strains located within human macrophages. 
Methods: Methicillin-resistant S. aureus (MRSA) (ATCC 43300) and 
niethicillin-sensitive S .  aweus (MSSA) (ATCC 29213) strains were used in 
these studies. Vancomycin (VAN) (LiUy USA), ofloxaciu (OFX) (Hoechst 
M.R-Germany) and two forms which were made up of distearyl 
phosphatidyl choline (DPPC)-dicetyl phosphate (DCP)-cholesterol 
(CHOL) and phospholipon 90G (PL 90G)-(DCP)-(CHOL) (10:1:4 molar 
ratio) of liposomal-vancomycin (L-VAN) and lipotomal-ofloxacin (L-OFX) 
were tested at different minimum inhibitory concentrations (MICs). The 
MICs of VAN and OFX were determined against S. aureus strains by the 
microdution method in cation-supplemented Mueller Hinton broth. The 
extracellular and intracellular bactericidal activities of antinlicrobial agents 
were investigated at the 4 MIC, 2 MIC, 1 MIC, 1/2 MIC, 1/4 MIC, and 
118 MIC values at 0, 3, 6 and 12 h time following inoculation. The 
liposomal forms were used at equal MICs with free drugs. The cultures of 
human macrophages were used for this aim. 
Results: The MICs of VAN and OFX were 0.250 mg/mL for MSSA. For 
MKSA, the MICs ofVAN and OD( were 1.000 rng/mL and 0.500 mg/mL, 
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respectively. The effects of liposomal forms were not observed in the 
medium without cells. The bactericidal activities of free drug were more 
effective at the tested concentrations against MSSA. The reduction in 
intracellular efficacy of VAN was observed after the sixth hour. When L- 
VAN and L-OFX were low effective at 4 MIC, They were ineffective at 
other concentrations, The intracellular CFU/mL values of only 1 MIC from 
our studies are shown in the Table. 
I Times Ihl+ I 3 1 6 1  12 I 
Conclusion: The intracellular e6cacy of OFX was more potent than VAN. 
The reason of the ineffective determined L-VAN and L-OFX may not have 
been enhanced at effective concentrations in macrophages, because of their 
intracellular inadequate uptake were probably related to the formulation 
factors and preparation techmques. 
v] Activity of antimicrobials against Staphylomccus 
aureus attached to porcine tissues 
R. Lewandowski, J. Grzybowski 
Warsaw, PL 
Objectives: To compare the action of vanconiycin (VAN), gentamicin 
(GEN), cefamandole (CMAN), bacitracin (BAC), and povidone iodine 
(PVP-I) against 24 h biofilm of S.  aureus (MSSA, strain no. 672) growing on 
porcine dermis and muscle tissue in uitro. 
Methods: MIC and MBC of VAN, GEN, CMAN, BAC, and PVF-I were 
determined using suspension of planktonic cells of the S. aureus (No. 672) 
isolated from bum wound, and macrodilution method according to NCCLS 
recommendations. Porcine dermis was prepared by dermabmion after incubation 
of the s k i n  in 1 M NaCI. The dermis and porcine muscle sections (3 mm h c k )  
were cut into small pieces (1 cm x 1 an), lyophylized and sterilized by radiation. 
S. aums  biofilms were formed by incubation of the tissue sections for 24 h at 
370C in the suspension ( 1 0 6  CFU/mL) of the S. aureus isolate. After incubation, 
the c o l o m d  tissue sections were washed and then were exposed to VAN, 
GEN, CMAN, BAC, or PVP-I in different concentrations. The nunber of 
residual viable bacteria adherent to the tissues were determined by sonication 
and plating method using Muller-Hinton agar. 
Results: The MIC values of VAN, GEN, CMAN, BAC, and PVP-I for 
planctonic bacterial cells were 0.24, 0.12, 0.24, 32, and 250 WmL, respectively; 
the MBC values of the antimicrobials were 1.96, 0.24, 3.90, 125, and 250 pg/ 
mL, respectively. After 24 h attachment of the bacteria to the surface of the 
dermis or the muscle an increased resistance to all tested antimicrobials was 
observed. MBCs of the antibiotics tested for adherent bacteria exceeded 40-100 
times MBCs for planctonic cells. MBC of the PVP-I for adherent bactena 
exceeded 20 t imes MBC for planktonic cells. EfZective bactericidal concentrations 
of VAN, GEN, CMAN, BAC, and PVP-I for killing bacteria adhered to the 
dermis were 157 pg/mL, 25 pg/mL, 313 pg/mL, 10 mg/mL, and 5 ing/mL, 
respectively. There were not sigdcant Nerences in surceptibility of the smile 
bacteria adhered to the dermis or to the muscle tissue. 
Conclusions: Eradication of the bacteria from the surface of the tissues 
colonized with S. aureeus susceptible to the antibiotics required high 
concentrations of the antimicrobials. Further investigation of different 
antimicrobials using presented methodology is necessary. 
/p5011 Coagulase negative staphylococci in nosocomial 
infections in an orthopaedic hospital 
I. Vingre, A. Zilevica, U. Viesturs 
Riga, LET 
Objectives: To assess the kequency and distribution of coagulase negative 
Staphylococci (CONS) in a 300-bed hospital and to determine their 
susceptibility to antibiotics. 
Methods: In the period tiom November, 1999 to November, 2000, samples 
&om patients with hospital-acquired purulent infections were examined. Cultures 
of the samples were performed by conventional niethods. The resistance to a 
panel of antibiotics (penicillin, oxacillin, cephazolin, ciprotloxacin, erythromycin, 
clindamycin, gentamycin, chloramphenicol, novobiocin, vancomycin, ttimetho- 
prim) was tested by the disk diffusion method according to NCCLS guidelines. 
Methi& resistance was c o h e d  by the agar screening method on agar plates 
supplemented with 6 mcg/mL oxacillin. The presence of mecA gene was tested 
by the PCR technique. Beta-lactamase production was detected by the c e h e  
method. For epidemiological analysis, the phenotypic methodsantibiotyping and 
genotypic methodqksmide profile analysis were used. 
Results: From the 642 isolated Staphylococci cultures, 213 (33.17%) were 
coagulase negative Staphylococci, from them 143 cultures (67.1%) were S. 
epidermidis, 41 cultures (19.2%) of S.haemolyticus, 10 cultures (4.6%) of 
S.hominis, 7 (3.2%) cultures of S. simulans and cultures of S.  cuhnii, S. 
wameri, S.  pulvereri, S .  lugdunensis, S.  capitis, S. auriculuris, S.  saprophyticus, S.  
homogenes. 14% of isolated strains were methicillin resistant-mainly S.  
epidermidis (senru rfricto), S. haemolyticus, S .  horninis. 100% of methicillin 
resistant CONS were resistant to erythromycin. The resistance to other 
antibiotics checked vaned &om 9 to 75%. All strains were susceptible to 
glycopeptides. Analysis of antibiograms yields 12 diffkrent patterns, 
genotyping yielded 8 pattea. N o  clusters were registered. 
Conclusions: CONS are one of the leading pathogens in our hospital. The 
increasing antimicrobial resistance of CONS has become a serious problem. 
14% of MKSE were found. However, no out-breaks were registered. The 
continuous monitoring of CONS is required. 
Genetic polymorphism and antibiotic susceptibility of 
coagulase-negative staphylococci infecting joint prostheses 
M. A. Dominguez, M. B. Orlando, F. Tubau, R. Verdaguer, X. Cabo, X. 
Ariza, J. Linares, R. Martin 
Barcelona, E; Buenos Aires, RA 
Introduction: Coagulase-negaave staphylococci (CNS) are mcreasingly identified 
as a cause ofjoint prostheses infection PI). However, it is &cult to estahlih 
their pathogeiuc role because they are also the most fiequent contaminants in 
microbiological cultures. We studied 117 samples &om 22 patients @ts) that 
undenvent surgical joint prostheses replacement for suspected dection, fkoni 
1997 to 2000. All patients had samples obtained before the surgery (by aspiration 
or joint biopsy) and samples during the surgical joint replacement. 
Objectives: 1. To identifi the most common species involved in JPI. 2. To 
establish the identity between CNS strains isolated from preoperative 
samples and CNS strains isolated from surgical samples. 3. To analyze the 
polyclonality in CNS populations infecting joint prostheses 4. To determine 
the incidence of methicillin resistance. 
Methods: Identification to the species level and antibiotic susceptibility 
were performed by Microscan. Identification was confirmed by ID32Staph 
system in selected isolates. Resistance to methicillin was confirmed by Etest, 
according to NCCLS criteria, and mecA PCR detection. AU samples were 
screened for distinct CNS morphotypes and genotyping was performed by 
PFGE in at least three colonies from each sample. 
Results: The most fi-equent species isolated was S. epidermidis (20122 pts). as 
a single pathogen in 18 pts and together with other CNS species in 2 pts (S. 
haemolytinrs and S .  horninis, respectively). One pt was infected by S. iuameri and 
the other showed a polymicrobial dection caused by S .  horninis and S .  capitis. 
In 14 pts the same clone was found in both preoperative and surgical samples; 4 
pts had major clones in a l l  samples and, at least, another genotype in single 
samples; and 4 pts had genotypes in preoperative samples that were distinct 
&om those found in surgical samples. Altogether 29 clones of S. epidmidis were 
found, of which 21 were methi& resistant by MIC and 20 carried the mecA 
gene (one strain with MIC = 0.75 mg/L was mecA negative). All isolates had 
MIC of vancomycin 6 2  mg/L and teicoplanin 6 4  mg/L. 
Conclusions: S. epidmidis was the most common species involved in JPI, 
showing a high incidence of methicillin resistance (72%)). In most cases the pts 
were infected by a single clone, detected in preoperative cultures. The 8 ptc 
(36%) whose samples yielded unrelated CNS clones probably had polyclodP1 . 
I P503 I Nosocomial catheter colonization by teicoplanin- 
resistant coagulase-negative staphylococci in 
immunocompromised patients 
M. Knausz, A Ghidan, F. Rozgonyi 
GyZr, Budapest, H 
Objectives: Nosocomial polyresistant Gram-positive cocci have acquired 
resistance to glycopeptides at an alarmmg rate in recent years. We report 
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here four teicoplanin-resistant but vancomycin-sensitive strains of coagu- 
lase-negative staphylococci causing intravenous catheter colonization in 
seriously ill, immunocompromised patients. 
Methods and results: The central venous catheters were removed because 
of suspected catheter site infections, and examined by microbiological 
methods including roll plate culture and Gram staining. Further identifica- 
tion in the ATE3 Automated System (bioM6rieux) resulted in a strain of 
Staphylococcus epidermidis, Staphylococcus lugdunensis, Staphylococcus chromogenes 
and Staphylococcus haemolyticus, respectively. Hernocultures of patients in 
Vital bottles (bioM6rieux) were negatives. The susceptibility of strains to 
antimicrobials was determined with a semiautomated system (ATB, 
bioMCrieux), and the sensitivity patterns were Werent in each isolate. All 
strains but S. epidermidis were multiple resistant including oxacillin. The 
minimum ihbi tory  concentrations (MICs) of vancomycin and teicoplanin 
were determined by E-test method (Al3 Biodisk) and susceptibilities were 
predicted according to NCCLS breakpoint standards. The results showed 
the following MICs: 96 mg/L teicoplanin and 1.5 mg/L vancomycin for S. 
epidermidis, 256 mg/L teicoplanin and 4 mg/L vancomycin for S. 
lugdunensis, 32 mg/L teicoplanin and 3 mg/L vancomycin for S. chromogenes, 
96 mg/L teicoplainin and 6 mg/L vancomycin for S. haemolyticus. The 
mechanisms by which staphylococci have become resistant to glycopeptide 
antibiotics are not clearly understood yet. Therefore, all strains are to 
examine further for the presence of Van A, I), C, D, E genes and structural 
variations of cell walls. 
Conclusions: Glycopeptide-resistance in coagulase-negative staphylococci 
has appeared in Hungary, too, and such strains may infect patient with 
underlying diseases during a long hospitalization. This is the first report from 
Hungary on such unusual strains. 
Significance of coagulase-negative staphylococci in 
urinary tract infections 
E. Chinou, E. Tsiganou, M. Georgouli, Z. Chiolou, N. Trobouki, P 
Golemati 
Athens, GR 
Objectives: To determine the importance of the role of coagulase-negative 
Staphylococci in the aetiology of acute lower urinary tract infection. 
Methods: Seventy-two isolates identified as CNS, were collected from mid- 
stream specimens of urine during a three and a half years period Oanuary 
1997-June 2000). The identification of CNS strains was carried out under 
standard methods and an Api 20 staph system. Antibiotic resistance was 
performed with the method of disk diffusion and interpreted according to 
NCCLS standards. The criteria for CNS isolates as the reason of UTI were: 
more than 50 white cells per hlgh power field on light microscopy of urine 
sediments and a pure growth of more than lo5 colony forming units per 
d. 
Results: We isolated 72 CNS strains (3.5%) from 2.030 positive urine 
cultures. 62 CNS strains were from positive cultures of 1463 inpatients 
(4.2%), while 10 strains were from 567 out patients (1,6%). S. epidermidis 
and S .  raprophyticiis accounted for approximately 90% of isolates, whde the 
rest 10% of CNS isolates were S. hominis, S. xylosus, S .  warnen and S. 
simulans. There was little variation in the antimicrobial susceptibility pattern 
in the various species. Susceptibility rates to antimicrobials tested were: 
vancomycin and teicoplanin loo%, netilmicin 85%, tetracycline 60%, 
ciprofloxacin 40%. clindamycin 30% and oxacilline 30%. 
Conclusions: The results of this study suggest that in our population, CNS 
isolates other than S. saprophyficus are frequently responsible for urinary tract 
infections. 
VRE and MRSA: diagnostic methods 
v1 Molecular identification and typing of vancomycin- 
resistant enterococci isolated in a university hospital in Athens 
E. Demertzi, S. Zappas, A. Papapanagiotou, N .  Woodford, M. E. 
Kaufmann, A. Avlamis 
Athens, GR; Loitdon, UK 
Objectives: Due to the fact that the first clinical strains of vancomycin- 
resistant enterococci (VRE) appeared in Greece the last two years, we set 
out to characterize all the VRE isolates detected in Laikon General Hospital 
of Athens during the years 1998, 1999. We also determined the accurate 
identification of E. duraris and E. hirae using three separate PCR assays and 
we examined the correspondence between the determination of VanA/ 
VanS phenotype and genotype. 
Materials and methods: 26 strains of VRE, 6 from clinical samples and 20 
&om rectal swabs of the VRE fecal camage screening, had been previously 
identified by standard methodology and by PASCO Gram positive panels 
(DIFCO, USA). The susceptibility patterns had been determined by the 
Kirby-Bauer disk method, by PASCO MIC/ID and by E-test. Identifica- 
tion by multiplex PCR of vancomycin resistance genes and o-ala D-da 
ligase genes specific for E. jaecium, E. faecalis, E. gallinarum, E. casseliJavus 
and E .  auium was performed using crude extracts as target DNA. In order 
to identify the strains that gave negative results in the multiplex PCR, 
E. durans/E. hirae PCR assays were performed detecting the ddi, copy 
and murG genes. All the isolates were examined for the presence of VanA 
and V a d  genes by a single multiplex PCR and were typed by PFGE 
using SmaI. 
Results: 19 of the 26 (73%) were identified by PCR as E.Jaecium, however, 
only 10 (53%) of these had been identified correctly by the biochemical 
system. E. gallinarum accounted for 3 (12%) of the isolates, as E. jaecalis, E. 
avium, E. durans and E. casseliJavus for only 1 (4%), respectively. The 
conventional identification gave 52% (1 3/26) concordance. There was 
agreement between VanA/Vad phenotypic and genotypic determination 
for only 16 (62%) isolates. One of the E. gallinamm strains had VanA 
genotype which is very unusual but not impossible. Based on macrorestric- 
tion banding patterns the majority of the isolates were genetically unrelated. 
Conclusions: PCR confirmation of species identification and determination 
of van genotypes of glycopeptide resistance offers a specific, accurate and 
rapid alternative to the conventional methods. 
Lp5061 Evaluation of the EVIGENE VRE detection kit for the 
detection of enterococci harboring the vancomycin resistance 
genes vanA and van0 
A. Rhod Larsen, R. Lykke Poulsen, F. Espersen, L.V. Pallesen 
Copenhagen, DK 
We have developed a new kit based on DNA probe hybridization for 
detection of the vanA and vanS genes in vancomycin-resistant enterococci 
(VRE). The aim of ths  study was to evaluate the performance of the kit 
using multiplex PCR as the golden standard for gene detection and to 
correlate the minimum inhibitory concentration (MIC) for vancomycin and 
teicoplanin with the genotypic results. The VRE Detection Kit is based on 
microwell plates whereto DNA probes specific for the bacterial target DNA 
are bound. A test includes: a positive (16s rRNA) and a negative control, a 
vanA and a v a d  microwell. The test results are read after 3.5 h either visually 
or using an ELISA reader. A test is considered positive in case of a clearly 
yellow color OD > 0.8. The multiplex PCR detects the 16s rRNA gene as a 
positive control and the vanA, v d ,  vanCl and vanC2/3 genes. The MIC 
determination was performed by agar dilution according to the NCCLS 
guidelines. We tested a total of 145 diverse enterococci: E.faecium (n = 99), E. 
faeuzlis (n = 22), E. gallinamm (n = 1 l), E. cassill$aw (n = 6) and others (n = 7). 
All strains were positive in the 165 rRNA well (OD: a l l  strains > 4) and 
negative in the negative well (OD: mean 0.03, range 0.000.10). Sx ty - s i x  
s t r a i n s  were vanA positive (OD: all strains >4), 49 strains were vanB positive 
(OD: all strains >4), one was both vanA and vanB positive, and 29 were vanA 
and v d  negative (OD. mean 0.02, range 0.014.10). No cross-hybridization 
of the vanA or vanB genes was observed and nor did vanCl or vanC2/3 
positive strains give any signal ~fl the vanA or v a d  well. The results obtained 
with the VRE kit were all confirmed by the multiplex PCR. The MIC 
determination correlated with the PCR and kit results for all vanA and vanB 
positive strains with high MIC for vancomycm. However, 16 strains had low to 
intermediary MIC for vancomycin and where sensitive to t e i c o p h ,  making 
it impossible to distinguish the VANB and VANC phenotypes. The PCR 
revealed that 11 were vanC positive suains whereas five had the v d  gene. In 
conclusion, the EVIGENE VRE Detechon Kit is able to clearly distinguish 
VRE with the vanA and v d  genotypes among a large collection of 
enterococci and with the same specificity as PCR. In order to get a correct 
detection of the v a d  positive strains with low resistance to vancomycin 
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one of the described genotypic tests will be advantageous compared to the 
MIC determination. 
v] Genotyping and nosocomial surveillance of 
vancomycin-resistant enterococci by multiplex PCR 
J. Lu, C. Pemg, S. Lee, W. Chi 
Taipei, RC 
Ninety-three clinical isolates of vancomycin-resistant enterococci (VRE) 
collected &om nine hospitals in Taiwan were examined for the presence of 
vanA, vanB, vanC1, and vanCZ/vanC3 genes by a multiplex PCR. O f  the 
93 VRE isolates identified, 47 were vanA positive. In addition, one vanCl 
and vanA, 40 vanB, two vanC1, and three vanC2/3 isolates were identified. 
Twenty-four vanA VRE isolates were sensitive to teicoplanin and thus did 
not have a typical VanA phenotype. Five VanC phenotype isolates harbored 
vanl3. None of the 40 vancomycin-sensitive E. faecium or E. faecalis and 
vancomycin-resistant Leuconostoc and Pediococcus isolates were positive 
for any of the van genes. While performing nosocomial surveillance, VRE 
were isolated &om 47 of 467 rectal swabs by culture. Compared with the 
conventional method for detecting VRE, the sensitivity and specificity of 
multiplex P C R  for detecting and genotyping vancomycin-resistant 
enterococci directly from positive enrichment broth were 97.9% and 
loo%, respectively. The results suggest that genotypic characterization is 
necessary for all clinical isolates of VRE and that the multiplex PCR assay 
can be an alternative method for detecting and genotyping VRE isolates in 
clinical and nosocomial surveillance specimens. 
jP508 Utility of the Vitek system in detection and sensitivity 
of Enrerococcus spp. resistant to vancomycin 
S .  C. Kaufman, L. Errecalde, R. Labat, S .  Montibello, L. Guelfand, R. 
Goering 
Buenos Aires, RA; Omaha, USA 
Background and goal of the study: VRE can be present in the human 
intestinal bacterial flora, which, in turn, can serve as a pathogenic reservoir. 
There is a rapid increase in the incidence of infection with VRE. Detecting the 
presence of these organisms has important implications in infection control. 
The aim of this study is to evaluate the Vitek GPI+ and Vitek GPS-TA in rapid 
idendcation and sensitivity of VRE isolated &om Herent clinical sources. 
Method A total of 266 samples with VRE where analyzed between 
October 1997 to October 2000. The sources were: fecal, 248, blood cultures, 
9, urine 5 and skin and soft tissue 4. The fecal samples were cultured on bile 
esculine aide agar (Biokar) with 6 p g / d  of Vancomycin. Dark brown 
colonies were identified using the Vitek automated methods and conventional 
tests: Pyrazinamidase (PYR-A-ENT Britania) and Methyl a D Glucopiranoside 
(MGP Fluka Chemie). To Herentiate E. avium from E. gullinarum we used 
some additional tests: Pyruvate utilization, Arginine dhydrolase and fermenta- 
tion of sorbitol, sorbose, and raffinose. Antimicrobial susceptibilities were 
determined by standardized microdihsion technique (NCCLS), Vitek 
GPS-TA and confirmed by MIC (E-TEST AB Biodisk). 
Results: GPI+ idended 198 strains in > 90% (90%). 7 between 80 and 
89% (3.6%) and 14 between 70 and 79% (6.4%). All the isolated strains of 
VRE were genotype vanA. We find 11 different sensitivities profiles. In 31 
we have done the PFGE and we obtain 6 different clones. The global 
sensitivity was 0.5% for ampicfin, 0.5% for p e n i c h ,  98.6% for 
tetracycline, 72.6% for nitrofurantoin, 0.5% to norfloxacin, 28.2% and 
0.8% to gentarnicin and streptomycin h g h  concentration, respectively. All 
the methodologies used for sensitivity had 100% of correlation. The median 
time for obtain the final result with Vitek were 6 h. 
Conclusion: The Vitek system was a rapid alternative to detect VRE in 6 h. 
This allows us to implementation isolation of the patient colonized or 
infected in order to avoid dissemination. 
v1 Identification of me&-positive methicillin resistant 5. 
aureus strains by a PBPZa-latex-agglumination test 
E. Petinaki, S .  Maralu, A. Georgdadakis, V. Minagou, F. Kontos, M. 
Maniati, Y. Tselentis, A. Maniatis 
Lanisa, Heraklion, Athens, GR 
Objectives: The purpose of this study was the evaluation of a PBP2a-latex 
agglutination test (Slidex MRSA Detection kit) for the identification of 
mecA-positive methicillin-resistant S. aureus isolates. 
Methods: One hundred nonrelated S. aureus isolates, 50 expressing 
borderline-methicfin resistance (MIC: 2-4 pg/mL) and 50 expressing 
methicillin-resistance (MIC: 8-1000 pg/mL) were examined. The presence 
of mecA-gene has been detected by PCR. The expression of PBP2a 
was examined by the commercially available latex agglutination test 
(Slidex MRSA Detection lut, bioMeneux), according the procedures of 
manufactures. 
Results: Sixty-five out of one hundred isolates were found to carry mecA- 
gene. Results obtained by Slidex-MRSA Detection test were in excellent 
agreement with those of the PCR assay. The test was positive for 63 mecA- 
containing strains(sensitivity 97%). Only two mecA-positive strain, having 
MIC: 2 pg/mL gave a result equivocal. O f  the 35 mecA-negative isolates, 
all were negative with the Slidex-h4RSA Detection test (specificity 100%). 
Conclusions: The excellent concodance of Slidex-MRSA Detection test 
with PCR-based detection of mecA-gene, permits to Diagnostic Labora- 
tories to use it for accurate detection of mec-related methicdlin resistance 
among S. aureus isolates. 
Comparison of VITEK automated system results with 
mecA gene analysis for determining oxacillin resistance in 
Staphylococcus aureus 
Z. Gulay, T.  Atay, S .  Ozsu Caymaz, N. Yulug 
Izmir, TR 
Objective: The optimal phenotypic method for detecting oxacillin 
(metkcillin) resistance in staphylococci is still sought for. Ths study 
compares the results of the VITEK system with that of mecA gene detection 
for the determination of OX resistance in S. aureus. 
Methods: 100 clinical S .  aureuz isolates were included in the study. All 
strains were screened for the presence of the mecA gene by PCR using the 
(5' GTT GTA GTT GTC GGG TTT GG33 and (5' CCA C C C  AAT 
TTG T C T  GCC AGT TTC TCC3') primen. Susceptibility testing was 
also performed by VITEK GPS-101 cards. 
Results: The mecA gene was positive in 70 isolates and negative in 30. All 
of the mecA isolates were also detected by the VITEK system. Five 
additional strains which were mecA negative were also found to be OX 
resistant by VITEK giving sensitivity and specificity values of 100% and 
86%. respectively. 
Conclusion: Oxacillm resistance for S .  auretrs isolates can reliably be detected 
by the VITEK system. 
vl Real-time fluorescence PCR for the rapid identification 
of methicillin-resistant Staphylococcus aureus 
S. Palladino, I. D. Kay, R. Fonte 
Pertk, AUS 
Rapid and accurate identification of methicfin-resistant S. aureus (MRSA) 
is crucial in the management and treatment of both colonised and infected 
patients. The advent of real-time P C R  technology offers the potential for 
more rapid confirmation ofMRSA than is possible with either conventional 
PCR or culture-based methods. In this study we describe the modification 
and evaluation of an existing PCR-based method for the simultaneous 
amplification of the staphylococcal nuc gene, encoding the thermostable 
nuclease (TNase) which is specific for S. uureus, and. the mecA gene, 
encoding the penicillin-binding protein 2a which is associated with 
staphylococcal methicdhn resistance, into a real-time P C R  assay suitable 
for use with the Lightcycler system. To date, the multiplex Lightcycler 
PCR assay has been used to test 78 strains of methicdlin resistant and 
susceptible S. anreus and coagulase-negative staphylococci (CNS). The 
results obtained were compared with the conventional PCR multiplex assay 
and disk a s i o n  susceptibility testing. In the preliminary results obtained 
so far, the multiplex Lightcycler P C R  assay was able to correctly idennfy 
35/35 MRSA, 13/13 methicillin-susceptible S. aureus, 15/15 methicillin- 
resistant CNS and 15/15 methicillin-susceptible CNS. Results were 
available within 1.5 h for the real-time PCR assay compared to up to 5 h 
for the conventional PCR assay. The Lightcycler provides the platform to 
perform an assay which is capable of accurately and rapidly identifying 
MRSA, and which can be easily incorporated into a diagnositc clinical 
microbiology laboratory. 
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Usefulness of the buffered charcoal yeast extract 
selective agar with 4 pg/mL of cefamandole and colistin nalidixic 
acid agar in the detection of methicillin-resistant 5taphy/ococcus 
aureus from clinical samples 
A. Ramirez, J. Reina, M. Galmes, E. PadiUa, T.  Serra, P. Alomar 
Palma de Mallorca, E 
Objectives: Our  aim was to evaluate the reliability of buffered charcoal yeast 
extract agar (BCYE) with 4 pg/mL cefamandole, and colistin nalidixic acid agar 
(CNA) in the h t  detection methicillin-resistant Staphylococncc aureus (MRSA) . 
Methods: During 5 years (1995-99), we studied retrospectively the type of 
samples, the culture media used and those media which recovered some 
MRSA or niethicillin-susceptible Staphylococcus aureus (MSSA) in our hospital. 
Results: 71 of 134 sample containing MRSA were cultivated in one of two 
medium studied, BCYE (30) and CNA (41). 1216 clinical specimens with 
Surveillance of antimicrobial resistance 
MSSA were cultivated in BCYE (248) or CNA (968). Twenty-eight of 
30MRSA were recovered in BCYE from respiratory samples, while only 1 
of 248 mettucllln-susceptible Staphylococcus aureu grew in BCYE (NPV: 
99.2%, WP 96.5%, E: 99.6% and S: 93.3%). In four cases MRSA was 
recovered only in BCYE agar due to a mixed culture with gram negative 
hacih in others me&a. Thirty-eight of 41 strains were isolated from 
nonrespiratory exudate samples in CNA agar (NPV: 99.6% VPP: 53.5%, E: 
96.5%, S :  92.6). In 15 of the 38 nonrespiratory samples, MRSA wa, isolated 
primarily only &om the CNA agar, because the cultivation was nlixed with 
Gram negative bacih on blood agar. 
Conclusion: In those laboratories where a routine and specific screening of 
MRSA of all the samples is not carried out due to low prevalence, the 
growth in BCYE agar or CNA agar can alert us to the presence of 
niethicillin-resistant Staphylococcus aureus. In combination with quick 
agglutination methods that detect the PBP2a proteins, it is possible to 
detect MRSA in 24 h. 
EARSS in Ireland 1999-2000 
D. Whyte, 0. Murphy, D. O'Flanagan 
Dublin, Cork, I R L  
Objective: Antmicrobial resistance (AMR) is a major threat to public 
health. The National Disease Surveillance Centre (NDSC), established in 
Ireland in 1998, began participating in the European Antinlicrobial 
Resistance Surveillance System (EARSS), a network of national surveillance 
systems in 1999. The aim is to collate comparable and reliable AMR data in 
Europe and this paper presents the results of 2 years' participation by Ireland 
in EARSS. 
Methods: In all countries E A R S S  used case definitions prescribed in a 
protocol to collect data on two important pathogens in hospitals and the 
community - Staphylococcus uureus and Streptococcus pneumoniae. Twelve 
centres in Ireland provided data on a quarterly basis in 1999, this expanded 
to 19 laboratories in 2000. Anonymized data are entered into a database 
(WHONET 5) and dtspatched to the EARSS Management Team in RIVM 
(National Institute for Health and Environment) in The Netherlands. 
Results: Results from 976 isolates of S. aureus, to date reveal a high, rate of 
methicillin resistant S. aureuz (38-39%). Isolates of S. aureus were more 
commonly isolated &om men and an older age group (> 50 years). Of  307 
isolates of S. pneumot?iae, the rate of penicillin nonsusceptible isolates has 
varied between 20% in 1999 and 11% in 2000. The reason for this reduction 
is unclear at present. Most of these isolates were detected in older (> 60 
years) and younger (< 5 years) age groups. A characteristic seasonal variation 
was also evident. 
Conclusions: These data highlight many unanswered questions and the need 
for Ireland to tackle the problem of A M R  as a priority. Participation in a 
Europeah network has acted as a catalyst for the development of a national 
system in Ireland and allows comparison of resistance rates with other 
European countries. This surveillance system informs public health at local, 
national and international level about AMR in selected pathogens in a 
timely, on-going and consistent manner. It is a useful measure by which to 
gauge the effects of any intervention to reduce AMR in Ireland. 
vl 5. pyogenes resistance to macrolides and clindamycin, 
in Italy in the 2000 GlSPneumo internet project 
A. Caniporese, M. Cerletti, A. Piscina 
Porderrorie, Ponte Sari Piirtro, Rirnini, I 
Monitoring the resistance of Srreptococcus pyogenes to antibiotics is an 
important help to a rational prescription. The www.gispneumo.com is an 
active website aimed to collect data on Streptococcus pyogenes resistance to 
antibiotics from Itaban microbiological laboratories. This project started in 
1999, 58 Italian microbiology units entered their findings on antibiotic 
resistance by Streptococms pyogenes in a website [l]. This permitted instant 
analysis for each unit and for the overall data, so that percentages of 
resistance could be made known in real time, so as to be useful to the 
medical community. In 2000, this survedlance project has been added the 
data related to S.  pneumoniae. Each laboratory is issued its own log-in and 
password, to ensure data security. Data are entered on forms provided in the 
site, collecting inforniation on the patient characteristics, the microbiolo- 
gical niethod used, and the microorgamsni's response (sensitive, inter- 
mediate, resistant) to: erythromycin, clarithromycin, azithromycin, 
rokitamycin and clindamycin. Each laboratory was free to test their routine 
antibiotics. Participating units thus have up-to-date information constantly 
at their fingertips, regarding their own data and the overall picture. I n  Jan- 
Dec 1999 data were collected by 58 microbiology units on 5199 positive 
swabs, and between Jan-Oct 2000, 66 microbiology units throughout Italy 
collected data on 6436 cases. The sensitivity percentages were (in brackets 
the 1999 percentages): erythromycin 65.0 on 6363 strains (66.8 on 4124 
strains), clarithromycin 62.2 on 2254 strains (68.0 on 1802 strains), 
azithromycin 64.0 on 1527 strains (66.7 on 876 strains), rokitamycin 91.3 
on 5660 strains (92.8 on 3372 strains) and clindamycin 77.4 on 3292 strains 
(81.4 on 1433 strains). to GPs, pediatricians, and pharmacists wanting up- 
to-date information on drug resistance. The doctor is issued a password and 
log-in on a special 'sensitivity card', to permit access to the data. T h ~ s  creates 
a virtual network, connecting microbiologists and clinicians in real tinie 
with the aim to give a rational basis for the empirical therapy. 
Reference 
I Tcrrrniocci I< et dl Soweglianza drlln rrnabihti dr S pp,qe,iur nelb p r a t a  quoridurn di liiternet. 
L'Lrlm,Dt', 20Ilfr: 8: 1-9 
lq516i Antimicrobial resistance in ~taphy/ococcus 
saprophyticus from UTI in Sweden and from UTI in the ECO-SEN5 
project 
G. Kahlmeter 
Vaxjo, S 
Introduction: Staphylococcus saprophyticus is a primary albeit rare pathogen in 
uncomplicated community acquired lower urinary tract infection in 
women. The ECO-SENS project is an ongoing survey in 16 countries in 
Europe and in Canada of antimicrobial resistance in bacteria causing 
uncomplicated iower urinary tract infections in otherwise healthy women. 
In this material 56 S. saprophyticus were isolated during the same period that 
1312 E. coli were isolated (ratio 0.043). In a Swedish material collected over 
the past 10 years the S. saprophyficus/E. coli ratio was 0.036. Several reports 
have shown a seasonal variation in the occurrence of S. saprophyticus. 
Method: 505 centres in 16 European countries and Canada recruited female 
patients (18-65 years) with uncomplicated urinary tract infection. All 
susceptibility testing was performed in one centre using the SRGA 
methodology and interpretative criteria (http://www.srga.org). The anti- 
microbial resistance of S.  saprophyticus in the ECO-SENS study and a 10- 
year material from urinary tract infections in Kronoberg county, Sweden 
were compared. 
Results: Of the 56 Staphylococcus saprophyticus from the 16 European 
countries and Canada none were resistant to ampicillin (anioxycillin with or 
without clavulanic acid), cefadroxd, trimethoprim, sulphamethoxazole, 
trimethoprim-sulphamethoxazole, ciprofloxacin or nitrofurantoin. Of the 
1296 S. suprophyticus in the Swedish material the corresponding figures were 
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< 1% for these antibiotics. All strains were technically resistant to 
mecillinani, nalidwc acid and fosfomycin. The Swedish material exhibited 
a pronounced seasonal variation with a sharp maximum during late summer. 
Conclusion: Although resistance development is of grave concern in E. roli 
and other urinary tract pathogens it seems not to occur in S. saprophyticus. 
For mecillinam there are publications to suggest a sufficient clinical activity 
despite the poor inherent activity otherwise shared with fosfomycin and 
nalidixic acid. The Swedish data show a marked seasonal variation in the 
occurrence of S. saprophyticus infections. This might suggest that the lack of 
a natural human habitat for this species and a regular influx of fiesh strains 
each late summer season prevents the rapid selection of resistant variants. 
Antimicrobial susceptibilities of Haemophilus 
influenzae and Moraxe//a catarrhah collected from respiratory 
infections during the European 1999 Sentry antimicrobial 
surveillance programme 
R. Canton, E. Loza, A. Pascual, G. French, P. M. Shah, M. Pfaller, 
European Sentry Participants Group 
Madrid, Seuilla, E; London, UK; Frankfurt, D; Iowa City ,  USA 
Different surveillance studies have demonstrated the increment of p-lactamase 
producing H. influenrae (Hi) and M .  catavrhalis (Mc) isolates, which aflect 
susceptibilities to aminopenich.  A total of 21 1 Hi and 91 Mc isolates causing 
lower and upper respiratory tract infections recovered in 10 laboratories &om 8 
European countries during the respiratory disease season were studied. 
Susceptibility testing were c e n t b e d  (University of Iowa, IA, USA) and 
performed by the microdilution techque  accordmg to NCCLS standards. 
Susceptibility testing analysis of both organisms was performed using the 
NCCLS cntena for Hi (document M100-Sl0, 2000). elactamase production 
rates were 19.4 and 94.5% for Hi and Mc, respectively. No amoxic&/ 
clavulanate or cehroxime resistances were observed among elactamase 
producing Hi and Mc isolates. However, a low incidence of elactamase 
negative amomcillin/clavulanate or cefuroxinie nonsusceptible Hi isolates was 
detected (0.5% and 1.9%, respectively). As expected, all isolates were inhlbited 
by 2 pg/mL of cefotaxime or cefepime. Macrolide resistance (clarithromycin 
resistance, '32 pg/mL) was low (1.4%) in Hi and it was not detected in Mc 
isolates. S d r l y ,  no ciprofloxacin-or levofloxacin-resistant Hi or Mc isolates 
were detected. Chloramphenicol and tetracyche resistances in Hi were 0.9 and 
1.8, respectively, and was not detected in Mc isolates. Resistance to 
cotrimoxazole was higher in Hi (18.9%) than in Mc (1.1%) isolates. With 
the exception of aminopenichs in both Hi and Mc isolates, and 
cotrimoxazole in Hi, this survey demonstrated that antimicrobial resistance 
is currently low in these organisms. 
[p5181 Susceptibility patterns of Streptococcus pneumoniae 
isolates: the European 1999 Sentry antimicrobial surveillance 
programme analysis considering different breakpoint criteria 
R. Canton, E. Loza, J. Bille, J .  LiEares, M. J. Struelens, F. Baquero, R. N. 
Jones, European Sentry Participants Group 
Madrid, E; Lausanne, CH; Barcelona, E; Brussels, B; l ouu  City, USA 
During the last decades resistance rates in S. pneumoniae has risen to 
prominence in d&erent geographic areas. A total of 213 S. pneumoniae 
isolates causing lower and upper respiratory tract infections recovered in 10 
laboratories from 8 European countnes during the respiratory disease season 
were studied. Susceptibility testing were centralized (University of Iowa, 
IA, USA) and performed by the microdilution technique (NCCLS 
standards). Overall penicillin, cefotaxime and cefepime resistance rates 
(intermediate plus resistant, NCCLS cnteria) were 41.4, 20.6, and 18.8% 
respectively. The corresponding resistance values for erythromycin, 
clindamycin and quinupristiddalfopristin were 19.7, 15.9 and 0% 
respectively. As expected, higher erythromycin resistance was found among 
penicillin-intermediate (33.3%) and -resistant (40.0%) isolates. Erm type 
phenotype accounted for > 75% of macrolide-resistant pneumococci. 
Chloramphenicol, cotrimoxazole, and tetracycline resistances reached 
values of 12.6, 13.1, and 20.6%, respectively. Resistance to new 
fluoroquinolones was rarely observed as only one isolate displayed MIC 
values for levofloxacin and gadoxacin 2 2  pg/nL. To note that different 
resistance values were obtained when Considering amodcillin and 
a~noxicillin/clawlanate results and the 1999 and 2000 NCCLS breakpoints, 
particularly within the penicillin resistant isolates (see table). 
vl Streptococcus pneumoniae resistance to antibiotics in 
Italy in the 2000 GISPneumo internet project 
A. Camporese, D. Natoli, G. F. Satta 
Pordenowe, Palerrno, Caglian, I 
Resistance of S. yueumoniae is an actual important problem. In 1999, 58 
Italian Microbiology Units collected their data on antibiotic resistance by S. 
pyogenes in a website now called www.gispneumo.com [l]. This pemlitted 
to know in real time the percentages of national and local resistance making 
it useful to the medical community. At the beginning of 2000, this project 
added the data on S. pneumoniae. The gispneumo.com is an active website 
aimed to collect data on S. pneurnoniae resistance to antibiotics from Italian 
niicrobiological laboratories. Each laboratory si issued its own log-in and 
password, to ensure data security. Data are entered on fomis provided in the 
site, collecting information on the patient characteristics, the microbiolo- 
gical method used, and the microorganism's response (sensitive, inter- 
mediate, resistant) to penicillin, amoxicillin/clavulanic acid, cefaclor, 
erithromycin, azithromycin, clarithromycin and rokitamycin. Each labora- 
tory was i?ee to test their routine antibiotics. Participating Units thus have 
up-to-date information constantly at their gingertips, regarding their own 
data and the overall picture. Between 1st January and 7th November 2000, 
33 Italian Microbiology Units throughout Italy took part in the project, and 
data was collected on 540 cases. S. pneumoniae showed the following 
sensitivity (in brackets the number of strains tested): penicillin 77.2% (466), 
amoxicillin/cladanic acid 95.9% (270), cefaclor 100% (295), erithromycin 
61.3% (492), azithromycin 55.7% (104), clarithromycin 58.3 (108), 
rokitamycin 82.2% (371). As of 2000, local and natlon-wide data are 
available to GPs, pediatricians and pharmacists wanting up-to-date 
information on drug resistance. The doctor is issued a password and log- 
in on a special 'sensitivity card', to permit access to the data. This creates a 
virtual network, connecting microbiologists and physicians in real time with 
the aim to give a rational basis for the empirical antibiotic therapy. Usually 
the data of local laboratories are not available because of the di6culty of 
systematic collection, problems for that GISPneumo project gives a 
straightforward practical solution [2]. 
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vl Surveillance of antibiotic resistance at St. Elizabeth 
Cancer Institute, Bratislava: overall results from January 1999 
until August ZOO0 
R. Babela, V. Krcmery, G. Kovacicova, M. Lovaszova, 1. Svetlansky, M. 
Gogova, J. Trupl, I. Gould 
Bratislava, SK; Aberdeen, UK 
Objectives: The main objectives of the study are to nionitor epidemiology 
of resistance, monitor resistance according to standardized methods, identify 
new/emerging resistance mechanisms at an early stage, prevent their 
dissemnation, early detection and prevention the outbreaks, search and 
document anticipated events such as VRSA, VRE, PRCD, multiresistant 
Mycobacterium tuberculosis, MRSA. 
Methods: We used antibiotic disc sensitivity testing methodology, which 
complies with the NCCLS 1993 and utilized adequate controls. The 
NCCLS method has been used because of its best standardzed disc 
sensitivity testing method. Zone sizes were measured objectively using a 
BIOMIC automated radius zone reader. We used disc method because it 
is preferred for long-term surveillance as it allows both measurement of 
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MICs (regression line analysis) and detection of more subtle changes in 
MIC levels. 
Results: Throughout January 1999 and August 2000 we tested 2609 
organisms collected from Medical Dept. (633, 24.2%), Surgical-Oncology 
Non ICU Dept. (139, 5.3%), ICU Dept. (137, 5.2%), Radio-Oncology 
Dept. (816, 31.2%), OBG Dept. (190, 7.2%) and from Outpatient Dept. 
(940, 36%). From 240 (100%) strains of beta-hemolytic streptococci the 
highest resistance was to erythromycin (15, 6.2%). We collected 306 (100%) 
strains of enterococci whereabouts 17 (5.5%) were beta-lactamase positive, 9 
(2.9%) were high level gentamicin resistant and 2 (0.6%) glycopeptide 
resistant. From 1267 (100%) strains of Enterobacteriaceae 59 (4.6%) were 
ciprofloxacin resistant, 52 (4.1%) were gentamicin/aminoglycosides resis- 
tant, 30 (2.4%) were extended spectrum beta-lactamase positive add just 1 
(0.07%) strain was carbapenem resistant. From 52 (100%) of Acinetobacter 
spp. 15 (28.8%) were gentamicin resistant and &om 179 (100%) tested strains 
of Pseudomonas aeruginosa 72 (40.2%) were gentamicin resistant, 9 (5%) were 
ceftazidime resistant and 5 (2.8%) were piperacillin/tazobactam resistant. 
Finally, from 60 (100%) strains of anaerobes there was 20% resistance to 
metronidazole (12 strains). 
Conclusion: Surveillance helped us develop effective reporting and audit 
system in our hospital. Thanks to good local antibiotic policies we can go on 
in fighting high resistance of Pseudomonas aeruginosa to aminoglycosides, 
metronidazole resistance in anaerobes and aminoglycosides resistance in 
Arinetobucter spp. 
The ECO-SENS project - antimicrobial resistance in E. 
coli with and without resistance to ampicillin, trimethoprim and 
nalidixic acid respectively 
G. Kahlmeter 
Viixjo, S 
Introduction: The ECO-SENS project is an ongoing survey in 16 countries 
in Europe and in Canada of antimicrobial resistance in bacteria causing 
uncomplicated lower urinary tract infections in otherwise healthy women. 
This report deals with resistance in a total of 1312 E.coli. An interim report 
on 1163 of these isolates describing the methodology and preliminary 
overall resistance figures for E. coli was recently published (IAC 2000; 46 
Method: 505 centres in 16 European countries and Canada recruited female 
patients (18-65 years) with uncomplicated urinary tract infection. Women with 
symptom for more than 7 days, with more than 3 UTIs within the last 12 
months, or who had been on antibiotics during the last 2 weeks were excluded. 
A uticult dip-slide was sent to a cenaal laboratory for isolation of UTI 
pathogens. All were sent to the present author for susceptibility testing using the 
SRGA methodology and interpretative criteria (http://www.srg.org). 
Results: In the 1312 E.  coli the overall resistance to ampicillin was 30%, to 
trimethoprim 16% and to naldxic acid 6%. With few exceptions, E. coli 
resistant to one of these drugs were more often resistant to any of the other 
antibiotics than E. coli without such resistance. For class-related antibiotics 
these figures were very high: For ampicillin resistant and sensitive E.  coli 
8.3% and 0.1% were resistant to amoxycillin-clavulanic acid, 3.0% and 0.3% 
resistant to mecillinam and 5.0% and 1.0% resistant to cefadroxil. For 
trimethoprim resistant and sensitive E. coli 88% and 19% were resistant to 
sulphamethoxazole, and 91 % and 0.5% resistant to trimethoprim-sulpha- 
methoxazole. For n&&c acid resistant and sensitive E. coli 42% and 0% 
were resistant to ciprofloxacin, respectively. 
Conclusions: Due to high frequencies of antimicrobial resistance to 
traditionally used antibiotics (ampicillin, sulphonamide (30%), trimethoprim 
and trimethoprim-sulphamethoxazole (15%)) in community acquired E. coli 
in many parts of Europe and Canada the choice of empirical antibiotics in 
uncomplicated urinary tract infection needs to be revised. The revision must 
take into account the local antimicrobial resistance patterns as well as the fact 
that resistance to one annbiotic dramatically increases the risk of resistance 
not only to related antibiotics but also to antimicrobials of completely 
different antibiotic classes. 
(Sl): 15-22). 
m] Evaluating a European-wide surveillance system: the 
European antimicrobial resistance surveillance system (EARSS) 
Bilthoven, NL 
Introduction: EARSS is a European network aiming to facilitate the set up 
U. Buchholz, P. Schrijnemaker, C. Meffre, S .  Bronzwaer 
of national surveillance systems to obtain standardised information on 
antimicrobial resistance ( A M R ) ,  to assess AMR data over place and time, 
and to provide feedback to those who need to know, e.g. policy makers. At 
present 408 laboratories from 18 countries are reporting. During the first 2 
years, EARSS focussed on setting up this large network. Evaluation is an 
important step in consolidating the system and to come to recommendations 
for improvements. 
Methods: We used guidelines published by the CDC and WHO for the 
evaluation of surveillance systems. From stating the objectives we deducted 
which system attributes are most important to achieve those objectives. 
Results: Simplicity: Some aspects of the surveillance system are simple: the 
protocol is not extensive, the data format has few variables, and reporting is 
straightforward. Other aspects are not simple: for example, within countries, 
data are ofien forwarded on paper. Acceptability: participants followed in 80% 
the testing scheme for S. pneumoniae, and in 70% that for S .  aureus. 
Flexibility: The network seems to be too big to be hghly flexible, but the 
current inclusion of 2 new pathogens demonstrates its flexibility. Quality of 
data: We distributed a software programme to the national centers that 
checks data for correctness, and gives immediate basic analytical feedback on 
the data. Quality of microbiological test results: A recent quality assurance 
exercise among 433 laboratories, which already are or will be participating 
in EARSS, confirmed that susceptibility test results from these laboratories 
are reliable and comparable. Representativeness: Population coverage among 
participating countries is on average 53% (range: 1&90%). Timeliness: The 
average delay until delivery of acceptable data from reporting countries has 
decreased over time from 8 weeks to 3 days after the deadline. Feedback: 
There is no interactive feedback yet through the internet. 
Discussion: Overall, EARSS is a simple system. The QA-exercise 
confirmed comparability of the data. The data are representative, and 
timeliness in reporting has improved. Recommendations are made to 
increase electronic data transfer, to further increase completeness of data in 
adherence to the EARSS protocol, and to work on the feedback through 
the internet. Individual countries are encouraged to perform an EARSS 
surveillance system evaluation in their own country. 
lp5231 New results from the European antimicrobial 
resistance surveillance system (EARSS): implications for 
intervention efforts 
U. Buchholz, S .  L. A. Bronzwaer, W. Goettsch, P. Schrijnemaker, J.  
Monen, J. L. Kool, J. E. Degener 
Bilthoven, Croningen, N L  
Introduction: EARSS is an expanding network of national surveillance 
system collecting data on antimicrobial resistance (AMR). Until now, two 
pathogens were included, Streptococcus pneumoniae (SPN) and Staphylocorcns 
aureus (SAU). E A R S  provides data for policy decisions and interventions, 
e.g. antibiotic use campaigns or vaccination recommendations. 
Methods: Laboratories that participate in EARSS follow a simple protocol 
screening invasive SPN and SAU for oxacillin nonsusceptibility. Further 
tests confirm penicillin nonsusceptibility in SPN (PNSP) and methicillin 
(oxacillin) nonsusceptibility in SAU (MRSA). Laboratories interpret results 
according to their own standards and send results in a standardised fashion to 
the national EARSS centre which forwards it to the central database at the 
National Institute of Health (RIVM), The Netherlands. For statistical 
analysis we used SAS software. 
Results: In 1999 and 2000, 410 laboratories from 18 countries reported 
6886 SPN and 11264 SAU isolates. Fifty-seven percent of SPN and 60% of 
SAU strains came fiom male patients. Sex was not statistically associated 
with nonsusceptibility. The relative SPN incidence has the shape of a U and 
is highest in the elderly, lower among teenagers and adults, and has a second, 
but lower, peak among the under 5-year-old. Similarly, the likelihood of 
resistance is also lower among teenagers and adults compared to the elderly. 
However, the under 5 years-old are 1.5(95% confidence interval (CI) = 1.2- 
1.9) times more likely to have a PNSP compared to the elderly. The 
country-specific proportion of PNSP among the under 5 years-old vaned 
between 0 and 57%. In contrast to PNSP, the likelihood for MRSA is 
lowest among the under 5 years-old (odds ratio = 0.1 (95%CI= 0.06-0.29; 
> 64-year-old = reference). Controlling for country, the variables age and 
hospital department were significant predictors for MRSA. Overall, 
Southern European countries have both higher proportions of PNSP as 
well as MRSA. 
Conclusions: AMR data collected through EARSS can facilitate public 
health interventions. The high relative incidence of SPN combined 
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with the highest likelihood for PNSP among the under 5 years-old suggests 
to put emphasis on physician and parent education, as well as to 
promote use of the new conjugate vaccine that benefits primarily children. 
Individual countries may wish to tailor their approach according to 
their situation. For SAU, prevention needs to focus on the situation in 
indimdual hospitals. 
1 P524 1 Statistics and GIS for the spread of antibiotic resistance 
D. Steffen, H.  Kmeger, T. Knappe 
Rostock, D 
In 1928, Fleming discovered the sensitivity ofpathogens to penicillin. Since 
that time, many antibiotics have been developed and applied successfully. 
Nevertheless, the danger of resistant pathogens has not been banished. 
Above all, since the sensitivity of the different pathogens to antibiotics is not 
stable. Generally, an increasing resistance of pathogens can be noticed. The 
local occurrence of resistance often is related to the use of antibiotics in 
stockbreeding. The frequent and unfortunately often thoughtless use of 
antibiotics has led to the cultivation of resistant strains. Within the 
Antibiotic Resistance Project a computer program has been developed for 
the collection and geostatistical analysis of data concerning resistances. Thus, 
the program represents an application of medical informatics, whch will 
enable M D s  to adapt the use of antibiotics to the local condition of 
resistances.The program presents not only the actual condition of resistance 
but also local differences, the course of time (Figure 1) and the expansion of 
resistances. Therefore, it is possible to choose other, more efficient 
antibiotics, if an increased local and temporal resistance is detected by our 
program. For the evaluation of the collected data, we use geostatistical 
methods The data will be presented and visualized in the Internet. For the 
realization of this project, surveillance data from the microbiologic 
laboratories of Mec!denburg/Vorpommem, a state of North-east Germany, 
were used. The data were sorted and processed according to zip code 
areas. In that way, the current resistance situation of each area can be 
presented. The crossover of resistance factors often encourages the 
geographical spread of pathogens. Therefore, each change of resistance 
will be documented and collected in a case base (Figure 2). If a similar 
situation arises, it is possible to predict an acute resistance change and 
the therapy can be adapted by choosing an other, appropriate antibiotic. 
This helps to enhance the general resistance situation of Medenburg/  
Vorpommem. Moreover, detailed resistance and pathogens statistics are 
developed considering the origin of the microbes (ambulant/nosocomial), 
localization site, infected material, sex and age of the patient and the already 
prescribed antibiotic. 
Figure 1 
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lp5251 European surveillance of antibiotic resistance (ESAR) in 
Gram-negative alert organisms 
I .  M. Gould, F. M. MacKenzie, H. Haverkamp, J. Trupl, W.  Hryniewicz, 
A. Rodloff, M. Helmerking 
Aberdeen, UK; Munich, D; Bratislava, SK; Warsaw, PL; Leipzig, D 
Since 1998 ESAR has been funded by the European Commission DGXII 
Inco-Copernicus initiative to provide antibiotic resistance data through 
Alert organism surveillance in Eastern Europe. The centres are Slovakia, 
Poland, Germany (Leipzig) with a comparator in Scotland (Aberdeen). The 
data are generated from routine laboratory surveillance data sent electro- 
nically to the European Society for Biomodulation and Chemotherapy 
(ESBiC) data centre in Munich where it is analyzed and put on to the 
ESBIC website (http://www.esbic.de/esbic/). Comparative data for 1999 
and the first quarter of 2000 for more than 70 000 Gram-negative, Alert and 
denominator isolates are presented beta-lactamase production in H .  
influenzae has doubled although the rate is stdl very low at  3.41%. 
Approximately 1/3 were admitted to hospital, 1/5 of these to ICU. 4FQ 
and gentamicin resistance remain around 2% in Enterobacteriacea and 
extended spectrum beta lactamase at <1%. Three cases of carbapenem 
resistant Enterobacteriocea were detected in the fint quarter of 2000. 
Carbapenem resistance also remains rare in Acinetobacler although gentamicin 
resistance has increased from 14 to 20%. Over 70% of Enterobacteriacea Alerts 
were fkom patients admitted to hospital, over 2/5 of these being adrmtted to 
ICU. Over 1/4 did not respond to treatment. Over 50% of cases were UTI 
but only 2% from blood cultures. Over 90% of An'rietobacter Alerts were 
hospitalised, 2/3 in ICU. 60% of infections were nonresponding. UTI, 
LRTI and WI were the most common sites of isolation. Only 3% were 
from blood cultures Gentamicin resistance in P. aenrginosa increased from 
11.3 to almost 15% and third/fourth-generation cephalosporin resistance 
from 3 to 4.5% but resistance to piperacillin/tazobactam was stable at under 
4%. Over 80% were hospitalized, of these over 50% in ICU. 40% were 
nonresponding. UTI was the most common site of isolation followed by 
LRTI and SSTI. In conclusion, a high proportion of Alert organisms seem 
to cause serious disease or to be acquired in ICU. A high proportion did not 
respond to treatment. In general, resistance rates are lower than expected 
from the published literature and remain stable. 
(p5261 lnvasive bacterial disease surveillance in the Arctic: 
international circumpolar surveillance 
A.A. Bell, J.S. Spika, F. Stenz, A.J. Parkinson 
Anchorage, USA; Ottawa, CDN; Nuuk, Greenland, DK 
Objectives: Establish population-based surveillance of invasive bacterial 
diseases in circumpolar regions; describe epidemiological factors for 
aboriginal and nonaboriginal people; characterize serotype and antimicrobial 
resistance. 
Methods: ICS was established 1/1/1999, for all residents of Alaska (AK), 
northern Canada (NCAN), and for Greenland on 1/1/2000. All 56 
diagnostic labs serving ICS regions submit blood and CSF isolates of S. 
pneumoniae (Sp), H. irguenzae (Hi) [all seratypes], N. meningitidir (Nni), and 
Groups A and B streptococci (GAS, GBS) to reference labs where they are 
serotyped and tested for drug susceptibility. Demographlc and clinical data 
are gathered by public health personnel. 
Results: Up to 31/10/2000@rovisional), there were 281 Sp isolates 
submitted from AK and NCAN (1999 + 2000 combined). Estimated mean 
annual rates are 19/100 000 population in AK and 27/100 000 in NCAN. 
Those &om children < 2 years comprised 29% of isolates, of which 83% 6om 
AK and 71% &om NCAN were serotypes contained in the 7-valent conjugate 
pneumococcal vaccines. In those >2-year-old, 87% and 91% from AK and 
NCAN were serotypes in the 23-valent Sp polysaccharide vaccine. The Sp 
incidence rate in aboriginals is 6X and 3X higher than in nonaboriginals of AK 
and NCAN, respectively. Serotypes in descending frequency were 14, 04 
and 7F in AK, and 01,9 V and 14 in NCAN, and represented 39% and 48% 
of all Sp isolates from each country, respectively. Penicillin nonsusceptibility 
was seen in 24% of AK and 14% of NCAN Sp isolates. In 2000 (up to 31/ 
lo), other ICS diseases were reported from AK and NCAN as follows: Hi 
(all types)=20, Hib=8 (all from AK); N m = 9 ;  GASz14; GBS=13. 
Three Sp isolates are reported from Greenland (data pending). 
Conclusions: Collaborative, standardized international surveillance of 
invasive bacterial disease is feasible. Using conjugate and polysaccharide 
pneumococcal vaccines as recommended is anticipated to reduce the 
incidence of invasive disease in recipients and may exert herd immunity to 
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nonrecipients. Areas where Sp serotype 01 predominates might benefit most 
from a conjugate vaccine containing that serotype. ICS in the future: 
Iceland, Norway, Sweden and Finland will participate in Sp surveillance in 
2001. Involvenient by northern regions of Russia is anticipated. The 
International ICS Steering Committee is considering cooperative surveil- 
lance and control measures for TB. 
lp5271 Surveillance of infections and their risk factors in 
patients treated for cancer at the St. Elisabeth Cancer Institute 
0. Benova, R. Babela, M. Lovaszova, V. Krcmery 
Tmaua, Bratislava, SK 
Background and objective: Surveillance of Treatment and Infection in 
Cancer Patients [ESIC] is prospectively conducting a study in patients 
undergoing treatment of cancer in order to identify the type and incidence 
of risk factors for developing infections and for an inferior outcome. 
Results: There were 1410 adnussions through June 1999-July 2000. 122 
[8.6%; t i =  14101 patients fitted to our criteria. 25 [20.4%; r i= 1221 received 
chemotherapy, 11 (9%; n =  1221 received radiotherapy. We found resistant 
nlicroorganisms in 51 141.8%); t i=  1221 cases. 14 [27.4%; n=51]  cases were 
probably associated with administering the chemotherapy and 4 [7.8%; 
ti = 511 were probably associated with radiotherapy. The broadest resistance was 
in Pseudumortar amjrtosa with highest resistance to amikacin, ciprofloxacin, 
nehlniycin. Mebsiella przeumortiae was mainly resistant to anipichl, cotrinlox- 
azole, ocarcillin, carbenicillin and gentamicin. Eschetidiia mli was mainly resistant 
to ampicillin, cotrinioxazole, tetracycline. Enferococcur j&ralis was mainly 
resistant to tetracycline, erythromycin, chloramphenicol and spiramycin. 
We found approximately 20 beta-lactanlases positive microorganisms 
[Enterobacreriaceae] in patients recelving intravenous ATD treatment. 
Conclusion: Only a large amount of prospectively collected and centrally 
validated date obtained from our center together with other centers with a 
wide geographic dismbution can help us to effectively identify and 
eliminate those nsk factors associated not only with infection, but with a 
fatal outcome [infection related mortality]. Recognition of the risk factors, 
including etiology and resistance to antimicrobial agents based on a large 
database, may help us better to organize therapeutic and prophylactic 
strateges with particular antimicrobial agents. 
lp5281 Korean nationwide surveillance of antimicrobial 
resistance of bacteria in 1999 
K. Lee, S. Jeong, G. Ha, G. Park, C. a m ,  W. Lee, Y. Chong 
Seoul, Pusarr, K y o r i ~ u ,  Suwori, KOR 
Objectives: To detennine the trend of such womsome resistance as E.  coli 
and K. prieurnuriiae to cefotaxime (CTX), ceftazidime (CAZ) and cefoxitin 
(FOX), P. aemginosa to imipenem (IMP), E. coli and P. aerufinosa to 
fluoroquinolone (FQN) and enterococci to vancomycin (VAN). 
Methods: The susceptibility data in 1999 were collected from 33 hospitals 
and those from 30 hospitals with reliable quality were analyzed. 
Results: Resistance rates of E. coli to CTX (8%) and that of K. pneumoniae to 
CAZ (24%) were sirmlar to those in 1998. FOX resistance rate of K .  
prieumoriiae, 22%. were slightly higher than in 1998. IMP resistance rate 
(6.2%) of A .  baiurramiii remained similar, and that of P. aeri~ginosa (19%) 
remained high. Significant proportion of IMP-resistant P. aerugiuoza and A. 
hauriianrrii were VIM-2 metallo-beta-lactaniase producers. FQN resistance 
rates of E. coli and P .  aenrgirtosa were 28% and 39%, respectively. Oxacillin 
(OXA) resistance rates were 69% for S. uureus and 67% for Coag.-Neg. 
staphylococci. Among the enterococci tested, 35% were E. &ecium and the 
VAN resistance rate significantly rose from 3% in 1997 to 15%. OXA-&sk 
screening showed 78% of pneumococci were nonsusceptible to penicillin. 
The resistance rates of K. pmwmorriae to CAZ and FOX, P. aeruginosa to 
CAZ, and A.  baurnarzrzii and P. aeruginosa to IMP were hgher in medium 
size hospitals with < 1000 beds in Seoul than in large hospitals with > 1000 
beds. OXA resistance rate of pneumococci was slightly lower in non-Seoul 
medium hospitals. IMP resistance rate vaned significantly from 0% to 28% 
for A .  bauritaruiii and 6% to 30%) for P. aerugiitosa depending on hospitals. 
Conclusion: New threat in resistances in Korea are to 3rd generation 
cephalosporin and FOX in K. pneumoniae, IMP in P. aerugirzosu, FQN in E. 
coli and P. aerugirrusa, and VAN in E. faeciuwi. More prevalence of resistant 
bacteria in medium hospitals suggests lax control of antimicrobial use or 
inefficient control of nosocomial infection in these hospitals. 
Antimicrobial susceptibility in Gram-negative 
nonfermentative bacteria from APUA-Bulgaria Chapter survey 
P. Sotirova, M. Sredkova, I. Haydoushka, I. Haralambieva, E. Keuleyau, N. 
Hadjieva, I .  Mitov 
Slara Zagura, Pleuen, Ploudiu, Sqfiu, BG 
Objective: To survey the current antimicrobial susceptibility (S) in Grani- 
negative nonfermenters (GNNF) from 5 university hospitals: in Sofia, Stara 
Zagora, Pleven and Plovdiv. 
Method: S towards 19 antimicrobials among the selected 147 GNNF, 
resistant at least to carbapenems or cephalosporins-third/fourth generation, 
or aminoglycosides or ciprofloxacin, during 3-6 months of 1999/2000, 
have been studied according to NCCLS-2000. 
Results: The rates of S to carbenicillin (CAR), ceftazidime (CAZ), 
imipenem (IMP), meropenem (MER), amikacin (AMK). gentamicin 
(GEN), ciprofloxacin (CIP) and polymyxin B (PB) were, respectively: 
33%, 50%, 85%, 83%, 35%, 8%, 27% and 99%. The first top most active 
antimicrobials were: for P. aeruginosa ( r t  = 77) - PB > CAZ > IMP > 
MER > aztreonam (ATM); for A .  baurnartrzii (n = 59) - PB = IMP > MER 
> rifainpicin @IF) > ampicilldsulbactam ( S A M ) ;  for S. maltophilia 
( N =  11) - PI) > trimethopnm/sulfamethoxazol (SXT) > CIP > 
IMP = MER. S to carbapenems and ATM in P. aenrginoza from urine was 
significantly higher than that from the low respiratory tract infections 
(LRTI), A. baumaitnii from blood-cultures were significantly more 
susceptible to SAM than from medical devices. S to AMK of A .  baumanrrii 
from urine was hlgher than tiom LRTI. 
Conclusion: The studied GNNF are problematic nosocomial pathogens: the 
most of them being multiresistant, including to carbapenems. From this 
study PB is the most active antibiotic against GNNF, but unfortunately it is 
not used in the clinical practice in Bulgaria. 
Antimicrobial activity of quinupristinldalfopristin 
against Gram-positive cocci isolated from 5 Brazilian centres: 
results from LSMART surveillance study 
C. Mendes, S. Sinto, C.  Oplustil, A. Hsiung, A. Nicodenio 
Sao Paulo, B R  
Gram positive cocci (GPC) are currently responsible for major types of 
infections, and the increasing resistance to several antimicrobial agents is 
encountered in conununity and hospital settings. Since resistance among 
these orgarusnzc may vary according to geographical location, we conducted 
a multicenter surveillance study with isolates from 5 Brazilian cities. 
Quinupristin/Dalfopristiii (Q/D), also known as Synercid, is a combination 
of streptogramin A and B with activity manly restricted to GPC. 
Additionally, the combination of both of these streptogranins (A and B) 
inhibits the resistance conferred by erm gene produced by many GPC. The 
in vitro activity of Q/D and 8 other antimicrobials was monitored against 
651 strains of GPC isolated from 5 Brazilian centres. Minimal Inhibitory 
Concentrations (MICs) were determined by E-test methodology (AB 
BIODISK, Solna, Sweden), using standardized and controlled procedures. 
The evaluated strains are as follows: Staphylorocm aureus (267), Coag. Neg. 
Staphylomccus (131), Sfreptococcus przeumoniae (130), beta hemolytic Strepto- 
coccus (28), Enleroocci~sfaecalis (44), and E. j iecium (51). The MIC90 values 
for the antimicrobials tested are shown in the table. In conclusion, Q/U 
presented excellent acovity against Staphytococrus spp., regardless if the isolate 
was susceptible or not to oxacillin. This leads to an alternative therapeutic 
option to multiresistant strains, since the only current optlon are the 
glycopeptides. Against S. pneumoniae, Q/D also showed good activity, 
including towards penicdlm intermediate and resistant strains. Among E .  
Jaecium isolates, the MIC90 was 2 p g / d  which 70% were susceptible and 
30% revealed intermediate resistance to Synercid. 
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[p5311 Prevalence and epidemiology of vancomycin-resistant 
enterococci in a renal unit 
T. Worthxngton, A. Perry, P. Lambert, T. Cochrane, G. Liplun, T. Elhott 
Birmingham, UK 
Vancomycin resistant enterococci (VRE) have emerged as important 
nosocomial pathogens. A significant risk factor associated with acquisition of 
VRE is the use of third generation cephalosporins and vancomycin. The 
faecal carriage rate and molecular epidemiology of VRE was determined in 
34 patients attending an out-patient clinic following treatment with 
ceftazidime and vancomycin for continuous ambulatory peritoneal dialysis 
(CAPD) associated peritonitis. Nineteen (56%) patients were colonised with 
VRE during a 10-month period. VRE was also recovered from patient 
bedside tables and an automated peritoneal dialysis (APD) nuchine. 
Phenotypic characterization identified patient isolates as Enterueuccur Jzeciunt 
( I T =  11), E. durans (n=6), E..faecalis ( n =  1) and E. avium ( n =  1). Pulsed field 
gel electrophoresis of strains of E. faecium revealed a heterogenous 
population, however, 5 of the isolates of E. duranr were genetically related. 
All of the environmental isolates of VRE had closely related genotypes to 
strains recovered from patients. These results suggest that common 
genotypes of VRE persisted on the CAPD unit and transmission to patients 
may have occurred via contaminated APD machmes. 
/p5321 Sensitivity to quinolones of Staphrfococcus aureus and 
Enterococcus faecalis isolated from patients in Silesia 
Z. Wydmuch, J. Pacha, R. D. Wojtyczka, M. Kepa, S. Glab, D. Idzik 
Sosnowiec, PL 
Introduction: Staphylococcus aureus and Enterocuccus jaecalis cause often 
infections in healthy humans as well as hospitahzed patients in Silesia, 
Southern Poland, and quinolones, particularly fluoroquinolones, with broad 
spectrum of activity against multiresistant bacterial strains, are widely used in 
therapy of these infections. So the aim of our study was to determine the 
sensitivity to 4-quinolones and fluoroquinolones of S. aureus MSSA (38 
strains), S.  auveus MRSA (31 strains) and E.faecalis (60 strains), isolated from 
patients, hospitalized in Silesian clinics and hospitals. 
Methods: Species identification of tested strains was confumed by standard 
methods.The susceptibility was tested by disk difFusion procedure according 
to the recommendations of the National Reference Center of Bacterial 
Drug Sensitivity based on NCCLS standards. The following antibiotics 
were tested: fluoroquinolones: enoxacin (ENX-lo), ciprofloxacin (CIP-5), 
norfloxacin (NOR-lo), lomefloxacin (LOM-10). ofloxacin (OFX-5); and 
4-quinolones: oxolinic acid (OA-2), pipemidic acid (PI-20). nahdixic acid 
(NA-30), cinoxacin (CIN-100) 
Results: The methicilh-sensitive staphylococci demonstrated 100% sensitivity 
to EM-10,  CIP-5, NOR-10, LOM-10,OFX-5 and 92.1% of strains was not 
resistant to PEF-5. They were less sensitive to 4-quinolones: 89.4% to OA-2, 
44.7% to PI-20 and 15.7% to NA-30 and CIN-100. The methcillin-resistant 
bacteria were less sensitive to tested fluoroquinolones: 64.5% to O K - 5 ,  
NOR-10, CIP-5, and 61.2% to LOM-10, PEF-5, E m - 1 0 ,  and the sensitivity 
to 4-quinolones was as follows: 48.4% of strains were sensitive to CIN-100, 
NA-30; 45.2% to PI-20,38,7% to OA-2. In Enterocuxusfaecalis the resistance to 
quinolones was hgh: 100% were resistant to NA-30, PI-20, OA-2; 81.7% to 
CIN-100 and 73.3% to ENX-10, LOM-10 and PEF-5. Ahnost all tested E. 
faecalis mains were resistant to Cquinolones. 
Conclusions: Only fluoroquinolones can be effective antibiotics in therapy 
of methich-sensitive and resistant Stuphyloroccus aureus strains in Silesia. 
Quinolone therapy of infections caused by Etiterucuccus faecalis is rather 
ineffective in this region 
Ip5331 Resistance phenotypes in enterococci isolated from 
clinical specimens during a 3-year period 
M. Toutouza, V. Skandami, M. Poujiouka-Bei, H. Fakin, V. Karabassi, Z .  
Komninou 
Athens, GR 
Objectives: To investigate the species distribution of enterococci isolated 
&om hospitalized patients and their resistance to antibiotics. 
Methods: During a 3-year period (July 1997-July 2000), 766 clinical isolates 
of enterococci were collected from hospitalized patients. Strains were 
isolated from urine 30.8%, blood cultures 18.6%, surgical infections 10.7%, 
intravenous catheters 9.3%, abscess 9.1% peritoneal fluid 7.4%, pus 7.3% 
and other specimens 6.8%. All strains were identified with API 32 Strept 
(ATB Bio-Merieux,France) and susceptibhty was determined by the disc 
a s i o n  method according to the NCCLS guidelines. 
Results: Species level identification results were as follows: Euferucoccus 
.faecalir 487, E. faecium 247, E. casselij7avus 15, E. auium 9, E. durans 8. 
Resistance rates for the most common strains E. faecalis and E. jaefium, 
respectively, were: penicdlin 75.8% and 95.5%, ampicillin 32.8% and 66.8% 
gentamicin HL 28.7% and 47%. streptomycin HL 48% and 66.4%, 
vancomycin 0.6% and 2%, Teicoplanin 0.4% and 1.6%. Of all strains, 10 
(1.3%) were vancomycin resistant and 8 (1%) teicoplanin resistant. The most 
common resistance phenotypes were AM, P, GEN, STR (19.6%), P (18%), 
AM, P (14.6%), P. GEN, STR (11.9%), AM, P, STR (8.9%). Concerning 
the glycopeptides resistance, we had Van A phenotype in 0.3% and Van B 
phenotype in 1% of all strains. 
Conclusions: Enterococci resistant to penicfin and high-level aminoglyco- 
sides are of high incidence. Also, although glycopeptide resistance was not 
detected in our hospital before 1997, in this study the increasing resistance 
to vancomycin and teicoplanin seems to be an emerging problem. 
v] Glycopeptide use and glycopeptide resistance among 
enterococci in a hospital of Florence, Italy 
G. Corti, R. Degl’Innocenti, M.  I. Buonomini, V. Taddei, S. Bocci, 
R. Cinelli, D. Messeri, F. Paradisi 
Florence, I 
Objectives: Enterococci, the increasingly common agents of hospital 
infections, are intrinsically resistant to many antibiotics. Enterococcal 
resistance even to glycopeptides has emerged in recent years, pnmarily in 
the intensive care units (ICUs), prompting clinicians to use those antibiotics 
more properly. We carried out this study in order to compare the use of 
teicoplanin (TEI) and vancomycin (VAN) and the incidence of glycopep- 
tide-resistant enterococci (GRE) in the ICU and non-ICU wards of a 400- 
bed hospital in Florence during a 2-year period. 
Methods: Between 1 January 1998 and 31 December 1999, 340 
nonrrpetitive strains of Enterococcus .faecalis and 108 of Enferococcits .faecium 
were isolated from clinical samples in our microbiology laboratory. Both 
bacterial identitication and MIC determination were assured by automated 
methods (VITEK ‘). Use of glycopeptides was calculated on the basis of the 
defined d d y  doses (DDD) percent. Statistical analysis was camed out by the 
chxsquare and Fisher’s exact tests, and results were considered statistically 
significant for P < 0.05. 
Results: No GRE isolates were found among E. fueculis in 1998, whereas 
two GRE strains out of 108 (1.85%) were isolated in the ICU in 1999 
(P= 0.52 in comparison with non-ICU wards, where none of 30 isolates 
were resistant). As regards E. faecium, 17 out of 108 strains (15.7%) were 
resistant to VAN and 9 out of 98 (9.2%) to TEI, with s igdcant  differences 
in both isolation rate and use of glycopeptides between ICU and non-ICU 
wards (see table). Interestingly, the rate ofE..faeciunt found to be resistant to 
VAN in the ICU decreased from 36.4% in 1998 to 17.2% in 1999 
(P=0.16); at the same time, in consequence of changes in therapeutic 
protocols, VAN consumption in the ICU decreased by 10.2%. Even the 
rate of TEI-resistant E.faecium isolates from the ICU decreased from 26.1% 
in 1998 to 10.3% in 1999 (P= 0.13), although TEI use increased by 10.7% 
in the same period. 
Ward\ VAN-R TEI-R VAN TEI 
MJ) (%) DDD% DDD% 
ICU 27.4* > 17.3 17.44 15.65 
Non-ICU o* > o  0.15 124  
*P= 0.0003 and + P= 0.002. 
Conclusion: Our study shows that the highest prevalence of bacterial 
resistance is found where use of antibiotics is wide, and that reduction in 
antimicrobial consumption can result in concurrent decrease of resistance. 
Clinicians (and primanly, intensivists) must make every effort to use 
glycopeptides properly in order to limit the spread of GRE. 
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/p5351 Isolation of glycopeptide resistant enterococci from 
hospitalized Greek patients 
H. Vagiakou-Voudris, D. Mylona-Petropoulou, G. Ganteris, H.  
Michadidou, A. Zoulamaki, E. Lambrinidou, H.  Malamou-Lada 
Athens, GR 
Objectives: To present the isolation and resistance phenotypes of 
glycopeptide resistant enterococci (GRE) strains from clinical specimens 
obtained from patients hospitalized in a tertiary general hospital during one 
year period (November 1999 to November 2000). 
Methods: Clinical specimens obtained from hospitalized patients were 
inoculated on appropriate media and enterococci were identified by 
conventional methods (Gram stain, catalase, growth in the presence of bile 
and 6.5% NaC1, esculin hydrolysis) and by automated system Vitek-2 (Bio 
Merieux). The susceptibility of enterococci to antibiotics was examined by 
the Kirby-Bauer method. The resistance of enterococci to vancomycin was 
also tested by esculin azide agar (Oxoid), supplemented with 6 pg/mL 
vancomycin. MICs of enterococci were studied by Vitek-2 system. 
Results: During the one year study period 18 GRE strains were isolated. 
Most of the patients with GRE infection were hospitalized in the Intensive 
Care Unit (ICU) (10/18) and the Hematology Unit (4/18). The isolated 
strains included 12 Ettterococcus.faecium and 6 Enteroroccusfaecalis. GRE strains 
were recovered &om blood ( n  = 9), peritoneal fluid collections ( n  = 3). pus 
( = 3), venous catheters ( n  = 2) and urine ( n  = 1). All GRE strains had MICs 
32 pg/mL to vancomycin and teichoplanin, which characterizes VanA 
glycopeptide resistance. They were also resistant to erythromycin (MIC 8 
mcg/nll), ciprofloxacin (MIC 8 pg/mL) and streptomycin (high level). 
Five out of the 18 GRE strains were resistant to quinupristiddalfopristin 
(MIC 16 pg/mL), seven to gentamicin (high level) and 12 to ampicillin 
(MIC 32 pg/mL). All GRE strains were sensitive to tetracycline and 
chloramphenicol. 
Conclusions: Glycopeptide resistant enterococci have become an increasing 
problem in our patients. Further studies to investigate the epidemiology and 
the resistance mechanisms of GRE strains in our hospital are warranted. 
lp5361 Isolation of enterococci resistant to vancomycin from 
faecal samples of swine and raw poultry products in Portugal 
C .  Novais, C. Rku, J. C. Sousa, T. M. Coque, L. Peke 
Oporto, P; Madrid, E 
Objectives: To screen vancomycin resistant enterococci (VRE) in poultry 
(Pt) and swine (Sw), to characterize vancomycin (Vc) genes and to 
investigate the occurrence of resistance to different antibiotics used in 
human therapy. 
Materials and methods: Faecal samples of 37 Sw collected between 1997 
and 1998 were inoculated onto Slanetz-Baaley media and colonies were 
tested for Vc resistance by plating onto Brain-Heart Infusion agar plus 6 
mg/L ofVc. Samples of Pt skin (16 chicken lots and 3 turkey lots) collected 
in local markets between 1999 and 2000 were pre-enriched in buffered 
peptone water and then, plated onto Slanetz-Baaley media plus 6 mg/L of 
Vc. Susceptibility testing ofVRE to other antibiotics was performed by chsk 
diffusion (amoxicihn, chloramphenicol, ciprofloxacin, erithromycin, tetra- 
cycline), and agar dilution (vancomycin) methods following NCCLS 
guidelines. Characterisation of van genotypes was performed by P C R  using 
specific primers for vanA, v a d ,  vanCl and vanC2 genes. A P C R  assay 
based on the specific detection of genes encoding u-alaninx-alanin ligases 
(ddl) was used to identified E. faecalis and E .  faecium isolates. 
Results: 6 swine samples (SwS) and 10 poultry samples (PtS) presented 
reduced susceptibility to Vc. vanA gene was observed in 4 SwS (4/37-10%) 
(MICVc > 256 mg/L) and in 9 PtS (911947%) (MICVc=16 mg/L to 
,256 mg/L). vanCl gene was observed in 2 SwS and 5 PtS (MICVc=8 
mg/L-16 mg/L). All 4 vanA Sw isolates as well as 2 out of 9 vanA Pt isolates 
were identified as E. Jaerium. All vanCl isolates were identified as E.  
gallinarum. All VRE were fully susceptible to amoxicillin and resistant to 
tetracycline. 
Conclusion: E..fnerium isolates harbouring vanA (which has the possibility of 
transference) were found in 4 SwS and 2 PtS for human consumption. 
Simultaneously, it was observed reduced susceptibility to erithromycin, 
ciprofloxacin and tetracycline in these 6 anunals. These data are of concern 
because the possibility of spread multiresistant strains to human via 
food chain. 
wl Molecular epidemiology of Enterococcus spp. from 
children's bacteremia 
E. Alexandrou-Athanasouh, S. Pournaras, N. Siristatidis, M. Kossou, A. 
Maniatis, A. Pangah 
Athens, Larissa, GR 
Objective: To report on the epidemiology of Enterococcus spp. isolated &om 
children with bacteremia. 
Method: 52 Errterococcus spp. isolated during a 4-year period from blood 
cultures were identified and typed. The isolates were identified to the 
species level by the API20 STREP System (Biomerieux). The resistance 
phenotype to 14 antibiotics (Penicilline, amoxicdline + clavulanic acid, 
vancomycin, teicoplanin, chloramphenicol, erythromycin, tetracycline, 
nitrofurantoin, ciprofloxacin, norfloxacin, rifmpicin and high level 
gentamicin, kanamycin streptomycin) was performed by disk diffusion 
and by agar dilution methods according to NCCLS recommendations. 
Molecular typing was performed by pulsed-field gel electrophoresis (PFGE) 
after SmaI macrorestriction. 
Results: During a 47-month period (1996-2000) 30 Enterococcus spp. were 
isolated from ICUs (57.7%) and 22 (4203%) from other paediatric clinics. 
The percentage of E.faecium was hgher in ICUs (36.7) comparing with that 
rate in other clinics (18.2%).The overall HLGR (21.2%) was almost equally 
distributed among isolates &om ICUs (23.3%) and other clinics (18.2%).No 
isolate was resistant to glucopeptides or produced beta-lactamase. Because of 
the variability of antibiotic resistance phenotypes, the majority of isolates 
(46/52) were characterised by PFGE, which revealed a genomic 
heterogenicity among isolates from ICUs as well as from other wards. 
Conclusion: Molecular typing revealed poor genetic relatedness among 
Enterococcus isolates and suggests that no clonal dissemination is responsible 
for the spread of enterococci causing bacteremia anlong children in our hospital. 
1 P538 1 Faecal carriage of antibiotic resistant enterococci 
isolates from food-handlers and healthy-volunteers in Spain 
R. Del Campo, M. P. Sinchez, P. Ruiz, R. Cant&, F. Baquero, 
T. M. Coque 
Madrid, E 
We investigate the rate of antimicrobial resistance, of recent Enterocorrus 
faecalis isolates 6om healthy volunteers (HV) ( n  = 42) and from food-handlers 
(FH) (n = 42) not recently hospitalized nor exposed to antibiotics aanuary- 
June 2000). Stool samples were seeded onto m-Enterococcus plates with 
and without different antibiotics: ampicillin (AMP) 10 pg/mL, erythromy- 
cin (ER) 2 pg/mL, tetracycline (TET) 4 pg/mL, vancomycin (VAN) 4 pg/ 
mL., gentamicin (GM) 128 pg/mL, kanamycin (KAN) 256 pg/mL, and 
streptomycin (SM) 500 pg/mL. Samples were pre-enriched in BHI broth 
with 4 pg/mL ofVAN. By the five-colony method, representative colonies 
of every morphology were picked per plate. Isolates were primarily 
identified as enterococci by testing with 6.5% NaCl and BE medium. E. 
faecalis and E .  faecium species were determined by PCR. Susceptibility 
testing to 15 antibiotics by agar dilution method (NCCLS) was undertaken 
for those colonies exhibiting different antibiotic profile in the initial 
screening. Enterococci were found in 88% of HV (37 out of 42 individuals) 
and in 97% (41/42) of FH. A total of 163 isolates &om HV and 147 from 
FH were further studied (1-6 isolatedpatient). E .  .faecium-VanA phenotype 
were detected in 3/42 (7%) of the FH but not in HV individuals. One of 
these VanA isolates showed high level resistance (HLR) to all tested 
aminoglycosides and trimethoprim (TMP), and resistant to macrolides and 
tetracyclines. Two other FH carriers enterococci with VAN MIC = 8 pg/ 
mL. HLR to GM was detected only in FH group (8 out of 42 subjects, 
19%). The percentages of nonsusceptible isolates in HV and FH were: EK: 
82% and 88%; telithromycin: 23% and 23%; synercid: 96% and 73%, 
chloramphenicol: 23% and 16%; TET: 66% and 62%; minocyclin: 62% and 
53%; TMP: 6% and 3%. HLR to KAN, STREP and TMP was detected in 
29%, 11% and 3% of isolates belonging to FH and in 2%, 7% and 2% of 
those &om HV. No resistant isolates to AMP or linezolid were recovered. 
Four isolates with MIC of 4 pg/mL for moxifloxacin were detected in each 
group. In conclusion, high percentage of faecal carriage of Enterococcus 
resistant to antibiotics was found in both populations. The recovery of faecal 
VRE isolates from FH after 3 years avoparcin ban in Spain indicates the 
persistence of some resistant clones, eventually suggesting breaks in adopted 
antibiotic policy in animals. These findings implicated a potential risk of 
spread multidrug resistant enterococci through the food chain. 
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1 P539 1 Impact of rational antibiotic usage on occurrence of 
vancomycin-resistant enterococci in hematological patients 
M. Kolar, I .  Vagnerova, R. Pantucek, P. Cermak 
Oloniouc, Bmo, Hradec Kralove, CZ 
Objectives: The hematological patients are jeopardised by staphylococci and 
enterococci from the group of Gram-positive bacteria. Especially great 
danger for the hematological patients are the vancomycin-resistant 
enterococci that may be a very big therapeutic problem in some cases. 
Methods: Enterococci were isolated &om clinical samples of patients 
hospitalised at the Department of Hemato-oncology of University Hospital 
in Olomouc, Czech Republic, during period 1995-2000. The usage of 
antibiotics was expressed as the number of defined daily doses (DDD) per 
1000 bed-days (RDDD) during the observation periods according to the 
following formula: RDDD = DDD x 100O/NB (NB = number of bed-days). 
To evaluate the selection pressure of antibiotics and occurrence of VRE, we 
used each six-month interval from 1st half of 1997 to 1st half of 2000. 
Results: In total, 1918 strains were isolated in the Department of Hemato- 
oncology, &om which 138 (7.2%) were identified as VRE. The percentage 
of VRE in the mentioned department was withm the interval 1.7-15.1%. 
The highest occurrence (15.1%) was detected in the second half of 1998. In 
the following periods, the number of VRE gradually decreased to the value 
of 6.1% in the first half of 2000. The application of glycopeptides has 
decreased by 68.2% after evaluating the period of 1997-2000. A distinct 
decline is accomphshed especially in vancomycin. A distinct decline (by 
75.3%) is achieved in the case of IIIrd generation cephalosporins as well. 
The selection pressure of fluoroquinolones was not reduced untd 1999, 
when the usage of these antimicrobial preparations decreased by 47.3% 
compared to 1997 and compared to 1998 by 46.4%. 
Conclusion: Based on the coniparison of the selection pressure progress of 
antibiotics and the percentage o f W  in each period of observation, we can 
assume the influence of the application of each antibiotic group on the 
occurrence of VRE. A distinct decline of the application of thrd-generation 
cephalosporins, glycopeptides and fluoroquinolones and its replacement 
with penicillin antibiotics combined with inlubitors of bacterial beta- 
lactamases (amoxicdldclavulanic acid, ampich/sulbactam, piperacdin/ 
tazobactam), had a great influence on the cessation of the increasing 
occurrence o f V M  and a following dechne ofits occurrence from 15.1% in 
the second half of 1998 to 6.1% in the first half of 2000. 
/p5401 In vitro activity of fosfomycin combined with 
glycopeptides, moxifloxacin, gentamicin and ampicillin against 
Enterococci, assessed by the modified spectrophotometric method 
A. Georgopoulos, W. Graninger, P. Bezecny, A. Buxbauin 
Vienna, AT 
Fifty vancomycin-susceptible and six vancomycin-resistant clinical strains of 
enterococci were tested on their susceptibllity to fosfomycin, gentamicin, 
teicoplanin, vancornycin, moxitloxacin, ampicillin, piperacillin-tazobactam, 
ceftazidinie, cefpironie, cefepime, ceftriaxone, meropenem, and imipenem 
in vifro by the broth microdilution method. Fosfomycin MICs ranged &om 
16 to 128 pg/mL and were not significantly influenced by the antibiotic 
susceptibility patterns of the strains. The activity of fosfomycin, a 
phosphonic acid derivative with a broad spectrum of bactericidal activity 
against Gram-positive cocci and several Gram-negative bacteria, combined 
with vancomycin, teicoplanin, moxifloxacin, gentamicin, and ampicillin 
was studied in hnetic spectrophotometric assays using the automatic 
turbidometer Bioscreen-C-Analyzer which permittes continuous monitor- 
ing of bacterial growth. All five antibiotics provided an enhanced 
(synergistic or additive) bacteriostatic effect in combination with fosfomycin 
against most enterococcal strains. While a weak or moderate beneficial effect 
was observed with vancomycin, gentamicin and moxifloxacin, a strong 
effect was demonstrated if fosfomycin was combined with teicoplanin and 
ampicillin. Fosfomycin and teicoplanin appeared to be the most effective 
combination and exhibited synergistic activity against 44 of 50 vancomycin- 
susceptible and 4 of 6 vancomycin-resistant strains, respectively. T o  
compare the Bioscreen results with a conventionally used technique, 
evaluation of antibiotic combinations was performed also by checkerboard 
titration. Good overall correlation between the spectrophotometric assay 
and the checkerboard technique could be observed. We conclude that 
the new approach of spectrophotometnc assessment of antimicrobial 
combinations using the Bioscreen analyzer could be a valuable alternative 
for routine investigations. 
Surveillance of high-level aminoglycoside resistant 
Enterococcus species colonization 
U. mkar, N. Ceryan, N. Ertugrul, A. Mert 
Ankara, TR 
Background: Eiiterorocrus species may acquire transferable plasniids that 
encode for the production of aminoglycoside-modifying enzymes. Strainc 
that produce these enzymes exhibit high-level resistance to various 
aminoglycosides. These strains are resistant to the synergistic activity that 
would occur between penicdin or other cell wall active agents and an 
aminoglycoside. Detection of high-level aminoglycoside resistance with 
standard disks used for d i s k - ~ s i o n  test is not a reliable method. 
Objective: Surveillance of high-level aminoglycoside resistant Enteroroms 
spp. colonization among hospitalized children between 0 and 16 years age. 
Methods: Rectal high-level aminoglycoside resistant Etrferororcus spp. 
colonization was surveyed among 244 children hospitalized at Social 
Security Children's Education Hospital between November 1999-January 
2000. High-level aminoglycoside resistance was investigated with high- 
content (120 pg) gentamicin and (300 pg) streptomycin disks. Gentamicin 
resistance was also investigated with agar screen method on brain-heart 
infusion plates containing 500 pg/mL gentamicin. 
Results: 197 of the 244 screened patients were colonized with Enterococcus 
spp. High-level gentamicin resistance was detected in 96 (48.7%) of 
the isolates with agar screen method and 97 (49.2%) with high-content 
disks. High-level streptomycin resistance was detected in 80 (40.6%) of 
the isolates. 
Conclusion: In this study we wanted to emphasize the importance of 
investigation of high-level aminoglycoside resistance. High-content disks 
seem sensitive and convenient for detechon of high-level aminoglycoside 
resistance. 
vl Ampicillin, gentamicin, and vancomycin resistance 
among enterococci in Nordic countries: analysis of clinical 
isolates from five laboratories 
G. Skov Simonsen, L. Smaabrekke, D.  Monnet, T. Sorensen, J. Moller, 
K. Kristinsson, A. Lagerkvist-Widh, E. Torell, A. Diganes, S. Harthug. 
A. Sundstjord 
Tromso, N; Copenhapz,  D K ;  Rejkjavik, IS; Uppsala, S; Bexen, A' 
Objectives: (1) Examine the prevalence of ampicillin, high-level gentamicin 
(HLGR), and vancomycin resistance among enterococci from in-and 
outpatients in Nordic countries. (2) Correlate resistance profiles to local and 
national antibiotic consumption data. 
Materials and methods: Enterococcal strains were selected in three groups 
Gom five laboratories: (1) blood culture isolates Gom 1999; (2) Consecutive 
inpatient isolates (max. 40); and (3) consecutive outpatient isolates (nlax. 40) 
collected during March-May 2000. A registration form was filled out for 
each isolate containing data on sex, age, in-or outpatient, hospital 
department and type of specimen. Species identification was performed 
by conventional methods and/or dd-PCR. Susceptibility to ampicillin, 
gentamicin, or vancomycin was tested following NCCLS breakpoint 
criteria using quality control strains. Ampicfin-and vancomycin resistance 
were verified by E-test. 
Results: A total of 509 strains were collected (male/female 249/260, 
inpatient/outpatient 340/169); E. faecalis (N= 420, 82.5%), E.  faecium 
(N= 82, 16.1%). E. gallinarum (N= 4), E. casselijlavus (N= 2), and E.  hime 
(N= 1). The proportion of E.faecium was 75/340 (22.1%) among inpatients 
and only 7/169 (4.1%) among outpatient isolates. Overall, 49/156 (31.4%) 
blood culture isolates were identified as E. faeciurn. Susceptibility testing of 
420 E.  faecalis strains showed no resistance to ampicillin, no resistance to 
vancomycin, and HLGR in 42 strains (mean 10%; range between hospitals 
I-27.7%). Susceptibihty testing of 82 E.faeciurn strains revealed no resistance 
to vancomycin, ampicillin resistance in 40 strains (mean 49%; range 33- 
61.3%). and HLGR in 9 strains (Mean 10%; range &52.9%). HLGR E .  
faecium strains (N= 9) were detected in only one hospital. Six of those strains 
were also resistant to ampicillin. Resistance rates will be correlated to local 
and national antibiotic consumption data. 
Conclusions: (1) A high proportion (31.4%) of E. faecium was detected 
among enterococci in blood culture isolates. (2) Resistance to vanconiycin 
was not detected. (3) Ampicfin resistance was not detected in E.faecalis, in 
contrast to E. faecium strains (49%). (4) HLGR rates varied considerably 
between hospitals and species. (5) A relative high prevalence of ampicdin- 
resistant and HLGR E. faecium strains was detected in one hospital. 
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lp5431 Outbreak of vancomycin-resistant enterococci after 
the Marmara earthquake in a back-up university hospital in 
Istanbul, Turkey 
V. Korten, L. Mulazimoglu, H. Atalay, G. Culha, F. Dilnien, U. Ersoy, F. 
Babacan, G. Soyletir 
Istaisbul, TR 
Objectives: To investigate and control an outbreak of infection and 
colonization of VRE occurred among earthquake victims. 
Materials and methods: Mamiara University Hospital is a 400-bed 
university medical center that served as a back-up hospital after the major 
earthquake on 17 August 1999. Epidemiological investigation, including 
culture surveys of patients and healthcare workers (HCW), pulsed-field 
gel electrophoresis (PFCE) typing and institution of control measures 
were used to handle the outbreak. Medical intensive care unit (MICU), 
surgical intensive care unit (SICU) and internal medicine ward, all on 
the same floor, were affected from the outbreak. Rectal swap samples 
were obtained from all patients in internal medicine ward, MICU 
and SICU on the fifth day of unit stay and then weekly. Heinodialysis 
patients received care in October and HCWs worked in effected units were 
also screened. 
Results: Between 22 September 1999 and 20 December 1999 four patient5 
were infected and 8 patients were colonized by VRE. The index isolates 
were cultured &om two disaster victims with crush syndrome and 
fasciotomy wound infections on the same day. All strains were E. faerium 
exhibited high-level resistance to vanconiycin and teicoplanin, indicating 
the VanA phenotype. 271 stool samples from 118 patients were obtained. 65 
of the targeted 117 HCWs could be screened. Cultures of HCWs and 
hemoddpis patients were negative for VKE. PFGE typing indicated that 
the outbreak was clonal. No more than two patients were colonized with 
VRE at the same time in the ICUs. We followed the recommendations of 
CDC (MMWR 1995/Vol. 44/No. RK-12) to prevent the spread ofVRE. 
Using barrier isolation, cohorting, dedicated use of noncritical items, 
environmental decontanlination program, restricting glycopeptides in 
MICU and SICU led to the eradication of VKE from the hospltal. 
Fourteen weeks after the last VKE isolation, screening was discontinued on 
3 April 2000. 
Conclusions: We describe the first outbreak due to VRE in Istanbul. We 
believe that hospitalization of many patients with open wounds, heavy use 
of prophylactic and therapeutic antibiotics and less than ideal wound care 
under unusual conditions led to the VKE outbreak in our hospital. 
Screening procedure5 and isolation precautions adapted from CDC 
guideline?, and low colonization pressure in ICUs led to the termination 
of the outbreak. 
1 P544 1 First report of the clinical isolation of vancomycin 
resistant Enterococcus faecalis in Turkey 
B. Ongen, N. Curler, M. Akova, B. Awn, K. Akpir, K. Toreci, 0. Ang 
Istaribul, Aukura, TR 
Vancomycin resistance in enterococci (VRE) was first reported in 1988. 
Since then the frequency of infections with VKE (especially with 
Enterococcus .faecium) is increasing dramatically and becoming endemic in 
many hospitals throughout the world. In Turkey, vancomycin resistance has 
been recognized in clinical isolates of E. jzeciurrs for over three years. There 
has been n o  report describing the isolation of vancomycin resistant 
Enteromcrus $era/is in Turkey. We report here the clinical isolate of 
vancomycin resistant E.  j m u l i s  from a 70-year-old intensive-care unit 
patient with vasculitis who had before received vancomycin therapy. on 10 
April 2000 an Enterococcus strain isolated from his blood culture and 
identified as E.faecafis using API 20 Strep (bio-Mkieux) and Crystal Gram- 
Positive ID (BBL) systenls. The strain isolated was high-level resistant to 
vancomycin and teicoplanin. MIC for vancomycin was 128 mg/L and for 
teicoplanin was > 256 with microdilution and agar dilution methods based 
on the NCCLS criteria. The strain showed resistance also to most antibiotics 
tested including high-level resistance to gentamycin (MIC: > 512 mg/L) 
and to streptomycin (MIC: 1000 mg/L) although it was sensitive to 
ampicillin (MIC: 8 mg/L). The bacteriological and clinical features of the 
case are discussed. Because of the emergence of vancomycin resistance 
aniong Enterococcus species in our country, prevention and control Studies 
should be revised. 
lp5451 TWO clinical isolates of vancomycin resistant 
enterococci and the finding of VRE on inanimate surfaces in a 
Turkish university hospital 
L. Atasever, A. Aridogan, S. Ordek, H. Erdogan, M. Kucuker, C. Bal, 
Istanbul, TR 
In spite of the fact that vancomycin resistant enterococci (VKE) are still 
relatively rare in Turkey, the incidence seems to be increasing. Vanconiycin 
resistance is common among E. faecium strains but it is quite rare in E. 
faecalis. A VR-Enterococcur j&mlts main with vancomycin and teicoplanin 
MIC > 256 pg/rnL was isolated &om heniocultures of an adult intensive 
care unit (ICU) patient who experienced total cystectomy due to cystic 
tumor 3 weeks before. T h s  is the second isolate of VR-E. fueculis in our 
hospital and also in Turkey, and the fourth isolate of VRE in our hospital 
within a year kom infected patients, excluding reports on carriage. The 
Infection Control Team was warned on this isolation and general preventive 
measures were reviewed once more. Three months after, a linlited survey 
was started on the occasion that another VKE strain, this time an E. ,faerium 
with vancomycin MIC > 256 pg/nL and teicoplanin MIC = 128 pg/mL 
was isolated from urine of a urology patient transferred to our hospital &om 
a private one. The surveillance study was focussed on the adult ICUs where 
vancomycin is extensively used for Gram positive infections and on the 
urology ward where the last VRE patient was still hospitalized, to observe if 
VRE insisted on inanimate surfaces. A total of 103 environmental swab 
specimens were processed using the enrichment method and VRE- 
screening media. Any growth of > 1 colony of Enteroroms spp. on 
screening media after 24 h was evaluated. Three VK-E. .faerium isolates were 
obtained &om the urology unit in this environmental survey, all having 
vancomycin and teicoplanin MICs of > 256 and > 16 kg/mL, respectively. 
According to the vancomycin and teicoplanin MICs of the clinical and 
environmental strains, all VKE isolates seemed to have the vanA resistance 
type, O n  the other hand, no VRE isolates were encountered in any of the 
ICUs where infection control studies in our hospital are concentrated on. 
VRE can be imported into hospitals through patients transferred from other 
centers but infection control measures, if taken seriously, are important in 
preventing spread of VRE. 
0. Ang 
v1 Infections with enterococci-estimation of change in 
drug-susceptibility (correlations with clinical features and 
prognosis) 
C. Popescu, G.  Popercu, G. Burduja, R. Moroti, L. Gavriliu 
Burhares t, R 0 
Objective: Estimation of enterococci drug-susceptibility from haspitalized 
patients in “Matei Bals’ Infectious diseases National Institute in 1996-99 
penod, of its determinants and its influence on clinical advance. 
Methods: Study of 266 drug-susceptibility tests performed in our institute 
by di&simetric methods. We also correlated this findings with clinical and 
laboratory data. 
Results: Enterococci was isolated from: untie - 69.92%, blood - 12.78%, 
skin - 7.51%, auricular secretions - 4.13%. The chart of drug-susceptibihty 
is the following (see Table 1). The niultiresistance was correlated with 
isolation from other fluid than urine. The analysis of patients indicated 
sepsis in 21.05% (for isolated from blood-34%, urine-12%, CSF-5%) with 
high degree of resistance. We analyzed antibiotics regimen and the advance 
of patients. 
Conclusions: We found the increase of aminosides’ resistance, the same 
susceptibility at aminopenicillines (which remained first intention therapy), 
and the appearance of vancomycin and piperacillin-resistance strains. 
Table 1 
Interiiiedidtc 
Susceptibility cusceptibllity Rrsistniicr 
An tibiotic (%) (%) (%) 
Aiiiinopenicillin 79.75 14. lH  6.07 
Piperacillin hO.06 19.04 11.9 
Imipenetii 81.7 3.3 15 
Streptomycin 2.9 5.1 92 
Fluorqumolonrs 33.38 46.62 20 
Gentarnicin 23.44 45.45 31.11 
Vancomvcin 75.54 11.4 13 Oh 
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/p5471 Antimicrobial susceptibilities of 5. Aureus, coagulase- 
negative staphylococci and Fnterococcus spp. isolated from an 
Algerian hospital 
N. Ranidani-Bouguessa, N. Bensafar, R. Denine 
Algiers, DZ 
Objectives: To study the prevalence of methicillin resistance of S. uureus and 
coagulase negative staphylococci (CNS), and to evaluate vancomycin 
resistance of both staphylococci and enterococci in hopitalized patients. 
Methods: Our study was performed in a 800-bed teaching hospital from 
1998 to 2000. Antimicrobial susceptibility to oxacillin and other drugs was 
determined by agar disk diffusion method. Resistance to oxaciliin was 
confirmed by the oxacillin-salt agar screening test. Minimum inhibitory 
concentration (MIC) of vancomycin was performed to methicillin-resistant 
staphylococci and all enterococci by agar d u t i o n  method. The NCCLS 
interpretative criteria were used. 
Results: A total of 307 S.  ailreus, 211 CNS were collected and only 31 
enterococci were identified. Sxty-elght (22%) of S. auras, 40 (19.5%) of CNS 
and 4 (10%) of enterococci were isolated kom blood cultures. Methidm 
resistance was found in 43 (14%) of S .  uuracr, 109 (51.7%) &om SCN. Resistance 
to other drugs &om both strains was, respectively: 7-33% for gentamicin, 1537% 
for eythromycin, and >15% for dampicin. All MRSA were susceptible to 
vancomycin MIC50 and MIC90 were 2 and 4, respectively. Three isolates of 
m e t h i d i n - m i s t  CNS, two S. haemolytinrs and one S. snun, and five 
enterococci, 4 E. &calis and 1 E. jiecium, showed an intermediate resistance 
to vancomycin, MIC were 8 mg/L and 6 mg/L, respectively. 
Conclusions: Rates of MRSA are relatively low in comparison to 
methicillin resistance in CNS. Identifymg enterococci and continuous 
monitoring of antibiotic resistance patterns is required. 
lp5481 Prevalence of antimicrobial resistance of enterococcus 
species isolated from blood in adult patients (1994-99) 
J. Ayats, F. Tubau, M. C. Cisnal, M. A. Dominguez, J. Linares 
Barcelona, E 
Objectives: The aim of this study was to determine the prevalence of 
enterococcal species isolated from blood cultures and their antibiotic 
susceptibility in a Spanish Hospital throughout a 6-year period (1994-99). 
Methods: The identification and antibiotic susceptibility were performed by 
a commercial method (MicroScan), according to NCCLS criteria. The 
study of beta-lactamase production was performed using nitrocefin disks. 
Results: A total of 463 consecutive enterococcal strains were isolated &om 
blood cultures, in 463 different patients. 407 (88.1%) strains were idended as 
E.-faeculis, 41 (8.9%) E../uecium, 10 (2.2%) as E. gullinarrrm, and 4 (9.9%) as E. 
case/@wus. Among the E. $eculis (n = 407) isolates the resistance rates were as 
follows: 2 (0.5%) strains were resistant to ampicdh (AMP) and 2 (0.5%) to 
vanconiycin (VAN) (vanA gene was detected by PCK), 159 (39.1%) to 
ciprofloxacin (CIP), high level resistance to gentanicin (HLRG) were detected 
in 107 (26.3%) of strains and high level resistance to streptomycin (HLRS) in 
149 (36.6%) both HLRG and HLRS were confirmed by disk-&sion and E- 
test methods. Among the E..fwdum (n= 41) the resistance rates were as follows: 
AMP 51.2%, VAN 12.2% (vanA genotype), CIP 73.2%, HLRG 19.5%, HLRS 
31.7%. Among E .  gullinarum s w a i n s  ( n =  10). all isolates were susceptible to 
a m p i a h ,  7 were resistant to VAN, 3 to CIP, 2 showed HLRS, and HLRG 
was not detected. AU isolates of E. cusselijluvus were susceptible to all antibiotics 
studied, including VAN by NCCLS criteria. 
Conclusions: (1) E. fieralis was the predominant enterococcal species 
isolated &om blood cultures, and resistance to VAN and AMP was rare in 
our hospital. (2) E..hecium was the enterococcal species with more multiple 
antibiotic resistance (3) Isolates of enterococcal species other than E. fbrculis 
and E. juecium, were rare and more susceptible to antibiotics. (4) In our 
hospital resistance to VAN among enterococcal blood isolates is very low. 
p549 Antibiotic resistance patterns of enterococci isolated in 
Kuwait hospitals 
E. Udo, N. Al-Sweih, P. John, L. Jacob, T. Chugh 
Safat, K W T  
Objectives: As vancomycin-resistant Enterococci has become a n q o r  focus 
of attention in hospitals worldwide, this study was conducted to investigate 
the prevalence of resistance to vancomycin and other antibiotics in 
Enterococci isolated in some hospitals in Kuwait. 
Methods: Enterococcal isolates were isolated &om different clinical materials 
and identifies by cultural chaacteristics, Gram stain, catalase and bile esculin 
tats, and by biochemical reactions using API Strep (bioMerieux, Marcy, 
E’toile, France). The disk dlasion method was used to determine susceptibility 
to antibiotics. Minimum inhibitory concentrations were determined for 
vancomycin and teicoplanin with E-test strip while the MIC for gentamicin, 
streptomycin and kanamycin was determined by agar dilution. 
Results: A total of 415 Enterococci consisting of E.&ecu/is (85.3%), E.Jaeiitin 
(7.7%), E. cusseliflauus (4.0%), E. &urn (1.2%). E. dumm (1.0%), E. ~allinuriutn 
(0.5%) and E. Iiouis (0.2%)). They were isolated &om unne (36.6%), Blood 
(10.4%), wound swabs (ll%), rectal swabs (12%), H V S  (9.0%), endocervical 
swabs (3.0%) and mscellaneous sources (18.0%). None of the isolates produced 
beta-lactaxlase. However, they were resistant to tetracycline (60.5%), 
erythromycin (63.3%), ciprofloxacin (49.0%), chloraniphellicol (28.0%), 
vancomycin (3.0%) and t e i c o p h  (1.4%). 14, 19 and 20% of them expressed 
high-level resistance to gentamicin, kanamycin and streptomycin, respectively. 
Conclusions: The results demonstrated a low incidence of vancomycin 
resistance among the isolates studied but high incidence of resistance to 
tetracycline, erythromycin, ciprofloxacin and chloramphenicol. 
[-m1 The incidence of MRSA among staphylococcal strains 
isolated in a regional hospital in Yugoslavia 
M. Jovanovic, B. Komazec, M. Jasikovic, I .  Jovanovic, G. Kovacevic, V. 
Rangelov, S. Pavic 
cizice, W 
MRSA (methicillin-resistant Sraphylororrus aweus) has emerged as a major 
infection control problein in our hospital. We carried out a review of the 
new patient episodes of MRSA colonization/infection and new pahent 
episodes of MRSA bacterenlia in General Hospltal Uzice, Yugoslavia. 
During the period between 1991 and 1999 the proportion of MRSA has 
steadily increased &om 23.05% in 1991 to 51.21% in 1999. The overall 
incidence of colonization/infection with MRSA for 1991-99 was 1.08/100 
admissions (range 0.57-1.44) and 0.97/1090 patient-days (range 0.50-1.28). 
In 1991 and 1992 the incidence of colonization/infection with MRSA were 
much lower (average 0.625/100 admissions and 0.56/1000 patient-days) but 
since 1993 that figures were much higher (average 1.21/100 admissions and 
1.09/1000 patient-days). The incidence of MRSA bacteremia was quite 
stable through the whole period, 0.02/100 admissions and 0.02/1000 
patient-days, except for the 1994, when it was 0. For clinical areas, the 
highest incidence of MRSA was found on the department of orthopedics, 
where it was 3.34/100 admissions (range 1.68-5.03) and 2.06/1000 patient- 
days (range 1.20-2.95). 36,20% MRSA isolates from the whole hospital 
belonged to the departments of orthopedics and surgery. The infection 
control practices were largely unchanged during the period of study. The 
increased proportion of MRSA to methicillin-sensitive Staphylococcus allreus 
in the last 7 years can be explained by the lack of hygiene and items for 
everyday care of patients. 1993 was the year of the greatest lack of resources 
ever seen in our hospital and, ever since, the situation with resources has 
never been stable and quite good. 
/p5511 Antimicrobial susceptibility to glycopeptides of 
methicillin-resistant staphylococci in a teaching hospital of 
Central Greece 
E. Petinaki, M. Maniati, V. Miriagou, F. Hatzi, A. N. Maniatis 
Larissa, Athens, GR 
Objectives: The purpose of this study was to evaluate the prevalence of 
methicillin-resistant Staphylococcus spp. isolates with reduced susceptibility to 
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glycopeptides in the &strict of Thessaly (Central Greece). 
Methods: A total of 160 consecutive methicillin-resistant Staphylococcus 
isolates (60 Staphylococcus aureus and 100 CNS), collected from clinical 
speclinens in the University Hospital of Thessaly (October 1999-0ctober 
2000), were included Species identification was camed out by conventional 
tests and the API Staph System. Methicillin-resistance was confirmed by the 
detection of rwcA gene using PCK. Resistance to glycopeptides 
(vancomycin and teicoplanin) was assessed by agar dilution method, in 
BHI agar, at 37 'C for 24 h incubation. Population analysis was performed 
in 20 random isolates. 
Results: AU isolate? were susceptible to glycopeptides according NCCLS 
standards. The mean value ofMlCs to vancomycin and to teicoplanin for S. 
a u r u s  isolates were 2.6 and 3.4 pg/mL, respectively, while 2.98 and 3.7 pg/ 
mL for CNS. None of the 20 tested strains contained a subpopulation of 
cells that grew in higher concentration of antibiotic. 
Conclusions: In our institution, inteniiediate or full resistance to 
glycopeptides has not been yet observed among methicillin-resistant 
staphylococci, despite the use of vanconiyciii to the treatment of infections 
caused by multiresistant strains. 
rpsSZ1 The relatedness of Scottish MRSA to worldwide MRSA 
clones 
D. Morrison, G. Edwards, U. Cosgove, Z. Al-Doon, S. Murchan, B 
Cookson, C. GeinmeU 
Clasplc: klrrdofr,  UK 
Introduction: MRSA are one of the most Important nosocoinial pathogens 
worldwide. Periodically, 'successful' (epidemic) clones emerge which spread 
locally, nationally and internationally. Much work on the characterization 
of such cloiies has been performed locally and nationally, however, there has 
been little international sharing of data. In this study the relatedness of 
Scottish MRSA to several European (Hannony Collection) and worldwide 
MRSA clones was investigated. 
Methods: The Scottish MRSA were characterised by PCR-ribotyping and 
PFGE typing and designated SMRSA (Scottish MRSA) types. Analysis of 
the DNA fingerprint patterns was performed with the Phoretix software 
package. Although PCR-ribotyping has lower discriminatory power than 
PFGE, it reveals relatedness at a higher evolutionary level and is useful for 
identifying clonal groups. 
Results: I n  addition to the 'English' MRSA (EMRSA-15 and 16), 17 
Scottish MRSA clones have been characterized and designated SMRSA 
types 99, 105, 107-109, 111, 112, 115-124. PCR-nbotyping data indicates 
that SMRSA-108 is clonally related to the original (Jevons) UK MRSA 
reported in 1961. In addition, the niajonty of the English epidemic strains 
(EMRSA 1, 2, 4, 6, 7, 9-11, 13 and 17) arid an Irish strain (Irish-1) fall 
within this clonal group. The SMRSA-105 clone appears to be very widely 
dispersed and has been found in England, wveral European countries, the 
USA and Japan. Isolates from the latter two countries had reduced 
susceptibility to vancomycin and this clone has been tentatively referred to 
as the 'VISA clone'. SMRSA-99 is part of the Iberian clone reported in 
three other European countries. By PCR-ribotyping SMRSA-109 falls 
within the same clonal group as the Iberian clone. The SMRSA-11 1 clone. 
which has borderline resistance to methicillin, has been isolated in England 
and several other European countries. 
Conclusion: It is apparent that certain MRSA clones have spread 
internationally and it is now important that character data on  these clones 
are shared and that they are given unique, internationally agreed 
designations. This will enhance our understanding of the global 
epidemiology of MRSA. 
vl Prevalence of methicillin-resistant 5taphy/ococcus 
aureus in nursing homes in Austria 
W .  Lingnau, N. Trend, F. Allerberger 
Iwiisbrurk, AT 
Objectives: To evaluate the prevalence of nasal colonisation with 
Staphylococcus aweus and corresponding risk factors in community nursing 
homes in Innsbruck, Austria 
Methods: The Ethics Committee approved this study at the University of 
Innsbruck. W e  took nasal swabs from nursing home residents and processed 
them in the nicrobiologcal laboratory within 2 h. Cultures were performed 
on colistin-nalidicic acid (CNA)-supplemented Columbia blood agar (A), 
Mueller Hinton Agar supplemented with 40 g NaC1, 10 g mannitol and 25 
mg/L phenolate (B), and MRSA-selective agar supplemented with 6 mg/L 
dicloxacilliii (C). All plates were incubated 48 h at 35 "C. Suspected S. 
aureus colonies were subcultured on sheep blood agar plates. Identification 
of S.  aweus was based on the morphology of colonies, a positive coagulase- 
test, Api-Staph I 20 (bio Merieux), the presence of penicillin binding 
protein 2' (MRSA-Screen, Innogenetics), pretence of clumping factor and 
Protein A (Staphaurex Plus, Abbott) and suqceptibility testing (Staphychroni 
MRSA, Niemetz). We perfonned antinucrobial susceptibility testing 
according to the guidelines of National Committee for Clinical Laboratory 
Standards (NCCLS) by using disk diffusion test, and we determined MlCs 
by E-test niethodology (AB Biodisk, Solna, Sweden). 
Results: We screened 623 residents (mean age 85.0 8.9 year., male 
17.2%) in five community nursing homes for nasal carriage of S. aureus. 
Among these residents 311 (49.9%) were colorused with S.  aureus, 39 of 
them were MRSA (12.5%). We found significantly more male residents 
colonised with MRSA (inale 20.0%) vs. female 10.5%; P < 0.05). Other risk 
factors were the presence of cardiovascular diseases (14.9% vs. 0.0%), 
diabetes (26.0% us. 7.7%), bedsore (50.0% us. 11.7%), a history ofbacterial 
infection during the past two months (pulmonary 42.9%, unnary 27.8%, 
none 10.1%), or recent treatment at the university medical center (18.6% us. 
10.5%). There was a linear correlation between the category of nursing 
intensity and MRSA-prevalence ( A  0,0'%,; B: 5.9%; C: 8.3%; D: 15.6'%; E: 
20.4%). Resistance of colonizing MRSA to other antimicrobials: cipro- 
floxacin 100%, imipenem 9 1.7%, mupirocin 29.2% cotrimoxazol 8.794, 
fusidinic acid and vancomyciii 0%. 
Conclusion: The prevalence of MRSA is higher in nursing homes than in 
average. It is pivotal tu stop the spread of resistance by screening for and 
eradication of colonizing MRSA in concert with hygienic measures. 
vl Evaluation of the control program of MRSA during 
1999 in a teaching hospital 
T.  Staub-Schmidt, J. C. Schnit, V. Arendt, F. Landercy, P. Kirpach, 
R. Helimier 
Luxeirrhoug, L 
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) is one of 
the most important multiresistant pathogens. Control programs are usually 
recommended, but the efficacy of the measures are controversial. 
Methods: W e  performed a retrospective study in 1999 to evaluate the 
efficacy of the control program to eradicate MRSA. The Centre Hospitalier 
de Luxembourg is a 445-bed teaching hospital. In 1999 every patient with a 
clinical specimen positive for MKSA was evaluated for MRSA carnage. 
Sampling of nose, throat, skin (hand and perineum) were taken. Contact 
isolation was performed, nasal mupirocin to the antenor nares was given 
twice a day, combined with chlorhexidin solution 0.2% for mouth and 
throat and patients were washed with chlorhexidin soap for five days. If at 
day 7 MRSA was still isolated, a second course of mupirocin and 
chlorhexidin was reinstituted. Samples were taken again at day 9. If samples 
from day 7 and 9 were negative, MRSA was considered as cleared. 
Results: In 1999 38 patients with a clinical specimen positive for MRSA 
were detected, 23 men and 15 women, niean age 65 years (1-98). MRSA 
was isolated in wounds (42.8%), throat (16.6%), endotracheal aspiration or 
expectoration (11.9%), on the skin (9.5%), in urine (7.1%) or blood cultures 
(7.1%). Samples to establish the MRSA camage were perfornied in 30 
patients (78.9%). Control samples a t  day 7 were done in 26 patients (68.4%). 
Twelve patients died (31.5%). Among the 26 patients alive, 17 (65.4%) were 
still carrying MRSA when they left the hospital. 
Conclusions: The control program was not able to eradicate MRSA in 2/3 
of patients. A prospective study is being performed to evaluate the efficacy 
of the program. 
(p5551 5taphy/ococcus aureus nosocomial infection and 
oxacillin resistance levels: a prospective survey 
A. Nanetti, R. Manfred, R. Valentini, L. Calza, F. Chiodo 
Bologna, I 
Objective: T o  assess the frequency and features of oxacillin-resistant (oxaR) 
S. aureus strains in selected wards of a large Italian hospital, 1998-2000. 
Methods: AU S. aureus isolates obtained froin blood cultures, tracheo- 
bronchial aspirate or bronchoalveolar lavage in 6 wards interested by 
nosocomial bacterial disease of immunocompromised patients @) (general, 
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surgical, neonatal, and specialized intensive care units, pneuniology department, 
and transplant surgery), were considered. Multiple positive cultures obtained 
within 30 days &om one p were regarded as a single isolate. 
Results: Of 507 S aureus strains causing infection of blood stceam or lower 
respiratory tract, 317 (62.5%) were oxaR. The resistance rate had not a 
progressive increase throughout the study penod (62.5% in 1998, 63.7% in 
1999, and 60.6% in 2000), and no significant difference was observed with 
regard to the origin of clinical specimens. OxaR pathogens prevailed over 
sensitive ones in all wards but pediatric intensive care unit, which registered 
a 41.4% rate of oxaR strains. The niajonty of oxaR isolates was recovered 
from the general intensive care unit (135 of 317: 42.6%), followed by the 
pneumology department (18%), the respiratory intensive care unit (16.4%), 
the heart surgery intensive care unit (8.2%), the pediatric surgery/neonatal 
intensive care unit (7.6%), and the transplant surgery (7.2%). OxaR 
organisms were isolated from lower respiratory tract more fiequently than 
from blood cultures (92.8% vs. 7.2%: P < 0.001): most of the 23 episodes of 
sepsis occurred in intensive care units (16 cases), compared with the 
transplant surgery (7 cases). Very elevated resistance to all beta-lactam 
antibiotics was found in oxaR S. uureus strains, which remained susceptible 
to glycopeptides. A variable sensitivity profile to cotrimoxazole, chndamy- 
cin, chloramphenicol, macrolides, rifampicin and anlinoglycosides was 
observed, while resistance to gentamyan and netilmicin increased over time 
Conclusion: OxaK is an emerging feature of gram-positive cocci, especially 
when immunocompromised p or hocpital-acquired strains are of concern. 
I n  high-risk war& of our hospital, oxaR S. aureus strains largely prevailed 
over sensitive ones, in a 3-year survey. Long-term surveillance studies can 
update local sensitivity maps, and significantly contribute to improve 
chemoprophylaxis of immunocompromised p, and to select the best 
empirical therapy of possibly life-threatening diseases. 
( P  < 0.001). 
v1 GlSA phenotype in quinupristin/dalfopristin resistant 
MRSA 
W. Witte, G. Wemer, C. Cuny, F. J. Schmitz 
Weuri@ode, Dusse/olf;  D 
When quinupristin/dalfopristin resistant S. aureus strains collected by the 
SENTRY-study in Europe have been investigated in more detail, 22 
isolatec from a hospital in LiUe revealed as hetero-GISA. These isolates 
exhibit resistance to penicillin, oxacillin, gentamicin, erythromycin, 
clindamycm, fiisidic acid, rifampicin, trimethoprim/sulfamethoxazole, 
ciprofloxacin, moxifloxacin, quinupristin/dalfopristin and MICs for vanco- 
niycin and teicoplaniii are 2-4 nig/niL, population analysis confirms the 
hetero-GISA phenotype. They are sencitive to phosphomycin and to 
linezolid (MtCs are 8 and 0.5 mg/L resp.). The isolates exhibit different but 
related Snial-macrorestriction patterns, P C R  typing by 3 different 
polymorphisms indicates ancestral relatedness. Quinupristin/dalfopristin 
resistance is based on ermA and/or ermC and vatB, vgaB. Loss of resistance 
detenninants indcates that both resistance mechanisnls against stceptogramin B 
and A compounds are essential for quhupristh/dalfopristin resistance. 
vl Identification and characterisation of teicoplanin 
intermediate 5. aureus blood culture isolates 
F. M. MacKenzie, P. Greig, D. Morrison, G. Edwards, I. M. Gould 
Aberdeen, Glasgow, IJK 
Background: It has been suggested that the best indicator of hetero- 
vancomycin resistant S. aureus isolates is an E-test MIC of > 12 mg/L to 
teicoplanin (TEIC). Screening of blood culture isolates from wards of high 
glycopeptide usage in the north-east of Scotland was camed out. Two 
multiply resistaiit, niethicillin resistant S. uureus (MRSA) and five methirillin 
sensitive S. aweus (MSSA) isolates were found to be hetero-resistant, 
teicoplanin intemiediate (TISA) according to NCCLS breakpoints. These 
were characterized. 
Methods: MICs were camed out according to NCCLS methodology and 
antibiogram by disc difhsion. The isolates were characterised by PFGE, 
MecA PCR,  phage typing, transmission electron microscopy (TEM) and 
protein profiles were analyzed by proteonms. 
Results: The two MRSAs (EMRSA 16) were TEIC intermediate (MIC 16 
mg/L) with vancomycin (VANC) MICs of 1 and 0.5 mg/L. The five 
MSSAs (two distinct types) were TEIC intermediate and had VANC MICs 
of 4 mg/L and were MecA negative. Protein profiles of the GISAs were 
virtually identical to teicoplanin sensitive control strains. Differences 
however, were seen in the expression of phosphoglycerate kinace. The 
TISAs were notably more difficult to disrupt by sonication than the sensitive 
isolates. TEM revealed mixed populations of cells including thick cell walled 
cells and dark, granular material concentrated in the centre of the cells. The 
MSSAs were resistant only to penicillin G, whereas the MRSAs were 
multiply resistant. 
Conclusion: Unusually, both niethicillin resistant and sensitive S .  nureus 
were found to be intermediate to TEIC, but susceptible to VANC. 
Resistance was associated with morphological changes and over expression 
of phosphoglycerate kinase. 
p5581 Staphylococcus aureus: application of pulsed field gel 
electrophoresis to methicillin-resistant strains from human and 
animal pathology 
Peruc+, I 
The presence of methican-resistant Staphylocorcus aureus (MKSA)in 
medicine was first reported shortly after methicillin was introduced 
clinically to treat S. aureus-caused infection in men and animals. Generally, 
when S. aureus infections are treated with niethicillin and beta-lattaniic in 
both human and vetennarian pathologes, inethicillin-resistant strains can 
arise. The aim of this study was to identify MRSA strainc isolated from both 
human and animal samples and to subject these mains to inolecular studm 
of the chromosomal DNA using PFGE. Eighty-three samples were isolated 
from humans and 233 from animals. In all the trials S. aiireuj ATCC 25923 
and ATCC 8325 were used as control strains. The strams were subjected to 
the E-test and Sceptor System to determine the resistance (MRSA) and the 
sensitivity (MSSA) to methicillin. The presence of mecA gene, which is the 
expression of methicillin-resistance, was shown by PCR. The MKSA 
strains were characterized by a macrorestriction method using S i m I  resolved 
with PFGE on agarose gel. The PFGE was camed out using the CHEF 
MAPPER system. The  electrophoretic patterns were obtained using a 
telecamera along with suitable software. These were then analyzed to 
generated a similarity dendropam. The calculated similarity coefficients 
(Sab) range between 0 and 1, were 0 indicates that the patterns were not 
correlated and 1 ,  the patterns were strongly coirelated. Of the 233 strains 
examined which came from veterniary pathologies, 32 (1 4.34%) exprecsed 
resistance to methicillin, while in the 83 strains of huniau origtii, 53 (63.8%) 
were MRSA. Forty MRSA and 20 MSSA isolates, half from human and half 
from Veterinarian pathologies were then subjected to PFGE. The genomic 
similarity of MRSA strains, expressed in the dendrograni, showed varying 
results in the human and veterinanan pathologieq. In the human pathologies 
the MRSA strains, from different continents, were classi6ed indistinguish- 
able: therefore strains from both human and veterinarian origin from the 
same geographical regions were compared in an effort to see if the same 
conditions were obtained. The results did not show MRSA strains of 
human and animal origin that could be considered genetically identical, 
while in human pathologies, the indistinguishable and closely correlated 
strains suggest the presence of a doininant clone. 
C. Valente, V. Cuten, R. Mazzolla, L. Merletti 
Methicillin-resistant Staphylococcus aureus and 
coagulase-negative staphylococcus from APUA-Bulgaria 
Chapter Survey 
R. Markovska, M. Sredkova, E. Savov, I. Haydoushka, E. Dragijeva, A 
Oscar, E. Keuleyan 
S&, BG 
Objectives: T o  study MKSA and MRCoNS from diifferent clincal 
specimens icolated for 3-6 months during 1999/2000: to assess the ability 
of 5 laboratories to recognize these pathogens and to study the rates of 
resistance to other antimcrobial agents. 
Methods: Susceptibility to oxacillin was investigated according to NCCLS, 
2000, with Oxacilliii disk 1 pg and screen agar (for MRSA) and Oxacillin 
Etest (AB BIODISK, Solna, Sweden). Susceptibility to 11 other 
antimicrobials was tested by Disk Diffusion Method, NCCLS, 2000. MLS 
resistance phenotypes were determined according to Stimimann et nl. 
Results: From 91 submitted strams, 58 have been proven to be methicillin- 
resistant Staphylococcus (MRS). AU of them were susceptible to 
vancomycin and mupirocin. The rates of resistance to the other 
antimicrobial agents are listed in Table 1. A higher rate of susceptibility 
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to erythromycin, tetracycline, chloramphenicol, gentanlicin and ciproflox- 
acin was found, than in MKS from other countries. MRSA from wounds 
had statistically significant higher resistance towards nfampicin, tetracycline, 
chloramphenicol and ciprofloxacin than those from blood-cultures. MRSA 
from blood-cultures were more resistant to gentamicin than the others. 
Amongst MRSA thr predominant MLS phenowes were: MS and c MLS; 
while among MRCoNS, i MLS phenotype was the most kequent. 
Tdk l .ResLtuccin%i~ ~tLcr~nt*dE~bhllgn~~m~ng58MRS 
MRS - TEI C 2 E  LIN ERY CZI Q?N RIP ISU CiP 
M 58 29 29 21 60 22 68 12 31 38 
MRSR 34 35 21 12 38 18 50 9 21 32 
MRtOMj 24 21 42 33 92 33 15 17 46 46 
Conclusions: MRSA and MRCoNS from this study were more susceptible 
to different antimicrobial agents, than the strains from the most European 
and other countries. It is worth to note, that some of participating 
laboratories had made an over-diagnostic of MRS and only two of them 
identified perfectly the methicdin-resistant strains. 
( F 6 q  Genetical analysis of coagulase-negative MRSA strains 
isolated from children hospitalized in a large pediatric hospital in 
Poland from 1996 to 1999 
U. Lopaciuk, M. Kapusta, D. Dzierzanowska 
Warsaw, PL 
The aim of the study was a genetic analysis of coagulase-negative strams of 
MRSA isolated &om infected children treated in the Children’s Memorial 
Health Institute. (Warsaw, Poland) from 1996 to 1999. Resistance to 
niethicillin was tested using the PCR method and the latex test MRSA 
Screen (Innogenetics). AU the strains having mecA gene were positive in the 
latex test. Among all methicillin-resistant strains of Staphylococcus aureus 
16.2% could be distinguished due to lack of phenotypical expression of 
coaLulase. The tested strains were isolated from: blood, wound, sputum, 
drainage, CSF, bile, BAL. All tested strains were typed by PCR-RFLP for 
coagulase gene, Coagulase gene was amplified using primers: Coag 2-CGA 
GAC CAA GAT TCA ACA AG; Coag 3-AAA GAA AAC CAC TCA 
CAT CA. The product of amplification underwent digestion of restnction 
endonuclease Alu I. All the strains had the same restriction patterns. All the 
strains were typed also by PFGE and Sma I patterns were different for all the 
strains. In conclusion, typing of coagulase-gene by PCR-RFLP has too 
weak discriminatory power. Among coagulase-negative MRSA isolated in 
our hospital it is inipossible to distinguish any clonal similarity 
/p561/ Epidemiology of methicillin-resistant 5taphy/ococcus 
aureus at a university hospital 
I .  Montesinos-Hdez, T. Delgado-Meliin, C. MenPndez Rguez, M. 
Cuervo-Abarquero. M. Lecuona-Fdez, A. Torres-Lana, A. Sierra-Lhpez 
LA b p r r a ,  E 
Objective: To describe the epidemiology of methicillin-resistant Staphylo- 
coccus aureus (MRSA) at a University Hospital dunng a 4-year period. 
Methods: Prospective laboratory-based surveillance was implemented for 
clinical isolates of MRSA from January 1997 through April 2000. The 
Canary Islands University Hospital is an 600-bed, tertiary care instituhon 
affiliated with La Laguna School of Medicine. The medical records of 
patients identified by laboratory surveillance were reviewed for demo- 
graphic and risk factor data. Criteria for infections were as defined by Center 
for Disease Control and Prevention (CDC) guidelines. Isolates not 
associated with infection were classified as colonizing. MRSA was defined 
as nosocomial is the isolate was obtained after 48 h of admission. 
Results: The MRSA nosocomial infection rates among total S. aureus 
nosocoimal infection were 32.5% in 1997, 17.9% in 1998, 14.5% in 1999 
and 25.6%) in 2000. The number of MRSA nosocomal infection and 
colonization were 48 in 1997, 14 in 1998, 13 in 1999, and 14 in 2000. The 
major sites of isolation for nosocomial MRSA included the lower 
respiratory tract (29%). wound (22%), urinary tract (16%), skin (11%). and 
bloodstream (10%). 70 patients had MRSA nosocomial infection or 
colonization and the demographics data were: male 70%, female 30%; 
major underlying illnesses 67%; age 60 years (range 4 months-87 years); 
major admission diagnoses: acute infection 22%, cardiovascular disease 1894, 
trauma 1 1%1, malignancy 10%; previous surgery 51%; previous antibiotic 
therapy 71%. mean of antibiotics 3 (range G9) ,  mean of beta-lactams 1.2 
(range 0-3): hospital stay 27 days (range 2-145); urinary catheter 77%, 
cathetenzation 78%, intubation 51%; hospital service: Internal Medicine 
24%, Surgery 37’36, Intensive Care Unit 38%; death 38%. Multifocal 
interventions were implemented since 1997. 
Conclusions: The implementation of multifocal interventions appeared to 
have a substantial impact on infection control. 
lp5621 Outbreak of MRSA role of temporary nurses in the 
spread of MRSA 
P. Fascia, 1. Martin, F. Grattard, P. Berthelot, B. Pozzetto, F. Lucht 
Saifit-Etienne, F 
Objectives: first to describe an outbreak of MRSA infections in a gastro- 
enterology unit. Second to assess the role of student health care workers in 
the spread out of this outbreak 
People and method: People were included all MRSA colonized or infected 
patients hospitalized in the gastroenterology unit from the first ofJune to the 
30th of September 2000 and the whole health care workers (HCW) staff of 
the unit. The method consisted of descriptive epideiniological study, audit 
of cares delivered in the unit; MRSA nasal camage screening of HCW of 
the unit. MRSA was identified using standard laboratory procedures and 
pulsed field gel electrophoresis procedures were used to compare strains of 
patients and HCW. 
Results: 6 patients were infected in the unit (2 during June et 4 during July) 
with a MRSA strain. Four of 6 acquired either blood stream infection or 
intravascular devices infectiori. Among HCW. the nasal screening pointed 
out 6 persons with a MKSA camage. Analysis using pulsed field gel 
electrophoresis showed an epidemic strain concerning 5 patients and 3 
HCW. Two of these 3 HCW were students and were recently employed in 
the unit. Audit of HCW practices showed that there was a lack of use of 
antiseptic solution when nurses handled intravatcular devices. It was also 
noted that 12 different temporary HCW were employed from June to July. 
Conclusions: This outbreak of MRSA was controlled with reinforced basic 
hygiene measures such as hand washing with an antiseptic solution or by 
using hydroalcoholic solutions and such as cohorting of infected patients. 
The unit of gastroenterology refused new admissions during a week to 
overcome this outbreak. No cross contamination was notified since these 
measures were used. Nursing cares were undoubtedly responsible in 4 of 6 
infections concerning intravascular devices: 2 nurse students presented a 
natal carriage of epidemic MRSA strain. This outbreak illustrated the 
possible role of understaffed unit and of less effective hygiene measures used 
by temporary H C W  in the spread out of MKSA. 
(p5631 Molecular characterization of methicillin-resistant 
5taphy/ococcus aureus strains isolated from hospital-acquired 
infections 
C. Bartzavali, M. Christofidou, G. Dimitracopoulos, I .  Spiliopoulou 
Patras, C R  
Genotypic characterization of methicillin-resistant S. aureus (MRSA) 
clinical isolates, by hybridization with specific DNA probes and polymerase 
chain reaction (PCR) can discriminate even closely related bacterial strains. 
Thirty-three MRSA isolates collected during 1999, from chnical specimens 
of different inpatients, were studied by probing Clal chromosomal DNA 
digests with m e d  gene and Tn554 transpoqon, and by randomly amplified 
polymorphic DNA (RAPD). Genomic fingerprinting PCR was perfomied 
by the application of RAPDl, RAPD7, 935,1026, ERIClR and ERIC2 
primers separately and in combination of two (RAPDl/RAPD7, 935/ 
1026, ERIClR/ERIC2). By the hybridization assays the isolates were 
included into four groups on the basis of their ClaI/mecA and ClaUTn554 
patterns (mecA::Tn554j, named III::KK, III’::KK, a subtype of the previous 
type, X’::KK. all with one hybridization band with Tn554, and VII’::NH 
without insertion sites for Tn554 (see table). The isolates were further 
discriminated by P C R  and the application of primers 935, ERICZ, KAPDl 
and the combination RAPDl/RAPD7, while the rest of the reactions did 
not dfferentiate the strains. The table shows the hybridization and the PCR 
groups of the studied strains. Unique MRSA clonal types are endemic and 
distributed at the University Hospital of Patras. Isolates belonging to the 
hybridization group VI1’::NH appeared genetically more variable by PCR. 
By the application of several primers in different reactions we were able to 
further discriminate the strains, and it seems that this approach is well suited for 
genetic analysis and nionitoring of nosoconlial spreadmg of staphylococci. 
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/p564 Methicillin-resistant Staphy/ococcus aureus 
nosocomial infection 
M. A. de Zirraga, J. A. Cart6n, N. Corral, R. Cinladevdla, 1. L. Lagunas 
Avilis, Ouiedo, E 
Introduction: The nosoconlial infection (NI) due to niethicillin-resistant 
Staphylocouur aureus (MRSA) is a growing problem in the world and since 
the beginning of the nineties is affecting the larger and more complex 
Spanish hospitals, including the Hospital Central of Asturias. 
Aim: Study of the risk factors predisposing to NI by MRSA, with special 
emphasis on the prior antibiotic therapy to try to predict the development of 
this infection and to assess its clinical virulence. 
Patients and methods: Unmatched case-control study. The study was 
carried out in the Hospital Central of Asturias, a 1400-bed teaching hospital 
in Oviedo (Spain) with an annual adnuttance rate of 22000 patients We do 
not include patients admitted in the Intensive Care Unit (ICU). The study 
was restricted to patients admitted in conventional acute hospitalization 
units (AHU). All patients satisfying MKSA NI criteria were selected as 
cases. Controls were chosen at random among MU-admitted patients with 
N1 due to methicih-sensitive Staphylococcus aureus (MSSA). The customary 
statistic study was completed with a stepwise logistic regression analysis. 
Results: At the AHU, 144 patients infected by MRSA and 187 controls 
were studied. The two groups proved to be very dinkrent. The patients 
with NI by MRSA were older as a rule (62 + 16 vs. 53 + 21 years; P < 
0.001), had more associatedpathology (1.6 us. 1.2 intrinsic risk factors, P < 
0.001), greater severity (classification of McCabe, P < 0.001), longer 
previous hospital stay (median 28 us. 14 days; P < 0.001) greater number of 
therapeutic treatments (3.6 us. 2.4 extrinsic risk facton, P < 0.001), more 
previous infections (70 vs. 27%, P < 0.001) and more antibiotics (93 us. 
37%, P < 0.001). The multivariate analysis showed that the number of 
antibiotics received was the most useful variable to differentiate between 
both groups of patients. Mortality associated with the NI due to MRSA was 
greater than mortality associated with the NI due to MSSA (17 us. 6%) but 
this was due to the different characteristics ofthe patients and not to the type 
of the infecting strain. 
Conclusions: The previous administration of antibiotics was the most closely 
related factor to NI by MRSA hospital-acquired infection at AHU. The clinical 
virulence of MRSA nosocomial infechon is not greater than MSSA nosocomial 
infection, since once corrected the differences among the epidemiological 
chanctrristin of the patients, other di6erences cannot be shown. 
lp565 Identification of enterotoxins and the toxic shock 
syndrome toxin (TSST-1) in S. aureus isolates from Polish 
hospitals 
J. Krzysztofi-Kussjan, W. Hryniewicz 
Warsaw, PL 
Background: Staphylococcus uureus can produce a high variety of extracellular 
toxins including enterotoxins (SEA-E and SEG-J), exfoliative toxins (ETA- 
B), and the toxic shock syndrome toxin (TSST-1) that are responsible for a 
wide range of pathological symptoms associated with staphylococcal 
infections. All these toxins demonstrate superantigen activity, which 
stimulates the polyclonal T-cell proliferation. 
Objectives: T o  evaluate the frequency of production of enterotoxins SEA- 
D and the TSST-1 toxin among MRSA and MSSA isolates collected from 
severe hospital mfections. 
Material and methods: Twenty-three MRSA and 6 MSSA tiom 3 Polish 
hospitals were studied. The isolates were collected mainly from adult patients 
and were associated with severe cases of enteritk, bacteremia, and wound 
infections. The SEA-D and TSST-1 toxins were detected by the revetsed 
passive latex agglutination (RPLA) test. The isolates were typed by PFGE. 
Results: The PFGE typing has revealed a high clonal chversity of both 
MRSA and MSSA isolates studied, however, a certain degree of relatedness 
could be observed among some isolates within each hospital group. The 
majority of the isolates were found to produce at least one of the toxins 
identified. As many as 22 MRSA isolates and only 2 MSSA produced 
enterotoxin A (SEA), and one of these MSSA isolates produced also TSST- 
1. Enterotoxins B and C were not detected. 
Conclusion: The enterotoxin A (SEA) was the most commonly produced 
toxin by the collected isolates (24129). This observation corresponds well to 
previous data, which have suggested SEA to be the most prevalent type of 
staphylococcal toxins. Identification of other types of toxins and detection 
of toxin-encoding genes in the isolates is under investigation. 
lP5661 Impact of an infection control program on the 
incidence of nosocomial methicillin-resistant 5. aureus 
A. Widmer, H. Siegrist, R. Frei, Epi-team 
Basel, La Chaux-de-Fonds, CH 
Background: Methicillin-resistant Staphylococcus aureus (S. aweus) is an 
emerging pathogen. Many European countries and the United States report 
a prevalence of >30% among S.  aureus. Switzerland has a very low 
prevalence, but also demonstrate a gradient from north to south. It has been 
questioned if infection control programs are able to control MRSA in a 
region surrounded by high-prevalence countries. The goal of this study was 
to evaluate the impact of an infection control program on the incidence of 
nosocomial MRSA after opening a division of hospital epidemiology. 
Methods: The division of hospital epidemiology was opened in 1993, after 
two MRSA outbreaks were observed. The new guidelines included contact 
isolation of MRSA patients in single-rooms, screening of neighbor patients 
and health care workers who cared for MRSA patients. On adnnssion, 
swabs from nares and throat of patients from high-risk areas were routinely 
taken. Attempts were made to decolonize MKSA patients. Three 
consecutive negative screening of at least 5 body sites defiiied the absence 
of MRSA. All isolates were typed by pulsed field gel electrophoresis. In 
1999, a survey was performed in Swiss microbiology laboratories to estimate 
the prevalence In Switzerland. 
Results: 45 nosocomial cases and 97 non-nosocomial MRSA cases were 
recorded between 1994 and 1999. There was a statistically significant 
decrease of nosocomial MRSA cases (D < 0.001), but not of non- 
nosoconlial cases. The incidence of NI cases dropped from 0.108 to 0.013/ 
100 ahss ions ,  and slightly increased in non-nosocomial cases from 0.0410 
to 0.046/100 admission. A In 1999, patients with nosoconllal MKSA 
remained in isoiation for 18 days compared to 14.1 days for non-nosocomial 
cases ( P  < 0.05). The percentage of MRSA among S. aureus reported by 
the microbiology laboratories was between 1 and 23% indicating similar 
trends of the emergence of MRSA as observed in southern European 
countries and the United States. 
Conclusion: Nosocomial MRSA cases can be controlled by a n  infection 
control program. However, this mulcifacetted approach requires increasing 
resources to cope with the increasing prevalence in and around Switzerland. 
lp567 Metastatic MRSA endophthalmitis in a patient with B 
cell lymphoma 
C. M. Schneider, R. Sellmer 
Freiburg, D 
Metastatic endophthalmitis is a n  unexpected, severe complication that may 
occur in immunocompromised patients. Management is even more difficult 
when the infectious agent is multi drug resistant. The patient presented is a 
63-year-old man with a two year history of low malignant B-ceU- 
lymphoma. He was admitted to an external hospital for chemotherapy. Two 
days later he developed catheter related phlebitis of the left forearm, 
followed by septicemia. Blood cultures drawn on day 6 yielded S. airreus. 
The laboratory concerned reported the isolate to be resistant to all beta- 
lactam antibiotics tested, except oxacillin and imipenem (reported 
susceptible) and treatment was changed from cefazolin to oxacillin. The 
patient subsequently developed an abscess of the right orbita and gentamicin 
was added on day 11. However vitreous infiltration occurred 4 days later 
and the patient was transferred to OUT centre. During vitrectomy intravitreal 
vancomycin was administered and in a second step the vitreous cavity was 
filled with silicone oil. Our laboratory could culture S. aurem from the 
vitreous aspirate. It was diagnosed as MRSA by susceptibility testing 
(oxacillin MIC h mg/L) and confirmed by PBP2a Latex agglutination 
testing and mecA gene PCR. 17 days after onset of infection the causative 
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agent was finally reported as MRSA. Systemic antibiotic treatment was now 
changed to fosfoniycin and gentamicin. However the infection had resulted 
in a nearly complete visual loss. Three weeks after vitrectomy the patient 
had to be reviewed for suspicion of a recurrent orbital abscess. A prolapse of 
silicone oil into the orbita was found and the eye was enucleated. This case 
shows how incorrect interpretation and reporting of in uitro data may lead to 
unusual and severe complications and a delay in adequate treatment. Efforts 
for reliable detection and reporting of multiresistant bacteria should be 
increased to expand clinicians alertness in such situations. 
(p5681 In vitro activity of vancomycin and teicoplanin against 
methicillin-resistant Staphy/ococcus aureus 
B. Bayar, 0. Memkoglu, 0. Kurt, F. Coksa 
Ankara, TR 
Objectives: The infections caused by methicillir-resistant Sfaphylocums aurew 
(MRSA) strains mcreased si&cantly and nosocomial infectionc caused by these 
isolates have become a serious problem. Teicoplanin and vancomycin are the 
agents of choice in MRSA infections. We detected glycopeptide susceptibilities 
of MRSA strains since occasional isolates are reported as resistant or 
intermediately susceptible to teicophin by Kirby-Bauer disk difksion method. 
Methods: A total of 226 MRSA were isolated &om various clinical materials 
of hospitalized patients. The isolates were tested for susceptibility to 
vancomycin and teicoplanin by Kirby-Bauer disk diffusion method. The 
strains reported as intermediately susceptible or resistant for teicoplanin by 
disk a u s i o n  method were also tested by agar dilution method accordmg to 
NCCLS guidelines. 
Results: AU 226 MRSA strains were uniformly susceptible to vancornycin 
(> 15 mm). Seven strains were found to be intermediately susceptible (11- 
13 mm) and 1 strain was resistant (310)  to teicoplarun by disk diffislon 
method (Totally 3.5%). These eight strains were found susceptible by agar 
dilution method (Minimal inhibitory concentration = 1 mg/L). 
Conclusion: Since teicoplanin has a large molecular size, disk diffusion tests 
may show decreased susceptibility for occasional strains. Disk diffusion 
results showing decreased susceptibility or resistance to teicoplanin should 
be considered cautiously and should not be reported before confirming with 
minimal inhibitory concentration results. 
I P569 I In vitro susceptibility of methicillin-resistant 
Staphy/ococcus aureus to fusidic acid and trimethoprirn- 
sulfarnethoxazole 
0. Memikoglu, B. Bayar, 0. Kurt, F. CokCa 
Atikara, TR 
Objectives: Methicillin-resistant S. aureuS (MRSA) dections have become 
important nosocomial pathojens and glycopeptides are the first line agents of 
therapy. Various duucal isolates of MRSA were studied for their susceptibilihes 
to hidic acid and nimethoprim-sdhethoxazole (TMF-SMX). 
Methods: A total of 225 MRSA were isolated from sputuni, surgical wound, 
tracheal aspirates, blood and other stenle body fluids &om hospitalized patients. 
These isolates were tested for susceptibility to fusidic acid and TMP-SMX by 
Kirby-Bauer disk &&ion method according to NCCLS guidelines. 
Results: Two hundred and eighteen isolates (96.9%) were susceptible to 
both fusidic acid and TMP-SMX. Two isolates (0.9%) were resistant only to 
fusidic acid, whereas one isolate (0.4%) was resistant only to TMP-SMX. 
Four isolates (1.8%) were resistant to both antibiotics. 
Conclusion: MRSA have become one of the major threats of hospitalized 
patients especially for those in intensive care units. Glycopeptide (GP) 
antibiotics are the most active agents against these isolates. Since GP 
antibiotics have to be used in serious infections bf parented route, TMP- 
SMX and fusidic acid may be considered as alternative oral therapies in 
selected cases of MRSA infections. 
Methicillin resistance in both 5taphyfococcus aureus 
and coagulase negative staphylococci in blood cultures 
S. Cesur, F. Albayrak, S. Birengel, T. Sozen 
Ankara, TR 
Objectives: Methcillin resistant staphylococcal infections are increasing in 
most of the centers, and these infections result in difficulties in treatment of 
patients. In this study we aimed to detect the antimicrobial susceptibility of 
staphylococcus strains to nuny agents. 
Methods: Between 1997 and 1999, we obtained Staphylococcus spp. by 
BACTEC 9120 blood culture system. This is a study perfomied with 7865 
blood cultures of hospitalized patients in 3-year period. The most 
conmionly isolated pathogens among the Gram positive bacteria were; 
Coagulase Negative Staphylococcus spp. (n  = 240) and S. aureus ( n  = 50). 
After obtaining the strains we tested the antinlicrobial susceptibility of 
both pathogens with NCCLS recommendations by Kirby-Bauer disk 
diffusion method. 
Results: Table 1 shows results of antimicrobial susceptibility of isolates: 
Antibiotics MSCNS MIICNS MSSA MRSA 
(%) f%) f%) (%) 
Oxacillin 1 15/240 125/240 27/5lJ 23/50 
(47.9) (52.1) (54.0) (4O.iJ) 
Pen G 30/115 21/125 5/27 I / 2 3  
(26.1) (16.8) (18.5) (4.3) 
An~picrllrn 30/45 15/40 1 I27 5/23 
(66.7) (37.5) (25.9) (21.7) 
Amoxicillin- 33/115 2 n / m  7/27 3/23 
Clavulanate (28.7) (16.0) (25.9) (13.0 
Ccfazolinc 115/115 34/125 10/27 4/23 
(1 00) (27.2) (37.0) (17.4) 
Erythroniycin 1( l5/115 110/125 12/27 6/23 
(91 3) (HX.0) j44.1) j26.l) 
(:lindamyciii 20/64 I 5/60 16/27 5/23 
(31.2) (25) (5Y.2) (21 -7) 
Co-Tninoxazole RS/I 15 33/125 16/27 17/23 
(73.9) (26.4) (59.2) (73.Y) 
Teicoplarun 72/76 120/125 27/27 2 1 /23 
(94.7) ('16.0) (100) (91.3) 
Fusidrc Acid 111/115 28/35 25/27 19/23 
(96.5) (80.0) (92.6) (82.6) 
Vanconiycin 115/115 125/125 27/27 23/20 
(1 00) (ll,O) (100) (100) 
Ciproflovaciii 76/115 46/125 18/27 8/23 
(66.1) (36.8) (66.6) (34 8) 
Kifanipicin 18/25 21/25 21 127 12/23 
(72.0) (84.0) (77 -7) (52.1) 
(80.8) (46.4) (55 5 )  (30.4) 
(55.6) (41 6 )  (44 4) (26. I) 
Gcntamiciii Y3/115 58112.5 15/27 7/23 
Imipenmm 64/115 52/ I25 12/27 6/23 
Conclusion: Nosocomial staphylococcal infections, especially in intensive 
care units increase day by day. According to our experiences the rate of 
methicillin-resistant strains in our hospital also increased in years. 
Staphylococcal infections presents itself as a major problem in many 
centers. As shown in study multidrug resistance makes the treatment 
more difficult. 
vl Evaluation of trimethoprim-sulfamethoxazole 
susceptibility in methicillin-resistant and susceptible 
Staphylococcus aureus and coagulase negative staphylococci 
S. Ercis, A. Ergin, G. HasCelik 
A,ikara, TR 
Objectives: The aim of this study was to evaluate the trimethoprim- 
sulfamethoxazole susceptibility pattern of methiciUin resistant and suscep- 
tible staphylococci strains and investigate if trimethoprim-sulfamethoxazole 
can be an alternative choice in the treatment of staphylococcal infections, 
isolated in Hacettepe University Clinical Pathology Laboratory. 
Methods: A total of 2955 methicdlin resistant and susceptible S. aureus and 
coagulase negative staphylococci isolated from various clinical samples from 
January 1999 to November 2000 were included in the study. Identification 
to the species level and MIC (pg/mL) values were done by using Sceptor 
(Becton-Dichson, USA) system. 
Results: The methicillin resistance rate for S .  aureus (n = 766) was 45.2% and 
44% for coagulase negative staphylococci (M = 569). The rnethcillin resistant 
S. aureus and coagulase negative strains have shown 91.9% and 31.5% 
susceptibility to trinethoprim-sulfamethoxazole, respectlvely, in 22 months. 
The m e t h i c h  susceptible (n = 727) S .  aureus and coagulase negative strains 
(n = 723) showed 96.1% and 64.7% susceptibility to trimethoprim- 
sulfamethoxazole. 
Conclusions: 1. The methicillin resistance among our isolates is significantly 
high. 2. The in vitro activity of trimethoprin-sulfamethoxazole has shown 
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that it is still active against methicillin resistant S. aureus strains while the 
coagulase negative staphylococci has much less susceptibility. 3. Due to the 
satisfactory results against methicillin resistant S. aweus strains in vitro, 
trimethoprim-sulfamethoxazole has to be confirmed for its in vivo activity 
when considering in the treatment of staphylococcal infections. 
/p5721 In vitro activity of methicillin, vancomycin, teicoplanin 
and other nonbeta-lactam antibiotics on coagulase positive and 
negative staphylococci isolated from hospital and community 
originated specimens 
0. Aktas, Z .  Calik 
Erzurum, TR 
Objective: The objective of thk study was to investigate the resistance to 
meth iah  and also to vancomycin, teicoplanin and nonbeta-lactam other 
antibiotics in our region for coagulase positive and negahve staphylococci (CPS 
and CNS) isolated from various specimens originated hospital and comniunity. 
Methods: Two hundred clinical and nonclinical isolates of CPS and CNS 
from different origins were used. Identification of strains was performed 
with routine technique; susceptibility testing with disc dihsion method 
according to NCCLS guidelines used as the reference method for 
antimicrobial susceptibility testing. 
Staphylococci 
Results: O f  the 105 hospital acquired strains; 81 were S. aureus of which 
29.6% and of the 24 CNS strains, 33.3% were methicillin resistance. 
Methicillin resistance of the 95 community acquired staphylococci was less 
than hospital acquired ones. In this group 11.7% of S. auieus strains and 5.7% 
of CNS strains showed meth ic ih  resistance. No resistance to vancomycin 
was observed. However, in the methicillin resistant S. aureus (MKSA) 
strams 3.2% and in the methicilliti resistant coagulase negative staphylococci 
(MRCNS) strains 10.0% resistance to teicoplanin was noted. The most 
effective nonbeta-lactam antibiotics for the MRSA strains were imipenein 
14.0% triniethoprini-sulfamethoxazole 24.0%. amikacin 25.0'%, and genta- 
micin 29.0%. Of the methicillin sensitive S. aumu (MSSA) strains the 
most effective antibiotics are as follows; ciprotloxacin 13.0%, imipenem 
15.0%, erythromycin 16.0%, clindamycin 16.0%, and of the MRCNS 
strains the effective antibiotics were imipenem 7.0%, and clindamycin 
17.0%, erythromycin 24.0% for the methicillin sensitive coagulase negative 
staphylococci. 
Conclusion: Based on these results, the percentage of methicillin resistant 
staphylococcus strains is on the rise where as no resistance was seen to 
vancomycin, which has been in use for a long time. However, there is a low 
resistance to teicoplanin which is a glycopeptides antibiotic and recently 
introduced to our country, teicoplanin resistance in staphylococci showed 
be observed in future. 
Prevalence of serum antibodies to toxic shock 
syndrome toxin-I among healthy blood donors in the EU 
H. Goossens, P. Van Damnie, K. Van Herck, J. Brugmans, B. Schenkel, L. 
Peeters, M. Martin 
Edegem, B 
Objectives: Production of toxic shock syndrome toxin (TSST-1) by Staph. 
au~eus is associated with toxic shock syndrome (TSS). TSS can develop 
when a person becomes infected with a toxigenic strain of Staph. au~eu5, 
which is triggered to secrete toxin, in the absence of a protective level of 
antibody to that toxin. We studied the prevalence of antibodies to TSST-1 
among healthy blood donors in Belgium, Germany and the UK. 
Methods: We developed a noncompetitive enzyme-linked immunosorbent 
assay (ELISA) using highly purified TSST-1. Sera along with the reference 
preparation (Sandoglobulin '' , Sandoz-Pharma) were added and incubated 
for 2 h. The TSST-1 antibodies were detected using goat F(ab')2 anti- 
Human IgG, labelled with Horse Radish Peroxidase (UioSource, Tago) and 
substrate ABTS (Roche). 
Results: Number of samples by country and percentage of samples by serum 
titre are shown in the table. 
Conclusion: Most healthy individuals have antibodies to TSST-1 and the 
prevalence is comparable among the three EU countries investigated. 
lp5741 Toxic shock syndrome: a review of 22 cases 
A. Mert, K. Ozaras, F. Tabak, R. Ozturk, Y. Aktuglu 
Istanbul, TR 
Toxic shock syndrome (TSS) is a mulnsystem disorder due to an exotoxin 
(TSST-I) elaborated by toxigenic strains of Staphylococcus aureus. It may 
present with high fever, a difise 'sunburn' rash which subsequently 
desquamate and may lead to acute renal failure, hepatic involvement, 
disseminated intravascular coagulation, and prolonged shock. The diagnosis 
is based on clinical criteria. Twenty-two cases (10 male, 12 female, median 
age 49, range: 20-76) have been followed in our unit between 1985 and 
2000. The most common clinical and laboratory abnormalities were as 
follows: fever (loo%), hypotension (loo%), rash with desquamation (100%). 
mucous membrane hyperemia (SO%), renal hlure  (70%), hepatic involve- 
ment (68%), gastrointestinal involvement (59%), muscle involvement (27%). 
cardiopulmonary mvolvement (25%), anemia (100%), leukocytosis (82%). 
eosinophilia (50%), thrombocytopenia (41%), pyuria (90%). heniaturia 
(55%), proteinuria (90%). Vancomycin treatment initiated at the time of 
diagnosis was continued or changed according to the results of cultures and 
sensitivity tests. Methicillin-sensitive S. nureus was isolated from 5 patients (3 
Gom abscess, 2 from throat) and methicillin resistant S. aureus was isolated 
Gom 5 patients (1 nose, 1 abscess, 1 throat, 1 noqe + sputum, 1 nose + throat), 
but all blood cultures remained negative. Four patients died w t h  a clinical 
picture of adult respiratory distress syndrome. All suivivuig panents became 
afebnle within 7 days afrer the initiation of the treatment. TSS should be 
considered in a patient adrmtted with high fever and 'sunburn' rash. 
vl Detection of various staphylococcal toxin genes in 
Staphy/ococcus aweus clinical strains isolated from deep 
infections 
G. Vrioni, I. Poumou, E. Papoutsaki, N.-I. Legakis, P. Matsiota-Bernard 
Athens, GR 
Objectives: Many Staphylorocrus aureus strains produce one or more of a 
group of specific exotoxins that include staphylococcal enterotoxins (SEs), 
staphylococcal exfoliative toxins (ETs), and toxic shock syndrome toxin-1 
(TSST-I). The SEs are responsible for food poisoning, the ETs for the 
staphylococcal scalded-skin syndrome, and TSST-1 for the toxic shock 
syndrome. In recent years, the responsible genes have been established for all 
these toxins. The aim of this study was the detection of the staphylococcal 
toxin genes from S. uureus clinical strains isolated Gom different infections. 
Methods: Forty clinical staphylococci strains, isolated from January 2000 to 
September 2000, are included in the study. These strains were isolated from 
various cultures such us blood, bone, deep trauma, bronchoalveolar 
aspiration and joint aspirate. Both identification and susceptibility testing 
were performed on Vitek automated system (bioMerieux). These strains 
were analyzed for the presence of toxin genes m f A  and errtB for SEs, eta and 
eth for ETs, and tsf for TSST-1 using the PCR method. 
Results: From the 40 examined strains, 17 (42.5%) gave positive result in 
one or more toxins. 14 strains (35%) were positive for eta gene, 7 (17.5%) 
for etb, 7 (17.5%) for e i f f A ,  11 (27.5%) for entB and 12 (30%) for tst gene. All 
the examined strains had more than one toxin genes: 3 strains had the eta + 
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erirB genes, 3 rth + tst, 3 eta + entB + fst, 3 had all the examined toxin genes, 
1 strain eta + tst, 1 eta + enfA, 1 eta + eritA + entB, 1 eta + eritA + entB + trt, 
and 1 eta + etb + enfA + ts f .  
Conclusion: S .  aureus strains isolated from deep infecuons may have in their 
genome different tomn genes, even thought the related syndromes do not 
appear, either because these genes are inactive or because of the presence of 
specific antibodies in the patient's serum. Moreover, we cannot exclude 
the fact that these strains may be more virulent due to the emstence of 
these genes. 
1 P576 Development and implementation of a PCR-based 
system for the detection of toxin genes encoded by 
Staphylococcus aureus 
G. L. O'Neill, H.  M. Aucken, V. Mithani, J. McLauchlin 
Birrtiiii&arn, Lwirfuorz, UK 
S. auwus causes a variety of diseases from food poisoning through minor skin 
infections to toxic shock syndrome (TSS). Pathogenicity IS in part mediated 
by expression of a number of dfferent types of toxic proteins including the 
enterotoxins (with at least nine now descnbed: A, B,  C, D, E, G, H, I ,  and 
J), toxic shock syndrome toxin (TSST) and the exfoliative toxins. 
Previously, the Central Public Health Laboratory (CPHL) offered to test 
isolates of S. aur~us for enterotoxins A-D and TSST using reverse passive 
latex agglutination (KPLA) assays, and for exfoliative toxin genes A and B 
by PCII. As the liinited range of immunoassays does not allow detection of 
all 12 toxins listed above, a new service using PCK was developed. The 
system utilises a simple boiling DNA extraction method followed by 3 PCR 
multiplex assays and agarose gel electrophoresis for detection of P C R  
products. Multiplex 1 detects the genes for enterotoxins A-E, multiplex 2 
the genes for enterotoxins G-J and multiplex 3 the exfoliative toxin genes 
and TSST gene. Incorporated into all multiplexes is an internal 
aniplification control based on 16s rDNA sequences. The assays were 
initially evaluated with a collection of 101 clinical isolates of S. aweus sent to 
CPHL for epidenliological typing. These isolates had been examined for 
toxins/toxin genes by individual PCR assays and RPLA. There was 
complete agreement between the previous results and those obtained using 
the new PCR n~ultiplexes. The new PCR-based service was introduced on 
1 January 2000 and until 31 March 2000 ran in parallel with KPLA testing 
of isolates. During this period, 214 isolates were tested and < 1% of tests (2 
cultures) produced discrepant results. Also, the percentage of isolates in 
which no toxins were detected was reduced from 38% to 24%. The most 
frequently camed genes were those encoding enterotoxins G and I and 
these were almost always camed together. In addition, these two genes were 
camed by the majority of phage group 11 isolates causing skin disease. This is 
perhaps the most interesting finding, as it had been previously suggested that 
phage group I1 strains do not carry enterotoxin genes. I n  conclusion, the 
new I'CR-based multiplexes have proved a reliable replacement for the 
previous combination of KPLA and PCR for detection of toxin genes in S. 
aweus at CPHL and may help determine the importance of the newer 
enterotoxin genes in disease. 
A comparison of phagocy&osis of methicillin-resistant 
and methicillin-sensitive Staphyrococcus aureus by 
polymorphonuclear leukocytes 
M. Kubio, F. Gonzilez, S. Salso, M. Gbmez, J. Romero-Vivas, J. Picazo 
Villnviriosa de Od6n. Madrid, E 
Objective: The aim of this study was to assess the possible differences in 
phagocytosis by nornial polymorphonuclear leukocytes (PMN) between 
isolates of methicillin-resistant (MRSA) and methiciuin-sensitive (MSSA) 
S. aureus. 
Methods: We have studied nine MSSA and nine MRSA isolated from 
blood cultures between 1991 an 1993. PMNs were isolated from EDTA- 
anticoagulated blood of healthy volunteers by Histopaque (Sigma) 
centrifnganon. Bactena were labelled by incubation with 0.1% fluorescein 
isothiocyanate for 30 min at 37 "C protected hom light, washed twice, 
suspended in Hank's balanced salts solution and opsonized with 10% 
autologous serum at 37 "C for 15 min. Labelled and opsonized 
staphylococci were mxed with PMNs adjusting the ratio bacteria:PMN 
to 10:1 and incubated for 30 nliti at 37 "C. Ethidium bromide was added to 
obtain a final concentration of 50 pg/mL and 10 microliters of the mixture 
wa5 viewed using a flnorescence microscope. We examined 25 consecutive 
PMNs per sample and we counted the number of ingested and attached 
bacteria. All isolates were tested in duplicate in each experiment and all 
experiments were repeated twice using PMNs from different donors. The 
differences between MRSA an MSSA were assessed by ANOVA followed by 
Students's two-tailed t-test. 
Results: The niean of MSSA and MRSA attached per PMN was 1.51 
Confidence Interval 95% [1.2-1.8] (range 0.04-5.12) and 1.29 CI IO.91- 
1.671 (range 0-4.56). respectively, but this dinerence was not statistically 
significant (P= 0.36). However, the mean of MRSA phagocyted per PMN: 
0.047 CI [0.02-0.071 (range G0.32) was significantly lower (P= 0.024) 
than the mean of MSSA phagocyted:: 0.13 CI [0.06-0.19] (range 0-0.8). 
Conclusion: This study suggests that MRSA strains that caused bacteremia at 
our hospital have a lower susceptibility to phagocytosis by PMNs than 
MSSA strains. 
/p5781 Staphylococcus aureus in community acquired 
infections 
E. Arlukowicz, A. Samet, L. Naumiuk 
Gdansk, PL 
Objectives: The aim of the study was to detemene the susceptibility of 
Staphyloruccus aureus (SA) isolated from outpatients from January 1998 to 
June 2000. 
Methods: We analyzed 6818 specimens mainly: throat and nasal swabs, 
sinus aspirates, wound exudates, urine and others. SA were identified by 
standard methods and disk-diffusion susceptibihty testing was done 
according to NCCLS. 
Results: 383 specimens were SA positive which constituted 5.6% of all 
materials. S.A. was most frequently isolated from nasopharynx - 66.7% - 
1998, 41.8% - 1999 and 50% in 2000, and wound exudates 14.3%, 26.6% 
and 15.4'34, respectively. 51 SA were susceptible to all tested antibiotics. 
85.6% were penicillin resistant (R), 16.2% tetracycline R, 8.1% eiythro- 
niycine and clindamycine R. MRSA strains (2.1%) were isolated froni 
patients with chronic ostitis after many surgical interventions. 
Conclusions: Our SA were susceptible to most tested antibiotics, penicillin 
being the only exception. MRSA were never isolated from coimnunity 
acquired infections 
lp579/ Factors affecting the carriage of Staphylococcus aureus 
in young adults 
M. V. Boost, M. M. O'Donoghue 
Hong K o q ,  VRC 
Introduction: Several studies have reported the presence of Stap/iylurocrus 
aureeus in the nares and on finger tips of hospital staff, but there has been little 
investigation into the factors affecting acquisition and long-term camage of 
these strains. We report the results of a two year longitudinal study on 
camage of Staph. auretis in young adults in Hong Kong. 
Objectives: To determine risk factors for long-term camage of Staph. aureus 
in young adults. 
Method: 331 subjects aged between 19 and 21 years who were students of 
either a health care (HC) course, n =  143 (nursing or biomedical science) or 
a hospitality management (HM) course, I I =  148, were recruited. Samples 
were collected from the anterior nares on four occasions over a two year 
period and cultured for the presence of Staph. aureus. Students were asked to 
complete a short questionnaire giving details of age, sex, course of study, 
skm care regime and recent antibiotic use. Prevalence and persistence of 
camage were noted and associations between camage and possible iisk 
factors were examined. Persistence of the same strain was determined by 
antibiotic sensitivity patterns and pulsed field gel electrophoresis. 
Results: The overall level of carriage of Staph. aureus was found to be quite 
high ranging &om 33.6 to 35.4%. Being a student ofa H C  course involved a 
higher risk of carriage (OR = 1.35, P =  0.022) as the rates of carriage were 
higher in the H C  group (38.242.0%) than the HM group (27529.7%). 
There was no difference in rates of long-temi camage between students of 
different courses, with 59 and 60% of those positive on first sampling 
remaining positive on later sampling. Sex was found to be a risk factor for 
persistent carriage. Although there was no significant difference in initial 
carriage rates between males and females, in later sampling of those who had 
been initially positive, 87.5% of males remained camers but only 47.5% of 
females (P' < 0.001). Age, skin care routines and recent antibiotic use &d 
not have a significant effect on persistence of camage. 
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Conclusions: Carriage rates in HC students who were exposed to the 
hospital environment as part of their course, were higher than those found 
in H M  students. Although persistence of carriage did not differ between the 
groups, sex was found to be a risk factor for persistent carriage. The 
difference may be due to biological factors such as hormone levels or to 
social factors wch as personal grooming. 
p 8 0 1  11-8 production in monocytes and macrophages after 
stimulation with coagulase-negative staphylococci 
K. Jung, A. Moshfegh, J. Lundahl, A. Brauner 
Stockholm, S 
Objective: To compare IL-8 production in nionocytes and macrophages, 
induced by coagulase-negative staphylococci (CNS) isolated either from 
peritonitis in patients with continuous ambulatory peritoneal dialysis 
(CAPD) or from the resident normal flora. 
Materials and methods: Cell line: a human monocyte cell line (THP-1) 
differentiated to macrophages. Peritonitis strains: CNS isolated from 
peritoneal fluid during peritonitis among patients with CAPD. Normal 
flora strains: CNS strains isolated at least twice over a period of 3 months 
from the skin of healthy individuals. Stimulation: Monocytes and 
macrophages were stimulated with live CNS (ratio 10 bacteria per cell). 
ELISA: The supernatant was tested for IL-8. Transmigration: Monocytes 
were allowed to migrate through a membrane towards MIP-la. 
Results: During a 2-year period 9 patients had 12 epirodes of peritonitis 
with CNS. Three patients had repeated infections and in two of these the 
infecting strain? were identical as verified with PFGE. Monocytes and 
macrophages were stimulated with the 10 different CNS isolated from the 
peritonitis and 10 CNS &om the normal flora. The rnonocytes stimulated 
with the normal flora showed a significantly higher IL-8 response compared 
to macrophages stimulated with the same strains ( P  < 0.05). When 
comparing a representative CNS strain from CAPD peritonitis with a 
representative strain from the normal flora we found that the resident 
normal flora strain gave higher IL-8 response after 4 h compared to the 
peritonitis strain. By contrast, when bacterial concentration was increased 10 
fold, we found higher IL-8 production after stimulation with the CAPD 
strain. Monocytes that had transmigrated towards MIP-1 a had, when 
stimulated with CNS, reduced ability to produce IL-8 as compared to cells 
that did not tranrmigrate. 
Conclusions: Monocytes lugher IL-8 as compared to macrophages afrer 
stimulation with the same CNS strain. The ability of CNS to induce an IL-8 
production seems to depend on both the ongin of the strain and the 
concentration of the inoculuni. CNS is the most frequently cause? of CAPD 
Diagnostic tests for pneurnococci 
peritonitis. The lower IL-8 response induced by the CAPD strains are of 
particular interest, since CAPD patients are treated with repeated changes of 
their peritoneal effluent and these changes do not allow the infecting 
bacterial agent to increase as in other diseases. 
v] Coagulase-negative staphy/ococcus native valve 
endocarditis 
J. A. Herrero, E. Exposito, G. De la Morena, E. Siniarro, J. Ruiz, 
N. Ortega, J. G6mez 
Murcia, E 
Objectives: To know the incidence, clinical course, and prognosis of CNS 
native valve endocarditis. 
Patients and methods: We retrospectively reviewed all clirucal records of 
patients with the diagnosis of endocarditis during a 10-year period (1980- 
99) in our center and selected the cases in which CNS was responsible. All 
patients had a definitive endocarditis according to Durack criteria. At least 
one echocardiographic study was performed in each patient. The minimal 
follow-up was six months except for the patients who dled. Identification of 
bacteria was performed with standard methods. 
Results: During the period of study a total of 105 cases of native valve 
endocarditis were diagnosed. Ten cases (9.5%) were caused by CNS (8 S .  
epidemidis, 1 S .  Iugdunerisis, 1 S. siniulatis). The patients ranged in age 
between 25 and 75 years. Male patients predominated ( 1 1  = 7, 70%). Five 
patients did not have a previous history of cardiac disease, 2 had nitral 
prolapse, 1 had a bicameral peacemaker for an atrio-ventricular blockade, 1 
had a degenerative mitral estenosis. Six (60%) patients suffered previous 
vascular manipulation (2 injection of illegal drugs, 1 peacemaker placenient, 2 
cenual venous catheter, 1 arterio-venous fistula for hemodialysis). Tricuspid and 
was affected in 4 cases, m i d  valve in 4, and aortic valve in 2. All patients 
presented with fever and &se but only in 2 significant heart hilure was 
detected on admission. During the course of the dL7eae 4 patients (.lo'%) 
developed embolic events (1 brain, 1 lungs, 1 spleen, 1 s n d  bowel). Antibiotic 
treaanent was instituted in all patients with an agent active against bacterial wall 
(Vancomicin 8, Cloxacillin 2 depending on susceptibility) plus an anunoghco- 
side. Suc patients received additional Rifampicin. In three patients early valve 
replacement was performed. Two (20%) patients died both of them as a 
result of septic embolism (1 brain, 1 small bowel). 
Conclusions: 1. CNS are responsible for a significant prrcenulge of native valve 
endocarditis. 2. Endocarditis should be ruled out in patients w t h  repeated 
positive blood cultures for CNS and compatible clinical history, specially in 
those in which a previous vascular procedure has been perfomied. 3. Mortality 
remaia7 hgh, although an early diagnosis can increase the survival rate. 
jP5831 Characterization of serotype 23F penicillin 
nonsuscepti ble Streptococcus pneumoniae strains isolated in 
Germany with multilocus sequence typing 
K. K. Reinert. A. Al-Lahhani, S. Muckel, K. Liitticken 
A a h e i i ,  D 
Background: Strqtoturrus prieurnoniae is one of the most important bacteria 
causing bacterenuc pneumonia and meningitis worldwide. Multilocus 
Sequence Typing (MLST) was developed to identify clones of major 
epidemiological concern within populations of pathogenic microorganisms. 
This study is aimed at detemGning the genetic relatedness and the clonal 
distribution of the 23F penicillin nonsusceptible pneuniococcal strains (Pen 
'0.125 nig/L) with MLST. 
Methods: Thutyfour clinical strains of penicillin nonsusceptible S.  
pneumoriiae (PNSP) of serotype 23F were isolated as part of an ongoing 
surveillance study by the Geman National Reference Center for 
Streptococci &om 1992 through 2000. MICs to other antibiotics were 
detemined accordmg to NCCLS recommendations. Seven internal loci of 
the genes recP, xpf, spi, aruE, yki, gdk,  and ddl were amplified by standard 
PCR methods and their products were then sequenced with the ABI prism 
310 sequencer. The sequences were then sent to the central web database 
(http://mLst.zoo.ox.ac.uk), from which the allelic profie of each sequence 
was obtained. A combination of seven allelic profiles of the seven loci was 
then sent to the same address and compared with those available in the 
MLST database to obtain an MLS type. 
Results: Of the 34 PNSP strains, 18 (52.9%) were shown to have MLS type 
81, and 6 (17.6%) MLS type 277. Two strains (5.9%) among the 23F PNSP 
were shown to be homologous to the Netherlands MLST clone 277 with 
one allelic variation in the xpt gene, so that the allelic combination of these 
two strains was as follows: re# (6), xpt (6). spi (6), amE (7), @i (8), ydk (13). 
and ddl (8). One other strain (2.9%) showed allelic homology to MLST 
clone 278 reported in Cuba with one allelic variation in the xpt gene locus. 
This strain showed the following allelic combination: recP (12), xpt (6), spi 
(6), aroE (2), gh(8), gdh (13), and ddl (18). Data of 7 strainr are pending. 
Conclusions: Two known major MLST clones are present in Germany 
among the 23 F PNSP strains: MLS types 81 and 277. Three strains were 
shown to have nonreported allelic conibinations homologous to those 
isolated in the Netherlands and Cuba. MLST is a valuable method for 
molecular epidemiological analysis of pneumococcal infections. 
Fl New rapid test for detecting S. pneumoniae in lower 
respiratory tract infections 
R. Lienhard, H. H. Siegrist, D.  Genne 
La Ckaux-de-Fonds, C H  
Objective: The purpose of thls rtudy was to evaluate the use of a new 
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pneumococcal urinary antigen teyt (UAT) ( Ihax,  Inc.) in the management of 
patients admitted to the hospital presenting a c h c a l  picture of pneumonia. 
Methods: Pneumonia was defined by the presence of fever or leucocytosis, 
dyspnea or new sputum production, and a new infiltrate on the chest X-ray. 
The result of the bacteriological sputuni culture (or broncho-alveolar 
asplrate or lavage) or blood culture provided the etiology of pneumonia 
(pneumonia group). Concomitantly, a urine sample was provided. The 
urine was collected within the first 7 days from the day of diagnosis. The 
sensitivity of the UAT was based on the presence of S. pneumoniae in one of 
the sample cultures. Specificity was determined using urine samples of a 
population with suspicion of urinary tract infection (control group). 
Results: Of the 75 patients included in the pneumonia group, 34 (42%) had 
a positive culture and 25 (30%) had S. piieumoriiae. From these patients 13 
urine samples were positive with the UAT showing a sensitivity of 52%. In 
the sanie group we found 8 positive tests for the patients with no 
microbiological evidence of S .  pneumoniae (n = 50). This could mean that 
we gain sensitivity with the UAT. Of the 84 urine samples included in the 
control group, 4 (4.8%) were positive. After exclusion ofrecent pneumonia 
episodes or pneumococcal vaccination, only 1 sample remained as a false- 
positive result giving a specificity of 98.8%. 
Conclusion: Considering its high specificity and despite its poor sensitivity 
the UAT has the potential to enhance the etiological diagnosis of lower 
respiratory tract infections. 
lp5851 Allelic variations of an internal locus of the pyruvate 
oxidase gene spx6 among pneumococci isolated in Germany 
R. R. Reinert, A. Al-Lahhani, A. Marek, R. Lutticken, B. Spellerberg 
Aaclm, D 
Background: Streptororcus ptieumoniae is well known as a causative agent of 
severe infectious diseases, such as pneumonia and meningitis. Hydrogen 
peroxide is produced by the pneumococcus through the pyruvate oxidase 
leading to a bactericidal effect on other inhabitants of the upper respiratory 
mact, such as H. ir$ueiitae, and may therefore play a major role in the 
pathogenesis of pneumococcal infection. The objective of this study was to 
identlfy the allelic variations of an internal locus of the pyruvate oxidase 
gene (spxB) among strains responsible for chfferent pneumococcal infections. 
Methods: A total of 188 isolates of S. pizeumoiiiae were chosen from the strain 
collection of the German National Reference Center for Streptococci. These 
thains originated from Merent types of infection. Sites of isolation were as 
follows: blood (ri=36), CSF (35), nasopharynx (45), eye (15). bronchial 
alveolar lavage (15), ear (21); 9 strains came from other sources, and 12 from the 
American Type Culture Collection representing internationally predominant 
clones. Primers hybridizing in a conserved region of the spxB gene (accession 
number L39074) at positioils 90&928 (forward primer) and 1442-1462 
(reverse primer) were selected for PCR amplification. PCR was performed by 
standard methods. PCR products were sequenced using an AB-Prism 310 
sequencer. All strains were serotyped by the Neufeld Quellung reaction. 
Results: Of the 188 pneumococcal strains, thus far the spxB-locus was 
sequenced in 61 strains (32.4%). Thirtyfour pneuniococcal strains were 
penicillin nonsusceptible (serotype 23F). The PCR-product contained 464 
bp (position spxB 950-1413). The sequence analysis of this product showed 
14 different sequence types (ST) among the pneumococcal isolates. Each ST 
contained at least 10 point mutations in the spxB locus cornpared to the 
published sequence of the S.  pneumoniae K6 strain. The sequence analysis of 
the 23F penicillin nonsusceptible pneumococci (34 strains) showed only 3 
different ST; ST 1 (2.9%), ST 2 (85.29%) and ST 3 (1 1.76%) of the 23F 
strains. The sequence analysis of the 61 isolates analyzed so far showed no 
correlation between the ST and type of pneumococcal infection. 
Conclusion: S p x B  of the ST 2 was the most prevalent among the penicillin 
nontusceptible serotype 23F pneumococcal strains isolated in Germany. 
SpxU typing is a useful tool for identification of clonal relatedness among 
pneumococcal strains. 
lp5861 Performance of WIDER 1W MIC panel compared to a 
NCCLS method for Streptococcus pneumoniae susceptibility 
Ma Morera. D Fontanals, F Salceda, J Hernandez, M Simb, D Manscal 
Terraua, Sabadrll, E 
Objective: To evaluate the perforniance of a new broth nucroddution dried 
overnight panel, WIDER 1W MIC (Francisco Sona Melgulzo SA), for 
Srreptococrus piieunioruae susceptibhty 
Methods: We compared the results of WIDER 1 W MIC broth 
microdilution panels with the results of agar dilution susceptibility method 
(National Reference Laboratory for Streptococcus pneumoniae, Majadahonda, 
Madrid), against 119 strains isolated from invasive disease samples [blood 
(107), pleural fluid (8),  cerebrospinal fluid (2) and ascitic fluid (2)) between 
October 1999 and September 2000 in Hospital of Terrassa and Corporaci6 
Parc Tauli of Sabadell. Panels were inoculated accorchng to the instructions 
of the manufacturer and the filial panel inoculum density was approximately 
5 x 10' CFU/mL. The results of each antimicrobial agent were interpreted 
using the NCCLS interpretative recommended breakpoints. 
Results: Overall ageenlent for Streptococcus pneumoitiae at 1 + log- dilution 
was 98.7%. Agreement between the two methods was higher for 
vancomycin (100%) and erythromycin (100%) than chloraniphenicol 
(99.2%), cefotaxinie (99.1%), tetracyclin (97.5%) and penicillin (96.6%). 
We detected 3 very major errors [2 (1.7%) in tetracyclin and I (0.8%) in 
chloramphenicol] and 18 nlinor errors [11 (9.2%) in penicillin, 6 (5%) in 
cefotaxime and 1 (0.8%) in tetracyclin]. 
Concfusion: The performance of WIDER 1 W MIC panel for susceptibility 
testing of Strepturocrus piteumortiae, demonstrates good correlation in 
comparison to NCCLS agar ddution susceptibility method. 
jp5871 An optochin resistant Streptococcus pneumoniae isolate 
H. Guducuoglu, M. Berktas, H .  Bozkurt, K. Onbasi, S. Andic 
Van, TR 
Developing resistance to a lot of antibiotics is a probleni in diagnosing and 
treating of many microorganism. We have isolated a Gram positive- 
diplococcus like appearing bacteria by Gram staining during defining a 
Streptoroms prieumoniae species. I t  showed a inucoid colony niorphology by 
culture. The sensitivity of the bacteria to Vancomycin was indicating for a 
pneumococcus species. Advanced tests demonstrated an optochin resistant 
bacteria. After capsule quellung reaction, capsule staining and bile solubility 
test a Streptococcus pneumoniae was identified. An antimicrobial sensitivity test 
with a Kirby-Bauer disc difision method revealed that the species was 
sensitive to Cephalothin, Ampicillin, Vancomycin, Chloramphenicol, 
Ceftriaxone, Ofloxacin, Cefotaxime and Anioxicillin-Clavulanate, but it 
was resistant to Penicillin, Tetracycline, Clindaniycin, Trimethoprim- 
Sulfamethoxazole, Ceftazidime and to Erythromycine. During identifica- 
tion of Streptococcus pneunioriiae species using an optochin test in addition to 
the other diagnostic tests may reveal optochin resistant pneumococci and 
this maybe helpful in diagnostic and treatment modalities. 
I P588 I Evaluation of the Oxoid Dryspot pneumo Test 
S. A. Martin, A. E&.tratiou, R .  C. George, 0. Sidnell, A. Parker, T. Hamnan 
London, Basiiigstoke, UK 
Objectives: The Oxoid Dryspot pneumo Test is a rapid latex confirmatory 
test that has been developed for the rapid detection of capsular antigen from 
Streptococcus pneumottiae. The test is designed for use on presumptive 
pneumococcal isolates, from plate culture and blood culture. The a m  of the 
study was to evaluate the specificity of the Dryspot pneumo Test using a 
panel of previously characterized pneumococcal strains, and the sensitivity 
using a diverse collection of competitor orgamsnis including streptococcal 
species, related genera, and other respiratory pathogens seen clinically. The 
Dryspot pneumo kit was compared to the currently available Biomeneux 
Slidex pneumo-kit. 
Method: A total of 216 isolates were examined using the Dryspot pneumo 
Test system in parallel with the other commercial latex system. Among the 
129 isolates of pneumococci examined, 63 were type strains obtained from 
NCTC and ATCC, 77 were clinical isolates and 4 were nontypable strains. 
In addition, 42 representative strains from 31 different streptococcal species, 
and 30 isolates from other respiratory genera were also tested. 
Results: The test results using both kits were comparable. The Dryspot 
syytem however, produced results that were easier to interpret and the lut 
system was straightforward to use. There were four anomalous false positive 
results using both systems, these were isolates of S. mitis, S. ovalis and S. 
anginosus with the Dryspot test, and S .  initis, S. oralis, S. anginosus and S. 
salivatius with the Slidex lut. Cross-reactivity is not unexpected with strains 
of S .  rnitis and S. oralis due to their close genetic relationship to S. 
ptirumuniae. The anomalous results were clarified by the use of biochemical 
confiimatory tests. The three false negative results obtained with the 
Dryspot yystem, and the two obtained with the other kit were primarily 
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isolates that were either noncapsulate, or rarely seen in a clinical setting- 
serotype 41A arid 38. The strain of serotype 19A that gave a false negative 
result was found to be atypical of this serotype upon further testing of 
serotype 19A isolates. 
Conclusions: The Oxoid Dryspot pneunio Test system is a comprehensive, 
standardized system which is comparable to currently available commercial 
tests. The results obtained are clear-cut and easy to interpret, with a 
specificity of >97%1. Therefore, it is an ideal test for use in a clinical 
diagnostic microbiology laboratory. 
Diagnosis of enteric bacteria and viruses 
/p5891 Feasibility of introducing rejection criteria for stool- 
cultures: 12-month experience in Portugal 
T. Hanscheid, J .  Melo Christina, M. J. Salgado 
Cabanas, P 
Introduction: Stool-cultures are regarded as expensive routine testc and 
rejection criteria have been suggested, e.g. from the College of American 
Pathologists (CAP): < 3 days of hospitalization and < 2 samples/patient. 
We evaluated the introduction of these criteria in our laboratory where 
currently all specimen are accepted. 
Methods: Specimen were cultured for 24 h on McConkey, SS, McConkey- 
Sorbitol and Campylobacter-selective media (72 h). Tetrathonate broth 
was subcultured after 24 h on McConkey agar (24 h incubation). Triple- 
Sugar-Iron agar and Urea broth were used for screening. 
Results: Of 854 specimen from 533 patients 154 specimen (18%) fi-om 92 
patients (17%) were positive. Salmonella spp. caused 67% (48 S .  enteritidis, 5 
S .  Gr. B, 4 S. Gr. C and 5 S. typhimurium), Campyluhairer spp. 23% and 
Shgella spp. 10% of the episodes (4 Sh.  dysenteriae, 2 Sh.$exneri and 3 Sh. 
soi i i tp i ] .  More positive inpatient specimen (75% of 124) than and negative 
ones (49% of 551) were collected in the first 3 days of hospitalization. Using 
> 3  days as rejection criteria 10 episodes would have been missed (5 
Campylubaiter spp. and 5 S. enteritidis), using > 4  days 5 episodes and 
applying > 5 days 3 episodes for a reduction in specimen of 36% 28% and 
2596, respectively. Using a maximum of 2 specimen/patient only 1 episode 
would have been missed (Salmonella Gr. B) for a 27% reduction in specimen. 
Combining > 5 days and < 2 specimen, 4 episodes would have been nlissed 
for a 47% reduction in specimen. 
Conclusion: In our institution a high proportion (17'94) of stool-cultures 
harbor pathogens. Using the rejection criteria from the CAP the workload 
would decrease by more than SO%, however, an unacceptable number of 
cases (> 10%) would have been missed. More cases would have been missed 
using days of hospitalization than specimen number (10 us. 1). Combining 
> 5 days and > 2 specimen/patient the workload would have decreased by 
47%, however, 4 cases would still have been missed. The CAP criteria may 
depend on prevalence of pathogens, rapid collection of stool as well as well 
functioning infrastmctures, that may not be equal in all hospitals. 
vl Colony-blot assay with anti-€. coli 0157 antibodies as a 
fast identification method 
B. Rhzalska, A. Bonar, J. Jagiela, M. Wieckowska-Szakiel, W. Rudnicka 
Lo&, PL 
Objectives: The laboratory dagnosis of E. ioli 0157, based on cultivation of 
bacteria on sorbitol-MacConkey may produce false-posltive or -negative 
results. Our study report on the evaluation of colony-blot method with anti 
E. ioli 0157 antibodies which permit detecting of small number of E. coli 
0157 organism in a specimen. 
Methods: The immune rabbit IgG anti-E. coli 0157 antigens were prepared 
and used for identification of bacteria on Glters or on nitrocellulose imprints 
(repilcas) of colonies grown on selective or nonselective agar plates. The 
immunostaining was achieved by use of immune IgC, secondary peroxidase 
conjugated antibodies and enzyme substrate (colony-blot). 
Results: Intense navy-blue stained E. coli 0157 colonies (or colony imprints) 
were observed indicating the specific recognition of bactena by the immune 
IgG used. This serological method allowed to distinguish E. id i  0157 &om 
other E. coli serotypes and other representatives of the EnetrobacteGceae 
family wihout necessity of further biochemical identification. 
Conclusions: Our serological method ofE. roli 0157 is very simple. It seems 
to be very useful in microbiological food control and hagnosis of clinical 
specimens. It allows to obtain accurate results in 48 h, even in the samples 
containing small number of target organisms among other bacteria. 
Prevalence of selected virulence markers of 
diarrheagenic Esherichia coli among strains isolated from ill and 
healthy children 
J .  Paciorek, A. Cieslik, J. Szych, S. Kaluzewski 
wausaw, PL 
The aim of this study was to establish the prevalence of selected virulence 
markers indicative of enteropathogenic (EPEC), enterohaeniorrhagic 
(EHEC) and enteroaggregative E. coli (EAEC) among isolates regarded as 
belonging to EPEC serotypes in Poland. E. ioli isolates were also tested for 
their adhesion patterns in cultured HEp-2 cells. In the Ftudy 428 E.  iali 
isolates from children with diarrhoea and 104 faecal isolates from healthy 
children examined for the presence of genes encoding intimin (eae), bundle 
fomGng pili (bfp), verotoxins (slt I and slt 11). and a fragnient of the plasnlid 
pAA from EAEC by means of the PCK. Strains isolated from ill chiIdreii 
were found to belong to 018 (110 isolates), 0 2 6  (65), 0 4 4  (97), 0127 
(48), 0126 (48) and 0 8 6  (60). Of the 428 strains tested, 106 were atypical 
EPEC (i.e. ear+, bfp,slt-), among them were identified 0127 (44 itolates), 
0 2 6  (60), and 0 8 6  (2). Two isolates of 0 2 6  were positive for the presence 
of eae and slt I. Fifty-one isolates of 0 8 6 ,  12 of 0126 and 9 of 0 4 4  
possessed pAA. When tested for HEp-2 adhesion, 243 isolates showed no 
adhesion to the HEp-2 culture. Seventy strains displayed aggregative 
adhesion (21 of 0 4 4 ,  37 of 086 and 12 of 0126). Twenty strains displayed 
localised adhesion (11 of 0127,  and 9 of 026) ,  and 77 isolates of 0 1 8  
adhered in an undefined way. The adhesion pattern of 18 isolates of 0 1 8  
strains could not be established because of excessive damage to the cell 
cultures. Of the 104 E.  roli isolates recovered from 36 healthy children, 13 
were 018, 2 were 0127 and 3 were 0 2 5  (all these isolates were found to be 
negative for the presence of the markers investigated and were not 
adherent). Among remaining, non-EPEC strains, 10 possessed pAA of 
EAEC. Fifty-four strains showed no adhesion to the HEp-2 culture, 9 
displayed aggregative adhesion and 10 displayed diffuse adhesion. We were 
unable to establish the adhesion pattern of 31 E.  coli isolates. Among 428 
strains isolated &om children with diarrhoea and considered in Poland as 
EPEC, only 106 (24,8%) conformed to the marker &splay associated with 
atypical EPEC. Moreover, the frequent presence of E.  ioli 0 1 8  in samples 
isolated from healthy children demonstrates the requirement for improved 
evaluation of their potential pathogenicity. Our data confirm that EI'EC 
diagnostics based on serogroup identification is not efficient. 
/p592) Comparison of molecular and conventional detection 
of Campylobacter, Salmonella, Shigella, EHEC, and Clostridium 
difficile in feces 
E. M. Bik, M. Brok, P. Foppen, S. van Haniersveld, M. Tersmette, B. M. 
de Jongh 
Nieuuqein, NL 
We investigated whether molecular techniques could offer advantages over 
conventional techniques in the detection of pathogenic bacteria in fecal 
samples. PCRs were developed for the detection of Cumpylobuiter species 
(16s rRNA gene), Salmonella species (invA gene), Shigella species (ipaH 
gene), enterohemorrhagic Esrlierirhia ioli (EHEC) (~ tx l ,  stx2, and rfb0157 
genes), and Closiridium &@ciIe ( t o d  gene). The sensitivities of the PCKs on 
feces samples were found to be 197 colony forming units (cfu) for the 
Salmonella PCR, 21 cfu for the Sht&dla PCR, and 35 cfu for the 
Campylobacter PCR. Two commercial methods were tested for the 
extraction of DNA from feces samples, i.e. the QlAanip DNA nllni kit 
(optimized protocol) and the QIAamp DNA stool test kit. The first method 
gave the best results, and was used in further expenments. PCR was 
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performed on 108 consecutive clinical fecal samples. Results from PCR 
were compared with culture on specific agars and C. d@ile agglutination. 
Two percent of the samples were inhibited in PCR. This inhibition could 
be overcome by tenfold sample dilution. No stool qamples were found 
positive for Shkella of C.  d@cile by either PCR or conventional methods 
(culture of agglutination). In  3 samples, Salmonella was detected by cultures 
as well as by PCR. In 12 samples, Campylobacter was detected by PCK, 
while only 4 were culture positive for this organism. Of the 108 stool 
samples, none yielded E. coli 0157 by culture, while 1 sample was positive 
in all three EHEC PCKs. Four additional samples were stxl-PCR positive. 
Furthermore, we evaluated the performance of both culture and P C R  on 
samples stored for long periods at different temperatures. While culture of 
Catnpyfobacfer or SIiigella was negative after a few days or sometimes weeks, 
depending on the storage conditions, P C R  detected these bacteria for 
periods up to 4 months. Also, it was possible to detect Campylobarter in 
samples treated with the parasite futatlve SAF. In conclusion, direct 
molecular detectioii of enteric bacterial pathogens in stool samples IS 
sensitive and specific, and could offer advantages over conventional 
methods, especially with stool samples stored under suboptimal conditions. 
Effect of culture conditions on yield of verotoxins from 
Escherichia coli 
M. Sattari, A. R. Kezaee, A. R. Nazari 
Telirart, IR 
Objectives: Verotoxins are a f a d y  of cytotoxins produced by some strains 
of Esclrcn'chta mli. These toxins are toxic for vero cells. Various media culture 
is used for production and detection of these toxins. The purpose of this 
study was therefore to investigate culture con&tions(type of media and 
incubation period) which affect the yield of verotoxins. 
Methods: The effects of selected media [Trypticase Soya broth (TSU), 
CAYE broth and Cooked meat broth] on the production of verotoxins by a 
strain of Esrherirlria c d i  (0157) in different periodic incubation were 
examined. Toxin were detected in supematant and cell mass by VTEC- 
RPLA Kit. 
Results: The toxins were assayed in different amount$ in T.S.B and CAYE 
media both in supeniateiit and cell mass but in cooked meat medium only 
vt2 could be detected in supernatant and vtl was remeined in bacterial cells. 
The most amount of toxins after 24 h. was  belong to TSB medium. 
Conclusions: The trypticase Soya Broth is an economic and suitable 
medium for detection and assay of verotoxins in clinical specimens. 
The CRMOX-positive phenotype predominates among 
clinical strains of Yersinia enterocolitica isolated from humans in 
Poland 
K. Gierczyliski, S. Kaluewski, J. Szych, M. Jagielskl 
Warsaiv, PL 
Pathogenic Yrr.vinia rods harbour the virulence plasmid (pYV) encouraging 3 
characteristic phenotype. Unfortunately, pYV niay be lost easily when a 
carrier strain is incubated at 37 "C-a temperature commonly applied in 
clinical microbiology laboratories. For this reason, the &agnostic methods 
based on p W  detection, are often considered as unsuitable for such 
laboratories. O n  the other hand, Congo red, magnesium oxalate agar 
(CKMOX) descnbed by Riley and Toma offers the easy way for parallel 
scanning of two pYV-associated features. Therefore we decided to use the 
CRMOX agar for the routine screening. The goal of our study was to 
check the preqence of CRMOX-positive phenotype among clinical strains 
of Y. errterocditira isolated from humans in Poland. Three hundred and 
twmty-eight Y. errterorofitirn strains were tested. These strains were isolated 
from rtool samples iu bacteriology laboratories of Sanitary-Epidemiological 
Stations (SES) or in the other collaborating clinical laboratories, from 
January of 1996 to November of 2000. The staff of SES laboratories was 
instructed to incubate strains suspected to be Yersinia only at the rooin 
temperature. Bacterial strains delivered to our laboratory were biochenii- 
cally and serologically checked and plated on CRMOX agar as 
recommended by Riley and Toma. AU tested strains belonged to serogroup 
0 : 3 .  The CKMOX-positive phenotype was observed for 271 (82.6%) of 
328 tested strains. The remaining 57 strains were judged as CFLMOX- 
negative. Addtional studieg done on 130 CRMOX-positive and 22 
CRMOX-negative strains showed that all of them belonged to biotype 4 
and possessed ail gene. The exact correlation between CRMOX-positive 
phenotype and p W  was also noticed. All tested strains belonged to the 
pathogenic serogroup and according to the additional tests results, we 
recognised them as virulent. The CRMOX agar was sufficient method to 
confirm the pathogenic properties up to 82% of them. Moreover in case of 
SES laboratories in Wabrzych (41 strains isolated) and in Lom0a (16 strains 
isolated) use of C R M O X  agar yielded 90% and even 100% of positives, 
respectively, showing that the p W  lost rate can be reduced significantly by 
appropriate handling. Thus, obtained results contradlct opinion, that pYV is 
so easily lost that, plasm~d-associated virulence markers are practically 
ineffective for routine distinguishing of pathogenic Y. enterocolifica strains in 
clinical microbiology laboratories. 
The PCR based virulence characterization of the 
clinical strains of Yersinia enterocolitica 0:3 isolated in Poland 
from humans 
R. Gierczyiish, M. Jagielski 
Warsaw, PL 
The range of the genetic virulence markers of Yersinia mterocolitica have been 
already described and stdl a novel ones are reported. We decided to check 
the presence of the few selected genes considered as the virulence niarkerr in 
clinical strains of Y. enterocolitira isolated from humans. For examinations we 
selected the well known genes yadA, virF, ail, yst and some of the novel 
virulence-associated genes: my@, ureC, irpI and ymoA, respectively, 
encoding subunits of MYF-hbriae and urease or involved in siderophore 
production and regulation of expression of virulence functions. The aim of 
our study was the comparison of the presence of selected genes in clinical 
strains of Y. enterocolitica 0 : 3  isolated from humans. The examinations were 
done on 55 clinical strains of Y .  enteroolitira 0:3/4  isolated in Poland from 
humans during last four years. All these strains were obtained from stool 
samples and possessed the virulence plasimd pYV. In addition 30 isogenic, 
plasmid-cured strains were tested. The 24 strains including: Y. enrerornlifica 
1A and other Yersinia species, E .  cult, Citrubafcer and Salmonella were used as 
controls. The DNA templates obtained from tested stmins were subjected to 
the target specific polymerase chain reaction (PCK). A single pair ofprimers 
were used for detection of each tested gene separately. The specificity of 
obtained PCR-products were confirmed by RFLP. The PCK assay resulted 
in detection of genes: yadA, virF, ail, yst, myfA, ymoA and ureC in 
genoinic DNA of all 55 tested clinical strains of Y. enteroculttira p W + .  These 
genes. excluding virF and yadA, were also detected in all tested isogenic, 
plasnlid cured strains. The irpI gene was not detected in any one of tested Y. 
enteroco/itica 0:3 strains but its presence was shown in tested Y.  
pseudotuberculosis and E. coli strains. The ymoA gene PCK product was 
also obtained for all control strains of genus Yersinia other than Y.  
enterocolitica. The ureC homologous DNA Wac detected in examined Y. 
kristenrenii strain. Only my@ gene was exclusively detected in Y .  
enfrrorulitica strains. Obtained results confirmed that genes: virF, yadA, ail, 
yst, myfA, ymoA and ureC are present together in genome of pathogenic 
Y.enterorolitica 0 : 3  strains. Among the novel Y. enterocolitica virulence 
markers tested, myfA gene seems to be most reliable, because other were 
also found in strains considered as nonpathogenic. 
/p596) Pulsed-field gel electrophoresis for food-related 
salmonellosis - results from an international workshop 
proposing standardization of methodology 
T. M. Peters, E. J. Threlfall 
Londun, CJK 
Salmonella entcrica remains second only to Campylobarter spp. as the most 
commonly isolated pathogen fiom cases of food-poisoning in humans in 
England and Wales. A total of 23 728 irolates were referred to the 
Laboratory of Eiiteric Pathogens (LEY) a t  the Central Public Health 
Laboratory, London in 1998 with a provisional figure of 17 251 irolates in 
1999. International trade in food animals and food products facilitates the 
spread of infectious strains that are now widely dismbuted throughout the 
world. Standardized serotyping and phage-typing methodologies remain5 
the principal means ofidentification and subtyping for S. enterica. However, 
the use of molecular typing for subdivlsion of serotypes and phage types is 
increasingly important for precise identification of salmonellas. A number of 
DNA-based methods are employed to supplement serotyping and phage 
typing. These include nbotyping, insertion sequence (IS) 200 fingerprinting 
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and macrorestriction fingerprinting based on pulsed-field gel electrophoresis 
(PFGE). A standardised methodology for DNA fingerpnnting will allow 
rapid comparison of the Salmonella subtypes responsible for international 
food-related outbreaks between laboratories in the European Union (EU). 
PFGE is currently the ‘gold standard’ for the molecular subtyping of 
salmonellas but extensive variation in methodology exists between EU 
laboratories. Enter-net is an international surveillance network for human 
gastrointestinal infections with S. enterica and Vera cytotoxin-producing 
Escherichia roli (VTEC) involving all E U  countries plus Switzerland and 
Norway. Six Enter-net member countries were invited to participate in an 
International Workshop with the aim of harmonizing PFGE protocols. We 
have, for the first time, a standardised PFGE protocol for the molecular 
subdivision of S. enterica that takes into account differences between Enter- 
net laboratories. The new protocol is rapid and reproducible, entailing a 2-h 
lysis stage followed by a system of hot washes prior to resmction digestion. 
The methodology has been applied in selected laboratories within the 
Enter-net group, using a panel of isolates representing serotypes and phage 
types of epidemiological importance. Electronic transmission of gel images 
between centres uses the tag image f ie  format (TIFF) to facilitate rapid 
exchange of results, and has already proved invaluable in the investigation of 
an international outbreak of multiresistant S .  typhimurium 204b. 
Brucellosis 
v1 Optimized RT-PCR procedure for detection and typing 
of calicivirus in clinical specimens 
N. P. Nenonen, S. Olofsson, T. Bergstrom 
Gothenburg, S 
Establishment of a one-step reverse transcriptase polymerase (RT-PCR) test 
system for the detection of Calicivirus R N A  in specimens of stool is 
described. Results obtained from the use of different primer pairs in the 
Calicivinis RT-PCK correlated well with those obtained from parallel 
hybridization and sequencing qtudies. The one step RT-PCR described 
facilitated the routine laboratory diagnosis of calicivirus infection implicated 
in hospital and community outbreaks of winter vomiting disease. As well as 
providing a relatively rapid diagnostic tool for the detection of cahcimrus in 
the stools of infected patients, the method was found to allow preliminary 
identification of the viral subtypes implicated in different outbreaks. The 
importance of a reliable viral R N A  extraction method for ease in handling 
samples of faeces and vomit must also be considered; Boom’s silica 
extraction method using the Organon Teknika, NucliSens Extractor proved 
to be the method of choice. Results are presented correlating the RT-PCR, 
hybridization and phylogeny studies obtained from a 3-year penod of 
monitoring outbreaks associated with Calicivirus infection in hospital and 
local communities. 
1 P q  Human brucellosis in Calcutta, India 
S. Das 
Calrurta, IND 
Brurella abortus was isolated from the blood of 38 patients who were suffering 
from long, continued fever and who were not cured by any conventional 
therapy at Calcutta. After analysis of the data it was found that on an 
average 34% patients of this group at ths  Centre in Calcutta were found 
suffering from brucellosis and all of them were cured after treatment of 
brucellosis. Many patients who had been cured in this category were 
moribund. The diagnosis was based both on serological test and culture. 
Another interesting and new finding is that all of these patients showed 
positive aldehyde tests. After analysis of the available data in this study it 
can be safely concluded that this simple aldehyde test caii be used as a 
screening test for brucellosis in human beings. One case in this series was 
diagnosed as Brucefla liver abscess in which Br. abovtus was isolated from the 
aspirated pus. Cytological examination revealed plenty plasma cells 
intermingled with pus cells which also appears to be a new finding. We 
are now looking for possible sources of this infection and our initial 
observation revealed intake of contaminated raw milk may be the possible 
source of infection. 
Prevalence rate of human brucellosis in Yazd, Iran 
(1993-98) 
G. Hassanpour 
Tehran, IR 
Bntrella infections have a world wide dstribution, more then 500 000 
documented cases are reported annually. In this study 792 patients with 
brucellosis that referred to the Yazd health services centers were investigated 
(1993-98). The results were obtained as follows. Frequency distribution of 
human brucellosis on the basis of year was 114 cases (14.4%) in 1993, 49 
(6.2%) in 1994, 69 (8.7%) In 1995, 234 (29.5%) in 1996, 258 (32.6%) in 
1997 and 68 (8.6%) in 1998. Frequency distribution ofhuman brucellosis on 
the basis of age were &4 years 17 cases (2.2%~)~ 5-9 years 70 (8.8%), 10-14 
years 106 (13.3%), 15-19 years 112 (14.1%), 20-24 years 73 (9.3%), 25-29 
years 69 (8.7%), 30-34 years 63 (7.Y%), 35-39 years 68 (8.5%), 40-44 years 
52 (6.6%), 45-49 years 43 (5.4%), 50-54 years 39 (5.1%) and >55 years 80 
(10.1%). Frequency distribution of human brucellosis on the basis of sex was 
455 cases (57.4%) men and 337 cases (42.6%) women. 
1 P600 1 Prevalence of human brucellosis among animal 
farmers in the Yazd province 
M. Salan 
Tehran, IR 
In this study 933 specimens of animal husbandmen by serological and blood 
culture methods were investigated. Frequency distribution of animal 
husbandmen with brucellosis on the basis of sex were 25 (3.1%) men and 
10 (8.1%) women. The highest prevalence of human brucellosis was among 
of age group 21-30 years. Clinical symptoms of disease were fever (77.2%). 
chill (60%), night sweats (65.7%), weakness (51 -4%). myalgia (31.4%). 
arthralgia (48.6%), boneache (37.1%), backache (8.6%) and headache (40%). 
Fever was highest prevalence of clinical rymptom of disrdse among patients. 
The results of blood culture and serological tests were obtained as follow: 
Rose bengal plate (RBPT) Positive was 37 c a m  (4%),Standard tube 
agglutination test (STA) positive 35 cases (3.8%), 2-mercaptoethanol test 
(2ME) Positve 5 (0.5%) and total blood culture was negative. 
rp6011 A study of secreted cytokine profile in human 
brucellosis 
T. D. Chugh, H. Nusrat, A. S. Mustafa 
Kuiuait, KWT 
Brucellosis is a zoonotic infectious disease that often becomes chronic in 
humans with a high rate of recurrence. Kuwait is an endemic country for 
this disease. Brucellae are facultative intracellular bacteria that mainly invade 
and survive in the reticuloendothelial system. Protective inmiunity against 
mtracellular pathogens depends upon the interplay between different T cell 
subsets and cytokines. It has been shown in a munne niodel that the 
acquired protective immunity to Bvucellae depends on cell-mediated 
immunity (CMI) and involves T cell-dependent activation of macrophages. 
Both T cells and macrophages produce cytokines that affect CMI and 
therefore, the cytokines produced by these cell types are likely to have 
function in protection or pathogenesis of human brucellosis. In this study, 
sera and culture supernatants obtained after in virrr, stimulation of peripheral 
blood mononuclear cells (PBMC) from brucellosis patients and healthy 
controls were studied for secreted cytokine levels. To obtain culture 
supernatants, PBMC were stimulated with a nonspecific mitogen ConA and 
specific antigens BCG and Brucella. All the samples were tested by ELSA 
for a panel of cytokines produced by T cells and/or macrophages, i.e. IL-2. 
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IL-4, IL-5, IL-6, IL-10, IL-12, IFN-y and TNF-a. The overall results 
showed that IFN-y was specifically elevated in the sera as well as culture 
supematants of Brurella antigen-stimulate PBMC from brucellosis patients. 
These results suggest that, although, the macrophage activating and 
protective cytokine IFN-y is produced, the macrophage activating function 
of IFN-y a to kill and clear the Brucella infection is somehow defective in 
brucellosis patients. 
I P602 1 Brucellosis in Lebanon 
A. A. Tohnie, B. Hammoud, M. El-Rassi 
Beirut, RL 
Objectives: T o  present epidemiological and clinical features of brucellosis in 
Lebanon. 
Methods: Sixty-three patients were seen at H6tel-Dieu de France Hospital 
of Beirut between 1994 and 1998. Diagnostic criteria were febrile 
agglutinins at titer > 1/160 with symptoms suggestive of brucellosis in 
the absence of other diagnosis. W e  also present an epidemiological study of 
1137 cases registered by the Ministry of Health during the same period. 
Results: Among the 1137 cases, 40% of patients'ages were more than 60 
years and only 16% were less than 14 years. The overall male to feniale ratio 
was 1.01. The disease predominate in springs and summers (69%). Among 
the 63 patients, 10 pediatric cases were noted. Brucellosis was acute in 41 
(65%), subacute in 21 (33%) and chronic in 1. The main presenting 
symptonlr were fever, sweating, easy fatigability and joint pain.No 
significant difference were noted in clinical features presentation and 
complication related to sex or between adults and children. Osteoarticular 
involvement was the most prevalent complication (68%) and rpondylitis was 
the most frequent with a special localisation to the lumbar spine. 
Neurological complications were noted seen in 13,h% of patients. Among 
the haeniatologcal tests, relative lymphocytosis was significantly more 
fkequent in children than adults (80% us. 13%; P < 0.001). Treatment with 
a combination of either tetracyclines-rifampicine or trimethoprim-sulfa- 
methoxazole-rifanipicine resulted in an excellent cure rate and resolution of 
symptoms without sequelae or mortality. Surgcal treatment was needed in 4 
cases: Aortic valve replacement for endocarditis in one case, drainage of 
paravertebral abscess with spondylitis in 2 cases and also of a subcutaneous 
abscess in one case. 
Conclusion: Brucellosis is still an endemic disease in Lebanon and should be 
considered especially in the differential diagnosis of prolonged fever, 
articular and neurological manifestations. 
Ip6031 Ventriculoperitoneal shunt infection and 
subcutaneous abscess due to Brucella abortus: a case report 
0. Tansel, F. Akata, N. Shokry, H. Gezici, M. Otkun 
Ediriie, TR 
A 60-year-old woman was hospitalized with the diagnosis of subarachnoidal 
hemorrhage. O n  the seventh day of hospitalization, abdominal distention 
and tenderness developed so explorative laparotoniy was planned and 
appendectoniy and bridectoniy was performed. She was operated on the 
22nd day of hospitalization for aneurysm. Three months after the operation 
hydrocephalus was diagnosed and ventnculoperitoneal (VP) shunt was 
perfomied. The patient was re-admitted to the hospital one year later 
beacuse she had abdominal pain, nausea, abdominal tenderness and 
constipation. Bridectoniy was performed during an emergency explorative 
laparotomy. O n  the tenth day of the operation, alteration of consciousness, 
suspected neck stiffness, nausea, vonliting, high fever and purulent drainage 
from the abdominal incision site was observed. Abdominal tenderness and 
positive defence were detected. A subcutaneous abscess was found by 
Iaparotoiny and was drained. Bruceita abortus was cultured from this abscess, 
blood and the cerebrospinal fluid (CSF) taken from the end of W shunt 
during the operation. Standard tube agglutination test for brucelln (STA) was 
positive at 1 :320 dilution in serum. CSF analysis taken by lumbar punction 
revealed 100 cells/nm', predonlinandy lymphocytic in character, protein 
30 mg/dL, glucose 48 mg/dL (blood glucose level: 143 mg/dL), but culture 
and STA were negative. Triple-therapy consisting of trimethoprim/ 
sulfamethoxazole, doxycycline and rifampin was initiated for subcutaneous 
abscess and VP shunt infection due to B .  abortus. At the third week of the 
therapy, B. aboriirs was isolated from CSF taken from shunt reservoir also, 
but blood culture was negative. In conclusion, Brucellosis is a systemic 
infection that can affect many organs and tissues. In this case, it has probably 
inlitated acute abdomen by gastrointestinal symptoms like nausea, 
abdominal pain and constipation, and the etiologic agent, B. abortus, has 
caused subcutaneous abscess a t  the incision site and VP shunt infection. The 
diagnosis could only be made by the isolation of B. abortus from abscess, 
CSF from W shunt and blood at these rarely seen infection sites. 
1p6o4l Bone marrow hypoplasia during Brucella infection 
Y. Yildirmak, A. Palanduz, L. Telhan, M. Arapoglu, N .  Kayaalp 
Istanbuel, TR 
Pancytopenia, although mainly reported in adults, has also been described in 
children dunng the course of brucellosis. However bone niarrow hypoplasia 
is a rare feature of the infection. An 1 1-year-old boy was admitted with the 
complaints of fever, vomiting and abdominal pain of 10 days duration. By 
physical examination, pallor and high fever was detected in the absence of 
lymphadenopathy and hepatosplenomegaly. His hemoglobin was 8.6 g/dL, 
white blood cell 11 00/mni3, neutrophil 500/mm3, platelet 56 O O O / m z ,  
reticulocyte 0.1%. Hypocellular bone marrow was found by aspiration, and 
bone marrow biopsy revealed hypocellularity. Brucrlla agglutination titer 
was greater than I /640. He was started on trimethopnm/sulfamethoxazole 
and amikacin. His fever subsided at the fifth day and pancytopenia improved 
subsequently. In conclusion, pancytopenia associated with brucellosis is 
attributed to hypersplenism, hemophagocytosis and granulomatous lesions 
of bone mamow which is usually hypercellular. Bone niarrow hypoplasia is 
rarely reported and should be kept in mind in the etiology ofaplastic anemia 
in a country where brucellosis is frequently encountered. 
1p6051 Brucellar spondylodiscitis in Cukurova, Turkey 
Y. Tasova, N. Saltoglu, A. S. Inal, T. Seki, I .  H.  Dundar 
Adana, TR 
Objective: To evaluate features of Brucellar spondylodisciitis cases at Cukurova 
region of Turkey. 
Methods: Twenty-two patients with Brucellar spodyludisn'itis followed 
between January 1995 and July 2000, were evaluated. The initial evaluation 
included a complete blood count, erythrocyte sedimentation rate (ESK), 
biochemical profile, chest radiograph, urinalysip. All patients were 
performed tuberculin test. Diagnosis of spondylodisciitis was made by 
following cnteria: (a) history of exposure to dairy animals or ingestion of 
raw dairy products. (b) clinical evidences of the disease (c) bruceella 
agglutination titer more than 1/80 (d) radiographic findings by plain 
radiograph and C T  or M R I  Tc99m bone scanning. AU patients were 
followed a t  least 6 months after ti-eatment. 
Results: O f  22 patients 8 were male (36.4%) and 14 were feniale (63.6%). 
Mean age was 56.5 f 12.2. The duration of the clinical picture from the 
onset of symptoms to diagnosis were more than 29 days in 15 patients 
(68.2%). The most frequent consntutional complaints were arthralgia 
(100%), fever (81.8%), night sweating (54.5%), fatigue (50.0%). Physical 
findings were determined as follows: tenderness on affected vertebrate 
(81.8%), hepatomegaly (22.7%), splenomegaly (9.1%), arthritis (9.1%), and 
lymphadenopathy (4.5%). Abnormal laboratory findings were elevated ESR 
(>20mm/h;81.8%),AST(>4OIU/mL,31.8%), ALT(>40IU/mL,27.3%)), 
ALP (>305 IU/mL; 13.6%). Serum agglutmation test were detemlined higher 
than 1/640 in 15 patients (68.2%)). In 15 pahents (68.2%) involvement was 
limited to only one or two vertebrae. Lumbar vertebrae were the most afXected 
region (n: 17, 77.3%) followed by thoracal spine (n: 5, 22.7). 
Conclusion: In our region, Brurellar spundyelitis was seen among elderly and 
interestingly feniale individuals. Thus, in elderly diagnosed as brucellosir, 
scintigraphy and/or CT or M R I  should be used to determine whether the 
patient had spine involvement. 
1 P6061 Demographic and laboratory findings in patients with 
brucellosis infection 
N. Saltoglu, Y. Tasova, S. Inal, T. Seh,  H. S. Z .  Akw 
Adana, TR 
Objectives: There are 164 patients with brucellosis are treated in our c h i c  
between January 1994 and July 2000. In this study we intended to 
demonstrate the differences between two groups of rifampisin + 
doxycycline and rifanipin + quinolone. 
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Methods: There are 81 (49%) males, and 93 females and mean age IS 40 1 
(15-70) in both groups Doxycychne 2 x 100 mg/day + nfampni 2 x 300 
mg/day or quinolone (ciprofloxacine 2 x 500mg/day or oflavacine 2 x 
400 mg/day) + nfampisin 2 x 300 mg/day were gwen to the patients for 6 
weeks Patients ulth Bvucella spondihtu were treated for 3 months 
Results: Patients data of both groups are gven in the Table 1 
Conclusion: Patients are followed 6 months after the treatment. There is no 
significant differences of effectiveness and relapse rate between two groups. 
(p6071 Complication rate and significance of serum C-reactive 
protein levels in brucellosis cases 
M. A. Yetkin, F. S. Erdinc, M. A. Cevik, A. A. Tumturk, N. Tulek 
Aitkara, TR 
Introduction: Brucellosis is endemic in Turkey. It is a multisystem disease 
that may present with a broad spectrum of clinical manifestations and 
complications. The object of this study was to determine the existence and 
type of complications in the brucellosis cases diagnosed in our clinic. We 
also aimed to investigate the significance of C-reactive protein (CRP) (as an 
acute phase reactant) serum levels in complicated brucellosis cases. 
Methods: Eighty-two patients diagnosed as brucellosis in our clinic between 
August 1998 and October 2000 were reviewed retrospectively. The 
diagnosis of the cases was based on serological and/or blood culture 
positivity. Duration of complaints (less than three months and longer), 
physical examination and laboratory findings (including serum C R P  and 
ALT levels, relevant ramological tests) were evaluated to investigate the 
existence of coniplications. CRP assay was performed by nephslometric 
method and quantitatively. 
Results: The mean age of the patients was 43.6 18.2. The male and 
female ratios were 48.8% (40/82) and 51.2% (42/82), respectively. F o q -  
seven patients (57.3%) had a focal or complicated illness. Osteoarticular 
complications were the most frequent focal forms, being present in 25 cases, 
representing 30.5% of aU patients and 53.2% of the complicated cases. Of 
those 25 cases, 16 had spondilitis (four with adjacent abscess), 6 had 
sacroileitis and 3 had monoarthritis. There was a statistically significant 
difference between the mean CRP serum levels of complicated and 
noncomplicated patients (P' 0.002). However, serum C R P  levels of the 
patients with osteoanicular involvement when compared with the others, 
there was not a statistically significant difference between them. Elevated 
ALT levels due to brucellosis were detected in 20.7% of patients (17/82). 
That was the second most frequent complication detected. The other 
complications were neurobrucellosis, orchitis, endocarditis and uveitis. 
Higher complication rates was found in the patients with history of 
complaints less than three months (P' 0.035). 
Conclusion: Brucellosis is a disease which may present with various 
complications. Detection ofhigh serum CRP level may be a good indicator 
of existing complication. 
lp6081 Detection of Brucella spp. by using BACT/ALERT 
automated system vs. brucella broth culture 
Z. Ozkurt, S. Erol, M. A. Tasyaran, A. Kaya 
Erzurum, Mersin, TR 
The data obtained &om modem blood culture systems for detection of 
Bnrceila spp, are insuscient. In this study, we aimed to compare the 
sensitivity of BACT/ALERT blood culture system and traditional hrucellu 
broth medium for detection of Brucella spp. The study was prospectively 
carried out in 50 patients thought brucellosis, that they were hospitalized in 
our clinic. The blood and bone marrow samples were obtained from each 
patient. Five ml of blood and 4 mL of bone marrow samples were 
inoculated into BACT/ALLERT bottles and incubated for 7-day protocol. 
At the end of 7 days, the cultures which were still negative incubated again 
for 2 weeks and so subcultures have been obtained. Also 5 mL of blood and 
2 mL of bone marrow samples were inoculated into brucelh broth medium 
and incubated at 37 C for 4 weeks. Growth time of brucella was 
aproximately 4.5 days (range: 32 h-16 days) in BACTIALERT and 5 days 
(range: 2-14 days) in brucella broth. There was no significant difference 
between BACT/ALERT and brucella broth with respect to growth time of 
the microorganism ( P  3. 0.05). When BACT/ALERT system was used, 30 
of 100 blood or hone marrow cultures were positive However when 
brucelln broth medium method was used, 59 of 100 cultures were positive ( P  
< 0.05). This result suggest that brucella broth medium is more sensitive 
than BACT/ALERT for detection of Bnrcella spp. But even if the BACT/ 
ALERT system is used, it is mandatory to subculture all negative bottles to 
maximize detection of the microorganism. 
/p609] Hepatosplenic abcess caused by Brucella melitensis: 
resolution with levofloxacin-containing combination 
T. Yildirmak, F. Yiiksel, N. Iris, G. Cetmeli 
Istanbul, TR 
Brucella is asystemic mfection that can affect many organs. The complicated 
manifestations of brucellosis have special problems and the dtagnosis may be 
easily missed. There is no uniformity of opinion regarding the drug of 
choice and the duration of treatment. We report the case of 50-year-old 
male admitted to the hospital because of fever, malaise and weakness for 4 
weeks of duration. We obtained a history of ingestion of unpasteurized n d k  
product at 8 weeks before admission. Laboratory finding included the 
following values: Hemoglobin, 8.5 mg/dL; hematocrit, 26%; leukocytes, 
1800/nm3; platelets, 52 000/m3.The  serum alanine aminotransferase was 
352 IU/L, and serum aspartate amino transferase 633 IU/L. On the third 
day of admission, the serum brucella agglutinin titer of 1/640 was found. At 
this time Brucella mefitensis was isolated from hemocultures (fifth day). The 
patient was treated initially by doxycycline (200 mg/day, orally) plus 
rifampin (600 nig per day, orally) plus streptomycin (1 g per day, 
intramuscularly). After 15 day course of therapy, because of persistent fever 
and presence of multiple hepatosplenic abscess (the biggest one measuring 
21 x 13 mm in size) identified by ultrasonography and computerized 
tomography of abdomen, levofloxacin (500 mg/day, included 12 days of 
intravenous therapy) was added to the regimen. Doxycycline plus rifainpin 
plus levofloksasin therapy continued for 6 weeks. The fever and 
pancytopenia improved and all abscess showed complete resolution. After 
45 days he was discharged. 6 months later the patient is completely healthy 
and there is no sign and symptoms of relapse 
(p610 Brucellosis in Eastern Turkey 
F. Ergun 
Van, TR 
Retrospectively 73 patients with brucellosis was evaluated. Their mean age 
was 28.5 (range 11-70), 35 were female and 38 male. The diagnosis of 
brucellosis was based on consistent clinical findings and a Wright's serum 
agglutination titer of 1/160 or  greater. The symptoms of patient were: 
arthralgia (79.4%) sweating (76.7%), fewer (65.7%), stomach ache and lack 
of appetite (34.2%). Localized complications were arthritis and joint 
effusions (8.2%), urinary infection (8.2%), sacroileitis-discitis (6.8%), 
enlargement of spleen (6.8%). enlargement of liver (5.4%) and orchitis 
(2.7%). Four different drug regiment was used. Regimen A: IM 
Streptomycin 21 days (1 g per day) plus oral Rifampicin 45 days (600 mg 
per day) used in 34 patients. Regimen B: IM streptomycin 21 days plus oral 
Doxycycline 45 days (200 mg per day) used in 31 patients. Regimen C: IV 
Cefiriaxon 10 days (2 g per day) plus oral Doxycycline 45 days plus oral 
Trimethoprim-Sulphamethoxazole 45 days (1600 rng per day) used in 4 
patients, Regimen D: IM Streptomycin 14 days (1 g per day) plus oral 
Doxycycline 45 days plus oral Trimethoprim-Sulphamethoxazole 45 days 
used in 4 patients. Disappearing of fewer and the other non specific 
symptoms in regimen A (mean 3.2 days) was faster than regimen B (mean 
5.1 days). In regimen A 2 patients was relapsed although no relapses in 
group B. As a result Regmen B was found more effective than regimen A. 
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Regimen C and D is used only patients with chronic brucellosis and 
localised osteoarticular complications. In this group totally 8 of patients was 
fully recovered and no relapses occurred. The use of combination therapy in 
this group of patient may be the alternative therapy but some widely studies 
have to be done. 
Fl Detection of brucella lgG, IgM and IgA antibodies with 
ELISA method in patients with brucellosis 
A. Kostoula, H .  Bobogianni, G. Vrioni, A. Dea, P. Paraschou, S 
Levidiotou-Stefanou 
loannina, GR 
Objectives: Brucellosis renlains a common infectious disease in many parts 
of the world, notably in Mediteranean countries and the Middle East. 
Because syniptoms are usually nonspecific and blood cultures are often 
unsuccessful, especialiy in chronic brucellosis, most patients are diagnosed 
by the demonstration of serum antibodies. Wright and Rose Bengal 
agglutination tests are the most used serological procedures worldwide for 
the diagnosis of brucellosis. The aim of our study was the detection of 
Brrrc~llu specific I&, IgM and IgA antibodies by ELISA method and the 
comparisoii of these results with those from conventional serological tests: 
Wright and Rose Bengal agglutination tests. 
Methods: We studied 383 seruni specimens from patients with suspicion of 
clinical brucellosis suspicion and 100 serum specimens from healthy 
individuals as control group with ELISA Bmcella comniercial kit provided 
by SERION Co. These sera were also tested w-ith Wright and Rose Bengal 
tests. All the patients were tested a second time, 15 days later. 
Results: From 383 tested samples with ELISA, 156 were found positive and 
227 negative. In 156 serum specimens positive for Brucella antibodies, 98 
had IgM antibodies, 143 IgG antibodies and 104 IgA antibodies. From 156 
ELISA positive specimens, 155 were positive with Rose Bengal test and 141 
with Wright test, of which 24 showed the prozone pheiionienon. From 100 
control specimens, 5 were positive in Wright test and none with Rose 
Bengal and ELISA methods. In 17 patients with positive blood culture for 
Bnrcellu melitensis, all had positive ELISA, 16 Rose Bengal and 12 Wright 
agglutination tests. All the patients with positive ELISA (156) have received 
therapy for brucellosis. 
Conclusion: ELISA appears to be more sensitive than conventional tests for 
the diagnosis of human brucellosis, because this method detects specific IgG, 
IgM and IgA antibodies. Thus, for the diagnosis of brucelloris, Wright and 
Rose Bengal tests should be done simultaneously, but brucellosis should 
not be excluded kom differential diagnosis without the perfonnance of 
ELISA assay. 
Brucellosis and osteoarticular involvment 
A. Zacharof, C. Petrogiannopoulos, M. Mouroutsou, E. Vartzioti, K 
Gourgouli, L. Kondili, K. Mpethimouti 
Atkefis, GR 
Objectives: We try to detect the rate and types of osteoarticular 
involvement of Brucellosis in hospitalized patients in our department. 
Methods: We review the clinical, laboratory, and imagmg data from 398 
hospitaliscd pahents between the years 1985-99 with Brucellosis and 
osteoarticular iiivolvement. The diagnosis of brucellosis was exablished on 
positive blood cultures or in B. tnelirensir infection with bone marrow 
culture and/or characteristic clinical findings of brucellosis. We use standard 
tube agglut~iiation test measuring antibody to B. uhorlus antigen. A fourfold 
or greater rise in titer (1 : 160 or higher) is consider significant. 
Osteoarticular involvement was confirmed if one or more X-rays films of 
joint/bone disclosed consistent findings. 
Results: Among the 398 patients 60 (15.1%) had osteoarticular involvement 
(mean age 53 8 years, 65% were females). Body temperature was elevated 
above 38 "C in 355 (89%) patients. The constitutional symptoms in our 
patients were easy fatigability, intermittent fever especially at night, 
headache, malaise, night sweats and arthralgias. The most frequent physical 
sings were cervical and axdlary lymphadenopathy, hepatomegaly and 
splenomegaly. The source of infection was not identified in 16 patients 
(4%). The types and rates of osteoarticular (bone and/orjoint) lesions in our 
patients involve: sacroilitis (62%, 55% of them were bilateral), peripheral 
arthritis (25%, 83.7% of them were suppurative monoarthritis), spondylitis 
(8%, five patients have cervical and the rest of them had osteoarticular 
lesions in the lumbar region). Erythrocyte sedimentation rate were above 35 
nim/h. in 214 (54%) cases. The median age of the patients with spondylitis 
was 48 f 7 years and 32 & 6 years in the other osteoarticular locations. 
Combination drugs regimen in cases without spondylitis was given 
doxycycline or ciprofloxin plus rifampiii or tetracycline plus streptomcin 
for 6 weeks. All the cases with spondylitis taken cotrimoxazole at high doses 
plus doxycline plus rifampin over periods of 4 months. Relapses in our series 
occur only in 8 pts. (2%). 
Conclusions: Brucellosis should be taken into consideration when 
osteoarticular manifestation and fever occur. 
Hemophagocytic syndrome in brucellosis 
C. Michailidis, G. Adamis, E. Psaras, E. Giannikoc, D. Mpogiatzis, P. 
Tsouroulas, P. Gargahanos 
Athens, GR 
Human brucellosis, a well known zoonotic disease, IS a significant public 
problem in Greece, mainly with the predominence of Brucella melitensis 
species. It is also well known that the manifestations at the time of 
presentation vary a lot. Here we describe a case of Brucellosis with 
phagocytic syndrome. A 28-year-old man, who worked in a slaughter- 
house, was admitted to our hocpital with fever, fatigue and myalgias. A full 
blood count performed in another hospital revealed pancytopenia. He gave 
no history of any h e s s  in the past and he was not on any medications. O n  
physical examination he was found to have moderate hepatomegaly. The 
laboratory results on admission were as follow: WBC 3600/mm3 
(neutrophils 43%, lynipocytes 51%, monocytes 6%), Hb 9.3 g/dL, platelets 
60 OOO/mmi, reticulocyte count 1.2%, ESR 18 m / h ,  C R P  102.2 nig/L, 
SGOT 104 IU/L, SGPT 421 U/L, LDH 1180 IU/L, total bilirubin 2.10 
mg%, direct barubin 0.5 nig%, INK 1.56. A bone niarrow aspiration 
revealed histiocyte-like phagocytes (5% of bone marrow cells) with 
hemophagocytes mainly red blood cells and erythroblasts (hemophagocytic 
syndrome). The thrd day after patient's adrmssion, a positive blood culture 
and a positive bone marrow culture for Bmcella melitemis, established the 
diagnosis. Serological tests were also positive: Wright Coombs 1/640. The 
patient received dolcycyclin 200 mg per day along with rifampicin 900 mg 
per day for an overall 60-day period with complete resolution of syniptoms. 
Thirty days after the onset of therapy a full blood count was normal. 
Hemophagocytic syndrome is rarely related with Brucellosis and this 
illustrates that unusual clinical features and complications of that disease, 
might sometimes lead to diagnostic difficulties. 
[p6141 Acute brucellosis: a retrospective analysis of 44 cases 
during 1999 
M. Kalkani, P. I .  Andriopoulos, M. Dionisopoulou, E. Kalkani, M. 
Kafentzi, A. Vounassis 
Sparta, GR 
Objectives: To describe and analyze the clinical features, the diagnostic 
procedures and treatment of patients with acute brucellosis during the year 
1999 in a relative small area of Greece, Sparta Laconia. 
Methods: 44 patients hospitalized in the pediatrics, urology and internal 
medicine departments were reviewed. Occupational data, clinical symp- 
toms, magnostic methods and treatment were analyzed for the year 1999. 
Results: 27 men and 17 women of all ages were recorded. The mean 
duration of hospitalization was seven days. 68% had occupational association 
with animals. A variety of clinical symptoms was presented: all the patient 
had fever (altered with antipyretics), 43% had splenomegaly, 14% 
hepatosplenomegaly, 27% low back pain, 14% of the men orcheoepidy- 
dymitis, 41 % arthalgias, and 9% hematological disorders including anemia 
and thrombocytopenia. All of the patients had positive Wright agglutination 
test but in an endemic area like Laconia a titer like l/lhO cannot be 
diagnostic by itself and blood cultures were also assessed: 84% had positive 
cultures for Brucella sp. (with the mini-Vitek system of bioMerieux), but also 
4 patients (11%) had titers not higher than 1/80 and positive cultures. The 
patients were treated with streptomycin plus doxyxrxline for at least 6 
weeks with the addition of rifabycin for the pedlatric patients. 
Conclusions: Brucellosis remains a inajor public health problem in Laconia 
and also the whoIe Greece, especially in endemic regions. The prevention 
of the disease by animal testing and education of high risk populations is far 
beyond optimal. 
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[p6151 Brucellosis in Kichevo, Macedonia during the period 
1991-2000 
I. Z .  Mehmedi, G. R. Mehmeti, R. M. Mehmedi 
Kiclievo, Skopje, MAK 
Introduction: Brucellosis remain a major zoonosis worldwide. Consunip- 
tion of contaminated foods and occupational contact remain the major source 
of infection. Sheep and goat and their products remain the main source. 
Objective: The presentation of the epidemically and chnical characteristics. 
Methods: The material is collected &om the department of Infective diseases. 
In the last 10 years there were 67 cases registered with human Brucellosis. The 
diagnosis of human Brucellosis was based on the clinical features of the disease 
and serological testes (the standard tube Bnrrella agglutination test-STA). 
Results: In the above-mentioned period in the department for infective 
diseases were registered 67 caqes with Brucellosis, 14 at which are female 
and 53 male. The average age was 41 & 30 years. According to the place of 
residence, 56 (83.58%) lived in rural areas. In our environment, 64 (95.53%) 
persons lives on cattle-breeding and manufactured of products. According 
to the questionnaire, 34.3% of the patients were infected in direct contact 
with diseased animals and their products. Brucellosis in the municipal of 
Kichevo, is a seasonal disease. Lowest morbidity is registered in the month 
December (2.9%), highest in the month ofJune (16.7%)) and July (17.9%). 
In the municipal of Kichevo, similarly as in other municipals in 
Macedonian, children aged 0-9 are most rarely infected by the disease 
(2.9%), while the most people infected are aged 20-49 (58.2%). High 
morbidity rate was reported among people aged 50 or more (29.85%) which 
was not the case in other countries. The group aged 10-20 is 14.92% 
infected. These dates speak of the professional character of the Brucellosis 
infection. The most &equent features in the patients disease of acute 
Brucellosis are: fever 47 (70.14%); joints pain (mostly in the spine and in the 
hips) 54 (80.59%); sweat 46 (68.65%); loss ofappetite 31 (46.27%); headache 
35 (52.24%); hepatosplenomrgaha 8 (11.66%). 
Conclusion: The most infected people are the ones in the following 
professions: shepherds, goat keepers and the people in touch with them. 
The most frequent features in the patient? disease of a Brucellosis are: joint 
pain (80.59%), fever (70.14%), sweat (68.65%). Children aged C-9 are moct 
rarely infected by the disease (2.9%), whde the most frequently infected 
people are age 20-49 (58.2%). 
Osteoarticular involvement of human brucellosis in 
childhood 
E. D. Dimitrovska 
Bifula, MAK 
Introduction: Since 1980 brucellosis in Macedonia has been present as an 
endemic and epidemic infectious disease among the cattle and people. 
Objectives: The aim of this paper is to present the osteoarticular involvment 
of human brucellosis in childhood in our town and surrounding villages 
between 1980 and 1999. 
Methods: This paper is a retrospective study of patients younger than 14 
years with human brucellosis and with predominant damages of 
osteoarticular system. 
Results: We have been analyzed a group of 49 chlldren at the age between 3 
and 14 years. 19 patients were living in Bitola and 30 were &om the villages 
around Bitola. 31 patients were male and the rest were female. Predominant 
symptoms were fever (loo%), sweating (85%), malaise (80%). Osteoarticular 
symptoms were evident in 64% manifested with pain, limited mobility, 
h o s t  immobility, with or  without swollen joints. In 67% the bigjoints of 
the lower limbs were involved, in 29% the joints of the upper limbs, and in 
4% spinal and pelvic joints. Monarticular form was present in 41% 
poliarticular in 59% of the total number of children. Swollen joints were 
present in 16% of the children. Artralgia was present in al l  of the children, 
whereas complete immobility in 12%. The diagnosis was confirmed with 
serological findings (Rose-Bengal, Wright, Coombs, RVK Bnrcellae, ELISA), 
by radiological imaging, bone-scanning and CTM. The treatment lasted 
between 30 and 42 days; Streptomycin and Cotrimoxasol, Rifanipicyn and 
Cotrimoxasol were used and also Doxicyclyne was used in the treatment of 
children over 8 years. The overall relapse rate was 6.3%, whereas sequel was 
registered only in one of the children manifested as aseptic necrosis. 
Conclusions: Human brucellosis is significant health and social-economic 
problem in Macedonia especially among the children. Human brucellosis is 
presented with a broad spectrum of clinical manifestations. Osteoarticular 
involvement is one of the kequent clinical manifestations in childhood. It is 
very important to organize more serious education and very severe sanitary 
and veterinary control of the cattle, meat, n d k  and dairy products in order 
to eradicate the disease. 
Familial brucellosis in immigrants in Denmark 
B. Bruun, N. Hsjlyng 
Copenhasen, Roskilde, DK 
Objective: Brucellosis is a rarely seen disease in Denmark with an incidence 
ofabout one case per year during the last 10 years. We describe an outbreak 
of brucellosis occurring in a Turkish immigrant family. 
Results: Two cases of brucellosis in a 50-year-old woman and her 19-year- 
old pregnant daughter-in-law occurred withn 1 year. I n  neither case was 
there an initial suspicion ofbrucellosis. Both casec were diagnosed by blood 
cultures taken because of fever of unknown ongin, in the case of the 50- 
year-old during her third hospitalization for fever and abdonunal pain. The 
pregnancy of the 19-year-old ended with a febrile abortion be-fore the 
diagnosis was made. The elder woman had visited Turkey prior to the 
illness and eaten goat-and sheep milk products, while the younger woman 
had not travelled, but eaten milk products brought back by the family. Both 
isolates were identified as Brucellu abortus and both patients recovered 
uneventfully on gentamicin and doxycyline. 
Conclusions: Diagnosis of brucellosis in countries of northern Europe may 
be difficult and delayed, as awareness of the infection is low among 
physicians. A history of travel to endemic areas is not a prerequisite, as 
infection may be the result of ingestion of unpasteurized dairy products 
privately imported by patient contacts. 
I P618 I Clinical utility of dipstick assay in the diagnosis of 
human brucellosis 
M. Casao, H. S i ~ t s ,  J. Solera 
Albacete, E; Amsterdunr, N L  
Objective: A study of the dipstick assay for detection of BnrreUa specific IgM 
antibodies has been done in a group of 26 patients with different evolution 
of human brucellosis, to demonstrate the clinical uthty of the assay. 
Methodology: Patients admitted to the General Hospital of Albacete (Spain) 
over a two-year period, were included in the study; 20 were male and six 
female. The diagnosis of the disease was, isolation of Bnrcella nieliferrsis in 
seven blood cultures and in one sinovial fluid. The remaining cases, in 
which culture was negative, were diagnosed on the basis of serological 
criteria and characteristic clinical findings. The duration of symptoms before 
admission ranged &om three days to three years (median, 20 days). The 
following tests were performed for each serum sample: seroagglutination 
(SAT), dduothreitol (DTT) agglutination (DTT-SAT), Coombs test and 
dipstick test, according to the methods described in previous works. 
Results: The sensitivity of the hpstick at the moment of the diagnosis was 
simdar to SAT (6296, 73%, respectively, P=0.37),Iugher than DTT-SAT 
(46%, P= 0.26), although there was not statistical diEerence with dipstick, and 
lower than Coonibs test (10094, P=0.0004). Patients dipstick negative at the 
moment of diagnosis displayed a period of evolution of the disease longer than 
the dipstick positive patients. After the beginning of therapy, dipstick was the 
first test, which became neganve, with a positive recult for only 7% at 30 days of 
treatment. In contrast, SAT and DTT-SAT were still positive 30 days after the 
beginning of treamient in 46% of patients, and persisted positive even 3 months 
after the end of therapy in some patients (28%, 21%, respectively). 
Conclusions: Our  results confirm the dipstick assay as a new technique, 
which provides similar information to the classical serological test SAT at 
the moment of diagnosis, hut with the advantages to be easy to use and does 
not require specialised equipment; co it  could be an uceful clinical test. 
Though patients with a long period of evolution will probably present a 
negative dipstick, they could he diagnosed with the aid of Coombs test and 
clascical clinical findings. 
/p619/ Serological follow-up of brucella patients using an 
immunocapture-agglutination test (Brucellacapt), Coombs anti- 
Brucella and LPS-ELISA tests 
A. Prado, P. Gutierrez, A. Duenas, M. A. Miguel, L. Ruiz, M. A. 
Mantecon, M. A. Bratos, A. Orduna 
Valladolid, E 
1 10 Abstracts 
Introduction: We evaluated a new test for the diagnosis and follow-up of 
huinan brucellosis based on immunecapture-aggluunation technique 
(Brucellacapt) compared with seroagglutination test (SAT), Coombs anti- 
Brucella test and IgG, IgA, and IgM ELlSA against smooth hpopolysac- 
charide (S-LPS) &om Brircella melitensis 16 M. 
Materials and methods: We stumed 82 ulltial sera &om patients with a 
diagnosis of brucellosis and 277 follow-up sera horn 53 patients of 
brucellosis. Four hundred and twelve sera &om people living in rural areas 
with endemic brucellosis (Castilla y Leon, Spain) were included as a control 
group. Brucellacapt (Vircell, Santa Fe, Cranada, Spain), SAT, Coombs test 
(Linear Chemcals,Spam) aud IgG, IgA and IgM ELSA against S-LPS from 
Brucella melitensis were performed for each serum sample. S-LPS was 
obtained by phenol-water extraction technique (Redfeam method). All sera 
from the same patient were studied simultaneously. The curve results were 
expressed as a percent of variation of the logarithm of the inverse of the 
titers of evolution sera in relation to the titers of corresponding initial sera. 
Results: Ifa > 1/160 diagnostic threshold titer was defined for Brucellacapt, 
SAT, Coonibs tests, IgG ELISA, IgA ELSA and IgM ELISA, the seuitivities 
were 95.1, 65.8, 91.5, 92.6, 89.0 and 85.3%, respectively. For the 412 control 
sera the specificities were 99.0, 100, 99.8, 97.8, 100 and 10096, respectively. 
The antibody titers of all serological test decrease after the beginning of the 
treatment. One year later, the highest titea were obtained by IgG ELISA 
(90%). The lowest titers were obtained by SAT (66%) and ELlSA IgM (70%)). 
The curve ofthe follow-up titers ofBrucellacapt was similar to the Coombs test 
and the titers persist high one year after treatment. 
Conclusions: The study shows very good correlation between the Brucellacapt 
and the Coonlbs tests, with a high concordance between titers obtained in the 
two tab. The evolution of the titers after treatment is very similar in both tern. 
Utility of Fourier-transform infrared spectroscopy in 
the characterization of bacteria of genus BruceNa 
M. Bratos, M. A. Miguel, A. Duehas, P. Gutikrrez, A. Orduiia, J. Martin 
Gil, A. Rodriguez Torres 
Valladolid, E 
Introduction: Fourier-transform infrared (FTIR) spectra of bacteria are 
fingerprint-like pattenis that are highly reproducible and typical for Werent 
bacteria. Since complete cells are tested, the spectra are the very complex 
images of the chemical composition of the cell. 
Objectives: The aim of the present study is to test whether FTIR can be 
used to characterize bacteria of genus Brucellu. 
Material and methods. The type stains of Merent species and biotypa of B w e h  
are studied. The strains were cultured in bnvl heart infusion broth at 37 "C for 3 
days with agitation and lulled by adding formaldehyde (final concentration 0.5%). 
The sediment of cenmfugadon was washed 3 times with distilled water and 
Chlamydia trachomatis 
fieme-dried. After mkmg with KBr the spectra were obtained in a CypmuG 100 
FT-IR Spectrometer (Matson Instruments) with a MTC detector. The second 
derivates of spectra were obtained, and the peaks with highest variability w i h  
strains were chosen. Pnncipal components analysis was made with SPSS 7.3 
Results: The mean and standard deviation of eight peaks with highest 
variability were: V1: 769.58, 2.09; V2: 858.74, 8.33; V3: 889.47, 5.98; V4: 
943.89, 2.83; V5: 1522.53, 3.24; V6: 1553.74, 3.59; V7: 1684.05, 3.52; and 
V8: 1742.68, 5.83, respectively. The analysis of principal components gave 
three components, the first retains the 36.50% of variance, 16.62% the 
second, aud 14.74% the third (cumulative 67.87%). The graphical 
representation of these three principal components showed three groups, 
the first was fonned by with the strains of B .  melitensis, the second by the 
stains of B. abortus, and the third by the strains of B. suis; neither of this 
groups included B. neotomae, B. avis or B. canis. 
Conclusion: FTIR is a useful tool in the microbial characterization, but 
more studies are needed to be applied in the routine analysis of bacteria 
Ip621/ Comparison of three different combination therapies 
in the treatment of human brucellosis 
Y. Ersoy, E. Sonmez. A. D. But, Y. Bayindir 
MaLatya, TR 
Objectives: The tolerability and efficacy of ofloxacin plus nfampin, 
doxycycline plus rifampin and streptomycin plus doxycycline combination 
therapies were compared in the treatment of human brucellosis. 
Methods: Ninety-three patients were enrolled into this prospective 
randomized study that diagnosed with brucellosis based on standard clinical 
and microbiological findings. Patients were divided into three groups that were 
comparable regardmg age and sex dismbution. T h q  patients (group I) were 
treated with 400 mg of ofloxacin plus 600 mg of dampin, 33 patients (group 11) 
received 200 mg of doxycycline plus 600 nig of rifampin and 30 patients (gronp 
111) taken 1 g streptomycin plus 200 mg of doxycychne once dady P.O. for 6 
weehs (except 3 weeks of streptomycin IM in group 111). Student's I and chi- 
square tests were used for statistical analyses. 
Results: There was no therapeutic failure in group 11 and I. One pauent did 
not respond to the treatment in doxycycline-streptomycin group. During 1- 
year follow-up period, 2 patients &om group I11 and 1 patient &om each of the 
groups I1 and I had clinical relapse. There was no statistical difference between 
the groups for relapse rates. Gastric imitation was the major side-effect and the 
rates were 6.5%, 8.8% and 13.3%, respectively, in groups I, I1 and 111. 
Conclusion: The combination therapy of ofloxacin plus rifampin applied for 
6 weeks is effective as the other classical treatment combinations such as 
doxycycline plus rifampin and doxycycline plus streptomycin. In addition, 
the tolerability of ofloxacin plus rifanipin combination therapy was better 
then the other combinations. 
lp622 The evaluation of the VIDAS PROBE Chlamydia 
trachomatis test in a preclinical study 
A. Hem, D.  Fuller, T.  Davis, R. Diaz, K. Hedstrom, S. Redly, K. Kacena, 
C.  Rogers, R. Johnson 
Rocklarid, Indianapolis, Sari Diep, USA 
Objective: To evaluate the preclinical performance of the VIDAS PROBE 
Chlamydia trachomatis (CT) Test in female urine, endocervical and self- 
Collected vaginal specimens. 
Methods: The VIDAS PROBE Chlamydia trachomatis Test (this product has 
not been cleared by the US FDA and is not yet available for conunercial 
use) is an automated nucleic acid amplification assay that employs the 
existing VIDAS instrument atid Transcription-mediated Amplification 
(TMA) for the amplification and detection of C T  ribosomal RNA (rRNA). 
Automated coaniplification of target and an internal control as well as 
detection of the amplified products occurs within the VIDAS PKOBE snip. 
An internal control monitors the success of amplification in each individual 
saniple and control. As part of an on-going study, preclinical performance in 
a female population was evaluated by comparing VIDAS PROBE CT to a 
patient infectivity Status. Fcniak patient infectivity status was determined 
using an algorithm employing C T  cell culture, Abbott's LCx C T  and Gen- 
Probe's AMP C T  tests. Preclinical sensitivity and specificity was calculated 
for matched urine and endocervical swabs collected from 338 female study 
subjects attending an urgent care OB/GYN clinic. Of those 338 study 
subjects, 252 also provided self-collected vaginal swabs. 
Results: Based on patient infectivity status, the prevalence rate for CT in the 
evaluated population was approximately 12%. Preclinical sensitivity and 
specificity of the VIDAS PROBE CT Test for endocervical and self- 
collected vaginal swabs was 100%. Pre-clinical specificity for female urine 
samples was also 100Y6, sensitivity for female urine was 97%. Invalid results, 
as monitored by internal control amplification, were observed in 4.4% of 
female urine specimens and less than 1% of swab specimens. 
Conclusions This preclinical study demonstrates that the VIDAS PROBE 
Chlamydia trachomatis Test, codeveloped by bioMPrieux and Gen-Probe, 
Inc. provides a sensitive and specific automated assay for the detection of 
Chlamydia trahomatis in a convenient unit-dose format. 
/p623/ Detection of urogenital infections from Chlamydia 
trachomatis in women by molecular methods in north-western 
Greece 
N. Hita, G. Tsanadis, G. Vrioni, E. Papatlikou, D. Lolis. S .  Levidiotou-Stehou 
Ioannina, GR 
Clinical Microbiology and Infection, Volume 7,  Supplement 1, 2001 11 1 
Objective: Detection of C. trac/Jomafis in genital and urine specimens from 
adult women in north-western Greece. 
Methods: For this purpose, 1366 clinical specimens were studied from 864 
women (864 cervical swab specimens, 502 urine specimens) in 2-years 
period of time (from 11/1998 to 11/2000). All the specimens were 
examined with two automated amplification systems: PCR Cobas 
Amplicor, CT-PCR test (Roche Diagnostic Systems) and LCx (Ligase 
Chain Reaction-Abbott Laboratories). All women completed a question- 
naire about nationality, age, mental and social state, purpose of clinical 
examination, and behavioral risk factors for sexually transmitted diseases. 
Women who had received antibiotic therapy two weeks before examina- 
tion were excluded from our study. 
Results and conclusions: C .  trachomatis were detected in 17 women (7/864, 
1.96%) simultaneously in urine and cervical swab specimens and in 5 
women only in cervical swab specimens. There were no discrepant results 
with the two methods. The presence of inhbitors, in 9.5% of the 
specimens, was detected by the use of the Internal Control (Cobas 
Amplicor). According to our results, tested female population from north- 
western Greece is low prevalence (1.96%). Both molecular methods offer 
the benefits of automation for routine diagnostic testing and they are equal 
sencitive and specific. 
p624 Nucleic acid hybridization vs. culture in McCoy’s cells 
as a method for Chlamydia trachomatis detection 
B. Zawilinska, A. Bialecka, B. Slawinska, E. Daszkiewicz, A. Kasprowicz 
Krakotu, PL 
introduction: Culture in McCoy’s cells is regarded as the ‘gold’ standard for 
Chlamydia trachoinatis (C. Trurh.) isolation. However, in the diagnostics of 
ch/amydia, similarly as in many other procedures, molecular methods for 
detection of specific nucleic acid sequences have become used more 
frequently recently. The aim of the study was to compare the results 
obtained in the culture and hybridization methods. 
Materials and methods: The samples for the study were urethral and 
cervical swabs collected onto appropriate transport media. Only the 
materials with negative results of mycological and bacteriological examina- 
tions were enrolled. The collected samples were inoculated into McCoy’s 
cell culture. The presence of C. tach. inclusion bodies was demonstrated 
after 48 h incubation by staming with Jones iodine. Hybridization method 
was performed using a commercial PACE 2 assay (Gen-Probe, bioMerieux) 
strictly according to the manufacturer instruction. In this DNA-rRNA 
hybridization test, the DNA probes labelled with acridine ester was 
hybridized to a specific sequence of chlaniydial 16s rRNA. The results were 
measured by chemiluminiscence and expressed in relative light units. 
Results: A total of 128 clinical samples, C. tach. were found significantly 
higher in McCoy’s cells compared with the hybridization method, 18% and 
15.696, respectively (Chi-squared test, P =  0.005). The correlation coeffi- 
cient for both methods amounted to 79%. The sensitivity and specificity of 
the PACE 2 assay was established to 87% and 97%, positive predictive value 
(86%) and negative predictive value (97%) respectively. 
Conclusions: An undoubted advantage of hybridization, which does not 
require much effort to manage cell culture, enables its wide use in the 
diagnostics of chlamydia. The method of C. tach. culture, because of its 
work-consuming character, is not suitable for the screening. The obtained 
preliminary results indicate the necessity of implementation of the new 
diagnostic method with caution. 
v/ Increasing trend of chlamydial infection 
J. Ruczkowska, I. Choroszy-fiol 
Wruclaw, PL 
Objectives: Chlamydia trachomafis (Ct) is a sexually transmitted pathogen of 
urogenital (UG) tract. In Poland patients with UG-Ct infections, as well as 
their partners, were treated and controlled by specialists and the frequency 
of infection was steadily monitored till 1999. The imposition of reforms in 
the health service has created chaos both for patients and medical sta& Not 
only a bare minimum of care is provided, for reason of cost, but also all the 
epidemiological procedures have collapsed. The aim of our work was to 
estimate the difference in frequency of Ct infection in 1999 vs. 2000 in 
Lower Silesia District. 
Methods: In two years period 979 (416 and 563) patients (aged 18-65), 615 
women and 364 men, with UG disorders were examined for Ct infection. 
They were directed to our lab mainly by GPs. Only about 20% of 
patients were hospitalized in gynecological or urological clinics. Cervical 
(17 = 170) and urethral (men n = 364; women n = 445) specimens were 
tested by Direct Immunofluorescence Assay (Chlaniyset, Orion Diagnos- 
tics, Finland) 
Results: Totally, 190 (19,4%) out of 979 patients were found to be infected 
with Ct. Positive results of testing were as follows: men (urethral samples) 
66/364 (18.1%); women (urethral s.) 89/445 (20.0%): (cervical s.) 35/170 
(20.5%). Comparative study of the positive results in 1999 vs. 2000 showed 
however, increasing trend in Ct infection among patients of both genders: 
men (urethral samples increase from 10.6% to 23.3%; women (urethral s.) 
from 6.6% to 29.1%; (cervical s.) from 7.1% to 34.1%. Ct infection was 
noticed in prevalence (38.8%) in cervix of young women aged 18-27 years. 
Conclusion: In 2000 in comparison to 1999 (and also to 3 previous years) 
a great increase in nuniber of Ct infected cases was noticed from 8.1% 
to 27.7%. 
lp6261 Comparative evaluation of three nonculture rapid test 
assays for detection of Chlamydia trachomatis in patient 
specimens - a pilot study 
S. Mahmutovic, E. Beslagic, S .  Cavaljuga 
Sarajevo, BJH 
Objectives: Chlamydia tradzomatis has been recognized as one of the most 
common sexually transmitted pathogens. Rapid diagnosis of sexually 
transmitted diseases (STDs) is essential for both therapeutic and epidernio- 
logical purposes. This study was a pilot study with the purpose to compare 
current test assays (rapid tests) for detection of Chlarnydia trarltomatis. 
Patients and methods: Sixty (60) fertile female patients from gynecology 
clinics in Sarajevo during 2000 were tested for the presence of Chlamydia 
trachomatis in the endocervix. The patients represented two risk groups: 30 
(30) patients with genitourinary symptoms (moderate risk); 30 (30) 
asymptomatic patients as a control group (low risk). AU patients with 
symptoms represent all the patient who came to clinics. The moderate risk 
patient has genitourinary symptoms and no documented history of STDs. 
Asymptomatic patient were chosen randomly; they were screened for 
Chlamydia trachomatis routinely without symptoms and history of STDs. 
Three endocervical swab specimens per each patient were collected, and 
each of specimens was analyzed with rapid immunoassay -SOVO TEC; 
enzyme immunoassay -EIA by Behring; and direct fluorescence assay -DFA 
by Orion. 
Results: Total five (5) patients were positive on ChIamydia trachomatis. Out 
of that three (3) were from low risk group, and two (2) from moderate 
risk. Four (4) out of five (5) patients were found positive with three test 
assays (rapid immunoassay, EIA and DFA). One (1) positive patient was 
confirmed by EIA and DFA, but was not confimied by rapid inmunoassay 
(SOVO TEC.). Results from the test sites indicated that there was no 
difference overall in the sensitivity and specificity of the two test assays (EIA 
and DFA). However, there was some interlaboratory variation in the 
sensitivity of the rapid immunoassay test (SOVO TEC.), but little difference 
in the specificity. 
Conclusion: Both test assays (EIA and DFA) are coniparable and highly 
specific and sensitive procedure for the detection of Chlamydia antigen in 
genital specimens, especially in laboratories without cell culture facilines. 
lp6271 Genital infection by Chlamydia trachomatis in 
Novosibirsk, Russia 
A. A. Khryanin 
Novosibirsk, RUS 
Objective: To document trends of Chlamydia rrarhomatis (CT) infection 
recorded in Novosibirsk in 1996-99. 
Methods: Novosibirsk is a largest city of Siberia and the third largest in 
Russia with a population of about 1.5 nlillion. The incidence rates of CT 
infection for the period 1996-99 were investigated. The data from all 
&strict STD clinics were obtained and registered in the Department of 
Social Statistics of the Regional Committee of Statistics of Novosibirsk 
region. The tests available for detection of C T  are ELISA, Direct 
imniunofluorescence and PCR. 
Results: The incidence rates were calculated and expressed per 100.000 
population. The data for the entire population of Novosibirsk were as 
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follows: 1996-241.0; 1997-396.4; 1998-385.4; 1999-317.2 Incidence of 
CT in Novosibirsk according to age, sex and year (per 100.000 inhabitants) 
are shown in the table. The incidence rates were 2-3 times higher in females 
than in males during 1996-99. The rates were relatively constant through 
1996-99. 
Age 
1996 
Males 
Females 
Total 
1997 
Males 
Females 
Total 
1998 
Males 
Females 
Total 
1999 
Males 
Females 
Total 
0 -14 
0 8  
4 2  
2 5  
2 4  
11 9 
7 1  
8 5  
36 6 
22 2 
8 5  
23  2 
1 5 7  
15-19 
63 8 
448 2 
257 6 
205 1 
610 9 
409 6 
1497 
794 8 
474 0 
244 3 
908 8 
578 4 
2 0 1 9  
595 2 
1026 4 
822 7 
1062 4 
17146 
1403 5 
932 4 
1660 3 
1309 6 
1005 1 
1554 8 
1289 9 
3 0 3 9  
214 5 
470 3 
346 a 
565 9 
765 9 
669 3 
568 4 
758 6 
667 4 
312 1 
346 2 
329 9 
> 40 
45 0 
70 1 
59 9 
111 6 
121 1 
117 2 
126 6 
137 9 
133 3 
47 6 
43 3 
a5 1 
Conclusions: These figures are simdar to those in other regions of Russia, 
and higher than in Western European countries. The state program is 
needed for prevention of Chlamydia trachomafir infection among risk groups. 
)p6281 Treatment of nonspecific prostatitis with roxitromycin 
R. Jakimoska, M. Kuzmanoski, J. Jordanoski 
Pn'lep, MAK 
Objective: To assess the efficiency of roxitromycin once daily in treatment 
of nonspecific prostatitis caused by Mycoplasma and Chlamidiae. 
Materials and methods: During 1996-99 we selected 65 patients with 
nonspecific prostatitis aged 25-35 years. The all undergone microbiological 
investigations of the urine, sperm and in 54 also of the prostate secret. We 
used commercial IST mycoplasma Biomerieux test and immunohistho- 
graphic test for Chlamidiae. We perform 3 examinations: before, aiter 15 
days and after 6 months oftreatment. All positive findings were treated with 
300 mg roxitromycin once a day for 14 dayc. 
Results: In 51 patients the tests were positive, and in 5 we found combined 
infection. After treating, 49 patients w-ere successfully treated, and second 
and third control was negative (after 6 months). 
Conclusion: Roxytronucin 300 mg once a day for 2 weeks is very effective 
in treating of the above prostatitis. We recommend it as a drug of choice. 
Chronic manifestations of Chlamydia pneumoniae 
[p6311 Serological markers of infection with Chlamydia 
pneumoniae, Helicobacter pylori, cytomegalovirus in patients 
with acute coronary syndrome 
K. Thenieli-Digalaki, E. Orkopoulou, C. Zouras, C. Antonakoudis, S. 
Christakos, C. Koutsia-Carouzou 
Athens, CR 
Objectives: To exanline the possible associations between acute coronary 
syndrome (ACS) and serologigal evidence for Chlamydia pneumoriiae (C.p), 
Helicobarter pylon' (H.p) and Cytomegalovirus (CMV) infection. 
Methods: In total, 53 patients aged 40-72 years, who had acute coronary 
syndrome and 15 as asymptomatic controls were examined. Sera for C.p 
(IgM, IgA, IgG) antibodies were tested by MIF test. Antihelicobacter 
antibodies (IgA, IgG) were deteimined by EIA. Titers of IgM and IgG 
antibodies to CMV were measured by MEIA and IFA. 
Results: The prevalence of specific IgG antiboches to CMV was 54.7% in 
ACS and 46.6% in controls, with corresponding results for C.p 
(p629) Detection of antibodies to Chlamydia trachomatis in 
male patients with urethritis 
A. Agacfidan, M. Onel, N. Isik, S. Badur, 0. Ang 
Istanbul, TR 
IgM, IgG and IgA antibodies against pooled serotypes of C. trachomafir in 
patients with urethritis using a commercial microimmunfluorescence (MIF) 
test (Orgemum, Finland) were investigated. The results were compared 
with ligase chain reaction (LCR) test (LCx, Abbott, USA). Blood (serum) 
and urethral specimens were collected and tested according to the 
manufacturers' instructions. A total of 204 patients with urethritis who 
had sexual contact with commercial sex workers were enrolled to this study. 
C. trachomatis prevalence was 30.3% (62/2O4). C. trachomntis IgM positivity 
by LCR positive patients was 85.8%. IgG positivity was observed in 93.6% 
and IgA in 34.8% In the LCR negative patients, IgM positivity were 
detected in 11.8%, IgG in 77.9% and IgA in 10.8%. Only single positivity to 
one of the serotypes was used as a criterium for calculation of the most 
common serotype. Some samples had positivity to more than one serotype at 
the same time. The most common serotype was B complex (BDE), the second 
was C complex (CHID among overall positive serum specimens. C. trarhomatis 
serotype spechc test with the detection rate of 86% for IgM in LCR positive 
patients can be explained with rather late application for medical help by 
patients to the physician for sexually transmitted diseases in Turkey. 
p630 Detection of Chlamydia trachomatis in female patients 
with genital infections by EIA and transcription-rnediated 
amplification assay 
Malntya, TR 
Y. Bulut, 13. Durmaz, R. Durmaz, B. Otlu, S. Hacplik, N. Gursoy 
Objectives: To detect Chlamydia trachornatis (CT) in female patients with 
genital infections using different methods. 
Methods: Serum samples and endocervical swabs were taken Gom 78 
female patients having symptoms for genital infections. CT-antigen and 
CT-antibodies were determined by enzyme immunoassay. Transcription- 
Mediated Amplification (TMA) assay (Gen-Probe) was used for detection of 
CT ribosomal RNA (rRNA). 
Results: The positivity rates of Chlamydial TMA assay and EIA-CT antigen 
were 17 (22%) and 12 (15%) in 78 endocervical swabs, respectively. Of 78 
serum samples, 15 (19%) were positive for both specific IgM and IgG 
antibodies to CT, 22 (28%) were positive for only IgM antibodies by using 
EIA. Twelve endocervical samples (15.3%) gave the positive result for both 
EM-CT antigen and Chlamydia TMA assay. Five endocervical samples were 
positive by Chlamydia TMA assay only. Among the panents 11 (14%) were 
found to be positive for CT-antigen. CT-rRNA and CT-IgM annbodles. 
Conclusion: Chlamydia TMA assay seem to be a more valuable tool than 
EIA. The Gequency of Chlamydia tmclmrnatis was 14% in female patients 
showing clinical symptoms for genital infections. 
seropositivity 28.3% and 13.3%, and H.p seropositivity 49.1% and 20%, 
respectively. In two cases were found higher titers of 1gM and IgA 
antibodies to C.p. Seroprevalencr to both C.p and H.p were found in 
18.6% only in ACS. 
Conclusions: The serologic evidence of previous infections with CMV was 
not a risk factor for acute coronary syndrome, whde seropositivity for C.p 
was associated with ACS. The seroprevalence of H.p was moderate, but 
seropositivity to both C.p and H.p may be predict increased nsk for ACS. 
p6321 Chronic Chlamydia pneumoniae infections in patients 
hospitalized with acute myocardial infection or unstable angina 
in Cardinal Wyszynski's Hospital in Lublin 
A. Witkowski, J. Niedzwiadek, E. Mazur, M. Koziol-Montewka 
Lwblin, PL 
Objectives: Chlamydia pneumvniae is a newly described human pathogen 
belonging to genus Chlamydia. It causes a range of respiratory tract 
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infections. Fundamental in chlamydia1 pathogenesis is the tendency of this 
microorganism to cause recurrent and chronic infections. There is seroepide- 
nliologic and experimental evidence for a ltnk between Ch.p. and 
atherosclerosis. However, the clinical importance and the pathogenic pathways 
implicated remain unclear. The aim of this study was to evaluate the fi-equency 
of Ch.p. chronic infection in patients hospidsed with acute myocardial 
infection or unstable angina in Cardinal Wyszynski's Hospital in Lublin. 
Material and methods: 47 consecutive patients (39M, 8F), mean age 64.4 
years, with acute inyocardial infarction (AMI) or unstable angma have 
participated in the research. 20 control subject, matched for age and sex 
(IfiM, 4F) without chmcal signs and syniptoms of cardiovascular and 
pulmonary disease took part in this study. Microimmunofluorescence 
method has been applied. Chlamydia pneumoniae Micro-IF test (Labsystems, 
Finland) has been used accordmg to manufacture's insa~ctions. Sera analyzed for 
ChP. IgA were duted in IgG blocker (Labsystems, Finland) to remove possible 
interference with IgG. According to reference data, the following criteria have 
been adopted: (1) chronic (persistent) infection: IgG '1:128 ang, simultaneoudy, 
IgA '1:32; (2) infection in the past/contact with pathogen IgG < 1: 128. 
Statistical analysis has been carried out usmg SPSS for Wmdows. A P-value of 
0.05 has been taken as indicative of statistical significance. 
Results: Serologic markers for chronic Chlamydia pneumoniae infection were 
detected in 53% (25/47) patients and in 20% (4120) healthy controls. 13 
patients had specific Ch.p. IgG titers > 1:512 and IgA titers of > 1 :64. The 
titers of specific IgG and IgA antybodes to Ch.p. in patients were 
significantly higher then in control population of the same age. 
/p6331 Presence of Chlamydia pneumoniae DNA in PBMCs, 
tissue specimens and specific antibodies in patients with 
coronary heart disease 
E. Podsiadly, M. Kruk, J. Przyluski, W. Ruzyllo, S. Tylewska-Wierzbanowska 
Warsaw, PL 
Objective: To determine the presence of C. pnelrmoniae DNA in tissue 
speciments obtained by directional coronary atherectomy, in PBMCs 
(peripherial blood mononuclear cells) and level of antibodes in patients 
with coronary heart diseases. 
Methods: 11 patients suffered from coronary heart disease and 28 persons 
with nomial angiogranx were examined. The DNA was extracted from 
tissue samples obtained from 6 CHD patients and PBMCs isolated from 
patients and controls using the QlAainp DNA Mini Kit (QIAGEN, 
Germany). An amplification was performed using CpnAEVCpnl2 and 
CPN90/CPN91 primers. All the samples were amplified twice in the 
presence of positive and negative controls. Specific C .  pneumoniae IgG and 
IgA antibodies levels were quantified by ELISA (ELEGANCE Chlamydia 
pnelrwloniae IgA and IgG ELISA, Bioclone, Australia). 
Results: C. piieumoniae DNA was detected in PBMCs of 1/11 patient and 
3/28 controls subjects with CPN90/CPN91 primers as well as 0/11 patients 
and 2/28 controls subjects with CpnAB/Cpnl2 primers. In patient with C. 
pneumotiiae DNA detected in PBMC we did not fmd DNA of the 
microorganism in tissue sample from atherectomy, but in patient with the 
presence of C .  pneumoniae DNA in tissue speciment we did not detect DNA 
of the microorganism in PBMC. There were no significant differences 
between level of antibodies in patients and control subjects. C. pneumoniae 
specific IgG and IgA antibodies were detected in 54.5% and 45,5% of 
patients as well as in 39% and 57% of control group, respectively. Specific 
C .  piteumoniae IgG antibodies were present in 1/4 person with DNA C. 
pneumorziae in PBMC and in a patient with DNA C. pneumoniae in tissue 
sample from atherectomy. Specific C. pneumoniae IgA antibodies were 
detected in 1/5 persons with bacterial DNA in PBMC. C .  pneumoniae IgA 
antibodies were not detected in patient with the presence of C. pneumoniae 
in tissue speciment. 
Conclusions: There was no positive correlation between the presence of C. 
pneumotiiae DNA in PBMCs, tissue specimens and presence of chlamydia 
antibodies in serum. 
FA Chrarnydia pneurnoniae and multiple sclerosis 
M.-V. Borobio Enciso, M.-D. Navarro, G. Izquierdo, E.-J. Perea 
Seville, E 
Introduction: MS is a demyelizing disease of the CNS which has been 
linked to multiple infectious agents as being responsible for thelr ethlology 
or as a triggenng cofactor. C.pn has been incriminated as ethological agent 
in the last few yean. T o  evaluated ths  hypothesis, the presence of anti-C.pn 
antibodies in a group of patients with MS was evaluated and compared to a 
control group consisting of patients who suffer inflammatory and 
noninflammatory diseases of the CNS. 
Material and methods: One hundred and two patients (65 women and 27 
men) were studied and clinically evaluated: average age 39.4 i 11.2 years. 
Time from onset of the disease 10.3 k 9.9. EDSS 3.79 2.5. Sixty-five 
patients showed relapsing-remitting courses, 31 showed secondary pro- 
gressive courses and six were classified as primary progressive courses. The 
coiitrol group was made up of 89 patients with non MS neurological 
diseases and 5 cases of neurosyphilis. Anti-C.pn antibodies were studied by 
means of the microimmunofluorescence technique (MIF) (MRL Diag- 
nostics) in sera and CSF of all patients. Intrathecal antibodies secretion was 
studied in all positive patients. 
Results: Anti-Cpn antibodies were detected in 26 patients with MS and in 6 
patients with in the control group 6 of the 38 patients with non-MS 
neurological diseases and 4 of the 5 patients with neurosyphilis. There were 
no statistically significant differences among the different clinical courses of 
the MS, sex or age of the onset of the disease. 
Conclusions: In our  opinion, the higher incidence of anti-C.pn antibodies 
in the MS group ofpatients is not related to the ethiology of the disease due 
to the high positive results in the neurosyphilis group. The presence of anti- 
C.pn could be due to a shared alteration of the CNS in all inflammatory 
diseases of these patients. 
p635 Prevalence of specific serum antibodies in patients 
with multiple sclerosis 
S. Tylewska-Wierzbanowska, E. Podsiadly 
Warsaw, PL 
Objectives: To evaluate the correlation between C. pneumoniae infections 
and multiple sclerosis (MS). 
Methods: The study group consisted of 37 patients suffered from multiple 
sclerosis and 8 with other neurological dsorders. Control group included 28 
people w t h  normal coronary angiograms. The level of serum IgC and IgA 
antibodies for C. pneumoniae was measured with ELISA (ELEGANCE 
Chlamydia pneumoniae IgA and IgG ELISA, Bioclone, Australia). 
Results: C. prreumoniae IgG and IgA antibodies were detected in both, 
patients as well as in healthy volunteers. 10.8% (4/37) patients with MS and 
3.5% (1/28) control subjects were strongly positive for C. pneumoriiae IgG 
antibodes. 29.7% (11/37) patients with MS and 35.7% (9/37) control 
subjects were positive in this class of antibodes. IgA antibodies were present 
in serum samples of 13.5% (strong positive results) and 40.5% (positive 
results) MS patients. IgA were present with similar frequency in serum 
samples of people &om control group-57% people. IgA antibodies were 
found in 5 out of 8 patients with other neurological disorders IgG and. 
Conclusion: We have detected specific C. pneumoriiae antibodies in similar 
percent of patients with MS and people without MS. Our results do not 
support the role of C. pneumoniae in pathogenesis of MS. 
Ip6S61 Are healthy volunteers with persistent Chlamydia 
pneumoniae infection characterized by a pro-inflammatory 
immune-status? 
C. Hermann, K. Graf, T. Hartung 
Konsfanz, D 
Persistent infection with Chlamydia pneumoniae (C.P.) has been suggested to 
be associated with atherosclerosis. In lme with this hypothesis, primary C.p. 
infection as well as development of early atherosclerotic lesion occur in 
childhood and both have a world wide distribution. Persistent C.p. 
infection could contribute to inflammatory processes which are crucial for 
progression of atherosclerotic lesions. Recently, C-reactive protem (CKP) 
serum levels were identified as independent risk-factor of atherosclerosis. 
Therefore, we investigated, whether spontaneous and iiz uitro stimulated 
release of inflammatory mediators from blood of healthy volunteers depends 
on the C.p.-serostatus. Since the validity of current serological diagnostic is 
questioned, we evaluated 11 tests for anti-C.p.-IgG with serum of 80 
healthy donors. which differed in performance and antigens employed. One 
species specific ELISA was chosen as a search-test and one MIF to confiml 
IgG nters of positive samples. Furthermore, one rELlSA was used for 
determination of genus-specific anti Chlamydia-LPS antibodies, which 
occur with kinetics different from antiprotein antibodies. Blood and serum 
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Gom 160 healthy volunteers with a mean age of 30 were taken and basic 
levels of TNF. 1L-6 and CRP,  as well as nionokine and lymphokine release 
after LPS-and SEB-stimulation of whole blood were determined and 
analyzed in dependence of the serostatus. 73% of the study group was found 
positive for C.p. IgG by the species specific ELISA. First results show no 
difference of the release of stimulated cytokines between the IgG positive and 
negative group. However, stratification of subgroups depending on different 
IgG titer and presence of anti LPS antibodies is ongoing. Furthermore, direct 
assessment of C.p. by PCR of whole blood of the donors might enable to 
distinguish between resolved and persistent infection. 
Genital infections 
Vaginal and cervical microflora of outpatients women 
clinic 
S. Novikova, I. Andreeva 
Perm, RUS 
Objectives: To study the reproductive women tract microflora of 
outpatients' clinic during September 1999-September 2000. 
Methods: 397 women have been examined. Bacteriological investigations 
of vaginal and cervical materials have been defined. 
Results: 503 bacterial and Saccharomyces cultures had been found. 350 (69.58%) 
Gram-positive, 47 (9.35%)) Gram-negative, 106 (21.07%) Candida sp. isolates 
were been obmed.  The Gram-positive category was consisted of Staphylo- 
coccus (225 isolates - 64.29%), Sfreptucoccaceae (68 isolates - 19.43%), 
Curynebm~um sp. (57 isolates - 16.28%). 122 (34.85%) of Gram-positive 
microorganisnx have been the haemolpcal activity. The Gram-negative bacteria 
were included E. coli, Entmobactm sp., Mebsiella sp., Pseudomom sp., Proteus sp. 
Conclusions: The Gram-positive microorganimu were prevded in v a g d  and 
cemcal nlaterial at women clinic. The rate of S ~ p h y l o c u m  sp. has been more 
than Streptucmmae and Corynebartoilrm sp. The haemolyhcal activity of Gram- 
positive microflora is dangerous for reproductive women health. Candidiasis of 
vagina must been treated together with main gynecological disease. 
lp6381 Genital infections in women: role of some risk factors 
M. A. Latino, G. De Intinis, E. Spagnolo, M. Pellecchia, A. Petrozziello, 
E. Girardi 
Turin, I 
Objectives: to evaluate the correlation between genital infections and some 
risk factors in asymptomatic women in Italy. 
Methods: From 1 January 1999 until 31 December 1999, 4087 sexually 
active women in fertile age, attending the STIs Centre of Sant'Anna 
Hospital in Turin were evaluated. Socio-demographic and anamnestic data 
were collected from all patients. Statistical analysis was performed using the 
chi-square test. 
Results and conclusions: 2435 (59.6%) out of 4087 patients showed 
symptoms of infection of the lower genital tract, 1652 (40.4%) were 
completely asymptomatic. One infection was found in 53.2% of both 
symptomatic and asymptomatic women contiming thus the often 
subclinical course of these infections. Furthermore some risk factors (young 
age, early beginning of sexual activity, multiple panners in the last six montbs, 
intravenous drug use, belonging to high incidence of sexually transmitted 
infections Countries, partners with urethritis) were evaluated. 290 (17.6%) out 
of these women had one or more risk tictors: in this cases genital infections 
were found in 52.1% vs. 36.4% of women without risk tictors (P  < 0.001). 
Table 1 shows the rate of some infections in both groups. 
Infectlolls Risk <actors No nrk P 
Chln,ri)viia r .  3.2 0.7 <0.001 
I ircuplmrrr~i t i .  18 2 16.2 <0.001 
'7'riilrortrorros 1,. 1 0.07 <0.0(11 
Ractenal vagnosic 11.1 3.8 <0.001 
?H,) factors (9%) 
vl Association between bacterial vaginosis and abnormal 
colposcopic findings 
A. Georgijevic, J. Sisovic, S. Djukic-Ivancevic, M. Bujko 
Belgrade, Podgurica, W, 
Objectives: The aim of the study was to investigate if there is an association 
between bacterial vaginosis (BV) and abnomial colposcopic findings. 
Methods: Ninety-six nonpregnant women of reproductive age were 
examined in the Gynecology Department of one Belgrade Outpatient 
Climc. The exarmnation included: gynecological and colposcopic examina- 
tion, Papanicolaou test and microbiological analysis of vaginal secretion. 
Diagnosis of BV was made by Nugent criteria. Using Nugent scoring system 
women were divided into three groups: women with BV, women with 
intermedial vaginal flora and women without BV. The data were statistically 
analyzed using chi-squared test and Fisher's exact test. 
Results: Among examined women 21% of them had BV. Nomial 
colposcopic findmgs were found among 30% of women with BV and 
86% of women without BV ( P  < 0.01). Vaginal hyperemia with increased 
vaginal discharge was found in 30% of women with BV and in 4% of 
women without BV ( P  < 0.01). Chronic cervicitis had 15% of women 
with BV and 2% ofwomen without BV ( P  < 0.05). Leukoplakia was found 
in 20% of women with BV and in 3% of women without BV ( P  < 0.05). 
Women with intermedial vaginal flora had colposcopic findings similar to 
those found among women with normal vaginal flora. 
Conclusions: Some abnormal colposcopic 6ndmgs such as leukoplalaa, chronic 
cervicitis and vagmal hyperemia with increased vaginal discharge can be found 
more often among women with BV compared to women without BV. 
1p6401 Is there any difference between biotypes of 
Gardnerella vaginalis isolated from pregnant women with and 
without bacterial vaginosis? 
S. Djukic-Ivancevic, S. Stepanovic, B. Vranes, N. Opavski, V. Mijac, L. 
Ranin, M. Perwlov, M. Bujko 
Bekrade, Podgurica, W 
Mounting evidence that bacterial vaginosis (BV) predisposes to significant 
upper genitounnary tract disease and adverse pregnancy outcomes under- 
scores the importance of continuing the nearly century-long quest to 
elucidate the pathogenesis of this condition. Currently, one of the most 
important controversies surrounding BV has to do with its etiology.. 
Gaudtierella vaginalis is the predominant organism isolated from the vaginal 
fluid of women with BV, but it also can be isolated &-om a significant 
percentage of women exhibiting no evidence of the infection. The aim of 
our study was to examine whether certain biotypes of Gardnerella vaginalis 
are more often associated with BV among pregnant women. A scheme for 
identifying biotypes of Gardnerella vaginalis has been developed, based on 
reactions for lipase, hippurate hydrolysis and beta-galactosidase, Twenty 
isolates of Gardnerella vaginalis were recovered from pregnant women with 
BV, while 10 isolates were Gom pregnant women without BV. The 
distribution of biotypes observed among BV positive women was as follows: 
1 (7/20), 2 (8/20), 3 (1/20), 4 (0/20), 5 (2/20), 6 (1/20), 7 (0/20) and 8 (I /  
20). Among BV negative women the distribution ofbiotypes was as follows: 
1 (1/10), 2 (IIlO), 3 (0/10), 4 (0/10), 5 (6/10), 6 (1/10), 7 (1/10) and 8 (0/ 
10). The most common biotypes among pregnant women with BV were 
type 1 (beta-galactosidase positive, lipase positive, hippurate positive), and 2 
(beta-galactosidase negative, lipase positive, hippurate positive). The 
distributions of biotypes from pregnant women with and without BV were 
found to be significantly different, with lipase-positive biotypes (biotypes 1 
and 2) being more predominant in BV positive womens ( P  < 0.05). Our 
data suggest that women who acquire BV more probably have shift in 
biotype of Gardnerella vaginalis and that the Iipase-positive isolates are 
associated with BV. 
/p6411 Role of ureaplasma urealyticum serotypes in bacterial 
vaginosis 
F. Echahidi, M. Laubach, W. Foulon, S. Lauwers, A. Naessens 
Brurselz, B 
Clinical Microbiology and Infection, Volume 7, Supplement 1, 2001 11 5 
Bactenil vaginosis (BV) and genital tract colonization with U. urealyticum 
during pregnancy are two conditions which can be related to adverse 
pregnancy outcome. We investigated the relationship between BV and 
genital mycoplasmas (U.  urealyticum and Mycoplasma hominis) in 343 pregnant 
women and studied the distribution of U. urealyticum serotypes in pregnant 
women with and without BV. From each woman a vaginal swab for culture 
and Gram stain was obtained during the first prenatal visit. By Gram stain, 
the vaginal flora was considered to be normal when predominantly 
lactobacillus morphotypes were found and was considered to be consistent 
with BV when predominantly Gram-variable rods were seen without or 
with only few lactobacdi. U. urealyticum isolates were serotyped by ELISA 
and IFA using MAbs to the 14 serotypes. U. urealyticum was isolated from 
148 (43%) of the women and M .  hominis from 12 (3%). On gram stain a 
normal vaginal flora occurred in 249 (86%) of the women and abnormal 
vaginal flora in 49 (14%). Among women with a normal vagiual flora, the 
isolation rate of M.  horninis was 1% as compared to 18% in women who had 
an abnormal vaginal flora ( P  < 0.001). For U. urealyticum, the isolation rate 
raised from 41% in women with normal vaginal flora to 51% in women 
with abnormal vaginal flora (P=0.276) 102 U. urealyticum strains were 
serotyped, 85 strains were isolated from women having a nomial vaginal 
flora and 17 from women with BV. No significant differences in the 
distribution of the different serotypes were found among women with 
nomial and abnormal vaginal flora except for serotypes 3 and 6. Serotype 3 
was significantly more isolated in women with normal vaginal flora (54% vs. 
18%; P=O.007) and serotype 6 had a higher incidence in women with BV 
(13% us. 35%; P=0.035). These preliminary results can point to a possible 
implication of serotype 6 in BV. 
v1 Microorganism isolates in urethral exudates in 
outpatients - retrospective study 
M. A. Orellana, M. Aramendi, G. Galera 
Madrid, E 
Objectives: To know microorganisms producing of urethral infections in 
outpatients of the south-west and central area of Madrid, Spain. 
Methods: 675 samples of urethral exudates were collected in the laboratory 
between October 1993 and March 2000. The age ofpatients was from 17 to 
65-year-old. The clinical symptoms were from nonspecific discomfort to 
leucorrea. We took three samples: (1) for Gram stain and culture in blood- 
agar, Tayer-Marrin agar and Sabouraud agar; (2) for detection of M.  Hominis 
and U. Urealytirum for the Mycoplasma DUO method (Pasteur); and (3) C.  
Trachomatis determination for enzymatic Testpack method (Abbott). 
Results: 248 of 675 samples studied were positive (36.74%). The 
microorganim isolates were: U. Urealyticum 132 (55.22%), N. Gonorrhoeae 
41 (16.53%),G(-) bacillus 29 (11.69%), C. Trachomntis 22 (8.87%), Ec. 
Faecalis 16 (6.45%), M.  Hominis 14 (5.64%), Candidas sp. 12 (4.83%), St. 
Agalartiae 11 (4.43%), S.  Aureus 3 (1.21%). Haemophylus sp. 2 (0.8%) and St. 
Pneumoniue 1 (0.4%). There was association of 2 or more microorganisms in 
37 samples (14.92% of positives cultures and 5.48% of total). The 
associations were: U. Urealyticum and M .  Hominis 10 (27.02%), U. 
Urealytirum and N. Gonorrhoeae 5(13.51%), U. Urealyticum and E. Coli 
5(13.51%), U. Urealyticum and Ec. Faecalis 5 (13.51%), U. Urealyticum and C. 
Trachomatis 4 (10.81%), C. Trachomatis and N. Gononhoeae 2 (5.40%) U. 
Ureafyticum and St. Agalartiae 1 (2.70%), Serratia and Candidu sp. 1 (2.70%), 
U. Urealyticum and Candida sp. 1 (2.70%), N. Gonorrhoeae and H. 
Parainfluenme 1 (2.70%), M. Hominis, U. Urealyticum and St. Agalactiae 1 
(2.70%) and M. Hominis, U. Urealyticum and Candida sp. 1 (2.70%). 
Conclusions: More of 1/3 of samples studied were positive (36.74%). The 
most frequent microorganism isolated was U. Ureulyticum (55.22%). There 
was association of 2 or more microorganisms in a elevated proponion 
(14.92%), when U. Urealyticum was the more frequently associated. 
(p6431 The rational microbiological diagnostic procedure of 
reproductive tract infections 
A. Bialecka, A. Kasprowicz 
Krakow, PL 
There are great numbers of different etiological factors that may cause 
vaginal infections. The frequency of their occurrence in particular 
investigated group ofpatients is also very Merentiated. The article presents 
rational and efficient diagnostic procedures that enable detection of 
etiological factor. 1275 vaginal and endocervical swab specimens taken 
from women aged 19-53 years have been tested. Patients from Southern 
Poland before the treatment were qualified to the examinations. 
Immediately, after the collection of specimens, the rnatenal was elaborated 
according to the following procedure. (1) Preliminary examination (pH, 
and amine test, Gram staining). (2) Basic examination (culture of aerobic 
and anaerobic bacteria, fungi, Tnchomonas vaginalir, Neisren'a gonorrhoea). (3) 
Selective examination (Ureaplasma ureulyticum, Myroplasnia hotninis - 
Mycoplasma IST bioM6rieux test, Chlamydia trachomatls - PACE 2 GEN- 
PROBE test, basing on rRNA hybri&zation. Ths procedure was successful 
in 81.7% clinical materials. The most fkequently isolates were aerobic 
bacteria 38%, as a single infecting factor in 18% exanuned patients. 
Chlamydia trachomatis was the cause of 35% infections, and in 10% cases it 
was a single etiological factor. Anaerobic bacteria, e.g. Gardnerella va@ialis, 
Mobillunrus sp. was detected in 30%, and in 7% they were single factor. 
Fungi, mainly Cundida albicam were found in 29% clinical material, and in 
9% it was as single. Ureaplasma urealyticum was detected in 16% of examined 
women and Trichomonas vagitzalis was found in 1% of this group. High 
frequency of vaginal infections and the heterogenicity of their etiological 
factor require use exact and efficient microbiologic diagnostic methods. The 
procedure described is an attempt of the rational standard in magnosis of 
vaginal infections. Correct identification of the pathogen is the main 
condition for starting further rational and effective treatment. 
lp644 Involvement of some cytokines in pathogenesis of 
inflammatory diseases of small pelvis organs caused by sexually 
transmitted infections 
A. Rudenko, 0. Romashcenko, L. Yakovenko, A. Romanenko, I. Vovk, 
N. Spivak 
Kiev, UKR 
Objectives: Immunophatogenesis of inflammatory diseases of small pelvis 
organs caused by Chlamydia trachomatis and such their complications as 
infertility and extrauterine pregnancy has not been studied completely. 
Methods: Eighty women aged 15-18 years, with chronic salpingitis, five 
women with tuba-ovarian dlseases who had been operated on for acute 
pelvic peritonitis, and 20 clinical healthy women as control, were studied. In 
73 (91.25%) patients C. trachomatis was found in association with other 
pathogens and in 7 (8,75%) patients it was in monoculture. C.  trachomatis 
was documented in the hgments of uterine tubes in all patients operated 
on. To diagnose C. nachomatis a complex of methods was used: 
immunofluorescence test (DIFM and IDIFM), DNA-diagnostic in PCR. 
The serum interferon (IFN) titration was performed in human diploid 
fibroblast culture M-19. The biological activity of tumor necrosis factor 
(TNF) was determined with cytotoxic test on mice fibroblast culture L-929. 
Results: 42.3% of patients showed the evaluated interferon titres in blood 
serum (160440 ME/mL). Supematant ofperipheric blood cells in 26.2% of 
patients had 3 times higher in comparison to the control TNF-activity. It 
was stated that the elevated serum IFN levels and the increased TNF activity 
took place in women with often recurrence of inflammatory processes in 
organs of s m a l l  pelvis, in patients with systemic chlamydiosis and also in 
women with tubo-ovarian diseases. In morphological studies of tissues of 
injured uterine tubes in women operated on, an accumulation of 
collagenous fibers and a decrease of elements of a connective tissue 
(sclerotic destruction of an organ) on a background lymphoidno-cellular 
infiltration. in the main perivascular, were detected. One of women 
operated on showed destructive alterations accompanied with destruction of 
uterine tubal fibres with the development of 'balb' tube phenomenon. 
Conclusion: IFN and TNF can participate in realization of inflammatory 
processes in organs of small pelvis and as a result in appearance of 
anatomofunctional alteration of uterine tubes. 
lp6451 Detection of human papillomavirus (HPV) DNA in 
cervical specimens by nucleic acid hybridization assay 
A. Agacfidan, M. Onel, D. Onel, S. Berkman, E. Yildirim, S. Badur 
Istanbul, TR 
Human papdlomavims (HPV) is probably the most common sexually 
transmitted virus in humans. Infected persons are usually asymptomatic. 
HPV can cause genital or skin warts, and some types are associated with 
cervical cancer. Cervical cancer is now recognized to be first identified 
virally induced cancer in women. Based on morphological, molecular and 
epidemiological studies, the high risk genotypes of HPV, mainly HPV 16 
1 16 Abstracts 
and 18 are likely to be responsible for a high proportion ofsquamous-origin 
carcinomas of the cervix, vagina, vulva, anus and penis world-wide. In this 
study, a total of 323 women aged 19-50 (mean: 34.5) with initial PAP 
smears having atypical results were evaluated. Exfoliated cervical specimens 
were obtained from the patients and these specimens were tested by HPV- 
DNA assay (Digene Hybrid Capture System) according to the manufac- 
turer’s instructions. The Digene Hybrid Capture HPV DNA assay is an in 
vitro chenduminescent test for the analysis of two HPV DNA groups in 
cervical specimens: HPV types 6,11,42, 43.44 (low risk genotypes) and 16, 
18, 31, 33, 35, 45, 51, 52, 56 (hgh risk genotypes). In ths  study, the 
cervical specimens were only tested for high risk genotypes. Fifty-one of 
323 specimens (15.8%) were found positive for HPV DNA. In conclusion; 
our study showed that the prevalence of HPV infection among women is 
common. However, further surveys in large populations are needed to 
de tem~ne the frequency of HPV infection in women in order to decrease 
cervical cancer risk due to this virus. 
wl A prospective surveillance study of sexually 
transmitted diseases among teenagers in Italy: 1991-99 
C. Bel t rm,  R. Manfred, A. D’Antuono, F. Chiodo, C. Varotti 
Bo/ogna, I 
Objective: To assess socio-demographic, epidemiological, clinical features, 
and risk factors of STD among teenagers followed at a STD centre. 
Methods: Two hundred and 84 patients @) aged 13-20 years and diagnosed 
with a STU, were prospectively evaluated since 1991. 
Results: Teenagers showed an appreciable and increasing risk to suffer from 
a broad spectrum of STD, and represented 3.6-13.3% o f p  yearly diagnosed 
with a STD in a 9-year period; > 10% of p were under the age of 18, and 
did not report condom use in the 6 months preceding diagnosis in 96.7% of 
cases. A significant increase of the female gender was found since 1993 (P  < 
0.001), but our series was greatly influenced by the recent immigration of 
fenule sex workers (who declared frequent condom use), while male 
homosexuals and drug addicts represented a minority (6 and 1.1% of p, 
respectively). Non-Italian p increased through time and overcame Italian 
ones since 1997 (P  < 0.001). When excluding p engaged in prostitution, > 
50% of p declared only 0-1 sexual partners during the last 6 months, but a 
significant increase of sexual promiscuity was observed over time ( P  < 
0.02). Over two thirds of our p never used a condom prior to the diagnosis 
of STD, and the apparently increased trend to condom use was related only 
to the recent immigration of sex workers ( P  < 0.001); lack of condom use 
proved linked to the male gender ( P  < 0.05), and a lower education ( P  < 
0.04). The 284 p of our series suffered from 297 overall STD: 
nongonococcal diseases (103 cases) and HPV infection (78 cases) accounted 
for > 60% ofoverall episodes, while the kequency of molluscum confagiosurn, 
gonorrhea, HSV and Chlaniyma disease ranged from 6.1 to 7.496, and that 
of syphilis, phthriasis, trichomoniasis and HIV infection varied from 1.3 to 
4.7%. Non-gonococcal STD and syphilis were increasingly diagnosed over 
time ( P  < 0.001 and P < 0.02, respectively), especially in immigrated 
prostitutes (and despite condom use). 
Conclusion: A nuniber of socio-demographic, epidemiological, and clinical 
features of STD showed significant variations over time among evaluated 
teenagers: recent immigration, spread of prostitution, increased sexual 
promiscuity, and infrequent condom me, are relevant and persisting risk 
factors. A permanent monitoring of STD in young adults and adolescents is 
strongly warranted, to allow a timely diagnosis and treatment, and to plan 
preventive strategies specifically addressed to this target population 
(including immigrants and sex workers). 
pml Prevalence of HHV-8 antibodies in HIV infected 
patients, sex workers and blood donors in Istanbul, Turkey 
P. Basaran, E. Ozkan, S. Ozel, G. Yilmaz 
Islanbd, TR 
Introduction: An understanding of HHV-8 seroepidemiology is critical for 
the study of its pathogenesis within a specific environment. 
Objective: Determination of the seroprevalence of HHV-8 in HIV infected 
patients, sex workers and blood donors. 
Material and methods: SO HIV-1 infected patients, 50 sex workers and 71 
hlood donors were screened for the presence of a titre of 1/40 IgG type 
HHV-8 antibodies using an indirect immunofluorescence test (Biotrin). 
Results: Out of 50 HIV-1 infected pabents, SO sex workers and 71 blood 
donors, HHV-8 antibodies were detected in 8 (16%), 5 (lo%,) and 3 (4.3%) 
people, respectively. 47 of the HIV-1 infected patients had acquired 
infection through heterosexual contact and the HHV-8 antibody positives 
were in this group. 
Conclusion: The prevalence of HHV-8 antibodies were significantly higher 
in HIV infected people when compared with blood donors (c2 yates = 3.6 P 
< 0.05), whereas the seroprevalence of sex workers was not significantly 
different &om the seroprevalence of blood donors ((c2 yates = 0.79 P > 0.05). 
Lp6481 The incidence of syphilis in Constantza county, 
detected in 1999 in the laboratory of the clinical hospital 
K. Stoicescu, V. Braga, D. Tencaliec, S. Tomasian, M. Nita 
Corzstantza, RO 
Objective: To investigate the incidence of infection with Treponema pallidurn 
in population of Constantza County. 
Method: Serum saniples were taken from 14.850 subjects (hospitalized 
patients or for screening tests). The techniques used were: VDRL, RPR, 
CFR, ELISA, TPHA. Positive samples for nonspecific tests, that showed the 
presence of anticardiolipinic antibodies, were confimied by TPHA, that 
showed the presence of antitreponemal antibodies. 
Results: Positive results were obtained in 2302 subjects (15.5%). The 
highest incidence was for the patients from dermatological wards, that was 
683 (29.66%), followed by institutionalised persons including prisoners that 
were 324 (14.07%). Screening tests for the patients from different wards of 
the hospital have detected 1032 positive subjects (44.83% from the number 
of all positive cases), with a highest incidence in gynaecology, 489 
representing 21.24% and 72 new born babies (3.1%). 
Conclusions: The incidence of syphilis in Constantza County is high and it 
is important to underline the reappearance of congenital syphilis. 
wq Syphilis and hepatitis 6 in a HIV high risk population 
J. L. Grandi, M. C.  Palhares, S. Goihman 
Sao Paulo, BR 
Objective: To determine the aPsociation of HIV infection, with syphilis and 
hepatitis B. 
Methods: HVB testing was offered to ail subjects that searched the 
Anonymous Testing Center (ATC) from Sao Paulo State Program. HVB 
tests were performed using ELISA Immunoblotting (Abbott-MEIA). 
Routine tests were used syphhs (VDRL and FTA-ABs) and for HIV- 
two ELLSA tests as screening and IFA or WB was used. 
Results: Positive test where found 18.8% for HUV, 8.6% for HIV and and 
4.1% for VDRL. AU three associations - HBV*HIV (Odds Ratio= 2.48), 
HBV*VDRL (OR= 3.47) and HIV*VDRL (OR= 7.30) were statistically 
significant (P= 0.000). Logistic regression pointed as prediction variables for 
HIV infection: VDRL (P=O.OOO); sexual preferences for the last 10 years 
(P= 0.082). In the other hand number of partners, sex, age, steady partner 
and education where not significant (aZ0.1). 
Conclusion: Both syphilis and hepatihs B infection were associated to the 
HIV, although more intensively with syphilis (OR = 10.45) than HBsAg 
(OR = 1.99) Bisexual and homosexual partners and blood transfusion where 
important covanables in the model. 
Use of fluorescence in situ hybridization for the rapid 
differentiation of pathogenic Neisseriae from other Neisseria 
species derived from clinical samples 
S. Juretschko, A.-M. Buccat, M. McDowell, R. Gautom, T. Fritsche 
Shoreline, Seattle, USA 
Pathogenic Neisseria species continue to causr significant morbidity and 
mortality, despite advances in rapid diagnostics and an expanded therapeutic 
armamentariuni. The presence of nonpathogenic species of Neissena that are 
recognized members of normal human flora in the upper respiratory and 
urogenital tracts, including N. subfluflava, N. rinerea, N. polysaccharea, among 
others, may lead to mistaken identifications and unwanted clinical 
outcomes, and occasionally to litigation. Because of these limitations, 
conventional culturing methods for pathogenic Neissena (long considered 
the gold standard) are increasingly being replaced by antigen detection and, 
more recently, nucleic acid amplification techniques. Despite technological 
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advances, some of these methods are also known to have significant 
linlitauons with sensitivity (false-negative results), specificity (false-positive 
results) and costs associated with their performance. To address the last two 
concerns, we have developed a rapid, approximately 2 h, oligonucleotide 
probe assay for the detection and differentiation of pathogenic Neisseria 
from related species. A hierarchical oligonucleotide probe-set consisting of 
six probes was designed from 16s and 23s sequence data available from 
public ribosomal sequence databases. These probes included 2 Neisseria 
genus-specific probes; one probe specific for N. gonorrhoeae; one probe 
specific for N. meningitidis; and 2 additional group probes, one inclusive of 
N. gonurrhoeae and N. meningitidir only (but not N. cirzerea or other species) 
Paediatric 
and one probe inclusive of N. n'rierea and other species, including N.  
nrenirzgitidir, but exclusive of N. gonorrhueue. Optimal hybridization 
stringency conditions were determined for each probe, including 
formamide concentrations used in the hybridizauon buffer, using 
characterized strains of Neissena and Moraxella acquired from a recognized 
culture collection (ATCC). When applied to 70 cultured isolates of N. 
menirigitidis and 20 isolates of N. gonorrhoeae derived &om upper respiratory 
and genitourinary samples, respectively, the probe set agreed 100% with 
standard culture results, serotyping, and biochemical tests. Future efforts will 
include the direct application of the probe-set to upper respiratory and 
genitourinary samples as well as for confirmation of cultured isolates. 
/p6511 Occult bacteremia in children 3 months to 5 years of age 
A. Palanduz, I. Yalcin, N.  Salnian, N .  Kayaalp, B. Ongen, A. Kaygusuz, 
N. Uzun 
Istanbul, TR 
Objectives: Occult bacteremia is the presence of bacteria in blood of 
previously healthy children with fever of short duration and no detectable 
focus of infection. In this study we planned to determine the rate of occult 
bacteremia in febrile children 2-36 months of age, to identlfy the causative 
micro-organisms, to assess the predictive values of clinical and laboratory 
cntena and to compare the efficacy and safety of ceftriaxone and 
arnoxiciuin-clavulanate treatments. 
Methods: Patients adnlitted to the Emergency Department with fever of 
>38 "C lasting less than 5 days were enrolled. Complete blood count, 
erythrocyte sechmentation rate, concentration of C-reactive protein, 
presence of bactena antigens in serum and urine were determined. Blood 
cultures were obtained. Patients received ceftriaxone or amoxicillin- 
clavulanate consecutively. 
Results: Bacterenua was identified in 14 of 430 patients (3.3%). S. 
pneumoniae, N. meningitidis, H. influenzae, and group B streptococcus were 
isolated in blood cultures. The mean age was 19 months (range 3-36 
months) in bacteremic children. The mean temperature was 40.4 "C, 
leukocyte count 24 752/m' ,  PNL count 17 230/mm3, C R P  88.2 ng/dL, 
ESR 61 nuti/ h. The laboratory parameteir were significantly higher in the 
bacteremc patients compared to those without bacteremia. Bacterial 
antigens were detected in both serum and urine of 6 bacteremic patients, 
in only serum of 4 cases and in only urine of 4 patients with positive blood 
cultures. Bacterema was treated effectively and no major complication was 
noted in any treatment group. 
Conclusion: Occult bacteremia should be kept in mind in febrile children 
aged 3-36 months without a focus of infection. Risk of bacteremia is 
high in children with fever > 40*C, leukocyte count >20 OOO/mm3, 
PNL count >15 0 0 0 / m 3 ,  CRP > 48 ng/dL, ESR > 30 mm/h 
and detectable bacterial antigens in serum or urine. Cefiriaxone and 
anioxicillin-clavulanate are both effective and safe in the treatment of 
occult bactereniia. 
(p6521 Ochrobactrurn anthropi bacteraemia in 
immunocompetent children 
A. Christidou, M. Bitson, E. Galanakis, E. Giannousi, S .  Sbyrakis, 
Y. Tseleutis 
H~rakfiori, GR 
Objectives: To present the clinical spectrum of Ochrobartwm artthropi 
bacteraemia in immunocompetent children. 
Methods: All children hospitalized in the University Department of 
Paediatrics, Herakhon, during January 1997-Novenber 2000 with a positive 
blood culture for 0. anthropi were included. 
ResuIts: a blood cultures were collected on admission. 0. anlhropi was 
isolated from the blood cultures of 10 children, aged 2 months to 7 years. 
None of the chddren had a history indicative of underlying disease. All 
children but one were febrile on admission and two presented with febrile 
seizures. Four of the children were diagnosed as having an upper respiratory 
tract infection, four as having a viral infection without a documented source 
of fever and the remaining two as having a viral gastroenteritis. The children 
presented with leucocytosis (mean, 15.0; range, 7.3-36.2 x 109/L) and 
neutrophilia (mean, 9.8; range, 3.8-20.5 x 109/L). Erythrocyte sedimen- 
tation rate was d d l y  elevated (mean, 33; range 9-67 mm/h). All other 
cultures did not yield pathogenic organisms. All strains of 0. arithropi 
isolated were resistant to beta-lactamic antibiotics except for inupenem and 
susceptible to aminoglycosides, cotrimoxazole and quinolones. Five patients 
&d not receive any antibiotics and only two received regimens effective for 
0. unthropi. AU patients had a rapid and full recovery and were discharged 
after a mean hospitalisation duration of 2.5 days. 
Conclusions: Our findings indicate that 0. anthropi is a potential pathogen in 
iinmunocompetent children, associated with commuruty acquired infec- 
tions of nonspecific clinical presentation resembling viral respiratory tract 
infection and gastroenteritis and bacteraemia. The organism seems to be of 
low virulence and both the clinical significance and the appropnate 
management remain undefined. 
[p6531 Case report of a Sphingobacterium rnultivorurn 
septicemia in an infant 
M. Aydogan, Z. Yumuk, V. Dundar, E . 3 .  Aritoy 
Kocaeli, TR 
A 73-day-old male was admitted to Kocaeli University Faculty of Medicine 
Hospital on 21 November 1999 with a 12-h history of lethargy, 
unwillingness to breast-feed, vomiting, convulsion and a fever to 39 'C. 
He was transferred for further management from a 'tent-city health center' 
in Kocaeli, where an earthquake of7.4 Richter scale centered on 17 August 
1999. The fanuly was living in a tent set on the ground after the earthquake. 
The patient was the first child of a 15-year-old mother. He was a fulltemi 
infant with no perinatal problems and his medical history was unremarkable. 
The patient was hospitalized with a diagnosis of suspected sepsis. S. 
multivorum was isolated from cultures of two blood samples drawn on the 
day ofadmission after an incubation of48 h at BACTEC 9050. On the third 
day he was afebrile and the next day he was taking oral feedings well. The 
serum immunoglobulin and circulating lymphocyte surface marker profile. 
and C3 and C4 concentrations tested on 25 November 1999 and retested on 
12 July 2000. were normal. Both mother and patient were seronegatlve for 
HIV. The organism grew low convex, smooth and opaque. nonhemolytic, 
light yellow pigmented 1 mm diameter colonies on blood agar after 24 h 
incubation. The isolates were gram negative bacilli, oxidase-and catalase- 
positive and nonmotile. Biochemical identification of the isolates was 
acconiplished by using the Sceptor Gram Negative BreakpointAD panel 
(Cat. no. 4480430) with the results ofprofile number: 2304040, validity: 12 
and confidence: 95.01. The definitive identification was reached by means 
of the set of tests described in the Manual of Clinical Microbiology. 
Antibiotic susceptibility test were performed by the same Sceptor panel and 
confirmed by the Kirby-Bauer disk diffusion method according to NCCLS 
guidelines. We describe the first case to our knowledge of invasive disease 
caused by S.  multivorum in a patient without a predisposing condition. The 
isolation of S. multivorurn from clinical specimens has been considered as an 
oppurmnistic pathogen, probably acquired nosocomially, appears to affect 
patients with predisposing conditions. The evidence in the present case, 
however, demonstrates the pathogenic potentialities of this organism and 
strongly suggests that under certain circunistances S. niitltirmrunt should be 
added to the list of micro-organiml that may cause invasive disease m an 
otherwise normal host 
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Conclusions: (1) The incidence of subdural effusion in acute bacterial 
frequently during the first year of life. (90.9%). (3) All the effusions ttudied 
/p654] Of and susceptibili~ Of meningitis in our area is 17.7%. (2) Subdural collections occur nlOSt 
from pediatric blood stream, community- and nosocomially 
- I  . . .  - 
acquired pneumonia infections are not associated with clinical signs. (4) The overall outcome is good and 
no lace complications are observed 
A. C.  Fluit, F.-J. Schnutz, J. Verhoef, European SENTRY Participants 
Group 
Utrerht. h'L ~. 1 P656 1 Characteristics of Haemophilus inffuenrae isolates 
causing meningitis in Poland 
Background: Antibiotic susceptibilities of bacterial isolates causing infections 
in adults and special groups of children, e.g. those with otitis media, are 
A. Skoczynska, A. Klarowicz, W. Hryniewicz 
Wucsalv, PL 
well-known. However, little is published about the antibiotic susceptibilities 
of isolates causing infections in hospitalized pediatric patients (PP). Here we 
report those cusceptibilities for isolates from blood stream infections PSI), 
community- and nosocomially acquired infections (CAP and NAP). 
Methods: Twentyfive European university hospitals sent nearly 3000 
isolates from BSI, CAP, and NAP infections as part of the SENTRY 
Antinlicorbial Surveillance Program 1997-98. The isolates were tested 
against at least 12 different antibiotics according to NCCLS criteria. 
Results and discussion: The frequency of isolation of the major pathogens 
among PP compared to all patients (AP) is similar with the exception of 
Esherirhia c d i ,  which is less frequently isolated from PP with BSI (13 vs. 
21%). For nearly all antibiotics tested, pediatric Staphyiororrus aureus isolates 
from BSI were less susceptible. This was not observed for coagulase negative 
staphylococci (CNS). Susceptibilities of pediatric isolates for some beta- 
lactam antibiotics and ciprofloxacin was higher than for isolates from AP. 
N o  clear differences were observed for E. roli, but Pseudomonar aeruginosa 
and Klebsiellu piieumoriia from PP BSl generally were also less susceptible. S. 
arrreus isolates from NAP among PP were generally also less susceptible, but 
Streptocorrus prteumurriue isolates from these infections tended to be more 
susceptible when isolated from PP. Pedatnc P. aeruginosa and Enterohurler 
spp. isolates 60111 NAP were also less susceptible. No clear differences in 
susceptibilities among H .  it?fluerirae and M .  ruatawhalis isolates from CAP 
were observed, however, S. prieumoniue isolates were less susceptible when 
isolated from PP. The generally lower susceptibility of isolates from PP 
might be caused by their colonization by hospital strains which usually are 
more resistant to antibiotics. However, this does not explain the higher 
susceptibibty among CNS. The lower susceptibility among pneumococci in 
CAP may be explained by the high antibiotic pressure caused by the 
treatment of antis media. 
Conclusions: Isolates from BSI, CAP, and NAP obtained from PP generally 
are less susceptible to antibiotics than those obtained from adult patients. 
Objective: T o  investigate the relatedness of Hoemophilus ir!fluerrzae isolates 
responsible for meningitis in Polish children. 
Methods: The study Wac performed on all H .  ir!fluenzoe isolates collected 
between 1997 and 1998 during the routine moiiitonng of bactenal 
meningitis in the National Reference Centre for Dactenal Meningitis 
(NRCBM). All the strains were identified and serotyped according to 
standard procedures. PCK reactions were run to confirm species 
identification and serotype determination, and to detect capsule-specific 
genes. The  relatedness among icolates was evaluated by restriction fragment 
length polymorphism (RFLP) of SmaI-digested chromosomal DNA 
following PFGE and arbitrary primed PCR analysis of total DNA with 
ERICl  and ERIC2 primers. 
Results: Fifty-eight H. influenrae strains isolated &om CSF were collected in 
the NRCBM. Meningitis caused by thic pathogen predominated in the age 
group of 2-24 months (64.0%). Fifty-four isolates (93.1%), which belonged 
to serotype b (Hib) had very similar patterns of PFGE according to criteria 
of Tenover ef al. These patterns however, showed variations with 12 
subtypes, where the most common subtype was present in 55% off all tested 
isolates. Three out of five Hib isolates, producing beta-lactamases had an 
identical PFGE patterns. Four distinct PFGE patterns were characteristic for 
four remaining noncapsulated isolates. RAPD analysis with the ERICl  
primer has shown 11 different DNA amplification patterns and with the 
ERIC2 primer 6 patterns. 
Conclusions: Haemiyhilus influerizae type b is still one of the most common 
etiologic agents of bactenal meningitis in Poland, because mass vaccination 
has not been fully implemented in our country yet. The analysis of the 
PFGE patterns showed that the Hib isolates, even without epidemiological 
links, belonged to the came clone or to closely related subclones. 
lp655; Subdural effusion in acute bacterial meningitis: study 
in 97 paediatric cases 
lp657) Nasopharyngeal carriage rate of Haemophilus 
influenzae in children of 7-12 living in Erzurumflurkey 
M. A. Mate, C. BLAez, E. Vizquez, C.  Aso, C. Figueras 
Bordoria, E 
Background: Subdural effusion during acute bacterial meningitis is common 
in infants. The factors that influence its formation remain unclear. 
Objectives: T o  deternune the incidence, characteristics and outcome of 
subdural steryl collections complicating bacterial meningitis in our area. 
Methods: W e  reviewed the medical records of 97 patients aged between 0 
and 36 months with bacterial meningitis admitted in our Children Hospital 
from 1992 until 1999. 
Results: We studied 97 patients who were admtted at our hospital with 
bacterial meningitis. A cranial computed tomography (CT scan) and/or 
ultrasonography was performed in 62 patients and sudural ehs ion  was 
diagnosed in 11 patients. O f  these patients (9 males and 2 females), 5 were 
younger than 6 months (45.5%) and 5 were between 6 and 12 months old 
(45.5%). Haemophilus ir$uemae was the most frequent etiologic agent 
(54.5%). In Neisseria rtrenirzgitidis and Streptococcus pneumowiae infection the 
rates were 27.2% and Y%, respectively. There were no clinical differences on 
admission among the patients with and without subdural effusion 
complication (fever, meningeal signs, irritability, shock coma, etc.). The 
cerebrospinal fluid profile on admission was also studied without variability. 
2 patients developed secondary fever. Seizures occurred in 3 patients 
(27.2%). Prolonged or recurrent lethargy was not observed in any case. 
Focal neurological signs were obseived in 2 cases (18.1%). Abnormality on 
electroencephalography was present in 3 cases (27.2%). The duration of 
antimicrobial therapy was horn 7 to 31 days (mean= 16 days). Needle 
aspiration was not performed in any case. The mean duration of 
hospitalization was 22 days (range 12-32 days). The neurological status 
on discharge was normal in all cases. 
A. Ayyildiz, A. E. Aktas, H. Yazgi, S. KZjse 
Erzurum, TR 
Micro-organisms of genus Haemophilus and especially Haemophilur iujuenzae 
( H .  ir$uenzue) type b (Hib) are responsible for a considerable number of 
invasive bacterial diseases seen during childhood period, and the source of 
infection caused by these micro-organisms is generally healthy individuals 
carrying the micro-organism in their nasophaxynx. The prevalance of 
camage is high in children under 5 years of age and relatively low in those in 
adults. I t  was aimed in this study to determine the rate of nasopharyngedl 
carriage of Haemophilus species by children of 7-12 at the age of primary 
education and living in Erzunim, and to investigate the factors affecting this 
rate. The study covered 143 female and 157 male, totally 300 students 
selected from 3 schools with different socio-economic features. Nasophar- 
yngeal swabs taken from these students were streaked into chocolate agar 
medium to which 0.3 nig/mnL (18.9 U/mL) bacitracin were added, and 
then incubated for 24-48 h at 37 " C  in an atmosphere with 5-10'% CO2. 
Haemophilus species were identified by macroscopic and microtcopic 
exanullahons of suspicious colonies reproduced and by determining their 
X and V factor needs. Later those identified as H .  influenroe were serotyped 
by specific capsule antisera. As a result, micro-organisms of Haemophilus 
species were recovered from 51 (17.0%) students. It was observed that 9 
(3.0%) ofthose were found to be H. influenme type b (Hit), 30 (10.0%) H .  
infuenzue non type b (other types), and 12 (4.0%) were found to be H.  
parair$uenzae. Our  findings indicate that Hib camage rate decreased ac the 
age increased, but in contrast with the findings in literature, risk factors such 
as sex, number of sisters and brothers, having brothers or sisters attending 
nursery, presence of smoking habit in the family, and economical status of 
the family have no relation with carriage. 
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v/ invasive pneumococci in children under 5-years old 
A. Gene, C. Latorre, T.  Juncosa, C. Munoz, A. Gonzalen-Cuevas 
Barcdona, E 
Introduction: S. pr~umotiiae is a main cause of invasive infections in 
children; some of them could be prevented with the introduction of the 
new conjugate vaccine useful in young children and infants. As the number 
of included serotypes is limited, it is worth to know their distribution in our 
target population, as well as their degree of penicillin resistance, which is 
very high in our pediatnc patients. 
Objectives: To know peniciUin susceptibility and serotypes of invasive 
pneumococci isolated from chddren less than 5-years old in order to predict 
the usefulness of heptavalent conjugate vaccine in our population according 
to these characteristics of the strains. 
Patients and methods. We studied all 92 pneumococcal strains isolated 
between January 1989 and June 2000 &om usually sterile sites of children less 
than 5-years old (57 of them younger than 2 years) attendmg our hospital. 
Results: Dinlitiished penicillin susceptibility (penR) was detected in 48.9% 
ofstrains (MIC: 0.1-1 mg/L in 35 strains and 2 mg/L in 10 strains). This is 
slightly higher than penR rate of invasive strains infecting all our children 
less than 15-years old (43%) but much lower than that of all invasive and 
noninvasive strains infecting this same population (64%). Resistance level 
was similar along the years of the study. PenR rate was higher (though 0.25 
> P > 0.05) in children less than 2-years old (54.4%) than in those aged 
two to five (40%) and osteoarticular isolates showed the highest penR 
percentage (90%). 73 of our isolates (40 of them from infants under two) 
were antigenically related to serotypes included in the heptavalent conjugate 
vaccine. Set-otypes of all penR strains were thoce of the vaccine. 
Conclusions: I .  High percentage of invasive penK pneumococci, mainly 
among strains isolated from patients < 2 years old and in those producing 
osteoarticular infections. 2. Most of our isolates from sterile sites belong to 
serogroups/types anugenically related to those included in heptavalent 
conjugate vaccine. 3.  Heptavalent vaccine would cover all children less than 
5-yean old of our study suffering &om a penR pneumococcal invasive disease. 
lp659 Abnormal findings on chest high-resolution computed 
tomography in children after Mycop/asma pneumonia 
P. Korovessi, E. Tnka-Graphakos, S. Lafogianni, E. Garou, E. Papadakis 
Athem, GR 
Introduction: Mytoplusma pneumatziae is a frequent but underdlagnosed cause 
of community acquired pneumonia in children and therefore appropriate 
macrolide treatment is often given late. The clinical course of Mycoplusma 
ptietrtnoniae pneumonia is typically mild and self limted. There are however, 
several case reports of severe complications following this illness. 
Objectives: This study was conducted to investigate retrospectively the 
clinical course and possible complications of all diagnosed Mycoplasma 
infections in our Paediatric Department during the last year, and to identify 
the likelihood of developing pulmonary structural abnornialities. 
Methods: All children's hospital records with Mycoplasma infection were 
reviewed. We Ftudjed their X R  findings, mycoplas~na antibody titers, 
length of therapy and clinical course of the disease. 
Results: 14 children were included in the study. Abnormal X R  findings, 
compatible with pneumonia, were present in 78%. (11/14) of children. 3 
out of 11 children (27%) who had a history of recurrent pneumonia in a period 
of 8-12 months, underwent chest high resolution computensed tomography (2 
months after the last episode ofpneumoma. 2 children (18%) had bronchectasis 
and 1 had bronchal wall thickening. There were no significance dfferences in 
age of children studied or in the initiation and length of treatment. Also no 
other causative agent of the infection was identified. 
Conclusion: Our abnormal chest HRCT findings suggest that Myioplasma 
pneumonia, although is considered a mild and self limitted disease, may 
predispose to some of the chronic pulmonary diseases that affect adults. In 
view of thls findings a prospective study is now conducted in our 
department in order to identify possible risk factors. 
Ip6601 Pulmonary tuberculosis in children: a review of 324 cases 
F. Baquero-Artigao, M. J .  Garcia Miguel, I. Sanchez-Albisua, M. 1. De Jose, 
F. del Castillo 
Madrid, E 
Objectives: To describe the features of pulmonary tuberculosis (Tb) in 
children treated during two decades (1978-97) in a reference hospital in 
Madrid (Spain). 
Methods: From 1978 to 1997, the medical records of children younger than 
14 years of age with diagnosed pulmonary Tb were reviewed. Criteria for 
pulmonary Tb included a positive Mantoux skin test (i5 nini induration) 
and abnormal chest roentgenograph, or a positive culture for M .  tuheriulosis 
from gastric aspirate, bronchial exudate, pleural fluid or sputum. 
Results: A total of 416 cases of Tb  were diagnosed during the study period. 
Of these, 324 children (77.8%) had pulmonary involvement. Four percent 
were foreign-born. A history of BCG vaccination war documented in 10% 
of children. The median age at diagnosis was 4.4 years. Sixty-five percent 
were younger than 5-year-old. Only 4/175 (2.3%) were HIV positive. 
Diagnosis resulted from the examination of an ill chlld in 47% of cases, a 
case contact investigation of and adult suspected of having Tb in 38%, and 
routine tuberculin sktn testing in 13%. The adult source case was identified 
in 63% of cases (15'36 after the child diagnons). In most cases (86%) the 
source was a household contact. The proportion of known HIV-infected 
adult contacts was 10.8% (1 1/102). The radiological pattern were as follows: 
hilar adenopathies (38%), pulmonary infiltrates (19%). nuxed (34'%), pleural 
(5%), cavitary (2%) and miliary (1%). Gastric aspirate cultures yielded M. 
tuberculosis from 31% (85/272) of the chddren. The culture yield was 
lower from bronchial exudate obtained from bronchoscopy (5/39 children, 
13%). Most patients (70%) received a 6-month-course chemotherapy. A 
total of 313 patients (96%) have been followed up for at least 18 months, and 
no relapses have been found. Susceptibility test were perfoned only in the 
last 10 strains, one of which was resistant to isoniazid. 
Conclusions: Pulmonary Tb is the most important form of the infection and 
remains an important cause of morbidity in our countiy. The risk of 
developing the disease is higher in the first years of life. The most common 
radiological pattern is the presence of hilar adcnopathirs. The short-course 
chemotherapy regimen is effective and well-tolerated. Early examination of 
pediatric contacts in infected adults and epidemiological investigation after the 
diagnosis of Tb m a child are the key to controlling Tb in the community. 
/p6611 Combination therapy of cefixime and amoxicillin for 
pediatric sinusitis patients resistant to amoxicillin monotherapy 
K. Sugita, Y. Fujimah, N. Komatsu, S. Harada, S. Kimura. H. Watanabe, 
K. Shinmu, Y. Yoshida 
Chiba, J 
Objective: Pediatric sinusitis tends to recur due to inixed infection and IS 
often resistant to arnoxicillin (AMPC) therapy alone. Recently, increasing 
strains of S.  pneumoniae and H .  influenrap isolated &om the nasopharyiuc are 
resistant to beta-lactams, which IS one of the major factors of AMPC 
treatment failure. In this study, we examined the clinical efficacy of cefixime 
(CFIX) + AMPC in pediatric sinusitis patients with clinical failure of 
AMPC alone. 
Methods: Pediatric patients whose sinusitis was resistant to AMPC (40 mg/ 
kg per day) monotherapy were the wbjects in this study. CFIX (8 mg/kg 
per day) and AMPC (40 mg/kg per day) were administered in combinanon. 
Clinical efficacy was assessed by the following equation: [(Amount of 
otorrhoea + type of nasal or postnasal discharge + nasal obstruction + cough 
and sputum)/nurnber of symptoms] + Amount of nasal/postnasal discharge. 
Bacteriological effects were evaluated in terms of the bacterial eradicanon rate 
Results: 51 of 54 cases, for whom initial AMPC monotherapy was 
ineffective were further treated with CFIX + AMPC combination therapy, 
and analyzed in terms of clinical efficacy. O f  these 51 cases, 49% had mixed 
infections. The averages of age, body weight and duration of combinauon 
therapy were 4-year-old, 15.4 f 3.9 kg and 6.5 f 3.2 days, respectively. 
The amount of nasal or postnasal discharge decreased in 70.2% of the cases 
at the end of the combination therapy. The symptomatic score improved 
from 3.2 f 1.0 (Initial) to 1.2 (End of therapy). The therapy was judged to 
be clinically effective in about half of cases (41.7% had excellent response). 
The overall efficacy rate was 72.9% when partial response was also included. 
The percentages of the cases in which causative pathogens were eradicated 
from nasal/postnasal discharge were 46.2% (S. prreumoiiiae), 69.2% ( H .  
influenzae), and 77.8% (M.  cutarrhalis). The MIC90s of CFIX and AMPC to 
S. pneumoniae were 4 mg/L and 0.5 mg/L, and to H .  it!fluwzae, 0.06 mg/L 
and 16 mg/L, respectively. 
Conclusion: Combination therapy of CFIX + AMPC was effective in 
72.9% of the cases including the partial response. In about half of the cases, 
the clinical response was excellent, which may indicate the strong antibiotic 
activity of CFIX and clinical synergy. Thus combination therapy could be 
recommended as an alternative treatment for mixed infection with S. 
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puetrmoniue, H .  ir!fluenzae and M. rotarrhalis, frequently seen in acute sinusitis 
cases resistant to AMPC monotherapy. 
p6621 Evaluation of pathogens isolated from cases of acute 
suppurative otitis media in children obtained by parasnythesis 
A. Bayram, 1. Balci 
Gaziantep, TR 
Acute suppurative otitis media is a common illness of childhood and usually 
occurs secondary to an upper respiratory tract infection. In order to evaluate 
the etiological agents of these infections in our region, children between 0 
and 7 years of age who admitted to various clinics with coniplaints of acute 
onset of earache and/or drainage from ear were examined. During a period 
from March 1999 through March 2000, 75 cases were diagnosed as acute 
suppurative otitis media and their nliddle ear aspirates were collected via 
parasynthesis under local anesthesia. Clinical specimens were directly 
inoculated onto routine bacteriological and mycological culture media. Any 
growth on culture was evaluated first by direct methods and than confirmed 
with the Sceptor Sycteni (Becton Dickinson). Antimicrobial susceptibility 
tests were perfomed with the &sc diffusion technique. From 61 (81.33%) 
of cases bactenological pathogens were isolated and their antimicrobial 
susceptibility tests were performed. The most commonly seen nlicro- 
organism was Streptorocrus prreumoniae (26.23%) followed by coagulase- 
positive staphylococci (24.67%). Sfrepturorrus pyugenes (group A)(16.39%), 
Haemop,philus ir!fluenzae (9.83%). Pseudornoiius species (6.55%) and Esrherirhia 
roli (3.28%). No mycological pathogen was defined. Isolates of Sfreptororeus 
piieumouiue were mostly sensitive to ampicillin (81.25%) and to second and 
third generation cephalosponns like cefuroxime (87 SO%) and ceftriaxone 
(81.25%). Although some children with acute suppurative otitis media may 
improve without the use of antimicrobial agents w i h n  2-7 days, appropriate 
antibiotic therapy IS necessary to prevent recurrent episodes of infection. 
lp6631 Clinical evaluation of azithromycin in 
odontostomatological infections in children 
E. Pinientel, E. Salazar 
Caracas, YV 
The flora of oral cavity is normally coniposed of commensal, noninvasive 
organisms, including Gram-negative and Grani-positive cocci and bacilli, 
both aerobic and anaerobic species, living in equilibrium. If this equilibrium 
becomes disturbed, for example by the build up of dental plaque, invasion of 
the tissues can occur. Particularly if damage has occurred to the dentine, the 
dental pulp, normally resistant to infection, may become infected, and this 
may progress to the formation of 3 periapical abscess. Infection of the dental 
pulp leads to increased pressure, characterized by percussion pain, and there 
is  the nsk of the dissemination of organisms from a periapical abscess into 
the bloodstream. The purpose of this study was to evaluate the clinical 
efficacy and the safety of oral azithroniycin in odontostomatological 
infections in children. The study was performed using an open test method, 
without a comparative drug. Twenty-five children, aged between 2 and 8- 
year-old, were included in the investigation. These patients showed clinical 
and radiographic signs and symptoms of periapical abscess. Samples obtained 
for niicrobiological evaluation. Patients were treated with an oral suspension 
of azithromycin (10 mg/kg) given once daily for three consecutive days. 
Results showed that there typical odontogenic infections of the oral cavity 
are mixed infections with a predominance of anaerobic organisms. We 
could also demonwate that the implemented therapy was effective in all 
patients treated (100%). Only two patients (8%) reported adverse events 
(mostly of gastrointestinal nature). We concluded that azithromycin was 
well tolerated and effective against the periapical abscesses presented by this 
group of patients. 
lp6641 Pediatric diarrhoea in Bahrain 
Y. Ismaeel. A. Janisheer, A. Arzese, A. Qarieballa, M. Al-Otaibi, A. Rotta 
Mauarna, BRN; Udine, I 
Objectives: To ectablish the most coiiimon causes of severe diarrhoea in 
children in Bahrain including residents and expatriates admitted to the 
Accident and Emergency Department of Salmaniya Medical Complex with 
special attention to bactenal, viral and parasitic agents. 
Methods: During the period November 1998-June 2000, 805 fecal samples 
&om children up to 15 years were examined for parasites, ova and cysts by 
direct wet preparation, formol-ether concentration and modified Ziehl- 
Neelsen stain. Samples were routinely cultured for Salmonella, Shigella, 
Campylobarter and Enteropathogenic E. coli (EPEC) on appropriate selective, 
liquid and solid media. AU stools from children below three years of age 
(653 samples) were processed for adenovims and rotavirus using Iliarlex ' I  
Kota-Adeno (Orion Diagnostica) card agglutination test kit. 
Results: Four subjects were found positive for parasites. 83 (10.3%) samples 
from 75 Bahraini children and 8 non-Bahraini were found positive for 
clinically relevant bactena: Shipllapexnen' (7). S. sorrnei (8),  S. dysente~iae (1) 
and S. boydii (8), Salmonellae (48), Enteropathogenic E. roli (4) were isolated 
and Campylobacter jejuni was found in seven (1.6%) children out of 426 
samples examined. 91 (13.9%)) samples were found positive for rotavirus and 
only 4 (0.6%) samples were found positive for adenovirus. 
Conclusions: Although a seasonal variability must be taken into account 
when analyzing the results, our data suggest a prudent use of antibiotics 
since bacterial infections appear to represent only 10.3% of cases. 
)p665) A comparative study of prevalence of 
enteropathogens causing diarrhoea in children in Ifakara, 
Tanzania during the rainy season vs. the dry season 
M. Vargas. J .  Gascbn, H. Urassa, J. Vila 
Barcelona, E; lfakara, EAT 
Objectives: Diarrhoea is an important cause of morbidity and mortality in 
children under 5 years of age from developing countries The aim of this 
work was to determine the prevalence of the enteropathogens causing 
diarrhoea among children under 5 from Ifakara-Tanzania during the dry and 
rainy season. 
Methods: During the July-September 1996 (dry season) and February-May 
1997 (rainy season) stool specimens from 348 and 123 children under 5, 
who attended Saint Francis Hospital were cultured for E. roli and other 
bacterial eiiteropathogens for conventional methods. Rotavirus were 
detected using an agglutination test. The virulence factors associate with 
diarrhoegenic E. roli were detected by PCR technique. It was used specific 
primers to detect enterotoxigenic E. roli (ETEC), enteropathogenic E. coli 
(EPEC), enteroaggregative E. mli (EAEC), enteroinvasive E. colt (EIEC), 
and verotoxigenic E. coli (VTEC). The statistic analysis was performed using 
the Mantel and Hensel Test. 
Results: The most prevalent enteropathogens during the dry season were 
diarrhoegenic E. coIi (37.36%), Skigella spp. (24.14%), and Rotavirus 
(23.56%), other enteropathogens as Campylobatter spp., or Salmanella spp., 
presented an incidence lower than 3%. In rainy season the most prevalent 
enteropathgens were diarrhoegenic E.  coli (28,5%) followed of Ciardia 
lamblia (17.1%), Shigella spp. (1 2.2%,), Rotavirus (3.2%~), presenting other 
enteropathogens an incidence lower than 3%. Of the 130 diarrhoegenic E.  
coli isolate in the dry season, 73(56.2%) were associate with other 
enteropathogens, whereas in the rainy season were 13 (37.4%. Among 
diarrhoegenic E. roli, ETEC was the most prevalent during the rainy season 
with a significant difference respect dry season ( P  < 0.0001). 
Conclusion: Diarrhoegenic E. coli is predominant enteropathogen in both 
season without significant differences, however, the prevalence of some 
patrons of virulence of E .  coli in each season were significant. Skigella spp. 
and Rotavirus were more prevalent in the dry season, and Giardia lamblia 
and Shigella in the rainy season. 
lp6661 Clinical features of contemporary E. co/i infection in 
infancy 
T. Milanova, M. Stoycheva 
Ploudiu, BC 
Objectives: To analyze clinical features laboratory data and the outcome of 
Colienteritis in infants in the last 2 years. 
Methods: 210 infants aged from 5 days to 2 years with culture confimied P. coli 
infection were studied, with respect to morbidity rate, the group of isolated 
organisms, clinical features, a bequency of complications and an adequacy of 
management. Conventional clinical and laboratory methods were used. 
Results: The highest value of specific morbidity was in infants 1-3 months 
of age (38.5%). The most common pathogen was E. coli 06 (38.2%) 
followed by E. coli 026 (30.0%), E. roli 01 11, E.  coli 0144 and others. E. roli 
infection was nosoconllally acquired in 43.81% of cases. 83% of the cases 
Clinical Microbiology and Infection, Volume 7, Supplement 1, 2001 121 
were asymptomatic camers of pathogen E. coli. The most commonly 
presented symptoms in the rest patients were analyzed with respect to their 
intensity and duration: temperature (67%), vomiting (73%), diarrhoea (63%) 
and presence of mucus (70%) or blood (17%) in the faeces. Toxicosis, 
neurotoxicosis, ileus paralyticus, hepato-and splenomegaly were also 
observed. The most common clinical form was enterocolitk (41%). Treatment 
was canied out with antibiotics and intensive rehydration only in ill children, 
not in asymptomatic camers. Two of the children reported died. 
/p6671 Socioeconomic factors and incidence of acute diarrhea 
during the first 3 months of life: a cohort study 
C. Macias, F. Franco, K. D. Long, Y .  Martinez, M. C. Lopez 
Cuemavaca, Mexico City, Durango, MEX 
Introduction: Available evidence indicates that the incidence of infectious 
diseases is lowered by breastfeeding. In thls paper we report on the role of 
breastfeeding along with relevant socioeconomic factors, regarding the 
incidence of acute diarrhea during early infancy. 
Objective: To assess the effect of breastfeedmg and its interactions with 
socioeconomic factors, in regard to the incidence of acute infantile diarrhea 
during the first three months of life. 
Material and methods: We carried out a prospective cohort study with a 
follow up of three months. The study population was a total of 327 pairs of 
mother and child, living in the city of Durango, Mexico, spanning the 
penod April-June, 1994. Data analyzed included simple univariate and 
bivariate crosstabulations, and also the fitting of multivariate logistic 
regression models with random effects, to take into account every different 
point of observation during follow-up. 
Results: Infants who do not receive exclusive breastfeeding are a t  a 
significantly increased risk of having acute diarrhea during early infancy. 
Moreover, the protective effect of breastfeeding is independent of the effects 
of factors such as lacking potable water, poor conditions of the household, 
lack of social support for baby care, and having an adolescent mother. 
Conclusions: Alike previous studies, we found that exclusive breastfeeding 
has great importance, since this practice protects child's health and allows for 
a better development, despite unfavorable social and economic conditions. 
Diagnosis of fungal infections 
lp6681 Urinary infection in school population 
R. Jakimoska 
Pnlep, M A K  
Objectives: To make statistic analysis of the urinary infections of the tchool 
population, according to age, sex, etiology, symptoms, blood and urine 
analysis and complications. 
Materials and methods: During 1995-99 we selected almost 795 patients 
with or without symptoms. We checked general data, urine and blood 
analyses, urine antibiogram. In occasion, we performed an ultrasound or 
radiological examination. 
Result: Urinary infections present almost 56% of all infections in school 
population. 81% of them goes to girls. Eschekhia coli is main cause, with 74.9%. 
55.4% has clinical symptoms, 44.6% are without. Urine analysis shows: mcreased 
white blood cells in 73.4%, increased proteins in 59.90/0, ,and blood in urine in 
23.4%. 78% ofall infections are treated completely, and 22% had complication: in 
former recidicvant infections developed in 36%, and in latter in 5.9%. 
Conclusion: 44.6% €-om all urinary infections are without symptoms We have to 
undentand characteristic features, in order to prevent early and late complications 
[m] Microbiological study of vulvovaginitis in children 
K. Bojkova, P. Vassileva 
Varna, BG 
Purpose: To investigate vaginal swab specimens from girls with clinical 
diagnosis of vulvoovaginitis. 
Patients and methods: For a period of 2 years (1998-2000) 87 chddhood 
and adolescence with bacterial vulvovaginitis, at an age ranging from 1 to 18 
years have been researched. Vaginal secretions from girls with clinical 
findings were examined. Most mportant pathogenic agents were 
investigated and if there was an inflammatory reaction in the Gram stain 
and a heavy growth on culture, other potentially pathogenic agents were 
considered also. Sensitivity to antibiotics is determined by the method of 
Bauer-Kirby on Mueller-Hinton agar according to NCCL (1998). 
Results: In 26 (30%) of the 86 panents a potentially pathogemc micro- 
organism was found: two cases (7.69%) due to Sfreptocomu pyo'qenes. six 
(23.08) cases due to Staphylococcus spp.. seven cases (26.92%) due to 
Enterococcus spp., eight cases (30.77%) due to Carididn albicans and three cases 
(1 1.54%) due to Enterobacteriaceae. Infections were usually located in both 
the vulva and the vagina (48%). The main symptoms were vaginal discharge 
(62.85%), erythema (42.85%), and pruntus (77.14%), dyspareunia (45.71%). 
Conclusion: Vulvovaginitis is a common disease during childhood and 
adolescence. Effective treatment, reassurance, and appropriate consultation 
based on the prevention of relapses are the most important steps for the 
management of the disease. 
/p6701 Infant feeding as a source of galactomannan 
A. Wams, T. G. Abrahamsen, I. M. Breuker, J. F. G. M. Meis, P. Gaustad, 
P. E. Venveij 
Nijmegen, NL; Oslo, N 
Introduction: In paediatric patients, and in particular low birth-weight 
infants, circulating galactomannan (GM) is detected, without any suspicion 
of an Aspergillus infection. In this study, we examined if infant feeding 
contains GM molecules and if this might explain the positive results found 
with the antigen testing of serum. 
Materials and methods: Breast n d k  samples (18 samples Gom 6 mothers) 
and 22 different artificial mdk formulas and additives wed in infant feeding 
were tested for the presence of galactomannan. AU the samples were 
centnfuged and the supernatants were used in the Platelia Aspergillus ELISA 
by following the guidelines of the manufacturer. Indices higher than 1.0 
were considered to be positive. 
Results and discussion: Of the 20 artificial milk formulas and additives, 11 
were positive for GM as tested by ELISA. In contrast, mother mdk samples 
were all negative in the antigen testing. We hypothesize that serum from 
infants receiving fomiula feeding might give positive results in the GM 
testing by absorption or leakage of GM molecules through the immature or 
damaged intestinal mucosa. 
v\ Rapid detection and identification of medically 
important Candida spp. by nested PCR 
Z. Khan, S. Ahmad, Z. Khan, A. S. Mustafa, T. D. Chugh 
Kuwait, KWT 
Rapid detechon and identification of Candida species in clinical laboratories 
is extremely important for the proper management of patients with Candida 
infections. Currently available identification methods are time-consuming 
and sometimes may not be accurate due to strain dependant similarities 
in the biochemical profiles. In this study, we first developed a generic 
PCR using universal hngal primers (CTS) which amplified the 3' end of 
5.8s and 5' end of 28s rDNA including the internally transcribed spacer 
region (ITS) generating a 350-410 bp fragment from the four medically 
important Candida species, viz. C. albicanr, C. tropicalis, C. ghbrata and C. 
parupsilosis. To establish nested PCR for species identification species- 
specific primers complementary to unique sequences within the ITS of each 
test species, were then used in the reamplification step of the nested PCR. 
The nested PCR was evaluated for Candida speciation by testing 73 clinical 
isolates of Candida originating from blood ( n  = 25) and other speciniens/sites 
(n = 48). previously speciated by biochemical tests. The nested PCR 
accurately identified the species of 67 (92%) Candida isolates previously 
identified using Vitek yeast identification system. The identity of the 
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remaining six discrepant isolates was then confirmed by another 
conmercially available biochenllcal test, ID 32C. Using this test, five 
of these six isolates were shown to of be the 3ame species as identified 
by the nested PCR, thus raising specificity to 98.6%. Only one blood 
culture isolate identified as C. tropicalis by the nested PCR was speciated 
as C. parapsihis by both biochenlical tests. The results suggest that the 
nested PCR developed in the study could be used for specific detection 
and identification of Cardido species thus avoiding the complexities of 
currently available biochemical tests. Diagnostic evaluation of this PCR 
using serum specimens from suspected and proven cases of candidemia is 
in progress. 
Acknowledgement: The study was supported by Kuwait University grant 
No. MPI 118. 
lp672 Effect of a crude extract of protein produced by 
lactobacilli on germ tube formation by Candida albicans 
A. GonGalves Rodrigues, C. Pina-Vaz, S. Costa-de-Oliveira, P. Mardh, 
A. Freitas da Fonseca, J. Martinez de Oliveira 
Porto, P; Lutzd, S 
Three strains of lactobacilli isolated fiom the vaginal fluid of healthy females 
were cultured in Werent culture media, i.e. in Rogosa broth (Difco, Detroit, 
MI, USA) and in Schaedler broth (Difco) at 37 "C for 48 and 72 h, in 
anaerobiosis. The lilmte was used to detemne the percentage of ihbi t ion of 
gemi tube formation, in compkson to controls. The tests were perfomied 
with Candida cells suspended in human serum and in FU'MI 1640 medium 
(Sigma, USA) without and with the Lactubarillus Gltrate in different amounts. 
The tests were run m duplicate. Different amounts of the &rate produced a 
dose-related effect on the percentage of germ tube formation. In some instances 
hindered completely formation of any germ tubes. The effect was independent 
of whether human sera or RF'MI 1640 medium was used. The inhibiting 
principle was crudely characterized by ion change chromatography (Phamncia, 
Uppsala, Sweden) and the protein content was determined by optical 
absorption at 280 nm. V a g d  lactobacilli produce a flterable protein that 
has an inhibitory effect on germ tube formation by C. albicans. That means that 
women with a Lactob~ci'llus dominated vaginal flora possess an antibiosis-based 
protective factor against development of vulvovaginal canddosis. 
lp6731 Evaluation of CHROMagar candida medium for the 
identification of candida species 
M. Yiicesoy, G. Ergor, N. Yulug 
Izwiir, TR 
CHROMagar Candida, a recently described medium, was evaluated for the 
identitication of Candida species by using a total number of 209 Candida straim 
including 175 Candida albicaris, 12 C. parqsilosis, 7 C. tropicalis, 4 C. k&r, 4 C. 
guillimnondii, 4 C. krurei, 2 C. luritaniae and 1 C. glabrata. The strains were first 
idendfied by gem1 tube test, morphological characteristics on commeal Tween 
80 agar, carbonhydrate fermentation test and Vitek system. They were also 
streaked onto CHROMagar Candida plates to give isolated colonies. The results 
were read by three Werent people bhdly according to the color, morphology 
of the colonies and the existence of halo after 24,48 and 72 h of incubation at 37 
"C in the dark. All strains did grow and the colors of the colonies were able to be 
Merentiated after 24 h of incubation. However; the color of the colonies and the 
halo around them were more clearly distinguished after 48 h of incubation. 
When the 24 h results were compared with 48 and 72 h results, the agreement 
was found to be 97.6% in both cases. This percentage reached 100% when 48 
and 72 h results were considered. The sensitivity of this medium for C. albicam 
s& were 98.9 and 96.0 after 24 and 48 b incubations, respectively, and the 
specificity was detected to be 100% after both incubation periods. These values 
were found to be 85.7 and 100.0% for C. trvopiralir s& after 24 and 48 h 
incubations. The agreement between the results of three difEerent observers were 
IW?. As a result it can be concluded that the use of CHROMagar Candida 
medium is an easy, vahd and reliable method for the identdication of Cmdida 
species especially C. albiram, C. hopicalis and C. kwei strains. 
[p6741 Evaluation of two new yeast identification systems 
and comparison of these systems with API 20C AUX 
S. Gundes, S. GiilenC, R. Bingo1 
Kuraeli, TR 
Background and objectives: To compare the performance of current 
chromogenic yeast identification methods, we evaluated three commercial 
systems (API 20C AUX, Fungicrom I and Candifast) to identify yeasts 
comnionly isolated in our clinical microbiology laboratory. 
Methods: One hundred 16 clinical isolates, including 68 of Candida albicans, 
12 of Candida parapsihis, 12 of Candidaglabrata and 24 of other yeasts, were 
tested. The comparative study of Fungcrom I and Candifast were done in 
parellel with API 20C AUX system. Germ tube production, microscopic 
morphology and other conventional methods were used as needed to 
definitively identify yeast isolates. 
Results: The percentage of correctly identified isolates vaned between 
82.7% and 95.6%. Overall, the performance obtained with Fungicrom I was 
highest with 95.6% (111 of 116 isolates). The performance of API 20C Aux 
was higher with 87% (101 of 116 isolates) than Candifast with 82.7% (96 of 
116). The Fungicrom I method was found to be rapid since 90% of strains 
were identified after 24 h incubation at 30 "C. 
Conclusion: Both of the chromogenic yeast identification systems were 
found to provide a simple, accurate alternative to conventional assidation 
methods for the rapid identification of most conunonly encountered isolates 
of Candida species. Fungicrom, seem the most appropriate system for use in 
a clinical microbiology laboratory, due to their good perfomlance of 
sensitivity, ease of use and reading, their rapidity, and the cost per use. 
Evaluation of the Microring M system for identifying 
clinical yeast isolates 
S. Gundes, S .  GiilenG, R. Bingo1 
Kucaeli, TR 
The Microring YT (MYT) is a conmercial system for identifymg clinical 
yeast isolates. The system uses a series of discs impregnated with inhibitory 
agents mounted on a ring. The pattern of growth and inlxbition produced 
provides a six digit code which can be compared with a table provided by 
the manufacturer. The performance of the system was compared with the 
API 20C AUX system because it is the commercial system inost widely used 
by clinical laboratories to identlfy yeasts and because the results show high 
correlation with conventional methods. 100 clinical isolates compared and 
only 69 (69%) were correctly identified by the MYT system. The API 20C 
AUX system has a more extensive database than MYT and thus more 
reliable for use, but it is more expensive. In conclusion, although the MYT 
is cheap, easy, convenient to use and results are available in 24 h, it is 
inadequate for identification of many commonly isolated Condida species. 
lp676) Improved diagnosis of vulvovaginal candidosis by 
plating flushing samples in chromogenic agar 
A. Gonplves Rodrigues, M. Sampaio, C. Pina-Vaz, S. Costa-de-Oliveira, 
P. Mardh, J. Martinez de Oliveira, A. Freitas da Fonseca 
Portu, P; Lund, S 
Current available methods for a laboratory diagnosis of vulva-vaginal 
candidosis (WC) mainly rely upon cultural methods. However, the 
sensitivity of the commonly performed cultures in media like Sabouraud 
agar is rather low, particularly when sampling is made by swabbing the vulva 
or the vaginal mucosa. The present study was undertaken to establish the 
possible increase in sensitivity and specificity by using chromogenic culture 
media for the isolation of Candida and also to evaluate the absorption of the 
organism to the swabs and thereby the loss in sensitivity by sampling with 
cotton tipped swabs. Yeast suspensions with serial cell concentrations, 
prepared with each of s i x  Candida strains (different species) were plated on 
Sabouraud agar (Difco) and in chromagenic agar media, namely 
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ChromagarR (Becton Dickinson), CandiselectR (Sanofi Pasteur) and 
Candida ID2 (BioMtrieux), in 90 mm Petri dishes. Sets of cotton swabs 
from different manufacturers were used to inoculate the media, which were 
incubated both at 37 "C for 24-48 h and at 20 "C (room temperature, 
protected from light) for 5 days. Number, size and colour of colonies was 
registered. Results showed a quality span with the a e r e n t  chromogenic 
solid media; Chromagar came out as the superior one. The reliability of the 
identification achieved with this medium seems however, to compensate 
the apparent drawback of its price. Although chromogenic media can be 
incubated at room temperature, incubation time will however, be shorter at 
37 "C. Candida produces tiny white opaque colonies in such media after 48- 
72 h at 20 "C, although some extra time wiU be needed for development of 
the typical pigmentation of colonies that wiU easily provide identification of 
difTerent species. However, a considerable variation in colony counts was 
found when plating from the same yeast suspension was performed with 
Merent sets of swabs, both in Sabouraud agar and in chromogenic media. 
The study revealed that a high proportion of Candida organisms that are 
collected from clinical samples will generally remain attached to the swab 
and will not be recovered on culture. Thus, the low sensitivity of current 
diagnostic methods may not only be related to choice of culture medium 
but also if not to the choice of sampling technique. The present study 
indicates that the classical culture tests for W C  using cotton tipped swabs 
and Sabouraud agar may well be exchanged with advantages by the use of 
vaginal tlushmg samples inoculated on chromogenic agar. 
ml Use of chromogenic tube and Methyl Blue Agar for the 
identification of Candida albicans strains 
M. Yiicesoy, N.  Esen, N. Yulug 
Izmir, TR 
Because Candida albicans is one of the most frequently isolated yeasts in 
clinical laboratories, its rapid and true identification is very important. Thls 
study was performed to investigate the use of chromogenic tube and methyl 
blue agar for the presumptive identification of C. albicans. 124 Randomly 
selected c h c a l  isolates, including 11 1 C. albicans and 13 Candida spp. strains 
which had been identified by morphology on cornmeal tween 80 agar, vitek 
automated identification system were evaluated. Three different identifica- 
tion procedures (a) germ tube test (b) chromogenic tube test by using 
CHROMagar Candida (c) methyl blue agar test were performed to the 
isolates. The results of CHROMagar Candida were read according to the 
color of the colonies after 2, 4, 8,24 and 48 and 72 h of incubation at 37 "C 
in the dark. Methyl blue agar results were read under UV light after the 
same incubation periods. 88 of 11 1 (79%) C. albicarts strains were detected to 
be positive by germ tube test. 87 (78%), 97 (87%) and 102 (92%) of these 
isolates were identified as C. albirans by chromogenic tube test after 2 , 8  and 
24 h of incubation, respectively. 88 (79%), 92 (83%) and 88 (79%) of the 
isolates were correctly identified as C. albicans by methyl blue agar test after 
2, 8 and 24 h of incubation, respectively. The sensitivity and specificity 
values were found to be 79.3 and 69.2 for the germ tube test. These values 
ranged between 78.4 and 91.9% and 69.2-76.9% for chromogenic tube test 
and 79.3-82.9% and 76.9-84.6% for methyl blue agar depending on the 
incubation period. As a result, it can be concluded that the use of 
chromogenic tube and methyl blue agar are rapid, simple and objective 
methods for the identification of C. albicans strains. 
pml Simplified method for rapid preparation of fungal 
DNA for PCR 
V. Levterova, S. Panaiotov, S. Stefanova, T. Kantardjiev 
Soja, BG 
often preferred. Considerable eEorts have been made to enable improved 
DNA preparation from fungi, especially for epidemiological typing of 
nosocomial infections. After experimenting with several DNA purification 
regimens, we have optimized a mini-preparation procedure for fungal 
DNA. The procedure includes the following steps: i. fungal lysis with 
l%SDS/2% Triton X100, subsequent eeatments with ii. RNase, iii. 
proteinase K, vs. boiling, vi. NaCl/CTAB vii. two phenol/chloroform 
extractions and prcipitation with isopropanol. The whole procedure can be 
completed w i h  3 h and is applicable to various b g ~ .  Up to now, we have 
used the technique to isolate DNA from about 150 Candida, Tnibuphyton, 
Crypmms and Staphykuom spp. The obtained DNA is with excellent q d t y  
with 260/280 nm ration above 1.9 and suitable for restxiction analysis, PCR, 
PCR-RFLP, and AFLP. The concentration is about 50 pg. The procedure 
provides a rapid and reliable alternative to the existing DNA purification 
protocols used in research and clinical laboratories. 
r-1 Aspergillus fumigatus and PCR a panfungal and a 
species-specific approach 
C. Andreutti-Zaugg, K. Jaton, J. Bille 
Lausanne, CH 
Objective: Current diagnosis of invasive fungal infections remains ddiicult. 
In order to improve an integrated diagnostic approach (talung into account 
clinical data, risk factors and mycological methods), a panfungal PCR assay 
was set up, allowing sensitive and specific detection of yeast and fungal 
species. Aspergillusfirmigatus was chosen as model organism. In parallel, a real 
time PCR assay specific for A .  fumigafus was developed. 
Methods: Special care was taken in validating the DNA extraction 
procedure. In blood of patients with invasive aspergdlosis, the hngus is 
probably present as hyphal fragments. To  mimic the in viuo fungal cell wall 
composition, conidia of A. fumigatus were germinated in uifm and grown to 
1 mycelial cell. By t h ~ s  mean the fungal cells were countable. Whole blood 
samples were then spiked with serial dilutions of geminated spores and cell 
lysis followed by DNA purification was performed. First, erythrocytes were 
lysed with alcaline ciaate-cysteine (Flahaut et a/. 1998). Then, to disrupt 
efficiently the fungal cells the lysing enzyme Novozyme 234 (Calbiochem) 
was chosen. This multienzyme preparation is active against the two major 
components of the mycelial cell wall, alpha-1,3 glucan and chitin. Finally. 
DNA was purified with the QIAamp DNA Mini kit (Qiagen). The 
DNA was amplified with panfungal primers previously described (Van 
Bunk et al. 1998). The fungal P C R  products were detected on an agarose 
gel containing ethdium bromide and hybridized to an Aspergillus sp.-probe 
coated on a microtiter plate (Boehringer PCR ELISA kit). In parallel, 
the same extracted DNA was run on a TaqMan 5700 instrument 
(Applied Biosystems), targeting the A .  furniptus cytochrome b gene in 
the mitochondrion. 
Result% With the padmgal procedure, 1C-1 rungal cells were detectable and the 
Novozyme lysk step increased the yield about 100 tims. Moreover, the real time 
PCR allowed the detection of 1 gene copy: a clear positive result was obtained 
when DNA correspondmg to one fungal cell was ampued. Therefore t h i q  
method was about 100 times more sensitive than the panfungal approach. 
Conclusion: The developed extraction procedure using Novozyme 234 and 
germinated spores, followed by a panfungal amplification or a real time 
PCR approach allowed highly sensitive detection of A .  fumi@us DNA in 
whole blood samples. 
Ip681; Comparison of different PCR based approaches for 
typing of Candida and Cryptococcus strains in Bulgaria 
Nucleic acid detection methods such as PCR and its applications have 
become a common tool for microbial diagnosis and typing. Although PCR 
amlification can be performed dlrectly for various microbial cultures, for 
filamentous fungi and yeasts, prior isolation and purification of DNA is 
v. Levterova, T. Kantardjiev, s. Panaiotov, A. Kuzmanov 
so,a, BG 
Three different molecular epidemiology typing approaches (RAPD, AFLP 
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and PCR-RFLP) have been applied for better evaluation of genetic 
diversity among Candida and Crptotoctus clinical isolates. Main objectives of 
the study were to investigate the reproducibilty, disciinnnatory power and 
typeabhy of each method applied. By using seven short oligomer primers 
(10-15 men) with arbitrary chosen sequences in the polymerase chain 
reaction, lstinctive and reproducible sets of PCR products were observed. 
The PCR-RFLP was performed on the engl gene of Candida albicans. The 
AFLP technique was applied by amplifying specific PstI/BamHI restriction 
fragments. More than 60 Candida and Cryptorocrus clinical isolates have been 
evaluated. 22 strains of Candida albicans were isolated 6om different body 
sites of 9 patients. With the applied typing methods it was found that the 
isolates obtained from a single person show polymorphic kagments. We 
demonstrate possible relationshp or difference between the isolates of a 
single person. We performed an attempt to demonstrate nosoconlial 
transmission of Cnridida and Cryptococcus strains in hospitalized patients. 
PCK-RFLP was found to be reproducible, but with limited discriminatory 
power. AFLP is a method with good reproducibility but laborious. RAPD 
needs strict peifoniiance criteria. 
v] Cultureand direct microscopy-negative AIDS-related 
cryptococcosis before and during the highly active antiretroviral 
therapy (HAART) era 
R. Manfredi. L. Calza, F. Chiodo 
Bolo,pin, I 
Objective: To assess the frequency and clinical features of AIDS-related 
cryptococcosis (C) diagnosed by an isolated positive antigen (Ag) testing. 
Methods: A cryptococcal Ag latex agglutination assay was included in the 
diagnostic workup for all HIV-infected patients (p) with suspected C or 
fever of unknown origm, since 1992. 
Results: O f  37 p with C diagnosed since 1992, 8 (21.6%) were initially 
identified by an isolated positive Ag assay: 5 cases of 32 (15.6%) in the pre- 
HAART era (1992-96), and 3 cases of 5 (60%) in the HAART period 
(since 1997); in 7 cases of 8, C was the AIDS-defining event. Compared 
with the pre-HAART era, during the last 4 years this feature became 
increasingly frequent ( P  < 0.001), interested p with a higher mean CD4 
count (96 vs. 20 cells/--?: P < 0.01), and occurred in absence of prior 
antifungal use (camed out in 3 of 5 cases of the pre-HAART era). An 
isolated positive Ag assay involved only the cerebrospinal fluid (CSF) in all 5 
cases diagnosed until 1996, while a positive serum Ag testing interested 2 of 
3 p followed since 1997. Despite a suggestive clirucal picture, all p had 
repeatedly negauve dlrect microscopy and cultures. Immediately after 
obtaining a positive Ag msay, all p underwent a systemic antifungal therapy: 
in the pre-HAART era 2 p died in a few days (with necropsy findings 
confirming a C), and 3 late relapses occurred in association with positive 
microscopy and/or blood or CSF culture, while the 3 p identlfied since 
1997 were cured. 
Discussion: An isolated positive cryptococcal Ag assay represents a rare 
event (in particular in the CSF), but it became increasingly frequent, with 
some features changed since HAART use: less severe immunodeficiency, 
absence of prior antifungal therapy, involvement of serum compared with 
CSF, and improved prognosis (no lethal or relapsing cases occurred since 
1997: P < 0.02). Since cryptococcal Ag assay is notably sensitive and 
specific, all p with an isolated positive Ag testing warrant timely treatment 
and prolonged monitoring, in order to avoid a life-threatening disease. 
Increased Ag testing as a screening procedure, prior antifungal use, and 
pathoniorphism of C caused by both antifungal and anti-HIV therapy, may 
support an apparent increase of this phenomenon. Most literature reports 
pointed out abnomial clinical or laboratory features of AIDS-related C since 
1997, so that persistently negative microscopy and culture studier cannot 
exclude a C, especially m the HAART era. 
Fungal infections in non immunocampromised host 
I Ramichloridium obovoideurn: an etiological agent of 
cerebral phaeohyphomycosis in the Middle East 
Z Khan, S J Lanidhade, A. Thussu, M Johny, I Al-Obaid 
Kuwait, KWT 
Ratnirhlondiui obo ideurn  (R tnackenaei] is an emerging etlologc agent of 
cerebra1 phaeohyphoniycoris All the cases of the dsease reported, so far, 
occurred in individuals indgenous in Middle-East regon We descnbe heie 
the eleventh case of the disease in a 56-year-old Egyptian male who was 
employed as mason UI Kuwait since 1994 Except the hstory of chronic 
hepatins B w t h  portal hypertension and splenomegaly, he had no other 
idenhfiable underlying condmon or nsk tictor He presented w t h  symptoms of 
mcreased ~~itracrarual tension The CT Scan of the head revealed a large cvcular 
lesion w t h  nioderate surroundmg edema u1 the left occipital lobe of the bram 
The aspmted pus from the leion showed branched, septate. brown-colored 
hyphae The ehO1OgIc fungus was lsolated m culture and idended as R 
obovordeutn on the basis of typical colomal and mcroscopic morphology 
Although, the pauent was treated wth amphotencm B (1 mg/kg/day), he 
eapved after one week A rewew of hterature revealed that R obovordeurn 
infects mmunocomproliused or munoconipetent hosts aLke and has no sex 
preddecnon Thr fungus demonstrates a strong neumotropic tendency w t h  
almost no evidence of &senUnahOn to other organs/sltes All the reported cases 
of the disease mere dngnosed after 30 years of age, and the infecnon proved 
mvanably fatal despite anthngal therapy Iti vrtro susceptibhty profile of R 
obovoideutn appears to be main vanable The reason for its restncted 
geographic distnbunon remains unknown 
/p684] Microscopic examination of three subsequent 
cerebrospinal fluid specimens of a patient leading to diagnosis 
of cerebral phaeohyphomycosis 
A S Kantarcioglu, A Yucel 
Istntibul, TR 
The purpose of this report is to present an example of the vanety of it2 utvo 
fungal elements observed withm three subsequent cerebrospinal fluid (CSF) 
specimens of a patient leading to mcroscopic diagnosis of cerebral 
phaeohyphomycosis As it was learned from the physician’s specmien 
submssion document the patient was a 30-year-old apparently immuno- 
competent male who had had &plopla and on computed tomographic scan 
and magnetlc resonance unage was shown stains on brainsteni The first 
CSF specmen subtmtted to our systetmc mycology laboratory with fungal 
exanunation request was centnfuged and the selment was stained with 
Gram, EhrLch-Ziehl-Neelsen, Giemsa (Wnght’s) techniques and India ink 
to provide several shde preparations and was plated onto mfferent 
appropriate agars Meuculuos nucroscopic exaimnation of the stained slides 
revealed a number of lrregularly cwollen, septate, subhyaluie to pale-brown 
hyphal elements and chlamydospore Lke globose or oblong, thick walled 
conilal chains, inchdual comdia with visible scars at one or both ends and 
a few multicelled conidium with long beak All types of fungal elements 
observed were documented by photomcrographs The physician was 
alerted upon mcroscopic detection of the dematiaceous fungal elements 
present withm CFS specimen The second CSF specimen sent three days 
after and the thrd one submtted after one month showed the same 
elements plus individual yeast cells and short arthrospore hke elements 
Some of the demauaceous fun@ have the abihty to produce both budding 
yeast c e h  and have internal septatlons in tiswe The term phaeohypho- 
mycosis introduced by Ajeuo el al covers infectious of a cutaneous, 
subcutaneous and systemc nature caused by hyphomycetous funp that 
develop in the host’s tiscue in the form of dark-walled (denianaceous) 
mycehal elements At this point the tern1 cerebral phaeohyphomycosis was 
helpfully used to inform the physician immediately about the preliminary 
definition before culture results 
/p685/ Isolation of Absidia cotymbifera and Scopulariopsis 
koningii from the wound of an immunocompetent patient 
R M Winn, K Y Anderssen, M Walberg, A Warns, S Sund, Y Gaustad 
Oslo, N, Ngmegen, NL 
Introduction: Oppormrusnc fungal infections are becomng more prevalent 
in immunocompromsed panents, particularly those w t h  haematolopcal 
mahgnancies However, such infections are still u n c o n ~ ~ o n  in patients with 
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normal immune function. A previously healthy patient with a wound 
infection is presented from which Absidia cotymbifira and Scopulariopsis 
korrirxii were both isolated. 
Case study: A 44-year-old male patient was adrmtted to our hospital 
following accidental amputation of three fingers during a fanning accident. 
The fingers were surgically reattached. Three months later, the patient 
showed signs of localised infection in the right middle finger and on 
examination, a black, necrotic area was seen. Culture yielded a zygoniycete, 
initially identified as Mucor sp., but was considered to be a probable 
contaminant, despite subsequent re-isolation. The wound infection was 
treated orally with 150 mg Clindamycin four times daily. Progression of the 
necrosis resulted in surgical amputation of the finger 10 weeks later. At this 
time, microbiological culture yielded A. rorymb!fira from the necrotic tissue 
and S. koniqi i  from the healthy tissue surrounding the wound. Subsequent 
re-examination of the isolate from the initial culture revealed that the isolate 
had been misidentified and was in fact A. corymb!fifera. Histopathology 
sections showed broad, nonseptate hyphae consistent with local invasion by 
a zygomycete. Evidence for tissue invasion by S. koniq i i  was not found. 
Conclusion: Fungal isolates are often disnnssed as either laboratory or 
specimen contaminants, especially in immunocompetent patients. This 
report shows that even otherwise healthy individuals are susceptible to 
opportunistic fungal infections when normal anatomical barriers are broken. 
Fungi should be considered as potential pathogens in any case where 
infection complicates tissue injury or trauma, particularly if isolated on more 
than one occasion and if necrosis is present. Certain occupations, 
particularly fann workers and other outdoor labourers, are at risk from 
various filamentous fungi following soft tissue injury. 
Methods and results: Rhinocerebral mucoomtycozis is a rare fungal infection of 
the nasal cavity and sinuses that can spread to the orbits and cranium within 
days. The disease can he fatal and survival is directly linked to early detection 
and appropriate treatment. We report two diabetic patients with 
Rhinocerebral mucoomtycosis successfully treated with liposomal amphoterin B. 
Case 1: A 79-year-old male was admitted, with symptoms of lower respiratory 
tract infection. Past medical history included a noninsulin-dependent diabetes 
inellitus, COPD, heart mure and renal insufficiency. The patient complained 
for malodorous discharge from his nose and an ENT examination showed 
necrotic lesion of the palatal mucosa. A biopsy of the lesion disclosed 
mucormycosis. Patient was treated successfully with combination of surgery 
and administration of liposoinal aniphoterin B (16 g cumulative dose) at the 
dose of 3 mg/kg/day for a period of two months without serious adverse 
events. His lesion have been improved. A second MKI examination showed 
significant decrease in the size of the lesions. He died three months later for 
causes unrelated to mucorinycotis froni cardiac arrest. 
Case 2: A 65-year-old, male, with a 10 years history of hypertension, was 
admitted to the hospital because of pain, swelling, and visual disturbances of 
the left eye. A biopsy confirmed the diagnosis of mucorniycosis. Left orbital 
enucleation was perfomied combined with repeated sinus debridenient, and 
followed by liposomal amphoterin B treatment. A total amount of 16 g has 
been given and the patient is doing very well and he will continue his 
treatment for another month in alternate day administration 3 ing/kg. 
Conclusions: Liposomal amphotericin B has few side-effects allowing the 
administration of higher doses of it can be given. Combination of liposomal 
amphotericin B with surgical removal of necrotic tissue, and effective 
control of underlying condition may improve the outcoine of these patients. 
lp6861 In vivo treatment of mice with interferongamma and 
granulocyte-monocyte colony-stimulating factor (GM-CSF) 
enhances neutrophil-induced damage of Scedosporium 
prolificans and Apiospermum hyphae 
C. Gd-Lamaignere, R.V. Vitale, R .  Vitale, J. Curfs, P. Verweij, E. 
Roilides, EUKOFUNG Network 
Thessalofiiki, G R ;  Nijmepi, NL 
Objective: To study the effects of in-vivo treatment with IFN-7, GM-CSF 
or coinbination of both cytokines on neutrophd (PMN)-induced damage of 
Sredosporiurn prollfiuus (SP) and Scedosporium apiospermum (SA) hyphae. 
Scedosporium spp. are hyphoniycetes highly resistant to antifungal agents and 
emerging opportunistic moulds causing serious infections in immunocom- 
pronused patients. 
Methods: UALB/c mice were treated with murine IFN-y, murine GM- 
CSF or combination of both cytokmes daily for 4 days. PMN were elicited 
to the peritoneal cavity by peptone injection and collected by peritoneal 
lavage with PUS after 3 h. For hyphal damage assay, hyphae of either SP or 
SA were incubated with PMN at effectortarget ratio 5.1 in RPMl 
supplemented with 10% munne pooled serum. Damage of hyphae was 
assessed using XTT colorimetric assay. 
Results: Treatment of mice wlth cytokines significantly enhanced PMN- 
induced SP-hyphal damage from a mean & SE 3.0 f 6.8% for control to 
25.6 f 4.6%, 24.1 & 3.0% and 40.2 & 2.2% for IFN-y, GM-CSF and the 
combination of both cytokina (P  < 0.0001, 5 experiments). Similarly, PMN- 
induced SA-hyphal damage was enhanced from 12.9 f 10.6% for control to 
48.4 & 5.%, 37.4 5.4% and 55.5 & 3.5% for IFN-y, GM-CSF and the 
combination ofboth cytokines ( P  < 0.001,4 experiments). In all the experiments 
performed, the combined treatment showed the highest degree of enhancement 
as compared to control (P= 0.002 and 0.027 for SP and SA, respectively). 
Conclusions: The treatment of mice with IFN-y and GM-CSF significantly 
enhances PMN-induced damage of SP and SA hyphae, especially when 
both cytokines are used. These promising data warrant further animal 
studies of the effects of these cytokines on the outcome of scedosporiosis. 
Acknowledgements: EC TMR FMKX-CT970145. 
(p6871 Two cases of Rhinocerebral mucormycosis treated with 
liposomal amphotericin B 
D. Kofteridis, J. Bizakis, M. Ergazakis, N. Klapsinos, J.  Papadakis, E. 
Barbounakis, A. Gikas 
Heraklion, GR 
Objectives: T o  report two cases of Rhiizocerehral niuconnycosis successfully 
treated with amphotericin B. 
1 P688 1 Mycetoma: infection with tumefaction and draining 
sinuses 
S .  Gundes, G. Unal, H. Giindes. H. Vahaboglu 
Koraeli, TR 
Mycetoma, also known as niadura foot, is a local, chronic, slowly progressive 
disease of skin and subcutatieous hssue, with the classic presentation involving 
tumefaction, multiple draming sinuses, and grains Med pus. It is primarily 
caused by either a bacteria (actinomycetoma) or a fungal (euniycetonta) 
organism. The three cardina features are tumefaction or the appearance of 
indolent inflammatory nodules with secondary fibrosis, formation of sinus tracts 
and fistulas that may have the ability to penetrate deep tissue, and the presence 
of grain\ or granules in the effected tissue. Diagnosis is based on biopsy, for 
gross, microscopic, and histopathologcal evaluation, with definitive idenhfica- 
tion of the organism needed for effective treatment. AU types of mycetonla 
infections should be treated with surgical debridement and tissue culture. In 
addition to surgical management, these patients should be managed adjunctively 
with a prolonged course of chemotherapy. This article provides an overview of 
this disorder and report. two cases with niycetonia of foot. One of the cases, an 
17-year-old boy have this disease for 12 years and presented with an infection 
due to eumycetoma and demonstrates successful treatment with surgical 
debridement and prolonged antifungal therapy with flucytosine. Second case, 
an 57-year-old lady, have the disease for the last 15 years, presented with an 
infection due to Actirtomadura madurae, treated with Doxycycline in addition 
to surgical resection but recurrences occur with failure of the therapy. 
Although mycetoma is relatively uncommon in Turkey, increasing 
morbidity should lead to a greater awareness of this disease. Our cases 
seem to be rare, because effective treatments for actinoniycetoma are known 
to be available with high success rates, whereas euniycetoma is often known 
as difficult to treat with high recurrence rates. Also, subcutaneous fungal 
infections are relatively uncomnion in the lower extremity. In conclusion, 
mycetoma begins as painless papules or nodules that increase in size and 
progress to involve the connective tissue; therefore, when evaluating 
ordinary skin or fungal infections, we must widen our differential diagnosis 
to include mycetoma; because, early diagnosis with effective treatment, 
decrease morbidity and increase the chance of patient to shorten the 
duration of this slowly progressive infection. 
lp689) Increase in Microsporum canis infection rate in 
childhood in the larger Athens area 
A Kaftopoulou, N Petropoulou, K Lytma, A Stathi, K Chrysalu, A Pangalls 
Athens, GR 
Dunng the last years a steady nse in the number of fungal infections and 
especially in those of Microsporum cams has been observed in children 
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population residing in majority in Athens and suburbs. The children, 40 day 
till 16-year-old, were examined with the established direct examination and 
culture methods in the hospital, as outpatients or inpatients. In the 6-year 
period 1989-94, 845 skin lesion samples were examined from which 24.8% 
were positive for fungal pathogens. M. canis isolation rate reached the level 
of 83.7%. In the next 6-year period, 1995-October 2000, 1006 skin samples 
were exanined. From them 31.9% have been found positive and the M. 
cariis isolation rate was 78.6%. Comparing these findings with previous ones 
coming from our laboratory, a significant increase m fungal and especially in 
M.  canis isolation rate IS noted. During the 3-year period 1986-88, 491 skin 
lesion samples were examined. From them 16,4% were positive and M.  ranis 
isolation rate was 77.7%. The infecuons, especially of hair, were not always 
easily treated using the new antifungal agents. Terbinahe and Itraconamle were 
inefficient to conuol the M. canis hair infection in > 25% of the cases treated and 
the older Grizeofulvin had to be used to obtain negative culture results. 
jP6901 Determination of cell growth and lipase activity in 
Malassezia furfur 
M. Shams, J. Refaee, A. Allameh, M. Razzaghi Abyaneh 
Tehran, IR 
Objective: To determine optimal conditions required for cell growth and lipase 
(extracellular and cytoplasmic) activity in merent strains of Malarsezia furf.i. 
Methods: 10 strain of M. fur& isolated from patients with tinea versicolor 
were grown on modified liquid sabouraud medium. Cultures were 
separately incubated on shaking or stationary conditions at different 
temperatures (28, 32, 37 "C) for several periods of time (2, 4, 6, 8, 10 
and 12 days). Fungal wet weight measured and extracellular and cytoplasmic 
lipase activity was determined by para-nitrophenyl pahutate as substrate. 
Results: Cell growth and lipase activity were better in shaking cultures as 
coinpared with stationary ones. Optimal pH. temperature and time for 
enzyme activity were 5, 8, 28 "C and 4-6 days, respectively. The maxlmum 
extracellular and cytoplasmic lipase activity were detected a t  sixth and forth 
days of cultures, respectively. 
Conclusion: In general, optimal pH, temperature and tiines for cell growth 
and lipase activity in M. .fufur isolates were determined as 5, 8, 28 "C and 
fourth incubation days, respectively. Under these conditions, specific 
activity of cytoplasmic forms of enzyme were higher than extracellular 
fomis in all of the isolates. 
FI Candida pelliculosa fungaemia due to use of 
indwelling venous catheters in a neutropenic patient 
N. Kiraz, G. Dumiaz, A.V. Aslan, Z. Gulbas, Y. Akgiin 
Eskisehir, TR 
Catididapellicrrlosa is a rare Candida species causing localised and disseminated 
infections. A case of C. pellinrlosa infection is presented and cases previously 
reported in the literature are reviewed. A 33-year-old woman (P. no. 503530, 
M.Y., housewife) was diagnosed w~th non-Ho&&n's lymphoma grade I11 B, 
and was treated with two cycles of cyclophosphanide, adrianiycine, vincristine 
and prednisolone. As there no response to this treatment the therapy was changed 
to a combination of cisplatin, fludarabin, and cystosine arabinoside. Five days 
later, neutropenia developed (absolute neutrophil count w a ~  between 20 and 100 
neutrophils/nL) and ceftazidime (6 g/d in three divided doses), vancomycin (2 
g/d in two divided doses), ciprofloxacin (800 mg/d m two divided doses) and 
amphotericin B (1 mg/kg of body weight per day) was started. The patient's 
neutropenia continued in spite of granulocyte colony-stirnularing 6mr (300 pg/ 
d) was given. Candda pelliculosa was isolated two times from catheters and 
peripheral blood saniples that were taken at 2day intervals. After four days, the 
Asperg illus 
patient died because of fungaemia of Candida pelliculosa. Caridida pelliculosa 
should be considered as a etiologic agent of fungaemia in patients with 
neutropenia and indwelling intravenous catheters. 
lp692 Candida pelliculosa as an emerging nosocomial 
pathogen in immunocompromised children 
M. Bakir, N. Cevikcioglu, A. Tirtir, E. Ozek, C. Canpolat 
Istanbul, TR 
Candida pelliculosa (Syn. Hansenda anomala) is a yeast which has seldom been 
reported as a human pathogen and is an ascosporogenous yeast of the 
Azcomycefes class found in the transient normal flora of skin, throat, and 
alimentary tract. We describe a patient with port-catheter infection and two 
patients with fungemia due to C.  pellicidosa. The first case was an 18-month- 
old boy with leukemia who developed febrile neutropenia following 
chemotherapy. His initial blood cultures grew methicillin-resistant S. aureus. 
O n  10th day of antibiotherapy C. pelliculosa was isolated from blood samples 
obtained through port-catheter 5 more days after liposomal amphotericin B 
therapy was started. Peripheral venous blood cultures remained sterile. 
Treatment was continued for 21 days. No fungal infection was recurred 
during his follow-up for eight months after discharge. The second case was a 
preterm infant, product of a 27-weeks gestation. He had been on ventilator 
and received antibiotics and total parented nutrition via umblical catheter 
for first 2 weeks. O n  the 5th day of antibiotherapy he developed apnea, 
tachychardia and persistent fever. At the end of 2nd week, blood cultures 
obtained on 2 consecutive days grew C. pellicnlosa. He was treated with 
liposomal amphotericin B for 2 weeks. The patient was discharged from 
hospital after 4 weeks with no recurrence at follow-up. The 3rd patient was 
an 1 1-month-old boy with severe combined immunodeficiency syndrome 
with pneumonia and enteritis. His fever persisted despite 4 weeh of 
antibiotherapy. Five subsequent blood cultures revealed C.  pellirulosa. The 
patient was treated with arnphotericin B for 4 weeks. Systemic candidiasis 
was ruled out by echocardiograpy and abdonlinal ultrasonograpy in all 
patients. In recent years the yeast has become an important pathogen in 
imrnunocomproinised patients. T o  our knowledge, C. pelliculosa port- 
catheter infection responding to liposomal amphotericm B treatment has not 
been reported before. First two cases stayed on the same ward at the same time 
for a week. One month after the last patient with C. pellinrlosa discharged, the 
third case was admitted in the neonatal intensive care unit at which the pediatric 
nmes and residents from pedianic ward take care of neonates. This 
epidemiological relation suggests that C. pellinrlosa, like other Caridida species, 
may cause nosocomial epidemics in imniunoconipromised children. 
Lp6931 Tinea capitis prevalance in primary schools in Aeon/ 
Turkey 
M. Altindis, E. Bilgili 
Afyon, TR 
Tinea capitis is a superficial fungal infection and more common among children 
living at low socioeconomic mas. The aim of our study was to determine the 
prevalence of that infection in w o n  and to conipare our results with other 
similar reports from our country. 2850 primary school student, aging &om 8 to 
15 (mean: 11 f 3.2) and as being 1423 (49.9%) male and 1427 (50.1%) female, 
were examined for 7kea capitis and hair and supehcial scalp specimens of 
suspected caws were obtained and these specimens were examined at direct light 
microscope. 3 (0.1%) Knea capits infection cases were dwgnosed both &caUy 
and nlicroscopically. Our rate was higher than that of our county's average, so 
we concluded that mas screening examinations might be performed at both 
primary and kindergarten schools for a better and m e  epidemiological data. 
Background: The increasing number of patients susceptible to fungal 
infections together with the fact that Aspergillus spp. has been reported to be 
resistant to itraconazole both irr uiuo and in uitro has made it necessary to 
perform susceptibility tests mainly in those infections refractow to 
lp694 Comparison of the Sensititre YeastOne colorimetric 
method against reference M38-P for testing susceptibility of 
Aspergillus to amphotericin B and itraconatole 
treatment. The reference method M38-P is labour intensive and not 
available commercially. 
Method: The in uitro activity of amphotericin B and itraconazole has been 
assayed against 68 clinical isolates of Aspegillus (30 A. glaucus, 25 A .  
J. Pemln. E. Canton, A. Valverde, S. Bemal, M. Chaves, C.  Serrano, E. 
Martin-Mazuelos 
Valencia, Seoilla, E 
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fumigatus, 9 A .  niger, 2 A .  terreus, and 2 A. j a w s )  by the reference M38-P 
and the Sensititre YeastOne colorimetric methods. Inoculum suspensions 
were prepared recovering the coruda from a 7-day culture growth on 
Potato dextrose agar at 35 "C, and adjusted to 0.09-0.11 optical density. 
Final inoculum: 0.5-5 x 104 CFU/mL. MIC readings were performed at 
48 h and 72 h. 
Results: MICs for amphotericin B increased one dilution for 50% and 61% 
of strains when read at 72 h by the reference and colorimetric method, 
respectively. While for itraconazole readings did not change for 94% and 
58% of the strains, respectively. By the M38-P, all strainr were inhbited 
with 6 1 mg/L of amphotericin B and G0.25 mg/L of itraconazole. MIC 
ranges at 48 h/72 h for colorimetric method were 0.25-2/0.254 mg/L for 
AMB and 0.016-0.25/0.034.5 mg/L for itraconazole. The overall 
agreement (+ 2 log) between reference and colorimetric method was 
95.31% for amphotericin B and 85.7% for itraconazole. 
Conclusions: The YeastOne method appears to be a suitable alternative 
procedure for antifungal susceptibility testing of Aspergillus spp. MICs for 
amphotericin B must be read at 72 h. 
rp695 Voriconazole secondary prophylaxis in an HLA 
identical bone marrow transplant recipient with previous 
pulmonary aspergillosis 
N. Mordini, D. Mattei, A. Gallamini, A. Bacigalupo, C. Viscoli 
Cuneo, Genoa, I 
Introduction: Invasive Aspergillosis (IA) during the remission/induction 
treatment of acute myeloid leukemia (AML) is expected to relapse if the 
patient undergoes bone marrow transplantation. We report an AML patient 
who developed proven pulmonary aspergillosis (according the revised 
EORTC Mycoses Study Group criteria), failed secondary prophylams with 
liposomal amphotericin-B (Am-B), was treated with voriconazole (VOR) 
and successfully underwent BMT under VOR prophylaxis. 
Patients and methods: A 44-year-old man was diagnosed on July 2000 
with M4 AML. On day 05.07 he was given standard induction treatment 
with daunomycin, etoposide, cytosine arabynoside. The patient was 
monitored with twice weekly ELISA assay for galactomannan and weekly 
chest C T  scan. The patient had 3 consecutive positive ELISA test on days 
10.07, 13.07 and 17.07, without fever or respiratory symptoms. He started 
conventional Am-B on 15.07. The 1st C T  scan was negative, but the 2nd 
(27.07) showed a pulmonary lesion, that later (03.08) became escavated. 
Needle biopsy culture yielded Aspergillus. Antigenemia fell to negativity 
following standard and then liposomal Am-B treatment. O n  day 12.08 
reinduction treatment for resistant leukemia with high-dose ARA-C, DNM 
and VP16 was started, associated with liposomal Am-B secondary 
prophylaxis. The patient achieved hematological recovery and complete 
remission, but on day 04.09, despite negative antigenemia, fever and chest 
pain recurred and a C T  scan showed a second pulmunary nodulation. 
Treatment with voriconazole (VOR) was started on day 15.09 and the 
patient underwent BMT. After conditioning regimen with TBI and 
cyclophosphamide, he was grafted with sibling HLA-identical BM on day 
05.10. The patient reached ANC count >500/mm3 on day +16 and Plts 
>30 O O O / m m 3  on day +22. During neutropenia there was only 1 FUO 
episode, and aspegillus antigenemia was always negative. There was only a 
mild liver toxicity, leading to VOR dosage reduction. C T  scan performed 
on day 27.10 did not show any pulmonary lesion. 
Conclusion: At least in this case VOR was very effective in preventing 
further relapse of pulmonary aspergillosis. Obviously, this result should to be 
confirmed in prospective studies. 
/p6961 Surveillance of Aspergihs spp. air contamination in a 
haematology and transplant department 
H. Jaw, P. Naaber, S. Kaljalg, J. Lehtmaa, M. Maimets 
Tartu, EE 
introduction: Department Haematology and Bone Marrow Transplantation 
(BMT) is located in a 20-year-old building without any air filtration system. 
There have been two cases of proven invasive aspergdlosis at 1998. After 
that a step by step renovation was started during the recent three years 
Objectives: To evaluate environmental contamination with pathogenic &q'llus 
spp. as nsk hctor for deep &gal infections in immunocomprotnked patients. 
Methods: Indoor mycoflora was investlgated in the Dept. Haematology and 
BMT (15 beds; 10 wards) during three sampling periods in October- 
November 2000. Sampling was carried out every second week at the 
patients bed rooms/bathrooms and linking corridors using Rodac contact 
plates (138 samples) with three different agar media (2% malt extract, 
Czapek Dox and dichloran 18% glycerol). Additionally sedimented dust was 
collected during two 7-days periods (20 samples). Dust was &luted and 
calculated CFU/m3 of air. Fungal colonization of patients by nasal swabs (1 1 
samples) was studied after the case of isolation pathogenic Aspergillus sp. 
from the environment. 
Results: The total fungal count varied from 0 to 210 colony forming unit 
(CFU) on Rodac plates and 1-34 CFU/m3 of air. The most commonly 
isolated were Cladospotium cladosponoides (in 76 samples), Penicilliunt sp. (57), 
Aspergillus sp. (29). Zygornycetes (Mucor racemosus, Rhizopus sp.; 23), Botryfis 
n'nerea (12) and Alternatia altemata (7). Two pathogenic Aspergillus species 
(A.furnigatus and A.Jmu5) were isolated with Rodac plates in four different 
locations. There was not any fungus isolated in surveillance cultures from 
patients' nasal cavities. 
Conclusion: Our study suggests that environmental sampling give general 
information about fungal contamination in hospital. Our finding of 
pathogenic fungi bighhghts the need for air filtration. Any clinical 
symptoms suggestive to aspergdlosis in haematological patients should be 
carefully interpreted in context of environmental contamination with 
pathogenic asper&. 
/p697) Epidemiological study of Aspergillosis in a tertiary 
university hospital during a period of constructions 
G.L. Petrikkos, P. Giakkoupi, I.  Georgopoulos, A. Skiada, A. Kanta, A 
Avlami, E. Petrikkou, A. Toskas, E. Roilides 
Athens, GR 
Introduction: Nosocomial aspergdlosis is a well known complication of 
immunosuppression in cancer patients and those undergoing transplantation 
and has usually been associated with major building construction or 
demolition. 
Aim of the study: Recording of invasive aspergdlosis in an Athens hospital 
during a construction's period, isolation, identification and sensitivity testing 
of the corresponding fungi. 
Material and methods: The period of constructions lasted from February 
1998 till October 2000. During this time, 22 cases of aspergillosis were 
identified from the hospital records and characterized as definite according 
to the extent of supportive clinical and laboratory findings. AU fungal 
isolates were identified by standard culture and morphological appearance. 
Sensitivity testing against amphotericin B and itraconazole was performed 
with the broth microdilution method according to the guidelines of 
the NCCLS. 
Results: The patients, 19 men and three women, aged 19-72. suffered 
mostly from hematological malignancies and over 50% were febrile. The 
isolates were collected from the respiratory tract and were identified as 
Aspergillus J a w s  14 and AspergiNus furnigatus seven. In one case no 
identification could be given. All the strains had MICs of amphotericin B 
and itraconazole below 1 mg/L. All the patients received antifungal therapy, 
and only 36% had n o  response. 
Conclusion: There is a specific relevance of building construction near a 
hematological unit to the development of fungal infection. Although the 
corresponding moulds had low MIC for the first choice antifungal agents, 
some patients did not have positive response to therapy. 
p698/ Environmental surveillance for filamentous fungi in a 
tertiary care hospital 
P. Panagopoulou, 1. Filioti, E. Farmaki, E. Roilides for the Greek Invasive 
Mycoses Study Group 
Thersaloniki, GR 
Objective: To study the load of filamentous fungi in the environment of a 
tertiary care hospital, as part of a multicenter (tudy of environmental fungal 
load and invasive mycoses. 
Methods: Two buildings of a 1020-bed University hospital were surveyed 
once a month from January to November 2000. Solid Organ Transplanta- 
tion (SOT) and Hematology (H) Departments are located in the older 
budding A, whereas Pediatric Intensive Care Unit (PICU) and Pediatric 
Oncology (PedOnc) Departments are situated in the newer building B. Air, 
surfaces and tap water were sampled in each department. Every month, 
1600 L of air was sampled by Biotest RCS Air Sampler. Swabs were taken 
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from predefined surfaces of each department. Air and surface samples were 
cultured on Sabouraud Dextrose Agar (SDA) plates. In addition, 500 mL of 
tap water were filtered through 0.22 pm diameter pores and the filters were 
placed in SDA broth. All cultures were then incubated at 37 "C for 7 days 
and inspected every day for growth. 
Results: While from January to May fungal load in the air was low, ranging 
from 0.8 to 6 cfu/m' in both buildings A and B, it increased to values from 
9 to 20 cfu/m' during the summer months when higher temperatures and 
hunlidity exist in our area. The most common fungi recovered from the air 
were Aspe~i l ius  Juvus (29%). A .  &migatus (21%) and A .  nigev (18%)). Less 
frequent isolates included A .  terreus, A .  nidufans, zygomycetes and 
dematiaceous moulds. Overall, there were no significant differences 
between the two buildings studied. Among the departments studied, air 
Paediatric HIV 
fungal load was lowest in PICU (14% of total fungal load) as compared to 
PedOnc (33%). SOT (28%) and H (25%). 50% of the swabbed surfaces 
yielded moulds in generally low cfu counts which were similar to the 
moulds recovered from the air. In addition, there was occasional isolation of 
Candida spp. from some of these surfaces. Of note, despite the vigorous 
sampling tap water taken from the same departments yielded no fungi 
during the period studied. 
Conclusions: Air fungal load was very low during winter and spring while it 
increased during summer. Aspeqitlilirts spp. were the most common fungi 
isolated. No h g a l  growth was detected in the water supply system ofthe hospital. 
The low environmental load of h g i  may contribute to the low incidence of 
invasive mould infections seen in high rkk departments of the hospital. 
Acknowledgement: This work was supported under PENED99 no. 99ED14. 
jp6991 A critical assessment of the size and site of lymph 
nodes in HIV-1 infected and uninfected children 
K. F. Leschner, W. P. Rennert 
South Africa, ZA 
Lymphadenopathy is a conmion physical sign in HIV infection. The actual 
size. site and extent of lymphadenopathy have not been well described. This 
prospective study describes the size of epitrochlear, cervical, axillary and 
inguinal lymph nodes in children between 1 and 72 months of age, a h t t e d  
for lower respiratory tract infection. Lymph node size and other signs were 
compared in HIV infected and uninfected chddren. 287 children were 
examined. The largest diameter of the largest lymph node at four bilateral 
sites (8 sites) was measured using a calliper. The size of the liver and spleen 
below the costal nlargin were measured with a tape measure. Children were 
placed in one of five nutritional groups using the Wellcome classification. 
138 children were HIV infected and 74 were uninfected with median ages 
of 5 months and 4 months, respectively. Infected children had larger lymph 
nodes with mean ndimeter values of 2 vs. 1 (epitrochlear), 6 vs. 4 (axillary), 
5 tis. 3 (cervical) and 6 us. 3 (inguinal) P < 0007. Lymph node sizes in each 
child were added to fomi a score which was greater in the infected group 
(mean of 36 us. 20 mm). T h s  score increased by 0.44 mm per month of age 
in both groups, but was not affected by gender or nutritional status. Using 
the International Classification of Diseases (ICD) definition of generalized 
lymphadenopathy (at least 3 sites > 5 mm) in HIV infected children, the 
sensitivity of this sign was 0.52 in detecting HIV infection with a specificity 
of 0.86. A score incorporating lymphadenopathy, hepatomegaly and 
splenomegaly was found to be more versatile. The score had a maximum 
of 24 points. Cervical, axillary and inguinal nodes scored 1 point if > 5 mm. 
Epitrochlear nodes scored 1 point if palpable. Hence lymph nodes could 
score a maximum of 8 points. A liver measuring 2 30 mm scored 8 points 
and a palpable spleen scored 8 points. Infected children had higher scores 
with a mean of 16.03 us. 6.99 ( P  < 0.0001). The score was not affected by 
age, gender or nutrition. A score of 10 or more bad a sensitivity of 0.82 and 
a specificity of 0.74 for HIV infection. A score of 13 or more had a 
sensitivity of 0.68 and a specificity of 0.81, In sunmay,  generalized 
lymphadenopathy (ICD definition) has poor sensitivity as a marker for HIV 
disease. A lymph node-liver-spleen score which is easy to calculate is more 
sensitive and could be a useful tool in the assessment of children with 
possible HIV infection. 
JP700] The diagnostic value of gastric aspirates in 
infected children 
E. Dumea, E. Gorun, C.  N. Rugina, R. Matusa. S .  Kugina 
Corrsfanfza, RO 
HIV- 
Introduction: The stomach is the subject of disease processes and 
opportunistic agents including mycobacterium and fungi. The gastric 
aspirate can be useful as a diagnostic method in climcal pediatric practice. 
Identification of the opportunistic agents in gastric aspirates could he the 
sign of systemic infection in HIV patients. 
Objectives: Detection of opportunistic infections in gastric aspirates of HIV 
infected children. 
Methods: HIV infected chddren with age between 8 and 12 years carried 
out a retrospective study with 251 specimens of gastric aspirates. 98 
specimens were positives. The sediment of gastric aspirates specimens made 
it Giemsa and Ziehl-Neelsen stained smears, and then culture (Lowenstein- 
Jensen, Sabouraud agar, Sabouraud dextrose agar-without cycloheximide 
and agar-inositol) and identification using API 20C Aux system 
(bioMerieux SA). The susceptibility was examined using ATB fungus, 
bioMerieux (for amphotericin B, ketoconazole, nystatine, fluconasole). 
Results: At 14th patients it was identified Myiobaiteritrm tuberiulosis (by 
Ziehl-Neelsen stain and culture), 74 specimens have developed Candida 
strains (Candida albicans 87.8%, Candida parapsilosis 4%, Cundida glahrata 5.5%) 
and CaMdida knrsei 2.7%), 8 cryptococcus s t r a i r ~ ~  (Cyptococms neqjimtm<s 63%, 
Ciyptocornrs laurenfii 37%). At the HIV- atients with positive specimens (98) the 
values of CD4 were: less then 50/mm at 53%, between 50 and 100/mm3 at 
24.576, 100-150/mm7 at 12.3%. and 15C-200/mm3 at 10.2%. 
Conclusion: Examination of gastric aspirates it is be useful in clinical pediatric 
prachce when diagnosis of mycobactenum infection could be CWicult. 
Identification of the opportunistic agents in gastric aspirats is the harbinger 
of the systemic infection at the patients with CD4 less then 200/m.'.  
9 
vl Tuberculosis in children dying from HIV-related lung 
disease 
W .  Rennert, D. Killner, G. Stevens, W. Stevens, H. Crewe Brown, M. Hale 
Johannesburg, ZA 
The diagnosis of TB in children with HIV is difficult. Clinical studies report 
a high correlation between TB and HIV. However, clinical criteria used to 
identify TB are shared with CMV infection, PCP and LIP. Post morteni 
studies do not confirm a high coinfection rate between TB and HIV in 
children. We have tried to correlate post mortem histopathological and 
biochemical data with clinical findings in 93 children dying from HIV 
related lung disease. Post mortem lung and liver biopsy specimen were 
processed for histology using HE, ZN, Grocott's and CMV inimunoper- 
oxidase staining. Further specimen were processed for TB culture and PCR, 
as well as PCP PCR and immunofluorescence. Clinical data were derived 
fiom chart review. TI3 was documented on biopsy specimen culture in 4 
patients (4.3%). Ail 4 patients showed acid fast bacilli on ZN staining. 1 
patient had a typical granuloma in the lung, 3 patients had granulomata in 
their livers suggesting niiliary disseminat~on. PCR amplification showed TB 
DNA in the lungs of 2 patients, but none in liver specimen. 2 patients had 
cultured TB on gastric aspirates before they died. The other 2 had died 
before aspirates could be obtained. A further 17 patients (18.2%) had been 
treated empiricaily for TB before they died. 16 of them had identifiable 
pathogens on post mortem investigations in their lungs (4 CMV, 1 PCP, 2 
PCP and CMV, 1 MAC and CMV, 3 viral pneumonia other than CMV, 2 
bacterial pneumonia, 3 LIP). 72 patients died without TB therapy. Post 
mortem investigations showed similar results. Clinical findings were similar 
in patients with documented TB, suspected TB, and those without TB. 
There was difference in oxygen saturation, the presence of bronchial 
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breathing, crepitations, tachypnea, fever or the CDC classification for HIV 
disease between the groups. However, patients with documented TB were 
significantly older than those without. The simdarity in clinical presentation 
of HIV related lung diseases makes the diagnosis of TB difficult, if not 
impossible. Clinical studies overestimate the prevalence of TB in this 
population. While it may be justified to continue empiric anti-TB therapy 
in patients with source case contact, suggestive clinical findings and positive 
gastric aspirates, there is no place for prophylactic anti-TB therapy in all 
children suffering from category B or C HIV disease. 
Lung pathology in HIV seropositive children - a 
postmortem study 
DJ. Kdner, W.P. Rennert, M.J. Hale, H. Crewe-Brown, W. Stevens, 
G. Stevens 
Johannesburg, ZA 
Background: Relatively little is known about pulmonary conditions in HIV 
infected chlldren in Africa. In many of these countries there is limited access 
to complex laboratory services as well as the inability to perform invasive 
diagnostic procedures. Thus postmortem studies, although concentrating 
on advanced disease, provide essential information that would not otherwise 
be obtained. 
Objective: The aim of the present study was to delineate the spectrum 
of pulmonary disease in HIV seropositive children from a developing 
country and to determine the differences, if any, from other countries on 
the African continent. 
Setting: The general paediatric wards of Chris Hani Uaragwanath Hospital, 
Soweto, South Atiica. 
Methods: Over a 5-month period, postmortem tissue biopsies of the lungs 
were performed on 93 HIV Elisa positive children who had clinical or 
radiological evidence of respiratory tract disease. In addition to histological 
exanination, specimens fiom the lungs were also sent for mycobacterial culture. 
Results: The mean age of the patients was 10.5 months (range 1 m o n t h 4  
years). The commonest pathogen was cytomegalovims (CMV) with 29 out 
of 91 (32%) cases, mean age 5.4 months (range 1-16 months). This was 
followed by Pafurnocystis carirzii pneumonia with 20 out of 91 (22%) cases, 
mean age 3.2 months (range 2-4 months). Co-infecnon with CMV and 
Pneumocystis cannii occurred in 9(10%) cases. There was 1 case of 
Mymbacten'um avium intracellulare with CMV infection. Lymphoid inter- 
stitial pneumonitis was present in 10(11%) cases, mean age 32 months (range 
6-69 months). Of the 4 cases of Mycobacten'um tuberculosis (TB), 3 were 
disseminated. The mean age of the TB cases was 32 months (range 3-63 
months). Therefore, AIDS defining finesses were present in 53 out of the 
91 (58%) cases. Pyogenic pneumonia was present in I6 (18%) cases, mean 
age 21.5 months (range 2-69 months). 
Conclusion: The 6ndings of this study are similar to other postmortem studies 
performed on the A6ican continent which have found a high prevalence of 
PCP and CMV and a low prevalence of TB. In our population more than half 
of the cases had an AIDS dehing h e s s  at the time of death. Sigtllficantly, 
heumocystis rariiiii pneumonia was present in 22% of the cases and the disease 
occurred at a young age. As this disease is potentially preventable with 
prophylaxis, public health effom should be mrected at identifying chddren at 
risk and implementing prophylaxis from a young age. 
r p m l  Perinatal exposure to antiretroviral therapy: benefits 
and risks 
A. Maccabmni, I .  Pacati, F. Ravagni, T. Figar, M. Furione, M. Gatti 
Pavia, I 
Background: Current reports suggest that the rate of perinatal HIV 
transmission is 2% or less when the maternal viral load is reduced to 
undetectable levels by highly active combination antiretroviral therapy. The 
majority of H1V-infected women meet the criteria for antiretroviral 
treatment with two reverse transcriptase inhibitors @TI) and protease 
inhibitor (PI). There is concern about the possible adverse effects of 
intrauterine or neonad exposure to antiretroviral therapy. 
Methods: Antiretroviral safety was studied in 27 pregnant women and in 
their 24 newborn. All mothers received two RTI, combined with PI in 12 
of them (SQV: 4, IDV: 6 ,  NFV: 2) and with NNRTI (Nonnucleoside 
Reverse Transcriptase Inhibitors) in only one case (MTP) .  
Results: The main adverse effects in the women included: anaemia in one 
patient on double therapy; nephrolytiasis and recurrent urinary tract 
infections in one case on triple therapy with IDV. We moreover observed 
one case of fatal death at birth (29 week of gestation) in a patient receiving 
ZDV + 3TC + SQV and 2 cases of abortion at 6 weeks of gestation (STV + 
3TC + NFV; ZDV + &I). 5/24 chddren were premature. Elective 
Cesarean delivery has been performed in 19/24 caes and 5 newborns were 
born through emergency Cesarean section. Birth weight resulted < 2500 g 
in 7 neonates. 21/24 newborns received ZDV. 13 cases of nlild anemia 
were observed; one premature baby (ddI + STV iri utevo) had nonlife 
threatening intracranial hemorrhages detected by transfontanellar cerebral 
echography and another one (ZDV + 3TC + IDV in utero) developed a 
necrotizing enterocolitis. All babies resulted HIV negative. 
Conclusions: Our observations coi& the role and the efficacy of a correct 
maternal therapy in reducing the risk of perinatal transnlission of HIV. 
Major adverse events in women and newborns, resulted quite rare but 
emphqize the necessity to maintam updated registers on antiretroviral safety. 
Neurological follow-up of children perinatally exposed 
to antiretroviral therapy: evaluation of a diagnostic protocol 
A. Maccabruni, I .  Pacati, D. Caselli, F. Piazza, R. Callieco, P. Zucch 
Pavia, I 
Background: Aim of ths  study is to better evaluate the risk of CNS 
impairment in children perinatally exposed to antiretroviral therapy. 
Methods: From January 1998 to January 2000 we selected 14 children born 
to HIV-infected women treated during pregnancy with: AZT alone (5 
cases), 2 NRTI (3 cases), 2 NRTI + 1 PI (5 cases). 5 were already on 
antiretroviral treatment when they became pregnant; in the retnaining cases 
the therapy was started during the first or the second trimester ofpregnancy. 
The planned diagnostic protocol, depending on clinical criteria and 
supported by neurological and electrophysiological assessment, includes: 
periodic neurobehavioural assessment (1-3-6-12-18" month of lite, 
neurological examination by Amiel-Tison method); evaluation of mental 
development by Griffiths Mental Development Scales; electrophysiological 
examinations at sixth month of life: Brainstem Auditory Evoked Potentials 
(BAEPs), Visual Evoked Potentids (VEPs). 
Results: The neurological assessment showed in only one case a diffuse 
hypotonia and in another one mild hypertonia in the 6rst trimester of hfe. 
General Intelligence Quotient ranged &om tiom 85 to 110 in all chddren. 
BAEPs and VEPs were performed in 10114 cases: in one baby a lower 
amplitude of PEV in right eye with abnormal morphology was observed; in 
another one the BAEPs evaluation showed a lower amplitude in right ear. 
All babies resulted HIV u d e c t e d .  
Conclusions: Although we could evaluate only a small number of children, 
we did not observe any neurological a b n o d t y  related to prenatal exposure 
to an t i re t rod  drugs during the first 18 months of life. An effective 
antiretroviral treatment during pregnancy represents, on the other side, the best 
strategy to reduce the risk of H N  vertical transmission. To assess long-temi 
side-effects of maternal andretroviral therapy on children it is necessary to 
maintain updated registers concerning pregnancy, newborns and all data 
resulting koni clinical and neurological follow-up of uninfected children. 
v1 Genotipic mutations associated with antiretroviral 
drug resistance in HIV-1 infected children by vertical transmission 
C. Munoz, C. Fortuny, A. Gonzalez-Cuevas, B. Clotet, L. Ruiz, C.  Latorre 
Barcelona, Badalona, E 
Introduction: Vertical transmission of HIV-1 is a particular sort of 
primoinfection because, in case of previous identification of pregnant 
women, it is possible to establish preventive measures in order to diminish 
the risk of viral transmission. It is also possible to apply diagnostic techniques 
to their children, confirming or excluding infection during the first weeks of 
life. The possibility of vertical transmission of resistant strains would 
diminish the effectiveness of antiretroviral prophylaxis and of initial 
treatment of infected children. 
Objective: To detect the presence of mutations associated to antiretroviral 
resistance in naive pediatric cMdren infected by vertical transmission. 
Patients: During the study period (from May 1995 to A p d  2000) we 
analyzed retrospective samples kom 29 pediatric patients infected by vertical 
transmission. Eighteen of them were diagnosed before their mothers, as 
women didn't know they were infected. Three of the 11 remaining 
children had received correct antiretroviral prophylaxis according to the 
accepted reconmendations, one girl had been given incomplete prophylaxis 
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and seven children born before 1996, year when preventive measures were 
recommended in our country, had no received prophylaxis. 
Methods: The LIPA(R) assay (Innogenetics) was used to evaluate resistance 
mutations in all children. Pure resistant mutants as well as mixed susceptible 
and resistant patterns were both considered resistant. Sequencing of the 
genes of protease and reverse transcriptase was added in 10 patients, using 
Tru Gene HIV-1 Genotyping Test (R) reagents (Visibie Genetics). 
Results: Primary mutations were detected in three patients (10.3%): In a 
three months old girl (year 1995). the one with an incomplete prophylaxis, 
mutations K70R for zidovndine and M184V for lamivudme, in a 48 months 
old boy (year 1997) mutation K70R, and in the third patient (a girl studed 
in year 2000) mutation V106I for nevirapine. These two last patients had 
not done antiretroviral prophylaxis. 
Conclusion: The detection of resistant viruses in naive chddren, as 
demonstrated in our series, points out the interest of genotypic study: 
Patients will adequate to the best individual treatment according to their 
resistance pattern and public health will take advantage of the knowledge of 
resistance epidemiology, that d lend to a better design of strategies for 
prophylaxis and treatment of our society. 
p%%l The impact of antiretroviral treatment on incidence of 
herpetic infections in HIV-infected children 
C.S. Lungu, R. Matusa, S. Rugina, C. Rusu 
Constanfza, RO 
Objective: To evaluate the effect of antiretroviral treatment on the 
incidence of herpetic infections in two groups of HIV infected chddren: 
A-without antiretroviral treatment and B with antiretroviral treatment. 
Methods: The study compared the incidence of cutaneous herpetic 
infections (herpes simplex, varicella, herpes zoster, herpes zoster varicello- 
sus) in HW infected chddren admitted in the Children Infectious Diseases 
C h c  between 1Y98 and 1999. 
Results: From 928 children HIV infected taken in our evidence, 420 were 
in the HIV infection stage, and 508 were in AIDS stage. Out of the chddren 
with AIDS 201 were not following any antiretroviral treatment (group A) 
and 307 received antiretroviral treatment (group €3). In the studied peiiod 
we observed 242 chddren with AIDS and herpetic infections, i.e. 112 with 
cutaneous heyes simplex, 78 with heyes zosfer 37 with varicella and 15 with 
heyes zosfer varicellosus. By comparing the overall incidence of herpetic 
infections in groups A and B, s igdcant  difference from 83.8% to 24.4% 
was observed. In particular the incidence from group A and B was 40.29%, 
respectively, 10.9% for cutaneous herpes simplex, 23.38%, respectively, 
10.09% for herpes zoster, 12.43%. respectively, 3.9% for vaticella and h.9%, 
respectively, 0.32% for heyes zoster varicellosus. 
Conclusions: This study establishes that a low incidence in herpetic mfections 
was noticed in HIV infected subjects that received antiretroviral treatment. 
v1 Detection of Ctyptosporidium oocysts as an enteric 
pathogen in HIV-positive children 
E. Dumea, E. Gorun, R. Matusa, C. N.  Rugina, S. Rugina 
Constanfzn, RO 
Introduction: Acute and chronic diarrhea are major causes of morbidity and 
mortality in HIV infected children. A significant portion of these illness remains 
without an identified etiology. In immunocompromised patients, cxyptospor- 
idial dianhea is a debllitating and potentially life-threatening infection. 
Objectives: T o  evaluate the kequency of the cryptosporidiosis in HIV- 
positive patients. 
Methods: This is a retrospective study of 210 HIV infected childrem, witch 
were examined for presence of Ctyptosporidium (40% had CD4 count less 
then 200/1nm.~, 40% have had CD4 200-500/mni3 and 20% CD4 more 
then 500/mm3). Fresh stool samples are collected kom each patient and are 
tested twice: (1) by microscopy ofsaline wet and iodme stained slides and by 
Ziehl-Neelsen stained slides; (2) by enzyme immunoassay (EIA) for the 
detection of antigens from Cryptosporidium in stool samples. 
Results: The presence of  Ctyptosporidium was detected in 25 patients (25%). 
5 patients suffered from severe and prolonged diarrhea, they had 
lymphocyres CD4 level less than 5 0 / m  and they deceased. The other 
patients with positive samples bad CD4 level between 200 and 5 0 0 / m 3 ,  
13 had nonspecific symptomatology and 7 were asymptomatic. The value of 
cut-off EIA was intense positive at all the patients with severe diarrhea, 
severe symptoms are usually associated with a high oocyst burder. There was 
no difference in oocystis excretion at the patients with CD4 level between 
200 and 500/mm3 asymptomatic or with atypical clinical illness. 
Conclusions: Cryptosporidiosis is often a devaqtating complication for 
persons with AIDS; it contributes sigmficantly to morbidity and hastens 
death. We monitored for the presence of Cryptosporidium all the patients 
HIV infected when CD4 deacreased under 500/mm3 with or without 
digestive symptoms. 
w81 Rescue antiretroviral therapy in children with 
congenital HIV infection: an emerging problem 
R. Manfredi, L. Calza, F. Chlodo 
Bologna, I 
Objective: To evaluate the need ofsalvage antiretroviral therapy (ARVT), a 
cross-sectional study of congenitally infected patients @) was performed. 
Methods and results: Of 19 p with vertical HIV disease, 11 received 
ARVT since > 3 years: in 6 p. > 3 different therapeutic changes (range 4-7) 
had been carried out, due to prior virologic and/or immunological fdure. 
However, during the last 6 months 5 p of 11 showed a rebound of viremia 
> 1 log or a viral load persistently > 10000 copies/mL, despite ARVT with 
4-5 drugs induding 2 nucleoside analogues (NA), one non nucleoside 
reverse transcriptase inhibitor (“RTI) ,  and one or 2 protease inhibitors 
(PI). In all p treated since > 3 years, viral genotype assessment showed a 
broad spectrum of mutations, which led to a high resistance profile to almost 
all available drugs: AZT, ddC, ddI, 3TC and abacavir among NA, 
nevirapine, efavirenz and delavirdine among “ R T I ,  indinavir, ritonavir, 
saquinavir and nelfinavir among PI. The resistance pattern was consistent 
with prior ARVT, when excluding the absence of mutations confemng 
resistance to stavudine, and the occurrence of resistance to all NNRTI in 4 
p who never used NNRTI. Waiting for novel molecules possibly available 
for children (adefovir, amprenavir, lopinavir and others), the continuation 
of an effective ARVT in these p represents a real challenge. 
Discussion: Compared with guidelines of ARVT of adults, those avadable 
for children are backward, due to limited controlled data, and reduced 
spectrum of drugs and formulations specifically developed for childhood. 
Only anecdotd data are avaiiable about rescue ARVT, and clinical 
validation of resistance testing in pediatric HIV disease is lackmg. An 
effective and sustained ARVT is threatened by the emerging of resistance, 
limited adherence, and adverse events: all these problems are exaggerated in 
children, since these p were likely to be exposed to prolonged suboptimal 
regimens, have special viral dynamics, experience greater compliance 
problems, and may suffer from increased drug interactions and toxicity. At 
this time, heavily pretreated p with an extended resistance profile seem to 
have exhausted all available therapeutic options, although virological failure 
is not invariably followed by immunological and clinical deterioration. 
Controlled data dealing with salvage ARVT are warranted for pediatric 
HIV disease, to update therapeutic recommendations and guarantee the best 
standard of ARVT in all situations. 
v/ lmmunogenicity and safety of a virosomal influenza 
vaccine in HIV-infected children 
G. V. Zuccotti, E. D’Auria, L. Tegaldo, D.  D U O ,  D.  Sala, M. Giovannini 
Milan, I 
Introduction: HIV-infected children are at increased risk of complications 
associated with influenza. Vaccination represents the only affordable 
prevention. Nevertheless, the impairment of immune system characteristic 
of HIV-infection could affect the vaccine effectiveness. 
Objectives: To assess immunogenicity, safety and effects on viral load of a 
virosomal influenza vaccine in HIV-dected chddren. 
Methods: Twenty-three HIV-infected subjects (13 females, 10 males; 
median age 7.2 years, range 2-17) followed in the Infectious Disease Ward 
of our Department entered the study. All the subjects received a single dose 
(0.5 mL) of a trivalent, inactivated, virosomal vaccine (Intlexal V Berna) 
during 1-month-period (October 1999). At enrolment 20 children had no 
evidence of immune deficiency (CDC class l),  while 3 chddren showed a 
moderate immune deficiency (CDC class 2). Serum antihemagglutinin 
antibody titers were determined by a standard hemagglutination inhibition 
assay method for each of the three viral strains a t  the time of immunization 
(TO) and 1 month later (Tl). Viral load (HIV-RNA) was measured by PCR 
(Amplicore HW-1 Monitor Roche) at the time ofimmunization (TO) and 1 
month (TI), 2 months (T2) and 3 months (T3) later. Outcome measures: 
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seroconversion, as a four-fold increase of antibody titer; seroprotection, as a 
postvaccination titer equal to or higher than 1:40. Informed consent was 
obtained &om the children’s parents and the study design was approved by 
the departmental ethics committee. 
Results: Seroconversion rates against the three viral strains A/H3N2, A/ 
H l N l  and B were 73.9%, 56.5% and 52.2%, respectively. The geometric 
mean time was signhcandy increased at T1 when compared to baseline values 
(A/H3N2: 70.9 us. 13.5; A/HlNI: 24.7 us. 5.8; B: 34.4 us. 9.1; P < 0.0001, 
Wdcoxon test). In the three months following vaccination no significant changes 
in viral load have been observed (logarithnuc mean: 4.18 at TO; 4.24 at T1; 
4.10 at T2 and 4.18 at T3; P=0.88, Friedman test). The vaccine was well- 
tolerated, with only a few minor symptoms attributable to immunization. 
Conclusions: Intluenza vaccine was proved to be effective and well- 
tolerated in our sample of HN-infected children. We suggest that influenza 
vaccination could be safely recommended in HIV-infected children. 
Antiretroviral therapy: side effects 
9 v] The effect of switching from protease inhibitors to 
nevirapine on HAART-assodated subcutaneous adipocyte apoptosis 
P. Domingo, X. Matias-Guiu, R. Pujol, E. Francia, J. Arroyo, M. Sambeat, 
G. Vazquez 
Barcelona, E 
Background: Long-term use of highly active antiretroviral therapy 
(HAART) has been associated with a previously unseen form of 
lipodystrophy. Subcutaneous adipocyte apoptosis has been demonstrated 
to occur in lipoatrophic areas. 
Patients and methods: Fourteen HIV-infected patients with HAART- 
associated lipodystrophy who had a subcutaneous adipocyte apoptosis demon- 
strated while on HAART includmg protease lnhibiton (€‘I) were included in the 
study. E&t patients had been switched to a nevirapine (NW-based HAART 
while 6 were kept on a PI-based HAART. A second subcutaneous biopsy was 
performed in the same area and the samples were submitted for a careful search 
for adipocyte apoptosis. Apoptosis was assessed by the Terminal deoxynucleotidyl 
aansferase dUTP-digoxigenin Nick End Labeling (TUNEL) method. using the 
ApopTag kit (Oncor, Gaithenburg, MD, USA). 
Results: All 14 patients had had the characteristic features of HAART- 
associated lipodystrophy. The mean exposure to NVP was 12.5 f 3.4 
months. Total cholesterol, and BMI did not experience significant changes 
in both groups. W H R  increased in NVP group (0.96 us. 1.01, P=0.07), 
triglyceride level increased in the PI group (2,48 us. 8.33 minol/L, 
P= 0.01), and the glucose/insulin ratio increased in both groups (0.03-0.06 
for PI group, P=0.04 and 0.03-0.05 for NVP group, P=0.02) 
Pathologdly, subcutaneous fat atrophy was still prepent, along with focal 
lipogranuloma formation and vascular proliferation. Apoptotic changes 
increased in three patients switched and in three who were kept on PI, 
decreased in 2 patients on PI and a patient on NW, and remained 
unmodified in a patient switched to NVP (P’ 0.81). All patients remained 
virologically below LOD ( < 20 copies/mL). 
Conclusion: Subcutaneous adipocyte apoptosis continues to occur in 
lipoatrophic areas of patients with HAART-associated lipodystrophy despite 
switching from HIV-1 protease inhibitors to NVP. This finding suggests 
that such a strategy will be useless for reversal of lipoatrophy. 
(p711 No evidence of mutations in exon 8 of the LMNA gene 
in patients with HAART-associated partial lipodystrophy 
P. Domingo, M. Baiget, J. Arroyo, L. Seco, M.  Sambeat, M. Domenech, 
G. Vazquez 
Barcelona, E 
Background: Chronic treatment with highly active antiretroviral therapy 
(HAART) results in a novel variety of partial lipodystrophy that resembles 
the autosomal dominant inherited PLD of the Duningan type (FPLD). Five 
different missense mutations located in exon 8 of the LMNA gene, 
encoding lamin A/C, have been identified in patients with FPLD and their 
families. The aim of the present study has been to look for these mutations 
in the LMNA gene in patients with HAART-associated PLD. 
Patients and methods: We have automatically sequenced exon 8 of the 
LMNA gene in 20 patients with HAPLD. Anthropometric measurements, 
lipid profile, and i n s d n  were determined together with the genotype. Total 
body fat and lean body mass were measured by means of bioelectrical 
impedance analysis. Statistical analyses were performed with the StatView 
4.5 statistical package for Macintosh. 
Results: There were 14 men and 6 women with a mean age of 41.4 rf: 8.1 
years (range: 29-63 years). Eleven patients were on protease inhibitor-based 
and 9 on NNRTI-based HAART with a mean exposure to antiretrovirals 
of 30.0 f 10.2 months (range: 1 0 4 6 )  Total body fat was 14.1 4.0 
(21.9 f 6%). AU the patients presented with the typical characteristics of 
HAPLD. 15 patients had predominant lipoatrophic changes, whereas 7 had 
mixed changes including 5 patients with lipohypertrophy (1 buffalo hump, 
4 breast hypertrophy). 7/20 (35%) patients had hypercholesterolemia, 13/20 
(65%) hypertriglyceridemia, and 9/19 (47.4%) hyperinsulinemia. Sequen- 
cing of exon 8 of LMNA gene did not show any mutation in the DNA 
samples of the 20 patients analyzed. 
Conclusion: No mutations in the whole exon 8 of the lamin A/C encoding 
gene have been detected in patients with HAART-associated partial 
lipodystrophy. This finding indicates that different mechanisms underlie the 
adquired and hereditary forms of PLD. 
v1 An ultrastructural study of lipoatrophic areas in 
HAART-associated partial lipodystrophy 
J. Lloreta, P. Domingo, R. Pujol, X. Matias-Guiu, J. Arroyo, M. Sambeat, 
M. Serrano, G. Vazquez 
Barcelona, E 
Background: Chronic treatment with highly active antiretroviral therapy 
(HAART) results in a novel variety of partial lipodystrophy that has been 
related with a selective inhibition of lipogenesis. In premous studies, we 
have reported the histopathological features of this disease and we have also 
shown that adipocyte apoptosis is involved in its origin. The aim of the 
present ultrastructural study has been to further elucidate the mechanisms 
underlying this peculiar disorder. 
Method: Biopsies from lipoatrophic areas were obtained after informed 
consent in 10 HIV-1 infected patients treated with HAART for 6-21 
months. Biopsies were fixed in glutaraldehyde and osmium tetroxide, and 
embedded in epoxy resin. Sections were examined with a CMlOO Philips 
electron microscope. 
Results: In all 10 cases, two main sets of ultrastructural changes were 
identhed. Some adipocytes showed progressive disruption of cell membranes, 
fragmented cytoplasmc rims, irregular cell outlines. and eventually large fat 
droplet7 laying fiee in the connective tissue, with a histiocytlc reaction around 
them. All these changes could be related with an apoptotic component. In 
addition, many adipocytes showed vanable compaaimendmtion of fat 
droplets, with decrease in cell size, and large, mitochondna-rich cytoplasm. 
Often, a dual white and brown fat appearance was observed, with a large 
unilocular vacuole surrounded by a rim of multilocular cytoplasm containing 
s m a l l  isometric fat droplets and numerous mitochondria. 
Conclusion: HIV-1 protease inhibitor-associated partial lipodystrophy is 
probably the result of a combination of apoptosis, defective lipogenesis, and 
also an increased metabolic activity in many of the fat cells. 
vl Comparison of abdominal fat distribution in HIV- 
patients using computed tomography 
R. Polo, M. Corcuera, J. Cobo, F. Gomez, M. Galindo, M. Gonzales- 
M d o z ,  P. Madrigal, S. Martinez, M. Alonso, J. Verdejo 
Madrid, Valencia, E 
Objective: To compare abdominal fat accumulation among HIV-patients 
with lipoatrophy, mxed syndrome and HIV-individuals without lipody- 
strophy (LD). 
Methods: The distribution of subcutaneous (SAT), visceral (VAT), total 
(TAT) fat and VAT/TAT and SATIVAT ratio in three groups of patients 
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was assessed by single slice computer tomography (CT) scan through the 
umbilicus. The HIV-patients consisted of three groups: patients with pure 
lipoatrophy (PL), patients with mixed syndrome (MS) and patlents without 
lipodystrophy (NL). 
Results: We evaluated 48 patients (PL 5, MS 24, NL 19). No significant 
differences were found in age, risk group, CD4 count, viral load, weight, 
abdominal skin fold, arm circumference, tricipital skin fold, fat mass and lean 
mass. In PL, MS and NL patients, we found, respectively: total fat 90.08, 
178.69 and 143.1 cm’, visceral fat 84.64, 109.43 and 77.86 cm’; 
subcutaneous fat 16.14, 69.26 and 71.62 cm’; VATJTAT 0.606, 0.586 
and 0.2926; and SAT/VAT 0.649, 0.704 and 2.417. Significant differences 
( P  < 0.05) were observed in visceral fat, SAT/VAT and VAT/TAT. 
Conclusions: C T  is useful to evaluate the abdominal fat redistribution and 
allow to measure visceral fat and total fat and calculate VAT/TAT and 
SAT/VAT ratios. In our experience, patients with pure lipoatrophy have 
more visceral fat than patients without lipodystrophy but without significant 
differences. 
males, 50.5% had AIDS, and 24.5% were fasting. AU the 308 treated patients 
were receiving at least one NRTI: 9.4% took one NRTI,  83.4% two and 
1.9% three; 26.5% took one NNRTI, 61.2% took one PI and 4.9% a 
combination of two PIS. Mean LA level was 1.7 0.9 mmol/L (mean SD), 
which is included in the n o d  range of the laboratory (0.4-2.2). The group 
without treatment had a sigfuscantly lower LA level (1.2 f 0.5) than the 
treatment group (1.7 f 0.8). O n  multivariate analysis, d4T treatment was 
associated with a sigruficantly higher level of LA (1.8 f 0.9; II = 170), as well as 
RTV (2.3 f l..l; n =  19 among which 12 received RTV + SQV). Age and 
nonfasting status were also associated with hgher LA level. On the other hand, 
there was no diffrrence according to CDC stage, AIDS category, and type of 
ART association or drug category association. A total number of more than 
two antiretrovirals was associated with a higher LA level, but the statistical 
signification disappeared in.multivanate analysis. 
Discussion: Systematic LA measure without chnical suspicion of hyperlac- 
tatemia is probably not warranted. Interestingly, the d4T group had a 
normal but significantly higher LA level that could reflect a particular 
mitochondrial toxicity of it. Although the design of this study doesn’t 
Dennit to ascertain a causal relationship, this observation remembers the 
(p7141 Comparative effects of initial anti,etroviral therapy numerous publications reporting severe lactic acidosis with patient treated 
with d4T. The higher level of LA with RTV is more difficult to interpret. 
regimens On cholesterol. triglYceridesr and glucose after Over 45 However, this studv underlines the need for well deslmed prospective - ~- 
months of therapy 
M. Perales, C. Ramirez-Ranurez. G. Gonzalez, C. Tampe, C. Ramirez- 
Ronda, S. Saavedra, C. Rivera-Vazquez 
Sun Juaii, USA 
studies concerning early detection of severe mitochondrial NRTl toxicity. 
Ip7161 Factors associated with hyperlactatemia in HIV+ 
patients under antiretroviral treatment 
Purpose: To compare the effects of different antiretroviral regunens on 
metabolic parameters, 
Methods: We reviewed the records of 159 HIV patients that had been 
followed in the HIV-ID clinics for over 45 months, and correlated 
abnonnahties in cholesterol (CHOL), Triglycerides (TG), and glucose 
(GLU) with initial and subsequent therapeutic HAART regimens. 
Abnormalities were graded Erom 1 to 4. 
Results: Eighty-nine patients were initially treated with 2 NRTIs, 58 
patients on 2 NRTIs + 1 PI, and 12 patients on 2 NRTIs and 1 NNRTI. 
After 24-30 months, those on 2 NRTIs had their treatment supplemented 
with either a PI (46 patients) or an NNRTI (27 patients), whde some 
remained on only 2 NKTIs a t  their own request (16 patients). After 12-30 
months, 25% of those on triple therapy were switched from a PI to an 
NNRTI, or from an NNRTI to 1 or 2 PIS. Patients were followed for an 
average of 52 weeks (range: 4549) .  Sixty-three abnormalities were found 
in 44 patients. Grade 2 4  abnormalities in CHOL, TG, or GLU in patients 
on only 2 NRTIs were 0, 6.25%. and 19%, respectively. For patients started 
on 2 NRTIs who had a PI added to their treatment, the abnormalities were 
13%, 15%. and 24%. respectively. For those started on 2 NRTIs who had a 
NNRTI added, the numbers were 7.4% 11%, and 11%. Those who were 
initially started on triple therapy including a PI, the abnomialities were 21%, 
l6%, and 5%, and for those on started triple therapy including a NNRTI,  
they were 0, 17%, and 8%. 
Conclusion: Abnormalities in CHOL, TG, and GLU are higher for patients 
that received a PI us. those who received an NNRTI,  with total cumulative 
abnormalities of 41% on PI us. 25% on NNRTIs. The patients on only 2 
NRTIs had even lower incidence of metabolic abnomialities. Metabolic 
abnormalities are common and should be monitored, but should not be a 
deterrent to antnretroviral use, as they can generally be managed medically. 
F. Blanco Quintana, T. Garcia-Benayas, J. de la Cmz, F. L ~ ~ u M ,  V. Soriano, 
V. Moreno, E. Valencia, M. J. Senchordi, J. Gbmez, J. Gonzilez-Lahoz 
Madrid, E 
Background: Hyperlactatemia (HL) is an adverse event of antiretroviral 
therapy (ART). Its prevalence, risk condtions, pathogenesis and clinical 
implications are stlll unclear. This study analyses possible facton related to 
HL in HIV+ patients (pts) on ART. 
Methods: Cross-sectional study of 128 HIV+ pts under ART for >6 
months. Venous lactatemia (normal > 1.77 miol /L) ,  nsk behavior for 
HIV infection, lipodystrophy body-shape changes, lipid levels, transami- 
nases and LDH values, inmunological and virological status, drug regimens 
(only NRTI or NRTI plus NNRTI and/or PI) and duration of ART were 
recorded. Univariate and multivariate analysis were performed. 
Results: Mean age 39 f 9 years, male 77%. Mean lactate 2.23 f 0.7 mmol/L 
(range 0.794.31): HL was recognized in 75% of pts, aU asymptomatic. 
Statistically significant differences between pts with hyper us. norm0 
lactateinia were found for: risk behavior (IDU, homosexual, heterosexual): 
30%, 55% an 15% us. 41%, 28% and 31% respectively; Hypercholester- 
olema (chol > 200 mg/dL.): 75% us. 56%; LDH: 395 110 
UI/L; pts on NRTI only: 3% vs. 17%; and pts on NRTI plus NNRTI and/ 
or PI: 97% 11s. 83%. Logistic regression analysis disclosed hypercholester- 
olemia, higher LDH values and regimens including NRTI plus NNRTI 
and/or PI as factors significantly associated with HL. 
Conclusions: HL is a Erequent metabolic disturbance among HIV+ patients 
under ART, often asymptomatic. Hypercholesterolemia, higher levels of 
LDH and triple combinaaons including NRTI plus NNRTI and/or PI are 
independent conditions associated with higher lactate levels. 
209 us. 322 
(p7151 Prevalence of lactic acid level in an out-patient HIV 
population 
Effect of diarrhea on health-related quality of life 
among HIV-infected patients receiving antiretroviral therapy 
X. Holemans, F. Biron, D. Bouhour, A. Boibieux, D. Peyramond 
Lyon, F 
A. Tramarin, N .  Parise, D. Yin, R. Grisetti, A. Capetti, A. Cattellan, M. T. 
Di Toro, A. Mastroianni, E. Pignattan, V. Mondardini, G. Callen, E. Raise, 
Introduction: New important adverse effects have been observed with 
HAART. Among them, lactic acidosis is one of the most severe. 
Objectives: T o  determine the usual level of lactic acid (LA) among an 
outpatient HIV infected population and to observe potential differences 
according to treatment’s regimen. 
Methods: From November 1999 to march 2000, venous LA level was 
measured once for 325 unselected HIV infected patients who came on 
routine outpatient consultation. At the same time, the following data where 
collected: age, sex, stage of infection ( C l X  classification), overnight fasting 
status and current antiretroviral therapy (ART). 
Results: All the data were collected for the 325 patients. Three hundred and 
eight of them were taking ART; mean age was 41.9 (f 10.4), 81.8% were 
F. Starace 
Vicenza, Padua, I; Whitehouse Station, USA; Milano, Padoua, F o m i a ,  Forli, 
Modenu, Belluno, Turin, Venice, Naples, I 
Objective: Diarrhea commonly occulli as a side-effect of treatment with some 
antiretroviral drugs (ART but the effect of diarrhea on patient quality of life 
(QoL) is not well understood. This study a k s  to determine the effect of diarrhea 
on health-related QoL as measured by MOS-HIV in HIV dected patients. 
Methods: Prospective observational study conducted in 1 1  AIDS clinics in 
Italy from June to November 2000. Consecuhve adult patients experiencing 
diarrhea while on ART were enrolled. For each patient enrolled, we 
identified a control patient with matchmg CDC disease stage who did not have 
diarrhea using data from another prospecnve observational study conducted in 
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34 AIDS clinics (includmg the 11 in current study) in Italy between 1998 and 
99 (Palladia study). CD4 cell count and age were used as additional matchmg 
criteria if two or more patients matched. MOS-HIV domain-specific scores 
were compared between the matched cohorts using paired f-test. 
Results: 62 patients with diarrhea were enrolled. Mean age was 40 7.3; 69% 
were male. Mean CD4 cell count was 330.7 228.4 cells/mm3; 50.1% had 
AIDS. The most common ART were lanliwdine (n=37), stawdine (32) and 
nelfinavir (22). 32 patients had severe diarrhea ( > 5  bowel movements or > 3  
watery per day) and 30 patients had moderate diarrhea (3-5 bowel movements). 
Matched control patients receiving indmavk plus two RTIs had slrmlar CD4 cell 
count (niean=336.1 k 218.0 cells/mm? and age (mean=37.4 k 6.9). Com- 
pared to those with matching disease stage, patients experiencing diarrhea whde 
on ART had si&cantly lower QoL scores (P < 0.05) in all MOS-HIV 
domains except physical functioning: general health (23.3 us. 38.2), pam (69.4 us. 
81.2), mental health (57.2 us. 67.7), energy/fitigue (46.1 us. 65.0), health distress 
(74.1 us. 86.0), quality of Me (44.8 us. 65.3), health msition (45.6 us. 68.6), 
physical functioning (72.7 us, 82.1), role functioning (60.5 us. 82.1), social 
functioning (70.3 us. 89.7), and cognitive functioning (79.5 us. 89.0). 
Conclusion: HIV infected patients reporting diarrhea whde on ART had 
significantly lower quahty of life scores. This significant adverse effect of 
diarrhea on patient quality of life should be considered when choosing 
antiretroviral drugs. 
v] Osteonecrosis, HIV infection and highly active 
antiretroviral therapy: report on five cases 
L. Calza, R. Manfred, A. Mastroianni, F. Chiodo 
Bologna, For& I 
Introduction: Osteonecrosis shows an increasing incidence in HIV-infected 
patients (p), since it has been observed in these p at a higher prevalence than 
in general population, being looked as a side-effect of HAART. 
HIV treatment and resistance 
Case reports: Five episodes of osteonecrosis were diagnosed since 1993, out 
of a cohort of 1368 p referring to our centre, and includmg 635 p on a 
protease inhibitor (PI)-based triple treatment since at least 6 months. Bone 
disease occurred in 5 male p aged 2 9 4 5  years (2 homosexuals and 3 drug 
users), with HIV infection recognized since 4-12 years. The diagnosis was 
confirmed by MRI in 4 p, and by skeletal scintigraphy in the fifth p; bone 
involvement appeared bilateral in 2 cases (involving both femoral heads), 
while resulted nionolateral in 3 p (when femoral head or knee were 
interested). At the time of diagnosis, CD4+ count ranged from 2 to 244 
cells/mm3; a plasma viral load exceeding 10 000 copies/ml was found in 
2 p, whereas thls assay was not yet available when the necrosis occurred in 
the remaining 3 p. At the time of first madestation of bone disease, 
ongoing anti-HIV therapy included at least one PI in 2 p, while 3 p never 
underwent any treatment. Both serum glucose and lipid levels tested always 
normal in all described p, save one; antiphospholipid antibodies (APA) 
proved repeatedly positive in 3 cases. Alcoholism, steroid treatment, 
hemoglobinopathies, coagulopathies, malignancies, vasculitis, systemic lupus 
erithematosus or traumatic events, were carefully excluded. 
Discussion: Although osteonecrosis remains rare in the setting of HIV 
disease (with a prevalence rate of 0.2-2%), its frequency increased during 
recent years, so that its association with HAART was supposed. Presently, 
62 cases of HIV-associated osteonecrosis have been quoted in the 
international literature, but 30 episodes were reported before the HAART 
era. Several pathogenetic mechanisms have been proposed for HIV-related 
osteonecrosis aside &om anti-HIV therapy, including steroid treatment, 
elevated APA, and increased production of proinflammatory cytokines. 
However, new antiretroviral compounds may interfere with several 
metabolic pathways, leading to hyperlipidemia, atherosclerosis, blood vessel 
obstruction, and avascular bone necrosis. Exposure to PI-based HAART, 
hypertriglyceridemia and APA were not present in all described p and these 
factors may concur with, but do not seem necessary elements in the 
etiopathogenesis of HIV-associated osteonecrosis. 
(p719/ Comparison of genotypic and phenotypic resistance 
analysis in HIV-1 patients on HAART therapy 
H. Knechten, C. Hohn, R. Ehret, P. Braun 
Aachen, D 
Objective: Determination of HIV-1 drug resistance is an important 
parameter to optimize antiretroviral therapy. There are two ways to detect 
drug resistance, by genotypic and phenotypic assays. We herein compare the 
results of these two different ways of detecnon on the basis of primary 
mutations defined in the jAMA consensus statement 5/2000 (JAM 2000; 
Methods: We examined genotypic and phenotypic resistance assays of 38 
patients pretreated with different HAART regimens. Genotyping was 
performed with the OpenGene'IM system (Visible Genetics Inc.) and 
interpreted with the True-Gene-Program. Determination of phenotypic 
resistance was performed at the University of Erlangen-Niimberg, 
Germany. The increase of the IC50 was divided into more than 10-fold 
for resistant, between 4-and 10-fold for weak and 4-fold and lower for 
not resistant. 
Results: Primary mutations for nonnucleosid reverse transcriptase inhibitors 
( " R T I )  were detected in 25 out of 38 cases. The appearance of a unique 
or a combination of those mutations correlate with phenotypic results of 
more than 10-fold. The results for nucleosid reverse transcriptase mhlbitors 
(NRTI) were more complex. For Zidovudine (AZT) the appearance of 
T215FY and for Lamivudine (3TC) the presence of M184V showed a high 
phenotypic resistance. The presence of both substitutions in 9 samples 
did not resensitize for AZT. Single primary mutations for AI3C showed 
only weak phenotypic resistance. D4T, DDC and DDI primary mutations 
led even in combinations to only weak phenotypic results. Multi- 
~g-resistance-substi~tions did not occur. The mutations D30N, M461, 
V82AFTS, I84V and/or L90M in the protease gene were only detected in 
combinations and showed in all cases a phenotypic resistance. The primary 
mutations G48V (Saquinavir) and I54V (Amprenavir) were not detected. 
Conclusions: This investigation shows that the appearance of distinct 
primary mutations for protease inhibitors, NNRTIs, AZT and 3TC 
283(18): 241 7-2426). 
correlates well with phenotypic results. To interpret the different mutations 
correctly it is necessary to consider also secondary mutations and to consult 
additionally continuously actualized databases, e.g. Stanford University and 
the AlamosResitanceDB in daily routine. 
v1 Sensitivity of different RNA extraction methods for 
HIV genotyping 
M. J. Torres, E. J. Perea, J. C. Palomares 
Seuiile, E 
Objective: To determine the sensitivity of the TruGene'-M HIV-1 
genotyping system (Visible Genetics, Inc) when used in conjunction with 
Roche Ultra Sensitive Amplicor I' HIV-1 RNA extraction method, 
compared to that obtained by Nucli-Sens ' . 
Methods: Samples were drawn from banked plasma from patients with 
viral loads ranged &om 500 to 10 000 copies/inL. R N A  was extracted via 
Roche Ultra Sensitive Amplicor ' (sensitivity cut-ofl- 20 c o p i e d d )  and 
NucliSens' . Results were defined as useful for genotyping (low back- 
ground, strong signal, even peaks), not useful for genotyping (hgh 
background, weak signal, stops) or failed (only primer peak detected, no 
sequence data). All genotypes were performed using TruGeneTM HIV 
Assay (RT PCR with Clip reaction and automated sequencing). 
Results: Ultra Sensitive Amplicor "-30 samples plus negative controls. 
82% usehl for gemtyping at viral loads between 500 and 1000 copies/nL; 
90% useful for genotyping at > 1000 copies/ml. Nuclisen"-30 samples 
plus negative controls. 83% useful for genotyping at viral load between 500 
and 1000 copies/mL; 90% useful for genotyping at > 1000 copies/mL. 
Conclusions: The TruGeneTM HIV-1 genotyping assay demonstrated a 
good sensitivity with both Roche Ultra Sensitive AmpIicor" and 
NucliSens ' I  HIV-1 RNA extraction methods and clinically relevant 
RNA concentration?. No significant diferences were found between both 
extraction methods. 
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ml Genotypic resistance mutations to antiretroviral drugs 
tested by INNO-LIPA in patients from southern Spain 
M. hvarez, F. Garcia, M. Martinez, F. Garcia Jr, C. Bernal, J. Hernindez, 
M. C. Maroto, G. Piedrola 
Granada, E 
Objective: To investigate the prevalence of mutations associated with 
genotypic resistance to nucleoside reverse transcriptase inhbitors (NRTIs) 
and protease inhibitors (PIS) in patients under antiretroviral regimens and in 
patients without treatment. 
Patients and methods: Genotypic resistance to NRTIs was performed by 
INNO-LIPA HIV-1 RT test (Innogenetics) on 110 patients; 83 were being 
treated with NRTIs at the moment of testing. Genotypic resistance to PIS 
was performed by INNO-LIPA HIV-1 Key protease (Innogenetics) on 50 
patients; 25 were being treated with PIS at the moment of testing. 
Results: (a) NRTIs: 27 patients were not treated with NRTIs and the 
mutation pattern was as follows: M41L (l), K70R (3), M184V (4), T215Y 
(4); 33 patients were receiving ZDV and mutations were M41L (8), K70R 
(lo), T215Y (11); 56 patients were with lamivudine and M184V was at 34 
patients; finally, 39 patients were with DDI/DDC, and the mutations found 
were T69N/D (2). L74V (l), M184V (8). (b) PIS: 25 patients were not 
treated with PIS and the mutation L90M was at one patient; 12 patients 
were receiving Indinavir and mutations were 154V (2), V/I82AT (4). I84V 
(1). L90M (1); 9 patients were with Ritonavir and mutations were M46I 
(1). I54V (l), V/I82AT (2). I84V (2), L90M (2); 13 patients were with 
Nelhavir with M461 at 1 patient, I84V at 4 and L90M at 4; hal ly ,  2 
patients were with Saquinavir and L90M was at one patient. 
Discussion and conclusions: A high prevalence of mutations against ZDV 
and lamivudine has been observed in patients with and without treatment 
with NRTIs and no differences in the pattern of mutations were observed 
for patients without and under treatment with NRTIs. In patients under PI 
treatment a high prevalence of mutations to all the drugs has been observed 
but genotypic resistance mutations were found only in one patient without 
experience with PIS. We consider that nowadays it is not necessary to test 
for genotypic resistance mutations to PIS in patients without experience 
with this drugs in our geographic area. 
Distribution of HIV-1 coreceptor polymorphisms in 
Luxembourg 
F. Roman, N .  Franck, J .  Servais, J. M. Zimmer, C. Burgy, I. Robert, 
T. Staub, V. Arendt, R. Hemmer, F. Schneider, J. C. S c h t  
Lxembouy,  L 
Background: C h e m o h e  receptors mutations are associated with rffistance to 
HIV or variations in progression towards AIDS. A homozygous 32-bp deletion 
in the CCR5 (CCR5-delta32) is associated with resistance to HIV. A 
heterozygous CCR5-delta32, a heterozygous V64I change in CCR2b 
(CCR2-641), a homozygous G to A mutation in an noncoding regon of the 
CXCR4 ligand SDF-1 (SDFl-3A) and a G/G polymorphism at position 303 of 
the CCR5 promoter (G303A) have been associated with a slower progression to 
AIDS. An A/G po1ymorphi.n at position 29 (A29G) and a C/T polymorphism 
at position 927 (C927T) of CCR5 promoter are closely Inked to the C C M -  
delta32 and the CCR2-64 I, respectively. Homozygous mutations V249I and 
T280M in CX3CR1 have been associated with a rapid progression to AIDS. 
Methods: The presence of mutations in the Luxembourg HIV cohort 
(HIVpos; N= 288) and in noninfected volunteers (HIVneg; N= 158) was 
screened using PCR followed by RFLP 
Results: 90 of 443 persons (20.3%) presented CCR5-delta32 heterozygously 
(allele Gequency AF: 0.1038), 63 (21.8%) among HIVpos and 27 (17.4%) 
anlong HIVneg. One HIVneg (0.2%) carried a homozygous CCR5- 
delta32. 69 of 415 (15.4%) had a heterozygous CCR2-641 (AF: 0.0831), 39 
(15.1%) among the HIVpos and 30 (18.9%) among the HIVneg. 13 of 429 
(3.0%) had a homozygous SDF1-3A (AF: 0.2296), 6 (2.2%) among the 
HIVpos and 7 (4.4%) among the HIVneg. 76 of 424 (17.9%) had a GIG 
polymorphism at position 303 of the CCR5 promoter (AF: 0.4398). 47 
(17.1%) among the HIVpos and 29 (19.3%) among the HIVneg. O n  426 
samples, only 7 (1.6%) presented a CCR5wt/delta-32, 29 A/A genotype. 
O n  372 samples, only 13 (3.5%) presented a CCR2wt/CCR2-641, 927 C /  
C genotype. 7 of 418 persons (1.6%) presented a double mutant 2491 280 M, 
7 (2.6%) among HIVpos and none among HIVneg. The Hardy-Weinberg 
Equilibrium was respected in all groups for all mutanons except for 
CCR5delta32, A29G. G303A and SDF1-3A in HIV-positives, due to a 
lack of mutant homozygotes. 
Conclusions: Allele Gequencies were similar to those described in other 
European cohorts. N o  major distribution difKerences exist between infected 
and noninfected persons. 
/p723/ Virological and immunological outcomes in HAART 
patients who experienced a treatment interruption of at least 
30 days 
J. Stansell, C. de Guzman, E. Hamel, D. Lapins 
San Francisco, USA 
Background The goal of this study is to determine viral load (VL) and CD4 
outcomes for HIV+ pts on highly active antiretroviral therapy (HAART) 
who experienced a treatment interruption (TI) of at least 30 days. 
Methods: Clinical Partners (CP), a national disease management organiza- 
tion providing data support and HIV case management to managed care 
organizations, maintains a database of clinical information, including 
antiretroviral (ARV) medication use, CD4 & VL test results. Data for 
1370 CP pts receiving HAART &om 1/96 to 9/00 were analyzed. Pts were 
treated in nonacademic practices at 9 different sites across the USA. 
Inclusion criteria were: TI of at least 30 days, immemately preceded by and 
immediately followed by at least 30 days of HAART (3 or more ARV 
drugs, including 2 NRTIs in combination with at least one PI, NNRTI or 
abacavir); VL and CD4 results available within 90 days pre-and post-TI. 
Results: 42 pts were included. Demographics: 85% male; mean age 39 & 
#61617; 8 year; 44% commercial insurance; 37% Medicare/Medicaid; 61% 
homosexual/bisexual male; 29% injection drug user. Median length of TI 
was 91.5 days (range 33-641). Median length of HAART pre-and post-TI 
was 265 (38-990) and 191.5 (42-833), respectively. Median VL and CD4 
pre-TI were 5250 and 324. Viral suppression rates (vRNA < 400) pre- and 
post-TI were 19.1% and 23.8% irrespective of change in HAART. 30 days 
after restarting HAART, 40% of patients experienced a decrease in VL and 
38% experienced an increase in CD4. However, 38% of patients still had 
increased VL and 62% decreased CD4 c/w basehe. 37/42 pts had a subsequent 
VL and CD4 measure avadable on HAART within 180 days of TI 
(mednn=91 days). At this measure, 38% of pts were suppressed, but 38% 
had higher VL and 54% had fewer CD4 than at baseline. At last measured 
CD4, 57% of subjects had unchanged or fewer CD4 c/w pre-TI levels. 
Conclusions: This study demonstrates that although TI may confer clinical 
benefits to a minority of pts failing HAART, the price of success may come 
at a clinical cost for the majority of pts who may not regain baseline 
immunological status. Further studies are ongoing to identify the subset of 
subjects who will benefit Gom TI. 
v1 Poor outcome of deep blvage antiretroviral therapy 
carried out with five or more drugs, in highly experienced 
patients with HIV disease: a cross-sectional survey at a large 
outpatient centre in northern Italy 
R. Manfredi, L. Calza, C. Beltrami, F. Chiodo 
Bologna, I 
Objective: To assess the efficacy and tolerability of deep rescue ART 
including 5 or more drugs, in highly pretreated patients @). 
Methods: A cross-sectional survey evaluated therapeutic background and 
c h c a l  outcome of p who received at least 5 concurrent anti-HIV compounds. 
Results: Of 798 p currently receiving ART, 42 (5.3%) were given 5 or 
more drugs: 29 M and 13 F, with AIDS diagnosed in 28 cases. Thirty-seven 
p of 42 (88.1%) took a 5-drug combination: mostly 2 nucleoside analogues 
(NA), 2 protease inhbitors (PI), and one non nucleoside reverse 
transcriptase inhibitor (NNRTI) (31 p), followed by abacavir (ABV)-based 
associations including 3 NA (4 p). and hydroxyurea (HU) (2 p). A 6-drug 
ART was experienced by 5 p only: 3 NA in 3 p (2 treated with ABV and 1 
with adefovir), and H U  in 2 p. Prior ART included > 24 months of NA-, 
and > I 8  months of PI-based ART; on the whole, prior ART lasted 
58.3 f 9.7 (range 42-138) months, and p experienced 5-13 changes of 
ART, due to failure or adverse events. At baseline, mean viremia was 
4.3 -t 1.1 log, while mean CD4 count was 102.3 f 24.6 cells/mm3. The 
mean follow-up period while on mega-ART was 5.5 ?c 2.7 (range 0.5-13) 
months, but 13 p (30.9%) intempted ART withui the first 3 months, due 
to severe adverse events (attributable to ABV in 5 p. and amprenavir, HU, 
NNRTI, and dual PI in 2 p each). A 6-and 9-month laboratory follow-up 
was available for 24 and 19 p, respectively. A mean 0.7 0.5 0.4 and 0.4 
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Log decrease of viremia was obtained after 6 and 9 months, respectively, but 
viral suppression was never reached, and a rebound of viral load interested 8 
p of 10 who attained a > 1  Log drop of viremia, throughout the study 
period. Genotyping testing detected an elevated number of mutations 
responsible for reduced sensitivity to all drug classes (NA, PI and NNRTI). 
The immunological response was more evident and sustained: mean CD4 
count increased of 21.2% and 29.1% after 6 and 9 months, and 14 p reached 
or maintained a CD4 count >200 cells/mm3; only 5 p suffered from a 
novel or relapsing AIDS-defining disease. 
Conclusion: The resort to mega-ART is increasingly frequent among p 
exposed to long-term prior ART. The underlying high resistance profile 
and complexity of mega-ART, are responsible for a frequently unfavorable 
efficacy and tolerabdity outcome. Waiting for drugs conjugating reduced 
cross-resistance and simptitied administration, mega-ART deserves con- 
trolled comparison with structured treatment interruptions. 
/p725] Twice daily vs. three times daily indinavir in 
combination with DDI and D4T: AGUA study 
D. Dalmau, L. Gomez, A. Guelar, A. Ochoa, H. Knobel, M. Rodriguez, X. 
Martinez-Lacasa, J. Colomes, P. Saballs, J. Hemeki, C. Sanchez, M. 
Xercavins, J. Garau 
Terrassa, Barcelona, E 
Background: Antiviral efficacy of twice dady IDV as a single protease 
inhibitor remains a matter of debate. Adherence is a major concern in 
antiretroviral therapy (ART) and attempts to simplify dosing regimens 
without phamucolunetic impairment must be pursued. 
Objective: To compare the efficacy, safety and adherence of bid IDV (1200 
mg q 12 h) to that ofa  tid IDV regimen (800 mg q 8 h), associated to D4T 
(30/40 mg q 12 h) and DDI (300/400 mg q 24 h). 
Methods: Multicenter, open-label, prospective, randomized trial carried out 
from January 1998 to July 2000. Inclusion criteria: Viral Load (VL) > 5000 
copies/mL and protease h b i t o r s  (PI), d4T and DDI nonexperienced patients. 
Results: 95 patients have been included. Subjects were 63% male, with a 
mean age of 35 y (range: 2M3) .  The majority (83%) were ART naive and 680h 
asymptomatic. Mean basehe CD4 and VL were 304.5 cells/mm2 and 4.28 log, 
respectively, without merences between groups. Thirteen (25%) patients in the 
bid group and 12 (27%) iti the tid group discontinued study due to adverse 
events. Optimal adherence: 51% in bid p u p  vs. 52% in tid group. In an 
intention-to-treat analysis (missing= hdure) at week 52, undetectable VL (<80 
copies/mL) was achieved in 49% in the bid regimen vs. 41% in the tid regimen. 
The mean decrease of VL were 2.05 and 1.85 log in the bid us. tid regimen 
(P= NS). IDV concennations were measured among 45 patients at 1 month of 
follow-up: the mean plasma trough levels in bid and tid regimens were 162 ng/ 
mL and 585 ng/mL, respectively (IC95: 75 ng/mL). 
Conclusions: Our results suggest that antiviral activity, adherence and safety 
profile of the bid regimen is similar to that of the tid regimen at 1 year of 
follow-up. Although pharmacokinetic data seem to favor tid regimen, both 
regimens had good enough trough levels above IC95. 
FI Cell-derived membrane proteins present on circulating 
HIV-1: comparative analysis in patients before initiation of 
HAART plus IL-2 and after controlled therapy suspension 
I. Abbate, F. Dianzani, 0. Tumziani, F. PandoE, G. D’Offizi, A. Span& 
R. Capobianchi 
Rome, I 
Objectives: To determine the profile of cell-derived membrane proteins 
(CMP) on HIV-1 circulating in the plasma of asymptomatic patients and to 
analyze possible changes after a cycle of highly active anti retroviral therapy 
(HAART) plus IL-2. 
Methods: Plasma from eight drug-naive asymptomatic subjects was tested to 
detect CMP by an immobilized antibody capture assay (IAC), followed by 
quantitative RT-PCR. Samples were collected before one cycle of 
HAART plus IL-2 and after controlled therapy suspension, at the time of 
viral rebound. Lymphocyte subset markers (CD45RO and CD45RA), 
activation markers (HLA-DR), adhesion molecules (LFA-3), costimulatory 
molecules (B7-2), lymph node homing receptors (CD62L) and pro- 
apoptosis molecules (Fas-L) were considered in the study. 
Results: LFA-3 and CD45RO and HLA-DR are the most represented 
CMP on the surface of HIV-1 present in the plasma of drug-nalve 
asymptomatic patients, whereas CD45FL4, CD62L, B7-2 and FasL are 
detected in a minority of cases, and to low extent. After therapy suspension, 
at the time of viral rebound, a sigdicant reduction in both HLA-DR and 
CD45RO embedded in virion envelope is observed, whereas LFA-3 
content is virtually not affected. At the same time, CD45RA. CD62L. B7-2 
and FasL remain not detectable on circulating HIV-1. 
Conclusions: Asssuming that CMP present on HIV-1 envelope represent 
a footprint of the cell actually replicating the virus, activated memory 
T-cell are the main source of plasma HIV-1 in asymptomatic patients. 
After therapy suspension, expanded nalve T cells do not became a major 
source of virus repkcation. The decreased presence of HLA-DR on 
HIV-1 after therapy is in agreement with a reduced activation status of 
the virus-producing cells. These findmgs can help to identify viral 
reservoirs responsible for virus rebound after therapy interruption. More 
extensive investigation may be useful to better clarify some aspects of 
AIDS pathogenesis. 
FI Detection of a significant pool of HIV-specific CD4 T- 
cells in HIV-infected cells from patients on prolonged HAART: 
HIV reservoir cells or recently infected cells? 
A. Demoustier, 0. Lambotte, C. Wallon, C. Goujard, J. Dehssy ,  Y. Taoufik 
Paris, F 
Background: HAART allows the reduction of plasma HIV RNA to 
undetectable levels for prolonged periods in many patients. In such patients, 
HIV-1 can persist in CD4 T cells known as HIV reservoir cells. It has also 
been shown, in these patients, the persistence of residual viral replication, 
whose origins remain unclear. Here, we examined, in patients on prolonged 
HAART, phenotypic features (CD45RA. CD45R0,  CD62L) and antigen 
specificity of HIV-infected T cells. We also investigated, in these patients, 
the presence of residual HIV replication. 
Methods: Antigen specificity of HIV-infected T cells was examined by the 
detection of HIV RNA in supernatants following h i t  dilution of HIV p24 
+ Nef-, tuberculin- or CMV-activated PBMCs. Residual virus replication 
was detected by using a quantitative P C R  method based on the detection 
and quantification of labile episomal HIV DNA.We also examined the 
presence of HIV gp120 mRNA. 
Results: Replication competent HIV was detected in CD4 T cells in the 12 
patients tested. A similar level of HIV DNA was found in CD45RO + 
CD62L +, CD45RO + CD62L-and CD45RA + CD62L + CD4 T cells.A 
significantly lower level of virus was found in CD45RA + CD62L-CD4 T 
cells. The frequency of HIV specificity among infected T cells was 
sigruficantly higher than that of CMV or tuberculin specificities in all 
patients tested. Episomal HIV DNA and HIV gp120 mRNA were detected 
in CD4 T cells in 5 and 9 of 12 patients tested, respectively. Episomal HIV 
DNA and HIV gp120 mRNA were detected predominantly in CD45RA + 
and CD45 RO + CD4 T cells, respectively. 
Conclusion: Altogether, these results suggest the presence of a significant 
pool of HIV-specific T cells among HIV-infected cells in patients on 
prolonged HAART. These cells may correspond to HIV latently infected 
long-lived T cells ‘the reservoir cells’ and/or recently infected cells. 
lp7281 The impact of HAART on the hospital outcome of HIV 
disease 
J. De La Torre, J. L. Prada, A. Del Arco, J. Garcia-Alegria, A. Lara 
Mavbella, E 
Introduction: HAART has provided .I manifest immunological iniprove- 
ment with reduction of opportunistic infections and other HIV complica- 
tions. Apart from the beneficial clinical impact, has it changed the 
characteristics in hospital outcome and mortality? 
Objective: To analyze the evolution of the number of admissions, stays and 
inpatients mortality by HIV infections in the last 5 years. 
Methods: Data from the ‘Costa del Sol’ hospital discharge database 6om 
1995 to 2000 were used. We assessed hospital admissions, total stays, average 
length of stay (ALOS) and inpatients mortality. 
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Conclusion: In our hospital HIV-associated mortality has continued 
declined since the introduction of HAART in 1997. The number of 
hospital admission and ALOS did not change sigTLlficantly. However, there 
was also a decrease in the number of stays. 
vl Megestrol acetate in HIV-infected patients with 
wasting syndrome: a comparative study of two different weekly 
maintenance dosages 
M. Colmenero, C. Miralles, P. Lainez, M.  Alonso, E. Ortega, J .  Flores, A. 
Muhoz, J. Verdejo, J. Gonzalez-Lahoz 
Sevilla, Kgo, Terierfe, Vakrtcia, Badajor, Madn'd, E 
Background Megestrol acetate (MA) has a strong power as an appetite 
stimulant. Its efficiency has been demonstrated over short periods of time, 
however, the withdrawal of the treatment bring back anorexia. 
Objective: To evaluate the efficiency and safety of two different weekly 
maintenance dosages of MA in patients with wasting syndrome and 
HIV infection. 
Methods: A randomized multicenter study, with a dosage of 800 mg/day 
for 12 weeks, and a follow up of 12 months with two different dosages (400 
mg/week vs. 800 mg/week) ofMA. 104 patients were included in the study 
between January 1998 and February 2000. Anthropometric measurements, 
laboratory data and clinical parameters were evaluated. Antiretroviral 
treatment was used in all patients. Statistics were performed using SAS 
version 6.12 (SAS Institute, USA) and statistical significance was assumed for 
P < 0.05. 
Results: Out of the 104 patients, 72.1% were male, 67% IDU, 49% 
belonged to CDC C3, and the median age was 35. The medians of the 
ba2eline parameters were CD4197 cells/mm', weight 55 kg, BMI 19.78 kg/ 
m-, tricipital skin fold (TSF) 7 mm, arm muscular circunlference (AMC) 
22.7 cm, arm circumference (AC) 25 cm, Transfemne 262.5 mg%, 
Albunun 4.8 g??. Viral load > 500 copies/mL. in 49% of the patients. 12 
weeks into the treatment, the medians were the following: CD4294 cells/ 
mm3, weight 62.8 kg, BMI 22.4 kg/m2, TSF 8.98 mm, AMC 23.9 cm, AC 
27 cm, transferrine 295 mg%, Albumin 4.6 g'??. Viral load > 500 copies/mL 
in 21.2% ofthe patients. 48 weeks into the treatment (dosage 400/800) the 
medians were the following: CD4369/372 cells/mm3, weight 65/66 kg, 
BMI 22.3/24.6 kg/m', TSF 9/10.5 mm, AMC 24/25.2 cm, AC 25927.6  
cm, Transfemne 270/268.5 mg%, Albumin W4.7 g%. Statistically, we 
found significant Merences between the baseline and week 12 ( P  < 0.001) 
in weight, BMI, TSF, AMC and AC; and between week 12 and 48 ( P  < 
0.002) in weight, BMI, TSF, AMC and AC. No significant differences were 
found in the maintenance dosages, between the dosage of 400 mg and the 
dosage of 800 rug. The treatment was withdrawn from one patient due the 
toxicity related with the MA. 
Conclusions: After 12 weeks of daily treatment, the weekly maintenance 
dosage of AM proved to be efficient in the maintenance of the nutritional 
parameters of the HIV patient, without the presence of secondary effects. 
Both dosages of 400 and 800 mg/week may be used with the same 
efficiency. 
IP730/ Dose regimen finding study in healthy volunteers for 
filgrastim treatment of HIV patients 
S. von Aulock, E. -M. Boneberg, T. Hartung 
Konstanz, D 
Recombinant granulocyte colony-stimulating factor (rhG-CSF, filgrastim) 
is already used to combat neutropenia associated with HIV infection. G- 
CSF treatment of volunteers increases not only granulocyte but also 
lymphocyte counts and modulates lipopolysaccharide-induced cytokine 
release in an anti-inflammatory manner. This combination may be suitable 
to aid in the immunoreconstitution of HIV patients from commencement 
of therapy untd an adequate immune status is restored. Currently, this takes 
about one year during which the patient remains susceptible to 
opportunistic infections. To develop a treatment scheme suitable for 
long-term administration of rhG-CSF for such indications, three Merent 
discontinuous treatment regimens were compared in healthy volunteers 
over the time span of 8 weeks. Six volunteen each were randomized into 
four groups: A, placebo; B, 300 pg filgrastim (rhG-CSF) once a week; C, 
300 pg lilgrastim three times per week; D, 300 pg filgrastim daily for five 
days followed by three weeks placebo. Peripheral blood was drawn to 
determine differential blood cell counts, including lymphocyte subtyping. 
Activation and proliferation marker expression were analyzed by means of 
flow cytometry. Whole blood incubations were performed with lipopoly- 
saccharide (LPS), and cytokine release was measured by ELISA. 
Lyrnphocytosis under daily treatment, as described previously, was observed 
in group D during the treatment phase, but was not sustained in the placebo 
phase. N o  changes in lymphocyte counts were observed in either of the 
other treatment groups. As there was no change in the expression of 
activation or proliferation markers on T cells, it seems likely that the 
lymphocytosis observed under continuous treatment in group D resulted 
from lymphopoiesis, not peripheral lymphocyte proliferation. After 
stimulation with LPS, the release of TNF-a, IL-lp and IL-10 per monocyte 
was strongly attenuated in group D, only after the treatment phase. TNF-a 
and IL-l per monocyte were slightly decreased in group C compared to 
group A throughout the treatment period, but IL-10 release per monocyte 
was similar. Treatment with rhG-CSF on alternate days may be sufficient to 
sustain anti-inflammatory effects, but intennittent treatment does not induce 
lymphocytosis. For the purpose of immunoreconstitution in HIV treatment, 
a regimen of cycles of continuous daily therapy separated by short breaks or 
the use of a new longer lasting formulation of rhG-CSF might be more 
efficient in stimulating lymphopoiesis. 
/p731/ Prophylaxis post blood and sexual exposure in a 
university hospital-prospective study of 887 cases 
Y. Douadi, A. Smail, C. Doutrellot, J. Lienard, C. Roussel, A. Vaidie, B. 
Vidal, F. X. Lescure, P. Bonnard, J. L. S c h t  
Amiens, F 
Background: Post exposure prophylaxis (PEP) has been proposed in our 
hospital for several years; each prescnption is discussed with infectious 
diseases speciahsts. 
Methods: From January 1997 to March 2000 all persons with occupational 
exposure (blood or body fluid) or sexual exposure were recorded with a 
follow up of 6 months. 
Results: 887 cases were included, 36 sexual and 851 blood exposure. In 
cases of blood exposures nurses accounted for 42%, physicians for 1894, 
surgeons for 6% and 297 others health care workers (HCWs). Predominant 
type of exposure was percutaneous (88%), the most common cause of injury 
was needle recapping (25%). The tource patient was HIV+ in 9 cases, PEP 
was performed in 19 cases. Double combination for 4 days was used in one 
case; 18 patients were treated with triple combination: 1 with d4T, ddI, 
nelfinavir for 4 days, 1 with AZT + 3TC and nelfinavir for 1 mouth and 16 
with AZT + 3TC and indinavir for 1 month. The serological follow up was 
negative for all the patients. The most common drug side-effects were 
gastrointestinal discomfort and asthenia (35%). Referred for unprotected 
sexual intercourse 36 patients (19 women and 17 men). Mean age was 28 
years (37-47 years). There were 20 receptive, 1 oral and 15 insertion 
intercourses. The partners HIV status was positive in 9 cases, negative in 5 
and unknown in 22. Twenty-four patients were treated, 19 with AZT + 
3TC + indinavir, one with AZT + ddl, 2 with AZT + 3TC + Nelfinavir, 1 
with d4T + 3TC + efavirenz and 1 with AZT + 3TC + nevirapine. Two 
PEP were stopped after 2 days because of a partner negative HIV test; all the 
others were continued for 28 days. There were no interruption of PEP 
because of side-effects but 12 persons complained of asthenia and 
gastrointestinal discomfort. After 6 months, no HIV seroconversion has 
been reported. The total cost of all PEP is approximately 110 000 French 
francs (USSl5 700). The total cost ofserological test was approximately 500 
000 French fiancs (USX71 400). 
Conclusion: PEP has been well tolerated and most often continued for 
28 days. Better evaluation for HIV risk after sexual exposure seems 
necessary. More educational campaigns are needed to reduce blood 
exposure for HCWs. 
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jP7321 Impact of combination antiretroviral therapy on the 
frequency, features and survival with AIDS-related 
Pneumocystis carinii pneu monia 
R. Matulionyte, Y. Yazdanpanah 
Vihitrs, LIT; Tonrcoing, F 
Objectives: To compare the frequency, demographic, clinical features and 
the survival with the diagnosis of Pneumocystis carinii pneumonia (PCP) of 
patients who developed PCP before and after the wide spread use of potent 
combination antiretroviral therapy (ART). 
Methods: A retrospective cohort study. Cases were HIV-infected patients 
with a confirmed diagnosis of PCP (nT127) hospitalized in Tourcoing 
Regional University Department of Infectious and Travellers' diseases from 
1989 to 1999. The cohort was divided into two groups: the first group 
consisting of 88 cases of PCP diagnosed from 1989 to 1994 and the second 
group of 39 cases of PCP diagnosed from 1995 to 1999. 
Results: 127 overall patients developed PCP in the considered period, but 
the frequency has decreased markedly during the 1995-99 us. 1989-94 (39 
us. 88 episodes) (see Figure). The percent of patients unaware of their HIV 
status has relatively Increased in the second period (62% us. 42%, P < 0.05). 
No significant difference was shown according to patient's age, gender, risk 
for HIV infection, status of advanced HIV disease (stage C) and use of ART 
and PCP prophylaxis in the beginning of PCP in two groups. Among 
laboratory values on presentation, a smaller median CD4 count (18 us. 69 
cells/pL, P < 0.002) and a smaller median p 0 2  (64 vs. 72 mmHg, P < 
0.02) were found during the combination ART era, together with a 
significant increase of median proteinemia (77 us. 70 g/L, P < 0.01). No 
significant mfference was found in disease outcome (9 cases of related death 
found in the first period, us. 3 in the second period). There was a significant 
difference in survival Erom the date of the PCP diagnosis. The median 
survival among patients in the first group was 18 months and the median 
survival in the second group was significantly longer (73% of patients 
survived for at least 60 months, P < 0,001). 
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Conclusions: The incidence of PCP has dramatically decreased after the 
widespread use of potent combination ART However, it stdl occurs in 
patients with advanced but previously missed HIV infecuon, those not 
receiving combinahon ART and in patients developing resistance or failure 
in ART The long-term sumval rates &d Fipficantly improve due to the 
introduction of potent combination ART 
I P733 I Paradoxical response of tuberculosis during 
chemotherapy: a case-control study 
0. De Sola-Morales, D. Dalmau, S. Quintana, E. Cuchi, M. Riera, J. Garau 
Tervassa, E 
Introduction: P R  of TB is noted during appropnate TB chemotherapy, is 
unusual and often unexpected. 
Objectives: To describe the clinical and epidemiological charactensacs of PR 
(excludmg cerebral tuberdomas) and to compare them to a control population. 
Methods: Case-control study performed among all patients treated for TB 
who suffered a P R  from 1988 to 1999. P R  was established in all patients 
under appropriate chemotherapy who developed clinical and/or radiolo- 
gical expansion of TB lesions and/or fever of unknown origin. 
Disseminated TB was considered when positive cultures were obtained 
from extratboracic samples. Cases ( n  = 13) were matched with controls 
( n  = 35) according to sex, HIV status and TB localization. 
Results: During the study period, 781 new cases of T U  were diagnosed 84 
(11%) had both TB and HIV+. PR was documented on 13 patients (1.7%), 
10 males and 3 females, with a mean age of 36. Nine (69%) were HIV+ (8 
males), had a mean age of 34 and a mean CD4 cell count of 93/mmJ; 6 
(67%) had a positive PPD test and 7 (78%) had disseminated TB; seven were 
receiving antiretroviral treatment (5 with monotherapy). The 4 HIV- 
patients (2 males) had a mean age of 36; 3 patients (75%) had a positive PPD 
test, and two had disseminated TB. After initiation of treatment, PR 
appeared significantly earlier amid HIV+ patients ( P  > 0.05). In the case 
cohort, no other differences were found between HIV+ and HIV-. There 
were no adverse events and P R  resolved in all evaluated patients. I n  
bivariate analysis comparing P R  cases to a control population, there were no 
differences neither in age, duration of HIV infection, PPD test, anti-TB 
treatment nor blood test parameters except percentage of lymphocytes. 
Conditional logistic regression analysis revealed percentage of lymphocytes 
to be an independent variable in patients with PR. 
Conclusions: In our small cohort, PK was a rare phenomenon with a good 
outcome. Compared to the control population only a low percentage of 
lymphocytes had a predictable value of PR.  
(p7341 Analysis of tuberculosis cases in HIV patients in Costa 
del Sol hospital, Spain 
A. Del Arco, J.L. Prada, J. De la Torre, F. Galeas, A. Galacho 
Marbella, Mhlaga, E 
Introduction: Tuberculosis (TB) is one of the main opportunistic infection 
in HIV infected patients in our area. 
Objectives: To know the epidemiological and clinical characteristics in HIV 
infected patients suffering from TB. 
Methods: We have analyzed retrospectively all that cases of TB HIV 
patients attended in our hospital from 1994 to 1999. Our center is a general 
hospital site in an area of 250 000 habitants in the south of Spain. We attend 
to a population of 220 HIV infected patient. 
Results: 40 HIV infected patients were diagnosed of TB. 30 (87%) were 
males and 5 (13%) females. The transmission behavior risk was intravenous 
drug abusers in 30 cases (75%), 6 heterosexual and 2 male homosexuals; in 2 
the risk remained unknown. In general the were very immunocoinpro- 
missed patients, 22 had less of 200 CD4/mm . In 17 cses (42.5%) the HIV 
infection was diagnoses simultaneously with TB. Pulmonary TB was diagnosed 
in 18 patients (45%) by Ziehl-Nielssen stain of sputum. 3 patients with pleural 
e&sion were diagnosed by biopsy. Disseminated TB was diagnosed in 22 cases 
(55%). 12 patients (30%) were studied by lymph-node biopsy. About the 
outcome: 25 patients (62.5%) had good evolution with treamient, 9 patients 
(22.5%) died (7 abandoned the treatment); 6 patients (15%) had been lost. 
Patients who &ed were not receiving antiretroviral treatment. 
Conclusions: In our patients half of the cases of TB are extrapulmonary or 
disseminated cases. The half of the patients are very immunocompromised 
patients. TB is frequently the first opportunistic event. The fatal cases are 
mainly related with an inadequate observance of the TB-treatment. 
Y 
vl Role of toxoplasma serology in predicting toxoplasmic 
encephalitis incidence in HIV-infected patients 
E. Pontali, V. Del Bono, M. Costantini, F. Toscanini, L. Papa, G. Flego, 11. 
Bassetti 
Genoua, I 
Background: Toxoplasmic encephahtis (TE) is still one of the most frequent 
opportunistic infections in HIV-infected patients. TE is generally due to the 
reactivation of a past infection and-in consideration of HTV patients' 
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prolonged survival achievable through HAART-it may occur with 
significant frequency. Several reports have shown that the risk of TE 
occurrence tends to increase in patients with relatively high titre (> 150 UI) 
of anti-Toxoplasma antibodes. We therefore studied several risk factors in 
TE incidence in a cohort of HIV-infected patients, with particular regard to 
Toxoplasma serology predictive value. 
Design of the study: Retrospective study. 
Patients and methods: We included in the study all patients with <200 
CD4/pL, whom a specific prophylaxis had been offered to. 258 pts were 
initially selected. 14 pts were excluded for either a follow-up <90 days 
(n = 9) or the occurrence of TE in the first 90 days of follow-up (5). All pts. 
had a serologic test for Toxoplasma performed at the study entry. Total Ig 
for Toxoplasma was assessed by Sabin and Feldman dye-test. Results were 
given in international units (IU) by means of a reference standard. IgM were 
assessed by both an immunosorbent agglutination test (IsAgA, bioMerieux) 
and an immunotluorescent assay (Dako, Denmark). Of 244 pts, 55 had 
negative Toxoplasma serology and did not have any TE occurrence. The 
remaining 189 pts. were divided into three groups according to serology: 
None had any positive IgM assay. Relative risk (RR) for a given serology 
titre was assessed and adjusted for CD4 cell count and specific prophylaxis 
regimen in a Cox's proportional hazards regression model. 
Results Of 189 pts with positive serology, 39 had TE. Median follow-up of 
TE pts was 422 days, while that of other pts was 1133 days. RR, in comparison 
with group 1, were 4.3 and 6.1 for the group 2 and 3, respectively, with a P- 
value=0.002. Prognostic sigdcance of higher antibody titre remained stable 
even after adjusting RR for CD4 cell count and prophylaxis. 
Conclusion: Toxoplasma serology titer is a potentially useful tool in order to 
predict TE occurrence in HIV-infected patients. Due to the significantly 
enhanced risk of TE for pts. with higher Toxoplasma serology titer, 
regimens of TE prophylaxis should be customised by increasing, for 
example, the usually administered dose. 
gr01ip 1:l-39 IU (57 pts.). group 2: 40-150 (75), group 3: ,150 (57). 
lp7361 Uncommon Helicobacter spp. isolated from blood 
cultures in immunocompromised patients 
M. Kachler, U. Futh, S. Dieckmann, W. Heise, G.  Roger, U. Gobel, E. Halle 
Berlin, D 
Objectives: Here we present 14 cases of unusual Helicobacter bacteremia in 
febrile inmunocompromised patients associated with gastrointestinal, 
rheumatological (arthritis) and dermatological (cellulitis) symptoms. 
Methods: Blood cultures were analyzed by using the BACTEC system. 
Gram staining, dark field microscopy and subcultivation on Columbia blood 
agar were performed by standard procedures. The isolates were identified by 
using commercial test systems (API CAMPY, API ZYM, API 2 0  A) and 
additional tests like cytochrome oxidase, catalase and nitrate reduction. 
DNA was extracted tiom pure culture and amplified by PCR using 16s 
rDNA universal eubacterial primers. Sequence analysis was performed on 
LI-COR 4000L automated sequencer using Thermo Sequenase cycle 
sequencing kit. Phylogenetic analysis was done using commercially available 
programs, such as HUSAR and TREECON. 
Results: A t o d  of 14 episodes of Hekobarfer bacteremia were detected between 
1992 and 2000. 13 of which were homosexual males suEexing for AIDS (CDC 
classification ranging &om 2B to 3C). One patient was HN-negative patient 
treated for chronic h e r  disease. All AIDS-patients received antimicrobd 
therapy, betalactam antibiotics (8), ciprotloxacin (2), conimoxazole (1) and 
erythromycin (2). The antibiotic therapy in these patients was clinically and 
inicrobiologically successhl. One HIV-negative patient had a spontaneous 
remission. Conventional biochemical identification failed. Only comparative 
16s rDNA sequence analysis classified these isolates as Helicobacter species, 
most closely related to Helicobacter uiestmeadii and HelicobacrerPnnelliae. 
Conclusion: These clinically relevant isolates formed a cluster of closely 
related Helicohacter spp. that may represent an emerging group of pathogens 
in inmiunocompromised patients. 
/p737) A novel Campylobacter species isolated from stool of 
an AIDS patient with hemorrhagic ulcerative colitis 
M. Kachler, U. Futh, S. Dieckmann, W. Heise, U. Gobel, E. Halle 
Berlin, D 
Objectives: A novel Campyluboaprsp. was isolated &om a stool sample of an AIDS 
patient with hemorrhagic ulcerative colih by coniparative 16s rDNA analysis. 
Methods: The stool specimen was cultivated for enteropathogenic bacteria 
including Campylobacter spp. by standard methods. Biochemical identifica- 
tion was done by using the API CAMPY, API ZYM and API 20 A test 
systems. Additional tests included reactions for cytochrome oxidase, catalase. 
indoxyl acetate hydrolysis and nitrate reduction. For phylogenetic analysis 
DNA was extracted fiom a pure culture and amplified by PCR, using 16s 
rDNA universal eubacterial primers. Sequence analysis was performed on an 
automated sequencer model LI-COR 40001. using the Thermo Sequenase 
cycle sequencing ht. Phylogenetic analysis was done using commercially 
available programs, such as HUSAR and TREECON. 
Results: The isolate is a Gram-negative, microaerophilic, elongated, slightly 
curved rod with positive oxidase and negative catalase reaction. The 
organism could not be identified by conventional identification systems. 
Comparative 16s rDNA sequence analysis classified the isolate as a new 
Campylobacter sp. differing &om all Campylobacter spp, previously described. 
Conclusion: The novel species may represent an emerging causative agent of 
gastrointestinal infection in imunocompromised patients. 
lp738 Acute renal failure as initial presentation of visceral 
leishmaniasis in a HIV-1 infected patient 
P. Clevenbergh, M. Okome, S. Benoit, J. Bracco, F De Salvador, M 
Elbike, E. Cassuto, P. Marty, P. Dellamonica 
Nice, F 
Visceral leishmaniasis is endemic in Mediterranean area where it is an 
important opportunistic pathogen for HIV-infected patients. In infected 
dogs, the natural reservoir of Leishmania, end-stage renal failure due to 
immune complex deposition glomerulonephritis is common. In humans, 
glomemlonephritis is usually mild and renal failure is rarely a feature of 
viscera1 leishmaniasis. We describe the case of a HIV-infected patient who 
presented with an acute renal failure due to visceral leishmaniasis. In 
September 1998, a 45-year-old HIV-infected heterosexual man, was 
admitted for fever up to 40 "C since 3 days, and loss of left eye vision 
due to macular hemorrhage. He was diagnosed HIV infected in 02/1998, 
and classified CDC B3. Physical examination disclosed: liver enlargement, 
and ankle oedemas. His therapeutic regimen consisted in zidovudine, 
lamivudine, and saquinavir hard gels begun 6 months earlier. Laboratory 
examination ddosed:  white blood cells: 1600/mm3 (neutrophils 64%, 
lymphocytes 19%), hematocrit 32%, platelets 100 x 105/mni3, CD4 
lymphocytes: 60/mm3 (20%), HIV viral load below level of quantification 
(200 copies/mL.), negative CMV antigenemia; normal liver enzymes, 
polyclonal hypergammaglobulinemia with positive rhumatoide factor: 11 1 
KUI/L, antinuclear antibodies: 1 /320; hypocomplementeniia and cryoglo- 
bulinemia. His renal function, normal 3 months earlier, was severely altered: 
creatinin clearance: 14 mL/min (creatinin 625 pmol/L, urea 24 pmol/L), 
microscopic hematuria, daily proteinuria: 2.5 g. Serology disclosed positive 
antibodies against Leishmania: immunofluorescence antibody test 1/40 000, 
confirmed by immunoblot with the full profile (14, 18, 21, 23, 31 kda). 
Grocott stained bone marrow aspirate showed aniastigote and Leishniania 
infanturn Man-1 was identified by starch gel electrophoresis. Renal biopsy 
showed 2 glomerules with mesangial hypertrophy and segmental scler- 
ohyalinosis, some tubular cells were vacuolated. Immunofluorescence 
staining showed predominantly lambda light chains tubular deposits. No 
protozoa were seen. Liposomal ainphotericin B 5 mg/kg/day (Ambi- 
some@)) was given for 20 days with slow normalization of renal function 
over 3 month. Renal failure in HIV infected patients can be due to HIV 
itself, drug toxicity including that of antiretroviral drugs, or infections. In 
endemic areas, visceral leishmaniasis could be added to the etiologies of 
acute renal failure in HIV-infected subjects. 
/p7391 Decrease in central venous catheter infections in 
Italian HIV seropositive patients due to HAART therapy 
M. Libanore, E. Prini, A. De Carla, M. Vem, R. Bicocchi 
Fenara, I 
Background Central catheter venous (CVC) implantation in HIV 
seropositive patients is one of the major risks of hospital infections. 
Objective: To evaluate the incidence and epidemiological features of CVC 
infections in HIV seropositive patients treated with HAART and to 
compare this data with those of patients without HAART. 
Methods: In the last 6 years (1994-99) a total number of 197 CVC were 
implanted in 177 HIV seropositive patients (144 males and 33 females). 
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Mean age was 35.8 years (range 2146) .  143 patients were drug abusers, 25 
heterosexuals and 9 homosexuals; 122 were full-blown AIDS; the mean CD4 
cell count was 56.4/mm3 ( e 1-784) and 13.7% of patients was 
neutrophenic (PMN < 1 0 0 0 , a .  The patients were divided into 2 groups: 
the first with all the patients with CVC fiom 1994 until 1996 when HAART 
was not avadable (154 CVC implantation in 399 HIV seropositive admitted to 
hospital [38.6]. The second group consists of all the patients with CVC &om 
1997 until 1999 43 CVC insertions in 226 HW seropositive admitted to 
hospital (19.02%). In the last 3 years the preparation of nutrition parented 
solutions was centralized. For all the patients with fever without other causes 
blood cultures were performed both &om CVC that &om peripheral blood. 
When CVC was removed culture of tip with Maki's procedure was done. 
From patients in whom systemic and local infections developed, epidemio- 
logical, clirucal features, microbiological data and outcome of infections were 
noted. Complications rate was evaluated for 100 catheter days. 
Results: In the last 3 years incidence of CVC infections was 11.6% in &om of 
29.2% of the period without HAART. In the same period no local infections 
were not noted (7.2% of cases in the other g~oup). The rate of CVC infections 
was 1.4 for 100 days of in situ catheter during 1994-96 and 0.84 in 1997-99. In 
the last 3 years CVC infections were present only in patients without HAART: 
5/20 (17%) vs. 0/15. Etiological agents isolated were: S. aureus (40%), S. 
epidemtidis (40%), S. auieus and Candida (20%). During 1997-99 no patients 
died for complications associated to CVC infections (4.5% in 199496). 
Conclusions: Our prospective study shows that CVC related infections were 
decreased in Italian patients with HIV. Risk factors were low number of 
CD4 (< 100/mm3)), drug abuse and absence of HAART 
v] Response to liposomal doxorubicin of HIV-1-infected 
patients with Kaposi's sarcoma in the HAART era: clinical 
outcome and predictor factors for response 
M. Nunez, P. Saballs, M.E. Valencia, J. Santos, E. Ferrer, I. Santos, A. 
Berrocal, M.J. Galindo, D.  Podzamczer, J. Gonzalez-Lahoz, G. Caelyx 
Madrid, Barcelurza, Malaza, Valenria, E 
HIV: epidemiology 
Background Regression of Kaposi's sarcoma (KS) has been reported to occur 
under highly active antirenoviral therapy (HAART), but some cases do not 
respond. Moreover, the therapeutic goal has shifted from palhative care to long- 
term, durable complete remission. Liposomal anthracyclines are first-line agents for 
KS systemic therapy, but their role in the HAART era has not been well defined. 
Objectives: To assess the impact of liposomal doxorubicin (LD) in the 
treatment of HIV-associated KS during the HAART era and to define 
predictor factors for response. 
Design: Prospective, noncomparative, multicenter study. 
Methods: Patients with > 10 cutaneous lesions or visceral KS were treated 
with 20 mg/m2 of LD (Caelyx) every 3 weeks. Tumour measurements and 
safety laboratory tests were performed at baseline and every 3 weeks, and 
HIV-RNA, CD4 count and HHV-8 PCR in PBMC every 3 months. 
Results: 79 Subjects were enrolled in the study. Median HIV-1 KNA and 
CD4 count were 3671 copies/mL and 148 c/mm', respectively. There was 
visceral involvement in 24 (30%) patients and 28 (36%) had received prior 
therapy for KS. Stage was T1 for 47 (59%), I1 for 41 (52%) and S1 for 32 (40%) 
subjects. The median cumulative LD dose received was 160 mg/m' (range, 20- 
480 mg/m*).Time offollow-up was 0-28 month (Md, 12 month). Nme (12%) 
individuals were not evaluable for response, 32 (40%) had complete response, 
30 (38%) partial response, 5 (6%) stable disease and 3 (4%) progression. A 
multivariate analysis model including CD4 count at the end of treatment and 
number of LD courses as predictor factors for response was statistically 
significant (P=0.04; OR of 1.011 [95% CI, 1.0002-1.02131). W - 8  PCR 
was positive in 37/53 (70%) patients with available PBMC samples and HHV-8 
viremia cleared in 14/27 (52%). Clinical response and HHV-8 viremia did not 
correlate well. Neutropenia was the most &equent side-effect (39 individuals, 
49%). During the study period 15 (19%) subjects died. Death was due to KS or 
its treatment in 2, to non-KS-related reasons in 6, and had unknown cause in 7. 
Eleven (14%) patients experienced a relapse of KS, while at the last update of 
data 49 (62%) remained stable. 
Conclusion: The response rate to LD treamient of patients with KS under 
HAART was high and response was most often durable. The CD4 count at 
the end of treatment and the amount of LD received were found to be 
predictor factors for response, while HHV-8 viremia did not correlate well 
with clinical outcome. 
I P741 1 Progressive increase of mean age of patients 
diagnosed with full-blown AIDS in a 16-year period 
R. Manfred, L. Calza, F. Chiodo 
Bologna, I 
Objective: To assess some demographic, epidemiological, and clinical 
features of patients who developed AIDS over a 16-year period, in order to 
investigate age variations and possible correlates. 
Methods: A substantially stable number of around 1000 HIV-infected 
patients referred to our centre since 1985, and 614 overall diagnoses of 
AIDS were notified up to October 2000. Age, gender, type of exposure to 
HIV infection, CD4 cell count at diagnosis, and clinical features were 
analysed according to temporal trend of diagnosis. 
Results: A sharp drop of AIDS notifications followed the introduction of 
highly active antiretroviral therapy (HAART) in 1996: from > 65 patients/ 
year in the period 1991-96, to 38 cases in 1997,21 in 1998, and 13 and 15 
in 1999 and 2000, respectively ( P  < 0.001). The mean age at diagnosis 
showed a steady increase since early AIDS pandemic. In particular, the 87 
patients diagnosed during the last 4 years were characterized by the oldest 
mean age (40.8 f 7.8 years in 1997-98, and 41.8 f 7.4 years in 1999- 
2000: P < 0.001 vs. years 1985-96), with 9 patients diagnosed when aged 
> 65 years. In the last 4 years, a concurrent increase of the female gender 
was noticed (33.3% vs. 27.1% in years until 1996: P < 0.001), together 
with a decrease of i.v. drug addiction and administration of blood 
derivatives as risk factors for HIV, vs. both homosexual and heterosexual 
transmission ( P  < 0.001). While a moderate increase ofmean CD4 count at 
diagnosis was found (91.6 101.1 in 1997-2000, vs. 69.4 f 97.2 cells/ 
mmc until 1996: P < 0.05). the distribution of AIDS-defining diseases 
showed limited changes since the introduction of HAART. Notably, only 9 
of 87 patients who developed AIDS since 1997 (10.3%) were regularly 
treated with HAART prior to diagnosis, since in the remaining patients 
HIV infection was detected concurrently with an AIDS-defining event, or 
HAART was refused or taken with poor adherence. In a multivariate 
analysis, the increase mean age at diagnosis observed since 1997 proved 
linked to sexual transmission ( P  < 0.01), and female gender ( P  < 0.03). 
Conclusion: Although the introduction of HAART significantly altered the 
natural history of HIV disease, a number of variables affecting the 
demographic and epidemiological features of AIDS seems independent of 
the availability of HAART, such as an increased mean age at diagnosis 
(possibly related to a more frequent sexual transmission, especially among 
female patients), the spectrum of AIDS-defining disorders, and the 
concurrent level of immunodeficiency 
lp742 Characteristic of HIV-infected patients admitted to a 
general hospital 
J. L. Prada, J. De la Torre, A. Del Arco, F. Galeas, A. Galacho 
Marbeila, E 
Introduction: From the introduction HAART we observed an decrease in 
the incidence of opportunistic pathology and changes in the characteristics 
of HIV patients that require hospitalization. 
Method: We analysed the HIV patients attended in the Internal Medicine 
Department of the Costa del Sol Hospital, during 1999. 
Results: Costa del Sol Hospital is a general hospital that attended to an area 
of 250 000 habitants in the south of Spain. During 1999 we have attended 
to 1920 in-patients, with a length of stay of 6.9 days with a total of 13 304 
stays. 38 episodes have been corresponded with 31 HIV patients. 37 
episodes were from Infectious Diseases Unit, and only 1 was attended 
outside of our section (in Cardiology by infarct). Mean age was 35 years 
(26-50); 29 HIV-1 and 2 HIV-2; 8 women and 23 men. Transmission was 
in 25 cases by parented drug user (14 active consumers), 3 male 
homosexuality and 3 heterosexual transmission. The mean time from 
HIV diagnosis was 7 years. According to CDC classification, 23 were C3, 1 
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C1, 1 B3, 1 B2.4 A3 and 1 A l .  19 have no treatment. 12 patients have been 
receiving HAART (5: D4T + 3TC + INV; 2: SQV + NFV + D4T + 
NVP; 2: AZT + 3TC + INV, 1: D4T + ddI + N N ;  1: D4T + ddl + 
NVP; 1: EFV + ddl + ABV). 9 from treated group recognized a inadequate 
observance. In 9 cases had a recent viral load: 6 were detectable all above 
10 000 copies; only 3 were undetectable. 14 were infected by hepatitis C 
virus, 5 by hepatitis B, 1 by hepatitis delta. The length of stay was 9.2 days 
(2-33). There were 33 regular discharges, 2 deaths and 3 voluntary 
discharges. The diagnoses were pneumonia (8) tuberculosis (5; 2 lung, 3 
disseminated), P.carinii pneumonia (4), oesophageal candidiasis (3), 
oesophageal ulcer (3: 2 idiopathic, 1 for CMV), urinary infections (3, 1 
kidney infection), wasting syndrome (3), zoster (3), respiratory infection (2). 
Discussion: HAART produce an important change in the profile of HIV 
patients who require admission. The patients attended in our centre were in 
2 specifics situations: (1) diagnosis of the HIV infection related with a 
opportunistic infection: (2) patients with irregular observance or those who 
were no treated (60% of this series), that situation was very associated to the 
active consumption of intravenous drugs. 
Conclusion: HAART has reduced the hospital admissions of HIV patients to 
those who are no treated (known or unknown HIV) or with inadequate 
adherence to treatment. 
w1 Prognostication model for the epidemic process of 
HIV/AIDS infection in Russia 
B. Boev, V. Bondarenko, V. Mitkov 
Moscow, RUS 
The results of the calculation studies aimed at the prognostication of HIV/ 
AIDS morbidity in Russia for the period of up to the year of 2010, based on 
the mathematical model of the epidemic process, are presented. This model 
has the form of the system of integro-differential equations in partial 
derivatives with the corresponding boundary and initial condtions, taking 
into account the paths of the transmission of human immunodeficiency 
virus and the main clinical forms of HIV infection and AIDS. This study 
reveals that in case of ignoring mass prophylactic measures for controlling 
the spread of HIV infection and AIDS this epidenlic may by high a 
considerable scale. As follows computation from the mathematical model of 
the epidemic process, in the start of the 21st century the development of 
HIV/AIDS in Rusria will have a complicated character with the 
corresponding rises and falls with the number of HIV-infected persons in 
2005 reaching 1 600 000 and 2010-743.000 and the number of AIDS 
patients reaching 355 000 and 795 000 correspondingly by 2005 and 2010. 
Expenses in connection with HIVIAIDS epidemic may reach about $US 
8.69 billion per year. 
lp7461 Seroprevalence study of HIV, HTLV, HBC and HCV 
infections among immigrant prostitutes in Spain 
S. de Miguel, I. Buhiga, M. del Alanio, N. Camino, M. Baquero, M. Gutietrez 
Madrid, E 
Objective: To evaluate the seroprevalence of HIV-1/11. HTLV-1/11, HBV 
and HCV infections among immigrant prostitutes in Madrid, Spain. 
Methods: We analysed 210 sera ofpatients, 196 were sub-Saharan Africans 
and 14 were Ecuadorians, between January 1998 and December 2000. The 
age range from 18 to 23 years old for African women. ‘Medicus Mundi’ 
referred samples to our laboratory between the first month and third month 
Hepatitis C virus (I) 
since the amval in our country. The screening tests were determined by 
detection of antibodes using EIAs and c o n h a t o r y  tests were made by 
lineal immunoassay (RIBA, Inno-LIA, Pepti-LAV) and Western blot. 
Results: We found eight (4%) patients infected by HIV-I (4/98 from Sierra 
Leone, 1/54 fiom Nigeria and 3/27 from Liberia); five (2.5%) by HBV 
(HbsAg positive) and only one (0.5%) from Sierra Leone was infected by 
HTLV-I. Sixty-nine (33%) had serological markers of past infection by 
HBV. No cases of HCV infection were identified. 
Conclusions: The seroprevalence of HIV-I in &cans was 4% and the 
major infection was found in Liberia (11%) and Sierra Leone (4%) while in 
the same group none of them was infected with HCV, despite the high 
prevalence of HCV found in African people. 
I P747 I HIV and syphilis in Brazilian male sex workers 
J. L. Grandi, S. Goihman, M. Ueda, G. Rutherford 
Sao Pado ,  BR; San Francisco, USA 
Objectives: To describe the epidemiology of HIV and syphilis infection and 
sexual practices among homosexual male sex workers. 
Methods: We studed 433 transvestites and 96 hustlers recruited by peers in 
the metropolitan area of Sao Paulo, Brazil. Data were collected based on 
interviews and blood tests. 
Results: Participants were young adults with low educational level, who had 
recently immigrated to Sao Pado and living basically &om prostitunon. HTV 
prevalence were 21.9% and 39.9%, respectively, and the prevalence of current 
or past syphil~s wa$ 27.1% and 43.4%, respectively. Rates were more associated 
with gender behaviour than to unsafe practices or use condom. Hustlers 
referred homosexual and transvestites more primarily heterosexual clients. High 
numbers of foreign clients and prostimtion outside Brazil are reported. 
Conclusion: HIV and syphilis among sex workers are urgent problems of 
public health and need continuous prevention programmes extended to 
customers and sexual partners. 
1 P748 I HIV, syphilis and hepatitis B and C coinfection among 
transvestites in Sao Paulo, Brazil 
J. L. Grandi, S. Goihman 
Sao Paulo, BR 
Objectives: To determine the association of HIV infection and syphilis and 
Hepatitis B & C among male street sex workers. 
Methods: A cross-sectional study with 643 sex workers recruited by their 
peers was held between 1992 and 2000. 
Results: HIV prevalence was 38.596, starting Gom 61.7% in 1992. Syphilis 
prevalence was similar from 60% in 1992 to 40% in 2000. Hepatitis B 
increased from 52.3% to 63.2%. Hepatitis C prevalence also increased from 
3.9% in 1998 to 14.5% in 2000. Odds Ratio for HIV*HVB coinfection was 
3.88 (P= 0.000). HIV*HVC was 10.3 (P= 0.000). HIV*VDRL was 2.30 
(P= 0,000). Simultaneity of the 3 viral infections was detected on 13 
(68.4%) of the HVC cases, 16 (84.2%) cases for HVC where only HBV + 0. 
HIV average seroconversion was 6,7% per year with a cumulative 
seroconversion of 30% for the year period. 
Conclusion: All infections where associated with HIV. Logistic regression 
detected-Time of residence in Sao Paulo (OR = 1.57), time of prostitution 
(OK= 2.06) and UDI (OR=2.84) and previous syphilis (OR= 1.99) 
where important covariables in the model. 
wl Prevalence of antibodies against HBV and HCV in sub- 
Saharan Africa immigrants 
Saharan Ahca referred to the Tropical &eases Service of Hospital Carlos 
111 of Madrid was carried out between Ilecember 1995 and January 2000. 
Of 1023 patieno, 798 (78%) were from Equatorial Guinea, and 225 (22%) 
1,  hi^^, s, de ~ ~ ~ 1 ,  N, ~ ~ ~ f i ~ ~ ~ ,  M, ~ ~ h ~ ~ ~ ~ ,  M. 1 3 ~ ~ ~ ~ ~ ~ ,  M, G~ ~~ ~ 
Madrid, E 
Objectives: To study the prevalence of serologrcal niarkrrc for hepatitis l3 
and C in sub-Saharan African immigrants attended in our hospital. 
Material and methods: A retrospective study of 1012 subjects from sub- 
from other sub-Saharan Africa couiitries. One thousand and 12 patients 
were teyted for hepatitis C by tu-o ELISAs (Axyym, Abbott and Murex) and 
confimied by an inmunoblot (RIBA VHC 3.0 SIA, Ortho) One thousand 
and 1 1 patients were tested for hepatitls U by ELlSA (Axsyi17, Abbott) 
Results: Antibodies against hepatitis C virus were detected in 188 (1 8.5%) of 
1012 patients (ELISA: positive; KIBA: positive or Indeterminate). Of 101 1 
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patients tested for hepatitis B, 726 (71.8%) passed hepatitis €3 during their 
life, 92 (9.1%) had markers of active hepatitis B (acute or chronic), 193 
(19,1%) had never been in contact with hepatitis B virus. 
Conclusions: There is a high prevalence of antibodies against HCV, specially 
if we compare with Spanish populauon (2%), ths  must be taken into 
account because of their risk of hepatocarcinoma and cirrhosis. Another bct 
is that we should consider their possible rule as a source of infection because 
of the high prevalence of positive H B s  Ag. 
41 02 
vl Screening HBsAg, anti-HCV, anti-HIV 1/2 serological 
markers in blood donors in Ege University Blood Center, Turkey 
R. Y. S. Yazan Sertoz, 1. A. Altuglu, S. E. Erensoy, A. B. Bdgic 
Izmir, TR 
Transmission of infectious agents are still a problem in blood transfusion. It 
is obligatory to screen HBsAg, anti-HCV, anti-HIV 1/2 to reduce the risk 
of transfusion transmitted diseases in Turkey. All the donors were asked to 
fill out a questionnaire before the blood testing. Objective of this study is 
to determine the seroprevalance of HBsAg, anti-HCV, anti-HIV 1/2 
antibodies in serum specimens of 33582 blood donors attended to Ege 
University Hospital Blood Bank between October 1998 and October 
2000. Blood samples were tested with a third generation microparticle 
enzyme immunoassay (Axsym, Abbott, USA). Among the 33582 serum 
specimens tested, 720 (2.1%) were found to be reactive for HBsAg; 153 
(0.5%) were found to be reactive for anti-HCV. One sample (0.003%) was 
repeatedly reactive for anti-HIV1/2 by EIA and confirmed to be positive 
with further testings. 
m1 Increased prevalence of mixed chronic hepatitis C 
infection in the Lebanese population; a hospital based study 
N. Halume, W. Alniawi, W. G. Karam, 2. Daoud, H. Samaha, J. Daccache, 
P. Rassam, J. P. Aoun 
Beiruf, RL 
Objective: Epidemiological studies indicate that some HCV genotypes are 
distributed worldwide such as genotypes 1, 2 and 3, while others are 
contined to restricted geographical areas like type 4 which has been reported 
as the predominant genotype in the Middle East. Knowing that HCV 
genotype might influence disease outcome and response to administered 
antiviral therapy, we have designed this study to determine the pattern of 
genotypic distribution of HCV in the Lebanese population. 
Methods: Serum samples tiom 42 chronically infected individuals were 
randomly collected and analysed using reverse transcription and nested PCK 
followed by hybridization to HCV subtype core region specific biotinylated 
oligonucleotide probes imniobhzed onto avidin coated wells. DNA-probe 
hybrids were detected by a standard ELISA using nionoclonal antibody 
specific for double stranded DNA (DEIA) 
Results: (1) An increased prevalence of HCV mixed genotypes wat 
detected; 17 patients had 2 genotypes whlle 2 had 3 genotypes. (2) l b  and 2 
were the most commonly detected genotypes in both single and mixed 
infections. (3) Genotypes 5, 6 and 2a were not detected in either nixed or 
single infections. 
Conclusion: Our results indicate that mixed HCV infecnons mght  be a 
common finding in HCV chronically infected patients. The most 
prevalence HCV genotypes detected are lb  and 2, which are also. the 
most fiequently reported Gom the western hemisphere. 
In contrast to other epidemiological studes fiom the Middle East, the 
prevalence of type 4 was lower that expected. 
vl Molecular markers of hepatitis C virus in HIV and non- 
HIV patients 
F. Garcia, M. hvarez, M. Martinez, F. Garcia Jr, C.  Bernal, J. Hemindez, 
M. Maroto. G. Pi6drola 
Grariada, E 
Objective: To describe the differences in molecular markers of Hepatitis C 
Virus (HCV) Infection in patients infected and not infected by Human 
Immunodeficiency Virus (HIV-I). 
Patients and methods: 109 patients with chronic type C hepatitis selected 
to start treatment with interferon plus ribavirine were studied. 35 patients 
were coinfected with HIV-1. Prior to therapy patients were screened for 
HCV viral load (CA HCV Monitor, Roche) and for HCV genotype 
(INNO-LIPA HCV, Innogenehcs). 
Results: The tkequency ofgenotypes at HIV patients was: la, 15 (42%); Ib, 
4 (11%); 1, 2 (5%); 3a, 9 (25%); 4c/4d, 5 (14%); mean viral load was 
1.27E6 f 1.13E6. For non-HIV patients genotypes were: la, 20 (27%); lb, 
35 (47%); 1, 5 (7%); 3a, 10 (13%)); 4c/4d, 2 (3%); 2c/2d, 2 (3%); mean viral 
load was 0.85E6 f 0.7E6. Significant differences were found between 
genotype and HIV positive or negative patients (P  < 0.001, Chi square 
test), and between viral load and HIV ( P  < 0.05, Student’s &test). 
Virological response to treatment has been achieved so far for 34% of the 27 
pahents that have been included into the treatment trial. 
Conclusions: The genotype distribution of HCV in patients Goni Southern 
Spain is different at HIV and non-HIV patients due to a lower presence of 
subtype l b  in HIV infected patients. HIV infected patients have shown a 
higher HCV viral load. 
vl Descriptive seroepidemiological data to evaluate the 
spreading of hepatitis C virus in a North-Eastern area of Romania 
(199599) 
D. Azoicai, A. Ivan, E. Carasievici, V. Luca, D. Ilcenco, D. Scripcariu, 
M. Grigoriu 
hi, RO 
The paper describes aspects in the natural evolution of hepatitis C virus 
(HCV) infection with severe outcomes induced by the typical or atypical 
clinical manifestations or chronic carrier state. In the interval 1995-99 in the 
Iasi district (North-Eastem area of Romarua) mortidity from all types of 
viral hepatitis ranged from 153.4 cases per 100 000 inhabitants in 1995 to 
66.6 in 1009. From e7tiniating the circulation of HCV in the population of 
1 m  district, reveral population categories have been screened for the 
pretence of HCV antibodies (anti-HCV). Testing 87 894 blood samples 
asserted the prevalence of anti-HCV in blood donors. 
Different annual v,iluet resulted l.9’% in 1995. and as a result of routine 
wreening, only 0.3’% in IW9. The cares of post-transfution hepatitis (PTH) 
admitted to the Clinic of Infectlour L)iseases of Iasi, the diagnosis of which 
war supported by epidemiological hirtory and confirmed serologically by 
the presence ofanti-HCV were of 12 in 1095 (3h.W ofall PTHs), 20 in the 
interval 1996-99, with an average for the 4 study year? of7.5%~ Anti-HCV 
wac found in 24.4% o i a  series of4504 patients with viral hepatitis, in 32.1% 
of 582 individuals with various ditot-ders or a t  rick. of which those with liver 
cirrhosis accounted for 37%. and in 9.6% of 94 patients with neurological 
disorders. Of the 1083 tested physician? and nurses working in health care 
settings at risk 6.6% were anti-HCV-positive. 
v) lntrafamilial transmission and genotypes of HCV 
F H m d i n .  F. K o k d  C. Aplar. C. Diri, C. Ergin, K.  Turkyilniaz 
:i1Ik(11c1, .~~<II I<I ,  L / w I v < ~ ,  7‘R
Aim: To in \  c v i + i t r .  t h e  g:cnotypc\ .md intr~itimilial horizontal transmission 
C I ~  H(:V 111 .inri-H(:V(+) h.icniodi.ily\i\ patient5 and their households. 
Method: The m i d y  g roup  \vcw iompored of ELSA-detected anti-HCV 
(+) 48 p.iticnt\ o n  h~ieinodialyri~ (Group I) and 50 nonhaenlodialysis 
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patients (Group 11). All the study samples were tested by RT-PCR and the 
negative samples (10 &om Group I, 17 from Group 11) were excluded. 131 
household persons of Group I and 65 of Group I1 formed the family groups. 
Results: Sex and age distributions of each group did not show any significant 
Merence. The genotypes of HCV were detected as genotype l b  (34 
patient, 85%), genotype 2 (3 patients, 7.5%), genotype 3 (2 patients, 5%) for 
Group I and genotype l b  (17 patients, 85%, genotype 2 (2 patients, 10%) for 
Group 11. A sample fiom each group could not be classified. Genotype l b  
was detected in 2 household persons of Group I .  The difference between 
the two groups was not statistically significant. Intrafamilial transmission was 
absent in Group 11. 
Conclusion: The most common serotype was lb. I n t r a f d a l  horizontal 
transmission of HCV may be disregarded. 
Epidemiology of HCV in Belgium 
R. Vranckx 
Brussels, B 
This study summarizes relevant epidemiological data about HCV in Belgium: 
General population 0.87% of a representative sample of the general 
population (n = 4059) was positive for anti-HCV. 
Health care workers (n=5068): 0,41% was positive for anti-HCV. 
Blood donors Two groups of the blood donors from the Antwerp 
transfusion center were selected. 
Group A (ti = 319) donors selected on the basis of their medical history, 
whch indicated an episode of viral hepatitis. 
Group B (n=301) donors selected at random. In group A 1.57% was 
anti-HCV sero-positive and in group B 0.33% were found to contain 
anti-HCV in their serum. A statistically significant difference existed 
between both groups. 
Std patients We determined the prevalence of antibodies to HCV in 
patients (n = 487) attending a clinic for sexually transmitted diseases. The 
overall prevalence was 0.82%. which is comiderably higher than the 
0.33% found in at random blood donors &om the same region. But this 
number is comparable with the prevalence in the general population. 
I _ _  
These data lead us to conclude that in Belgium HCV infections are far less 
important as STD than HIV and HBV infections. 
0 Prisoners: Among 903 prisoners we found 63 (6.97%) anti-HCV positives. 
Note that this group contains a considerable number of i.v. drug users. 
0 Patients ( ~ ~ 2 0 9 )  with clinic viral hepatitis: A study carried out on viral 
hepatitis cases diagnosed by general practitioners let us to conclude that 
HAV, HBV, HCV and HEV made up 66% 20%, 11% and 3%, 
respectively, of the clinically recognized viral hepatitis infections. 
lp756/ HCV transmission to children born to HCV-infected 
mothers following renal transplantation 
K. Dzierzanowska-Fangrat, K. Jobs, P. Jozwiak, K. Madalinski 
Warsaw, PL 
The rate and risk factors of vertical transmission of hepatitis C virus from mfected 
mothers to their chlldren during pregnancy and delivery are s t i l l  unclear. 
Objectives: The a m  of our study was to estimate the risk of HCV transmission 
from infected women after renal transplantation to their ofipspring. 
Patients and methods: Nineteen women with end stage renal disease who 
became pregnant after kidney transplantation and their 20 children were 
tested for HCV antibodies (Abbott Axym) and HCV-RNA (Roche HCV 
Amplicor 2.0). 
Results: Fifteen women tested positive for HCV antibodies and 14 of them 
were also HCV-RNA (f). Only two children were anti-HCV(+) and one 
of them had detectable HCV viraemia. 
Conclusions: Our results indicate that the risk of HCV msmission to children 
born to HCV-infected mothen following renal transplantation is relatively low. 
v1 Horizontal transmission of HCV infection among long- 
term hospitalized oncohaematological patients 
D Janusrkiewicz, J. Wyrocki, J. Nowak 
Poznari, PL 
Hepatitis C virus (HCV) infection is becoming real problem in long-term 
hospitalized patients. Oncohaematological patients undergoing chemother- 
apy are especially prone for HCV infection. These patients are usually 
deeply immunosuppressed and therefore lack of antibody to HCV may be 
observed despite of HCV-RNA presence in peripheral blood. The aim of 
the study was to monitor HCV anhbodies and HCV-RNA presence in 
serum of oncohaematological patients, those were anti-HCV negative at the 
time of first hospitalization. The study involved patients with lymphopro- 
liferative diseases (129) and solid tumours (36). All the patients received 
multiple intravenous injection of cytostatics and some of them blood 
products. All the patients have been monitored during 2.5-year-follow-up 
study. Detection of HCV-RNA in blood serum and HCV genotyping have 
been performed by Inno-Lipa HCV I1 test (Innogenetics). Among 165 
oncohaematological patients in 87 HCV-RNA appeared in the serum 
during subsequent hospitalizations. Majority of them (82/87) have l a  
genotype, 2 have lb, I-la + l b  and 1-la + 3a. Our study indicate that 
HCV infection in long-term hospitalized patients constitutes very serious 
problem. We have tried to establish the origin of HCV infection. Screening 
of medical staff for HCV infection appeared presence of la  genotype in all 
HCV-infected medical staff working with the patients. None of the HCV 
infected medtcal staff have l b  genotype. Since the l b  genotype is most 
prevalent in polish blood donors, HCV infection in oncohaematological 
patients is most likely due to horizontal transmission. Route of the HCV 
transmission is not fully known. In addition to parented transmission it is 
very likely that nonparenteral transmission could cause the horizontal 
transmission of HCV infection since HCV-RNA was found also in saliva of 
selected oncohaematological patients. For clinical practice early detection of 
HCV-RNA is important in immunosuppressed oncohaematological 
patients, who were not able to produce anti-HCV antibodies. Early 
diagnosis of HCV infection may help to introduce some prophylactic steps 
in order to prevent spreading of HCV infection by horizontal transmission. 
jp758 Significant association between HCV infection and 
isolated anti-HBc seropositivity 
A. Tsinnga, A. Xanthaki, V. Skandami, N. Alexandropoulos. K. Kotoula, 
Z. Komninou 
Athens, GR 
Introduction: A relatively common finding is the presence of antibodies 
against the core antigen as the only serological marker for hepatitis B virus 
infection. This finding is either nonspecific due to low sensitivity of the test 
system used or compatible with chronic or past hepatitis B infection. The 
correct interpretation may be diflicult. The aim of this study was to evaluate 
the frequency of anti-HBc alone between non selected individuals and to 
estimate the possible influence of coexisting HCV infection between 
carriers of anti-HBc as the only marker of HBV infection. 
Materials and methods: We tested patients of our hospital who were 
seropositive for anti-HBc alone as well as for coexisting HCV infection. 
Serum samples were collected during the time interval from March 2000 to 
November 2000. Anti-HBc and anti-HCV were detected using micro- 
particle enzyme immunoassays (AXSYM Core MEIA, Abbott) and 
(AXSYM HCV MEIA, Abbott). 
Results: Out of 1079 serum samples sent to our laboratory at that time 
period, 31 (2.8%) were tested positive for anti-HBc alone. Sera confirmed 
to be positive solely for anti-HBc were then tested for the possibility of a 
coexisting infection with hepatitis C virus. Of these 31 anti-HBc positive 
samples, 9 (29.3%) were also tested positive for anti-HCV. 
Conclusions: A significant correlation was observed between the presence of 
anti-HCV and anti-HBc alone. We suggest that anti-HCV testing should be 
performed in individuals with antibodies against hepatitis B core antigen as 
the only serological marker for HEW infection. 
(p7591 Distribution and clinical course of acute viral hepatitis C 
0. Boykinova, S .  Novakov 
Plovdiv, BG 
Background: According to the available data in 20% of hepatitis C viral 
(HCV) infection the clinical course is in acute form. The basic mechanism 
of infection is by transfusion of blood and blood products. 
Aim: To follow the distribution, mechanism of infection and the clinical 
course of HCV infection. 
Patients and methods: We followed 76 patients &om the clinic of 
Infectious Diseases in Plovdiv for 7-year period of time. The diagnosis was 
proved anamnestically, biochemically (blood bilirubin, ALT) and serologi- 
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cally. The methods of EIA I1 and 111 generation with Abbott kits, PCR, 
Murex for subtyping were used. The patients were distributed according to 
the purpose of infection, sex, age and clmical course of the disease. 
Results and conclusions: The groups of high percentage of HCV infection 
are: patients having a history of blood transfusions for different purposes; 
intravenous drug users and risky professions. The percentage of the disease is 
high among patients with unknown mechanism of the transition of the 
infection -35.5%. The infected male patients (55.22%) are more compared 
with female (44.78%). The most commonly infected are 45 to 60 year olds. 
In 40 (52.64%) patients the course ofthe disease is light; in 30 (39.48%) cases 
the course is moderate heavy, in 5 (6.57%) the course is heavy and in 1 
(1.31%) there is a lethal outcome. In 32.89% the acute HCV infection runs 
with expressed intrahepatic cholestasis and in 77.11% without it. 
1p76o The current trends in the epidemiology and prevalence 
of viral hepatitis B and C in mixed population groups in 
Novosibirsk, Russia 
S. A. Kurilovich, 0. V. Reshetnikov, A. A. Khryanin, T. R. Teinina, N .  A. 
Krivenchuk 
Novosibirsk, RUS 
Objective: The aim of the present study was to study the occurrence of viral 
hepatitis B and C among various population groups of Novosibirsk. 
Methods: Five groups were examined representative samples of adults and 
adolescents, students of medical college, students of medical academy (IV- 
VI years), and blood donors. HBsAg and HCV antibodies were tested in 
serum samples using previously vahdated kits (Vector-Best, Novosibirsk). 
Results: The prevalence rates of viral hepatitis markers are shown in 
the table: 
Group N M I F  Meanage HbsAg HCV 
(%I (y ears) (?A) (oh) 
School 278 43157 155 2 5  0 7  
Medicalcollege 103 9191  19.4 0 0 2 9 
Medicalacademy 173 23177 214  3 5  6 4  
Adults 448 36144 4 2 0  2 2  5 3  
Blooddonors 4552 66/  34 Nodata 1 1  2 1 
Conclusions: (1) HEW and HCV positivity among the general population is 
2-2.6 times higher than among blood donors, thus the latter could not serve 
as an estimate of viral hepatitis prevalence in the community; (2) The 
prevalence of HBsAg in teenagers is the same as in adults, and HCV is much 
lower; (3) Medical students represent risk group for acquisition of 
these infections. 
FI Handwashing and hepatitis C nosocomial transmission 
in haemodialysis 
N. Grinberg, C.  Lavorato, M. Pissano, M. Khoury, E. Olivera, E. Diaz 
Williams, E. Tabbia, E. Sanguedolce 
Buenos Aim, RA 
Objective: to investigate the relationship between Dialysis Units (DU) 
hepatitis C (HCV) seroconversions and hand washmg practices. 
Methods: 155 Dialysis Units (DU) have been surveyed in the field by the 
Infectious Control Team of CADRA, from 2 January 1998 to 30 July 1999. 
Solid soap for hand washing, Iodopovidone for hand washing, availability of 
> 2 sinks per haemodialysis (HD) room, no sink in HD room, or dedicated 
hand washing smk were surveyed. Relationship between this hand washing 
markers and HCV seroconversion was analysed. Categorical variables were 
analysed by xz test. Odds raho (OR) and 95% confidence intervals (IC 95) 
were calculated for these variables. 
Results: DU with anti-HCV (+) patients represented 58.71% (91 D U  Unit) 
in this survey, and 34.84% of then registered seroconversions (SC +) during 
the last two years before the visit. 
Conclusions: Increasing the number of locations where materials suited for 
hand washing are available is a priority to improve compliance with this 
practice. Hospital administrators should make improving hand hygiene a 
strategic priority of the institution, and should provide the resources needed 
for developing multidisciplinary educational programs in order to improve 
adherence to recommended hand washing procedures. Continuous 
surveillance of dialysis practices is essential in order to improve quality of 
care and to reduce the impact of nosocomial infections. 
lp762 Distribution and change of HCV genotype of 
hospital personnel and health care workers in out-patient 
service in Hungary 
I. Mihily, L. Telegdy, E. Ibrinyi, A. Lukics 
Budapest, H 
The HCV seroprevalence is significantly higher among health care workers 
( H W s )  than in the blood-donor population. The HCV seroprevalence of 
the Hungarian blood-donor population is 0.73%, while it is 2.7% in our 
hospital personnel according to our earlier data. Serum samples of all of the 
patients working in health care were examined for HCV infection with 3rd 
AND 4TH generation antibody EIA (UBI, Innogenetics, etc.) and the 
antibody positive HCV samples were tested with HCV RT-PCR (Roche 
Amplicor, Monitor). The genotype of HCV was determined by line 
hybridization assay (Inno-Lipa HCV 11-Innogenetics) and by serotyping 
assay (Murex). In 1998 and 1999 32 chronic C hepatitis H W s ,  four HCV 
carrier H W s  and 76 HWs with needle-stick injury were investigated for 
HCV antibody and HCV-RNA. The determination of HCV genotype was 
made twice in four HWs, the first being an early sample the second a sample 
2 4  years later. 
Results: 
(1) Genotype distribution of HCV infected HWs in 1999 
In St. Liszl6 Hospital,* In outpatient servicc 
lb 8 H w s  (47.0%) 35 HWs (94.0%) 
l a  0 I H W ~  (3.0%) 
1 3 H w s  (17.7%) 0 
3a 1 HWs (5.9%) 0 
4 2 HWs (11.7%) 0 
Chron. C hepatitis 6 HWS (35.0%) 31 HWS (849.0%,) 
Untypeable 3 HWs (17.7) 1 HWF (3.0%) 
Gender 4 (CAPS) m/13F 9 (CAPS) m/28F 
Mean age 40 yean 46 years 
(range: 18-70) (range: 25-67) 
Activity of H W s  with chronic C hepatitis: nursing sta8 19 (51%), 7 
physicians (19%). 3 emergency technicians (8%), 2 laboratory technicians 
(5%), 2 house keeping staff (5%). 1 dissectors, 1 dental technician, 1 
midwife, 1 epidemiology technician. 
(2) The HCV genotype was l b  in the first and in the second samples in 
three HWs. In the fourth nurse with chronic C hepatitis HCV genotype 
was Ib  in the first sample and 3a in the second sample drawn 2 years later. 
During the period between the first and the second blood drawing 
she suffered a needle-stick injury with the blood of a patient infected 
with AIDS. 
Conclusions: (1) The HCV genotype distribution of our hospital workers 
comparing to health care workers of outpatient service reflects the 
dlfference of the patient population. (2) The development of chronic C 
hepatitis is more fiequent following infection with blood contaminated with 
HCV genotype l b  than with other HCV genotypes. (3) The HCV 
genotype was changed in one health care worker with chronic C hepatitis. 
The change is probably a consequence of exposure to blood infected with a 
different HCV genotype. 
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/p763/ Sarcoidosis developed after use of interferon for 
chronic hepatitis C 
V. Tahan, R. Ozaras, A. Mert, F. Tabak, T. Cagatay, H. Senturk 
Istanbul, TR 
Interferon may lead to development or exacerbation of autoimmune 
phenomena and diseases, including sarcoidosis, because of the strong and 
complex inlmune action of interferons. Pulmonary side-effects of 
interferon-alpha therapy of chronic hepatitis C (CHC) seem to be rare. 
So far, only a few cases of sarcoidosis in association with interferon-alpha 
treatment of CHC have been described. A 36-year-old woman was 
admitted with newly diagnosed asymptomatic CHC with positive HCV 
RNA-PCR and mild elevations of aminonansferases. Liver biopsy revealed 
chronic hepatitis, nlild inflammatory reactions, minimal fibrosis. She has 
been treated with recombinant interferon-alpha2a in combination with 
ribavirin for CHC. Ten weeks after beginning interferon therapy, she 
admitted for nodosities on lower leg, weakness and shortage of breath. Her 
physical examination was normal except for multiple erythema nodosums 
on lower leg. Ophthalmologic examination and echocardiography were 
normal. Her laboratory findings were revealed the following results; ESR 
Herpes viruses 
28 m / h ,  Hct 38%, Hb 12.1 g/dL, leukocyte 7200/mm3, platelet 255000/ 
mm3, ALT 26 U/L, AST 10 U/L, ALP 152 U/L (N: 64-306 IU/L), total 
protein 7.8 g/dL, albumin 4.4 g/dL,  total biluubin 0.3 mg/dL, FEVl 2.07 
(71%). FVC 2.72 (81%), ACE 121 U/L (N: 8-52). Her chest radiograph 
demonstrated new on set of bilateral hilar adenopathy without parenchymal 
disease. Tuberculin skin test resulted in an endutaion of 8 mm. Abdominal 
USG was negative. HKCT revealed bilateral LAP and subpleural minute 
nodules. The patient diagnosed as pulmonary sarcoidosis. Interferon therapy 
was discontinued. A nansbronchial needle aspiration of the right Mar lymph 
node revealed granulomas. Spontaneous remission was observed in 
symptoms and erythema nodosum resolved 4 months after the cessation 
of interferon therapy. She has stdl been on follow up on consideration of 
medical treatment. The occurrence of sarcoidosis in association with 
interferon-alpha therapy CHC may have been underestimated so far. This 
could be due to the fact that symptoms of sarcoidosis and common side- 
effects of interferon are similar. We speculate that IFN-alpha as a potent 
stimulator for immune responses triggered clinical manifestations of 
sarcoidosis in this patient. Patients should be monitored during and 
following interferon-alpha therapy, since the autoimmune diseases induced 
by interferon therapy do not always improve after cessation of treatment. 
v] Revealing of antibodies to Epstein-Barr virus in sera of 
patients with infectious mononucleosis, tuberculosis and HIV 
infection 
S. Zagorodnya, N.  Nesterova, N. Dyachenko, L. Vasilenko, L. Kolos 
Kiev, UKR 
Objectives: Studying of spreading of antibodies to Epstein-Barr virus 
among patients with tuberculosis, HIV infections and dectious mono- 
nucleosis. 
Methods: Investigations of patients’ sera on presence of antibodies to EBV 
were camed out by mean of ELISA kit created in our laboratory (‘ELISA- 
AtEBV-strip’). 
Results: Sera of patients with infectious mononucleosis, tuberculosis and 
HI!! infection were tested with ELISA kit created in our laboratory 
(‘ELISA-AtEBV-strip’), with in based on using of EBV proteins synthesized 
in lyniphoblastoid cells as antigenes. 222 sera samples of patients with 
clinical symptoms of infectious mononucleosis and positive results of Paul- 
Bunnel nonspecific reaction of heteroagglutination were investigated. IgM 
to EBV revealed in samples of 122 patients, that was an evidence of 
infectious process in acute phase. Anamnestic IgG were revealed in 82 cases, 
18 sera samples had negative results. Among 176 sera samples of patients 
with tuberculosis, presents of IgG to EBV were revealed in 28% of samples, 
of IgM in 19%. Investigations of 39 sera samples patients with HIV infection 
resulted in 34 samples that contained both types of immunoglobulins and 
5 samples with IgG only. 
Conclusions: Conducted investigations allow to determine the phase of 
infectious process in patients with infectious mononucleosis, and to bring 
out frequent encountering of F.BV in patients with tuberculosis and HIV 
infection among Kiev population. 
Acknowledgements: The work was financed by Kiev municipahty. 
lp765/ Fulminant hepatic failure and autoimmune haemolytic 
anaemia associated with Epstein-Barr virus infection 
A. Palanduz, Y. Yildirmak, L. Telhan, M. Arapoglu, N. Urganci, S. 
Tufekci, N. Kayaalp 
Istanbul, TR 
Objectives: Acute hepatic failure has been reported in the presence of 
Epstein-Barr virus infection. Autoimmune haemolytic anaemia may also 
occur in the course of this infection. We report a rare case of fulminant 
hepatic failure and autoimmune haemolytic anaemia associated with 
Epstein-Barr virus. 
A 7-year-old girl was admitted with the complaints of abdominal pain, 
vonliting and jaundice. She was irritable, confused and had mdd 
hepatoniegaly with marked splenomegaly. Serum aminotransferase levels 
were moderately; dnect and indirect bhrubin levels markedly elevated. 
Prothrombin time was prolonged. Haemoglobin was 3.9 g/dL. Anti-HAV 
IgM, HbsAg, anti-HBc IgM, anti-HCV and anti-CMV IgM were negative, 
while IgM VCA, IgG VCA and anti-CMV IgG were positive. Serum 
copper and ceruloplasmin levels were normal. The patient received 
supportive therapy for hepatic failure. Meanwhile, the cause of the deep 
anaemia was investigated and autoimmune haemolytic anaemia was 
ascertained by means of increased reticulocyte count and positive Coombs 
test. Steroids were administered. The prognosis was good. 
Conclusion: Although not reported before, the combination of acute hepatic 
failure and autoimmune haemolyhc anaemia may complicate the come of 
Epstein-Bm virus infection. Physician$ need to be aware of this association. 
v] Investigation of possible relation between 
cytomegalovirous infection and acute coronary heart disease 
S. Castellanos, S. Kastellanos, S .  Karachalios, J. Rizos, G. Vyssoulis, I. D. 
Papaioannou, A. Paschali, C. Kontou-Castellanou 
Athens, GR 
Objective: The aim of this study was to inveshgate if human cytomegalovirous 
(CMV) infections are part of the aetiology of acute coronary heart disease. 
Methods: During an 8-month period (20 April 1999 until 20 January 2000) 
serum samples were taken Gom 39 hospitalized patients with acute 
myocardial infarction or unstable angina clinically and angiographically 
documented and were evaluated for the presence of IgG and IgM antibodies 
to CMV. Twenty-seven normal adult subjects, who were Gee of all 
symptoms of cardiovascular hsease, were used as a control group. The 
presence of IgG and IgM antibodies in both groups was determined with a 
commercial EIA kit (AxSYM Abbott). IgG titres higher than 24.3 AU/mL 
and IgM tines higher than 0.432 were considered positive. 
Results: IgG antibodies to CMV were positive in the serum of 36 patients 
(92.3%) and 25 members of the control group (92.5%). IgM positivity was 
found in only 2 patients (5.1%) and 4 members of the control goup (14.8%). 
Ths  data was statistically examined and no statistical significance was found. 
Conclusion: Our study shows that CMV infections probably do not play a n  
independent part in the aetiology of acute coronary heart disease. 
[p767] Prevalence of CMV and EBV antibody in blood donors 
N. Delialioglu, C. Oztiirk 
Mersin, TR 
The only reservoir of CMV is the human being, and unhygienic conditions 
and close contact within the social group carry a great risk of infection. EBV 
is transmitted by close contact, blood or contaminated objects. It is seen 
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prevalently in the first years of life among people living in crowded and 
unhygienic conditions. The aim of the present study was to detennine the 
prevalence of CMV and EBV antibody positivities in healthy groups. In this 
study, CMV IgG antibodes were analysed in 186 blood donors from 
various professions by ELISA (Abbott, Axsym) and EBV VCA IgG 
antibodies were analysed in 92 blood donors by micro-ELISA (Zeus 
Scientific, Inc.). While all blood donors were found to be positive for CMV 
IgG antibodies, the positivity for EBV VCA IgG antibodies was 78.2%. This 
study provides data on the seroprevalence of CMV and EBV infections, 
showing that the rates in the Mersin region are comparable with the results 
of studies canied out in other parts of the country. 
Infectious mononucleosis presenting with severe 
cholestatic liver disease in the elderly 
V. Tahan, R. Ozaras, A. Mert, F. Tabak, A. Celik, R. Ozturk, G. Ozbay, 
H. Uzunismail, Y. Aktuglu 
Isfanbul, TR 
Infectious mononucleosis (IM) due to Epstein-Barr virus (EBV) is usually a 
self-limited disease of young adults. Mild liver enzyme abnormalities are not 
uncommon in patients with EBV infection, Hepatitis is rare and usually 
resolves spontaneously. We report 2 elderly cases with severe cholestatic 
jaundice and hepatitis. 
Case 1: A 72-year-old-woman was admitted with severe jaundice, nausea, 
weakness, and low-grade fever. 3 weeks prior to admission, she noticed sore 
throat and cervical lymphadenopathy and developed rash following use of 
amoxicillin. One week later, her jaundice became prominent. There was 
cervical LAP and splenomegaly (2 cm). 
Laboratory studies: ESR 78 mm/h, haematocnt 40%, Hb 13.8 g/dL, 
leukocyte 7400/mm' (46% PNL, 45% lymphocytes (none was atypical), 
platelet 129 O O O / m m 3 ,  total bilirubin 21.4 mg/dL (direct 15.9 mg/dL), AST 
904 IU/L, ALT 1258 IU/L, y-GT 250 (N1:4-38 IU/L), ALP 370 (N: 64- 
306 IU/L), t. bilirubin 6.7 g/dL, albumin 3.6 g/dL. Serological tests for A- 
E, CMV, HSV, HIV, Toxoplasma, monospot test were negative. But anti- 
EBV-VCA IgM was positive while anti EBV-VCA IgG was negative. On 
the tenth hospital day, repeated tests for both anti-EBV-VCA IgM and IgG 
were positive and also early antigen IgM and EBV-DNA were found positive 
by IFA and PCR, respectively. 6 week$ after discharge the patient was 
asymptomatic except for fatigue, and liver function tests were in normal limits. 
Case 2: A 67-year-old-woman was admitted with a history of 3 weeks' 
illness characterized by sore throat, weakness, anorexia and low grade fever. 
Two weeks later, she noticed jaundice. She had a history of prolymphocytic 
leukaemia and splenectomy. On admission, temperature was 38.2 "C, and 
jaundice was observed. A hepatomegaly (8 cm) was detected. 
Laboratory studies: ESR 55 mm/h, haematocnt 47%, Hb 16.4 g/dL, 
leukocyte 59100/mm3 (3% PNL 69% lymphocytes and 28% atypical 
lymphocytes), platelets 332 OOO/mm3,  t. bilirubin 11.4 mg/dL (direct 8.6 
mg/dL), AST 847 IU/L, ALT 499 IU/L, GGT 198 IU/L, and AP 1389 
IU/L. Serological tests for hepatitis A-E, CMV, HSV, HIV were negative 
but monospot test, anti-EBV-VCA IgM and anti-EBV-VCA IgG were 
positive. She improved spontaneously and 3 months after discharge, the 
patient was asymptomatic, and liver tests were nonnal. In conclusion, acute 
EBV infection should be considered in the differential diagnosis of patients 
presenting with cholestasis, and prognosis is not poor even in elderly. 
v1 An unusual presentation of EBV infection in an 11- 
month-old infant: a case report 
E. Papadakis, P. Korovessi, N. Manakou, E. Trika-Graphakos 
Athens, GR 
Primary infection with EBV in childhood IS generally silent but can often 
cause overt diseases such as infectious mononucleosis and lymphoprolifera- 
tive disorders. In developed countries primary infection of EBV is usually 
delayed until adolescence. Neurological complications are relatively rare in 
children with EBV infections, occumng approximately in 8% of those 
infected. The incidence of facial nerve palsy associated with EBV infection 
is unknown, although in one study concerning the complications in 
children with EBV infection, the incidence was found 0.9%. We present an 
11-month-old infant with a 4-days history of fever, 2 days history of facial 
weakness and mild cough. Physical examination revealed small cervical 
lymphnodes, (L)otitis media and (L) facial nerve palsy. Neurological 
examination was otherwise normal. No generalised lymphadenopathy was 
found. Liver was palpable 2 cm below the costal margin and there was no 
splenomegaly. His previous medical history was unremarkable. There was 
no evidence of immunodeficiency and he has not received any cytotoxic or 
steroid medication. Initial laboratory tests showed marked leukocytosis with 
atypical lymphocytes. WBC:82100/pL with lymphocytes: 70.9%. The 
haemoglobin was 11.5 g/dL and platelets 284000/pL. CRP and ESR were 
not raised. Hepatic transaminases were slightly elevated: SGOT:76 U/L, 
SGPT: 58 U/L. Primary EBV infection was established by serologic 
examination for specific EBVantibo&es: VCA-IgM(+),VCA-IgG:1/320, 
EA < 1/20, EBNA < 1/20. Bone marrow aspirates showed increased 
number of polyclonal B lymphocytes and no malignant infiltration. Also no 
monoclonality of the B lymphocyte was detected either by flowcytonietry 
immunophenotype or immunoglobulin gene rearrangement. Chromosomal 
analysis was normal. Serologic examination for other viral infections such as 
HSV, CMV, HIV and Hepatitis A, B, C were negative. There was no 
evidence of Lyme disease. Middle ear fluid was obtained by tynlpanocentesis 
was sterile on culture. Facial nerve palsy gradually resolved with no 
treatment and WBC returned to normal after 3 weeks tune. During the 
following 6 months the patient had 2 episodes with similar clinical and. 
haematological findings. 
Conclusion: This is a rare presentation of recurrent EBV infection with 
extreme leukocytosis and facial nerve palsy. 
[p7711 Detection of IgG and IgM antibodies against herpes 
viruses HSVI, HSVZ, CMV and EBV in patients on chronic 
haemodialysis 
S. Konstantopoulou, P. Kalocheretis, A. Drouzas, E. Kouskouni, E 
Mpaimakou, C. G. Gerolymatos 
Athens, G R  
Objective: The occurrence rate of IgG and IgM antibodies against herpes 
viruses HSV1, HSV2, CMV and EBV in patients undergoing chronic 
haemodialysis. 
Methods: 173 patients on chronic haemodialysis were prospectively 
examined. 97 of them were men and 76 women, with a mean age of 
60 k 12 years. The average time on haemodialysis was 24 months to 8 
years. 100 healthy persons were included as control group. 88 of them were 
men and 12 women with a mean age of 56 k 10 years. The detection of 
specific IgG and IgM antibodies against HSV1, HSV2, CMV and EBV was 
performed with ELISA. 
Results: Positive IgG antibodies against HSV1, HSV2 and EBV were found 
in 168 (97%) patients. IgG antibodies to CMV were found in 161 (93%) of 
patients. 93 (93%) of control cases had IgG antibodies to HSVl and HSV2, 
97 (97%) had IgG antibodies to EBV and 85 (85%) of them were IgG-CMV 
positive. Positive IgM antibodies to HSVl were found in 3 (1.73%) patients, 
IgM-EBV positive were found to 16 (9.2%) patients and IgM-CMV were 
found to 1 (0.6%) patient. Only 5 (5%) cases of the control group were IgM 
positive to EBV. 
Conclusions: IgG seropositivity to Herpes viruses, EBV and CMV seems to be 
equally distributed in haemodiaySis patients and healthy controls. IgM 
seropositivity is also similar in both goups for Herpes viruses and CMV. I@- 
EBV seropositivity seem to ba sigdcantly higher in haemodialysis patients. 
Detection of Epstein-Barr virus DNA in the palatine 
tonsil carcinomas 
A. Szkaradkiewicz, A. Kruk-Zagajewska, M. Wal, A. Jopek, M. Wierzhicka 
Pooznaii, PL 
Objectives: In the paper presented at the 10th ECCMID (Stockholm, May 
2000, Abstract no. MoP70) presence of serological markers of EBV 
infection was documented in patients with PTC in Poland. In present study 
we searched for EBV DNA in the PTC material. 
Methods: The studies were performed on 12 patients, aged 4 M 1  years, in 
whom PTC was diagnosed by histological methods. Sera of the patients 
were tested for IgG-anti-EA antibodies (ETI-EA-G; DiaSorin), IgG-anti- 
VCA antibodies (ETI-VCA-G; DiaSorin) and IgG-anti-EBNA (ETI- 
EBNA-G; DiaSorin). In parallel, DNA extracted from PTC material was 
tested for the presence of EBV DNA (Sharp Signal System; Digene). 
Results: Basing on serological markers of reactivated EBV infection (serum 
IgG-anti-EA, IgG-anti-VCA and IgG-anti-EBNA antibodies) the reactiva- 
tion was diagnosed in 5 patients whde in 6 patients an earlier experienced EBV 
infection was documented (serum IgG-anti-VCA, I@-anti-EBNA antibo- 
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dies). In all but one patient with PTC presence ofEBV DNA was identified. 
Conclusions: EBV may play role in aetiopathogenesis ofPTC even ifthe invasive 
stage of PTC is not always accompanied by reactivation of EBV infection. 
)p773 Detection of herpes simplex virus in accidental 
abortions in women 
L. Panchenko, Y. Grechanina, N. Popova, I .  Torianik, E. Radchenko, Y. 
Karazeev, V. Kazmirchuk 
Kharkov, UKR 
Background HSV is one of the principal causes of structural and functional 
changes in fetal organs which leads to an increase in accidental abortions. 
The establishment of the fact of virus accumulation in fetal organs is an 
important criterion of HSV infection diagnosis verification. 
Objectives: T o  determine the fetal organs in which HSV detection is 
accumulated and the relation between the virus findings in women’s 
placentas in accidental abortions. 
Methods: Immunofermental method for HSV in 9 fetal organs and 6 
placentas taken from women with accidental abortions of 2G28 weeks of 
gestation was used. 
Results: HSV is detected in fetal organs: 
Fetal organs Samples HSV 
Crrebrum brain 8 4 
Lungs 9 4 
Liver 9 7 
Kidneys 8 3 
Placenta h 6 
investigated detected 
In one fetus HSV was detected in all the investigated organs and in 2 
fetuses-in 3 organs. In all the investigated placentas HSV was detected. 
Conclusion: (1) Generalized HSV infection was established in 4 cases where 
in fetal organs viral dissemination was observed; (2) HSV presence in 
placental tissue proves its intrauterine transmission from infected mother to 
fetus ‘in vertical line’ by haematogenous way; (3) the most frequently HSV 
accumulation is revealed in fetal liver. 
Morphological changes in women‘s placenta in herpes 
viral infection 
I. Torianik, L. Panchenko, N. Popova, E. Radchenko, Y. Grechanina 
Kharkov, UKR 
Objectives: Placentas of women in childbirth with clinically established 
heyes simplex virus infection (HSVI). 
Methods: Placental preparations stained with haematoxylin-eosin and 
according to Van Hison were studied by histological method. 
Results: Typical destructive vascular lesions with pronounced disorganiza- 
tion of endothelial wall, signs of stasis and thrombosis in 8 preparation of 
placentas were established in morphological investigations. Si@cant leukocytal 
testified to come of the dlammatory process. In 3 of 8 studied preparations 
numerous focuses of necrosis were seen. In placental emulsions with the help of 
immunofermental method Herpes virus of the 1st type was detected. 
Conclusions: (1) Morphological placental investigation can be used as an 
important complementary diagnostic criterion of HSVI. (2) Histological 
placental changes in HSVI were accompanied by intlamnlatory process 
development (with signs of pronounced leukocytal infiltration); by stasis and 
thrombosis in microcirculatory canal; by sclerosis with posterior necrotic 
changes and small-focal infarction. 
(p7751 CMV infection after allogeneic bone marrow 
transplantation 
K. M. Abdulkadirov, S. I. Moiseev, M. L. Nuyya, V. Tchebotkevich 
St-Petenburg, RUS 
CMV infection is one of serious complications after allogeneic bone 
marrow transplantation (ABMT) which have been manifested as early as late 
period and increase nsk of the mortality. The aim of this study was to 
investigate the frequency and clinical features of CMV infection in ABMT 
recipients and to evaluate the protective effect of CMV hyperimmune 
immunoglobulin Cytotect (Biotest Pharma). From 1990 to 2000 years 24 
patients (pts) with haematological malignancies and severe aplastic anaemia 
received ABMT. Before transplant 23 pts were CMV-seropositive (IgG +, 
IgM-) and one patient was CMV-seronegative. 16 pts (group A) received 
preemptive Cytotect 1 mL/kg i.v. at days-11, + 1, + 11, + 21 and so on 
until day + 101. 8 pts (group B) underwent ABMT without CMV 
prophylaxis by Cytotect. In case CMV disease pts received Cytotect 2 mL/ 
kg twice a week until second negative PCR. The probabilities of CMV 
infection were greater in group B than for group A (5/8 (63%) vs. 5/16 
(31%), P < 0.05). Clinical signs of CMV disease were pneumonitis (40%), 
hepatitis (40%), gastroenteritis (lo%), haemorrhagic cystitis (60%). slow 
engraftment (30%), prolonged thrombocytopenia (40%), encephahtis (10%). 
Deaths pts with CMV disease were sirmlar in the groups A and B: 2/5 (40%) 
and 2/5 (40%) accordingly. 
Conclusions: our study demonstrates that CMV infection may to influence 
on prognosis after allogeneic bone marrow transplantation. Prophylaxis by 
CMV hyperimmune IgG decreased incidents of CMV-infections after 
BMT but not influence on mortality €-om CMV. In the case CMV decease 
the treatment must include combination gancyclovir with Cytotect. 
187761 Varicella: complications in childhood 
A. Schinaki, A. Tsilimigaki, G. Zampetakis, N.  Serafidi, T. Tsekoura, S .  
Stefanaki, G. Vlahaki, V. Agelakou 
Hevaklion, G R  
Introduction: Varicella is a highly infectious disease that may be prevented 
by vaccination. 
Objectives: We describe Vaticella complications that led to hospitalization of 
otherwise healthy children over a period that other countries have already 
begun an immunization program, which prevents or modifies the clinical 
manifestations of the infection. 
Patients and methods: The tiles of 66 chddren with Varicella infection and 
without any underlying illness or Vaticella vaccination were retrospectively 
studied. All cases were hospitalized in our department from January 1990 to 
October 2000. 
Results: Seventy-eight per cent of admissions occurred during winter and 
spring months. Fifty-nine per cent of children were less than 4 years old and 
16% of cases were less than 12 months. Common complications were reported 
in 99.4% of children. Causes for admission were: skin super infections (28.7%), 
lower and upper respiratory tract infections (24%, 22.7%, respectively), 
encephalitis or cerebellar ataxia (7.5%), hepatitis (7.5%), conjunctivitis (3%), 
osteoarthritis (GABHS invasive disease was confirmed) (3%) and thrombo- 
cytopenia-haemorrhagic rash (3%). Fifty-two per cent of children received 
antimicrobial therapy and only 10% acyclovir. AU children recovered 
completely. Average length of hospitalization was 7 days. 
Conclusion: From the results of our study we conclude that a considerate 
number of children stdl need hospitalization following complicated Varirella 
infection. The commonest cause for admission was respiratory infections. 
vl Differential diagnosis of neonatal herpes simprex 
encephalitis and nonaccidental head injury 
J. Kurtz, P. Anslow 
Birmingham, Oxford, UK 
Encephalopathic illness in infants is rarely caused by herpes simplcx and its 
diagnosis may be confused with the more frequently (approx. 20/100 000) 
occumng NAHI. We have reviewed the clinical and diagnostic features of 
41 infants adnutted to hospital between October 1996 and May 1999, 
where the final diagnosis in 13 was HSE, and a suspected NAHI in 28. 
Accurate diagnosis depended on polymerase chain reaction (PCR) analysis 
of the CSF for HSV DNA and magnetic resonance imaging of the brain. 
Neither a history of maternal genital herpes in pregnancy, nor skin lesions in 
the baby were helpll diagnostically. In 12/13 infants with HSE, the PCR 
detected HSV DNA and in 5 of the 6 who had a MRI, this indicated 
cortical haemorrhages, but no subdural blood. The 28 suspected NAHI 
infants also had MRI evidence of similar cortical haemorrhages and, in 
addition, they had varying extents of subdural haematomata, the hallmark of 
NAHI. HSE relapsed in 4/13 infants. Relapsing HSE may mimic recurrent 
encephalopathy caused by multiple NAHIs. To prevent relapses of HSE 
after treatment we suggest infants receive antiviral prophylaxis for 6 months. 
O n  subsequent assessment, 6/13 HSE infants had neurological sequelae, 6 
appeared normal, and one was lost to follow-up. Early clinical features of 
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HSE and NAHI may be indistinguishable. Infants with an unidentdied 
encephalopathic dlness should be examined by M R I  and their CSF tested 
for HSV DNA. 
lp778 Functional characterization of Varicella-Zoster virus 
immediate early 62 protein in a herpes simprex virus transient 
origin-dependent replication assay 
K. Shahzamani, M. Sadeghzadeh, F. Sabahi 
Tehran, IR 
The human herpesvirus Varicella-Zaxter Virus (VZV) is the cause of two 
diseases: Varicella, which results from a primary infection and aster ,  a disease 
caused by reactivated latent virus. Unfortunately, the poor growth 
characteristics of VZV in vitro have severely hindered efforts to study its 
biology. However, the generation of the nucleotide sequence of the 
genome has markedly improved prospects for basic work on VZV, largely in 
the context of its organizational similarities to Herpes Simplex Virus (HSV). 
As a consequence, many of the function of VZV gene products can be 
inferred from their HSV counterparts. Such assumption must, however, be 
guarded, as functional interchange between VZV and HSV proteins appear 
to be limited. Since the HSV genes required for in vitro On-dependent were 
known, we decided to take advantage of this approach to test the abihty of 
VZV DNA replication protein to substitute foe their HSV counterparts, 
both as a way to test the function of the VZV proteins and as a mean of 
comparing the two systems. To  test our system the first product of VZV 
gene that substitute HSV-1 genes product was IE62 protein. In addition to 
significant sequence homology between VZV IE62 and ICP4 of HSV, these 
two proteins have been shown to share many other functional features. 
Recent works reportedly others have demonstrated that HSV-1 mutants 
with deletions in ICP4 could be complemented either by transfected 
plasmids or by functional cell lines whch express VZV IE62. The open 
reading frame for the IE62 protein, transcriptional control of VZV (gene62) 
was separated from its cognate promoter and cloned downstream of the 
strong IE promoter of human cytomegalovirus (HCMV).The functional 
characterization of the protein produced by t h s  plasmid was shown using 
reporter gene Beta-galactosidase (B-gal)and Western blotting. The results of 
substitution experiments showed that VZV gene 62 protein was able to 
support origin-dependent DNA synthesis when it was substituted for ICP4. 
v] Avidity of cytomegalovirus (CMV) IgG antibody in CMV 
infection 
T. Us, Y. Akgiin, L. Ozunel 
Eskisehir, TR 
Human cytomegalovirus (HCMV) is now the most common cause of viral 
intrauterine infection. Present serological methods differentiate poorly between 
acute primary CMV from reinfection (past immunity) and is of particular 
interest in pregnant women. Avidity describes the binding strength of specific 
antibody to antigen. In our study a simple test for &criminating between high 
Ig G avidity index, which are usually present in chronic infections and low Ig G 
avidity index, typical ofprimary infection, was evaluated. Ninety-three subjects’ 
serum samples, positive or equivocal by CMV IgM assays and containing CMV 
I@, were examined for the avidity of CMV IgG. Among 2 serum samples 
showing latent infection (both specific Ig G and IgM positive). The avidity 
index Ig G CMV less than 35% was detined as a positive result. The avidity 
index was > 45% in 97.8% of all patients. The avidity index was < 35% in 
2.2% of all patients. Patients with primary infection exhibited a low avidity of 
CMV specific Ig G. In contrast, all subjects with past immunity had a high 
avidity of CMV IgG. Avidity index Ig G CMV seems to be a good serological 
test to diagnose primary CMV &ease with only one serum. 
\p781\ Is the cytomegalovirus seroepidemiology in Spain 
changing? 
F. de Ory, R. Ramirez, L. Garcia Comas, P. Lebn, M. Femindez, J. C. Sanz 
Majadahonda, Madrid, E 
Objective: To compare the seroprevalence against cytomegalovirus (CMV) 
in women, in two different periods of time (1993 and 1999), in relation to 
the seroprevalence obtained against a virus transmitted by oral-faecal route 
(hepatitis A virus, HAV) and another virus of respiratory transmission 
(varicella zoster virus, VZV). 
Material and method: Were studied a total of 1813 serum samples of 
females aged 2-40 from two Merent  serosurveys representative of the 
general population in the Autonomous Region of Madrid. Of them, 933 
were taken in 1993, and 880 in 1999. CMV-and VZV-specific IgG was 
tested by indirect ELSA (Dade-Behnng, Germany); HAV-IgG was studied 
by I d  (Abbott, USA) in the samples taken in 1993, or by Vidas 
(BioMirieux, France), in those taken in 1999. 
Results: A sigdcant rise in the CMV seroprevalence age related was observed 
in both serosurveys (P  < 0.01). The seroprevalence obtained was lower in all 
age groups in 1999 in relation to 1993. The aerences were statistically 
sigdcant in two age groups: 2-10 years old (52.2% vs. 42.9%. P < 0.01), and 
30-40 years old (90.3% vs. 79.1%. P < 0.01). In the first age group the decline 
to CMV was accompanied by a si@cant decrease in the seroprevalence to 
VZV (74.1% vs. 64.8%, P < 0.01). In the women aged 3 W 0  a significant 
decrease to HAV was also seen (82.2% vs. 57.5%, P < 0.01). 
Conclusions: Two different seroepidemiological patterns against CMV 
seems to coexist. The first one appears in the population aged 3WO and it is 
probably related with the socio-sanitary changes happened in our country 
before 1980, reflected in a decrease in the infections due to oral-faecal 
viruses, as happened with HAV. The second pattern appears in the 
population younger than 10 years, and it seems to be d u e n c e d  by more 
subtle changes, not related with the socio-sanitary development, and 
reflected in the decrease in the seroepidemiology against VZV. 
(p7821 Cytomegalovirus contact rate estimated from 
seroprevalence data 
L. N. B. Almeida, R. S. Azevedo, M. Amaku, E. Massad 
90 Paula, BR 
Objectives: To determine the contact rate b among susceptible and CMV 
infected individuals in order to develop a mathematical model of the 
transmission dynamics of CMV based on seroprevalence data. 
Methods: CMV seroprevalence profile, obtained by a representative urban 
community (City ofcaieiras, SBo Paulo State, Brazil), was used as reference 
to estimate the constant contact rate b, among susceptible and CMV 
infected individuals, as presented in the compartmental model (Figure 1). 
On this chart, M(a) represents the individuals that were born with maternal 
antibodies; S(a), the susceptible; I(a), the infected individuals in incubation 
stage; T(a), the infected individuals who were able to transmitted the virus; 
L(a), the ones who were convalescent and became latent hosts, and finally 
V(a), the vaccinated individuals considered immune to CMV disease. Rates 
were represented by letters where d ,  is the decay of the maternal derived 
antibodies; b, the contact rate between the susceptible and the infected 
individuals; s, the inverse of the incubation time; g, the inverse of the 
recovery time; r, the reactivation rate; v, the vaccination rate and p .  the lost 
of immunity after vaccination. I t  was supposed that the mortality rate was 
compensated by the births, then the population should be in an equilibrium 
state. It was established a stationary system without any dependence of time 
to study the dynamic of transmission and the impact of vaccine strategies 
using a system of differential equations to represent the chart. The 
population migration &om the compartments was represented by the 
following rates: d =  1.5 years-’ (the decay of maternal derived antibodies 
during the first 8 months of age); s = 2 6  years-’ (considering the 2-week 
average period of the disease incubation); g=8 years-’ (considering the 
period of 1.5 months for the convalescence rate); r=0.05 years-’ 
(considering the reactivation dsease rate 1 case every 20 years). Differential 
equation system was solved by computer software SOLVEK, to try to 
represent better the data of the seroprevalence curve. 
Modelling CMV transmission dynamics 
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Results: The b rate among susceptible and infected individuals that better 
represented the seroprevalence curve was situated between 12 and 16 
contacts per year (see Figure). 
So we have opted by b = 14 in our simulations to study the impact of the 
CMV vaccine introduction in this community. 
Conclusion: A b rate of 14 contacts recovers the pattern of seroprevalence 
data for the studied community. 
Viral diseases 
lp7831 Relationship between HHV-6 activation and multiple 
sclerosis disease activity 
S. Chapenko, A. Millers, R. Kukaine, M. Murovska 
Riga,  LET 
Viruses have long been suggested as initiating events or as direct pathogens 
in plaque fomiation in the development of multiple sclerosis (MS). 
However the precise cause of MS remains unknown. The aim of this work 
was to study a relationship between human herpesvirus 6 (HHV-6) 
activation and MS disease activity. 
Patients and methods: 26 patients with clinically defined MS were 
included in d u s  examination. Out of 26 cases 11 were classified as RRMS 
and 15 as SPMS. The RRMS patients were studied in the relapse and 
renltssion phases of the disease, the SPMS patients-in the period of 
intensifying of clinical signs and relative remission. 21 patient with other 
neurological disorders (OND) and 150 blood donors were included as the 
control groups. The diagnosis of MS was based on clinical signs supported 
by finding of deniyelinating lesions (MRI). The concentration of IL-12 
(p70) in serum samples was measured by ELISA. Nested PCK was used to 
detect the latent and active HHV-6 infection. 
Results: H W - 6  DNA in peripheral blood mononuclear cells (PBMC) was 
found in 16 out of 26 (62%) MS patients compared to 28. 6% in OND 
patients (P= 0.039) and 28.7% in blood donors ( P =  0. 0003). To  ascertain 
a possible correlation between HHV-6 activation and disease activity three 
inhces were compared with each other: the presence of virus in plasma, 
data ofMR1 and serum level ofIL-12.7/11 (64%) patients with RRMS had 
HHV-6 sequence in the PBMC DNA. HHV-6 DNA in plasma was found 
in 4 out of 7 RRMS patients and they all were in relapse phase. 9/15 (60%) 
patients with SPMS had HHV-6 sequence in PBMC DNA, however, 
HHV-6 DNA in plasma was determined only in the period of intensifying 
of clinical signs of the disease (4/7). Concentration of IL-12 was 
significantly higher (2.6 times) in sera of the patients with active HHV-6 
infection in relapse of RRMS compared to the patients with latent HHV-6 
infection in relapse phase (P=O. 05). Also the concentration of IL-12 was 
1.8 times higher in sera of patients with actwe HHV-6 infection in the 
period of intensifylng of the clinical signs by SPMS compared to patients 
with latent HHV-6 infection in relative remission (P=0.  001). 
Conclusion: Our findings showed statistically significant prevalence of 
latent HHV-6 infection in MS patients compared to O N D  patients and 
blood donors. The active viral infection correlates with the disease activity: 
relapse by RRMS and period of intensifjmg of clinical signs by SPMS. 
lp784- HPV infection in women under radiotherapy for 
cervical cancer 
S. Szostek, M. Klunek, B. ZawiIinska 
Krakoui, PL 
Objectives: To investigate the prevalence of papillomavirus (HPV) infection 
and to attempt to find correlation between the presence of the virus and effects 
of radiotherapy in two groups of women with cervical cancer. 
Materials and methods: Our studies comprised two groups of patients 
hospitalized in the years: 1989-92 and 1997-98. The first group, including 
39 women (av. age 47) with histologically proven squamous cell 
carcinoma of the cervix in Ib stage (4), IIa (13), IIb (8), IlIb (14). The 
second group of 24 women (av. age 57) was diagnosed in IIa stage (15), 
IIb (7), lIIb (2). All patients were subjected to radical irradiation therapy, 
conducted from external source under megavoltage conditions using 2-or 
4-irradiation fields technique. The dose inside the pelvis minor amounted 
to 50 Gy in 20-24 fractions. Epithelial cell swabs from the cervix were 
collected onto a transport medium. The presence of HPV DNA, in the 
first group, was tested by the hybridization in s i tu method. The biotinilic 
probes containing sequences specific for types HPV 6/11, 16/18, 311331 
35 were used (Vira Type, Digene). In the second group, 9 high and 
moderate oncogenic types (HPV 16, 18, 31, 33, 35, 45, 51, 52, 56) and 5 
with low oncogenic potential (HPV 6, 11, 42, 43, 44) were tested by the 
liquid hybridization method (Hybrid Capture Digene). Results were 
analysed with Log-rang test or x2 test. 
Results: In the first group HPV infection was demonstrated in 61.5% pts. 
The most common was HPV 16/18 type (67%). The actuarial overall 3- 
year survival rates were 65K for HPV(-) pts and 33% for HPV(+) pts, 
respectively (P=O. 16). Actuarial msease free 3-year survivals were 63% for 
HPV(-) pts and 18% for HPV(+) pts (P=O. 0432). This Merence is 
statistically significant. In the second group HPV was detected in 54% pts 
(DNA HPV high 'risk' 91.6%) At least 2-year survival time without 
neoplastic symptoms was observed in 66.6% of HPV infected as well as non 
infected pts. 
Conclusions: (1) No statistically significant differences of prevalence of 
HPV dec t ion  were found in the study groups. (2) The predominance of 
high risk HPV types in cervical cancer was confirmed. (3) The effect of 
HPV infection on survival time of clinically diagnosed cervical cancer pts 
was not clear. 
lp785 Detection and typing of the human papilloma virus DNA 
in cervical cancer by in situ hybridization (ISH) method in Iran 
M. Niakan, Z .  Eftekhar, G. Ahpour 
Tehran, IR 
Background To evaluate the utility of human papdoma virus (HPV) 
detection in identlfying women with abnormal Papanicolaou smear who 
can be safely followed up with cytological study only, we conducted a study 
using the in situ hybridization (ISH) for detection of cervical neoplasia in 
colposcopic biopsy specimens. 
Methods: We enrolled 8000 women who referred to our centre for 
cytological studies for cervical abnormalities. In this study Papanicolaou 
staining, cytological and pathological examination of the samples were 
performed. In adhtion, we used HPV probes (ENZO Diagnostics Inc.) and 
materials for HPV typing test. 
Results: 620 of the 8000 women (7.75%) showed abnormal cytology. 
Pathological examination of the samples resulted in positive cervical cancer 
in 388 patients (4.85%). In 388 cancer patients were positive for CIN 1-111 
and dysplasia, 170 had metaplasia and 50 had SCC. Sixty of the 388 cancer 
patients were further tested by ISH and 42 (70%) of them were positive for 
HPV DNA, Genotype analysis of the HPV DNA positive patients showed 
13 patients to carry 6/11 types, 14 with 16/18 types and 15 women with 
31/33/51 types. 
Conclusion: Human papillonla virus appears to be causally associated with 
cervical cancer. It is believed that HPV typing will play a great role in early 
detection, diagnosis and prevention of cervical cancer in patients. 
/p786( Incidence of the HPV genotype in premalignant (HSIL, 
SCC) disease in Mirza hospital in 1999 by in situ hybridization 
M. Entezar, M. Niakan, Z. Eftekhar, F. Go1 Alipour 
Tehran, IR 
Carcinoma of the cervix is the second most common cancer in women 
worldwide, and the most important risk factor of cancer of cervix is human 
papilloma virus. We decided to study the incidence of HPV in premahgant 
and malignant (HSIL, SCC) diseases of the cervix in Iranians patients and in 
this study, distribution if HPV genotype in patients with SCC and HSIL 
who were referred to Mirza Kochakkan Hospital in 1999. In this 
dissertation from patients who were referred to the Clinic of Gynecology 
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of the same hospital, &om papsmear and &om biopsies, 20 cases of CIN2, 
CIN3, SCC were chosen from abnormal HPV Typing with DNA probe 
kits (ENZO Inc.) HPV (6, l l ) ,  HPV (16, 18), HPV (31, 33, 51) in the 
Shahed university for molecular hybridization method. However, the result 
showed HPV was positive in 90% of patient aged over 45 years, Also in 
women who used OCP all 3 type of HPV had higher incidence. Patient 
who mamed earher (6, 11) bad a higher incidence. Also patients who had 
higher parity type (16, 18) 81 (13, 33, 51) had higher incidence. Patients 
who had higher staging type (16, 18) had a higher incidence. 
lp7871 Enzyme-linked irnmunosorbent assay compared with 
neutralization test for detection of mumps virus IgG antibodies 
R. Edalat, F. Sabahi, M. Roostai, K. Zandi 
Tehran, IR 
Mumps virus is the cause of a contagious disease mostly seen in children and 
young adults. Mumps virus specific IgG protects individuals from 
reinfection. Control of transmission of the disease is considered difficult 
due to broad range of incubation time in various individuals, presence of 
mumps virus in saliva before the appearance of clinical symptoms. 
Vaccination is the best way to control the disease and spread of viral agent. 
Laboratory methods with high sensitivity are needed to determine vaccine 
efficiency and to identify susceptible groups and infected individuals. In this 
research, we used serum neutralization test (SNT) and designed an ELISA to 
determine mumps TgG titres in 400 cord blood samples. Of this 92.7% 
were detected as positive in SNT. Vera cell line was infected with mumps 
virus (Hushino Strain). The cultured virus was then concentrated by 
PEG6000, purified by sucrose gradient and protein concentration was 
determined. The purified virus was coated on the microtitreplates and 
indtrect ELISA was performed. we used SNT as a golden standard to 
determine the efficiency of our designed ELISA method. The results 
demonstrated that the two methods had a good correlation. Sensitivity and 
specificity of our ELISA system was 100% and 97% respectively, and is a 
reliable method to determine mumps virus antibody titre. This system is 
recommended for performing broad epidemiological studies in younger age 
groups in all country. Such approach can help us make appropriate decisions 
for including mumps vaccine along with measles vaccine In national 
vaccination programs. 
lp7881 Genotypic analysis of enterovirus 71 isolated in South 
Korea, 2000 
E.-C. Kim, J.-H. Lee, J.-Y. Hong, Y.-H. Choi 
Seoul, Ch+, KOR 
Objectives: In May 2000, an outbreak of enterovirus infections occurred 
throughout Cheju island, which is located about 100 km off the southem tip 
of the mainland of South Korea and visited by many tourists from Taiwan 
and Japan. During the outbreak, about 300 patients occurred and most of 
them were diagnosed as hand-foot-mouth disease. There were no fatal cases 
during this outbreak. Since 1997, several outbreaks due to enterovirus 71 
(EV71) infection had been reported &om Malaysia, Taiwan, Hong Kong, 
and Japan. In this study, nucleic acid sequences of partial VP1 gene of EV71 
isolated at Cheju island were determined for the companson of genotypes 
with strains of other countries in South-east Asia. 
Methods: For the isolation of virus, specimens were inoculated RD cell 
and Vera cell. The viral RNA was extracted from cell lysates with QIAamp 
Viral KNA kit. After the confirmation of enterovirus by RT-PCR with 
EVl/EV2 primers, RT-PCR was performed with 012/040/011 or 1871 
188/189/222 primers for the sequencing of VI’1 gene according to Oberstes 
method (j Clin Mirrobiol2000; 38: 1170). PCR products were puritied with 
QIAquick Gel Extraction kit and sequenced on an automated DNA 
sequencer with fluorescent dideoxy-chain terminators. 
Results: EV71 was isolated from stool or serum specimen of three patients. 
The partial W 1  nucleic acid sequences of these three isolates (GenBank 
accession numbers: AF276912, AF276913, and AF276914) were 99% 
identical to each other, but distinct from strains of other countries in South- 
east Asia, differing by about 9%. Clinical manifestations of three patients 
were ac follows: (1) 8-month-old boy with chief complaints of fever, cough, 
and diarrhoea (2) 3-year-old-girl with fever, vomiting, and diarrhoea (3) 7- 
year-old boy magnosed as hand-foot-mouth disease. 
Conclusion: EV71 isolates of Cheju island in South Korea may have 
different lineage with strains of other countries in South-east Asia. It may be 
concluded that an outbreak of EV71 mfectlon m Cheju island, 2000 IS not 
anociated with Taiwan outbreak of 1998. 
lp789/ Immunological properties of a synthetic peptide 
mimicking a part of major neutralizing epitope of fusion protein 
of respiratory syncytial virus 
V. 2. Krivitskaya, A. A. Sominina, V. V. Zarubaev, V. 1. Korolkov, G. P. 
Vlasov 
St.-Rtersburg, RUS 
Respiratory syncytial virus (RSV) is the important pathogen responsible for 
lower respiratory tract illnesses in children, elderly, immunocompromised 
adults. The development of an effective vaccine for RSV infection has not 
been realized. One of the approaches in investigation of KSV infecnon and 
development of vaccine is to use the synthetic peptides (SP). SP mimicked a 
part of major neutralization epitope of the RSV fusion protein (F) (residues 
221-232) conjugated with bovine serum albumin (ESA)-or lauric acid 
aldehyde (LA) was used for study of immunological response in rabbits. The 
SP-specific antibodes (Abs), determined by ELISA, appeared 20-30 days 
and 1.5-3 months after injection of BSA-SP and LA-SP, respectively, and 
persisted for next 14-20 months. Virus neutralizing Abs after SP 
immunization were registered much later than after injection of whole 
RSV. Surpnsingly SP-immunization was associated with Abs response to 
normal cells antigens (Ags). It was postulated earlier that Abs formation to 
BSA may reflect a nonspecific defect in immunological tolerance associated 
with a predisposition to autoimmune reaction. Not only BSA-SP but also 
LA-SP-inoculation led to appearance of high levels of Abs to BSA, which 
were determined in blood up to 7-20 months. These data demonstrated that 
SP inoculation misdirect the immune system and lead to immunological 
priming of cross-reactive Abs able to interact with the normal cells Ags. 
According to competitive ELISA date SP had structural homology with 
surface Ags of normal tissue culture cells. One from the immunized rabbits 
with high autoimmune response was kded 2 years after LA-SP injection for 
histopathological investigation. Lung interstitial inflammation (neutrophil 
infiltration), spleen necrosis, destruction of blood cells nuclei in the spleen, 
exhaustion of peripheral lymph nodes were detected. Thus 221-232 amino 
acid neutralizing epitope of RSV F-protein (221-232 amino acid) may 
participate in pathogenesis of RSV infection and have a possible mgger 
function in autoimmunity. 
___ Urinary polyornaviruses excretion in healthy 
individuals 
C. Polo, P. Perez, C. G. Fedele, S. Cardona, A. Mielnichuk, A. Tenorio, J. 
L. Perez 
Hospitalet de Uobvegat, Majadahoizda, E 
Introduction: PV infections are common in humans. Although mostly 
asymptomatic. these viruses are able to cause severe infections in 
immunoconipromised patients. JC virus UCV) is the aetiological agent of 
progressive multifocal leukoencephalopathy. BK virus (BKV) has been 
associated with haemorrhagic cystitis in bone marrow transplant patients, 
and with interstitial nephritis in renal allograft recipients. PV remain latent 
in renal tissue since primary infection. When reactivation occurs, PV are 
excreted in urine. The prevalence of the infection and temporal pattern of 
urine excretion of both viruses in longitudinal studies from healthy people 
are not well known. 
Methods: (1) Samples: a total of 185 urine samples &om 37 healthy 
individuals, 28 adults (aged 25-57 y), and 9 children (aged 3-13 y), were 
obtained. Samples were taken in all persons at base-line, and then after 7 
days and 15 days, 1 month, and 3 months. (2) Virologcal methods: 
detection of both viruses by a multiplex P C R  method Vird Methods 1999; 
82:137-44) after thiocyanate DNA extraction. (3) Definitions: occasional 
excretors [OC (only one positive specimen)]; short-temi excretors [ST (215 
or 3/5 posiuve samples within a 15-day period]; long-term excretors: [LT 
(2/5 or 3/5 positive specimens separated at least 15 day]; continuous 
excretor [C (4 or 5 positive samples)]. 
Results: A total of 23/28 (82.1%) adults and 2/9 (22.2%) children excreted 
PV (at least one positive sample). Thirteen out of 23 adults (56.5%) were 
positive forJCV, 1/23 (4.3%) for BKV, and 9/23 (39.1%) for bath vimses. 
As for children, 1 was positive for BKV, and other for both JCV and BKV. 
Overall, 17, 7, and 1 out of 25 were C,  LT, and O C  PV excretors, 
respectively. When considered separately 17, 5, and 1 were C,  LT and OC 
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JCV excretors; the 12 individuals excreting BKV were 5 OC, 6 LT, and 1 
C. Results after 6 months follow-up d be presented. 
Conclusions: (1) PV excretion is very frequent in healthy adult 
population, but not in children; (2) JCV is the most frequent PV excreted 
in urine, but detection ofboth viruses altogether is relatively common; (3) 
most people infected with JCV are long-term excretors; BKV excretion is 
mainly occasional. 
vl Comparison of DNA extraction methods for PCR 
detection of polyomaviruses in urine samples 
J. L. Pkez, C. Polo, P. Pkez, A. Mielnichuk, R. Martin 
Hospiraler de Llobrexat, E 
Introduction: Human PV [BK virus (BKV) and JC virus flCV)] remain 
latent in renal tissue since primary infection, but they are excreted in urine 
during reactivation. Because urine is a easrly obtained and more convement 
clinical sample, excretion in this body fluid can be used as a virological marker 
for PV-associated diseases, such as haemorrhagic cystitis and intersatid 
nephritis. The presence of PV in urine samples is commonly determined by 
PCR. However, urine samples might contain PCR inhibitory substances, so 
the most convenient DNA extraction method should be determjned. 
Polyethyleneglycol (PEG) and guanidinium thyocyanate (GTH) have been 
used for nucleic acid extraction from urine samples. 
Methods: (1) Samples: 235 urine samples were obtained from 37 healthy 
people, 30 pregnant woman, 42 HIV positive patients and 35 bone marrow 
recipients (22 adults and 13 children), at different times. Specimens fi-om 
healthy indwiduals were obtained at different intervals, then more than one 
specimens was taken (total, 129 urine samples. (2) Virological methods: 
PCR detection of PV was carried out by a multiplex method (J H r o l  
Methods 1999; 82: 137-144) after extraction with GTH u Virol Methods 
1995; 53: 25-36) or PEG cf  Virol Mefhods 1997; 67: 61-66). 
Results: A total of 1431235 (60.8%) specimens tested positive by PCR. 
Coincident results between PEG and GTH occur in 141 instances (60.0%). 
In contrast, 94 samples (65.7% of the positive specimens) gave discrepant 
results: 82 samples were negative after PEG extraction but positive by the 
GTH method. Conversely, 12 tested positive by PEG extraction but were 
negative afier GTH. Differences were statistically significant (McNemar 
test, P < 0.001). A similar trend was observed when considering BKV and 
JCV separately ( P  < 0.001 in both cases). 
Conclusions: (1) PV sequences are easily and frequently detected in urine 
specimens. (2) the guanidiniun thiocyanate-based procedure, although more 
labour-intensive, is overtly more sensitive than the PEG extraction method. 
vl Evaluation of different continuous cell lines in the 
isolation of mumps virus by the shell vial method from clinical 
samples 
J .  Reina, F. Ballesteros, A. Ramirez, X. Mesquida, M. Galmes 
Palm0 de Mallorca, E 
Objectives: To prospectively compare the efficacy of the Vero, LLC- 
MK2. MDCK, Hep-2 and MRC-5 cell lines by the shell-vial method in the 
isolation of the mumps virus from 48 samples (41 saliva swab and 7 CSF). 
Methods: Two vials of the cell lines were inoculated with 0.2 mL of the 
samples. The vials were incubated at 36OC for 2 and 5 days. The vials were 
then fixed with acetone and stained by a monoclonal antibody against 
mumps virus by an indirect immunofluorescence assay. 
Results: The mumps virus was isolated in 36 (75%) samples: 35 (85%) saliva 
swab and 1 (14%) CSF. The Vero and LLC-MK2 displayed 100% 
qualitative sensitivity (detected all positive samples), 77.7% the MDCK, 44. 
4% the M R C d  and 22.2% the Hep-2 lines. The Vero and LLC-MK2 lines 
showed a statistically significant difference with respect to the other cell lines 
( P  < 0.001). Sensitivity for the Vero and LLC-MK2 lines at 2 and 5 days of 
incubation was identical (100%). The values obtained in the study of the 
quantitative sensitivity (detection of > 5 infectious focci in all the 
nionolayer in positive samples) were 94.4% for the Vero, 97. 2% for the 
LLC-MK2. 5.5% for the MDCK, 5.5% for the Hep-2 and 0% for the 
MKC-5 cell h e .  The Vero and LLC-MK2 lines showed statistically 
significant differences w t h  respect to the rest (P < 0,001). 
Conclusions: It seems that for the isolation of the mumps virus from 
clinical samples the Vero and LLC-MK2 cell lines are equally efficient at 2 
and 5 days' incubation, and the use of the shell vial method shortens 
considerably the time of aetiological diagnosis with the hgher specificity. 
/p7931 Anti-HTLV 1/11 seroprevalance in healthy Turkish blood 
donors and lymphoma patients in Izmir, Turkey 
R. Yazan Sertoz, S .  Erensoy, M. Tobu, H. Ozcam, M. Tasbakan, A. Bilgic 
Izmir, TR 
Human T-cell lymphotropic virus type I (HTLV-I) is the first human 
retrovirus to be associated with malignant disease-namely, adult T-cell 
leukaemia/lymphoma. HTLV-I has also been associated with several 
dueases. HTLV-I has a worldwide distribution with major endemic foci 
in the Caribbean and Southern Japan. HTLV-I1 is a closely related 
retrovirus that shares considerable genomic homology with HTLV-I but has 
not been proven to be a pathogen. Major routes of transmission are blood 
transfusion, breast milk and sexual activity. In this study, we examined the 
seroprevalance of HTLV 1/11 among healthy blood donors and lymphoma 
patients attended to Ege University Hospital in Izmir. Nine hundred and 13 
healthy blood donors and 81 lymphoma patients were examined for the 
presence of anti-HTLV 1/11 antibody in their sera. Serum specimens were 
tested with an enzyme immunoassay (EIA) (Organon Tekiiika, Vironostika 
HTLV 1/11 Microelisa System, Holland). All of the 913 healthy blood 
donors and 81 lymphoma patients were seronegative wlth EIA. These 
findings indicate that HTLV 1/11 is not endemic human retrovinrs in Izmir. 
Screening of blood donors for HTLV 1/11 is not necessary at present time. 
v/ Prenatal diagnosis and therapy of maternal fetal 
infection 
E. Grechanina, L. Panchenko, S .  Biriukova, L. Zub, B. Grechanin 
Kharkov, UKR 
Background: Maternal fetal infection (MFI) acquires especial clinical 
significance as ir leads to intrauterine fetal injuries, to postnatal complica- 
tions in mothers. 
Objective: T o  determine the possibility of early prenatal diagnosis and 
adequate therapy. 
Methods: For MFI detection, prenatal somatogenetic investigation, 
bactenological, virological methods and PCR were used. 
Results: MFI was revealed in 38, 3% of pregnancies examined in 1999 in 
connection with reproductive losses. Combined infection was detected in 
50% of fandies; HSV, in 17.1% chlamydia infection, in 7.2%. toxoplas- 
mosis, in 4.5%, rubella, in 2.3%, cytomegalovirus in 30.6'36, bacteria were 
seen in 64.3% of families. Criteria of ultrasound differential diagnosis of 
viral, bacterial and mycoplasmatic infection were camed out. Original 
methods of treatment with the accent on immunological correction and 
natural preparations were tested. The deliveries were conducted in Clinical 
Maternity Hospital of the Center. 
Conclusions: Prenatal MFI is possible in the 1st term of the pregnancy. The 
elaborated system of diagnosis and treatment proved to be effective. Normal 
deliveriff resulted in 62.3% of cases; premature deliveries were observed in 
22.5% (some of them were induced); 15.2% of fetuses died intrauterinely. 
p%( Clinical and virological characteristics of respiratory 
infections caused by enterovirus in paediatric patients 
J. Reina, F. Ballesteros, M. Galmes, X. Mesquida 
Palma de Mallorca, E 
Objectives: To report a prospective study about the clinical and virologcal 
characteristics of paediatric patients with the isolation of enterovirus in 
respiratory (nasophaxyngeal) samples. 
Methods: In the period 1997-99 we studied 740 respiratory samples 
(Respiratory Syncytial Virus-negative; EIA dot-blot). The samples were 
inoculated in a vial of the MRC-5, Hep-2, MDCK and LLC-MK2 cell 
lines (vircell, Granada) and processed by the shell-vial method. After 3 days 
of incubation the monolayers were stained by monoclonal antibodies against 
different respiratory viruses. For enteroviruses we used the 5-D8/1 clone 
and an indirect immunofluorescence assay. 
Results: The enterovims were isolated in 30 (4%) patients but only 10 of 
them (1.3%) have really a respiratory tract infection. The other 20 patients 
have clinical manifestations considered as complications postvaccination and 
were caused by the poliovirus vaccine. The respiratory pathologies 
associated to enterovirus nonpoliovirus were bronchiolitis (80%), bronch- 
opneumoniae (10%) and chronic pharyngitis (10%). 60% of patients with 
bronchiolitis have an age less than 3 months. The isolated enterovirus were 
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identified as Echovirus in eight cases and in two cases as nontypable (20%). 
Conclusions: The enterovirus could be responsible of the respiratory tract 
infections detected in patients less than 3 months of age with a clinical 
syndrome ofbronchiolitis similar to the caused by the RSV. It could be very 
recommendable to study the presence of enterovirus in the respiratory tract 
all the months of the year to know the real significance of these viruses in 
this clinical pathology. 
/p7961 Investigation of arbovirus infection in Cukurova, Turkey 
N. Saltoglu, S. Inal, Y. Tasova, T. Seki, I. Diindar 
Adana, 7R 
Objective: To investigate arbovirus infection who have fever, headache, 
fatigue, and myalgia-artralgia, with 500 patients followed in our clinic 
between 1998 and 2000. 
Methods: We took the acute and convalescence period blood specimen 
from 40 patients who are chosen by random and from 20 who make the 
control group. Count blood cell (CBC), asparate amino transferase (AST), 
alanine aminotransferase (ALT), lactic dehydrogenase (LDH), creatinine 
phosphokinase (CPK) level, brucella standard tube agg test (STA), g. widal 
agg. test and the bacterial cultures are requested from all patients. All these 
patients and control group’s blood specimens are preserved at -40°C and 
they are tested at CDC Division of Vector-Borne Infectious Diseases 
National Arbovirus Research Center. In these specimens are searched IgM 
and IgG antibodies to Chikugunya, Sindbis, dengue-2, tick-borne 
encephahtis, West-Nile virus and Snowshoe virus. 
Results: AU of the patients have the symptoms of fever more than 38”C, 
fatigue and headache, 35 patients have myalgia, 26 patients have artralgia, 9 
patients have sore throat and 7 patients have nausea. In physical examination 
we also determined conjunctival hyperaenlia in 10 patients, hepatomegalus 
in 7 patients. AU patients have the results as WBC < 4000/mm3, 38 patients 
have lymphocytosis, platelets < 150 OOO/mm3,  38 patients have AST, ALT 
> 45 U, 25 patients have increase in LDH and 20 patients have increase in 
CPK. None of them has any positive bacterial culture and positive gruber 
widal agg. test and STA. Also there are no positive IgM and IgG antibodes 
to these arbovirus. As a result, the epidemics in our province are not 
associated with any of these arboviruses. 
vl The viral infections in exacerbation of COPD 
2. Goseva, M. Dimitrovski, A. Gjorcev, K. Bozinovska 
Skopje, MAK 
The role of viral infections in the pathogenesis of chronic obstructive 
pulmonary disease (COPD) is very important in some investigations. In 
some studies it has been found that the infections plays a role in at least 
several exacerbations of COPD ( 1 4 )  during the year. In this study we have 
examined the role of respiratory viral infection in the exacerbation of 
COPD. We have studied 32 patients with chronic obstructive pulmonary 
disease. They were clinically diagnosed, we have made symptom score, gas- 
analyses and functional measurements were made before and after the 
treatment. Most of our patients had one or more symptoms of a viral 
infection such as fever, rhinorrhoea, headache, or myalgia. In the same time 
most of the patients had moderate to severe obstruction. The blood samples 
for virus serology were taken the first day and two weeks later. The positive 
isolates were found in 14 patients (44%): irlfluenza 7 (22%), Mycoplama 
pneumoriiae 4 (12%), RSV (resp. sic. vir.) 2 (6%) and Coxiella b. in one 
patient. Two weeks later positive viral detection were found in 10 patients 
(32%). We suggest that respiratory viral infections are connected with the 
worsening of symptoms in the exacerbation of COPD. The relation 
between viral infection and COPD remains open and important. 
(p7981 Influenza virus detection in pleuritic and pericardial 
fluid of two patients after influenza vaccination 
G. Vrioni, 1. Poumou, N.-I. Legakis, P. Matsiota-Bernard 
Athens, GR 
Influenza virus infections of the respiratory tract have significant morbidity 
and mortahty. Influenza is an acute, usually self-limited, febrile illness of 
global importance. It can have serious pulmonay, cardiac and neurological 
complications. It has also been associated wlth toxic shock syndrome, 
myositis, myoglobinuria and renal failure. We report the detection of 
influenza virus A in the pleuritic fluid of two patients. In one of them 
influenza virus A was also demonstrated in a pericardial effusion. These 
patients have vaccinated for mfluenza, and one of them, two times. The 
pleural and pericardic fluid &om these patients were tested for influenza A 
and B viruses, parainfluenza type 1, 2 and 3 viruses, respiratory syncyntial 
virus and adenoviruses with Multiplex Reverse Transcription Polymerase 
Chain Reaction molecular method (Multiplex RT-PCR), and they were 
found positive for influenza A virus after hybridization. An increased 
awareness of influenza A and B viruses vaccination as causes of viral pleuritis 
and pericarditis is necessary, and studies to determine the relation between 
vaccination and complications should be undertaken. This report of 
pericarditis and pleuritis after influenza vaccination illustrates the need for 
increased awareness of influenza vaccination and suggests that PCR in 
pleural and pericardial fluids may be a useful tool for diagnosing hture  cases. 
vl Biological and antigenic characteristics of influenza 
viruses type a isolated in Varna city during 1990-99 
V. Russev 
Varna, BG 
Characteristic and unique feature of influenza virus type A is the 
comparative instability of its antigenic structure. Fifteen isolated strains 
influenza of type A viruses were examined for their antigenic structure and 
some of their biological properties. Immunological monitoring was 
accomplished by the following tests: macrophagal, eosinophilic and enzyme 
activity, lysosyme in the serum, index Th/Ts and monocytic rosette for Fc- 
and C3. Fifteen haemagglutinative viral agents have been isolated by using a 
model of chicken embryos during the epidemic waves of influenza in the 
period 1990-99. The following biological features of 10 of all isolated 
viruses have been studied: ability to be isolated on chicken embryo models, 
haemagglutinative, eluative, inhibitorsensitive, toxic and immunogenic 
ability, as well as thermostability of haemagglutinin and neuraminidase, and 
also antigenic structure. The results show that the influenza virus strains 
&om the period 1990-96 have been isolated only after the second-third 
passage with haemagglutination titre 1: 32-1: 64, whereas in the years 
1997-99 they have been adapted and isolated after the first-second passage 
with a haemagglutination titre 1: 128-1: 256. The study of haemagglutinin 
thermostability of isolated epidemic influenza virus strains has shown 
definite tendency towards an increase at 56°C. The investigated isolates 
influenza viruses demonstrated both, high and low inhibitor sensitiveness. 
The studied viruses were intoxic or with slightly expressed toxic features on 
experimental mice after intranasal and intraperitoneal infection. The 
antigenic profile data of the second supercapsid component (neuraminidase) 
of the influenza virus has shown an association to N2, when tested by 
reaction delayed neuraminidase activity. When studying the inhibitory 
neuraminidase activity of EDTA on reduced glutation, L-cysteine and Zn 
’+ ions in highest grade EDTA inhibited the studied viral enzyme (60.2%) 
and in lowest grade Zn” ions (43.1%). Immunological monitoring has 
shown that immunological results had peak most frequently after 72 h and 
less 6equently after 48 h. After the tenth day, which probably was the 
border, the restoring of immunological results followed. These studies show 
good opportunity for analysing the periodic of the disease and predicting of 
the phases of exacerbation, remissions and reconvalescence. The studies 
showed continuing active circulation of influenza type A viruses with 
formula H3N2, antigenically similar to standard strains A/Sychuan/12/87. 
A/Shanghay/l1/87, A/Washington/15/91, A/Beijing/32/92, A/Johanes- 
burg/33/94, A/Uhan/359/95 and A/Sydney/5/97 with the respective 
biological properties. 
Ip8001 Transient and mild influenza A-associated encephalitis 
in children 
Y. C. Huang 
Kweirhan, Taoyuan, ROC 
Background Acute encephalitis or encephalopathy is known as a rare 
complication of influenza infection and most reported cases are severe, not 
idequently with neurological sequelae. Recently, we documented five cases 
of mild, transient influenza A-associated encephalitis during a 1-month period. 
Patients: Within 3 days of the onset of a influenza-like dltiess, five children, 
aged 3-6 years, developed visual hallucination and inappropriate behaviour 
and were admitted to our hospital in January 2000. Vomiting, ataxla and 
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auditory hallucination were also noted in 4, 2 and 1 cases, respectively. All 5 
cases were fully conscious and communicative on examination. Cere- 
brospinal fluid was sampled in 3 children, all showing negative findings. 
Computed tomography scan of the brain was performed in 2 cases, also 
showing negative. Elevated serum transaminase was noted in 1 case. EEG 
showed a generalized slow wave in all 5 cases, indicating mffuse cortical 
dysfunction. W i t h  5 days, all 5 children recovered uneventfully. 
Virologic study: In5uenza A virus was isolated from the throat swab in 4 
cases and identified as influenza A/New Caledonia/20/99 (HlNl) -like and 
influenza A/Beijing/262/95 (H1 N1) -like in 2 strains, respectively. 
Serological evidence of influenza A viral infection (paired serum, 
complement fixation) was documented in all 5 cases. Serologic studies 
were negative for acute infection of Epstein-Barr virus, herpes sitnplex virus 
and Mycoplasnia pneumoniae. 
Conclusion: We recognized 5 children with a transient and n d d  influenza 
A virus-associated encephalitis, which might be neglected by both the 
physicians and parents. Influenza A virus-aysociated encephalitis may be 
more conmion than previously recognized. 
Ip801 Typical and atypical parvovirus B19 infection in adults: 
report of three cases 
L. Calza, R. Manfredi, F. Chiodo 
Bolopa, I 
Introduction: Human Parvovirus I319 (B19) is associated with a number of 
cli~ucal manifestations, which are usually benign in healthy persons. B19 
generally leads to erythema infectiosum or fifth disease in children, or 
several kinds of febrile skin rash accompanied by arthropathy and moderate 
anaemia in adults, but B19 infection can also prove asymptomatic in about 
20% of cases. On the other hand, B19 may be responsible for transient 
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aplastic crisis in patients with chronic haemolytic disorders, or severe 
persistent anaemia in immunocompromised hosts; during pregnancy, B19 
can induce hydrops fetalis and fetal death. 
Case reports: Three female patients aged 35-39 years with acute B19 
infection are described: 2 patients also suffered from beta-thalassaemia minor 
and sideropenic anaemia, and presented a concurrent chronic moderate 
anaemia. Clinical presentation included rash, middle grade continuous 
fever, asthenia and arthropathy in all reported patients. Rash showed a great 
variability, with erythematous, maculo-papular or purpunc lesions invol- 
ving hands, feet and abdomen, pruriginous in 2 patients; arthralgias were 
diffuse and involved mostly wrists, knees and ankles. Fever and rash 
improved withm 5-10 days, but asthenia and arthropathy persisted for 3-6 
weeks. Laboratory tests showed a nuddle grade anaemia in all patients 
(haemoglobin levels ranged from 9.6 to 12.3 g/dL), and was more severe in 
women with beta-thalassaemia. One patient presented a highly pruriginous, 
symmetric swelling and erythema of both hands and feet, followed by 
purpuric lesions involving dorsal and palmar surfaces of the distal 
extremities; subsequently, she developed an enantheni charactenzed by a 
painful hyperaemia of oral mucosa, with petechial lesions involving the soft 
palate; signs and symptoms disappeared after 10 days. This atypical 
manifestation of B19 infection is reported as ‘papular-pulpuric gloves and 
socks syndrome’ (PPGSS): to date, only 25 cases of this syndrome were 
described, and other aetiological agents implicated besides B1 9 (Cytome- 
galovirus, Coxsackievirus B6, and Measles). In our series, acute B19 
infection was documented by a concurrently positive IgM serology (by 
enzyme immunoassay), and serum B19 DNA search (by polymerase chain 
reaction); IgM reactivity disappeared within 12-1 6 weeks. 
Conclusion: €319 usually causes typical manifestations in adults (including 
fever, rash and arthropathy), but can also lead to asymptomatic or atypical 
infection (such as the PPGSS), described in one patient of ours. 
1-02 I Increasing consumption of /actobaci//us GG as a 
probiotic and the incidence of lactobacilli bacteraemia in Finland 
M. K. Salninen, A. J M e n ,  M. Saxelin, S .  Tynkkynen, H. Rauteh, V. Valtonen 
Helsiuki, FIN 
Objective: To evaluate the influence of the increased Consumption of a 
specific probiotic, Lactobacillus rhamnosus GG (ATCC 53103) (LGG), on the 
incidence of Lactobacillus bacteraemia in Finland. 
Background and methods: Lactobacilli are considered nonpathogenic. 
They are found in the mucosal sudaces of gastrointestinal and urogenital 
tracts and are only seldom detected in blood cultures with incidence of 0.1- 
0.3%. Predisposing factors to Lactobadus bacteraemia have become more 
usual when broad spectrum antibiotics are widely used to older, severely ill 
patients suffering from mahgnant o r  senous underlying diseases. Consump- 
tion of so-caiied functional foods, including probiotics, has increased 
rapidly. LGG ongnates from human intestine and is adhesive on intestinal 
mucosa. LGG dairy products were launched in 1990 and until 2000 the 
consumption rose to 6 L per capita per year in Finland. 
National Public Health Institute (NPHI) of Finland (population of 5 
million) has registered bloodstream infections since late 1994. Between 1990 
and 1994 lactobacilli in blood cultures have been collected from southern 
Finland (population of 1.3 million) at the Department of Bacteriology, 
University of Helsinki. 
Results: During years 199G94 there were in total 14 lactobacillaeinias 
reported in southern Finland. L. rkamnosus was found in three cases in 1990 
and one in 1992 and 1994, respectively. In total 75 Larto6acillits bacteraemias 
were reported to NPHI between October 1994 and 1999. Since 1990 in 
total 17 isolates of L. r/iammrus have been charactenzed and five of them 
were genetically indistinguishable from the commercial strain, L. rhamnosus 
GG, used in  probiotic products. The yearly L. rhamnosus findings vaned 
from 2 to 4 in 1995-98 but only one 1999. Annual number of LGG isolates 
was 0-1 since 1990, except 1996 when two isolates were found. The 
incidence of lactobacillaemia varied 0. 16-0. 38/100 000 people with no 
increase during years 1995-99. Lactobacilli formed in an average 0. 24% of 
all to NPHI reported blood culture findings 1995-99. 
Conclusions: A slight elevation in the total number of reported Lactobacillus 
findings in blood cultures was observed during the studied period. 
However, when these findings were related to population or to the 
number of all blood culture isolates no significant increase in the incidence 
could be detected. Furthermore, despite the concurrent increase in 
consumption of LGG products there was no rise in the incidence of L. 
rhamnosus bacteraemias. These data support the evidence of low clinical 
virulence of lactobacilli and L. rhamrrosus GG in special. 
(p8031 Isolation of Leuconostoc and Lactococcus spp. from 
renal dialysis patients in Kuwait 
P. W. J. West, M. Johny, I. Al-Obaid 
Suleibikkat, K W  
Objectives: During the last two years we recovered seven isolates 
resembling streptococci fiom the blood or peritoneal dialysis 5uid of six 
nephrology patients. Four of the isolates were identified as Leuconostoc spp. 
and three as Lactococcus spp. We report the biochemical characteristics and 
antinucrobial susceptibilities of these isolates. W e  also compared them with 
strains recovered from unpasteurized cheese samples. 
Methods: Isolates were identified using the API 20 Strep and the methods 
of Facklam and Elliot (Clin Microbial Rev 1995; 8: 479). Antimicrobial 
susceptibility testing was carried out by disc diffusion on Mueller Hinton 
agar with 5% lysed horse blood, using Streptococcus prieumoniae criteria. 
Results: The patients were aged &om 19 to 73 years. AU the isolates were 
Gram positive, catalase negative cocci with a tendency to elongate. Haeinolysis 
was vatiable, most isolates were nonhaemolyhc. One L?rtucocnrs isolate was 
initially recorded as beta haemolytic. Biochemical patterns 111 the API were 
diverse and some isolates gave profles which offered Lartocucclrs, Leucoriostoc or 
Aerococcus uiridans as altemahves. Aerococtns was excluded by cell morphology. 
One patient isolate was reported as htococms based on vanconiycin 
susceptibility, although the AF’I profile gave a higher probability for Leucottostor, 
whereas a vancomycin resistant isolate reported as Leuconostoc, gave a higher 
probability for fncfococrw. Results for some tests, notably Voges-Proskauer and 
24 h carbohydrate fermentation, sometimes varied on retesting. The two 
clinical isolates of h t o c o u u s  &om dialysis fluid were penicillin and oxacillin 
resistant and one was also resistant to eythromycin. Cheese samples yielded high 
counts of bacteria including Lactococcus and Leuronostoc spp, 
Clinical Microbiology and Infection, Volume 7, Supplement 1, 2001 153 
Discussion: The origin and significance of the clinical isolates was not 
established. However the studies on the unpasteurized cheese, which is very 
popular in Kuwait, suggect that the patients may have been exposed to large 
numbers of these organisms, which may have been on the skin or in the 
mouth and gastrointestinal tract. 
Conclusion: Lacforocrur and Leucoriortoc spp. may be pathogem in severely 
debhtated pahents, such as renal dialysis cases. Differentiation between these 
and other genera of catalase negative, Gram positive cocci, requires 
examination of microscopic appearance, biochemical testing and vancomycin 
susceptibility testing. These genera are common in unpasteurized cheese. 
[p804 Fever of unknown origin: a review of 130 patients 
A. Mert, A. Celik, R. Ozaras, F. Tabak, R. Ozturk, Y. Aktuglu 
Istanbul, TR 
Fever of unknown origin (FUO) provides a diagnostic challenge for the 
clinician. Its aetiology may changes according to geography, but infectious 
diseases seem to he the leading lagnostic category all over the world. We 
reviewed 130 cases admitted to our unit between 1984-2000. The criteria 
ofpetersdorfand Beeson (Medicine 1961; 40: 1-30) were used for definition: 
temperature of > 38. 3°C for at least 3 weeks and fdure of diagnosis after 1 
week of investigation, usually in the hospital. 56 were male, and 74 were 
female (median age 36, range: 14-75). The diagnostic categories and leading 
diseases are as follows: I. Infectious diseases, n=51 (miliary TB, n =  18; 
primary TB, n=6) ,  11. Neoplasms, n=28 (lymphomas, n =  15), 111. 
Collagen vascular diseases, n=32 (Still‘s disease, n =  15; temporal arteritis, 
11 = 6; SLE, t? = 5), IV. Miscellaneous, n = 12 (subacute thyroiditis, IZ = 5), V. 
Undiagnosed, n = 7. Infectious diseases are the leading diagnostic category 
of FUO in Turkey. In decreasing order, miliary TB, lymphomas, Still’s 
disease, primary TB, temporal arteritis, SLE, and subacute thyroiditis are the 
main diseases that cause FUO. 
vl Early hospital mortality due to infectious diseases 
J. R. Blanco, J. D. Mosquera, I. Bergua, A. Molina, L. Echevema, 
M. Zabalza, E. Perez 
Lqro,io, E 
Aim: To know the causes of EHM (first 48 h) due to infectious diseases in 
our Hospital. Because few data are available about EHM we analysed it in 
our Hospital. 
Patients and methods: We reviewed the medical records coded by the 
ICD-9-CM of all patients that suffered from EHM due to infectious diseases 
during the period 1992-99. All death were directly caused by infection. Patients 
readmitted to the hospital because of n o s o c o d  lnfections were excluded. 
Results: Of the 170 667 admitted patients during the period analysed, 1185 
died of EHM (0.7%). Of these, 82 died due to infectious diseases (6.9%). 
Median age was 73.2 years (range, 7-96), 46 (56.1%) were men. Index of 
comorbidity was less than 1 in 45.1%; and there was less than 1 predisposing 
factor in 84.1%. Causes of death were respiratory (76.8%; pneumonia 
58.5%) followed by urinary (6.1%), abdomnal (4.9%), neurological (4.9%) 
and others (1.2%). There was not a clear aetiology In 6. 1%. Pneumonia was 
more frequent among aged 65 years and older (P’ 0.03). Fever was present 
in 43.9%. The severity of sepsis were 60.9% sepsis, 24.4% severe sepsis, 
13.4% septic shock and 1.2% multiorgan failure. In 69.5% no diagnostic 
procedure was performed, mainly among aged 65 years and older (P= 0.03). 
In 85.4% the casual agent was unidentified, hut gram positive was the most 
Gequent microorganism isolated. 
Conclusions: Infections are an important cause of EHM, and conununity- 
acquired respiratory tract infection (mainly pneumonia) the most fiequent 
cause of EHM. Among aged 65 years and older, pneumonia was the main 
aetiology, an diagnostic procedures were rarely employed. Sepsis was the 
most important clinical finding at admission. When a microorganism was 
identified, Gram positive was the main causal agent. 
JP806/ Extreme granulocytic leukocytosis and infectious diseases 
M. Zabalza, J. R. Blanco, A. Arizti, A. Garcia, J. Salcedo, E. Perez, A. Polo 
Logrolio, E 
Objective: To know whether degree of extreme granulocytic leukocytosis 
(EGL) (> 20 000 leukocytes/mL with more than 50% granulocytes) could 
be used to predict infection aetiology. 
Patients and methods: Analysis of 110 consecutive patients diagnosed of 
EGL adnutted to our hospital. EGL was attributed to infection when there 
was a positive culture &om a normally stenle body site and/or iniprovenient 
in the clinical condition and resolution of EGL in response to antimicrobial 
therapy. Patients previously diagnosed of malignancies, haenlatological 
disorders, surgery and EGL due to drugs known to cause leukocytosis were 
excluded. A statistical analysis was performed. 
Results: O f  110 patients, 71 were men (64.5%). Infection was present in 75 
patients (68.2%); 47 men (62.6%). Variables associated to inlection were 
left-shift (54.7%; P=O.O02) and fever (68% P < 0.0001). Among infection, 
pneumonia (37.3%), bronchitis (24%) and sepsis (13.3%) were the most 
important causes. We did not find any statistical apsociation when we 
analysed age, leukocytes, granulocytes, lymphocytes counts or ratio 
lymphocytes/granulocytes. 
Conclusions: EGL is associated with infection in 68.2% of cases. Patients 
with EGL, fever and left-shft, have a great risk of infectious diseases, so 
empirical treatment should be necessary. 
/p8071 Human leptospirosis associated with ingestion of 
Agouti paca in South America 
M. Silverman, L. Aronson, M. Eccles, J .  Eisenstat, D. Nauth-Misir, M 
Segal, R. Rowsell, D. Scolnik 
Toronto, Oshaiua, CDN 
Background: Agouti paca (AP), a large rodent common throughout 
CentralISouth America, is a major dietary protein source whose ingestion 
has not been reported a risk factor for Leptospirosis. 
Methods: Men reporting fever and recent AP ingestion at a free clinic in 
the Guyanese rain forest over 2 weeks in February 2000, were screened for 
malaria using thick and thm Giemsa stained smears, and Leptospirosis using 
the INDX Leptospira Dip-s-ticks kit. This is an IgM specific qualitative 
enzyme-linked imniunoassay (EIA) for detection of antibodies to L. bij7exa. 
Positive specimens were confirmed by a microscopic agglutination test. 
Patients were treated according to clinicians’ best judgement after hrtory 
and examination, since serological results were not immediately available. 
Results: Leptospirosis was twice as common as malaria in this highly 
malarious area: 6/18 (33%) evaluable patients had serology compatible with 
acute leptospirosis ( k 2  as per manufacturer) vs. 3/19 (16%) with nialaria (1 
patient’s lipaemic serum was unsuitable for serological testing). A clinical 
decision model enabling prediction of serological results without costly 
testing, suggests that all febrile patients with recent AP ingestion should have 
malaria smears with treatment if positive; if smears are negative and the 
patient has no previous history of malaria, skin rash, lymphadenopathy or 
abnormal urine sediment, then the patient should be treated for 
Leptospirosis. Ths leads to 83% sensitivity and 100% specificity for 
Leptospirosis, a significant improvement over initial clinician performance. 
Conclusion: Leptospirosis is a significant health problem among AP eaters 
in South America. A simple clinical algorithm can be used to guide diagnosis 
and treatment 
1 P808 I Clinical profile of snakebite patients admitted at RITM 
July 1995 - July 2000 
J .  R. Sugiarto, G. C.  Lucero, E. B. Cendana, G. G. Bibera, M. L. Chua 
Metro Mattila, PI 
This is a retrospective descriptive study aiming to increase the awareness 
regarding the morbidity of snakebite victinic based on its clinical 
manifestation, and complications by presenting a clinical profile of snakebite 
patients admitted in RITM from July 1995 to July 2000. Results showed 79 
snakebite patients were admitted at RITM: 97.5% were discharged 
improved, 2.5% died. Majority were male (83.5%), came from Calabarzon 
(Laguna 20.394, Cavite 17.7%, Batangas 13.9%), rice farmers except for 6 
students and 1 preschooler. Locations of bite were mostly on the foot, 
occumng mostly at day time, and usually unprovoked. Majority of patients 
seen at the emergency room had Level I1 Envenomation (59.5%) with ptosn 
(48%), and blumng of vision (26.6%) as the most common signs of 
neurotoxicity. One patient presented with ptosis accompanied by bleeding. 
First aid measures done prior to consult at RITM were tomiquet (31.6%), 
incision and suction (16.5%)). 38% were initially brought to nearby hospitals. 
Twelve patients (15.1%) developed pneumonia after intubation. Endo- 
tracheal cultures of these patients showed in decreasing frequency 
Preudornonas aeruginosa (33%), Enferobacter cloacae (25%), Klebsiella prteuvroniae 
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(17%), Streptococcus pneumoniae (17%), and Haemopbilus influenzae (6%). 
Wound culture revealed Enferobacter cloacae (20%), Enterobarter sakazakii 
(20%), Senatia marcescens (20%), Arinetobacter iwofii (20%), Streptococcus viridans 
(20%). One patient developed bradyarrhythnua. Two patients (20%) with 
Level IV Envenomation died. 
Conclusions: Snakebite cases continue to occur in our country affecting all 
age groups and people in the field. The mortality rate associated with it may 
seem to be low. Nevertheless, one should not be complacent about this, 
because as yet only the locally prepared antivenom is effective to reverse all 
the signs of neurotoxicity associated with cobra bite. Neostigmine may be 
used as an adjunct therapy but if the patient presents with h g h  level of 
Envenomation, its effect may be limited when used alone. 
v] Changes in the epidemiology and management of 
infective endocarditis 
T. Lejko-Zupanc 
Ljubljana, SLO 
Objective: To study the changes in epidemiology, prognosis and 
management of infective endocarditis in time period from 1984 to 2000. 
Material and methods: All the patients treated for infective endocarditis at 
the Department of Infectious Diseases in Ljubljana in the years 19842000 
were prospectively studied. The following data were recorded: type of 
underlying heart disease, other concomitant diseases, isolated pathogens, 
outcome of the disease and type of management. The periods 198493 and 
19942000 were then compared. The statistical analysis was performed 
using EpiInfo6 programme. 
Results: In the period of 1984-93 there were 146 patients with LE (90 
male156 female). 115 patients had native valve endocarchis ( W E )  and 31 
prosthetic valve endocardtis (I'VE). Mean age in this group was 49.9 years. 
The most common causative agents were viridans streptococci in 32.8% 
patients followed by S. aureus in 14. 3%. Rheumatic heart disease was the 
most common underlying heart disease present in 23% of the patients with 
native valve. Eleven patients were operated in the active phase of the disease 
with postoperative mortality of7.5%. The overall mortality rate was 21%. In 
the time period of 1994-2000 143 patients were treated of infective 
endocarditis (113 NVE, 30 PVE). The mean age in this group was 56.8 
years. The most common underlying disease was degenerative valvular 
disease in 34% patients. S. aureus was predominant causative agent (28%). 
24% of the patients were operated in the active phase with postoperative 
mor t l ty  rate of 20%. Overall mortality was 27%. There were significant 
differences between the two time periods. Rheumatic heart disease has 
significantly decreased as an underlying heart disease ( P  0.05). In the time 
period 1994-2000 significantly more patients had a severe underlying 
disease such as diabetes, malignancy or previous invasive procedure ( P  
0.001). S. aweus has sigmticantly increased in frequency in the period 1993- 
2000 (P0.03). Although more patients were operated in the active phase the 
mortality was reduced only in patients with staphylococcal endocarditis (P 
0.05) (61% vs. 30%). 
Conclusion: It appears that in the 1990s IE has in many ways become a 
nosocomially acquired infection. The combined medical/surgical treatment 
has signiftcantly reduced mortality in our patients with S. aureus 
endocarditis. Our data are insufficient to conclude whether this kmd of 
treatment would influence the prognosis of MRSA endocardnis. 
Ip810 Bacteraemia in patients in the medical department of a 
tertiary hospital 
E. Karabatsaki, E. Kalogeropoulou, C. Kakari-Tsiropina, E. Vagiakou- 
Voudri, D. Petropoulou-Milona, P. Tsiodra, E. Maiamou-Lada, 
A. Efrtratopoulos 
Athens, GR 
Objectives: To monitor the kequency of bacteraemia, as well as the 
spectrum of pathogens isolated in blood cultures of patients admitted in a 
general medical depamnent of a tertiary hospital. 
Methods: We evaluated the results of 1501 blood cultures and studied the 
notes of the 787 patients these cultures were taken fiom. 
Results: O f  the total of 1501 blood cultures, 124 were positive (8.26%). 
Polynlicrobial bacteraemia was detected in 14 cases (11.3%), with two 
pathogens isolated in all of the cases. The mean age of the patients was 60.3 
years (standard deviation 14 years), 57 men and 67 female. Gram negative 
microorganisms consisted 57.25% of the pathogens and these were: E .  coli 
23.2%, Pseudomanas aewginosa 13%. Klebsiella spp. 8.7%. Proteus spp. 5.8%, 
Enterobacter spp. 3.6%, Acinetobarter spp. 2.2%. Salmonella spp. 0.7%. 42% of 
the isolates were Gram positive microorganisms, in particular: S. aureus 18. 
8%, Staphylococcus coagulase negative 14.5%. Enterococcus spp. 5.8%. 
Streptococcus pneumoniae 1.4%, Coynebactenum jeikeium 0.7%. Strep. anginosus 
0.7%. Candida albicans has been isolated in a patient with polymicrobial 
bacteraemia, suffering kom lung cancer. All of the patients found to have 
polymicrobial bacteraemia had been suffering fiom a disease that would 
cause immunosuppression (50% haematological malignancies, 21.4% solid 
tumoun, 14.3% diabetes mellitus, 7.14% chronic renal f d u r e  and 7.14% 
hepatic cirrhosis). Immunosuppressive factors were present in 65% of the 
patients with monomicrobial bacteraemia. The mor t l ty  of patients with 
bacteraemia was 11.3%. 
Conclusions: Gram negative bacteria are isolated in more than half of the 
patients with bacteraemia. The increase in the isolation of coagulase 
negative staphylococcus is attxibuted to the use of intravenous catheters. 
The increase in the isolation of enterococcus is due to the fiequent use of 
antibiotics and to the increasing numbers of immunosuppressed patients. 
Critically ill patients with community-acquired 
bacteraemia: a multicentre study 
J. Vallks, A. Ochagavia, E. Diaz 
Sabadell, E 
Introduction: In recent years, several studies have reported the 
characteristics of nosocomial-acquired bacteraemia in the ICU, but no 
specific studies focusing solely on community-acquired bacteraemia (CAB) 
on admission to the ICU are available. 
Objectives: The objective of this study was aimed to know the 
characteristics and prognosis of critically ill patients with CAB requiring 
ICU admission. 
Methods: A prospective, multicentre study (30 ICUs) was carried out to 
investigate the clinical and microbiological characteristics, and variables 
(infection-related, comorbidities and severity of illness) influencing out- 
come in patients with CAB at ICU admission over a 18-month period. 
Results: During the study period, a total of 33 21 1 patients were admitted 
to the participating ICUs. Three hundred and thirtynine patients presented 
true CAB, accounting for a bacteraemia infection rate of 10.2 episodes/ 
1000 admissions. The commonest sources of CAB were lower respiratory 
tract infections (21%), genitourinary tract infections (20%). and intrabdom- 
inal infections (20%). Polymicrobial episodes accounted 9%, and between 
monomicrobial episodes, 45% were caused by Gram-negative pathogens 
and 41% by Gram-positive microorganisms. The systemic response to CAB 
was classhed as severe sepsis or septic shock in 75% of episodes. The crude 
mortahty was 41%. Variables significantly associated with a higher mortahty 
in the multivariate analysis were: an Apache I1 > 15 at admission, unknown 
origin of CAB, inadequate initial antimicrobial treatment, and septic shock, 
ARDS or liver Mure  as complication of CAB. 
Conclusions: Critically ill patients with CAB admitted in the ICU present 
a severe systemic response and a high crude mor t l ty  rate. 
Ip8121 Phenotypic diversity between Ochrobactrum species 
D. S .  Hansen, K. Boye, B. Bruun 
Copenhagen, DK 
0. antbropi are aerobic, motile, Gram-negative, nonfementing bacdli. They 
are ubiquitous in nature and occasionally give rise to catheter-related 
bacteraemias. 0. intermedium has recently been described as a new species. It 
resembles 0. anthrupi biochemically to such an extent that the two species 
initially only could be differentiated by DNA-DNA hybridization or by 
sequencing of the 16s rRNA gene. Resistance towards polymyxin B (0. 
intermedium resistant) is the single phenotypic trait found to differ between 
the two species. Consequently, the aim of this study was to characterize a 
collection of Ocbrobactrum strains by phenotypic methods and by ribotyping 
to see if other Merentiating characteristics could be found. 
Methods: A total of 29 Ocbrobactmm strains &om 5 different countries were 
included; among these were 5 0. anthropi (DNA-group I) and 3 0. 
intermedium (DNA-group 11) reference strains. The strains were phenoty- 
pically characterized by extensive conventional methods, ID 32 GN, Vitek 
NFC, and by taxonomic susceptibdity testing. Genotypical characterization 
was done with a Brucella specific PCR technique and by Ribotyping 
(RiboPrinterTM) with the enzymes EcoRl and PvuII. 
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Results: Numeric taxonomic analysis resulted in two large, somewhat loose 
clusters. In both clusters subdivisions were seen. The smaller cluster 
consisted of 9 strams, including the 0. intennediurn reference strains. All 
strains that were polymyxin resistant and reacted in the Brucella specific 
PCR were found in this cluster. The larger cluster consisted of 20 strains, 
including the 0. anthropi reference strains. Several conventional tests were 
found associated with the 0. intermedium cluster, e.g. growth at 42°C and 
niucoid growth on solid medm Wbotyping with EcoRl and PvuII 
produced two and three clusters, respectively. Although the 8 reference 
strains clustered in separate clusters with both enzymes, several other strains 
with conflicting phenotypic results were intermingled in these clusters. 
Conclusions: Several conventional tests gave promising results as 
differentiating characteristics between the 0. intennediuni and the 0. 
atithropi groups. However, numerical taxonomy showed subdivisions in 
both groups, which were not resolved by ribotyping with EcoRl aiid 
PvuII. The subdivisions might be explained by recent 16sRNA sequence 
data indicating the possible existence of two additional Othrobactrum species. 
Thus, the taxonomy of Ochrobactrum awaits further investigations. 
Pathogenicity of environmental isolates of 
L. monocytogenes 
H. Moshtaghi 
Shahrekord, IR 
The microorganitms belonging to genus Listeria are ubiquitous and widely 
dismbuted in the environment. L. nionocyrogenes constitutes the most 
important species of the genus which IS pathogenic to man and a large 
variety of animals. the present investigations were carried out to study the 
pathogenicity of L. monocytogenes isolates from. the local environment. 
Twelve isolates of L. monocytogertes obtained from agricultural soil, faecal 
matter of animals and sewage were tested for pathogenicity in mice. Each 
mice inoculated intrapentoneally with 0.1 mL overnight cultures of the 
isolates in tryptic soy broth (TSB). A group of three mice was inoculated 
with 0.1 mL of TSB to act as control. The mice were observed dady for 
clinical signs and mortality up to 12 days. The mice that survived were 
killed after 12 days and were examined by necropsy for gross changes. 
Portions of liver, spleen and intestine were collected and reisolation of the 
test organisms from these was done by direct plating. Formalin 6xed tissues 
were processed and sections were cut which were stained by Eosin and 
Haematoxylin staining method. Out  of 12 isolates of L. monocytogenes, 11 
were pathogenic to mice and led to mortality. The mortality started 2 days 
pott inoculation and continued up to 6 days, after which the mice survived 
the infection. Microbiological examination of liver, spleen and intestine of 
all the dead mice led to recovery of L. monocytogenes in large numbers. In the 
infected group, grossly there were a number of small, white necrotic foci in 
liver and spleen. At places the liver was congested. The number of foci was 
more in mice that died 2 or 3 days post inoculation. Histopathological 
examination of liver revealed congestion and pyogranulomas consisting of 
necrosed hepatic cells, macrophages and neutrophils. There was lymphocyte 
depletion and necrosis of lymphocyte in whte pulp of spleen of the infected 
mice. Brain tissue showed microabscesses and necrosis of neurons which 
characterized by satellitosis and neuronophagia. In kidneys, histopathological 
changes were characterized by focal interstitial nephritis and focal areas of 
hyaline casts in tubules. Sections of intestine showed the characteristics of 
enteritis. The find~ngs suggested that L. motmytogenes isolates which are 
commonly known to lead saprophytic existence in the environment are 
potential pathogens and may pose serious threat to human and animal health. 
(p8141 Role of multiple sclerosis associated retrovirus in the 
aetiopathogenesis of MS 
J. Nowak, D. Januszkiewicz, I. Liwen, J. Rembowska, M. Pemak, K. 
Nowicka, H.  Hertmanowska, M. Wender 
Pooznan, PL 
In the aetiopathogenesis of multiple sclerosis (MS) both genetic and 
environmental factors play important role. Among environmental factors 
viral infections is thought to he indirectly related to the aetiology of MS. 
Recently there are more and more papers devoted to possible involvement 
of retroviruses in the development of autoimmune &eases including MS. 
Among viruses multiple sclerosis associated retrovirus (MSRV) seem to be 
the important candidate for viral aetiology of MS. The aim of the study was 
to analyse MSRV related pol sequences in MS patients and healthy 
individuals. The MSRV related pol sequences have been studied in RNA 
isolated from the serum and in DNA and RNA of peripheral blood 
lymphocytes taken from 10 untreated MS patients and 27 healthy donors. 
The MSRV related pol sequences have been identified by PCR technique 
using specific ohgonucleotide primers. In all healthy individuals and MS 
patients MSRV related pol sequences have been found in the DNA from 
peripheral blood lymphocytes. It is well known that sequences of many 
retroviruses are present in the human genome including MSRV pol 
sequences. However, MSRV related pol sequences were detected also in 
R N A  from lymphocytes of all MS patients and 13 out of 17 healthy donors. 
In the serum RNA MSRV related pol sequences have been identified in all 
MS patients and in 18 out of27 healthy individuals. It can be concluded that 
MSRV related pol sequences are widespread in lymphocyte DNA and 
RNA of MS patients as well as of healthy individuals. More frequent 
expression of MSRV sequences in MS patients may indicate on some role of 
MSRV in the aetiopathogenesis on MS. 
Acknowledgements: This work was sponsored by KBN grant nr 4P05A 
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p8151 The study of nocardiosis in advanced symptomatic 
pulmonary disease patients in Maseeh-e-Daneshvari Hospital 
(Tehran 1998-99) 
S. Eshraghi, M. Anlin, K. Ghazisaeedi, M. Masdjedi, F. Mohammadi 
Tehran, IR 
Pulmonary Nocardiosis is an acute or suppurative chronic disease which is 
caused by aerobic actinomycetes of the soil. Since Nocardia has been isolated 
from the soil of different areas of Iran and there have been different case 
reports of Nocardiosis the study of this infection can be of importance. In 
this study 142 pulmonary patients were surveyed in Maseeh-e-Daneshvari 
hospital (Tehran) during 7 months. Of all the patients surveyed, 102 were 
tested both for their BAL (bronchoalveolar lavage) and sputum. For the rest 
of the patients sputum samples were not accessible. From each sample three 
thin smears were prepared for microscopic observations. The samples were 
cultured in Sabouraud's dextrose agar and paraffin agar. Medical history of 
patients were also recorded in the certain questionnaires for further data 
analysis. Positive Nocardial cases were only one who was a patient suffered 
from Cushng's syndrome with bronchogenic carcinoma (Ectopic ACTH 
syndrome). The differential tests on Tyrosin agar, Xantine agar, 
Hypoxantine agar and Casein along with microscopic observation 
confirmed that the organism grew on primary media was Nocardia astroides. 
The experiment made in this study revealed that even low concentrations of 
NaOH can inhibit the growth of Nocardia. Growth of Nocardia in 
concentration above 1% NaOH was inhibited in this experiment. 
Ip816 Systemic nocardia infection in a patient with Behget's 
disease 
G. E. Pamuk, 0. N.  Yamuk, F. Tabak, A. Mert, R. Ozturk, Y. Aktulu 
Istanbul, TR 
Infections with Nucardia species are rare; and, generally seen in 
immunocompromised subjects. N. asteroides is mostly associated with skm, 
lung, and brain abscesses. We present a patient with Behqet's disease (BD) 
who used immunosuppressives for a long time, and died due to systenuc 
nocardial infection. A 29-year-old man was a h t t e d  to our hospital with 
fever, cough, sputum. He was unable to move his left extremities. He had 
blurred vision, oral apthous and genital ulcers. He was diagnosed as BD 5 
years ago. He had used a variety of immunosuppressives (steroids, CsA) to 
suppress the attacks of uveitis. O n  admission, he had fever. O n  the right side 
of the abdomen, there was the opening of a fistulizing tract from whch pus 
was draining out. Neurological examination revealed a left-sided hemipar- 
esis. His ESR was 132 mm/h; CRP,  20 mg/dL (N < 0.5); WBC, 144001 
mm3. Anti-HIV was (-). LP showed no cells and a slightly elevated level of 
protein. Cranial CT demonstrated cerebral oedema, multiple ring- 
enhancing lesions-the largest measuring 2 cm. In pelvic CT, there were 2 
abscesses in the iliopsoas muscle region which had fistukzing tracts to the 
skin. Examination of the sputum specimen and pus obtained from opening 
of the fistula in the abdomen revealed acid-fast, branching Gram (f) rods 
consistent with Nocardia species. After 3 days of moculation, white- 
coloured, chalky rough colonies grew on chocolanzed agar and agar 
supplemented with 5% sheep blood. Haemocultures were sterile. It was 
detected by E-test that the bacterium was susceptible to cefmaxone and 
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TMP-SMX. Therapy with i.v. TMP-SMX (400/2000 mg qid) and 
Ceftriaxone (2 g daily) was initiated. There was no regression of the 
abscesses. The patient's clinical situation deteriorated and he died after 6 
weeks of hospitalization. Disseminated nocardiosis in BD has not been 
reported unul now. We assume that the cause of disseminated nocardiosis 
was immunosuppressive therapy, rather than the primary disease itself. 
Neurological involvement might be present in 5% of patients with BD. 
High-dose steroids are used for treatment. Neurological symptoms in 
patients with BD, should alert one to the presence of neurological 
involvement of the disease. However, CNS involvement by opportunistic 
infections-like Nocardia-may cause simiIar neurological presentations. Due 
to this reason, cerebral imaging is advisable before administration of 
immunosuppressives. This is the first case of disseminated nocardiosis in a 
patient with BD. 
I P817 I Primary actinomycosis of the hand 
A. Mert, M. Bhr ,  H. Bahar, M. Torun, F. Tabak, R. Ozturk, R. Ozaras, 
Y .  Aktuglu 
Istanbul, TR 
Primary actinoniycosis of the hand is very unconmon. We present the 
clinical, bacteriologcal, and pathological findings and the outcoine for a 
patient with actinomycosis of the hand without known trauma and review 
of the literature. 
A 35-year-old man was admitted with 6-month history of increasingly 
pain, swelling with erythema, and indurated nodules with inteiniittent 
discharge on the dorsum and plantar surface of his right hand. No did not 
note any trauma. His right hand was swollen dorsally and plantarly over the 
second, third and fourth metacarpals. There were 3 nodules associated with 
fluctuance surrounded by enduration, and erythema on ths  region. 
Laboratory investigations: Leukocytes 8700/mni', haernoglobin, 15 g/ 
&, ESR 10 nim/h. X-ray iilm and M R  imaging of the right hand showed 
changes consistent with osteoniyelitis of the nght second, third and fourth 
proximal metacarpals. 
The patient was operated: A 5uctuant area over the distal portion of the 
second metacarpal was incised. Serosmginous exudate was taken. Under- 
lying granulation tissue was biopsied and curetted and sent for culturing, and 
histological exaimnation. Gram's stain of exudate and granulation tissue 
imprinting revealed polymorphonuclear leukocytes, numerous branching, 
flamentous. Gram-positive rods. Anaerobic cultures of these specimens 
yielded Actimmyces israelii. Histological exanination of the subcutaneous 
tissues specimen was consistent with actinoniycosis. Ampicillin was given 12 
g daily, for a month. doxycycline (200 nig daily) was started due to drug 
eruptions against ampicillin and was continued for an additional 11 months. 
At the end of antibiotic therapy, a total clinical improvement was obtained. 
In conclusion, increased awareness of actinomycosis especially following 
punch injuries is required in the differenual diagnosis of any subacute or 
chronic inflammatory lesion involving softy tissues and progressing to 
osteoriiyelitis in the hand. 
/p8181 Actinomycosis: a frequently misdiagnosed infection 
Kgo, E 
M. Rubianes, J. De la Fuente, A. Nodar, P. Lamas, B. Sopefia, C. Martinez 
Background: Actinoniycosis is an indolent and slowly progressive 
infection with extension to contiguous structures by crossing natural 
anatomic boundaries causing fistulas and sinus tracts. 
Objectives: To descnbe the clinical presentation and treatment of 
histological confirmed actinomycosis during the last five years. 
Methods: We reviewed four consecutive cases of actinomycosis who 
were diagnosed a t  our hospital between 1995 and 1999. Clinical 
presentation, initial misdiagnosis and therapeutic procedures are described. 
Diagnosis was established in pathological specimens by demonstration of 
typical sulphur granules surrounded by inflammatory cells and branched 
filaments in all patients. 
Results: Four cases were diagnosed in this period, two females with 
intrauterine devices and two males. Locations of infection were pelvic (2), 
thoracic and cervical one each. The infection was penoperatively 
misdiagnosed in all patients: ovarian neoplasm and cyst of urachus in the 
pelvic actinomycosis in women, tuberculosis-associated henioptysis in 
thoracic location and tumoral lymphadenopathy in cervical area in men. 
Antibiotic therapy was ulteriorly administered for a variable times: 4 weeks 
to 8 months. There are not recidives or surgical reinterventions. 
Conclusions: The infection7 caused by Actinomyces are commonly 
confused with other chronic infection or malignant diseases in the region of 
the head, chest or pelvis. A high degree of suspicion clinical is essential to 
avoiding unnecessary surgical interventions and prompt the appropriate 
antibiotic treatment. 
lp8191 Elevated soluble CD4 levels in the cerebrospinal fluid 
in patients with infections of central nerve system 
M. Vrbic, L. Konstantinovic, M. Krstic, V. Kostic, Z. Rankovic, 
M. Jovanovic 
Nis, YU 
Possible pure or even normal cytological finding in the cerebrospinal fluid 
(CSF) is the most frequent problem in diagnosis of acute encephalitis. 
Guided by hypothesis that inflanu~~ation f parenchymal brain tissue can be 
illustrated by realized surface molecules of inmiunocompetent cells we 
exanlined soluble CD4 antigen (sCD4) presence in CSF of patients with 
different central nerve system (CNS) infections. Enzyme linked imniuno- 
sorbent assay (ELISA) was used. In contrast to healthy persons, we verified 
detectable concentrations of sCD4 which were not in direct correlation 
with CSF pleocytosis but were dependent of underlying disease. In general, 
sCD4 levels in CSF of acute encephalitises (36.4 k 11.8 U/nL)  were 
substantially higher than in aseptic meningitises (22.9 k 9.3 U/mL), while 
acute bacterial nieningitises has increased sCD4 in CSF just during recovery 
(21.2 f 13.4 U/mL.). Given results shows that determination of sCD4 in 
CSF can improve our ability to diagnose CNS infections. Theirs closer 
monitoring during the disease, like a following of others soluble 
immunological markers, will produce better understanding of the 
pathogenesis and true extant of CNS involvement. 
/p820/ Evaluation of endoscopically guided pretreatment 
bacteriology of the middle meatus in chronic sinusitis 
S. Gundes, 0. Aydin, S. Akhan, Z. Bolca, H. Vahaboglu, A. Alma$ 
Kocaeli, TR 
Objective: Chronic sinusitis is one of the most common health care 
complaints leading patients to outpatient clinics. Although it is known that 
culture-directed therapy along with surgery increases treatment success; the 
antimicrobial therapy is usually selected on empirical basis. Therefore most 
of the centres follow up the treatment protocols directed against the known 
sinus pathogens. Here, we tried to characterize the bacteriology of 
outpatient chronic maxillary sinusitis, and argue about the effectiveness of 
well known antimicrobial agents against these microorganisms. 
Design: A prospective study was carried out on 44 consecutive patients 
referred to an outpatient clinic at The Kocaeli University Hospital, between 
May 1999 and January 2000. Swabs of 44 chronically inflamed maxillary 
sinuses were processed for aerobic and anaerobic bacteria as well as yeast and 
yeast-like organism$ during endoscopy. Antibiogranis canied by Kirby- 
Bauer disc diffusion technique. 
Results: Of the 44 total cultures, there were 38 (86.3%) positive cultures 
yielding 53 isolates. Thirtyfour cultures had two or fewer isolates; four 
cultures had three isolates. The most eequently isolated organisnis were 
coagulase negative rtaphylococnrs (21 of 53, 39.6%), Sfreptococcus spp. (12 of 53, 
22.6%), Staphylococcus aureus (8 of 53, 15%), Pseudumonas aenrginosa (5 of 53, 
9.4%) and Candida albicans (3 of 53, 5.6%)). The portion of anaerobic 
pathogens in culture were poor, only were recovered from 4 (9%) of the 
specimens. The predominant anaerobic organism were anaerobic cocci. 
According to antimicrobid susceptibility testing, therapy with amoxicillin- 
clavulanic acid was shifted to an another antibiotic in 19 of the 44 cases (43%)). 
Conclusion: Findings indicate the major role of aerobic, Gram positive 
organism in the polymicrobial etiology of chronic sinusitis. Although 
Streptococcus pneumonia and HaemophiIus influenza are known as the most 
important pathogens; Staphylococcus spp. accounted for more than 50% of 
cases in our study. Therefore beta-lactam antimicrobials as amoxicillin- 
clavulanate, which show the best activity against pneumococci, Haemophilus 
influenza and Moraxella catarrhalis, would not be a n  appropriate agent and 
should not be chosen as a first drug in our vicinity. As a conclusion, 
antimicrobial treatment should be based on serial culture and sensitivity 
results and coordinated with surgical drainage. 
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Ip827  Cerebrospinal fluid rhinorrhoea and recurrent 
pneumococcal meningitis following operation of nasal 
submucosal resection for deviated nasal septum: a case report 
S. Erol, 2. Ozkurt, M. A. Tasyaran 
Erzurum, TR 
A 24-year-old female patient admitted to our clinic four times with bacterial 
meningitis. On the first admission, she had an operation history of nasal 
submucosal resection for deviated nasal septum 12 months ago. She had 
been suffering from rhinorrhoea starting after this operation. Further three 
episode occurred 3 months, 6 months and 8 months after the first one. 
Streptococcus pneuwiunim was identified from cerebrospinal fluid (CSF) and 
the patient was treated successfully with penicillin G (24 mU/day, 14 days) 
in each episode. Site of CSF leakage could not be visualised by coronal and 
axial computerized tomography, magnetic resonance imaging and radio- 
nudid ventricle cistemography with Tc 99. The patient underwent 
neurosurgical intervention to repair fistulous tract but, because of the site 
of CSF leakage could not be demonstrated by neuroradiological methods 
and the patient did not accept surgical procedure, dural repair could not be 
performed. Rhinorrhoea ceased spontaneously after the last episode of 
meningitis. In the following 9-month period after the last episode, 
rhnorrhoea and another attack of meningitis were not recorded. We 
emphasized that CSF leakage and recurrent bactenal meningitis can be 
occurred after nasal surgical procedures and neuroradiological methods can 
be failed to demonstrate the localization of leakage. 
/p8%1 Surgical vs. medical treatment of brain abscesses 
M. Vilendecic, J. Skrlin, T. Kobetic 
Zagreb, HR 
There are still controversies about surgical and medical treatment of brain 
abscesses. Since the new antibiotic era many authors advocate pure mehcal 
treatment with good results. On contrary many advocate combinations of 
surgical and medical treatment, because pure medical treatment IS often 
unsuccessful, long and expensive. In the past 10 years we managed 21 
patients with brain abscesses (17 males and 4 females; age 6-69). In 12 cases 
were solitary and in 9 cases were multiple abscesses (2-1 I), supratentorial and 
mfratentorial. Nine patients were considered as had brain tumour (mostly 
ghoblastoma), m e  considered that had abscess and three had possible abscess, 
ghoblastoma or metastasis. In 16 patients we evacuated pus stereotactically, in 
three by ‘free hand puncture and in two cases by open operation. In 15 patients 
we had positive cultures (aerobes in 5, anaerobes in 4, mixed culture in 4, 
parasites in one and fungi in one); seven of them had been previously treated by 
empiric medical therapy. Other six patients had sterile cultures and only one 
had not been previously treated medically. In three cases we left catheter three 
days for intracavitary drmage and local antibiotic therapy. Surgical treatment 
was followed by target i.v. medical therapy 3-4 weeks and after that by peroral 
drugs 2-3 weeks in cases with positive cultures. In patients with negative 
cultures we continued empiric i.v. therapy 1-9 weeks according clinical status 
and neuroradiological findings. Eighteen patients were completely cured with 
excellent regression of neurological deficits, one improved and two patients 
died (Cyptococcw granulorna in pons with sepsis and severe neurological deficit; 
abscesses in left thalamus and nght trigonal regon ulth sterile cultures and 
untreated hydrocephalus). The both deaths was not related to surgery. Patients 
with surgically treatment as the first choice had been treated medically 
sigruficantly shorter than others, w t h  faster recovery. According our results we 
think that first choice in the treament of brain abscesses must be surgical, 
followed by target or enipiric medical therapy. Minimal invastve surgery (‘fiee 
hand’, stereotactically or ultrasound guided abscesses puncture) can be 
performed in any patient without risk, independently of his status, site and 
size of abscess. In that way we avoid wrong diagnosis, decompress brain 
tissue, identify pathogens and decrease pus amount, with shortening medical 
treatment and better patients’ improvement. 
1-1 Burkholderia cepacia complex in Italian cystic fibrosis 
patients: correlation between bacterial genomovar status and 
epidemicity of infection 
A. Agodi, E. Mahenthiralingam, M. Barchitta, V. Giannino’, A. Sciacca, 
S. Stefani 
Catania, I; CurdE UK 
Objectives: This study was performed in order to. (I) evaluate the 
prevalence of Burkhojderia cepan’a complex infection in CF patients attending 
four Italian treatment centres; (ii) identify the genomovar of B. cepacia 
complex isolates; (iii) study the epidemiological relatedness of Buvklzoldmria 
isolates; (iv) evaluate the Frequency and the epidemiological significance of 
transmissibility markers. 
Methods: From September 1998 to July 1999, 683 patients attending the 
centres in study were screened for Burkholderia infection. Identification of 
genomovar was performed on the basis of a 16s and 23s rDNA based 
procedures (Bauernfeind et al., 1999), and on RFLP analysis of the recA 
gene (Mahenthiralingam et al., 2000). PFGE fingerprinting was by the 
method of Grothues el al., 1988. PCK-detection of cblA and esniK were as 
previously described (Sajan et al . ,  1995, Mahenthiralingam et a l . ,  1997). 
Results: The prevalence of B. repacia infection was of 8.6% (59 out of 683 
patients). Three isolates (3.3%) were found to be B. repacia genomovar I; 4 
isolates (4. 3%) were B. multiuorans; 51 isolates (55%) were B. cepacia 
geriomovar 111-A; 13 isolates (14%) were B. cepacia genomovar 111-B; 3 
isolates (3.2%) were B. stabilis, 12 isolates (13%) were B.  cepan’ageriornovar I/ 
111 indeterminate status and 6 isolates (6.5%) were not B. cepacia complex. B. 
rrpacia getiomouar 111 was the dominant species present among the Italian 
isolates examined (69.5%) and of these, the majority (80%) belonged to B. 
repacia geriomovar recA group 111-A. A predominant clone was identified 
among the two Sicilian centres (Catania and Palenno), closely related to the 
reference strains C5424, the transoceanic clone (Sun et a/., 1995; Johnson ef 
al., 1994; Mahenthiralingham et al.. 1997). Although the majority ofpatients 
involved in the Sicilian outbreak were colonized by strains possessing the 
cblA gene, 5 out of the 26 patients were colonmd with a cblA negative 
variant of the clone, suggestmg that the region may be subjected to some 
instability, as it was already suggested for the esmK sequence. The highest 
correlation between cross-infection and genomovar was associated with 
strains of B. cepacia complex genomovar 111, recA group A. The relative risk 
posed by infection with cblA positive strains and epideniicity is not so 
evident, therefore cblA should not be reliably used for PCR identification 
of epidemic clones, as it has been recently proposed (Clode e l  a/., 2000). 
Mycoplasma horninis: review of 5 extragenital 
infections cases at the Hospital La Paz, Madrid, Spain (1990-2000) 
P. Andris, L. Valdis, A. Garcia-Perea 
Madrid, E 
M .  liominis is a small bacterium that lacks a typical bacterial peptidoglycan 
cell wall. Because of this property, it is not visualized on bacterial gram stains 
and is resistant to antibiotics affecting peptidoglycan synthesis. M.  kuminis is 
a common commensal of urogenital and respiratory tracts of healthy adults, 
but it can occasionally cause extragenital infections. This diagnosis is often 
delayed because the infection is not suspected or because growth in routine 
culture media is slow or absent. We descnbe 5 cases of extragenital 
infections caused by M .  hombiis in our Hospital in the last 10 years. 
Case no. 1: A 50-year-old man in chronic kidney failure secondary to lupic 
nephropathy. He was in course of CAPD during 5 years and later he 
underwent kidney transplantation. Three weeks later he had fever, 
abdominal pain and peritoneal reaction. M. hotnilris was isolated from the 
CAPD liquid and drainage of the surgical wound. The patient Improved 
after tetracycline therapy. 
Case no. 2: A 71-year-old woman underwent hysterectomy for 
endometrial adenocarcinoma. Fifteen days later she had fever. It was found 
an intra-abdominal abscess and M .  hominis was isolated. The clinical 
condition improved after doxycycline therapy 
Case no. 3: A 44-year-old woman underwent simple hysterectomy for uterine 
disease. A week later she had fever and drained purulent fluid from surgcal 
wound. A4. horniris was isolated. The panent’s evolution was not reported. 
Case no. 4: A middle-age man underwent surgery for kidney disease. Two 
months later we isolated M .  hominis from the supuration of the surgcal 
wound. The patient had a good response to oral clindaniycin and doxycycline. 
Case no. 5: A 73-yeam-old man that had a right knee prosthesis cince three 
years ago underwent surgery due a damaged prosthesis. Subrequrntly he 
presented acute bacterial arthritis. M. kominis was isolated from articular 
fluid. The patient had a good response to oral doxycyclinr. 
Conclusions: It is apparent from this series that M .  korniriis can be 
responsible for a broad array of clinical infections. It should be considered as 
a possible pathogen particularly when cultures are sterile or yield scant 
bacteria in culture, yet Gram stains shows numerous neutrophils. In this 
situation, anaerobic specimens should be carefully examined for pinpoint 
colonies and the specimen plated on specific niycoplasma medium. 
158 Abstracts 
Ciprofloxacm 
Nalidixic Ac 
Quinolones 
Sensitive Paxtial sensitive Resistant Total 
N r l %  Nr 1 %  N r ] %  
219 I 69,9 32 I 10,2 62 I 19,8 313 
193 I 61.6 20 I 6,4 100 I 31,9 313 
lp825 Compared sensitivity study of 313 bacterial strains 
isolated in urine cultures exposed to nalidixic acid and 
ciprofloxacin 
V. Arama, M. Chiotan, E. Mitache, E. Andrei, A. Iancu, V. Molagic, 0. 
Benea, M. Podani, I. Stoica, R. Nastase 
Bucharest, RO 
Objective: Compared evaluation of sensitivity for Nalidixic Acid (NA) and 
Ciprofloxacin (CIP) of 313 bacterial strains isolated in urine cultures during 
January 1999-December 1999. 
Material and methods: We analysed and compared the results of 313 
difusimetric antibiograms made for different bacterial species isolated in 
urine cultures. 
Results: The distribution of isolated bacterial species and their sensitivity to 
NA and CIP are presented in Table 1, while the cumulative sensitivity to 
NA and CIP of all bacterial strains tested is represented in Table 2. 
Conclusions: The percentages of E .  coli, Proteus and Klebsiella strains CIP 
resistant (20%) are similar to those NA resistant. The percentages of 
Eiiterobacter and Enterococcus strains NA resistant are greater than those CIP 
resistant, while the percentage of Enterobacter strains CIP resistant is 
significantly high (40%). AU strains of isolated P. aeruginosa were both 
resistant to NA and CIP. 
Under these circumstances we consider that for the start and follow up of 
all antimicrobial therapy in urinary tract infections, an antibiogram, even for 
CIP. would be useful. 
lp8261 In vitro activity of gatifloxacin compared to 
trovafloxacin, ciprofloxacin, beta-lactams and clarithromycin 
against 581 recent clinical isolates 
M. Souli, G. Poulakou, D. Halkiadaki, D.  Katsala, M. Bourousi, H 
Giamarellou 
Athens, GR 
Newer quinolones because of their excellent pharmacokinetic properties 
and broad spectrum of activity may have a role in the treatment of 
problematic infections. We examined the in vitro efficacy of Gatifloxacin 
(GATI) in comparison to that of Ciprofloxacin (CIPRO), Trovafloxacin 
(TROVA) Cefmaxone (CEFTRI), AmoxyciUin (AMOX) and Clarithro- 
mycin (CLARI) against 581 Gram-positive and Gram-negative nosocomial 
isolates collected between October 1998 and May 1999 in Greece. Fourteen 
hospitals from the metropolitan area of Athens, Thessaloniki and Patras 
participated in the study. All clinical isolates were submitted to susceptibility 
testing by agar dilution, as recommended by NCCLS. E-test was used to 
test CIPRO, CEFTRI and CLARI against pneumococci. MIC50s/MIC90s 
(pg/mL.) are shown in the table below. GATI was found to be as active as 
the comparator yuinolones against Gram-negatives and the most potent 
against P. aeruginosa. It was comparable to TROVA against Gram-positives 
although TROVA was the most active against S. pneumoniae and MSSA. 
(Table 1) 
lp8271 lnterspecies prediction of the antimicrobial effects of 
gemifloxacin and ciprofloxacin on Haernophilus influenzae 
based on the comparative pharmacodynamic studies in an in 
vitro model 
S .  Vostrov, I. Lubenko, Y. Portnoy, S. Zinner, A. Firsov 
Moscow, RUS; Cambridge, USA 
Objectives: To compare the antimicrobial effects of GEM and CIP on H. 
it$urnzae by in vitro simulation of the human pharmacokinetics. 
Methods: Two differentially susceptible clinical isolates of H. influenrae 
were selected for the pharmacodynamic studies. The MICs of GEM 
determined by multiple serial dilutions were of 0.09 and 0.25 mg/L and 
those of CIP were of 0.5 and 1 mg/L. Monoexponentially decreasing 
concentrations of GEM (single dose, half-life 7.4 h) and CIP (two 12-h 
doses, half-life 4 h) were simulated in an in vitro dynamic model over %fold 
ranges of the AUC/MIC ratio: 58-466 h with GEM and 116-932 h with 
CIP. The observation periods were designed to determine CFUs from 
initial killing to the end of regrowth phase. The total antimicrobial effect 
was expressed by the I(E) parameterarea between the control growth and 
time-kill curves &om time zero to the time when bacterial counts on 
the regrowth curve acheve the same maximal numbers as in the absence 
of antimicrobial. 
Results: Both GEM and CIP induced rapid killing of H. influenrae with 
subsequent bacterial regrowth that occurred later with GEM than CIP at 
comparable AUC/MICs (116, 232 and 466 h). Moreover, the time to 
regrowth was strictly dependent on the simulated AUC/MIC ratio: the 
higher AUC/MIC-the later the regrowth. Linear relationships between 
I(E) and log AUC/MIC were bacterial strain-independent but specific for 
each quinolone: GEM'S and CIP's plots were not superimposed (r2 = 0.98 
and 0.96, respectively). At a given AUC/MIC of more than 150 h, the I(E)s 
of GEM were greater than those of CIP, suggesting that the antimicrobial 
effect of GEM relative to CIP may be even greater than might be expected 
from the difference in MICs. For example, at AUC/MIC of 250 h, GEM 
displayed 25% greater I(E) than CIP. Due to the bacterial strain- 
independent AUC/MIC relationsbps of the I(E), the findmgs obtained 
with specific bacterial strains may also be used to predict the antimicrobial 
effects of GEM and CIP on a hypothetical strain of H. i&erlzae with MIC 
equal to the respective MIC90 (0.016 mg/L for both fluoroquinolones). 
Based on these predictions, the clinically achievable AUC/MIC90 of GEM 
(750 h) might be 15% more efficient than the AUC/MIC90 of 1370 hours 
for CIP. 
Conclusion: These data predict greater efficacy of GEM against H. 
inzumrae relative to CIP at clinically achievable AUC/MIC ratios. 
v] Different integral endpoints of the total antimicrobial 
effect at clinically achievable ratios of area under the curve to 
MIC: the pharmacodynamics of gemifloxacin with Moraxella 
catarrhalis in an in vitm dynamic model 
A. Firsov, I. Lubenko, S. Vostrov, Y. Portnoy, S. Zinner 
Moscow, RUS; Cambridge, U S A  
Objectives: To  compare four different integral endpoints of the total 
antimicrobial effect of gemifloxacin, levofloxacin and ciprofloxacin on 
M .  catarrhalir at clinically achievable ratios of area under the curve (AUC) 
to MIC. 
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Methods: A clinical isolate of M. catuvhalis with MICs of gemifloxacin, 
levofloxacin and ciprofloxacin of0.01,0.06 and 0.03 mg/L, respechvely, was 
selected for this study. Monoexponentially declining concentrations that are 
observed in human plasma after oral administration of 320 mg gemifloxacin 
or 500 mg levofloxacin (both as a single dose) and 1000 mg of ciprofloxacin 
(as two 500 mg doses with a 12-h interval) were simulated in an in vitro 
dynamic model. The respective half-lives were 7.4 h, 6.8 h and 4 h and the 
AUC/MICs were 1130, 920 730 h. The observation periods were designed 
to determme CFUs &om initial killing to the end of the regrowth phase. 
Results: The time-kill/regrowth curves observed with gemifloxacin, 
levofloxacin and ciprofloxacin yielded sirmlar patterns: a rapid reduction 
in bacterial numbers followed by bacterial regrowth that occurred later with 
gemifloxacin than with levofloxacin and ciprofloxacin. The total anti- 
microbial effect of gemifloxacin as expressed by the I(E) parameter (area 
between the control growth and time-kill curves from time zero to the time 
when bacterial counts on the regrowth curve achieve the sanx maximal 
numbers as in the absence of antimicrobial) was 40% and 20% greater than 
those of ciprofloxacin and levofloxacin, respectively. Unlike I(E), the other 
integral endpoints determined over a tixed time ( t  = 24 h), area between the 
control growth and time-kdl curves (ABBC), area above the time-kill 
curve (AAC) and area under the time-kill curve (AUBC) were similar and 
did not differentiate among the fluoroquinolones. This resulted from 
underestimation of the total antimicrobial effect by the t-related ABBC, 
AAC and AUBC. 
Conclusion: These data highhght possible limitations of t-related endpoints 
as indices of the total antimicrobial effect and predict better efficacy of 
gemifloxacin compared with levofloxacin and ciprofloxacin. 
lp829 Comparative in vitro activity of gemifloxacin against 
Gram-positive and Gram-negative nosocomial isolates 
A. Antoniadou, M. Souli, P. Greka, K. Athanasiou, P. Giannakou, M .  
Bourousi, D. Katsala, H. Giamarellou 
Athens, GR 
The activity of Gemifloxacin, a novel fluoroquinolone with extended 
spectrum against both Gram-positive and Gram-negative microorganisms, 
was tested in vitro against 475 clinical nosocomial isolates both Gram- 
positive and Gram-negative and respective comparators. The strains were 
collected from May to November 1998 from six tertiary Athens hospitals 
and represented isolates from blood, sputum, urine, pus and bronchial 
secretions. The agar dilution method was used according to the NCCLS 
methodology and results are shown in the table below. Conclusively, 
Gernifloxacin exhibits comparable or unproved activity against difficdt-to- 
treat nosocomial pathogens, compared to already used antimicrobial agents 
and may have an important clinical role m the treatment of nosocomial and 
ICU infections. 
(Table 1) 
Organism [no) GEM1 CllPRO CEFTA CEFE I M P  
P.aenrginms$57j 1 / >64 8x54 05/>64 
E.coli(5 7) 4 0 3 / 0 2 5  COO31025 01251025 <003 /006  0 2 5 / O ? E  
Entemhcter sd57l 0 06/ 16 c0 031 32 I/ >64 0125116 112 
A c i n e t h a r & 8 ~  21 32 32/>64 >64/ >64 16/64 ?I  4 
G E l l  CIPRO TEICO WANCO Q / D  
-i) 025116 025115 0 5 / 1  2/ 4 16/ 232 
M?SN431 2/4 16/64 1/2 112 
. d c a  UL5Ilb LI k i L  u 51 LI 4 i a, >32 
~ssnp35)  00610125 112 112 112 
~sse26j 0 1 ~ 0 5  0 5 / 8  2/ 4 212 
M?SEOII 1/ 1 16/64 4/4 2/ 4 
Ip8301 In vitro antimicrobial activity of 4”-alkylciprofloxacin 
analogues against different microorganisms 
R. Talens Visconti, J. M. Pla Delfina, E. Canton Lacasa 
Valentia, E 
Introduction and objectives: Since the introduction of nalidixic acid in the 
1960s. many quinolone derivatives have been synthesized and analysed for 
antibacterial activity. Among the quinolones in use, ciprofloxacin has 
demonstrated therapeutic success, it being one of the most extensively used, 
although it presents a poor oral bioavailability. In this context, four 
homologous compounds have been synthesized in order to find more active 
and bioavailable quinolones than the parent drug ciprofloxacin. 
Methods: Four perfect homologues of ciprofloxacin (CIP) were 
synthesized: 4”-methyl CIP (M), 4”-ethyl CIP (E), 4”-propyl CIP 
(P), and 4”-butyl CIP (B) and the in vitvo activity determined by the 
NCCLS method. 
Results: The Table shows the results of the in vitro activity of the 
ciprofloxacin homologues. 
Conclusions: The best derivative against all the microorganisms studied is 
M except in Stuphylococms spp. in which E is the best active. Since both 
compounds are far more bioavailable than CIP (data not shown), they could 
be optimal candidates for infections produced by these microorganisms, if 
their safety tests demonstrate them to be suitable. 
Acknowledgements: T h s  work is part of the SAF 97-1710 project, 
financed by the MEC, Spain. R.Tal6ns. is a granted PhD student of 
Generalidad Valenciana. 
Ip8311 Activity of the novel des-fluoro(6) quinolone BMS- 
284756 against methicillin-susceptible and -resistant 
Staphylococcus species 
J. Fung-Tomc, L. Valera, B. Minassian, D. Bonner, E. Gradelski 
Wullingford, Connecticut, USA 
Objectives: The des-F(6) quinolone BMS-284756 has enhanced potency 
against Gram-positive bacteria. In this study, the activity of BMS-284756 
was compared to those oflevofloxacin and ciprofloxacin against 144 mecA- 
positive (including vanomcycin-intermediately susceptible S.  aureus VISA]) 
and 124 mecA-negative (includmg borderline oxacihn-resistant S. aureus 
[BORSA]) strains. 
Method MICs were determined by agar dilution using Mueller-Hinton 
agar, with approximately 50 000 CFU/spot, for 24 h incubation at 35°C. 
Results: The MIC90s (or modal MIC for species in which < 10 strains 
were tested) were in pg/mL: 0.034.13 for BMS-284756; 0.25-0.5 for 
levofloxacin and ciprofloxacin against mecA-negative S.  aureus ( n  = 27), S. 
epidemidis (n= lo), S .  haemolyticus ( n  = lo), S. honrinis (n = 15), S. siniulans 
( n =  18), S .  warnen’ ( n =  15), S. capitis (n=8) ,  S .  saprophyticus ( ~ = 5 ) ,  and .C. 
xylosus ( n  = 5). While the BMS-284756 MIC90 against BORSA ( n  = 11) 
was 0.13 bg/mL, they were hgher with levofloxacin (MIC90= 16) and 
ciprofloxacin (MIC90 = 4). The MIC (or MIC90) ranges against mecA- 
positive S. hominis (n=13), S. simulans (n= 1). S. warneri (n=  l ) ,  and S.  
cupitis (n= 1) were in pg/mL: 0.03-0.06 for BMS-284756; 0.25 for 
levofloxacin; and 0.06-0.5 for ciprofloxacin. The MIC90s against mecA- 
positive S. aureus (n = 62), S. epidermidis ( n  = 39), and S. huemofycicus (n = 18) 
were in pg/mL. 1-4 for BMS-284756; 4-32 for levofloxacin; and 32 or 
greater for ciprofloxacin. The modal MIC against the VISA ( / I  = 9) stains 
were in pg/mL: 4 for BMS-284756; 32 for levofloxacin; and greater than 32 
for ciprofloxacin. 
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Conclusions: BMS-284756 is approxunately 4-to &fold more active than 
levotloxacin and ciprofloxacin against staphylococci. BMS-284756 is active 
against mecA-negative (including BORSA), and most mecA-positive 
(including VISA) staphylococcal strains. 
(p832) Efficacy of BMS-284756 against a quinolone and 
penicillin-suscepti ble Streptococcus pneumoniae strain and 
strains harbouring single or double isogenic mutations, and 
clinical strains with a single or triple mutation, in a mouse 
pneumonia model 
E. Azoulay-Dupuis, T. Kohler, J. Mohler, J. -P. Bedos, P. Moine, V. 
b e n u ,  C.  Carbon 
Paris, F; Cerieua, CH 
Background: BMS is a novel des-F(6) quinolone that exhibits enhanced in 
uitro activity against Gram positive and negative bacteria. 
Methods: This study compared BMS to ciprofloxacin (cipro) in in uitro 
activity, ability to select resistance in vim,  and efficacy in a mouse model of 
acute pneumonia caused by a virulent wild type Streptococcus pneumoniae (Sp) 
strain (WT) and isogenic resistant mutants: ParC (Ser7YTyr), GyrA 
(Ser81Tyr), ParC/GyrA (Ser7YTydSer81Tyr) or efflux mutant and by 
avirulent clinical strains with a ParE (Ile460Val) or with ParC/GyrA/ParE 
(Ser7YTyr/Ser81Tyr/lle4MIVal) mutations. lmmunocompetent or leuco- 
penic Swiss nuce were infected w t h  5 log10 or 7 log10 CFU of Sp, 
respectively. Drugs were administered q 12 h for 6 doses beginning either 3 
h (leucopenic) or 18 h postinfection. 
Results: BMS and cipro MICs were: 0.06/2 (WT), 0 .1250 (ParC), 0.25/2 
(GyrA), 1/32 (ParC/GyrA), 0.125/4 (emux), 0.125/16 (ParE), and 1.0164 
pg/mL (ParC/GyrA/ParE). Pharmacokinetic parameters in serum of P- 
4241 infected mice treated with BMS (25 mg/kg) vs. cipro (100 mg/kg) 
were, respectively: C tuax (7.5 vs. 12.6 pg/mL), peak/MIC ratio (125 vs. 
6.3), AUC (23.9 vs. 15 pg/h/mL), AUC/MIC ratlo (398 vs. 7.5) and time 
above MIC 24 vs. 8 h. Control mice died within 3-4 days. The efficacy of 
BMS (25 and 50 mg/kg), in uiuo was high (Y0-100% survival) against the 
W T  and mutants harbouring a single mutation whereas, with cipro (100 
mg/kg) no animals survived. Cipro at 250 mg/kg with treatment initiation 
at 6-h postinfection produced survival rates of 77% (WT), 27% (ParC), 80% 
(GyrA), 78% (efflux). Neither cipro (250 mg/kg) nor BMS (50 mg/kg) 
were efficacious against double and triple mutants. 
Conclusion: BMS was a more potent agent in uitro and more effective than 
Cipro against Sp strains harbouring single QRDR mutations. 
(p833 Effects of BMS 284 756 on articular cartilage in 
immature rats in comparison to ofloxacin and ciprofloxacin 
E. Kappel, S .  Fasheber, E. Lozo, U. Rahm, 1. Baumann-Wilschke, K 
Stahlmann 
Berlin, D 
Objectives: BMS 284 756 is a des-(6) fluoroquinolone exhibiting a 
comparatively low chondrotoxlc potential in juvenile dogs. We studied the 
chondrotoxicity and pharniacokinetics of the drug in immature rats. 
Methods: Immature Wistar rats ( n  = 42) were treated once daily for 5 dayc 
by oral intubation with BMS 284,756 at doses of 0 (vehicle), 200, 400, and 
600 mg/kg bw. Animals were treated from day 32 to day 36 postnatally 
before they were killed and the knee joints studied histologically. Further 
rats at the same developmental stage were treated correspondingly with 
ofloxacin or ciprofloxacin at 600 mg/kg bw. Plasma concentrations of BMS 
284 756 were measured by HPLC. 
Results: Under our study conditions we did not observe any signs of 
chondrotoxicity in immature raw treated for 5 days with oral doses up to 
600 mg BMS 284,756/kg. Similarly, ciprofloxacin had no effect on joint 
cartilage, but ofloxacin induced typical cartilage lesions. Peak plasma 
concentrations of 25.5 11.4 mg BMS 284,756/L were measured 30 min 
after multiple doses of 600 mg/kg which declined to 3.7 & 2.5 mg/L 480 
min after docing. 
Conclusions: In this direct comparative study, ofloxacin exhibited 
chondrotoxicity. but BMS 284,756 and ciprofloxacin did not cause cartilage 
lesions in juvenile rats. Assuming that this model is predictive, BMS 284,756 
and ciprofloxacin should be more suitable for paediatric use than ofloxacin. 
[ P834 1 /n vitm selection of fluoroquinolone resistance in 
Streptococcus pneumoniae 
K. I hvidson, A. Toptchieva. J. Gillis, D. Low, D. Bast. J .  de Azavedo 
Halqax, Toronto, CDN 
The increasing use of fluoroquinolones to treat respiratory tract infections 
has raised concerns about the development of resistance, particularly in S .  
pneurnoniae. In this study, we compared the propensity of S. pneumoniae to 
develop in uitro resistance against 3 fluoroquinolones, ciprofloxacin (CIP), 
levofloxacin (LEV), and moxifloxacin (MXF). 
Using agar dilution, S. pneirmoniae were exposed to CIP, LEV, or MXF at 
concentrations ranging from 1 to 8-fold MIC. MICs were determined using 
a microbroth ddution method recommended by the NCCLS and by E-test. 
The Q R D R  regions of the gyrA and parC genes were amplified and 
sequenced from isolates growing at super-inhibitory concentrations and the 
frequency of selection calculated. 
In total, 16 fluoroquinolone resistant mutants were isolated. The gyrA 
and parC genes were amplified and sequenced in 14 isolates. First-step 
mutants selected using CIP or LEV demonstrated cross-resistance to each 
other, but not to MXF. AU firs-step mutants selected with CIP or LEV 
possessed a parC (Ser7YPhe) mutation; MXF selected mutants possessed a 
gyrA (Ser81Phe) mutation. First-step mutants could be selected with CIP 
less than or equal to 8xMIC and as high as 4-fold MIC with LEV. First-step 
mutants could only be selected with MXF at less than or equal to 1-fold 
MIC. The frequency of selecnon for 1st step mutants with CIP and LEV 
was 1.1 x l o p 7  and 1.6 x respectively. The first step frequency of 
selection with MXF was 7.8 x lop7.  Second-step mutations could be 
selected with CIP and LEV at up to %fold MIC. The frequency ofselection 
ranged from 4.1 x lop" to 1.1 x lo-' for both antibiotics. Second-step 
mutations with MXF could be achieved at less than or equal to 2-fold MIC 
at a frequency of 2.1 x The results of our in uitro studies have 
significant clinical implications. That CIP and LEV were able to select for 
both first-and second-step mutations at concentrations above those achieved 
clinically is disconcerting, particularly because LEV currently has an 
indication to treat pneumococcal disease. In contrast, first-step mutants 
could only be selected for with MXF at less than or equal to MIC, well 
below achievable therapeutic levels. The recognition that second-step 
mutations occur more easily in strains possessing a firs-step mutation 
suggests that the best strategy to minimize resistance is to prevent the 
selection of an initial mutation. This can be achieved best by preferentially 
using a more potent agent, such as MXF, over less potent agents in the 
treatment of suspected pneumococcal infections. 
Persistent changes in rat Achilles tendons after a low 
single dose of a fluoroquinolone 
M. Shakibaei, G. Schulze-Tanzil, P. de Souza, I. Baumann-Wilschke, S. 
Metzner, R. Stahlmann 
Berlin. D 
Objectives: Quinolones have the potential to induce pathological changes 
in tendons that can manifest clinically as tendinitis or even tendon rupture. 
However, it is unknown for how long alterations may exist after short-term 
exposure to these drugs. 
Methods: Wistar rats (n=75) were treated with a single oral dose of 0 
(vehicle), 30, 100, 300 or 600 nig fleroxacidkg bw. The animals were 
killed 1, 4, or 12 weeks later and samples of Achilles tendons were studied 
by electron microscopy and Western blotting. 
Results: Pathological alterations were seen in tendon specimens at all dose 
levels, which increased in severity with increasing doses (dilatations and 
swellings of the rough endoplasmic reticulum and mitochondria; the 
nucleus was densified and the chromatin had clumped forming rough 
plaques). The cells detached from the extracellular matrix. Densitometric 
analysis of the Western blow with antibodies against vanous proteins showed 
that the relative deconn expression had decreased by 27%, fibronectin by 
30%, collagen type I by 30%. PI-integiin by 23% (4 weeks after treatment; 
low-dose fleroxacin compared to control samples). Similar results were 
obtained as late as 12 weeks aker single dose treatment. 
Conclusions: Our finding that rather low single doses of a fluoroquinolone 
induce persistent ultrastructural and biochemical changes in rat Achilles 
tendons is of concern. Ainied studies in patients suffering from such adverse 
effects are needed to define additional risk factors that render patients 
susceptible to this toxic effect of widely used antimicrobials. 
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/p836] Synergistic chondrotoxicity of ofloxacin at low doses 
and magnesium deficiency in juvenile rats 
K. Kiecke, E. Lozo, R. Schwabe, I. Baumann-Wilschke, R. Stahhnann 
Berlirt, Weihenstephan, D 
High single doses of fluoroquinolones or a magnesium-deficient diet, when 
given over a sufficient period of time, cause chondrotoxicity in j u v e d e  rats. 
Lot- i dow of fluoroquinolones administered for several days together with a 
slight magnesium deficiency mimic more accurately the therapeutic 
situation. We studied the effects of ofloxacin given at rather low doses 
together with a simultaneously administered magnesium-deficient diet in 
immature rats. 
Levof loxaci n 
Juvenile rats (4 weeks old) were treated twice daily with ofloxacin and fed 
either a standard or a magnesium-deficient diet for 5 or 7 days (Table). Knee 
joints were examined histologically, plasma levels of ofloxacin were detennined 
by HPLC. Incidence of ofloxacin-induced lesions wac higher in the 
magnesium-deficient animals suggesting a synergistic effect. Peak plasma lev& 
were < 10 mg/L in the high dose group and thus were in the same range as 
plasma levels in man during therapy. These results must be taken into account 
for a benefidrisk evaluation if ofloxacin is considered for use in paediatrics. 
Acknowledgement: Data are part of the doctoral thesis of Edith Lozo to 
be submitted to the Fachbereich Humanmedizin, Freie Universitat Berlin. 
This study was supported by a grant from the Deutsche Forschungsge- 
meinschaft (DFG). Imtitut flir Khnische Pharmakologie und Toxikologie, 
FU Berlin, D-14195 Berlin. 
/ps37j comparative in vitro activity of levofioxacin against 
Streptococcus pneumoniae and Haemophilus influenza strains in 
a Turkish university hospital 
P. Zarakolu, D. Giir, S. Kocagoz, S. Unal 
Arikara, TR 
Background: Levofloxacin and the other commonly used antimicrobials for 
respiratory system infections (RSI) were tested against 103 S. piienmoniae and 
28 H. i@uenzae strains isolated from patient? with community acquired RSI. 
Materials and methods: All S. pneutnoniae strains were isolated from adult 
(n=37) and chlldren (n=66) patients between 1996 and 2000. The 
specimens included sputum (n = 61), bronchoalveolar lavage (BAL, rz  16). 
blood (n = 14), deep tracheal aspirate ( 1 1  = 6), pleural fluid ( n =  3) and ear 
aspirate (n  = 3). H. irlflnenzae strains whch were isolated from children 
included sputum (n=19), BAL (n=5), ear aspirate ( n = 3 ) ,  and blood 
(rx = 1). Antinllcrobial susceptibility testing was performed by E-test strips 
(AB Biodisk, Sweden) and the results were evaluated according to the 
NCCLS criteria. 
Results: Intermediate penicillin resistance was observed in 40.% of S. 
pneumotiiae isolates, none of the isolates had high-level resistance to 
penicillin. All isolates were susceptible to ceftriaxone and levofloxacin 
(Table 1). All H. infuerizae strains were beta-lactamase negative and 25% 
were resistant to tnmethoprim-sulfamethoxazole. 
RasMmm (%) 
TrincPqAmf SuiBnrlh.aroL 71  39" 2J% 
L.e"omacin 0 % 0% 
Ce-s NT Ng*"Uv. 
a W r n h d r b i d I  w-**.-a 
Conclusion: As 40.5% of S. pnelrmonrae strains showed resistance to 
penicillin and 25% of H. infuenrae strains showed resistance to 
trimethoprim-sulfmethoxazole, ceftriaxone and levofloxacine can be 
alternative agents in the treatment of RSI. 
/p838) Comparative in vitro activity of levofloxacin and other 
antimicrobial agents against respiratory tract pathogenic 
bacteria isolated in Belgium 
P. De Mol, P. Mehn, F. De Ceulaer, G. Christiaens, M. P. Hayette 
Li&, B 
Objectives: to compare in vitro susceptibility patterns of Streptocorms pnenmoniae 
(Sp), Hamophilus influenrae (Hi) and Mormdla c~tarrhalis (MC) n order to select 
antimicrobd agent for treating bacterial respimtory infections. 
Methods: during 1999, 696 Sp, 474 Hi and 162 MC were collected from 
10 different hospitals located in different parts of Belgium. Susceptibility 
testing was performed by using E-test method. MICs were interpreted 
according to NCCLS. Antimicrobial agents tested included Levofloxacin 
(LEV), Ciprofloxacin (CIP), Penicillin (PEN), Erythromycin (ERY) for Sp 
or Clarythromycin (CLA) for Hi and Mc, Trimethoprim-Sulfmiethoxazole 
(SXT), for p e n i c h  non susceptible Sp (PNS): Amoxicillin (AMO), 
Cefotaxime (CTX), Cefuroxime (CEF) and for Hi and Mc: CEF. 
Results: 99% of Hi were susceptible (S) to LEV, CIP and CEF; 16% 
produced beta-lactamase, 82% were S to SXT and 12% to CLA. Mc were 
fully S to LEV, CIP, CLA, CEF; 75% of the strains produced beta-lactaniase 
activity. For Sp. of the 22% PNS, 7% were fully resistant (R); AM0 showed 
a good activity on those strains (S:92%), better than CTX and CEF. LEV 
was highly efficient on Sp (92%) and markedly more active than CIP. R to 
SXT (23%) and EKY (47%) were h g h  and correlated to PNS (R SXT: 
72%, R ERY: 79%). 
Conclusions: LEV offered the best spectrum of activity against Sp. Hi and 
MC; macrolides resistance rate was high and correlated to lower 
susceptibility to PEN. 
[p8391 Levofloxacin: low Prevalence of resistance amongst 
respiratory tract pathogens 
D. Felnlmgham, I .  Harding 
London, Upwell, Cambs, UK 
Introduction: Multinational surveillance studies continue to show 
increasing prevalence of antibiotic resistance among respiratory tract (RT) 
pathogens. The high prevalence of penicillin and/or inacrolide resistance in 
Streptococcus piieunioniae causes particular concern for empirical therapy. 
Levofloxacin, a fluoroquinolone with excellent in uitro activity against R T  
pathogens, has proven highly efficacious and well tolerated in clinical studies 
and offers an alternative treatment for RT infections. 
Objectives: To review fluoroyuinolone resistance development in RT 
pathogens and to determine the in vitro activity oflevofloxaciu against recent 
isolates from international surveillance studies, including PKOTEKT, the 
interactive internet-based surveillance database (www.protekt.org), and the 
Alexander Project. 
Results: The Alexander Project data show no increase in the mode MIC, 
MIC50 or MIC90 for S. pneumoniae (1 992-99), Haernophilw influenrue and 
Moraxella caturrhalis (both 1996-99) against ciprofloxacin or ofloxacin (the 
racemic form of levofloxacin). The prevalence of ofloxacin-resistant isolates 
has never exceeded 1% among S .  pneumoniae or 0.2% among H. irlfluenzae 
and M .  catunhalis. Global data &om Protekt 2000, including countries with 
high resistance prevalence, shows no marked increase in fluoroquinolone 
resistance in any of the major RT pathogens. 
Conclusions: The overall prevalence of levofloxacin resistance remains low. 
Combined with proven efficacy and tolerability, this makes levofloxacin an 
appropriate agent for the treatment of respiratory tract infections (Table 1). 
PROTEKT 2000 
MlCm 96 Pathogen (n) % % 
S.pneumn!ae (1327) 
( m a )  Suscepuble Intermediate Resistant 
Clprofloxann' 2 
c,profloxaan 0 01s 99 8 0 0.2 
L ~ Y D ~ O X ~ C ~ ~  n.015 ion 
Clpronoxacln 0 03 100 0 0 
Levofloxac!" 1 98.0 0 6  1.4 
H.mr7uenzae (1063) 
0 0 
Cl.catdrh3iis (465)  
Levofloxacln 0.03 100 0 0 
* N O  NCCLS breakpoint 
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Ip8401 In vitro activity of levofloxacin and ciprofloxacin on 
clinical isolates obtained from patients with cystic fibrosis 
G. Golini, F. Favari, F. Marchetti, R. Fontana 
Verona, I 
Patients with cystic fibrosis (CF) undergo frequent antimicrobial therapy 
courses for recurrent p u l m ~ ~ r y  infections. The administered drugs should 
include in their spectrum the more kequent bacterial pathogens such as S. 
aweus and P .  aerugimsa. Due to the repeated drug exposition, C F  isolates 
may develop resistance to several antibacterial agents. Levofloxacin (LVX) is 
a new fluoroquinolone suitable for infection therapy in CF patients. 
Susceptibility (S) according to NCCLS breakpoints to LVX and cipro- 
floxacin (CIP) on 20 strains of S. aureuc, 20 mucoid and 20 nonmucoid P. 
aeruginosa was detemllned by means of the E-test method following standard 
procedure. Quality controls were also introduced. The bactericidal activity 
(BA) of LVX and CIP on selected P. aeruginosa antibio-phenotypes was 
further assessed at lX, 2X, 4XMIC and serum C max (5.7 and 2.7 mg/L, 
respectively) in Mueller Hinton broth and logarithmic decrease plotted at 0, 
4, 8, 12, 24 h. Against S. uureus, mucoid and nonmucoid P. aeruginosa, LVX 
and CIP S percentages were as follow: 100,95; 65,70; 80, 80, respectively. In 
the BA experiments, both LVX and CIP determined a > 3 log decrease on 
all the studied strains even when intermediate or resistant. Re-growth at 12th 
h was observed mainly in mucoid strains, even tough a final decrease > 3 log 
was observed at 24th h. In the C mnr assay, both drugs exerted good 
bactericidal activity either at 12th and 24th h. In conclusion, LVX in vitvo 
activity on CF isolates was high and comparable to CIP. 
I 7 17-D) 
73 llM)O/l 
7 13-24) 
in 1 ~ x 1  
IX 195%) 
9 12-21 I 
n 2 
1p8411 In vitro activity of levofloxacin and comparators 
against clinical isolates of Pseudornonas aeruginosa 
G. BonGgho, G. Russo 
Catania, I 
Objectives: Pseudomonar aeruginosa is an important nosoconlid pathogen, 
responsible for 10-15% of worldwide nosocomial infections and, in Italy, 
for more than 15%. Despite the development of new antibiotics, 
multiresistant strains of P. aemgirtosa represent an important therapeutic 
problem. Levofloxacin (the L isomer of the racemic ofloxacin) is an oral and 
injectable fluoroquinolone, with a broad spectrum of antibacterial activity, 
good clinical efficacy and safety. The aim of this study was to investigate the 
activity of levofloxacin in comparison with Merent  antipseudomonal 
antibiotics against clinical isolates of P. aeruginosa. 
Methods: According to the NCCLS methodologies, the following tests were 
carried out: (1) the in uitro activity of levofloxacin against 300 P. aeruginosa 
isolated from hospitalized patients, with exception of those admitted to 
intensive care or haematology units, compared to ofloxacin, ciprofloxacin, 
piperacillin, amikacin, ceftazidime and imipenem; (2) the inoculum effect on 
the activity of levofloxacin and ciprofloxacin; (3) the munmal bactericidal 
concentration (MBC) of levofloxacin and ciprofloxacin; and (4) a comparative 
study of the rate of killing by levofloxacin and ciprofloxacin on P. aeruginosa 
ATCC27853 and on different isolates of P. aetuginosa. 
Results: The respiratory tract was the principal site of isolation (48.3%) 
followed by urinary tract (29.4%), blood (11.3%), skin and soft tissue (4.7%) 
and other sites (6.3%). The best activity was showed by in~penem (81.6%) 
followed by piperacillin (80.7%. The activity of levofloxacin was equal to 
ciprofloxacin (75.3%) but better than ofloxacin (58.1%). Moreover, the 
MIC values of levofloxacin did not show any statistical difference using two 
different inocula. Levofloxacin showed an excellent bactericidal activity, 
generally within one doubling dilution of the MIC. These results were also 
confirmed by the time-killing studies. 
Conclusion: According to the in vitro activity, levofloxacin could be considered 
a good option for the treatment of infections sustained by P. amginom, and 
c h c d  trials are required to corroborate this excellent in vitro data. 
lp842 Comparative analysis of levofloxacin vs ceftriaxonel 
azithromycin in the treatment of community acquired 
pneumonia: length of stay 
A. Gupta, S. Rai, T. Mckenzie 
Brenigsville, USA 
Background: CAP represents an important disease category both clinically 
and economically worldwide. Lately there has been an increased use of 
Fluroquinolone like LV as first-line agent Vs. CX + -Macrolide. Since no 
data is available relating the length of stay (LOS) and additional antibiotic 
use, we carried out this study. 
Methods: A retrospective study where 248 patients with clinical diagnosis 
of CAP were studied. 140 patients in the LV Gp were carefully matched to 
s d a r  108 patients in CX/AZ Gp, Although CX/AZ Gp showed hgher 
mean Fine score than LV Gp (103VS 88, P < 0.0001) on the predictive 
model of risk for CAP. Therefore, LOS analysis was stratitied by risk class. 
Results: 9 cases (LV Gp) with LOS > 14 days due to nosocomial infections 
were excluded from analysis (Sensitivity analysis conducted with and 
without 9 cases produced similar results). LOS was longer in LV Gp with 
Mean= 6.59, SD = 2.50 VS Mean = 4.29, SD = 1.83 in the CX/AZ Gp 
with sig. P < 0,0001. A two-way ANOVA showed convincing homogeneity 
of this treatment effect on LOS for Fine Score seventy risk classes 11-V(non 
sig. P= 0.288 for interaction effect). Risk classes by itself also predicted LOS 
significantly ( P  < 0.0001). 53 patients or 40% had additional abx added in 
LV Gp VS 10 or 9.3% in the CX/AZ Gp. AZ=13.9%, CX=8%, 
Clinda= 7%, Vanco = 7% additional abx used in the LV Gp. 
Conclusion: Despite lower Fine Scores, patients in the LV Gp had longer 
LOS by 2 days VS C X / A Z  Gp. Considerable amount of additional abx 
were used in the LV Gp. This could translate into significant total cost to the 
hospital. Total clinical outcome with first-line therapy must be considered 
rather than just the price of the antibiotics. Since this study is retrospective, 
additional prospective randomized studies needed for further analysis are 
now being undertaken. 
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hospitalized with CAP. Starting oral antibiotic at admission may facilitate a 
patient’s management and reduce treatment costs. 
lp844 Review of levofloxacin for the treatment of 
community-acquired pneumonia 
A. O’Hare, I. Simpson 
Upwell, UK 
Objectives: To assess the efficacy and tolerability of levofloxacin (LVFX) in 
the treamient community-acquired pneumonia (CAP) by meta analysis of 4 
clinical studies. 
Methods: Four mnlticentre international phase 111 studies (2 open, 1 double 
blind, comparative, and 1 open noncomparative) were performed in 
patients aged=18 years with mild, moderate or severe CAP. Patients 
received either oral LVFX or i.v. LVFX followed by oral, 500 nig once or 
twice daily. 
Comparator therapy included oral coamoxyclav 625 nig 3 x /day a 
macrolide; cefmaxone i.v. 1-2 g/day followed by oral cefuroxime axetil 
500 mg 2 x /day f a macrolide or cycline and ceftriaxone i.v. 4 g/day. 
Treatment duration was 5-14 days. The primary efficacy variable was 
clinical cure rate at test of cure (2-5 days post therapy) in evaluable patients 
(those with clinical signs and symptoms of pneumonia including radio- 
graphical ewdence). Efficacy analyses were also performed in patients with 
bacteriologically proven infection. 
Results: 1979 patients were clinically evaluable and 714 (36.1%) had 
bacteriologically proven infection. The most common pathogens were S. 
pneumoniae (279/786, 35.5%) and H. influenzae (193/786, 24.6%). Clinical 
success rates were 93.4% for LVFX and 89.6% for pooled comparators. 
Bacteriological success rates were 93.5% for LVFX and 87.4% for pooled 
comparators. Eradication rates for S .  pneumoniae (including penicillin- 
resistant isolates) and H. inJuenzae were 95.5% and 100%, respectively, for 
LVFX, and 93.8% and 90%, respectively, for comparators, LVFX was well 
tolerated with 9.6% of patients reporting serious adverse experiences of 
which < 1% were possibly related to study therapy. 
Conclusion: LVFX 500 mg is a safe and effective therapy for patients with 
CAP, including bacteraemic CAP or with infection due to penicillin 
resistant pneumococci or atypical pathogens. Levofloxacin is a suitable agent 
to replace combination therapy with p-lactams and macrolides. 
Levofloxacin and other fluoroquinolones as empiric 
treatment for community-acquired pneumonia 
M. O’Hare, I. Harding 
Upwell, UK 
Introduction: Community-acquired pneumoniae (CAP) is the sixth 
leading cause of death and the number one infectious disease in the USA. 
Streptococcus pneumoniae and Haemophilus infuenzae predominate among 
causative pathogens. However atypical pathogens (i.e. kgiowlla pneumo- 
phila, Chlamydia pneumonia and Mycoplama spp.) are of increasing 
impottance. Antimicrobial chemotherapy is necessarily empirical and 
options include a vanety of p-lactams, macrolides and fluoroquinoloues. 
Global increases in penicillin and macrolide resistance, particularly among S. 
pneumoriiae, are causing clinical concern in the treatment of CAP. 
Objectives: To rewew the c h c a l  and bacteriological success rates ofpenicillins, 
CephalosponnS, macrolides and fluoroquinolones in the treatment of CAP. 
Methods: 16 large, well-conducted and peer reviewed multicentre 
studies (1989-97) were reviewed on the basis of specific antibiotics and 
antibiotic class. 
Results: funongst the f3-lactams reviewed, clinical and bacteriological 
success rates ranged from 77% (penicillin) to 91% (coamoxyclav) and from 
84% (amoxicillin) to 96% (piperacillin), respectively. The parented 
cephalosporins ceftriaxone and ceftazidime achieved 90% and 100% clinical 
success. The macrolides vaned considerably in both clinical snccess 
(clarithroniycin 65% to roxithromycin 98%; mode 87%) and bacteriological 
success (mode 71.4%). S i x  ofthe seven fluoroquinolones reviewed achieved 
clinical success rates in excess of 90% (levofloxacin, 96%) and two agents 
(levofloxacin and temofloxacin) achieved 99% bacteriological success. 
Conclusion: The fluoroquinolones, and in particular levofloxacin, 
consistently offer the highest rates of clinical and bacteriological snccem in 
the empirical treatment of CAP. This situation, combined with conve- 
nience of dosing supports levofloxacin as a replacement for penicillin/ 
macrolide combination therapy in the treatment of CAP. 
/p8461 Treatment with levofloxacin of community-acquired 
pneumonia caused by Legionella spp 
M. Sinchez-Conde, J. A. Pkrez-Molina, L. Moreno, C. Sinchez-Camllo, 
M. Rivera, E. Bouza 
Madrid, E 
Levofloxacin (LEVO) is a third generation fluoroquinolone with proven 
efficacy in the treatment of community-acquired pneumonia (CAP) which 
also shows good in oitro and in animal model activity against Legiotiella spp. 
Given that 1-5% of CAP can be attributed to this microorganism, our 
objective was to evaluate the clinical efficacy of LEVO in the treatment of 
CAP caused by Legionella spp. 
Methods: Retrospective review of clinical records from January 1999 to 
October 2000 ofpatients diagnosed with CAP caused by Legioriella spp. who 
received LEVO as part of the treatment. 
Results: We studied 9 men and 1 female with a mean age of 50 years. Fine 
score at emergency room was: 2 patients class I ,  one patient class 11, five 
patients class III and two patients class IV. AU patients but one showed a 
McCabe score of 3. Two patients were HIV + and one was a heart 
transplant recipient. Clinical picture was characterized by fever (mean 5.7 
days before admission), moderate-severe dyspnoea (5 patients), severe 
hypoxaemia (8 patients) and hyponatraemia (6 patients). Most frequent 
radiological pattern was consolidation (10 patients), which was multilobar in 
7 patients, and multilobar and bilateral in 4 patients. Two patients developed 
pleural effusion and two showed interstitial infiltrate. Diagnosis relied on 
anhgenuria in all cases. Serology was positive in 4/6 patients, direct 
immunofluorescence in 1/3 patients and culture in 2/3 patients. Six patients 
received LEVO as only antibiotic therapy (one of them took 500 mg of 
clanthromycin on first day). The most frequent treatment schedule was 500 
mg qd i.v. two days followed by 12-19 days 500 mg qd P.O. All patients 
but one showed clinical improvement and disappearance of fever in the first 
48 h with no adverse events attributable to LEVO. One patients improved 
slowly because of complication (not related to pneumonia). Of the other 
four patients, two changed treatment because of fever: one from LEVO to 
erythromycin after four days and one from macrolides to LEVO after three 
days. The remaining two received macrolides plus LEVO, one received 
macrolides for six days before treatment with LEVO and the other for 12 
days at the same time. 
Conclusions: We think that LEVO is a good therapeutic option for the 
treatment of patients with moderate-severe Legiorrella pneumonia given its 
apparent clinical efficacy, safety and tolerance profile. This drug may indeed 
be more valuable in people susceptible to drug interactions with macrolides 
and/or rifampin, e.g. transplant recipients. 
ml Levofloxacin: review of advantages over 
cephalosporins in the treatment of acute exacerbations of 
chronic bronchitis 
1. Harding, I .  N. Simpson 
U p  well, UK 
Introduction: Streptocorms pneumoniae, Haemophilus ir$upnzae and Morawella 
catarrhalis are among the principal bacterial pathogens responsible for acute 
exacerbations of chronic bronchitis (AECB) in adults. Current empirical 
therapy with p-lactams and macrolides is becoming more problematic in some 
countries due to high and increasing incidence of resistance to these agents. 
The newer fluoroquinolones offer an alternative treatment for AECB. 
Objective: To review surveillance data kom PROTEKT, the interactive 
internet-based surveillance database (www.protekt.org), on the prevalences 
of p-lactam, macrolide and fluoroquinolone resistance and relate this 
information to clinical efficacy of levofloxacin in the treatment of AECU. 
Results: Recent global data from PROTEKT show no resistance to 
levofloxacin amongst H. influerazae ( n  = 1063) and M. catarrhalis (ti = 465) 
and low levels of resistance (< 2%) amongst S.  pneumorriae ( ) I  = 1327). In 
contrast, resistance to clarithromycin (42.%), cefaclor (50.4%) and 
cefuroxirne (34.2%) is high amongst S. pneumoniae and at least 10% of H. 
inJuenzae exhibit resistance to both clarithromycin and cefaclor. Clinical 
trials of AECB, including complicated cases, show that levofloxacin exhibits 
clinical success and bacteriologic eradication rates as least as high as cefaclor 
and cefuroxime axetil. 
Conclusion: High and increasing levels of macrolide and p-lactam 
resistance, and once-daily dosing favour levofloxacin as an alternative 
treatment for patients with AECB. 
(Table 1) 
164 Abstracts 
Treatrn mt  Outcome (96) Reference developed CDAD. Although not statistically significant (P=0.08), the trends 
Study  Abx Dose Duration Clinical Bact are suggestive of considerable difference between the two groups. Patients 
with CDAD stayed significantly longer in the hospital. In those with CDAD 
the median and mode duration of stay were 16.5 and 10.0 days, respectively, 
CXM 250 m g b i d  10 9 2 6  9 5 0  compared to 9.0 and 7.0 days, respectively, in those without CDAD. There 
was no difference in the clinical outcome of the two groups. 
CXM 250 mq bid 7-10 66.0 6 8  0 Conclusion: Levofloxacin appem to cause a lower incidence of CDAD 
compared with beta-lactam based treatment for LKTI. In light of these 
CCL ?SO m g  tid 7- 10 92.0 87.0 findings we are continuing thig study to determine if there is a true difference. 
(days) succes5 eradication 
AECB LVFX 500 rng od 5-7 94.6 97 0 DeAbate. 
1996 
Complicated LVFX 500 m g  od 7-10 7 9 0  77.0 Shah, 
AECB 1999 
AECB LVFX 500 rnq od 5-7 92.0 9 4  0 Habib, 
1998 
(p8481 Levoftoxacin is as effective as amoxicillin/clavulanate 
and clarithromycin in the treatment of acute sinusitis 
M. O’Hare, I .  Harding 
Upiidl, U K  
Introduction: Bacterial agents, primarily Streptococcus pneurnoniae, and 
Haemopliilus iuj7ueiizae followed by Moraxella iutanhalir and Stupaphylococcus 
aureux, been shown to be responsible for up to 80% of the adult cases of 
acute sinusitis (AS). Current empirical therapy with p-lactams and 
inacrolides is becoming more problematic in some countries due to high 
and increasing incidence of resistance to these agents. Levofloxacin, a newer 
fluoroquinolone, offers an effective alternative treatment for AS. 
Objective: To review surveillance data from PROTEKT, the interactive 
internet-based surveillance database (www.protekt.org), on the prevalences 
of p-lactam, macrolide and levofloxacin resistance and relate this 
infomiation to clinical efficacy of levofloxacin in the treatment of AS. 
Results: Data from PKOTEKT shows global resistance to clarithromycin 
has reached 16% and 42.5% amongst H .  ir$uenzae ( n =  1063) and S. 
yneirmoriiae ( a  = 1327). respectively. Penicillin-resistance has also reached 
42.3% in S. prieunioniae and is associated with 7% resistance to amoxicillin/ 
clavulanate. In contrast, there is no resistance to levofloxacin amongst H. 
irfluerizae and low levels of resistance (< 2%) amongst S. pneumoniae. In 
nonconiparative studies in respiratory tract infechons, levofloxac~n achieved 
clinical success rates of 82.9% and 91.6% with 89.5% and 100% 
bacteriologic eradication, respectively. In comparative studies, levofloxacin 
500 mg od exhibited clinical success rates as least as high as arnoxicillin/ 
clavulanate 500 mg tid and clarithromycin 500 mg bid. 
Conclusion: Once-dady dosing and high levels of macrolide and p-lactarn 
resistance support levofloxacin as the treatment of choice for patients with AS. 
(Table 1) 
Antibiotic Dose Duration Clinical Reference 
Levofloxacin 500 m g  od 10 R2.9 Gehanno, 1998 
Levoflaxacin 500 m g  od 10 -14 91.6 Syndor, 1995 
Levofloxacin 500 nj g od 14 88.4 Adelglass, 1998 
Am ox/clav. 500 m g  tid 14 87.3 Adelglass, 1999 
Levofloxacin 500 m g od 14 96.0 Adelglass, 1998 
(days) success (96) 
Clarithromycin 500 m g  bid 14 93.3 
v] Levofloxacin: review of pharmacokinetic and 
pharmacodynamic principles to clinical studies 
I .  Harding, I .  N. Simpson 
Upwell, UK 
Introduction: Pharmacokinetic and pharmacodynamic (PK/PD) models 
indicate that, for concentration-dependent killing agents (e.g. fluoroquino- 
lones), an AUC/MIC ratio of > 30 is necessary for effective eradication of 
Gram-positive organisms and good clinical outcome. However, in clinical 
use there is potential for considerable variation in both AUC and MIC of 
causative pathogen. 
Objective: To assess the robustness of the AUC/MIC model applied to 
levofloxacin efficacy against Streptococcus pneumoriiae in the treatment of 
pneumococcal respiratory tract infections in the clinical situation. 
Methods: Phannacokinetic parameters for a single 500 mg dose of 
levofloxacin, in human volunteers and patients with normal or impaired 
renal function were obtained from publications. Data from 3 large antibiotic 
resistance surveillance studies provided MIC distributions for S .  pneumoniae 
isolates obtained from respiratory tract infections. AUC/MIC ratios were 
determined for combinations of specific patient groups and organisms of 
varying susceptibilities to levofloxacin. 
Results: In healthy volunteers (n  = 20; mean age: 26.3 years; creatinine 
clearance [CLCR]:140 mL/min), the mean AUC of levofloxacin was 42.6 
nig/h/L. Amongst 933 patients (mean age 68.6 year; mean CLCR of 60 
mL/min), the AUC ranged from 21 to > 200 (mode: 71-80). Amongst 
groups of renally impaired patients ( n  = 47), the mean AUC ranged from 93 
to > 200. Susceptibility studies (Alexander 1999, 3523 isolates and TRUST 
111, 4296 isolates) returned an MIC90 for S. pneumoniae of 1 mg/L for 
levofloxacin, indicating AUC/MIC ratios of > 30 for over 99% patients. 
PROTEKT, the internet survedlance study (www.protekt.org) confirmed 
96.5% and 98.1% susceptibility to levofloxacin at 1 and 2 rng/L, 
respectively. On the basis of AUC/MIC > 30, MlCs of 1 and 2 mg/L 
predict 99% and 82% successful clinical outcome, respectively. Thete results 
support current clinical experience. 
Conclusion: The AUC for levofloxacm is generally higher in patients than 
healthy volunteers. Consequently, the PK/PD criteria AUC/MIC > 30 
provides a robust model for predicting clinical outcome with levofloxacin 
against S. pneumoniae. 
Ip851( Levofloxacin: low potential for hepato-biliary adverse 
reactions 
I. Harding, I. Simpson lp8491 Incidence of Clostridium difficile associated diarrhoea 
in patients with lower respiratory infection treated with 
levofloxacin or beta-lactam based therapy 
r-rPwe[/, [JK 
Introduction: Attention has focused recently on safety profiles of 
fluoroauinolone antimicrobials and several have been withdrawn from 
G. Gopal Kao, C. Mahankah Rao, I. Starke, P. Sedgwick 
hIld017, UK 
Aim: To compare the incidence of C .  digrile in patients with LRTI treated 
with Levofloxacin or beta lactain based treatment (BLT). 
Methods: Prospective clinical trial: the physicians in the hospital were 
divided into two groups, A and B. Patients admitted to the hospital with 
LRTI were allocated to either of the groups depending on the day of 
admission. The patients in group A were given Levofloxacin and in group B 
were given BLT. Patients were followed up till discharged from the hospital 
to record the course of Illness, outcome of treatment and occurrence of 
diarrhoea. Faeces from patients with diarrhoea were tested for C. d$de 
toxin A (CDT). Patients with 3 or more diarrhoea1 stools with presence of 
CDT were diagnosed as having CDAD. 
Results: 298 patients have been recruited so far. S i x  out of 158 patients 
treated with Levofloxacin compared to 12/140 patient7 treated with BLT 
clinical use. However, there are marked merences among the safety profiles of 
fluoroquinolones. Levofloxacin, the L-isomer of ofloxacin, is approved for use 
in adult patients with the following infections: acute sinusitis, acute 
exacerbations of chronic bronchtis, community-acquired pneumonia, skm 
and soft tissue infection and urinary tract infections. This review analyses safety 
data, collated from completed registration and postmarketig surveillance data, 
on the effects of levofloxacin upon liver and biliary systems. 
Results: Registration studies. A total of 8916 patients have participated in 
28 clinical pharmacology and 19 phase 111 registration studies; 5388 of these 
patients were treated with levofloxacin and 3528 with comparator drugs. 
Serious adverse events (SAEs) related to the liver system were observed in 
< 1% of the levofloxacin or comparator treated groups regardless of causal 
relationship to study drug. Most of these events consisted of increased liver 
enzymes, less often bilirubinaemia. 
Post-marketing experience. Over 100 inillion prescnptions for levo- 
floxacin have been sold worldwide since 1993. Since 1996 (67 million 
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prescriptions), the overall reporting rate of 167 SAEs relevant to liver and 
biliary systems is very small. Cases of hepatitis (23), liver failure (13) and 
necrosis (1) are very rare. Most of the 167 SAEs indicate a reversible 
hnctional disorder of the liver. 
Conclusion: Adverse event data to date do not indicate that levofloxacin 
has significant effects on the liver. The cumulative number of 37 cases of 
clinically significant liver disorders is very rare in relation to overall 
experience, i.e. > 100 million prescriptions sold. Strong evidence for a 
causal relationshlp with levofloxacin treatment, including a possible 
mechanism cannot be demonstrated for any of these cases as in most of 
the serious liver reactions reported for levofloxacin, plausible alternative 
causes (concomitant medication, underlying diseases and pre-existing 
conditions) could also provide an explanation. 
lp8521 Levofloxacin: low potential for cardiovascular adverse 
reactions 
M. O’Hare, I. N. Simpson 
Upiuell, Combs, UK 
Introduction: Some fluoroquinolone antibiotics have the potential to 
affect cardiac electrophysiology. Sparfloxacin and grepafloxacin lengthen the 
QT interval, typically in a dose-dependent manner. However, few of the 
electrophysiological changes associated with moxifloxacin and gatifloxacin 
have resulted in clinically significant adverse events. This review analyses 
safety data, collated from European (EU) registration studies and ongoing 
postmarketing studies, on the effects of levofloxacin upon cardiovascular 
(Cv) systems. 
Results: In preclinical and clinical studies, levofloxacin has shown no 
tendency to &ect or interfere with normal cardlac conduction. There were 
no serious adverse events of Torsade de Pointes or of Q T  prolongation 
either amongst the 5388 evaluable patients from the 19 clinical trials 
included in the EU registration or in recently completed clinical trials. 
Reported adverse events, which might be a manifestation of undiagnosed 
and/or untreated QT-prolongation (syncope, ventricular tachycardia, 
ventricular fibrillation, sudden death), were identical to those in the 
comparator arms in controlled studies. In 6 years of market exposure, 
encompassing over 130 d o n  prescriptions, the incidence of reported 
cardiovascular toxicity has been very low, both in controlled clinical studies 
and from spontaneous reports as part of postmarketing surveillance. 
Conclusion: Levofloxacin has had extensive postmarketing exposure, and 
has proven safe and very well tolerated across a full spectrum of populations, 
even including those with pre-existing cardiovascular disease. Significant 
cardiovascular adverse events are very rare, and many that have occurred are 
not hkely to have been associated with levofloxacin itself. AU reported 
clinically significant cardiac event cases across the fluoroquinolone class 
appear to have occurred in patients with pre-existing and typically severe 
heart disease, and/or with concomitant medications known to affect cardiac 
electrophysiology, and/or with other known risk factors. It is therefore 
reasonable to conclude that levofloxacin maintains a high benefit-nsk ratio. 
(Table 1) 
Phase Ill Non Studies Intensive 
Registration registration completed Monitoring 
studies studies after studies 
siibrnission 
All subjecb treated 53851 1,137 1 Y22 ?7,UOO 
Number and incidence@$ 
SAES 307 (5.71 40 (3.51 175 (9.11 186 (0.71 
Subjectswith CVSAEs 20 (0.37) 1 (0.09) 6 ( 0 3 )  ii (0.MJ 
Subjeaswilh SAEsnith fatal outcome 57 (1.1) 5 (0.441 48 (2 .q 7 6  (0.28) 
SubjedswithCVSAEs.vithfata1 outcome 16 (0.30J 1 (0.09) 5 (0.26) 10 (0.MJ 
Note SAEspossibly indicative of undiagnosed or untreated QT prolongation 
Moxifloxacin 
lp8531 /n vitro activity of moxifloxacin against streptococcus 
pneumoniae and Streptococcus pyogenes collected from centres 
throughout the UK and Eire 
D. Felmingham, I. Momssey 
London, UK 
Centres throughout the UK and Eire collected Streptococcus pneumoriiae and 
Streptococcus pyogenes from patients with respiratory tract and other 
infections. MIC were determined using the NCCLS broth microdilution 
method. Of 663 isolates of S.  pneurnoniae from Great Britain (England, 
Wales, Scotland), 3.5% were of intermediate susceptibility to penicillin 
(MIC 0.12-1 mg/L) and 5.6% were resistant (MIC > nig/L). Penicillin 
resistance was more prevalent in Ireland (N. Ireland and Eire) with 4.5% of 
intermediate susceptibility and 23.4% resistant. All isolates of S.  pyogenes 
(1152) were susceptible to penicillin. Macrolide resistance was found in 
10.7% of S. pneumouine from Great Britain and 7.1% in those from Ireland. 
Macrolide resistance in S. pyogenes was 5.1% in Great Britain and 3.3% in 
Ireland. Using breakpoints of 1, 2 and 1 mg/L, respectively, for 
ciprofloxacin, levofloxacin and moxifloxacin, 64, 99.4 and 99.8%, 
respectively, of isolates from Great Britain were susceptible to these 
fluoroquinolones. Similar results, 63.6, 100 and loo%, were found amongst 
strains from Ireland. All S. pyogeries isolates were susceptible to levofloxacin 
and nioxifloxach. Moxifloxacin was four times more potent than 
levofloxacin, which was twice as active as ciprofloxacin. These data 
confirm the improved potency of moxifloxacin against S. pneumoniae and S.  
pyogenes currently circulating in the UK and Eire which is retained against 
penicillin and macrolide resistant strains. 
lp8541 Antibacterial activity of moxifloxacin against 
pathogens related with respiratory tract infections 
A. Speciale, G. Blandino, R. Musumeci, G. Aleo, I .  Milazzo, G. Nicoletti 
Catania, I 
Moxifloxacin is a new synthetic 8-metoxy-fluoroquinolone that, even if It 
retains good activity against Gram-negative bacteria, has improved its 
activity against Grain-positive cocci, anaerobes, and intracellular and 
atypical pathogens. The inhibitory activity of nioxlfloxacni yeems to be 
little influenced by the known single genetic tnutations or by the presence 
of norA emux mechanism and the appearance of resistant bacteria among 
Gram-positive pathogens in iti v i m  studiec has been less comion with 
moxifloxacin than with other fluoroquinolones. Recently we carried out a 
study on 667 respiratory pathogens evaluating the activity of moxifloxacin 
in comparison with that of other antibiotics in common chnical use. MICs 
were performed by the NCCLS recommended broth-microdilution or 
agar-dilution method for susceptibility testing of different bacteria. The 
MIC range of moxifloxacin for Streptorocccw piieumoniae (1 OO), including 
strains resistant to penicillin and macrolides, was 0.03-0.25 mg/L 
(MIC90=0.12 mg/L), and for Streptococcus p y o p i e s  (120) was < 0.03- 
0.12 mg/L (MIC90 ~ 0 . 1 2  mg/L). All the strains of Haemophilus ir@wizae 
(120), Haemophilus paraiflfluenzae (120), and Moraxella ratanha/is (100). both 
beta-lactamase positive and negative, are inhibited at concentrations 
between 0.05 and 0.12 mg/L (MIC90=0.06 mg/L). The MIC range of 
moxifloxacin was for Esckerirkiu mli (30) and for Mebsiella prteumoniae (30) 
0.06-0.5 mg/L (MIC90 was 0.06 mg/L and 0.12 mg/L. respectively). 
Moxifloxacin also shows a good activity against intracellular and atypical 
pathogens of the respiratory tract, namely Mycoplasma sp. (12) 
(MIC90 = 0.06 mg/L) and Chlamydia sp. (10) (MIC90 = 0.06 nig/L). The 
MIC range of moxifloxacin for Bacteroides-forsythus (2) was O.Of~0.12 nig/L, 
for Fusobactenum sp. (14) and Peptostreptococcus sp. (11) was < 0.064.25 mg/ 
L (MICVO 0.25 and 0.12 mg/L, respectively), and for Bacteroides-fiofilis (12) 
was 0.12-2 mg/L (MIC90 = 2 mg/L). This study shows that moxifloxacin 
displays potent in vitro activity against respiratory pathogens and superior to 
that of other fluoroquinolones in particular against S. pneumoniae, anaerobic 
and atypical microorganisms. Moreover, moxifloxacin is a promising new 
agent for the treatment of respiratory tract infections. 
I P855 I Comparative in vitro activity of moxifloxacin against 
community-acquired respiratory tract pathogens isolated in France 
R. Leclercq, P. Allouch 
Cam, Le Chesnay, F 
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Objectives: To determine the current susceptibility to modoxacin  
(MXF) and to routinely used antimicrobials in Streptococcus pneumoniae (Sp), 
Haemophilus inyuenrae (Hi), Moraxellu catarrhah (Mc), Stophylococms aureus 
(Sa) and Klebsiella pneumoniae (Kp) isolated from community-acquired (CA) 
respiratory infections. 
Methods: Between January and April 2000, 2345 consecutive strains (Sp: 
1037; Hi: 708; Sa: 394; Mc: 165; Kp: 41) were isolated from 2088 adult 
patients wlth CA infections in 97 hospital laboratories. Susceptibility of all 
microorganisms to MXF, of Sp to penicillin G (P). amoxycillin (AMX), 
cefuroxime (CXM) and cefotaxime (CTX), and of Hi and Mc to AMX and 
coamoxyclavulanate (AMC) was determined in the participant centres by 
the E-test method. Other antibiotics including ofloxacin (OFX) against all 
organisms and oxacillin (OXA) against Sa were tested by the disk difision 
method. Sp isolated from blood cultures (n = 315) and all pneumococci non 
susceptible to penicillins (PDSP) were tested further in a single central 
laboratory for susceptibility to beta-lactams Tp, AMX, CXM, ceftnaxone 
(CRO)] and fluoroquinolones (FQs) [ofloxacin (OFX), ciprofloxacin (CIP) 
and MXFJ using the agar dilution method and E-test, and against 
levofloxacin (LEV) by E-test. Interpretation of susceptibllity categories 
were according to the CASFM standards. 
Results: 501/1037 Sp. (48.3%) had MICs o f P  greater than 0.06 mg/L and 
were thus considered PDSP. The percentages of P, AMX, CXM, C R O ,  
OD(, CIP and MXF intermediate susceptibility/resistance in pneumococci 
isolated from blood cultures (n =315) were 48.3, 35.9, 41.0, 6.3, 95.5, 40.3 
and 0.3, respectively. In PDSP isolated from blood cultures/respiratory 
samples (PI = 362), the corresponding intermediate susceptibility/resistance 
percentages were: 100.0, 71.5, 82.9, 15.7, 91.4, 36.5 and 1.9, respectively. 
Considering FQs activity, the MIC90s (E-test) were 6 mg/L, 1.5 mg/L, 1.5 
mg/L and 0.38 mg/L for OFX, CIP, LEV and MXF. Against Hi (32.1% of 
beta-lactamase producers) and Mc MIC90s were 0.094 mg/L and 0.125 
mg/L, 64 mg/L and 8 mg/L, 1.5 mg/L and 0.25 mg/L for MXF, AMX and 
AMC, respectiveiy. MIC90s of MXF against OXA-S (78% of strains) and 
OD(-S Sa were 0.125 mg/L and 0.094 mg/L, respectively, whereas it was 
0.845 mg/L for Kp. 
Conclusions: The rate of PDSP isolated from clinical samples, including 
blood cultures, was high. Resistance rates for MXF were low with no resistant 
Hi or Mc strain, less than 1% resistance in Sp and only 1 resistant strain of Kp 
(3%). MXF had the best iu-vitm activity among all antibiotics tested. 
Preventing the production of resistant mutants of 
Staphy/ococcus aureus with moxifloxacin and levofloxacin: dose 
ranging studies using an in vitro dynamic model 
I .  Lubenko, S. Vostrov, Y .  Portnoy, S .  Zinner, A. Firsov 
Mosco~e, RUS; Cambridge, USA 
Objectives: To compare the pharmacodyuamics of MXF and LVF with 
S.  aureuf and their ability to prevent bacterial resistance in multiple dose 
simulations over wide ranges of the ratio of area under the curve (AUC) 
to MIC. 
Methods: A clinical isolate of a methicillin-resistant strain of S .  aureus was 
used. The MICs of MXF and LVF determined by multiple serial dilutions 
were 0.37 and 0.6 mg/L, respectively. A series of monoexponential 
phamiacokinetic profiles that mimic once-daily administration of MXF 
(half-life 12 h) and LVX (half-life 6.8 h) for three days were simulated in 
vitro. The daily doses corresponded to comparable AUCT/MICs (T is a 24- 
h dosing interval) for both drugs-28-444 h for MXF and 31-484 h for 
LVX. CFU counts were recorded from the initial reduction to the end of 
the regrowth phase that followed the third dose. The total antimicrobial 
effect induced by the simulated regimens was expressed by the IE 
parameterarea between the control growth and time-kill curves from 
time zero to the hnie when bacterial counts on the regrowth curve achieve 
the same maximal numbers as in the absence of antibiotic. Possible changes 
in S. aureus susceptibhty were examined by daily MIC testing. 
Results: Except for the highest MXF AUCT/MIC (444 h). bacterial 
regrowth was observed to follow the initial reduction even after the third 
dose with both drugs at each level of exposure. The LE vs. log AUCT/MIC 
curves fitted by an E niax model were fluoroquinolone-specific: at each 
AUCTIMIC > 50 h. the IE of MXF was greater than LVX. With MXF, 
an increase in MIC was observed only at the lowest AUCT/MIC (28 h), 
whereas increased LVX MICs were seen at AUCT/MICs of31. 61 and 121 
h. Based on these data, the minimal MXF AUCT/MIC that prevented 
resistance is almost 5 times lower (54 h) than that of LVF (242 h) and a 7- 
fold lower peak concentration/MIC ratio prevented resistance with MXF (4 
vs. 27 for LVX). These values correspond to a 300-mg daily dose of MXF 
(less than the usual clinical dose) and 1370 mg of LVX (in excess of its 500 
mg clinical dose). 
Conclusion: These data suggest that MXF provided greater antimicrobial 
effect and more efficiently prevented resistance with a S. aureus strain. This 
method is useful to study the relative ability of different fluoroquinolones to 
prevent the selection of resistant mutants. 
[ P857 1 Pharmacodynamics of moxifloxacin with 
nonfermenters and 5. aureus 
I. Schneider, A. Bauemfeind, A. Dalhoff 
Munich, Wupperfal, D 
Objective: The intravenous formulation of MFX is at present under clinical 
investigation; the dose for treatment of infections caused by bacteria with 
elevated MICs is not yet definitely established. Twice daily 400 mg dosing 
could be more appropriate in comparison with 400 rng once daily. In order to 
define a pharmacodynamic cut-off concentration for high dosing we analysed 
the kinetics of &g of organisms exposed to fluctuating MFX conceutra- 
tions simulating the pharmacokinetics of 400 mg MFX i.v. twice ddy .  
Method: In this pharmocodynamic model the concentration gradients of 
MFX were simulated in bacterial cultures while the dynamics of CFUs 
were followed. MFX concentrations of twice daily i.v. infusion of 400 mg 
cover 1 h in healthy volunteers at steady state were used. C max at the end 
of the infusion period was 5,16 mg/L, t I l 2  was 12 h. Recent clinical 
isolates of S. aureus, S. maffophifia and P. aeruginosa with MICs of MFX 
between 1 and 8 mg/L were enrolled. Killing of 3 log of the initial 
inoculum of 10E6 CFU/mL of Mueller-Hinton-Broth (Difco) was 
considered as a clinically relevant parameter. 
Results: W n g  by at least three logs was found up to an MIC of 4 mg/L 
(tentative pharmacodynamic breakpoint) both for the nonfermentative 
organisms and for S.  aureus strains. W l n g  ofstrains with an MIC of 8 mg/L 
was limited to 1 log. 
Conclusion: We conclude that MFX at twice daily 400 mg dosing has a 
high therapeutic potential for the majority of infections caused by S. 
maltophifio (MIC90 4 mg/L*), S. aureus (MRSA MIC90 4 mg/L*) and a 
remarkable perspective for P .  aerufinoso (MIC50 4 mg/L*) infections. 
Reference: *Bauemfeind, JAC 1997; 40: 639-651. 
lp8581 Assessment of the pharmacodynamic parameter- 
recovery timefor moxifloxacin 
F. M. MacKenzie, K. Milne, I. M. Gould 
Aberdeen, UK 
Background: In order to optimise dosing schedules of antibiotics it is 
important to understand the details of their pharmacodynamic action. This 
enables appropriate breakpoints to be set and the best possible clinical 
outcome to be achieved. 
Methods: Recovery time (RT) is a relatively new pharmacodynamic 
parameter which is a measure of the time required for an initial inoculum to 
decrease due to kiU, remain static due to PA-SME and consequently regrow 
to the original inoculum. The in vitru test conditions, as far as possible, 
reflected the in vivo pharmacokinetics based on the recommended single 400 
mg moxifloxacin dose. 
Recovery time was measured for the 8-methoxyquinolone, moxiflox- 
acin, in combination with 13 isolates. They were 3 x Entewbarteriaceae; S. 
aureus 2 x resistant (R) and 2 x sensitive (S) to methicillin; H. injuenzae 
1 x R and 1 x S to ciprofloxacin and S.  pweuntoriiae 2 x R and 2 x S 
to penicillin. 
For each isolate, T > MIC was measured using a published time/serum 
concentration profile. The equivalent area under the inhibitory concentra- 
tion (AUIC) was calculated, simulated using kill curve methodology and the 
resultant kill measured. 
PA-SME was measured after exposing isolates to 10 x MIC for 2 h 
followed by continuous exposure to 0.3 x MIC. 
The time for regrowth to occur to the original inoculum was calculated 
based on the generation time for each isolate. 
Results: Mean recovery times for the S. pneumoniae isolates was 47 h, 64 h 
for the S.  aureus isolates, > 52 h for the Enterobactericaea and > 80 h for the 
isolates of H .  infuenrae. 
Conclusions: Recovery times far in excess of the 24 h dosing schedule for 
moxifloxacin, indicate iu  potent activity against the test isolates. The 
antibiotic Concentration w h c h  gives a recovery time equal to the dosing 
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schedule is termed the minimal effective dose and could be used to 
calculate breakpoints. 
1 P859 1 Bactericidal action of moxifloxacin 
T. G. Dora-John, C. J. Thomson, S. G. B. Amyes 
EdinbuYgh, Newbury, UK 
Bactericidal antibiotic action is usually determined at the optimum or 
maximum bactericidal concentration. This makes for direct comparison 
between different classes of antibiotics. It is generally accepted that for an 
antibiotic to be effective, a concentration of at least four times the minimum 
inhibitory concentration (MIC) must be acheved by the drug. Therefore, 
2-hour logarithmic cultures of Streptococcus pneumoniae R6, Moraxella 
catarrhalis and Haemophilus irg'7uertrae NCTC 11 931 were challenged with 
two, four and eight times the MIC of moxifloxacin, coamoxiclav (2 Fg/mL) 
and clarithromycin. The viable count was monitored for the following 3 h, 
on blood agar for the first two and chocolate blood agar for the latter. 
Against S. pneumoniae, moxifloxacin showed rapid killing of this organism (2 
logs/h), with coamoxiclav giving a much slower bactericidal response. 
Clarithromycin had very little bactericidal action at 4 x MIC and was 
generally less effective than moxifloxacin. Moxifloxacln had the most 
significant bactericidal action against H. influerzzae in comparison to both 
coamoxiclav and clarithromycin and was able to maintain this kill rate over 
the entire 3-hour period. Co-amoxiclav reduced the viability of M. 
catarrhalis by 2 logs in 3 h and clarithromycin N e d  this organism by a 
maximum of 1 log over the same time. Overall, moxifloxacin had the most 
rapid bactericidal effect against all three pathogens at all multiples of the 
MIC tested. 
Ip8601 Pharmacokinetics and tissue penetration of 
moxifloxacin in male rats with acute necrotizing pancreatitis 
R. G. Mundkowski, N. Block, R. Wacke, S. Park, B. Drewelow 
Rostock, D 
Despite of high standard intensive care and surgical management acute 
necrotizing pancreatitis is still related with an extremely high mortality rate. 
The high lethality is determined by local infectious complications, especially 
in necrotizing areas. Limited penetration of antimicrobial drugs in these 
areas is considered to be a major cause for failure of therapy of severe 
infections. On that score, the value of fluoroquinolones has not been 
sufficiently investigated yet. In order to address the penetration capability of 
moxifloxaciu with respect to the healthy and inflamed pancreas, the 
pharmacokinetic profiles in blood and the distribution into the relevant 
tissues, pancreas and muscle, were monitored. Young adult male Wistar rats 
(224 30 g), ofwhich one group has been pretreated with 0.2 mL olive oil 
into the pancreatic duct to induce an acute necrotizing pancreatitis, were 
anaesthetized by intraperitoneal injection of ketamine (200 rng/kg). 5 mg/ 
kg moxifloxacin were slowly administered through the caudal vein. From 
each animal (7 pancreatitis rats and 7 controls per time point), samples were 
taken Gom blood (1 mL), pancreatic and muscle tissue (c. 400 mg) at either 
10, 30 min, 1 or 4 h after application. Concentrations of moxifloxacin were 
determined by H P L C / W  using ofloxacin as an internal standard. Mean 
serum concentrations of Moxifloxacin at 10 min in rats with pancreatitis 
were 1886 ng/mL vs. 1805 ng/mL in controls, at 30 min 1616 vs. 1165 ng/ 
mL, at 60 min 1020 vs. 960 ng/mL and at 240 min 350 vs. 222 ng/mL, 
respectively. Corresponding concentrations in pancreatic tissue were in the 
mean 3-fold higher (range 1717-5916 ng/mg), and in muscle 2-fold higher 
(833-5574 ng/mg). The mean serum elimination half-lives ( t l ,Z)  were 1.9 h 
in rats with pancreatitis and 2.0 h in controls. The MICs of the pathogens 
encompassed by moxifloxacin (e.g. E.coLi-60-1000 ng/mL; Klebsiella spp.- 
500 ng/nL; S. aureus-60-130 ng/mL) were exceeded at least 4 hours in 
pancreatic tissue and one hour in serum. Furthermore no significant 
dil5erences between healthy and pancreatitis rats have been detected for 
all checked parameters. In conclusion, moxifloxacin has been demonstrated 
to penetrate rapidly and efficiently into pancreatic tissue, even into 
the inflamed pancreas. Although the pharmacokinetic data do not allow 
to predict a clinical impact, the characteristics of moxifloxacin may have 
a potential benefit from a microbiological and pharmacokinetic point 
of view. 
Ip8611 Moxifloxacin and levofloxacin: antibacterial activity in 
a dynamic model simulating lung and serum concentrations 
U. %am, S. Schubert, A. Dalhoff 
Kiel, Wuppertal, D 
Objectives and methods: To compare the bactericidal activity of 
moxifloxacin (MXF) and levofloxacin (LEV) against Staphylococcus aureus 
133 and Klebsiella pneumoniae 63 considering the pharmacokinetic properties 
ofMFX and LEV in the respiratory tree in parallel to serum. MFX and LEV 
concentrations in serum (S, C may 3.316.6 mg/L), bronchial mucosa (EM, 
C max 5.5/8.3 mg/L), epithelial lining fluid (ELF, C max 24.4/10.9 mg/L), 
and alveolar macrophages (AM, C max 62.0/41.9 mg/L) following a single 
oral dose of 400 nig and 500 mg, respectively, were simulated in a one 
compartment in uitro pharmacokinetic model. The colony forming units 
(CFU) were determined immediately after inoculation (lo-" CFU/mL) 
and after incubation for 1-24 h at 37°C. 
Results: The time to 99% kilhng (h) is shown in the Table. 
Both MFX and LEV were rapidly bactericidal against the indicator 
organisms. Concerning S.  aureus MFX required 0.5-2 h less time to achieve 
99.9% kdhng than LEV. Against K .  pneumoniae the results were comparable. 
The in toto bactericidal effect of MFX was more pronounced showing a dose 
dependent increase at the concentrations relevant in the respiratory tree. 
Additional the postantibiotic effect of MFX at the ELF concentrations was 
longer than that of LEV. 
Conclusion: Moxifloxacin was slightly more effective than Levofloxacin. 
jp8621 Moxifloxacin i.vJp.0. compared with amoxicillin/ 
clavulanate i.vJp.0. with or without clarithromycin in the 
treatment of community-acquired pneumonia 
R. Finch, 0. Collins, R. Kubin 
Nottingham, Newbury, UK; Wupperfal, D 
Objectives: To compare the efficacy of sequential i.v./p.o. modoxacin 
400 mg qd for 7-14 days in the treatment of patients with clinically and 
radiologically documented mild-moderate or severe CAP. 
Methods: The study was powered to demonstrate equivalence of efficacy 
(delta of 10%). A total of 628 patients were enrolled in an open label study 
comparing moxifloxacin to sequential high-dose i.v./p.o. amoxicillin/ 
clavulanate (1.2 g i.v. q8 h/625 rng p.0. q8 h) with or without i.v./p.o. 
clarithromycin (500 mg bid). 538 patients were valid for efficacy, 258 
(MXF) vs. 280 (CMP, 193 patients on amoxicillin/clavulanate with 
clarithromycin and 87 patients on amoxiclllin/clavulanate alone); 131 were 
microbiologically vahd, 64 (MXF) vs. 71 (CMP). The two groups were 
comparable in terms of demography, clinical status and bacteriology. 
Results: The clinical success rate at the test of cure visit (Day 5-7 post- 
therapy) for MXF (93%) was statistically superior to that of anioxicillin/ 
clavulanate & clarithromycin (85%) [95% C.I. 2.9%, 13.2961. Microbiolo- 
gical success (eradication + presumed eradication) was also statistically 
superior for MXF-treated patients (94%) compared to those treated with 
the comparator (82%) [95% (2.1. 1.2%, 22.9%]. The incidence of adverse 
events (AEs) was similar in both groups, however, there were fewer deaths 
in the moxifloxacin arm (3% vs. 5.3% for CMP). Of note, the time to 
apyrexia was also statistically significantly quicker for MXF-treated patients 
than for CMP-treated patients (median 2 vs. 3 days P=0.008). 
Conclusions: Sequential i.v./p.o. moxifloxacin is both clinically and 
bacteriologically statistically superior to the current recommended treatment 
regimen for patients with CAP who require hospitalization. 
lp863 Safety assessment of sequential i.v./p.o. moxifloxacin 
in the treatment of patients with community-acquired pneumonia 
L. Mandell, S. Choudhri, R. Kubin 
Hamilton, CDN; West Haven, USA; Wuppertal, D 
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Objectives: To assess the safety of (i.v.) moxifloxadn 400 mg once daily (qd) 
for the treatment of patients with clinically and radiologically documented 
nild to moderate or severe community-acquired pneumonia (CAP). 
Methods: Two prospective, randomized, controlled, Phase 111 studies, 1 
North American (NA) and 1 European, were conducted to evaluate the 
safety and efficacy of sequential IV/PO moxifloxacin for the treatment of 
inild to moderate or severe CAP. The NA study used a double-blind, 
double-duinniy design; the European mal was open label. Both compared 
sequential i.v./p.o. nioxifloxacin (400/400 mg qd) to sequential i.v./p.o. 
comparator drugs (NA study: i.v. alatrofloxacdp.~. trovafloxacin [200/200 
mg] or i.v./p.o. levofloxacin [500/500 mg]; EU study: i.v. Amoxac&n/ 
clavulanate (A/C) 1.2 g QS h/PO A/C 625 mg tid with or without i.v./ 
p.0. Clarithroniycin 500/500 mg qd)). In both studies, Day 1 preinfusion 
and Day 3 postinfusion ECGs were taken to specifically assess cardiac safety. 
Pre- and postinfusion ECG data were used to calculate the mean QTc 
change following MXF infusion. 
Results: Safety data were available for 550 MXF and 579 comparator 
patients in the 2 i.v./p.o. studies. The incidence of AEs (68% vs. 73%), 
serious adverse events (SAEs) (17% vs. IS%), drug-related AEs (33% vs. 
31%)) and treatment discontinuation due to AEs  (6% vs. 5%) was sirmlar for 
the MXF and comparator-treated patients, with GI events occumng most 
frequently in both groups. No QTc-related cardiac events were noted for 
either i.v./p.o. MXF or the comparators. Post drug infusion ECGs in the 
combined i.v./p.o. studies revealed a QTc change with nioxifloxacin of 
3 29 nu (delta QTc not different from oral moxifloxacin) and with the 
coniparators of -4 29 ms. Of note, there was no correlation between the 
plasma MXF concentration levels and the observed QTc prolongation. 
Conclusions: Sequential i.v./p.o. moxifloxacin at a dose of 400 mg once 
daily has a favourable safety profile, similar to that observed for oral 
nioxifloxacin and the comparator drugs. Moxifloxacin has been shown to be 
safe and efficacious in the treatment of conmunity-acquired pneumonia, 
with no unusual or unexpected drug-related AEs reported. 
p8wl Safety and efficacy of moxifloxacin vs. levofloxacin in 
the treatment of AECB 
J. Urueta, H. Ariza, J. De Brito, A. Caballero, A. Garcia, G. Gonzalez, 
A. Torres 
Mexico, MEX 
Objectives: To compare the rafety and efficacy of MXF (400 mg od 5 days) 
vs. LEV (500 mg od 7-days) in the treatment of AECB. 
Methods: A total of 563 patients with AECB were enrolled, with 437 valid 
for e6cacy (PP). 221 (MXF) vs. 216 (LEV); 278 (63.6%) were 
microbiologically valid, 143 (MXF) vs. 135 (LEV). 
Results: Clinical success (resolution) rates at Test-of-Cure-visit (7-4 days 
post therapy) were: MXF 91 .O% vs. LEV 94.4% (95% confidence interval- 
7.55%. 2.06%). Microbiological success (eradication + presumed eradica- 
tion) rate was 93.7% (MXF) vs. 94.0% (LEV). The incidence of adverse 
events (AEs) were similar in both groups. Most AEs were digestive systeni- 
related: overall 17.3% (MXF) vs. 17.7% (LEV), diarrhoea 4% (MXF), 3.9% 
(LEV) and nausea 6.1% (MXF) vs. 6.0% (LEV). Discontinuations due to 
AEs were similar in both groups. 
Conclusions: Five day MXF is as safe and effective (clinically and 
bacteriologically) as 7-day LEV in the treatment of AECB. 
ip8651 Safety and efficacy of moxifloxacin vs. amoxicillinl 
clavulanate in the treatment of acute sinusitis 
J. Atrieta, A. Galgano, E. Sakano, X. Fonseca, G. Gonzalez, A. Torres 
Cot. Toriello Guewa, MEX 
Objective: To compare the safety and efficacy of MXF (400 mg od 7 days) 
vs. AMOX (625 mg tid 10 days) in the treatment of acute bacterial sinusitis. 
Methods: A total of 526 patients were enrolled with 460 valid for efficacy 
(PI'): 227 (MXF) vs. 233 (AMOX); 237 (51.5%) were nlicrobiologically 
valid: 116 (MXF) vs. 121 (AMOX). 
Results: Clinical success (resolution) rates at Test-of-Cure-visit (7-4 days 
post therapy) were: MXF 93.0% vs. AMOX 93.6% (95% confidence 
interval:-5.38%, 4.13%). Most frequently isolated organisms were S. 
pneumonaie, H.  ir!fluenzae and S .  aureus. Microbiological success (eradica- 
tion+ presumed eradication) rate was 95.7% (MXF) vs. 97.5% (AMOX). 
The incidence of adverse events ( A E s )  were sindar in both groups. Most 
A E s  were digestive system-related: overall 24.9% (MXF) vs. 25.8% 
(AMOX), diarrhoea 7.3% (MXF), 11.3% (AMOX) and nausea 9.0% 
(MXF) vs. 5.3% (AMOX). Discontinuations due to AEs were similar in 
both groups. 
Conclusions: The overall results of the clinical and bacteriological response 
demonstrate that 7-day MXF is as effective and safe as 10-day AMOX for 
the treatment of acute bacterial sinusitis. 
In virro testing of antimicrobials 
lp866 Susceptibility of amoxicillin/clavulanic acid and 
15 other agents: comparison of BSAC, DIN, SFM and NCCLS 
MIC methods 
L. Koeth, A. Bauernfeind, D. Fehngham, R. Leclerq, K. Saunders, 
V. Schafer 
Westlake, USA; Muiiich, D; Loridori, UK; Caeri, F; Harlow, UK; Fran@rt, D 
Background: Variations in susceptibility methodology and interpretive 
breakpoints niay mpact the integration of MIC data from multinational 
studies. Data from methods used in Europe and United States were 
compared to determine if there were aiiy significant differences. 
Methods: MIC testing was performed using BSAC method for 881, DIN 
method for 889 and SFM method for 874 organisms and compared 
with NCCLS methods. Organisms tested included Streptococcus pneunioniae 
(SP), Hneitrciphilus ir!flueiizae (HI), Morureh rafarrhaiis (MC), methicillin- 
susceptible Slaphjrlococcus aidreus (MSSA), niethicillin-susceptible Staphyb- 
coccus epiderwiidix (MSSE), Streptococcus pyogeizes (PY), and viridans Strepto- 
Results: Essential agreement rates for amoxicrUin/clavulanic acid are shown 
in Table I .  
coccus (SV). 
The range of essential agreement rates (9! within 1 dilution of NCCLS) for 
all agents for each organism are shown in Table 2. 
Conclusion: Overall, the coinparison of methods with NCCLS methods 
corn most Comparable to least comparable was DIN, BSAC aiid SFM. 
jp8671 Evaluation of European standards for routine state 
control of antiseptic in vitro activity 
E. Bocian, S. Tyski 
Warsaw, PL 
Medicinal products such as antiseptics are used for slun dirinfecting, most 
often hands. European Conunittee for Standardisation approved several 
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European Standards, which described test methods for establishing, whether 
an antiseptic does or does not have a bactericidal or fungicidal activity under 
the laboratory conditions defined by EN. In Poland test methods and 
requirements of Standards Phase 1 and Phase 1/Step 1, have been recently 
used during registration procedure of antiseptic preparations. Basic 
bactericidal (EN 1040) and fungicidal (EN 1275) activity were investigated 
as well as bactericidal activity of products for hygienic and surgical handrub 
and hand wash used in human medicine @rEN 12054). All methods and 
used neutralizers were validated. Several commercial antiseptic preparations 
containing alcohol (ethanol or propanol) and chlorhexidine were analysed 
in different existing forms: liquid (emulsion), gel or cream. 
Standard bacterial strains: S.  aureus ATCC 6538, P. aerufinosa ATCC 
15442, E. coli ATCC 10538, E. hime ATCC 10541 and standard fungal 
strains: C .  albicans ATCC 10231, A .  niger ATCC 16404 were used, when 
EN standards were evaluated. 
Significant, at least 100 000 or 1000 reduction factors in viable count, 
depending on manufacturer handrub or handwash recommendation, were 
achieved. Different biocidal efficiency of antiseptics tested was observed 
when 2-fold preparation dilutions were tested. All antiseptics investigated 
complied with the applied appropriate European Standards. Additional 
analysis of alcohol-based preparations (for hygienic and surgical handrub), 
with the usage of clinical S.  aureus (MKSA) strains and ESBL producing 
Gram-negative rods-E. coli and P. aeruginosa, were performed. Standardized 
bacterial suspensions were applied. In the test, preparations nondiluted as 
well as diluted 2 x , 4 x , and 8 x were analysed twice in exposure-30 sec 
and 1 min. Liquid alcohol antiseptics seem to be more effective than these in 
gel fomi. 
w] Evaluation of daptomycin susceptibility by the €-test 
method and the effect of varying calcium concentrations in the 
test medium 
S. D. Brown, A. L. Barry, P. C. Fuchs 
Wilrorrviiie, U S A  
Daptomycin MICs were determined simultaneously by the NCCLS broth 
microdilution method and by E-test for a total of 195 Gram-positive 
bacteria, representing 17 species. In addition, a subset of 20 organisms were 
tested by E-test on 10 lots ofMueller-Hinton agar and one lot of Isosensitest 
agar, for whch calcium and magnesium levels were assayed. The geometric 
mean daptornycin MIC for the entire collection was 0.46 pg/mL when 
tested by broth microdilution and 0.73 pg/nlL when tested by E-test. But 
the MIC differences between the two methods vaned aniong the mfferent 
species tested. For some enterococcal species the E-test MICs were 
essentially the same as those by broth microdilution; for S. agalactiae the E- 
test MICs were nearly threefold higher. This trend of slightly higher E-test 
MICs resulted in no very major discrepancies, 5 (2.6%) major discrepancies, 
and 27 (13.9%) minor discrepancies. The concentration of calcium in the 
different lots of Mueller-Hinton agar vaned from 4 to 36 pg/mL. 
Daptomycin E-test MICs varied inversely with the calcium concentration. 
E-test daptornycin MICs for the quality control strains were consistently 
within the proposed quality control range only on media with > 20 pg/mL 
of calcium. Therefore, for determining daptomycin MICs by E-test it is 
important to monitor the calcium levels of the test medium by testing 
appropnate quahty control strains. 
)p869/ Comparison of Microscan Dried Overnight panel to an 
NCCLS reference panel for antimicrobial susceptibility testing of 
S y n e r c i d 
J. Hinder, P. Schreckenberger, D.  Ballou, L. Clarke, J .  Johnston, 
S. Connell, B. Zimmer 
L o s  Anfeles, Chicago, Albuquerque, Brouklyct, West Sacramettto, U S A  
A multicentre study was conducted to compare the accuracy and reliability 
of antimicrobial susceptibility testing of Synercid (quinupristin/dalfopristin) 
on a Microscan Dried Overnight panel (TEST) as compared to an NCCLS 
broth microdilution reference panel (REF). A total of 255 Gram-positive 
isolates (164 fresh and 91 stock) were tested at four sites during the clinical 
study. An additional 284 stock culture isolates were tested at Microscan. 
Essential agreement between the TEST and REF panels for the efficacy 
phase was 98.0% (5281539) for all organisms. Interlaboratory reproducibility 
was evaluated at the four clinical sites using 10 Gram-positive organisms, 
selected to include strains with on-scale MlCs in addition to the 
recommended NCCLS Quality Control (QC) strains. During the 
Reproducibility phase results obtained with the autoSCAN-4 and Walk- 
Away Systems were compared to those obtained from manual reads. The 
interlaboratory Reproducibility (manual readings) was 99.4% (1791 180). 
The instrument Reproducibility was 100% for the autoSCAN-4 and 98.9% 
for the WalkAway Systems. All results from daily testing of the NCCLS QC 
strains were within the expected range. Results obtained with Synercid on 
Microscan Dried Overnight panels showed excellent correlation with those 
obtained using an NCCLS broth microdilution reference method. 
1p870) Determination of antimicrobial activity of daptomycin, 
vancomycin and linezolid against enterococci, staphylococci, 
streptococci and pneumococci using disk and €-test strip testing 
methods 
A.  Sullivan. A.-C. Palmgren, C. E. Nord 
Srockhofm, S 
Objectives: To detemne the in oitro activity of daptomycin, vancoinycin 
and linezolid against recent clinical isolates of enterococci, staphylococci, 
streptococci and pneumococci using different methods. 
Methods: Eighty-four isolates of Staphylococcus aureus (53 methicillin 
sensitive and 31 methicillin resistant), 101 isolates of Staphylococcus epiderntidis 
(51 methicillin sensitive and SO methicillin resistant), 61 isolates of 
streptococci (30 Streptococcus group A and 31 Streptococcus nongroup A), 
56 isolates of Streptococcus pneumoniae and 100 isolates of enterococci (50 
Enteroc~,ccurfaecaliss and 50 Enteroroccus-faecjum) were tested for susceptibility 
against daptomycin (30 pg). Enterococci were further tested for suscept- 
ibility against vancomycin (30 pg) and linezolid (30 pg). The strains were 
isolated from wounds and urinary and respiratory tract infections. The agar 
disk mfision method and the E-test nirthod were performed using 
Mueller-Hinton agar according to the NCCLS reconmmendations. 
Results: The results of daptomycin 30 pg disk di&sion method and E-test 
(Median zone (mm), MIC50, MIC90, Range) are as follows: MSSA (53). 
1.0, 1.5. 0.19-1.5; MRSE (50), 23.5, 0.75, 1.5, 0.125-1.5; Streptococcus 
group A (30), 24, 0.125, 0.25, 0.094-0.75; Strqtococrus nongroup A (31), 
22, 0.38, 0.75, 0.094-2.0; S. pneumoiziae (56), 24, 0.5, 0.5, 0.38-1.0; E. 
faecalis (50), 21, 2.0, 2.0, 0.125-6.0; E..faecium (50), 18, 4.0, 8.0, 1.0-8.0. 
The susceptibihty of enterococci against vancomycin and linezolid with the 
disk di&sion method was for E. fmcalis 19 and 28 mn and for E. &en'urn 24.5 
and 27 nun, respectively. The result of the E-test for E.-faecalis was (MIC50, 
MIC90, range) 1.5, 3.0, 0.5-3.0 against vancomycin and 1.0, 1.0 and 0.5-1.5 
against linezolid and the corresponding figures for E.faerium were 0.75, 1.0, 
0.38-16 against vanconiycin and 1.0, 1.0, 0.5-1.5 against linezolid. 
Conclusions: The present data indicate that there is a good agreement 
between the agar disk and the E-test strip methods for the detemiination of 
daptomycin susceptibility against enterococci, staphylococci, streptococci 
and pneumococci. Daptomycin was as active as vancomycin and linezolid 
against the tested enterococci. Clinical studies are underway which will help 
determine the clinical significance of daptomycin potency. 
20, 1.0, 1.5, 0.25-2.0; MRSA (31), 20.5, 1.0, 1.5, 0.5-2.0; MSSE (Sl), 22, 
1p8711 Antimicrobial susceptibilities of anaerobic bacteria and 
comparison of the €-test, ATE ANA and agar dilution 
susceptibility testing techniques 
0. Koru, M. Ozyurt, C. Acikel, H. Aydogan, A. Basustaogh 
Ankara, TR 
A total of 322 strains were isolated from different clinical specimens. These 
isolates were tested for susceptibility to eight antibiotics (PeniciUjn G, 
Amoxicillin/Clavulanic acid, Cefoxitin, Imipenem, Chloramphenicol, 
Vancomycin, Metronidazole, Clindamycin) by using two different methods 
which are ATB-ANA sttips, PDM Epsilometer test (E-test) strips. The 
results were compared with those of gold standard agar dilution method 
which were performed according to the NCCLS criteria. Iniipenem was 
found as the most effective agent in oitro among the agents tested(100%). 
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Susceptibility to penicillin G, amoxicillin/clavulanic acid, cefoxitin, 
chlorampheilicol, vancomycin, metronidazole and clindamycin are 36.7, 
83.3, 88.3, 96.6. 30, 85 and 90, respectively. E-test have showed statistically 
a good correlation ( r =  0.62,P=0.001) with the results of agar d u t i o n  (total 
agreement for all antibiotics changing between 90.01 and 98.45%) and a 
moderate correlation ( r =  0.45,P= 0.048) with the results of ATB-ANA 
method (total agreement for all antibiotics changing between 75.46 and 
98.76%). However, it was concluded that the routine use of agar dilution 
procedure might cause some difficulties due to its difficult and nonpractical 
applicability and requiring experienced personal to interpret. 
Fm] Evaluation of synergy between levofloxacin and 
cefiazidirne against 5. maltophilia using checkerboard and Rest 
methods 
L. Piccoli, A. Felici, F. Marchetti, A. Zanoncelli, E. Di Modugno 
rmotta, r 
Stenotrophornonas nialtophilia is an emerging pathogen that causes a variety of 
nosocomial infections. Even though the pathogenic role has not yet been 
fully elucidated, antimicrobial therapy is urgently required whereby S. 
malfophilia has been isolated. TMP/SMZ, ticarcillin-clavulanate or CAZ are 
the drug of choice against infections caused by this pathogen although their 
clinical efficacy may be poor. New fluoroquinolones have been reported to 
In vitro activity of antifungals 
have good in oitro activity as single agent or in combination with beta-lactam 
antibiotics vs. S .  maltophilia The synergistic effect of the combination of 
CAZ/LEVO against 26 clinical isolates obtained f?om respiratory tract 
infections was determined by the conventional checkerboard test and two 
new different E-test methods. The antibacterial activity of CAZ and LEVO 
was determined against all clinical isolates as single agent and in combination 
with checkerboard method. In addition, the antibiotic combination was 
evaluated against 10 isolates using two E-test methods by superimposing 
antibiotic strips following the manufacturer’s procedure (AB BIODISK) and 
crossing strips at 90 & #61616; angle so that the scales met at the MIC of 
each drug alone (White et al. AAC, 1996). Standard definition for synergy 
was considered with Fractional Inhibitory Concentration index (FIC-index) 
less than 0.5. MICs of CAZ and LEVO ranged between 4-> 32 mg/L and 
0.5-4 mg/L, respectively. Results of the checkerboard test showed synergy 
for 7 out of 26 isolates (27%). The agreement between the results obtained 
by checkerboard test and both E-test methods was nearly 70%. The 
advantage of ‘E-test superimposing method’ is the possibility to assay the 
isolates without knowing the MIC. However, procedure required could be 
critical because of the exact superimposition of strips. The other ‘E-test 
crossing strips method’ required preliminarily MIC values but it was easier 
to perform than the other two methods. In conclusion, the results support 
the rationale to use CAZ/LEVO combination in S.  nialtophilia infections. 
Considering that synergistic effect is strain dependent, the E-test method 
may represent a valid alternative to checkerboard assay, because easier and 
faster to perform than the conventional method. 
Fungaemia and resistance to antifungal agents in a 
children’s hospital 
A. Raftopoulou, M. Tjanoudaki, E. Petridou, A. Pangalis 
Atheis ,  GR 
Fungaenlla represents a serious patients management problem as approxi- 
mately 10% of the nosocomial blood stream infections are caused by 
Candida spp. and results in substantial mortality especially for the 
iniinunoconipromised patients. The aim of this study was to estimate the 
fungaemia in our  hospltal, a large teaching paediatric hospital and to 
evaluate the susceptibdity of the isolates to the antifungal agents in use 
today. From January 1998 to October 2000, 39 746 blood cultures were 
performed in the lab by the Bactec 9240 system and the use of PEDS 
PLUS/F bottles. The patients, 14 days to 16 years old, were from the 
general wards or were nursed in ICUs for fetal imiatunty, haeinatological 
diseases (mainly leukaemia), malignant turnours, large general surgery, bone 
marrow transplantation, renal insufficiency. All patients had received 
antibiotics prior to blood fungus detection. The blood cultures revealed 
35 positive for fungi samples id 0.1%, conung in majority from the ICUs 
(85.7%). The isolates were: Candida albicans 26 strains, C. parapsilosis 3, C. 
rropicalis 2, C. girillerrnorrdii 1, C. krusei 1, Ammonium stticrum 1, Aspergillus 
n i p  1. The susceptibility testing for the yeasts isolates by the MICs 
estimation, gave 28.6% resistance to Itraconazole, 7. 1% to Fluconazole and 
Flucytosine and no resistance to Amphotericine and Ketoconazole. Despite 
the appropriate therapy 10 patients (28.5%) &ed during the period of fungal 
infection management. This mortality rate is very high. Probably the use of 
a more specific for fungi blood culture isolation method would result in 
fungal detection in an earlier infection stage which would benefit the patient 
in treatment and survival rate. 
)p8741 In vitro susceptibility of bloodstream Candida spp. to 
voriconazole 
E. Cantbn, J. Pemsn, A. Viudes, P. Tallbn, M. C. Pefialver, J. Frasquet, M. 
Gobernado 
Valencia, E 
Background The increased use of antifungal agents for prophylaxis in 
imniunodepressed patients has resulted in a decreased susceptibility of yeast 
to azoles. Voriconazole (VZ) is a novel broad spectrum triazole active 
against yeast and inany filamentous fungi. 
Objective: To determine the susceptibility of yeast strains isolated &om blood 
to VZ and compare with that of fluconazole (FZ) and itraconazole (IZ). 
Material and methods: A total of 131 yeast strains (48 C. albicans, 31 C. 
parapsilosis, 14 C. krusei, 16 C. tropicalis, 13 C. glabrata, and 10 miscellaneous 
yeast species) isolated in 1998 and 1999 were tested by the M27-A 
microdilution method using a visual reading performed after 48 h of 
incubation. 
Results: The range of MICs of VZ was < 0. 004 to > 2 mg/L for C. 
albicans and C. parapsilosir and the geometric mean MIC (GM MIC) was 0. 
007 and 0. 013 mg/L, respectively. C. krusei, C. tropicalis and C. glabrazu 
were less susceptible with a range of MICs/GM MIC Gom 2 to 0. 25/0. 7, 
2-0. 0310. 14 and &om 2 to 0. 06/0. 68 mg/L, respectively. For the 
miscellaneous group the VZ range was 0. 12 to < = 0.004 with a GM MIC 
of 0. 004 mg/L. The GM MIC of FZ/IZ were 0. 34/0. 08 mg/L for C. 
albicans, 0. 5710. 06 mg/L for C. parapsilosis, 55. 1610. 4 mg/L for C. krttsei, 
1. 91/0. 14 mg/L for C. tropicalis, 13. 63/1. 89 mg/L for C. glabrata, and 2. 
63/0. 17 p g / d  for miscellaneous group. Six of eight strains of C. albicans 
inhibited with > 2 mg/L of VZ were resistant to IZ (MIC > 4 mg/L). 
Two strains of C. albicans resistant to FZ (MIC > 64 mg/L) were 
susceptible to VZ (MIC < = 0. 004 nig/L). 
Conclusions: Cross resistance among azoles do not appear to be absolute; 
however, most strains that require higher concentrations of FZ to be 
inhibited result in elevated MICs for IZ and VZ. CK and CG are the least 
susceptible species tested. 
p8751 Genotypes and antifungal susceptibility of the 
aetiological agents accountable for oral pseudomembranous 
candidiasis in head and neck cancer patients receiving radiation 
therapy and GM-CSF mouthwash 
0. Kostoula, 0. Nicolatou-Galitis, D. Toukas, A. Mitroussia, N. J.  Legakis, 
A. Velegraki 
Athens, GR 
Objectives: To divulge susceptibility to antifungals and genotypes of oral 
pseudomedramus  candidiasis (OPC) aetiological agents before, during and 
after head and neck radiotherapy (AT), in a cohott of 61 patients. To  
attest if DNA fingerprints assist in  revealing if Candida albicans strains 
colonizing the oral cavity are responsible for subsequent invasion and to 
recogmze recumng from new infections owing to the same Candida species 
during RT. 
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Methods: From clirucally evaluated patients specimens &om the oral lesions 
were microscopically examined and cultured on CHROMagar Candida 
(Paris, France). Definitive identification was pursued by API 32 ID 
(BioMerieux) and by additional tests. Susceptibility to antifungals was tested 
by E-test (AB Biodisk, Solna, Sweden). Vonconazole (Pfizer) was tested by 
the NCCLS microdilution method. Each isolate was genotyped by RAPD- 
like microsatellite polymorphism (MLP) analysis, using a microsatellite 
DNA VNTR derived primer at high annealing temperature. 
Results: Nine patients were colonized by C. albicans before RT. OPC was 
diagnosed in 31 (51%) patients, where C .  albicans was the most frequent 
isolate. Multiple Candida species (C. albicans, C. tropicalis, C. glabrata and C. 
holmit? were isolated from lesions of 4 patients. Seventeen patients 
developed concurrent candidiasis and oral mucositis. Foay-six developed 
oral mucositis (grades I, 11, 111 & IV), despite use of GM-CSF mouthwash. 
AU isolates were susceptible to amphotericin B (MIC range: 0. 047-0. 5 pg/ 
mL), all but 2 isolates were susceptible to itraconazole (0. 125-0. 25 pg/ 
mL), 7 strains were resistant to fluconazole (> 32 pg/mL) and all isolates 
were susceptible to vonconazole (0. 032-0. 25 pg/mL). MLP analysis typed 
strains in distinct clusters. 
Conclusions: At the end of RT the grades of mncositis were subordinate 
compared to those during RT. In this am1 of patients however, the benefit 
of GM-CSF mouthwash could not be substantiated. OPC before, during & 
after RT requires systematic clinical and laboratory monitoring. According 
to MLP analysis there was more than 90% probability for the colonizing 
strain to invade the oral mucosa during RT. MLP analysis could 
differentiate between recurring episodes and new infections when the same 
Candida species was isolated from OPC cases in the course of RT. 
Acknowledgements: Supported by the Greek Secretariat of Research and 
Technology, ergo PENED (99ED 39-70/5062) & the European Union. 
pml Antifungal susceptibility testing of Candida isolates 
from bloodstream infections 
S. Lee, J. Lu, C. Chen, W. Chi 
Taipei, RC 
Fungal infections have dramatically increased in recent years along with the 
occurrence of drug-resistant isolates in immunocompromised patients. We 
have isolated 98 Candida spp. &om blood cultures performed at the Tri- 
Service General Hospital, Taiwan from 1998 to 2000. These isolates 
included 50 C. albicans, 13 C. glabrata, 24 C. tropicalis, and 11 C. parapsilosis. 
To investigate their susceptibility to commonly used antifungal drugs, 
minimum inhibitory concentrations (MIC) of amphotericin B, fluconazole, 
flucytosine, and ketoconazole to these isolates were determined. Both the 
conventional macrodilution method and the E-test were employed. The 
MIC90 for these isolates were determined to be 0.5 p g / d  for 
amphotericin B, 32 pg/mL for fluconazole, 0.125 pg/nL for flucytosine 
(0.25 pg/mL by the E-test method), and 4 pg/mL for ketoconazole. 
MIC50 of these 4 different drugs were 0.25, 2, 0.06 and 0.06 pg/mL, 
respectively. Ninety-five isolates were susceptible to amphotericin B at a 
concentration < or= 1 pg/mL. Three C. parapsilosir isolates &om 2 patients 
had an amphotericin B MIC of 2 pg/mL. AU isolates were susceptible to 
flucytosine in vitro. C. glabrata isoiates were more resistant to fluconazole 
with MICs ranging from 16 to > 64 pg/mL. MIC values for various 
isolates determined by the two different methods were quite consistent with 
an agreement rate of 99.0% for amphotericin B, 81.4% for ketoconazole, 
82.7% for fluconazole, and 91.8% for flucytosine. The results of this study 
suggest that E-test can be used as an alternative method for antifungal 
susceptibility testing. 
lp8771 Penetration of amphotericin B into the cornea 
following systemic treatment with amphotericin B and its lipid 
preparations in a rabbit model 
D. Goldblum, K. Rohrer, B. E. Frueh, R. Theurillat, W. Thormann, 
S. Zimmerli 
Bern, CH 
Objectives: In fungal keratitis antifungal drugs are commonly applied 
topically as well as systemically for fear of threatening exogenous 
endophthalmitis. Aniphotericin B (AmB) and various lipid formulations 
of AmB are available for the treatment of fungal infections of the eyes. Their 
hngicidal activity against a broad range of pathogenic fungi makes these 
drugs a suitable choice for the empirical therapy of keratomycoses. Little is 
known, however, about their penetration into the cornea following 
systemic treatment. The corneal concentration of amphotericin B following 
7 daily doses of parenteral And3 lipid complex (ABLC) or liposomal AmB 
(L-AmB) was compared to that of AmB deoxycholate (D-AmB) in a 
rabbit model. 
Methods: Mter induction of unilateral uveitis by intravitreal injection 
of endotoxin, rabbits ( n = 5  per treatment) were given daily doses of 
D-AmB (1 mg/kg) ABLC (5 mg/kg) or L-AmB (5 mg/kg) by central 
venous catheter on 7 consecutive days. And3 concentrations were 
determined by high-pressure liquid chromatography in corneae collected 
at autopsy 24 h after the 7th dose. Data were analysed using the Mann- 
Whitney U-test. 
Results: After 7 days of treatment, mean corneal concentrations of AmB in 
the inflamed eyes were highest after treatment with L-AmB (2.38 1.47 
pg/g) compared to ABLC (< 0.009 pg/g) and D-AmB (0.46 0.2 pg/g) 
( P  < 0.008 for L-AmB vs. ABLC and D-AmB, and P < 0.02 for D-AmB 
vs. ABLC). No AmB was detectable in the corneae ofthe nonintlarned eyes. 
Conclusions: In our model, amphotericin B penetration into the cornea was 
significantly higher after systemic adrmnistration of L-AmB than after 
conventional D - A d  or ABLC. 
1-1 Combined immunotherapy and amphotericin B 
colloidal dispersion for the treatment of invasive mycoses in 
non-neutropenic patients 
A. Mastroianni, C. Cancellieri, F. Alegrini, S. Pignatari 
Forli, I 
The incidence of systemic fungal infections has continued to increase over 
the past three decades, particularly in immunosuppressed patients. The 
conventional formulation of amphotericin B remains the therapeutic 
reference standard in this setting, however, its use is limited by infusioti- 
related adverse events and toxic side-effects. Current investigation efforts to 
develop improved antifungal therapy have concentrated on new com- 
pounds, as well as on the emerging role that immunomodulation may play 
in defending against invasive mycoses. 
Objective: To evaluate the safety and efficacy of GM-CSF in combination 
with ABCD for the therapy ofproven invasive mycoses in non-neutropenic 
patients. 
Patients and methods: Five patients (3 males and 2 females; range of 
age, 37-65 years) were elegible for this study. ABCD was administered 
at a dose of 4-6 mg/kg daily. The dosage of GM-CSF was 10 pg/kg daily 
given s.c. GM-CSF therapy was given for 7-14 days. All patients, except 
one, had predisposing conditions, these were predominantly of gastric 
origin (gastrectomy because of gastric NHL in 1 patient, and because of 
gastric carcinoma in 1 patient). One patient had recent tuberculosis and one 
other patient had diabetes mellitus. Clinical presentation included: Candida 
albicans peritonitis 1, pulmonary aspergillosis 1, Aspetgillus sinusitis 1, rhino- 
cerebral aspergillosis land CVC-related fungaemia due to C. albiraris 1. 
According with our results ABCD combined with GM-CSF was an 
effective treatment for invasive mycoses. As a matcer of fact, three patients 
recovered and the remaining two patients survived fungal infection but 
eventually died. 
Discussion: The results of this study support the conclusion that ABCD + 
GM-CSF combination is safe and effective in the treatment of severe deep- 
seated fungal infections in patients with apparently normal immune status. 
The limitations of our limited case-series are obvious. However, inspite of 
this factor, it is critical to note that all survivors at long-term follow-up were 
clinically cured. Thus, we suggest that it is reasonable to consider the 
necessity of a more extensive evaluation of antifungal therapy combined 
with immunotherapy to confirm the efficacy of this strategy in the treatment 
of these life-threatening infections. 
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lp879 Erythromycin-resistance determinants are differently 
distributed in serotype 6 and serotype 14 Streptococcus 
pneumoniae strains from Italy 
M. Del Grosso, A. Scotto d’Abusco, E. Bordi, F. D’Ambrosio, N. 
Petrosillo, A. Pantosti 
Rome, I 
Objective: Resistance to erythromycin (ER) in S. pneumoniae has increased 
greatly in Italy in recent years and now exceeds 30%. E R  resistance is linked 
to the presence of either the e d  methylase gene, conferring the MLSB 
phenotype, or the efflux gene mef, conferring resistance to 14-and 15- 
membered macrolides only. While in the USA the mef gene is the most 
common determinant of ER resistance, in Italy the erm gene is more 
frequent. We studied the distribution of these two genes in S. pneumoniae 
strains belonging to two different serotypes, 6 (st6) and 14 (st14), that in 
previous studies were found to be commonly E R  resistant. The strains were 
isolated from invasive diseases (blood or CSF) and ham the nasopharynx of 
healthy children. 
Methods: 43 st6 and 31 st14 strains were tested for suscepnbility to ER,  
penicillin (PEN), clindamycin (CL), tetracycline (TE) and chloramphenicol 
(CH) using the E-test. Presence of e m  or mef genes was detected by a 
duplex PCK assay. In the case of mef, the gene was further characterized as 
mefA or m e E  by sequencing and/or by allele-specific PCR. 
Results: 21 of 43 st6 strains (49%) and 27 of 31 st14 strains (87%) were E R  
resistant. All E R  resistant st6 strains except two, showed high MIC to ER 
(2 256 mg/L), and to CL,  and possessed the enn gene. Two st6 strains 
showed low level resistance to ER only and harboured the nief gene. The 
majority (17 out of 27) of E R  resistant st14 strains showed low-level 
resistance to E R  (MIC from 4 to 32 mg/L), susceptibility to CL, and 
possessed the mef gene. The other st14 strains harboured the erm gene and 
showed the MLSB resistance phenotype. The sequences of the mef genes 
present in st14 strains were identical to mefi ,  while the sequences of the 
mef genes present in st6 strains were identical to meE.  All strains bearing 
ermU were also resistant to TE, and in some cases (4 st6 strains), also to CH. 
Nonsusceptibility to PEN was present in 6 out of 43 (14%) st6 strains and in 
4 out of 31 (13%) st14 strains. In all cases but three PEN resistance was 
associated with ER resistance. 
Conclusions: The distribution of the genetic determinants conferring E R  
resistance is associated with the serotype of S. pneumouiae: erm is more 
common in st6, and mef in st14. Therefore the difFusion of E R  resistance 
can be due to both dissemination of the resistance genes and expansion of a 
certain serotype. 
Ip8801 Antibiotic use and resistance of Streptococcus 
pneumoniae in The Netherlands in the period 1994-99 
A. J .  de Neeling, B. P. Overbeek, A. M. Horrevorts, E. E. J. Ligtvoet, W. 
G. Goettsch 
Bilthoveri, Leeuwarder?, Ni jmep,  Haarlern, N L  
Antibiotic use in the Netherlands in the period 1994-99 is described in 
relation to the resistance of routine isolates of Streptococcus pneumoniae. The 
average antibiotic use in the study period was 3.4 Defined Daily Doses per 
I000 persons per day (DDD/lOOO/day) penicillins, 0.066 DDD/1000/day 
0-lactams other than penicillins, 2.3 DDD/1000/day tetracyclines and 0.71 
DDD/l000/day tnmethoprim and sulfonamides, without apparent rise or 
decline. In contrast the use of macrolides doubled Gom 0.51 DDD/1000/ 
day in 1994 to 1 .0 DDU/1000/day in 1997 and stayed at that level. In 1994 
the first pneumococci isolated from each patient showed 0.7% resistance to 
penicillin (intermediate plu5 full resistance). 2.5% to erythromycin, 4.2% to 
cotrimoxazole and 4.7% to tetracycline. In 1999 first isolates showed 1.5% 
resistance to penicillin, 3.8% to erythromycin, 3.9% to cotrimoxazole and 
6.7% to tetracycline. The modest but significant rise in the resistance to 
penicillin and erythromycin may have been caused by the increased use of 
macrolides in the years 1994-97. 
Antibiotic resistance in Streptococcus pneumoniae and 
Haemophilus influenzae isolated in Casablanca 
H. Belabbes, A. Redouani, N. ElMdaghri, M. Benbachir 
Casablanca, M A  
Objective: To determinate the antibiotic resistance rates of Streptomaus 
pneumoniae and Haemophilus influenzae isolated in Casablanca from invasive 
and noninvasive diseases in children and adults. 
Isolates and methods: 167 Streptococcus pneumoniae and 119 Haemophilus 
influenzae isolated during 1998-2000 from clinical samples analysed a t  the 
microbiology laboratory of the IbnRochd university hospital. Susceptibility 
testing was done by the E-test method. Quality controls, and breakpoints 
used for analysis were those recommended by the NCCLS (1999). 
Results: Overall 15% of Streptococcus pneumoniae isolates were not susceptible 
to penicillin G (12.6% intermediate and 2.4% resistant). The majority 
(81.9%) of the nonsusceptible isolates belong to serotypes 23, 19 and 14. 
Amoxicillin (94%), cefotaxime (96.3%), cefuroxime (93.4%), chloramphe- 
nicol (95.8%) and erythromycin (97.6%) were highly active. Resistance 
rates to tetracyclin and cotrimoxazole reached 20.4% and 21.6%, 
respectively. There was no difference in the penicillin resistance rates 
between invasive and noninvasive isolates and between isolates from adults 
or from children. Beta-lactamase production in Haeinophilus iyfluenrae was 
rare (4.2%). All the isolates were susceptible to amoxic~llin-clavulanic acid, 
cefpodoxime, cefuroxinie and ofloxacin. Chloramphenicol was highly 
active (92.8%) and resistance rate to cotrimoxazole was 6.8%. H. influerrzae 
invasive infections occurred mainly in children and were mostly due to 
serotype b whereas the majority of respiratory tract infections was due to 
nontypable isolates. 
Conclusions: These data are useful for generating recommendations for first 
line treatment and for prevention of infections due to these two pathogens. 
Pharyngeal carriage of Streptococcus pneumoniae in 
children in Central Greece 
1. Paraskakis, E. Bozavoutoglou, A. Makri, A. Chrissakis, M. Papadatou, T. 
Panagea, A. Photinou, H. Papavasileiou, A. Pangalis, P. Tassios, N. J. 
Legakis 
Athens, GR 
Objectives: To determine the nasopharyngeal carriage of pneumococci in 
children attending as outpatients the Paediatric Departments of two 
Children’s Hospitals located in the area of Athens. 
Methods: A total of 1509 nasopharyngeal swabs were collected from 
children with no history of respiratory disease, aged tiom 1 to 5 years, 
during a 2-month period each year (October-November) from 1992 to 
2000. The antimicrobial testing was performed by the Kirby-Bauer 
difision disc method. In addition the MIC values of penicillin in 
nonsusceptible strains were assessed by the E-test method. The phenotype 
of erythromycin-resistant strains isolated during 2000 was characterized by 
the double-disc induction test. The serotyping of these isolates was carried 
out by commercial antisera (Quelling reaction). 
Results: A total of 420 pneumococci were isolated with carriage rates 
ranging from 12.6% to 37.5% through the study period. Resistance to 
penicillin was detected in 81 strains (19.3%: immediately resistant 17.2%, 
fully resistant 2.1%). The rates of resistance to other antibiotics were as 
follows: cotrimoxazole 17.6%, erythromycin 13.896, tetracycline 8.6%, 
chloramphenicol 5.0%, chndamycin 4.5%. Nonpenicillin susceptible strains 
were significantly more kequently recorded in 2000 compared to 1992 
(13.0% vs. 29.5%). Similarly, the resistance rates to cotnnioxazole and 
erythromycin were dramatically increased through the study period: 
cotrimoxazole: 1992 = 5.696, 2000 = 28.0% and erythromycin: 
1992 1.8%1, 2000= 21.5%. Most of erythromycin-resistant isolates (65%) 
had the M-phenotype, while the 35% had the constitutive MLS phenotype. 
Serotypes 23 and 19 predominated in penicdlin resistant strains both 
representing 81.2% of these isolates and serotypes 6, 19 and 14 were 
recovered most frequently among the penicillin susceptible strains, 
consisting 63.7% of the above strains. 
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Conclusions: Increasing rates of resistance to various first line antimicrobials 
used in pneumococcal infections observed in this study. The currently 
available 23-valent vaccine covers all serotypes detected in our study. 
Ips831 Proficiency of Spanish laboratories in detecting 
penicillin-resistant pneumococci 
J. L. Perez, C.  Gimeno 
Madrid, E 
Introduction: PRP are frequently isolated in Spain. Because of their 
importance, two strains with different susceptibilities to penicillin were 
sent as part of a nation-wide, external quality control progranltne sponsored 
by the Spanish Society of Clinical Microbiology and Infectious Diseases 
(SEIMC). 
Methods: Two dlfferent strains were sent in separated controls along with a 
clinical history. Control a was a clinical isolate showing high resistance 
(HR) to penicihn (MIC = 2 pg/mL). The strain was also intemiediate- 
resistant to cefotaxime (MIC= 1 pg/mL). The clinical history was 
suggestive of meningitis. Control b was a intermediate penicillin resistant 
(IR) strains with a MIC of 0.25 pg/mL; the strain was also resistant to 
erythromycin, and the clinical hstory related to a case of pneumonia. 
Results: Control A total of 233 participants gave results on penicillin 
susceptibility. Of these, 22 (9.4%), 58 (24.9%) and 153 (65.7%) considered 
the strain to be smceptible, IR, and H R  to penicillin, respectively. When 
methods were concerned, 19.8% and 3.3% of the laboratories found the 
strain susceptible by disk-diffusion and microdilution techniques, respec- 
tively. Control B: a total of 240 responses were returned. Of these, 119 
(49.6%) were coincident with the reference laboratory (IK), but 70 (29.2%) 
and 51 (21.3%) of the laboratories reported the straiu as susceptible and H R  
to penicdhn, respectively. Again, significant differences were found between 
participants using the disk-diffusion method and those performing 
quantitative tests for penicillin susceptibility. In the later case, most errors 
arose from the MIC itself they obtained, and not from misinterpretation of 
this value. Most errors, both in controls A and B became from private 
laboratories not specifically devoted to clinical microbiology. A more 
detailed information will be presented. 
Conclusions: (a) Despite PRP are frequently isolated in our country, a 
significant proportion of laboratories showed difficulties in recognizing 
strains with some degree of resistance to penicillin; (b) Erroneous selection 
of the susceptibhty technique is responsible for most errors. 
lp884 surveillance of streptococcus pneumoniae serotypes 
before vaccination 
M. Montaner, R. Moreno, M. Gil, J. Ramin, M. Gobernado, E. Cant6n 
Valenria, Casfrlldn, E 
Background: There is a lack of data on the pneumococcal serotypes present 
in our sanitary area. We examined the seratypes of S. pneumoniae isolates 
from adult hospitalized patients before starting the use of 23-valent 
polysaccharide S. pneurnoriiae vaccine that began in October, 2000. 
Method: S. pneumoniae from different chnical samples were serotyped by 
Quellung reaction. The MIC of penicillin, ampicillin, amoxicillin- 
clavulanic acid, cefotaxinie, cefuroxinie, enthromycin, rifampicin, vanco- 
mycin and levofloxacin were determined by the E-test method. New 
NCCLS breakpoints (M7-A5) were applied. Isolates were considered 
multidrug-resistant if they were resistant to penicillin plus two other 
antibiotics. 
Results: A total of 123 S. pnpumonine were consecutively serotyped between 
June 1999-September 2000. The most prevalent of the 21 serotypes 
identiGed, were: 19 (17%), 6 (14.6%), 23 (11.38%), and 3 and 14 (8.94%). 
Ninety percent of the seratypes are present in the vaccine. The most 
frequent serotype in respiratory samples was 23 (18.42%) and in blood 
samples were: 14 and 6 (17.2% both) followed by 3 and 19 (13.8%). With 
respect to penicillin, 12.1% were resistant, 44.4%) intermediate and 43.4% 
susceptible. Among the penican-resistant strains, which belong to 
serotypes 19, 6, 8, 9, 14, and 23, 75% were also resistant to enthromycin. 
The total percentage of resistant strains to erythromycin was 43.4. Two per 
cent of the strains were multidrug-resistant. 
Conclusions: The use of the 23-valent polysaccharide S. pneumoniae vaccine 
has potential to prevent the vast majority of S. pneumoniae infections. Our 
percentage of penicillin-resistant strains are lower than those reported for 
other areas of Spain. 
v/ Molecular epidemiology study of invasive 
5treptococcus pneumoniae isolated from children in Taiwan 
C. C. Wang, L. K. Siu, C. M.  Yu, M. L. Chu 
Taipei, ROC 
Objectives: To determine the ribotype and serotype of invasive S. 
pneumoniae strains isolated from paediatric patients in Taiwan. 
Methods: From July 1998 to June 1999, the 97 strain7 have been collected 
for study. The serotype was performed by Q u e h n g  reaction with standard 
antisera. An automated nbotyping system was used for molecular 
epidemiology study. 
Results: The most prevalence serogroup encounter in the invasive strains 
was 6 (25.8%) and 14 (25.8%), followed by 23 (23.7%) and 19 (12.4%). 
Molecular typing revealed that a higher degree of genetic polymorphism (37 
Merent nbotypes). Among isolates with serotype 23, high proportion 
isolates (12/24) had same ribotype to Spain 23F isolate; auother isolates with 
serotype 14, 6 and 19 also had predominant ribotypes. All these common 
serotype had high level (72-96%) nonsusceptible to penicillin. 
Conclusions: This study revealed that the invasive S. prreumotiiae isolated 
&om paediatric patients had common serotype and with predominant 
ribotypes. These suggesting some epidemic strains circulation in Taiwan. 
Almost all these epidemic strains had high level nonsusceptible to peuicillin, 
this means antibiotic overuse occurred in our country. Thus prudeut use 
antibiotics and through conjugated vaccine should be considered to control 
pneuniococcal infection m children in Taiwan. 
lp8861 Activity of telithromycin on S. pyogenes and S. 
pneumonie in Russia and Estonia: an epidemiological study 
T. 0. Linglof, B. Olsson-Lil~equist, L. Kaftyrea, P. Naaber 
Uppsala, S o h ,  S; St.  Pelenburg, RUS; Tartu, EE 
Objectives: The worldwide incidence of infections caused by antibiotic 
resistant streptococci has increased during the past two decades. However 
there are few reports from Eastern Europe. The aim of the present study was 
to investigate the in vifru activity and the incidence of resistance to 
telithromycin and other antibiotics on recent clinical isolates of S. pyogenes 
and S. pireumoniae in Russia and Estonia. 
Methods: An agar diluhon method was used to test the activity of 
telithromycin compared to penicillin G, erythroniycin, arid clindaniycin 
against 393 recent clinical isolates of S. pyogenes and S.  pneumoiiie from 
patients in Tartu, Estonia and St Petersburg, Russia. 
Results: In S. pyogenes isolates sensitivity rates were as follows in Russia 
( n =  100): Peniciuln and clindamycin 100%, erythromycin A 89% and in 
Estonia ( ~ = 9 3 ) :  Penichn 92%. clindamycin 98%, erythromycin A 92%. 
AU isolates of S.  pyogenes were sensitive to telithromycin. In S.  przeumoriiae 
isolates sensitivity rates were as follows in Russia (n = 100): Penicillin 94%, 
clindamycin 0%, erythromycin A 86% and in Estonia (n=93): Penicillin 
91% clindamycin 94%, erythromycin A 87%. All isolates of S. pneumoriiae 
were sensitive to telithromycin. Almost simdar results were obtained when 
using E-test for MIC determination in Sweden. 
Discussion: Telithromycin had excellent activity against S.  pyogeries and S.  
pneumoniae, when tested locally. 
lp8871 lnvasive pneumococcal infections in Denmark during 
1995-99: epidemiology, serotype and resistance data 
H. B. Konradsen, M. S. Kaltoft, K .  Ekelund 
Copenhagen, DK 
Stvepfocncmr pneumniiiae is a common cause of morbidity and niortaltty. In 
Denmark, the vast majonty of pneumococcal strains isolated from patients 
with invasive pneumococcal infection is sent to Statens Serum Institut for 
surveillance by typing and antibiotic susceptibility testing. The frequency of 
antibiotic resistance among pneumococci in Denmark has been low for 
inany years. In this study, we monitored the number of invasive 
pneumococcal infections in Denmark in 1995-99 and studied the type 
distribution and antibiotic sutceptibllity among the pneumococci. 5464 
pneumococcal isolates were received during the 5-year period. 91% of the 
isolates came from blood and 9% from CSF. 8.8% were from children < 14 
years old, and among these 65% were from children < 2 years. The age- 
specific incidence was hghest among young children and elderly people. 
The total yearly incidence increased to 27/100 000 in 1996 and decreased to 
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17/100 000 in 1999 corresponding to a decline in number of blood isolates 
per year fkom 1309 in 1996 to 778 in 1999. Parallel to ths, we found a 
decline in proportion of all invasive isolates belonging to types 1 (26.5- 
5.4%) and 12F (10.&4.7%) from 1996 to 1999. Only minor changes were 
observed in the fkeqnencies of the remaining 34 serotypes. The coverage 
rate of the 23-valent polysaccharide vaccine was 92.9% among the elderly 
and the coverage rates of the 7-, 9-, and 1 1-valent pneumococcal conjugate 
vaccines among chddren < 2 years were 71.7, 75.2, and 81.4%. 
Pneumococcal isolates with decreased susceptibility to penicillin raised 
from 0.5% in 1995 to 3.1% in 1999. Only few strains had reduced 
susceptibdity to both penicillin and erythromycin, whereas an increasing 
number of penicillin susceptible pneumococci had decreased susceptibility 
to erythromycin, i.e. 0% in 1995 and 3.6% in 1999. < 0.5% of the strains 
had reduced susceptibhty to tetracycline, chloramphenicol and ceftriaxon. 
2.3% of the strains in 1999 had reduced susceptibhty to sulfa compared to 
0.3% in 1995. Of all isolates with decreased susceptibhty to penicdh, 
10.3% were isolated from children < 2 years old and 57.3% &om people > 
60 years old. As a result, the continuously rising number of invasive 
pneumococcal infections in Denmark until 1996 was followed by a marked 
decrease in 1996-99. Most Danish pneumococcal isolates are still susceptible 
to various antibiotics although there has been a s m a l l  increase during 
the period. 
lp8881 Susceptibility of Streptococcus pneumoniae strains 
isolated from blood of children 
K. Chrysakis, A. Mavromatis, V. Mamalis, A. Raftopoulou, M 
Koulissoglou, A. Pangal~s 
Athens, GR 
Streptococcrrs pneumoniae is the most keqnent cause of otitis media, sinusitis, 
pneumonia, bacteremia and meningitis, among very young age groups, 
infants and children (M years of age). Recently, p e n i c h  and other 
antibiotics resistant isolates have been reported through the world. The aim 
of this study was to obtain data on the resistance of pneumococci causing 
invasive infections in order to determine appropriate empirical therapy, 
until culture and antibiotics susceptibility has been completed. During the 
period January 1999 to November 2000, 76 strains of S. pneumoniae were 
isolated tiom blood cultures of children entered the hospital for different 
reasons. Snsceptibhty to different antibiotics as penicillin (screen with the 
1 pg oxacillin disk), cefotaxime, chloramphenicol, erythromycin, cotri- 
moxazole and vancomycin was determined by the Kirby-Bauer diffusion 
methodology according to NCCLS recommendations. MICs to penicillin 
and cefotaxime were also determined by E-test. Most isolates were 
recovered ham chddren 3-5 years of age and the vulnerable age group 
under 1 year old and predominated in March and October. The underlying 
disease or symptom of the 76 children with S. peneumottiae bacteraemia 
were: fever without focus of infection (40.7%), pneumoma (36.8%), otitis 
media (10.5%), meningitis (6.5%), orbital cellulitis (2.6%) and arthritis 
(1.3%). Resistance rates to erythromycin, cotrimoxazole, chloramphenicol 
and cefotaxime were 34.2%, 11.8%, 6.5% and 3.9% respectivly. A 
significantly increased rate of intermemate and hgh resistance to penicillin 
(9.2%) was observed along the years of the study; (1.3% of the strains were 
lgh ly  resistant). Resistance to vancomycin was not observed. In 
conclusion, these findings suggest the need for a continuous surveillance 
of the resistance of pneurnococci to appropriate antibiotics that should be 
taken into consideration before initiating empirical therapy. Cefotaxinie 
seems to be the antibiotic of choice for empincal therapy in caws of invasive 
pneumococcal diseases. 
/p8891 Evolution of Streptococcus pneumoniae antibiotic 
resistance detected 
V. Badea, V. Braga, S. Tomasian 
Consrarita, RO 
Objective: We ctudy the evolution of Streptococcus pneumoniae resistance 
isolated from: sputum, pleural fluid, blood, and CSF to antimicrobial agents. 
Method: The specimens were collected from patients in University Hospital 
Constantza; the identity of all isolates was confirmed by their susceptibility 
to optochin. Susceptibility to antibiotics was determinate using standardized 
disk antibiotics by diffusion on Mueller-Hinton agar according to the 
NCCLS recommendations. CMI for: Penicillin, Erythromycin and Pef/ 
Otloxacin were detected by E-test. 
Results: We examined 69 strains of S. pneumoniae from 3 years (1997-2000); 
62% strains were susceptible to Penicdlin, 30% were intermediate, and 8% 
were resistant to Penicillin. Resistance to Penicillin increased &om 8% in 
1997 to 16.5 in 2000; resistance to Tetracycline increased from 18.5% in 
1997 to 22% in 2000; resistance to Erythromycin increased from 22% in 
1997 to 30% in 2000; resistance to Pef/Ofloxacin, Amoxycillin/Clavulanate 
is only 1% during this period. 
Conclusionr: From 1997 to 2000 our study have founded that the resistance 
of S. pneumoniae increasing for many antibiotics; that’s why the S. 
pneumoniae surveillance is needed. The most active antibiotics against S. 
pneumoniae remam Amoxicillin/Clavulanate and Pef/Ofloxocin. 
(p8901 Antimicrobial resistance among clinical isolates of 
Streptococcus pneumoniae in a Greek university hospital 
S. Maraki, A. Christidou, Y. Tselentis 
Heruklion, GR 
The last decades resistance to beta-lactam antibiotics as well as to other 
antimicrobial agents among clinical isolates of Streptococcus pneumoniae has 
been increasing worldwide. 
Objective: To determine the antimicrobial resistance of S. pneumoniae 
isolated from clinical specimens submitted to the Laboratory of Clinical 
Bacteriology, at the University Hospital of Crete, Greece, during a 3-year 
period (1997-99). 
Methods: One hundred and twenty-five S. pneumoniae isolates were 
studied. Susceptibility testing was performed using the agar d u t i o n  method 
as described by the National Committee for Clinical Laboratory Standards. 
The following antibiotics were tested penicillin, cefuroxime, ceftriaxone, 
cefepime, iinipenem, meropenem, erythromycin, clarithromycin, chlor- 
amphenicol, tetracycline, trimethoprim-sulphamethoxazole, levofloxacin, 
sparfloxacin, and vancomycin. 
Results: Among the 125 isolates, 23 (18.4%) demonstrated intermediate 
resistance and 15 (12%) had high-level resistance to penicillin. Resistance 
rates to nonbeta-lactam antimicrobial agents was as follows: erythromycin 
16.8%, chloramphenicol 10.4%, tetracycline 19.2%, trimethoprim-sulfa- 
methoxazole 24.8%, and sparfloxacin 9.6%. Eight penicillin-resistant 
strains and 14 with intermediate resistance were also resistant to three or 
more antimicrobials. Vancomycin and levofloxacin were the most active 
agents tested. 
Conclusion: The results of the present study indicate that in our region not 
only penicillin resistance is high but also resistance to multiple antibiotics, 
restricting the choice of alternate antimicrobial therapy. 
Ip8911 Ex vivo serum bactericidal activity of amoxycillin- 
clavulanate and amoxycillin against Streptococcus pneumoniae 
in healthy volunreers 
M. Dan, F. Poch 
Holon, IL 
Serum bactericidal activity (SBA) was studied in a crossover manner in 10 
healthy volunteers after oral administration of amoxycillin-clavulanate 
(amoxy-clav) 875 mg tid, amoxycillin (amoxy) 1000 mg tid and amoxy 500 
nig tid, for 2 days. SBA was measured by a standardized microdilution 
method on blood samples obtained just before the last dose, and 2 h and 4 h 
after the last dose. Test organisms consisted of newly recovered Streptococcus 
pneumoniae clinical isolates: 4 penicillin-susceptible (mean MIC, 0.015 mg/ 
L), 4 with intermediate resistance (mean MIC, 0.68 mg/L) and 4 penicillin- 
resistant strains (mean MIC, 2.25 mg/L). While all drug regimens showed 
an excellent SBA against the susceptible strains (mean peak serum 
bactericidal titres [SBTs] 1 : 845, 1 : 889 and 1 : 608, respectively), activity 
against the intermediately resistant isolates was only borderline (mean peak 
SBTs, 1 : 5, 1 : 5.4 and 1 : 3.2, respectively), and invanably absent against 
the penicillin-resistant strains (mean peak SBTs, < 1 : 2). We conclude that 
high-dose amoxy-clav exhibits an antipneumococcal bactericidal potency 
similar to that of high-dose amoxy; however, these regimens should not 
be relied upon in areas with high prevalence of penicillin-resistant 
Streptococcus pneumoniae. 
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lp892 Streptococcus pneumoniae: resistance to penicillin and 
cefotaxime: comparative study 
E. Martin, R. Cias, F. de la Torre, J. J. Picazo 
Madrid, E 
Objective: S.  pneumoniae is an important pathogen responsible for upper and 
lower respiratory tract infection. For the time being, beta-lactam antibiotics 
are the treatment of choice these infections. However, increasing levels of 
resistance to penicdhn, and more recently to cefotaxime, have been 
observed in these bacteria. The objective of ths  study was to evaluate the 
prevalence of S. pneumoniae resistant to beta-lactam and determinate its 
clinical importance. 
Material and method: We studied 142 isolates of S. pneumoniae recovered 
from clinical specimens by the microbiology laboratory during the present 
year. Results of susceptibllity to beta-lactams were compared with those of 
126 isolates from five years ago, in 1995. The MICs for all clinical isolates 
were determined according to the guidelines of the National Committee for 
Clinical Laboratory Standards. 
Results: Susceptibllity of 126 isolates from 1995 were: 84 strains (66.7%) 
sensitive to penicilltn 38 (30%) showed intermediate resistance, and only 4 
(3.2%) were resistant to this antibiotic. In 2000, however, the resistance to 
penicdhn increased to 35 strains (24.6%) 29 strains (20.5%) had intermediate 
resistance and 62 strains (43.7%) were sensitive. Results with cefotaxime 
showed the same trend: in 1995, only one strain (0.8%) was found resistant 
to cefotaxime and 8 (6.35%) had intermediate resistance. The remaining 117 
strains (92.8%) were fully susceptible to this antibiotic. Five years later, only 
110 strains (77.5%) were susceptible to cefotaxime; resistance of 
intermediate strains increased to 29 (20.5%), and 3 (2%) were found to be 
S. pneumoniae fully resistant. 
Conclusions: (1) Susceptibility of S. pneumoniae for penicillin diminished 
drastically over the last 5 years. The resistance increased by seven, the 3.2% 
to 24.6%. (2) Resistance to cefotaxime increased in similar way, particularly 
those showing intermediate resistance. 
lp8931 Penicillin resistance in Streptococcus pneumoniae 
C. Ozakin, E. Yilmaz, Y. Heper, H.  Akalin, S. Gedikoglu 
Bursa, TR 
Streptococcus pneumoniae is an important pathogen causing a wide range of 
infections of children and adults such as pneumonia, otitis meha, sinusitis, 
bacteraemia and meningitis. Penicdlin has been the mainstay of therapy for 
pneumococcal infections for more than 4 decades. The fiat documentation 
of infection caused by S. pneumoniae with decreased susceptibility to 
penicillin was reported in 1967. S. pneumoniae has become a worldwide 
problem because of antimicrobial resistance to penicillin. 
A total of 84 clinically s igdcant  patient isolates of S. pneumoniae were 
prospectively collected from January 1999 to October 2000 at the Clinical 
Microbiology Laboratory of the Uludag University, School of Medicine. 
Eighteen blood isolates, 8 cerebrospinal fluid isolates and 58 lower 
respiratory tract isolates were included. Penicilhn susceptibility test was 
performed by E-test (Oxoid). Sixty of 84 S.  pneumoniae (71.4%) isolates 
were found to be susceptible to penicillin, 23 isolates (27.4%) were 
intermediate and 1 isolates (1.2%) were found to be resistant(high-level) to 
penicdh. S. pneumoniae isolates that resistant (hgh-level) to penicdlin were 
isolated in one blood specimen and isolates that intermediate resistant to 
penicillin were isolated in 6 blood, 1 cerebrospinal fluid and 16 lower 
respiratory tract specimens. Although penicillin resistance does not appear to 
be very high in our country, the intermediate resistance to penicillin may be 
problematic in invasive infections such as pneumococcal meningitis. As a 
result, it is convenient to perform serious laboratory surveillance for 
revealing regional differences. 
vl Evaluation of the Dade Microscan MlCroSTREP plus 
MIC panels with selected Streptococcus pneumoniae challenge 
strains and recent invasive clinical isolates 
P. C. Schreckenberger, J. T. Tjhio, W. M. Jan& 
Chicago, USA 
The Microscan MICroSTREP plus panel is a dehydrated broth micro- 
dilution panel for susceptibility testing of various streptococci, including 
Streptococcus pneumoniue. A group of 104 clinical isolates of S. pneumoniae 
were selected to include isolates with previously documented resistance to 
penichn, as well as recent invasive clinical isolates. All isolates were tested 
simultaneously with a reference flozen microdilution panel prepared in 
accordance with the National Committee for Clinical Laboratory Standards 
(NCCLS) guidelines. Antibiotics tested included p e n i c h ,  ceftriaxone, 
chloramphenicol, erythromycin, levofloxacin, and trimethoprim-sulfa- 
methoxazole. Of the 104 isolates, 1 f d e d  to grow in the MICroSTREP 
panel but did grow in the NCCLS reference panel. Essential agreement (test 
MIC f one ddution of the reference MIC) was 96% with erythromycin, 
97% with penicdlin, and 100% with chloramphenicol, ceftriaxone, 
levofloxacin, and mmethoprim-sulfamethoxazole. There were no very 
major or major category errors resulting &om the MICroSTREP plus panel. 
The MICroSTREP plus dehydrated panels are simple to inoculate, easy 
to read and provide susceptibility results with pneumococci that are 
essentially equivalent to results derived by the NCCLS reference broth 
nlicrodilution procedure. 
(p8951 The antibiotic resistance of Streptococcus pneumoniae 
in children with otitis media 
E. K. Kenesei, H. Mercz 
Budapest, H 
Streptococcus pneumoniae represents the prevailing bacterial pathogen in 
children with otitis media. Frequent use of antinlicrobial therapy in young 
children fachtates the selection of penicillin-resistant strains in this 
population. 
The middle ear fluid of hospitalized children were cultured and 
susceptibihty to penicdlin, erythromycin, trimethoprim/sulfamethoxazole 
and ceftriaxon was determined by disk diffusion method. The minimal 
inhibitory concentration of penicillin and ceftriaxon were measured by the 
E-test. Overall, 56% of 105 Streptococcus pneumioniae isolates were susceptible 
to penicillin, 31% were intermediate and 12% were resistant to penicillin in 
the last 2 years. The erythromycin, trimethoprim/sulfamethoxazole and 
ceftriaxon susceptibility was 51%. 28% and 87%, respectively. 
The antibiotic resistance of Streptococcus pneumoniae &d not changed in 
our hospital in Hungary, comparing with previous years, however, it 
is important to monitor the susceptibihty pattern to keep a check on 
an increase in the number of antibiotic resistance of this common 
respiratory pathogen. 
Ips961 In vitro activities of 11 antimicrobials against 246 
Streptococcus pneumoniae strains isolated from adult patients 
with community-acquired pneumonia 
F. Tubau, J. Linares, B. Roson, R. Pallares, F. Gudiol, R. Martin 
Barcelona, E 
Objective: The aim of this study was to compare the activities of penicdh, 
amoxicillin, cefuroxime, cefotaxime, erythromycin, clarithromycin, azi- 
thromycin, josamycin, clindamycin, tetracycline, and cotrimoxazole against 
246 clinical isolates of S. pn obtained from adult patients with moderate-to- 
severe CAP admitted to our hospital from Feb 1995 to Dec 1999. 
Methods: The in vitro studies were performed by microdution method 
(NCCLS). The sources of strains were blood (n = 106), transthoracic needle 
aspiration ( n =  15), pleural fluid (n=13), and sputum ( ~ ~ 1 1 2 ) .  
Results: The MIC-90 (mg/L) and frequency of resistance (%) were as 
follows: penicillin 2 (21.5%: 12.2% resistant and 9.3% intermediate); 
amoxicillin 1 (5.7%), cefuroxime 4 (16.6%), cefotaxime 1 (3.7%). 
erythromycin 0.12 (9.3%); clarithromycin 0.06 (9.3%); azithromycin 0.12 
(9.3%); josamycin 0.25 (9.3%); clindamycin 0.12 (9.3%); tetracycline > 32 
(16.3%); cotrimoxazole > 4/76 (26.8%). Twenty-three (9.3%) pneumo- 
cocci were resistant to 14-, 15- and 16-membered macrolides and 
clindamycin showing an MLS-B-phenotype. No M-phenotype strains 
were detected. The serotypes/groups 3, 8, 4, 19, 9 and 14 were the more 
frequent found. Serotype 3 account 28% of strains. 
Conclusion: The rates of betalactams, macrolides and niultiple drug 
resistance in this study were lower than those reported by us in previous 
studles. This difference may be explained by the fact that the present study 
did not include AIDS and cancer patients, nosocomial pneumonias, nor 
chronic bronchitis. In addition more than 75% of pneumococci belonged to 
serotypes susceptibles to all antibiotics studied. In summary, aminopeni- 
cillins, third generation cephalosporins or macrolides could be effective to 
treat CAP pneumococcal in our area. 
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lp8971 Antimicrobial resistance pattern of clinically significant 
Streptococcus pneumoniae isolates in Northern Israel 
R. Colodner, Y. Keness, D. Miron, W.  Sakran, B. Chazan, R. Raz 
dfu la ,  IL 
Objectives: To assess the resistance pattern of Strepfococcus pneumoniae 
isolated from clinically significant specimens in our region. 
Methods: The susceptibdity to penicillin of 604 clinically significant 
Streptococcus pneumoriiae strains isolated in our laboratory (44 and 560 from 
invasive and noninvasive sites, respectively) during a period of 17 months 
was tested by oxacdhn disk diffusion screen test and resistant strains were 
confirmed using E-test. Susceptibility to erythromycin, thrimetopnm- 
sulfinethoxazole and tetracycline was tested by disk-diffusion test. 
Results: The overall resistance rate for penicillin was 40.3% being 39.1% of 
the strains partially resistant (MIC between 0.1 and 2 pg/nL) and only 1.2% 
hghly resistant (MIC > 2 pg/mL). 40.4% and 1.1% of the noninvasive 
strains were partially and highly resistant to penicillin, respectively, but only 
20% (P=O.012) of the invasive strains were partially resistant. No highly 
resistant invasive strains were isolated. No sigrtlficant differences were 
observed between the resistant rate for penicillin of ctrains isolated from 
paediatric and adult patients (43.9% and 32.9%, respectively, P= 0.09). 
Overall resistance rate for erythromycin, thrimetoprim-sulfmethoxazole and 
tetracycline were 5%, 43% and 2.7% respectively. 
Conclusions: The incidence of penicihn highly resistant pneumococci in 
our region remains very low, especially in adult patients and invasive 
infections. According to the new infection-site-related breakpoints, 
penicdlin remains the recommended empiric treatment for pneumococcal 
infections. Erythromycin and tetracyclin proved to be in v i m  good 
alternative drugs for the treatment of penicdhn allergic patients. 
lp8981 Comparison of the in vitro activity of beta lactam and 
macrolide antibiotics against Streptococcus pneumoniae isolates 
from the Middle East 
A. Shibl, A. A-Ajeel, A. M. A-Rasheed, I .  Balik, T. D. Chugh, W. Dibb, 
A. Elbashier, K. El Hag, M. Izhar, I. Ahmed, A. Osoba, K. Toreci, T. 
Yasin, E. Power 
Riyadh, SA; Slwjalr; Ankara, TR; Kuwait City, K W ;  Abu Dhabi; QatiJ SA; 
Muscat, 0; Laliure, Karachi, PK;Jeddah, SA; Istanbul, TR; Brenlford, UK 
Background: Surveillance of streptococcus pneumoniae isolates for resistance to 
the most commonly prescribed oral antibiotics can contribute to the 
selection of appropriate empinc antibiotic therapy for indications where ths  
pathogen IS suspected. The present study determined the activity commonly 
prescribed antibiotics against isolates of S. pneumoniae from 12 centres in the 
Middle Eastern region. 
Methods: lsolates were collected during 1996-98 from a variety of clinical 
sources and identified to the species level at each study centre. Susceptibhty 
testing was perfoniied accordmg to NCCLS guidelines and the manufac- 
turer’s instructions using commercially available E-test strips. NCCLS 
interpretive criteria (MlOO S-10) were used to determine susceptibility rates. 
Results: MIC90 (pg/nL)/% susceptible results are gwen below, NA = not 
applicable. 
Conclusion: Of all the agents tested, Amoxicillin/Clavulanate demonstrated 
best overall activity against S. prreurnoniae. Cefaclor & penicillin had poorest 
activity amongst the beta-lactams tested. The results suggest that, in the 
Middle East, amoxiclav should be considered the agent of choice where S. 
ptieuinoiiiae infection is suspected. 
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lp8991 In vitro activity of levofloxacin and other antimicrobial 
agents against 300 strains of Streptococcus pneumoniae isolated 
in 1999-2000 in Madrid, Spain 
J. Oteo, B. Aracil, J.-L. G6mez-Garck, J.-I. Nos 
M h l e s ,  E 
The high prevalence of resistance to beta-lactams in Streptococcus pneumoniae 
isolates, frequently associated with resistance to macrolides and other 
antibiotics, makes it more and more difficult to treat infections caused 
by this pAthogen. The newer 5uoroquinolones are more active than 
the previous compounds against pneumococci. We studied the ‘ i n  vitro’ 
activity of a new fluoroquinolone, levofloxacin, and other antibiotics 
against 300 strains of S. pneumoniae isolated in 1999-2000 in 10 Health 
Authority Areas of Madrid. The number of strains collected was 
proportional to the number of inhabitants of each area. The antimicrobial 
susceptibilities were determined by the agar dilution method. AU results 
were interpreted according to the breakpoints of the NCCLS manual of 
the year 2000. 
Antibiotics tested and the results obtained (CMI90 and percentage of 
susceptible strains) were as follows: penicillin G (CM190 = 4  m g / b  34.4?4), 
amoxicillin (CMI90= 2 mg/L; 90.6%). oral cefuroxime (CMI90=8 mg/L; 
53.5%), parented cefuroxinie (CM190 = 8 nig/L; 50.9%). cefaclor (CMI90 
> 32 mg/L; 33.7%). cefixlme (CMI90 > 16; -), cefotaxime (CMI9O= 1 
mg/L; 71.9%), erythromycin (CMI90 > 16 mg/L; 63,8%), azithromycin 
(CMI90 > 16 mg/L; 64.6%), miocamycin (CMI90=16 nig/L; -), 
clindamycin (CMI90 > 16 mg/L; 70.1%), tetracycline (CMI90 > 8 
nig/L; 61.5%), cloramphenicol (CMI9O > 8 mg/L; 82.3%), ciprofloxacin 
(CMI90 = 1 mg/L; -) and levofloxacin (CMI90 = 1 mg/L; 99.6%). 
A high percentage of beta-lactam intemiediate and resistant strains, variable 
according to the antibiotic, was observed. Strains with decreased 
susceptibility to penicillin shown a significant increase of the MICs of all 
the beta-lactam, directly proporrional to the increase of the MICs to 
penicillin. High percentages of resistance to macrolides, clindamycin, 
tetracycline and cloramphenicol were also observed, mainly in penicillin- 
resistant isolates. All the strains except one were susceptible to levofloxacin. 
/p900/ Kinetics of bactericidal activity of amoxicillin. 
ceftriaxone, cefixime, teicoplanin, moxifloxacin, and 
pristinamycin against seven strains of 5. pneumoniae of various 
susceptibilities to beta-lactams and macrolides 
F. Jehl, L. Linger, C. Renault, C. Doit, V. Murbach, H. Monte11 
Strasbouy, Paris, F 
We studied the bactericidal activities of AMX, C R O ,  CFX, TEC, MOXI, 
and PRI against seven strains of Sp of various susceptibilities to beta-lactani 
and macrolide antibiotics. The time-kdl lanetics of antibiotics were 
performed at 1 MIC, 2 MICs and 4 MICs of each antibiotic for each 
strain. The experimentations were carried out in brain-heart broth medium, 
supplemented with 5% horse serum. The counting of surviving bacteria at 
TO, and 1 h, 3 h, and 6 h after seeding the broth with the starting inoculuni 
adjusted to lo’, was realized by plating 100 pL of pure and 10-‘-1OPh 
dilutions of pure broth on blood agar medium maintained for 18 h a t  37 “C 
under 10% COz. The overall resuln show an excellent bactericidal activity 
of PRI against all pemdin-susceptible @mi-S)-and -I strains (macrolide- 
S), and to a slightly lesser extent against those resistant to macrolides (peni- 
R). Beta-lactams and PRI are the most active ( 3 4  logs decrease of the 
starting inoculum) against peni-S strains. PRI is the most active against 
peni-I strains (5 logs decrease), followed by MOXI and beta-lactams (1.5- 
2.5 logs decrease). PRI remains active against peni-R macrolide-R strains 
(2.5 logs decrease), and the other antibiotics show a bactericidal activity 
resulting in a 1-2.5 logs reduction for these strains. For alI the studied 
strains, the bactericidal activity of MOXI results in a two logs decrease. 
These data confirm the excellent iir vifro bactericidal activity of PRI agamst 
Sp, including strains resistant to beta-lactams and macrolides, and the 
interesting bactericidal activity ofMOXI. As expected, AMX and CRO are 
also very active. 
Clinical Microbiology and Infection, Volume 7, Supplement 1, 2001 177 
vl Susceptibility of 150 penicillin-resistant Streptococcus 
pneumoniae and 110 ampicillin-resistant Haemophilus inffuenzae, 
isolated in 1999-2000, to moxifloxacin and 21 other antibiotics 
J .  I. Albs, J. Oteo, B. Aracil, J. L. G6mez-Garcts 
Mbstoles, E 
Streptococcus pneumoniae and Haemuphilux intuenzae are the commonest 
bacterial pathogens of the respiratory tract. Worldwide isolation strains of S. 
pneumoniae resistant or intermediate to penicillin and other beta-lactam 
antibiotics is increasing. Many of these strains are also resistant to other 
antibiotics such as niacrolides, causing problems in the choice of antibiotic 
therapy. Ampicillin-resistant strains of H. injuerzrae, by beta-lactamase 
production or by other mechanisms, are also frequently isolated. 
Moxifloxacin, a recent fluorquinolone, has enhanced activity against 
respiratory pathogens. The aim of this study is to assay the antimicrobial 
susceptibihty of moxifloxacin and 21 other antibiotics against 150 strains of 
S. przeumoniae, 57 penicillin-intermediate and 93 penicillin-resistant, and 
against 110 ampicillin-resistant strains of H. iifluenzae (1 05 producing beta- 
lactaniase). Strains were isolated in 26 Spanish centres during 1999 and 
2000. The agar dllution method was used. Results were interpreted using 
the breakpoints of the NCCLS manual of the year 2000. We have also 
camed out timekill studies with moxifloxacin on 9 penicillin resistant 
pneumococci (MICs 2-4 nig/L) using 4 X MIC of each strain. The most 
active antibiotics against penicillin-intermediate S.  pneurnoniae were 
moxifloxacin (100% susceptible, MIC90 = 0.25 mg/L), cefotaxime (100% 
susceptible, MIC90 = 0.5 mg/L), levofloxacin (100% susceptible, 
MIC90= 1 mg/L), and amoxicillin (100% susceptible, MIC90 = 1 mg/L). 
against penicillin-resistant S. pneumoniae were moxifloxacin (98.9% 
susceptible, MIC90 = 0,25 mg/L), levofloxacin (98.9% susceptible, 
MIC90= 1 mg/L) and amoxicillin (77.4% susceptible, MIC90=4 mg/L), 
and against ampicillin-resistant H. iqflueenrae ciprofloxacin (1 00% suscep- 
tible, MIC90 = 0.015 mg/L), moxifloxacin (100% susceptible, 
MIC90 = 0.03 mg/Lj, trovafloxacin (100% susceptible, MICYO = 0.03 
mg/Lj and cefixime (100% susceptible, MIC90 = 0.12 mg/L). Moxifloxacin 
at four times the MIC was bactericidal for the 9 strainc of pneumococci 
tested after 24 h (> 3 log10 decrease in cfu/mL). Moxifloxacin 
demonstrates excellent in uitru activity against both penicillin-resistant S.  
pneumoniae and ampicillin-resistant H. injuenzae. It could be a very good 
alternative in the management of infections caused by resistant strains of 
pneumococci and H. influenzae. 
Immune response 
vl Antibiotic resistance of Streptococcuspneumoniae and 
Haemophilus influenzae 
0. M. Dorobat, T. Biolan, E. Ceausu, P. Calistru, D. Sofronie 
Bucharest, RO 
Objectives: To assess the prevalence of resistance in 405 Streptococcus 
pneumoniae (SP) and 41 1 Haernophilus infuenrae (HI) isolated in 2000 from 
patients and carrier, both HIV and non-HTV. 
Methods: Susceptibility tests were done by disk diffusion method according 
to NCCLS recommendations. SP was tested to oxacdhn (OX),  chlor- 
amphenicol (CL), tetracycline (T), erythromycin (E), rifampin (RD), 
vancomycin (VAN), ofloxacin (OFX), trimethoprirdsulfamethoxazole (SXT). 
HI was tested to ampicih (AMP), amoxicllin/clavulanic acid (AMC), cefaclor 
(CEC), cefuroxime (CXM), cefniaxone (CRO), imipenem (IPM), azneonam 
(ATM), CL, T, chlarithromycin (CLR), ciprofloxacin (CIP), SXT. For 
o x a c h  resistant SP strain? we determined MIC by Etest (AB Biodisk, 
Sweden) for penicillin (P) and cefotaxim (CTX). Beta-lactamase testing was 
performed with Mast ID Intralactam Strip. Etest established MIC to 
erythromycin and azithromycin (AZM) for 48 HI isolates. 
Results: Resistance rate for SP isolated from non-HIV patients (154 strains) 
and HIV patients (62 strains) was, respectively: P 48-70%, CL 1.2-1.6%. T 
41-46%, E 20-48%, R D  7-40%, OFX 1-17%, SXT 54-69%. High 
resistance to P was 7.1% for non-HIV patients and 40.3% for HIV patients. 
The percentages of resistance for camer non-HIV (76 strains) and HIV (1 13 
strains) were: P 38-65%, E 15-32%, KD 5-3296, OFX 0-15%, SXT 57- 
69%. From ali the SP strains were resistant to CTX 8.1%. There was no 
resistance to VAN. For HI 35 (8.5%) of the isolates were resistant to AMP 
of which 32 produced beta-lactamase. Percentages of resistance for the 
another antibiotics were: CEC 0.9%, CL 4.3%, SXT 51% and T 68.6%. AU 
strains were susceptible to AMC, CXM, CRO, IPM, ATM, CLR, CIP. E- 
test for erythromycin detected only two strains resistant and none to 
azithromycin (MIC between < 0.016-4 pg/mL.). 
Conclusions: The prevalence of resistance in SP was not uniformly 
distributed, with a trend for higher resistance rates for penicillin, 
erythromycin, rifampin and ofloxacin in HIV patients and carrier. 
Resistance to ampicillin and chloramphenicol for HI continues to be low. 
The prevalence of beta-lactamase positive strains between AMP resistant HI 
was high. 
The correlation between levels of mannose-binding 
protein and 196 against mycobacterial antigens in patients with 
tuberculosis and in healthy individuals 
A. Bonar, M. Kowalewicz, P. Mackiewicz, 2. Krawczyk, M. Chmiela, 
B. Rbzalska 
Lodz, PL 
Objectives: MBP plays a role in the first line of antibacterial host defence. 
However, under certajii circumstances MBP may be deleterious to the host, 
leading to autoimmune processes or facilitating of infections from 
iiitracellular pathogens. The present study was performed to investigate 
the relationship between the levels of serum MBP and levels of IgG against 
antigens derived from Myrobacterium, m patients with tuberculosis and in 
healthy people. 
Methods: Sera were obtained from 25 adult patients with confirmed 
pulmonary tuberculosis (TB) and from 37 healthy blood donors. MBP 
concentration was determined in an ELISA by comparison with standard 
curve prepared with rMBP (gifk from A. Ezekowitz, USA). Serum IgG to 
Kp90ImCRAC was measured by Kp90 IgG kit (Kreatech Diagn., 
Netherlands). Serum IgG to PPD (Serum Statens Institute, Denmark) and 
serum IgG to Hsp 65 M bovis BCG (gift from K. Huygen, Belgium) were 
determined in an ELISA house-test. 
Results: The h g h  level of anti-Kp90 IgG was detected for 72% of TB 
patients and for 18.9% of blood donors. As many as 52% of TB sera contain 
a high level of anti-PPD and anti-Kp90 IgG. In contrast, about 5% of sera 
from healthy blood donon contained a high level of anti-PPD and anti- 
Kp90 IgG. A high level of serum MBP (> 100 micrograms/mL) was found 
for 52% of TB patients and for 19% of healthy blood donors. In 32% TB 
sera, the high h4BP levels correlated with the high levels of IgG to PPD and 
anti-Kp90. Such correlation was not found for healthy subjects. No 
significant difference in the levels ofant-Hsp65 IgG was found between TB 
patients (16/23, 69.5%) and control (20/37, 54%). 
Conclusions: The correlation of the high levels of MBP and anti-Kp90/ 
PPD IgG found in sera of TB patients indicate that increase in the MBP 
synthesis might be one of the risk factors for tuberculosis or may be related 
to M.  tuberculosis induced pathology. 
Acknowledgements: Supported by KBN Grant No. P05D 06016. 
IP904) Cytokine concentrations in the nasopharyngeal 
aspirates and the serum of hospitalized children with 
bronchiolitis 
G. Antonaki, K. Kallergi, N. Paleologou, G. Stamos, M. Tsolia, 
M. Foustoukou 
Athens, GR  
Objectives: To determine 11-6, 11-8, 11-10, MIP-la and RANTES 
concentrations in the nasopharyngeal aspirates (NAs) and the serum of 
hospitalized children with bronchiolitis in relation with disease aetiology 
and severity. 
Methods: The study group consisted froni 85 chddren aged less than 2 
years, hospitalized with bronchiolitis. NAs were analysed for respiratory 
viruses antigen detection (RS, Influenza, Parainfluenza, Adeno) by DFA 
and for eosinophils presence by Gienisa staii~ng. 11-6, 11-8, 11-10, MIP-la 
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and RANTES concentrations were measured in NAs and serum samples by 
ELISA. Disease severity index was assessed according to four parameters: (a) 
abnormal C R P  values (b) abnormal blood gas measurement (c) abnormal 
chest radiography and (d) oxygen administration. Student's t-test and 
regession analysis were used for the statistical evaluation. 
Results: In 56 children out of 85, RSV antigen was detected in the NAs. N o  
statistical difference was found in the cytokines concentrations in NAs or 
serum, between the RSV bronchiolitis and the non-RSV bronchiolitis 
children. Disease severity index correlated statistically significant ( P  < 0.05) 
with elevated cytokines concentrations (11-6, 11-8, MIP-la and RANTES) 
only in NAs. No correlation was observed between the cytokines 
concentrations in NAs or serum and the presence of eosinophils or the 
family history of atopy. 
Conclusion: Elevated cytokines concentrations in nasopharyngeal aspirates 
correlated with more severe disease of the lower respiratory tract, but not 
with the causative agent 
m1 Monocyte HIA-DR expression and CRP in patients with 
severe sepsis 
A. Lekkou, M. Karakantza, F. Kahentzos, A. Maniati, H. Bassaris, C. Gogos 
Patras, CR 
Objectives: To estimate the prognostic value of human leukocyte antigen 
(HLA-DR) expression on circulahng monocytes and serum C-reactive 
protein (CRP) for the clinical outcome of patients with severe sepsis. 
Patients and methods: 27 patients (15 males, 12 females, mean age 
69.8 f 8.5 years) with severe sepsis (septic SIRS plus at least one organ 
dysfunction) were studied. The aetiology of sepsis was: skin or joint 
infection ( n  = 5), pneumonia ( n  = 8), lung abscess ( n  = l), pyelonephritis 
( n  =5), intra-abdominal infection ( n =  8).The control group included 10 
healthy subjects (6 males, 4 females, mean age 66.5 f 7.2 years).The 
Simplified Acute Physiology I1 (SAPS 11) score (range 28-73) was used to 
assess the severity of sepsis. The percentage of monocytes expressing HLA- 
D R  (CD14-HLADR) was determined by flow cytomeny on admission, 
days (d) 3, 10, 13 and on discharge. C R P  was measured with the N Latex 
C R P  testkit on the same days (normal values < 0.8 mg/dL). 
Results: 16 patients died 1-14 days after admission. SAPS I1 score of 
survivors (group A) was not found to be significantly lower than 
nonsurvivors (group B) on admission (43.1 vs. 48.7) and d 3 (32.2 vs. 
40.6). O n  d 10 group B had significantly higher SAPS I1 score compared to 
group A ( P  < 0.05). Significantly reduced monocyte CD14-HLADR 
expression was observed in group B compared to group A on admission 
(17.5 f 13.6% vs. 36.2 f 25.6%. P=O.O3) and d 3 (19.2 i- 8.2% vs. 
40.2 +_ 26.3%, P < 0.05). CD14-WADR expression in group A was 
increased on d 10 (48.9 i- 21.9), d 13 (44.7 f 23.5), and on discharge 
(53.6 f 12.3), while in group B remained always below 30%) (d 10: 
27.5 2.4, d 13: 28.2 f 1.7). In the control group monocyte HLA-DR 
expression was > 85%. C R P  levels were high in both groups on admission 
(group A: 13.2 mg/dL vs. 
Group b 23.7 mg/dL, NS). In group A C R P  was reduced during follow up 
but no significant difference was noted between two groups (d 3: 12.17 vs. 
28.2 mg/dL, d 10: 5.16 vs. 19.4 mg/dL, d 13: 11.43 vs. 23.6 mg/dL). 
Conclusions: Monocyte HLA-DR expression is an early prognostic marker 
of outcome &om severe sepsis and a diagnostic tool for identihing patients 
at high risk of mortality. It can also be used for monitoring septic patients, as 
values < 30% were consistently associated with poor outcome. C R P  has 
widespread clinical use but limited prognostic value. 
vl Enhancement of immune response following mucosal 
administration of E. coii fimbriae entrapped in liposomes in 
conjunction with V. cholerae antigen 
V. Dima, R. Palade, C. Balotescu 
Bucharest, RO 
In this work we explored the potential of E.  mli 078:Hllfimbriae (CFA/I) 
encapsulated in liposomes and associated w t h  V. cholerae killed antigen to 
induce humoral and mucosal immune response. Groups of young rabbits 
were orally immunized with large, lamellar liposomes containing E. culi 
fimbriae antigen (800 pgldose) associated with V. cbolerae killed antigen (1.0 
X lo' cells/dose) as immunoadjuvant. The results showed that the three 
oral doses of liposomes containing CFA/I antigen associated with 
immunoadjuvant were protective against oral challenge with 2.1 x 109 
E.  coli 0 7 8 : H l l  cells. The administered therapy promoted enhanced 
immunity of E. colifimbnae as shown by humoral (IgA, IgG) and cell- 
mediated immunity (assayed by uptake of 3H-Thymidine by intestinal t- 
lymphoid cells) as well as by bacteriological and histopathological findings. 
The fimbnae alone were less effective in inducing specific humoral and 
mucosal immune response. Summing up, our results showed that: (1). E. coli 
fimbriae entrapped in liposomes in association with V. cholerae immunoad- 
juvant enhance humoral and mucosal immune response and (2) the V. 
chulerae antigen represents a strong mucosal adjuvant with potential 
application in oral vaccines directed against intestinal pathogens. 
1 P907 1 The role of macrophage stimulation and depression in 
inflammation models 
T. A. Korolenko, 0. A. Levina, 0. V. Falarneeva, S .  Ja. Djanayeva, E. E. 
Filjushina, M. A. Dergunova 
Novosibirsk, RUS 
Macrophage (Mph) stimulation and depression are closely related to 
nonspecific host defence mechanism$. Beta-glucans of microbial sources are 
nontoxic and effective immunomodulators, perspective for usage in 
different fields of clinical mehcine. 
Aim: to investigate the role of macrophage (Mph) stimulation and 
depression in development of liver inflammation with special attention to 
marker lysosomal enzymes of Mph cathepsin B and new macrophage 
enzyme chitotriosidase activity as a possible marker of inflammation. 
Methods: Macrophage stimulation was induced in CBA mice and Wistar 
rats by zymosan (100 mg/kg), beta-glucan (25 mg/kg), the selective 
inhibitor of Kupffer cell function gadolinium chloride was administered in a 
dose of 7.5 mg/kg 24 h before zymosan.Cathepsin B activity in liver 
samples (Kirschke et al. 1995) and serum chitotriosidase (Guo et al. 1995) 
activity were measured fluorimetrically. 
Results: During inflammation induced by zymosan, increased cathepsin B 
activity was noted in liver, lung, and pretreatment by gadolinium chloride 
prevented liver innammation, decreasing activity of cathepsin B up to the 
normal values. During Mph stimulation by beta glucan in CBA mice 
increased number of liver Mph and serum chtotriosidase activity were 
revealed; similar data were obtained in Wistar rats and CBA mice during 
Mph stimulation by other agents (zymosan, Triton WR 1339). There was 
no significant difference between groups of Mph stimulation induced by 
different stimulators. Mph depression (gadolinium chloride, 24-48 h) was 
followed by decreased serum chtotriosidase activity (about twice); in this 
group of animals the number of liver Mph was decreased, as well as their 
phagocytic activity. 
Conclusion: Both mice and rats revealed increased serum chitotriosidase 
activity in all models of Mph stimulation. Serum chitotriosidase activity can be 
used as a new informative marker of Mph stimulation or depression in vivo. 
v] Role of alveolar macrophage subpopulation A in the 
formation of mucosal antiplague immunity 
C. 1. Vasilieva, L. M. Verkina, A. K. Kiseleva, E. P. Doroshenko, 
I .  A. Bespalova 
Rostov-on-Dun, RUS 
Recently we have demonstrated the importance of the alveolar macro- 
phages in the formation of mucosal immunity after aerogenic immunization 
with Yevsiniapestis vaccine strain. The objective of this study was to estimate 
the role of different alveolar macrophage subpopulations in this process. 
Alveolar macrophages were obtained from intact and immune guinea-pigs 
on 14 day after vaccination. The animal immunization was performed with 
Y. pestis EV by aerogenic and subcutaneous routes. Alveolar macrophage 
subpopulations were isolated by absorption and elution at different 
temperatures (2, 10, 28 and 37 "C) and signed A, B, C ,  D, respectively. 
The relative content of these subpopulations in the total pool of alveolar 
cells before and after immunization was established. The redistribution of 
the macrophage subpopulations was evaluated by the index of macrophage 
subpopulation redistribution (IMSR). The expression of la-antigen, Fc and 
C3-receptors, kequency of phagosome-lysosome fusion and microbicidal 
activity were investigated in these cells. Beside the ability to produce IL-I, 
TNF-alpha and monokines, that mediate macrophage-neutrophil coopera- 
tion was studied. Y.  pestis EV cells were used as inductor of monokines. To  
evaluate the development of antiplague immunity intact and immune 
animals were infected with virulent strain of Y. pestis by aerogenic route. 
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Our data demonstrate that highest activity in all investigated tests was 
determined in subpopulation A. It was established that aerogenic 
immunization in contrast to subcutaneous vaccination enhanced alveolar 
macrophage activity and stimulated redistribution of the macrophage 
subpopulations of the total pool of the alveolar cells. The increase of the 
relative content of the most active subpopulation (A) was determined 
(IMSR 10). The results of this study show an important role of alveolar 
macrophage subpopulation A in the formation of mucosal immunity after 
aerogenic immunization with Y.  pestis vaccine strain. Thus, our data 
demonstrate that one of the possible factors determining the efficiency of 
antiplague aerogenic immunization is the ability of vaccine preparations to 
stimulate macrophage subpopulation A. 
/p9091 Effects of low pH nitric oxide synthesis from human 
monocyte derived macrophages 
A. Y. Coban, B. Ekinci, A. Birinci, B. Durupinar, M. Erturk 
Samsun, TR 
Objectives: The aim of this study was to asses the effects of environmental 
pH changes to acidic range on N O  synthesis from macrophages. 
Methods: Human monocyte derived macrophages were obtained from 
peripheral blood of healthy human volunteers by using Ficoll-Hypaque 
density gradient method. Isolated monocytes were seeded into tissue culture 
flasks and incubated at 37 "C in a 5% COz humidified incubator for 7 days 
in RPMI 1640 medium with 10% Fetal-calf serum (FCS). Macrophages 
were then harvested and seeded in 96-well plates at 105 cells/well. RPMI 
1640 containing 10% FCS at three different pH ranges of 7.4, 7.0 and 6.8 
was added to all wells. Samples from each well were taken for determining 
nitrite concentration at 3, 6, 24 and 48 h time. 
Results: The amount of NO detected in each groups of was incubated at 
varying pH are summarized in Table 1. 
Table I. The amounts of nitrite 
Time (h) pH=7.4 (pM) pH=7.0 (pM) pH=6.8 (pM) 
3 5.4 i 0.3 30.9 f 4.2 22.7 i 2.9 
6 9.2 n.4 45.1 f 8.3 58.2 i 5.1 
24 17.6 & 0.6 45.8 f 1.9 52.1 f 3.3 
48 16.2 + 0.8 66.3 + 4.2 84.5 + 1.7 
Conclusions: The results indicate that the state of pH to which 
macrophages, exposed to causes significant improvement in NO synthesis. 
vl Eosinophile cationic protein in serum of children with 
Mycoplasma pneumonia 
G. Anton&, N. Paleologou, K. Kallergi, A. Zafiropoulou, E. Lebessi, M. 
Foustoukou 
Athens, GR 
Objectives: To assess whether Mycoplasma pneumonia in children correlated 
with elevated eosinophil cationic protein (ECP) levels in their serum. 
Methods: We studied three groups of patients. The first consisted from 63 
children aged 2-12 years old with Mycoplasmapneumonia, diagnosed by chest 
radiography and a positive IgM ELISA titre. The second one h-om 23 
children with pneumonia caused by Streptococcus pneumoniae, Chlamydia spp. 
or respiratory viruses and the third from 15 children with no disease, as 
normal controls. Blood samples were obtained for the measurement of ECP 
concentrations by a FEIA method. In 18 children of the first group, a 
second blood sample was also obtained after 2 months. Student's f-test and 
regression analysis were used for the statistical analysis. 
Results: No difference was found for ECP concentrations in serum between 
the first and the second group of pneumonia patients. ECP levels in both 
groups of pneumonia were statistically s igdcant  (P  < 0.01) elevated 
compared to the normal controls group. N o  correlation was observed 
between the ECP levels and the anti-Mycoplasma pneumorziae IgG ELISA 
concentrations or the IgM index value in the first group of patients. In 
the second serum sample of Mycoplasma pneumonia patients, ECP levels 
were statistically significant (P  < 0.001) decreased, compared to the first 
serum sample. 
Conclusion: Pneumonia in children associated with elevated ECP 
concentrations in serum, independently from the causative agent. 
Beneficial effect of recombinant human granulocyte- 
colony stimulating factor (rhG-CSF) on the functions of 
polymorphonuclear leukocytes from patients with diabetes 
mellitus in vitro 
S. Kulotu, M. Bakir, N. Elaldi, 1. Dokmetas, S. Dokmetac 
Kahramanmaras, Sivas, TR 
Objectives: The effect of recombinant human granulocyte-colony stimulat- 
ing factor (rhG-CSF) on the functional status of polymorpbonuclear 
leukocyte (PMNL) in diabetic patients was investigated in in-vitro 
conditions. 
Methods: PMNLs were prepared from heparinized whole blood of 14 
patients (Mean age 46.9 years) and 14 normal healthy volunteers (Mean age 
47 years) by dextran sedimentation and Ficoll-Hypaque density gradient 
centrifugation of the leukocytes rich supernatant. PMNLs (1 d i o n  cells) in 
Hanks Balanced Salt Solution (HBSS) were incubated for 30 nlin with or 
without the dserent concentrations (1500, 3000, 4500, and 6000 units/ 
mL) of rhG-CSF. Equal numbers (1 &on cells) of rhG-CSF-pretreated or 
buffer treated PMNLs and Candida albicans CBS 2730 blasroronidia were 
mixed in HBSS and incubated for 15 min on a shaker. At the end of this 
incubation phagocytic functions of the PMNLs were tested. The incubation 
continued for another 45 min and intracellular kdmg of the blastomnidia 
was tested. 
Results: rhG-CSF had no statistically s igdcant  effect either phagocytic and 
fungicidal functions of PMNLs from healthy volunteers ( P  > 0.05). 
Phagocytic and fungicidal activity of PMNLs of the patients were 
significantly impaired with respect to normal subjects ( P  < 0.001) and 
cytokine enhanced both phagocyting and intracellular killing of the 
blastoconidia above the base-line activities by dose-dependent. These 
enhancements were significant at 4500 and 6000 units/mL of the cytokine 
Conclusion: These data demonstrates that PMNL of the diabetic patients 
have impaired phagocytic and hngicidal activity in vitro. In our opinion 
rhG-CSF can improve these activities. 
( P  < 0.001). 
v] G-CSF is produced in various organs during murine 
peritoneal infection 
L. Hareng, M. Lehner, T. Hartung 
Konstonr, D 
The haematopoietic growth factor G-CSF is in broad clinical use to treat 
neutropenia, and trials on its use in immunosuppressed conditions and 
infectious diseases are ongoing. However, little is known about the 
endogenous production of G-CSF in these pathophysiological conditions. 
As shown in several animal studies, endogenous G-CSF plays a pivotal role 
in models ofbacterial infection and septic shock. Therefore, G-CSF protein 
and mRNA levels of various organs were determined in control mice and 
mice with peritoneal Salmonella typhimun'um infection by ELISA and RT- 
PCR. In control mice, only basal G-CSF protein levels (up to 3 ng/g wet 
weight) were detectable in all organs assayed. 2 h after peritoneal injection 
of Snlmonella (107 bacterialkg), G-CSF protein became detectable in serum, 
peritoneum and all organs assayed, and did not peak within 24 h of 
infection. A strong rise in G-CSF serum levels was found between 2 and 4 h 
and in peritoneum after 6 h, while G-CSF levels increased steadily in all 
other organs. No significant increase in G-CSF levels was detectable in bone 
marrow during infection. Compared to control mice, G-CSF mRNA was 
present in peritoneal cells and all organs studied 6 h after challenge with 
Salmonella, whereas no G-CSF specific PCR product was measurable in 
bone marrow samples. A study of the kinetics of G-CSF mRNA formation 
in liver showed first detectable levels of G-CSF mRNA 1 h after infection 
and a peak in mRNA production after 6 h. The elevated protein levels and 
the presence of mRNA indicate the involvement of many organs in the 
production of G-CSF in response to systemic mfection, whereas the bone 
marrow, a major target for G-CSF, plays a minor role in its production. 
Injection of heat-lulled Salmonella into the peritoneum showed a 
predominant G-CSF mRNA formation in peritoneal cells compared to 
the other organs. Therefore, it is suggested that the site of infection is 
responsible for the formation of G-CSF, providing a signal for neutrophil 
production and recruitment. Furthermore the action of G-CSF as an 
antiapoptotic factor and chemoattractant may also be important for a local 
neutrophil accumulation in the infected organ. 
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/p9131 Comparison of serum antigiiadin, antiendomysium 
antibodies by IFA and ELLA in patients with Familial 
Mediterranean Fever 
0. Yilniaz, S. Kirdar, Y. Dogan, S. Kavukcu, S .  Sarioglu, E. Unsal, 
I. H.  Bahar, N. Yulug 
Ianir ,  TR 
This study was conducted to investigate the prevalence and clinical 
relevance of antiendomysium (EMA) and antighadin (AGA) antibodies at 
the onset of Familial Mediterranean Fever (FMF) patients by serological 
methods. The high levels of AGA and EMA have been reported in patients 
with severe abdominal Pam. Although it has been pointed out that coeliac 
disease (CD) has been shown to be associated with many differrent diseases, 
the relationship between the C D  and FMF, in which main sign is abdominal 
pain, has not been investigated so far. A total of 25 patients (ages between 5 
and 17 years) were studied. Fifteen of them were FMF patient having 
abdominal cramps and discomfort and the rest of them were healthy 
controls. AGA IgA and IgG antibodies were detected by a commercial 
ELISA (Euroimmun), EMA IgA and AGA IgA antibodies were determined 
by indirect immunofluorescence test (IFA, Euroinmun). Six (40%) FMF 
patients were found positive for AGA IgG, two (13%) were found positive 
for AGA IgA by ELISA, four (26.6%) were positive for EMA and two (13%) 
were positive for AGA antibodies by IFA, respectively. Statistical analysis 
revealed that there was statistical difference (P' 0.05, Fisher's chi-square 
test) of the AGA IgG antibodiey by ELISA between FMF patients and 
controls. There was no statistical difference for AGA IgA by ELISA, AGA 
IgA and EMA IgA by IFA, respectively. Those found to be AGA IgG and 
IgA positive and/or EMA positive by both methods could not be further 
investigated with the intestinal biopsy. In order to determine the accuracy of 
AGA and EMA antibodies for the diagnosis of C D  in FMF children with 
digestive symptoms, it is necessary to search for these antibodies among 
larger FMF patient group. 
Effect of cyclosporin on uropathogenic E. coli 
adherence to  human endothelial cells 
A. Szkaradkiewicz, M. Wal 
Pozriari, PL 
Objectives: The studies aimed at examination of the effect of cyclosporin A 
(CsA) on adherence of uropathogenic E. coli to human endothelial cells. 
Methods: The studies were performed using 12 E .  roli strains, which were 
isolated from urine of adult patients. The strains were identified as belonging 
to E. roli species using API ID 32 GN test and the ATB system 
(bioMerieux). Adherence of bacterial cells to human umbilical vein 
endothelial cells (HUVEC) was stumed after labelling of the bacteria using 
BrdU. Adherence of bacterial cells was detected by immunoenzymatic assay 
with peroxidase labelled monoclonal anti-BrdU antibodies. HUVEC were 
preincubated for 30 min at 37 "C in PBS containing CsA (Sandoz) at 25, 50, 
100, 150 and 200 pg/mL or containing no CsA (control). 
Results: Mean value of absorbance for the E .  coli strains amounted to 
0.46 & 0.04. As compared to the control values, bacterial adherence to 
HUVEC significantly increased following preincubation at 50 pg/mL 
(P < 0.05) and, more significantly, to H W E C  preincubated with CsA at 
Conclusion: CsA administered in vivo in therapeutic doses may result in an 
increased bacterial adherence to host cells. 
100 pg/mL-200 pg/mL (P  < 0,001). 
vl Characterization of immunogenic proteins of 
Toxoplasma gondii by 2-DE and mass spectrometry 
W. Sokolowska-Kohler, A. Otto, E.-C. Mdler, M. Schumann, P. R 
Jungblut, W. Presber 
Berlin, D 
Toxoplasma gondii is known to cause a variety of diseases ranging from 
asymptomatic infections to serious conditions in immuncompromised hosts 
such as AIDS-patients or transplantant recipients. In addition they may 
muse abortion or fetal abnormalities during pregnancy. Despite the clinical 
importance, diagnosis, treatment and prevention still remain unsatishctory. 
Analysis of the parasitic cell determinants, recognized by specific humoral 
and cellular immune responses, may have important implication for 
diagnosis, therapy and vaccination strategies. Two-dimensional electro- 
phoresis (2-DE) was used to resolve and compare protein patterns &om 
Toxoplasma gondii strains KH and BK. In second series of experiments, the 
reactivity of the spots with human sera was tested. Proteins were transferred 
to PVDF-membranes and were detected with sera kom different panents 
with acute toxoplasniosis. Depending upon the immunglobulin class (IgG, 
IgM and IgA) merent  epitope patterns were observed. 
Spots of interest were excised out of the gel and the analysis was performed 
by enzymatic in-gel digestion in combination with matrix assisted laser 
desorbtion/ionization mass spectrometry (MALDI-MS, TofSpec E.) and 
nanoelectrospray ionization mass spectrometry (ESI-MS) using a hybrid 
quadrupoleorthogonal acceleration time-of-flight mass spectronieter (Q- 
Tof) equipped with a Z-spray probe. Peptide masses and partial sequences 
were used to search in parasites data bases (www.ebi-ac.uk/blast2/ 
parasites.hd). 
Ip9161 Role of Th-1 and Th-2 cytokines in the immune 
response of uncomplicated Plasmodium falciparum malaria 
D. Torre, F. Speranza, M.  Giola, A. Matteelli, K. Tambini, G. Biondi 
Varese, Brescia, I 
Background: It is becoming increasingly important to understand the 
protective immune response to malaria. The relative balance between Th-1 
and Th-2 cytokines appears crucial, since the role of cytokines has been 
evaluated in several studies by comparison of clinically heterogeneous 
groups of patients. Aim of this study is to determine the roie of pro- 
inflammatory Th-1 cytokines (IL-12, IFN-gamma and IL-18) and anti- 
inflammatory Th-2 cytokines (IL-4 and IL-10) in an homogeneous group of 
patients with uncomplicated P. faliparum malaria. 
Methods: Senmi levels of IL-12, IFN-gamma, IL-18, IL-I0 and IL-4 were 
determined in 20 patients and in 15 healthy control subjects by an immune 
enzymatic assay. 
Results: Serum levels of Th-1 cytokines, IL-12 (8.6 f 2.8 pg/mC) and 
IFN-ganm (39.2 5 67.6 pg/mL), were significantly increased at admis- 
sion; three days later serum levels of IL-12 remained high, whereas IFN- 
gamma levels returned to control values. 
The anti-inflanmiatory response of Th-2 cytokines (IL-10 and IL-4) was 
distinct. Serum levels of IL-10 were persistently and significantly high at day 
0 and day 3 (306.6 f 200.4 pg/mL and 56.6 k 38.4 pg/inL, respectively). 
In contrast, serum levels of IL-4 were not high on admission (3.4 1.2 pg/ 
mL), but significantly increased afier 3 days (4.5 & 1.7 pg/mL). All patients 
improved and recovered in 3-5 days, afier antimalarial treatment was 
started. 
Discussion: These results provide insight into the pathogenesis of malaria by 
strengthening the contention that cytokines such as IL-10 and IL-4 are 
involved in modulating the immune response to P.  f~k@vtrm in 
uncomplicated malaria. In particular, these data suggest that IL-10 is a 
natural component of the inflammatory response dunng unconiplicated 
malaria, and serves to both shorten its duration and reduce its magnitude. 
The inability to mount and maintain balance between Th-l and Th-2 
cytokine response may underlie the progression from uncomplicated P. 
jdciparuin malaria to severe, life-threatening complications. 
vl Peritonitis induces the production of a novel peptid, 
daintain 
C.-G. Ostenson, E. Alkstrand, Z.-W. Chen, 0. Hertting, E. Sandberg, 
A. Brauner 
Stockholm, S 
Objective: T o  study the occurrence of a novel macrophage-derived peptide, 
daintaidallograft inhibitory factor-1 in peritoneal dialysate and the response 
of this peptide in peritonitis of patients on continuous ambulatory peritoneal 
dialysis (CAPD). In addition, to investigate the production of daintain in 
monocytes and macrophages in response to bacterial stimulation. 
Material and methods: Peritoneal fluid was obtained from 14 patients (10 
males and 4 females) on CAPD treatment during noninfected steady state. 
During peritonitis peritoneal effluent was drawn immediately after arrival to 
hospital and on days 3 and 10. A human monocyte cell-line, THP-1 was 
differentiated to macrophages and both nionocytes and macrophages were 
stimulated with live and heat inactivated E. coli, S. aureus and S. epidermidis. 
Daintain was analysed with RIA technique. 
Results: Low levels of daintain were detected in all control samples kom 
CAPD patients. O n  the first day of peritonitis, daintain increased more than 
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four-fold and reached peak values ( P  < 0.05 vs. noninfected state and 
controls) and decreased thereafter. E. coli, S. aureus and S .  epidermidir all 
induced a three-fold or more damtain response in monocytes as well as 
macrophages ( P  < 0.05 vs. nonstimulated cells). Peak levels were reached at 
6 h for live E. coli and S. aureus, while S. epidermidis peaked at 24 h. Live 
bacteria gave a higher daintain response compared to the same heat 
inactivated bacteria, indicating a possible relevance of one or more heat 
labile virulence factors. 
Conclusion: Daintain is up-regulated during bacterial peritonitis in CAPD 
patients. We also observe that monocytes and macrophages are able to 
produce daintain especially in response to live bacteria. 
Induction of human macrophage VEGF and ICAM-1 by 
ureaplasma urealyticum and down-regulation by steroids 
A. Brauner, J. Skov Jensen, Y.-H. Li, K. Tullus 
Stockholm, S; Cupenhagen, DK 
Background: Chronic lung disease (CLD) ofprematurity is a major problem 
in the neonatal care. The contribution of U. uredyticum to the development 
of CLD is still controversial. In the inflammation and induction of 
angiogenesis in fibroproliferative states macrophages play a key role. 
Vascular endothelial growth factor (VEGF) functions as a regulator of 
vascular permeability, which is considered important for the initiation of 
aiigiogeiiesis, during embryogenesis and fibroproliferation. It is clear that 
cell-cell interactions as well as cell-extracellular matrix interactions are 
critical for the pathogenesis of pulmonary fibrosis. One of the essential 
mechanism by which cells interact with the microenvironment is through 
the expression of cell adhesion molecules like intracellular adhesion 
molecule-1 (ICAM-1). There is increased collagen deposition in the 
periphery of the lung, with thckening of alveolar walls. This increased 
collagen is associated with increased numbers of fibroblasts in the 
interstitium and in the alveolar space itseK To prevent or treat CLD but 
also to influence postnatal lung growth and development corticostero~ds are 
widely used in premature infants. 
Objective: To analyse if U. urealyticum is able to induce production of VEGF 
and ICAM-1 in macrophages. 
Methods: A human monocyte cell line (THP-I) difiirentiated to 
macrophages was exposed to heat killed U. urealyticum alone. or in 
combination with dexamethasone or budesonide. ELISA was used to detect 
VEGF and SICAM-I in the supernatant of the cell culture. RT-PCR was 
used for VEGF mRNA analysis. 
Results: U. urealyticum antigen stimulated the macrophage to produce 
VEGF and SICAM-I in a dose dependent manner ( P  < 0.05, respectively). 
Budesonide and dexamethasone significantly inhibited the VEGF and 
SICAM-1 production ( P  < 0.05, respectively). The expression of VEGF 
mRNA was also induced by U. urealyticwn and inhibited by steroids ( P  < 
0.05, respectively). 
Conclusions: Our findings suggest that U. uredyticunz may be an important 
factor in the development of CLD due to its abllity to induce macrophage 
VEGF and SICAM-1 production. The down-regulation of VEGF and 
SICAM-1 production of steroids can partly explain the beneficial effect of 
steroids in neonates with CLD. 
Procalcitonin 
vl Procalcitonin in adults with community-acquired 
pneumonia and pyelonephritis 
M. Martinot, Y. Hansmann, N. Henoun Loukili, V. Remy, G. Coumaros, 
S. De Martino, E. Noel, D.  Andriamisolo, E. Pencreach, M. Bertrand, 0. 
Lesens, D. Chnstniann 
Strarbourg, F 
Procalcitonin is an acute phase protein of inflammation specific of severe 
bacterial or fungal infections. PCT is not or slightly elevated in others 
inflammatory diseases. Yet this protein lacks of sensitivity in focal infections. 
Objective and methods: To investigate PCT, CRP,  ESR, leukocytosis and 
fibrinogen values at admission among adult patienrs hospitalised for community- 
acquired pneumonia (n=33), pyelonephritis ( ~ ~ 3 0 )  and among a control 
population (n 27) with viral infections and non dectious dammatory diseases 
(13 viral infections, 3 phlebitis/phonaty emboli, 4 solid tumous, 2 lymphoma, 
2 acute thyroiditis, 1 Horton, 1 chondrocalcinosis, 1 urdcaria, 1 sickle cell 
disease). PCT gU < 0.5 ng/mL) was measured by a specific and ultrasensitive, 
inmuno~omehic test (BRAHMS diagnostica, Berlin, Germany). 
Results: Values were compared between septic group and pneumonia or 
pyelonephritis group by Mann-Whitney test. 
PCT and C R P  values difTer significantly between the control group and the 
2 septic groups ( P  < 0.0005). None of the others inflammatory parameters 
investigated (leukocytosis, ESR, fibrinogen) reach such a difference 
between the control group and the septic groups. The sensitivity value 
of PCT (threshold of 0.5 ng/niL), is of 61% for the diagnostic of 
pneumonia and of 44% for the diagnostic of pyelonephritis. The specificity 
value is in both cases 92%. In comparison the sensitivity value of C R P  
(threshold of 50 mg/L) is, respectively, of 94% and 91% for a specificity in 
both cases of 33%. 
Conclusion: PCT is a specific but a low sensitive marker of community- 
acquired pneumonia and pyelonephritis among adults hospitalized in 
medical services. 
v] Procalcitonin, CRP, ESR, TNFalpha and IL6 in adult 
septic, rheumatoid and crystal-associated arthritis 
M. Martinot, J. Sibilia, Y. Hansmann, G. Coumaros, P. Guggenbuhl, X. 
Pukhal, M. Soubrier, F. Liotk, F. X. Limbach, V. Remy, D. Christmann 
Strasbourg, F 
Procalcitonin (PCT), the calcitonjn peptide precursor, is a new specific 
marker of severe bacterial and fungal infections. PCT is not (or slightly) 
elevated in others inflammatoiy diseases. PCT measurenients could help to 
differentiate bacterial arthritis from other fornis of acute arthritis. 
Objective: T o  determine the values of CRP,  erythrocyte sedimentation rate 
(ESR), plasma (P) and synovial fluid (SfJ PCT, IL6 and TNF alpha in 
patients with acute arthritis. The aetiology (septic, rheumatoid and crystal- 
associated) of arthritis was determined by specific synovial fluid (Sf) analysis. 
Methods: A I-year prospective study (RR study group): sera and Sf from 
32 adult patients with acute arthtitis were immediately frozen (-20 "C) 
before treatment. PCT (N < 0.5 ng/mL) was measured by a specific and 
ultrasensitive, immunolometric test (BRAHMS diagnostica, Berlin, Gemiany). 
IL6 and TNF alpha were measured by a specific immunoenzymatic method. 
Results: See Table 1 
For the diagnosis ofseptic arthritis, PCT > 0.5 ng/mL has a 50% Sensitivity 
(Se), a 90% Specificity (Sp). In comparison C R P  > 50 mg/L has a 100% Se, 
a 40% Sp. 
Conclusion: These preliminary results show that plasma PCT levels are 
highest in patients with septic arthritis. PCT sensitivity remains insufficient. 
In case of arthritis, PCT in association with CRP,  could be however, of 
great help for clinicians, as its increase is in favour of a bacterial origin. PCT 
is not present in all biological fluids. If Sf PCT does not seen] to be helpful 
in clinical diagnosis, this study is, to our knowledge, the first to demonstrate 
PCT existence in synovial fluid. 
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v] Procalcitonin (PCT) as an index of the severity and of 
the prognosis of acute pancreatitis 
P. Grecka, G. C. Nikou, E. J. Giamarellos-Bourboulis, Th. Arnaoutis, Ch. 
Toumpanakis, N. Katsilambros 
Athens, CR 
Objective: To define the role of PCT in the prognosis of acute pancreatitis 
which is recognized as a major cause of SIRS. 
Methods: Twenty-eight patients - 15 male, 13 female, 64.1 f 19.2 years 
old with acute pancreatitis were enrolled in the study. Blood samples were 
collected daily and PCT was determined in serum by an assay based on 
immunochermluminescence (Normal values < 0.5 ng/mL). Values were 
expressed by their mean ( f SE) values. 
Results: APACHE 11 score of patients was 5.25 f 0.95 and PCT of the first 
day of all patients was 0.69 f 0.18 ng/mL (Limits Not Detectable - 3.34 
ng/mL). Acute pancreatitis resolved without complications in 25 patients 
and PCT values were 1.12 f 0.54, 0.77 0.25 and 0.66 f 0.21 n g / d  on 
the second, h r d  and fourth day after enrolment in the study, respectively 
(PNS compared to values of the fiat day). PCT values in three patients 
progressing to SIRS were 12.12 f 8.57 n g / d  on the second day (P:0.008 
compared to the first day) and 47.41 20.05 ng/mL on the third day 
(P:0.015 compared to the second day). 
Conclusions: Moderate increases of PCT are found in the field of acute 
panCreatihS which become extremely elevated upon progression to SIRS. 
v] Evaluation of a semiquantitative rapid test for 
procalcitonin measurement to distinguish between bacterial and 
viral meningitis in children 
C. Prat, C. Rodrigo, M. GimCnez, J. Dominguez, A. Alonso, C. Rand,  
V. Ausina 
Badalona, E 
Objective: T o  evaluate the usefulness of a fast semiquantitative immuno- 
chromatographic assay for procalcitonin (PCT) measurement in serum to 
distinguish between bacterial meningitis and/or sepsis and nonbacterial 
meningitis in children, To evaluate the diagnostic sensitivity and specificity 
of a rapid (30 min) semiquantitative test comparing to quantitative 
immunoluminometric assay. 
Methods: Serum samples for measurement of PCT were obtained from 
patients admitted to Pediatric Emergency Department with suspicion of 
systemic infection based on clinical and laboratory findings. Bacterial 
sepsis and/or meningitis was documented on 20 patients by positive blood 
and/or cerebrospinal fluid (CSF) cultures. Nan-bacterial meningitis was 
diagnosed on 12 patients. PCT was measured by immunoluminometric 
assay (Lumitest PCT Brahms Diagnostica) and by immunochromatographic 
assay (Brahms PCT-Q). 
Results: Systemic bactenal and viral infections showed a mean PCT value, 
by quantitative test, of 34.58 ng/mL (range: 2.26-253) and 0.535 ng/mL 
(range: 0.231-0.71), respectively. PCT result by semiquantitative test was 
< 0.5 in all viral infections, and intensity of the test band corresponded to 
> 2 (2 cases) and > 10 (18 cases) in systemic bacterial infections. Using 2 
ng/mL as the cut-off, sensitivity and specificity of PCT in distinguishing 
between bacterial and viral infections, in both tests were 100%. 
Conclusion: PCT yields significant sensibvity and specificity to discriminate 
between bactenal and viral systemic infection at the time of admission. 
Semi-quantitative test measurements correlate 100% to quantitative test 
determinations. Serm-quantitative test allows an acute and rapid differential 
diagnosis of systemic sepsis, making it very useful in Emergency 
Departments for diagnostic and therapeutic purposes. 
(p9231 Procalcitonin as a useful tool for the differential 
diagnosis between viral and bacterial infection 
C. Petrogiannopoulos, A. Zacharof, E. Vartzioti, A. Skarmoutsou, P. 
Drimalas, D. Dandakis, C.  Flevaris, K. Mpethimouti 
Athens, GR 
Many clinical trials have shown the positive correlation of P-CT with 
systemic infections. 
Objective: Was to estimate the role of P-CT on the Merential diagnosis 
between bacterial and viral systemic infection comparing its usefulness with 
C-reactive protein (C-RP) levels. 
Methods: We studied 58 hospitalized patients with different type of 
systemic infection based on clinical and laboratory findings. Blood samples 
were obtained for white blood count, blood cultures, CRP, P-CT, and 
antibodies for viral infection such as CMV, EBV, ECHO and coxhackie. In 
order to establish the normal P-CT levels serum samples were obtained 
from control group of 25 same age healthy persons. P-CT was measured by 
immunoluminometric assay (Lumitest P-CT Brahms Diagnostica). 
Results: According to the clinical and laboratory findings 35/58 patients had 
bacterial systemic infection while the rest of them (23/58 patients) had viral 
systemic infection. The mean P-CT value for control group was 0295 ng/ 
mL (range 0.130-1.01) while for systemic bacterial and viral infections the 
mean P-CT value were 14.8 ng/mL (range 0.1440.14) and 0.36 ng/mL 
(range 0.1&0.59), respectively. In comparison CRP concentrations were 
8.54 mg% (range 0.47-29.2) and 6.78 mg% (range 0.5-22.8), respectively. 
After that P-CT showed 100% sensitivity and specificity to dminguish 
bacterial from viral infection while CRP showed high sensitivity (80-100%) 
but very low specificity (< 30%). 
Conclusion: Accordmg to the results P-CT is a useful and important tool 
for the clinicians to diagnose the kind of systemic infection (bacterial or 
viral) mainly when clinical and laboratory signs are non specific for 
this determination. 
Procalcitonin as a marker of bacterial infection in acute 
pancreatitis 
C. Petrogiannopoulos, A. Zacharof, D. Dandakis, P. Drimalas, E. Vartzioti, 
S. Lyberopoulou, L. Kondili, C. Flevaris, K. Mpethimouti 
Athens, GR 
Objective: Was to evaluate if P-CT establish the diagnosis of bacterial 
infection in patients with acute pancreatitis. 
Material: We studied 18 hospitalized patients with acute ilopathic 
pancreatitis. Blood samples were obtained for white blood cells count, 
CRP, P-CT, and blood cultures. All the patients the first day of their 
admission got a C T  scan of the upper abdomen. 
Results: According to the C T  scan 10 patients had oedematous pancreatitis 
(group A) and 8 patients had acute necrotizing pancreatitis (group B).The 
white blood cell count and the C R P  levels did not change significantly 
between the two group of patients (white blood count: 13 000 f 1215 vs. 
14 566 f 1450/mm3 and CRP: 14.64 f 0.2 mg% vs. 12.25 k 0.3 mg??, 
respectively) while the mean value of P-CT changed significantly (PCT: 
0.29 & 0.04 ng/mL for group A vs. 2.95 f 0.07 ng/mL for group B). AU 
the blood cultures were sterile for both group. After these results all the 
patients of group B started antibiotic therapy with good response of P-CT 
levels (2.95 k 0.07 ng/mL before therapy, 0.85 f 0.02 ng/mL after). 
Conclusion: Procalcitonin could be a useful marker for the early 
development of bacterial infection in patients with acute necrotizing 
pancreatitis but we need much more patients to establish this. 
lp925) Procalcitonin and CRP serum levels4n patients with 
sepsis and bacteraemia - a pilot study 
Ajula, IL 
R. Colodner, M. Mines, Y .  Keness, R. Raz 
Background: Procalcitonin (PCT) is considered an important marker in the 
diagnosis of systemic bacterial infections. In contrast to CRP, PCT levels 
rise and return to normal quicker and probably increased specifically in the 
presence of bacterial infections. 
Aims: The aims of the study were to measure and compare PCT and CRP 
levels in patients with sepsis and bacteraemia. 
Materials and methods: PCT and C R P  levels were taken in 20 patients 
with sepsis and positive blood cultures during the firs 24 h of hospitalization. 
A second sample was obtained 3 days later. In a second group of 27 patients 
with sepsis and bacteraemia, PCT and C R P  levels were obtained 48-72 h 
after hospitahzation and one week later. PCT and CAP levels were also 
taken from 10 healthy patients (control group). PCT was measured with an 
immunoluminometric assay (F3rahms Diagnostica, Berlin, Germany) and 
C R P  with CRPLX (Roche Diagnostics GmbH, Manheim, Germany). 
PCT and C R P  levels above 0.5 ng/mL and 10 mg/dL, respectively, were 
considered significantly elevated. 
Results: The mean PCT level in 20 patients taken during the first 24 h was 
12.6 ng/mL f 20.2 (0.02-81.8) and the mean CRP level 192.8 mg/ 
dL 5 90.4 (65.5-359). Levels taken 3 days later dropped considerably to 3.1 
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ng/mL + 5.4 (0.01-20.5) and 131.9 mg/dL f 96.9 (16.4359). respec- 
tively. The mean PCT level in 10 control patients was 0.08 ng/mL 0.1 
(0.054.1) and the mean C R P  level 4.0 mg/dL 5 2.6 (1.1-8.0). However, 
in three patients with sepsis and bacteremia PCT levels were normal (0.1, 
0.02 and 0.06 ng/mL) but elevated CRP levels were observed. In the 
second group of 27 patients, mean PCT and C R P  levels after 48-72 h of 
hospitalization were 6.0 ng/mL + 16 (0.16-60.8) and 130.0 mg/dL 78.1 
(20.0-358.0), respectively. One week later, PCT and C R P  serum mean 
Tetanus - Diphtheria - Botulism 
levels dropped to 0.42 ng/mL 0.35 (0.01-1.54) and 70.8 mg/dL ‘I 40 
(2.0-178.0). However, in 9/27 patients (33.3%) PCT levels were normal in 
the first sample. 
Conclusions: In contrast to previous studies, the sensitivity of PCT in 
patients with sepsis and bacteraemia was 85% when the serum sample was 
taken within 24 h of hospitalization. In samples taken 48-72 h after 
hospitahation, sensitivity decreased to 66.6%. CRP levels were elevated in 
all cases. 
/p9261 The outbreak of diphtheria in closed community with a 
high protective titre 
L. Viksna, B. Rozent%e, A. Brila, A. KGmiba, V. h e ,  V. Sondore 
Riga, LET 
Objective: Assessment of diphtheria changing patterns in closed community 
with high IgG antibohes titres. 
Patients and methods: During 10 months of 2000, 221 persons were 
affected by diphtheria in Latvia. 149 patients (67.4%) of all affected came 
from a closed military higher school. This very group of patients was 
analysed. The patients were under 30 years of age, 95% of them were men, 
all of whom were vaccinated against diphtheria and on entering the higher 
school they had undergone the health examination confirming that 
everybody was healthy. The diagnosis of diphtheria was based on clinical 
data, establishment of Corynebacterium diphtheiiae and the presence of specific 
IgM antibohes. 
Results: The clinical courses were estimated as severe in 2 cases, moderate - 
in 137, and mild in 10 cases. The carriers of C.  diphtheriae were not found 
among the admitted patients at the in-patient department of the Infectology 
Center of Latvia. The causative agent was found in smears from 
nasopharyngeal cavity of 117 patients, IgM antibodies were established in 
40 cases, and both the causative agent and the mentioned antibodies were 
found in 30 cases. The check of unmune status confirmed that the 
immunograms were estimated at normal level only in 49.2% of the 
examined patients, a reduced CD4/CD8 ratio was found in 20%. and in the 
rest of the patients increased CD4/CD8 ratio was revealed. Antitoxic sera 
and antibacterials were used for the treatment ofpatients in compliance with 
W H O  recommendations. A single course of antibiotics was sufficient only 
for 97 patients (65.1%), 41 patients (27.5%) received two courses of 
antibacterial therapy, and 11 patients (7.4%) got three courses of 
antibacterial therapy. 
A very substantial findmg was the level of IgG antibodies, namely, above 1.0 
IU/mL in 113 (5.8%) patients; up to 0.1 IU/mL -in 5 patients, 0.3 IU/mL 
- in 8 patients, 0.5 IU/mL - in 6 patients; 0.7 IU/mL - in 4 patients, 1.0 
IU/mL - in 9 patients. IgG antibodies were not found in 3 patients (2%). 
Conclusions: It is clear that the level of IgG antibodies, which has been 
considered to be sufficient till now, is not efficient for the protecting of 
people against dphtheria in closed communities. 
It is advisable to reconsider the treatment recommendations and to consider 
a rational antibacterial therapy: either antibacterials of two different groups, 
or a longer course of therapy. 
vl External quality assessment study for the molecular 
typing of Corynebacterium diphtheriae 
S. Lai, P. Grimont, K. Engler, F. Grimont, C. von Hunolstein, J. Vuopio- 
Varkila, A. De Zoysa, G. Gilbert, T. Popovic, A. Efstratiou 
London, UK; Paris, F; Rome, I;  Helsinki, FIN; Westmead, AUS; Georgia, 
USA 
Objective: An External Quality Assessment Study was established w i h  the 
remit of the European Commission DGXII, BioMed 2 BMH4-CT98-3793 
Programme to monitor the reproducibility of ribotyping between laboratories. 
Method: Twenty C.  diphtheriae strains in duplicate, were ribotyped by each 
participating country using a semistandardized protocol; a common 
restriction enzyme; BstE 11, molecular size marker; Citrobarter koseri CIP 
105177 digested by M u  I, probe; OligoMix5 and gel analysis programme; 
Taxotron (R), in addition to a common nomenclature and validation of 
ribotypes between centres. 
Results: Complete results of 14 strains were obtained from three of five 
centres. Variations in fragment sizes between the centres indicated that 
interlaboratory error was higher than intralaboratory error. Highest 
intralaboratory error was observed for the largest fragments. However, 
one laboratory showed the lowest intralaboratory error and a comparison of 
protocols between laboratories indicated that the error could be due to the 
concentration and the brand of agarose. 
Conclusion: Ribotyping represents a reproducible and universal molecular 
typing technique for the epidemiological study of C.  diphtheriae strains. 
Results from participating countries have contributed towards the 
standardisation and harmonisation of the methodologes towards building 
and maintaining a ‘ribotype database’. The nomenclature for C. diphtheriae 
ribotypes have been assigned geographic names to reflect the priniary 
isolation of the strain and progress is being made towards the establishment 
of the first international genotype database for C. diphtheriae. 
lp9281 A silent persistence of Corynebacterium diphtheriae 
for 30 years in a highly immunized population from Emilia- 
Romagna region, Italy 
M. Bergamini, R. Cultrera, A. Grilli, C. Contini 
Fenara, I 
Objective: In Italy, despite several studies on diphtheria immunity in the 
Italian population were published, few data exist on the extent of 
symptomless camage of Corynebacterium diphtheriae. 
Methods: A total of 1970 throat swabs &om healthy children, 6-14 years of 
age, were inoculated onto Tinsdale’s tellurite agar medium Standard 
microbiology techmquesl yielded three nontoxigenic strains of C. 
diphtheriae, biotype mitis. To  provide further information on the circulation 
of these strains, we wanted to compare them to six archival isolates. These 
were obtained as following: two strains since the 1970s from as many 
diphtheria patients, CN 2000, C7 and C8 from ‘Istituto Ricerche 
Imunologiche Siena’, Siena, Italy, and one W H O  standard strain from 
‘Istituto Superiore di Sanid’, Rome, Italy. AU isolates were assayed by a 
molecular subtyping method. DNA was extracted according to the universal 
procedures’. After digestion with restriction endonuclease Dam HI, and 
electrophoresis, chromosomal DNA was blotted and hybridized with the 
probe Sal I ,  whch is a fragment internal to the insertion element of C.  
diphtheriae for the prophage beta coding diphtheria toxin. 
Results: The different number of copies and the position of the insertion 
element in different sites withm the chromosome allowed us to distinguish 
different patterns. The strains isolated from healthy carriers in our study and 
archival isolates from patients with clinical diphtheria had the same 
hybridisation patterns, All other archival strains were different from those 
and from each other. 
Conclusions: Archival strains collected kom patients with respiratory 
diphtheria came from the Eda-Romagna region, Italy, where we have 
isolated the strains illustrated in the present study. The children, who harboured 
C. diphthetiae strains, attended different schools, appeared with a normal degree 
of immunity, and had undergone a complete series of vaccinations. The 
absence of reported histories of mvels in endemic areas or disease exposures 
supports the hypothesis that these recent isolates were not the result of 
importation but rather of a silent persistence of C.  diphtheriae in our temtory. 
References 
1 Efstratiou A, Maple PAC. WHO manual for the laboratory d a g x n i r  o i  diphrhend Reference 
no. ICP-EPI 038 (C). World Health Organization. Geneva. Sw~tzerland. 1994. 
2 LM, Swammathan B Univenal bartsnal DNA isolation procedure, p.617-621 111 Prrring IIH, 
Smith TF, Tenover FC, Whithe T] (eds), D~agnostic Molecular Prinriplrr, and Appllcatmnr. 
Amencan Society for Microbialog, Warhmgton, D. C . ,  1993 
184 Abstracts 
vl Infectious Diseases Control Project in Turkey: a 
preliminary study for determination of protective antibody 
levels in diphtheria, pertussis and tetanus in Samsun 
B. Esen, I .  Yoshida, N. Coplu, B. Levent, G. Afacan, D. Akca, M. Morita, 
A. Gozalan, D. Kurtoglu, S. Isluda, E. Akbas, K. Miyamura, N. Noyan, C. 
Yalniz, M. A. Torunoglu, N. Dikmen, E. Ozoglu, H. Hamzacebi, F. Uzen 
Aizkara, Sanrsun, TR 
Objectives: An Infectious Diseases Control Project is carrying on with the 
aim to conduct a model for serological surveillance to EPI related infections 
in Turkey, co-operation with Ministry of Health (MoH) and Japan 
International Cooperation Agency (JICA) since 1997. In this study, as a part 
of the Project, immunity to diphtheria, tetanus and pertussis was 
investigated in Samsun. 
Methods: Three hundred and 22 samples were collected from healthy 
volunteers (160 males and 162 females) aged 0-82 years, in February, 2000. 
In-house ELISA tests were used for measuring diphtheria and tetanus 
antitoxin levels and pertussis antibodes against fdamentous haemaglutinin 
(FHA) and pertussis toxin (PT). Diphtheria antitoxin titres were also 
confirmed using Cell Culture Method (CCM). Parallel line assay was the 
sole method for calculation of ELISA test results. 
Results: According to widely used criteria, 8.7% of the total population 
were susceptible to diphtheria (antibody levels < 0.01 IU/mL.), 18.9% had 
basic protection (0.014.09 IU/nL) and 72.4% were fully protected (> = 0.1 
IU/nL). For tetanus, 96.6% ofpopulation had immumty at the protective level 
(> = 0.1 W / d )  and the othen were susceptible (< 0.1 IU/mL). The ratio of 
susceptible population (< 5 IU/mL) regarding with pertussis were detected 
between 6.7% and 62.5% for FHA where 4.4-59.4% for PT. 
Conclusion: High levels of immunity for diphthena and tetanus has been 
observed among children and adults. Almost all age groups had protective 
immunity against tetanus, however, the mean antibody titre is decreasing 
above 30 years of age. Susceptibility of the pertusis infection was higher 
among the children than adults. 
w1 Retrospective evaluation of 41 generalized tetanus 
cases 
0. Ozer, S. Ulusoy, D. Gokengin, E. Ertem, D. Serter 
Izmir, TR 
Objective: To analyse patients with generalized tetanus with respect to the 
clinical and epidemiological aspects of the disease. 
Methods: A total of 41 tetanus patients (22 men, 19 women) aged 15-70 
years, hospitalized in the Department of Clinical Microbiology and 
Infectious Diseases, in Ege University, School of Medicine, between 1990 
and 1997 were included in the study. The records of the patients were 
analyzed retrospectively and information on the age and sex of the patient, 
history of immunization, mode of transmission, incubation period, 
complaints, clinical findings, treatment regimen and the course of the 
disease were noted. 
Results: Most of the patients (34.1%) were in the 46-55 age group. The 
most common complaint (56.1%) was difficulty to open the mouth and the 
most common symptom was trismus which was present in all of the patients. 
Rhisus snrdoriitus followed trismus in frequency (24.4%) and opistotonus was 
Neisseria meningitidis 
present in only 9.8% of the patients. While 92.7% of the patients gave no 
history of pre or postexposure immunization, 7.3% declared inadequate 
immunization procedures (1 or 2 doses of vaccmation) following exposure. 
The most common way of transmission was through a penetrating injury. 
The mode of transmission could not be identified in two patients. The 
incubation period of the disease varied from 4 to 25 days (mean time 10 
days). The highest mortality rate was detected in patients with an incubation 
period of < 10 days. All patients were treated with 100 000-150 000 1U of 
equine antitetanic serum or 1000-3000 IU of human tetanus immunoglo- 
bulin and penicillin. Of the 41 patients, 19 died and 22 were cured. 
Conclusion: Tetanus is still a threatening disease with high rates of inortahty 
in developing countries. The main reason for the development of the 
disease is inadequate pre and/or postexposure immunization procedures. 
Although tetanus vaccination is mandatory in Turkey, there are still 
unvaccinated populations especially in the rural parts of the country. 
vl Wound botulism among injecting drug users in 
Switzerland 
P. Graber, G. Eich, A. Burnens 
Basel, Bern, CH 
Background: Wound botulism (WB) in injecting drug usen has become a 
public health problem in certain parts of the USA. It has been associated 
with the subcutaneous injection of black tar heroin. In Europe, only a few 
cases have been reported up to the prerent time. We describe 9 cases of WB 
in injecting drug users diagnosed in Switzerland since September 1998. 
Methods: Patients were identified based on the request for botulinum toxin 
analysis in serum at the Swiss Reference Laboratory for Foodborne Diseases. 
Clinical and epidemiological data were collected retrospectively. Isolates of 
C. botuliizu,n were analysed for toxin type and compared genotypically by 
pulsed field gel electrophoresis (PFGE). The main outcome criteria were the 
total length of stay in the hospital and intensive care unit (ICU), and the 
duration of mechanical ventilation. 
Results: The clinical picture was that of classical WB in all patients. Bofulirzus 
toxin in serum was negative in all but one patient. C. bofulirzum was isolated 
6om subcutaneous abscesses in three cases occumng within one week 
around New Year 2000. Two isolates elaborated toxin type A, and one type 
B. AU three strains showed unique PFGE patterns that differed. In the 5 
patients treated with antitoxin, there was a trend towards shorter duration of 
hospitalization (57.8 +. 44.2 days vs. 117.8 f 57.1 days, P=0.12), ICU stay 
(31.0 f 32.0 days vs. 43.0 26.6 days, 0 ~ 0 . 5 7 )  and duration of 
mechanical ventilation (30.6 33.0 days vs. 39.3 f 42.9 days, P= 0.74) 
compared with the untreated patients. Patients receiving antitoxin within 10 
days after onset of symptoms had a significantly shorter duration of 
hospitalization compared with the patients receiving antitoxin after 10 days 
or no antitoxin (38.8 
Conclusions: WB in injecting drug users is an emerging problem in 
Switzerland. The exact mode of transmission remains unknown. A point 
source can be excluded considering the genotypic diversity of three isolates 
identified during an outbreak around New Year 2000. Cultures of abscess 
material result in a higher diagnostic yield than the mouse bioassay for 
botulinus toxm in serum. Antitoxin treatment substantially reduces 
morbidity, especially when administered early in the course of the illness. 
13.6 days vs. 121 49.9 days, P=0.02). 
/p932j Characteristic of Neisseria meningitidis strains isolated 
from sputum in a Polish Hospital 
S. Tyski, W. Grzybowska, M. Wilczewska, R. Zebracka, D. Krawiecka 
Warsau), Bydgosztz, PL 
Neismia meiiingrtidis - main bacterial pathogen of central nervous system 
might be also an etiological agent of lower respiratory tract infections. An 
increasing number of niemngococcal cases of primary and chronic 
pneumonia is being reported. Other, rarely occurring N. rneningifidis 
infections include meningococcal arthritis, pericarditis and conjunctivitis. 
During April 1998 and May 1999 14 N.  mizingitidis strains were isolated 
from sputum obtained from 14 patients hospitalized in Hospital of 
Tuberculosis and Lung Diseases in Bydgoszcz. The patients suffered from 
chronic bronchitis (1 1/14), pneumonia (1/14), lung cancer (1/14), and 
injury of chest (1/14). In 9 cases N. meningitidis was the only bacteria 
isolated from the sputum, while in the other 3 samples, meningococci were 
found together with Strepfococcus pneumoniae and in 2 cases were 
accompanied by Haernophilux i@mtme .  
The mean age of the patients was 59 within the age range 38-68 years. 
Twelve patients were males and two females. The predominant serogroup 
of N. meningitidis strains isolated &om sputum was B (35.7%). One strain 
belonged to serogroup C and one to W-135. Seven isolates were 
nongroupable. Four different serotypes and 7 serosubtypes were detected. 
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Seven strains were nontypable and 4 strains were nonsubtypable. Complete 
phenotypes could be determmed only for four isolates. Only two strains had 
the same phenotypeNG:21:P1.7. For 11 strains ribogroups were 
determined and each strain belonged to separate rihogroup. All strains 
were susceptible to penicillin (MIC < 0.06 mg/L), ciprofloxacin, 
cefotaxim2, rifampin, tetracycline and chloramphenicol. Six isolates were 
resistant to sulphametoxasole (MIC 2 32 mg/L). Obtained results showed 
great heterogeneity of N. rneninyitidis isolated fiom sputum. Phenotypes of 
these strains generally differ from predominant phenotypes in Poland, 
characteristic for strains invasive as well as isolated from carriers. 
vl Investigation of disseminated intravascular 
coagulation in 118 patients with meningococcal disease 
L. Roznovsky, V. Struncova, V. Dostal, S. Plisek, I .  Burget, Z. Herodes, P. 
Chalupa, P. Dlouhy, J. Svejda, P. Kriz 
Osfruva, Plzerz, Hradec Kraluve, Brno, Usti nad Labem, Prague, CZ 
Objectives: Presence of disseminated intravascular coagulation (DIC) is a 
serious complication in the course of invasive meningococcal disease. 
Methods: Platelet count, prothrombin time, partial thromboplastin time, 
fibrinogen degradation products, 11-dimmers, antithrombin, protein C, 
protein S, fibrinmonomers and plasnlinogen were investigated in 118 
patients with meningococcal disease in the period 1996-2000. Meningo- 
coccal meningitis was proved in 23 patients, septicaenlia in 37 patients and 
meningitidsepticaemia in 58 patients. Ten patients died, 7 of them suffered 
by septicaenlia. Statistical analysis was performed using Fisher’$ exact test. 
Results: Level of fibrinogen lower than 2 g/L was proved in 13 patients, 8 
of them died, level of antithrombin lower than 70% was detected in 32 
patients, 8 of them died and prothrombin time lower than 30% was 
observed in 20 patients and 9 of them died. Platelet count lower than 50 x 
109/L was proved in 13 patients, 6 of them died and criteria of DIC 
according Aoki were evidenced in 25 patients, also 8 of them died. Presence 
of these parameters was connected with high presumption of death and 
statistically significant differences were proved ((CAPS) p below 0.001 for all 
parameters). Evaluation of other markers of coagulation doesn’t allow easy 
determination of patients with severe forms of meningococcal disease. For 
example levels of protein C, protein S and plasminogen lower than 70% 
were observed in 82.4% 67.6% and 49.4% patients, the presence of 
fibrimnonomers were detected in 38.9% patients. No statistically significant 
differences in relation to death were proved for these parameters. 
Conclusions: The presence of DIC according Aoki criteria, level of fibrinogen 
below 2 g/l, antithrombin below 7003, prothrombin time below 30% and 
platelet count below 50 x 10‘/L were connected with statistically significant 
high presumption of death in patients suffered by meningococcal disease. 
Grant support: Grant Agency Czech Republic N.  310/96/K102. 
1 p934 1 Systemic meningococcal infection: which children may 
benefit from adjuvant haemostatic therapy? Results of an 
observational study 
M. W .  A. Niirnberger, R. van Kries, 0. Bohme, U. Gobel 
Dusseldug Miinchen, D 
The indications for haemostatic therapy (heparin, antithromin [AT] 
concentrate, kesh frozen plasma [FFP]) in severe systemic meningococcal 
infections (SMI) remains to be determined and may well depend on the 
severity of the disease. The Neisseria sepsis index (NESI), which grades the 
severity of SMI from 0 to 8 has proven to he a reliable tool for predicting 
the outcome of the disease. Observational data from a nationwide, active 
surveillance in all German children’s hospitals over a year period was used to 
assess whether the potential beneficial effect of heparin, AT concentrate 
and/or FFP treatment was related to the severity of disease (NESI 0-2 vs. 
NESI 3-8). For 176 of the 305 registered children, complete data sets were 
available. According to these, all children with NESI 0-2 (n= 129 [73%]) 
survived. Therefore, the presumed impact of haemostatic therapy (given to 
45 of them) on survival would be indetectable in ths  group. A NESI 
between 3 and 8 was found in 47/176 (24%) patients, 35 of whom received 
heparin, AT concentrate and/or FFP. The 35 patients with haemostatic 
therapy had a survival rate of 80% compared to 50% in the 12 patients 
without such intervention (odds ratio 0.25; 95% confidence interval 0.06- 
0.98). Patients with NESI 3-5 (28 survivors of 31 children with adjuvant 
haemostatic therapy [90%], compared to 6 survivors of 11 children without 
such therapy [55%]) were the ones who derived the greatest benefit from 
haemostatic therapy. No single one of the five patients with a NESI of 6-8 
survived, although 4 of them had received adjuvant haemostatic therapy. 
Conclusions: This population based, observational study suggests that 
children with NESI 3-8 are more likely to survive, when adjuvant 
haemostatic therapy is given. Further efforts are needed to identify an ideal 
dosage and choice of the components of haemostatic preparations in patients 
with NESI 3-5. An alternative therapeutic strategy may be required in 
children with NESI 6 8 .  Children with NESI &2 will probably not need 
haemostatic therapy. 
v1 Characteristic of Neisseria meningitidis strains with 
decreased susceptibility to penicillin isolated in Poland 
W. Grzybowska, S. Tyski 
Warsaw, PL 
Invasive infections caused by Neisseria metringitidis continue to be a serious 
clinical problem. Within the last decade, the emergence N. mettirigitidis 
strains with elevated MICs for penicillin have become more common 
world-wide. Penicillin G has been considered a drug of choice for 
meningococcal meningitis treatment. 
In Poland, among 166 N. meriiitgitidis isolates collected from invasive casec 
during the last five years, 29% were found to have decreased susceptibility to 
penicillin: 29 %rains with MIC=0.125 mg/L, 12 strains with MIC=0.25 
mg/L, 2 strains with MIC = 0.5 mg/L, and 5 strains with MIC = 1 .0 mg/L. 
One strain was resistant to penicillin (MIC = 2.0 mg/L). About 50% of N. 
rnfningitidis strains were highly sensitive to penicillin (MIC C 0.03 nig/L). 
Agar dilution method was used for penicillin susceptibility testing. Isolates 
were obtained from cerebrospinal fluid (44/166) and blood samples (5/166) 
received from patients hospitalized in 14 of 16 provinces of Poland. Half of 
the patients (24/49) were younger than one year old. 
The predominant meningococcal serogroup was B (8O%), then serogroup C 
(10%) and W-135 (6%). Two isolates were nongroupable. Among analysed 
strains 4 different serotypes and 8 serosubtypes were found. Generally, 21 
different phenotypes were determined. The most frequent phenotype was 
N. muzingitidis b: 22:P1.14. Strains belonging to type 22 were icolated most 
frequently among strains with decreased susceptibility to penicillin (25 out 
of 49). Forty-five N. menirzgitidis strains were classified into 30 different 
ribogroups. Each ribogroup w a s  generally represented by 1-5 isolates. 
However, the highest number of strains belonging to one ribogroup (250- 
S-7) was 7. For 24 strains belonging to serotype 22, 15 different 
electrophoretic types (ET) were determined. Atialysed strains were 
susceptible to selected antimicrobial agents (cefotaxime, ciprofloxacin, 
rifampin, tetracycline, and chloramphenicol), except sulphonamides. About 
76 percent of N. meningitidis strains (37/49) were resistant to sulphame- 
toxasole (MIC232 mg/L) and 8 oftheni showed MIC= 128 mg/L. Strainr 
with decreased susceptibility to penicillin, as like as all N. merrirrgitidis strains 
isolated from invasive cases in Poland were very heterogeneous. 
p936/ Study of serum in volunteers vaccinated for A and A + 
C meningococcal reaction latex-agglutination 
A. Alliluev, 0. Kotelnikova, A. Kharitonova, N. Iashina 
Moscow, RUS 
Latex diagnosticums based on microspheres made of polymerized polystyrol 
with epoxygroups sensitized by serogroups A, B, C meningococcal capsular 
polysaccharides were used for detection of antibodies (Ab) in serum samples 
of healthy and vaccinated volunteer A + C meningococcal vaccine for 
epidemiological prognosis. The simplicity, sensitivity and specificity of the 
latex-agglutination reaction (RLA) during screening of large populations 
allows quickly and cheaply detect individual with a high level of 
antimeningococcal Ab protect them from meningococcal infection. Latex 
particles were washed by phospate buffer p H =  8 before setisibilization with 
meningococcal antigens. After suspension was incubated in glycine buffer 
pH = 7.8 for an hour to inactivate free epoxy groups. The workmg latex 
concentration is 0.05% for RLA in nicroplate. It has been revealed, that 
vaccine induced distinct immunological shifts in during an estimation of a 
degree protection of various groups population from meningococcal 
infection after introduction of a monovaccine on a basis capsular PS A or 
bivaccine, containing capsular PS A + C. It is visible, that in group healthy 
not vaccinated people A serogroup Ab in serum meet mainly in low 
dilution, and only in individual serums they come to light in dilution 1:128. 
A completely different picture is observed a titration A-Ab in serums 
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vaccinated of the people. The serums with low (C-1 : 8) dut ion  are absent 
absolutely, and their maximal percent (more than 40) contain A-Ab in 
dilution 1 : 128. In serums the increase A-Ab as in RLA was registered, and 
in RPHA, but in the first case average ddution made 6.25 f 0.26, while in 
RPHA average dilution did not exceed 4.66 0.26. The distinction 
between results RPHA and RLA has repeated at parallel titration C and B- 
Ab,4 .08+0.26and5.26~0.19 ,4 .08+0.26andS.87  f0.2accordingly. 
Absence diagnostic dilution (for A-Ab 1 : 128, B-Ab 1 : 64 and C-ab 1 : 32) 
and their positive seroconversion in serum of the healthy persons and 
presence those at vaccinated specify an oppomnity to judge about 
immunity macroorganism to introduction of the activator under the 
contents of Ab revealed in RLA. The carried tests the latex test-system on 
revealing a level of Ab at vaccinated A and A + C meningococcal by 
vaccines have shown high diagnostic value of the developed method. Thus, 
it is possible to conclude, that RLA has high sensitivity and specificity, and 
simplifies procedure of the analysis. 
Salmonella 
/p9371 Molecular epidemiology approaches to identify clonal 
lineages of S. typhimurium, 5. enteritidis, and S. abortusovis 
originating from different geographic areas 
S. Rubino, A. Piana, G. Nikbakht, M. Raffatellu, G. Falchi, N.  Canu, M. 
P. Satta, Y. Asara, H. A. El Rahman, E. Muresu, G. Leon, S.  Uzzau 
Sassari, I; Teherari, IR; Ismailia, E T  
One of the major Public Health problems in the world is represented by 
mfectious diseases affecting the gastroenteric system, particularly those that 
are epidemic and endemic. W H O  recently indicated that Salmonella, 
together with some other enteric pathogen (i.e. Vibrio cholerae), is increasing 
its musion all over the world, especially in Developing Countries. 
The current Salmonella classification, based on somatic and flagellar antigens, 
shows more than 2200 serotypes. Among these serotypes some are 
ubiquitous (i.e. S. enteritidis), some other mfect only spec& hosts (i.e. S. 
abortusovis). Depending on serotype, Salmonellae are associated to food-borne 
infections, related to gastroenteric system, or cause systemic diseases. The 
knowledge of the epidemiology of different serotypes circulating in a 
country is very important to control human and animal health and to carry 
on prevention strategies. The aim of this work is to analyse the molecular 
marker(s) that may effectively define the epidemiology of different strains 
isolated from different sources. Collected strains came &om unrelated 
geographic areas: Sardmia (Italy), Albania, Palustan, Egypt, Iran and 
Zimbabwe and belong to different serovars. A number of methods have 
been applied IS200 fingerprinting, ribotyping, plasmids detection and 
virulence plasmids identification (i.e. carrying spv genes), Pulsed-Field Gel 
Electrophoresis (PFGE) and Random Amplified Polymorphic DNA 
(RAPD). IS200 fingerprinting has shown to be the most mscriminative 
technique when applied to S. typhimurium and S. abortusovis epidemic 
strains. In fact, S. typhimurium showed several Werent patterns possessing 
1-30 copies of IS200 sequence. Among S. abortusovis strains, IS200 allowed 
to distinguish between Sardinian and Iranian isolates. O n  the other hand, 
IS200 is not discriminative in S. enteritidis. Isolates belonging to this serotype 
where, instead, accurately characterized by RAPD. Taken together, the 
results obtained in this study show that well defined epidemiological analysis 
can be obtained by applying, for each SalmonelZa serotype, appropriate 
combination of the techniques above indicated. 
v] Clinical and microbiological aspects concerning 
multiresistant Salmonella - a 21-month study 
C. Corcaci, R. Fintinaru, V. Luca, D. Mihalache, I. Placinschi, L. Grigore, 
T. Turcu 
h i ,  RO 
Objectives: T o  present climcal and therapeutical problems due to Salmonella 
multiresistant strains. 
Methods: We reviewed the patients' files suffering &om salmonelosis due to 
Salmonella mulrtiresistant strain. Beginning 1999 until the end of September 
2000, 45 patients suffering &om diseases due to multiresistent SalmoneNa, 
were admitted in the Clinical Hospital of Infectious Diseases Iasi. We 
reckon multiresistance, the one noticed to at least four antibiotics, more 
than a half (60%) of the patients came from suburban areas; 57.77% of them 
were male. The majority of strains were Salmonella type B (40 patients). 
More than two thirds (73.33%) of the patients were children aged less then 
one year old involving enteral aspects (39 cases). ShighellaflPuneri was also 
identified in 3 out of all the cases. Most of the children were stray and 
suffered from associated diseases such as dystrophia, carential anaemia, 
bronchopneumonia, pemphigus. None of them were HIV infected. All of 
the strains had preserved susceptibhty to colimicine but four to 
fluorochinolone (1 00%), to CHI (80%). to ampiciline sulbactam (SO%), 
cloramphenicol, tetracycline, kanamicine, ampicdine, nalidixic acid, 
trimethoprim-sulphametoxazol were completely inefficient when tested. 
The treatment was performed by means of CIII (35.55%), fluorochinolones 
(28.88%) and CIII + fluorochinolones in 13.33%. 
Conclusions: Fluorochinolones seem to be the treatment of choice in 
salmonellosis in children suffering also from associated diseases and 
colimicine is definitely to be adrmnistrated in Iasi County in children in 
whom there are no other associated diseases according to the survey. 
vl Salmonella rib osteomyelitis and lung abscess in a child 
with S-beta haemoglobinopathy 
E. CiftGi, E. Ince, U. Dogru, M. Ertem, H. Giinz, D. Aysev, S. Fitoz, 
T.  Kendirli, S. Cin 
Ankara, TR 
Patients with sickle cell anaemia have a increased susceptibility to Salmonella 
inkctions. The mechanisms for this increased susceptibility appear multi- 
factorial and include several proposed immunological mechanisms. We 
report a case of Salmonella rib osteomyehtis and lung abscess in a child with 
S-Beta haemoglobinopathy. A 10-year-old boy with known S-Beta 
haemoglobinopathy was admitted to our hospital with a 7-day history of 
fever, cough and a painful thoracic mass. He was diagnosed with S-Beta 
haemoglobinopathy at 7 months of age, and underwent splenectomy and 
cholecystectomy at 8 years of age. His body temperature wa5 39 "C; there 
was a thoracic mass 4 x 5 cm in diameter on the left hemithorax. His 
breathing sounds were decreased in the left hemithorax. Cracking rales was 
noted in the same hemithorax. Laboratory examinations included 
haemoglobin level of 6.8 g/dL, leukocyte count of 20 800/mm3 with a 
shift to the left, and platelet count of 646 O O O / m m .  Sedimentation rate was 
107 mm/h and C-reactive protein level was 12.4 mg/dL. Chest X-ray 
examination showed pneumonic infiltration in left upper and middle zone 
and laterally located dense appearance resembling left pleural efhsion. A 
computed tomography scan revealed lung abscess and extrapleural thoracic 
abscesses surrounding the ribs. Radionuclide scans showed accumulation in 
left lung and left thoracic wall. There was not any bone involvement in 
bone radionuclide scans. Thoracic abscess was drained and purulent material 
was obtained. Gram staining obtained from the abscess showed Gram- 
negative rods and Salmonella was isolated from the culture. Salmonella was 
also isolated from blood specimen. He was treated with intravenous 
ceftriaxone 100 mg/kg per day. O n  the fifth day of the therapy radiography 
of the thorax showed an osteolytic lesion on the left 4th, 5th and 6th ribs, 
and this was confirmed on CT scan. After 1 month of treatment with 
ceftriaxone, oral ciprofloxacin was staned for another 1 month and the 
patient was discharged from the hospital. At the end of 2 treatment months 
the patient had no  evidence of pulmonary abscess or rib osteomyelitis. 
Patients with sickle cell anaemia have an increased risk for osteomyelitis, 
especially caused by Salmonella. Ths possible diagnosis must be 
remembered even if there is not any osteomyelitis finding. 
Salmonella septic arthritis: report of two cases 
A. Erbay, N. Baykam, S. Eren, S. Sayin, B. Dokuzoguz 
Ankara, TR 
Salmonella infections are seen in five Werent  forms. These are 
gastroenteritis, enteric fever, bacteraemia, chonic carrier state and localized 
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infection. Locahzed salmonella infections are generally seen following 
salmonella bacteraemia. We present two cases of salmonella arthritis as an 
uncommon extraintestinal manifestation of salmonella infection. 
Case 1: A 17-year-old female patient was admitted for fever, fatigue, pain 
and swelling of the left knee. She has taking corticosteroid therapy 
irregularly since three years due to haemolytic anaemia. Artrocentesis 
yielded fluid containing abundant leukocytes with 80% neutrophlls, gram 
strain was negative. Sabnonella typhi was isolated from the synovial fluid 
culture. The patient was treated with ofloxacin 2 x 200 mg p.0. The 
antibiotic therapy was completed to two months. She showed complete 
resolution of the salmonella infechon of the left knee. 
Case 2: A 75-year-old female patient presented with a 4-day history of fever 
and diarrhoea, 2-day history of right knee pain, swelling and restriction of 
motion. Physical exanunation showed that right knee had a moderate 
e5hion with warmth and tenderness. SahoneIla hirschjedii was isolated fiom 
the synovial fluid culture. Surgical drainage was performed and the patient 
was treated with ciprofloxacin 2 x 500 mg p.0. for two months. 
Salmonella species in blood may invade any organ or tissue and may cause 
localized infection. Salmonella arthritis was reported in 0.24% of patients 
with salmonella infection. The patients responds to medical treatment well. 
In some patients surgical drainage may be necessary. In of our case medical 
therapy without surgical intervenuon for two months and in the other one 
surgical drainage in addition to antibiotic therapy was found to be successful. 
(p9411 Characteristics of typhoid fever in adults in Vienna, 
Austria: a review of 49 cases between 1989 and 1999 
H. Laferl, H. Ringl, E. Wallis, H. Pichler, W.  Graninger 
Vietiria, AT 
Background: Typhoid fever continues to be a global health problem, with 
an estimated 16 d o n  cases occumng each year. It has, however, become 
an uncommon msease in western countries. 
Objective: To study the epidemiology, clinical manifestations and 
laboratory findings in a retrospective study of adult patients with typhoid 
fever. A confirmed case was defined as any clinically compatible illness 
caused by S. typhi isolated from either blood or stool. 
Results: There were 49 cases; the majority from our department (73%)) and 
the General Hospital of Vienna (16%). Median age was 33 years (16-60); 
53% were male. 63% were Austrians, 33% immigrants, and 2 patients were 
refugees. All but 1 patient had travelled to endemic areas w i t h  7 weeks 
before onset of Illness. Most had been to the Indian subcontinent (50%), 
22% in SEA, 14% in the Americas, 8% in Africa, and 4% in the Middle East. 
All patients had fever with a median duration of 6 days (1-28) on admission. 
Other symptoms were headache and chills (each 57%). nausea (55%), 
diarrhoea (49%), vomiting (29%),abdominal pain (24%), constipation and 
cough (each 17%). 5 patients were somnolent on presentation. The mean 
maximum body temperature recorded was 39.5 f 0.6 "C. Splenomegaly 
was noted in 35% rose spots in only 8%. Typical laboratory findings 
included an elevated LDH (96%), AST (88%) and ALT (84%), as well as 
aneosinophilia (87%) and a shift to the left (> 4% band forms) in the 
differential blood count (75%). Leucopenia and thrombocytopenia was 
observed in 39% each. No patient had leukocytosis. S. typhi was isolated 
fiom blood in 84%, from blood and stool in 29%, and in stool only in 16% 
of cases. 13% of the tested strains ( P I  = 46) showed resistance to a m p i c h ,  
TMP/SMZ and tetracyclines. There was no resistance against quinolones 
and third generation cephalosporins. 92% of patients were treated with a 
quinolone, most conmionly ciprofloxacin; 3 patients received ceftriaxone. 
Median defervescence time was 4 days (1-11). Case fatality rate was nil. A 
complicated clinical course was observed in 20%; it included GI-bleeding, 
encephalopathy, haemolysis, jaundice and acute renal failure. 2 patients 
required prolonged treatment on an ICU. 
Conclusion: While autochthonous cases have become rare in countries like 
Austria, typhoid fever remains an important cause of fever in the returning 
traveller. Early diagnosis and adequate antibiotic treatment is warranted as 
life-threatening disease does occur. 
w] Parasite as an important carrier of bacteria: recurrent 
septicaemia by Salmonella typhimuriurn in association with 
Schistosoma intercalatum and hybrids 5. intercalatum- 
haematobiurn in stools 
M. Subirats, M. Mellado, P. Simarro, F. Gbmez, C. Taro, M. Baquero 
Madrid, Barcelona, E 
Objectives: We report a case of recurrent septicaemia by Sabnonella 
typhimurium in a patient infected with S. intercalatrrm and S. infercalarum- 
haematobiurn hybrids. A 13-year-old boy fiom Batd (Equatorial Guinea, 
Afiica), who came to our hospital with fever (40 "C) and diarrhoea. On 
fisical exploration spleen and liver were enlarged (7 cm and 6 cm, 
respectively). Bacteria results by standard microbiological methods: in 
blood, urine and stools were isolated Salmoraella typbimurium. 
Parasites results: In faeces, we used Ridley's method and looked Srbistosoriin 
ititerrdatum and S. ir?tercalarum-haematobium hybrids eggs and Tricbtrris trichiura, 
Hookworm eggs, and Blastocysfis hominis. Parasites in urine of 24 h by 
filtration method (pore 12 pm) were negative and ELISA in serum for 
Schistosoma was positive (1/2560). Thick and thin Glms for malaria (Field 
stain method) were negatives. The patient was treated with cefotaxinla i.v. pIus 
praziquantel20 mg/kg/day oral in three doses and recovered succrss~lly. 
Conclusions: Recurrent bacteraemia could be due to parasites associates 
infections and should be investigated, in special, in patients where parasites 
infections are frequent. 
Simultaneous treatments of parasite and bacteria will be necessary, otherwise 
Salmonella spp. cannot be eradicated to eliminate the bacterial infection. 
v1 Bacteraemia caused by Salmonella spp. in Crete, Greece 
A. Christidou, S. Marah, A. Georgdadahs, Y. Tselentis 
Heraklion, GR 
Objective: To study the clinical and bacteriological characteristics of 
Salmonella bacteraemius diagnosed at the University Hospital of Crete, 
Greece, from January 1995 to September 2000. 
Methods: Salmonella species were isolated from blood cultures of 40 febnle 
patients treated in our hospital during this period. Age, underlying disease 
and primary focal infecuon of the patients were studied, as well as the 
serotype dismbution and the antibiotic resistance of the strains isolated. 
Susceptibdity test was performed by the disk diffusion method according to 
guidelines of NCCLS. 
Results: All cases were community acquired infections. Among the 40 
patients, 8 (20%) were children (age < 14 years) and 14 (35%) were 
compromised hosts (solid turnours, 8; haematological malignancies. 2; 
autoimmune diseases, 3; AIDS, 1). Gastroenteritis was the primary focal 
infection in 21 patients (52.5%), abscess in 3, urinary tract infection in 2, 
osteoniyelitis in 1 and unknown in 13 (32.5%). Serotype dismbution of 
strains was: S. enteritidis, 26 (65%); S. fyphirnurium, 5 (12.5%); S. vircbow, 4 
(10%); S.  paratyphi B, 1; S.  n e u p t f ,  1; S. iqfaritis, 1; S. agorra, 1; S. badar (1). 
This distribution was in accordance to that of strains isolated from faecal 
specimens. Antibiotic resistance rates were as follows: ampicillin, 22.5%1; 
chloramphenicol. 5%; tetmcycline, 35%. cotrimoxazole, 5%. All isolates were 
susceptible to cefoxitin, cefotaxime, norfloxacin, ciprotloxacin and gentamkin. 
Conclusion: Salmonella bacteraemia without gastroenteritis occurred in 
almost a half of the patients and a significant number of them were 
compromised hosts. However, most of the isolated strains were sensitive to 
the antibiotics tested. 
wl Excretion of Salmonella enteritidis 
E. Trajkovska-Dokic. I .  Ha&-Petruseva, M. Petrovska. N.  Panovski 
Skopje, MAK 
introduction: Although It has been known that prolonged excretion of 
nontyphoid Salmonella can occur after gastrointestinal illness, most of the 
literature relates to Salmonella typhi murium. There is no enough data about 
the prolonged excretion of Salmonella eriteritidis, which now exceeds 
Salnionella typhi mutiurn as the most common cause of salmonellasis. 
The aim of our s t u d y  was to follow the excretion of S. nripriidis during and after 
an outbreak which occurred in June 20m in one fast food restamit in Skopje. 
Materials and methods: In our laboratory, in the middle of June 2000, 
more than usually stool specimens were received. Within 3 days (between 
June 14-17) 33 strains of S. enteritidis from 33 patients were isolated. The 
isolates originated from Clinic for Infectious diseases in Skopje. Epidemio- 
logical data suggested that all patients were on the same birthday party the 
day before the symptonls occurred. The age of all examined patients ranged 
from 2 to 25 years, with the majority (17 patients) at the age between 5 and 9 
years. The isolated strains of S. ententidis, which originated from stool specimens 
and rectal swabs, were detected with standard bacteriological techniques. 
Results: The first negative results in 15 and 6 cases, were obtained 3 and 4 
weeks after the consumption of the birthday meal, respectively. These 
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negative results were followed with another two negative results, subsequently. 
In the second week ofthe exposure definitely negative results, only in two ca.ses 
were obtained. The remaining 10 cases showed alternately positive and 
negative results within the h t  6 weeh. They become definitely negative after 
the sixth week of exposure. Our study revealed the Merence in the duration 
of excretion of S. enferitidis &om 2 up to 6 weeks after the exposure. These 
findings suggest that it is necessary to obtain at least two negative results 
wthm 2 to 3 weeks after determining S. etzteritidir infection. 
[p945/ Epidemiological characteristics of salmonellosis in 
Plovdiv region, Bulgaria 1991-2000 
N. Vatev, M. Stoycheva, M. Bachurova 
Plovdiv, BG 
Objectives: To study the morbidity and camage rate of sahiionellosis as well 
as some epidemiological indexes: aetiology, age structure and forms of the 
epidemical process. 
Methods: The study was made of data, according to the register for control 
of infectious diseases in the region. 
Results: The morbidity rate of salmoneliosis vanes from 35.48% ooo (1992) 
to 15.35%00 (1999) with unstable trend to decrease during the last years. 
The same tendency shows the camage rate, which varies from 4.24%000 to 
18.18%00. A total of 1586 Salmonella spp. were isolated Gom patients and 
706 &om carriers. S. enteritidis was the most kequent serotype (patients 
63.11%; carriers 49.72%), followed by S. typhimurium (resp. 22.64% and 
37.39%). Age distribution showed the highest morbidity in the group of 0-1 
years (25.47%), followed by children 1-3 years old (16.33%). After the age 
of 8th morbidity rate was considerably lower and remained approximately 
constant. Most of the cases were sporadically 87.14%, but 21 outbreak; with 
204 pahents have been described. 
Conclusion: The morbidity rate in the region is still high. Most frequently 
isolated serotypes are S. enterifidir and S. typhiwiurium. Salmonellosis occurs 
most frequently in early childhood and sporadic cases prevail. 
(p9461 Dynamics of aetiological structure of nontyphoidal 
salmonellosis and patterns of antibiotic susceptibility of 
Salmonella spp. isolated in Plovdiv, Bulgaria, 1991-2000 
M. Stoycheva, N. Vatev 
Plovdiv, BG 
Objectives: T o  investigate the changes of the aetiology of nontyphoidal 
salmonellosis, as well as the patterns of antibiotic susceptibility of Salmonella 
spp. isolated in town of Plovdiv for a 10-year period. 
Methods: The study was made of 1051 inpatients with salmonellosis, 
admitted at Clinic of Infectious Diseases, from 1 January 1991 to 30 June 
2000. Diagnosis was culture contained in all of them. NTS spp. were 
obtained Gom stool (1041), blood (13), and urine (8). Bacteria were 
identified by standard methods and serotype (Hauffman-White scheme). 
The sensitivity pattern to the most frequently used antibacterials (Nalidix 
acid, Co-mmoxazol, Chlorampbenicol, Gentamicine, Amikacin, Cipro- 
floxacin, Cefa-second and third generation) was assessed by disk-diffusion 
method (Baner-Kurby). 
Results: A total of 1051 Salmouella spp. (19 serotypes) were isolated. S. 
enterifidis and S. typhbiun'um were over 90% of the cases. S. typhimurium 
dominated &om 1991 to 1993 (63.5%). but recently is replaced by S. 
enreriridis (7570%). The kequency of the other serotypes remained 
approximately constant. S. typlzimurium showed steadlly low sensitivity to 
Chloramphenicol (21-30%) but trend to elevate susceptibility to the rest 
antibiotics though out the years. S. enteritidis showed trend to decrease 
sensitivity to all tested antibacterials and elevated frequency of polyresistant 
spp. During the last 2 years, S. enteritidis showed resistance even though to 
Rocefin (3.8%) and Ciprofloxacin (18%)). 
Conclusion: S. enferitidic is the leading serotype since 1994. The antibiotic 
sensitivity pattern showed n gradual increase in resistance over the yearv, 
especially S. eriferitidis isolates. Antinlicrobials with little demonstrated 
resistance were Amikacin. Rocefin and Ciprofloxacin. 
v] Rapid Salmonella detection and quantification in food 
C. Palomares, J. C. Paloinares, M. J. Torres 
Seville, E 
Objective: T o  evaluate a rapid real-time PCR method for the detection and 
quantification of Salmonella strains in mayonnaise sauce. 
Methods: 25 g of comercial mayonnaise with and without preservatives 
(obtained &om Ibarra S.L.) was added to 225 mL of BPW and then 
inoculated with an average of 5 cells of Salmoneh eriteritidis each, and 
incubated at 37 "C. After 2, 4, 6, 7, 8,9,12, 14, 16 and 24 h, 300 mL were 
used to extract DNA with Chelex100. DNA extracts were used for real- 
time PCR using primers designed to amplify a regon between the invE and 
invA genes. To  detect and quantify the amplicons a pair of labelled probes 
directed against an internal region of the amplicon were used. 
Results: Using a theoretical method based in the generation time of 
Salmonella, we should be able to detect theu after 5 h 40 min of incubation 
by PCR. In mayonnaise without preservatives we were able to detect the 
presence of Salmonella DNA by PCR after 7 h of incubation, and in 
mayotlnaise w t h  preservatives the bacterial DNA was detected only after 24 
h of incubation. 
Conclusion: This rapid method (the test could be completed in 90 min) 
allow detection and quantification of Salmonella contamimted food in less 
than 10 h without any postamplification analysis. 
Evaluation of Gruber-Widal test in diagnosis of 
typhoid fever 
A. W. Willke, 0. Ergiin, B. B. Bayar 
Koraeli, TR 
In this study, the diagnostic value of Widal tube agglutination test was 
assessed in typhoid fever. The test was done on 317 nomial individuals 
(blood donors), 52 typhoid cases (31 bacteriologically, 21 clinically and 
serologically proven cases) and 41 nontyphoidal fevers. All the patients were 
in adult age group. In the patient groups the Widal test was performed in 
paired serum obtained 7-10 days apart and the diagnostic value ofa fourfold 
or greater rise of agglutinins was also evaluated. Of 317 blood donors 2% 
had an H agglutinin titre of 1/200 and 7% had an 0 agglutinin titre of I /  
200. O n  the basis of this criteria a significant H and/or 0 agglutinin titre 1/ 
200 and more was observed in 29% and 52% of culture proved typhoid cases 
and only 5% and 12% of patients with nontyphoidal fever. 
Using an 0 antibody cut-off of greater or equal to 1/200 Widal tube 
agglucination test yielded a sensitivity 52% and specificity of 88%. The positive 
predictive value (PPV) was 7694, negative predictive value (NPV) was 71%. 
According to the second Widal test results after 7-10 days, both specificity 
and sensitivity were found 90%. PPV was 88%. and NPV was 93%. 
According to the results of the study: (1) 0 and H agglutinin titres of 1/200 
are recommended as being diagnostic significance. (2) Widal test as an easy, 
cheap and noninvasive method can be of diagnostic value where blood 
cultures can not be done. But the results must be interpreted with caution, 
negative results do not exclude the typhoid fever. (3) The Widal test 7-10 
days afrer hospitalization gave the most reliable results with h g h  specificity, 
sensihvity, PPV and NPV. 
Characterization of Salmonalla enterica ssp. enterica 
serovar enteritidis ( 5. enteritidis) strains coming from outbreaks 
A. Cieslik, D. Brown, J. Paciorek, J. Szych, S. Kaluzewski 
Warsaw, PL; Glasgow, UK 
In Poland in 1999, S. enteritidis was the cause of 90.0% of all human 
salmonellosis (30 233 isolates). In contrast with most other European 
countiies, the most commonly isolated phage type of S. enterifidis was phage 
type 8 (PT8). In this study, antibiotic resistance testing, phage typing, 
plasmid profile analysis and pulse field electrophoresis of chromosomal 
restriction patterns have been applied to characterize 122 Polish S. enteritidis 
isolates coming Goin two outbreaks. Susceptibility testing was performed by 
an agar-dilution method in accordance with the guidelines of the NCCLS. 
All isolates of S. enteritidis were phage typed according to the method of 
Ward et al. at the Scottish Salmonella Reference Laboratory, Fame being 
sent to the CPHL, Colindale, London, for confirmation. For plasmid 
analysis, partially purified plasmid DNA Gom S.  enterifidis strains was 
extracted by the method of Kado and Liu. Whole cell DNA for PFGE 
experiments was prepared as described previously by Powell et a!. with some 
modifications by D. Brown. Two out of the 122 isolates were found to be 
resistant to ampicillin. A total of 117 (96%) of the 122 isolates examined 
were found to belong to PT4. The remaining five isolates belonged to other 
phage types: PT6 (1 isolate), PT7 (1) and PT8 (3) and should therefore be 
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excluded from the two groups of outbreak isolates. Plasmd profiling 
revealed that 117 isolates had the same plasmid profile comprising a single 
plasmid of 57 kb. All PT4, PT7 and PT6 strains carrying 57 kb plasmid gave 
the same XbaI Pulsed-Field chromosomal restriction profile (PFP) 
previously designated as SentXl by Ridley et al. All three PT8 isolates 
possessed the same PFP as one another, lacking a fragment of 265 kb in 
comparison with SentX1, but possessing an additional fragment of 70 kb. 
This conformed to the pattern designated as SentX12 by Ridley et al. 
Macrorestriction fragments of I0 selected PT4 strains, PT6, PT7 and one 
PT8 strain, generated by SpeI were identical to SentSl described by Ridley 
et al. Remaining two PT8 strains showed the same PFP described and 
designated by Ridley et al. as SentS3. Our findings confirmed earlier 
suggestions that the increase of cases of human salmonellosis in Poland was 
caused by S. entmritidis PT4 and was due to consumption of contaminated 
food. This study confirmed the importance of using PFGE in combination 
with phage typing, plasmid typing and antibiotic resistance testing for 
studying the epidemiology of S. enteritidis. 
vl Evolution of susceptibility of nontyphi Salmonella in a 
Spanish hospital 
S. Garcia Bujalance, M. L. Guerri Santos, L. ValdCs, A. Carvajal, C.  Ladrbn 
de Guevara 
Madrid, E 
Objective: To analyse the evolution of the antimicrobial resistance 
of nontyphi Salmonella in a Spanish Hospital during the last nine years 
Material and methods: We studied 2103 Salmonella enterica ssp. enterica 
(designated ssp. I) isolated from stool samples. AU strains were isolated on 
culture media routinely used for the isolatlon of enteric pathogens. 
Identification was made according to standard microbiological procedures 
and was confirmed by serotyping with commercial antisera (Difco 
Laboratories). Antimicrobial susceptibility was performed by a broth 
microddution automated method (Pasco " and Wider " since 1999) system. 
The antimicrobials studied were amoxicillin ( A m ) ,  amoxicdlin-clavulanate 
(A/C), cotrimoxazole (Cotr) and ciprofloxacin (Cipr). As the majority of 
the isolates (95%) belongs to serotype 0 : 4 (B), and to serotype 0 : 9 (Dl)  
we have only included these two in our results. 
(1992-2000). 
Results: 
Table 1 Evolution of number if isolates by serotype 
I992 1993 1994 1995 I996 1997 1998 1999 2000 
Table 2 Evolution of resistance (%) to  different antimicrobial agents by 
serotype 
1992 1993 1094 199s 1996 11107 1998 1999 2ooo 
Ainx 
I l :4 (B)  57.7 50.0 53.8 63.6 63.4 68.0 89.X 85.7 
IJ . 9(Dl) 12.2 17.3 25.0 21.9 20 6 13.8 15.11 9.1 
A/C 
0 : 4(B) 23.0 34.8 ND 45.4 15.6 29.3 64.1 23.4 
11 : 9(Dl) 5.6 6.1 ND 6.5 1.9 5.6 9.8 0.7 
Cotr 
0 : 4(B) 3.8 42.0 17.3 19.4 16.4 18.6 11.3 16.9 
( 1  : 9(111) 0.0 1.3 0.8 1.6 2.9 0.6 1.1 2.7 
Cipr 
l l :4 (B)  0.0 0.0 1.0 11.0 (1.11 (1.11 C1.C 0.0 
o : ~ ( D I )  0.0 o.11 0.o o.o O.O 0.o o.o n.o 
ND. nondate. 
85.1 
19.3 
1.5 
1 .I1 
29.Y 
0.5 
0.0 
0.0 
Conclusions: (1) Serotypes of (B) shows a linear trend to increase 
amoxicillin resistance from 57.7% in 1992 to 85.1% in 2000. Serotypes 0 
: 9 (Dl)  resistance rate (RR) to Amx presents a small increase from 12.5% to 
19.5% in these years. (2) Serotype 0 : 4 (B) shows a peak of resistance 
(64.1%) to A/C in the year 1998. For the combination A/C, serotype 0 : 4 
(U) presents a misleading low RR in the year 2000, because the isolates had 
a high level (32.4%) of moderate resistance (intermediate strains). (3) 
Serotype 0 : 9 (Dl) has a high sensibility rate to Cotr. The serotype 0 : 4 (B) 
RR to Cotr had increased from 3.8% to 29.9%. 
1 P951 1 Antibiotic resistance of Salmonella and Shigella isolates 
S. Florescu, 0. Dorobat, C. Chirculescu, P. Calistru, E. Ceausu 
Bucharest, RO 
Background: Acute diarrhoea is an important issue of public health. The 
increasing resistance of bacterial isolates at common antibiotics has become a 
problem in last years. 
Objective: to study antimicrobial resistance of S a h n e l h  (Sm) and Shkella 
(Sh) isolates. 
Methods and results: 78 patients (7.9% from acute dnrrhoea cases admitted 
in our department between Jan-Sept 2000, mean age 25.3 (24.5) years, 37 
men) had positive stool cultures for Sm (7.3%) and for Sh (0.4%). In Sm 
group 52.7% of isolates were DO subtype, 43.1% BO subtype, and 4.2% 
C O  subtype; in SH group 4 cases were with S. sotiriei, and S.  j7exiieri was 
involved in 2 cases. Antibiotic resistance of isolates was detemuned using 
diffusimetric method. All Sm and Sh isolates were susceptible to 
fluoroquinolones. In Sm group 33.3% of isolates were resistant to 
amoxicillm ( A m ) ,  37.8% to anipicilin (Amp), 47.2% to nalidixic acid 
(Nxa), and 31.9% to cotrimoxazole (Ctx). Two Sh isolates were pluri- 
resistant to Amp, Amx and Ctx. In Sm BO subtype group 11 isolates 
(35.4%) were resistant to Amx, 13 (41.9%) to Amp, 14 (45.1%) to Nxa, and 
12 (1 6.6%) to Ctx, respectively. None of Sni C O  isolates were resistant to 
A m ,  Amp or Ctx, but 1 isolate (33.3%) was resistant to Nxa. In Sm D O  
group resistance to Amx was recorded in 13 cases (34.2%), to Amp in 14 
cases (36.8%), to Nxa in 19 cases (50%), and to Ctx in 10 cases (26.3%). 
Conclusions: in our geographical area the resistance of Sm and Sh isolates to 
Ctx and Nxa is high; susceptibility to flnoroquinolones is still preserved 
probably in relation with a low frequency of using these antibiotic$ as first 
choice drugs in the treatment of acute diarrhoea. 
v1 Serotypes and antimicrobial resistance of Salmonella 
spp. isolated from diarrhoea1 patients in Crete, Greece 
S. Maraki, G. Samonis, A. Georgdadakis, Y .  Tselentis 
Heraklion, GR 
Objective: To determine the serotype distribution and the antimicrobial 
resistance of Salmonella spp. isolated from patients with acute diarrhoea in 
Crete, Greece, during a 5-year period (1995-99). 
Methods: Four hundred and twenty-eight Salmonella strains isolated from 
stool specimens were studied. Serotyping was perfomied with commercial 
antisera by the shde agglutination method. Antimicrobial susceptibility to 
seven antibiotics was checked by the &sk difision method as recommended 
by NCCLS. 
Results: The 428 Salmonella strains studied corresponded to 18 serotypes. 
Salmonella enteritidis was the most fiequent serotype (324 strains) accounting 
for 75.7% of the Salmonella isolated. Salmonella typlzimtrriuiri (70 strains) 
constituted 16.3%, while the remaining 16 serotypes were rare, constituting 
8% of the strains. Thirtytwo per cent of the isolates were resistant to 
ampicillin, 27% to tetracycline, 6.8% to chloramphenicol, 4.4% to 
cotrimoxazole, 1.6% to nortloxacin, and 0.5% to gentaniicin. Nineteen 
strains were concurrently resistant to 3 or 4 of the antinllcrobials studied, 
most of them (89.5%) belonging to typhimurium serotype. AU Saltnoriella 
isolates were susceptible to ciprofloxacin. 
Conclusion: Continuous surveillance for changes in resistance to antibiotics 
is necessary for deterrmning therapeutic regimens, whenever needed. 
vl Susceptibility of nontyphoidal Salmonella isolated 
in stool cultures in Madrid (Spain): five years of surveillance 
(1 995-99) 
B. Orden, R. Martinez, K. Millin 
Madrid, E 
Objective: Report the evolution of the antimicrobial resistance of the NTS 
strains isolated during the last 5 years (1995-99). 
Methods: The isolates (one strain per patient) were identified according to 
standard laboratory techniques by means of the automated Pasco method. 
The identiiication was confirmed by serogrouping with latex agglutination. 
In addition, all strains were sent to a national reference laboratory for further 
serotyping. (Carlos 111 Laboratory). Susceptibility testing (MIC) was 
performed according to the National Committee for Clinical Laboratory 
Standards (NCCLS) by using a broth microdilution automated method. 
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The antibiotics studied were ampicillin, cotnmoxazole, nalidixic acid, 
ciprofloxacin, gentamicin, tobraniicyn, cefotaxime and ceftazidime. The 
breakpoints used u’ere those recommended by NCCLS. Statistical 
significance of quantitative variables was analysed by means of the chi- 
square test. 
Results: Data of 948 NTS isolates were recorded: 184 serogroup B, 95 
serogroup C, 659 serogroup D and 10 serogroup E-G. Isolates belonging to 
serogroup B and C have shown a significant decrease, from 26.1% and 
10.9% in 1995 to 14.8% and 7.2% in 1999 ( P  < O.OOOl),  while the rate of 
isolation for serogroup D increased from 61.3% to 78% ( P  < 0.0001). 
Resistance to NAL has increased spectacularly (P < 0.0001) in the last 5 
years (5.9% in 1995 to 30.0% in 1999); and to SXT decreased progressively 
(P < 0.0001) over the same time period (10.1% in 1995 to 4.5% in 1999). 
Rates of resistance to AMP have remained stable. Resistance to 
aminoglycosides waF uncommon (2% to gentamicin and 1.3% to 
tobramycin). None of the strains were resistant to extended-spectrum 
cephalosporins or to fluorquinolones. 
Conclusion: In our area, resistance of NTS to AMP and NAL is high, but 
SXT show very good ‘ i i t  vifro’ activity. A continuous survelllance of 
susceptibility of salmonellae to antimicrobial agents and a more prudent and 
restricted use of them, in both humans and animals, are desirable. 
vl The emergence of multiple antibiotic resistance in 
Salmonella enterica serovar typhimurium phage types DTl2 and 
DT120: a case of DT104 in disguise? 
A. J. Lawson, M. U. Dassama, L. R.  Ward, E. J. Threlfd 
Londoii, UK 
Multiple antibiotic resistance first emerged in a single phage type of S. 
typhirnurium - DT104 -in the early 1990s. Multiresistant (MR) DT104 is a 
zoonotic pathogen and remains second only to S. enwitidis phage type 4 as 
the principal agent of human salmonellosis in England and Wales. M R  
DT104 is characterized by a 90-kb plasmid and resistance to ampicillin, 
chloraniphenicol, streptomycin, sulphonamides and tetracyclines (R-type 
ACSSuT). In M R  DT104 these antibiotic resistance genes have been 
accumulated in a chromosomally incorporated class 1 integron, a mobile 
genetic element, capable of potential horizontal transfer to other salmonella 
serotypes or phage types. Since 1996 the R-type ACSSuT has been 
identified in isolates of S. fyphirnurium DT12 and DT120 received by the 
Laboratory ofEnteric Pathogens, although as yet numbers remain small (13 
M R  DT12 and 15 MR DT120 isolates in 1999). In the present study we 
investigated the nature ofantibiotic resistance in M R  DT12 and DT120. T o  
this end both M R  and antibiotic-sensitive strains were examined using 
pulsed field gel electrophoresis (PGFE), plasmid profiling and integron 
fingerprinting. Of the M R  DT12 and DT120 strains examined so far, all 
those with R-type ACSSuT shared an identical integron fingerprint w t h  
M R  DT104. Notably, all DT12 and DT120 strains of R-type ACSSuT 
possessed PFGE profiles that were very Fimilar (one band dfference) or 
identical to the predominant PFGE profile typical of M R  DT104 - xtml. 
Whereas, the PFGE profiles of non-ACSSuT R-types or sensitive strains of 
DT12 and DT120 formed distinct groups of phage type-specific patterns. 
All DT12 strains and those DT120 strains with R-type ACSSuT possessed 
the 90 kb plasmid typical of MR DT104. All sensitive and non-ACSSuT 
resistant DT120 strains were plasmid-free. From these data it would appear 
that M R  DT12 and DT120 strains of R-type ACSSuT are more closely 
related to M R  DT104 than to non-MR strains of their own phage type. 
Such strains may have arisen due to changes in phage susceptibility rather 
than cross-phage type transfer of the resistance integron. 
)p9551 Study of multiple drug resistance of Salmonella typhi 
in children in Tehran hospitals 
G. Hedayah 
Sari, IR 
Typhoid fever is a systemic clinical syndrome produced by certain 
Saltnodla organisms. In recent years multi drug resistant strains of 
Salmoriella fyphi (MDRT) have emerged in many countries. The incidence 
has decreased markedly in developed countries but incidence has increased 
In developing countries. MDRT is a major problem in treatment of typhoid 
fever and requires an excessive hospitalization period. Since 1989, strains of 
Salrnoriella fyphi resistant to chloramphenicol, ampicillin, and co-trimoxazole 
have been responsible for numerous outbreaks of many countries. Before of 
1993 M D R T  was not reported &om Iran. In 1993 MDRT was reported 
about lo%, in 1994 MDRT was reported 40%. a t  1995 was reported 78% in 
Iran. in this study from 200 patients of suspected typhoid fever, 61 patients 
with positive blood culture were selected. 20 patients with, positive culture 
were MDRT. MDRT incidence in girls and boys were equal. There was no 
significant difference in the clinical presentation, laboratory findings 
between our study, textbook and other study. In this study, most common 
symptoms and sign were fever and chill, anorexia, nausea and vomiting, 
abdominal pain, hepatomegay, splenomegaly and rose spot. In this study 
chloramphemicol was drug of choice in the, sensitive cases. Patients 
generally become a febrile within days. Although chlormphenicol therapy is 
associated with a more rapid defervescence and sterilization of blood the rate 
of relapse is somewhat higher, and this agent can cause potentially serious 
adverse effect. Ciprofloxacin is etficacious, but is not approved for children. 
In this study, cehriaxon was drug of choice in the sensitive cases, become, 
febrile within 5 days. In patients with suspected resistant, we recommend 
therapy with ceftriaxone until antibiogram are available. 
(p956) Dual emergence in food and humans of a novel 
multiresistant serotype of salmonella producing SHV-12 beta- 
lactamase in Senegal 
A. Aidara-Kane, A. Gassama, J. D. Pemer-Gros-Claude, E .  Cardinale, P. 
Colbachiru 
Dakar, SN 
Foodborne diseases remain one of the most widespread public health 
problem in the contemporary world; the problem is more acute in 
developing countries where there is an increased number of vulnerable 
people as immunocomprormsed and/or undernourished individuals. 
Objectives: To evaluate the role of food in the transmission of pathogens 
and multiresistant strains to hunian in developing countries. 
Methods: Determination of somatic and flagellar antigens was performed by 
the agglutination method with commercial antiserum (Biorad-Pasteur, 
Paris, France). Antibiotic susceptibility was determined by the disc diffusion 
method according to National Committee for Clinical Laboratory Standards 
criteria. 
Results: In the Senegalese National Salmonella and Shigella Reference 
Laboratory at the Pasteur Institute in Dakar, during the same month, 6 
isolates of an unusual Salmonella entevica ssp enterica serovar (group C of the 
Kauthiann-White scheme) were isolated from food (poultry, 1 strain) and 
from human samples (4 from stool and 1 from blood culture). All strains 
expressed the same antibiotic resistance pattern, with resistance to third 
generation cephalosporin. The definite antigenic formula established by the 
French National Salmonella and Shigella Reference Laboratory at the Pasteur 
Institute in Paris was: 35: c: 1 ,  2. All isolates produced the same extended- 
spectrum beta-lactamase, encoded by SHV-12 @I 8.2), responsible for 
high-level third generation cephalosporins-hydrolysing activity (aztreonam, 
cefotaxime, cehazidinie: MIC > 128 mg/L). The food isolate and one of 
the human isolates showed an indistinguishable pattern by pulsed-field gel 
electrophoresis (PFGE) of genome macrorestriction patterns with Xba-I. 
The other strains showed very very similar pattern, differnt from the first 
one by only one two weak bands 
Conclusion: It is the first report of SHV-12 in Salmonella. Typing of the 
strains showed that all isolates are probably epidemiologically related. 
Although epidemiological investigation fail to prove any relationship 
between the animal and humans isolates, the spread of these strains from 
animal to human is the most probable explanation. Therefore more prudent 
use of antibiotics in veterinary or human medicine and a perfect adherence 
to measures of Good Manufacturing Practice during production and 
processing of poultry products are necessary to control the spread such 
multiresistant strains. 
Classification of the complications of typhoid fever 
N. Como, D. Kraja, E. Cam 
Tiram, AL 
Objectives: Determination of forms and frequencies of typhoid fever 
complications in 163 cases of the age 14-73 years old, hospitalized in our 
service during the years 1976-2000. 
Methods: The diagnosis of typhoid fever was set on the basis of positivity of 
blood culture and Widal test for salrnordla typhi. The complications were 
classified according to the topographic localizations, the manifested clinical- 
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paraclinical complex and the time it becomes evident in relation to the 
beginning of the disease. 
Results: The nervous system - 9.8%: meningeal syndrome - 2.45%; 
eiicepbalopathia grave - 6.74% with visual-auditive hallucinations - 2.45% 
stato-acusfic neun'tis - 1.84%; cerebellar ataxia - 0.6%. The cadiovascular 
system - 15.33%: myocarditis - 14.1%; cardiac shock - 1.84%, 
endotoxinenlic shock - 0.6%. The respiratory apparatus - 14.74%: unilateral 
bronchopneumonia-l0.4%, bilateral - 0.6%, unilateral pneumonia - 1.2%; 
pleuropneumonia 1.2%; pleuritis. The digestive tract - 5.52% perforation - 
2.45%; enterorrhagia - 2.45%; perforation syndrome - 0.6%. The 
Bartonella - Ehrlichia - Rickettsia - Coxiella 
hepatobiliary system 15.3%: hepantis - 24.5%, cholecystitis - 0.6%. 15, 
33%. Septicopyemia - 1.22%: hepatic abscess - 0.6%; spleen abscesses - 
0.6%. The haemopoetic system - 1.22%: haemolytic anaemia - 0.60/, 
thromborytopevia grave - 0.6%. Urinary system - 1.84%. The locomotion 
system - 1.84%: spondilitis lumbosacralis - 0.6%; penarthritis scapulohumeralis - 
0.6%; gonitis - 0.6%; aloperiagravis - 1.84%; death - 0.6%. In 3.06% of the 
cases, the first manifestation of the disease was a complication; 15.33% of the 
complications appeared in the stage of blooming and 61.34% later on. 
Conclusions: Out of our 163 cases of typhoid fever, 72 patients had various 
complications (44.17%); mortality resulted in 0.6%. 
Role of Bartonella quintana and its lipopolysaccharide 
in apoptosis of endothelial cells and neutrophils 
A. Foci, M. Liberto, A. Quirino, A. Lamberti, G. Barreca, G. Matera 
Catanzaro, I 
The interaction between Barfonella quintaria and endothelium appears to be 
important in the development of neovascular pathology. On the other hand 
polymorphonuclear cells (PMN) represent professional phagocytes which 
play an important role during early phases of an infection. Moreover recent 
studies underline the role of such cells in the angiogenesis induction. We 
investigated the effect of B .  quintana and its lipopolysaccaride (LPS) on 
apoptosis of an endothelial cell line, such as ECV304, and on human 
polymorphonuclear cells. Moreover the intracellular fate of B. quirttana 
within PMN was evaluated. Kinetic curves of programmed cell death of B. 
qnintana-infected ECV304 showed a peculiar course. Even if early phases of 
apoptosis reached the peak after 6 h, quickly cell fate reversed. Such 
apoptosis inhibition seemed not to be mediated by B. quiritana 
lipopolysaccharide, since LPS-stimulated ECV304 did progress to late 
phase of cell death. Evaluation of multiple cell signal transduction pathways 
revealed an overexpression of Apaf 1 and caspase 8 after 2 h of infection, and 
ofbcl-2, starting since 10 h post B .  quintana infection, in ECV304. Human 
neutrophils infected with B. quintana exhibited a reduced peak of early 
apoptotic PMN percentage (6 h) and an increase of the late apoptosis/ 
necrosis peak at 24 h, in comparison with control PMN. This behaviour 
could be linked to the phagocytic and intracellular killing activity evaluated 
in the PMN during parallel experiments. B.  quintana LPS-stimulated PMN 
did not change early phase of programmed cell death at 6 h, even if the level 
of such cells appeared higher with respect to control PMN at 24 h. 
Moreover late apoptosis/necrosis percentage were strongly reduced at 24 h. 
This feature could reflect a delay of biological cycle of this terminal type of 
cell. B.  quintana appears to be able to develop strategies aiming to modulate 
host cell apoptosis which represent an advantage for its intracellular life and 
may be relevant for its pathogenesis. 
Serological evidence of Bartonella henselae infection 
in children 
G. Antonaki, M. Foustoukou, N.  Paleologou, P. Sanida, K. Malliou, 
K. Kallergi 
Athens, GR 
Objectives: To determine the epidemiological data of Barfonella henselae 
infection in children. 
Methods: We studied 405 children with lymphadenitis aged &14 years old, 
submitted for Barfonella serology from October 1998 until October 2000 
and 65 control children with no disease. The two groups of children 
reported history of contact with domestic animals. Serum samples were 
examined for IgG and IgM antibodies against Bartonella spp., at a dilution of 
1 : 16 with diluent buffer and 1 : 20 with an antihuman IgG pretreatment 
diluent, respectively, by IFA. Titration followed any serum positive for IgG 
antibodies. Recent Barfonella infection was established by an IgM titre of > 
20 or an IgG titre of > 256. 
Results: Evidence ofrecent 8. henselae infection was observed in 45 chddren 
of the lymphadenitis group of patients (ll.l%), 30 males (66.6%) and 15 
females (33.3%). Seasonal distribution analysis showed that 32 of the 45 
patients with evidence of infection (70%), were isolated in winter and fall. 
Serological evidence ofpast infection in the lymphadenitis group of patients 
was obtained in 61 children (15%). In the control group positive IgG titres, 
ranged &om 1 : 16 to 1 : 128, were found in 16 children (24.6%). 
Conclusions: (1) In 11.1% of children with clinically diagnosed lymphade- 
nitis, B .  henselae was identified as the causative agent. (2) Males had higher 
incidence of Barfonella infection than females. (3) Winter and fall were the 
seasons with the hghest rate of Barforiella seropositivity. 
/p9601 First description of acute human granulocytic 
ehrlichiosis in Bulgaria 
I. Christova, K. Bakardjiev 
Sqfia, Burgas, B G  
Objectives: Accepted in the near hture as a veterinary problem, today 
granulocytic ehrlichiosis is the most common, after Lyme borreliosis, tick- 
transmitted human disease in America. In Europe, several seroepidemio- 
logical studies have been conducted and a few cases have been documented. 
This paper represents the first clinically and serologically confirmed case of 
human granulocytic ehrlichiosis (HGE) in Bulgaria. 
Methods: Physical examinations and laboratory studies in the course of the 
disease were performed. A modification of an indirect immunofluorescence 
assay (IFA) with an antigen prepared from HL60 cells infected with the 
HGE agent (Webster strain) was applied for diagnostic confirmation. 
Results: A 47-year-old man was hospitalized after 3 days of fevers, chills, 
severe headache, myalgias, and arthralgias after removal of a tick. Physical 
examination revealed hepatosplenomegaly, and laboratory studies showed 
transitory leukopenia, thrombocytopenia, and abnormal results from liver- 
function assays. Immunofluorescent serology showed 4-fold change in HGE 
agent antibody titre between two samples-in the beginning of the illness and 
2 months later. Serological investigations for Lynie borreliosis, made in 
parallel with HGE serology, gave unchanging borderline results. 
Diagnosis: HGE was accepted due to epidemiological anamnesis for tick 
bite, clinical manifestations and serological findings. A therapy with 
doxycycline was given to the patient. The patient completely recovered 
and a blood count and liver-function tests became normal. 
Conclusion: It should be pointed out that in regions endemic for Lyme 
disease a possibility for simultaneous HGE and Lyme disease exists and 
probably is not rare. HGE is most likely to take a significant place in 
infectious pathology of patients with tick bites in Bulgana. 
/p9611 Detection of Ehrlichia phagocytophila genogroup and 
Borrelia burgdorferi s.1. in Bulgarian lxodes ricinus ticks 
I. Christova, S. Panaiotov, V. Lefterova, T. Kantardjiev 
Sqfia, B G  
Objectives: Bulgaria is a region where Lyme borreliosis is known to be 
endemic infection. Recently described, human granulocytic ehrlichiosis 
(HGE) is an emerging infectious disease, transmitted by ticks of genus 
Ixodes, the same that transmits also Borrelia burgdoferi sensu lato, the agent of 
Lyme disease. Our aim was to prove earlier observations for wide 
distribution of HGE in Bulgaria 
Material and methods: I. ririnus ticks were collected by flagging vegetation 
and investigated by PCR for presence of B. 6urgdotj?ri s.1. and HGE agent 
DNA. Two sets of primers were used-one using as target flagehn gene 
sequence of B .  burgdoferi s.1. and another using as target epankl gene for 153 
kDa species-specific protein antigen of E .  phagorytopbila genogroup, recently 
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described more tensitive sequence for detection of HGE than routinely used 
16s rRNA. 
Results: A total of 96 I. ririnus ticks were analysed. Of 11 pooled DNA 
samples made from 50 ticks, in 6 (55%) B. buqdofen's.1. -specific DNA was 
detected, in 5 (46%) - E. phagocytophila genogroup - specific DNA, in 3 
(27%) of them coinfection with both agents was detected. Of additional 46 
ticks investigated separately, 18 (39%) contained B. burgdoferi - specific 
DNA and 15 (33%) - E. phaprytophila genogroup - specific DNA, 9 (20%) 
of them - DNA of both agents. 
Conclusion: A high prevalence of E. phagoqmyhila group infection in tested 
Bulgarian I. r icimts ticks was detected. Co-infection with B. burgdolferi in 
ticks pointed out the potential for dual infection in patients and supports 
necessity of carefill clinical examination and laboratory testing of patients 
with nck bites. 
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lp9621 Clarithromycin vs. azithromycin in the treatment of 
Mediterranean spotted fever in children. A randomized 
controlled trial 
A. Cascio, C.  Coloniba, L. Titone 
Palenno, I 
Introduction: Mediterranean spotted fever (MSF) caused by Rickettsia coriorii 
endemc in Mediterranean, transmitted by Niipicephahs sanguineus. Till now 
there has not been a gold standard therapy for rickettsial diseases in children. 
Standard rreatnient for MSF in adult is the oral adininistration of 
tetracyclines or chloratnphenicol. Effective intracellular antimicrobial 
concentrations are considered the sine qua noii of a successful treatment 
for MSF. In a previous study we compared the efficacy and safety of 
clarithromycin vs. chloraniphenicol in treatment of MSF obtaining good 
results (Cascio er al. in press). 
Objectives: To compare the efficacy and safety of azithromycin (10 mg/kg/ 
day once daily for 3 days) vs. clarithromycin (15 mg/kg/day in two divided 
doses for 7 days) in treatment of children with MSF. 
Patients and methods: All children admitted to our department, From June 
1999 to September 2000 with clinically suspected MSF were randomly 
assigned to receive either clarithroinycin or azithromycin. The final study 
population was that group of enrolled children who had a confirmed 
diagnosis of MSF. Confirmation was by way of a score of > 25 by the MSF 
diagnostic score described by Raoult et a/.  (Eur] Epidemiol 1992; 8: 192-7). 
The major endpoint was considered the time to persistent defervescence. The 
analysis of the data was carried out with Stadstica and Epi-Info software. 
Results: 97 patients were randomized to receive the ttudy drugs. 87 reached 
a diagnostic score > 25 and were considered the final study population; 45 
had been assigned to clarithroinycin group and 42 to azithromycin group. 
The base-line characteristics of the patients are in Table 1. 
No statistically significant differences between the two groups were seen. All 
patients recovered within 7 days from the beginning of therapy. 
Defenrescence was achieved after a mean & SD of 46.2 36.4 h in the 
clarithromyicin group and after a mean ? SD of 39.3 31.3 h in the 
azithromycin group, these differences were not statistically significant 
(P=O.34) (Fig. 1). 
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Clarithromycin and azithromycin were equally well-tolerated and no major 
side-effects were observed. 
Conclusion: Clarithromycin and azithromycin could constitute an accep- 
table therapeutic alternative to chloramphenicol and to tetracyclines for 
children aged under 8 years with MSF. Azithromycin thanks to its long half- 
life offers the advantage of a single daily dose and shorter duration of therapy 
that increases the compliance especially in children. 
Table 1 Base-line characteristics of the 87 patients with MSF.  Values are 
median and (range) 
Figure 1. Hours before the achievement of persistent defervescence in the 
two treatment groups plotted by the whisker method. Differences were not 
statistically significant ( P  = 0.34). Lower and upper horizontal bars 
correspond to minimum and maximum values, respectively; the rectangles 
correspond to  the 25th and the 75th percentiles; the squares represent the 
median values. 
Clinical and epidemiological study of murine typhus in 
Euboea, Greece 
G. Chaliotis, A. Gikas, T. Gozadinos, A. Chrysanthis, D.  Kofteridis, E. 
Barbounakis, A. Diakos, Y. Tselentis 
Chalkis, Heraklion, GR 
Forty-nine serologically confirmed (elevated antibodies against Rickettsia 
typhi) clinical cases of endemic typhus were studied in the period from 
August 1998 to October 2000. Between them 27 were men (55%) and 22 
were women (45%) The mean patient age was 42.6 years (range 18-82). 
Contact with rodents was found in 32 cases (65.5%) and a concentration of 
cases was observed mainly during late summer to early autumn time. 
Clinical manifestations: Fever was recorded in 49 patients (loo%), headache 
in 45 patients (90%) and rush lesions in 39 patients (79.5%), Spleen 
enlargement was found 9 patients (18.3%), liver enlargement in 12 patients 
(24.5%), pulmonary manifestations in 14 patients (28.5%) and conjunctivitis 
in 8 patients (16.3%). 
Biochemical findings: Elevated levels of serum transamnases were found in 
47 patients (95.9%), thrombocytopenia in 25 patients (51 -02%) and anaemia 
in 26 patients (53.06%). Blood traces in urine were recorded in 13 patients 
(26.51%). Anti-inicrobial treatment: 25 patients were treated by Doxycy- 
cline, 5 patients with Doxycycline + Ofloxacin, 5 patients with 
Chloramphenicole, 9 patients with Ofloxacin, and 5 patients Doxycycline 
+ Chloramphenicole. The most serious complications recorded were, 
Disseminated intravascular coagulation in 16/49 (32.6), confusion 5/49 
(10.2%) and acute renal failure in 3/49 patients (6%). AU patients recovered 
and the mean time for the defervescence was 4.1 (2-5) days. 
w/ A case report: rickettsial meningoencephalitis 
N. Ceylan, N.  Ozgiines, T. Ceylan, P. Ergen 
Istanbul, TR 
A 35-year-old female patient was admitted with fever, unconsciousness, 
agitation, widespread eruptions, and icterus. The patient had been treated 
for allergic dermatitis and measles before her admission to our department 
because of manifestations suggestive of a central nervous system (CNS) 
infection. A clinical diagnosis of rickettsial meningoencephalitis due to 
Mediterranean spotted fever was made depending upon the features of 
eruptions, 'tache noire', and cerebrospinal fluid findings, which was then 
contirmed by laboratory investigation. Aetiology of the CNS infection was 
difficult to ascertain because of the lack of purulent character of acute 
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bacterial meningitis. The cerebrospinal fluid was xanthochromic, the 
pressure was increased. and a positive Pandy reaction was obtained. 
Laboratory studies revealed the following: erythrocyte count 400/nL, 
leukocytes 52/mL (80% PMN), protein 146 mg/dL, glucose 47 mg/dL, 
chloride 117 mEq/L. A concomitant blood glucose was 153 mg/dL. Of 
interest was the presence of icterus and a 7-8-fold increase in transatninases. 
Manifestations were suggestive of an involvement of more than one system. 
Eruptions might be attributed to meningococcaemia. Despite penicillin 
treatment, she had high fever at 48 hours and deteriorating general 
condtion. Wed-Felix agglutination test performed upon the detection of 
'tache noire' showed positive OX 2 and OX 19 agglutinins at 1/320 and 1/ 
640 titres, respectively. Intravenous chloramphenicol of 4 g/dady was 
administered for 12 days. Taking into consideration the literature reports as 
to recurrences following chloramphenicol administration, and multiorgan 
involvement, she was given oral doxycycline 200 mg/dady for a week. 
Wed-Felix agglutination test performed two weeks later showed positive 
OX 2 and OX 19 agglutinins at 1/1280 and 1/2460 titres, respectively. 
Complete recovery was achieved at the end of 4 months of treatment. 
vl Neurological complications of acute Q fever infection 
D. Kofteridis, E. Barbounakis, Y. Tselentis, A. Gikas 
Herakliori, CR 
Objectives: To investlgate the neurological complications of acute Q fever 
Infection. 
Methods: Patients were identified from a retrospective study of adults 
hospitalized for a febnle illness associated with serological evidence of acute 
Coxiella burnefii infection. Over a period of 7 years (1989-96), serum 
samples from 3300 patients suspected of being infected by Cowielln bunzetii 
were assayed for the presence of antibodies against antigen phase I1 of the 
microorganism, using the indirect immunofluorescence antibody technique 
(IFA). In order to increase the specificity of IFA technique, we considered 
titres of IgG 1/960 or IgM1/400, and/or a four-fold increase of the titre 
between two assays (titres should be at least 11200) as a strong indication of 
acute infection. One hundred and twenty-one (121) patients fulfilled the 
clinical and serologic criteria of acute Q fever infection and their medical 
recorb were reviewed. 
Results: Foq-nine patients (40.5%) complained of severe retro-orbital 
headache. Seven cases (5.8%) had additional neurological features at 
presentation. Three patients presented with signs of meningitis, and 4 
patients with confusion. CSF was performed in three patients. The findings 
were a moderate increase in cells (32O/md) and protein (142 nig/mL.) in 
the first patient, normal cells and protein in the other two patients. All three 
patients had normal CSF glucose levels. Moreover s i x  of the patients had 
pneumonia with additional neurologml features at presentation, while 
abnormal liver function tests was found in four of these patients. The 
outcome was favourable for all patients. 
Conclusion: Our data suggest that cluucal evidence of CNS involvement IS 
not a rare feature of acute Q fever. It is usually presented as severe retro- 
orbital headache, accompanying pneumonia that is the main clinical feature 
of the disease in our area. 
Lyme disease 
/p966 Infection of lxodes ricinus ticks with different species 
of Borrelia burgdorferi s. I. in Central Italy 
M. del Piano, I. Santino 
Rome, I 
Objectives: Aim of the study was to establish the prevalence of different 
species of B.  burgdorferi s.Z.  in Ixodes ricinus collected in Central Italy by 
polymerase chain reaction (PCR). 
Methods: I. ricinus ticks were collected from vegetation in a protected area 
of the province of Rome, Caste1 Porziano Presidential Reserve. The 
presence of B. burgdofen s.1. was investigated by PCR. Specific primers for 
B.  burgdorfen sensu stricto, B .  afrelii, B. garinii and group VS116 were used in 
PCR tests to identify the genospecies. 
Results and conclusions. 8. burgdorferi s. l .  was detected in 13.8% I. ricitius 
nymphs collected in 295 pools of five specimens each. 
Four species were identified B. burgdofen sensu str ido,  B. afrelii, group 
VS116 and B. garinii. VS116 (63.4%) was the most predominant 
genospecies, followed by B. afielii (26.8%), B. garinii (7.3%) and B. 
burgdoferi sensu stricto (2.5%). 
The selected area has been reaflorested with Pinus pinen, the underbrush is 
compound by a typical Mediterranean flora and reserve fauna is composed 
by numerous wdd ungulates, this can explain the identification of Werent  
Borrelia genospecies in ticks. 
In this study the identification of the four major Bovrelia genospecies 
confirnis the presence of the different species in European I. ricinus. 
vl Reactivity of sera belonging to patients in early stages 
of Lyme disease in Borrelia blot assay 
B. Hernandez Novoa, M. Ortega, J. L. b i z ,  M.  A. Mantecon, J. M. Eiros, 
A. Orduna, J. A. Oteo, M. L. Moreno 
Vdladolid, Logrorio, E 
Objective: The aim of this study is to investigate immunoblot patterns in 
patients with early stages of Lyme disease. 
Methods: We tested 42 sera from patients with early Lyme disease from 
which 24 belonged to patients with early localized disease and 18 to subjects 
with early dmenlinated disease. Borrelia blot was carried out in all of them 
being specific IgG and IgM antibodies (Ab) determined separately. 
Results: The distribution of the presence of antibodies to the antlgens 
included in the Borrelia blot was analysed taking UI account both, the 
frequency of each band, and the Werent patterns of bands observed. This 
analysis was done for the whole group of patients and individually according 
to the stage of the disease. In all cases the most frequently detected Ab were 
those against p41 of Borrelia burgdogen s. l .  (globally 95.3% for IgG and 65.1% 
for IgM; in early localized disease: 95.8% for IgG and 70.8% for IgM; and in 
early disseminated disease: 94.4% and 61 .I%, respectively). Considering IgG 
and the totality of patients following p41 the most frequently observed 
bands were pl00 and OspA. Patients that did not show any band at all 
accounted for the 4.6% of samples. Accordmg to IgM response considered 
globally, despite p41 the most frequently observed bands were OspA and 
OspC. Up to 27.9% of samples showed no bands at all. The analysis of band 
patterns showed that except for IgG against p41 alone (which appeared in 
60.5% of cases) no other pattern exceeded 29.2% in frequency. The 
interpretation of the strips following the manufacturer instructions led to a 
low number of IgG positive results in both stages of the disease (20.8% for 
early localized disease and 22.2% for early disseminated dsease). Samples 
that reached positive criteria for IgM were mainly from early disseminated 
disease (66.7% vs. 37.5%). IgG determination rendered more sera classified 
as 'questionable' than IgM one did. 
Conclusions: Borrelia blot is another tool in the serologic diagnosis of Lyme 
disease which can be useful, but in a large percentage of cases it is not helpful 
enough to clanfy it. 
lp9681 Usefulness of ELISA and IFA tests in the diagnosis of 
early stages of Lyme disease 
B. Hernandez Novoa, M. Ortega, M. Fmtos, M. A. Mantecon, J. M. Eiros, 
A. Orduna, J. A. Oteo, A. Rodriguez Torres 
Valladolid, Logrorio, E 
Objective: The aim of this study is to asses the usefulness of four ELISA and 
one IFA tests in the diagnosis of early stages of Lyme disease. 
Methods: We studied 42 sera belonging to patients in early stages of Lyme 
disease (24 of them with early localized disease and the other 18 with early 
disseminated disease). As control sera we used 100 blood donor samples a\ 
well as 76 serum samples &om patients with infectious disorders other than 
Lyme disease, and 53 sera from patients with non infectiouc diseases. All 
samples were tested with four ELISA techniques: Borreliosis de Lyme IMx 
(Abbott), B. garinii ELISA (Virotech), Borrelia burgdo@ri IgG/IgM ELISA 
(Wanipole Laboratories) and Platelia Lyrne (Pasteur) and an Immunofluor- 
escence assay Borrelia burgdofen' IFA (BAG). 
Results: The most sensitive test was IFA IgM (80.9%) followed by 
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Borreliosis de Lyme IgM (52.4%). The least sensitive one was Borrelia 
buxdorferi IgG/I@ ELISA (Wampole Laboratories) (4.8%). The specificity 
of the different tests used vaned from 90 to 100% in the blood donors 
group, from 40 to 100% in the group of patients with infectious disorders 
other than Lyme disease and from 60 to 100% in those with non infectious 
diseases. Note that taken together all tests provided low specificity in 
patients with syphdis, and in cases of coinfection with HIV this effect was 
generally strengthened, specially in B. gaririii ELISA (Virotech) test (0% in 
IgG and 40% in IgM). In non infectious diseases, all tests showed less 
specificity in those cases were autoantibodies were present. 
Conclusions: Serologic diagnosis of Lynie disease based on the assays 
employed provides unsatisfactory values of sensitivity and specificity and 
thus it could only be an additional tool for clinical diagnosis. Due to the lack 
of speclficity in case of a positive result the presence of other conditions such 
as syphdis, HIV infection or autoimmune disease with antinuclear 
antibodies should be ruled out. 
(Table 1) 
[p9691 Seroprevalence of antibodies against Borrelia 
burgdorferi among forestry workers from north-eastern Poland 
S. Pancewicz, T. Hermanowska-Szpakowicz 
Bialysfob, PL 
Objective: the purpose of this work was to evaluate the risk of infection 
with Borrelia hurgdo@ri of forestry workers from north-eastem Poland. 
Material and methods: The group of 358 workers was analysed twice in 
1995 and 2000 to detect antibodies against B. buxdofeti.  The examination 
was performed with use of ELSA kit (Biomedica, Austria). 
Results: I n  1995 138 (38.55%) persons had detected antiboles against B. 
burgdofen IgM-35 (9.78%) IgG-103 (28.77%). In 2000 156 showed presence 
of these antibodies IgM-29 (8.1%) IgG-127 (35.47%). Comparing data from 
two examinations we stated that 256 persons had same serologic status. *1 
persons who were previously negative became positive IgM-18 IgG-63. 63 
persons who in 1995 had antibodies I@-24 IgG-39 in the period of five 
years became negative. The differences in prevalence of IgG were 
statistically significant but not IgM. 
Conclusion: Our data shows that forestry workers from north-eastem 
Poland can be treated as high risk group of infection with Borrelia burgdofen. 
Improvement of laboratory methods for Lyme 
borreliosis recognition 
S .  Tylewska-Wierzbanowska, 7. Chmielewski 
Warsaw, PL 
Sensitivity of serological, culture and PCR methods in the recognition of 
Lyme borreliosis were compared. The study group consisted of 270 patients 
with clinical symptoms of Lyme borreliosis. Levels of IgM and IgG 
antibodies specific for Borrefiu burgdoferi were measured in serum, cerebro- 
spinal and synovial fluids by recombinant anngens ELISA (BIOMEDICA, 
Austria). Blood, cerebra-spinal and synovial fluids collected from patients 
with symptoms of Lyme borreliosis were cultured in L-929 cell line. 
Isolated bacterial DNA was amplified by PCR with 16s rRNA gene 
primers. B. burgdorfert IgM and/or IgG antibodies were detected in 60% 
patients. In 70% of patients diagnosis was confirmed by isolation spirochetes 
in L-929 cell line, and in 22% of patients by P C R  with 16s rRNA gene 
primers. Detection of spirochetes in cell line culture is a very sensitive and 
usehl method comparing with serological and PCR tests for recognition of 
Lynie borreliosis. 
vl Isolation of Borrelia burgdotferi sensu lato from the 
blood and spinal fluid of patients with erythema migrans and 
neuroborreliosis 
K. Schwarzova, K. Holeckova, R. Dolanova 
Bratislava, SK 
Lyme borreliosis (LB), the highest prevalent tick-borne disorder, is a 
multisystenlic infectious disease, caused by the spirochete Bonelia burgdo& 
semu fato. During the last 20 years, muitiple species within the category 
Borrelia burgdofen s. l .  were isolated and identified. The aim of the study was 
the isolation of pathogens from the blood and spinal fluid of patients with 
LB. Blood and spinal fluid samples from nine patients with Erythema 
migrans (EM) and clinical neuroboneliosis were analysed by ELISA and 
ImmunoDot serodiagnostic methods. By these methods six samples were 
negative and did not show antiborrelia antibodies. Samples were hereby 
cultivated in BSK-H medlum by a molfied cultivation method. After the 
cultivation the spirochetes were observed in seven samples. Ths study 
demonstrates, that the direct detection of spirochetes can be an efficacious 
procedure for confirming the diagnosis of LB. 
Liver function in early Lyme borreliosis 
R. Komitova, L. Angelov, G. Genev. T. Rakadjieva, I. Christova 
Plovdiv, SoJia, BG 
Lyme boneliosis (LB) is a multisystemic infection caused by the tick-bome 
spirochete Borrelia burgdoferi. A great deal of attention has been paid to the 
dermatological, musculoskeletal, cardiovascular and neurological manifesta- 
tion of the disease. Acute hepatitis has been observed in the early stages of 
LB. Hepatic enzyme elevation have been reported in 20% to 50% ofpatients 
(pts) with Erythema migrans (EM), the characteristic rash of early disease. 
Objectives: to evaluate the frequency, pattern and severity of liver function 
tests abnormalities in pts with EM. 
Patients and methods: Sixty consecutive pts with clinically defined EM 
were studied between 1995 and 1998. No other identifiable cause for liver 
function tests abnormalities were found. Pts had serum biochemical analysis 
performed including alanine transaminase (ASAT), aspartate transaminase 
(ASAT), alkaline phosphatase, y-glutaniyl transpeptidase and bhrubine 
before and 4 weeks after the initiation of therapy. 
Results: Thirtyfour pts had at least one test abnormality. ASAT and ALAT 
were the most frequent elevated liver tests - in 13 pts (21.67%)) and 19 pts 
(31.83%). respectively. On presenting physical examination abnormal 
tenderness and hepatomegaly were found in none pts; light jaundice - in 
2 pts. After antibiotic therapy elevated liver function tests resolved in 
most pts. 
Conclusion: Liver function tests abnormalities are common in pts with EM, 
but are mild, most often not associated with symptoms and resolved by 3 
weeks afier the onset of antibiotic therapy in niost pts. 
vl Observation of percentages of CD4.CD8.CD25 
lymphocytes and their soluble receptors in Lyme borreliosis 
before and after treatment 
J. Zajkowska, T. Hermanowska-Szpakowicz, M. Kondrusik, S. Pancewicz, 
R. Swierzbinska, S. Grygorczuk 
Biafystok, PL 
Objectives: Estimation of percentages of lymphocytes with receptor CD4, 
CD8, CD25 in whole blood and their soluble concentration in serum of 
patients with Lynie borreliosis in stage Erythema migrans (Group I) and 
Lyme arthritis (Group 11) before (examination 1) and after of antibiotic 
treatment (examination 2) in comparison with 11 healthy persons (Group 
111-control) 
Methods: patients: With Erythema migrans, Group I II = 20, and Lyme 
arthritis, Group I1 n = 20. Diagnosis was based on epidemiological and case 
history (EM) confirmed presence antibodies against B. burgdoferi in ELISA 
(Biomedica) and Westemblot tests (Lyme arthritis). Percentage of 
lymphocytes subsets were measured by flow cytometry (COULTER EPIX 
XL., and Becton Dickinson antibodies), concentration of soluble receptors 
by ELISA (Endogen kits). Statistic analysis was perfomied with STATIS- 
TICA program. 
Results: The percentages of CD4 and CD8 subsets are lower than in control 
in Group in examination 1, CD8 is still lower in examination 2. SCD4, 
Clinical Microbiology and Infection, Volume 7,  Supplement 1, 2001 195 
sCD25 in this group in examination 2 is hgher than in control. In group I1 
CD4 were lower in examination 2, CD8 in examination 1, than in control. 
SCD8 in ths  group was hgher in examination 1 compared to control. 
Conclusions: Decreasing of percentages of lymphocytes CD4, CD8 and 
CD25 is connected with increase of their soluble receptors. It can indicate 
involvement this subsets in Lyme borreliosis especially in disseminated stage 
(Lyme arthritis) 
v] Estimation of CD8 cell response in Lyme borreliosis in 
early local and early disseminated stages 
J. Zajkowska, T. Hermanowska-Szpakowicz, S. Pancewicz, R 
Swierzbinska, M. Kondrusik, S .  Grygorczuk 
Bialystok, PL 
Objective: Evaluation of cellular response in Lyme borreliosis by measuring 
subset CD8 in whole blood and soluble CD8 in serum in two stages of 
Lyme disease before and after treatment. 
Methods: 40 patients aged 17-60 ( ~ ~ 4 1 )  with recognized Lyme disease 
were examined. Epidemiological. clinical diagnoses were confirmed by the 
presence of antibodies against B. burgdoreferi in ELISA test (Biomedica). 
Lymphocyte subset was estimated in flow cytometer (COULTER EPIX 
XL). soluble receptors by ELISA (ENDOGEN kit) twice before(examina- 
tion 1) and after antibiotic treatment (examination 2). Patients were divided 
into groups: Group I. n = 20 with erythema migrans. Group 11. n = 20 with 
Lyme arthntis. Control group 111. was consisted of 11 healthy persons. 
Statistic analysis was performed with STATISTICA program. 
Results: SCD8 in preliminary examination was higher compared with 
control in group 11, and decreased in examination 2 after treatment. The 
subset CD8 was lower compared to control in examination before and after 
treatment in Group I, and before treament in Group 11. 
Conclusions: Results indicate significant involvement of CD8 in pathogen- 
esis of Lyme borreliosis suggesting that cellular response maintains 
after treatment. 
1 v] Estimation of serum soluble receptors CD4, CD8 and 
CD25 in patients with Lyme borreliosis 
J. Zajkowska, T. Hermanowska-Szpakowicz, R. Swierzbinska, S. 
Pancewicz, M. Kondrusik, S. Grygorczuk 
Bialysfok, PL 
Objectives: Activation of CD4, CD8, CD25 lymphocytes are estimated by 
concentration of their soluble receptors in serum before and after treatment 
in different clinical stage of Lyme borreliosis. 
Methods: 60 patients were examined. Diagnosis was based on epidemio- 
logical suggestion, case history confirmed by presence antibodies against B. 
burgdofen (ELISA, Westem -blot). Concentrations of receptors were 
measured with ELISA assay (ENDOGEN kits). Examinations were 
pefiormed twice before and after treatment. Patients were divided into 
three clinical groups(Gr0up I, 11, 111). Results were compared with healthy 
Community-acquired lower respiratory tract infections 
persons (Group IV, control). Statistic analysis were peiformed with 
STATISTICA program. 
Results: in all examined groups: Group I - neuroborreliosis, Group I1 - 
erythema migrans and Group I1 - Lyme arthritis soluble receptors sCD4, 
sCD8, sCD25 increased in preliminary examination before treatment and 
decrease after treatment but to level still higher than in control group. The 
highest levels of examined receptors were in Group 111 - Lyme arthritis, the 
lowest in Group I1 - erythema migrans. 
Conclusions: Significant changes in concentrations of soluble receptors of 
chosen lymphocyte subsets indicate strong activation of these subsets in 
pathogenesis in examined stages of Lyme disease. 
jP9761 Two cases of orbital myositis and Lyme disease 
Y. Hansmann, P. Dounovetz, C. Hermsdorff, M. Martinot, V. Kemy, B. 
Jaulhac, D. Christmann 
Strasbouug, F 
Pseudotumour of the orbit are characterized by acute onset of pain, 
swelling, proptosis. They are in most of cases idiopathic, but can reveal 
Grave’s disease or lymphoproliferative disease. Diagnosis is made by C T  or 
MR imaging that show enlargement of one intraorbital muscle, with 
perimuscular infiltration. Few cases of orbital myositis due to Lyme disease 
have been reported. We report two cases of patients with symptoms of 
orbital pseudotumour. The first one was a 13-year-old girl who had a 
previous history of erythema migrans of the face 5 years ago. The symptoms 
began with ocular pain, followed by vertical diplopia. At examination, she 
had paresis of the right rectus lateralis and right exophthalmia. M R  imaging 
showed enlargement and hyperintense T2 signal of rectus lateralis, rectus 
inferior and obliquus inferior muscles. Other structures of the orbit were 
normal. The serology of Borreh was significantly positive with confirmation 
at Western Blot testing. The second patient, a 64-year-old woman, had an 
acute ophthalmoplegia. She lived in a high incidence area for borreliosis. 
The diagnosis of orbital myositis was assessed on the result of MR imaging. 
This examination showed an enlargement of the rectus medialis muscle in 
its anterior part without perimuscular signs of inflammation in the fatty area, 
with enhancement after gadolinium injection. Serological testing for the 
Lyme disease was positive. For each patient, treatment with antibiotics 
(cyclins) was proposed because of the suspected diagnosis of Lyme disease. 
None of the patient was taking any corticosteroid treatment, however, the 
evolution was rapidly favourable for each patient. The clinical signs 
disappeared in a few days. The control of MR imaging realized 4 weeks 
later showed the resolution of inflammation in both patients. Corticoster- 
oids are the treatment of orbital myositir and pseudo-tumour, but the exact 
cause of this disease is not well known. For our patients, we conclude to 
Lyme disease because of specific serology positivity, very good response to 
antibiotic treatment without corticosteroid and the previous history of 
erythema migrans or the residence in high endemic area. Only a few 
publications described patients Lyme disease and orbital myositis. 
Conclusion: Lyme disease could be one of the cause of orbital myositis, and 
antibiotic treatment against Bonetia could be an efficient treatment. 
ml Effect of clinical guidelines on antibiotherapy 
prescription for in-patients with community-acquired 
pneumonia 
0. Lamy, R. Stoianov, G. Zanetti, B. Burnand 
Lausanne, CH 
Purpose of the study: Variations in practices and published guidelines (GL) 
regarding the type and mode of delivery of antibiotherapy (AB) for 
community-acquired pneumonia (CAP) have been observed. The efficacy 
of GL to improve the appropriateness of use of AB in CAP patients 
hospitalized in a teaching hospital was measured in a pre postintervention 
study. In 1998 an evidence based GL that recommended which AB regimen 
to use and initial or early switch to oral therapy was proposed to staff 
members (grandground session plus GL in full and abstract form). 
Management practices among consecutive CAP inpatients (clinical and 
radiological criteria) admitted during the years 1997 and 1999 have been 
compared. 
Results: 152 and 181 patients were included in 1997 and 1999, respectively. 
Age (70 + 17 in both groups), gender (male 57% vs. 60%), high risk 
pneumonia according to Fine’s severity score (FSC IV/V: 64% in both 
groups), admission to ICU (14% vs. ll%), length of hospital stay (9 vs. 8 
days) and death (5% vs. 7%) were sinlilar in both groups. Mean duration of 
i.v. AB decreased from 120 & 124 h (median 92) in 1997 to 104 86 h 
(median 87) in 1999 (P < 0.1). Continuation 0fi.v. administration after 24 
h decreased from 92% (139/151)in 1997 to 81% (145/180)in 1999 (P < 
0.005). 47% (71/151) in 1997 and 52% (99181)  in 1999 received the one 
drug regimen ( p e n i c h s  (p) or cephalosporins (c) or macrolide); 53% in 
1997 and 48% in 1999 received a two drug regimen (addition of macrolide 
to p or c). Oral initial administration of macrolide in the two drug regimen 
increased from 51% (41/80) in 1997 to 86% (74186) in 1999 ( P  < 0.001). 
In 1997, none of the 20 parameters of FSC, neither FSC, neither admission 
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to ICU were associated with initial AB regimen. In 1999, patients receiving 
Initial two drug regimen were more severely ill: admission to ICU 18/86 vs. 
1/95 ( P  < 0.001), low arterial Pos 37/86 vs. 20/95 ( P  < 0.005) and low 
arterial pH 13/86 vs. 3/95 ( P  < 0.05). 
Conclusion: A small decrease in the use and length of i.v. antibiotherapy was 
observed after the introduction of the GL. Patients who received the two 
drug regimen were better identified. However the initial two drug regimen 
is probably still used too frequently. A better strategy of GL implementation 
is needed to improve these encouragmg results 
lp978; Impact of antibiotic resistance and cross-resistance in 
the out-patient treatment of adult community-acquired 
pneumonia 
M. E. Singer, I. Harding, M. R. Jacobs, A. Kemp, J. Chang 
Clevefagid, USA; Cambtidgeshire, UK; Btidgewater, USA 
Objective: To estimate the impact on clinical outcomes of antibiotic 
resistance and cross-resistance in adult community-acquired pneumonia 
(CAP) treated empirically with oral antibiotic agents. 
Methods: We developed a probabilistic model to calculate failure rates for 
adults with no comorbidities diagnosed with CAP. Pathogen distribution 
[spontaneous resolution] values were derived from a recent meta-analysis: 
Sfreptococcus ptieumoniae (SP), 55% [0%]; Haemophilus influenzae (HI), 14% 
[20%]; intracellular organisms, 11% [US%]; other bacterial, 12% [20%]; viral, 
8% [95%]. Antimicrobial susceptibility of SP and HI at pharmacodynamic 
breakpoints were taken from surveillance data. Intracellular organisms were 
regarded as susceptible to macrolides and quinolones and resistant to beta- 
lactams. Other bacterial infections were considered to be 50% susceptible to 
all antibiotics. We assumed susceptibility led to clinical cure in 90% of cases. 
Based on pnor models, we estimated that 20% of initial failures and all 
second-line treatment failures would be hospitalized. Analyses were done 
for SP and HI, and for CAP in general. Three 2-step strategies were 
considered arnoxycillin (AMX) followed by cefuroxime (CEF); AMX 
followed by clarithromycin (CLA); CLA followed by levofloxacin. We used 
1997 data for the UK where resistance is low but rising, and two countnes 
with high resistance, Spain and France. We considered three scenarios: 
actual resistance data in S? and HI; actual resistance data but ignoring cross- 
resistance; and no resistance. 
Results: Using actual resistance data, our model estimated that hospitaliza- 
tion rates for CAP ranged fiom 9.7 to 11.9% for Spain, 7.6-11.6% for 
France and 4.6-6.1% for the UK, but only 3.3-5.3% in the absence of 
resistance. In Spain, hospitalization for SP was four times as high as it would 
have been in the absence of resistance, and macrolide resistance of SP raised 
initial failure rates from 10.0% to 38.8%. For HI in Spain, hospitalization for 
AMX/CEF was 27.3%, mostly (23.0%) due to resistance, with almost half of 
the resistance effect due to cross-resistance. Resistance of HI caused 
hospitalization rates for AMX/CEF to increase from 2.2% to 13.5% in 
France, and &om 4.3% to 8.4% in the UK. 
Conclusion: Antibiotic resistance and cross-resistance may be having a major 
impact on hospitalization rates for CAP. Choice of initial and second-line 
therapies should be based on local resistance patterns. 
/p979 Clinical and aetiological profile of community-acquired 
pneumonia 
F. Caruntu, C. Picu, I .  Kebedea, G. Coltan, C. Marin 
Bucharest, RO 
Background Pneumonia continues to be a major health problem despite 
the availability of potent antinlicrobial drug.  Precise aetiological diagnosis is 
not always necessary, the treatment is empirically established on statistical 
criteria. 
Objective: To determine the frequency, aetiology, clinical features and 
treatment of community-acquired pneumonia. 
Method: Data are from 2065 medical patients older then 15 years, 
hospitalized in 01 January 1999-31 October 2000. The diagnosis was 
established by clinical presentation, laboratory findings and imaging 
(roentgenographic appearance, culture of ?puturn, bronchoscopy with 
bronchoalveolar lavage blood cultures, serologic test and C T  scan). 
Results: The pneumonia incidence is higher in the adult age group of 15-24 
years (19.6%) and 65-74 years (15.8%). Aetiology was viral in 49%, mixed 
in 26% and bacterial in 25%. The etiological agent was isolated and 
identified in 79 cases of bacterial pneumonia: Streptonocus in 49 cases, 
Sfaphylocorcus aureus 3 cases, Klebsiella pnelrmoniae 5 cases, E .  coli 5 cases, 
Mycoplasma pneumoiqiae 11 cases, Enterobacter 6 cases. There were about 818 
(39.61%) patients with comorbid conditions. The treatment was etiological 
and symptomatic. The most situation we used macrolide or p-lactardp- 
lactamase inhibitor combination as monotherapy. The evolution was good 
but 10 patients were transferred for surgery because of pulmonary abscess. 
Only 17 deaths occurred. 
Conclusions: The most cases of pneumonia occurs to patients with a 
predisposing illness: cirrhosis, alcohol abuse, diabetes mellitus, corticosteroid 
or immunosuppressive therapy, malignancy, smoking, preexisting lung 
disease. There is not any specific clinical, radiographic, or laboratory 
parameter for the aetiology. These parameters with a limited number of 
organisms commonly associated with each syndrome select the most likely 
organism involved. Because the assays require time, the antibiotic therapy is 
usually begun empirically. The viral pneumonia is more frequent then 
bacterial one. In bacterial pneumonia, the aetiological agent was identified 
in only 38 cases although the laboratory tests were constantly repeated in all 
patients. After treatment the evolution was favourable. Death is occurred 
only in inmunocompromised patients. 
Community-acquired pneumonia: epidemiology and 
clinical presentation in Greece 
E. Barbounakis, D. Kofieridis, M. Antoniou, A. Christidou, G. Margantinis, 
J. Papadakis, G. Vrentzos, G. Fanti, A. Gikas 
Hrraklion, GR 
Community acquired pneumonia (CAP) is one of the most common 
infections. Aim of our study was to define the epidemiology and the clinical 
presentation of CAP in hospitakzed patients in Greece. Medical records of 
141 patients (94 men (66.7%)] with CAP were studied. The median age was 
57 (range 17-96) years. The most fiequent clinical manifestations recorded 
were: fever in 132 (93.6%). cough in 102 (72.3%) and expectoration in 53 
(37.6%) patients. In 48 out of 141 (34%) patients the etiologic agent was 
identified by culture or serology. The responsible microorganism of the 
CAP was isolated in 33 out of 141 cases (23.4%). Twentyfour patients out 
of them (68.7%) had positive sputum culture and the remaining 9 (18.7%) 
had positive blood culture. The most frequently isolated microorganisms 
were: S. pnetrmaniue in 14 (42.4%), H. i@mmze in 7 (21.2%). S. aureus in 4 
(12.1%) and P. aertrginosa in 2 (6.1%) patients. Serological diagnosis was 
recorded in 15 out of 141 patients (10.6%). Between them 12 patients 
presented antibodies against C. bumetti, 2 Legioriella and 1 M. prteumoniae 
infection. Forty-six out of 141 patients (32.6%) had infiltrations in the right 
lower lobe, 38 (26.9%) in the left lower lobe, 21 (14.9%) in the right middle 
lobe, 13 (9.2%) in the right upper lobe and 7 (5%) in the left upper lobe. 
Finally, 16 out of them (11.3%) presented with multilobar or segmental 
opacifications. The most frequent prescribed antibiotics were cephalospor- 
iiies in 77 out of 141 patients, macrolides in 51, 0-lactams with lactamase 
inhibitor in 35 and aminoglycosides in 7 patients. The median duration until 
the day of defervencence was 3 (range: 1-10) days. Six out of 141 patients 
(4.2%) died due to or with pneumonia. 
Conclusion: Our study suggests that the most common cause of CAP is S .  
pwumottiae. C. bumetti infection was a frequent cause of CAP in our region. 
Most of the CAP remains undiagnosed. In spite of newer diagnostic tools 
treatment is in most of the cases empirically administered. 
Ip9811 Incidence, first line treatment and mortality of 
hospitalized patients with community-acquired pneumonia in 
northern Italy 
M.C. J. M. Sturkenboom, M. TineEi, M. C. Cerri, C.  Papetti, R. Ravasio, 
G. Picelli, F. Romano, A. Belloli, M. Stroili, S .  Mannino 
Rotterdam, NL; Lodi, Milan, Chieti, I 
Background: To better understand current prescribing practices as well as to 
estimate both the incidence of hospitalization for community acquired 
pneumonia (CAP) and any association between empirical ancimicrobial therapy 
and patient outcomes, we conducted a population-based retrospective cohort 
study in the Local Health Unit (ASL) of Lo&, a province in Northern Italy. 
Methods: We used computerized hospitalization claims data to identify all 
patients discharged with a diagnosis of CAP by the four hospitals within the 
ASL in 1999. The original medical records were abstracted to provide 
information on physical and clinical patient characteristics (including 
comorbidities), laboratory and microbiological tests, in-hospital treatment 
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with antibiotics. Severity scores for CAP were calculated according to the 
method by Fine e f  a/.  ' Deaths occurring within 30 days after discharge were 
identified using the ASL mortality file. 
Results: Of the 200 165 citizens registered with the NHS in the ASL of 
Lodi in 1999, 319 persons experienced at least one episode of CAP leading 
to hospitalization (1-year risk: 1.6/1000, 95%CI:1.4-1.8). Upon adnlission, 
30.196, 20.4%. 19.196, 26.3% and 4.1% ofpatients were classified as severity 
classes I-V, respectively; 19.1% of patients had already been treated with 
antibiotics, whtle 32.9% presented with no fever. Third-generation 
cephalosporins were the most frequent first-line treatment (47.9% alone 
and 8.5% in combination with macrolides), followed by wide spectrum p- 
lactam antibacterials (3.4%), macrolides (9.7%. mainly in children) and 
aminoglycosides (5.3%). Fluoroquinolones and carbapenems were infre- 
quently used as the initial therapy. The mortality rate during hospitalization 
or within 30 days after discharge was 8.2% (95% CI: 6.7-9.7%), and was 
increased upon higher severity class of CAP. 
Conclusion: The empirical therapy of CAP in hospitalized patients varied 
largely in our cohort, but was mostly represented by single use of 3rd 
generation cephalosporines. The average mortality rate withn 30 days after 
discharge was 8.2% and increased in patients with more severe disease as 
measured by the Fine class. 
Reference 
1. Fine MJ CI a / .  A prrdirrwn r d r  to idmufy lorn-risk patimts with rommumty riqwred 
pneumonid N Enpl J Alrd 1997, 336: 113-50. 
lp982) Early transition from parenteral to oral cephalosporins 
in treatment of hospitalised patients with CAP 
L. Zabaznoska, L. Ilieva, V. Markovski, D. Dokic, M. Ristevski, I 
Kikerkov 
Skopje, MAK 
Introduction: Parented application of antibiotics directly related with the 
improvement of the general condition, laboratory tests and pulmonary 
findings among panents with CAP, is an important factor for the duration of 
hospitalization. It was suggested that as soon as the patients show clinical 
improvement of the initially applicated Cephalosporins parenteral therapy, a 
switch to oral therapy protocol should be implemented. 
Aim: Evaluation of the efficiency of an early switch 6om parenteral to oral 
Cephalosporins among hospitalized patients with CAP. 
Methods: 124 patients with LRT, Rtg. confirmation of pulmonary 
infiltrate, accompanied with at least 3 symptoms indicating pneumonia 
(fever, fatigue, cough, leukocytosis, sputum production, etc.) were involved 
in this 5-year study. 67 of them were initially treated with i.v. 
Cephalosporins (Ceftriaxone, Cefotaxime, Ceftazidime), applicated once/ 
twice daily, in a recommended dosage. The resolution of fever, 
improvement of che general condition, as well as the improvement of 
leukocytosis, were 3 leading criteria for a switch therapy (implementing oral 
2nd/3rd gen. Cephalosporins), mostly after 24 h affebdty, approximately 
fifth or sixth day after hospital admission. 
Results: In all 67 patients there was no need of readmission for further i.v. 
therapy with Cephalosporins, although according to antibiogram data of the 
isolated microorganisms from sputum sample/Grani stain testings, in 17 of 
them Macrolides/Fluoroquinolones were supplemented. The duration of 
the hospital stay was from 7 to 15 days (approximately 10 days), when, 
besides the reSOlUhOn of fever, fatigue, blood count leukocytosis, we 
succeeded improving of the respiratory disorders and cough, as well as 
radiologlcal inflammatory lung process resolution. 
Conclusions: The length of hospital stay has become a critical factor in 
management of LRT inflammation from the point of threatening 
nosocomial infections, the expenses of hospital treatment, as well as the 
comfort of the patients. Compared to the length of hospitalization for 
treatment of LRT innammation when 3rd gen./i.v. Cephalosporins were 
admmistrated since the complete resolution of the inflammation (at least 10- 
14 days), the early switch to peroral therapy shows the same curative results, 
shortening of the hospital stay, with all the positive consequences, 
supplemented with the necessary control as for the out patients. 
lp9831 Bordetella bronchiseptica respiratory infection in two 
patients with chronic respiratory insufficiency 
L. Lerousseau, V. Blanc, H. Amrane, C.  Rotomondo, J. M. Chavaillon 
Antibes, F 
Bovdefella bvonchiseptiru is a Gram-negative coccobacillus, well-known in 
veterinary medicine as responsible for respiratory tract infections in 
mammals, but is very rarely involved in acute respiratory tract infections 
in humans. We report two cases of pulmonary infections in patients with 
severe obstructive chronic respiratory insufficiency (CRI). Patient 1, a 56- 
year-old HIV-positive man, with efficient antiviral tritherapy (viral load < 
40 copies/mL, CD4=255 cells/mm') was admitted for a bilateral 
pneumonia with hypoxia. B. bronchisepfica was isolated in large amounts 
from bronchoalveolar lavage (105 colonies forming unit/mL). Antibodies to 
aderiylate cyclase-hemolysin were detected in the patient sera. The patient 
was successfully treated by amoxicfin-ciprofloxacin. No clinical relapses 
occurred, the bacteria was not re-isolated from then on either. Patient 2, a 
66-year-old woman entered the hospital for acute bronchitis. Cultures of 
expectorations only yielded numerous colonies of B. bror&septitu, therefore 
considered as the causative agent. The patient thowed progressive 
improvement in chnical status, when treated with anioxicillin-clavulanate 
and ciprofloxacin. B. bronchiseptica is an uncommon pathogen in hunians. 
The few cases described in the literature involve respiratory tract and occur 
in immunocompromised hosts or in patients with underlying disease. Close 
contact with infected animals is rarely reported, and it was not in either of 
our two patients' cases. Only one of our two patients was mmunocom- 
promised, and no underlying disease was diagnosed in the second. To  our 
knowledge, no association with CRI was described. The virulence of the 
bacteria is due to its capacity to induce ciliostasis and impairment of the 
functions of alveolar macrophages. Expression of adenylate cyclase- 
hemolysine would be essential for the initiation of infection. Chronic 
bronchial mucosa alterations of CRI, in addition to the bacteria effects on 
pulmonary defences, may constitute an underlying condition for B. 
bronrhiseptica infection. The susceptibility to antibiotics of B. browclrisepplica 
is similar to that of nonfermentative Gram-negative bacilli. Fluoroquino- 
lones, aminoglycosides and antipseudomonal penicillins appear to be 
efficient. As suggested by some authors, B.  broftthiseptica may be considered 
as an opportunist pathogen in immunocompromised patients including 
HIV patients, and could as well, as attested by both our cases, complicate 
severe CRI. 
lp9841 Aetiological agents of infections in chronic obstructive 
pulmonary disease and their antimicrobial susceptibility 
V. Tomic, R. Erzen, E. Music 
Golnik, SLO 
Background: Chronic obstructive pulmonary disease (COPD) is a common 
disease in our country and has substantial associated morbidity and mortality, 
In about 50% of cases of acute exacerbations of COPD (AE COPD) we can 
identify a bacterial pathogen in lower airway secretions. Now it is widely 
accepted that  the majority of patients with AECOPD should receive 
antimicrobial treatment. In order to select the appropriate therapy we have 
to have a good knowledge of the antimicrobial resistance of the three most 
common bacterial respiratory pathogens. 
Material and methods: Strains of Streproroccur ptteunionioe, Huernopphilirs 
influenzae and Moruxella catanhalis were isolated from different respiratory 
specimens and blood cultures. Antimicrobial surceptibihty testing was 
performed by I s k  difision method according to NCCLS reconmien&- 
tions. Susceptibility of pneumococci to penicillin was detemiined by 
E-test method (Ab Biodisk, Solna, Sweden). We tested production of 
beta-lactamase with a nitrocefin disk (Cefinase disk, BD, Cockeysville, 
MD, USA). 
Results: During 1998 and 1999 we isolated 137 strains and 134 strains of S. 
pneumoniae with 77% and 78% of them susceptible to penicillin, respectively. 
I n  1998 we detected no S.  pneumoriiae strains highly resistant to penicillin 
but in 1999 we found 3 (2%)such strains. In the same 2-year period we 
detected 109 and 116 H .  ir!fluenzae strains and 50 and 61 M .  ratanhalis 
strains, respectively. Rate of beta-lactamase production in H. it!fluenzae 
isolated in 1999 (11%) was double the rate we detected in 1998 (S,S%). 
Percentage of beta-lactamase producing strains of M .  cdanhalii. was over 
80% in 1998 and 1999. 
Conclusion: In the past few years we have been observing constant rise of 
resistance rates in pneumococci and H. ir!flunirae in Slovenia and 
worldwide. Nevertheless these resistance rates vary considerably between 
countries and regions. Recommendations for antibiotic therapy must be 
based on local resistance data and we have to search for changing resistance 
patterns to be able to promptly modify national guidelines on antibiotic 
treatment. 
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jp985/ Development and characterization of monoclonal 
antibodies to human parainfluenza virus type 2 
T. R. Tsareva, A. A. Sominina, A. 0. Monaenkov, T. D. Smimova, M. V. 
Sverlova 
St-Peetenburg, R U S  
Objective: Human parainfluenza virus type 2 is a single-stranded negative- 
sense RNA virus belonging to the Rubulavirus genus of the Paramyxoviridae 
family in the order Moizoizegavirales. HPIV2 are important human pathogens 
that cause upper respiratory tract infections, especially in infants and young 
children. The purpose of this research was the creation of hybridomas 
producing anti-HPIV2 mAb and the development of rapid and factual 
diagnostic approaches of ELISA and IFA of HPIV2. 
Materials and methods: Two mAbs (PIV2-1/7 and PIV2-3/26) were 
prepared by fusing myeloma ceUs and spleen cells of SJL/J inice immunized 
with purified parainfluenza type 2 virus. The screening procedure of 
hybridoma clones was camed out using by ELISA. The ascite pools of mAbs 
were obtained by inoculating of hybridoma cells into abdominal cavity of 
F1 (SJL/J x Balb/c) mice with following collecting ascite fluids. 
Results: The PN2-117 and PIV2-3/26 mAbs were identified as antifusion 
surface glycoprotein. None of the mAbs inhibited viral infectivity through 
attachment inhibition or fusion inhibition of HPIV2. Antibody titres in 
hybridoma culture fluids were determined as 1/1000 for both mAbs, in 
ascite fluids - as 1/10(7) for PIV 2-1/7 and 1/10(6) for PIV2-3/26 in 
ELISA. PIV2-1/7 and PIV2-3/26 mAbs were the suitable reagent for 
preparation of antibody conjugates with HRP which was used in microplate 
ELISA for detection of HPIV2 in infected cell cultuies. Working dilutions 
of PIV2-1/7 and PIV2-3/26 mAbs in the ELISA were as 1/5000 and 1/ 
3000, respectively. The purified mAbs were used in a two-step IFA on cells 
infected with homologous and heterogeneous type of HPIVs. Both nAbs 
did uot cross-reactivity in indirect immunofluorescence test with parain- 
fluenza viruses of different types. Specific activity of PIV2-3/26 mAb 
characterized as bnlhant green granular fluorescence in cytoplasm of 
infected cells was higher than specific activity PIV2-1/7 mAb and was 
detected in dilution up to 1/400 (8 pg/mL). FITC-conjugates were 
prepared using PIV2-3/26 antibody and its specific activity were 
determined in dilution up to 1/128 (25 pg/mL). 
Conclusion: HPIV2 diagnosis is essential for control of the infection and 
management of memcal health surveillance system and requires sensitive 
and rapid diagnostic methods. The tests are specific for identification of the 
type 2 of human parainfluenza viruses and can be employing as diagnostic 
tool even in a mixed viral population. 
Current rapid and factual diagnostic tests for avian 
influenza - are we ready for the next flu outbreak? 
D. V. Volokhov, T. R. Tsareva 
Moscow, Sf. Petersburg, R U S  
Avian influenza viruses (AI) of 15 hemagglutinin subtypes and 9 
neuraminidase subtypes are known to circulate in birds and other animals, 
creating a reservoir of potential pandemic strains of influenza containing 
new combination of HA or NA genes. The introduction the strains in 
human populations caused development severe illnesses, that there were 
observed in 1957, 1968, 1997-98. The introduction and subsequent rapid 
spreading of novel subtypes of influenza containing avian-like HA and NA 
or internal genes within seronegative window of human and other animals 
are good known. The infection is a major cause of mortality of poultry and 
economic loss worldwide, thus the rapid verification of the subtype of field 
isolates have important pathological and epidemiological implications. At 
present, for detection of avian influenza viral antigens using standard tests 
such as virus isolation techniques in eggs or cell lines, agar gel 
immunodiffusion, immunofluorescent staining, inhibition of haemaggluti- 
nation, complement fixation, and neuraminidase enzyme activity tests. In 
addition to traditional antigen detection assays, the novel probe technology 
is establishing for rapid A1 diagnosis including different variants of ELISA 
employing a monospecific or a bispecitic monoclonal antibody to surface 
(HA) and/or internal (NP, M) proteins, and RT-PCR (multiplex, nested, 
TaqMan-PCR) assay for the detection and subtyping of influenza viruses. 
The influenza-specific RT-PCR can be combined with enzymatic-digested 
unique RFLP and SSCP analysis that specific for identification of the 
genotype of subtype viruses even in a mixed viral population. Our group 
has been developed new A1 nucleoprotein ELISA with a bispecific 
monoclonal antibody, reactive with both NP of A1 as a search antigen and 
HRP as an enzyme marker. The ELISA is a rapid, sensitive, and specific 
diagnostic method for screening large numbers of birds’ specimens. The 
sandwich ELISA was developed one of the monoclonal anti-NP antibodies 
was absorbed to the solid phase as the catcher and a bispecific anti-NP/anti- 
HRP antibody as the attestor detected viral antigen. With such ELISA, the 
relative level of NP could be conveniently estimated in different avian 
samples containing the viral protein in an experimental environment or in 
field conditions. The combination of new generations of ELISA and PCR 
technologies to accurate A1 diagnosis is essential for control of the infection 
and management of flu surveillance systems. 
Respiratory tract infections: Chlamydia, Mycoplasma & Legionella 
jp987; Incidence of Chlamydia pneumoniae in community- 
acquired pneumonia: seven year experience in Bari, South Italy 
R. Monno, G. Losito. D. De Vito, F. Coscia, G. Sibho, G. Rizzo 
Bari, I 
Chlamydia pneurnoniae (Cp) represents a new addition to the list of microbial 
pathogens involved in human respiratory tract infections. In addition, like 
other chlamydiae, it has a tendency to cause chronic infections such as 
obstructive lung diseases and atherosclerosis. During January 1993 to 
December 1999 we evaluated a total of 311 patients with pneumonia to 
assess the aetiological role of Cp by the microimmunofluorescence test 
(MIF) using formahized TWAR strain €rom Washington Kesearch 
Foundation, Seattle, USA. Acute Cp infection was found in 39 patients 
(12.5%). In 16 patients the diagnosis was based on the presence of IgG titre 
major or equal to 1 : 512, in three patients on the presence of IgM alone, in 
10 on the presence both of IgG and IgM and in the remaining on 4-fold rise 
in IgG titre between paired sera. Low level of IgG antibodies were found in 
another 126 patients that uot appeared for reexamination and the possibility 
that the diagnosis of current infection was missed may not be ruled out. Co- 
infection with Streprocoms prieurnoniae and Mpplasma prieurnoniae was found 
in three and one patient with pneumonia, respectively. Cross reaction with 
C. trahoniatis was detected in few patients whereas no cross reaction with C. 
psilfaari was found. In our experience pneumonia due to C.p. occurs in the 
cold months and in early spring with another peak in September-October. 
In addition, we have observed periods of increased incidence of one year’s 
duration and penods oflow incidence lasted 1-2 years, whereas the duration 
of epidemic infection reported by others was of 2-3 years duration and the 
periods of low incidence of 2-4 years. In C.p. positive patients laboratory 
features showed elevation of white blood cell count in the 40% and 
erythrocytes sedimentation rate was elevated in the 60%. Pharyngitis, fever 
and non productive cough were reported by the 40%, 90% and 45% of 
patients, respectively. Alveolar and interstitial opacities were found in the 
59% and 41% of the patients, respectively. Six patients received 
cephalosporin and, because of therapeutic failure and laboratory results, 
were treated successfully with clarithromycin. All the other patients were 
treated with erythromycin, clarithromycin, azithromycin or levofloxacin 
with a favourable course. 
lp9881 Chlamydia pneumoniae acute lower respiratory tract 
infection in adults 
I. Kondova, D. D. Dimitriev, T. G. Gradanovska, N.  P. Panovski, M. 
Filipce, L. I. Ilieva, C. N. Nastevska 
Skopje, MAK 
Chlamydia pneurnoniae has been recognized as a frequent cause of lower 
respiratory tract infections in adults. 
Aim: To detect the possible role of Chlamydia pneurnoniae as an aetiological 
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agent of the acute lower respiratory tract infections in adult patients with 
community acquired pneumonia (CAP). 
Material and method: There were examined 231 adult patients with CAP 
with middle age of x 45.44 years; 130 (56.28%) male and 101(43.72%) 
female. Chlamydia pneumortiae specific IgM, IgG, IgA antibody were 
detected with Sero CPtm (Savyon Diagnostics) - EIA test, Sero FIA tm 
(Savyon Diagnostics) - IF test and Immuno Comb Chlamydia Bivalent IgG 
(Orgenics, Israel) - EIA test. 
Results: Specific Chlamydia pneumoniae IgM antibody were detected in 
18(7,79%) patients, 9 male and 9 female, with middle age of 5 38 years. 
Four-fold rise of IgG and IgA antibody or single IgG titre > 512 and single 
IgA titre > 512 were detected in 14 (6.06%) patients, 10 male and 4 female, 
with middle age of 5 57.29 years. 
Conclusions: Chlamydia pneumoniae acute lower respiratory tract infection 
was detected in 32 (13.85%) patients with CAP, with middle age 5 46.44 
years, more frequently in male - 19 (59.37%) then in female - 13 (40.63%). 
/p9891 Comparison of two immunofluorescence tests for 
detecting antibodies to Chlamydia pneumoniae 
R. Monno, D.  De Vito, G. Sibiho, L. Marcuccio, G. Rizzo 
Ban’, I 
The serology represents the most commonly used method for diagnosis of 
Chlamydia pneumoniae (Cp) infection and available methods for clinical 
laboratories to detect antibodies to Cp include the enzyme immunoassay 
and the microimmunofluorescence test (MIF) considered to be the 
reference method. This study compares two commercially available MIF 
test: The MIF produced by the Washmgton Research Foundation that we 
as antigen formalinized, purified elementary bodm of TWAR strain AR39 
and the Serofia test using purified elementary bodies of C. pneumuniae (TW- 
183), C. trachomatis and C. psittaci. Serum samples (223 in toto) were 
obtained from patients with respiratory tract infections. Concordant 
negative results (antibody titre minor to 1 : 8)were 88 for IgG and 222 
for IgM. Concordant positive results (antibody titre major or equal to 1 : 8) 
were 135 for IgG and one for IgM. Minor variation in the numeric titre 
values was found in 8 sera, whereas extensive variation in the numeric titre 
value was found in 11 sera. In particular, in two patients the MIF titre was 1 
: 32 whereas the Serofia titre was 1 : 256; the MIF titre was 1 : 64 with a 
Serofia titre 1 : 256 in two patients and 1 : 512 in the other. In one patient 
the MIF titre was 1 : 128 and the Serofia was 1 : 1024. In three patients the 
MIF titre was 1 : 512 and the Serofia titre was 1 : 128 in two patients and 1 : 
256 in the other. In two cases the MIF titre was 1 : 1024 and the Serofia titre 
was 1 : 256. In our opinion these discrepancies may be due to several 
factors: (1) The Merent strain of Cp used as antigen by two tests; (2) The 
amount of antigen spotted on the slide; (3)The type of antibody response 
because it has suggested that may be type specific; (4)The concentration of 
conjugates; (5) The subjectivity of the immunofluorescence depending on 
the reader. Because single rather than acute and convalescent samples are 
received, the titre of the acute phase serum is often used for the diagnosis. 
Recently, a multicentric ctudy have demonstrated, with an extensive 
variation in the numeric titre value, that percentage agreement with the 
reference standard titres from the University of Washington was 80%. 
Further studies must be underway to determine the source of inter- 
laboratory or intralaboratory variation for diagnosis of Cp infections. 
wl Recent experience with psittacossis requiring 
hospitalization 
B. Rosbn, J. Carratala, N. Fernindez-Sabi., F. Llopis, A. Casanova, F 
Gudiol 
Barcelona, L’Hospitalet de Llobregat, E 
Background: CAP caused by C .  psittaci is thought to follow a benign course. 
Current information dealing with cases requiring hospitalization is limited. 
Objective: To review clinical features and outcomes of C. psittaci 
pneumonia requiring hospitalization. 
Methods: From February 1995 through September 2000, we have 
prospectively studied 1291 nonimmunosuppressed adults adrmtted to our 
institution for community-acquired pneumonia (CAP). Fourteen (1%) of 
them had a four-fold increase in Ig G titre for C. psittaci and no other 
pathogen was identified. These cases are compared with 295 cases of 
pneumococcal pneumonia. 
Results: There were 10 (71%) men and 4 women; mean age 58 years (29-76 
years). No cluster of cases was documented. Main reasons for hospitalization 
were acute respiratory failure (PaO? < 60 m a g )  7 pts; significant 
comorbidities 7 pts; multilobar pneumonia 4 pts; and older age (> 70 year) 
4 pts. Nine (64%) pts had more than one reason for admission. Clinical 
characteristics and comparison with pneuniococcal pneumonia are 
summarized in the table. Psittaccosis was suspected in 8 (57%) cases, seven 
of them reported contact with birds. The remaining 6 pts were diagnosed 
after serological results were available. Conversely, psittacosis was suspected 
only in two cases (4%) among the 50 pts with pneumococcal pneumonia 
who reported contact with birds. 
Conclusions: Psittacosis is currently an uncommon cause of CAP requiring 
hospitalization. The occurrence of an atypical pneumonia syndrome in pts 
with birds strongly suggests the diagnosis to clinicians. Even in severe cases 
the outcomes are favourable. 
Use of latex agglutination test for serological 
diagnosis of infections caused by Mycoplasma pneumoniae 
W. Rastawiclu, M. Jagielski, S. Kaluewski, R. Gierczyiiski 
Warsaw, PL 
In the diagnosis of M. pneumoniae infections, a number of serological tests 
have been applied, of which the complement fixation test (CFT), 
immunoelectroprecipitation test (IEPT) and lately ELISA are the most 
commonly used tests in Poland. The aim of this study was the evaluation of 
the usefulness of latex agglutination test prepared in our laboratory for 
serodiagnosis of M. przeumoniae infections. Total of 628 serum samples, 
including 543 obtained from patients with respiratory tract infections and 85 
obtained from blood donors were investigated. All samples were tested by 
complement fixation test and by latex reaction after 3, 10 and 20 nlin of 
mixing reagents. 274 samples were tested by immunoelectroprecipitation 
test (IEPT) and by ELISA for Ig A, Ig G and Ig M antibodies. Comparison 
of detectability rates for antimycoplasma IgM and IgG antibodies obtained 
with the latex test, CFT, IEPR and ELISA demonstrated high accordance of 
results. The highest sensitivity of the latex reaction in comparison with CFT 
(81.0%), LEPT (70.0%) and ELISA for Ig M (82.1%) and for Ig G (77.3%) 
was demonstrated after 20 nlin mixing. The highest specificity of the test 
was demonstrated as in comparison with CFT (89.0%), IEPT (87.6%) and 
ELISA for Ig M (89.6%). Positive latex test results in our investigations were 
associated only with the presence of Ig M antibodies and were not 
dependent on the Ig A and Ig G antibody classes. The results obtained in 
own investigations indicate that the developed latex reaction test, simple and 
fast, can be successfully used for preliminary, differential diagnostics of 
mycoplasmosis, especially when we deal with samples collected from 
patients at an early stage of the disease. The result of the latest test should be 
confirmed by a more sensitive and specific test, i.e. complement fixation test 
or immunoenzymatic ELISA test. 
vl Sequencing of 165 rRNA gene of Mycoplasma spp. 
detected by PCR in patients with low respiratory tract infections 
R. Cultrera, E. Angelici, A. Grilli, S. Seraceni, V. Monda, M. Magno, C. 
Contini 
Ferrara, Rome, I 
Objectives: DNA sequencing of mycoplasmas DNA has been rarely 
performed. The polymerase chain reaction (PCR) that employs 16s rRNA 
gene target, has been widely applied to detection of a number of 
mycoplasmas in human specimens. The algnment of 16s rRNA genus- 
specific sequence with the corresponding 16s rRNA gene of several 
prokaryotes revealed the existence of highly conserved regions and regions 
which displayed sequence variabhty. In order to define the specificity of 
PCR assay to identify Mycoplasma DNA in human samples, we analysed 
sequences of amplified products resulted PCR-positive for M .  pirunt from 
sera of 18 patients with low respiratory tract infections alone or 
complicating other diseases. 
Methods: Oligonucleotide probes labelled with fluorescein were used in a 
Southern blot analysis to confirm amplifications products. The 579 bp 
amplified fragments obtained by M.  pirum species-specific primer (PIK: 
GTCCGTTTGGACCGCTATAG 203-222) and genus-specific primer 
(UN-: TAATCCTGTTTGCTCCCCAC 782-764). were analysed by 
cycle sequencing (Ampli-Cycle Sequencing Kit, Per!& Elmer). PCR 
products were purified from amplification reaction mixture by specific 
binding of amplified DNA to surface of glass fibre filter in polypropylene 
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tubes and precipitated with ethanol 70% (High Pure PCR Product 
Purification Kit, Roche Diagnostic). For each sample, cycle sequencing was 
performed by adding to 2 p1 of each of the A, T, G, and C temiination 
mixes, 6 pl of 30 pl of the reaction mixture contaming 18.5 gC [alfa-35S]- 
dATP ( R e d i v d M ,  Amersham Pharmacia Biotech, UK), 20 pmol of PIR 
primer. 5 ng of PCR product, 4 p1 of cycling buffer. PCR temGnation 
cycling conditions were performed according to manufacturer. 
Results: No differences were found between sequences of PCR-products of 
samples and sequence of positive control M .  pirum strain 70-159 (ATCC 
25960). We observed a greater efficiency of primer PIR than genus-specific 
UNI-. The alignment of sequence of M .  pimm 16s rRNA gene product 
with M .  pneumoriiae, M .  genitalium, M.  horninis, M. &wwnfans, M.  perietraris, 
and U. urealyticirrii corresponding 16s rRNA sequeuce confirmed 
divergences of variable region. PIR primer is only represented in DNA 
of M .  pirum 
Conclusions: M.  pirum has been rarely found in nonimniunocompetent 
persons only. PIR oligonucleotide is able to detect and distinguish M .  pirum 
DNA in human specimens from other human mycoplasmas. Further analysis 
of sequence of amplification products could evidence possible differences at 
nucleotide level, thus revealing different strains of M .  pirum. 
11>9931 Recovery of Mycoplama pirum DNA in blood 
specimens from immunocompetent patients with respiratory 
diseases 
C. Contini, R. Cultrera, S. Seraceni, G. L. Pavoni, M. Bergamnini, K. 
Romani, E. Angelici, M.  S. Magno 
Fewara, Rome, I 
Objective: The purpose of this study was to perfornt a comparative 
evaluation between serology and PCR in order to determinate the 
occurrence and the frequency of infections caused by niycoplasmas from 
patients with respiratory diseases. 
Methods: A total of 25 serum samples were analysed. 
Patients: (age ranging 2-73) were recruited from Departments of Clinical 
Medicine, Haematology and Paediatric clinic of University of Rome ‘La 
Sapienza’. Patients presented with various respiratory disorders and 
radiographic abnormalities and most of them had no final diagnosis. All 
samples previously examined by immunofluorescence (VirceH, S.L 
Mycoplasnra ptieuntorriae-lgM Bio Line) were screened by PCR for DNA 
Mycoplasma genus (MGSO/GPOl) and species followed by Southern blot. 
Each sample resulted MGSO/GPOl +, was analysed with a panel of 
primers for Mycoplarim human species. The specificity of PCR assay was 
continned by Southern-blot. 
Results: M p p / a s m a  serology and Mycoplasmu genus specific PCR were 
positive in 15 and 19 cases, recpectively. Both methods agreed positively or 
negatively in 10 and 1 samples, respectively, but disagreed in 15 samples. 
Among the PCK + specimens, 9 (47%) resulted positive for Mycoplusma 
pinrnr species and 5 of these agreed with serology. No other Myroplarma 
species were found. 
Conclusions: The detection of M.  pirtrm DNA is a unusual finding which 
deserves great interest. To date, its occurrence has been rarely described in 
HIV-infected persons as a possible infectious cofactor in the progression of 
AIDS. This only species detected in high rates by PCR in noninvasive 
Fpecimens such as serum, suggests the utility of this method as interesting 
diagnostic approach in defining of uncertain Myqdasma spp. aetiology in 
absence of other criteria or when they are misidentified by other methods. 
The epidemiology and clinical features of community 
acquired Legionella pneumonia in hospitalized patients older 
than 60 years 
D. Miron, G. Viar, M. Zuker, G. Ben-Dror 
Gkd, IL 
Background: Risk factors associated with LP are highly prevalent in patients 
who are older than 60 years. The aims of this study were to assess the 
incidence, the epidemiology and the clinical features of LP in such patients 
admtted to hospital with community-acquired pneumonia. 
Study design: The study was conducted during the year between 1 June 
1999 and 31 May 2000 and included all patients older than 60 years old who 
had been hospitalized with community-acquired pneumonia. Diagnosis of 
LP was nude by the Urine Antigen Test (which identifies Legionella 
pneumophila type 1 and 14 other legionelia antigens). From each patient data 
was obtained regarding risk factors, clinical presentation and complication of 
the disease. T h s  data was compared on a 1 : 2 ratio to sirmlar data obtained 
from patients with non-legionella pneumonia matched by age, sex and week 
of admission. 
Results: During the study period 8/202 (4%) of patients that were 
hospitalized with community-acquired suffered from LP. 6/8 (75) of them 
were admitted between June-September. Significant clinical findmgs in 
patients with LP as compared to patients with non-legionella pneumonia, 
respectively, were: severity score (86 + 58 vs.s 4 7 5  + 34, P < 0.02), 
history of smoking (in 75% vs. 54% P < 0.05), mental status alteration (in 
62.5% vs. 6.2%, P < 0.01), respiration rate on admission > 30/minute (in 
50% vs. 6.2%, P < 0.01), arterial blood PH on admission < 7.35 (in 62% 
vs. 6.2%, P < 0.01), arterial blood POz on admission < 60 mmHg (in 75% 
vs. 20%), mechanical ventilation (of 50% vs. 6.2% P < 0.01). All patients 
with LP were treated with macrolides, however, the death rate was 50% as 
compared to 0% in the control group ( P  < 0.001). 
Conclusions: The incidence of community-acquired LP in hospitalized 
patients older than 60 years in our study was low. The disease occurred 
mostly during the summer and fall. Patients with LP had unique clinical 
features and the death rate was high inspite of appropriate antimicrobial 
therapy. 
vl Improved laboratory diagnosis of Legionella 
pneumophila using NASBA with ‘real-time‘ detection 
M. leven, K. Loens, P. Sillekens, M. Overdijk, H. Goossens 
Wilrijk, B; Boxtel, A’L 
Objective: Development of an improved molecular diagnostic assay for the 
detection of Legionelfa species using the NASBA aniplification technology in 
combination with ’real-time’ detection. 
Methods: Guanidine thiocyanate/silica-based extraction, NASBA-based 
amplification, and semiautomated electrochenliluminescence (ECL)-based 
detection employing a biotydated probe for the specific capture of 
generated aniplicons were used. For ‘real-time’ detection, a molecular 
beacon was used. 
Results: The original assay consisted of amplification and subsequent ‘end- 
point’ detection by ECL. Sensitivity waq about 10-50 molecules of if1 vitro 
generated RNA and about 0.1-1 .O CFU for cultured serotypes of Legionella 
pneurtrophila. Specificity of the assay was demonstrated by a positive test 
result for 6 Lecqioflella prieumophila strains, whereas 26 other bacterial species 
tested negative. Subsequently, the assay fomiat was simplified by 
incorporating a molecular beacon for ‘real-time’ detection. The sensitivity 
of the assay was not influenced despite the presence of the nlolecular beacon 
during the amplification process. The specificity of the assay did not change 
either, as could be expected since the molecular beacon was derived from 
the capture probe for ECL detection. 
Conclusions: A molecular assay for the detection of Legionella pneumophila 
could be modemised by making use of a molecular beacon for the 
detection. Combined amphfication and detection did not compromise the 
sensitivity and specificity of the assay. 
18996 Evaluation of a new ELISA Legionella urinary antigen 
for detection of Legionella antigen in urine samples 
J. Dominguez, S. Blanco, N. Gali, P. Pedroso, C.  Prat, L. Matas, V. Ausina 
Badalona, E 
The aim of the present study was to evaluate the Bartels ELISA Legionella 
Urinary Antigen (Intracel). We assessed the utility of the Bartels EIA for 
detecting L.yrtenmophila s.1, antigen in nonconcentrated urine (NCU) and 
concentrated urine (CU) samples. 
Materials and methods: Group 1: we studied 42 urine samples from 
patients with pneumonia caused by L. pneumophila. Legionnaires’ disease 
was diagnosed by isolating L. pneumophila from respiratory specimens and by 
seroconversion. The second group consisted of 47 urine samples from 
patients diagnosed exclusively by detection of soluble antigen from L. 
prwumophila s. 1. in C U  by Binax EIA. The third group contained 49 urine 
samples from patients with pneumonia of other aetiologies. The fourth 
group consisted of 73 urine samples from patients with no clinical or 
radiological signs of pneumonia. 
Results: Using Bartels ELISA, soluble antigen was detected in 34/42 
(80.95%) N C U  &om group 1, and in 32/47 (68.08%) NCU from group 2. 
Using Binax EIA, antigen was detected in 27/42 (64.28%) and in 19/47 
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(40.42%) NCU samples from groups 1 and 2, respechvely. The overall 
sensitivity ofBartels ELISA was 74.15%) (66/89) and the overall sensitivity of 
Binax EIA was 51.68% (46/89). Specificity for both EIA tests was 100% in 
NCU. The sensitivities for C U  samples were 72.22% (13/18) in group 1 
and 100% (41 /41) in group 2 by Bartels ELISA and Binax EIA, respectively. 
Specificity for both EIA tests was also 100% using concentrated samples. 
The ratios of saniples Lrom patients with diagnosis of legionellosis (group 1 
and 2) obtained by Bartels ELISA in NCU and C U  were significantly 
higher (P < 0.0001) than the ratios obtained by Binax EIA. 
Conclusions: (1) Banel? ELISA is a rapid, sensitive and Fpecific diagnostic 
test to diagnose legionellosis. (2) The sensitivity of Bartels ELISA is 
significantly higher than Binax EIA when NCU samples are used. (3) The 
concentration of antigen present in urine increases significantly the 
sensitivity. 
vl Detection of Legionella nonserogroup 1 antigen in 
urine with urinary antigen EIA test kits 
J. Horn 
Dreieick, D 
The dominant anhgenic compound of kgionella piteumopkila which is 
recogmsed by Urinary Antigen Kits is very heterogenic. Urine from 35 
Non-Serogroup 1 Infections Lroni patients suspected of Legionella infections 
were evaluated with the Biotest and Binax urinary Antigen tests. The 
sensitivities for Non-Serogroup 1 infections were found to be 60% for 
Biotest and 28.5% for Binax. By examination of standardised soluble 
Antigen preparations from ultrasonicated bacterial cell suspensions of known 
concentration the reactivity ofBiotest Urinary Antigen EIA could be shown 
with all serogroups as well as different species although with variable 
detection limits of the different serogroups and species. The Biotest Urinary 
Antigen EIA demonstrates a considerably broader crossreactivity with the 
Non-Serogroup 1 Legionella Antigens while still having the same sensitivity 
for Serogroup 1 Isolates as the Binax EIA. 
lp9981 Different serologic methods in the diagnostics of 
legionnaires’ disease 
0. Rode Uakovic, 1. Kuznian, V. Drazenovic, I. Puljiz 
Zagreb, H R  
Objectives: To evaluate the possibilities of different serological methods in 
the diagnosis of legionnaires’ disease (LD). 
Methods: A total of 353 sera from 299 patients were tested for Legionella 
prteumophila serogoup (LP SG) 1-7 by enzyme linked immunosorbent assay 
(ELISA) at the Laboratory for Serology of the University Hospital for 
Infectious Diseases ‘Dr Fran Mihaljevic’, Zagreb, Croatia, in the period 
from October 1, 1999 tdl October 1, 2000. Of these, 145 were also tested 
for LP-SG 1-7 and Legionella micdudei by using the indirect fluorescent 
antibody (IFA) test. Soluble urinary antigen LP SG 1 was detemiined in 255 
urine samples. In patients with proved LD, first serum and urine samples 
were collected at the beginning of hospitalization (3-1 8 day of illness), and 
paired sera after 9-25 days (median 10 days). LD was diagnosed according to 
the following criteria: (I) positive Legionella urinary antigen, (2) antibody 
seroconversion, (3) IFA titre hgher or equal to 256 with clinical symptoms 
present. Serum samples were at the same time tested for C. pneuinoniae (CP), 
M.  pneumoniae (MP), C. bumetii. 
Results: LD was diagnosed in 33 (11,0%) patients, 24 males and 9 females. 
LD cases occurred sporadlcally. Coinfection was proved in 6 patients (in 3 
with CP, in 2 with MP, in 1 concurrently with CP and MP). Legionella 
urinary antigen (LP UAg) was positive in 46.2% of urine samples in patients 
with LD (ratio value 3.3-9.6, positive > /=3.0) .  In 4 (15.4%) urine 
samples in patients with subsequently proved positive seroconversion, ratio 
value was 2.6-2.9, while in 38.5% LP UAg was negative. Seroconversion of 
IgM and/or IgG by ELISA method was confirmed in 16 patients. 
Seroconversion or significant increase of antibody titre was detemned by 
IFA method in 12 cases. Significant IFA titre > / = 256 was detected in 13 
acute serum samples. Significant IgM and/or IgG titre (more than double 
cut-off point) in acute serum was detected in 6 patients. The sensitivity of 
ELISA IgM compared with IFA was 25.5%, while the specificity was much 
higher 98.8%. The sensitivity of ELISA IgG compared also w t h  IFA was 
41.296, and specificity was 95.9%. 
Conclusion: Since serological response is various not a single method can 
detect all cases of LD. LD can be diagnosed more promptly and more 
accurately o d y  by using a combination of Merent  methods, by 
determining urinary antigen, by immediately testing acute, and later on 
paired sera. 
Clinical efficacy of azithromycin in the treatment of 
community-acquired legionnaires’ disease: a review of 74 cases 
1. Kuzman, I. Puljiz, 0. Rode Dakovic, V. Drazenovic, K .  Oreskovic, J. 
Vukovic, J. Culig 
Zagreb, HR 
Objective: Til now, erythromycin has been recommended as a rational 
treatment of legionnaires’ disease (LD). Controlled studies of treatment with 
new macrolides are underway. The aim of this clinical, retrospective and 
noncomparative study was to evaluate the eficacy and tolerability of oral 
azithromycin in the treatment of community-acquired pneumonia (CAP) 
caused by Legionella pneumophila. 
Patients and methods: A total of 115 patients with clinically and 
radiologically documented CAP, confirmed for LD, were hospitalized in 
our hospital during the last 10 years. The LD was confimied serologically 
(IFT or ELISA-test) and/or by specific Lefioriella antigen in  urine (EIA). 
Out of them, 74 (64%) were treated with azithromycin, given orally in a 
total dose of 1.5 g. Eleven patients (at the beginning of the period) received 
azithromycin over 5 days (500 nig once daily at day 1, and 250 mg at days 
2-5), 54 over 3 days (500 nig once daily), and 9 as a single i .5 g dose. Cure 
was defined as a resolution of fever within 96 h after treatment initiation 
with improvement of other clinical sings and symptoms of pneumonia. 
Results: All patients, except one, treated with azithromycin were cured, and 
there were no complications or relapses of illness. Majority of them, 48 
(65%) patients became afebrile within 48 h, 13 (18%) within 72, and 12 
(16%) within 76 h after initiation of the treatment. Only one patient was 
febrile over 96 h, and remained febrile for six days. There were no 
differences in efficacy or tolerability between 5-day, standard 3-day and a 
single 1.5 g dosage regimens. Azithromycin was very well tolerated and 
there were no clinically registered side-effects. Transient mild elevation of 
liver enzymes occurred in 13 (18%). and eosinophilia in 3 (4%) patients. 
Conclusion: Our clinical results indicate that azithromycin, given orally in a 
total dose of 1.5 g, is Clinically very effective and well tolerated in the 
treatment of mild to moderately severe community acquired pneumonia 
caused by LP. 
lploool Virulence of epidemiologically related clinical and 
environmental isolates of Legionella pneumophila serogroup 1 
M. Garcia, M. L. Pedro-Botet, N. Sopena, E. Reynaga, C. Rey-Joly, 
M. Sabrii 
Badalana, E 
Legionella microorganisms are part of the flora of aquatic ecosystems, where 
they are able to rnult~ply extracellularly. We previously deiuonstrated 
different degrees of virulence of 25 environmentai isolates from 17 (CAPS) 
catalonian hospitals. Some authors suggest that the intracellular growing in  
pulmonary macrophages of humans may be due to the expression of some 
virulent traits. The aim of this study was to compare the virulence of clinical 
and environmental isolates of Legiortella ptieumaphila sgl from the same 
hospital epidermologically linked. Fourteen isolates of Legioiiella yttptrmophila 
sgl (7 clinical and 7 environmental strains), belonging to the same hospital, 
were screened for virulence in a U937 macrophage-like cell model. The 
monolayers were stained with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl- 
tetrazoliuiii bromide (MTT) dye and their viability was determined 
measuring the optical density at 590 nm in order to quantify cell killing 
by Legionella pneutnophila. The clinical and environmental isolates were 
genotypically identical by Sfi-I pulsed field gel electrophoresis. Kesults were 
analysed by Scheffe Test. The mean log 10 ID50 of all the strains was 
6.35 + 0.74 CFU/mL. No statistically significant differences were observed 
in the ID50s between clinical and environmental isolates (6.72 f 0.57 
CFU/mL vs. 5.09 f 0.74 CFU/mL). Furthermore, no statistically 
significant differences were observed in the ID50s values among either 
the clinical or environmental strains. In conclusion, epidemiologically 
related isolates of Legionella pneumophila sgl express the same degree of 
virulence regardless of their clinical or environmental origin. 
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vl A comparative study of the efficacy and tolerability 
of 3-day once-daily azithromycin with 10-day twicedaily 
clarithromycin in out-patients with lower respiratory tract 
infections primarily due to atypical pathogens 
A. Arguedas, S. Fisher, G. Treadway 
Salt Jose, CR; N e w  York, USA 
Objective: A niulticentre, randomized, open-label study comparing the 
efficacy and tolerability of A with those of C in outpatients with 
community-acquired LRTI primarily due to Myroplasma pneumoniae, 
Chlamydia pneumoniae, or Legionella pneumophilia. 
Methods: Patients (ti = 266) (age range 8-65 years) &om Germany and Latin 
America were randonlized to receive either A or C. Dosing of A paediahics: 
(oral suspension) 10 mg/kg 4 2 4  h for three days, adults (includes any child of 
weight > 45 kg): 50(1 mg tablet 424  h for 3 days. Dosing of C: paediahics: (oral 
suspension) 8-9 years, 187.5 mg Q12 b; 1C-12 years, 250 mg 4 1 2  h for 10 days, 
ad& (includes any children over 12 years of age): 250 mg tablet Q12 h for 10 
days. LRTl was diagnosed by the assessment of signs and symptoms of lnfecnon 
at the baseline visit and blood was drawn for serology. At follow-up assessments 
(end of therapy POT] Days 10-22, and end of study @OS] Days 39-57) further 
blood samples were drawn for serology. 
Central nervous system infections 
Results: Between treatment groups, demographics were not statistically 
significantly different. There were no statistically significant differences 
among the treatment groups in any clinical response category at either 
follow-up visit. Of266 patients randomized, 134 A and 128 C patients were 
evaluated for tolerability, 127 A and 116 C evaluated for efficacy at EOT 
and 123 A and 105 C at EOS. Serology results showed the percentage of 
patients infected with M .  pneumoniae, C. pneumoniae and L. pneumophilia 
were A: 4.1?6, 4.9%, 4.1% and C: 5.7%, 12.4% and 3.8%, respectively. The 
proportion of patients with a satisfactory clinical response (cure or 
improvement) in the efficacy evaluable analysis was simdar (EOT, A: 
1241127 [97.6%] C: 112/116 [97.4%] EOS, A: 119/123 [96.7%] C: 98/105 
[93.3%]). A lower proportion of patients treated with A reported treatment- 
related adverse events (AE) compared with C; A: 6/134 (4.5%) vs. C: 12/ 
128 (9.4%). Treatment-related gastrointestinal AEs were also lower in those 
treated with A: A: 6/134 (4.5%) vs. C: 11/128 (8.6%). No treated patients 
discontinued therapy due to an AE. 
Conclusion: .?-day once-daily dosing with azithromycin is as effective and 
tolerable as 10-day twice-daily dosing with clarithromycin in the treatment 
of LRTI primarily due to atypical pathogens. Acknowledgement: We 
should like to thank the investigators that formed the STUDY team for 
their help and support with this work. 
v1 Streptococcus pneumoniae meningitis in adults. A 
review of 53 patients 
H. Akalin, C. Ozakin, Y. Heper, E. Yilmaz, F. Erbay, S. Helvaci, 0. Tore 
Bursa, TR 
In this study, we evaluated prognostic factors on admission in adult 
Streptococcus pneumoniae meningitis. We reviewed the charts of the 53 
patients older than 16 years of age in whom S. pneumoniae meningitis was 
diagnosed at Uludaz University Hospital from January 1985 to October 
2000. The correlation between mortality and altered mental status, cranial 
nerve palsy, major motor deficit, positive cerebrospinal fluid Gram stain was 
examined by logistic regression analysis. Patient characteristics, clinical 
features and clinical outcome are shown in Table 1. 
Table 1. Pattent charactcrrsticr. clinrcal features and rhmcal Outcame In S pncumoniae 
meningitis CBSOS 
Age(medrum;tSE. range) 40+2 6(16-87) 
SCX "(V") 
Cllnlcal fcaturcr n(%) 
Female 22(42%) 
Malt 31(58%) 
Fever 40(75%) 
Headache 42(79%) 
Altered mental Status 36(67%) 
Vomiting 42(72%) 
SeU7"r.S 5(9 4%) 
Nuchal rigidity 5 1 M 9 6 )  
Major motor deficit 5(9 4%) 
Cranial nerve palry 8( 15%) 
Cllnlcal outcome n(%) 
Survwcd(without ncurologic deficit) 35(66%) 
Survwed(with ncurologic deficit) 5(9 5%) 
Mortality 13(24 5%) 
The correlation between mortality and altered mental status, major motor 
deficit was found statistically significant (Table 2). 
Table 2. Ths correlation between mortality and altered mental Status , map' motor deficit In 
S pneumoniae menrngitir 
Altered mental stat"$ Mortality OX(95WUI) P Value 
Yes 36 13 
No 17 0 1 565(1 224-2 001) 0 01 
YE 7 4  
No 46 9 5481(1 037.28967) 0 053 
Cranml nerve palsy 
Major mctor deficit 
Yes 5 4  17 333(1724-174 285) o n i  
No 48 9 
Positive cerebrospinal 
flurd Cram Stain Yes 46 12 
No 7 1  2 I I ( O  231.19437) >n 05 
In conclusion, the mortality rate for adults who have S. pneumoniae 
meningitis remains 20-30% despite antimicrobial therapy. Prognostic factors 
such as altered mental status and major motor deficit which was found in 
our study may assist to define eligible patients for adjunctive therapies. 
v[ Analysis of Streptococcus pneumoniae isolates 
causing meningitis in Poland 
A. Skoczynska, A. Klarowicz, W. Hryniewicz 
Warsaw, PL 
Objective: To characterise Streptororcus pneumoiiiae isolates responsible for 
meningitis in Poland. 
Methods: The study was performed on all S. pneumoniae isolates collected 
between 1997 and 1998 in the National Reference Centre for Bacterial 
Meningitis (NRCBM). AU the strains were identified based on typical 
morphology, Gram stain, susceptibility to optochin and bile solubility. 
Serotypes of S. pneumoniae were determined by the QueUung reaction at the 
Statens Serum Institut, Copenhagen, Denmark. The relatedness among 
isolates was evaluated by restriction fragment length polymorphism (RFLP) 
of SmaI-digested chromosomal DNA following PFGE. 
Results: Foq-six S. pneumottiae isolated from CSF were collected in the 
NRCBM. More than half of them were derived from patients with 
meningitis aged over 20 years, with the highest number of cases from 
individuals between 25 and 44 years of the age. Twenty-three serotypes and 
one rough strain were found among pneumococcal isolates. The most 
common were serotypes 3 (13%), 8 and 22F (8.7% each). Penicillin 
nonsusceptible isolates constituted 13.0% of all pneurnococcal isolates. 
PFGE analysis revealed 35 different patterns among all tested isolates. The 
most common was pattern A (with 2 subtypes), represented by all 6 isolates 
of serotype 3. In three cases the identical PFGE patterns for isolates 
representing different serotypes were found. 
Conclusions: The great heterogeneity of Polish pneumococci was found what 
was reflected by the broad dismbution of serotypes and also by the PFGE 
patterns. However isolates of serotype 3, which ic the most common serotype 
responsible for meningitis in our country, had identical/similar patterns 
indicating the possibility of clonal spread of this particular serotype. On the 
other hand, identical PFGE patterns, found for isolates representing different 
serotypes, may indicate that capsule switching could have taken place. 
vl Spontaneous Gram-negative bacillary meningitis in 
adults 
P. Domingo, M. Gurgui, R. Pericas, G. Vazquez 
Barcelona, E 
Background: Spontaneous gram-negative bacillary meningitis (GNBM) in 
adults is uncommon and usually occur in patients with severe underlying 
conditions. 
Patients and methods: Twenty-eight patients with spontaneous GNBM 
were diagnosed at our hospital from 1982 to 1998. Criteria for diagnosis 
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included clinical characteristics consistent with the diagnosis, a cyto- 
biochemical CSF profile of purulent meningitis together with isolation and 
identification of a pathogenic Gram-negative baclllus kom the CSF culture. 
Patients were excluded if there were a prior neurosurgical procedure. 
Statistical analyses were performed with the StatView statistical package for 
Macintosh. 
Results: There were 15 men (51.7%) and 14 women (48.3%) with a mean 
age of65.2 f 14.3 years (range: 19-88 years). Fourteen patients (50%) were 
older than 65 years. Twenty-one patients (75%) had underlying diseases 
predisposing them for acquiring GNBM. The most frequent were: 
malignancies (4). hepatic cirrhosis (4), and diabetes mellitus (4). Twenty- 
three patients (82.1%) had a primary extrameningeal focus of infection, the 
most fiequent being urinary tract infections (13). Al but 5 patients (82.3%) 
had an abnormal consciousness level on admission, 10 (35.7%) had focal 
neurological signs, and 4 (14.3%) had had seizures. Only a patient had 
cutaneous lesions. The mean interval from the beginning of clinical 
symptoms to diagnosis was 76.7 f 57.7 h. Mean CSF values were 4.6 k 4.7 
g/L for proteins. 25 f 0.27 for CSF/serum glucose ratio, and 2727 k 3675 
cells/cu mm. The CSF Gram-stained smear disclosed Gram-negative bacili 
in 14 patients, and blood culture was positive in 24 patients (85.7%). The 
most kequent causative agents were Escherichia colr (14 patients), Pseudomonas 
sp. (3), Pseudomonas aeruginosa (2), Klebsiella sp. (2), Proteus mirabilis (2), 
Serrutia sp. (2), Citrobacterfreundii (l), Enterobacter cloacae ( l ) ,  and Bacteroides 
melaninogenicus (1). Thirteen patients (46.4%) developed neurological 
complications whereas 16 (57.1%) developed extraneurologic ones. Twenty 
patients (71.4%) received an adequate empiric antibiotic therapy. Sixteen 
patients died for an overall case-fatality rate of 57.1%. 
Conclusion: GNBM occurs predominantly in patients with severe under- 
lying conditions or elderly patients. Escherichia cooli is the most frequent 
etiologic agent. GNBM frequently is accompamed by bacteraemia, an bad 
prognosis in terms of survival. 
vl Treatment of multidrug-resistant Acinetobacter 
baumannii meningitis with intravenous colistin. Serum and CSF 
levels of colistin 
M. E. JimPnez-Mejias, C. Pichardo, F. J. Mkquez-Rivas, B. Becerril, D. 
Martin-Lozano, J. Palomino, J. Pach6n 
Seville, E 
Acinetobacter baumanni may be resistant to a wide variety of antimicrobial, 
including sulbactam and carbapenems. Colistin is the only therapeutic 
option in these cases. Until now CSF phannacokinetic of colistin has not 
been studied. 
Objective: To describe two cases of meningihs caused by A .  baumnnnii 
susceptible only to colistin, and treated with intravenous colistin. Serum and 
CSF levels and pharmacokinetics of colistin were determined. 
Methods: On 4th day of treatment, serum and CSF levels of colistin were 
studied 1 h after of i.v. colistin (Case 1); and basal, 0.5,1,2,3,4,5 and 6 h 
(Case 2). They were determined by broth-dilution assay using E. coli ATCC 
25922 (NCCLS). The MIC of colistin were determined by microdilution 
using Muller-Hinton I1 Broth Cation-Adjusted. Escherichia coli ATCC 
25922 was used as mcroorganism. 
Case 1: A 55-year-old female underwent a craniectomy to resect a relapse of 
meningioma. O n  the 30th day she showed hydrocephalus, surgical site 
infection, frontal epidural and brain abscesses caused by Sfaphylococcus uureus. 
Cloxacillin treatment was established, excision of abscesses performed, and a 
external CSF shunt placement. O n  the 50th day she presented fever and 
coma. CSF showed pleocytosis (8100 cells/pL), proteins of 522 mg/& and 
glucose of 5 mg/dL. A. baumani?ii susceptible only to colistin (MIC 1 mg/L) 
was irolated. Treatment with i.v. colistin 1 000 000 U1 q6 h during 15 days 
was instaured, and she cured. The levels in CSF and serum were 1.25 mg/L 
and 5 mg/L. 
Case 2 A 14-year-old male suffered cranial trauma. On the 40th day a W- 
shunt was placed. On the 42th day he showed fever, lethargy, abdominal 
pain and meningismus. CSF showed 5580 cells/pL, proteins of 456 mg/dL, 
glucose of 0.00 mg/dL. A .  baumannii susceptible only to colistin (MIC 0.3 
mg/L) was isolated. He was treated with i.v. colistin 1.000.000 UI q6 h 
during 30 days and cured. The serum levels (mg/dL) were: 1.25 (basal), 5 
(0.5 h), 5 (1 h), 5 (3 h) and 1.25 (6 h). The CSF levels (nig/dL) were: 
0.3125 (basal), 0.625 (0.5 h), 1.25 (1 h), 0.625 (2 h), 0.625 (3 h), 0.625 (4 h), 
0.3125 (5 h) and 0.3125 (6 h). 
Conclusions: Colistin penetrates in CSF (25% of serum level) and may show 
bactericidal activity in CSF. The clinical and bacteriological response after 
i.v. colistin was favourable in the two patients, without adverse effects. 
These results demonstrate that i.v. colistin may be a good therapeutic option 
for treatment of meningitis caused by multidrug-resistant A .  bau~nannii. 
Sepsis and meningitis caused by Listeria 
monocytogenes: 10-year review 
M. Giierri, M. J. Uria, P. Pefia 
Madrid, E 
Objectives: To review the incidence, clinical course and outcome of 
meningitis and sepsis caused by L. monocytogenes in a teaching hospital in 
Madrid. 
Methods: The samples were cultured in the standard media. Microorganism 
was identified by Gram stain, betahemolisis, catalase reaction, esculin 
hydrolisis, CAMP test reaction and motility. Gram positive identification 
card GPI (VITEK) was also made. Susceptibilicy to antibiotics was tested by 
PASCOn system until 1998 and by WIDERn system from 1998 to 2000. 
Results: W e  isolated L. monocytogenes &om blood in 10 patients, from CSF 
in four patients and in both of then] (blood + CSF) in 6 patients. 25% of the 
patients were neonate and 40% were older than 65. Between this ages only 
one has no underlying disease. The clinical outcome is favourable in 12 
patients (60%) and 8 patients (40%) died. Six patients were treated with 
ampicillin (A)and gentamycin (G), four with vancomycin (V) and 
cefotaxime (C), four with A alone, two with V + C + A, one with A 
and tobramycin, one with A + C and one with amowcillidclavulanate. 
Only one patient has no treatment. The number of isolates from 1991 to 
2000 were: 1, 0, 3, 3, 2, 2, 0, 3, 9, 3, respectively. 
Conclusions: (1) From 31 cases of listeriosis in the last decade in our 
hospital, L. moriocytogenes has been isolated mainly from blood (51.6%). (2) 
60% of meningitis had also bacteriaemia. (3) Although in 1999 there is a 
high increase in the number of cases a phage typing study does not support 
an epidemic outbreak. (3) Early treatment with ampicillin and gentamycin 
had better clinical response that any other. 
v1 Acute bacterial meningitis in adults: factors related 
to mortality 
M. Rubio, 0. Corral, J. Sanchez-Portocamero, E. Perez-Cecilia, J 
Koniero-Vivas, J. Picazo 
Madrid, E 
Objectives: Acute bacterial meningitis is a life-threatening infection. This 
study tries to assess the clinical features and mortality-associated factors of 
this disease. 
Methods: A retrospective study was conducted to examine the clinical, 
laboratory features and outcome of all cases of acute bacterial meningitis in 
adults diagnosed in a tertiary hospital in Madrid (Spain) during a 3-year 
period (1996-98). 
Results: We studied a total of 60 cases. The mean age was 52 years (range 
15-86), and 36 (60%) were male patients. Fifty-five per cent of cases were 
nosocomially acquired. Recent neurosurgical procedures (48%). neurosur- 
gical devices (40%), neoplasia (20%), respiratory tract infection (13%) and 
immunosuppressive treatment (10%) were identified as the main predis- 
posing factors for acute bacterial meningitis. The most frequently isolated 
microorganism$ were: Streptococcus pneumouiae (20%), coagulase-negative 
Staphylococcus (17%). Staphylococcus aureus (8%) and polymicrobial infection 
(8%). The mortality related to bacterial meningitis was 22%. The factors 
related to mortality were: age (D=0.01), nosocomial acquisition (P' 0.01), 
neoplasia ( P  < 0.01), lack ofheadache (P=O.Ol), lack ofnauseas (P=O.O5) 
and lack of neck stitfness (P=O.Ol). 
Conclusions: (1) The avadability of a neurosurgery department at a hospital 
confers a higher incidence of nosocomial meningitis. (2) The lack of clinical 
manifestations was associated with mortality in the univanate analysis. 
v1 Risk factors of death in acute bacterial meningitis 
A. Hristea, M. Chiotan, C. Popescu, S. Spiridon, G. Popescu 
Bucharest, RO 
Objective: The aim of the study was to identify the risk factors for death in 
acute bacterial meningitis in adults. 
Material and methods: We retrospectively studied 208 patients (56.7% 
male, 43.3% female, mean age 41.3 & 18.3 years, hospitalized in our clinic 
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in 1997-99 period. We divided the patients in two groups: 161 panents 
cured and 47 patients died. We look after the link between death and sex, 
age, evolution time before admission, neurological impairment (Glasgow < 
7). altered immune states, recurrent meningitis, seizures, focal neurological 
signs, CSF glucose value, albumin value and pleocytosis. We performed the 
statistical analysis with EPI info 6. 
Results: the organism isolated were pnruniococcus in 17.3% meningo- 
coccus in 19.2%, Gram negative bacilli (GNB) in 3.8%, Lisferia in 1.9% 
staphylococcus in 1.9% and unknown aetiology 55.8% of cases. The overall 
case fatality rate was 22.6%. Risk factors for death ( P  < 0.05) were: age 
(death 57.1% of cases in 7G74 years group), evolution time before 
admission (death 34.2% for evolution time before adrmssion > 48 h), 
decreased mental status at admission (death 41.4% of cases), immune 
impairment (death 43.1% ofcases), seizures (death 71.4% ofcases), causative 
organisms (mortality rate 75% for GNB and staphylococcus, 25% for 
pneumococcus, 7.5% for meningococcus 22.4% for unknown aetiology), 
initial CSF cell count < 1000/mc (200% mortality), low glucose CSF level 
(25.7% mortality). 
Conclusions: The case fatality was statistically significant higher in older 
patients, with evolution period before admission > 48 h, mental status 
decreased, immune status altered, seizures, pneumococcal, staphylococcal, 
Gram negative bacilli or unknown etiology of meningitis. We also noted a 
statistically significant difference in mortality rate according to CSF cell 
count and glucose level. 
w1 Brain abscess: review of 84 cases 
T. Hakan, P. Goktas, N. Ceran, 0. Er 
Istanbd, TR 
Introduction: Although there is a significant improvement in the diagnosis 
and treatment modalities, brain abscesses are still keeping importance. In this 
study the brain abscesses treated in our hospital are presented. 
Methods: 84 brain abscesses are evaluated, between years 1988-2000, 
according to clinical symptomps, risk factors, localisation of the abscess, 
causative agents, diagnosuc and treatment methods and prognostic factors. 
Results: Fifty-five (65.4%) of84 patients were male and 29 (34.6%) of them 
were female and the age ranged &om 1.5 to 80 years (median age 28.6). 
Abscesses were single in 72 (85%) cases and multiple in 12 (15%) cases. The 
predisposing factors were determined in 66 of 84 (78%) cases. Chronic 
otitis-niastoidtis was the major causative factor m 35 (42%) cases. Ten cases 
were treated medcally. In 52 cases free hand aspiration, in 10 cases 
stereotactic aspiration and in 12 cases excision were used in surgically treated 
group. In diagnosis and treatment we used Magnetic Resonance Imaging 
scan and/or Computed Tomography scan in all cases. Intravenous 
antibiotherapy were given to all patients at least 4 4  weeks. Therapeutic 
methods were chosen accordmg to the size, localisation, number of the 
abscess and their responses to the antibiotherapy. Five of 84 cases were died. 
The mortality rate was 5.9%. 
Conclusion: There are important iniprovements in the treatment rates. In 
some cases although medical treatment is sufficient in most cases surgical 
treatment must be considered. Aspiration method (free hand or  streotactic) 
is the most preferable method because of low morbidity and mortality rates. 
This method provides idenhfication of the causative agents and also 
improves treatment success on abscesses which are 3 cm and above. 
m q  Acute cerebellar syndrome due to Salmonella 
enteritidis 
Z .  Boztas, A. Curuk, S. Yildinm, M. Fmcanci, R. Uluturk 
lstarrbtrl, TR 
Table 1 for P1011 
Background: Although enterocolitis caused by Salmortella errteritidir i s  
usually a self limited disease, occasionally it is complicated by some unusual 
organ involvements. 
W e  observed a case of acute cerebellar syndrome due to Seriteritidis which, 
to our knowledge, is the first case reported. 
A 30-year-old man was admitted to the hospital with a three-day history of 
diarrhoea, nausea, vomitlng and fever followed by difficulty in walking and 
speaking two days later. Neurological examination showed dysarthria, 
nystagmus, dysmetria, dysdiadochokinesia, and gait and extremity ataxia. 
Blood cultures revealed S. enteritidis and this result was confirmed by a 
reference laboratory (Department of Microbiology, Istanbul Faculty of 
Medicine, Istanbul University, Istanbul, Turkey). A series of four 
consecutive brain magnetic resonance imagng carried out through a period 
of 6 weeks showed a progressive cerebellar athrophy, predominantly of the 
vermis. The patient received ceftriaxone and on the 42nd day of 
hospitahzation all the symptoms and s i p s  (excluding dysarthria) improved. 
Conclusion: S. erzteritidis may be one of the etiological agents causing acute 
cerebellar syndrome. 
vl Tuberculous meningitis: retrospective study of 
126 cases 
L. L. Santos, H. H.  Lecour 
Porto, P 
Portugal is the country of Southern Europe with the highest prevalence 
of tuberculosis, 47.8/100000 in 1998, with 46 cases of central nervous 
system infection. 
Aim: Retrospective review of clinical manifestations, cerebrospinal fluid 
(CSF) study and mortality of patients with tuberculous meningitis (TM), 
with and without human immunodeficiency virus (HIV) infection, 
admitted in an Infectious Disease Service from 1985 to 1998. 
Patients and methods: Patients with a clinical symptoms and CSF changes 
compatible with the diagnosis were included; confirmation was based in a 
positive culture, biopsy or necropsy. Patients with negative cultures but 
with a favourable clinical evolution to treatment were also considered. 
Results: T M  was dagnosed in 126 patients, 20 (16%) of them, all adults, 
coinfected with the human immunodeficiency virus (HIV), with CD4 cell 
count ranging from 6 to 403/mmc (122 + 126). Patients age ranged from 3 
months to 75 years, being 28 (22%) of them less than 14 years-old. Sixty- 
nine (55%) were males and 57 females. Clinical findings and are presented in 
the Tables: (see below) 
According to the Medical Research Council classification of the patients at 
admission was: stage 1-27 (21%), stage 11-34 (27%) and stage I1145 
(52%).CSF study at admission: 
CSF Glucose Protein ZN positive Lowcnstein 
cells/crnrn mg/dL mg/dL posit1vc 
(x * SD) (x f SU) (x f SU) 
HIV negdtive = 1 Oh 9-241 0 0-200 24-678 4 (4%) 56 (53%) 
(335 i 240) (36 f 19) (224 f 196) 
(182 k 43) (33 + l l i  (182 k 33) 
HIV pocitive=20 1-1U80 14-56 5Wi000 0 I 0  (50%) 
Diagnosis of T M  was confirmed in 88 (70%) patients. Nineteen (15%) 
patients died, 8 (42%) with HIV infection. 
Conclusions: (1) C h c a l  presentation was similar in patients with or 
without HIV infection, but neurological signs were more common in the 
later. (2) CSF findings were similar. (3) The kequent occurrence of 
tuberculosis in AIDS justifies that patients with the disease should be 
checked for HIV infection. 
fever headichec vomiting weight seizures abnormal ncck crmial motor 
loss mental stitliirss* n C N C  palsy 
status palsy 
HIV iirgatitive = I(l6 
HIV powive=211 
*bulging fontanel in 1 I infants 
1 02/96'% 72/68% hl/5896 3Y/37X 34/32% Y7/92% 97/92'%! 45/42'%, 49/4-6'%> 
17/8.5% 11/55% 3/ 1 S%> 9/45%, 3/15%1 7/35") 7135% 2/ 1 I)%> 3/ 15% 
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m] The case of TBC leptomeningitis and myelitis 
S. Kose, H.  Uc, M. Avci, Y. Zorlu, T. Batur, M. Helvaci 
Dmir ,  TR 
22-year-old female patient was transferred to our hospital with abdominal 
pain, high fever and confusion and she was performed LP due to presence of 
nuchal rigidity and Kemig-Brudzinsky signs. The following data were 
found in cerebrospinal fluid (CSF) anal sic High pressure, xantochromic 
appearance, Pandy (+ +), 42 cells/mm (90% lymphocytes), protein 312 
mg/dL, glucose 69 mg/dL. As the patient was applied a therapy (uncertain) 
considered to be mistreated purulent meningitis and cefiriaxon (2 x 2) 
treatment was started. She was considered to have tuberculosis meningitis 
due to the data obtained in her control LP: which was increase of cells and 
decrease of the glucose level. Therefore antituberculotic therapy (consisting 
of streptomycin, pyrazinamide, isoniazid, rifampin) and corticosteroid 
(dexamethasone, 4 x 81ng) was started. By the help of this therapy it was 
Y .: 
Skin and dental infections 
observed a decrease in her fever and unconsciousness but in the tenth day of 
the therapy symptoms like bilateral loss of strength in lower extremities, 
flask bladder and back pain have occurred. Although no pathology was 
observed in her C T  scan, in the following control LP’s it was realized a 
decrease in the number of the cells, glucose levels and increase in protein 
levels. Due to this data capsule painting, acid-fast painting, PCR for M .  
tuberculosis and Rose-Bend tests were performed and no pathologic data 
were found out. During the neurological examination it was ascertained a 
possible lesion in the lower thoracal and upper lumbar and MKI research 
was required. At the level of T8-11 a granulomatous inflammatory tissue 
(possibly leptomeningitis) which completely fills epidural sack and surrounds 
the radixes was found. Therefore a high dose ofcorticotherapy (100 nig/day 
prednisolone) was started. After a period of 10 days the therapy was 
decreased gradually. Meanwhile in her CSF’s culture (Lowenstein-Jensen 
Medium) M. tuberculoris was observed. Clinical recovery has started after the 
second month of the therapy and the patient was discharged without the 
necessity of a sonda usage and capable of walking with help. 
lip10131 Fine needle aspiration in the diagnosis of cellulitis - a 
reappraisal 
P. Gaffney, H. Law, L. Hill-King, S.  Walsh, K. Kerr 
b e d s ,  UK 
Objectives: To reassess the usefulness of fine-needle aspiration (FNA) as a 
diagnostic tool in cases of simple, non-necrotizing cellulitis in adults 
Background: FNA is often suggested as a useful investigation in the 
diagnosis of cellulitis. Two advantages are cited firstly, that Gram-stain 
morphology may allow tailoring of empiric antibiotic regimens and 
secondly, that culture may yield a definitive diagnosis which would not 
otherwise have been obtained in cases where the skin remains intact and 
blood cultures are not performed, or are negative. We describe an audit of 
this technique in the setting of an accident and emergency department of a 
large teaching hospital. 
Materials and methods: 45 adults with a clinical diagnosis of cellulitis were 
examined prospectively. Patients with open lesions and those with chronic 
infections were excluded. FNA was performed using a standard technique 
from the leading edge of erythema. Aspirates were submitted mnediately 
to the laboratory for Gram-staining and both direct (and where sample size 
permitted) enrichment culture. 
Results: Forty-four patients (mean age 32y with a range of 18-66, male/ 
female ratio 2.5 : 1 were examined; one specimen was lost in transit. The 
majority (89%) had disease of such severity that required adnussion to 
hospital. The lower limb was affected in the majority of cases (90%). A 
primary lesion was identified in 86% of case7. Gram-stains were available in 
44 patients. Although polymorphs were seen in 12 (27%) cases, no bacteria 
were seen in any specimen. No specimen yielded bacteria on direct culture. 
Enrichment culture of 37 aspirates yielded an unequivocal pathogen, 
Staphylumccus a117eus, in only one instance. 
Conclusions: FNA is of limited usefulness in cases of ‘simple’ cellulitis either 
as a guide to empiric therapy or in as a means of making a definitive diagnosis. 
v1 Clinical features and outcomes of adult patients with 
recurrent cellulitis 
J. Carrataii, €3. Aoshn, E. Shaw, N. Femindez-SabC, 0. del Ria, A. Rivera, 
F. Gudiol 
L’Hospitalet, Barcelona, E 
Objectives: The aims of this study were to analyse clinical features and 
medical outcomes of patients with recurrent cellulitis. 
Methods: Review of medical records of all consecutive adult patients 
hospitalized for community-acquired cellulitis. Patients with orbital 
cellulitis, cellulitis complicating diabetic foot ulcers, postoperative wound 
infection, and cellulitis related to injection of drugs in addicts were 
excluded. 
Results: From 1 January 1995 through 31 December 1999, 273 patients 
were hospitalized for infectious cellulitis. Fifty-five of them (20%) had more 
than one episode of cellulitis (overall, 73 episodes occurred in these patients 
during the study period). There were 32 women (58%) and 23 men. The 
mean age was 57 years (22-89 years). Forty patients (73%) had underlying 
diseases, being the most common diabetes mellitus (19 patients), cancer (12), 
hepatic cirrhosis (6). and congestive heart failure (4). Forty-five patients 
(82%) had some predisposing factor, mainly a possible portal of entry (24%), 
venous insufficiency and/or lymphoedema (22%), interdigital athlete’s foot 
(16%), and morbid obesity (11%). The majority of cellulitis involved the 
lower extremities (74%), and less frequently the upper extremities (18%). 
The infection was microbiologically documented in 30 (41%) of the 73 
episodes of cellulitis (blood cultures 15/60, needle aspiration culture 19/39, 
culture of the surgical sample 3/5). The causative organisms more 
frequently isolated were Staphylococcus aumx 10, Streptomilts py9prs  6, 
betahaemolytic streptococci 5, viridans group streptococci 4, Prrudotnorias 
aemgifiosa 2, and Escherichia coli 2. All patients were giveu empirical antibiotic 
therapy, mainly betalactam antibiotics (96%). Surgical debridenient was needed 
in 13 eplsodes (18%); in two cases subsequent plaqtic surgery was also required. 
Other complications occurred in 7% of cases. Overall mortality (< 30 days) 
was 9% (5 of 55 patients). Two patients died of shock (1 due to P. aem@m 
and I due to toxic shock syndrome caused by S. pyogmes). 
Conclusions: Recurrence occurs in a substantial number of adult patients with 
celluliti$ and it causes sigtllficant morbidity and rnortaI~ty. Active efforts should 
be done in order to correct predisposing conditions for t h i s  6-equent infection. 
/p1015/ Antibiotic-resistant Propionibacterium acnes on the 
skin of patients with severe acne 
E. Borglund, L. Emtestam, F. Nyberg, J. Lapins, L. Lundeberg, G. 
Wennersten, E. Sillerstrom, C. E. Nard 
Stockholm, S 
Acne udgaris is a disease in whch Propionibarterium acries is considered to play 
a role in the pathogenesis ofinflamed skin lesions. Antibiotic therapy of acne 
has been used during 40 years by demlatologists. P. acries strains resistant to 
antiacne antibiotics have been reported in USA, UK, France, Germany, 
Japan and New Zealand in increasing frequencies. In the Scandinavian 
countries the number of resistant P. aeries strains in patients treated with 
antibiotics is unknown. 
Objectives: To study the incidence and antibiotic susceptibility patterns of 
P. acnes strains isolated from patients with severe acne in Stockholm, 
Sweden. The mechanisms of resistance to tetracycline, erythromycin and 
clindamycin were also investigated. 
Methods: 99 antibiotic-treated patients and 30 nonantibiotic-treated 
patients with severe acne participated in the investigation. Facial, neck 
and nunk skin samples were taken with the agar gel technique. The gels 
were homogenized in prereduced m e l a  and incubated aerobically and 
anaerobically on nonselective and selective media. The different colony 
types were identified to species level by morphological, biochemical and 
molecular analysis. The susceptibility of P. acnes strains to tetracycline, 
erythromycin, clindamycin and trimethoprim-sulpha was determined by the 
agar ddution methods. The mechanisms of resistance to tetracycline, 
erythromycin and clindamycin were studied by genetic analysis. 
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Results: In the group of patients treated with antibiotics, resistant P. acries 
strains were recovered in 28%, while in the nonantibiotic group of patients 
the incidence of resistant strains was 6%. The minimum inhibitory 
concentrations of P.  acna strains in the antibiotic-treatment patient group 
were: clindamycin, 0 .00844 mg/L; erythromycin, 0.008-128 mg/L; 
tetracycline, 0.008-32 mg/L; himethoprim-sulpha, 0.016-2 mg/L. In the 
nonantibiotic patient group, the following values were observed: clinda- 
mycin, 0.008-16 mg/L; erythromycin, 0.008-128 mg/L; tetracycline, 
0.064-4 mg/L; aimethoprim-sulpha, 0.064-2 mg/L. The resistance to 
clindamycin and erythromycin was associated with mutations in 23s rRNA. 
Conclusions: Antibiotic-resistant P. acnes strains were significantly more 
often isolated from antibiotic-treated patients with severe acne than fiom 
nonantibiotic-treated patients. The use of antibiotics to treat acne should be 
restricted and other regimens should be tested. 
A case of Fournier gangrene 
S. Ordek, S. Okutan, C. Bal, 0. Ang 
Istaiibul, TR 
Foumier gangrene is fatal fasciitis of the perineal region. It is a mixed 
infection comprising aerobic and anaerobic bacteria and is generally an 
extension of a colorectal infection or a perineal abscess or infected lesion. It 
is encountered most often in men and one of the major predisposing 
conditions is diabetes mellitus. A case of Foumier gangrene in a diabetic 
male patient is presented where a necrotizing inguinal lesion extended down 
to his patella. Despite wide debridement and transverse loop colostomy, the 
patient was lost soon after. Eight dfferent bacterial species were isolated 
from the debridement specimen of the patient. The two aerobic isolates 
were Escherichia coli and Enteroroccur faecalis. The additional six isolates were 
anaerobic bacteria and these were identified by as Bacteroidesfragilis (99.4%). 
Clostridiurn septicum (98.5%), Peptostreprococcus anaerobius (95.6%), Peptostrep- 
tococcus micros (99.9%). Preuotello oralis (91.8%) and Porphyromonas endodontalis 
(98.1%)). The Rapid ID 32 Strep and the Rapid ID 32 A kits were used for 
identification and ATB ANA kit for the antibiograni of the anaerobic 
isolates with the Min~ APl system (bioMirieux, France). E. coli, enterococci, 
Bacteroides spp. and Clostridia are the classical pathogens of Foumier 
gangrene and anaerobic cocci like Peptostreptococcus spp. most often are 
included, as well. P. oralis and Porphyromonas spp. are frequent inhabitants of 
the human oral cavity and are rare pathogens in extraoral mfections, like 
endocarditis or abscess of various sites. Their probable role in Foumier 
gangrene is emphasized. 
v1 Periodontal status in Sardinian young adult 
population. Prevalence and association with parodontopathic 
bacteria 
C. Maida, G. Campus, A. Piana, M. O d ,  A. Santoni, G. Solinas, P. Castigha 
Sassari, I 
Objectives: To determine the prevalence of periodontitis in the young adult 
population of the town of Sassan (Italy) and examine the relationship 
between Adnobarillus actinomyceterncomitans (Aa), Porphyromorm gingiualis 
(Pg), Preuotella intermedia (Pi) in subgingival plaque and clinical conditions. 
Methods: 70 subjects (22 M, 48 F) were recruited in the student population 
attending the courses of the Faculty of Medicine of the University of Sassari 
during the year 2000. The protocol consisted of a standardized 
questionnaire, a dental examination and subgingival plaque specimen. Data 
were collected according W H O  (CPITN index), Loe and Silness (1963) 
(Probing Depth PD) and a diagnosnc threshold (DMFS index). Subgingival 
plaque samples were taken from or the mesial or  the buccal subgingival sites 
of one tooth o each quadrants with sterile Gracey curette. Aa, Pg and Pi 
presence was turveyed using a multiplex PCK. 4 primers, amplifying the 
16s rRNA subunity has been synthesized to identify the three bacterial 
strains. A ubiquitous primer set matching all bacterial 16s rRNA was the 
first. The other 3 primers specific for each bacteria were coniposed, 
respectively, by 33 pair for Aa, 25 for Pg and Pi. 
Results: 11.9% of the sample reveals a healthy gingival condition while 
bleeding at probing is present in the 44.8% and calculus in the 43.3%. 
DMFS index was 11.6 k 10.0: 1.4 f 1.8, 2.3 k 4.9 and 7.9 k 7.3 for DS, 
MS and FS component, respectively. In respect to pocket depth, 22.9% of 
the sample exhibits a normal PD, 65.7% a PD of 4-5 mm and 11.4% a PD 
more than 5 nun. Bacteria were discovered in 216 (79.4%) quadrants: 103 
(37.9%), 105 (38.6%) and 8 (2.9%) quadrants for one, two or all three 
microorganisms, respectively. Pi is the most common bacteria with a 
prevalence of 37.5% as single microorganism and a prevalence of 4.0% in 
association with the other microorganisms. Aa has a prevalence of about 4%, 
like Pg but this bacteria was detected only with the others. No sigrufkant 
association was observed between pocket depth and the bacteria. A 
significant linear trend of gingival conditions, across categories (healthy, 
bleeding at probing, calculus presence) was detected for Pi (OR 4.0, CI95% 
1.7-9.8) and Aa (OR 4.3, CI95% 2.2-8.4). 
Conclusions: Clinically periodontitis seems restricted to the 12% of the 
young-adult population. Gingival conditions seem the best indicators and 
predictors for periodontal and oral diseases. The outlook for general dental 
practice in the future should be to identify individuals and communities at 
risk, high-quality periodontal epidemiological information is of more 
importance than ever before. 
Ip10181 New OP technique allows optimal extraction of 
dental granuloma samples for bacterial analysis 
A. Esluci, A. Bogiatzis, D. Steinort 
Grar, Vienna, AT 
Introduction: T o  date, studies on the bacterial analysis of dental granuloma 
using conventional methods cannot rule out a possible contamination by 
normal oral flora. We describe here the results of microbiological analyses 
which were made using a new OP technique. 
Materials and methods: After mobilization a large mucoperiostal flap, a 
bone-lid was prepared and removed fiom the apical area. Sample collection 
was done directly through this window using a sterile strip. The samples 
were transferred immediately after collection to the appropriate transport 
medium, namely CSL for aerobic or thioglycolate for anaerobic specimens. 
The samples were analysed immediately thereafter. 
Results: Fortyone out of 51 patients examined hat positive results. Of these 
isolates, we identified 49% as Srreproocci, 32% as Staphylococci (S. aureus) and 
39% as anaerobic strains. The high proportion of S. aureus which was found 
among our sample group differs markedly from results published to date. All 
of these isolates were tested for resistance to cefalexin, amoxicfin/ 
clavulanic acid, and clindamycin. 
Conclusions: This new O P  technique allows reliable and contamination- 
free sample collection. Depending on the types of infecting bacteria and the 
resistance profile, the use of cefalexin, arnoxicilldclavulanic acid and 
clindamycin as a short antibiotic therapy is recommended. 
v1 Potential pathogens in the oral cavity after radiation 
- a long-term prospective trial 
B. A-Nawas, K. A. Grotz, S. Genitsariotis, H. D. Kufher, W.  Wagner 
Mainr ,  D 
After radiation therapy of head and neck malignoma changes in the oral 
flora are well documented regarding an increase in Cartdida spp. and a 
potential shift to Gram negative bacteria. However despite a high rate of 
potential infectious clinical problems after radiation therapy only few data is 
available concerning periodontal and dental pathogens. Moreover a possible 
long-term normalisation IS merely documented. 22 patients after radiation 
therapy of the head and neck were enrolled into this study. All patients 
received a mucositis prophylaxis during the radiation consisting of nystatin 
and chlorhexetidine. Prior to therapy and at 3, 6, 9 and 12 month after 
therapy samples from the deepest periodontal pocket were drawn and 5 mL 
NaCl oral rinsing solution. Both oral cavity and salivary glands were lying 
within the radiation field. The following parameters were determined. (1) 
Periodontal pathogens: Bucteroides forsythus, Porpi~ymmoms &givriiis, Pre- 
uoteila iritennedia, Treponema denticolafa, Actirrobucillus actinomyretemcomitans 
(qualitative test using PCR technique, Hain Diagnostica, Germany); a 
qualitative iudex [0-5] is given. (2) Caries pathogens: Streptococci, Lactobacilli 
(commercially avadable selective agar, Hain Diagnostica, Germany) 
semiquantitative Index 10-31. (3) Cundida group: (quantitative microbiolo- 
gic method on selecnve agar using the oral rinse). Statistical analysis revealed 
statistically significant elevation of the candida CFU from 6 to 12 months 
post radiation. Both the periodontal and the caries pathogens show no 
changes in number, despite of dental hygiene training and close follow up. 
Consistent to the antimycotic prophylaxis administered only during 
radiation candida group counts are one a high level showing no 
normalisation after 12 months follow up. This might give a microbiologic 
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/p1020/ Peculiarities of local oral immunity in students of 
medical colleges in present ecological conditions 
0. Y. Lutova, E. F. Malisheva, L. G. Komarova 
Nizhny Nougorod, RUS 
Objectives: According to the program of young people healthcare a group 
of students fiom Medical Colleges was examined to determine the 
condition of local immunity of the oral cavity. The aim of the investigation 
is to reveal peculiarities of natural colonization of Sfreptomcclrs salivanus 
lactobacteria on environment of h g h  level antropogenic pollution. 
Methods: 106 students of Medical Colleges have been observed. Fifty (50) 
of them were &om the industrial city centre - an area of unfavourable 
Urinary tract infections 
ecological condition, and 56 studied in the rural region. Deternunation of 
Strepfomcclrs salioarius natural colonization on the buccal epithelium cells 
(BEC) was carried out to all of them by the method perfected by E.F. 
Malisheva and A.N. Mayansky. Cells were obtained on the day of the 
experiment by scrapino mucous membrane fiom the inner surface of the 
cheeks with a spatula. The cells were washed away into the test-tubes with a 
sterile saline solution, settled and washed three times. From the cell 
settlement smears were prepared, fixed with ethyl alcohol, and stained with 
methylene blue. 50 epithelial cells were investigated in the smear. Natural 
colonization was estimated by the number of Streptococcus saliuarius bacteria 
per an epitheliocyte. 
Results: Three levels of Streptococcus saliuarius natural colonization on BEC 
have been obtained (low, medium, high) in the students of both groups, 
amounting to 67.2%. 21.8%, and 9% in persons living in polluted 
environment, and 9%, 45.6%. and 45.0% in those studying in rural regions. 
Conclusion: It has been estimated that the condition of local oral immunity 
in the examined persons fiom various ecological regions H e r s  sigruficantly. 
Thus, the value of Smptocou salivatius natural colonization on mucous 
membranes of the oral cavity in persons kom the industrial centre was low in 
67.2% cases, while in students !?om rural regions only in 9%. We can draw the 
conclusion that in ecologically d v o u r a b l e  conditions reduction of the local 
immunity of the oral cavity takes place, which manifests itselfby weakening of 
Streptococctls ~aliuarius adhesion on BEC. The test can be used for health 
evaluation as well as reveahng the risk of gastroenterological diseases. 
v/ Piperacillin/tazobactam vs. imipenemkilastatin in 
the treatment of pyelonephritis and complicated urinary tract 
infections-a mukicentric, randomized, double-blind phase 111 study 
K. G. Naber, 0. Savov, H. C. Salmen and the UTI-Study Group 
Sfraubing, Miimter, D 
Objective: PiperacdldTazobactam (P/T) is a widely used combination of 
an extended-spectrum penicillin and a potent beta-lactamase-inhbitor. In 
order to demonstrate clinical and microbiological efficacy, tolerability and 
safety of ths  drug in the treatment of acute pyelonephritis and complicated 
urinary tract infections this randomized, double-blind, multinational clinical 
trial vs. Imipenem/Cilastatin (1/C) was conducted. The trial was performed 
between 1995 and 1998 in 23 hospitals in Germany, Hungary, Croatia and 
the Slovak Republic. 
Methods: P/T was applied in the lower dosing of 2 g/0.5 g whereas I/C 
was used in the standard dosing of 0.5 g/0.5 g; both drugs were 
administered every 8 h intravenously. Major objectives were microbiolo- 
gical and clinical efficacy 7 days after the end of therapy ('test-of-cure'). 
Minor objectives were the same parameters at the end of therapy and 4-6 
weeks after therapy, as well as tolerability and safety of the treatments. 
Statistical analysis was performed as a single-sided test for noninferiority 
with an equivalence range C=10% at a significance level a=0025 
corresponding to a dlffeerence between the two therapy a m  by a 95% 
confidence interval (CI). A total of 337 patients were recruited, 57% were 
male. The two treatment groups were homogenous concerning demo- 
graphic data and baseline characteristics. The age of the patients varied from 
18 to 92 years with mean age of 64 years. Complicated urinary tract 
infections were diagnosed in 88.1% of d patients. The infections were 
predominantly acquired as primary infection (69.4%). 29.4% of all infections 
were nosocomially acquired, in average after 8 days of hospitalization. 
Results: Clinical success rates at the test-of-cure visit were 87.8% for P /T 
compared to 81.3% for I /C (PP-evaluation). The corresponding data in the 
ITT-evaluation were 83.0% and 79.9%1, respectively. The clinical outcome 
was confirmed by microbiological results. At the test-of-cure visit complete 
eradication of pathogens without relapse/reinfection was observed in 68.8% 
for P/T vs. 63.6% for I/C (PP-evaluation), and 66.9% vs. 62.5% (ITT- 
evaluation), respectively. All results at the test-of-cure visit were found 
within the lower margin of a 95% CI thus proving clinical and 
microbiologjcal noninferiority of P /T towards I/C. O n  a descriptive level 
an advantage of the treatment with P/T was observed. Adverse events were 
equally balanced between the two therapy arms and observed in 16.9% (PI 
T) and 16.4%) (I/C), respectively. Only 11 wrious adverse events were 
reported. None of these was estimated to have causative relationship 
towards the study medication. 
Conclusion: P/T has excellent success-rates in the treatment of acute 
pyelonephritis and complicated urinary tract infections. P/T was statistically 
demonstrated to be as effective as I/C. P /T has an excellent safety profile. 
(p10221 ~oss of virulence factors among quinolone-resistant 
clinical isolates of F. coli causing pyelonephritis and cystitis in 
women 
K. Simon, J. Ruiz, M. Velasco, J. P. Horcajada, M. Barranco, G. Roig, A. 
Moreno, M. T. Jimenez de Anta, J. Mensa, J. Vila 
Barcelona, E 
Objectives: To analyse the presence of different virulence factors among E. 
Cali strains causing pyelonepritis and cystitis in women, taking in account the 
susceptibility or resistance to quinolones. 
Methods: 35 clinical isolates of E. coli (18 susceptible to quinolones, and 17 
resistant to these antibacterial agents) causing female pyelonephritis and 31 
causing women cystitis (14 susceptible to quinolones and 17 resistant) were 
selected. MIC to nalidixic acid and ciprofloxacin was tested by E-test trip. 
Alterations in codon 83 of gyrA gene were detected by PCR and RFLP 
with Hinfl. Presence of cnfl, hly, pap and aer genes was determined by 
PCR. While presence of fimbriae type 1, and haeniolysin activity was 
determined by agglutination and grow$g on blood agar plates, respectively. 
Statistical analysis was performed by x- test. 
Results: All the strains presenting resistance to nalidixic acid presents a 
mutation in the amino acid codon 83, mutation absent in all the quinolone- 
susceptible isolates. cnfl gene and hly gene were always found 
concomitantly. Among the E. coli isolates causing pyelonefiitis, 100% of 
susceptible strains expressed the fimbnae type 1, 72% posses the pap operon, 
61% aerobactin gene, 50% hly and 50% cnfl and hly genes, while 71% of 
resistant strains presents the fimbriae type 1, 82% the aer gene, 59% the pap 
gene, and only a 12% the hly and cnfl genes. Among quinolone-susceptible 
E. coli isolates causing cystitis, a 93% express the fimbriae type 1 and a 21% 
posses the cnfl and the hly genes while a 14% and a 7% presents aer and pap 
genes, respectively. Meanwhile, 71% of the quinolone-resistant isolates 
express the fimbriae type 1, 42% presents the aer gene and a 18% of the 
isolates presents the pap gene. No isolate presents cnfl or hly. The statistical 
analysis by chi-square reveal which the loss of hly and cnfl genes was 
statistically significant. 
Conclusion: Resistance to quinolones is associated with a general loss of 
virulence factors, being specially noticeable the significant loss of haemolysin 
and necrotizing factor type 1. Only aerobactin has a nonsignificative 
increase among quinolone-resistant isolates. 
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v1 Genotyping uropathogenic Escherichia coli 
K. Truusalu, I. Vainumae, T.  Talvik, M. Mikelsaat 
T a m ,  EE 
Urinary tract infection (UTI) is one of the most frequent bacterial infections 
in childhood. E.  coli causes nearly 90% of all community acquired UTIs. 
The severity of UTI depends on the virulence of infecting bacteria and the 
susceptibility of the host. Virulence factors of uropathogenic E. roli strains, 
important in recurrent mfection episodes are not exactly known. 
Objective: (1) To deternke genotypes of E. coli in chtldren with recurrent 
UTI. (2) To assess if E. coli isolates from the first and recurrent episode are 
genetically similar. 
Materials and methods: Sixty-four E. roli strains were isolated from 28 
children with recurrent UTI. In most cases two E. rol i  isolates were 
obtained. The bacteria were grown in LB media a t  37 "C for 18 h. Total 
DNA was punfied by phenol/chloroform extraction. The primers used 
were: M13 (5'-GAC GGT GGC GGT TCT-3') and DAF4 (5'-CGG CAG 
CGC C-3') Randomly amplified polymorphic DNA (KAPD-PCR) 
program was: 5' 94". followed by 40 cycles: 1' 94"; 1' 50"; 1' 72". A 
100-bp ladder was included in all gels. Gels were stained with ethidium 
bromide and documented under UV illumination (Syngene). The images of 
the gels were processed by the software Gene Tools. 
Results: Among 8 E. coli strains, isolated from 3 patients the s i d a r i t y  of 
DNA band pattern was over 90%; in 8 strains from 4 patients-80%; in 14 
strains from 7 patients-70%. The 34 strains of 14 patients did not show the 
similarity more than 70%. 
Conclusion: E. roli strains causing recurrent UTI have Merent  RAPD- 
PCR genotype patterns. In half of patients some sinlilanty between the first 
and recurrent episode causing E. roli strains can be detected. 
vl Antibiotic susceptibility of Escherichia coli from 
urinary tract infections and bacteraemia: genetic 
characterization of sulfonamide resistance 
M. B. Kerrn, T. Klenunensen, F. Espersen, N. Friinodt-Moller 
Copenhagerr, DK 
Background: In the community the general practitioner determines the 
resistance of UTI. If one could predict the susceptibihty among E.  roli in the 
community fiom community-acquired bacteraemia (CAB) outgoing from 
the urinary tract (UT) it would be advantageous. The resistance toward 
SULs in E. coli has increased since the 1980s. Despite this SULs are still the 
first choice when treating unconiplicated urinary tract infections in general 
practice in Denmark. Few studies have investigated the mechanism behind 
SUL resistance in Danish E. coli isolates. 
Methods: Consecutive E. coli isolated from UTIs among practitioners (I: 
n = 148) and a hospital (11: n = 75) in Roskilde County were collected. The 
bacteraemic strains (111: it = 74) were fiom the same hospital and selected 
according to the following criteria: probable focus in the UT, community 
acquired infection (bacteraemia < 3d after hospitalization). MIC was 
determined by the agar-dilution method using Mueller-Hinton agar BBL- 
11. The tested antibiotics were ampicillin (A), mecillinam (M), sulfamethi- 
zole (S), triniethoprini (T) and nitrofurantoin (N). MIC-breakpoints 
according to NCCLS were used (KOSCO for M). A multiplex PCR 
was used to detect the presence of sul-genes. Fisher's exact test was used to 
compare the distribution of resistance and sul-genes. respectively. 
Results: The resistance among the three stram collections I, I1 and 111 in 
percentage of total were as follows; A: 28, 47, 42; M: 1. 3, 0; S: 32, 49, 43; 
T: 17, 28.20; N: 3, 0, 1. There were significant differences between I vs. I1 
for A, M and S ( P  < 0.05). Among 165 S susceptible strains (MIC 16-256 
pg/mL.) only one isolate was sulI positive. Of 24 mains with S MIC-values 
from 512 to 1024 pg/mL only 1 strain had sulI and sulII. Distributions of 
sul-genes among 106 S resistant strains (MIC > 2048 pg/mL) in percentage 
of total were as follows: 27 sulI, 50 sulII, 20 sulI + sulII and 3 with lack of 
genes. The distribution of the sul-genes among the three strain collections 
were not significant di8erent (P  < 0.05). 
Conclusion: The resistance pattern was identical for the strain collections 
except between U T I  in general practice and UTI in hospital. The resistance 
among CAB outgoing &om the UT can be used as a predictor for the 
resistance among UTI in general practice. S resistance (3249%) was 
explained by the presence of sulI or sulII genes which correlated with MICs 
> 2048 pg/mL. SUL breakpoint should be changed to: R more than or 
equal to 2048 pg/mL. 
v1 A new easy method for urine-culture in general 
practice: the 551 flexicult kit 
M. Blom, J .  Damsgaard, F. Espersen, N. Frimodt-Mder 
Copenhagen, Roskilde, DK 
Background: The majority of diagnoses of urinary tract infection (UTI) in 
general practice (GP) in Denmark is performed by the GP's themselves, 
either by direct phase-contrast microscopy, by dipstick (nitrite and 
leukocyte esterase) or by the dipslide method. Some also try to perform 
susceptibility testing by placing discs on the dipslide, a method which has 
low sensitivity and specificity. We developed a simple culture test kit, which 
is an agarplate divided into 6 segments, one for colony counting and the 
other five with agar containing 5 Merent  antibiotics, i.e. sulphamethizole, 
trimethoprim, nitrofurantoin, ampicilhn or mecillinam, respectively, chosen 
in such a way, that no growth on the individual fields will signify 
susceptibility to the drugs in question. The plate is floated with the urine for 
a couple of seconds and the urine poured off again, and the plate incubated. 
Growth from 1000 cfu/mL can be read on the plate. 
Material and methods: The plate was tested in our laboratory and in a field 
trial among 12 GP's, who compared the SSI FLEXICULT kit with their 
routine method, usually dipslides for diagnosis ofbacteriuria in patients with 
syiiiptoms ofUTI. A urine sample, appr. 10 mL, was collected also in a tube 
containing 85 mg boric acid, which conserves the bacteria until culture is 
performed, and sent to our laboratory for con6rmation of the results 
obtained by the GPs. Isolates kom these cultures were tested also for MIC's 
of the 5 antibiotics by agar plate dilution. 
Results: 121 urine samples from as many patients were tested of which 42 
had < 1000 cfu/mL., 6 showed 1000-10000 cfu/mL, 12 had 1 0 O O C b  
100000 cfu/mL, and 61 > 100000 cfu/mL. respectively. Overall error rates 
between the SSI FLEXICULT kit and urine sample was 4% only. 
Contamination with nonurinary pathogens hampered the reading of some 
plates for inexperienced observers. Regardmg susceptibility testing the SSI- 
urinary kit had a sensitivity of 8596, specificity of 94% and an accuracy of 
92% when compared with MIC's. 3% of the susceptibility test5 showed 
major errors, i.e. no growth on the test-plate but high MICs. This was most 
marked for mecillinam 
Conclusion: Generally, the testkit perfomied very well with few major errors 
on the antibiotics used. The combination of fields for counting of cfu's and 
the fields with antibiotics worked well in practice, and most GPs thought the 
I t  was easier to handle than the other methods for dlagnosing UTI. 
I PI026 1 Contribution of Doppler ultrasonography in 
diagnosis of acute pyeionephritis in adults - 30 cases 
V. Remy, Y. Hansmann, C. Montigny, D. M. Chrismiann, M. Martinot, 
S. Affenberger, D. Christmann 
Strmbourg, F 
Urinary tract infections are common but complications such as pyelone- 
phritis are misestimated. If pyelonephntis diagnosis is clinical and 
microbiological, in some cases, radiological exams may be of great help to 
confirm diagnosis and to discover complications. Tc99-DMSA scintigraphy 
is gold standard exam in children, and renal computed tomography (CT) in 
adults. These exams deliver radiation, iodinated contrast agent and are 
expensive. For these reasons, paediatrics have been using ultrasonography 
with Colour or Energy Doppler (US-D) for a long time. This technique is 
poorly evaluated in adult practice. 
Objective: The aim of our retrospective study is to compare US-D and C T  
renal examination in diagnosis of 30 confirmed (clinical and microbiolo- 
gical) pyelonephritis. 
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Methods: Inclusion criteria of pyelonephritis: fever > 38"C, lumbar pain, 
urine culture positive (> 100 000 bacteria/mL and leukocytes > lO/mL), 
P C R  > 10 mg/L. AU patients must have benefit of a renal C T  and renal 
US-D (3 experimented operators). The studied population is representative 
of population with pyelonephritis: 27 women (90%), age (32 f 14 years) 
and E .  coli isolation in 96% cases. 
Results: Sensitivity of US-D is (73%) better than in literature (27-63%) and 
sensitivity of CT is 83% (80-95% literature), there is no statistic difference 
between US-D or C T  to diagnose pyelonephritis. These examinations have 
to be realized 7 f 2 days after the beginning of symptoms to be more 
infonnative (positive exams with a delay < 4, < 7, < 10 days: US-D 60% 
87% and 82% CT 80%,93% and 90%). Treatment length does not influence 
these results (positive exams with a treatment length < 4, < 7, < 10 days: 
US-D 80%, 77%, 75% and CT 89%, 88%, 85%). US-D have some limits. It 
is an operator-dependant examination, obesity and difficulty to maintain 
apnoea may alter these results. 
Conclusion: US-D seems to be interesting because (1) it has a correct 
sensitivity to diagnose acute pyelonephritis (2) I t  is less invasive and cheaper 
than CT.  (3) US-D may be applied to allergic or pregnant patients and 
patients with diabetes mellitus, renal insufficiency or old age. Prospective 
studies are necessary to confirm our results and to determinate if the others 
pathologies could modify renal flux and interfere with US-D signal. 
Characterization of Aerococcus urinae strains of 
worldwide origin 
J. Christensen, M. Kilian, J. Blom, B. Korner 
Copenhagen, S; Aarhus, DK 
Objectives: The clinical importance of Aerococcus urinae was first described in 
1989. This new microorganism causes unnary tract infection and more 
seldomly septicaemia with or without endocarditis. Characteristically it 
resembles staphylococci in Gram stain and a-haemolytic streptococci on 
blood agar, and the taxon was designated in 1992. In this study, an emended 
description of 24 blood and urine isolates from Denmark, Sweden, 
Switzerland, the Netherlands, France, USA, Canada and South America was 
composed and compared to the attributes of Aerococcus viridans T. 
Methods: The following methods were used for characterization: Electron 
nucroscopy, conventional phenotypic tests and Rapid 11) 32 Strep, 
ribotyping (using XbaI), and multilocus enzyme electrophoresis (MLEE; 
examining for activity of 10 metabolic enzymes). 
Results: A .  urinne strains are Gram-positive, catalase-negative cocci dividing 
in two planes being leucine-anlinopeptidase (LAY) positive, pyrrolidonyl- 
aminopeptidase (PYR) negative, and vancomycin senntive. Two pheno- 
typic patterns were identified. The niajonty of strains belonged to pattern I 
(n = 18) characteristically being esculin-hydrolysis negative, not producing 
acid from salicin and amygdalin, not producing p-glucosidase, producing p- 
glucuroilidase, and producing acid from methyl-B-o-glucopyranoside in 
contrast to pattern I1 (n = 6) consisting of strains with opposite reactions in 
those tests. Results of ribotyping and MLEE showed, that 11 strains with 
phenotypic pattern I belonged to a separate group, all pattern I1 strains 
belonged to another equally well-defined group of strains, and 7 strains 
belonged to a heterogenous group. All A .  urinae strains were only distantly 
related to A. uiridans T.  
Conclusion: A. urinne strains isolated from urine and blood can easily be 
separated tiom other Gram-positive, catalase-negative cocci dwiding in  two 
planes. For the routine laboratory identification the LAP, PYK, and 
vancomycin susceptibility tests are especially useful. W i t h n  the species A .  
Tularaemia - Anthrax 
uririae two major phenotypic patterns were found independent of 
geographic origin. Ribotyping and MLEE results were in accordance with 
the phenotypic patterns. 
Ip10281 Urinary calculi; bacteriological and chemical 
association 
T. Naas, S. Al-Agili, 0. Bashir 
Tripoli, LY 
Objectives: To study the bacterioIogy of  urinary calculi in relation to 
urinary tract infection, stone formation, chemical composition and 
antibiogram. 
Methods: Fifty-two patients with urolithiasis were ctudied. Urine, serum, 
and urinary calculi specimens were collected and subjected to laboratory 
investigations: serum biochemical tests to detect uric acid, calcium and 
phosphorus; calculus, unne analysis and culture were performed. 
Results: Thirty-seven (71%) inale patients affected with urohthiasis, more 
than female patients (29%). Nineteen (37%) had associated urinary tract 
infection with E. coli and Pr. mirabilis as the most common causative 
microorganisms. E. coli was found to be associated with stones where 
calcium oxalate is one of the components in addition to phosphate. 
Differences between the bacterial isolates from urine and those from calculi 
in their susceptibility to antimicrobial agents. 
Conclusion: Urine culture of patients with urolithiasis can detect to a certain 
extent, the infecting organisms associated with stone formation and the 
organisms residing within urinary calculi in more than 50% of the patients. 
/p10291 Agents of nosocomial and community acquired 
urinary tract infections and antibiotic resistance patterns of 
pathogens 
L. Sahinoglu, A. Sarica, N. Agus, F. Cevik, S. Kose 
Izmir, TR 
Bacterial agents in UTIs could be nosocomial or community acquired and 
their antibiotic resistance varies due to rational or irrational use of 
antibiotics. In order to carry out a cheap and effective treatment of UTls, 
clinicians should know the frequencies of the agents and their antibiotic 
resistance patterns in their hospitals. In this study, culture and antibiotic 
susceptibility test results of urine specimens send to the Microbiology 
Laboratory between October 1998 and March 1999 were evaluated 
retrospectively. E. coli was the most fiequent agent (73%), and it was 
followed by Proteus spp. (6%) and Enterobacfer spp. (1.8%) in patients with 
community acquired UTIs. In the nosocomial group, E .  coli and 
Pseudomonas spp. were common and they were found in 73% and 25% 
respectively. They were followed by Entreobacter spp. (7%), Aciiiefobacter spp. 
(5%), S. dureus (4.5%), m e b s i e h  spp. (4%), Proteus spp. (4%), Eiiterococcus spp. 
(2%), Coagulase negative staphylococci (2%), S. maltophilia (1.5%), Senaria 
spp. (1%). In the susceptibility tests, most of the agents of community 
acquired UTIs were found resistant to ampicillin, cephalotin and 
cotrimaxole. In the nosocomial group, most of the isolates were resistant 
to all antibiotics except vankomisin, imipenem and cephdazidym. T o  
mediate the empiric antibiotic treatment of community acquired UTIs and 
control of nosocomial UTIs, each unit must be aware of own isolation and 
resistance patterns. 
110301 An outbreak of oropharyngeal tularaemia in La Rioja 
(Northern Spain) 
animals, inhalation and ingestion of contaminated water or food. The 
clinical presentation depends on the route of inoculation. Oropharyngeal 
tularemia is rare condition due to ingestions of potentially infected - 
water or food. However, we can not always find the risk factor. During 
the last 10 years no cases of tularaemia has been described in La Rioja 
(Northern Spain), and now we have observed 5 cases of this conmtion. O n  
the other hand we have not observed any cases of ulceroglandular 
M. Zabaleta, J. R. Blanco, C. Gutierrez, J. A. Oteo 
Loyrorio, E 
Background: Tularaemia is a zoonotic disease caused by F. fulavensis. Its 
transmission to humans includes tick-bite, direct contact with infected tularaemia. 
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Objective: T o  report the clinical characteristic of patients diagnosed of 
oropharyngeal hllaraemia in our commumty. 
Patients and methods: Description of an outbreak of tularaemia in our 
community. Diagnosis was made by clinical picture and the following 
criteria: antibody titre to F. tularewsis > 1: 160, seroconversion or recovery 
of F. tularensis from biological material or PCR positive. 
Results: Five patients were diagnosed of oropharyngeal tularaemia. The 
patients had fever, malaise, anorexia, fatigue, sore throat, supurative 
tonsillitis and or pharyngitis, cervical lymph nodes, and two of them 
tongue ulcers. Risk factor associated to the outbreak has not been identified. 
During this outbreak, we have not obsemed other clinical pictures 
(ulceroglandular, glandular, oculoglanddar, typhoideal and pneumonic). 
AU patients had a good response to antibiotic. 
Avidity of lipopolysaccharide-specific IgG antibodies 
in the diagnosis and follow up of Francisella turalensis infection 
A. Orduna, I .  Garrote, I. Duenas, J. L. Ruiz, J. M. Femandez, M. L 
Moreno, M. A. Bratos, A. RodriguezTorres 
Valladolid, E 
Introduction: The serological diagnosis of tularaemia is difficult to establish 
in endemic areas because the long persistence of antibodies after infection. 
An avidity test for Fraririsella tularettsis infection was developed and applied 
to the study of usefulness of IgG Immunoglobulin maturation kinetics in the 
diagnosis and follow up of tularaemia patients. 
Material and methods: One hundred and fifty-one serum samples from 55 
tularaemia patients were studied. Forty-one patients were followed clinically 
and serologically and the sera were obtained at 0 (baseline sera), 1,3, 6 and 9 
months (evolution sera) after the clinical diagnostic was made. Lipopoly- 
saccharide (LPS) from Francisella ttrlarensis NCTC 10857 was obtained by 
phenol-water extraction method. The avidity of the IgG anti-LPS responses 
was measured using the 10 M urea elution technique. The results were 
expressed as the percentage ratio between the test reading for eluted and 
noneluted samples (avidity index). 
Results: Twelve sera (21.8%) &om 55 baseline sera showed and avidity 
index below 50%, 20 (36.4%) presented and avidity index between 50% and 
75%, and 23 (41.8%) were higher than 75% (Table 1). 
Table 1- Distnbution of patients accodmg to I@ avidity index in each control 
~ 
Avidityindex Omonth lmonth Smonthr timontkr 9montha 
21,87* 19,5 Yo 18,l % 7,7 K 7,l % 
Considering all patients, the means of avidity index increased kom 
70. + 27.% (baseline sera) tol. rf: 19.% ninth months later. Studying the 
evolution of the avidity index of the sera from each individual patient we 
found than 78.2% of the patients do not present an avidity index variation 
higher than 10% during the follow up, in the 13.0% ofthe patients increased 
more than 10% and 8.2% decreased. 
Conclusions: The avidity index of the IgG anti-LPS was not useful for the 
diagnosis of the majority of the cases of human tularaemia. Most of the cases 
present an avidity index higher than 75% in the moment of the clinical 
diagnosis, and its variation during the follow up is very low. 
Usefulness of an IgG, IgA and IgM anti-LPS ELISA-test 
in the diagnosis and follow-up of tularaemia patients 
1. Garrote, P. Gutierrez, M. A. Miguel, M. A. Mantecon, J. M. Femandez, 
B. Hernandez Novoa, M. A. Bratos, A. Orduna, A. Rodriguez Torres 
Valladolid, E 
Introduction: The serological diagnostic of human tularaemia can present 
some difficulties in endemic areas. Using standard tube agglutination or 
microagglutination tests sometimes it is difficult to distinguish between 
active tularaemia or a past infection with Francisella fularensis. 
Objective: To assess the utility of an IgG, IgA and IgM anti LPS ELISA test 
in the diagnosis and follow up of tularaemia patients. 
Materials and methods: One hundred and fiftyone serum samples &om 55 
tularaemia patients and 44 serum samples from healthy blood donors were 
studied. Forty-one patients were followed clinically and Ferologically. In 
these patients sera were obtained at 0 (diagnostic serum), 1, 3, 6 and 9 
(evolution sera) months after clinical diagnostic was made. Standard tube 
agglutination, microagglutination, ELISA IgG, ELISA IgA and ELISA IgM 
against lipopolysaccharide (LPS) from Francisella tularetisis were performed. 
LPS from F. tularensis NCTC 10857 was obtained by water-phenol 
extraction method. All sera from the same patient were studied 
simultaneously. The curve results were expressed as a percent of variation 
of the logarithm of the inverse of the titre of evolution sera in relation to the 
titre of the corresponding diagnostic sera. 
Results: Considering all the diagnostic sera from the 55 patients the 
sensitivities of the standard tube agglutination test, microagglutination test, 
IgG ELISA, IgA ELISA and IgM ELISA were 85.5%, 94.5%, 98.2%. 96.3% 
and 98.2%, respectively. The specificity obtained for all the serologic test 
were over 90% in all cases. All seronegative patients became positives 1 
month after the clinical diagnosis. The antibody titres increased during the 1 
month after the clinical diagnosis was made. From this 1 month onward, 
antibody levels decreased in all serological test studied. Only two patients 
became seronegative in the ELISA IgM and IgA tests before the 9th month 
after beginning of treatment. 
Conclusions: The ELISA LPS tests have a good sensitivities and specificities 
in the diagnosis of human tularaemia. The presence of specific IgM usually 
inmates recent infection and it decreases faster than the specific IgA and 
IgG after treatment. 
v1 Anthrax in adults and children: a review of 132 cases 
A. Kaya, M. A. Tasyaran, S. Erol, Z: Ozkurt, B. Ozkan 
Mersin, Erzurum, TR 
In this retrospective study, 132 cues with anthrax admitted to our hospital 
in the last 14 years (from October 1986 to October 2000), were evaluated 
in respect to clinical features, therapy and prognosis. Patients were 4-77 
years old and 31 of them were children (under 14); 62 (47.0%) of 
the patients were female and 70 (53.0%) were male. It was understood 
that from July to September, in arid months of our region, there was an 
increase in anthrax cases and 82 (62.1%) of the cases were admitted to 
our hospital in these three months. A history of direct contact with 
slaughtered animals was obtained in 94 (71.2%) cases. Incubation period was 
found 1-10 (average: 4.7) days. All cases were cutaneous anthrax; 79 
(59.8%) of them were malignant pustule and 53 (40.2%) were malignant 
edema. One of the patients with malignant pustule developed meningitis. 
Culture positivity was found in 22 (16.7%) of the patients and direct 
microscopy revealed the bacillus in 22 (25.8%). In 15 patients both were 
positive. Penicillin was used in the treatment of all patients with addition of 
systemic corticosteroid in patients with malignant edema. The average 
hospitalization period was 6.8 days for malignant pustule and 12.9 days for 
malignant edema. The patient with anthrax meningitis and another with 
malignant edema who had extensive edema that was causing tracheal 
compression have died. Our report shows that anthrax is a significant 
problem in our region (eastern Turkey). Preventive measures such as 
education and vaccination of the animals against anthrax may reduce the 
incidence of the disease. 
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/p10351 Anthrax meningitis: a case report 
M. A. Tasyaran, 0. Deniz, M. Ertek, K. Cetin 
Erzurum, TR 
Anthrax is still a significant problem in West Africa, Central Asia and 
Middle East (including eastern region of Turkey). Anthrax meningitis may 
occur as a complication of cutaneous, inhalation or gastrointestinal anthrax, 
although it occurs rarely. In ths  report we present an anthrax meningitis 
case which is an uncommon cause of meningitis. A 19-year-old farmer 
came to us with a necrotic wounded lesion on h s  left hand with 
surrounding gelatinous edema, and a four-day history of flaying a dead 
Nosocomial infections: epidemiology 
cow. One day before admission the patient developed a headache with 
vomiting and fever. In a few hours later he became unconscious. On the 
admission to our clinic, he had a temperature of 38.5"C, a stiff neck and 
bilateral Babinski signs. Brain computed tomography revealed subaracnoid 
hemorrhage and hematoma on the left tiontoparietal region. The specimen 
of cerebrospinal fluid was grossly bloody and microscopical examination 
revealed large Gram-positive bacdi. The organism isolated from blood and 
cerebrospinal fluid was later identified Bacillus anfhracis. Treatment was 
begun immedately with 24 million U of penicillin G per day but he died 
13 h after hospitalization. Autopsy could not be done because of the 
religious reasons. 
Epidemiological typing of a cluster of Fnterobacter 
cloacae isolates by PFGE and RAPD analysis 
D.-H. Forster, A. Becker, E. Kniehl, D. Jonas 
Karlsuuhe, l+eiburg, D 
Objective: To compare epidemiological typing with PFGE and KAPD in a 
cluster of Enterobacter rluacae isolates. 
Methods: Twelve E .  doace isolates &om 11 patients were isolated on 
different paediatric wards (Klinikum Karlsruhe, teaching hospital, 1500 
beds) in a 4-month period of which eight were epidemiologically related. 
These strains were isolated on three wards including the neonatal ICU. The 
sources included blood cultures, urine, tracheal aspirates, stool and swabs 
&om different body sites. Strains were identified with the rapid ID 32 E 
system (bioMerieux, Mary I'Etoile, France). PFGE (Klinlkum Karlsruhe, 
ZLMT) was performed using the GenePath strain typing system (Bio-Kad, 
Hercules, CA, USA) with Spe I restriction according to the manufacturer's 
protocol. PFGE patterns were analysed visually. KAPD (National 
Reference Center for Hospital Hygiene, University Hospital Freiburg) 
was done with automated laser fluorescence (ALF) analysis (Pharmacia 
Biotech, Freiburg, Germany) using primers M13 and DAF4. Fingerprints 
were analysed by means of Gelcornpar software (Applied Maths, Kortrijk, 
Belgium). Degree of similarity between fingerprints were calculated with 
the Pearson product moment correlation coefficient. 
Results: All of the eight epidemiologically related strains were classified in 
one cluster by PFGE. With RAPD, seven of these eight strains were 
classified in one cluster whereas one strain was classified to be unrelated. 
All of the four epidemiologically unrelated strains from different wards 
were unrelated to the outbreak strain according to the results of both 
PFGE and KAPD. 
Conclusion: Both PFGE and KAPD are suitable for epidemiological typing 
of E .  cloacae. Combination of the gold standard PFGE and RAPD can result 
in additional discrimination. 
IP1037/ Epidemiological analysis of Fnterococcus strains 
isolated from infected children hospitalized in Children's 
Memorial Health Institute 
J. Wieczynska, D. Dzierzanowska 
Warsaw, PL 
Introduction: The kequency of nosocomial infections caused by antibiotic- 
resistant Enferucuccus sp. is still increasing. These infections represent 
important problems due to the rapid dissemination of resistant strains 
among hospital patients and very limited therapeutic options. 
Objectives: The aim of our study was a molecular characteristic of 
Enferucuccus strams isolated from infected children. 
Materials and methods: Forty-five strains of Enterocuccus jaecalis and 94 
strains of Enferucuccus faecium isolated &om children hospitalized in our 
Institute during 1996-2000 were analysed by pulsed-field gel electrophor- 
esis (PFGE). Tested organisms were isolated from liver and renal transplant 
recipients, dialysed and cancer patients and cudren  with shunt infections. 
The strains were obtained from various clinical specimens (i.e. blood, bile, 
BAL, surgical wounds, colostomy, etc.). 
Results: All isolates of Enferucoccus sp. cultured tiom a given patient showed 
identical resistance profiles and PGFE patterns suggesting an endogenous 
source of infection. Clonal patterns were observed among strains isolated 
tiom children hospitJzed in the same ward. 
Conclusions: PFGE is a useful tool for epidenliological analysis of 
Eriferucuccus sp. 
Rep-PCR applied to epidemiological study of 
Acinetobacter baumannii bacteraemia 
D. Martin-Lozano, J. M. Cisneros, B. Becerril, L. Cuberos, M. T. Prados, 
C. Ortriz-Leyba, J. Pach6n 
Seville, E 
Background: The source of bacteraemia by A. baurnannii has epidemioloical 
and prognostic interest. In many cases the real source cannot be traced, 
because of A. baumannii is widespread in the hospital environment. 
Genotyping is useful to characterize A. baumanrtii clinical strains and may be 
useful in the determination of source of bacteraernia. 
Methods: A prospective study was carried out in a tertiary hospital with 
1700 beds. All patients with true nosocomial bacteraemia by A.  baumanrtii 
were included. When strains tiom possible primary infection sources were 
avadable, REP-PCK was carried out in order to check the identity or not 
with its respective blood culture. 
Results: From April 1997 to March 1999, 67 patients with A .  baumarrnii 
bacteraemia were included; 42 of them with isolate5 from possible primary 
focus. In bacteraernic strains six different fingerprint profjles were found (I 
to VI genotype groups) with 21, 27, 3, 9, 3, and 4 strains, respectively. All 
isolates but one were resistant to ciprotloxacin, 66% were resistant to 
ceftazidime, and mipenem was the most active antimicrobial with 68% of 
susceptible strains. Attending to REP-PCR patterns, in 67% of cases the 
primary focus isolate matched to blood isolate. According to genotype the 
sources of bacteraemia were the respiratory tract (43%). surgical sites (27%), 
intravascular catheter (13%), bums (lo%), and urinary tract (7%). The 
comparison between antimicrobial resistance profiles (phenotype) from 
blood isolates and primary source isolates showed discordance in 7 (23%) 
out of 30 cases with identical genotypes. O n  the contrary, in 15 cases with 
discordant genotype, phenotype was identical in 7 (47%). At 30 days after 
the blood culture, mortality was 38.8%. According to sources ofbacteraemia 
the mortality was: burns 2/3 (67%)- urinary tract 1/2 (50%). respiratory tract 
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5/13 (38%), s u r g d  sites 3/8 (37.5%), and intravascular catheters 1/4 (25%). 
When the source ofbacteraemia was unknown, mortality was 14/37 (38%). 
Attenduig to genotype, mortality was: group 19/21 (439'4, group I1 8/27 
(30%), group 111 1/3 (33%), group IV 5/9 (55%), group V 1/3 (33%) and 
group VI 114 (25%). 
Conclusions: In this study there were six different genotypic profiles of A .  
baumannii. The most important source of nosocomial A. baumanni 
bacteraemia was the respiratory tract. The antimicrobial resistance patterns 
have a low discriminatory power in order to compare the isolates froni 
blood to possible primary focus of bacteraeniia. 
v1 Epidemiological characterization of nosocomial 
Acineiobacfer baumannii isolates from a 1500-bed teaching 
hospital by phenotypic and genotypic methods 
A. Basustaoglu, 0. Kisa, S. Sacilik, M. Ozyurt, S .  Yildiran 
Ankara, TR 
During a one-year period, 32 Aciiietubncter baumaiinii isolates were recovered 
from patients in the three intensive care units (surgery, neurosurgery and 
bum centre) of a 1500-bed capacity teaching hospital. The isolates were 
characterized by using antibiotyping (susceptibility pattern to antimicrobial 
agents), plasnlid profile analysis (PPA), arbitrary primed polymerase chain 
reaction (AP-PCR) and cell envelope protein sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis (SDS-PAGE). All the isolates were found 
to be resistant to ceftazidime, chloramphenicol. aztreonam, cefepinie, 
ceftriaxone, and were found to be susceptible to imipenem. O f  32 isolates, 
24 were considered to be outbreak strains occurring in five different clusters, 
whereas remaining eight isolates presumably derived from sporadic cases. 
While AP-PCR was the most discriminative method by discrimination 
index of 0.854, PPA was the least one by 0.695. T o  obtain a high 
discrimination power, it would be preferable to use SDS-PAGE in 
combination with antibiotyping as observed (discrimination index of 0.91 1) 
in this study. In conclusion, it would be necessary to characterize 
nosoconlial strains by using more discriminative typing methods for 
epidemiological purposes. 
Ip104Ol Optimization of surveillance of nosocomial infection: 
notification by the physician 
L. Ferrer, J. de Otero, M. Gayi, R. Capmany, A. Portell, J. Masip, S. Elk, 
M . Sanhurnenge 
Barrelma, E 
Surveillance of nosoconlial infection (NI) in our hospital is usually 
performed with the microbiologic data daily reported by the clinical 
microbiological laboratory. NI cases with negative or nonperformed 
cultures are not detected with this method. We decided to optimize 
surveillance of NI introducing a case finding method: notification of any 
suspected case by the attending physician to the mfectious diseases specialists 
Objective: To evaluate the impact of a case finding method (notification by 
the physician) on the surveillance of NI. 
Methods: An study ofNI  incidence was performed &om June 1997 to May 
1998. In June 1998 physicians were compelled to notify aIl suspected cases 
of NI to the infectious diseases specialists and an educational program was 
started to enforce notification (length 3 months). After that, a new incidence 
study was performed for 1 year (from June 1998 to May 1999) to evaluate 
the results. AU cases of suspected NI were collected and rates of NI 
incidence were computed. Contributions from physicians' notifications 
were compared to the total NI incidence and to the microbiologic daily 
reports' contribution. 
Results: A total of 375 cases of NI were collected 152 in the first year and 
223 in the second (46.7% of increase). NI incidence rate was 1.92% m the 
first year. After the start of the program notifications a maximum incidence 
of N1 was observed (4.79%, 144% increase). The 38.6% of all cases of NI 
were notified by the physicians. Notifications were also maximum at 3 
months (85.7% of all cases). After finishing educational presentation.$, the 
number of notifications gradually decreased until beginning levels. NI rate 
returned to previous level? at the end of the second year (1.51%). 
Conclusions: (1) Notification by the physician was a useful data source for 
NI control. (2) Efficacy of this surveillance method was enhanced by an 
educational program. (3) Decrease of physician notification was related to 
the end of the educational program. (4) To  maintain identification of NI by 
this method, periodical educational presentations are proposed. 
v1 Surveillance of infections following orthopaedic 
operations - an evaluation over 4 years 
H. Giindes, S. Gundes, Y. Cirpici, A. Sarlak 
Kocaeli, TR 
Objectives: Although technological advances aimed at acheving aseptic 
conditions in the operating rooms and the use of prophylactic antibiotics 
have considerably reduced the risk, infection is still a serious problem in 
orthopaedic surgery which, highly contributes to morbidity and mortality. 
Methods: We reviewed the medical records of all  paaenn admitted for operation 
between February 1996 and August 1999. Special attentlon was nude to type, 
aetiology, acquisition and direct conmbution of infection to deternine the 
postoperative wound infection rate w t h  the specaum of organisms. 
Results: O f  the 1440 orthopaedic operations performed between February 
1996 and August 1999, 877 (60.9%) operation were found to defined 
elective clean procedures. The wound infection rate among these operations 
were 4.6% (401877). Staphylococcus aureus was the single most common 
pathogen recovered in both major and minor infections. Five group of 
organisms namely, S.  aureus, Staphylocorrtrs epidermidis, Pseudomoms aeru- 
ginosa, Streptococcus spp., and Klebsiella spp. are responsible for 82% of the 
infections. Infection rates increased with age and duration of operation. 
Conclusions: (I) Infection is still a serious problem in orthopaedic surgery. (2) 
Staphylorucci is the donlinating pathogens among the othea. (3) It is important 
to know the prevalence of your resistant hospital species and to monitor the 
extensive use of antistaphylococcal antimicrobials in clinical practice. 
v) Resistance rates of Burkholderia cepacea and 
Stenotrophomonas maltophilia over 5 years in a Spanish 
paediatric hospital 
S .  Garcia hjalance,  A. Rico, M. L. Giierri, P. Andres, A. Garcia Perea, 
A. Carvqal 
Madrid, E 
B. reparea and S. malrophilia are nonfermentative Gram-negative bacteria; 
they are widely distributed in nature and they are opportunistic pathogens. 
Because of their ability to acquire resistance to antirmcrobial agents, these 
organisms have become particularly involved in nosocomial infections. 
Objectives: T o  detemiine the susceptibility of clinical isolates of B. cepacea 
and S. maltophilia from January 1995 to September 2000, in a Paediatric 
Hospital ('La Paz'), in Madrid. 
Material and methods: We studied 136 isolates of B. cepacea and 140 of S. 
inaltophilid from hospitalized children. These clinical samples were incubated 
aerobically at 37°C on a nonselective medium, routinely used in our laboratory. 
Before 1999 isolates were identified by the VITEK" Gram-Negative 
Identification card (GNI) and their susceptibility was done with the PASCO ' 
System. Identification and susceptibility was made by the WIDER ' System 
since 1999. The antimicrobials studied were Piperacillin (PIP), Ceftazidinie 
(CTZ), Cefepime (CEF), Imipenem (IMI), Meropenem (MER), Cotri- 
moxazole (COT), Gentamicin (G), Amikacin (A) and Tobramycin (T). 
Results 
Table 1 Resistance rates (I%) of B. rrpaccra 
No. of kolntes (n  = 8 )  (17 = 50) (n = 34) ( t i  = 33) (PI = 9) 
1995 1996 1997 1998 1999 
Piperacilliii 12.5 0.0 17.6 12.1 55.6 
Ceftandimr n.o 0.0 0.0 0.0 33.3 
Cefepinir 0 (1 8.0 17.6 21.2 66.7 
mipenem 33.3 34.0 38.2 24.2 33.3 
Meropenem 1 1  0 0 0 0.1) 3.0 33.3 
Commoxazole 0.0 2.0 23.j 21.2. 22.2 
B.cepacea is intrinsically resistant to all the aminoglycosides (G,T,A). 
because we have only two isolates. 
Table 2 Rr%i%tancr 1-atec ('%I) of S mdi~roi~i l in  
The resistance rates (RR) in the year 2000 are not reflected in the table 
1995 1996 I'W? 1'108 1999 2lllII) 
No. of isolxez ( 2 ,  = 25) (W = 18) ( U  = 1'1) (,I = 2 I) ( t i  = 46) (2, = 1 I) 
Pipcr.icillin 72.C 61.1 73 7 76.2 X9.1 YO.0 
Cefiazldlme 32.2 33.3 31.6 9.5 34 8 63.6 
Cefep1me 85.7 66.7 78.9 61.9 Y3.5 90.11 
Amino~lycos~dcs 8 W  711.0 45.6 Y8.4 95.0 8x.11 
Cotnmoxazolc 0.0 0.0 63.2 33.3 17.4 45.5 
S.  maltupliilia is intrinsically resistant to the carbapenems (MER, IMI). 
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Conclusions: (1) The lowest RR of B. cepacea is seen to ceftazidime and 
meropenem but there is a high increase (33%) in the year 1999. (2) S. 
maltophilia has a high RE1 to cefepime, piperacan, and the aminoglycosides 
(G,T,A). (3) The RR to C O T  has increased from 0% to 45.5% with a peak 
of 63% in the year 1997. (4) S. maltophilia RR to CTZ has increased even 
though there is a clear low value in 1. 
/p10431 Broadly applicable AFLP-typing for molecular 
epidemiology of bacteria in the clinical microbiology laboratory 
A. van der Zee, E. Thijssen, G. Noordhoek, T. van’t Blik, J. Nelson, A. 
vaii’t Veen, A. Uuiting, A. Bergmans 
Tilburg, Leeuwarden, NL 
Subtyping of bacterial species is important for recognition of outbreaks, 
detection of transmission of nosocomial pathogens, determination of the 
source of infection, and recognition of virulent strains. Methods for DNA- 
fingerprinting need to have a high dlscriminatory power and good 
reproducibility. Many investigators have demonstrated that amplified 
fragment length polymorphism (AFLP) can meet these criteria. Our goal 
was to develop broadly applicable AFLP typing conditions for epidemio- 
logical investigation of various bactenal species. The AFLP system described 
previously 1,2 was slightly adapted, and several resmction enzyme/primer 
combinations were tested in order to select a suitable combination with 
broad performance possibilities. Analysis of AFLP fragments was performed 
using agarose gel electrophoresis and GelComparII software (Applied 
Maths, Gent). We tested Legionella pneumophila (> 200 isolates), Pseudomo- 
nas aerugiiiosa (I 9 isolates). KIehsiella pneumoniae/oxytoca (33 isolates), 
Acinetobacter baumannii (20 isolates), Citrobacter freuridii (15 isolates), 
Enterobacter cloacae (10 isolates), Serratia inarcescens (1 0 isolates), and 
methycillin resistant Staphylocorrctr aureus (50 isolates) with several restriction 
enzymdprimer combinations. The DNA patterns were analysed with 
regard to the appropriate number of amplified fragnients, reproducibility of 
the pattern, and discriminatory power. However, more isolates have to be 
analysed for estimation of interspecies diversity in comparison with other 
available typing methods to be able to draw conclusions with respect to 
discriminatory power. For aU bacterial species analysed, one restriction 
enzyme/primer combination seemed suitable for broadly apphcable 
subtyping purposes. Using AFLP, we analysed recent outbreaks of Legioiiella 
piieurnophila, Citrobarter frertndii, Acinetobactev baumairii, and Klcbsiella 
pneumoniae. The results show that AFLP on agarose gels is an eligible 
method in the clinical microbiology laboratory for investigation of 
outbreaks caused by different bacterial species. 
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Nosocornial infections (1) 
v 1  Nosocomial Crimean-Congo haernorrhagic fever in 
Iran (1 999-2000) 
M. Mardaiii 
Tehran, IR 
Crimean-Congo haemorrhagic fever (CCHF) is a potentially fatal diseases 
that occurs in parts of Africa, Asia, Eastern Europe and Middle East. CCHF 
is primarily a zoonosis, however, sporadic cases and outbreaks affecting 
humans do occur. Contact with blood, secretions or excretioii of infected 
animals or humans may also transmit infection. Nosoconiial transmission is 
well described in reports from Pakistan, Iraq, Dubai and South Africa. We 
report two general practitioners infected with CCHF virus in a university 
hospital in Iran. Both of cases were laboratory confirmed by serological test 
like Immunofluoresence, (CAPS) Elisa and PCR in reference laboratory of 
WHO, South Afiica. First case was survived and his wife who was the 
second case was died with fever-haemorrhage and shock. Her diagnosis was 
confirmed with positive viral culture after death. None of thein received 
Ribavirin treatment. This is the first nosocomial CCHF report from Iran 
and standard precautions such as bamer nursing, effectively prevent 
secondary transmission in endemic area can prevent it. 
Were Legionella bozemanii infections seen in one 
hospital in the UK caused by an endemic strain? 
J. P. Duncan, N. K. Fry, T. G. Hamson 
London, UK 
Background: Legionella borernanii is a common environmental isolate, but is 
rarely isolated from clinical cases of Legionella infection (legionellosis). From 
1982 to 1999, 19 cases oflegionellasis in the UK caused by L. bozemanii 
were reported to the Legionella Reference Unit, London. Seventeen of 
these 19 cases were reported from one hospital (Hospital A). 
Objective: To characterize clinical and environmental isolates of L. 
bozemanii to see if any convincing epidemiological link could be established 
between the isolates from Hospital A. 
Methods: Standard phenotypic tests together with molecular methods; 
macrophage infectivity potentiator gene (mip) sequencing and Amplified 
Fragment Length Polymorphism (AFLP) analysis; were used to examine 
isolates: from Hospital A (clinical; n = 10: environmental; II = 6); from 
elsewhere in the UK (clinical; n 1 : environmental; 17 = 2) and reference 
strains from culture collections ( n = 3 ) .  Sequencing of the mip gene was 
used to confirm the species identification of the isolates. 
Results: Analysis of the 22 isolates of L. bozenzariii using AFLP revealed a 
total of eight distinct types. Nine of 10 clinical isolates from Hospital A and 
all six of the associated environmental isolates were indistmguishable by 
AFLP, and designated L. bozemanii AFLP Type B1. AFLP analysis of the 
remaining clinical isolate (from Hospital A) and the six unrelated strains 
comprised seven distinct AFLP types (Types B2 to B8). 
Conclusion: AFLP analysis of the clinical and environmental isolates indicate 
that a single AFLP type of L. bozemanii (Type Bl), which was common in the 
hospital environment but distinct from strains found elsewhere, was 
respoisible for 90% (9/10) of L. bozeinanii iniectioils in this hospital. 
A comprehensive study on handwashing patterns in 
an intensive care unit 
S. Karabey, P. Ay, F. Esen, T. Erbaydar, S. Derberitli, A. Eksik 
Istanbul, TR 
Background and objectives: Since most of the nosocoinial infections are 
transmitted by the hands of healthcare workers, handwashing is considered 
as the single most important method of preventing nosocomial infections. 
However previous studies have shown that handwashing practices are poor 
among the medical personnel (17-75%). The objective of this study was to 
determine the knowledge, attitude, practices and rates of handwashing 
among healthcare personnel in the Intensive Care Unit (ICU) of Istanbul 
Medical Faculty. 
Material and methods: The research was camed out in the ICU of Istanbul 
Medical Faculty between November 1998 and June 2000. Three different 
methods were used for data collection: direct observation, questionnaire and 
in-depth interview. 
Results and discussion: Hands were washed in 46 of the 357 detected 
indications, during the two hour observation of 32 healthcare personnel. 
Therefore the rate of handwashing was determinrd as 12.9% in the ICU. 
The rate was 15% among nurses, and 0% among physicians. The low rate of 
handwashing was noteworthy. It should be remembered that the 
handwashing indications were actually higher than the detected because 
our microbiological investigation had indicated that generalized contanlina- 
tion was present in the umt which increased the risk of contamination 
nearly after every contact. Also in some samples that were taken from the 
hands of the personnel after washing, infectious microorganisms were 
isolated. In other words there was a deficiency both in the frequency and 
the technique of handwashing. Using handrub in this unit would be a 
practical solution when there is no visible dirt. The knowledge of the 
healthcare personnel was sufficient. So the poor handwashing practices were 
related to factors other than knowledge. Likewise both in the questionnaires 
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and interviews it was stated that the working conditions in the unit were 
effecting the handwashing practices in a negative way. These conditions 
were expressed as the low number of healthcare personnel compared to 
high number of patients, low number of wash basins, insufficiency of 
handwashing and drying supplies. 
Conclusions: We can conclude that this research has not only provided 
considerable amount of detailed data about handwashing practices of 
healthcare workers, but also has given a chance to healthcare workers to 
examine their own handwashing practices. Also it has been stimulating for 
improving the working conditions. 
[p10471 Effect of hand washing on transient microbial flora 
F. Soysal, M. Fincanci, F. Kumaz 
Istanbul, TR 
Objectives: To assess in what rate the Gram-negative bacilh (GNB) 
colonized transiently on the hands of health care workers (HCW) can be 
removed by hygenic hand washing with soap and water, and to find out if 
contaminated soaps may cause further colonization. 
Methods: Bacteriological samples were taken from the hands of 100 HCW (31 
physicians, 69 nuaes) by (.)finger imprint method and (b) using swabs soaked 
with hipticase soy broth before and after hand washing. GNB on MacConkey 
agar were identified and underwent susceptibility testing. Bacteriological samples 
were also taken from the soaps before they were used for the procedure. 
Results: GNB were recovered from 58% of the soaps used for hand 
washing. 16 HCW (16%) had GNB on their hands before hand washing, 
and after the procedure, 13 ofthem (81%) were &ee ofthese organisms. The 
same bacilli (1 Acirietobacter sp., 1 Enterobacter sp., and 1 Pseudomonas sp.) 
which were recovered before the procedure were recovered again in 3 
HCW (19%). The soaps which these 3 HCW used harboured different 
bacilli &om the ones that were recovered from their hands. 
Conclusion: O u r  data show that hygienic hand washing with soap and water 
is largely effective in removing the GNB transiently colonized on the hands 
of HCW, and contaminated soaps do not cause contamination when they 
are used for hand washing. 
JP10481 Burkholderia cepacia outbreak in an endoscopic unit 
related to a contaminated batch of throat anaesthetic spray solution 
C. Petignat, D. S. Blanc, E. Guignard, S. Ostermann-Kraljevic, A 
Pannatier, J. Bille, P. Francioli 
Lausanne, CH 
Objectives: Investigation and control of a nosocomial outbreak of 
Burkholderia cepacia. 
Material and methods: Standard outbreak investigation and molecular 
typing (pulsed field gel electrophoresis). 
Results: Over a period of 17 days, respiratory tract specimens of 14 patients 
revealed the presence of B.  cepacia. The outbreak investigation revealed that 
all of these patients had undergone a bronchoscopic examination. The 
endoscopic procedure was evaluated, but was not conclusive. Environ- 
mental cultures of the endoscopic unit were obtained (endoscopes, washing 
machines, materials and dmgs used during endoscopic procedures, etc.). B. 
repacia was found in an oxybuprocain spray solution used for throat 
anaesthesia. The solution was prepared by the hospital pharmacy. Several 
cultures from various materials at the pharmacy revealed the presence of B. 
cepacia. PFGE typing of isolates of the patients, of the anaesthetic solution 
and of the environment at the pharmacy strongly suggested that the 
contamination was due to the use of water from an inappropriate tank for 
the preparation of the solution. 
Conclusions: Molecular typing enabled to identify the source of this 
outbreak which was related to an anaesthetic spray. 
IP1049) Susceptibility testing and epidemiological 
relatedness of Stenotrophomonas maltophilia nosocomial 
isolates in Greece 
C. Masgala, I .  Galani, M. SOUL, 2. Chrysouli, H. Giamarellou 
Athens, GR 
Objectives: Stenotrophomonas maltophilia is an important emerging pathogen 
causing a variety of infections. As it is inherently resistant to many antibiotics, 
only few therapeutic options are avadable. The main objectives of this study 
were to perform susceptibility testing and genotyping in order to assess 
epidemiological relatedness of Greek nosocomial S. maltophilia strains. 
Methods: A total of28 nosocomial isolates &om 5 Greek hospitals, collected 
during the period 4/98-5/99 were studied. Susceptibility testing was 
performed by the agar diffusion (Kirby-Bauer) test, E-test and a commercial 
broth microdilution method (Sensititre Ltd, West Sussex, UK), using the 
National Committee for Clinical Laboratory Standards guidelines (M7-A5, 
V0120, No2,2000). Genotyping was performed by pulse field gel 
electrophoresis (PFGE) of Spel-restricted genomic DNA. 
Results: The results of the two difision methods of susceptibility testing 
(disk and E-test) showed the closest correlation. Trimethoprim-sulfa- 
methoxazole (TMP/SMX) was active against the majority of the strains 
tested (89.3%), followed by ciprofloxacin (71.5%). Relatively few isolates 
were susceptible to the combination of piperacillin/tazobactam (25%) and 
only one was susceptible to aztreonam. Ceftazidime was active against 60% 
of the isolates tested. Amikacin showed the lowest level of resistance of all 
the aminoglycosides tested inhibiting 46% of S. maltophifia strains of our 
study. After macrorestriction analysis with PFGE we observed 27 
genotypes. The isolates fiom different hospitals had different PFGE patterns 
and appeared unrelated. The same was true for isolates deriving from the 
same hospital and even from the same department, with the exception of 
two isolates from the bronchology department of our hospital. 
Conclusions: The S. maltophilia isolates were genetically unrelated, even 
those isolated from patients of the same department. TMP/SMX remains 
the treatment of choice for S. maltuphilia infections in Greek hospitals. 
v1 Bacteriological water quality in haemodialysis 
M. N. Pissano, N.  Grinberg, C. Lavorato, J. Perez Loredo, J. Lercari 
Buenos Aires, RA 
Objective: The purpose of this study was to know the compliance of dialysis 
facilities to the standard bacteriological recommendations for water quality 
in haemodialysis (AAMI, National Law of Dialysis). 
Methods: A nephrologist and an infectologist went to 258 dialysis facilities 
all over the country in a period of 40 months. This is 75% of all dialysis 
facilities in our country. This survey was made as part of a program of 
quality control of the Argentine Confederation of Dialysis Associations 
which supervises dialysis treatment of 348 dialysis facilities (90% of all). We 
asked about bacteriologic control of water. We analysed 200 protocols of 
bacteriological analysis. 48 facilities were excluded because they were not 
functioning at the moment of visit, and a bacteriological control is a 
mandatory requirement. In 1.52 units we studied frequency, laboratory, 
quality of results and La1 test. 
Results: Frequency: more than one by month: 5%, monthly: 37%, 
bimonthly: 19%, quarterly: lo%, every six month: 9%, 8 per year and any 
one in the last year: 12%. Of this, 31% were uncompleted studied. Only 
34% asked for Pseudomonas spp., 16.4% Fungi, anyone for Mycubacterium 
atypical and 21% did LAL test. 45% were made by a bacteriologist or 
microbiologist, 18% by a water engineer and 37% by a person not trained in 
water cultures. 
Conclusions: The use of inadequately treated water for haemodialysis poses 
a severe threat to the health and safety of the hemodialysis patient. The 
water not only is used to prepare dialyse but also for reprocessing of dialysers 
for multiple use and to prepare disinfectants which have direct contact with 
the blood-side of the dialyser. Despite numerous reports documenting the 
importance of using water adequately treated, it is an area of hemodialysis 
often neglected and there is low compliance to standard recommendations 
(42%). Also it is important to remark that the bacteriological analysis must 
be done by a trained microbiologist. It emphasizes the importance of a 
continuous education and training of clinical staff in haemodialysis facilities, 
and monitoring quality standards for microbiological purity of dialysis water. 
v1 Thermos bottles: a reservoir of multiresistant 
Acinetobacter baumannii in hospitals 
R. Watschinger, A. Bocksrucker, G. Fluch, C. Luger, J. Schallauer, 
C. Jebelean, L. Binder, M. Haditsch, H. Mittermayer 
Linz, AT 
After several reports in the literature of outbreaks of Acinetobacter baumannii, 
we began collecting all multiresistant A .  baumannii strains that were isolated 
in our lab from clinical material as well as from surveillance cultures from 
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neutropenic patients and patients in intensive care unit. during 1995-99. An 
analysis of our data on the origin of our A. baumannii isolates showed that a 
high percentage had been isolated from the gastric tubes of patients, many of 
which were artificially ventilated. In order to find the source of the 
colonization of the gastric tubes, we began surveillance cultures of tapwater, 
of the solution for oral decontamination and of tea that was used to rinse the 
gastric tubes. We found no isolates of A .  baumannii in these solutions. We 
therefore examined two thermos bottles in which the tea was kept warm 
before using it to rinse the gastric tubes of intensive care patients. In one of 
the two bottles we successfully isolated a multiresistant A .  baumannii strain. 
Subsequently we examined 56 themios bottles from nine different wards in 
three different hospitals. Twenty-six out of the 56 thermos bottles examined 
were positive for A .  baumannii. In one bottle we even found two A .  
baumannii strains. The A. baumannii strains were typed biochemically by API 
NE and the resistance profile to nine antibiotics was determined. Twenty- 
four of these strains were typed by AP-PCR; ths  analysis yielded 10 
different genotypes. The same genotypes were identified in clinical samples 
from patients in the different wards. In one case, directly after isolation of an 
A. baumannii strain 6om the gastric tubes of two patients, it was possible to 
examme the thermos bottle used to store the tea before rinsing the gastric 
tubes. Genotype, biotype and resistance profile analysis showed that the 
three strains were identical. 
Conclusions: Thermos bottles may play a significant role in colonisation of 
the gastrointestinal tract of hospitalized patients and hence pose a threat for 
patients at risk for subsequent infection. 
v1 Antimicrobial activity of LavasepfR against methicillin- 
sensible and methicillin-resistant Staphy/ococcus aureus 
W. Fabry, C. Trampenau, T. h e m  
Essen, D 
Minimum inhibitory (MIC) and minimum bactericidal (MBC) concentra- 
tions of the disinfectant Lavasept I' (h-actionated polyhexamethylene bigua- 
ride and polyethylene glycol 4000) were determined by a serial broth 
microdilution test against 31 methcih-susceptible (MSSA) and 33 
methicillin-resistant (MRSA) Staphylococcus aureus strains. In addition, 5 
MSSA and 5 MRSA strains were tested in broth supplemented with 4% 
albumin, 0.1% mucin, or 0.01% mucin. The MSSA type strains ATCC 
25923 and ATCC 29213 and the MKSA type strain ATCC 33591 served as 
quality control. To prevent the testing of multicopy strains, the clonal 
diversity was proven by pulsed field gel electrophoresis. The MSSA strains 
had an MIC50, MIC9O and MBC50 of 1 mg/L and an MBC90 of 2 mg/L 
with MIC and MBC ranges of 0.5-2 mg/L,. The MRSA strains had an 
MIC50 and an MBC50 of 1 mg/L, and an MIC90 and MEC90 of 2 mg/L 
with ranges of 0.5-2 mg/L. The MICs and MBCs remained unchanged 
when 4% albumin was added. A maximal fourfold increase of MICs or 
MBCs occurred with addition of 0.01% mucin. Addition of 0.1% mucin 
increased all of the values towards > 64 mg/L. The type strains ATCC 
25923 and ATCC 29213 showed an MIC and MBC of 1 mg/L, the type 
strain ATCC 33591 an MIC and MBC of 2 mg/L. The Lavasept '' MICs 
and MBCs found in this study are far below mucosal concentrations 
reachable in uiuo. It is concluded that Lavasept! may be suitable for the 
topical treatment of MSSA and MRSA infections. 
Pseudomonas aeruginosa bacteraemia at an 
academic hospital in South Africa 
0. P. Perovic, H. Crewe-Browne, H. Koomhof, A. Duse, W.  Van Nierop, 
T. Gomes, M. Khoosal, M. Kassel, J. Galpin 
Johannesburg, ZA 
Objectives: To assess the clinical manifestations, outcome and prognostic 
factors associated with Pseudomonas aenrginosa bacteraemia; to describe and 
quantify resistance to antipseudomonal drugs; to apply phenotypic and 
genotypic methods to clinical itolates for epidemiological purposes. 
Methods: The study was perf med at Chris Hani Baragwanath Hospital. 
Adult patients with positive biood cultures for P. aeruginosa were followed 
up during 1998 and 1999, and children were followed during 1999. An 
episode of P. aeruginora bacteraemia was defined as nosocomial if it took 
place = 48 h after admission. Blood samples were processed using the BacT/ 
Alert system. Susceptibility to antibiotics was determined by disk diffusion. 
For P. aerrrginosa resistant strains, MICs and MBCs were determined by a 
standard microdilution method. Epidemiological tools used included 
serotyping by slide agglutination and macro-restnction analysts for 
molecular typing of P. aeruginosa isolates. 
Results: A total of 96 P. aewginosa blood isolates were collected from 91 
patients during the 2-year period. Nosocomially acquired infections were 
estimated to occur in 58% of patients; these were associated with catheters in 
24% of cases, the respiratory tract in 14%, skin and soft tissue in 12% and in 
49%. multiple sites were involved. Of underlying conditions that potentially 
contributed to pseudomonas bacteraemia, the most common were bums in 
29%, and human immunodeficiency virus in 26% of patients. Outcome was 
poor; 50% of patients died. Resistance to antipseudomonal antibiotics tested 
occurred in 21 (22%) strains. O f  these, the percentage resistant to each 
antibiotic by MIC breakpoint was as follows: imipenem (> 4 mg/L), 52%; 
meropenem (> 4 mg/L), 57%; ceftazidime (> 8 mg/L) 57%; cefepime 
(> 8 mg/L) 62%; piperacillin (> 64 mg/L) 71%; piperacillin/tazobactam 
(> 64/4 mg/L) 71%; ciprofloxacin (> 1 mg/L) 4%; amikacin (>  16 mg/L) 
19%. P. aeruginosa serotype was determined in 83 (86%) isolates; serotype 3 
was the most frequent serotype (26%). RFLP by PFGE profiles were 
obtained in 91 strains and transmission was shown to be more prevalent in 
the bums unit, the ICU and in paediatric wards compared with medical and 
surgical wards. 
Conclusions: P .  aenrginosa blood stream infection was associated with a high 
death rate. Predisposing conditions played an important role in acquisition 
of infection and adverse outcome. In high risk areas, several clones caused 
invasive infections. 
IP1054/ Clinical features of and risk factors for bacteraemia 
caused by nonferrnentative Gram-negative bacteria 
Y. Balaban, S .  Ascioglu, Y. Cetinkaya Sardan, G. Sain, M. Akova, S. Unal, 
0. Uzun 
Turkey, TR 
Background: h s k  factors for infection with nonfemientative Grain- 
negative (NfGN) bacteria have been studied for individual bacterial species. 
The clinical features and risk factors for bacteraeima caused by these 
organisms, however, have not been investigated in previous studies. 
Methods: In the setting of a 800-bed university hospital, ail patients with 
blood cultures positive for gram-negative bacteria from January 1997 to 
January 2000 were identified and their charts were reviewed retrospectively. 
Results: During the study period, 3.5 episodes of Gram-negative 
bacteraemia per 1000 adult admissions (256 episodes) were identified. and 
36% were due to NX;N bacteria. E. coli (28%). Klebsiella spp. (22%), P. 
aenrginosa (16%), Acinetobacfer spp. (12%) and S. maltophilia (9%) were the 
most common causative microorganisms. Ninety-three episodes of NfGN 
bacteraemia were compared with 163 episodes of fermentative Gram- 
negative (FGN) bacteraemia. Multivariate analysis showed that minor 
surgical interventions (Odds ratio (OR) = 6.02, P-value = 0.01 42) and 
presence of a central venous catheter (OR = 13.35, P-value = 0.0003) were 
independent risk factors for NfGN bacteraemia whereas haemodialysis 
(OR= 8.18, P-value = 0.0042) and total parented nutrition (OR= 11.56, 
P-value = 0.0007) were associated with FGN bacteraemia. Severity of 
underlying disease (McCabe-Jackson classification), prior anbiotic use and 
staying in ICU were not significant. Inappropriate antibiotic use was more 
common in NfGN bacteraemia (16% vs. 396, P =  0.0002). There was a trend 
towards a worse clinical outcome in bacteraemia caused by NfGN (39% vs. 
51%, P= 0.059), and more modifications in the antibiotic regimen were 
made in this group (36% vs. 19%, P=0.003). 
Conclusions: Nonfermentative Gram-negative bacilli are a major cause of 
nosocomial bacteraemias in tertiary care hospitals. Minor surgical interven- 
tions and presence of central venous catheters are independent risk factors 
for bacteraemia with NfGN bacilli when compared to FGN bacteraemias in 
a logistic regression model. 
Catheter-related bacteraemias by coagulase- 
negative staphylococci: strain relatedness and polyclonality 
M. A. Dominguez, M. M. Gamarra, F. Tubau, J. Linares, R. Martin 
Barcelona, E; Buenos Aim RA 
Coagulase-negative staphylococci (CNS) form part of the flora and are a 
common cause of catheter related bacteraemia (CRB). Infections due to 
multiple CNS strains may occur, but the exact incidence of polyclonal 
infections is unknown. As part of ongoing prospective surveillance of 
bacteraemia, a total of 30 consecutive patients (pts) with bacteraemia caused 
216 Abstracts 
by CNS and positive catheter tip culture and/or superficial cultures (hub, 
skin surrounding the catheter insertion site) were studied. 
Objectives: T o  confirm molecular identity between CNS isolated from 
blood and from catheter sites; to evaluate the importance of polyclonal 
CRB: and to analyse the ability of phenotypic analysis to discriminate 
between isolates and clones. 
Methods: 151 CNS isolates (90 from 81 blood cultures and 61 from 46 
catheter sites) from 30 pts were studied. Identification to species level and 
antibiotic susceptibility were performed by Microscan-TM and &sk-d&sion 
methods, according to NCCLS criteria. Identification was confirmed by 
ID32Staph-TM system. Cultures were screened for distinct morphotypes. In 
order to detect polyclonal bacteraemia, 0.1 mL from blood culture bottles 
were plated on MH agar and disk-diffusion method was performed. 
Molecular typing was performed by pulsed field gel electrophoresis. 
Results: In 10 pts, CNS isolated from catheter sites and blood showed 
different phenotype (biotype and antibiotype). In 20 pts, isolates from 42 
blood cultures showed the same phenotype than isolates from catheter sites 
(30 from 20 tips and 18 from 13 superficial cultures). Of these 20 pts, 17 had 
CNS isolates in blood and catheter sites with the same genotype: one pt was 
infected by S. lufduwensis; a second pt showed a polymicrobial infection by 
S. epidermidis and S. auricularis; and among the remaining 15 pts the only 
pathogen found was S. epidennidis, 3 of the5e pts had two or more different 
genotypes in  both blood and catheter samples. Altogether, 12 antibiotypes 
and 42 genotypes were identified. 
Conclusions: Polyclondity in CNS populations from CFU should be 
considered. In our study of 17 pts with truly CRB, 4 had polyclonal 
bacteraenlla (3 pts had several genotypes of S.epidemidis and 1 had an 
infection by two CNS species). Thus, to ensure all strains with different 
antibiotypes are detected, direct disk-diffusion testing from grown blood 
culmre bottles is advisable. Biotype and antibiotype showed Iimitatioiis for 
epidemiological typing of CNS, concerning reproducibility and discrimi- 
natory power. However, considering single patients this methods proved 
useful in identifying strain relatedness. 
Ip10561 Comparative study of risk factors and outcome to 
mortality in polymicrobial bacteraemia 
J. Kuiz, A. Noguerado, A. Pizarro, J. Meiidez, J. San Martin, F. La Hulla, 
F. Hernindez, I. Hernindez, M. Fernindez, J. Alvarez, F. Salvanes 
Madrid, E 
Objectives: Eighty episodes of polymicrobial bacteraemia were compared in 
two different years (1986-87 and 1996-97) in adults to asqess differences in 
risk factors and outcome to mortality. 
Methods: A prospective univariate analysis was perfomied of all episodes of 
polymicrobial bacteraenlia in Hospital Universitario de la Princesa de 
Madrid. A stratificated analysis by penods was realized with the risk factors 
with statistic significance (P  < 0.10). 
Results: At all, the ODDS Ratio of mortality during the fmt period was six 
times higher than mortality during the second one OR 6 (IC 1.91-18.77) P 
< 0.001. The clinical characteristics associated with mortahty at the onset of 
Device related nosocomial infections 
vi Do different local care strategies affect the risk of 
infectious complications of temporary haemodialysis catheters? 
N .  Ank. S. Esen, C .  Dundar, E. Guner, H.  LebIebicioglu, E. Duyar, 
A. Bilge, M. Gunaydin, K. Cengiz 
Samsurl, TR 
Objectives: Intravascular catheters play an important role in infections in 
haemodialysis patients. Some strategies such as cutaneous antisepsis, catheter 
replacement, and prophylactic antimicrobials are followed widely for the 
prevention of infectious complications of temporary haemodialysis 
catheters. In this study, effect of different local care strategies on prevalence 
of infectious complications in temporary subclavian and femoral haemo- 
dialysis catheter was investigated. 
Methods: Ninety-three patients were randomly divided into three groups 
equally. Povidon-iodine was used alone for local care in the first group, 
povidon-iodine plus mupirocin and povidon-iodine plus h d i c  acid were used 
bacteraemia in both periods were steroids treatment ( P  0.022), respiratory 
tract manipulations ( P  0.01 9), unknown bacteraemia origin (0.058), not 
leucocytosis ( P  0.097), disseminated intravascular coagulation ( P  0.006), 
hypotension ( P  0.001) and septic methastasis ( P  0.036) The variables found 
to be independently associated with increased mortality with clinical 
significance in the first period and not in the second one using a stratificated 
analysis by periods were: steroids treatment OK 10.5 (IC 1.12-97.9). 
hypotension OR 5.33 (IC 1.37-20.7) and disseminated intravascular 
coagulations OR 2.46 (IC 1.6-3.6). 
Conclusion: Ten years ago mortality was six times higher than nowadays. 
The different risk factors were all about depending on steroids treatment, 
hypotension and drssenllnated intravascular coagulation that were clinically 
associated with mortality in the first penod but not in the second one. 
Fungaemia associated with vascular catheter in 
cancer patients in Slovakia 
I. Svetlansky, S. Spanik, V. Krcmery, S .  Grausova, A. Koidova 
Trnava, Brutislava, SK 
Fungaenlia in cancer patients is of increasing incidence and mortality is 
reported to be 2540% depending on type of the patient, aetiology, 
underlying disease and other immunosupressive factors. The aim of this 
study is to compare risk factors and outcome in catheter associated (CAS) vs. 
non catheter associared (Non-CAS) fungaemias appearing within 10 years 
(1988-97) in two cancer institutions-National and St. Elisabeth Cancer 
institutes in Slovak republic. CAS was defined as fungal bloodstream 
infection with at least one positive blood culture positive for fungi when the 
same pathogen was isolated additionally from a catheter tip. Organisms from 
routine blood culturing and catheter tlp culture were identified with Viterk 
jr. identification system (Vitek, Bio Merieux Hazelwood). From 101 
fungaemic patients, 14 had CAS. Five episodes of CAS were due to C. 
albirans, 4 due to nonalbicans spp. and 5 due to non-Caitdida spp. yeasts. 
When comparing various risk factors in 14 CAS vs. 87 Non-CAS 
fungaemia duration offkgaemia for 3 and more days was significantly more 
associated with CAS in comparison to Non-CAS (42.8% vs. 11.5%, P 
< 0.03), CAS presented more than 2 positive blood cultures (71.4% vs. 
25.2%, P < 0.05) and were more frequently breakthrough during 
prophylaxis with ketoconazole (KET) (28.6% vs. 8%, P < 0.045) or 
enipiric therapy with aniphotericin B (AnlB) (35.7% vs. 11.5%, P < 0.04). 
However, both attributable and crude mortality were similar, and 
surprisingly was lower (14.3% attributable and 7.1% crude mortality). 
Non-Candida spp. yeasts were more frequent among CAS vs. non-CAS 
(35.7% vs. 11.5%). Most of 14 patients (12, 85.7%) were treated with 
catheter removal and chemotherapy ( A d - 1  0, FLU-2) in two, infected 
catheter was extracted only (one d e d  and one survived). Among CAS, 
previous prophylads with KET or chemotherapy with A d ,  persistent 
fungaemia and non-Candidu spp. aetiology were significantly associated with 
CAS but mortality on CAS was similar to the control group of non-CAS 
fungaemias, and was lower than reported previously by Lecciones et al. 
(1 992) and Viscoli et al. (1 997). 
for local care in second and third groups. Catheter insemon sites were inspected 
for the signs indicating possible infection and local care was apphed daily. 
Results: Catheter colonization was detected in 26.9% of the patients. 7 
patients (7.5%) developed catheter-induced local Infection. Catheter-related 
bloodstream infection was determined in 13 patients (13.9%). The most 
common isolated agent from colonized and infected catheters was coagulase 
negative staphylococci. Staphylococc-ur aureus was never isolated in mupirocin 
and fusi&c acid groups. Nasal carriage of S. a u r e u  was detected in 10 
patients (10.6%). None of them developed catheter Infection in this study. 
Neither the site of catheterization nor the type of local care effected the 
incidence of catheter-induced local infection, catheter colonization, and 
catheter-related bloodstream infection significantly. Isolated microorganisms 
were not statistically different in three groups and in two inserted sites. 
Conclusion: In conclusion, local care policies with fusidic acid and 
mupirocin can reduce S. a m u s  colonization and infection but these agents 
and catheter insemon sites dos not affect total colonization and infection 
rates in temporary haemodialysis catheters. 
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vl Bacterial filter breathing circuits: do they reduce the 
incidence of respiratory colonization or infection? 
L. Lorente, M. Lecuona, J. Malaga, C. Revert, M. J. Ramos, M. L. Mora, 
A. Sierra 
La L q u i i a ,  Tenerr+, E 
Objetive: to evaluate the efficacy of bacterial filters (BF) in breathing circuits 
to reduce the incidence of tracheal colonization (TC), tracheobronquitis 
(TB) and pneumonia (PN) in patients under mechanical ventilation in a 20- 
bed medical-surgical Intensive Care Unit (ICU). 
Method: Prospective, randomized study. Patients were randomly assigned 
to one of two groups at admission. In one group patients were ventilated 
with bacterial filters and in the other, patients were venalated without 
bacterial filters. Throat swabs were obtained from the patients at the 
moment of admission and then twice a week until discharge, in order to 
analyse the carrier state. Respiratory infections were diagnosed according 
C P f .  reria and classified based on throat flora in: primary endogenous, 
secuiiLi.. endogenous and exogenous infection. Statistical significance of 
the variables was tested using Chi-square test or Student's t-test when 
appropriate. Values P < 0.05 were considered statistically significant (S). 
Results: 87 patients fulfilled all criteria (62% ndes). Mean age was 
57.58 f 16.56 years, APACHE-I1 15.99 5.66 and mortality was 21.83%. 
45 patients ventilated with bacterial fdter and 42 without bacterial filter. 
Both groups of patients were similar in age, mortality, days of mechanical 
ventilation and APACHE-11. Patients ventilated with bacterial filter 
(62.22% males) had APACHE-I1 16.27 5.90, 13.13 !c 14.29 days of 
mechanical ventilation (total 591 days) and 22.22% died. Patients ventilated 
without bacterial filter (61.90% males) had APACHE-I1 15.72 f 5.42, 
18.50 23.66 days of mechanical ventilation (total 777 days) and a 
mortality rate of21.42%. 31.11% ofpatients with BF and 33.3% without BF 
developed pneumonia (P N o  S). Density of incidence of tracheal 
colonization (TC), tracheobronquitis (TB) and pneumonia (PN) in patients 
undergoing mechanical ventilation (MV) with and without bacterial filters 
were the following: 
BF Nu BF P 
N" PN 25.38 19.30 No S 
per 1000 
MV-days 
N TB 
per 1000 
MV-days 
N' TC 
per 1000 
MV-day5 
N" I" & T B  
per 1000 
MV-days 
N P N , T B &  
TC per 1000 
MV-days 
N Ex-Events 
per 1000 
MV-divs 
10.15 6.43 
3.38 11.5x 
35.53 25.73 
38.91 37.32 
5.07 3.86 
Nu S 
Nu S 
No S 
No S 
Nu S 
Conclusion: Bacterial filter in breathng circuits neither reduce the incidence of 
tracheal colonization, respiratory infections nor exogenous events. 
Ip10601 The incidence and risk factors of nowcomial pneumonia 
P. Ergin Ozcan, S. Tugrul, I. 0. Akinci, C. Sani, A. A. Cagatay, N. Cakar, 
F. Esen 
Istartbul, TR 
Introduction: Nosocomial pneumonia (NP) contributes to the niortahty 
and morbidity of critically dl patients on mechanical venalation. This 
retrospective study aimed to evaluate the incidence, risk factors and the 
mortality rate of nosocomial pneumonia in an ICU of an University Hospital. 
Method: Among the 2937 patients admitted to our ICU between the dates 
1997 and 1999, 507 patients were evaluated. Those 210 who received more 
than 48 h ventilatory support were allocated. NP was defined as the 
presence of at least three of the following criteria: new appearance of 
infiltrates on chest radiogram, high or low leucocytes count, fever, 
variations of tracheal secretion and positive tracheal aspirate culture. Age, 
surgical procedures, accompanying diseases (such as COPD, diabetes 
mellitus), nutritiond status, approach to gastrointestinal protection, pre- 
ICU antibiotic usage, presence of infection on adnussion and neurological 
state were evaluated as the risk factors for NP. t-test. x square, odds ratio 
(OR) were used for statistical evaluations. 
Results: N P  diagnosed in 126 patients (uh60). Mortality rate was 41,3% in 
NP (+) patients, however, 3,6% were in NP (-) patients. Relevant risk 
factors were coma (P: 0.01), duration of ICU stay (I? 0.0026) and 
mechanical ventllation days (P: 0.02). Etiologic factors appeared to be 
highly correlated to niortahty rates. 
Conclusion: The role of NP on mortality rate of ICU patient is important 
due to our results. Duration of mechanical ventilation and coma have 
important role as risk factors in NP. 
Ip10611 Evaluation of ETA, PTC, and PSB techniques for the 
diagnosis of ventilator associated pneumonia 
S. Barut, C. Eroglu, S. Esen, M. Sunbul, M. Gunaydin, H. Leblebicioglu 
Samsun, TR 
Objectives: Nosocomial pneumonia whch is the second most seen infection 
among hospital infections, especially it could be seen in patient who have 
mechanical ventilation (MV) in intensive care u n i t y .  Currently, bronchoscopic 
methods have been considered more valuable in diagnosis of vennlator 
associated pneumonia (VAP). It was aimed comparison of endotracheal 
aspiration (ETA) and plugged telescoping catheter (PTC) methods with the 
protected specimen brush (PSB) niethod in patient with VAP. 
Methods: This study was done in a surgical intensive care unit which had 10 
beds at Ondokuz Mayis University Hospital. Thirty-nine adult patients 
requiring continuous MV for more than 48 h were included in the study. 
There were 36 patients whose cultures had been done at least one time &om 
the beginning of intubauon. Pneumonia was diagnosed clinically if three of 
the following findings were found 1-fever, 2-leucocytosis, 3-increase in 
volume or new onset of purulent sputum, 4-pulmonary infiltration. Lower 
airway samples were obtained &om all patients twice a week by two 
methods (ETA and PTC). Blind PSB, was also used to obtain sam les from 
patients with pneumonia. The patients with microbial growth "10 cfu/nL 
in blind PSB samples were considered to have pneumonia. Correlations 
between the methods were tested by Spearman's method. Memans of 
quantitative results of PTC and ETA methods in colonization and 
pneumonia groups were found and compared by Mann-Whtney U-test. 
Results: Colonization with Gram positive and negative bacteria was seen in 
61% and 22% of patients at the first 48 h, respectively. After the fourth 
sampling all patients had both Gram negative and Gram positive 
colonization. The most kequent organisms isolated Gom cultures were 
Staphylococcus aureus, Pseudomoms aeruginosa and Klebsiella piie~riiioniae. 
Correlation coefficients between ETA and PTC, ETA and PSB, PTC and 
PSB were 0.58, 0.48, 0.66, respectively. So, the most accepoble correlation 
was obtained between PTC and PSB. Quantitative ETA and PTC cultures 
were found to be distinguish colonization from infection (P  < 0.01). 
Conclusion: PTC technique is simple, cheap and easily applicable and high 
risk of pneumonia in patient whose lower airways have been previously 
colonized with pathogenic microorganisms it will be a rational approach to 
obtain repeated lower airway sample using PTC t e c h q u e  throughout the 
MV period. 
P 
Ip10621 Value of direct examination of protected specimen 
brush (PBS) in intubated patients with suspected pneumonia 
D. Mariscal, J .  Vall&s, J. Rello, M. Gallego, F. Salceda, D. Fontanals 
Sabadell, Tarragom, E 
Objective: The aim of this study was to evaluate whether the direct 
examination of PSB specimens could predict the recult of the 
quantitative cultures. 
Methods: We consecutively studied PSB samples from patients with 
suspected VAP admitted to the ICU from January 1996 to Auguct 1998. 
PSB were sampled and the remaining fluid was centrifuged, but citospin was 
not used. Two smears for Gram (GR) and Gienisa (GI) stains were 
perfornied with the pellet. G R  and GI were first exanuned at x 100 for the 
presence of polymotphonuclear neutrophils (PMN), cquamous epithelial 
cells (SEC), bronchial cells (BC) and alveolar macrophages (M). Screening 
for nlicroorganisms was perfornied at x 1000 on Gram-stained slides. 
Results: Two hundred PSB were practised during the period of the study. 
All patients were under mechanical ventilation and 160 were administered 
antinlicrobials > 48 h. 94 cultures were positive and 106 negative. G R  and 
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culture agree in 156 (76 positives) cases and were completely discordant in 
44 (1 false positive and 43 false negatives). Global sensitivity (S), specificity 
(Sp), positive predictive value (PPV) and negative predictive value (NPV) 
were 63.9%, 98.8%, 98.7% and 65.0%. In case of P. aemginoro these values 
were 46%, 98.8%. 95.5% and 76.2%. Mean cell count was 53.3 +-38.8, 69/ 
200 had PMN, 27/200 had M and 51/200 had BC. In 50 specimens the 
number of SEW x 100 were > = 1; in all of them grew aero-anaerobic 
oropharyngeal flora. In presence of > = 90% PMN Gram stain was positive 
in 62.5% compared with 34,9% when PMN were < 90%; however, 75% 
and 54% of cultures were positive, respectively. When bacterial counts were 
> = lo3  CFU/mL., direct examination only was positive in 13.2% and 
100% when the culture had > = 10' CFU/ml .  
Conclusions: (1) Sensitivity is low, especially for P. aerugimsa isolates, and 
correlates with the inoculum of the sample. (2) Identification of 
microorganisms by direct examination of G R  in PSB samples provides a 
rapid and specific information of the causative pathogens and may be used to 
guide specific antimicrobial therapy. (3) The lack of PMN or microorgan- 
isms on direct G R  examination should be considered with caution and not 
be interpreted as absence ofpneumonia. (4) Presence of > = 1 SEC/ x 100 
is a useful screening for distinguish between contamination and aspiration. 
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Patients: data (mean SD) are mentioned in the table. Criteria for catheter 
removal was the lack of necessity for further monitoing. After removal, 
distal catheter segments were processed by the roil plate technique. All 
patients, were under chemoprophylaxis with a 2nd generation cephalos- 
porine plus an aminoglycoside. 
Results: Six patients (4.8%) had a posinve catheter culture. Three (2.4%) 
presented catheter infection and the other 3 (2.4%) catheter colonization. The 
isolated organisms were Staph. epidemris niethicfin sensitive (n:4), Staph. cohnii 
methicillin sensitive (n:l), and Strep. faecalis (n:l). Two of the patients died in 
the ICU because of the severity of their disease, one was discharged with 
moderate disability, while the remaining three fully recovered. 
Conclusion: The low infection rate associated with the jugular bulb 
oximetrix catheter should not deter the decision to monitor cerebral 
oxygenation in patients with severe brain insult?. See Table 1. 
Ip10631 Pacemaker infection. Clinical characteristics and 
outcome 
M. Gurgui, F. Montero, A. Mauri, J. Bamo, P. Domingo, A. Sambeat, 
R. Pericas, F. Sanchez, G. Vizquez 
Barcelona, E 
Objective: The aim of the study was to determine the clinical characteristics, 
aetiology, therapy and outcome of patients with pacemaker (PM) infection. 
Patients: From January 1995 to December 1999, 1059 patients (p) had a PM 
implantation (PMI). We retrospectively studied 31 p with PM infection. 
Results: 16 p had generator pocket idection and 15 p had bacteraemia. 
Pocket infection (PI) were caused by S. epidemidis (lo), S. aureus (5) and S. 
enterica (1) Twelve were early infections (< 6 months after PMI) and 8 
(50%) appeared after the initial implantation. All p had local signs and 50% 
had fever. All p were cured: 8 were treated conservatively with antibiotics 
(S. epidermidis) and the others were treated with antibiotics and removal of 
the whole PM. Bacteriemic infections (BI) were due to S. epidertdis (8), S.  
aureus (5) and Gram-negative bacteria (3), 12 were late infections and 10 
occurred after two or more replacements. AU p had fever, 5 had pocket 
infection and 5 had endocarditis diagnosed by echocardiography with 
pulmonary embolism in 3. Eleven p (all p with PI and BI) were treated with 
antibiotics and surgery and 3 died of unrelated causes. There were 6 relapses 
in patients with partial explantation, 1 mediastinitis and 1 pericarditis and 
total removal of PM was necessary for successful outcome. Four h g h  risk p, 
in whom surgery was contramdicated, were treated with antibiotics for 
prolonged period and 3 were cured. 
Conclusions: Infection remain a relatively rare complication of PM insertion 
or replacement. Most infections are caused by Staphylococcus. Pocket 
infection are early infections and bacteraemic infections are late infections. 
In bacteraemic patients echocardiography is useful to exclude endocarditis. 
When possible treatment should include the removal of the entire system 
and prolonged antibiotics. 
v] Jugular bulb Opticath catheter-related infection 
E. Anastasiou, M. Yannakou, E. Geka, A. Euthinuou, 0. Vlahos, 
D. Papakonstantinou, E. Sofianos 
Thessaluniki, GR 
Objectives: Continuous monitoring of global cerebral oxygenation with the 
jugular bulb oximetrix catheter is a useful method for estimating cerebral 
metabolism. It guides therapeutic interventions in patients with severe CNS 
impairment. The aim of the study was to evaluate the incidence of infection 
associated with the use of ths  catheter. 
Methods: One hundred and twenty-two patients that underwent 
continuous jugular venous oxygen saturation (SjvO,) monitoring were 
included in the study. Forty patients (32.78%) suffered head injury, 38 
(31.14%) multiple trauma with head injury, 34 (27.86%) intracerebral 
hemorrhage and 10 (8.19%) underwent clipping of cerebral aneurysm. A 4 
Fr polyurethane fiberoptic catheter (Opticath. Oximetrix, Mountain View, 
CA) was placed in the jugular bulb by a retrograde internal jugular vein 
approach using an aseptic technique. 
p10651 Catheter site infection caused by Vibrio cholerde 
non-01 in dialysed patient 
J. Komarnicka, A. Samet, E. Dziemaszkiewicz, L. Naumiuk 
Gdansk, PL 
Objectives: Vibrio cholerae non-01 (VC) is mainly involved in gastroenteritis, 
septicaemia and wound infections in cirrhotic patients. It is very seldom 
isolated from Polish patients. We present a case of local infection with this 
microorganism. A 29-year-old woman with diabetes mellitus and a 5-year 
hstory of peritoneal dialysis was admitted (March 2000) to Public Hospital 
with Tenckhoff catheter insertion region pain, without fever and peritoneal 
symptoms. The site was erythematous and swollen. Blood pressure was 
decreased, leucocyte counts-6000/mn~-3. Purulent wound exudate was 
taken. Within 18 h at 37°C a pure culture of Gram negative, oxidase and 
catdase positive rod had grown. The bacterium was identified as VC with 
Vitek GNI card and Api 20E test. By NCCLS disk diffusion test the 
organism was susceptible to cephalotin, cefuroxitne, chloramfenicol, 
cotrimoxazole, ciprofloxacine, resistant to ampicillin, piperacdhn and 
intermediate to amoxicillin/clavulanic acid. Therapy wlth ciprofloxacin 
was started but consecutive swabs were s n l l  VC positive. Only after 
replacing the distal pan of catheter, which was VC positive, the swabs from 
the insertion site became VC negative. In reference centre in Warsaw the 
isoiate was identified as VC non 01. Also the presence of heat stable 
enterotoxin was detected. The source of the infection was unknown 
because patient denied any contact with sea water and fresh fish. 
Conclusion: To our knowledge this is the first report of VC catheter site 
infection in literature. This pathogen should be added to the list of 
organisms involved in infections in dialysis patients. 
/p1066/ Comparison of effect of 'Edith Humidifier' and 'Pall 
Filter' on microbial contamination during administration of 
anaesthetics 
A. Kizirgd, M. Aral, M. Ydmaz 
Elazig, TR 
Transmission of microorganisms can be easily encountered during 
administration anaesthetics from the patient to the device and then from 
the device to another patient. The antibacterial filters are used to prevent 
this kind of contamination. In this study we compared the effect of 'Edith 
Humidifier' an older antibacterial filter and 'Pall Filter' a newer antibacterial 
Hter. Edith Hutnidifier were tried in 16 cases, and Pall FiIter were tried in 
16 cases. The swab specimen were taken from filter in side of ventilator and 
side ofpatient, and tracheal aspiration fluid and throat swab specimens taken 
from patients, and cultures fiom all the samples were carried out. Pure 
bacterial growth was detected in throat swabs taken from 8 out of 32 
patients, and n o m d  bacterial flora was detected in remaining 24 patient's 
throat swab specimens. Four St~epfococcz~s pneumonia, two beta huemolytic 
streptococcus, one coagulase negative staphylococcus and one Esckerichia coli was 
isolated from throat swab specimen in these 8 patients presented pure 
bacterial growth. Whde the identical bacteria were also isolated from the 
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same patient in the side of patient in the device during anaesthepia, no 
microorganisms was detected in the side of the device for both 6lter. We 
concluded that both filters used prevented bacterial contamination. 
Ip10671 Transfusion mediated Yeninia enterocolitica 
septicaemia in a beta-thalassaemia patient 
A. Roussos, P. Angelis, M. Stampori, M. Makarona, C. Kapralos, 
P. Garzonis, S. Kanavaki, A. Dalamaga, A. Ferti 
Athens, GR 
Yersinia enterocolitica (Ye), a Gram negative bacillus, is extremely iron- 
dependent. Chronically transfused patients are at increased risk for Ye 
infection. Systemic iron overload and use of iron chelators are responsible 
for this susceptibility. Septicaemia is the most severe manifestation of 
yersiniosis with a high mortality rate. 
We report a case of a 43-year-old female with homozygous beta- 
thalassaemia who was admitted to our hospital because of a 5-day history of 
high-grade fever with chills. She was chronically transfused and on 
desferioxamine chelation. Five days ago and three hours after a three red 
blood cell packs transfusion she developed hgh-grade fever (39.5"C). 
During the following days she experienced 2-3 fever bouts daily, without 
other symptoms. On admission, physical examination revealed a toxic 
patient. Her temperature was 40°C. The laboratory evaluation showed 
white blood cells count 33700/mL (neutrophils: 80%). Neither the imagmg 
studies of chest and abdomen nor the heart Doppler ultrasound revealed the 
site of infection. Ye serotype 0 3  was developed in blood and stool cultures 
obtained on the first and seventh day of hospitalnation, respectively. The 
patient was initially treated with ampicillin and nenlmycin without any 
clixucal improvement. High fever persisted and she also presented right 
lower quadrant pain and diarrhoea. The antimicrobial therapy was changed 
to ceftriaxone plus ciprofloxacin but the response was poor. On hospital day 
18 high fever still persisted and a new CT-abdomen revealed an ileocaecal 
mass. Fortunately, on hospital day 22 the patient recovered completely. Our 
patient had received red blood cell packs from three different donors. 
Antibodies against Ye serotype 0 3  were detected in the senmi of two of 
them. Transfusion-mediated Ye septicemia cases are extremely rare and no 
thalassaemia patient has yet been reported, in the Mediterranean area. A 
modification of policy against Ye red blood cells packs contamination, in 
chronically transfused patients, may be justified. 
Ip10681 Transfusion reaction associated with a bacterial 
contamination of platelet concentrates with Bacillus cereus 
J. Akli, P. Radon, J. Salmon, A. Le Floch, G. Courouble, L. Estepa 
Blois, F 
Bacterial contamination of platelet concentrates remains with the 
haemolytic accident one of the most frequent causes of mortality through 
transfusion. We report a case of platelet transfusion-associated bacterial sepsis 
due to Bacillus cereus contamination. 
A 71-year-old woman, with high-grade lymphoma and thrombocyto- 
penia (10 G/L) received a leucocyte-depleted platelet concentrate produced 
by apheresis (CPA). Rapidly after the infusion began, the patient developed 
fever (40°C) and chills without haemodynamic failure. A Gram stain of 
CPA and of all blood cultures showed gram positive rods identified as B. 
cereus. Antibiotherapy associating piperillin-tazobactam and metronidazole 
was begun itnniediateiy. Outcome was favourable. Several mechanisms can 
explain bacterial contamnation and proliferation in platelets products: 
bacteraemia in the donor, inadequate donor skin preparation or disinfection, 
deficient bags and inadequate bag storage conditions. To  preserve platelet 
integrity, CPA are stored at room temperature (20°C) and bacteria 
accidentally introduced can proliferate rapidly. Any measure to reduce the 
risk of bacterial contamination must be adopted during donation, 
preparation and mstribution of the CPA. Septic signs associated with blood 
transfusion are not specific and require bacterial testing on CPA, blood 
culture, and even donor's arm skin. 
jP10691 Candida contamination of colloid solutions 
A. Freitas da Fonseca 
Porto, P 
A. Gonplves Rodrigues, S. Costa-de-Oliveira, C. Pina-Vaz, C. Tavares, 
Candida species are the third most cormnon organisms reported to cause 
catheter related infections. Septicaemia, the most life-threatening coniplica- 
tion associated with the use of intravascular devices, has been related to 
contaminated infusate. The aim of our study was to evaluate the potential 
contamination of colloid solutions, commonly used for therapeutical 
purposes by Candida species. Albumin (4% and 20%), gelatin and starch 
(6% and 10%) solutions were inoculated with different Candida species and 
the number of colony forming units (CFU) was deternlined at different 
incubation periods. Growth cuwes were determined for each tested strain in 
similar conditions. Additionally the abiIiry to fonn germ tubes was evaluated 
in 12 strains of C. albirans, in the diluted and non-diluted tested colloid 
solutions. No significant growth was detected during the initial six hours of 
incubation in all tested suspensions, under our experimental conditions. No 
noticeable germ tube formation was registered in undiluted colloid$. 
However diluted albumin solution promoted a marked dose-dependent 
increase of germ tube formation rates. Thereby, the tested colloids seem to 
be associated to a low risk of nosocomial primary fungaemia by Candida spp. 
due to its low potential of contamination whenever infused shortly after its 
use. However, albumin solutions by promoting mycelium formation, 
enhance the invasiveness and pathogenesis by Candida organisms. 
v1 Bacterial and fungal growth in thermos bottles: a 
microbiological survey 
R. Watschinger, H. Hutter, G. Fluch, C. Jebelean, L. Binder, M. Haditsch, 
H.  Mittermayer 
Linz, AT 
Introduction: Thermos bottles are used widely in private households as well 
as in the hospital setting. The most frequently used thermos bottles consist 
of five parts: a screw-on top, an O-ring, an isolating bottle, an outer bottle 
and a screw-on bottom. 
Materials and methods: 56 thermos bottles 6om three mfferent hospitals 
and 8 bottles &om private households were investigated for bactenal and 
fungal growth. The bottles were visually inspected for cleanliness and two 
swabs were taken from each bottle, one from the O-ring at the top of the 
bottle and one from the inside bottom of the bottle after taking it apart. 
Results: All of the swabs, both fiom visibly clean as well as from visibly 
contaminated bottles gave rise to bacterial growth; nearly all of them yielded 
fungal growth. We isolated not only Gram-positive bacteria such as 
Micrococcus spp., coagulase-negative sfaphylorocci and Bacillus spp ., but also 
Gram-negative bacteria such as E. coli, Hebsiella pneumoniae, Enterohacter 
aerogenes, Enterobacter agglomerans and other enterobacteriaceae. We also 
found Pseudomonas aemzinosa, Stenotrophomonas ntaltophilia. Acinetobacter 
baumannii, An'nerobacter lumfi and other nonfermentative Gram-negative 
rods as well as yeast species such as Candida spp., Rlmdotomln spp., and 
several molds including Aspetgillus +migatus. 
Conclusions: For use in a hospital, especially in certain risk areas like 
intensive care, oncology and neonatal units, the use of themios bottles 
which can be subjected to thermal processing is highly reconmended. 
v/ In vitro activity of three different types of antibiotic/ 
antibacterial coated/integrated central venous catheters against 
Gram-positive bacteria 
K. Yorganci, C. Krepel, J. Weigelt, C. Edmiston 
Miltvaukee, USA 
Objectives: Catheter related bloodstream infections are a major cause of 
morbidity. Antibiotic coated/inipregnated catheters appear to lower the 
incidence of these infections. We evaluated antibacterial activity of three 
different catheters against Gram positive bacteria. 
Methods: Catheter A was silver sulfadlazine-chlorhexidine impregnated. 
Catheter B contained silver, platinum and carbon. Catheter C was bonded 
with nlinocycline and rifampin. A nonantiseptic catheter was used as the 
control group. Two Gram-positive bacterial strains (S. aureus 
ATCC#29213 and S. epidennidis ATCC#35984 (RP62A) - slime 
producing) were used. 1-cm trisected pieces of catheter were immersed 
in 1-mL of phosphate buffered saline (0.01 mol/L) with 0.25% dextrose 
(PBSD) and incubated at 370C. The PBSD was replaced daily. Removed 
emuents were frozen at -7OOC for subsequent determination of 
bacteriostatic and cidal activity. O n  day 1, 3, 7, 14 and 21 after initial 
immersion, 1-mL standardized inoculum (sufficient to yield 100-1000 cfu 
per segment on control catheter) was added to 15 tubes for a period of 30 
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minutes. The moculum was then replaced with PBSD. One third of the 
samples were immediately sonicated (20 kHz, 60 s) and plated to determine 
bacterial growth. The remaining segments were incubated for 4 and 24 h, 
followed by sonication to determine the bacterial persistence with time. All 
plates were read after 48 h of incubation. 
Results: There was a significant reduction (85.6-99.8%) in the persistence of 
Gram-positive bacteria for the three catheters compared with the control 
group. However, there was no difference between the three treated 
catheters. The results of the bacteriostatic and bactericidal eflluent studicr 
indicated that catheter A’s impregnated agents were bactericidal, and 
catheter C’s bonded agents were bacteriostatic. The antibacterial activity 
from the effluent of catheter A dissipated by 7 days, whlle catheter C 
continued to show activity at day 21. No antibacterial activity was 
measurable in the effluents of catheter B. 
Conclusion: Although there was no antibacterial activity detected in the 
effluents of the catheter containing silver, platinum and carbon, they are 
effective in eliminating Gram-positive microorganisms. The silver-sulfadla- 
zine-chlorhexidine impregnated and minocycline and rifampin bonded 
catheters were also effective in etiminating Gnm-positive bacteria. The 
minocycline and rifampin bonded catheters had no bactericidal activity. 
Infections in transplant recipients 
1-1 Evaluation of infections following liver transplantation 
T. Yamazhan, B. Arda, S .  ulusoy, Y. Tokat, A. Hassan, M. Sertpolat, 
D .  Gokengin 
Izitiir, TR 
Objectives: T o  evaluate post transplant infections in patients with liver 
transplantation. with respect to their distribution, causative agents and 
progresion. 
Materials and methods: A total of 52 patients with a history of liver 
transplantation during the 1994-99 period in the Center for Organ 
Transplantation. Ege University School of Medicine were included in the 
study. The patients were analysed retrospectively accordmg to age and sex 
and the inmunoruppressive therapy used, causative agents of post transplant 
infections, the time to the first infection and the progression of the disease 
was noted. 
Results: Thirteen of the 52 patients were women and 39 men. The ages of the 
patients were 7-62 (mean 20.96). All patients received a standard 
inmunosupressive therapy regimen with azathioprine, cyclosporine A and 
prednisolone. A total of 48 infection episodes in 43 pauents during the first 
year of the transplantation were detected. Thirty-one out of 48 infechons 
(64.5%) appeared in the post transplant first month. The nio% common type of 
infecuon by 75% w a ~  bacterial, followed by viral (12.5%) and mycotic (12.5%) 
infections. The most common sites of infection were the abdomen, urmary 
tract, surgical wounds, catheter, lung and central nervous system, respectively. 
Esdierirlio iuli, Pselrduiriurra amginosa, A~irietubacter spp., and Enterorumr~ were 
the most 6equrntly isolated bacterial pathogens. Overall there were 6 patients 
with v d  inkctiom, 4 symptomauc CMV and 2 HSV. There wac only one 
patient with cryptococcal meningitis. Two patients (3.84%) died in the post 
transplant fint year due to coniplicatiom related to infections. 
Conclusion: The highest risk of infection is in the first 6 months following 
transplantation. Being aware of possible infections in this period and rapid 
diagnosis and treatment are of utmost importance in decreasing the 
mortality rate. 
v/ Documented infections in liver transplant recipients 
D. Paola, S .  Di Donienico, F. Dodi, E. Andomo, A. Antonucci, A. 
Genzone. N Morelli, A. Pellizzari, G. Ardizzone, R. Valente, U. Valente, 
C. Viscoli 
Gfrlon, I 
With the aim of understanding the natural history of infection in orthotopic 
liver transplant (OLT) recipients, we retrospectively reviewed incidence, 
main clinical characteristics, etiology and outcome of documented 
infections developing during the first 3 months after transplant in 91 
evaluable pts. who underwent OLT during a 3-year period, from 1997 to 
1999. The overall incidence ofinfection was 67% (61/91) and did not vary 
significantly based on the year of observation. However, there was a trend 
toward a hgher incidence in the first 2 years of observation (65% and 74% 
vs. 50%). Ou t  of61 pts., 49 (80%) developed infection within 17 days after 
transplant. A total number of 97 episodes was observed (1.06 episodes/pts). 
Based on strict case definition$, we detected 50 bacteraemias (18 with a 
clinically or microbiologically detectable source) and 47 other infections, 
including 11 pneunionias (3 due to CMV), 7 abdonlinal infections, 8 
hepato-cholangitis (3 due to CMV), 2 wound infections and 16 CMV 
reactivations. Among 75 bacterial and fungal infections 88 pathogens were 
isolated. Of them, 36 (41%) were Gram-positive cocci, 43 (49%) Gram- 
negative rods and 9 fungi (10%). During the study period we observed a 
trend toward an increasing incidence of Gram-neg. infections. The rate of 
CMV seropositivity in our patient population was 93% There were 6 
CMV-related diseases and 16 CMV reactivations. The overall crude 
mortality rate at the end of the follow up period was 23% (21 of 91), and 
varied Goni 31% (19161) in pts. with infection to 7% (2/30) in those 
without infection (P= 0.009). In umvariate analysls factors significantly 
associated with the risk of infection (P < 0.05) were the type of transplant 
(patients undergoing split liver transplantation had more infections than 
other patients, in absence of any difference in demographic and disease- 
related factors) and the number of fresh frozen plasma units transfused 
during transplant. O f  borderline statistical significance were the number of 
packed red blood cell units (P=0.07) and the type of vascular anastomosis 
(P= 0.08). In addition, there was a non statistically significant trend toward 
a higher incidence of infection in patients with fulnlinant hepatitis than in 
other patients. 
vl Respiratory tract flora in blood/marrow 
transplantation recipients with acute leukaemias 
E. Mroz, K. Kuzko, E. Dworniczek, A. Seniuk, B. Byczynska 
Wrodaiv, PL 
Objectives: Determination of respiratory tracts flora and its changes among 
AL patients (pts) undergoing auto and allo blood/niarrow transplantations. 
Methods: The group consisted of 71 patients hospitalized in BMT 
Unit of K.Dluski Hospital in Wroclaw and included 31 pts with AML 
and 40 pts with ALL (27 females and 44 males). 42 patients were undergoing 
bone marrow and 14 pts blood transplantations. The autologous 
transplantation group consisted of 15 pts (14 were grafted with blood and 
1 with bone marrow). Microbiological check-up was followed beginning 
from SO days before until 28 days (d) after transplantation. All patients 
received nonabsorbable antibiotics mcluding amphonioronal. Clinical 
manifestations and/or fever prompted to antibiotic treamient according to 
the standard protocol and strain susceptibility testing results. Pharyngeal 
swabs and/or sputum, bronchoalveolar lavage fluid (if indicated) were 
inoculated onto media: MacConkey, Sabouraud, blood and chocolate agar, 
sugar broth. Strains were identified with the use of ATB system 
(bioMerieux, France). 
Results: O n  admmion in 71 pauents the following microorganisms were 
detected: ‘viridans strepturocii’ in 97%. Gram negative cocci in 74%, coagulase 
negative sfuphyfococci (CNS) in 20%, S. aurcur in 17% Enterucurcus spp. or 
Srreptocuccus spp. in 12%, Entembncfenaceae in 17%, nonfermentative bacilli in 
1,5% and Candida spp. in 48% of patients. During the hospitalization (horn- 
50 to-20 d) the percentage of pts colonized by CNS, norifermentative 
bacilli and Candid0 spp. increased to 29%, 7% and 52%, respectively. As a 
result of decontamination (0 d) the percentage of pts with CNS (42%) and 
Ertteroamus spp. (1 1%) increased significantly while colonization of patients 
by other microorganisms was diminished. During the post-transplant period 
(0-28 d) the groups of patients colonized by CNS, Etirerubncteriaieae and 
Cuiididu spp. were still increasing (51%. 12% and 66%, respectively). The 
percentage of pts colonized by ‘uiridunr sfrepfururn‘’ and Gram negative cocci 
was decreasing constantly (74%, 34%, respectively). 
Conclusions: The long period of hospitalization favoured the colonizatlon 
of patient? by CNS, nonfemientative bacilli and Cartdida spp. 
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jP10751 Lower respiratory tract infections in patients after 
transplantation 
D. Jastrztbski, J .  Kozielski, S. Dwomiczak, M. Siola, M. Zakliczyiislu, 
M. Zembala 
Zabrre, PL 
Lower respiratory tract infections remains the leading cause of serious 
complications in patients after heart transplantation. Transplant recipients 
are under iinniunosuppressive regmens so infections becomes acquired 
exogenously through usual nosocomial and community modes or as a result 
of endogenous reactivation of latent organism most often then in other 
population. 
A retrospective analysis was performed on the records of 106 pts who 
underwent heart transplantation at the Dpt. of Cardiosurgery Silesian 
Medical Academy between January 1999 and October 2000. In 34 patients 
(32%) lower respiratory tract infections were observed. In all cases bacterial 
factor was detected in sputum and bronchoalveolar lavage. Most often, in 42 
pts Gram negative stains bacteria was detected. Pseudomonas aeruginosa (1 5 
pts), Acinetobacter baumannii (7 pts) and Eiiterobacter cloacae (6 pts) were 
predominate. Gram positive stains bacteria was detected only in two cases 
(Streptococcus pneumoniae/PRP/and Staphylocorcus aureus/MRSA/). In 2 pts 
we observed lung tuberculosis and in 2 pts yneuniorystis can'nii pneumonia. 
I n  study population we analysed such factors as age of the patients, the 
intensity and duration of immunosuppression, pre-existing diseases and 
timing after transplantation. 
Microflora of throat and faeces in bone marrow 
transplant patients 
N. Petrova, G. Kliasova, T. Tolkachova 
Moscoui, RUS 
Objectives: The goal of this study was to evaluate the microflora of throat 
and faeces in bone marrow transplant (BMT) patients. 
Methods: Fifty patients, with a niedlan age of 31 (range 13-53) underwent 
BMT @ - d o ,  27-auto) were enrolled in this study. The microflora of 
throat (276 smears) and faeces (133) were analysed before BMT, at +7 ,  
+ 15, + 21 days after BMT. All patients received orally ciprofloxacin (480 
mg/day) and fluconazole (200-400 nig/day) for prophylactic infections. 
Results: 
Before BMT + 7 davs + 14 davs + 21 davs 
Throat 
Cram-poitive cocci 63% 74% 75% 56% 
Grain-nrgative bacillus 1 'X 4%) 6% 16% 
Faeces 
Caiididu ~ p p  36% 2 2 4  1 9% 28% 
Coag. nrg. Sfnpli 4U'% 6U% 54% 30'% 
Gram-negative 26% 13%) 23% 12% 
C a n d i h  EPD 29% 26'% 27% 29% 
Among the throat isolated Gram-positive cocci after BMT most often were: 
alpha-, beta-haemolytic or nonhemolytic Sfrepfococri (67%), Aerococcus 
oiridans (17%), Enterococci (7%); Gram-negativtEnterobocfer spp. (1 1/17), 
Acinetobacter spp. (5/17), Ps. aeru@nosa (1/17). 
Thus, microorganisms natural for fieces, i.e. Bijdobacfm'um and 
hctobarilhs were not practically detected by neutropenic patients. Escherichia 
coli titre of which was low (< 4.0 Ig CFU/mL) was found in 80% recipients 
after BMT. 
Conclusion: The natural microflora of throat and faeces in patients after 
BMT was more often represented by the microorganism, which are not 
Malignancy & infection 
usual the normal condition. Gram-positive microflora was prevailed in bone 
marrow transplant patients. 
v] Changes in bacterial and fungal oral flora during 
autologous stem cell transplantation 
H. Loevenich, C. Keulertz, D. Soehngen, U. Bethe, H. Schuett-Gerowitt, 
0. A. Comely 
Koln, D 
Objective: To determine the changes in bacterial and fungal oral flora and 
the severity of mucositis during autologous SCT. 
Methods: From 5 to 10/00 the oral microflora of 4 male patients (age 29- 
49; median: 35) undergoing PBSCT for relapse of high-grade Iyniphonia 
was examined. Days (d) of examinations: before myeloablative BEAM 
chemotherapy (d-6), on the day of peripheral blood stem-cell transplanta- 
tion (do) and on d6, d14 and d100. All patients received prophylactic 
ciprofloxacin 500 mg bid and fluconazole 400 nig qd and mouth rinses with 
polyene antifungals, povidone-iodine and hexetidine. 
Patients chewed on a para& block saliva and then buccal and palatinal swabs 
were taken by the investigators. Following stepwise dution, samples were 
cultured on different plates to evaluate aerobes, gram-negative anaerobes and 
fungi. Severity of mucositis was determined by the Oral Assessment Guide and 
oral pain was self-assessed using a 0-100 visual analogue scale by the patient. 
Results: In all cases a decrease of bacterial and fungal colony forming units 
occurred until d6 (range-85-9996, median 97%). Siniultaneously the 
severity of mucositis and oral pain increased. The remaining flora 
underwent considerable changes in composition, but these were incon- 
sistent between the four patients. Microbial infection of the mucosa by any 
specific oral pathogen was not observed. 
Conclusions: Oral mucositis in high-dose chemotherapy appeared to be 
associated rather with antineoplastic treatment than with bactenal or fungal 
overgrowth. Chemotherapy plus local and systemic anti-infective prophy- 
laxis resulted in changes of the oral microflora. 
Ip10781 Comparative examinations of bacteriuria in 
transplant patients 
Zs. Gal@, A. Rusz, Zs.  Gerlei, D. Gorog, A. Remport, J. Jansen, E 
Sarvary, J. Jaray, F. Pemer 
Budapest, H 
Urinary tract infections are the most common bacterial infections found 
after most of the surgical interventions. The aim of this study was to collect 
data the incidence of urinary tract infections comparing the different 
transplant patients taking into consideration the differences of constitutional 
effects of the imniunsuppressive therapy. Altogether 5238 urine samples 
were examined. The distribution of the patients were: 103 liver transplant 
patients and 947 renal transplant patients. Cultures, CFU determinations 
and the identification were performed by the regular bacteriological 
methods. All samples were prepared by microscopic exanunations. From 
4426 urine samples of the renal transplant patients were found Gram 
negative bacteria in 53%, Gram positive bacteria in 33% and Candida sp. in 
10%. From 812 urine samples &om liver transplant patients were found 
Gram negative bacteria in 49%, Gram positive bacteria in 34% and Candida 
sp. in 14%, respectively. The results has indicated clearly, that the incidence 
and the seriousness of the UTI has not increased by the immunsuppressive 
therapy. There are even more serious factors that have an effect on 
Developing the bacteriuria metabolic disorders, diabetes, anatomical 
disorders of urinary tfact and disorders of urine flow away. 
Objective: The aim of this retrospective analysis was to define the spectrum 
of pathogens isolated and their resistance to antibiotics, in a population of 
neutropenic patients, suffering &om a malignant haematological disease. 
Methods: Out of the 220 hematology patients treated in our department in 
a 2-year period, 52 developed febrile neutropenia during their treatment 
(absolute neutrophil count, ANC < 500/mm3. Specific pathogens were 
isoiated from the blood cultures of 30 out of the 52 neutropenic patients 
/p1079 Common pathogens and their resistance in 
neutropenic haematology patients 
E. Karabatsaki, E. Kalogeropoulou, D. Petropoulou-Mona, P. Tsiodra, C. 
Keramidas, E. Malamou-Lada, A. Efstratopoulos 
Athens, GR 
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(57.7%). These results, as well as the sensitivity of pathogens were evaluated. 
Results: There were 7 out of the 30 neutropenic haematology patients that 
had more than one pathogens isolated in their blood cultures (23.394, 
polybacteraemia). Nearly 49% of the microorganisms isolated in the blood 
cultures were Gram negative, while 46% were gram positive and in 5% of 
the cases, a fungus has been isolated. The microorganisms observed were: E.  
roii 8 (21.6%), S. nureus 5 (13.5%), Hebsiella spp. 4 (10.8%). Eliteromaus spp. 
4 (10.8%). Streptorotius spp. 4 (10.8%), Pseudomonas aerugiginosa 3 (7.9%), 
Staphylococrus coagulase negative 3 (7.9%), Eirterobacter spp. 2 (5.4%), Cutidida 
spp. 2 (5.494, Arirrrtobartev spp. 1 (2.7%) and Corynebaiten'um jeikeium 1 
(2.7%). Sixty-six per cent of the Stapkyloroiius aureus and all of the Coagulase 
negative staphylococcus Isolated were resistant to methicillin. All the 
Pseudornorias aerugimsa isolates were resistant to ceftazidime, tobramycin and 
aztreonani, but there was no resistance to ciprofloxacin or to imipenem. All 
Enterobaiter spp. strains isolated were resistant to ciprofloxacin. There was no 
resistance of the Entmroirirs spp. to vanconiycin. The mortality was 20%. 
Conclusions: the microorganism isolated in nearly half of the cases were 
Gram negative. The commonest bacterium was E. ioli, followed by 
Staphylorociur spp. 
(p10801 Funguria 
A. Valverde-Conde, I .  Femandez-Lopez, M. C. Serrano, R. Claro, 
E. Martin-Mazuelos 
Seuile, E 
Objectives: To study fungal isolates obtained from urine cultures of diabetic 
and 11011 diabetic patients during 18 month<. 
Methods: We revised the clinical histories and the archives of our laboratory 
referred to the patients which uniie cultures were evaluated from January 
1999 to June 2000. The specimens were cultivated on Sabouraud Dextrose 
Agar (Oxoid, Spain) and CHKOMagar Candida (Izasa, Spain). The isolates 
were identified using conventional methods. Colonies recount was reahzed. 
The patients were separated in two groups: diabetics and non diabetics. 
Results: We received 839 uniie specimens for fungal culture. Yeasts were 
isolated in 247 cases. C. ulbiraris was the most kequent (1 13) and C. glubrafa 
(90) wa? the second one. The relationship between C. albicans and C. 
glabrata isolates &om diabetic patients was 40 (41%)/40 (41%); whereas in 
non diabetics patients was 73 (49%)/50 (34%). The colonies recount was 
< 100 000 CFU/mL for the 95% of the diabetic pauents and the 37% of 
non diabetics. 
Conclusions: (I) The relationship C. nlbirans/C. glabuata was lower in 
diabetics that non diabetics patients, due to the greater kequence of C. 
glabrata isolates in diabetics. (2) Because of the low recount in habetic 
patients( < 100 000 CFU/mL) are necessary additional data for differentiate 
between colonization and infection?. 
resistant to methdl in .  All the Pseudomonas aeruginosa isolates were resistant 
to ceftazidime, tobramycin and aztreonani, but there was no resistance to 
ciprofloxacin or to imipenem. AU En~erobacfer spp. strains isolated were 
resistant to ciprofloxacin. There was no resistance of the Enterotoiius spp. to 
vancomycin. The mortahty was 20%. 
Conclusions: the microorganisms isolated in nearly half of the cases were 
Gram negative. The commonest bacterium was E. roli, followed by 
Staphyloiorius spp. 
JP10821 Serological assessment of Herpes group virus 
reactivation in seropositive oncological patients undergoing 
chemotherapy 
M. Georgouh, E. Chinou, E. Tsiganou, E. Skouteli, N. Trobouki, 
P. Golemati 
Athens, GR 
Viral infection is an important cause of morbidity and mortality in 
oncological patients, especially those undergoing chemotherapy. Hevpes 
Simplex Vinis (HSV), Varirelfa Zoster Virus (VZV), Epstein-Barr Virus 
(EBV) and Cytomegalouirus (CMV), all members of the herpes virus group, 
are the most important pathogens, being able to renuin latent after the 
initial infection and be reactivated under immunosuppression. 
Objectives: To assess the serologic incidence of herpes group viruses 
reactivation in seropositive oncological patients undergoing Chemotherapy, 
without previous prophylactic antiviral treatment. 
Methods: Overall 127 pts (66M, 61F), of mean age 45 years, undergoing 
chemotherapy for solid tuniour (n = 68) or haematological rnahgnmcy 
(17 = 59), were xudied serologically before, during and 1 month after their 
chemotherapy course. All patients were IgG seropositive for one or niore of 
the herpes group viruses: HSV: 1041127 (82,6%), VZV: 114/127 (8Y,8%), 
EUV: 108/127 (85%), CMV: 110/127 (86,6%). The presence of IgG and 
IgM serum specific antibodies to HSV, VZV, EBV and CMV was assessed 
using the indirect iinmunofluorescence and enzyme immunoassay (ELISA). 
Results: IgM serum specific antibodies against HSV, VZV, EBV and 
CMV were detected in 7.7% (8/104). 6,4% (7/114), 14.8% (16/108) and 
15.596 (17/110) of the patients correspondingly. The total incidence of 
reactivation was 18.1% (23/127). The incidence ofthe IgM seropositivity 
was not significantly correlated with the patients age or sex and was 
almost identical among the patients with solid tumours and those with 
haematological malignancies. 
Conclusions: The incidence of serological HSV, VZV, EBV and CMV 
reactivation in oncological patients undergoing chemotherapy is not so high 
as to justify the administration of prophylactic antiviral treatment In all cases. 
vl Pathogens isolated from blood cultures and their 
resistance to antibiotics, in neutropenic haematology patients 
E. Karabatsaki, E. Kalogeropoulou, D. Petropoulou-Milona, P. Tsiodra, C.  
Keramidas, E. Malamou-Lada, A. Efstratopoulos 
Athens. GR 
Objectives: The aim of this retrospective analysis was to define the spectrum 
of pathogens isolated kom blood cultures and their resistance to antibiotics, 
in a population of neutropenic patients, suffering from a malignant 
haematological disease. 
Methods: Out of the 220 haematology patients treated in our department in 
a 2-year period, 52 developed febrile nentropenia during their treatment 
(absolute neutrophil count, ANC < 500/mm3). Specific pathogens were 
isolated &om the blood cultures of 30 out of the 52 neutropenic patients. 
These results, as well as the sensitivity of pathogens were evaluated. 
Results: There were 7 out of the 30 neutropenic haematology patients that 
had more than one pathogens isolated in their blood cultures (23.3%, 
polybacteraemia). Nearly 49% of the microorganisms isolated in the blood 
cultures were gram negative, while 46% were Gram positive and in five 
percent of the cases, a fungus has been isolated. The microorganisms 
observed were: E.  ioli 8 (21.6%). S .  uureus 5 (13.5%), Klebsiella spp. 4 
(10.8%), Enterococcus spp. 4 (10.8%), Streptococcus spp. 4 (10.8%), Pseudomonas 
aemginosa 3 (7.9%), Sfaphyloiocms coagufase negative 3 (7.9%), Enterobacter 
spp. 2 (5.4%), Candida spp. 2 (5.4%), An'netobacfer spp. 1 (2.7%) and 
Corynebacterium jeikeium 1 (2.7%). S W - s i x  per cent of the Staphylococcus 
aureus and all of the Coagulase negative staphylococcus isolated were 
I PI 083 I Central venous catheter-associated bloodstream 
infections in patients treated for acute leukaemia 
M. Karthaus, T. Doellmann, T.  Klunasch, S. Weber, G. Heil, A. Ganser 
Bielefeeld, Hannouer, D 
Pts with AL generally receive noncuffed multilumen CVC's for adminis- 
tration of antineoplastic, antimicrobial or parenteral nutntional therapy. 
Fever during aplasia (neutroplul count < 500/pL) has been reported in up 
to more than YO% of pts with AL. Although the origin of fever is often 
assumed to relate to a CVC-infection, data regarding the incidence of 
CVC-bloodstream infections (BSI) are rare in pts with AL. 
Method: The Incidence of CVC-related infection? was analysed in 96 pts 
(42 m/54 t) treated for AL within 215 consecutive chemotherapy cycles 
6-om 1996 to 1999. All pts received a multilumen uncoated CVC (Arrow). 
Insertion sites were inspected daily and covered with a dry dressing and local 
adrmnistration of PVP. Proven CVC-related BSI was defined as the 
isolation of the same species from peripheral blood culture and CVC-tip 
(> 15 CFU Maki technique). 
Results: Within 215 chemotherapy cycles a total of 307 CVC (4432 CVC 
days; mean 14,4; SD 7.9; CVC range 1-4/cycle) were analysed. A severe 
neutropenia (< O.I/pL) was observed in all chemotherapy cycles, with a 
mean duration of aplasia of 15.9 days (SD 8.0)/cycle. Fever w s  noticed in a 
total of 149 out of 215 cycles (69.3%). Inflammation at the CVC insertion 
site was documented in 141 of 307 inserted CVC (45.9%), with fever in 51 
out of these CVC (36.2%). Colonized CVC-tips were documented in a 
total of 44 CVC (14.3%). Fever was observed in 22 out of these 44 CVC, 
however, proven CVC-related BSI were the origin of fever in 8 cycles 
(3.7%) only. All these CVC-related BSI were attributed to coag.-neg. 
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staphylococci, in one episode with Covynebacter sp. in addition. The 
incidence of proven CVC-related BSI was 1.8/1000 CVC-days. 
Conclusion: CVC-related infections were a rare origin of fever (3.7%). The 
incidence of proven CVC-related BSI was low (1.8/1000 d). Local 
inflammation at insertion site was common, however, proved to be an 
unspecific sign for CVC-related BSI. 
1 PI084 I Bloodstream infections in patients with 
haematological malignancies 
N. S .  Bagirova 
Moscow, RUS 
Objectives: To determine of basic pathogens in BSI in PTS with HM. 
Methods: Blood samples were collected from 278 PTS with HM (179 
adult, 99 children) during 3-year period (1997-99). NHL-115, HL-41, 
ALL-60, AML-39, CML-3, CLL-17, MM-3. The bacteraemic episodes 
were classified according to the definitions of the CDC. Laboi-atory 
detection of bacteraemia and fungaemia was perfonned according Cumitech 
1B (Blood Cultures 111, 1997). The strains were identified by the classical 
methods. Antmiicrobial susceptibility testing war perfomied by disk 
diffusion method, accordmg NCCLS recommendations. 
Results: The total number of blood samples obtained for blood culture wac 
602, of which 99 were positive, representing 165% episodes of significant 
bacteraemias (14,0’%NHL, 21.1%ALL, 17.1o/o--AML, 14.3YeCML, 
7.1Y”CLL, 19.3%-HD, but no MM4%).  BSI was confirmed micro- 
biologically in 76 of 278 febrile pts (27.3%). The most frequent pathogens in 
all haemoblastosis types were Gram-positive cocci (47.5% of all isolates). It 
was more often than gram-negative bacilli (30.3% P < 0.02) and fungi 
(12.1%, P < 0.0001). Gram-negative bacilli and fungi were isolated 
significantly more often in 1999 than In 1997 (P < 0.02. P < 0.01, 
respectively). Coagulase-negative staphylococci (CNS) represented 33.3%, 
S. aweus 6.1 %, Streptococcus spp. 4.0%, Enteroroccus spp. 4.0%, Eiiterobacter- 
iaceue 18.2%, P. aeruginosae 5.1%, other nonfermenting Gram-negative 
bacilli 7.1%. yeast 6.1%. mould 6.1’36, Batillids spp. 3.0% (only children), 
Cory~iebactenum spp. 3.0% (only children) anaerobes 4.0% (only adult). The 
antimicrobial resistance of the bacteria isolated from blood was also analysed. 
Overall, 100% CNS were resistant to penicillin, 45.5% to o x a c h ,  53.6% 
to clindamycin, 33.3% to cefazolin, 51.5% to cefotaxime, 57.6% to 
ceftriaxone, 75.8% to ceftazidime, 40% to cefepime, 33.3% to meropenem, 
27.3% to ciprofloxacin, 36.4% to amikacin, 43.3% to gentamicin, and no 
isolate was resistant to vancomycin. 
Conclusion: The results of this trial demonstrate that the predominant 
pathogens in all types HM were Gram-positive cocci. In contrast to results 
found in 1997, Gram-negative bacilli were isolated significantly more often 
in 1999. Yeast and mould were isolated in equal frequency. AU Gram- 
positive microorganism isolated from blood were sensitive to vanconiycin. 
(p10851 Spectra and resistance patterns of microorganisms 
isolated from patients with malignancies 
R. Karakus, E.  Senol, 0. Guzel, M. Yagci, G. Sucak, U. Coskun, N. 
Gunel, R. Haznedar 
Ankara, TR 
Objectives: To determine the spectra, kequency and resistance patterns of 
microorganisms isolated in febrile neutropenic episodes of patients with 
haematological or oncological malignancies over a 31-month period. 
Methods: Samples delivered to our clinics laboratory between January 1999 
and September 2000 were analysed in accordance with the patient data. AU 
samples were taken in neutropenic febrile episodes of cancer patients. 
Susceptibihty tests were performed by disk diffusion method according to 
the criteria of the NCCLS. 
Results: O f  the isolated 530 microorganisms S. uureus accounted for 51 
(9.6%), Enterococcus spp. for 33 (6.2%), E. o l i  for SO (9.4%), Klebsiella spp. for 
20 (3.8%), Pseudonionas spp. for 14 (2.6%) and Acinetobacfer spp. for 15 
(2.8%). Candida spp. were the most isolated microorganisms (n= 135, 
25.5%) followed by coagulase negative staphylococci (CNS) (n = 128, 
24.2%). The isolation samples mostly encountered for S. aureus was to be 
oropharyngeal cultures (31.4%) followed by wound cultures (23.5%). 
Enterococcus spp. and E. coli were mostly isolated from urine samples 48.5% 
and 60%, respectively. Forty-one (32%) of the CNS were isolated from 
blood cultures. The methicillin-resistance (MR) rates for S. aureus and CNS 
were 54.9% and 77.3%, respectively. The resistance rates for S. aureus tested 
for amikacin (AK) (ti = 47), ciprofloxacine (CIP) and tnmethopriin- 
sulfainethoxazole (n  = 50) were 21.3%, 33.3% and 32%, respectively The 
tested number and resistance rates for CNS for the former antibiotics were 
(n  = 116) 28.4% (n = 125) 49.6% and (IZ = 120) 68.3%, respectively. None of 
the tested Staphyiococci or Enterococci were found to be resistant to 
vancomycin. Among the Klebsiella spp. tested 2 (10%) were resistant to 
cefepime (n=20), 2 (11.1%) to amikacin (n=18) and none to imipenem. 
Nineteen (38.8%) E. roli were resistant to ceftriaxone and 11 (22%) were 
resistant to CIP. The resistance rates of E. coli for meropenem ( t t  = 49), AK, 
and piperacillin-tazobactam were 4.1%, lo%, and 14%. respectively. 
Conclusion: This is the first widely encompassing report from our imhtution 
about the bactenal spectra and their resistance patterns observed in  our 
pahents with haematological or oncological malignancies. S. aureus and CNS 
together make up 33.8% of all isolates. This rate shows a shift to Gram- 
positive microorganisms at our institution. Moreover, the high M R  rates 
among the Staphylococci alamv for improving infection control means. 
v1 Corynebacterium jeikeium bacteraemia in a patient 
with acute myeloblastic leukaemia: case report 
C. Kuzucu, E. Kaya, B. Durmaz, S .  Tekerekoglu, N. Altinisik, 1. Aydogdu, 
T. Bayraktar 
Malafya, TR 
Curynehacterirrm jeikeium has been reported to lead to sepsis primanly in 
patients with haematological malignancies. Skin lesions, swelling and bruise 
on the fourth metacarpophalangeal joint, associated with fever, developed in 
a 49-year-old man with acute myeloblastic leukaemia following induction 
therapy. C. jeikeium was isolated from two blood cultures and was found to 
be multiresistant, being sensitive only to vancomycin and teicoplanin. There 
was a symptomatic Improvement dramatically and the patient was cured 
with vancomycin therapy. C. jeikeium must be considered as an ietiological 
agent in patients with haematological malignancies presenting with sepsis. 
Ip10871 Initial empiric antibiotic treatments in childhood 
febrile neutropenia: meropenem vs. ceftazidime plus amikacin 
combination 
B. Antmen, 1. Sasmaz, A. Tanyeli, A. Yaman, E. Kocabas, 1. Bayram, Y. l l i n c  
Adana, TR 
Introduction: In this randomized study, the effectiveness of meropenem 
monotherapy was compared with ceftazidime plus amikacin combination 
for empiric antibiotic therapy in 67 febrile neutropenic episodes in 52 
children with childhood malignancies. 
Methods: The patients were 28 children with acute lyniphocytic leukaemia, 
12 children with acute nonlymphocytic leukaenua, 9 children with 
neuroblastoma and 3 children with non-Hodgkin’s lymphoma. The 
patients’ age range was 11 months to 15 years (mean age 7 years). 
Results: Meropenem monotherapy was used in 38 febnle neutropenic 
episodes (56.7%), and ceftazidime plus amikacin combination treatment in 
29 febrile neutropenic episodes (43.3%). Overall success rate without 
treatment modification was 35.3% with meropenem monotherapy and 
26.4% in the ceftazidime plus amikacin group. These rates were increased to 
84.8% and 80.2%, respectively, with modification. There was no statistical 
difference in the response rate between the two study groups. Both 
treatments were well tolerated. 
Conclusions: These results indicate that initial empiric meropenem 
monotherapy appean to be as effective and well tolerated as ceftazidime 
plus amikacin combination therapy in childhood febrile neutropenia. There 
appears to be a slight trend with meropenem monotherapy for a better 
response without modification. 
p10881 Bacteraemia and fungaemia in patients undergoing 
high-dose chemotherapy with auto-PBPC transplantation 
E. Mroz, K. Kuzko, E. Dworniczek, A. Seniuk, M. Fleischer, A. Lange 
Wroclaw, PL 
Objectives: The purpose of this study was to determine frequency of 
bacteraemia/fungaemia @/f) and aetiological facton of b/f in patients @t~) 
undergoing high-dose chemotherapy (HDCh) with peripheral blood 
progenitor cell transplantation (PBPCT). 
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Methods: 107 pts were undergoing transplantation from 1993 until 1999 
(47 females and 60 males). 49 pts suffered from solid tumours and 58 from 
haematological malignancies. 81 pts underwent single, 19 tandem and 7 
triple courses of HDCh with PBPCT. AU pts received nonabsorbable 
antibiotics and in a caSe of clinical manifestations and/or fever antibiotics 
according to the standard protocol and antibiograni. Microbiologcal check- 
up covered period fiom-40 days before transplantation to 30 days after 
PBPCT. Blood was collected on Hemoline (bioMerieux) or Bactec 
medium (Becton-Dickinson) just after an increase in body temperature, 
usually 30 nun to 1 h after a fever peak. Blood was inoculated onto media: 
blood, chocolate, MacConkey, Tryptic Soy and Sabouraud agar. Identifica- 
tion of bacterial and fungal strains was performed using the ATB system 
@ioMeneux). Data were analysed using a test of Statistica programme. 
Results: The incidents of b/f were observed less frequently in pts before (9/ 
107) than in pts after (33/107) transplantation (8,41% vs. 30.84%, P=0000). 
The frequency of b/f in females and male5 groups was comparable as before 
(8.51% vs. 8.33%, respectively, P=0.4870) as after (31.91% vs. 30.00%, 
respectively, P= 0.4123) transplantation. B/f were observed with s i d a r  
frequency aniong pts with solid tumours and haematological malignancles 
(6.12% vs. 10.34%, P =  0.2176) before transplantation. After transplantation 
incidents of b/f in pts with haematological malignancies in relation to pts 
with solid tunlours were more frequent (24.48% vs. 36.20% respectively, 
P= 0.0971). B/f were caused by: coagulase negative staphylococci, S. 
auretrs, 'viridaiis srreptorocc<, Leucoriostor spp., E. cd i ,  E. cloacae, K .  pneumoniae, 
P. aertrgirrosn. Atirretobacter spp., B. cepacia, S.  maltuphiria, Zygosaccharornym. T. 
cutaneum, C. alhicarrs, C. sake, Rbodotorula minrrta. 
Conclusions: The frequency of bacteraemia/hngaemia was clearIy 
associated with transplantation. These infections appeared equally in females 
and males. 
Ip10891 Monotherapy with meropenem vs. combination 
therapy with ceftazidirne plus amikacin as ernpiric therapy for 
febrile neutropenic bone marrow transplant patients 
G. Kliasova, V. Savchenko, L. Lubimova, L. Mendeleeva, E 
Parovichnikova, T.  Tolkacheva, N. Petrova, B. Singemian 
MOSCOU: R U S  
Objectives: A randomized study compared the efficacy and safety of 
monotherapy with nieropenem vs. combination therapy with ceftazidime 
plus amikacin. 
Methods and results: At study entry, the characteristics of patients in 
meropenem group (22 patients, 23 episodes) were: median age 31 years (16- 
43), alloBMT 12, autoBMT 11, haeinatological diseases (13-CML, 5-HD, 
3-AL. 1-NHL), L < 1.0 x lU"/L in 22/23 pts; cefiazidime plus amikacin 
(20 patients)-median age 36 years (15-50), alloBMT 9, autoBMT 12, 
haematological diseases (I2-CML, 2-HD, 4-AL, 1-NHL, 1 cancer), L < 
1.0 x lO'/L in 20/20 pts. The median duration of neutropenia (L 
< 1.0 x 10"/L) were 13 days (6-108) for meropenem group and 15.5 
days (7-41) for ceftazidime plus amikacin group, during the antibiotic 
treatment-8 (5-13) and 11.5 (3-26) days, respectively. Patientr received 
meropeneni 1 g every 8 h Lv., cefiazidime 2 g every 8 h i.v, amkacin 500 
nig every 8 h i.v. 
Rrruln 
Success mithout 
modification 
Afchnle <it 72 h 
Modification of 
sntihiotic trrannent 
a t  72 h 
Succccr with 
moditicatjon 
plus vancomycin 
DILW miohorenciii U 
Meropenmi Ceftazidimr 
+ amlkacm (17 = 20) 
10/20(50%) 
4/20(20%) 
j/20(2SU) 
The median duration of treatment were 10 (7-13) days for meropenem, 14 
(6-26) days for cefiazidime plus amikacin ( P  < 0.005). An adverse event 
occurred in 12/20 (60%) in ceftazidime with amikacin group, 4/23 (17%)- 
meropeneni group. 2 pts died in ceftazidime plus amikacin group at 38 and 
60 days, 1 pt in meropenem group at 45 days after stopping of treatnient. 
Conclusion: Monotherapy with meropenem is as effective as the 
combinanon of ceftazidime plus amikacin and may be associated with a 
lesser requirement for the addition of glycopeptides and amphotericin B. 
v1 Continuous infusion of ceftazidime for patients with 
breast cancer and multiple myeloma receiving high-dose 
chemotherapy and peripheral blood stem cell transplantation: 
are there different risk profiles? 
G. Egerer, H. Goldschnlidt, M. Hensel, A. Schneeweiss, G. Bastert, A. Ho 
Heidelberg, D 
Background: Within our efforts to develop an outpatient transplant 
program, we have assessed the safety and efficacy of continuous infusion 
of ceftazidime in neutropenic patients after HDCT and PBSCT. 
Material and method: From September 1997 to July 2000, 55 patients with 
breast cancer (54 female, 1 male) and 30 patients with Multiple Myeloma 
(MM) (9 female, 21 male) received a 2-g intravenous bolus of ceftazidime 
followed by a 4-g continuous infusion per 24 h of ceftazidime, using a 
portable infusion pump (Walkmed Pumpe, Logomed, Germany). If the 
fever failed to resolve after 72 h, teicoplanin (400 mglday) or vancomycin 
(2 x 1 g/day) was added. Patient characteristics: Group I: Breast cancer pts: 
Age: median 42 years (range 22-59), days of neutropenia < 0.51111: median 
11 (range 7-17); Group 11: MM pts: Age: median 52 years (range 35-62), 
days of neutropenia < 0.5/nl median 11 (range 7-25). 
Results: 35 of 55 breast cancer patients (64%) and 18 of 30 (CAPS) nlm 
patients (60%) responded to the monotherapy of ceftazidime. After addition 
of glycopeptide antibiotics, 11 patients of group I vs. 9 patients of group I I  
became afebrile. The cause of fever in group I: fever of unknown origin 
(FUO) 49 patients, microbiologically diagnosed infection (MDI) 5 pts, 
clinically documented infection (CDI) 1 pt; cause of fever in group 11: FUO 
21 pts, M D I  7 pts, CDI 2 pts. The proportion of documented infectious 
complications was higher in patients with MM, compared to breast cancer 
patients. No premature interruption of the continuous infusion caused by 
the infusion pump was necessary. 
Conclusion: The antibiotic treatment is efficacious in both groups; the 
proportion of CDI and MDI is significant higher in group I1 ( P  < 0.018). 
1 P I  091 1 Toxoplasmosis after antineoplastic treatment in non- 
Hodgkin lymphoma. Mandate of preventive measures 
S. Garcia Bujalance, C. Ladrbn de Guevara 
Madrid, E 
Objectives: Toxoplasmosis is a well-recognized opportunistic infection in a 
variety of inmunocompromised patients populations, but this infection has 
generally been considered to be unusual in patients with lyniphoprolifera- 
tive or myelopoietic malignancies and bone mamow transplant (BMT) 
recipients. However several recent reviews have reported series describing 
cases of cerebral or disseminated toxoplasmosis following marrow 
tran$antation, mainly in patients who were seropositive before BMT 
and antineoplastic treatment. 
Patients and results: Two cases of toxoplasmosis are reported in patients 
with non-Hodghn's lyniphoma, without graft-vs.-host disease and positive 
serology response for Toxoplasma sp. In case 1, the most important clinical 
features was fewer and neutropenia and good response to selective treatment 
for toxoplasmosis. In case 2, the patient had undergone autologous BMT 
and after six months developed retinochoroiditis by reactivation of 
Toxoplasma sp. She improved greatly after clindamycin therapy. 
Conclusions: The excessive morbi&ty and mortality associated with the 
reactivating form of toxoplasmosis in patient with lymphoproliferative or 
myelopoietic malignancies and either allogenic or autologous BMT 
recipients, requires preventive measures. Pretransplantation serological test 
may help in evaluating the potential risk of toxoplasmosis due to 
reactivation of latent infection and preventive chemoprophylaxis could be 
beneficial for selected patients with positive serology. 
/p1092) Predominant 1/2 serotype associated with listerosis 
in patients with underlying malignancy in the United States 
A. Safdar, D. Armstrong 
Columbia, New York, USA 
Introduction: The antigenic diversity among the cellular (0) and falgdlar 
(H) components of Lisfetia monocyfqenes has lead to serotype determination. 
The serovars l a ,  Ib, lc, 3, 43, 4b, 5 are associated with human disease in 
over 98% of cases. Human listeriosis among the general population in 
United States is vastly (65-80%) due to serotype 4b. 
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Objective: To evaluate prevalence of common serotype among cancer 
patients with listerosis in US. 
Methods: A retrospective analysis of clinical isolates of L. monocytogenes was 
performed during past 50 years at a tertiary cancer centre in New York. The 
three study intervals included 1955-66 (published data), 1970-79 and 1985- 
97. Serotypes were determined by standard agglutination methods at the 
Centers for Disease Control and Prevention (CDC). 
Results: During 1955-66 and 197G-79, 65% and 67% of listerosis was due 
to 1/2 serotype. More recently (1985-97) L. mowocytogerzes infection was 
evenly distributed among 112 and 4b variety. Overall nearly two-thirds 
(60%) of Listerosis in 35 cancer patients belonged to 1/2 serovar. 
Conclusions: The prevalence of 112 serotype among the select population 
ofpatients with cancer in contrast to 4b was unexpected. This may represent 
a strain-related predilection for hosts with dysfunctional T-lymphocytes. Or 
may be related to clonal expansion and nosocomially acquired intestinal 
colonozation with L. morzocytogenes serotype 1/2 among the high-risk 
individuals. It remains unclear whence, the change in Lisfen'a serotypes 
directly impacts disease outcome in the compromised host 
vl Pulmonary nocardiosis in a non-Hodgkin lymphoma 
patient 
K. Hizel, K. Caglar, H. Cabadak, C. Kulah 
Ankara, TR 
Nocardia is usually enters through the respiratory tract and may produce 
infection in the lungs. Pulmonary nocardiosis is a tevere infection especially 
in immunocompromised patients and Nocardia artevoides it the predominant 
species. Therapy poses some difficulties. Although TMP/SMZ is regarded 
as the drug of choice, failure has been reported. The duration of therapy 
required is not well defined. Few cases has been reported with pulmonary 
nocardiosis in the literature. We describe a case of pulmonary nocardiosis 
who was successfully treated. A 33-year-old male patient with non- 
Hodgkin lyniphoma was admitted to the hospital with cough, dyspnoea, 
chest pain, sputum production, and fever on April 1999. He had been 
previously treated several times w t h  chemotherapy and radiotherapy since 
1994. He had received his last cheniotherapy one week before the 
admission. A chest roentgenogram on  admission showed a 4-cm nodular 
lesion in the right upper lobe. Microscopic examination of the sputum and 
bronchoalveolar lavage fluid revealed partially acid-fast and branched, 
Grani-positive filaments whch on culture proved to be Nocardia asteroides. 
Therapy with TMPISMZ and amikacip was started. His symptoms 
improved and control chest films taken after two weeks showed marked 
improvement. The patient was discharged from the hospital with a 
suppressive therapy with TMP/SMZ for one year. He received several 
chemotherapy regimens whde taking TMP/SMZ. After the cessation of 
therapy the patient has done well without any evidence of nocardiosis. 
v1 Acinetobacter infections in cancer patients and 
resistance to antibiotic- 10-year study 
C. Kontou-Castellanou, S. Karachalios, S. Kastellanos, A. Paschah, S 
Konstandopoulou, M. Dima, D. Archontakis, E. Douganioti 
Athens, GR 
Objective: The study examines clinical isolates of Adnetobacter spp. from 
infections of cancer patients and their resistance to antibiotics. 
Methods and results: During the 10-year period (1989-99) a total 7200 
positive cultures from varied clinical specmens of cancer patients were 
found in the Microbiology laboratory of the 'St Anargiri' Oncological 
Hospital. Positive cultures of Acinetobacter infections were grown in 436 
(6.1%) cancer patients. Regarding these 436 cases, A .  bnumanii was isolated 
in 298 of them (68.3%), A .  anitrutus in 49 (11.2%). A .  Iw@ in 8 (1.8%). 
Adcoaceticus in 6 (1.4%) and other Acinetobacter spp. in 72 cases (16.5%). 
Acirzetobacfer bacteraetnia was found in 20 cases (4.6%) with prevalence of A. 
baumanii (13 cases-65%). A total 18 (4.2%) Acinetobacter strains were isolated 
from urine, 42 (9.6%) &om sputum, 47 (10.8%) fiom IV catheters, 261 
(59.9%) fiom bronchial lavage, 11 (2.5%) from wounds, 3 (0.7%) from pus, 
6 (1 -4%) from tracheostomy sites and 28 (6.4%) from other specimens, with 
prevalence of A.  baumanii in all cases except for strains from tracheostomy 
sites (94.4%, 38%, 85%, 65.5%, loo%, loo%, 16.7% and 92.9%, 
respectively). Susceptibility tests were performed by the disk agar diffusion 
test (Kirby-Bauer) against 30 antibiotics. Acinetobacter strains were highly 
resistant to cefaclor (98.4%), cephalothm (96.5%), ampicillin (95.6%), 
cefurozime and tetracycline (95.4%), cefoxitin (94.4%), cefamandele 
(92.9%) and chloramphenicol (92.5%). They were less resistant to 
amoxycillin/clavulanic acid (85.8%), ticarcillin (85.5%), norfloxacin 
(83.8%1), azlocillin (82.7%), aztreonam (82.7%), ciprofloxacin (81.2%), 
ceftriaxone (81%), cefotaxiine (79.7%), gentamycin (76%). ceftazidime 
(75.5%) and cefepinie (74.8%). They were even less resistant to aniicacin 
(70.7%1), netilmycin (68.6%), cotnmoxazole (68.2%), tobraniycine (67.8%) 
and piperacdhn (66.7%). AU Acinetobacter strains were sensitive to imipeneni 
except for A. baumortii strams, which showed a low resistauce to imipeneni 
(18.7%). A .  baumanii strains were also resistant to colistin (14.9%). 
Conclusion: (1) Most Acinefobacter strains were found in specimens that came 
from the Intensive Care Unit of the Oncological hospital. (2) Aririctobarter 
infections in cancer patients are caused by multiresistant strains, are 
associated with very poor prognosis and a high mortality and constitute a 
serious problem in an oncological hospital. 
v1 Bacteraemia by Capnocytophaga spp. in 
inmunocompromised patients-presentation of two cases 
M. Almuzara, S. Palombarani, N. Petracini, A. Tuduri, G. Sly, S. Figueroa 
Sari Martin, RA 
Objectives: Presentation of 2 cases ofbacteraemia by capnocytophaga (C) in 
patients with malignancy and description of its nlicrobiological and clinical 
features, due to a few reports in literature. 
Materials and methods: (1) The medical histories of the appointed patients 
were consulted in order to establish the presence of a solid malignancy, 
oncohaeniatological illness, a previous chemotherapy, neutropenia or oral 
mucositis, all of these, constituting risk factors for the development of 
bacteraemia by (C). (2) (C) was isolated in Columbia agar with 5% sheep 
blood, incubated at 37" with 5-10% COz during 72 h. Identification was 
performed by conventional biochemical tests, following the scheme of 
Holmes, Pickett and Hollis. Eleven antibiotics were selected for suscept- 
ibility testing using Mueller-Hinton agar m t h  5% sheep blood in the same 
itolation conditions. The detection of beta-lactamasa was perfomied by the 
chromogenic cephalosporin method (Nitrocefin). 
Results: In both cases, growth was detected in blood culture bottles, after 2- 
4 days of incubation in an automatic detection system (BacT/ Alert, 
Organon Teknika Corp.).The subcultures developed after 72 additional 
incubation hours. Slender, fusiform Gram negative-rods were observed in a 
Gram stain. All the bacteria gave negative results with the following test: 
catalase, oxidase, indole production, urease, all decarboxylase reactions and 
acid production Lon1 mannitol and xylose. They gave positive results with: 
esculin hydrolysis and acid production from glucose, manose, maltose and 
sacarose. The isolates were identified as C. orhrarea and C. haemolytiru. The 
most active antibiotics were: penicillin, cefotaxime, iniipeneni. chloran- 
phenicol, erythromycin, clindamycin, amoxicillin-clavulanic acid and 
ciprofloxacin, whereas gentainicin, vanconiycin and colistin did not have 
any activity. None of the 2 strains produced beta-lactamase. One of the 
patients had lung cancer and the other one acute lymphocytic leukaemia, 
having both of them received chemotherapy treatment. One of them 
presented oral mucositis and neutropenia. 
Conclusions: Bacteraemia by (C) should be suspected in patients with solid 
tumours or with oncohaematological illnesses associated with neutropenia, 
previous chemotherapy and/or oral mucositis. It must be underlined that 
the isolation of these bacteria from blood samples are always of clinical 
relevance and never represents contaminant agents. 
v1 Can patient with antecedent fungal infection receive 
myeloablative therapy or not? 
E. Soydan, M. Arat, A. Bati, D. Yazman, 0. Ilhan, M. B e k q ,  H. KO$, 
A. Uysal, H. Akan 
Ankara, TR 
Invasive hngal infections are one of the main causes of morbidity and 
mortality in patients with haematological d g n a n c i e s .  Prolonged neu- 
tropenic period, damaged mucosal integrity; chemotherapeutic agents such 
as cytarabine, purine analogues and impaired cellular immunity are risk 
factors for fungal infections in these patients. C a n d i d  infections and 
aspergillus species are the mostly encountered aetiological agents. Clinical 
evaluation of the patient, radiological findings and if possible for eligible 
patients fiberoptic bronchoscopy and bronchoalveolar lavage are preferred 
methods for demonstrating invasive fungal infections. In spite of these 
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diagnostic procedures accurate diagnosis rate is as low as 9%. Ampotericin B 
1-4 mg/kg/day provides improvement in 5040% of the patients. In our 
departnient nine patients with acute leukaemia in induction or consolidz- 
tion phase of their treatment were diagnosed as having invasive fungal 
infection. In four of these patients pulmonary aspergdlosis was demonstrated 
by thorax computerized tomography one of whom the diagnosis was 
verified pathologically and microbiologically afier lobectomy. In two of the 
five patients with hepatosplenic candidiasis microbiologic documentation 
was performed by hepatic biopsy besides abdominal ultrasonography. All 
patients received liposornal amphotericin B in varying doses, 1-3 mg/kg/ 
day (Total: 3-log) according to their clinical status. None of the patients 
had severe side-effects that caused cessation of antifungal treatment. 
Parented amphotericin B treatment stopped when clinical infection 
subsided and radiological lesions were regressed. Itracanazole in a daily 
dose of 400 mg p.0. started as long-term maintenance therapy until 
following chemotherapy. During febrile neutropenic period they were put 
on amphotericin B in doses 1-3 mg/kg/day. One of the patients with 
hepatosplenic cadidiasis also underwent allogeneic haematopoietic stem cell 
transplantation and no progression of the lesions was in amphotericin B 
coverage. Six of these patients are still alive and in complete remission 
except one patient. One of the remaining 3 patients died of progressive 
pulmonary infection and the others died of disease progression free of fungal 
infection. In conclusion previous hngal infections does not constitute an 
absolute contraindication for further myeloablative treatment under 
liposomal amphotericin B application both for prophylaxis and treatment. 
Infections in lCUs 
1 PI097 I Epidemiology of nosocomial infections in six 
intensive care units in Italy 
M. Fiorio, M. Marroni, L. Prattichizzo, M. Bulletti, M. Meoni, C. 
Ferrazzano, P. Favetta, L. Lentischio, F. Della Zuanna, G. Bonaccorso, P. 
Malacame, A. Baraglia, M. Raponi, C. Franchi, G. De Socio, A. Chianella, 
F. Menichetti 
Perugia, Folipo,  Padooa, Pisa, Rorna, I 
Objectives: To describe the epidemiology of NI in 6 ICUs in Unibria, Italy. 
Methods: Using a software for NI surveillance, we analysed data on 
pathogens responsible for infections and their antibiotic susceptibility. 
Results: Since September 1999 to July 2000 (mean period of survey: 9.2 
months), 1048 patients were admitted in the 6 ICUs. The documented 
infections were 31 1 in 222 patient$. Sites of (CAPS) ni were respiratory tract 
(162 episodes, 52%), blood (80 ep., 26%), urinary tract (50 ep., 16%), skin 
and soft-tissues (19 ep., 6%). The 495 isolated pathogens were represented 
by 167 Grani-positive cocci (MR-CNS 45, MS-CNS 7, M L S A  64, MS- 
SA 25, others 26); 284 Gram-negative bacilli (P. aeruginosa 123: imipeneni- 
resistant 26%, ciprofloxacin-resistant 30%, meropeneni-resistant 30%; 
Acitiefobarter spp. 47: meropenem-resistant 0%, inupenem-resistant 22%, 
ampicillin-sulbactam resistant 88%; Enterobacter spp. 15%, gentamkin- 
resistant 90%; E. coli 13); and 44 yeasts (Cartdido albiruns 80%). 
Conclusions: The high rate of niultiresistant pathogens responsible of NI in 
ICUs suggest that need for specific control interventions. 
jP10981 Outbreak of Burkholderia cepacia complex (BCC) 
bacteraemia in a paediatric intensive care unit (PICU) 
S. A. Mihaylova, M.  P. Sredkova, E. C. Kanyovska 
Pleverz, BG 
Objectives: To investigate an outbreak of Bcc bacteraemia and to evaluate 
the risk factors for acquisition of ths  organism in the PICU of the 
University hospital in Plevm, Bulgaria. 
Methods: Epidemiological data were collected from children's treatment 
sheets. Cultures of specimens obtained from children, hocpital personnel, 
and the PICU environment were performed. Traditional methods 
(antibiotic susceptibility profile and biotyping) were used for epidenuolo- 
gcal typing of Ecc. 
Results: Bcc bacteraemia was detected in 21 children admitted to the PICU 
between January 1999 and October 2000. Bacteraemia was mononucrobial 
in 16 episodes and polymicrobial in 5. Two of the children had positive 
pleural punctates for BCC. There was one child with positive central venous 
catheter and another one with posihve conjunctival swab for this organism. 
Bcc was also found in three bottles with intravenous fluids. AU isolates 
belonged to the same biotype and had identical antibiotic susceptibility 
profile. Fourteen of the children were males and seven were females. Their 
ages varied from 7 days to 14 years. The mean PICU stay was 15 days (range 
2-56). Au children had peripheral venous catheters and were treated by the 
same medical staff. Antibiotics mainly prescribed were ceftriaxone and 
amikacin. Twelve children had serious underlying diseases. 
Conclusions: Ths investigation suggests that the acquisition of Bcc is 
associated with hospitalization. The most important risk factors for 
nosocomial Bcc bacteraemia are intravascular interventions and underlying 
hseases. Strict infection control measures should be undertaken to prevent 
similar outbreaks in the future. 
v1 Efficacy and safety of piperacillinltazobactam in the 
treatment of patients with severe infections in intensive care units 
K.-F. Bodmann 
Hildesheim, D 
Introduction: Piperacillin 4.0 g/Tazobactam 0.5 g (P/T) is a widely used 
combination of an extended-spectrum penicdhn and a beta-lactamase 
inhibitor. In order to evaluate the efficacy and safety profile of P /T  in 
patients with severe infections in intensive care units (ICU) this 
postregistrational utilization study was conducted. 
Methods: 1755 patients with a mean age of 62.0 years were treated with P/ 
T with a mean therapy duration of 8.6 days; 61.9% of these were male. 52% 
were suffering &om lower respiratory tract infections (LRTI), 33,7% fiom 
intra-abdominal infections (IAI) and 4,4% from skin and soft tissue 
infections (S/STI). 60% of all patients required mechanical ventilation; 
53% of these infections were nosocomially acquired. 90.5% of all patients 
had concomitant diseases, where cardio-pulmonal diseases were dominat- 
ing. 41.4% of the patients received antibiotic pretreatment while 33.7% 
received concomitant antibiotic treatment. In 78% a microbiological 
analysis was performed. Dominating pathogens were E. coli, S.  aureus, P. 
aevrrginosa and Enterorocci. 
Results: Clinical success was observed in 84.1% of all patients: 84.1% in 
LRTI; 78.0% in IAI and 83.2% in S/STI, respectively. These results were 
contirnied in subanalysis-sets of nosocomially acquired cases (efficacy rates 
of 82.8% in LRTI; 82.9% in IAI; 80.0% in S/STI) and mechanically 
ventilated patients (efficacy rates of 79.2% in LRTI; 80,7% in IAI; 91.3% in 
S/STI). Success rates of the antibiotic therapy were confirmed by 
monitoring of selected laboratory parameters. Microbiological success was 
observed in 72.2% of all evaluable patientc with complete eradication of all 
pathogens. Adverse events occurred only in 12.6% where gastrointestinal 
events were dominating. 
Conclusion: P/T was demonstrated to be a Fafe and effective drug in the 
treatment of ICU-patients with severe infections. Clinical and micro- 
biological success rates confirm the data of previous clinical trials. The safety 
profile of the substance was exceUent confirrmng previous results. 
respectively. 
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/p11001 Profile of surface protein of S. epidermidis isolated 
from newborn hospitalized in an intensive care unit 
M. Bartoszewicz-Potyrala, B. Maczynska, A. Przondo-Mordarska, J. Chiciak 
Wrorlaw, PL 
Objectives: The result of stumes from the last 10 years indicates a significant 
rise of frequency of isolations of S. epidermidis as etiological factors of 
newborn infections. Strains of S. epidevmidis are isolated fiom blood, urine as 
a pathogen responsible for serious and sometimes fatal infections. One of the 
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most important mechanism of virulence of these bactena is their adhesion 
ability. The formation of bonds inade up of adhesins-fimbria-like 
structures-is a specific mechanism of S. epidermidis adhesion to surfaces. 
The aim of the study was to determine the profiles of S. epidermidis surface 
proteins isolated from newborn hospitalized in ICU during one year period. 
Profile of surface protein were used to determine relationship between 
protein patterns of the strains isolated from the same patients or belonging to 
the same species. 
Methods: The total number of 60 S. epidermidis strains isolated from blood, 
urine, skin obtained from newborn hospitalized m the ICU was evaluated. 
Their surface protein were isolated and subjected to electrophoretic 
separation, then profiles obtained after separation were analysed using the 
GEL-DOC UPGAMA (Bio-Rad) software package. 
Results: Considerable similarity of rurface proteins strains originating from 
the same patients, or from the same clinical material shows that in many 
cases surface protein plays an important role in determinations of their 
pathogenic character, which may contribute to correct identification of the 
strain as an etiologic factor of infection. 
pml One month surveillance study of central venous 
catheters and arterial catheter colonization in a cardiosurgery 
intensive care unit 
G. Gregis, A. Grigis, F. Locati, M. Di Vita, F. Averara, S. Cesa, L. 
Donadoni, B. Carrara, V. Ravasio, F. Maggiolo, F. Suter, A. Goglio 
Bergatno, I 
Objectives: T o  evaluate the rate of catheter related bacteraemia (CRB) in 
relation to the incidence of central venous catheter (CVC), arterial catheter 
(AC), pericatheter skin and hub colonization. 
Methods: All the pts adrmtted to cardiosurgery ICU during one month 
surveillance period were enrolled. CVC and AC tips, skin around insertion 
and catheter hub were cultured once a week and every removal. All 
specimens were processed within 3 hours. Bloodstream cultures from CVCs 
and ACs were collected in presence of fever. Incidence rates of colonized 
(count < 1000 CFU) and infected (count > = 1000 CFU) CVC and AC 
were calculated. 
Results: 62 CVCs and 36 ACs from 55 pts were implanted. 52 CVCs and 29 
ACs fulfilled study criteria were evaluated. Mean time of insertion was 7.32 
days (SD 5.95) for CVCs and 7.48 days (SD 11.52) for ACs. Positive 
cultures were obtained from 65.4% of CVC tips and from 38.4% of AC tips; 
42.3% (48% with more than 100 000 CFU) of CVC tips and 11.5% of AC 
tips were considered infected. The global incidence rate of contaminated 
catheters (colonized + infected) was 30.4 per 1000 days of catheterization 
(CVCs) and 18.4 per 1000 catheter-days (ACs). The rate of infected CVCs 
and ACs were, respectively, 19.7 and 5.5 per 1000 catheter-days. Gram 
positive cocci represented 83% of the isolates from CVC tips and 75% 
from AC tips, Coagulase-negative Staphylococci (CONS) being the most 
common isolated (63.3%, 80% methicillin resistant). Gram negative bacteria 
were cultured only &om CVCs and represented the 11.9% of the strains 
(42.8% S. marcexens). One CVC tip was infected with C. albicans. Twenty- 
eight of the 59 strains isolated on CVC and AC tips were also found in 
surveillance skin and/or hub cultures, with a prevalence of s!un/hub 
colonization-related tip infection of 47.5%. CONS (67.8%), MRSA (17.8%) 
and P. aeruginora (3.4%) were the most common. Only one CVC-related 
bacteraemia, due to S. marresrens, was diagnosed and the saine bacterium was 
found in skin and hub swabs (incidence rate of CRB of 0.9 per 1000 
catheter-days). 
Conclusions: Our data confirm, according to the literature, the high rate of 
colonization of CVC and AC tips, and their correlation with skin and hub 
positive cultures. CRB was uncommon in our experience probably because 
of extended use of antibiotics. Even if the sample doesn’t allow to drown 
general conclusions because of the small number of observations, it suggests 
the importance of periodic surveillance programs. 
vl Nosocomial infection surveillance in a neurology 
intensive care unit 
G. R. Yilmaz, M. A. Cevik, F. S. Erdinc, N. Tulek 
Ankara, TR 
Introduction: Patients admitted to intensive care units (ICU) represent 5- 
10% of all hospital patienu, but account for an estimated 25% of all hospital 
infections. 
Methods: AU patients treated at a six-bed neurology ICU were 
prospectively observed for the development of an nosocomial infection 
and device-associated nosocomial infection from 15 March 1999 to June 
2000. The presence or absence of infection by type documented according 
to the standard definitions of the Centers for Diseases Control and 
Prevention (CDC). We used the standard definitions of the National 
Nosocomial Infection Surveillance System Intensive Care Unit surveillance 
component for analysis. 
Results: In 190 patients during 2006 patient days 169 nosocomial infections 
occurred. The overall rate for nosocomial infections was 87.9 per 100 
patient and 84.2 per 1000 patient days. Urinary tract infections (43.2%), 
pneumonia (26.7%) and primary bloodstream infections (1 9.5%) were the 
first three common types of infection. Ventilator associated pneumonia rate 
was 43.5 per 1000 ventilation days, urinary tract-associated urinary infection 
rate was 36.5 per 1000 urinary catheter days and central venous line- 
associated primary bloodstream infection rate was 35.3 per 1000 central 
venous line days. The most common microorganisms isolated were 
Klebriella pneurnoniae (20.6%), Enterococcus ~ p p .  (15.3%) and Cmnfida spp. 
(1 3.7%). 
Discussion: The high infection rates reported in this study may reflect a 
combination of factors related to the underlying illness and exposure to 
invasive procedures. The rates of nosocomial infections differ by the type of 
ICU. This observation suggests that each type of ICU has its own 
epidemiological findings for nosocomial infections and needs periodical 
surveillance studies to guide control measures. 
Prevalence and clonal diversity of hospital-acquired 
Clostridium difficile in ICU and burn units in Kuwait 
V. 0. Rotimi, E. M. Mokaddas, J. S. Brazier, W. Y. Jamal, T.  L. Verghese, 
K. El-Din, T. A. Junaid 
Safat, K W ;  C a r d 8  UK 
Objectives: Clostridiurn d&rile-associated dseases are often driven by nllsuse 
of antibiotics. The use of antibiotics in the ICU and burn unit (UU) of our 
hospitals is often excessive and sometimes defies rationalization. For this 
reason, nosocomial acquisition of C. d @ d e  and ribotypes of isolates were 
studied. 
Methods: Stool/rectal swabs were obtained from consecutive patients on 
admission and at subsequent weekly intervals whde in the units during a 
one-year study period. Isolates were typed using PCR-ribotyping method. 
Results: 13 (7%) of 187 patients in ICU1, 3 (6%) of 51 patients in BU and 
one (6%) of 17 in ICU2 acquired C. dfici le .  Acquisition occurred within 4- 
48 days of adrmssion; 13 (77%) of the 17 positive patients were infected in 
the first 15 days. Ten (59%) developed diarrhoea from whom no pathogens 
other than toxigenic C. d@cile were isolated. The stools of these patients 
also contained toxin A/B. The trigger-antibiotics were mainly the third- 
generation cephalosporins. PCR-ribotyping demonstrated clonal diversity 
among the clinical and environmental isolates. There were 11 distinct types, 
with ribotypes 78 and 10 being the predoininant ones. 
Conclusions: This study provides data which shows that the ribotypes 
prevalent in Kuwait is different &om those found in the UK and USA. All 
the nosocomial diarrhoeal cases in these units during the one-year period 
were due to C. difirile infections. 
v1 Endemic sources and transmission of Pseudomonas 
aeruginora in intensive care units 
D. S. Blanc, I. Nahimana, C. Petignat, A. Wenger, P. Francioli 
Lausanne, CH 
Pseudomonas aeruginosa is found in many aqueous environment and also in 
the intestinal tract of 5-10% of hospitalized patients. This bacteria was 
isolated from several taps in the different intensive care units of our hospital 
which have distinct water systems. In order to evaluate the relative 
importance of this contamination on the patients hospitalized in these units, 
a molecular epidemiological investigation was performed during a none- 
pidemic period of one year. All patients with clinical specimens positive for 
P. aeruginosa were investigated. Results showed that 43% of the cases (57/ 
132) had isolates identical to those found in the taps of the unit in whch 
they were hospitalized. This suggested that the reservoir of these strains was 
probably the water system of the units. Among patients with isolates that 
were not found in the environment, 30% (39/132) had isolates identical to 
those of at least one other patient hospitalized during the same period in the 
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same unit, suggesting patient to patient transmission. In 27% of the cases 
(36/132), the isolates showed a unique typing pattern, indicating that the 
source was probably endogenous. Molecular typing enabled the tracking of 
specific clones and helped to break down the endemic situation into 
microepidemics. The results showed that, in contrast with some other 
investigations of rndenuc setting, environmental sources were found to 
contribute to a substantial proportion of the isolates found in patients. 
Conclusions: Our results demonstrate (i) the transinision of two distinct 
clones of multiresistant A. baumannii in the ICU during the same period (ii) 
the isolates with higher IPM MIC values produced ARI-2, a plasmid- 
mediated beta-lactamase which represents a serious threat for the future of 
carbapenem therapy in an ICU setting; (iii) acquisition of multiresistant A .  
baumannii seems to be a major side-effect of broad spectrum antibiotic usage, 
particularly the carbapenems and quinolones. 
/p1105] Environmental contamination during a carbapenem- 
resistant Acinefobacter baumanii outbreak in an intensive 
care unit 
(p11071 Correlation of antimicrobial resistance patterns of 
Acinefobacter species isolated from intensive care unit and 
nonintensive care unit specimens 
G. Aygun, 0.  Dermrkiran, B. Mete, T. Utku, S .  Urkmez, H. Yasar, 
Y. Eralp, R. Ozturk 
Istanbul, TR Guziuntep, TR 
It is frequent to see outbreaks in the intensive care unit (ICU) with resistant 
strains. Hands of the medical staff and the surface area can be an important 
G. Orhan, A. Bayram, I. Balci 
Although Arinefoburter species usually cause opportunistic infections in 
hospitalized patients, community-acquired infections are also reported 
source during these outbreaks. In this study, a carbapenem resistant 
ArIiic.fo6acter harrinariii (CR-AB) outbreak and environmental contamination 
during this outbreak was investigated. 
Methods and results: Active surveillance was performed in the ICU, 
clinical materials were evaluated in the Clinical Microbiology and Infectious 
Diseases Laboratories by physicians, and the patients were visited daily by 
the sanie physicians. Between May and June 1999, 25 CR-AB strains were 
isolated from 12 of 170 hospitalized patients. 16 of these strains were 
determined as causative agents (7 cases of bacteraemia, 7 cases of 
frequently. As with other opportunistic Gram-negative microorganisms 
antimicrobial resistance IS increasing in An'netobacfer species. 
In this study done from January 1999 to October 2000 we retrospectively 
evaluated antimicrobial resistance patterns of Acinetobacter species in isolates 
identified from intensive care unit (ICU) and non-ICU specimens. 
Fifty-four cases of Acinetobacter infections were isolated from ICU and 52 
cases from non-ICU during this time. Table 1 demonstrates the 
antimicrobial resistance in ICU and non-ICU isolates. 
pneumonia, 1 case of empyenia, 1 case of wound infection 1). These AHTWCROBIALS 
strains are all thought to be the same strain by biotyping and antibiotyping 
but genotyping couldn't been performed. All the strains were sensitive to 
netilniisin and sefaperazone-sulbactam, and resistant to ciprofloxacin, 
iinipeiieni, meropenrm, amikasin, tobramycin, cefepim, cotrimoxazol, 
cefiazidime, cefotaxinie. It was intended to prevent the outbreak with 
appropriate antibiotherapy, isolation precautions, education of the staff but 
it was of no success. Environmental contamination was investigated, and 
intense Aciiietobacrer haunianii colonization was found out in environmental 
samplings obtamed with swabs (22 (39.3%) of 56 samples). Different 
antibiotic sensitivity patterns were obtained in these isolates; but 4 (7.1%) of 
the strains were observed to have the same sensitivity pattern with the agent 
causing the outbreak. Upon these findings ICU was closed, following 
equipment and environmental cleansing, terminal disinfection has been 
performed and controlled with repeated environmental cultures. AU control 
cultures were negative. For some time, this organism was not isolated from 
clinical materials of ICU. Later on it was recovered again in ICU from 
patients coming from other clinics but a recent outbreak did not occur. 
Conclusion: Environmental contamination may have an important reservoir 
role in  outbreaks of ICUs and to overcome the outbreak this contamination 
must be eradicated. 
/p1106( Clonal spread of multiresistant Acinetobacter 
baumannii in a Turkish intensive care unit 
Z .  Gulay, S .  Brown, S .  G. B. Amyes 
rzinir, T R ;  Ediribnrgh, UK 
Objective: Over a 6-month period in 1996, multiresistant A. baurnannii 
were isolated kom 31 ICU patients or 12.8% of ICU admissions. This study 
was undertaken (i) to assm the molecular relationship of the isolates (ii) to 
identify potential risk factors for acquisition, and (iii) to evaluate the 
mechanisms of beta-lactani resistance. 
Methods and results: The MIC50 values for imipenem (IPM), merope- 
nem, ciprofloxacin, amikacin and cehazidime (CAZ) were 4, 2, 64, 64 and 
> = 128 mgL, respectively. The isolates were divided into 3 groups 
according to their beta-lactani resistance profiles: (1) CAZR (CAZ MICs 
> = 128 mgL) (n=20); (2) IPMR (IPM MICs 16-32 mgL) ( n = 5 ) ;  (3) 
IPMI/R and CAZR (CAZ MICs > = 128 mgL, IPM MICs 8-32 mgL) 
(1i=6) .  Analytical IEF and inhibition assays showed that all IPMR isolates 
and two additional isolates that belonged to the 3rd group, produced ARI-2 
carbapeneniase, while the isolates within the 1st group nlainly produced 
enzymes with PI'S of 5.2. 5.6 and 10.0. Likewise, two major PFGE patterns 
(one for AN-2 producers and one for CAZR isolates) were detected after 
ApaI restriction. The major risk factors for infection with IPMR A .  
haumarwii were identified as prolonged stay in the ICU, previous and 
lengthy imipenem usage, quinolone therapy and mechanical ventilation. 
Antimcrobial resistance is markedly mcreased in isolates from ICU 
In order to prevent the spread of multidrug-resistant strains infechon 
correlated with non-ICU isolates for all of the antibiotics tested 
control procedures m ICU should be promptly reevaluated 
Ip11081 Central venous catheter-associated infections in 
intensive care unit patients and antibiotic-resistance pattern of 
isolated microbial strains 
G. Donelli, S .  Bacchiocchi, E.  Manso, C. Pruzzo, G. Samba, P. E. Varaldo 
Roma, Ancona, I 
In this study we investigated the possible microbial colonization, associated 
either with overt or subclinical infection, of 279 central venous catheters 
(CVCs) mostly explanted from neurosurgical patients recovered in the 
Intensive Care Unit (ICU) of the largest hospital in Ancona. Each catheter 
tip was cut in three segments of equal length (about 1 cm) to perfomi: (i) the 
'roU plate' semiquantitative culture method (1); (ii) the quantitative 
sonication procedure (2); (iii) the quantitative Clery technique modified 
according to Moro et al. (3). Microbial colonization was demonstrated for 
83% of positive CVCs by the sonication procedure, 81% by the Maki 
method and 72% by the modified Clery cultural technique. The total 
number of microbial isolates was 54: 61% Gram-positives, 26% Grani- 
negatives and 13% yeasts. Mixed cultures were obtained from 7 CVCs. 
The comparison of results obtained by the three different laboratory 
procedures allowed us to ascertain the involvement of microbial isolates in 
intralurniiial or extraluminal colonization of the CVCs or in both. The 
antibiotic-sensitivity and -resistance patterns of all the isolated nlicrobial 
strains were defined. Oxacilline-resistance was demonstrated in 70% of S. 
awretls strains and in 80% of coagulase-negative staphylococci. A high level 
of multidrug resistance was recorded in some strains of Enterobactev cloacae 
and Pseudomonas aeruzinosa. 
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/p11091 Predictors of fever in cardiac surgery ICU patients 
M. Toma, D. Schmidlin, E. K. Schnud, C. Kuef 
Zurich, CH 
Objectives: To examine the occurrence offever, its causes and risk factors in 
ICU patients after open heart surgery. To study the appropriateness of 
glycopeptide use in this population. 
Methods: Prospective surveillance in cardiac surgery ICU. All patients were 
monitored regardmg use of invasive devices, antibiotics and the occurrence 
of fever (> 39 "C). CDC definitions of nosocomial infections were used. 
Results: The median age of the study population (n  = 59, 71% male) was 62 
years. Median duration between admission and primary surgical procedure 
was 3 days (range 1-21 days). 18 of 59 patients underwent a second surgical 
procedure, performed a median of 6.5 days (range 2-23 days) after 
admission. The median length of stay in the ICU was 2 days (range 1-17 
days). Mechanical ventilation was used for a median of I day (range 1-17 
days). Intra-aortic balloon pump was used in 16 patients for a median 
duration of 3 days (range 2-9 days). In 3 patients haemofiltration w a  
needed for a median duration of 7 (range 2-7 days). CVCs were used in all 
59 patients, 89% were place in the internal jugular vein. The overall use of 
CVCs amounted to 338 days. In 9 instances local signs of mfection at the 
insertion site of the CVC were noted. Fever was recorded in 11 patients. 
Catheter-related blood stream mfection rate was 2.95 infections/1000 
catheter days. Blood cultures were performed in a total of 16 patients and 
remained negative in 13. In 3 patients coagulase-negative staphylococci 
were isolated. Glycopeptides were used in 4 patients for a median of 5 
(range 2-10 days) Other antibiotics were adnlinistered to 16 patients. 
Indications for glycopeptide use were: established bacteraemia in 1, initial 
empiric therapy in 1 patient and for no clear indication in 2 patients. 
Multiple regression analysis revealed ICU stay > 3 days, the use of an intra- 
aortic balloon pump, mechanical ventilation > 3 days, and the use of a 
CVC for > 5 days to be significantly associated with the occurrence of 
fever (P < 0.05), whereas the use of haemofiltration was not. 
Conclusions: The use of multiple invasive procedures in cardiac surgery 
ICU patients is associated with an increased risk for the development of 
fever. Despite an aggressive microbiological workup the aetiology of fever 
in this setting often remains elusive. This may prompt clinicians to use 
glycopeptides inappropriately. Our study identifies a subpopulation of 
cardiac surgery patients at increased risk for fever and glycopeptide use. 
(p11101 Inadequate salivary flow in intubated ICU patients is 
related to mucositis and is a precondition for oropharyngeal 
colonization with Gram-negative bacteria 
P. J. W. Dennesen, A. J. A. M. van der Ven, M. M. Vlasveld, L. Lokker, G. 
Ramsay, A. G. H. Kessels, P. A. M. Keijbus, A. van Nieuw Amerongen, E. 
C .  I. Veerman 
Maastricht, Atnsferdam, NL 
Introduction: Sahva has many properties essential for maintaining oral 
health. Besides lubrication and buffering, saliva is able to regulate the 
composition of the oral flora due to its antimcrobial activity. Patients who 
are admitted to the intensive care unit and require mechanical ventilation 
are at risk for developing ventilator-associated pneumonia (VAP). 
Oropharyngeal colonization with potentially pathogenic microorganisms 
(PPMO)and subsequently tracheal colonization, due to microaspiration, 
precedes VAP. 
Materials and methods: In this prospective study we describe salivary 
characteristics, incidence of oral mucositis, and oropharyngeal colonization 
in ICU patients and compared these results with patients admitted because 
of elective coronary by-pass surgery (CABG). ICU patients were examined 
on admission and subsequently every week during their stay in the ICU. 
CABG patients were examined the day before the operation, one day, one 
week and two weeks after the operation. 
Results: The following results were obtained (1) reduced postoperative 
stimulated salivary flow (SSF)and total salivary IgA output in CABG patients 
and nearly absent SSF in ICU patients; (2) oropharyngeal colonization with 
PPMO in ICU and not in CABG patients; (3) the increase in mucositis 
index in ICU patients is related with the increase in PPMO oropharyngeal 
colonization, especially Enterobacten'aceae and Pseudomoms aerugiginosa. 
Conclusion: In conclusion, inadequate salivary flow in intubated ICU 
patients causes severe xerostomia which in time results in mucositis, a 
precondition for oropharyngeal colonization with Grain-negative bacteria 
in ICU patients. 
/p11111 Prevalence of nosocomial infections in a hospital 
intensive care unit 
Z. Marjanek, I. Barcs 
Budapest, H 
Objectives: To control of nosocomial infections in intensive care unit 
(ICU), to survey incidence and resistance of bactenal/fungal infections to 
antimicrobial agents. 
Methods: Microbial results are summarized weekly. Incidence and risk 
factors of nosocomial infections are analysed. 
Results: A total of 166 patients suffered from infectious diseases were 
submitted during a period since January 1 to October 31, 2000. Sixty-four 
patients (38%) acquired infections at the ICU. Bronchopneumonia occurred 
in 4296, 3 patients had catheter related infections, in 5 patients were 
microbiologically detected blood stream infections. From clinical samples 
Gram positive organisms were isolated in 42.7%, Gram negatives in 45.5%,, 
occurrence of fungal isolates were 10%, that of anaerobes 1.8%. respectively. 
The species predominated were Pseudomoilas aerqitiosa (1 5%). Adwtobarter 
baumanii (8.1%), Enrerococcus spp. (12.3%), and Sfaphylotuaus a ~ r e u s  (7.7%). 
Carbapenems and cefepime were found to be the moFt effective 
antibacterial agents (sensitivity rate was 80% and 71%, respectively). Blood 
culture positivity was 23.1%. The species distiibution showed predomi- 
nance of Gram positives (43.1%) in contrast of Gram negatives (39.4%) and 
yeasts (16.7%). 
Conclusion: Broad spectrum antibiotics, in particular carbapenems and 
fourth generation cephalosporins would be the first choice in the treatment 
of nosocomial infection. 
vl Nosocomial infections: prospective surveillance of 
incidence in six intensive care units in Italy 
M. Fiorio, M. Marroni, L. Prattichizzo, N. Dentini, G. Pesciaroli, T. 
Garzilh, G. Bifarini, P. Fratta, L. Ferri, F. Della Zuanna, G. Bonaccorso, P. 
Malacarne, A. Bara&a, G. Orsi, C. Franchi, M. Venditti, P. Pietropaoli, G. 
De Socio, F. Menichetti 
Perqia,  Foligno, Padova, Pisa, Roma, I 
Objectives: To asses the incidence and to evaluate the feasibility of ititeninit 
continuous surveillance on nosocomial infection (NI) in six intensive care 
units (ICUs) m Italy 
Methods: All data are collected using standardized protocol according to the 
NNIS and HELICS. The main clinical characteristics of the patients, ICU- 
acquired infections, length of exposure to invasive devices and the 
microorganisms isolated are collected, by medical sta& using a personahzed 
software from Epinfo 6.0 program. 
Results: Since September 1999 to July (mean: 9 month) 1048 patieno 
(I 1.407 patient-days) were admitted in the 6 ICUs. In this period 31 1 NI 
were documented in 222 patients (21%)). The range of device-utilization 
ratios in the 6 ICUs was 0.46-0.98 for central line; 0.6-0.91 for ventilator; 
0.97-1 for urinary catheter. The mean of device-associated infections rate 
was 7.5 (range 0-15.1) for CVC-related bacteraemia; 19 (8.4-28.3) for 
ventilator-associated pneumonia and 7.8 (1.2-22) for catheter-associated 
urinary tract infection. 
Conclusions: This is one of the first experiences on multicentre longtudinal 
incidence survey in Italian ICUs. Definitions of the infections (the 
numerator) and of the populations at specific risk (the denominator) wdl 
remain central to vahdation of data. 
v1 First national prevalence study of hospital-acquired 
infections in Greek hospitals 
A. Gikas, J. Papadakis, J. Starakis, S. Levidiotou, P. Nikolaides, G. Kiounlis, 
E. Maltezos, J. Pediaditis, M. Lazanas. E. Anevlavis, M. Roumbelaki, 
Y. Tselentis 
Hevaklion, GR 
A prevalence study of hospital-acquired infections (MI) was carried out in 
14 Greek hospitals, scattered in all Greek territory. 3925 hospitalised patients 
were recorded during the one day study. The overall prevalence of HA1 was 
8.6%. The most common HA1 recorded was the lower respiratory tract 
infection (hospital acquired pneumonia included) (30.3%), following by 
urinary tract infection (24.7%). surgical site mfection (15.1%) and blood- 
stream infection (14.8%). The highest prevalence was observed in infants 
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under one year old (19.7%). However above this age, there is a very strong 
( P  < 0.001) linear correlation between age and rates of HAI. The greatest 
prevalence rate was found in the adult ICU (48.4%), followed by the 
neonatal ICU (30.3%). Patientc who had an operation classified as 
contaminated or dirty had greater prevalence rates of both HAI and SSI 
compared to those with a clean or clean/contaminated operation ( P  < 
0,0001). Positive cultures were found in 51.5% of the cases. The most 
frequently isolated microorganisms were: P. aeruginosa (22.4%), E .  roli 
(11.5%). K. prreunioniae (9.5%) and S .  aureus (8.3%). The administration of 
antibiotics was also recorded. The prevalence of antibiotic use for any reason 
was 51.4%. Between them empirical therapy was administered more 
frequently (26.4%). than rational or prophylactic. Patients with HA1 were in 
higher risk of death compared to the other hospitalized persons [RR 4.64- 
(95% CI 3.52-5.95). P < 0.00011. 
Conclusion: This study provides the first nationwide results on HAL It is a 
pilot study for the development of a network for the surveillance of HA1 
in Greece. 
v) Lessons in nosocornial infection control in paediatric 
cardiac surgery in a new hospital in a developing country 
A. Shahani 
Cocliirr, IND 
Paediatric cardiac-surgical patients are more prone to nosocomial infections 
compared to adults because of longer duration of ventilation and invasive 
lines, more number of infusions and lower immunity compared to adult 
patients. Retrospective analysis of data from 340 paedatric patients and 390 
adult patients who underwent open heart surgery between 1 July 1999 and 
31 Dec 1999 showed nosocomial infection rate of 12.3% in paediatric 
patients compared to 5.9% of adult patients. The measures taken to decrease 
problem of nosocomial infection included installation of laminar flow in the 
ICU for preparation and dilution of pharmacological infusions, installation 
of UV filter in scrub area, regular check on water quality by water cultures 
from OT and ICU area, improving quality control and checks at CSSD for 
sterility, intensive in-house teaching of staff about management of 
intravascular lines and use of intravenous and respiratory filters. With these 
measures the infection rate in next 6 months (1 January to 30 June, 2000) 
decreased to 5.7% in paediatric and 2.9% in adult patients. The measures for 
preventing nosocomial infections in paediatric sardiac surgery patients 
relevant to developing world would be dscussed in detail. 
Pathogenesis and animal models 
Resistance rates in colonizing and pathogen 
bacteria isolated by endotracheal aspiration in intensive care 
unit patients 
R. Karakus, M. Dizbay, D. Arman 
Ankara, TR 
Objectives: To determine the bacterial spectrum and resistance rates in 
colonizing and pathogen bacteria isolated by deep endotracheal aspiration in 
intensive care umt (ICU) patients to selected antibiotics 
Methods: Samples obtained from ICU patients by deep endotracheal 
aspiration (ETA) and delivered to our clinics laboratory between January 
1999 and October 2000 were taken into study. All of the sam les were 
cultured qualitatively and quantitatively in serial dilutions of lo-‘ mL and 
mL.. Antimicrobial susceptibility testings were performed by the disk 
diffusion method according to the NCCLS standards. Bactena grown either 
on qualitative cultures or in mL dilutions were regarded as colonizing 
and those grown in 
Results: The spectrum of isolates and antimicrobial resistance rates are given 
on the tables. Among the isolated microorganisms 55 (49.1%) grew in 
mL dilutions; 21 (50%) of the Pseudomonas spp., 9 (56.3%) of the 
Acinetobader spp., and 4 (36.4%) of S.  aureus were regarded as pathogens. 
AU of coagulase negative staphylococci were regarded as colonizing 
nlicroorganisms. In addition to bacteria, 3 (2.7%) Candida spp. were 
isolated at n L  dilutions. 
Conclusion: The high resistance rates we found in this study is quitely suggestive 
for improving dection control measures and rational use of antibiotics. 
mL dilutions were regarded as pathogens. 
Ip11161 The role of ethanol dependence on Brucella 
melitensis infection in rats 
Z. Yumuk, S. Ozdemirci, F. Erden, V. Dundar 
Koraeli, TR 
Objectives: Alcoholic patients display an increased susceptibility to bacterial 
infections. Once such infections develop, they are usually severer, and some 
are associated with a higher mortality than that found in the nonalcoholic 
population. The infection with intracellular pathogens is prevalent because 
inmiunological abnormalities after both chronic and acute alcohol 
consumption appear to be consistent with a decreased Thl-type immune 
response based on reduced antigen-spechc T cell prohferation and 
increased antibody and autoantibody. O n  the other hand Brucella species 
and the disease spectrum is partially explained by the ability of the organism 
to evade host defence mechanism by virtue of its intracellular existence. The 
spectrum of disease depends on many factors including the immune status of 
host, the presence of other underlying disease or conditions and the species 
of infecting organism. According to literature we reached in that the 
chronically ethanol receiving animals with brucellosis have not been studied 
before. The aim of the present study was to investigate whether the 
chronically ethanol consumption affects brucellosis progression in rat model. 
Method Ethanol receiving (f7 = 17) and ethanol naive (n = 12) adult male 
Wistar rats were used. We used five rats from ethanol receiving group to 
determine blood ethanol levels. Groups, each having 12 rats, were evaluated. 
One group was consisting of chronic alcoholic-dependent rats and the other 
group was consisting of ethanol-naive rats. After ethanol had given to rats for 16 
days, in both groups all rats were exposed to B. melitensis (16 M). 16 days after 
they had exposed to B. melitensis, they all operated for the weight of the spleen 
and liver and for the number of B. melitensis in those organs. 
Results: The weights of naive and ethanol fed rats were s d a r  on  the day of 
challenge ac expected. The number of B. melitensis isolated (log10 cfu) from 
spleen ( P  < 0001) and liver (P < 0001) significantly increased in ethanol- 
dependent brucellosis rats. There were no significant changes by the spleen 
(P= 0204) and h e r  (P= 0977)-body ratio between the same indicated 
paired groups. 
Conclusion: We saw that brucellosis proceeds more serious in chronically 
ethanol receiving rats than naive ones. Since the clinical picture in human 
brucellosis can be misleading and ethanol abuse is a serious health problem 
much attention must be given on this two intersecting groups. 
Development of a new guinea-pig experimental 
meningitis model due to fseudomonas aeruginosa to test the 
efficacy of rneropenern 
J. M. Maiques, A. Domenech, C. Cabellos, S. Ribes. F. Tubau, A. 
Femandez, F. Gudiol, P. F. Viladrich 
Hospitalet del Llobregat, Barcelona, E 
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Meropeneni may be a useful alternative therapy to treat Pseudomonas 
aeruginosa (PA) meningitis. C h c i a n s  have limited experience with this 
disease because of its infrequent presentation. Animal models are useful to 
evaluate new treatment strategies but the established models of meningitis 
infection in rabbits and rats are known to be inappropriate for meropenem. 
We have developed a guinea-pig model of meningitis in order to be able to 
test meropenem in PA meningitis and to compare it with other antibiotics. 
Method: A 27-gauge butterfly needle with infusion set was inserted, 
through the nucal area, into the cisterna migna without the use of any 
stereotaxic system. When clear CSF flowed, 0.1 mL of saline solution 
containing l0Eh CFU ofPA type P-5 was injected intrathecally. Four hours 
later the treatment was started. The antibiotics tested were meropenem 
(MPN) MIC = 1 pg/mL, ceftazidime (CFT) MIC = 2, tobramycin (TOB) 
MIC = 2, cefepime (CFP) MIC = 2 and aztreonani (AZT) MIC = 4, and 
saline solution in the control groups. Drugs were administered by 
intramuscular injection and at equal doses (200 mg/kg.) every 8 h (TOB 
was given 30 mg/kg every 24 h.). Several groups of animals were killed at 
different time points. CSF was obtained by the same way described above, 
to determine bacterial count (50 pL) and antibiotic concentrations. After 
removing the brain, a meningeal sampling in the basilar canal was performed 
with a swab to check residual infection. 
Results: All animals tested developed meningitis after 4 h of inoculation 
with a bacterial titre of4.51 (SD: 0.58) log10 CFU and 16.370 (SD: 12.627) 
WBC per ml of CSF. Without treatment, all animals died within 24 h. The 
results of the different drug regimens are shown in the table below. The 
time beta-lactamic antibiotic levels in CSF were above the MIC was: CFT 
loo%, CFP 100% and MPN > 50%. 
Conclusions: (1) Our experimental model has proved to be useful to assess 
MPN efficacy. (2) Both MPN and the combination of CFT with TOB 
obtained the best results. (3) The meningeal swab may be an adequate tool 
to evaluate residual infection despite negative CSF cultures. 
/p1118/ Toxoid of exotoxin A in pathogenesis of 
Pseudomonas aeruginosa 
M. Sattari, F. Mousavi, A. A. Allameh 
Tehran, IR 
Objectives: Pseudomonas aenrginosa IS an opportunistic pathogen which is the 
cause of severe lethal infectious in immuno-compromised hosts. The most 
important of which is exotoxin A. About of 90% of P. aeruginosa strains 
produce this toxin. Using of toxoid can be helpful in its treatment and 
inhbition of clonizing of this bacterium. 
Methods: Exotoxin A was produced by PA103 strain and purified. The 
amount of toxin was evaluated in mice (LD50%) and ring test against 
specific antitoxin. Antitoxin was prepared by injection of pretreatment 
toxin against formalin (toxoid) m rabbit. The mortality of mice and 
appearance of skin lesions of toxin A were estimated after immunization of 
animals with toxoid. 
Results: The yield of toxin production was about 0.05-0.09 pg/mL. Mortality 
was decreased in mice about 80% aker immunization with toxoid. Skin-lesions 
were not seen in guinea pigs after immunization and using of antitoxin. 
Conclusions: Using of toxoid and specific antitoxin A in Preudomonas 
aeruginosa could be suitable in treatment and delay of pathogenic effects of 
this bacterium. 
/p11191 Protective effect of Pseudomonas aeruginosa 
flagellar antibodies in burn-induced infection in white mice 
M. Sattari, M. Arzanloo, A. Zawaran Hoseini 
Tehran, IR 
Objectives: Pseudomonas aerufinosa is the major cause of septicaenia and 
wound infection in burned patients. This organism has intrinsic resistance to 
antibiotics and capable to acquired other resistance mechanisms. Thus 
antibiotic treatment is unsuccessful in most cases and iinmunoprophylaxis is 
the best practical way to prevention and treatment of these infections. 
Flagellar antigens as many other antigens due to its role in the pathogenesis 
of Prcudomonas aenrginosa is one of the vaccine candidates. 
Methods: Flagella were isolated h m  motile strain ATCC 27853 by shearing 
the tlagella followed by merent cenaifugation to obtain typical tilaments as 
viewed through light microscope by silver stain. Antiserum against the flagella 
antigens were obtained by immunization of rabbits. Contaminating antisomatic 
antibodies were delayed by absorption with somatic antigens of bacteria. 
Resuits: The specificity of absorbed felagellar antiserum was demonstrated in 
vitm by cross-agglutination assay and motility inhibition tests. In uiuo-test (in 
burned mice) indicated that H-antiserum reduced mortahty of infected 
burned mice which were challenged with ATCC 27853 strain, about 80%. 
Conclusions: Flagellar antiserum of Pseudomo~as aenrgiriosa could decrease 
mortality of its infection and also could effect on number of bacteria in skin 
and liver tissues of immunized mice. 
Comparison of vancomycin, flucloxacillin and 
amoxicillin/clavulanate in the treatment of experimental 
endocarditis due to methicillin-resistant and glycopeptide 
intermediate Staphy/ococcus aureus 
J. M. Entenza, K. Sieradzki, M. Giddey, J. Vouillamoz, M. P. Glauser, P. 
Moreillon 
Lausartne, CH; New York, USA 
Background: The emergence of GISA in the clinical environment warrants 
the search for new treatments. A/C was previously shown to be effective 
against EE due to methicllkn-resistant S .  aureus (MRSA). Moreover, the 
development of glycopepdde resistance in MRSA was shown to be paralleled by 
a decrease in methicillin-resistance expression. This phenomenon was recently 
referred to as the 'see-saw effect' (NEJM 1999; 340: 517), and suggests that A/C 
and maybe other beta-lactams night represent an alternative against GISA. 
Aim of the study: To compare the in uifro and in uiuo efficacy of VAN, FLU 
and A/C against two S. aureus clinical isolates (a Van-susceptible parent and 
its GISA derivative) sequentially isolated in the same patient. 
Methods and results: The parental MRSA PC2 and its GISA derivative 
PC3* (VAN MIC = 2 and 16 mg/L, respectively) were used. The MIC of 
FLU and A/C for these organisms was 4 and 2 mg/L and 16 and 4 mg/L, 
respectively. In population analysis profiles, PC2 and PC3* grew on plates 
containing either 8 and > 16 mg/L of VAN, 250 and 32 mg/L of FLU or 
64 and 4 mg/L of A/C. This underlines the above-mentioned 'see-saw 
effect'. Rats with aortic vegetations were challenged with 105 (PC2) or 106 
(PC3*) c h  and treated for 5 days with human-like kinetics of either VAN 
(1 g i.v./12 h), FLU (2 g i.v./6 h) or A/C (1.2 g i.v./6 h). Control rats were 
kded at the start of therapy. Results were (infected rats/totd [median 
(range) log cfu/g of vegehtion]. 
pc2 PC3' 
Cmhds 13113 7.7(47-86) W 7 3 ( i b 8 ! )  
V A N  13113 7.405.94) 78 8.2Q0-9J) 
FLU 11/12 8.8(4.6.97) 982 j j (20.81)1 
MC 4il3' 2.0@.@-4.6)' 1113' 2.000.5.9)' 
t P C  0 U I  vs controls VAN d F L U  ,t P<OOI ys FLU thaapy rEPC2 
Results and Conclusion: Compared to controls killed at the start of therapy, 
VAN was only bacteriostatic against PC2 and &led to inhibit growth of PC3*. 
FLU was ineffective against PC2, but signhcantly decreased vegetation bacterial 
titres against PC3*. In conaast, A/C was successful against EE due to both PC2 
and PC3* GISA isolates. This confirms the decreased ability of GISA to express 
niethicillin-resistance, and him6 the good activity of A/C against both the 
MKSA parent and its GISA derivatives in vim. 
v( Experimental study of clinafloxacin alone and in 
combination in the therapy of ciprofloxacin susceptible and 
ciprofloxacin resistant pneumococcal meningitis 
A. Domenech, C. Cabellos, S .  Ribes, J. Maiques, F. Tubau, Pf. Viladnch, 
J. Liiiares, F. Gudiol 
Barcelona, E 
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In the era of drug-resistant pneumococci, new quinolones may play a role in 
the therapy of invasive pneumococcal infections. Using a rabbit model of 
meningitis we sought to determine the efficacy of clinafloxacin, 10 mg/kg/ 
12 h alone and in combination with rifampin (RIF) 15 mg/kg/d or 
teicoplanin (TEI) 15 nig/kg/d in the therapy of CS or CR penicillin 
resistant pneuniococcal meningitis. Several groups of rabbits were 
iuoculated with a CS pneumococcal strain (MIC CTX 2, PEN 4, CLI 
0.06, RIF 0.06, TEI 0.03, CIPRO 2 pg/nL) or C R  pneumococcal strain 
(MIC CTX 1 PEN 2 CLI 0.5, RIF 0.03, TEI 0.12, CIPRO > 32 pg/mL) 
and 18 h later treated over 26 h. CSF bacterial counts, white blood cells, 
lactic acid and CLI levels (bioassay) were determined at different time 
points. Therapeutic failure (TF) was defined as an increase in 1 log ch/mL 
at any time point. 
Results: see Table. 
I n  the rabbit model, CLI alone was an excellent treatment for CS 
pneuniococcal meningitis being bactericidal at 2 h. Combination with RIF 
or TEI did not improve the bactericidal activity of CLI. Mean CSF peak 
CLI level was 13 times above the MIC of the CS strain. In the CR 
experiments, clinafloxacin was not able to reduce bacterial counts, with 
mean CSF peak CLI level close to the MIC. Our results suggest that a 
moderate decrease in quinolone susceptibility may render these antibiotics 
inadequate for therapy of pneumococcal meningitis. 
jp11zz/ Pharmacokinetic interaction explains lack of efficacy 
of combinations with imipenem or meropenem plus amikacin in 
experimental infections caused by Carbapenem-insensitive 
Acinetobacter baumannii 
M. Bemabeu-Wittel, C. Pichardo, L. Cuberos, M. J. Rodriguez- 
Hernandez, A. Garcia-Curiel, M. E. Jimknez-Mejias, J. Pach6n 
Seville, E 
Objective: To evaluate efficacy of imipenem (IMP), nieropenem (MRP) 
and their combinations with anlikacin (AK) in two models of experiniental 
infections caused by multirresistant A. baurnannii. 
Methods: 61 vitro studies: MIC, bactericidal activity, and synergy. 111 uiuo 
studies: Phamiacokinetics cmdies perfonned by bioassay (IMP, MRP); 
enzyme inununoassay (AK). Experimental endocarditis niodel in rabbit?, 
inoculated with a strain MIC: IMP = 8 g/L and AK = h4 g/L. Expenmental 
pneumonia model in guinea-pigs, mocillated with a strain MIC: IMP and 
M R P =  16 g/L, AK=4 g/L (strain 2). Treatment groupc: 24 h treatment 
course in the groups: control, IMP 60 1ng/K/8 h, AK 15 nig/K/24 h, IMP 
+ AK; and, in the guinea-pig model also: MRP 60 mg/K/8 h and MRP + 
AK. In all groups premortem blood cultures, quantitative cultures of 
vegetations and lungs were pedormed. Variables analysed: mortality, sterile 
blood and tissues cultures, bacterial clearance from tissues. Statistical analysis: 
Chi square, Fisher, ANOVA, and posthoc Dunett and Tukey tests. 
Results: IMP + AK and MRP + AK were synergistic in uitvo for both 
strains. Conibination pharmacokinetics showed a decrease in t,,~ and AUC 
of IMP (29 and 22.9% in rabbits; and 40.8 and 26% in guinea-pigs) and 
M R P  (32 and 25.2% in guinea-pigs) when administered together with AK 
conipared with alone administration. Phamiacokinetics of AK were similar 
when administered alone or in combination with carbapenems. Endocarditis 
model: IhlP reached higher sterilization of vegetations (64 vs. O%), and 
bacterial clearance (3 f 1.8 vs. 6.3 f 1.8 cfu/g) than controls; IMP + AK 
did not improve sterdization (22 vs. 64%), and was wone than IMP in 
bactenal clearance (5.3 f 1.8 vc. 2.9 f 1.7 cfU/g). Pneumonia model: all 
groups reached higher rates of sterile blood cultures than controls; IMP + 
AK (78 vs. 100%) and MRP + AK (100 vs. 90%) did not improve results of 
IMP or MRP; AK (5.3 f 0.4 vs. 7.3 1.1 cfu/g), and M R P  + AK 
(6 f 0.4 VS. 7.3 5 1.1 cfu/g) reached a higher bacterial lung clearance than 
controls; MRP + AK (6 k 0.4 vs. 5.3 f 0.4 cfu/g) did not improve results 
of AK, and IMP + AK (6.6 f 0.2 vs. 5.3 k 0.4 cfu/g) was significantly 
wone than AK. 
Conclusions: Combinations of carbapenems with AK in the treatment of 
experimental infections caused by carbapenem-insensitive strains of A. 
baumannii, do not improve efficacy reached with the most active 
antimicrobial. The decrease in t1,2 and AUC of IMP and MRP when 
used in Combination with AK is the most reliable explanation and warrants 
further evaluation in humans. 
Ip1123/ The enterotoxin equipment of Staphy/ococcus 
intermedius 
K. Becker, C.  van Ei& B. Keller, M. Briick, J. Etienne, G. Peters 
Miiwster, Hanrrover, D; Lyon, F 
Objectives: Staphylococcal food poisoning caused by enterotoxigenic 
staphylococcal strains is one of the main food-borne diseases resulting in 
major economical and public health impact. Unlike as for Staphylococcus 
aureus, only a few and partly contradictory reports mainly based on 
immunological procedures have been published conceming the detection of 
the staphylococcal enterotoxins (SEs) in Stuphylococrus intemedius. 
Methods: Since a systematic screening for the genes of the staphylococcal 
enterotoxlns has not yet been performed for ths  coagulase-positive species, 
we tested a total of 286 animal and 11 human isolates for the presence of 
classical enterotoxin genes (sea, seb, s, sed, see) by using a multiplex PCR- 
enzyme immunoassay (PCR-EIA) system. Culture filtrates of toxin gene 
positive S. intemedius isolates were tested for the production of SEs by the 
means of an enzynunmunoassay and a semiquantitative reversed passive 
latex agglutination test. 
Results: Thirty-two canine-derived S. intennediur isolates (1 1.2% of 286 
animal isolates) were found to be positive for a s gene coding for the canine 
type of staphylococcal enterotoxin C (SEC). In addition, one of the human 
isolates harboured the s gene. The production of this enterotoxin could be 
immunologcally confirmed in 30 of the s positive strains. Regarding SE 
genes sea, seb, srd, and see, all isolates tested displayed negative amplification 
results in the multiplex PCR. 
Conclusions: This study shows both on a molecular and immunoiogical 
level that S. intemedius harbours the equipment for enterotoxin C 
production and may play a role in the aetiology of staphylococcal food- 
borne poisoning. S.  intemedius chould not be disregarded when screening 
food products for contamination with potentially enterotoxin-producing 
pathogens or studying outbreaks of food poisoning. The use of 
amplification-based methods offers an alternative way for the rapid and 
specific detection of the toxin gene equipment of enterotoxigenic strains 
even for strains without or with very weak production of SEs under 
culture conditions. 
v1 Activity of antifungal drugs in an animal model of 
zygomycosis due to Apophysomyces elegans 
E. Dannaoui, J. F. Meis, P. E. Venveij 
Nijmegeri, NL  
Objectives: Apophysomyces elegans is an uncommon filamentous fungus 
responsible of severe mfections, even in immunocompetent patients. The 
aim of this study was to evaluate the in uitro and in uiuo activity of 
amphotericin B (AMB) and itraconazole (ITZ) against Apopkysomyces 
elepzs. 
Methods: The test isolate was recovered from a patient with severe 
osteoniyelitis. In uitm susceptibility testing was perfomied using a NCCLS- 
based microdilution technique (M38-P). For in vivo experiments, 
nonimmunocompromised mice were infected intravenously with spore 
suspensions. A preliminary study was performed to determine the lethal 
dose 90% (LD90). Treatment was started 2 h after infection and continued 
for 10 days. ITZ was given by gavage twice a day at 100 mg/kg/d and AMB 
was given at 4.5 nig/kg/d by once intraperitoneal injection. Lower dosage 
of AMI? were also tested. Efficacy was evaluated by mortality rate and by 
fungal InfechOn in organs. 
Results: The MICs of AMB and IT2 were, respectively. 2 and 0.5 p g / d  
after 24 h of incubation, and 4 and 1 pg/nL after 48 h. The LD90 wac 
3 x 10' spores/mouse. For the treatment experiment, a disseminated and 
lethal infection was obtained. Hyphae were demonstrated in kidneys, 
spleen, liver, and to a minor extend in the brain. All control mice receiving 
no active therapy died by day 3-6. In comparison, there was 100% survival 
for mice receiving AMB. ITZ was also active with 60% survival at the end 
of the experiment. 
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Conclusion: (1) A disseminated infection was obtained in nonimmuno- 
compromised mice with a relatively low inoculum. (2) AMEI showed a good 
antifungal activity in uiuo despite high MIC in uitro. (3) A good coi~elation 
between in uitro activity and iti viuo outcome was observed for ITZ. 
1 P I  125 1 Therapeutic efficacy of intravenous moxifloxacin in a 
murine model of severe systemic mixed infection with 
Escherichia coli and Bacteroides fragilis 
C. Eckhardt, K. Fickweiler, R. Schaumann, G. Ackermann, A. C. Rodloff 
hip+, Halle, D 
Background The therapeutic efficacy of intravenous Moxifloxacin (MOX) 
was studied in an experimental model of a systemic aerobic/anaerobic 
mixed infection and compared to therapies with either Imipenem (IMP) or 
Ciprofloxacin (CIP) plus Metronidazole (MET). 
Methods: Mice were intravenously infected with approximately 2.5 X lo6 
cfu of E.  roli and 2 x 1 O7 cfu of B.jagi l is .  Intravenous therapy was started 24 
h post infectionem @.i). Mice were treated with either 2 x 2 mg bid MOX, 
2.4 mg tid IMP or 2 mg bid CIP plus 2.4 mg bid MET, respectively, for 
three days. A control group of 20 mice was left untreated. Survival rate a t  
day 7 p.i. was recorded, mice were then sacrificed and bacterial organ 
contents of livers and hdneys were monitored. 
Results: All mice treated (20 per group) survived at day 7 while six mice of 
the untreated group had died. Two of the MOX treated animals displayed 
> lo3 cfu E .  roli in livers and/or kidneys, while five of the IMP treated 
animals and two of the CIP plus MET treated animals were positive for E. 
coli. B.ja@lis was not detected in any of the treated mice. In surviving mice 
of the untreated group, E. roli alone was found in livers and/or kidneys of 
eight animals and E. roli and B.  jiagilis were detected in two mice. 
Conclusion: In sumniary we showed, that all three regimens tested were 
equally successful in reducing lethality. MOX was at least as effective in 
clearing bacteria from animal organs as the other treatment options. Our 
results suggest that MOX should be studied in severe mixed aerobic/ 
anaerobic infections in intravenous monotherapy. 
I P I  126 1 Comparison of efficacy of penicillin, ceftriaxone and 
vancomycin in experimental endocarditis caused by 
5treptococcus pneumoniae with different susceptibilities of 
penicillin 
C. Pichardo, M. E. Jimbnez-Mejias, A. Garcia-Curiel, F. J. Caballero, 
I. Moreno, M. J. Rodriguez-Hernindrz, L. Cuberos, J .  Pachbn 
Seuille, E 
Objective: The objective of this study was to compare the efficacy of 
penicillin, ceftriaxone and vancornycin using a bacteraemic model as 
experimental endocarditis caused by S.  pneumoniae with different suscept- 
ibilities to penicillin. 
Methods: We evaluated the efficacy of penicillin (PEN), ceftriaxone 
(CRO) and vancomycin (VAN). New Zealand rabbits were inoculated 
with 106-107CFU/nL of S. pneumoniae susceptible to PEN (S) (MIC: 0.01 
pg/niL), intermediate to PEN (I) (MIC: 0.25 pg/mL), and resistant to PEN 
(R) (MIC: 2 pg/nL). The strains S and I were susceptible to C R O  and 
VAN; the strain R was intermediate to C R O  (MIC= 1 pg/nlL) and 
susceptible to VAN. The rabbits received during 72 h no treatment (CON), 
PEN (50.000 and 200.000 U/kg/l2 h, for the strains S-I and R, 
respectively), C R O  (40 mg/kg/l2 h), VAN (15 and 25 mg/kg/l2 h, for 
the strains S and I-R, respectively). Quantitative blood, vegetation and lung 
cultures were performed. MIC, MBC, timekill curves were studied. 
Statistical analysis: Fisher, ANVVA, and posthoc Dunnett and Tukey tests. 
Results: In uitro studies:PEN and VAN were bactericidal against the three 
strains of S. pneumoniae used, whereas C R O  did not show in vitro 
bactericidal activity at any used concentration. In uiuo studies: There were 
no sterile tissues (vegetations, lungs and blood cultures) in the control 
groups. All treatment improved the sterilization of all tissues (77.7-100%) in 
relation to the control groups (0%) with the three stram ( P  < 0.01). All 
treatment groups improved the bacterial vegetation clearance (log cfu/g) for 
the three strains of the study-Strain S: CON, 8.5 k 1.3 vs. PEN, 1.7 k 0.3; 
CRO, 2.4 0.5; VAN, 1.9 i 0.6; (P < 0.01)-Strain I: CON, 8.0 f 1.7 
VS. PEN, 2.2 k 0.8; CRO,  1.7 & 0.3; VAN, 2.2 k 0.4; ( P  < O.Ol)-Strain 
R: CON, 8.9 * 0.3 vs. PEN, 2.1 + 1.0; CRO,  2.2 k 0.8; VAN, 
1.9 0.5; ( P  < 0.01). The clearance of cfu/g from lung and c f d d  
from blood was better with all treatments than in control groups for the 
three strains of the study ( P  < 0.01). N o  differences were detected among 
the different treatments. 
Conclusions: Penicdlin is as efkctive as ceftriaxone and vancomycin in 
experimental endocarditis, caused by S. pnetrmoiriae strains with MIC of 
penicillin up to 2 pg/mL. In oitro, penicillin and vancomycin are more 
bactericidal than ceftriaxone. 
Are 5taphy/ococcus aureus small-colony variants 
involved in pathogenesis of a foreign body-associated 
cutaneous infection? 
B. Sadowska, J. Gatkowska, W. Rudnicka, B. Rbzalska 
LOLL, PL 
Objectives: Small colony variants (SCVs) of S. aureus cause various 
persistent and reiapsing infections. SCVs survival advantages are achieved by 
a defectiveness in electron transpon which provides protection from the 
immune system, antimicrobial peptides and some antibioucs. We report on 
the involvement of SCVs in the pathogenesis of cutaneous foreign body- 
associated staphylococcal infection. 
Methods: Mice ( n =  1Wgroup) were inoculated S.C. either with a clinical 
ttrain or its SCV variant (107). Both kinds of inocula contained nlicrocanier 
dextran beads. The mice were observed daily and examined for 
dermonecrosis and abscess size until sacrifice 3 days later for enumeration 
of live bacteria persisting in the abscess, axillary and inguinal lymph nodes 
and in the spleen. The number and phenotype (SCV or normal) of 
recovered bacteria was determined. 
Results: The SCV inoculated mice displayed significantly lower severity of 
local abscess and lower bacterial burden in the spleen and lymph nodes 
compared with mice inoculated with the parental strain. However, the 
recovery of SCVs f?om organs of mice inoculated with a parental strains as 
well as recovery bacteria presenting a normal staphylococcal phenotype, 
from nlice inoculated with SCVs, proved an iiz viuo conversion. 
Conclusions: The obtained results indicate that S. aureus SCVs are less 
virulent than parental strains in a murine model of foreign body-associated 
cutaneous infection. However, a possibile conversion/reversion of 
phenotypes in uivo suggests a necessity of including, in diagnosis for S. 
aureus, of microbiological procedures suitable for detecting and antibiotic 
susceptibility testing of SCVs. 
Supported: KBN Grant no. 4PO5A07518 
Ip11281 Use of an ascending urinary tract infection mouse 
model to study Escherichia coli response to mecillinam treatment 
M. B. Kern,  N.  Frimodt-Mder, F. Espersen 
Coperrhapi, DK 
Background: The treatment efficacy of lower urinary tract infections (UTIs) 
rely on the concentration of antibiotics in the urine or tissues in the urinary 
tract and the MIC-value ofthe bacteria. We studied the effect ofmecdlinam on 
two E. roli strains with varying MICs toward$ mecdlinam using a mouse model. 
Methods: 50 pL of saline containing 5 x lo7 bacteria was inoculated 
transurethrally into the mouse bladder. Samples of urine, bladder and 
kidneys were collected and CFU/mL or CFU/organ were detemlined. 
Eleven human UTI isolates of E.  mli (10 type 1 fimbriated) with different 
mecillinam MIC-values were tested for their uropathogenicity in the 
model. Corresponding to a standard human daily dose of 822 nig 
mecillinarn, 0.5 mg S.C. per mouse of mecillinam was administered BID 
to the animals the day after infection and over the next three days. Unne 
and serum samples were collected for niecillinam concentration deterrmna- 
tion. Among the 11 tested strains two E. coli with MIC-values of (A) 0.5 
and (B) 16 pg/mL, respectively, were selected for infection and treatment 
with mecihnam. Mice infected with A were followed two weeks after end 
of treatment. Mann-Whitney test was used to compare the untreated and 
treated group ( P  < 0.05). 
Results: The 11 tested strains produced infection in (no. infectedlno. total): 
37/40 in urine, 51/55 in bladder, and 57/105 in kidneys, respectively. The 
mecillinani dose resulted in serum C,,,,,,r of 18 pg/mL, and AUC-total serum 
of 399 pg x min/mL, and urine C,,,, of 341 5 pg/mL with AUC-total urine 
of 88590 pg x min/mL (in humans approximately 72000 pg X n l i n / d ) .  
The effect defined as the CFU difference of log median control nlice-log 
median treated mice were in urine/bladder/kidneys, respectively: (A) 
4.78***/1.77***/3.00***; (I3) 1.84/2.18/2.69* ( P  < 0.05). After end of 
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treatment the log CFU in the urine/bladder of the treated mice infected 
with A were as follows: 1 day after (d.a.): 0/3.2; 4 d.a. 4.W4.1; 8 d.a. 1.8/ 
3.4 and 14 d.a. 0/2.8. There were no bacteria in the kidneys at any time 
after end of treatment. 
Conclusion: There is a significant effect of mecillinam on strain A in urine, 
bladder, kidneys and for strain B only in the kidneys. This could indicate 
that the mouse model might be used to investigate in viuo breakpoints. The 
persistence of susceptible bacteria in the bladder after end of treatment has to 
be investigated further but could perhaps be due to biofilm formation. 
Serological study of chemically different Klebsiella 0- 
antigens obtained by two methods 
B. Maczynska, A. Przondo-Mordarska, J. Chiciak, D. Kisiela 
Wroclaw, PL 
Objectives: The iipopolisaccharides of Klebsiella bacilli are element playing 
an important role in infections with these bacteria, particularly in endotoxic 
shock. Klebsiella rods are regarded as the second, after E. coli, microorgan- 
isms responsible for Gram-negative bacteraeinia. The releasing of LPS into 
bloodstream leads to dangerous and Me-treating pathophysiologcal 
reactions is a serious therapeutic problem. The aim of this study are the 
serological relationships between chemically different LPSs extracted from 
Nebriella strains. These investigations inay be the basis to obtain the 
preparations useful to prevent endotoxic shock or specific antisera 
neutralizing the released LPS. 
Methods: K. prieumoniae references strains (LPS serotypes 0 1  - 0 7  and 012)  
and K .  oxytoca and K. prreuniotiiae clinical strains were tested. In order to 
obtain the specific 0-antisera as well as purified LPSs, all strains were 
transformed into uncapsulated variants. The LPS preparations were obtained 
either by phenol extraction fiom K(-) variants or from SDS-proteinase K 
whole cell lysates. The LPSs were separated by SDS-PAGE and were 
analysed by Westem blotting with different 0-antisera using system Gel- 
Doc 2000 (Bio-Rad). 
Results: The structurally identical ( 0 1  and 0 6 )  and sirmlar ( 0 3  and 0 5 )  
Klebsiella 0-antigens showed cross reactions with 0-antisera, but not in all 
cases ( 0 1  and 02) .  O n  the other hand some of chemically different O- 
antigens also demonstrated cross-reactivity (01  and 0 3 ,  0 5  with many 0- 
antisera). The antiserum against 01 serotype contained broad spectrum of 
antibodies, neutralising many serotypes of Klebsiella 0-antigens. Degrada- 
tion of capsulated Klebsiella strains with proteinase K leads to higher level of 
cross-reactivity with 0-antisera than in the case of pure LPSs obtained by 
phenol extraction. 
Conclusions: Despite the differences in chemical structure of Klebsiella 0- 
antigens, the formed antibodies often demonstrated the cross-reactivity. For 
the antibody production iri vivo, the arrangement of epitopes on the cell 
surface seems to be more important than the linear structure of LPS. The 
01 serotype may play the crucial role in construction of preparations useful 
in the therapy of the sepsis caused by Klebsiella. 
jp113oj Assessment of cefotaxime in treatment of murine 
experimental infection due to extended spectrum beta- 
lactamase producing Klebsiella pneumoniae strains 
R. Mighavacca, S. Ciochetta, P. Micheletti, L. Benedetti, M. Polimeni, L. Pagani 
Pauia, 1 
The antibacterial activity of cefotaxime against Klebsiellapneumoniae 96 strain 
and two its transconjugants SHV-2a and SHV-2 beta-lactamases producers was 
evaluated using an experimental model of sepsis in immunocompetent mice. 
Methods: Bacteria were inoculated intrapentoneally in mice as well as the 
antibiotic. The efficacy of the drug and therapeutic protocols were assessed 
by counting viable bacteria recovered from peripheral blood of treated and 
untreated mce.  The pulmonary infection was evaluated by histological 
assays K. ytreumotriae 96 was a chnical strain, its transconjugants SHV-2a and 
SHV-2 producers were obtained by mating with SHV-2a producing K .  
pireutnotiiae TN2, responsible for an outbreak in a neonatal ICU, and with 
SHV-2 producing E. mli C600 as donors. 
Results: The MICs of cefotaxime with an inoculum of 5 log10 CFU/mL 
were as follows: for K. prieunionine 0.5 pg/mL, for its cefotaxime-resistant 
transconjugants 16-32 p g / d  when SHV-2a was implicated and 3 2 4 4  pg/ 
mL when SHV-2 was implicated. In the first series of in viuo experiments the 
cefotaxime was injected at the dose of 150 mg/kg ofbody weight, 3 and 9 h 
after infection. In each experiment blood samples were collected at 3, 6, 9, 
20 and 30 h from infection. At each time point histological sections oflungs 
were examined. The second series of experiments was the same except that 
the antibiotic was administered at 3.7 and 11 h after infection. Both of these 
treatments induced a decrease in bacterial counts. The efficacy of the 
cefotaxime was quantified by comparing the bacterial counts in the blood of 
treated and untreated mice at each time point. In the first series of 
experiments performed with two drug injections, cefotaxime was able to 
fully eliminate only K. pneumotiiae 96, while in the second series of 
experiments which were camed out with three injections of the drug, the 
antibiotic resulted to be effective against K. pneumoniae SHV-2a and SHV-2 
producing strains with a decrease of 80% and 85%. respectively, in the 
number of viable bacteria recovered from blood samples. No emergence of 
beta-lactam resistant organisms or with increased MICs were detected 
during treatment. 
Conclusions: Experimental results obtained from this animal model may 
help in the design of further protocols for clinical trials. Our observations 
suggest infact that the effectiveness of cefotaxime in the treatment of 
experimental infections caused by extended-spectrum beta-lactamase- 
producing K. pneumoniae may be highly dependent on dosing regimens, 
even for a specific organism and site of infection. 
/p1131( Comparision of activities of some antibiotics against 
a TEM-1 and SHV-5 producing (ESBL) strain of KIebsiella 
pneumoniae in a neutropenic mouse thigh infection model 
2. Odabasi, H .  Atalay, M. Bicakcigd, H. Kocak, H. Tezcan, L. 
Mulazimoglu, V. Korten 
Istanbul, TR 
More than 50% of nosocomial Klebsiella isolates are ESBL (extended 
spectrum beta-lactamase) producing strains in tertiary care centres in 
Turkey. Some of those isolates are also resistant to p-lactam/ p-lactamase 
inhibitors and aminoglycosides. Whether any p-lactain agent except 
carbapenems could initially steal time against such pathogens is unknown. 
The in viuo activities of meropenem (M), piperacillin/tazobactam (P/T), 
cefepime (CEF) and ceftazidime(CAZ) alone and in combination with 
amikacin (AK) or isepamicin (ISP) were compared in a model of 
neutropenic mouse thigh infection with a clinical isolate of K. pneumoniae 
producing TEM-I and SHV-5 p-lactamases. MIC values of antibiotics 
against the study isolate were as follows (pg/mL.): M: 0.125, P/T: 128, 
CAZ: 256, CEF: 128, AIC 32, ISP: 1. To simulate the human 
pharmacokinetics renal impairment was performed by uranyl nitrate. After 
inoculation of 105-106 cfu of K. pneunioniae strain, each m c e  group was 
treated with (mg/kg/24 h): M: 50, CAZ: 100, CEF: 65, AK: 15, ISP: 15, 
PIT (8: 1): 300 alone and with combinations of P/T + AK, CEF + AK and 
P/T + ISP. At the end of 24 h of treatment mean viable bacterial counts of 
each m c e  group were as follows (log10 &/thigh): untreated control: 
10.19, CAZ: 9.12, M: 4.49, P/T: 8.83, CEF: 8.40, AK: 8.73, ISP: 4.70, P/ 
T + AK: 7.90, CEF + AK: 7.81 and P/T + ISP: 4.67. Combinations of p 
lactam antibiotics with amikacin were not effective to decrease the mean 
viable colony counts of the study isolate. Although isepamicin was able to 
decrease the initial colony counts of the study isolate, its combination with 
P /T was not more effective than ISP alone. 
p1132) Serum resistance in stenotrophomonas maltophilia: 
comparison of clinical and environmental strains 
L. Mooney, E. Ingham, M. Denton, K. G. Kerr 
Leeds, UK 
Background: Stenotrophomonns maltophila has emerged as an important 
nosocomial pathogen associated with an ever-expanding range of clinical 
syndromes in severely debilitated and irnmunocompromised patients. The 
management of related infections is problematic as S. maltophilia is resistant 
to many currently available antimicrobials, including the carbapenems. 
Despite reports of high mortality rates being associated with S. maltophilia 
sepsis, putative virulence factors are not well understood. In Gram negative 
bacteria, resistance to the bactericidal effects of human serum often 
correlates significantly with strains from cases of septicaemia. Indeed, 
preliminary work has shown that significantly more S. maltophilia clinical 
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isolates (from blood cultures) are serum resistant compared with environ- 
mental mains. Accordingly, we have expanded this study to include a 
greater number of isolates from both sources. In addition, to determine 
whether the S. tnaltuphilia isolates are resistant to the classical and/or 
alternative complement pathway, strains were used in an indirect 
immunofluorescence assay. 
Methods: Bacteria at mid-exponential phase were incubated with pooled 
human serum (or heat-inactivated control) for 0, 1, 2, and 3 h. Cultures at 
each time point were spread-plated onto tryptone soya agar plus yeast 
extract and colonies enumerated. Serum resistance was defined as an 
increase, in colony forming units, of the original moculum during the 
incubation period. Immunoflurescence assay: heat-fixed bacteria were 
incubated with pooled human qemm on a multispot slide, following 3 
washes, goat antihuman IgG conjugated to fluorescein isothiocyanate was 
added to bind to any antibodies which had adhered to the bacteria. 
Results: Significantly more clinical strains (1 1 /22) were resistant to human 
serum than environmental strains (2/12) (P= 0.05). Immunofluorescence 
indicated that there was antibody to S. mallophilia within the aliquots of 
pooled human serum examined. 
Conclusions: These results suggest that clinical strains are significantly more 
likely to be resistant to the antibody-mediated complement system as well as 
the alternative pathway. These attributes could contribute to the 
pathogenesis of infection, which we intend to investigate by correlating 
clinical outcome with serum resistance. 
v/ Effects of ibuprofen on nitric oxide levels during 
endotoxic shock 
A. Akbulut, I .  Celik, P. Vural, M. Canbaz 
Elazig, Istanbul, TR 
In endotoxic shock, proinflammatory cytokines induce nitric oxide (NO) 
synthase and consequently increases plasma nitric oxide levels. In the present 
study we aimed to determine the effects of ibuprofen, a known 
prostaglandin synthetase inhibitor, on plasma NO levels during endotoxic 
shock. The expenments were carried out in a rabbit model. For this 
purpose, animals were divided into 4 groups and to each group 7 animals 
were allotted. The first group served as control animals and were only given 
saline. In the rest of the animals, endotoxin was administered. To the 
animals in the thrd group, ibuprofen, were given 30 min before endotoxin 
administration and in the animals of the fourth group, ibuprofen were given 
30 min following endotoxin administration. Animals were monitored 
through the canulation of femoral arteries and venules under the complete 
anaesthetic. At 0, 30, 60, 90, 120, 180 and 240 mnutes, arterial blood 
pressure, heart rate, total blood count and N O  determinations were carried 
out. Ibuprofen before the endotoxin administration was more effective in 
controlling the increase in heart rate. Ibuprofen was also effective in 
inhibiting the sudden reductions in blood pressure if administered before 
endotoxin. However, if administered after endotoxin injection, ibuprofen 
seem to precipitate the reduction in blood pressure further. Ibuprofen 
reduced the N O  production which was induced by the endotoxin 
administration. In conclusion, during endotoxic shock, ibuprofen admin- 
istration seem to prevent sudden reductions in blood pressure and to 
decrease NO synthesis. 
Diagnostic methods for Mycobacteria 
vl Comparative evaluation of BDProbe Tec system with 
Roche Cobas Amplicor for the direct detection of mycobacterium 
tuberculosis complex 
R. Wejbora, W. R. Pohl, G. Hackel, F. Kummer, P. M. Bayer 
Vienna, AT 
Objectives: (1) Clinical Evaluation of BDProbe Tec system. (2) To test 
performance and work flow in routine laboratory. 
Methods: Respiratory specimen n = 248 (223 sputa/25 bronchial secretion 
were tested for Mycubactenum tuberculosis (MTB) complex using acid-fast bacilli 
(AFB-Ziehl Neelsen, Polymerase Chain reaction assay; Roche Diagnostics 
Cobas Amplicor (automated amplification, simultaneous detection of MTB and 
internal control) and homogenous S m d  Displacement amplification (SDA) 
BDProbe Tec. After clarification of discrepant results by review of the patient’s 
c h c a l  data we compared the results of conventional Loewenstein-Jensen 
culture and Bactec (460) radiometry liquid culture. 
Results: Sensitivity, specificity, positive predictive value (ppv.), negative 
predictive value (npv.) and efficiency (e&) were calculated for AFB, Cobas 
Amplicor and BDProbe Tec. AFB sensitivity was 59%, specificity 10096, 
ppv. loo%, npv. 8796, eff. 89%. Cobas Amplicor sensitivity was loo%, 
specificity 99%, ppv. 8996, npv. 100%, e& 99%. BdProbe Tec sensitivity was 
98%, specificity 98%, ppv. 97%, npv. 99% and eff. 98%. 
Conclusion: BDProbe Tec system showed in our study high performance, 
rapid diagnosis, easy handling and excellent sensitivity. 
v1 Comparison of BacTlAlert 3D liquid culture system 
and Lowenstein-Jensen solid medium for recovery of 
mycobacteria in a routine diagnostic laboratory 
A. Camcajo, N. Fonsale, A.-C. Vautrin, G. Aubert 
Saint-Etienne, F 
Objective: To compare the rate of recovery of mycobacteria and the time to 
detection using BacT/Alert 3D (Organon Teknica, USA) and Lowenstein- 
Jensen (LJ) medium. 
Methods: A total of 931 clinical specimens (536 bronchoalveolar lavage 
fluid, 198 sputum, 49 gastric aspirate, 21 urine, 5 pleural fluid, 28 
cerebrospinal fluid, 40 abscess, 40 tissue biopsy, 2 peritoneal, 4 pericardial, 2 
ascitic and 6 synovial fluid) from 780 patients were tested from 1 December 
1999 to 30 September 2000. Specimens were processed according a standard 
protocol using sodium dodecyl (lauryl) sulfate (SDS)-NaOH decontamina- 
tion for respiratory and urine specimens. 
Results: Mycobacteria were identified in 49 (5.3%) specimens (16 smear- 
positive, 33 smear-negative): 45 Mycobacferium tuberilrlusis complex, 2 M. 
malmoense, 1 M .  gordonae, 1 M .  auium. Recovery rates for all mycobacteria 
were 93.9% and 79.6%, respectively, for BacTIAlert 3D and LJ medium. 
The recovery rates for M .  tuberculosis complex were 93.3% and 84.4%, 
respectively, for BacT/Alert 3D and LJ medium. In smear-positive (15 
specimens) and smear-negative samples (30 specimens), the mean times to 
detection of M.  tuberculosis were 18.6 and 24.8 days, respectively, with LJ, 
and 13.9 and 19 days, respectively, with BacT/Alert 3D. In addition, the 
Accuprobe test for M .  tuberculosis complex identification showed excellent 
sensitivity with BacT/Alert 3D cultures. 
Conclusion: BacT/Alert 3D is more efficient and faster than LJ for recovery 
of mycobacteria. 
v/ Usefulness of a new mycobacteriophage-based 
technique for the rapid diagnosis of pulmonary tuberculosis 
P. Onis, P. Berlanga, N. Gali, F. Alcaide, S. Blanco, M. A. Benitez, 
J. Dominguez, P. Pedroso, V. Ausina, R. Martin 
Barcelona, E 
Objective: To evaluate the diagnostic value of the PhageTek (TM) MB kit 
(Organon Teknika Corporation, Durham, USA) for pulmonary tubercu- 
losis compared with standard culture and staining techniques. 
Methods: A total of 857 respiratory specimens from 652 patients between 
February and October 2000 were studied by both: (a) conventional methods 
(direct microscopic examination [ZN], and culture in BacT/ALERT 3D 
and solid media); @) PhageTek (TM) MB assay. These phenotypic test 
utilizes specific mycobacteriophages to detect the presence of live M. 
tuberculosis complex (MTB) organisms within a decontaminated (N-acetyl- 
r-cysteine-NaOH) clinical sample. 
Results: A total of 95 (1 1%) specimens were positive for mycobacteria (63 
patients): 65 MTB, and 30 (32%) nontuberculous mycobacteria (NTM) 
isolates (20 M. kansasii, 5 M .  xenopi, 2 M .  gordonae, 2 M. auium-intrurelullare, 
and 1 M. chelonae). (Table 1) 
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The sensiuvity, specificity, and positive and negative predictive values of the 
PhageTek (TM) vs. culture for MTB, were 64.6%, 98.5%, 77.8%, and 
97.196, respectively, whereas for Z N  vs. culture for MTB were 70.8% 
98.5%, 79.3%. and 97.6%, respecuvely. 
Conclusions: The PhageTek (TM) is a rapid (48 h), specific, and easy to 
perform test. However, its utility as a screening test for the routine diagnosis 
of respiratory tuberculosis could require an improved sensitivity, according 
to the prevalence of disease in the population studied. 
v] PCR in the laboratory diagnosis of pulmonary 
tuberculosis: which and how many samples 
J. Sintdes, R. Costa, T. Carvalho, N.  Dias, J. Aguiar-Nogueira 
Porfo, P 
Introduction and objectives: About one year ago we introduced polymerase 
chain reaction (PCR) for rapid diagnosis of tuberculosis. Based on the 
cultural confirmation of pulmonary tuberculosis (PT) we evaluated 
retrospectively the kind and number of PT patients specimens tested by 
PCR to get best sensitivity while containing costs. 
Material and methods: In a 9-month penod (November 1999 to July 2000) 
we tested 1006 samples- 645 sputum, 100 gastric aspirates (GA), 165 
bronchial washings (BW), 89 brochoalveolar lavage (BAL) and 7 lung 
needle aspirate specimens for diagnosis of PT by P C R  (Cobas Amplicor, 
Roche) and culture (MGIT, Becton Dickinson). The specimens were 
digested and decontaminated with the NALC-NaOH method and the 
sediment analysed by both methods. PCR internal control was always 
included. Other samples subnlitted were only cultured. During this period 
64 patients were culture positive for M .  tuberculosis. From these, 41 had only 
sputum samples, 8 GA, 6 bronchoscopy specimens, 6 brochoscopy and 
sputum, 3 sputum and GA, 1 sputum and lung needle aspirate. To assess PCR 
sensitivity for each kind and number of specimens in detecting F T  patients we 
considered PCR hue positives those corresponding to patients with growth of 
M .  tuberculosis in the sanie or another sample !?om the same patient and PCR 
false negahve a negative(s) result(s) in a culture positive patient. 
Results: Including all kinds of specimens, PCR detected all the 64 patients 
(100% sensitivity). For sputum the sensitivity obtained with only one sample 
was 78.496, but 2 or 3 samples were tested the sensitivities were 88.2 and 
96.1%. For GA the sensinvities with 1, 2 or 3 samples were 54.5, 72.7 and 
81.8%, for BW 90.9% and BAL 71.4%. In patients with sputum and an 
invasive specimen submitted, in all but one, sputum was PCR positive. 
Conclusion: The PCR good sensitivity of 3 samples of sputum make it a first 
line method for the rapid diagnosis of PT. The rapid answer and a good 
conmunication between the laboratory and clinicians can sometimes spare 
patients painful and costly invasive procedures. 
Ip1138 1 Evaluation of four different extraction methods for 
rapid detection of Mycobacterium tuberculosis resistance 
mutations in sputum samples 
A. C. Llanos, M. Ruiz,  M. J. Torres, A. Arroyo, J. C. Palomares, J .  Aznar 
Seville, E 
Objective: To evaluate the etlicacy of four different extraction methods for 
rapid detection of Mymbarten'um tuberculosis resistance mutations to rifampin 
and isoniazid ni sputum samples, when used in conjunction with real-time 
Lightcycler PCR. 
Methods: Thirty sputum samples obtained *om patients diagnosed of 
having tuberculosis with documented auramine counts, attended at the 
H.U.V. del Rocio in Sevde were studied. The saniples were extracted by 
the following methods: DNA IV (Unipath S.A.), Respiratory Specimen 
DNA Extraction method (Roche Diagnostic), Chelex-100 and boiling/&eezing 
method. Al DNA extracts were ampIified with the primer for rpoB and katG 
genes in a rapid real-time PCR using the Lightcycler instrument (Roche). 
Results: Firstly, all the four extraction methods were tested in 10 samples 
with 1-1 0 acid fast bacilb per field with the following PCK positive results: 
lo l l0  (loo%), with DNA IV, 4/10 with the Roche method and Chelex- 
100 and 8/10 with the latter. Secondly, DNA IV and boiling/heezing 
methods were used in 30 sputum samples with documented auramine 
counts, including 12 samples with less than lAFB/per field. The results 
obtained were 96.6% positives and 33% positives, respectively. 
Conclusion: DNA IV extraction method was the most efficacious for DNA 
extraction, detecting resistance mutations in all tested samples with 
auramine count higher than one acid fast bacilli per field and in the 82% 
of the samples with less than 1 acid fast bacdh per field. 
(p1139) Comparison of BACTEC 460 system with the egg 
based Lowenstein Jensen media, for isolation of mycobacteria 
from clinical specimens 
N. Esen, N. Yulug 
Izmir, TR 
Mycobacteria are reemerging as important cause of human disease. Recent 
technological advances in the clinical mycobacteriology laboratory have led 
to faster detection and identification of mycobacteria. BACTEC 460, the 
commercial broth system, detects the production of 14C-labelled CO? as an 
early indicator of the growth of acid fast bacilli. We compared its 
performance to that of egg based Lowenstein Jensen media. After processing 
with N-acetyl-L-cysteine-NaOH, 826 specimens were cultured in parallel. 
An identical volume of sample was inoculated in each media and incubation 
was camed out for 6 weeks. By performing both methods mycobacteria 
were isolated from 37 specimens, of these 23 (62%) were positive by both 
methods while 6 (16%) were only detected by Lowenstein Jensen and 8 
(22%) were positive only with the BACTEC 460 system. The use of 
combination of both methods was statistically significant compared to 
positives detected by only Lowenstein Jensen or BACTEC. These results 
suggest that BACTEC and the egg based Lowenstein Jensen media must be 
perfoimed together for optitnuni recovery of mycobacteria from culture. 
v1 Mycobacterium isolation in Bactec 960. A study 
developed during one year 
R. Cias, A. Benitez, F. de la Tome, J .  J. Picazo 
Madrid, E 
Objective: Evaluation of new automatic radioactive system to isolate 
mycobactena m liquid medium, by means of its comparison with 
Lowenstein-Jensen (LJ) solid medium. 
Methods: A total of 5051 clinical samples were seeded in LJ and 
Mycobactenal Growth Indicator Tube medium (MGIT). Incubations times 
were 60 days for LJ medium and 35 days for MGIT. N-acetyl-L-cysteine 
(MicoPrep system) was used like digestion-decontamnation methods. 
Results: A total of 357 (7%) isolated strains of Mycoburfen'um with chnical 
significance were recovered horn 5051 specimens. 336 (94.1%) were 
isolated with MGIT (313 M .  tuberculosis, 21 m. avium and 2 m. kansasir] 
while only 280 (78.4%) were isolated in LJ medium (269 M .  tuberculosis, 10 
M .  uviurn and 1 M. kansusii). The mean of detection of Mycobacterium were 
13.3 days in the MGIT system. The samples with smear positive had an 
average growth tune of 9.5 days while the samples with smear negative was 
15.5 days. The contamination rates were higher with MGIT than with LJ 
medium: 7.9% (404 samples) in MGIT and 4% (204 samples) in LJ. 
Conclusions: Our  results show that BACTEC 960 is an automatic 
nonradiometric system easy to use, more simple and more sensitive than 
Lowenstein-Jensen medium. Time needed for detecting Mycobacterium 
growth is significant shorter with this method than with traditional system 
in solid medium. 
v1 Diagnosis of tuberculosis by conventional and 
molecular methods 
H. Fegou, M. Christofidou, M. Sevdali, E. D. Anastassiou, G. 
Dinlltracopoulos, I. Spilioponlou 
Putras, GR 
Tuberculosis is a disease of increasing importance. Case detection and 
effective treatment are two of the key factors required for better control. 
The development of polymerase chain reaction (PCR)-based tests specific 
for mycobacteria allow the direct identification a t  a species level both in 
clinical specimens and in liquid media. New growth-based strategies such as 
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the MB/SacT (Organon Tekmka) and the BACTEC 9000MB (Becton 
Dickinson) have been also developed. A total of 2161 clinical specimens 
were received during one year period at our department for the 
identification of acid-fast bacilli. Respiratory specimens (n = 1797) after 
decontamination and all specimens derived from sterile sites ( ) I  = 364) after 
centrifugation were examined by Ziehl-Neelsen staining and inoculated on 
Loewenstein-Jensen (L-J) medium. A group of 775 selected samples (715 
respiratory and 60 nomially sterile fluids)were further inoculated in vials of 
aforementioned automated systems. These 775 selected specimens were 
tested by PCR (Aniplicor Roche) for the presence of M.  tuberculosis 
complex. Out of the total specimens cultured on L-J medium, M. tuberculosis 
was isolated from 46 respiratory samples (2.6%) and one cerebrospinal fluid 
(CSF). From the samples inoculated in the automated systems, a total of 38 
M. tubercuiosis isolates were idrntified (37 from respiratory specimens, 5.296, 
and the one &om CSF). However, the CSF-positive sample was not 
detected by PCR performed in the clinical specimen. Positive cultures from 
the automated systems were detected within 10-15 days of incubation and 
the bacteria were identified as M. tuberculosis by PCK and subculture in L-J 
medium. All L-J isolates were characterized by biochemical tests and by a 
reverse hybridization assay (GenoType). Antibiotic susceptibility testing was 
perfomied in 35 strains Gom different patients by the MGIT AST SIRE 
system (BBL), to streptomycin, isoniazid, rifampin and ethambutol. One 
isolate was found to be resistant to streptomycin, three to isoniazid and 
another three to ethanibutol. Two isolates were resistant to isoniazid and 
ethambutol, while one strain was resistant to the antimycobacterials 
isoniazid, streptomycin and ethambutol. Direct application of PCR in 
clinical specimens or in broth media provides reliable, rapid and accurate 
results. The antimycobacterial susceptibility testing seems to be necessary for 
the proper treatment of patients with tuberculosis. 
Ip'11421 Comparison of the sensitivity of two automated 
systems (BACTEC 9000MB and BACTEC MGIT 960) and the 
Lowenstein-Jensen medium Mycobacterium isolation from 
clinical samples 
I. Jesus de la Calle, J. Lopez-Barba, M. Jesus de la Calle, S. Perez-Ramos, 
M. Rodriguez-Iglesias 
h e r t o  Real, E 
To evaluate the automated systems BACTEC MGIT 960 (Becton 
Dickinson). BACTEC 9000 MB (Becton Dickinson) and Lowestein Jensen 
medium (LJ medium) used routinely in our laboratory in the Mycobacfenum 
detection. Three-hundred and 43 consecutive clinical specimens have been 
processed in the laboratory, they were inoculated in flasks of Bactec MycoF, 
MGIT and in LJ medium, The samples were digested and decontaminated, 
and introduced in their respective incubation systems. Of the 343 processed 
specimens, 30 were positive for some of the three methods. The BACTEC 
9OOOMB system registered 23 positive specimens (76.6% of the positive 
specimens), MGIT 960 recover 26 (86.6% of the positive total) and LJ 
medium 14 (46.6%). In the three systems 12 samples grew (40% of 30), 4 
(13.3%) alone in the system BACTEC 9000MB and 7 (23.3%) alone in 
MGIT. The half time of growth is very next in both automated analyzers 
(18,73 days i n  BACTEC 9000MB and 18,96 days in MGIT), wMe in the 
LJ medium was of 35.42 days. In the patients with LJ medium negative (161 
30), it has been observed that 10 (62.5%) they were patient in treatment for 
the tuberculosis. In the patients with LJ medium positive (14/30) it is not 
observed hfferences between the treaties previously and non treaties (816). 
The system BACTEC MGIT 960 is something more sensitive than the 
BACTEC 9000MB in the micobacteria detection, since in view of the 
results, if we use the analysing BACTEC MGIT we would only lose 4 
(13.3%) of the 30 positive specimens, while with the BACTEC 9000MB 
we would obtain negative cultures in 7 of them (23.3%). LJ medium 
presents a time of growth higher that automated systems. The sensitivity of 
the LJ medium is smaller when the patient has been treated previously. 
Evaluation of the BDProbTec ET System for the direct 
detection of Mycobacterium tuberculosis complex 
R. Velho, R. Tom6 
Cubnbra, P 
The aim of our study was to evaluate BDProbTecTM ET System DTB 
assay performance for Mycobarteriurn tuberculosis complex direct detection, 
comparing DTB results with microscopy and culture ones. We tested 164 
clinical specimens (126 patients) random selected during a 1 month period, 
&om the specimens sent to our lab for mycobacteria detection. We also 
include 3 lab environment specimens. From all specimens a Z N  smear, a 
Lowenstein culture and a liquid one (Mycobacterium Growth Indicator 
TubeBactec MGIT 960) were made. The remaining suspension was 
aliquoted and frozen for later ProbeTec assay. Mycobacteria isolates were 
idended  by DNA probes. DTB assay results were compared to microscopy 
and culture ones. From the 167 specimens, 19 was smear positive, 26 DTB 
positive and 23 culture positive (22 MTC from 17 patients and 1 MAC). In 
all specimens with MTC positive culture, DTB assay was positive. From the 
26 positive DTB specimens, 2 of them had a 5000 MOTA and, after 
retested were found negative. One bronchoalveolar aspirate (1 patient) and 
1 cutaneous biopsy (1 patient) with DTB positive, microscopy and culture 
negatives, are still in clinical evaluation for final diagnosis. All but one 
(cutaneous biopsy from a patient with Hansen disease) specimens with 
positive microscopy were DTB positive. From the 5 negative microscopy 
and positive culture specimens, 4 were DTB positive; a MAC was isolated 
in the other one. DTB assays were also made in specimens (9) from patients 
under treatment (5). All of them had DTB and culture positive results. The 
3 Lab environment samples were found negative for all tests. IAC MOTA 
was > 5000 in all negative DTB assays. From the 24 positive DTB assay, 
we still do not have a definitive magnosis in 2 of them (1 bronchoalveolar 
aspirate and 1 biopsy). Concerning the others 22 samples, a 100% agreement 
with culture were found; all positive microscopy had positive DTB and all 
MTC positive culture (18 smear positive and 4 smear negative) were DTB 
positive. Specimens from under treatment patients, was culture and DTB 
positive as well. In our study BDProbTecTM ET System DTB assay had a 
overall sensitivity and specificity of 100%. If the 2 patients still under 
evaluation will be confirmed as not tuberculosis ones, the final overall 
specificity will be 91.7%. However as the tested samples and tuberculosis 
patients are only a few, additional studies are needed. 
[p1144/ Diagnosis of Mycobacterium tuberculosis by 
multiplex PCR in sputum specimens 
K. M. Bindayna, A. Thani, B. Baig, G. A. Botta 
Manama, BRN 
Objective: This study evaluates the sensitivity of a multiplex P C R  as a rapid 
diagnostic test for the detection of mycobacteria and specific identification 
of MycobarteriuM tuberculosis complex in Merent  specimens. 
Design: Two sets of primers were used to amplify 997-bp from the gene 
encoding the 165rRNA and an intergenic region (IR) separating two genes 
encoding a recently identified mycobacterial two-component system named 
senX3-regX3. The senX3-regX3 IR is composed of a novel type of 
receptive sequence, called mycobacterial interspersed repetitive units 
(MIRUs). The senX3-regX3 IR segment is spec& for the M .  tuberculosis 
complex (M.  tuberculosis, M. bovis, M .  &canurn, and M. microti). 
Methodology used to lyse the mycobacteria, extract the DNA, and amplify 
the DNA target sequences is presented. The amplified PCR product is 
detected by examination of ethidmm-bronlide stained agarose gels. 
Results: A total of 139 clinical samples have been examined. Three different 
methods for DNA extraction were used to isolate the niycobacterial 
genome (extraction by TE buffer, Chelex-100, and the chlorofomi 
method). The sensitivity was 86.8, 34.5, 17.4% for the chloroform, 
Chelex-100, and TE buffer, respectively. 
Conclusion: The multiplex PCR established in this study may be a very 
useful tool for the rapid and specific diagnosis of tuberculosis and in 
differentiation of M .  tuberculosis complex &om other mycobacterial species. 
v1 Detection of M. tubercu/osis DNA by PCR in sputum 
samples from long-term-treated leprosy patients: associations 
with skin test and immunotherapy with M. vaccae 
A. Rafi, J .  L. Stanford 
Tabn'r, IR; London, LIK 
As part of a series of investigations at Baba Bash  Leprosarium in Iran, 44 
long-term-treated leprosy patients were selected for the study. Samples of 
early morning sputum were obtained &om each patient, examined by 
microscopy for acid-fast bacilli (AFB), and cultured for for tubercle bacdh. 
These test were negative, but the polymerase chain reaction (PCR) for an 
insemon sequence believed to be specific for M. tuberculosis was applied to 
each sputum sample and those from six patients were found to be positive. 
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Five of the six positive samples were from the 21 patients producing Koch- 
type responses to tuberculin, and none were from the 11 patients previously 
found to have skin-tissue fluid or sputum positive by PCR for M. leprae. 
Whereas immunotherapy with lulled M. uaccae given nearly 2 years earlier to 
23 ofthe patients strongly influenced PCR results for M. leprae (P= 0.01), it 
had no influence on results for tubercle bacilli. However, at a second 
sampling date 18 months later, the only 2 patients still positive by PCR for 
M .  tuberculosis came from the placebo recipient group. 
Ip?146) Evaluation of PCR commercial kit as adjunct to 
culture for direct detection of mycobacterial tuberculosis in 
patients in silesia 
R. D. Wojtyczka, J. Pacha, Sz. Dwomiczak, D. Idzik, M. Kepa, S. Glab, 
J. Kozielski, D. Ziora, D. Ja$trzebsh, M. Bajorek, J. Kieda-Szurkowska, 
W. Mazur, A. Krzywiecki, K. Oklek, Z. Wydmuch, M. Pikorska, 
0. Skowronek-Ciolek 
Sosnowiec, Zabrze, PL 
Background and goal of the study: Culture of M .  tuberculosis &om clinical 
specimens is, generally, the definitive diagnosis of tuberculosis, however, it 
is time consunring and takes up to 6 weeks. Recently PCR has been proven 
to be a very useful tool in the rapid diagnosis of mycobacterial infections. 
The aim of our study was to compare the detection of MTC and TB, 
isolated from patients in Silesia, by cultural methods and PCR, executed 
with a commercial detection kit (DNA-Gdafisk 11, Poland). 
Methods: All 56 strain of Mycobacterium sp. were supplied by Mycobacterial 
Laboratory, Dept. of Phthysiopneumonolgy. The mycobactend isolates 
were identified by standard procedures. Sensitivity of strains to isoniazid, 
dampin, ethambutol and streptomycin was also determined. Mycobacterial 
DNAs were extracted and purified from LJ cultures using QIAamp Tissue 
Kit (QIAGEN) with a modified lysis protocol. DNA was amplified using 
Mycobartenum tuberculosis Kit (DNA-Gdansk 11). The amplimers flank a 209- 
bp fragment of the IS 6110, common for MTC. O n  the basis of the 
nucleotide sequence of the mtp40 species-specific protein of the tuberculosis 
bacillus, a PCR technique which specifically amplifies a 317-bp fi-agment 
&om the M. tubeyculosis genome was used. The target DNAs were amplified 
in a Personal Cycler (Biometra) according to producent protocol. 
Amplification products were detected by polyacrylamide gel electrophor- 
esis. Gels were visualized by silver staining method. 
Results: We observed that tested strains grew on LJ medium 2-8 weeks. 
From 56 grown strains, 52 were classified, by standard methods, as MTC. 
Among 56 tested strains, 8 were resistant to isoniazid, 5 to streptomycin, 2 
to rifampin and only 1 to ethambutol. 51 &om 56 strains showed the 
presence of the IS61 10 fiagment in PCR and 1 strain, classified as MTC, 
was negative in PCR. Among strains, positive in PCR (IS6110), in 41 
isolates PCR was positive if primers tlank mtp40 region. 
Conclusions: PCR showed that the frequency of M. tuberculosis within 
MTC in Silesia is about 80%. Results obtained by cultivation method were 
very close to results showed by PCR, but the cultivation doe sot 
discriminate M .  tuberculosis from Mycobacterium tuberculosis complex. 
v1 Use of real-time PCR and fluorimetry for rapid 
detection of rifampin and isoniazid resistance-associated 
mutations in Mycobacterium tuberculosis from clinical samples 
M. Ruiz, A. C. Llanos, M. J. Torres, A. Arroyo, J. C. Palomares, J. Aznar 
Seville, E 
Objective: To evaluate a new rapid method for the detection of mutations 
in the rpoB and katG genes of RMP and/or of INH resistant M. tuberculosis 
clinical isolates. 
Methods: Fifty-six sputum samples obtained from patients diagnosed of 
having tuberculosis with documented auramine counts, attended at the 
H.U.V. del Rocio in Seville were studied. The samples were extracted by 
DNA IV method. All the DNAs were studied with a new-real time 
amplification method (Lightcycler, Roche Biochemicals), that uses two 
primers for the amplification and two short oligonucleotide probes 
(fluoresceinated anchor and Red640 sensor labelled probes) that hybridizes 
to an internal region of the amplified fragment. For the rpoB the rpo sensor 
probe covered the region containing the codons 526 and 531. For the katG 
gene the TB sensor covered the region containing the codon 315. 
Differences in the melting temperature (Tm) allows discrimination between 
susceptible and resistant strains and the results can be obtained in 40 min. 
DNA5 from susceptible M. tuberculosis H37Rv, a M .  tuberculosis ATCC 
35838 and M. tubernrlosis ATCC 35822 were used as controls (JCM 2000. 
38: 3194-3199). 
Results: AmpMcation was positive in 54 (96.7%) of the samples studied. 
Using ‘poB primers, Ser531  leu mutation was found in 2 (3.7%) samples 
and 1 (1.8%) with a 526 codon mutation. With the katG primers, Ser315 
“‘Thr mutation was found in 6 (1 1 .I%) samples. Two of the samples had a 
mutation in each of the genes tested. 
Conclusion: This is a rapid, sensitive and highly specific method to detect the 
most kequent point mutations at the rpoB and katG genes in sputum samples 
h m  patients having tuberculosis. Additionally, it could be applied to the 
detection of other mutations conferring antimicrobial resistance in M. rubmlosis. 
I P I  148 I A rapid method for Rifampicin susceptibility testing 
of Mycobacterium tuberculosis 
0. C .  Aktepe, M. Altindis, N.  Esen, N. Yulug 
AJyon, Izmir, TR 
Tuberculosis is a major health problem in many parts of the world. As a 
member of standard multidrug regimen, rifanipicin (RLt) resistance is a good 
inmcator of multidrug resistant Mycobacterium tuberculosis (M.tb).Conven- 
tional proportional susceptibility testing (Pst) of M.tb takes at least 3 weeks. 
We performed a rapid test for Rif susceptibility of M.tb strains. FASTPlaque 
(FTP)-RIF(Biotec Laboratory) is a mycobacteriophage based test for 
detection Rif resistance of M.tb isolates within 48 h. M.tb strains from 
fresh solid cultures are incubated overnight in a media with and without 
Rif Then both media are infected with phage. After 90 minute period, 
samples are treated with a virucide solution which permits survive of phages 
w i t h  viable M.tb, but not outside of the bacilli. At last step, rapid growing 
nonpathogenic mycobacteria is added to the sample that gives an 
opportunity to phage replication. The h a l  mixture is incorporated into an 
agar media and put in a second ovemight incubation. Plaques as a clear zone, in 
the cell lawn indicate the presence of M.tb in the sample and the number of 
plaques in control is compared with the number of plaques in Winduding 
media. The existence of plaques in the sample with Rif determines resistant 
M.tb. Forty M.tb suains &om two Merent regions were evaluated about U 
resistance with Pst and FT€-RIF tests. The resistance rates were found 22.5% 
and 42.5%, respectively. All Rfresistant samples by Pst were also positive with 
FTP-RIF. However, 8 samples which was susceptible by Pst were detected 
Rif resistant. These preliminary results suggest, FTP-RIF has a more 
accurate performance for Rif susceptibility than Pst. Also it may aUow rapid 
reporting opportunity of resistant strains. 
Ip1149/ Susceptibility testing of Mycobacterium tuberculosis 
using MBlBacT automated culture system 
V. Litvinov, 0. Ittuganova, A. Moroz, P. Seltsovsky, N. Smimom, 0. Rechlun 
Moscow, RUS 
Objectives: To evaluate M. tuberculosis susceptibility testing using MB/BacT 
automated culture system (Organon Teknika) and to demonstrate possibdity 
to reduce dramatically time for getting susceptibdity results. 
Methods: 196 M. tuberculosis strains were isolated on solid egg medium from 
c h c a l  samples obtained &om patients with various forms of pulmonary 
tuberculosis. Among of these strains 132 were detected as drug-resistant to 
one or more drugs, 85 (64.4%)-multidmg-resistant and 64 samples were 
susceptible to all four drugs. For testing with Ml3/BacT was used the 
procedure recommended by the manufacturer. O T  S.I.R.E. h t  includes 
four IyopMzed drugs: izoniazid (INH), rifampicin (RMP), streptomycin 
(SM) and ethambutol (EMB). The MB/BacT Process bottles were 
inoculated with mycobacterial test suspension adjusted to Nr. 1 McFarland 
standard. Final concentrations of drugs in MB/BacT media were 1 pg/mL 
for INH, RMP and SM and 2 pg/mL for EMB. Bottles without drugs were 
used as controls: one with undiluted mycobacterium suspension and the 
other with suspension dduted 1:100. An absolute concentrations method on 
Lowenstein-Jensen (LJ) media was used as reference. 
Results: The results of MB/BacT system were in rather good agreement 
with those obtained by absolute concentrations method on LJ media. For 
INH sensitivity of MB/BacT method was 115/118x 100%=97.5%, 
speci6city-67/78 x loo%= 85.9%, for RMP sensitivity-82 of 94-87.2%, 
specificity-101 of 102-99.0%, for SM sensitivity-107 of 112-95.5%, 
specificity-77 of 84-91.7%. Maximum number of discordant results was 
obtained for EMB; high sensitivity of MB/BacT method (100%) was 
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combined with low specificity (59.3%). 100% agreement for INH, PMP 
and EMB was registered for 109 drug-resistant and for 61 sensiuve samples. 
Mean detection time with MEVBacT system was 3.8 days for INH and SM 
and 5.0 days for RMP, whde standard susceptibllity method on solid LJ 
media gives results afcer 21 days. 
Conclusion: The use of MB/BacT automated system lets sipficantly 
reduce time for getting susceptibility results. Growth time of M. tuberculosis 
in MB/BacT is 18.7 days; susceptibihty testing takes 3-9 days. It means that 
after 25-30 days the susceptibility testing results are available for physician. 
Contrariwise, it takes 49-63 days to get the susceptibility results with 
bacteriology procedure on LJ solid medium. EMB critical concentration in 
S.I.R.E. Lt should be increased. 
Evaluation of the impact of successive sample 
examination on the diagnosis of tuberculosis by microscopy and 
Lowenstein-Jensen culture 
B. Gencer, I. Ceyhan, F .  Gumuslu 
Ankara, TR 
In this study we investigated the effect of examining three successive 
samples taken from the same person for the laboratory diagnosis of 
Mycobacterium ruberrulosis by Ziehl-Neelsen microscopy and culture. We 
retrospectively evaluated the results of culture and microscopic examination 
from 751 patients. M. tuberculosis was isolated by culture using Loweinstein- 
Jensen medium. Sixhundred and one patients were pulmonary, 150 were 
urinary tuberculosis cases. Of 558 pulmonary cases were dagnosed by 
sputum samples, 43 of them by early morning gastric aspirate (MGA) whde 
all urinary cases were diagnosed by concentrated urine specimens. Totally, 
results of microscopy and culture studies of 1667 sputum, 129 MGA and 
450 urine samples h m  patients taken on successive days were evaluated. 
We concluded that second and third samples were designated to make a 
considerable increase in the effect of both methods for sputum and urine 
samples. Successive MGA specimens increased the detection by culture 
isolation but did not improve by microscopic examination. 
/p11511 Susceptibility testing of resistant isolates of 
Mycobacterium tuberculosis to second line drugs and newer 
antibiotics 
A. Wanger, A. Qwamstrorn 
Houston, USA; Solna, S 
Although the prevalence of tuberculosis has remained stable in the U.S. 
over the past few years, it is still increasing uTorldwide. In many developing 
countries drug resistance in M. tuberculosis (MTB) approaches 50%. Despite 
this, no new antimycobacterial agents have been made available in many 
years. Due the increasing resistance and the difficulty in obtaining first line 
agents, especially in developing countries, the in vitro activity of older 
antituberculous agents and new antibiotics were evaluated using E-test. A 
full range MIC was determined for thiacetazone, clofazamine, rifabutin, 
gaafloxacin and linezolid for 30 clinical isolates of MTB, resistant to one or 
more first line antituberculous agents. A heavy suspension of MTB 
(McFarland 3.0) was swabbed onto Middlebrook 7 H l l  agar + 10% OADC, 
preincubated for 24 h before the E-test strips were applied and final 
incubation of the plates at 35 degrees plus 10% COz for 5-10 days. The 
most active agents were gatifloxacin (MIC50/90 0.008/0.03 mg/L) and 
Linezolid (MIC50/90 0.016/0.03 mg/L). MIC dismbutions for rifabutin 
and thiacetazone were bimodal with a susceptible population (MlCs 0.002- 
0.03 and 0.016-2.0 mg/L, respectively) and a resistant population (MICs > 
32 and 32-> 256 mg/L, respectively). Clofizamine MlCs ranged from 
0.125 to 8.0 mg/L (MIC50 1.0 and MIC90 4.0 mg/L). The excellent 
activity seen with gatifloxacin and linezolid may offer new therapeutic 
possibilities for resistant MTB and warrant clinical investigation. 
F l  Susceptibility of Mycobacterium tuberculosis strains 
to first-line antituberculosis drugs in Manisa 
S. Akgah,  C. Cigek-Saydam, S. Siiriiciioglu, B. Ozbakkaloglu, A. Bilgic 
Manisa, Izmir, TR 
Objectives: To determine the activities of first-line (isoniazid, rifarnpin, 
ethambutol, streptomycin) antituberculosis drugs on 75 isolates of 
Mytobacterium tuberculosis from isolated sputum specimens. 
Methods: Standard agar proportion dilution methods were used in this 
study. Mycobacten'um tuberculosis ATCC 27294, ATCC 35838, ATCC 35825 
and ATCC 35837 were used for internal quality control. 
Results: 19 (25.3%) ofthe 75 strains showed resistance to one or more of the 
antituberculosis drugs. Six of them (PA) had resistanced to a single drug and 13 
(17.3%) had resistance to more than one first-line drug. All of slngle drug resistant 
strains were resistant to streptomisin. The rate of resistance to two drugs was 6.6% 
and the three h g s  was 2.6% and all of the four first-line drugs was 8%. 
Conclusion: It is suggested that clinicians should know the current local 
epidemiology of tuberculosis and that health care institutions should 
maintain up-to date drug susceptibility data on the local isolates of 
Mycobacterium tuberculosis. 
1-1 Comparison of three methods for susceptibility 
testing of Mycobacterium tuberculosis strains to primer 
antituberculous drugs 
A. Birinci, A. Y .  Coban, B. Ekinci, B. Durupinar 
Samsun, TR 
Objectives: The purpose of this study was to determine the susceptibihty of 
Mycobacterium tuberculosis strains to isoniazid (H), rifampicin (R), strepto- 
mycin (S), and ethambutol (E) by using the proportion method on 
compared to MGIT (Mycobacteria growth indicator tube) and E-test. 
Methods: 40 M. tuberculosis strains were tested. The proportion method 
taken as a gold standard performed by 7 H l l  agar using NCCLS standards. 
MGIT and E-test were carried out according to manufacturers' instructions. 
Results: The results are summarized in Table 1. 
Table 1 The correlaoons between MGIT and E-test w t h  Dropomon method 
MGIT McNemar E-test McNemar 
correlation correlation 
(%) r M > )  
H P > 0.05 79.5 P > 0.05 84.4 
S P 0.05 80.8 P > 0.05 85.7 
E P > 0.05 82.8 P > 0.05 77.3 
Conclusion: The results suggested that MGIT and E-test methods can be 
routinely used instead of proportion method. 
R P > 0.05 82.8 P > 0.05 90.8 
(p11541 Minimal inhibitory concentrations of rifabutin 
against Mycobacterium tubemulosis com plex strains 
M. Uzun, Z .  Erturan, 0. Anz 
Istanbul, TR 
The number of infections caused by resistant Mycobacterium tuberculosis strains 
have been increased in recent years and there are also some difficulties in the 
treatment of these infections. For this reason new alternative drugs must be 
produced for the treatment of these infections caused by these resistant 
mycobacteria. In this study, in order to indicate the cross-resistance between 
rifampin (RMP) and rifabutin (RFB), minimal i h b i t o r y  concentrations of 
rifabutin against 25 R M P  susceptible (to 2 pg/mL) and 25 Rh4P resistant 
(to 2 pg/mL) M.tb. complex strains were determined by the Bactec TB 460 
system for the first time in Turkey. While all the RMP susceptible strains 
were found to be also susceptible to RFB (MIC = 1 pg/mL), 3 out of 25 
(12%) RMP resistant strains were susceptible to RFB. The high level cross- 
resistance between R M P  and RFB (88%) obtained in this study point out 
the importance of susceptibdity testing to RFB prior to its implementation 
into the therapeutic regimens. 
v1 In vitro antimicrobial susceptibilities of various 
mycobacteria species isolated from sputum samples of patients 
with pulmonary tuberculosis and identified by the microbial 
identification system (MIS) 
0. Aktas, S .  Gorgiin, A. Ozbek 
Erzurum, TR 
Objective: This study was planned to search susceptibility of Mycobacten'um 
species, isolated from the sputum specimens of cases w t h  the suspected 
diagnosis of pulmonary tuberculosis. 
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Methods: Fifty-five mycobacteria strains were identified in the Microbial 
Identification System (MIS) by gas-chromatography method as well as by 
routine diagnostic methods. The drug sensitivity of a total of 55 strains (52 
of whch were Mycobacrerium fubercolosis, 2 were M .  xenopi and one was M .  
nuium-itilrarellulare) was investigated in Lowenstein-Jensen medium by the 
proportion method. 
Results: In M.  tubercubsir strains, the drug resistance for critical drug 
concentration was detected as 17.3% to streptomycin (SM), 3.9% to 
isoniasid (INH) and also 3.9% to ethambuthol (EM). The resistance to 
ofloxacin (OFX) and rifampicin (RIF) was not observed. Only one strain 
showed multiple drug resistance (against INH + SM + EM). While one of 
M. xenopi strains has the resistance to INH and RIF, the M .  auium- 
iiitracellulare strain was sensitive to all of the drugs. 
Conclusion: Although the resistance rates of Mycobacterium strains isolated in 
our region against examined the antimicrobics were not much higher, 
worldwide increases in the fiequency of tuberculosis cases and increases in 
resistance patterns of mycobacteria could also affect our region. For the 
purpose of more efficient management of tuberculosis, it would be necessary 
to do the sensitivity tests in addition to standard and rapid identification of 
bacteria before therapy. 
Blood cultures 
v1 Blood culture results in a general hospital during the 
years 1997-99 
N. Konlitopoulos, Z. Roussou, J. Melas, M. Papadah, H. Merkouri, M. 
Kyriakopoulos, E. Varsamis, S. Kitsou 
Athens, CR 
Aim: To analyse the nicrobiology results of blood cultures examined in a 3- 
year period in our hospital and to determine the antibiotics resistance 
pattern 
Material and Methods: 3481 blood cultures obtained from hospitalized 
patients between 1l1997 and 12/1999 were studied. Positive cultures were 
found in 856 cases (24%). Isolation of microorganisms and sensitivity to 
antimicrobial agents were performed by PASCO and API system. 
Results: Gram(+) bacteria were isolated in 56% ofblood cultures. Coagulase 
negative Staphylococcus (CNS) was the most common GRAM (+) pathogen 
(44%), followed by S. aureus (4.8%), Enrerootorcur spp. (4.6%) and Streptococcus 
uiridans (1.4%). Among GRAM (-) bacteria E. coli was isolated in 12% of 
cases, Etiterobarfer sp. in 5.2% Klebsiella spp. in 5.1% Acinefubacter baumanii in 
4.4% and Prseudomoizas spp. in 3.3%. Resistance to Oxacillin was observed in 
40% of S. aureus, but all isolates were sensitive to Vancomycin. Of the E.  coli 
isolates 30% were resistant to Ampicfin. Carbapenems and Cefepime had 
the broader spectrum against multiresistant GRAM(-) bacteria. The 
resistance rate of Pseudomorlas spp. was proved lower to Ceftazidime 
(29%) and PiperacfinlTazobactam (32%)). The p-lactatnase inhibitor 
combinations showed a significant activity against Eitteroroccus spp. 
Conclusion: A high level of resistance to antibiotics was observed to bacteria 
isolated from blood cultures in our hospital, resulting to difficulties when 
treating serious infections. 
vl Relationship between volume of blood cultured and 
bacterial yield in a hospitalized population 
J .  Greig 
Surrey, UK 
Introduction: Controlled laboratory studies have shown that the more 
blood from bacteraemic individuals that is cultured the greater the yield of 
causative bacteria. This study was undertaken to demonstrate the impact of 
volume of blood cultured in a clinical setting and to identify if there is a 
relationship between culture contanlination and volume cultured. 
Method: Prior to ward distribution, paired sets of Bactec 9240 blood culture 
bottles were weighed. Seven hundred and one inoculated sets received from 
all departments (except Renal) were reweighed on return to the laboratory. 
The volume of blood inoculated was then calculated. Positive cultures were 
prospectively followed up and the isolate noted as climcally significant or 
contanlinant. The mean and distribution of inoculated volumes in the 3 
groups (significant, contaminant and stenle) was calculated and the 
differences between the groups statistically compared. 
Results: 7.7% of sets yielded a s igdcant  isolate. The mean volume 
inoculated and SD were 7.0 mL and 3.7 mL, respectively. 9.4% of sets 
yielded a contaminant with a mean volume per bottle of 4.7 mL and SD 2.8 
mL. Bottles not yielding an isolate contained a mean inoculated volume of 
5.6 n L  and SD of3.9 mL Escherirhia coli (22%) and Staph. aureus (15%) were 
the co~nmonest clinically significant isolates with coagulase negative Staph. 
(59%) and coryneforms (20%) the commonest contaminants. The average 
volume ofblood in all bottles was 5.7 nd, with 24.5% containingless than 3 
mL. There was significantly more blood inoculated into bottles yieldmg 
clinically significant bacteria when compared with sterile or contaminated 
bottles, P < 0.01 and P < 0.001, respectively. A statistically s igdcant  
difference also existed between sterile and contaminated bottles, P < 0.01. 
Comment: This study indicates that in the hospital setting, the more blood 
cultured the greater the yield of clinically significant isolates. Contaminated 
bottles contained less blood which may reflect poor sampling technique. 
The overall low volume inoculated is disappointing and demonstrates that 
blood cultures are not being used to their optimum. This is an area for 
improvement though changing behaviour has been shown to be difficult. 
Ip11581 Is blood volume cultured still important for the 
diagnosis of bloodstream infections? 
D. Sousa, M. Rodriguez-Creixems, C. Fron, E. Bouza 
Madrid, E 
introduction: According to classic literature, the volume of blood per 
culture is the single most important variable in recovering microorganisms 
from bacteraenlic o r  fungaemic patients. However, hterature reports wlth 
the new automated techniques are scarce and the role of blood volume nlay 
be well assessed fiom a microbiological, but not from a clinical, point of 
view. We intend to ascertain the yield of bacteraenic episodes detected in 
relation to the volume of blood withdrawn per patient with a suspected 
bloodstream infection (BSI). 
Material and methods: We analysed the results of blood cultures from adult 
septic patients with three cultures processed. We selected 308 patients 
with a significant bacteraemic or fungaenllc episode (cases) and 303 patients 
with 3 negative blood cultures (controls). To assess the volume of 
blood inoculated we weighted the blood bottles and used the following 
formula: volume= weightldensity. We followed the patients to study their 
clinical conditions and compared both populations about age, sex, 
comorbidity index, severity, predisposing factors of bacteraemia and other 
underlying conditions. 
Results: Mean volume of blood cultured per patient with BSI (30.01 
SD:14.9 mL) was lower than per patient without BSI (32.97 SD:15.2 mL, 
P= 0002) and more episodes of bacteraemia were detected with < 20 mL 
(58.8%) than with > 40 mL of blood (40.2%) (P=0.017). The clinical 
comparative analysis of cases and controls, demonstrated that ths  finding 
was related to an inverse relationship between the volume of blood 
processed and severity of patients (more severe patients were obtained a 
significantly less quantity ofblood, P < 0.01). The population was smatified 
according APACHE 11 scoring and the predicted value of blood volume was 
studied with a multivariate analysis. In the group of patients with APACHE 
I1 more than 18, higher volumes of blood were associated with better yields 
of detection ofbacteraemia (OR= 1.0379 IC95% 1.0001-1.0771). But, for 
patients with APACHE I1 < 18, blood volume was not the single most 
important variable on BSI detection. 
Conclusions: According to our results, higher volumes yield higher rates of 
bacteraemia in severely ill patients; but, for not severe patients, blood 
volume cultured may not have the same clinical significance on the 
diagnosis of bloodweam infections. 
/p11591 Viability of microorganisms in vital blood culture 
bottles after detecting positive results 
C. Perez, A. Lopez, C. Casado 
Monfpellier, Marry I’Etoile, F 
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The VITAL blood culture system (bioM6rieux) uses a three-branch 
algorithm for the detection of positive bottles. The threshold algorithm 
detects bottles which become positive before being inserted into the 
instrument. The slope and delta algorithms detect microorganism in bottles 
after their insertion into the instrument. To check the viability ofbacteria in 
positive blood culture bottles, a 2-month study was performed. 4770 aero- 
anaerobic bottles were analysed, 896 were found to be positive (414 aerobes 
of which 12 were false positives: 0.12%; 482 anaerobes of which 86 were 
false positives: 0.9%), i.e. 798 true positives. The bottles included in the 
study are aerobic and anaerobic bottles which are signalled as being positive 
by the slope or delta algorithms which were manipulated in the 3 h 
following the signal (TO). A microscopic examination after Gram stainmg 
was performed on all bottles studies. Positive broth were diluted from l o p 3  
to 10K9. The dilutions were inoculated on enriched chocolate agar and 
incubated for 24 h. A series of six subcultures was performed for each bottle 
at TO, then every 12 h for 48 h (Tl-T4) and then 24 h later (T5), i.e. for 72 
h in total. In parallel, the bottles included in the study were stored at 37 "C. 
The results for the 186 bottles were analysed. The bacteria isolated were 
Enterobacteriaceae, coagulase-positive or coagulase-negative Staphylomcci, 
miscellaneous bacteria: Aeromonas, Campylobarter, Corynebactena, Enterococci, 
Ptieumocorri, Streptococci, Listeria. The mean analysis of survival curves gave a 
value of 4 x  108 CFU/mL for Enterobacteriaceae at TO, at 72 h growth 
persisted at 7 x 108 CFU/mL. For Staphylococci, the mean value at TO was 
6 x 108 CFU/mL and at 72 h greater than 109 CFU/mL. For Pseudomonas, 
a value at TO of 6 x 108 CFU/mL was found and at T5 growth persisted at 
8 x 108 CFU/mL. For Streptorocci and Enterocorci, the mean value at TO was 
108 CFU/mL and 109 CFU/mL at 72 h. This study shows that the positive 
signal occurs early, and for all bottles a greater or equal number of colonies 
was noted after 72 h incubation. The viability of bacteria in Vital blood 
culture bottles therefore remains high. These results enable laboratories 
using this instrument to be ensured of obtaining positive subcultures even if 
the removal of bottles declared as being positive is delayed, notably in the 
case of pubhc holidays or weekends. 
1p1160 Comparison of Bactec 9240 and BacT/Alert systems 
for detection of bacteraemia and fungaemia 
H. Aydogan, M. Saracli, A. Basustaoglu 
Ankara, TR 
The prompt detection of bacteraemia and fungaenlla continues to be one of 
the most important responsibilities of the clinical nllcrobiology laboratory. 
Two of the mostly used automated continuous monitoring instruments for 
this purpose are ramometric BACTEC 9240 system and fluorometric BacT/ 
Alert system. A total of 1991 blood culture sets were obtained from patients 
with a suspected bloodstream infection. Prescribed blood volumes were 
inoculated into the bottles and incubated for a standard 7-day protocol or 
until the instruments signalled that they were positive. Of the 318 positive 
blood cultures, 184 were positive in both systems, 97 were positive in the 
BACTEC system alone, and 37 were positive in the BacT/Alert system 
alone. There was statistically significant difference in recovery between two 
systems ( P  < 0.001). The difference between the two systems in terms of 
ulicrobial recovery was attributable largely to dfferences in the ability to 
grow Staphylococcus aureus and Candida species. Of 77 monomicrobial 
isolates of S. aureus, 47 were isolated by both systems, 21 were isolated by 
the BACTEC system alone, and 9 were isolated by the BacTIAlert system 
alone (P=0.024). Of 30 Candida species, 3 were isolated by both systems, 
23 were isolated by the BACTEC system alone, and 4 were isolated by the 
BacT/Alert system alone ( P  < 0.001). The false-positive rate in the 
BACTEC system was 0.596, and that in the BacT/Alert system was 1.4%. 
There were no statistically significant difference between isolation times of 
the both systems. With the exception of the differences noted above, 
BACTEC and BacT/Alert culture bottles were comparable in their abilities 
to recover aerobic and facultative organisms. 
/p11611 Comparison of the effect on organism detection 
caused by the delayed entry of vials into four commercial 
continuously monitoring blood culture systems 
A. Basustaoglu, C. McDonald, J. Madden, S .  Mirrett, B. Reller 
Ankara, TR; Durham, USA 
We compared 4 different commercial automated blood culture instruments 
including Bactec 9240 (Becton-Dickinson, Diagnostic Instrument Systems, 
Sparks, MD), Difco ESP (Difco Laboratories, Detroit, MI), BacT/Alert 
(Organon Teknika Corp., Durham, NC), and Vital (bioMeireux, St. Louis, 
MO) for the detection of organism growth from vials whose entry was 
delayed. For each of 9 aerobic and 7 anaerobic media evaluated, 9 vials were 
inoculated with human blood and < 125 microorganisms of an ATCC 
strain of either S.  pneumoniae, S. uureus, P. aerugirrosa, E.  coli, C. albicatls, C .  
perfvingens, or B. Jagilis. Among aerobic media seeded with bacteria, the 
average delay in total time to detection (DTTD) divided by the number of 
hours delayed (DE) ranged from 0.56 (BacT/Alea, FAN medium) to 0.72 
(Vital) in vials held at R T  ( P  > 0.5) and from 0.08 (Uactec 9240, nonresin 
medium) to 0.35 (Vital) in vials held a t  35 "C ( P  > 0.5). For anaerobic 
media the DTTD/DE ranged from 0.61 (Bactec 9240 resin medium) to 
0.82 (Vital) in vials held at room temperature ( P  > 0.1) and fiom-O.01 
(Vital) to 0.43 (ESP) in vials held at 35 "C ( P  > 0.5). Whereas only one vial 
held at room temperature resulted in a false negative, a total of 13 (4%) of 
324 vials held at 35 "C resulted in false negative cultures. Delayed entry of 
blood cultures may be a frequent cause of delayed detection of bloodstream 
infection and that there is little difference in this effect among various 
commercial media and detection systems. Holding vials at 35 "C would 
likely reduce the impact of delayed entry on detection time; however, if 
delays last longer than 8 h these vials should undergo routine subculture 
before being interpreted as negative. 
Ip11621 Four-year evaluation of BACTEC blood-cultures at a 
small university hospital 
E. Keuleyan, K. Gergova, I. Haralambieva, L. Boyauova, G. Gergova, T. 
Ilieva, N. Gigova, Y. Dotcheva, I. Mitov 
Sofia, BG 
Objective: To assess Bactec blood-cultures sumelllance for 4 - y ~ ~  period at 
the Department of Microbiology, Medical University-Sofia. 
Methods: Blood-cultures from clinics for Trauma and Orthopedics, Internal 
Diseases and Therapy, Gastro-enterology, Rheumatology and Pneuniology 
ICU performed in Bactec 9120, Becton Dickinson System, for the period 
January 1997-November 2000, were evaluated. Identificanon of niicro- 
organisms was by the routine procedure. Susceptibility testing was by Disk 
Diffusion Method, NCCLS 2000 and/or Sceptor system, BBL. 
Results: A total 1372 blood-cultures were performed with average percent 
ofpositive 12.796, respectively/year 14.3%/3997, 11.3%/1998, 9.1%/1999, 
12.0%/2000. The number of Gram-positive microorganisms (GPM) was 3- 
fold than Gram-negative (GNM). The leading cause of bacteraemia among 
GPM were: coagulase-negative Staphylococcus (CONS)-33 cases, followed by 
S. pneumoniae (Spn) (16), S. uuretu (Sau) (14), E.-faecalis (Efa) (4). The first 
top GNM were: A .  baumannii (9), S. marcesrens (6). E. doacae (4), E. coli and 
E. aerogenes (by 3). The other GNM were: P. aerugigiriosa, K. yrieuwioniae, 
Salmonella Gr. C,  C .  j kund i i ,  A.  lwqfii, F .  indologenes, H .  influenzae. Six cases 
(2.3%) represented a polymicrobial bacteraemia. The overage rate of 
positive anaerobic bacteraemia was 0.9%. Fungi were isolated from 5 
patients (1.9%). The results from susceptibility testing have shown a high 
incidence of oxacillin resistant Staphylococcus, representing 70% for CoNS 
and 50% for Sau. 31% of Spn were penicillin-resistant. Vancomycin- 
resistant Efa were not found. Although among P .  aeruginosa and Acinetobacter 
spp. a few strains were multiply resistant, includmg to carhapenems, GNM 
flom blood-cultures were more susceptible than isolates from other sites 
of infection. 
Conclusions: Analysis of pathogens from this study has shown a prevalence 
of GPM, incl. high rate of oxacillin-resistant Sau and CoNS, as well as of 
penicillin-resistant Spn. The total number of the proceeded in Bactec 
blood-cultures is 5-1 0 fold less than for the same hospital bed standard in 
the world practice, so it is necessary the clinical nllcrohiology laboratories in 
Bulgaria to have sufficient funds to provide better care for patients. 
Ip11631 Evaluation of different blood culture bottles seeded 
with or without blood and X-V factors for the detection of 
Neisseria meningitidis, Streptococcus pneumoniae and 
Haemophilus influenzae 
A. Basustaoglu, A. Kucukkaraaslan, H. Aydogan 
Ankara, TR 
The purpose of this investigation was to determine the ability of commercial 
blood culture bottles to support the growth of the Neisseh  meningitidis, 
Streptocorrus pneumoniae and Haemophilus irifluenzae, which are the most 
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frequently responsible for meningtis and fastidious in their growth 
requirements. Their detection with the help of blood culture bottles from 
the cerebrospinal fluid, which are not supplemented with blood and X-V 
factors, leads to a high quota of false-negative results. Taking this problem 
into consideration, the bottles were seeded with blood, X-V factors and 
blood + X-V factors and the rates of recovery of these organisms were 
compared. Performance tests have been carned out with the commercially 
manufactured two different paediatric blood culture media (BACTEC and 
BacTAlert). The inoculum size was between 102 and 108 CFU per culture 
bottle. The bottles, which were supplemented with blood and X-V factors, 
proved to be more effective and time to detection is shorter than the 
unseeded blood culture bottles and supplemented only with 10% fresh 
human blood or X-V factors alone for culturing the considered spectrum of 
microorganisms. Time to detection for these microorganisms is changing 
between 3.54 and 18.6 h. Direct inoculation of cerebrospinal fluid into 
blood culture bottles supplemented with blood + X-V factors is therefore 
faster than the conventional culture methods. 
I PI164 1 Evaluation of the BacT/Alert 3D microbial detection 
system for use in screening of platelets to prevent bacterial 
transfusion transmission 
C. McDonald, A. Rogers, M. Cox, R. Smith, J. A. J. Barbara, S 
Rothenburg, L. Stutznian 
London, UK; Durham, USA 
Bacterial transmission is still the major cause of morbimty and mortality 
associated with transfusion transmitted infection. The BacT/Alert 3D 
automated microbial detection system offers the potential for blood 
components to be screened for bacteria. An evaluation was therefore 
performed of the BacT/Alert system against classical thioglycollate broth 
culture to determine its suitability for screening platelets. Platelets are the 
most common cause of bacterial transnussion. Isolates of Bacilhs cereus, 
Bacillus mbtilis, Candida ulbicans, Cfostridium pegingees, Cotynebacterium sp., 
Enterobacter cloacae, Escherirhia mli, Klebsieila oxyioca, Propionibarterium acnes, 
Pseudamorzas aerqinosa, Staphylococcus aurelrs, Staphylocorms epidemidis, Serratiu 
marcesceris, Streptococcus p y o p w s  and Streptoroccus viridans were inoculated into 
Day 2 apheresis platelet units to give a final concentration of approximately 
10 and 100 CFU/mL. Standard aerobic, standard anaerobic, FAN aerobic 
and FAN anaerobic bottles were each inoculated with 4 mL and Pedi BacT 
(paediatric aerobic) bottles were inoculated with 2 mL. 1 mL was inoculated 
into thioglycollate broth to maintain a 1 in 10 dilution of sample to media. 
Replicates of 10 were performed for each bottle type. Thioglycollate broths 
were Gram stained at 12 h intervals. BacT/Alert and thioglycollate broths 
were incubated for 14 days or until they became reactive. The BacT/Alert 
system with the exception of Propionibacterium acnes, which has dubious 
clinical significance, gave equivalent or enhanced detection times to the 
classical thioglycollate broth system. Mean determination times for BacT/ 
Alert bottles ranged &om 9.1 h to 48.1 h, excluding Propionibacterium awes 
The BacTIAlert demonstrated its ability to detect a range of organisms at 
levels of 10 and 100 CFU/mL. Propionibacterium acne5 determination times 
with BacTIAlert bottles ranged from 72 to 178 h compared to 77-86 h with 
thioglycollate broth. In conclusion, the study validates the BacT/Alert 
microbial detection system for the screening of platelets. Currently, the 
system IS the only viable option for screening to prevent bacterial 
transmission. The system could enable large numbers of platelets to be 
screened with positive sample identification, low labour costs and rapid 
determination times, potentially enhancing blood safety. 
jP11651 Comparison of direct and standard antimicrobial disk 
susceptibility testing with positive BACTEC aerobic plus/F blood 
culture bottles: evaluation of clinical and financial benefits 
Z .  Yumuk, V. Dundar 
Kocaeli, TR 
Objectives: The aim of this study was to evaluate clinical and financial 
benefits of direct antimicrobial disk susceptibhty testing with positive 
BACTEC aerobic Plus/F blood culture bottles. 
Method: Direct susceptibility tests were done on 96 specimens that have 
taken to BACTEC aerobic plus/F bottles and gave positive signal until the 
5th day of incubation. The positive cultures were included unless mixed 
flora was observed on gram stain. Direct disk ditrusion plates were examined 
after 5 h and overnight incubation. The results from direct susceptibility 
tests were compared with results from standard test and discrepancies were 
classified for each gram positive and negative bacteria groups as very major, 
major and minor. The discrepancies were also analysed by using Weighted 
Kappa statistic method. We assessed the clinical and financial benefits of 
direct antimicrobial susceptibility test by comparing empiric antimicrobial 
chemotherapy in the light of NCCLS recommendations. 
Results: Nearly half (54%) of the test with isolates had readable zones at the 
end of 5 h and 87% by overnight incubation. In the comparison with results 
from standard disk diffusion tests, the 5 h and overnight incubation results 
were in agreement for 88% and 97.8%, respectively. The frequencies of 
discrepancies were 0,85% very major, 4,9% major, 6.1% minor after 5 h, and 
0.1% very major, 1.1% major, 1.1% minor after overnight incubation. 
Weighted Kappa analysis results after 5 h and overnight incubation for gram 
negative were high (0.656) and extremely perfect (0.891), for gram positive 
bacteria were extremely perfect for both (0.826 for 5 h and 0.960 for 
overnight incubation), respectively. Evaluation of the data that were taken 
about the empiric antimicrobial chemotherapy, we found out 4 patients 
were taken empiric antibiotic that were resistant to the infectious agent and 
48 patients were taken empiric antibiotic that were not appropriate in the 
light of NCCLS recommendations. 
Conclusion: Direct susceptibility testing with positive BACTEC aerobic 
Plus/F blood culture bottles that were monobacterial provide reliable results 
24-36 h earlier than conventional procedures and decrease overall costs. 
These cost saving in antimicrobial therapy, coupled with changes in therapy 
made for efficacy reasons, support the usefulness of earlier reporting of 
antibiotic susceptibility patterns of blood cultures isolates. 
Ip11661 Comparison of Bactec system with conventional 
methods for culture of sterile body fluids 
S. Tsoulfa, A. Kontodemou, E. Tsorlini, E. Katsifa, K. Zafnna, L. 
Kousoulas, K. Trikaliotis 
Thessalorriki, GR 
The presence of microorganisnu in body fluids, sterile under normal 
conditions, is often hfe-threatening. However, the recovery of the 
microorganisms involves difficulties because of their low numbers and the 
large volume of specimen required for the culture. Alternatively the use of 
several blood culture systems is recommended in order to improve the 
detection of bacteria. In the present study we examined 343 body fluids 
(159 CSF, 153 pleural, 22 ascites fluid, 3 synovial, 5 bile specimens and 1 
pericardiac fluid) originating from patients of different departments and 
ICUs of our hospital comparing: (A) the conventional culture method and 
(B) the automated Bactec 9240 System, using the Bactec Ped Plus/F bottles. 
One hundred and twelve (1 12) of the processed body fluids yielded positive 
cultures (32.6%). Twenty-one (21) were detected by both the Bactec system 
and conventional culture and 91 by Bactec only. N o  isolate was recovered 
only by conventional culture method. The isolated bacteria were: 
Staphylococci coagulase negative (56), S. aureus (3), Enterococci (5), Streptococci 
(4), E.coli (6), Enterobarfer sp. (4), Klebsiella sp. (4). Pseudomonas sp. (9), 
Acinetobacter sp. (l), Haemophilus (2), Pasteurella (1) and Candida albicans (2). 
The Bactec System exhibited improved sensitivity in the recovery of 
bacteria in sterile body fluids without any significant advantage in the speed 
of detection. 
Ip11671 Widefti, System for direct identification and 
susceptibility of bacterias from positive blood cultures 
G. Ruiz, M. Uria, P. Peiia 
Madrid, E 
Objectives: To evaluate the presumptive identification and susceptibility of 
direct inoculation from positive ESP (Trek Diagnostic Systems Inc.) culture 
bottles to Wider 6 W MIC/ID, 5 W MIC SUP or 3 W MICAD (Francisco 
Soria Melguizo, SA) panels to report diagnosis 18-24 h sooner. 
Methods: We standardize the inoculum to evaluate 140 positive culture 
bottles with Gram-positive or Gram-negative bacterias on Gram stain. We 
compared the accuracy of Wider' panels directly inoculated with positive 
culture bottles vs. panels inoculated fiom isolated colonies. 
Results: WiderR panels showed 98.7% and 98.25% of complete agreement 
with the standard method for identification of Gram-positive and Gram- 
negative bacterias, respectively. 
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Susceptibility testing rates (%) were: Conclusions: (1). Direct inoculation from positive blood cultures provide an 
S. aweus 80.1 a 13b 5 . 2 ~  1.7d adequate presumptive identification and susceptibility 18-24 h sooner. (2) 
Neg.coag. Staphylococci 73.2a 1Sb 7 . 8 ~  -Id The main error rates are minor error rates and does not modify consistently 
Enrerocmiis spp. 
S. qalactinc 87.52 10.7b 1.8c Od 
L. nioiioqvogeiim 
Eiitervbniteriacenr 8S.3a 10.3b 3.sc Id  
Nonfennenter bdcilli 81.6a 1 1.4b 4.2c 2.8d 
the susceptibility patterns reported. 
Complete agreement (a), Minor error (b). Major error (c),  Very major (d) 
Intestinal parasites 
I PI168 1 External quality assessment schemes in parasitology; 
an example 
T. Crucitti, M. Van Blerk, J. Libeer 
Brussels, B 
Introduction: cyclospora cayetanemis is a newly (re)discovered parasite and 
detection capabhty by the clinical laboratories is not evident. Familiarisation 
of the clinical laboratories with these parasites can be achieved through the 
introduction of samples containing Cyclospora oocysts in the National 
External Quality Assessment Schemes of Parasitology. 
Method: The participants of the EQA schemes in Parasitology received 
formalin faeces suspensions samples in January 1997, January 1998, and 
October 2000, illustrated with clinical information. The samples were 
carefully examined by at least 3 experts in parasitology. The expeas did 
observe a mixed mfection with Blastocysfis horninis for the sample included in 
the scheme of October 2000. After each evaluation the participants received 
a report of the results and a brief overview of the epidemiological, clinical 
and diagnostic aspects of CyClospora cayeranensis. 
Results: The following table summanses the parasites reported by the 
participating clinical laboratories, some laboratories mentioned the presence 
of mixed infections, between brackets the percentage of participants 
reporting this result is noted: 
EOA 1997 EOA 1998 EOA 2000 
135 (52.9%) 
15 (S.O%) 
12 (4.7%) 
1 1  (4.3%)) 
43 (17.8%) 
52 (20.4%) 
(1 
0 
255 
214 (81.4%) 
9 (3.4%) 
4 (13%) 
9 (3.4%) 
8 (3.0%) 
0 
14 (5.3%) 
10 (3.8%) 
263 
192 (80.3%) 
3 ( 1  .”) 
2 (0.8%) 
I 4  (5.9%) 
13 (S.4%,) 
18 (7.8%) 
2 ((1.8%) 
18 (7.8%) 
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The percentages of laboratories, w h c h  were able to identfy Cyclospora 
iayetariensis are, respectively, 52.9%, 81.4%, and 80.3%. No parasite was 
found by 20.4%, 3.8%, and 7.8% of the laboratories. 
Discussion and conclusion: A significant improvement in Cyclospora detection 
was obtained &om January 1997 to January 1998. The improvement remained 
stable till 2000, despite that the report of absence of parasites doubled from 1998 
to 2000. Most laboratories never saw until 1997 C y ~ l ~ p r a  cayetanemis oocysts. 
The EQA sample allowed the laboratories to visualise the parasite and helped to 
detect the parasite in clinical specimens. To majntain the achievements 
obtained, it is important to include rare parasites on a regular basis in EQA 
schemes, a kequency of each two-year seems adequate, although an 
improvement of the results is still desirable. 
(p1169/ Cyclospora cayetanensis in a patient with traveller‘s 
diarrhoea 
A. Kansouzidou, C. Charitidou, T. Bamis, F. Kamaria 
Thessaloniki, G R  
In recent years, several studies have shown that C. cayetanensis is a 
worldwide intestinal pathogen and it has been implicated in a number of 
sporadic cases and epidemic outbreaks of diarrhoeal illness in several 
endemic areas. The parasite is associated with prolonged and relapsing 
watery diarrhoea in immunocompetent persons a5 well as in AIDS patients. 
Most reports of Cyclospora infection came from travellers visiting endemic 
countries. In European countries a few cases of C. cayetarreriris infection have 
been reported and almost all of them were observed in persons after foreign 
travel. We present a case of C. cayetanensix infection diagnosed in Greece 
concerning a patient who suffered from diarrhoea after a foreign travel. A 
44-year-old immunocompetent man presented in July 2000 with a 3-week 
history of diarrhoea. The patient had stayed in Morocco for about a month 
for a business travel. Hi s  illness was associated with relapsmg diarrhoea every 
two days, fever and general malaise. Routine stool bacteriological 
examinations were performed and they were unable to demonstrate the 
presence of known enteropathogenic bacteria (Salmodla ,  Campylobacter, 
Shigella, Yersinia and E .  mli 0157:H7). Two stool specimens stained by 
modified acid-fast procedure revealed numerous Cyclorpora oocysts (pink to 
dark red spherical bodies). Under fluorescence microscopy the oocysts 
showed a green autofluorescence. Antibiotic therapy with triiiiethoprini- 
sulfaniethoxazole was started and the patient recovered rapidly. At this time 
a new stool specimen was examined and did not reveal oocysts. Cyrlospora 
should be considered as aetiological agent in persons with prolonged 
diarrhoea who have travelled to the eiidenlic areas. 
v1 Cryptosporidiosis in Kuwaiti children: seasonality 
and endemicity 
J. Iqbal 
Kuwait, KWT 
This is one of the first reports of infectious diarrhoea due to Cryptosporidiim 
sp. in the Middle East. Over a period of 3 years, September 1995 to August 
1997, a single faecal sample from 3549 children was analysed by modified 
Safarain-Methylene-Blue (SM-B) staining and direct inmunofluorescence 
test. The patients presented with gastrointestinal disorders at the District 
Hospital and 509 (14%) children had diarrhoea ofvariable duration. The age 
of the patients ranged between 3 months to 12 years. Crypfosporidium oocysts 
were detected in 51 (10%) children with dlarrhoea. Prevalence was highest 
(73%) in chddren > 2 years of age compared with children < 2 years of 
age. The maximum number of cases, 38 of 51 (75%), were seen during the 
months January-Apnl indicating a marked seasonal variation. Poylparasitisni 
was common in children with diarrhoea, however, 43 of the 51 (84%) 
children with cryptosporidiosis had Crypfosporidiunr infection only. 
Blustocystis horninis and Etidolimax nana were the most common parasites 
detected (38% and 15%. respectively). 47 of the 51 (90%)) children with 
cryptosporidiosis were Kuwaiti and gave no history of travel abroad 
suggesting that the infection was acquired indigenously. Sociodemographic 
information on children with cryptosporidiosis suggests three possible mode 
of transmission of infection: by drinking contaminated water stored in the 
overhead water tanks, person to person or by contact with infected aninials. 
This study was supported by grants from Kuwait University (MI I13 81 
MI 0981 
v[ Prevalence of Fntamoeba histolyticddispar complex 
in adult population of Bangui, comparison of use of ELlSA 
TechLab kits and PCR amplification for specific detection of E. 
histolytica infection 
M. Balotescu, P. Nguyen, C. Men, P. Minssart, S. Yassibanda, W. Petri Jr, 
D. Lyerly, Y. Germani 
Bucharest, RO; Ho-Chi-Minh-City, VN; Bangui, RCA; Virginia, USA 
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Amebiases, the third parasitic disease in terms of mortality, after schistosomiase 
and malaria represents a major public health problem in under-developing 
countries. Humans are infected by two major Entamoeba species, morpho- 
logically identical: a pathogenic one, E. hkfolytica and a nonpathogenic one, 
E. dispar. The diagnosis of amebiases by microscopic identification of the 
parasite in stool is insensitive and unable to distinguish the invasive E. 
hismlytica from the commensal parasite, E .  dispar. The purpose of ths  study 
was to establish the prevalence of E. hisfolyfica/dkpar complex in the adult 
population of Bangui, Central Ahcan Republic and to evaluate the 
comniercially avdable TechLab E. hirtolytira-specific antigen detection hts  
for the specific diagnosis of E. histolytira infection in comparison with a PCR- 
based method and nlicroscopic exanination. Single stool samples were 
obtained from 149 patients divided in four groups in relation with the 
presence/absence of diarrhoea and their HIV status, in order to investigate the 
possible role of E. histolytim/dispar complex in HIV-associated opportunistic 
pathogenesis. The stools were examined in microscopy (performed on fresh 
preparations and after cysts concentration by MIF method) and subsequently 
submitted to molecular diagnosis by nested-PCR (Katzwinkel-Wladawch 
method-based on aniplification of the small subunit rRNA gene of E. 
hitrolyrica and E. dispar followed by restrichon dgest analysis of PCR product) 
and faecal antigen detection. Microscopic examination revealed a high 
prevalence of E .  hktolytica/dispar complex in the adult population of Bangui 
(23.35% symptomatic and 17.1% asymptomatic) but the complex was not 
significantly associated to HIV infection when compared with the HIV- 
negative group (38% vs. 47%). Antigen detection and P C R  had comparable 
sensitivities when performed directly on fresh preparations identifylng 10.47% 
and 8.56%, respectively, of E.  hisfolyhro infection. Antigen detection and 
PCR showed alto an excellent correlation for the specific diagnosis of E. 
lristolytica in stools, but only TechLab E. hirtolyfira antigen detection test was 
both simple (answer in 2 hours), technically simple and available for large- 
scale epidenliological studies. 
The prevalence of intestinal parasites in Tirana 
L. Fuga, N. Capodicasa, E. Cam, M. Fico, J. Llagami 
Tirana, AL 
Objectives: The low hygienic level atid difficult social conditions are the 
main factors of the high frequency of the intestinal infections in Tirana City, 
especially concerning the paediatric age. We have examined 1475 patients 
during June 1999-July 2000 period, to find the frequency and relevant 
epidemiological data about the intestinal parasite infections. 
Methods: The collected stool samples have been microscopically examined 
following the modified Ridley standard method (sedimentation in formol- 
ethilacetat), while for the determination of Enterobius uernicuularis, the Scotch 
Test method is used. All the studied patients have been grouped according 
to age (from 1 to 72 years old) and sex. 
Results: The obtained result shows that in 350 positive cases (24.1%) for 
intestinal parasites, we have found one, two or three parasites simultaneously 
on the same panent. Giardia laiitblia is observed in 236 (16%) of the 
exanined subjects, T. trirhiura in 49 (3.3%) cases, A .  lumbriroider in 33 (2.2%) 
cases, H. m n a  in 17 (1.2%) cases, E. uennirularir in 12 (0.8%) cases and Teniae 
spp. in 3 (0.2%) cases. The patients belonging to the group age between 1 
and 6 yean old are the most infected, while equally frequencies of male and 
female infected patients have been found. At the same time, there has not 
been observed any variation of parasite dstnbution along the year. 
Conclusions: G. lnniblin is the most frequent isolated parasite in Tirana City 
and the age group between 1 and 6 years old is the most infected one. This 
very high level of intestinal parasite contamination in Tirana City requires 
drastic improvement of the personal hygiene. 
Ip11741 Prevalence of intestinal parasites in families in Iran 
A. Naeini, N. Fallah 
Telhan, IR 
One of the most iniportant sanitation problems in Iran is parasitic intestinal 
infection. Ths study was carried out to determined type(s) and prevalence 
of intestinal parasites in 406 of 5700 Healthy city families to meet Healthy 
city gods. According to the text the samples examined by method formalin- 
ether. Our  finding showed following types and prevalence: Asraris (0.6%), 
Enterobius (0.2%). Trihocephal (0.1%), H. nana (0.7%), Giardia (10%). 
Entamoeba histolytka (0.6%), E. roii (lo%)), E. hartmanni (0.4%), EtzdoiiJnax 
n a m  (3.5%), bdamoeba brrfschiIi (0.3%), Blastocysfis hominis (16%),Chelomatix 
mewili (0.1%). In addition, samples showed one (31.2%), two (6.3%), three 
(l.l%),and four (0.15%) type(s) of parasites. Concerning the rather poor 
hygiene of families about intestinal parasitic infections, proper education can 
be very useful. The relationship of age, sex, parent educatio? with intestinal 
parasitic infection rate was not significant. 
v1 Comparison of single dose of ornidazole (Biteral) 
with metronidazole (Flagyl) in treatment of giardiasis in children 
A. Ozbilgin, P. Ertan, A. T. Tamay, 0. Kurt, K. Yereli, I. C.  Balcioglu, 
U. Z .  Ok, A. Kilinicioglu, A. Onag 
Manisa, TR 
Objectives: Giardiasis is a common infection in tropical and subtropical 
regions of the world, especially in children. Today, 5-nitroimidazoles are 
regarded as the drugs of choice in the treatment of gardiasis. Omidazole, 
which has a longer half-life than metronidazole, may be used in single dose 
treatment. We compared three different single doses of ornidazole with 
nietronidazole in the treatment of giardiasis in children. 
Methods: Stool samples from 66 children, who were admitted with 
diarrhoea, weight loss, lack of appetite and fatigue, were found to be 
positive for G. lamblia cysts and/or trophozoites by at least one method of 
saline-Lugol, formalin-ethyl acetate conrt.ntration and tnchronie staining. 
Of these chddren, 47 were treated with single dose of ornidazole (Biteral, 
RachelM), 16 with 30 mg/kg, 15 with 25 mg/kg, and 16 with 20 mg/kg, 
while 19 children were treated with 20 mg/kg/day metronidazole (Flagyl, 
Eczacibasi-Rhone PoulencTM) in three doses, for seven days. Stool samples 
Eroni all cases were examined on the 7th, 10th and 14th days of treatment by 
the same methods: clinical symptoms were also evaluated. 
Results: Giardia lainblia was eradicated in all patients treated with 30 mg/kg 
or 25 mg/kg single dose of onlidazole, while eradication was achieved in 15 
of 16 cases (94%) treated with 20 mg/kg omidazole and 16 of 19 patients 
(84%) treated with nietronidazole. No significant side-effects were observed 
in any patient treated with omidazole or metromdazole. Clinical symptoms 
disappeared in all patients, who were found to be negative for G. larnblia 
cysts and/or trophozoites, but persisted in all five positive patients. 
Conclusion: These results suggest that single dose omidazole treatment is a 
proper and effective method for the treatment of giardiasis in children. 
More studies are required to examine the effects of different drugs and 
regimens in the treatment of giardiasis. 
vl Antigiardial activity of Guinea-Bissau medicinal plants 
M. Rodrigues de Sousa, 0. Duarte Silva, E. Teuteira Games, 
J. Poiares-da-Silva 
Coimbra, Lisbon, P 
Giardia lamblia, a parasitic flagellated protozoan, is the most common 
causative agent of diarrhoeal h e s s  world-wide. Although various drugs 
have been available for several decades to treat this infection, none of them 
is entirely satisfactory, due to high incidence of undesirable side-effects and a 
significant failure in clearing parasites from the gastrointestinal tract. Because 
of these problem$, new compounds are being screened for antigiardial 
activity. The use of plants as medicinal agents has been well documented 
and in some cases was the origin of new drug discovery. Previous 
ethnopharmacological studies on plants &om Guinea-Bissau demonstrated 
chat Cryptolepis sanguinolenta, Terminalia macroptera and Guiwa seriegalenfis 
were active against some important diarrhoeal bacteria. In this work we 
study the antigiardial activity of these three West African medicinal plants. 
The activity of the extracts was evaluated in v i m  using Giardia lamblia 
trophozoites (ATCC 30957) as a cellular model. The susceptibhty to plant 
extracts (roots and leaves) was studied regardmg the effects on G. lantblia 
growth and adherence. The plant activines were compared with 
nietronidazole activity, considered a ‘gold standard’ antibiotic used in 
therapy of giardiasis. The results demonstrated that the most active extracts 
were the lipophylic fractions, resulting from the liquid-liquid partition of 
the Guiera reneplensis ethanol extract. Their activity is close to the activity 
found for metronidazole. Terminalia nlacroptera diethyl ether partition 
extracts and Crypfolopis ranguinolenta ethanol extract also demonstrated 
some activity against G. lamblia trophozoites. Our results suggest the 
potential use of these medicinal plants in the treatment of giardiasis. 
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Totalofpatients 137 16 116 
25.13% 
v1 Ascariasis of the gallbladder: report of a rare case 
M. Turan, N.  Elaldi, I. Oztoprak, S. Topaktas, C.  Aydin 
Sivas, TR 
A 58-year-old woman presented with a 24-h history of right upper 
abdominal pain, vomiting and fever. Physical examination revealed 
tenderness in the right upper quadrant. Liver function tests were mildly 
elevated (aspartate aminotransferase, or AST (353 U/L; normal, 9-36 U/L); 
alanine aminotransferase, or ALT (218 U/L; normal, 10-28 U/L)) and 
serum bilirubin was normal. Blood leukocyte count was raised to 18' 1OY/L 
with mild eosinophilia. Serum amylase level was withm normal limits at 
admittance. Abdominal ultrasonography (USG) showed a live Ascaris in the 
gallbladder. During the examination, ribbon-like echoes were seen and 
which later became curved within the gallbladder. Stool examination was 
positive for Ascaris lumbricoides. Ascariasis was treated with mebendazole. O n  
7th day of admittance serum amylase level was raised to 138 U/L (normal, 
27-1 02 U/L) and the patient underwent surgery. The gallbladder was free 
of Ascaris during the surgical operation. We reported here a female patient 
with right upper abdominal pain and diagnosed an Ascuris in her gallbladder 
by USG. We did not detect any parasites in surgcal operation. The worms 
move out of the ducts. In our opinion; ultrasonographic imaging must be 
performed before surgery. 
67 95 RR 
36.61% 18 08% 
Enterobius wermicularis egg positive rate in a primary 
school in Sanliurfa 
G. Aslan, M. Ulukanligd, A. Seyrek 
Mersin, Sanliufa, TR 
In this study the prevalence of Enterobius uermiculan's infections was 
investigated in schoolchldren in Sanliurfa. 500 chddren between 7 and 
11 years old were examined for pinworm eggs by penanal swab technique. 
The prevalence of Enterobius vermicuIaris infections was 37.8% among 
schoolchildren. Examination of penanal swab also revealed that 2,896 of the 
children were infected by Asraris lumbricoides eggs and 1.7% were Taenia 
sagiizata eggs. The greater prevalence of pinworm infection was in male sex. 
Poor socioeconomic status and poor environmental sanitation constitutes 
high endemic areas for intestinal parasitic infections in Sanliurfa. 
1 P I  179 1 DNA from three intestinal pathogens extracted from 
conventionally stained faecal smears on glass slides 
C. Amar, S. Pedraza-Diaz, J. McLauchlin 
London, UK 
Objective: To detect intestinal pathogens by P C R  in DNA extracted from 
faecal smears on glass microscope slides and stained by conventional 
techniques. 
Methods: Smears were produced on glass microscope slides from faeces 
collected from patients with diarrhoea where Cyptosporidium pawum, 
Giavdia intestirialis or Closttidium pefrirtgens were detected by conventional 
techniques. The smears were immunofluorescence (IF), modified Ziehl 
Neelsen (MZN), auramine phenol (AP) or Gram-stained by conventional 
methods as appropriate. The stained surface of the slides were vigorously 
rubbed using a sterile cotton swab and the resulting material mechanically 
disrupted in the presence of guanidiniurn thiocyanate and zirconia beads. 
DNA was extracted using activated sdica ('Boom' method). The P C R  
procedures specific to each of the pathogens used were; C. parvum, 
Cryptospotidiirnz oocyst wall protein ( C O W )  nested procedure; G. 
intestinalis, triose phosphate isomerase gene (TPI) nested procedure; and 
C. pelf"'ngens phospholipase C (CPA) unnested procedure. 
Results: The C .  paruum COWP gene was amplified from 87.5% of 156 
stained smears, 20 of which were stained by IF, 77 by MZN and 59 by AP. 
The 6. intestinalis TPI gene was amplified from 37.5% of 24 IF stained 
smears. The C. pftifn'rzgens CPA gene was amplified from 43% of 28 gram 
stained smears. No DNA was amplified from negative controls. 
Conclusion: We demonstrate here that it is possible to recover DNA from 
fixed faecal smears stained by convencional method and detect DNA from 
three different gastrointestinal pathogens by PCR procedures. This novel 
method has potential advantages for the diagnosis and genetic characterisa- 
tion of intestinal pathogens, including: transport of noninfectious source 
material; analysis of remotely collected material; and the ability to analyse 
archived material. Future work will involve developing PCR procedures of 
increased sensitivities and applying the technique to a wider range of 
intestinal pathogens. 
CMV - EBV 
Ip11811 Evaluation of a new assay for the Wantitation Of 
human cytomegalovirus in plasma 
V. Tormanen, S. Palm, E. Pisa 
Bromma, S 
Human cytoinegalovirus (hCMV) represents an important pathogen in 
immunocompromised hosts as transplant recipients and AIDS patients. The 
constant development of new effective antiviral drugs has increased the 
demand of sensitive, reliable and robust assays for the monitoring of 
treatment effectiveness of these drugs. PCR is widely applied in a number of 
laboratories for the quantitation of CMV DNA in seruni/plasnia specimens, 
but in many multicentre trials no standardization of the method has been 
performed. Therefore a standardized quantitative assay was developed and 
evaluated on the PE Biosystems GeneAmp 9700 system. The assay involves 
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CMV - EBV 
/p11811 Evaluation of a new assay for the quantitation of 
human cytomegalovirus in plasma 
V. Tormanen, S. Palm, E. Pisa 
Bromma, S 
Human cytomegalovirus (hCMV) represents an important pathogen in 
immunocompromised hosts as transplant recipients and AIDS patients. The 
constant development of new effective antiviral drugs has increased the 
demand of sensitive, reliable and robust assays for the monitoring of 
treatment effectiveness of these drugs PCR is widely applied in a number of 
laboratories for the quantitation of CMV DNA in serum/plasma specimens, 
but in many multicentre trials no standardization of the method has been 
performed. Therefore a standardized quantitative assay was developed and 
evaluated on the PE Biosystems GeneAmp 9700 system. The assay involves 
a three-step specimen preparation combined with amplification and 
detection of the CMV DNA in a 96 well format and has a colorimetric 
read-out. The assay requires only standard laboratory equipment and is 
amenable for automation, The assay was evaluated using VQC CMV panel 
plasnia specimens provided by the CLB Viral Diagnostic Laboratory in 
Holland. The developed assay has a higher sample bough-put and an improved 
dynamic range compared to other conlmercially available CMV assays. 
v) Correlation between the presence of pp65 antigen, 
specific serum antibodies and virus isolation as a marker of 
active form of CMV infection 
Krakolr/, PL  
B. Zawilinska, M. Koprynia, D. Rojek-Zakrzewska, J. Kopec 
Objective: A sensitive and reliable diagnostic test that d rapidly confirm or 
exclude active CMV infection (in@ is of practical clinical relevance. The 
purpose of this study was to compare value of different assays (antigenaemia 
pp65, virus isolation and serological examination) in detection of active 
CMV inf 
Materials and methods: 58 pts repeatedly examined on account of heart or 
kidney transplantations, or suspicion of CMV disease were enrolled in this 
prospective study. 
Materials: Serum for serological examination, urine or throat smears for 
virus isolation and leukocytes obtained from EDTA-treated blood for 
antigen (Ag) pp65 detection. Specific antibodies (Ab) - total and IgM were 
determined by ELISA (Organon Teknika). CMV cultures were realized by 
shell vial method on MRC-5 cells. IF-Ab staining of the cells to detect the 
CMV IE and E Ag was performed. The CMV Ag assay was carried out 
according to the procedure described earlier. The CMV-pp65 Ag was 
detected using monoclonal Ab and biotinylated link Ah with complex 
streptavidin-alkaline phosphatase. 
Results: The comparison of results was shown in Table 1. The correlation 
ratio between pp65 Ag and the detection of specific IgM Ab and/or virus 
isolation was 76%. In the group with concordant positive results, there were 
28% pts in whom Ag pp65, virus isolation and/or IgM Ab were detected 
simultaneously, whereas in majority (70%) of the examined pts CMV-pp65 
Ag preceded approximately 30 days the other signs of active inf. Among the 
pts with apparent discordant results there were 6 pts after organ 
transplantation, who had been CMV-IgM positive for 4-16 month. and 5 
pts with earlier confimied CMV inf and subsequent antiviral treatment. 
Conclusions: (1) The CMV-pp65 Ag in leukocytes is a specific method 
which allows to recognize the CMV inf earlier than virus isolation and 
specific IgM response; (2) the notified discordance between antigenaemia 
and other parameters of active CMV inf was probably a result of the 
differences in response to antiviral therapy. 
Table 1 Active C M V  infection. 
Agpp6S t40 3 43 
- 1 1  4 15 
Total 51 7 58 
* Contirnicd by viruy i d ~ t i o n  and/or specific IgM Ah 
I P I  183 1 Diagnosis of central nervous system herpes virus 
infections by a single multiplex PCR 
A. Sensini, G. V. L. De Socio, R. Castronari, F. Bistoni 
Perugia, I 
Objective: T o  evaluate the reliability and clinical utility of a single multiplex 
PCR for the diagnosis of herpesvirus central nervous system (CNS) infections. 
Methods: A multiplex PCR was employed based on a new type of primer, 
stair primers, which amplifies a well-conserved region of the DNA 
polymerase gene and at the same time detects six major herpesviruses (HSV- 
1, HSV-2, CMV, VZV, EBV, HHV-6) in a single reacnon. The ainplicons 
were analysed by hybridnation in microtitre plates. This procedure was 
performed on 35 specimens of cerebrospinal fluid (CSF) from 28 patients: 
15 immunocompetent and 13 inmunocompromised (oncohaematological 
malignancies) patients with presumed encephalitis or meningitis. 
Results: 11 CSF samples were positive in 6 patients (21%): 3 immuno- 
competent and 3 immunocompromised. In particular, 3 HSV-1, 2 VZV, 1 
EBV infections were identified. HSV-1 DNA was detected in 2 patients 
with meningoencephalitis and in 1 patient with benign lymphocytic 
meningitis who recovered without any specific antiviral treatment. CNS 
involvement by VZV revealed meningoencephalitis in the immunocompe- 
tent patient and neuropathy in the patient with Burkitt’s lymphoma, both 
without skin lesions. EBV was the cause of lethal meningoencephalitis in a 
child with acute lymphoid leukaemia, confirmed by autoptic relief. Two 
patients were examined after therapy with negative PCR results. 
Conclusions: The aetiological diagnosis of viral meningoencephalitis is 
dificult because of poor specificity of clinical findings. Since effective 
therapeutic treatments are available, early recognition of the causative agent 
is very important. Furthermore, although HSV-1 and HSV-2 are most 
frequently detected in meningoencephalitis, the addition of VZV, EBV and 
HHV-6 allows application of this test to immunocompromised patients at 
risk for severe life-threatening disease. The method employed requires only 
one reaction for 6 different herpesviruses with significant advantages 
includmg less sample material, reagents, and time. In conclusion, the 
herpesvirus consensus PCR appears to be reliable and easy-to-perform for 
routine use in the diagnostic laboratory. 
1p1184i Express method for the direct monitoring of virus- 
cell interaction 
A. P. Fedchuk, A. A. Fedchuk 
Odessa, UKR 
The problem of viru-cell interaction remains in the centre of 
contemporary antiviral research activities. Small size of the viral particles 
and short time of virus-cell interaction itself makes the search of new 
experimental methods of initial stages of viral infection process to be 
permanently actual. Experiments were conducted on cell culture HEP-2 
infected with Herpes simplex virus HSVl after 48 h since monolayer was 
formed. The treatment substance (macrocyclic pyridinophane MCP42l)was 
added after viral particles adsorbtion and into supporting media. Cellular 
monolayer was created over cover glasses. Some specimens were coloured 
according to the known method of viral intemuclear inclusion (VII) as the 
parallel measurement for the proposed optical method of laser diffracto- 
metry. Method of VII colouring is very complicated and provides the work 
of cytomorphology professionals of high level. The low energy (1 mW, 
wave length 0.6328 mkm) laser irradiation was directed onto the sample cell 
and diffraction pattern that was formed on the target was registered 
photographically. The eactal dimension D of the &&action pattern was 
examined and evaluated using the procedure of equivalent intensity points 
counting and sorting over the target plane as we have proposed before. The 
fractal mmensions obtained for di&action patterns of experimental and 
controls specimens were taken after 24 h and statistically reliable differences 
were seen quite distinctively. Standard method of VII takes not less than 48 
and even more hours in order to obtain comparatively stable results. We 
have discovered with the use of laser dif iactomeq (LD) method that the 
parameter D for control samples was significantly higher than for the 
experimental samples (Dc= 1.78 + 0.02 and De= 1.44 + 0.03). (1) It was 
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discovered experimentally that proposed method of laser diffractometry 
(LD) is much more rapid one than the existing methods of virus-cell 
interaction registration especially using computer-assisted device. (2) The 
fkactal approach proposed in the present paper has a lot of fundamental 
features that allow to predict its applicability to great variety of structural and 
f o n ~ n g  problems in experimental pharmacology. (3) LD method could be 
successfully used not only in antiviral but also in anticancer pharmacological 
research because it makes it possible to detect in a very sensitive manner a 
slightest deviation in cell structure and optical properties. 
Ip1185j Standardization of procedures for HCMV infection 
monitoring in solid organ transplant recipients 
C. Nazzari, A. Gaeta, C. Vaccarella, G. Fabri, C.  Mancini 
Rome, I 
HCMV represents an important pathogen in transplant recipients. Recently, 
HCMV diagnosis and monitoring have been greatly improved, detecting 
viral nucleic acid in peripheral blood using the polymerase chain reaction 
(PCR). Although PCR seems to be of easy application, it is really subjected 
to many problems essentially concerning samples storage, contamination, 
and the presence of impurity that could inhibit or  reduce the sensitivity and 
efficiency of amplification. The high sensitivlty of conventional qualitative 
amplification methods represents a limit in the differentiation between 
HCMV replicative and latent infection. Therefore, we selected a protocol 
taking into account all these aspects. From January to October 2000, we 
analysed 1100 samples from sohd organ transplant patients. DNA was 
extracted from penpheral blood leukocytes (PBL) by alkaline thermolysis; 
qualitative analysis of HCMV genome was obtained by a nested P C R  in 
which a 110-bp IE HCMV sequence was coamplified with a human beta- 
globin sequence. PCR products were separated in 2% agarose gel, stained 
with ethidium bromide and both amplicons were visualized by U.V. light. 
In the absence of beta globin amplification product, the analysis of 
specimens was repeated from extraction step. Thus, HCMV-DNA was 
quantified by competitive PCR protocol based on the coamplification of a 
positive internal control which shares the same primers with HCMV 
sequence target. The presence of HCMV DNA was evidenced in 330 (30%) 
of analysed samples. The quantitative evaluation showed that only viral 
genomic load higher than 1000/2 x I00000 PBL was associated to 
antigenaemia positivity and clinical symptoms. Therefore, the quantitative 
monitoring of positive patients allowed to early underline the risk of viral 
relapse in order to timely address specific antiviral therapy to prevent the 
life-threatening consequences of viral ksease. The results obtained from the 
methodical approach used in this study showed that in no one of 
monitorized patients clinically severe HCMV infection occurred. In 
conclusion, the hgh sensitivity of qualitative P C R  and the presence of an 
internal control, permitted to evaluate the efficiency of extraction step and 
the presence of PCR inhibitors avoiding false-negative results. Moreover, 
the evaluation of genomic copies by a system including an internal standard 
competitor allowed to speclfy the efficiency of quantitative amplification step. 
1p11861 Clinical utility of surveillance methods for pre- 
emptive therapy of cytomegalovirus infection in allogeneic 
stem-cell transplant 
P. De La Obra, N. Prieto, T.  Delgado, E. Lamas, R. De La Camara, 
M. L6pez-Brea, L. Cardeiioso 
Madrid, E 
Aim: To determine the clinical utility of surveillance methods used to 
monitor high risk cytomegalovirus (CMV) infection in dogeneic stem cell 
transplant (No-SCT) from sibling donors. 
Methods: 63 consecutive patients underwent Alo-SCT were evaluated 
between September 1997 and October 1999. CMV prophylaxis strategy: 
Group 1 (11 patients), CMV seronegative recipient (R) and donor (D), only 
received filtered unscreened blood products as CMV prophylaxis. Group 2 
(52 patients), all CMV seropositive or seronegative recipients with 
seropositive donor received prophylaxis with high doses acyclovir (500 
mg/m2/8 h) ham 5 days pretransplant to 28 days post-transplant (post- 
SCT). These patients underwent two survedlance bronchoalveolar lavages 
(BAL): early BAL (35-50 days post-SCT) and later BAL (80-100 days post- 
SCT). BALs were studied with shell vial centrifugation and conventional 
culture. All patients were monitored until day 100 post-SCT; weekly blood 
samples were tested with CMV pp65 antigenaemia (Argene) and viraemia 
(conventional cultures). High nsk CMV infection was defined as CMV 
positive BAL or a positive antigenaemia and therefore received pre-emptive 
therapy with ganciclovir. 
Results: We studied 63 consecutive transplant recipients. Group 1: none 
developed CMV infection or CMV disease. Group 2: In 15 of 52 patients 
(28%) a high risk CMV asymptomatic infection was detected: I 1  patients 
had a positive antigenaemia (2 also with a positive BAL), and 3 patients a 
positive BAL with negative antigenaemia. The antigenaemia and BAL were 
positive at a median of 61,7 days (range 41-97) and 84 days (range 63-96), 
respectively. All these patients were treated and only one developed CMV 
gastrointestinal disease 32 days after. Three new patients developed CMV 
disease (pneumonitis). Fatal CMV disease occurred in 2 patients. 
Pneumonitis were not preceded by antigenaemia, all had concomitant 
antigenaemia and 2 of these also had concomitant positive BAL. 
Conclusion: In CMV seronegative transplants (D and K) the transfusion 
policy obtained good results. Antigenemia plus surveillance BAL did not 
allowed a pre-emptive treatment in 3 out of 4 cases of CMV disease. New 
approaches have to be explored. 
Ip11871 CMV interstitial pneumonia in moderately 
immunocompromised patients: report of 2 cases 
A. Manna, S. Cordani, R. Maggiani, P. Canessa, L. Giorgi, P. Pronzato 
La Spezia, I 
Cytomegalovirus (CMV) is a major cause of morbidity and mortality in 
allogeneic bone marrow transplant; however, viral infection and subsequent 
disease in haematological malignancies are rarely documented in the 
literature. Here we report two cases of interstitial pneumonia in non 
transplanted nddly inmunocompromised patients. 
Case 1: A 66-year-old male patient was referred to the Pneuniological 
Department because of non productive cough, fatigue and weight loss; in a 
few days fever and dyspnoea developed chest X-ray, C T  scan picture and 
arterial blood gases ( 0 2  = 55 nmHg) were all consistent with interstitial 
pneumonia. CMV-DNA, documented by PCR was positive. At that time, 
diagnosis of T cell NHL on a cervical node was made. All laboratory tests 
were normal, with the exception of lymphocytopenia (total lymphocyte 
count= 830/mm). Despite chemotherapy (CHOP) for NHL and antiviral 
therapy with gancyclovir, the patient dled of respiratory failure. 
Case 2: A 65-year-old male patient was referred to the Internal Medicine 
Depaitment because of cough, fever and dyspnoea. Laboratory tests and 
bone marrow aspirate were consistent with IgA lamba myeloma; a 
lymphocytopenia was detected: total lymphocyte count = 689/mm, 
CD4 = 367/mm, CD8 = 185/mm. Chest X-ray and HRCT scan showed 
an interstitial picture, more evident in lower lobes with fibrotic and alveolar 
component. Arterial blood gases showed a severe hypoxaemia (02 = 55 
mmHg).CMV antigenaemia and CMV-DNA by PCR tesung were 
positive. Treatment with ganciclovir and chemotherapy for myeloma 
PAD) are in progress. 
Conclusions: These cases share a ‘mild’ lymphocytopenia; neither was 
treated previously with chemotherapy or immunosuppressive therapy. 
Therefore our experience suggest that CMV infection and/or disease should 
also be considered in moderately immunocompromised patients, out of the 
bone marrow transplant setting. 
Ip11881 Evaluation of Epstein-Barr viral load in organ 
transplant patients: clinical significance 
A. Gaeta, C. Nazzari, C. Vaccarella, A. Scocca, G. Fabri, R. Lubrano, 
P. Scoppi, S. Scateni, E. Travasso, C. Mancini 
Rome, I 
Solid organ transplant patients undergoing long-term immunosuppression 
have h g h  risk to develop post transplant lymphoproliferative disorders 
(PTLD). A strong correlation between EBV infection and PTLD has been 
recognized in particular, PTLD is most often observed in paediatric patients 
who experience primary EBV infection after transplant. Considering that 
many patients have responded to reversal of immunosuppressive therapy, 
early identification of EBV replication may be essential in order to reduce 
the immunosuppression and/or to introduce antiviral therapy to prevent 
progression to PTLD. Aim of our study was to establish a protocol for 
monitoring EBV infection in transplant patients. 13 paediatric patients were 
monitorized by determination of specific IgM to EBV viral capsid antigen 
(VCA-M) and presence of viral genome in peripheral blood leukocytes 
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(PBL) and serum samples. AU samples were analysed by a qualitative nested 
polymerase chain reaction (PCR) using primers designed for a 96-bp EBV 
sequence located in the BamHI-W regmn. Each sample was also amplified 
for human beta globin sequence as control for the extraction efficiency and 
PCR inhibitors presence. DNA positive specimens were quantitated for 
viral load using a competitive DNA PCR based on the coamplification of 
EBV genomic 121 bp sequence relative to BNRFl region with an internal 
standard molecule in a known concentration. Amplicons were quantified in 
microtitre plate by hybridization with probes specific, respectively, for EBV 
and competitor sequences. High VCA-M-values were observed in 7 
(53.8%) patients. DNA positivity in PBL was observed in 12 (92.3%) cases 
and only in 6 (46.1%) of these we also found EBV genome in sera. 
Hepatitis B virus (I) 
Quantitative analysis showed in cellular samples a wide range(100G14 000/ 
100 000 PBL) of EBV genomic load while in sera the mean value was < 
1000/mL genomic copies. Only two patients showed higher values in PBL 
and serum viral load; in one o f  these they were associated to clinical 
evidence suggestive of PTLD. Patient presented an unexplained fever, 
lymphoadenopathy and mediastinic infiltration. The reduction of  immu- 
nosuppressive therapy lead on the regression of clinical symptoms. In 
conclusion, our data suggest that the study of EBV load represents an 
essential approach in the diagnosis and evaluation of PTLD clinical outcome 
and the detection of  EBV DNA in serum samples could prove useful 
information in the post-transplant monitoring of patients at high risk. 
Ip1189-1 Comparison of the Cobas Amplicor HBV monitor test 
with a real-time PCR-quantification using the Lightcycler 
instrument 
C. Luger, A. Bocksrucker, S. Metz, D. Griindler-Thompson, H 
Mittemayer 
Lirrz, A 
Introduction: The new Cobas Aniplicor HBV Monitor Test (Roche 
Diagnostic Systems) allows the quantification of HBV DNA within the 
range of 200-200 000 molecules o f  virus DNA/mL (copies/mL) in serum 
or plasma. We compared this conlniercial test w t h  a real-time PCR 
developed in our laboratory. 
Material and methods: 40 clinical samples and HBV standards were tested: 
8 PCR-negative serum samples; 2 commercial quantification standards with 
3000 and 30 000 copies/ml; a dilution senes of a highly positive serum 
sample (dilution steps 1 OEO-1 OE-7); 7 con~ec~t ive  s rum samples from a 
patient with an acute hepatitis B infection; and 14 PCR-positive serum 
samples. The reference method was a nested PCR method routinely used in 
out laboratory with a sensitivity of about 1000 copies/mL. Real-time PCR 
was done on a Lightcycler instrument with a linear range of  quantification 
from 10E3 to 10E8 copies/mL. 
Results: The Cobas Aniplicor HBV Monitor Test (HBV Monitor) showed 
approximately the same positive and negative results as the nested PCR 
assay. Only two samples from patients with a former hstory of hepatitis B 
infection, whose serology was not conclusive, differed one was negative 
both in the nested PCR and the real-time PCR assay whereas one was 
negative in the nested PCR assay and positive on the Lightcycler. The 
HBV Monitor results for these samples were < 200 and 12 900 copies/mL, 
respectively. 4 nested PCR positive samples with viral titres of < 200 (two 
samples), 465, and 8170 copies/mL in the HBV Monitor assay were 
negative in the Lightcycler PCR. These results suggest that the real-time 
PCR method is slightly less sensitive. Two samples with titres > 10E8 
copies/mL gave no interpretable result in the HBV Monitor test. For 14 out 
of 28 positive qaniples a result was obtained with the HBV Monitor test. 
The difference to the results of the real-time PCR assay was never greater 
than 1loglO for each sample. The result o f  the HBV Monitor test for the 
other 14 positive samples was either > 200 000 copies/mL or undefined. 
Undefined samples have to be diluted to obtain definite tines according to 
the manufacturer. 6 negative samples were negative both in the HBV 
Monitor assay and in the real-time PCR. 
Discussion: Within the linear range of the HBV Monitor test, the results 
matched well with those obtained with the real-time PCR. Samples with 
titres above the upper limit of the linear range were recognized correctly, 
yet without a definite copy number. 
1 P I  190 I Determination of hepatitis B virus DNA with in-house 
PCR and hybrid capture-I HBV DNA tests 
C. Eroglu, A. Pekbay, S .  Esen, S. Havuz, M. Sunbul, M. Gunaydin, 
H. Leblebicioglu 
Satnsun, TR 
Objectives: The measurement of hepatitis B virus (HBV) DNA levels in 
serum has become an important tool for managing chronic HBV infection. 
Several molecular approaches, either commercially available or homemade 
tests, have been used in the last few years to quantify serum HBV DNA 
levels more accurately. We have evaluated in-house PCR and the hybrid 
capture-I HBV DNA test (HC-I HBV DNA, Digene) for HBV DNA 
detection. HC-I HBV is able to quantify HBV DNA at between 1.4 x 10" 
and 5.6 X loH HBV genonies per nd in sera. 
Methods: In-house PCR and HC-I HBV DNA were tested for HBV DNA 
determination in 75 sera. AU samples of tested were positive for Hb s antigen. 
Results: The ratio of HBV DNA positivity was found to be 36% by in- 
house PCR and 32% by HC-I HBV DNA methods. Of 51 HC-I HBV 
DNA negative specimens, 48 (94.1%) were negative and 3 (5.9%) were 
positive by in-house PCR. The results indicated that there was no 
statistically meaningful difference between these methods by chi-square test. 
Conclusion: As a result, it has been concluded that for clinical laboratories 
able to perform a sensitive in-house PCK assay for HBV DNA detection. 
Prescreening HC-1 HBV DNA requests by in-houge PCK may be the most 
cost-effective approach. 
Immunization of mice with plasmid DNA encoding 
hepatitis B virus core antigen 
M.-Z. Doymaz, Y. Bulut, H.  Bulut 
Elazk, TR 
Prevalence of Hepatitis B virus infection 111 Turkey is considered to be quite 
high. The studies on HBV infection mostly related to serological aspects of 
the disease. The aim of the current study was to clone, to express and to 
investigate the immunogenicity of hepatitis B v h s  core antigen (HBcAg) 
gene from a Turkish HBV isolate. For this purpose, HBcAg gene fragment 
was amplified in polymerase chain reaction from an HBV DNA positive 
individual. The amplified fragment was cloned into pcDNA 3 eukaryotic 
expression vector. After the confirmation of cloning and the expression of 
HBcAg gene, pcDNA 3 based HBcAg expressing vector was used in DNA 
immunization experiments. Four to 6-week old Balb/c mice were 
iimnunized with HBcAg expressing plasmids and anti-HBcAg antibody 
responses of mice were evaluated in ELISA. The results of these 
experiment5 indicated that HBcAg expressed fiom pcDNA 3 based 
eukaryotic expression vector induced a significant anti-HBcAg response 
when introduced intramuscularly into Balb/c mice. 
v1 Serum anticardiolipin antibodies levels in patients 
with chronic hepatitis B and in patients with HDV-superinfection 
J. Elefsiniotis, D. Panagiotakos, I. Papanikolaou, 1. Glynou, K. Avdelioti, 
R. Saramandou, H. Kada, G. Karvountzis 
Athens, GR 
Objectives: Viral and bacterial infections are stimulants for the production of 
antiphospholipid antibodies. The presence of the latter in viral hepatitis has 
been studied only in hepatitis C patients. Aim of this study was to evaluate 
the presence and the titre of anticardiolipin antibodies (ACA) in the serum 
of patients with chronic hepatitis B (CHB) and to compare the results with 
those of patients with HDV superinfection. 
Methods: Serum was obtained from 25, randomly selected, CHB/HbeAg 
(-) patients (ages=45 & 12.7 years, ALT= 174.3 107 IU/L, HBV- 
DNA = (2.4 2.3) x 106 cop/mL, inflammation = 6.8 2.9, fibro- 
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sis=3.1 1.3, PLT= 189523 f 51770/mm3), 18 patients with HDV 
superinfection (ages=35.7 k 14.5, ALT=171.2 k 46.6, inflamma- 
tion=6.6 k 1.9, fibrosis=3.4 k 0.9 PLT=189 400 f 47 800) and 32 
healthy volunteer blood donors of similar age (43 f 11.5 years) and sex. 
The presence and titre of serum ACA (IgA and IgG) was determined by 
ELISA. All patients were free of other acute or chronic illnesses. None of 
them was under any medication and had never received treatment in the 
past for hepatitis. All HDV-positive patients were HBV-DNA negative and 
had a very low titre of serum IgM-antiHbc. Statistical evaluation was based 
on multivariate logistic regression analysis. Statistical siguficance was 
acheved when P-Value < 5%. 
Results: 5 CHB patients, 8 with HDV superinfection and 1 control were 
found positive for the presence of ACA. Based on the statistical analysis we 
observed a significant correlation between presence of ACA, HBV and 
HDV superinfection (P-Value = 0.041). In particular, HDV superinfection 
4-fold the risk of the occurrence of ACA compared to CHB patients and 3- 
fold the aforementioned risk in CHB patients compared to controls, adjusting 
for age, sex, ALT, PLT levels and histological activity index (OR = 3.98, P- 
Value = 0.0213 and OR = 3.1 and P-Value = 0.05, respectively). 
Conclusions: Chronic HEW infection, as well as HDV superinfection seems 
to be potential stimulants for the occurrence of ACA. HDV superidection 
significantly increases the risk of ACA production and could be related with 
the worsen prognosis in these patients. 
vl Chronic hepatitis B in asymptomatic blood donors 
E. Minola, G. Gregis, 0. Fracassetti, G. Qninzan, F. Suter 
Bevatno, I 
Background: For many people infected with the hepatitis B virus (HBV), 
the route of exposure, risk of transmission, and severity of acsociated liver 
disease are unknown. We studied these variables in people who donated 
blood voluntxily. 
Methods: We stuhed, referred to ou r  Centre between June 1996 and June 
2000, 243 blood donors with persistently abnomial alailine anlinotransferase 
(ALT) serum levels. Twenty-six of these (10.796) were tested positive for 
HBsAg on enzyme immunoassay. None of the 26 HBsAg pocitive blood 
donors were positive for HDV, HCV and HIV. The evaluations included 
an assessment of risk factors, a physical examination, serial determinations of 
ALT serum levels and were determined the IgM HBc and a chemilunlines- 
cence assay for HBV-DNA. Also were offered testing for HBsAg of sexual 
contacts and family members, and liver biopsies were performed in some 
participants who were HBsAg positive. 
Results: A total of 26 donors were studied, mean age were 43.2 years (range 
24-61 years old), 19 males (73.1%) and 7 females. Significant risk factors for 
HBV infection among the HBV positive blood donors were one or more 
f a d y  members HBsAg positive in 4 patients (15.4%) and 'community- 
acquired' in 22 (84.6%). Four of26 sexual partners (21.1%) ofdonors tested 
were HBsAg positive. One out of 35 living together som (2.896) were 
HBsAg positive. None had evidence of acute hepatitis in ananmesis. Of the 
HBsAg positive donors, 15 out of 26 (57.7%) had biochemical and 
virological evidence of chronic liver disease. IgM HBc > 0.2 index ratio 
were detected 11 out of 20 patients (55%) and HBV-DNA determined in 
17 blood donors were elevated (10 pg/mL) in 3 patients (17.6%). One out 
of 23 patients (4.3%) was HBeAg positive. Among 15 out of 26 blood 
donors with IgM HBc > 0.2 index, HBV-DNA > 10 pg/mL and with 
altered ALT > 1.5 the normal values, 9 donors underwent a liver biopsy, 6 
had moderate-severe grading of chronic active hepatitis and with elevated 
staging of fibrosis (2 with associated cirrhosis). 
Conclusions: Among volunteer blood donors, household contacts with 
HBV are a important risk factors for HBV infection. In a high percent of 
blood donorc the itlfection of HBV were defined 'community-acquired'. 
The h g h  kequency of household contacts become necessary to screening 
for HBsAg the family members. 
Serum anticardiolipin antibodies levels in patients 
with chronic hepatitis B and their association with extra-hepatic 
manifestations 
J. Elekiniotis, D. Panagiotakos, I .  Papanikolaou, I. Glynou, M. Shou, P. 
Koukouletsou, H. Kada, G. Karvountzis 
Athens. GR 
Objectives: Chronic hepatitis B (CHB) is a major public health problem. Its 
natural history may include advancement to cirrhosis and/or hepatocellular 
carcinoma. Viral and bacterial infections are potent stimulants for the 
production of antiphospholipid antibodies. The presence of the latter in 
viral hepatitis has been studied only in hepatitis C patients. The aim of this 
study was to evaluate the presence and the titre of anticardiolipin antibodies 
(ACA) in the serum of patients with CHB, compared with healthy 
volunteer blood donors and to correlate them with seruni ALT levels, 
HBV-DNA, the platelet count (PLT) and with the presence of extra- 
hepatic manifestations of the infection. 
Methods: Serum was obtained from 25, randondy selected, CHB/HbeAg 
(-) patients (ages=45 12.7 years, ALT= 174.3 f 107 IU/L, HBV- 
DNA= (2.4 f 2.3) x 106 cop/ml, PLT= 189 523 f 51 77O/mni') and 
32 healthy volunteer blood donors of s d a r  age (43 f 11.5 years) and sex. 
The presence and titre of serum ACA (IgA and IgG) was determined by 
ELISA. All patients were 6ee of other acute or chronic illnesses. None of 
them was under any medication and had never received treatment in the 
past for hepatitis B. Statistic evaluation was based on the calculation of exact 
logistic regression analysis. Statistical significance was achieved when P- 
value < 5%. 
Results: Of the 25 CHB patients, 5 were positive for the presence of ACA, 
whereas 20 were negative. In the control group, only 1 was ACA-positive 
and 31 were negative. Of the 5 ACA-positive patient5 3 had presented 
extra-hepatic manifestations (2 leukocytoclastic angiitis and 1 membranous 
glomerulonephritis). Based on the results of statistical analysis, significant 
correlation between presence of ACA and HBV infection was obterved (P- 
value=0.0356). The possibility of the presence of ACA was 5-fold 
compared to the general population, adjusting for age, sex, ALT, HBV- 
DNA and PLT levels (OR=5.1,  P=0.05). 
Conclusions: Chronic HBV infection seems to be a potential stimulant for 
the presence of ACA. The occurrence and htres of ACA seems to be related 
with the presence of extra-hepatic manifestations whereac it is not correlated 
with viraenea and the severity of hepatocellular damage. 
Does platelet-activating factor play a role in anti-HBs 
seroconversion? 
C. Buke, M. Buke, M. Cicekhogln, S. Kamcioglu, I .  Erdem, G. Karakartal, 
A. Huseyinof 
Izmir, TR 
Purpose: In this study responses of two cytokines (IL-6, TNF-alpha) of 
peripheral mononuclear blood cells (PMBC) obtained from plasma H B s  
antibody positive and negative patients after hepatitis B infection were 
investigated and the role of PAF in these cytokine responses was evaluated. 
Materials and methods: Three groups of patients with a mean age of 
37 f 10 were included in this study. The characteristics of these groups are 
summarized in Table 1. 
Group n HRs Ag Total Anti-HRs AST ALT Hisroparology 
anri-HBc 
A 15 - - - N N *  
13 1 0  - + + N N *  
C 9 t  + - N N N  
-: negative, +: positive, N: nonnd ,  *: not cvaluatrd. 
Mononuclear leukocytes were extracted from heparinized blood via 
histopaque gradient method washed for three times and suspended in 
RPMI 1640 solution includmg AB serum and streptomycin as 5 x 10-" 
cell/mL. Cell suspension was incubated in v i m  with 1 ~nkM platelet 
activating factor (PAF C16) and 5 mkg concanavahn A (Con A) as a classical 
nlitogen for 72 h. Thereafter 1L-6 and TNF-alpha were calculated by 
ELISA (Genzynie Co. ABD) method from supernatant and results were 
given as picogram/5 x cell. Differences between these groups were 
tested by Levene's test and when P < 0.05 Kcuskal-Wallis test was 
performed. In order to obtain the differences in between these groups Man 
m t n e y  U-test was used and P < 0.0167 was considered significant. 
Results: Test results are summarized in Table 2. 
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Table 2 
IL-6 TNF-aloha 
Spontaneous rcsponsc 
Group A 15.1 f 6.7 14  7 f 4.5 
Group C 353.3 f 65.7 276.6 * 44.1 Group B 410.0 f 74.9 352.0 i 64.9 
P AB n.nnn 0.001) 
P AC n.ooo 0.000 
p nC 0.1 I3 0.018 
Group A 79.5 f 37.5 68 & 33.5 
Group B 378o.n k 603.3 2790.0 f 648.8 
Group C 2622.2 f 405.5 1372.2 k 734.4 
P AC 0.000 0.000 
Concanavahn A 
P AB 1).IlOO o.oon 
p 8C 0.000 0.001 
PAF C l 6  
Group A 64.8 & 1 1  -3 53 7 k 13.2 
Group B 3780.0 f 72X.4 2630.0 f 727.3 
Group C 2533.3 f 466.3 1633.3 i 793.7 
P AB 0.000 a.ooo 
P AC 1).01111 0.000 
P BC 0.IU)l 0.014 
P < O.Ol67 w t l i  M a n  Whitney 1.‘-tecc. 
Conclusion: The spontaneous response of cytokines and the response after 
stimulation were lower in the nonexposed group to hepatitis B virus than 
the other groups (pAB < 0.0167, PAC < 0.0167). Nevertheless these 
responses were hgher in group B than group C (pBC < 0.0167). It was 
detected that PAF like classical mitogen Con A can stimulate cytokine 
response in PMBC. These results may indicate that PAF which has a broad 
spectrum immune regulatory effect can play a role in anti-HBs 
seroconversion by controlling cell response. 
/p11961 Long-term results of interferon-alpha 2b plus 
indomethacin combination therapy in chronic hepatitis B 
Y. Cakaloglu, H.  Senturk, U. S. Akarca, K. Denllr. M. Akdogan, S. 
Kayniakoglu, G. Ersoz, H. Cetinkaya, A. Avsar, T. Sahin, S. Arslan, E. 
Arslan, T. Kozeoglu, N .  Sasmaz, C.  Yurdaydin, A. Sonsuz, S. Karayalcin, 
N. Tozun, 0. Uzunalimoglu, Y. Batur, A. Okten 
Istanbul, TR 
Background and patients: Irl vitro and irr vivo studies and pilot c h c a l  trials 
have shown that indomethacin (IND) may increase the effectiveness of 
interferon-alpha (IFN) therapy in chronic hepatitis B (CHB). This study 
including 176 pts (50 female, 126 male and mean age 361 12 years; ALT > 
2xULN. HBV DNA positive by hybridization, histological dx of chronic 
hepatitis and conipensated liver disease) with CHB was camed out between 
1995 and 1997 and pts were randomised to take IFN alone (IFN-alpha 2b 
10 ~ U / t i w - 6  months) in 88 pts or combination (IFN-alpha 2b plus IND 75 
mg/day/tiw-6 months and omeprazole 20 mg/day/tiw-6 months) in 88 pts. 
Results: There was no significance difference in age, sex, pretx ALT and 
HBV DNA levels, HA1 (Knodell), HBeAg or anti-HBe positivity between 
two groups. Total 28 pts. 20 pts in combination group and 8 in IFN group 
were excluded &om the study because of side-effects and/or noncom- 
pliance. The rates of end of treatment response (ETR), sustained response 
(SR) and relapse in 148 pts completed 6 months therapy and minimum 12 
months follow-up period after therapy are depicted in the Table: 
Hepatitis C virus (11) 
HUeAg + ve 
N o  of ETR* Relapse SR* 
pts no %> (“A) (%) (a) 
IFN-a 2b 80 38 48 63 24 49 
IFN-a 2b 68 25 37 62 31 47 
plus IND 
Total 148 63 43 62 27 48 
* P  > 0.05. 
On the con- of pilot studies, thls large study has clearly indicate that 
combination therapy with indomethacin does not increase the effectiveness of 
IFN-alpha in CHB. Additionally HBeAg positive and anti-HBe positive patients 
when evaluated separately did not show any signhcant Cttferences in terms of 
ETR, SR and relapse mtes between IFN-alpha and combination therapy groups. 
HA1 is s+cantly higher in SRs than in non-SRs (10.213.7 and 8.713.3 
respectively, P < 0.05). Anti-HBe positivity is the only parameter significantly 
associated with SR in multivariate analysis (r=0.1163, P < 0.05). Pre-ix HBV 
DNA levels was higher in non-SRs than in SRs (815.911402.9 pg/mL and 
447.51915.5 pg/mL, respectively) hut the merence did not reach siplicance. 
Conclusions: (1) Standard IFN therapy results in 48% SR in CHB patients. 
(2) Combination with I N D  does not increase the effectiveness of IFN therapy. 
(3) Combination therapy is associated with more kequent therapy withdrawal 
due to noncompliance and side-effects. (4) HBeAg and anti-HBe positive 
patients have similar SR rates. (5) When all ptq asessed together, anti-HBe 
positivity, higher HA1 and low HBV DNA level$ are more frequently 
associated with SR in CHB patients treated by standard IFN therapy. 
v] The conclusion of using interferon alpha and 
lamivudine in the therapy of chronic hepatitis B 
N. Saltoglu, Y .  Tasova, D.  Midikli, S. Inal 
A d a m ,  TR 
Objectives: The purpose of this study is to determine the effect of using the 
combination of interferon alpha and lamivudine in chronic hepatitis B. 
Methods: There are 21 patients in t h s  study; 16 are the primer and 5 are the 
relapse. Fourteen of the patients are male, 7 are female and mean age is 30.6. 
Before the treatment we determined the levels of hepatitic markers (EM-Abbott, 
ALT, AST, HBV DNA). The hepatic biopsy had taken before our study Knodell 
scoring system was used for the histopathological investigation. All the patients 
were informed about their treatment. Our plan was giving the combination of 
the 5 mp interferon alpha 2b and 150 mg knuvudine everyday for 6 months. At 
the end of 6 months our purpose for the patients whose HBV DNA didn’t 
become negative was stopping the treatment and whose HBV DNA became 
negative was giving lamivudine for 6 months more. These patients were 
controlled about 6 months after the treatment. If‘ HBV DNA and HBs Ag both 
became negative we called complete response. If HBV DNA became negative 
and seroconversion of W e  Ag were together determine we called partial 
response. And if only HBV DNA became negative we called transient response. 
Results: Transaminases were increased more than 1.5 times and HBV DNA 
was positive in all patients, 11 of them had positive HBeAg, 10 had positive 
antiHBe. After the 6 months treatment ALT and AST levels became normal in 
all patients; 2 of them had a seroconversion of HBs Ag, 511 1 (45%) of them had 
both seroconversion of HBe Ag and negative HBV DNA, 8 of them only had 
negative HBV DNA. But 3 of them had positive antiHBe at the beginning of 
the treatment. M e r  the 6 months controls, we had complete response in 2 
patients (9.5% and we had partial response in 5/11 (45%) patients. 
Conclusion: As a result, we thought that the combination ofinterferon alpha 
and lamivudine therapy was effective. 
v] Hepatic granulomas in chronic hepatitis C 
A. Men, R. Ozaras, V. Tahan, F. Tabak, G. Ozbay, Y. Aktuglu, H. Senturk 
Isfatibid, i zmir ,  Ankara, TR 
Hepatic granuloma (HG)s are chronic idammatory lesions composed of 
modified macrophages called epitheloid cells usually surrounded by 
lymphocytes. The common aetiologies include sarcoidosis and tuberculosis 
worldwide. Fomiation of HG is a very rare complication of chronic 
hepatitis C infechon. A 46-year-old woman has been followed-up by 
chronic hepatitis C (CHC) without any treatment for 9 years. Last year, she 
was admitted to our unit with fatigue. Laboratory studies revealed the 
followings: ALT 85 U/L, AST 69 U/L, ALP 151 U/L (N: 64-306). 
albumin 4.2 g/dL, totd bilirubin 1.1 mg/dL, HBsAg (-), anti-HBc (-), anti- 
HCV (+), HCV-RNA (+). A liver biopsy was performed and revealed the 
findings of chronic hepatitis with mild-moderate inflammatory reaction, 
moderate fibrosis and also epitheloid granulomas in some of portal regions, 
Further investigations for HGs including Rose-Bengal, Wright, anti-Brucella 
Ig G and M, and VDRL tests, chest X-ray, thorax CT,  and tuberculin skin 
tests remained negative. She was prescribed a combination therapy of 
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interferon-a 3-MU thrice weekly and ribavirin 1000 mg dady for one year. 
By the treatment, biochemical and viral responses were achieved. The liver 
biopsy repeated after the therapy revealed similar histological activity with 
the previous one, but granulomatous lesions were much more severe and 
widespread. In our unit, 250 patients with CHC have been followed-up 
during last 8 years. Except this patient, no one revealed a HG either in initial 
biopsies or in biopsies performed after interferon therapy. On the other 
hand, in our pathology department, 55 HG have been encountered during 
last 8 years and also hepatitis C was not the aetiology in any. Interferon 
treatment has been reported to cause HG in very few cases. CHC is also a 
very rare aetiology of HG. Because HG was detected before the therapy, the 
latter is more likely. However despite biochemical and viral response to 
treatment, increases in both numbers and severity of HG, IFN should also 
be considered as a contributing factor. In conclusion, CHC virus infection 
and/or IFN therapy may lead to HGs. But as these aetiologies are rare, other 
commoner aetiologies should be sought before ascribing them to HCV and/ 
or IFN. 
v1 Liver function tests of HCV-infected patients on 
chronic haemodialysis 
D. Siagris, M. Christofidou, K. Thomopoulos, I. Spiliopoulou, A. Lekkou, 
Ch. Labropoulou-Karatza 
Putrus, GR 
Objectives: To compare liver function tests of HCV infected patients on 
chronic haemodialysis (HD) to those of HCV patients with normal renal 
function (NR). 
Patients and methods: 73 patients (49 M, 24 F, mean age 57.8 f 13 years) 
on maintenance haemodialysis (HD) and 76 otherwise normal patients (39 
M, 37 F), mean age 52.1 f 16.6 years) w t h  chronic HCV infection were 
consecutively evaluated. All patients were HCVAb (+) by MEIA HCV 3.0 
(Axsyni Abbott) and by the confirmatory linked imniunoassay (Sorin). 
Patients with other causes of Ever dysfunction (chromc hepatitis B, 
increased alcohol intake, hepatotoxic drugs) were excluded. Serum 
HCVRNA was detected by RT-PCR (Amplicor Roche). Serum aspartate 
aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamine 
transpeptidase (GGT), bilirubin (Bil). albumin (Alb) and globulins(G1ob) 
were performed using an automated multirnzyme analyser. Conventional 
chi-square test was used to analyse qualitative differences. The differences 
between parametric data were evaluated with Student’s t-test. 
Results: The mean values of AST, ALT and GGT were significantly lower 
in HD than in N R  group (AST: 25.2 f 11.5 vs. 69.4 f 41.5 IU/L, P < 
0.001) (ALT: 28 f 22.2 vs. 72 f 43 IU/L, P < 0.001) (GGT: 32.8 k 29.6 
vs. 46.3 f 35.6 IU/L, P < 0.02). The mean values of Bil, Alb and Glob 
were not significantly different between the two groups (Bil: 0.85 k 0.52 
vs. 0.93 f 0.53 mg/dL, NS) (Alb: 4.23 f 0.38 vs. 4.30 f 0.73 g/dL, NS) 
(Glob: 3.26 f 0.70 vs. 3.43 f 0.69 g/dL, NS). Serum ALT activity was 
within the normal range for healthy adults (< 40 IU/L) in 89% of HD 
patients and in 20% of NR patients ( P  < 0.001). HCV RNA was detected 
in 56/73(76%) HD patients and in 66/76(87%) N R  patients (NS). 
Conclusion: Liver enzymes (AST, ALT, GGT) were found significantly 
lower in HCV infected haemodialysis patients than in those with normal 
renal function. The majority of H D  patients had normal AST, ALT and 
GGT levels. We conclude that the sensitivity of aminotransferase and GGT 
values to detect chronic HCV infection among ddysis patients is very low. 
The present data advocate for setting the threshold of normal values for liver 
enzymes (AST, ALT, GGT) at lower point in haemodialysis patients. 
v( Detection of hepatitis Cvirus by reverse transcriptase 
chain reaction and ELISA in patients with chronic liver disease 
T. Us, Y. Akgun, M. Kural 
Eskisehir, TR 
Hepatitis C (HCV) is a major cause of chronic liver disease. The aim of this 
study was carried out to investigate the presence ofAnti-HCV antibody and 
HCV-RNA by using reverse transcriptase polymerase chain reaction (RT- 
PCR) in sera of 202 patients with chronic liver disease who were 
prediagnosed as Hepatitis C virus (HCV) hepatitis in gastroenterology and 
infectious disease of Osmangazi University Hospital in Eskisehir (Turkey) 
during 1999-2000 period. Patients with viral infections other than HCV 
including Hepatitis B virus (by using HbsAg positivity) were excluded. All 
patients had chronic hepatitis, 81 (40.1%) of them were male, 121(59.9%) of 
them were female. Within a second generation ELISA kit Anti-HCV 
antibodies were found positive in 147 in 202 (72.8%) patients. By using 
RT-PCR; HCV-RNA was found to be positive in 1221202 (60.4%) 
patients. In all patients by using ELISA and RT-PCR; Anti-HCV 
antibodies + HCV-KNA positivity rate was 91/202 (45.1%), HCV-RNA 
positive + Anti-HCV antibody negative ratio was 311202 (15.3%). Withn 
all these Anti-HCV antibody positive + HCV-RNA negative ratio was 56/ 
202 (27.7%) found in patients. It was found that detection of HCV-RNA in 
Anti-HCV antibody negative patients were important as in antibody 
positive patients. So that in routine laboratories KT-PCR seemed to be a 
valuable assay for HCV-RNA determination for diagnosis and also 
following up therapies. It was conclude that by using ELISA and RT- 
PCR methods at the same time will be more suitable to show HCV in 
chronic liver diseases. 
v1 Virological features of HCV RNA positive patients on 
chronic haemodialysis 
D. Siagris, M. Christofidou, I .  Spiliopoulou, A. Lekkou, Ch. A. Gogos, Ch. 
Labropoulou-Karatza 
Putrus, GR 
Objectives: To compare viral load and genotype distribution, of HCV 
infected patients on maintenance haemodialysis (HD) to those of HCV 
patients with normal renal hnction (NR). 
Patients and methods: 58 patients (39 males, 19 females, mean age 
57.2 13.3 years) on maintenance haemodialysis and 59 otherwise nomial 
patients (32 males, 27 females, mean age 52.3 f 16.9 years) with chronic 
HCV infection, were consecutively enrolled in the study. All patients were 
HCVAb (+) by MEIA HCV 3.0 (Axsym Abbott) and HCV RNA (+) by 
RT-PCR (Amplicor Roche). Quantification of serum HCV RNA was 
performed by the branched DNA method (Quantiplex 2.0 Chiron, 
detection limit=0.2 MEquivalent/mL). An arbitrary value of 0.1 MEq/ 
mL was attributed to the serum samples that were positive by RT PCR but 
were negative by branched DNA assay. HCV genotyping was performed by 
line probe assay (INNO-LiPA HCV 111, Innogenetics). Differences in the 
frequency were analysed with the ch-square test. For numeric variables group 
comparisons were performed by the Mann-Whitney nonparametric test. 
Results: Serum HCV RNA levels were lower in the HD group 
(median = 2.076 MEiq/mL, range= 119.9 MEq/mL) than in the N R  group 
(median= 3.200 MEq/mL, range= 114.9 MEq/niL) ( P  < 0.05). Distribu- 
tion of genotypes in the two groups was as follows: HD patients: la:4(7%), 
lb:21(36%), 2: 3(5%), 3a:18(31%), 4: 0(0%), unclassified:12(21%). 
Nr patients: la: 6 (lo%), lb: 17 (29%), 2: 8 (14%), 3a: 21 (36%). 4: 2 (3%), 
unclassified: 5 (8%). The prevalence of genotypes was not significantly 
different for the two groups. 
Conclusion: HCV viral load was found significantly lower in haemodlalysis 
patients although these patients are considered to be immunoconipronlised. 
Other immunocompromised populations (AIDS and transplant patients), 
show hgher HCV viral load than immunocompetent HCV patients. It is 
possible that the cause of low viral load in haeniodalysis patients is the 
destruction of hepatitis C virus particles by dialyser membranes during 
haemodialysis. The distribution of genotypes was not difTerent between the 
two groups, despite the different way of infection. The prevalent genotypes 
were l b  and 3a, which are the most prevalent genotypes in Greek patients. 
v1 The role of the viral load and genotypes in the 
development of steatosis in patients with chronic hepatitis C 
virus infection 
M. Nogales, G. Gutikrrez, M. Komero, E. Martin Mazuelos 
Sevillu, E 
Objective: Studying the influence of intrahepatic replication, viraenlia, and 
genotypes in the development of steatom and fibrosis. 
Method: 108 patients with chronic HCV infection, 72 males and 36 females 
were included in the study. Their average age was 38 f 11. We determined 
the HCV viral load in the liver and in serum (n=50)(Amplicor-HCV 
Monitor, Roche). Genotyping (n=95) was determined by a Innolipa 
system (Innogenetics, SA). The presence of steatosis was quantified by the 
following classification: Type 0: no steatosis; Type I: hepatocytes and fatty 
vacuoles were < 25%; Type 11: > 25% and < 50%; and, finally Type 111: 
> 50%. The fibrosis rate of progression was quantified using a scale with 1- 
4 scores. 
252 Abstracts 
Results: The viral load quantified in setuni was 1.0 x lo6 f 1.1 x 10'' cp/ 
niL and 1.2 x 10" 5 1.6 x 10" 5 cp/ug total RNA in the liver. We found 
steatosis in 32% (14/44) of the patients with mild fibrosis and in 62.5% (40/ 
64) of the patients with advanced fibrosis ( P  < 0.01). Type I steatosis was 
fouiid in 36 patients (33'%1), Type 11: 12 patients (1 l%), Type 111: 6 patients 
(5%)). Steatosis was not found in 54 patients (50%). Genotype Ib was present 
in 57 patients (65%), l a  in 7 (8.4%), 2a in 3(3.4%), 3a in 20(23%) and 8 
patients were iinclasaifiable (7.4%). The 40% (25/64) of the patients infected 
with genotype 1 of HCV had steatosis, and 80% (16/20) with genotype 3 
was present (P  > 0.05). In the group of genotype positive patients, we 
found a positive linear correlation between intrahepatic viral replication and 
the severity of the steatosis (17 = 1 1, r =  0.70; P < OOOl), however, this was 
not the case in the global group nor in genotype 1 positive patients. 
Conclusions: (1) Genotype 3 is related with higher level ofsteatosis and with 
the level of intrahepatic replication. (2) These data are indicative of the need 
to perform the Genotype and Viral Load tects in patients with chronic HCV 
infection in order to obtain a prognosic of the progression of the dsease. 
vl Preliminary evaluation of a new assay for the 
quantitative determination of HCV viraemia 
L. Romano. F. K. Pulvirenti, L. Lennartz, G. Schneider, M. De Paschale, 
P. Vigano, M. A. Casiraghi, G. Tositti, A. R. Zanetti 
Mi/aii, ROIIIP, I; Wiedmd~ri, D; ChiiQgO, LISA; Lpg~zmu, !&etiza, I 
Objectives: To evaluate the specificity and plasma vs. serum equivalency of 
the Abbott LCx HCV RNA quantitative assay, and to compare LCx results 
with results from other PCR asrays. 
Methods: 213 paired samples (106 renim, 107 plasma) drawn koni 107 
Italim volunteer blood donors were tested to assess specificity. 239 samples 
tiom 131 patients (1 18 asymptomatic and 13 symptonlatic patients ofwhich 19 
were under IFN or IFN + ribavirin treatment) were tested to assess plasma vs. 
serum equivalency and to compare LCx resultr with those of other PCR assays. 
Results: A specificity of 98.6% (210/213; 95% C.I. 95.9-99.7%) was 
obtained, with all 3 reactive speciniens being negative on retest. 
Concordance of LCx results from paired plasma and serum samples was 
99.1% (107/108). Results froni 67 pairs were within the dynamic range of 
the assay and were correlated (r=0.972. slope= 1.06). 52 samples from 
asymptomatic patients were genotyped. The median log10 copies results for 
each genotype were: la (17 = 13) 6.74, l b  (11 = 22) 6.49, 2a/2c (n = 8) 6.62, 
3a (it = 7) 7.10, and 4c/4d (ti = 2) 6.39. The median LCx results from 61 
HCV only and 22 HCV + HIV infected patients (all asyniptomatic) were 
not different (6.57 vs. 6.77; P=n.s.). There was 97.4% (37/38) concordance 
with COBAS Quahtative. The discordant was positive by LCx on serum 
(2.62 log copies) but negative on the correrponding plasma. LCx and 
COBAS Monitor showed a 100% (41/41) concordance, but the LCx 
quantified 8 samples exceeding the COBAS Monitor upper limit of 
quantitation. LCx detected 3 more sample? than a home-made PCR with a 
500 copies/nL sensitivity (concordance 94.2% 49/52): all 3 specimens (log 
copies/mL: 2.31; 3.80; 4.92) were posinve by LCx on both serum and plasma. 
Conclusion: The LCx assay demonstrated good specificity, excellent serum/ 
plasma correlation, and a high degree of concordance between LCx results 
and those ofqualitative and quantitative assays. These data, coupled with the 
assay's 100 copies/nL sensitivity and wide linear range, suggest that the LCx 
assay may be useful for both pretreatment viraemia level determination and 
venfication of viral clearance. 
(p12041 Time and cost comparison of LlPA and RFLP analysis 
for HCV genotyping 
M. Sayan, T. Toklu, Y. H. Abacioglu 
D m i r ,  TR 
Evidence from a large number of studies have shown that HCV genotypes 
may differ in disease outcome and particularly in response to interferon 
therapy, suggesting a iieed for a reliable. rapid and cost effective typing. 
Method: for clinical use. In this study, we coriipared the cost-effectiveness 
of a conunercial typing method (Inno-lipa) with an RFLP based in-house 
assay. We alw investigated the use of Roche hipl icor  products directly in 
Inno-lipa assay. Ten HCV mfected patient samples were included in this 
study. The mean viral load in these samples was 5.4 x lo5 IU/mL (2.8 x 
104-1 -3 x 10" IU/mL). Viral sequences were amplified using biotinylated 
or unbiotinylated nested primer sets derived from 5'-UTR and typed by 
Inno-lipa and RFLP. Both assays gave concordant results and all samples 
were typed as HCV type lb. We found that Roche-Amplicor products 
could be used directly in the Inno-lipa assay provided that the viral load in 
the sample is hgher than 2.8 x 10' IU/mL. Cost analysis showed 
significant savings with the in-house RFLP assay. However, this procedure 
was the most time consuming of all (5 days). O n  the other hand, Inno-lipa 
assay when coupled with Roche-Amplicor assay could give results within 2 
days with a total cost of 174 USD, in comparison to 4 days and 126 USD 
with Inno-lipa preceded by a nested PCR approach. These findings should 
be confirmed by large number of samples with different genotypes. 
Hepatitis C virus serotypes in Romanian patients 
with chronic hepatitis and cirrhosis 
L. S .  Iancu, G. I. Yandele, C. Stanciu, V. Luca 
h i ,  RO 
Objectives: To determine the prevalence of hepatitis C virus (HCV) 
serotypes in Romaman patients with chromc hepatitis infections and the 
association between them and disease's severity. 
Methods: Anti-HCV antibodies were first investigated by an indirect 
ELISA (Murex -1IIrd generation). Froin 55 positive patients for anti-HCV, 
22 patients (11 male and 11 female) with chronic active hepatitis (CAH - 6 cases), 
chronic persistent hepatitis (CPH - 11 cases) and cirrhosls (C - 5 cares) were 
tested for HCV serotypes using an indirect ELISA ( M m x  HCV Serotype 1-6 
Assay). The average age for the selected group wa5 47.2 years (range 27-68 years). 
Results: The following serotypes distribution were found for the first time 
in our country in patients with chronic hepatitis infections and cirrhosis: * 
serotype 1-68.18%> (6/11 - CPH; 4/6 - CAH; 515 - C); * serotype 2, 3, 4, 
and &4.54% for each of them (all cases were CPH); * untypable - 13.66% 
(2 - CAH and 1 - CPH). 
Conclusions: (1) The 1st serotype seems to be predominantly in our region 
in patients with chronic HCV infections and it is associated with the most 
severe evolution. (2) The diversity of serotypes is bigger compared with our 
previous study group (e.g. in haeniodialysed patients the 1st serotype waq 
determined in almost 100% cases - unpublished data). (3)  Untypable strains 
(13.66%) require the sequences analysis for HCV genome characterization 
after PCR amplification. 
Ip12061 Chronic hepatitis C in asymptomatic blood donors 
E. Minola, G. Rizzo, B. Giuwni 
Bergamo, I 
Background: For many people infected with the hepatitis C virus (HCV), 
the route of exposure, nsk of transmission, and severity of associated liver 
disease are unknown. We studied these variables in people who donated 
blood voluntarily. 
Methods: We studied 172 BD who tested + ve for HCV antibodies on EIA 
and were classified according to whether the resuh of a cohmatory 3rd gen. 
RIBA for HCV who were referred to OUT Centre between June 1996 and June 
2000. None wa? positive for HEW and HIV. The evaluations also included an 
assessment of risk factoa, a physical examination, serial deteminations of ALT 
senmi levels and HCV serologc assays; a PCR assay for HCV-RNA and 
genotype were determined. ALro were offered testing of sexual contacts and 
family members, and liver biopsies were performed in some participant?. 
Results: A total of 172 BD were studied, mean age were 41 years (range 18- 
61 years), 109 males (63.4%). Sigmficant risk factors for HCV infection 
among the HCV + ve participants were a history of blood transfusion before 
1992 in 29 pts (16.9%). intravenous drug use (IVDU) in 7 (4.1%), 
'coinuiunity-acquired (CA)' in 136 (79.0%). 7 out of 114 sexual partners 
(6.1%) of BD tested were anti-HCV + ve; 2 with a history of blood 
transfusion, 3 were IVDUs and 2 partners were 'CU HCV positive. 4 out 
of 177 living together sons (2.3%) were anti-HCV + ve; one was IVDU and 
3 sons were 'CA HCV + ve. Five BD (2.9%) had evidence of acute 
hepatitis in anamnesis. O f  the HCV + ve BD, 82 out of 172 (47.7%) had 
biochemical and virological evidence of chronic liver disease. HCV-RNA 
determined in 149 BD were + ve in 92 pts (61.7%) and genotypes 
detemlined in 74 pts, according to Simmonds classification were: geiiotype 
2 in 37 pts (SO%), l b  in 23 pts (31.l%), l a  in 7 pts (9.5%,), 3a in 5 pts (6.8%) 
and in 2 pts the genotype were undetermined. Among 40 out of 82 BD + 
ve for HCV-RNA with altered ALT who underwent liver biopsy, 22 had 
severe grading of chronic active hepatitis, 16 with elevated staging of fibrosis 
(3 with associated cirrhosis); 18 had mild-to-moderate chronic hepatitis and 
24 with low staging of fibrosis. 
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Conclusions: Among volunteer BD, prior blood transfusion and IVDU, are 
important risk factors for HCV mfection. In a high percent of BD the 
infection of HCV were defined 'CA'. The high frequency of prior blood 
transfusion and IVDU was unexpected, because these BD had denied such 
risk factors when questioned directly at the time of their blood donations. 
APACHE II * ISS *' GCS Sy02 days ICU days 
193fJ6 278183  6 7 f 2 9  4581179 166f113 
vl Analytical performance of the newly developed 
Abbott LCx HCV-RNA quantitative assay 
L. Roman6, F. R. Pulvirenh, K. Abravaya, C.  Qiu, M. De Paschale, C. 
Tagliacarne, A. R. Zanetti 
Milan, Rome, I; Chicago, USA; Legtiatto, I 
Objectives: T o  evaluate the analytical performance of the newly developed 
Abbott LCx HCV R N A  quantitative assay for the quantitative detemuna- 
tion of HCV viraemia. 
Methods: The RT-PCR based LCx assay uses a competitive internal 
standard (IS) for quantitation and i&bition/extraction control purposes. 
After amplification, an IS-specific probe hybridizes to the IS amplified 
product, while an HCV-specific probe binds to the HCV amplicon. Both 
types of probe: amplified product are detected by MEIA on the LCx 
platform. An external calibration curve is used to convert the log HCV/IS 
signal ratio to copies/mL or IU/mL. Assay sensitivity is 100 copies/mL and 
the assay is linear to 10 million copies/mL. Reproducibility: assay controls 
(PC1 and PC2) were tested in singhcate in each run (n =33). Precision: a 3- 
member panel (PC1, BBI Accurun 305/300, PC2) was tested in five 
replicate for 5 days. Linearity/accuracy: a 7-member panel (1.70-6.30 log 
IU/mL NAP HCV-RNA Panel, Acrometrix) calibrated against the first W H O  
standard, was tested in singhcate on 5 runs. Negative results distribution (213 
blood donor sampleq) and percentage of invalid results/run served as indicators 
of good separation from cut-off and assay robustness, respectively. 
Results: Reproducibility: total SDs of 0.15 log copies/mL and 0.14 log 
copies/mL were observed for PC1 and PC2, respectively. Precision: 
within-rudbetween-rn/total precision in log copies/nL SD were 0.12/ 
0.12/0.06 for PC1 (mean log copies 3-09), 0.00/0.08/0.04 for BBI Accurun 
(mean log copies 5.10), and 0.12/0.15/0.07 for PC2 (mean log copies 5.95). 
Linearity/accuracy: regression data for the NAP Panel (LCx vs.Target log 
IU/mL) were: r =  0.999; slope= 1.00; intercept =i).Ci5. The upper h i i t  of 
negative population (copies/nL value corresponding to mean negative 
population plus 1.96 SD) was 25. The invalid results rate observed was 
0.13% (1/747) with no invalid tuns (N=37). 
Conclusion: For all the analytical performance characteristics investigated, 
the new Ahbott LCx HCV RNA Quantitative assay showed excellent 
results. It appears to be suited for HCV-RNA quantitative testing in a 
diagnostic laboratory setting. 
Ip1208 Utility of the lmmunoblot for the confirmation of 
cases with low-level antibodies of hepatitis C virus 
J. Lopez-Barha, M. Garcia-Valdivia, C. Leon, M. Rodriguez-Iglesias 
Puerto Real, E 
To study the specificity anti-HCV antibodies screening by convenuonal 
ELISA technique in those cases with low level of antibodies using a 
conmiercial inmunoblot. Seventy-rix sera with low level of antibodies anti- 
VHC have been studied. The screening ELISA test used was AxSym HCV 
3.0 (Abbott), those samples were selected with a value S/CO above the cut- 
off (1  .O) but smaller that the manufacturer positive control. It has been used 
as test confinnation ELISA technique in i~nniunoblot format (Innolia HCV 
ah 111, Innogenetics) that allows the detection of specific antibodies against 
core and non structural peptides of HCV tixed to a nylon ribbon. O f  the 
total of the studied samples, 43 (56.57%) they were interpreted as positive, 
20 (26.31%) they were negative and 13 (17.10%) as Uncertain by means of 
the confinnation test. The reactivity was more frequent against NS3 (45/76) 
followed by C1, NS4 and C2 (34, 27 and 24 samples, respectively). Eight 
samples only reacted for E2 and none for NS5. In 28 of the 43 samples 
interpreted as positive three or more positive lines they were detected. 
When our were selected with an index S / C 0  > 4 (24 cases), 79.16% of the 
same ones was interpreted as positive, 20.8% as uncertain and any as 
negative. The immunoblot techniques allow to confirm the presence of 
antibodies anti-HCV in cases with low level of antibodies. They are useful 
to detect false positive in the screening. Nevertheless, it is advisable to 
process a later sample or the use of a molecular technique before discarding 
the infection for the virus. 
vl Relationships between viral load, genotype and 
antibodies titre of hepatitis C virus in haemodialysis patients 
J. Lopez-Barba, C.  Leon, M. Garcia-Valdivia, M. Rodriguez-Iglesias 
Puerto Real, E 
W e  have followed a cohort of haemodialysis patients through five years and we 
have studied viral load, genotype and level of specific antibodes anti-HCV. 
Fourteen patients were selected from the Haeniodialysis Unit due to presence 
of viraemia and/or anhbodrs ann-HCV. Viraemia was measured by Cobas 
Amplicor HCV Monitor vs. 2.0 (Roche), the genotype was detemiined by 
hybridization with oligonucleotides (Innolipa HCV-I1 (Innogenetics), and the 
antibodies was detected by ELISA (AxSyln HCV vs. 3.0, Abbott) and 
quantified by absorbance and end-point titre. The statistical analysis WAF done 
with Statgraphics Plus 4.1 sohare. We have found a close inversal relationship 
between high titre antibodies and low viral load and vice versa. Exceptions was 
found in several cases: (a) patients with high-level antibodies and high load viral 
due to a good immune response but infected with escape variants 1 b genotype, 
and patients with high-level antibodes in mixed infections la / lb  (perhaps the 
efficient mlfnune response is directed against la  genotype), and (b) patienn with 
low-level antibodies and low v d  load, in these caqes due to InfeChOn with 
ininor genotypes (genotype 4). This study have demonstrated diKerent 
evolution patterns in haemodialysis patients according to genotype, mixed 
infections, time of infection and inmunological status. 
v1 Interferon-alpha treatment of chronic virus hepatitis 
C in children cured of malignancy 
M. Rusanova, 0. Geludkova, T. Ishkova, 0. Shipuliria 
Moscow, R US 
Purpose: T o  determine the safety and eficacy of interferon-alpha (INF-a) 
therapy of chronic hepatitis C (CHC) in children cured of malignancy. 
Methods: 135 children with C H C  fiom 4.3 to 16.7 years of age were 
enrolled into the study. The median follow up was 38.5 months (range 
12.M6.8 months). Diagnosk of C H C  was based on senim ann-HCV + or/& 
HCV RNA + for more than 6 months afrer Uitial detection. All children had 
abnonnal senun ALT levels and HCV KNA + 0. HCV genotypes were 
investigated in 63 patients and could be classified as lb  in 88.9% of cases, as 2 in 
3.2%, as 3 in 4.8%. 3.2% of children were infected by a mixed genotype 
population (2 3 or 3 lb). 84 patients (group I) received INF-a (3p /ni' tiw for 12 
months), among them 63 children (group Ia) had finished the treamient of 
malignancy, 21 (group Ib) were stiU receiving the maintenance chemotherapy. 
The other 51 patients (group 11) were considered as a control group. Groups 
were compared for age, gender, duration of nlaligriancy and Infection, primary 
ALT and HCV R N A  levels and viral genotype. No statistically sign&ant 
differences were observed between two groups. Group Ia were compared with 
group Ib for frequency of complete response (CR: clearance of serum HCV 
RNA by PCR and nomdization of ALT) and parhal response (PR 
normahation of ALT). Group I were compared with group I1 for fiequency 
of sustained response (SR) and spontaneous remission. SR was defined as 
undetectable HCV KNA levels for more than 6 months after completion of 
therapy. Spontaneous remission was defined as a normalization of ALT lasting 
more than 1 year in association with the disappearance of serum HCV RNA. 
Results: C R  was observed in 58.7% of pts Ia group and 14.3% of pts Ib 
group (P=O039), P R  - in 10.3% and 23.8% accordingly. After at least 6 
months offollow-up on these children relapses were detected in 13 (32.5%) 
children. Thus SR was marked in 27 patients (32.1%). Spontaneous 
renllssion was observed in 2 (3.9%) of children of 11 group (P=0.003). A 
low serum titre of HCV RNA was associated with spontaneous remission. 
Treatment related sideeffects of INF-a were found in most of the children. 
They included flu-like symptonis (87.3%), neuropsychiatiic symptoms 
(21.8%), leukopenia and thronibocytopenia (20'%), headaches (1 6.499, 
allergic reactions (6.4%) and lost weight (3.6%). 
Conclusion: INF-a is an effective treatment of C H C  in children cured from 
malignancy. Children receiving chemot !irrapy are less likely to respond to 
interferon-a. Treatment related side-effects were minimal or moderate and 
reversible. 
254 Abstracts 
Hepatitis virus (not B or C) 
I PI21 1 I Enterically transmitted viral hepatitis (HAV and HEV) 
in Kurdish immigrants 
M. Chironna, C. Germinario, P. L. Lopalco, M. G. Sponselli, F. Carrozzini, 
M. Quarto 
Bati, Maglie, I 
Objective: We evaluated the seroprevalence ofhepatitis markers in a sample 
of Kurdish immigrants who arrived in Southern Italy (Pugha) dunng 1999 
and 2000. 
Methods: A total of 417 unselected Kurdish refugees from all age groups 
were tested for the presence of serological markers of hepatitis A and E. 
Total anti-HAV and anti-HEV antibodies were detected by EIA. Serum 
samples repeatedly reactive for anti-HEV were then confirmed by 
immunoblot assay. 
Results: Among the 417 refugees, the prevalence of anti-HAV antibodies 
was 91%. In children up to 10 years the prevalence rate reached 55%. In the 
age group 11-20, antibodies to HAV were detected in 90%. All Kurdish 
over 20 years were positive for anti-HAV. Regarding hepatitis E, 12% of 
the subjects tested positive by screening test for anti-HEV. The 11.5% were 
confimied as seropositive by iinmunoblot assay for IgG antibodies, the 
majority of subjects presenting the entire pattern of reactivity against 0 2 N ,  
0 2 C  and 0 2 M  antigens. The proportion of refugees positive for HEV 
increased with age. None of the children G-10 years of age resulted positive 
for anti-HEV antibodies. In the age group 11-20, anti-HEV were found in 
5% whereas in the age groups 21-30 and > 30 the prevalence of anti-HEV 
antibodies was found to be 15% and 18%, respectlvely. No difference in the 
prevalence rate for HAV and HEV was found between males and females. 
Conclusion: The results of the serological survey show that enterically 
transnutted viral hepatitis are highly endemic in the Kurdish population. 
The high prevalence of anti-HAV in children confirms the high circulation 
of hepatitis A virus since very early life. The increasing prevalence of anti- 
HEV with age agrees with previous findings on population living in high 
endemic areas with poor hygienic and sanitary conditions. A continuous 
monitoring of the inmiigrant population is therefore advisable to plan 
adequate preventive measures. 
lplzlzl Prevalence of IT virus infection: influence of primer 
selection 
B. Fernindez, M. Basaras, S. Sinchez, E. Arrese, R. Cistema 
Bilbao, E 
Background and objectives: TT virus (TTV, Transfusion Transmitted 
Vinis) is a recently discovered agent originally obtained from transfusion- 
related hepatitis. The aim of this study has been to investigate the prevalence 
of TTV using conserved oligonucleotide primers from two independent 
regons of the virus genome in two different risk groups. 
Patients and methods: Two groups of patients were analysed (51 
maintenance haemodialysis patients and 107 patients with hepatitis of 
unknown aetiology). Serum TTV DNA was detected by 2 distinct nested 
PCR methods using primers derived from the N22 region (tiom 1901 bp to 
2228 bp) and T8 region (from 3087 bp to 3392 bp). 
Results: Overall, the rate of TTV infechon was 64% in patients with 
hepatitis of unknown aetioIogy and 67% in haemodialysis patients using the 
T8 region; in the case of N22 region, the prevalence of TTV infection was 
11% and 8%, respectively. No significant difference was observed between 
infection rates ainong male (prevalence of 67%) and female (64%) in 
haemodialysis patients. In patients with hepatitis of unknown aetiology, the 
prevalence of infection was higher in female than in male (71% vs. 52%). 
The prevalence of TTV in patients with hepatitis of unknown aetiology is 
similar among different age. However, the prevalence increased con- 
tinuously with age in haemodialysis patients, &om 50% among patients 
under the age of 60 years, to 77% in people older than 60 years. TTV/HCV 
and TTVIHGV coinfections were frequently identified in haemodialysis 
patients (h6,6% and 75%, respectively). 
Conclusions: The results suggest that TTV infection is very conmon in 
both groups. The selection of PCR primers crucially influences the 
detection of TTV DNA. The N22 region underestimates the prevalence of 
TTV infection. 
I P I  21 3 I Evaluation of two genomic regions of ll virus and 
their relation with liver function 
N. M. Martinez, M. hvarez, F. Garcia, F. Garcia Jr, C. Bernal, J. 
Hernindez, C. Maroto, G. PiCdrola 
Grmada ,  E 
Objective: to study liver function, through transaminase levels, at patients 
infected and not infected by TT virus (TTV), to relate it with TTV DNA 
detection of two different genomic regions: N22 (coding and variable) and 
5’UTR (non coding, constant), and to evaluate the pathogenicity of viral 
strains as detected by the N22 region. 
Patients and methods: N22 TTV DNA was performed at 274 patients 
(haemodialysis patients, n = 107; HIV patients, 11 = 103; chronic type c 
hepatitis, n = 22; type B hepatitis, n = 23; unknown aetiology hepatitis, 
n=19). 5’UTR detection was performed on I42 of the patients 
(haemodlalysis patients, M = 46; HIV patients, it = 43; chronic type c 
hepatitis, n = 22; type B hepatitis, N = 14; unknown 3etiOlOgy hepatitis, 
I !=  17). N22 region was amplified through seminested-PCR, and 5’UTR 
region was through a hot-start PCR, as previously reported. Amplificates 
were visualized by 2% agarose gel electrophoresis and ethidium bromide staining. 
Results: TTV-N22 DNA was detected in 53 patients (19%) and TTV- 
5’UTR DNA in 89 (63%). ALT and AST levels (UI/L) for TTV-N22 
DNA positive patients were 58 65 and 73 k 88, respectively, and 
61 f 82 and 69 f 80, respectively, for TTV-N22 negative. When 5’UTR 
region was studied, ALT and AST values were 69 k 68 and 72 f 77, 
respectively, for positive patients and 84 f 123 and 100 k 135, respec- 
tively, for DNA negative patients. 
Conclusions: No significant differences have been observed when TTV 
DNA negative or positive patients, by both genomic regions, were related 
to transminase levels. For positive patients by both tests, no differences in 
transaminase levels were observed. Our results do not support the findings 
of other authors that have associated TTV N22 DNA detection with higher 
pathogenicity. 
/p1214/ Prevalence of hepatitis A virus infection among 
waste water treatment plant workers 
P. Mamassi, M.  Arvanitidou 
Thessaloniki, GR 
Sewers are an environment where hepatitis A virus can remain viable for a 
prolonged period. In this cross sectional study, antibodies against hepatitis A 
virus (anti-HAV) were tested in 122 eniployees of a waste water treatment 
plant, in order to evaluate the risk of acquiring hepatitis A virus infection 
from occupational exposure to sewage. An epidemiological questionnaire 
was also f l e d  out with information concerning gender, age, educational 
level and history of past hepatitis infection. The overall prevalence of anti-HAV 
was found 61.5% in the examined workers and it did not ditrer between the two 
sexes. It was also found that the prevalence of aid-HAV was sigdcantly higher 
in employees with primary education (90.6%) than those with univenity level 
education (33.3%, P < 0.001). Moreover, it was confirmed that the prevalence 
of anti-HAV was sigdcantly increasing with age ( P  < 0.001). whereas the 
contact with sewage was also a risk factor for seropositivity (P < 0.01). No 
worker mentioned history of hepatitis. These resulu suggest that waste water 
treatment plant workers may be at increased occupational risk of acquiring 
hepatitis A infection, so they should be protected by active immunization 
after they have been examined for anti-HAV. 
I P1215 I Two autochthonous cases of acute hepatitis E in Spain 
D. Tarrag6, M. D. Hernindez, M. E. Moreno, M. L. Mateos 
Madrid, E 
We report here four cases of acute hepatitis E, two autochthonous and the 
other two imported. One of the two autochthonous cases corresponded to a 
patient who up to the hagnosis had been blood donor and used to ride 
horses weekly. The patient of the other autochthonous cases had not 
previous relevant medical findings. The diagnosis of HEV infection was 
achieved by detecting IgM and IgG antibodies to HEV by ELISA and 
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confirmed by Western Blot. A wide panel of serological test was performed 
in order to rule out diseases other than HEV hepatitis. These findings and 
the existence of a population of individuals who are positive for IgG anti- 
HEV (2.8% blood donors) supports the need to rule out VHE infection In 
patients with acute nonA-nonB-nonC hepatitis not only in patients who 
have previously travelled to endemic areas. Further epidemiological and 
phylogenetical studies are clearly warranted to elucidate the source and 
mode of HEV transmission in Spain. 
Ip12161 Hepatitis agents with enteric transmission; an 
epidemiological analysis 
G. Yayli, S. Kilic, A. R. Ormeci 
Isparta, TR 
Viral hepatitis is viral infections, charactenzed by special clinical, 
biochemcal, serological and histological findings. HAV is the common 
cause ofjaundice in the world and is seen as an infection of childhood in 
developing countries. Incidence of Hepatitis A (HA) is known to be 
lowering and its seropositivity is skidded to adult ages in developed 
countries. In Turkey, HA is common at school-age children and anti HAV 
positivity reaches to 88.&100% in adults. Hepatitis E (HE) is sporadic and 
its seroprevalence is less than 3% in developed countries. The prevalence of 
HE is less than 10% in Turkey. This study was panned to determine the 
seroprevalence, epidemologtcal characteristics, clinical and biochemical 
findings of Hepatitis A and E of an outbreak of jaundice in a village. 340 
children of 5-16 years age group were included in this study. 22 children 
had chnical symptoms of hepatitis. 80 children had high-level ALT. 58 
children were ann-HAV-IgM positive. Since all of the children were anti- 
HAV-IgG positive, HA prevalence was determined to be 100% in chddren. 
25 children were anti-HEV-IgM positive. This is the first study in Turkey 
that demonstrates simultaneous HA and HE outbreak duo water supplies. 
Evaluation of 50 viral hepatitis cases with fulminant 
and subfulminant course 
P. Goktas, D. Coskun, S. Akin-Ertem, E. Karagiil, S. Ozyiirek, F. Metin, 
S.  Selguk 
Istanbul, TR 
In this study, 50 cases of viral hepatitis with h n a n t  and subfulminant 
course which were followed by our clinic in Haydarpasa Numune 
Education and Research Hospital, between October 1990 and October 
2000 were evaluated retrospectively. The ones who died and who survived 
were compared according to the factors like age, aetiology, duration of 
jaundice until onset of encephalopathy, prothrombin time and serum 
bilirubin level whch were known to effect prognosis. Median age of the 
patient was found 33,5. 5.48% (34/620) and 2.86% (16/559) of cases with 
acute viral hepatitis were determined fulminant and snbhlminant course in 
first and second 5 years, respectively. 7 (14%). 37 (74%) and 6 (12%) of the 
cases were A, B and non-A non-B hepatitis, respectively. AU of the cases 
with non-A non-B hepatitis were defined in first five years, whereas no 
cases of non-A non-B hepatitis was not in second 5 years. MortaLty ratio 
was found to be 68%. 2 (29%) of hepatitis A cases, 29 (78%) of hepatitis B 
cases and 3 (50%) of non-A non-B hepatitis cases died. AU of the 16 
surviving cases were under the age of 40. Duration ofjaundice until onset of 
encephalopathy was longer than 7 days in 7 (22%) of cases who survived, 25 
(78%)of cases who died. Prothrombin time was longer than 50 s in 2 (12%) 
of cases who survived and 15 (88%) of cases who died. The effect of serum 
bilirubin level on prognosis was not clearly shown in our study. 
1 P1218 I Prevalence of hepatitis A and hepatitis E in blood donors 
N. Delialioglu, C. Oztiirk 
Menin, TR 
The hepatitis A and hepatitis E viruses are viral hepatitis agents that spread 
by the hecalkoral route. HAV is prevalent throughout the world, and is a 
common childhood illness in developing countries. It is associated with 
crowded environments and unhygienic conditions. HEV is epidemic in 
developing countries and hequently affects the young and middle age 
groups. The seroprevalance of HAV in Turkey reaches maturity by the age 
of 14, and the anti-HAV positivity in the adult age group has been reported 
in various studies to be between 88.8 and loo%, while the anti-HEV 
positivity in healthy people has been reported to be between 3 and 11.7%. 
The aim of the present study was to determine the anti-HAC IgG and anti- 
HEV IgG seropositivity in blood donors in our region. After histories were 
taken for hepatitis, chronic Illness, blood and blood tramfusion, suitable 
donors were selected. 186 blood donors (166 men and 20 women) from 
different professions between the ages of 20 and 52 were analysed by routine 
donor serologic scanning tests; HAV IgG antibodies were analysed by 
ELISA (Abbott, Axsym), and HEV IgG antibodies were analysed by micro 
ELISA (G.D.s.r.1.) in donors who tested negative for HbsAg, HCV, HIV 
and ROR. HAV IgG antibody positivity was found to be 91.4% and HEV 
IgG antibody positivity was found to be 11.2%. The HAV and HEV 
seropositivities in the Menin region were found to be comparable with the 
results of studies camed out in different regions of Turkey. 
(p12191 lT virus infection in subjects having hepatitis B DNA 
and effect of multiple freezing and thawing of serum on m- 
and HBV DNA positivity 
R. Duimaz, B. Otlu, S. Direkel 
Mdafya, TR 
Objectives: To determine whether HBV infection is a significant risk factor 
for the spread of TTV and also to test the effect of freezing and thawing of 
serum on the stability of TTV- and HBV DNA. 
Materials and methods: Using seminested PCR, TTV infection was 
investigated on 232 serum samples from 160 subject having HBV DNA 
with concentrations more than 5 pg/mL and 72 controls without HBV 
DNA. HBV-DNA concentrations were determined by Diagen hybnd 
capture system. Seven TTV-DNA positive samples were randomly selected 
among the sera having HBV DNA with the concentrations that ranged 
from 6 pg/mL to 4162 pg/mL and, they were frozen and thawed up to 
seven times and then analysed. 
Results: The prevalence of serum TTV DNA was 21/160 (13.1%) in the 
subjects with HBV DNA, and 7/72 (9.7%) in the control group. There was 
no statistically significance between the rates of these two groups. TTV 
positivity was not affected by the HBV DNA concentration. Seven cycles of 
freezing and thawing did not change TTV DNA positivity and HBV-DNA 
concentrations in any of the samples tested. 
Conclusion: Although transmission route of TTV and HBV are similar, the 
presence of HBV infection is not a significant risk factor for TTV, and 
furthermore TTV positivity was not affected by the levels of HBV DNA. 
Without take into consideration of DNA levels in the samples, TTV-and 
HBV DNA positivity continued till seventh cycles of freezing and thawing 
in all serum samples tested. 
v/ Acute viral hepatitis with severe hyperbilirubinaemia 
and massive haemolysis in a patient with G-6-PD deficiency 
A. Mert, R. Ozaras, F. Tabak, R. Ozturk, M. Kanat, Y. Aktuglu 
Istarrbul, TR 
Haemolytic anaemia as a complication of acute viral hepatitis may occur in 
normal patients but it is common when the patient had glucose-6- 
phosphate dehydrogenase deficiency (G6PD). However massive haemolysis 
with bilirubin levels higher than 60 mg/dL is rather rare. A 20-year-old 
male was admitted because of anorexia, fatigue, dark urine, and jaundice of 
3 days’ duration. O n  admission, he was clearly conscious, his temperature, 
respiration rate, pulse, and blood pressure were n o m d  The conjunctiva 
was normal and the sclera was icteric. The liver was felt 10 cm below the 
right costal margin. Splenomegaly, ascites, oedema, and LAP were absent. 
Laboratory studies: Haemoglobin 12.7 g/dL, leukocyte count 7700/mm3, 
platelets 309 000/mm’, ALT 126 U/L, AST 62 U/L, ALP 375 U/L (N: 
70-306), gamma GT 297 U/L (N: 7-50), albumin 3.7 g/dL (total protein 
7.8 g/dL), total bilirubin 14.5 mg/dL (direct &action 9.2 mg/dL), 
prothrombin time 12.2 s (96%), blood urea mtrogen 15 mg/dL, creatinine 
1.1 mg/dL. Serology showed only anti HAV Ig M and IgG (+).Two days 
after admission, total bilirubin level rose to 54.7 mg/dL, ALT to 2800 U/L 
and AST to 1250 U/L. The following day, total bilirubin level increased to 
80 mg/dL. Fourth day, haemoglobin dropped to 9 g/dL. Peripheral smear 
showed anisocytosis and polychroinasia. Reticulocyte index was 4 (1 2%) 
and LDH was 1237 U/L (N: 24M80) .  Haptoglobin level was too low to 
be measured. Platelet, leukocyte counts, serum iron, iron binding capacity, 
direct and indirect Coomb’s tests, osmotic Gaghty test and haemoglobin 
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electrophoresis remained nornial. Assay of G6PD showed a low level of 
activity (7.6 inU/10 ER,  normal: 131 f 13). After 5th day, bilirubin, ALT, 
and AST levels tended to decrease with a slow increase in haemoglobin 
level, and all these parameters returned to nomial within one month. His 
fainilly was screened for the enzyme deficiency and his mother also showed a 
very low level. Mild haeniolysis as a complication of acute viral hepatitis has 
been reported. But both incidence and severity may increase in patients 
with G6PD. The presentation with a progressing jaundice and a high level 
of bilirubin may be mistaken for fulminant hepatic failure. G6PD deficiency 
should be considered when a patient with acute hepatitis is presented with 
surprisingly higher levels of bilirubln. Patients with a deficient activity of 
G6PD should be vaccinated against both viral hepatitis A and B especially in 
endemic areas. 
[ml Incidence of virus hepatitis A, B and C in the 
community of Bitola 
R. Petkovska, B. Petkovski 
BifOIU, M’4K 
introduction: Virus hepatitis represents a seriouc world medicine problem 
both for its commonly chronic evolution and for therapeutic inefficiency for 
some of this fornis. 
Goal of the study: is to display the number of registered diseased in the 
community of Uitola in the period of 1995-99. 
Results: According to the diseased in the Republic of Macedonia type A 
hepautis participates with 3.75, type B with 4.45% and nondefined hepatitis 
with 0.25%). Hepatitis C in Bitola IS registered in 10 diseased. The highest 
percentage is registered in November (29%). Mb is higher in males for 1.62 
than in females. Mb for hepatitis A is for 8.57 greater in the town accordmg 
to the country whereas hepatitis B is bigger for 2.4. 47%~ children up to the 
age of 14 become diseased with hepatitis A. Adult persons, over 20 become 
diseased with hepatitis 13 with 74.5%. school children with 58.7%) from 
hepatitis A, and medical staff become diseased to the highest percentage 
18.6% with hepatitis B. 
Conclusion: The indispensable prevention of population for hepatitis A is 
the improvement of the low socially economic and hygienic standard, while 
hepatitis B it is the conduction of the compulsory vaccination stimulated by 
the statute. 
The levels of serum ferritin, iron and total iron 
binding capacity of acute viral hepatitis A and B cases 
A. Ozdeniir, N. Iris, T. Yildimiak, E. Din$, F. Simsek 
Isfmlbtri ,  TR 
This study has been planned to evaluate if there is any changes in iron 
metabolism during acute viral hepatitis. The levels of serum ferritin, iron, 
total iron binding capacity (TDBK) and liver enzymes have been detected in 
53 hospitalized patients with the diagnosis of acute viral hepatitis A or B and 
in the control group consist of 20 people. Two blood samples were taken 
from the patients, one IS at the beginning of the &less and the other one is 
during the recovery period. Femtin measurements were held with the 
Spectria Irma Test based on inmunoradiometric assay principles. The levels 
of TDBK and serum iron were detennined by the DMA Iron Procedure at 
Olynipus auto-analyser. In our study; 15 (60%) cases of 25 HAV infected 
group and 1 9  (67.8%) cases of 28 HBV infected group had high femtin 
levels. There could not be found a significant difference between the groups 
before the treatment, when we consider iron, TDBK, the levels of 
haeniatocrit and the average age. The results of this research suggests that 
the high ceruni femtin levels of the patients with acute viral hepatitis reflect 
the hepatic necrocis, and the observation of the ferritin levels of these 
patients can be very valuable during followup. 
/p12231 influence of HGV infection on HCV-RNA elimination 
from the serum of haemodialysed patients 
J. Nowak, D.  Januszkiewicz, J. Wysocki 
P ~ ~ Z I I U I I ,  PL 
Recently discovered hepatitis G virus (HGV) is flavivirus with sequence 
homology to HCV. The pathogenic significance of HGV infection alone in 
the development of hepatitis is still questioned. Many clinical studies have 
failed to demonstrate any significance for HGV in the aetiology of acute and 
chronic hepatitis. However some investigators have reported a potsible 
association between HGV infection and liver diseases. Despite the lack of 
hard evidence for pathogenic role of HGV, the frequently haemodialysed 
patients may be at risk for HGV infection. To  study the significance of 
HGV infection it should be taken into account the similarity of genomic 
organization of HGV and HCV. It is possible that there is a competition in 
replication between HCV and HGV. Therefore in a case of coinfection 
with HCV and HGV, either interference or synergism may occur. In our 
study we investigate the possible influence of HGV infection on incidence 
of HCV-RNA in haeniodialysed patients. The aim of the study was to 
analyse the influence of HGV coinfection on the elimination of HCV- 
RNA in haemodialysed patients. The study involved 72 persons, all with 
HCV-RNA, aud anti-HCV antibodies. HCV-RNA and HGV-RNA have 
been detected in blood serum by PCR technique using specific 
oligonukleotide primers. Anti-HCV antibodies have been detected by 
second generation HCV-test (Organon Teknika). 72 haemodialysed 
patients have been selected for the study. All of them were HCV-KNA 
and anti-HCV antibodies positive. Out of these patients 12 (1 6.7%) were 
positive for HGV-RNA. After 1.5 years of observation 40 patients (55.6%) 
were still HCV-RNA positive. Ainong these patients 9 (22.5%) were 
coinfected with HGV and 31 (77.5%) were HGV-RNA negative. After 1.5 
years follow-up 32 patients eliminated HCV-RNA from the serum. In this 
group only 3 patients (9.4%) were HGV infected. On the basis of obtained 
results it can been concluded that HGV iilfection is frequently seen in 
haeniodialysed patients. 16.7% infected person in selected group of 
haemodialysed patients (i.e. HCV-RNA and anti-HCV antibodies 
positive). Much higher incidence of HGV observed in HCV-RNA positive 
patients (22.5% vs. 9.4%) suggest that coinfection with HGV may influence 
(delay) the elimination of HCV-RNA from the blood. 
Acknowledgements: This work was cupported by KBN grant no. 4P05E 
056 17. 
v] Molecular evidence for nosocomial HGV infection in 
haemodialysis patients 
T. Toklu, Y. H. Abacioglu 
Irmir, TR 
HGV infections are conmion throughout the world and haemodialysis 
patients are at higher risk for acquiring HGV infections. In this study, the 
presence of HGV-RNA was sought out by reverse transcriptase-cDNA 
PCR in 42 haemodialysis patients, 17 dialysis unit personnel and in 158 
demiatological patients as a control group. The 5’-NCR sequences of the 
HGV isolates were determined by Sanger’c dideoxynucleotide chain 
teniunation method. PhyIogenetic analysis of these sequences along with 
the known HGV 5’-NCR sequences has been utilized to determine the 
genotypes and phylogenetic relationships. Five of the 42 dialysis patients 
(12%), one of the 17 personnel (5.8%) and two of the 158 dermatological 
patients (1.2%) have been shown to harbour HGV sequences. Even though 
the rate of HGV infiection in haemodialysis patients is significantly higher 
than the control group ( P  < 0.05), no known risk factors could be accribed 
to HGV-KNA positivity in these patients. All isolates from the 
haemodialysis unit were related to HGV group 2 sequences, whereas a 
HGV group 4 sequence was determined in one the positive patients in the 
latter group. Three of the five HGV sequences isolated from haemodialysis 
patients clustered closely together, with bootstrap support for all three 
sequences, indicating a common source of infection. Besides, these 
sequences contained a similar insertion of 4 nucleotides between positions 
- 180 and - 177. These data suggest that the viral sequences in these patients 
may have a common origin and nosocomial transmission of HGV infection 
in a haemodialysis setting is possible. 
/p12251 incidence of transfusion transmitted virus among 
patients infected with HCV or HBV 
I .  Liwen, D. Januszkiewicz, M. Pernak, J. Rembowska, K.  Nowicka, J 
Wysocki, J. Nowak 
Pornan, PL 
The TT virus (TTV) has been recently discovered as DNA virus. The role 
and clinical significance of TTV infection both in healthy individuals and 
patients with B and C hepatitis has not been fully clarified. The a m  of the 
study was to determine the prevalance and possible role of TTV in patients 
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with diagnosed hepatitis B or hepatitis C. The study involved 70 patients 
infected with HBV and 159 patients infected with HCV as evidenced by the 
presence in blood serum WV-DNA or HCV-RNA detected by PCK 
technique using specific oligonucleotide primers. TT virus has been 
identified by the PCK technique applying original priniers as described by 
Naoumov ef a/ .  Among HBV positive patients T T  virus has been detected 
in 17 out of 70 (24.3%). Incidence of TT virus in HCV infected patients 
was 25.5%) (40/159). In healthy blood donors the frequency of TTV was 
similar to that found in HCV- and HBV-infected patients (17/80, 21.2%). 
In HCV and HBV infected patients without TTV in the seem we have not 
observed any difference in aminotransferase activity. It was also not obvious 
difference in clinical course of the HBV- or HCV-infected patients with or 
without TTV coinfection. On the basis ofthe obtained results it can only be 
concluded that it is very unlikely that TTV coinfection play any significant 
role in HCV or HBV infection. In general it seems that TTV coinfection 
doet not contribute to the liver pathology. 
Acknowledgements: This work was sponsored by KBN grant nr 4P05E 
032 18. 
p 6  Prevalence of '17 virus infection in blood donors and 
individuals infected by hepatitis B and C 
0. Gurbuz, U. mkar, G. Yetkin, A. Mert 
Ankara, TR 
Viral gastroenteritis 
Background TT virus (patient initials: TT) a novel DNA virus. wac first 
isolated in Japan in 1997 from serum of a patient with post-trantfiision 
hepatitis of unknown aetiology. The vims has been found worldwide with a 
high prevalence in the general population but it has not established whether 
this virus is a significant cause ofacute or chronic hver disease. 
Objective: Detection of frequency of TT virus among healthy blood donon 
and hepatiris I3 and C infected individuals. 
Methods: 70 healthy blood donors, 65 anti HCV and HCV RNA positive 
and 65 HBV DNA positive patients who were admitted to Social Security 
Education Hospital between February 1999 and November 2000 were 
investigated. Seminested PCR was perfomied to detect TTV DNA using a 
set of primers synthesized accordng to the published sequence. 
Results: TTV DNA was detected in 5 of70 blood donors (7.14%), 15 of65 
HBV DNA positive patients (23.07%) and 26 of 65 HCV RNA positive 
patients (40.0%). Statistically there was significant &fference among the 
blood donors and HBV, HCV dected  patients and between H B V  and 
HCV infected patients. ( P  < 0.02). 
Conclusion: In this study TT virus had a high prevalence in W V  and 
HCV infected patients rather than blood donors. Detection of TTV as a 
viral agent and identification of high percentage of infected came- in 
healthy population leads more research about the significance of TTV as a 
human pathogen. 
m7/ Significance of rotaviruses in the aetiology of acute 
diarrhoea at the Clinic of Infectious Diseases in Pilsen and in the 
Czech Republic in 1999. first experiences with the diagnosis 
astroviral infections 
P. Pazdiora, A. Koubovi, J. Tlborski, M. Svecovi 
Pilsen, CZ 
Objectives: Rotaviruses are the most kequent aetiological agent among patient 
with diarrhoeal diseases not only in developing, but J o  in developed countries. 
These viruses are the most frequent in the aetiology of nosocomial dections. 
Methods: Their importance was analysed among patients from the Clinic of 
infectious diseases in Pilsen in 1999. With the help of questionnaires was 
analysed the detection of rotaviral infections in all the Czech Republic. 
Results: In 1999 were examined 455 children and adults hospitalized with 
diarrhoea at the Clinic of infectious diseases. A rotavirus aetiology was 
proved among small children 94x (i.e. 23.4%) and among older children and 
adults 7x (i.e. 13.2%). As to bacterial infections, salmonellosis was the most 
frequent (12.3%). The aetiology was not elucidated in 56.5% of cases with 
gastroenteritis. Nosocomial rotaviral infection was detected in 16 of 314 
infants repeatedly examined during the hospitalization (i.e. 5.1%). These 
infections protracted hospitalization on average by 4 days. In all the Czech 
Republic were rotaviruses detected 171 l x  in microbiological labs among 
examined patients in 1999. The most used method of the laboratory detection 
was the latex agglutination. Among children under 3 years of age were 75.4% of 
all detected r o t a d  infections. The calculated incidence of rotaviral dections in 
the Czech Republic in this age group is 898.7 cases per 100 000 children and 
year. From the year 2000 we started in Pilsen with detection of amoviral 
infections by ELISA (IDEIATM Astrovlrus, DAKO). Till were examined 355 
patients. The presence of the astro-virus antigen was revealed in 3 specimens 
(0.9%) of the investigated groups compronising children. AU these infections 
were ndd. the hospitalization time was in mean 4 days. 
Conclusion: The results inhcate the need to extend the laboratory spectrum 
of enteral pathogens elucidating diarrhoeal diseases and the use of more 
sensitive methods. The increase of the preventive measures against 
nosocomial infections is actual. 
Rotavirus infection epidemiology in Izmir, Turkey 
Z. Kurugol, Y. Karaca, S. Geylani, F. Umay, F. Vardar, S. Erensoy, A 
Bilgic, F. Ozkmay, C. Ozkinay 
Izmir, TR 
Rotaviruses are the most conmion cause of infantile diarrhoea worldwide. It 
is necessary to reveal the viral load to develop rotavirus gastroenteritis 
control and vaccine strategies. In this multicentre prospective study we 
aimed to evaluate the rate, the severity and the cost of rotavirus infection in 
acute gastroenteritis cases in Izmir. Our study group consisted of 862 acute 
gastroenteritis patients aged between 3 and 48 months, who attended three 
education hospitals in Izmir (Ege University, BehCet U z  Children Hospital, 
Tepecik SSK Hospital) between September 1999 and September 2000. 
Rotavirus serogroup A antigen was screened by micro-EIA (IDEIA 
Rotavirus test, Dako Ltd, UK) in stool samples. Among the samples, 307 
(35.6%) were found to be positive for rotavirus antigen. When the seasonal 
distnbution is analysed it was found that rotaviruses were be rerponsible in 
56% of the diarrhoea cases in winter months, whereas the incidence was low 
as 10% in summer months. It is concluded that rotavirus is the most 
common cause of infantile diarrhoeas in Izmir. 
Clinical characteristics of rotavirus disease 
S.  Zvizdic, S. Telalbasic, E. Beslagic, S. Cavaljuga, J. Maglajlic, A. Zvizdic, 
S.  Hamzic 
Sarajevo, 3JH 
Objectives: Rotaviruses are the major causes of viral gastroenteritis in infants 
and young chddren. There are a wide spectrum of clinical signs and 
symptoms of rotavirosis. Rotavirus infection is faecal-oral infection. Human 
group A rotaviruses are subdivide into subgroups I (2 and serotypes 8) and 11 
(1, 3, 4 and 9 serotypes). 
Methods: Rotaviruses infection clinical picture characteritticz result of 
ananlnestics data for 170 patients age of 0-7 years with proved rotaviruses in 
stool samples treated at the Clinics of Infections diseases, Clinical Centre 
University of Sarajevo, from 1988 until the end of 1991. Rotaviruses prove 
with Latex agglutination test and electron microscopy. These results can be 
reported as positive or negative for rotaviruses. 
Results: In a 4-year period 943 stool samples out of 527 hospitalized patients 
had been analysed. A presence ofrotavirus is proved with a LA arid EM tests 
at 170 (32.2%) patients age 0-7 years, in their stool samples. Analysing age 
groups of these patients, it was found that the rotaviruses infection the most 
frequently occurred at age group from 7 to 24 months. From 170 positive 
patients, 122 or 71.8% were in this age group. In all patients was found 
diarrhoea, vomiting in 90.5% cases. Mild fever had 65.5% patients, signs of a 
respiratory infection appeared at 60.7% patients, abdoninal pain at 13.3% 
patients. Severe dehydration had 49.9% patients and metabolic acidosis had 
79.2% cases. Macroscopically blood in stool had 6.4% pahents, slime in a 
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stool 46.0% patients was found, and aholic stool had 8.4%) patients. In all 
hospitalized patientc disease lasted in average 12.6 days, and the 
hospitalization in average 10.2 days. None of the patient had any kind of 
coniplication, all of them very successfully cured. 
Conclusions: These results confirm that rotaviruses are important health 
probleni among infant and the young children in Bosnia and Herzegovina. 
v1 Rotavirus infection in gastroenteritis cases among 
children under 5 years of age 
I3. Cetin, A. Ciinduz, S. Hatipoglu, E. 0. Sonmez, E. Seber, T. Olgun 
Istatibul, TR 
Objectives: The incidence of rotavirus among aetiological agents whch 
causes diarrhoea in children is considerable in epidemiological studies. In 
this study we aimed to estimate prospectively the incidence of rotavirus in 
cases of childhood diarrhoea under 5-year-old children and to estimate the 
incidence rate according to the months. 
Methods: From January 2000 to October 2000, 103 cases with diarrhoea 
admitted to the Clinics of Pediatrics of Sisli Etfal Hospital were investigated 
for rotavirus by performing latex agglutination test (Rotagen; Biokit). 
Results: Rotavirus was detected in 23 samples out of 103 cases (22.3%). The 
incidence of rotavirus acute gastroenteritis among different age goups was 
as follows: children under 3 months: l l . l%,  4-12 months: 28.694, 13-24 
months: 24%. 25-60 months: 14.8%. The incidence rate during January and 
April was hgher compared to the other months. 
Conclusions: As a result of this study we conclude that rotavirus detection 
has to be perfomled as a routine test along with the other tests of childhood 
diarrhoea. 
Jp1231] Acute motor and sensory neuropathy following 
gastroenteritic infection caused by echovirus: report of four cases 
0. Deniz, M. A. Tasyaran, S. Erol, R. Aygul 
Erzururti, TR 
Guillaiii-BarrP syndrome (GBS) is an inflammatory disorder of peripheral 
nerves and nerve roots characterized pathologically by lyniphocyte and 
niacrophage intiltration and by niyelin destruction. GBS recently has been 
recognized to consist of several variants: Acute inflanmiatory demyelinating 
poliradiculophaty, the most conmion fonn of GBS is an acute, niainly 
motor deniyelinating neuropathy; acute motor axanal neuropathy is an 
acute, predominantly motor ,uronal neuropathy; acute motor and sensory 
axonal neuropathy has prominent sensory features; Miller-Fisher syndrome 
is characterized by ophthalmoplegia, ataxia, and areflexia. Each of these 
disorders is believed to be autoinlniune in origin although the immuno- 
pathology of each differs. Approximately half o -thirds of patients with GBS 
Health care issues - prevention 
are reported to have a prodronial illness withm a 4-week period prior to 
onset GBS. Most commonly, the illness affects the upper respiratory tract; a 
predominantly gastroenteritic infection is next most common. Less 
commonly, certain specitic i&ections are implicated as definite (mycoplas- 
ma, cytoniegalovirus, Epstein-Barr virus, vaccinia, variola, and caniphylo- 
bacter), probable (varicella-zoster. measles, mumps, hepatitis A or B), or 
possible (rubella, mfluenza A and B, coxsachie, and echovirus) aetiological 
antecedents. I n  this report, we describe four patients with acute motor and 
sensory axonal neuropathy that they had gastroenteritic infection occurred 
by echovirus within a 2-4-week period prior to the onset of acute motor 
and sensory axonal neuropathy and discuss its clinic, electrophisyological 
and laboratory properties. 
I P I  232 1 Comparison of a monoclonal antibody with a 
polyclonal serum in enzyme-linked immunosorbent assay for 
detecting adenoviruses in faecal samples 
H. Saderi, M. H. Roustai, F. Sabahi, P. Owlia 
Tehran, IR 
In the present study, we constructed an ELISA for the detection of 
adenovirus antigens in which group-specific monoclonal antibody com- 
pared with a polyclonal serum. Both antibodies detected adenovirus 
antigens in cell culture and faecal samples and showed no reaction with 
heterologous viruses. These antibodies were used far the detection of 
adenovirus antigens in 872 faecal samples from children less than 7 years 
old with gastroenteritis. 72 samples were positive by both antibodies, 4 
only by monoclonal antibody, and 7 only by polyclonal serum. Our 
ELISA appeared to be a good and rapid test for detecting the adenoviruses in 
faecal samples. 
/p12331 Isolation of enteric adenoviruses in HeLa cells 
H. Saderi, M. H. Roustai, F. Sabahi, M. Sadeghizadeh, P. Owlia 
Tehran, IR 
One hundred and eighty-five stool samples from children with gastro- 
enteritis in Tehran, Iran, were tested for primary isolation of enteric 
adenoviruses in HeLa cells. Of  the 5 adenovirus isolates, 1 could be typed as 
Ad40 and 3 typed as Ad41 by type-specific monoclonal antibody enzyme- 
linked immunosorbent assay. O n  the basis of these results, the growth 
characteristic of adenoviruses in HeLa cell cultures, commonly used to 
distinguish enteric from nonenteric adenovirus types, are not valid for either 
diagnosis or epidenliological studies. 
/p12341 Review of a clinical year of infectious diseases 
fellowship training 
J. Ouderkjrk, G. Turett, J.  Kislak 
New Ynrk, USA 
What is the clinical experience of an Infectious Diseases (ID) fellow and 
what impact does ID input have on patient outcome? Review of case5 seen 
during one clinical year of training revealed interesting results. St. Vincent’s 
is a coniniuiiity and tertiary care teaching hospital in New York City. From 
August 1999 through July 2000 alniost 300 consultations were performed 
on iionprivate, hospitalized patients. 273 medical records were available for 
review. Demographic and clinical data were collected. The mean age was 
48 years (range 19-94). 2/3 were male. 1/3 each were African-American 
and Caucasian, 114 were Hispanic. 84 (30%) had HIV of whom 6 were 
newly diagnosed. and 5 met AIDS criteria. Consultations were requested 
primarily for advice on diagnosis and treatment. Specific issues included 
evaluation of fever, leukocytotis, eosinophilia, worsening clrnical status, and 
poor response to treatment. 51% of the consults were requested by general 
medcine, 25% by ICUs (medical, cardiac, surgical, and neurosurgical), and 
the remainder by neurology, surgical specialties, gynaecology, oncology, 
emergency medicine and psychlatry, in decreasing order of frequency. The 
most common final principal diagnoses were ventilator-associated pneu- 
monia (9%). osteomyelitis and cellulitis (6% each), and abscess, comniunity- 
acquired pneumonia and bacteraemia (5% each). In 23% a noninfectious 
diagnosis was made. Bacteria were the most frequently identified pathogens 
(56%). Viruses alone were detected in 10% of patients. Fungi and 
niycobacteria were each seen in 5%. Spirochetes, rickettsiae, protozoa and 
other parasites were less frequent. 30 patients died; overall mortality = 13%. 
In 84% of patients, the consultants’ advice was followed. Mortal~ty rate in 
those patients was 5%. In the 10% of patients in whom ID suggestions were 
not followed, mortality was 29% ( P  < 0.0001, RR = 5.9). In 6% ofpatients 
it was unclear if advice was followed. Interval between admission and ID 
consultation was also significantly associated with mortality. The mean 
number of days before consultation was 8.5 for those patients who survived, 
compared to 17 for those who died ( P  < 0.01). In nearly 300 patients seen 
during a year of ID consultations, both deiay in consulting ID and not 
following the consultant’s advice were significantly associated with 
mortality. Early consultation and close adherence to recommendations 
resulted in improved outcomes for patients requiring ID consultation. 
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Tertiary health care for infectious disease patients in 
the Republic of Latvia 
B. RozentSle, V. Sondore, L. Viksna 
Riga, LET 
The return of diphtheria in Latvia in 199Os, changing of diphtheria 
epidemiological and sometimes clinical patterns, appearance of some 
diphtheria paradoxes (old disease new tricks), real and growing threat of 
HIV infection as well as other serious problems associated with infectious 
diseases required rapid clinical and public health responses and efforts to 
control and overcome these problems. Therefore according to W H O  
recommendations and W H O  project ‘Health for all in 21st Century’ special 
state-controlled health care program which includes infectology subprogram 
is realized in Latvia. Health care for patients with infectious diseases in 
Latvia is organized in three levels: (1) primary health care, which foresees 
accessibility to dissolve the health problems of these patients by using a 
simple and cost effective medical technologies, is provided by general 
practitioners, therapeutists, paediatrists; (2) secondary health care - 
specialized ambulatory and/or stationary health care; (3) tertiary health 
care - highly specialized health care with more and more advanced 
diagnostics and treatment technologies of all infectious diseases, including 
dangerous and rare infections. Tertiary health care for infectious diseases 
patients is provided at the Infectology Center of Latvia - a  single institution 
for this purpose in Latvia. According to Regulations of the Cabinet of Latvia 
three major measures are indicated for this Center: (1) diagnostics and 
treatment of infectious diseases; (2) performing of the specific infectious 
diseases prophylaxis; (3) coordination and methodml management of 
infectology service in Latvia according to W H O  recommendations. To 
perform these tasks a special Center structure which includes inpatient and 
outpatient department, methodical and research department, diagnostics 
laboratory accredited according to European standards is organized. A close 
collaboration among these substructures ensures optimal conditions for 
research, development and introduction of modem technologies in 
infectology. Today’s tendencies in Latvia present evidence that really 
infectious diseases patients health care in Latvia has to be considered as a 
serioua constituent of catastrophic and accidental medicine. Therefore 
health care for these patients, especially tertiary health care, should be 
financed in full by state budget 
1p12361 Structural requirements for the treatment and 
epidemic management of viral haemorrhagic fevers 
R. Fock, M. Niedrig, E. Finke, T. Grunewald, K. Fleischer 
Berlin, Munchen, Lpipzig, W u r z b n p ,  D 
Those viral haemorrhagic fevers (VHF) which can be transmitted from 
human to human require special structural, logirtical and medical manage- 
ment of the disease and antiepidemic measures. Increasing numbers of 
imported cases in Europe as well as new developments in virology, 
epidemiology, diagnosis and treatment of VHF have led to a critical review 
of current practice. An immediate diagnosis of the index case is crucial for 
the management of VHF as well as early antiepidemic measures. Potential 
contact persons have to be traced and observed by a public health officer 
depending on their potential risk. Patients with (suspected) VHF must be 
transferred to adequate treatment centres in consideration of the safety 
precautions. These centres should have specific algorithms concerning 
isolation, diagnosis and therapy to be implemented by properly trained 
medical and care personnel. Improvements especially in intensive medical 
therapy call for giving up the still practised isolation of patients in a bed- 
isolator and to reverse the principle: while free access to the patient has to be 
guaranteed for medical and care measures the care personnel has to be 
protected by adequate protective clothing and respirator hoods (‘Barrier 
care’/‘Bamer nursing’). This conception consequently entails the creation 
of supraregional ’competence centres’ which involve not only the treatment 
centres but also the public health service as well as supporting institutions 
(rescue service, police, disaster control, etc.). Their duties should imply the 
advising of the primary care hospitals and public health officers as well as the 
information and training in their district. A continuous exchange between 
the centres will guarantee an equally high knowledge level and the 
possibility of mutual support. A diagnostic centre, a confirmation laboratory 
(BSL 4) and the Robert Koch-Institut as the leading public health institute 
figure as central links in this conception of a decentralized but supraregional 
(national) health care service. 
Occupational exposure to blood borne pathogens: 3- 
year experience in a new Greek hospital 
E. Trikka-Graphakos, A. Karaiskou, A. Anraniti, S. Marietas 
Athens, GR 
Prevention of occupational exposure of Health Care Workers (HCW) to 
blood borne pathogens is a major responsibility of the Infection Control 
Team. The aim of this retrospective study was to analyse the employee’s 
accidental exposure to blood or other body fluid? in our hospital during the 
first 3 years of its operation. An especially designed questionnaire was used 
to record the accidents during the period 1997-2000. There were 149 
occupational exposures reported. One hundred 37 (91.9%) were considered 
as ‘significant’ or ‘potentially significant’. These involved parented (94.1%), 
mucosal (3.6%) and cutaneous exposures to blood and body fluids (2.1%). 
Most of the parenteral exposures were due to needle-stick injuries (58.1%), 
followed by the accidents from other sharp objects (30.2%) and from 
‘butterfly’ needles (1 1.6%) The rate of exposure was found 72.9% in nur?ing 
staft; cleaning staff (12.4%), doctors (9.4%) and laboratory personnel (5.1%). 
Most of the exposures (69.3%) were reported in the age group of 2(!-30 
years old, whereas 30.6% was reported in persons older than 30 years. When 
the source of contamination was known and available for testing, antibodies 
of HIV, HBV, HCV were screened and previous vaccinations for Hepatitis 
B were investigated. The postexposure prophylaxis protocol for the 
nonitnniune persons was as follow: hepatitis B inuiiune globulin (HBIG) 
1.M and beginning of HB vaccine series. In one case, with known source 
positive for HIV, antiretroviral therapy was given. Seroconversion for HEW, 
HCV and HIV was not observed during the survey period. In conclusion, 
occupational exposure to blood and body fluids is common in our hospital 
especially in emergencies and operating rooms and may be due to personnel 
behaviour dunng the handling of the instruments. The risk of acquiring a 
blood borne disease through occupational exposure is still very low and can 
be further reduced through staff education and safer work practices. 
Identification of microorganisms which are routinely 
isolated in the pharmaceutical industry and investigation of 
their sensitivity against various disinfectants 
S. Dosler, G. Otiik 
Istanbul, TR 
Many pharmaceutical products may contanhated with microorganisms in 
nature. This contamination may spring from raw materials, production 
machines and equipment, package materials, air, water and manufacturing 
operators. To prevent the microbial contamination of drug is a matter of 
determining what the contaminants and the source of them IS. In our 
research, we tned to define the contaminanon sources and the contaminant5 
in pharmaceutical company. Then we investigated the sensitivity of these 
bacteria to the wide spread using disinfectant5 in pharmaceutical company. 
In this study, the samples were taken by open dishes, swabs and membrane 
filtration techniques from a company who manufactures pharmaceutical 
products in Turkey. Overall 255 bacterial strains were isolated from 112 
samples. Bacterial strains were identified according to their morphological 
and biochemical characteristics and 29 different species were determined. 
We found that 154 of the 255 isolated strains were coagulase negative 
Staphylococcus, 40 strains were Micrococcus, 44 strains were Bacillus and hvo 
strains were Coryizebacterium. W e  also identified 2 Pseudumnrins aerci&+osa, 2 
Burkholderia cepacia, I Saureus, Xarrfhomonas tnaltophilio, Aeronrotms sabria, 
Ochrohactmrn aiithropi and Meehella zooheirurn strains in the samples taken 
from the air of manufacturing areas, Pseudotriowas chlororaphis, X .  malt{~philia, 
A. sabria and A p b a c t e r  radiobacter from water and 2 Aradiobacfer strains from 
final products. Using 6 different disinfectants which were routinely used at 
the pharmaceutical company we assessed the inhibition, inferior and 
superior lethal coefficient against 29 strains of different species. For this 
purpose we used benzalkonium chlonde, a combination of 9% of 
benzalkonium chloride and nonionic surface active agent, a mixture of 
5% of benzalkonium chloride, 1.35% of formaldehyde, 0.75% of 
glutaraldehyde and 3.8% of glyoxal, a mixture of 0.1% of glutaraldehyde, 
32.5% of 1-propanol and 18% of ethanol, 10% of sodium hypochloride and 
chloramine-T trihydrate. Consequently, Sodiuni hypochloride and chlor- 
amine T trihydrate showed no activity against most of the strains at a 
concentration of 1/100, all the other disinfectants showed bactericidal 
activity and the combination of 9% benzalkonium chloride and nonionic 
surface active agent was the most active disinfectant against the strains were 
isolated from a pharmaceutical company. 
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v1 Totally implantable venous access port systems for 
patients undergoing chemotherapy for haematological 
malignancies: a prospective controlled clinical observation trial 
C .  Harter, G. Noldge, G. Egerer, H. Salwender, H. Goldschmidt, H 
Hansniann, G. Kauhiann, A. Ho 
Heidelbeg, D 
Goal: T o  detemune prospectively the outcome of radiological placement of 
central venous access devices in patients with haematological malignancies 
we prospectively evaluated the perforniance and rate of short-and long-term 
complications of the Z-Port-F-8 system (Zanibon Biomedica, Antibes, 
France), a totally implanted vascular access system. 
Materials and methods: In 86 patients (pts.) with haematological 
malignancies chest port systems were placed radiologically. The inedian 
follow up was 9 5 months (range 6-15 months). Success and complication 
rates (immediate and long-term) were recorded. 
Results: The median age of the pts. was 53 years (range, 16-78). N o  
extravasation, skin necrosis or leakage occuired after 16.536 days of use. 
Perioperative coniplications were recorded in 6 pts. (6.9%): pneumothorax 
in 2 pts. (2.3!%), bleeding in 2 pts. (2.3%), and haematoma in 2 pts. (2.3%). 
In 7 pts. (8.1 3%) late coiiiplications occurred: catheter msconnection in 1 
pts. (1.1 6%), thrombosis in 3 pts. (3.4%) and subcutaneous portal infections 
in 3 patients (3.4%). Late complications were higher in patients who had 
received chemotherapy prior to 24 h following implantation. Patency of the 
PAC system wac nuinwined using a regular flushing schedule once every 28 days. 
Conclusion: The Z-Port-F-8 system can provide a safe and reliable method 
for venous access in patients requiring intermittent or prolonged 
intravenout chemotherapy. T o  reduce the rate of late complications a 24- 
h interval after implantation of the Z-Port-F-8 system should be achieved. 
vl The efficacy of UV on staphylococci 
M. Yalinay Cirak, I. Fidan, A. Aydin, S .  Turet 
Ankara, TR 
The efficacy of W for the sterilization of metal surgery instruments like 
pens, penset and scissors was tested. Materials contaminated with 
Staphyloiucc-us upidemridis ATCC 35983; Stapliylococius aureus ATCC 25923; 
3 clinical isolates Staphylomrms epidemiidis (slime positive and coagulase 
negative), Staphylortirius aweus (slime negative and coagulase positive) and a 
slime negative and coagulase negative staphylococcal strain. These 
staphylococcal strains were subjected to W sterilization for the time 
periods of 5, 10, 20, 40, 60 and 120 min. Residual microorganisms were 
recovered and cultured. After overnight incubation, growth of these tested 
organisms were evaluated. All of these staphylococci were grown after 5, 10 
and 20 min UV sterilization except for the clinical isolate of Staphyiocoiius 
epidennidis. T h ~ s  train was grown only after 5 min W sterilization. These 
results indicate that W sterilization must be applied for at least 40 min for 
stenhzing materials contaminated with staphylococci. 
/p12411 Assessing the indications of an antibiotic, introduced 
as generic in the market by public authorities, based on most 
recent bacterial susceptibility and PK/PD data 
P. M. Tulkens, on behalf of the Belgian Transparency Commission 
Brussels, B 
The increasing costs of drugs have triggered the marketing of generics. The 
Belgian law provides generics must be given the same indications and 
conditions of usage, including dosages, as the corresponding original 
molecules. Since these may have been registered (or re-registered) several 
years before, generic antibiotics could be initially promoted at dosages and 
for indications causing potentially irreversible public health damages in 
terms of emergence and spreading of resistance. The problem has been 
addressed by the Transparency Commission, an official commission 
comparing drugs and writing advises used by the authorities for deciding 
on reimbursement schemes and policies. When a generic antibiotic is 
submitted to the Conlniission, the indications and dosages of the original 
molecule are compared with those considered reasonable at the present 
time, based on  (i) current antibiotic resistance patterns in Belgium and 
adjacent counmes; (ii) trends for decreating susceptibility for organisins with 
dowly ascending MIC’s; (iii) current information on the pharmacokinetic/ 
pharmacodynamic (PK/PD) properties of the drug class under study; (iv) 
Belgian and foreign guidelines. A provisional advice is then written in 
which (a) acceptable, less acceptable and nonacceptable indications are 
defined (b) the reasons for limiting the use of the drug are explained (c) the 
effective dosages (for eradication and, possibly, avoiding the selection of 
organisms with reduced susceptibilities) are underlined. Determining 
effective dosages is considered particularly important since inappropriate 
pricing (i.e. granting reinibursement based on too low doses) could result in 
a general underdosing and rapid selection and spreading of resistant 
organisms. This provisional advice is wbmitted for coniinents to the 
marketing authorisation holder (registrant) before the Commission issues a 
definitive advice that is sent to the Authorities. Over a period of 1 year, 
advises have been issued over 16 generic antibiotics, raising only minor 
remarks fiom the registrants. This scheme may help in meeting the public 
health concerns raised by the multiplication of generic antibiotics and 
anticipated commercial pressure leading to mappropriate use. 
New antimicrobial drugs 
v1 Peptide nucleic acid based drugs are effective 
antibiotia against multiresistant clinical isolates of Escherichia coli 
U. Giwercinan, 1’. E. Nielten, L. Malik, F. Beck, N. Frimodt-Moller 
Copenlrageii, DK 
PNA (Peptide Nucleic Acid) oligomers were synthesized with specificity for 
vital genes of Escheriihia coli. These oligonieric molecules were designed to 
hybridize with the complementary mRNA sequences thus interrupting the 
formation of the vital protein encoded by the mRNA. The PNA molecules 
were chenlicdy modified to enhance bacterial uptake for ensuring optimal 
antibacterial effects. In order to evaluate the in vifro antibacterial effect of a 
specific PNA compound (PNA # G), 110 consecutive clinical isolates of E. 
ioli were used as target organisms. 20 of the isolates were resistant to 
tetracycline, nfampicin, beta-lactams, flouroquinolones, chloramphenicol 
and aiiiinoclycosides. Broth iiiicrodilution and time-lull testing were used 
to examine the activity ofthe PNA, accordmg to NCCLS Guidelines. All of 
the 110 isolates were susceptible to the PNA. MICs were between 2 and 8 
pg/niL and MIC 90 was 6 pg/mL. MICs obtained were not related to 
known antibiotic resistance of the isolates. MBC/MIC ratio was 1-2. PNA 
exhibited bactericidal effect at < 2 h at concentrations of 4-10 times MIC 
and no significant postantibiotic effect was observed. In conclusion 
rationally designed PNA have bactericidal effect on niultiresistant clinical 
isolates of E. ioli. PNA represents an effective novel class of future antibiotics 
against niultiresistant pathogens. 
v] Drugs based on peptide nucleic acids are efficient 
antibiotics in vivo against Escherichia coli and Klebsiella 
pneumoniae in the mouse peritonitislsepsis model 
U. T. Ravn, B. Giwercman, J. V. Christensen, F. Beck, L. Malik, N 
Frimodt-MerUer 
Copenhupz, DK 
With the aim of developing antibiotics based on the antisense principle, 
Petide Nucleic Acid (PNA) oligomers were designed to specifically 
hybridize with sequences of nlKNA encoding a vital protein of Esihen’chia 
coli and Klebsiella pneumortiae. The PNA oligomers were chemically modified 
to improve the antibacterial effect. Four different PNA constructs (PNA 
#G, PNA #H, PNA #J, and PNA #K), directed against the same target 
sequence, but subjected to different chemical modifications, were 
investigated for in uiim antibacterial efficacy in the mouse peritonitis/sepsis. 
Female NMRI mice were inoculated intraperitoneally with 107 cfu of E. 
coli ATCC 25922 or 106 cfu of K. prreumoniae ATCC 10031. Samples were 
drawn tiom blood and peritoneal fluid at fixed intervals until 6 h post 
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infection, and the cfu/mL counted. At 1 h post infection the animals were 
treated once in groups with either standard doses of a positive control 
(gentamicin, ampicillin or cefuroxime), the test PNA or 0.9% NaCl (control 
group), Untreated animals developed fulrmnant clinical signs of infection 
and succumbed within 24 h after inoculation. At all time points PNA #G, 
PNA #J, and PNA #K in doses of 1 0 4 0  mg/kg reduced the cfu/mL by 3- 
6 log10 compared to the nontreated controls and as efficiently as the positive 
controls. The bacterial lulling effect coiTelated with survival of the mice. A 
clear dose-response relationship was observed for PNA #H when dosed to 
two groups of E. coli infected nllce at 9.5 mg/kg and 57 mg/kg, 
respectively. At all time points the low dose of PNA #H reduced the cfu/ 
mL by 1-3 logl0, whereas the high dose reduced the cfu/mL by 3-5 log10 
compared to placebo-treated controls. These results demonstrate for the first 
time that PNA based antisense compounds are efficient antibacterials in uiuo. 
vl Pharmacokinetic profiling of novel PNA-based 
antibiotics in mice 
E. Kristensen, J. V. Christensen 
Copenhagen, DK 
Peptide Nucleic Acid (PNA) based antisense oligomers have been 
specifically designed to hybridize with sequences of nlRNA encoding vital 
bacteria proteins, and tested as antibacterials against the targeted organisms. 
To support in viuo efficacy studies the pharmacokinetics (PK) of PNA #G 
and PNA #H were investigated in pilot studies with single i.v. 
administration to female NMRI mice. In the study on PNA #G plasma, 
peritoneal fluid and tissue samples were obtained from single animals a t  
intervals until 30 h after dosing. Drug concentrations were determined by 
HPLC analysis with UV-detection (260 nm) after solid-phase on-line 
extraction. Concentration data were analysed by noncompartmental 
methods. Concentration profiles in plasma and tissues appear in Fig. 1. 
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With a long plasma elimination half-life (t1,J of 3.1 h, large volume of 
distribution (Vz) of 8 L/kg and high concentration levels of intact drug in 
kidney, lung and heart tissue, the PK profile of PNA # G compared 
favourably with the PK profiles of traditional antibiotics in mice. In 
peritoneal fluid the area under the concentration curve (AUC) was 64% of 
the placina AUC. The pilot study on PNA #H was sinular in design except 
that the sampling period was 4 h and that only plasma and peritoneal fluid 
was collected. For PNA #H fx was estimated to be 1.1 h, CL to be 43 mL/ 
min/kg, Vz to be 4 L/kg and the peritoneal fluid:plasma AUC ratio to be 
0.08. The less favourable PK profile of PNA #H correlates well with in vitro 
stability studies in mouse plasma, where 85% of PNA #H is degraded in 45 
min as opposed to only 10% of PNA #G. It also correlates with iti uivo 
efficacy data Gom the sepdperitonitis model, where PNA #G is 
significantly less potent against E. roti than PNA #G in spite of sindar in  
uiuo MICs (c. 6 pg/mL.) of the two compounds. The results demonstrate that 
PNA antisense antibiotics can be constructed with favourable PK profiles in 
uiuo, and that early PK profiling is a key tool for evaluation and selection of 
potential drug candidates. 
v1 Is LY333328 glycopeptide a new cell-associated 
antibiotic? Comparative studies with vancomycin and 
azithromycin in a model of 5774 mouse macrophages 
F. Van Bambeke, A . 3 .  Snoeck, H. Chanteux, M.-P. Mingeot-Lerlercq. P. 
M. Tukens 
Brussels, B 
LY333328 is a new semisynthetic glycopeptide, which differs €-on1 
vaticoniycin mainly by the presence of an additional aminated sugar (4- 
epivancosamine), making it a polybasic drug, and by the addition of a 
chloro-biphenyl moiety, making it an amphiphilic compound. These 
features should considerably enhance its ability to interact with membranes 
of eucaryotic cells and to accumulate in these cells. In the present study, we 
investigate the accumulation of LY333328 in J774 mouse macrophages, in 
companton with vancomycin and azithromycin, a dicationic amphiphilic 
macrolide antibiotic well known for its marked cellular accunnllation. Cells 
were incubated at 37 "C with 25 pg/mL antibiotic for up to 24 h, washed at 
4 "C, scrapped off and lysed by sonication. Antibiotic and protein contents 
of the lysates were determined and used to calculate an apparent 
accumulation factor (drug concentration associated to the cellldrug 
extracellular concentration [Cc/Ce]). LY333328 showed a steady increase 
in Cc/Ce, from 62 14 at 24 h. In contrast, vancomycin 
Cc/Ce were below detection level after 2 h (which approximately 
corresponds to a Cc of 0.8 pg/mg prot) and reached only 8 f 5 after 24 
h. Azithroniycin accumulated markedly and very rapidly (Cc/Ce = 126 f 6 
at 2 h) and then remained at this plateau value for up to 24 h. Thus, 
LY333328 appears as a new type of cell-associated antibiotic warranting 
studies of efficacy in models of infected cells. Yet, its mechanism of 
accumulation is probably different Gom that of azithromycin. 
5 at 2 h to 332 
v1 In vitro activity of daptomycin against pneumococci 
and streptococci with genetically characterized resistance 
against fluoroquinolones. erythromcyin, clindamycin, or 
tetracycline 
A. C.  Fluit, F.-J. Schmitz, J. Verhoef, D. Milatovic 
Utrecht, NL 
Background Daptomycin is a novel lipopeptide compound with potent 
calcium-dependent activity against gram-positive bacteria, including 
methican-resistant Staphylorucms uureus, vancomycin-resistant enterococci 
and penicillin-resistant pneumococci. The present study examined the ill 
vim activity of daptomycin against pneumococci and streptococci with 
geneucally characterized resistance against fluoroquinolones, erythromycin, 
clindamycin, or tetracycline. 
Methods: Bacterial isolates were obtained from 20 European hospitals. The 
mechanism of fluoroquinolone resistance was determined by DNA 
sequencing, whereas the other resistance determinants were analyted using 
specific P C R  assays. In uitro susceptibility against daptomycin and 11 
comparator antibiotics was determined according to NCCLS criteria. 
Results and discussion: A total of 65 pneuinococci were tested, these 
isolates carried the following resistance determinants: end3 alone ( n =  ll),  
mefE alone ( n = 8 ) ,  tetM alone ( n =  12), e n d  and tetM ( r i=7) .  mefE and 
tetM ( t i =  6), 14 isolates had mutations in the gyrA and parC genes, 4 isolates 
in the parE gene, 4 isolates in all 3 genes, and 1 isolate had no mutations. 
The resistance phenotype of these isolates was in accordance with their 
genotype. The MICs for daptomycin ranged from 0.06 to 1 mg/L; the 
MIC50 was 0.12 mg/L and the MIC90 was 0.25 nig/L. Only 2 isolates had 
a MIC of 1 mg/L and 1 isolate had a MIC of 0.5 mg/L. The Streptorocrus 
species (ii=65) tested included: S. uguiarfzae, S. buuis, S. iniris, S. oralis, S. 
pyopt ies ,  and S .  suriguis. These isolates carried the following resistance 
determinants: ermA alone (n=3), ermB alone (i1=24), ermTR alone 
( n = 3 ) ,  mefA alone (tt=ll) ,  ennA and ermTR (n=2), e m B  and ermTR 
(n=3), ermC and ermTR ( I I =  l), ermA, ermB and emiTR ( a =  l), emlA 
and mefA (n = 1). The quinolone resistance determining region (QRDR) of 
17 isolates was sequenced. Two isolates had mutations in gyrA alone, 6 
isolates in gyrB alone, 2 isolates in gyrA and parC, 2 isolates in gyrA, gyrB 
and parC, and 5 isolates had no mutations in the QRDR.  The resistance 
phenotype of these isolates was in accordance with their genotype. The 
MICs for daptomycin ranged from 0.03 to 8 mg/L; the MIC50 was 0.25 
mg/L and the MIC90 was 1 mg/L. Only 1 isolate had a MIC of 8 mg/L, 1 
isolate had a MIC of 4 mg/L, and 5 isolates had a MIC of 2 mg/L. No 
correlation with a particular genotype was observed, but the S. niitis isolates 
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( I t  = 23) tended to have a higher MIC for daptomycin (range 0.25-8 mg/L; 
MIC50 1 mg/L; MIC90 2 mg/L). 
Conclusion: Daptomycin is a promising new antibiotic for the treatment of 
antibiotic resistant pneumococci and streptococci 
A mucoadhesive polymer extracted from tamarind 
seeds improves intraocular penetration of rufloxacin and 
enhances the drug efficacy in the topical treatment of 
experimental bacterial keratitis 
E. Ghelardi, A. Tavanti, F. Celandroni, E. Boldrini, S.  Senesi, M. Campa 
Pisa, I 
Objectives: Evaluation of the intraocular penetration and therapeutic 
benefit of rufloxacin, delivered by a natural mucoadhesive polysaccharide 
(tamarind gum polysaccharide; TGP), in the topical treatment of 
experimental bacterial keratitis. 
Methods: New Zealand male rabbits were infected with Pseudomunus 
aerufirma or Staphylococcus aureus by injection into the corneal stroma of 
both eyes. After 16 h, infected alum& were randomly divided into four 
groups and subjected to topical administrahon of either 3 m g / d  
rufloxacin, 3 mg/nL rufloxacin viscosified with TGP, 3 mg/mL ofloxacin, 
or 1% TGP, following different treatment schedules. Rabbits were N e d  
and samples of aqueous humor, obtained by paracentesis, were assayed for 
drug concentration. Corneas were homogenated, serially diiuted in sterile 
saline solution, and plated on hypticase soy agar for bacterial colony counts. 
Results: Whde rufloxacin resulted 4-fold less active than ofloxacin against D. 
aemgirtosn isolates iti vitro, the activity of the TGP-viscosified rufloxacin was 
found to be sindar to that exerted by ofloxacin in the topical treatment of P. 
aengirtosa keratitis. However, since rufloxacin and ofloxacin are similarly 
active against S. nureus strains iri vitru (MIC90=4 mcg/mL), the rabbit 
model of S .  aweus keratitis allowed the comparison of the therapeutic 
efficacy of rufloxacin vs. ofloxacin as well as the evaluation of TGP activity 
in improving the intraocular penetration of rufloxacin. While the 
administration of the three drug formulations every 30 min for 6 h 
produced a comparable reduction in bacterial burden in corneas, a treatment 
schedule consisting in the administration of the drugs every 90 min for 4.5 h 
showed that the treatment with TGP-viscositied rufloxacin was more 
efficient in reducing S. aureus CFU numbers than any of the other drugs 
tested. Remarkable higher levels of rufloxacin were obtained in the aqueous 
humour of animals treated with TGP-viscosified rufloxacin, compared with 
those recorded after the treatment with the drug alone. 
Conclusions: The topical administration of rufloxacin delivered by TGP 
produces intraocular levels hgher than those achieved with rufloxacin alone 
and enhances the therapeutic benefit of the adninistered drug. Therefore, 
TGP seems to be able to prolong the contact-time between drugs and 
corneal tissue and may be successfully used as a n  ophthalmic delivery system 
for antibiotics in the topical treatment of bacterial keratitis. 
/p1248j Antibiotic resistance reversal in clinical strains of 
5. aureus 
W. Kiczka, A. Szkaradkiewicz, T. Tulecka 
Pozrra~i, PL 
Objectives: Some drugs, like phenothiazines, have been documented to 
decrease antibiotic resistance in some bacteria. Our study aimed at 
examining the potential for reversal of antibiotic resistance in S. aurais 
<trains (MRSA and MSSA) using a lysozyme dimer (generated from 
monomer by lysozynie diinerization). 
Methods: The studies were performed on 26 S. aureus, strains, of which 13 
strains originating from hospitalized patients were identified as MRSA (in 
each of them mecA gen was detected by P C R  technique), while the 
reniaining isolates, originating from outpatients, were identified as MSSA. 
Sensitivity to selected antibacterial drugs (clindamycin, gentamicin and 
triinethoprini/sulfamethoxazole) was estimated by disc diffusion technique 
on Mueller-Hinton 2 agar (bioMerieux) and again, on the agar 
supplemented with lysozynie dimer (5, 10 or 20 pg/mL). 
Results: Ten MRSA strains proved resistant to all examined drugs while 
anioiig MSSA strains eight strains were identified to be resistant to 
clindamyciii, gentanucin and trimethoprim/sulfamethoxazole. Presence of 
the lysozynie dimer in the agar (10 pg/nL) was found to reduce resistance 
of S .  uureuz to the above listed drugs. 
Conclusions: Lysozyme dimer interactions with some antibiotics may 
provide new possibilities in treatment of bacterial infections. 
/p1249] Efficacy and tolerability of povidone-Iodine liposume 
complex in infected knee joints of rabbits 
D. Ganzer, L. Volker, K. Reimer, W.  Fleischer, B. Brogmann, S. Decker, 
H. Below, A. Kramer 
Gre$wald, Limburg, D 
Introduction: In this study the efficacy of a Povidone iodine (PW-I) 
liposome complex in different concentrations and the local effect on the 
synovial membranes and hyaline articular cartilage of adult male chinchilla 
hybrid rabbits was investigated. The PIT-I liposome complex was prepared 
as a liquid dispersion. Electron-microscopic evaluations indicated a direct 
attachment of the PW-I liposomes to microorganisms. A significantly better 
cell and tissue tolerability compared to equivalent conventional PVP-I 
formulations was demonstrated. 
Materials and methods: 60 rabbits were allocated to 4 groups with 15 
animals per group. Three days before the start of the treatment 1 x lo’ cfu 
of Staphylocucccirs aweus in 0.5 mL sterile s&ne were injected in the right 
knee joints. The groups were treated with Ringer’s solution, 0.5%, 1.5% or 
4.25% PW-I liposome complex using the distention-imgation method 
with 25 rinse-suction cycles of app. 2 mL each at a constant instillation 
pressure equivalent to 100 cm H20.  Treatment duration was 15 min, and 
was repeated 5 days in a row. The animals were killed 4 weeks after 
treatment. Two predefined representative synovial membrane and articular 
cartilage samples were prepared, fixed, and embedded in methylmethacry- 
late. Following removal of methylmethacrylate and staining, the thin 
sections were subjected to a descriptive hlstomorphological assessment and a 
morphometric cytoanalysis. 
Results: Clinical signs of septic arthntis (joint swelling, hot tender joint, 
flexion contracture) were pronounced 3 days after S. aureuz inoculation in 
all animals. The best recovering of this signs was found afier 5 days in the 
study group treated with 0.5% PW-I liposome complex. The histomor- 
phometry of the individual synovial membrane saniplesshowing significant 
differences in the parameters investigatedsupported the descriptive 
assessments. In the articular cartilage, varying results for the cellular 
parameters examined were found. 0.5% PW-I liposonie complex exerted 
the best clinical results and least intluence on intra-articular structures of the 
knee. Substance-specific damage profile in these groups are judged ac low-grade. 
Discussion: The 0.5% PW-I liposome complex appears to be suitable and 
effective for the local anti-infective treatment ofjoint infections and exhibits 
advantages in comparison with antibiotics. 
Antiviral and anticancer properties of macrocyclic 
pyridinophanes 
A. S. Fedchuk 
Odessa, UKR 
Macrocyclic pyridinophanes (MCP) in latest years attract attention of the 
researchers as compounds with high potential of phannaco-biological 
properties. The scope of the present paper was the experimental study of 
antiviral and anticancer properties of newly synthetized MCP. The results of 
investigation of anticancer and antiviral activities of 12 Schiff bases 2,6-bis 
(2-and 4-formylaryloxymethyl) pyridines are presented below. Anticancer 
activines of MCP designed and synthetized by our research team were 
tested in vitru in National Cancer Institute (Bethesda). The panel consisted of 
57 lines of 9 cell cultures of human malignant tumors each. All preparations 
have demonstrated anticancer activity of various grades towards various lines 
of human tumors. Ortho-replaced MCP-815 and MCP-635 have displayed 
the most expressed anticancer activity. The involution of cancer cells took 
place on all models in more than 50% cases of MCP-815 action (29 from 57 
investigated lines). MCP-635 demonstrated anticancer action in the cases of 
all 9-mmour models. Annviral activity in virvo was studied by inhibition the 
reproduction of influenza (Flu) virus A/HongKong/l/68 in tissue cultures 
of chorioallantoic membranes of chick embryos. Inhibitory action of MCP 
adenovirus type 5 (Ad5) and herpes simplex virus (HSVl, HSV2) was 
studed on Hep-2 cell culture. MCP-815 demonstrated anti-influenza 
activity in concentration 0.001 M. Logarithrnical average of viral 
reproduction ihb i t ion  was equal to 3.05 log TCID50 (tissue cultural 
infective dose). MCP-635 showed regular but low anti-influenza activity. 
MCP-815 and MCP-635 did not demonstrate anti-Ad activity. MCP-815 
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(concentration 0.001 M) did not show anti-HSV activity. The obtained 
experimental results were used for molecular topological model evaluation. 
QSAR problems resolution allowed obtaining the correlation equation that 
ties biological activity with MCP niolecular structure. This work was 
supported in part by INTAS GRANT 97-31528. 
Conclusions: (1) O n  the basis of the results obtained we could state that 
MCP IS the perspective group for QSAR-assisted design and synthesis of 
conipounds with antiviral and anticancer activities. (2)  New original 
mathematical software evaluated in our research team for Q S A R  problems 
resolution has proved to be effective in providing antiviral and anticancer 
activities of MCP compounds. 
/p1251/ Leishmanicidal activity of yuccasaponin MC 3, a new 
steroidal saponin from Yucca filamentosa L. 
A. Plock, M. Nimtz, V. Wray, W. Sokolowska-Kohler, W. Presber 
Berlin, Braunschnieig, D 
Leishmaniasis is a increasing major global public-health problem. The 
disease currently affects some 12 d o n  people in 88 countries, all but 16 
which are in the developing world. The pentavalent antimonials sodium 
stibogluconate and N-methylglucamine are the preferred drugs for the 
treatment of most forms of leishmaniasis. Treatment with these agents is not 
consistently effective and has serious toxic side-effects. It is known that 
natural products have potential in the search for new selective agents for the 
treatment of Leishmaniasis. In a prelirmnary screening of 150 extracts of 50 
plants, the ethanolic extract of Yucca jXzmentora L. showed a strong 
leishnianicidal activity against Leishmania mexicana amazonensis promasfigotrs. 
The bioactivity-guided fractionation of this extract led to the isolation of a 
new gitogeniii-based steroidal saponin, Yuccasapoilin MC3'. Yuccasaponin 
MC 3 has been characterized as 3-O-(@eta-o-glucopyranosyl13-beta-1)- 
glucopyranosyl12)(alpha-~-rhamnopyranosyll4-beta 1~-glucopyranosyll3) 
betaglucopyranosyll4-beta -~-galactopyranosyl)-25 R, 5 alpha-spiro-stan- 
2 alpha, 3 beta-dm1 by using various chemical and spectroscopic methods. 
The effect of the saponin on promastigote form of L. mexzcana nmmonrnsb 
was quantified and characterized by using flow cytometry and specific 
Ketolide antibiotics 
fluorescent dyes (propidium iodide, Syto 9 and DIBAC43). The data 
revealed that the membrane of the promastigote is attacked. The effect of 
Yuccasaponin MC 3 on intracellular forms (aniastigotes) was also 
characterized; green fluorescent protein-transfected Leishmania major' were 
used. By this method, an inhibition of intracellular growth of L. major was 
demonstrated. The data presented in ths  study underline once more that 
natural products are sources for the development of novel therapeutic agents 
in the fight against leishmaniasis. 
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lp12521 immune response after selenium supplementation 
with newly synthetized organic compounds 
M. Koziol-Montewka, I. Musik, A. Tokarz 
Lublin, PL 
Selenium has been shown to act as antioxidant that may enhance immunity 
during microbial infection. The main trends of the selenium stuhes concern 
their most suitable chemical forni, toxicity limits, organ cumulating and 
their effects on the immunological mechanisms. The aim of our study was 
to investigate the effect of selenium supplementation with inorganic and 
two organic selenosemicarbazide and selenazohe forniulas on cytokine 
production of mice spleen cells upon LPS stimulahon. Four groups of Swiss 
mice were included, three of them were fat with different formulas of 
selenium at the dose of lo-' g Se/kg of body mass during 10 days. 
Cytokine IL-12, TNF and IFN production of lipopolisaccharide (LPS), 
ConA and PHA activated spleen cells in culture system were measured. The 
results showed decreased spontaneous IL-12 production of lymphocytes 
supplemented with selenium. IL-12 production in LPS stimulated cells were 
higher in mice supplemented with sodium selenate. While, two hfferent 
organic compounds caused comparable IL-12 synthesis of cultured spleen 
cells. Our  results suggest that selenium supplementation can influence 
inlniunological lymphocytes response in compounds dependent manner. 
rp1253/ Telithromycin is highly active against clinical isolates 
of Streptococcus pneumoniae collected in the PROTEKT study, 
irrespective of penicillin, macrolide or fluoroquinolone resistance 
D. Felmingham, I. Harding 
London, Cambridgeshire, UK 
Objectives: Over the last 20 years, antirmcrobial resistance among respiratory 
tract pathogem has spread dobally at an alamling rate. PROTEKT (Prospective 
Resistant Organism T~ackmg and Epidemiology for the Ketolide Telithromycin) 
is an international surveillance study of the susceptibility of respiratory tract 
pathogens to current and new antimicrobials. We present here the latat results 
for isolates of S. pnarmoniar, one ofthe Commonest bacterial pathogens asociated 
wth community-acquired respiratory tract infections. 
Methods: A total of 72 centres in 25 countries are participating in 
PROTEKT. Bacterial isolates are being collected from patients with 
pneumonia, acute bacterial exacerbation of chronic bronchitis or chronic 
obstructive airways disease, sinusitis, tonsillitis/pharyngitis or otitis media. 
MICs are determined at a central laboratory by an NCCLS broth 
inicrodilution method for 26 licensed and developmental antimicrobials. 
Results: For 1327 S. pmumoniae isolates from around the world tested to 
date (November 2000), susceptibility (% of isolates, NCCLS breakpoints) to 
the antimicrobials tested was between 0% (cefixinie) and 100% Oinezolid, 
teicoplanin, vancomycin). Mode MIC, MIC90 and susceptibility rates for 
selected antinlicrobials are summanzed in the Table. Over 40% of the 
pneuniococcal isolates were resistant to penicillin and/or niacrolides. 
Fluoroquinolone resistance was rare (1.9%), although its emergence among 
the newer agents in this class is a concern. Mode MICs for telithromycin 
against penicillin-susceptible, -intermediate and -resistant isolates were 
0.015 mg/L, 0.015 mg/L and 0.06 mg/L, respectively. Mode MICs for 
telithromycin against macrolide-susceptible, -intermediate and -resistant 
isolates were 0.015 mg/L, 0.015 mg/L and 0.06 mg/L, respectively. At a 
tentative susceptiblity breakpoint of 1 mg/L or less, telithromycin was active 
against 99.8% of all S. pneumoniae isolates, including those resistant to 
penicillin (99.5%), macrolides (99.6%) and fluoroquinolones (100%). 
Conclusions: The worldwide prevalence of penicillin- and/or niacrolide- 
resistant isolates of S. pneumoniae is of great concern. There is an urgent need 
for new antimicrobials such as the ketolide telithromycin, which shows 
excellent activity against all isolates of S. pneumoniar irrespective of 
penicillin, macrolide or multiple resistance. 
b. pneumoniae MIC (mgh) Susceptibility 
(1327 isolates) Mode MICaa (%of Isolates) 
I 
57 9 g 8  1 I Telithromycin 0 015 0 25 Peniciiiin 0 015 4 
Cefaclor 
Cefuroxime 
Eythromycin 57 3 
Clan thromyci n 57 5 
Qilhromycin 57 6 
gn o 
Ciprofloxmn Not available 
Levcfloxacin 
Moxifloxacin 0 12 0 25 98 Y 
v/ Telithromycin shows excellent activity against 
bacterial respiratory isolates collected from Japan in the 
PROTEKT study 
D Fehngham, I Hardmg, M Inoue 
London, Cambndphrrr ,  UK; Kanapariq J 
Objectives: The emergence and spread of antimcrobial resistance is of 
major international concern, and levels are particularly lngh in south-east 
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(308 Isolates) 
Asia. PROTEKT (Prospective Resistant Organism Tracking and Epide- 
miology for the Ketolide Telithromycin) has been established to study the 
antimicrobial suscephbility of bacterial pathogens isolated fiom patients with 
community-acquired respiratory tract infections &TI). 
Methods: In this ongoing surveillance programme, a total of 1039 isolates 
from Japan (H.  ir$.wrrme, 281; H. p a r a i i @ x a x ,  57; M. catawhalis, 122; S. 
aweus, 151; S. pyogenes, 120; S. prteumoniae, 308) have so far been analysed. 
MICs were deterniined at a central laboratory by an NCCLS broth 
nucrodiiution method for 26 licensed and developmental antinllcrobials. 
Results: Notable levels of resistance were evident among all common 
respiratory pathogens: 80.5% macrolide resistance and 65.6% penicillin 
resistance among S. prieunroriiae; 17.5% macrolide resistance among S. 
pyogeries; and 159% niethicillin-resistance among S. aureus (MRSA). The 
majority (96.7%) of M cafarrhalis isolates and 8.5% of H. influenme isolates 
were beta-lactaniase positive. Emergence of fluoroquinolone resistance 
among S. prieumoriiae isolates (1.6%) was of particular concern. Mode MIC, 
MIC90 and percentage susceptibdity (NCCLS breakpoints) for S. 
pnerrmorziae for the ketolide aiitinllcrobial telithromycin compared with 
antinlicrobials currently ured in the treatment of community-acquired RTI 
are sunmarised in the table. At the tentative breakpoint of 1 mg/mL, 
telithromycin was active against all S.  prieuinoriiae isolates (niode MIC, 0.06 
mg/L; MIC90, 0.25 nig/L), irrespective of penicillin or macrolide 
resistance. Telithroniycin was also active against 99.2% of S .  pyopies  
isolates (mode MIC, 0.015 mg/L; MIC90, 0.25 mg/L), 98.9% of H. 
ir!fl.emue isolates and 100% of M. catarrhah isolates. 
Conclusions: A high proportion of respiratory tract pathogens from Japan 
are resistant to beta-lactam and/or macrolide antimicrobials. However, this 
problem niay be overcome by the introduction of new antimicrobials such 
as the ketolide telithroniycin, which shows good activity against all key 
pathogens, including resistant strains. (Table 1) 
MIC (mgn) Susceptlblllty 
Mode I MIC.. " 
Telithmmvein I3 Ci6 n 2: 100 
Fen,'-, Ill,? 4 34 4 
I I I 
,-s.,*,- I"l I fi4 I re4 I 19 2 
/p1255/ Telithromycin is highly active against respiratory 
tract isolates collected from Italy in the PROTEKT study 
D. Felmingham, I .  Harding 
Loiidoii, Cambridgeshire, UK 
Objectives: Awareness of local patterns of antimicrobial resistance is essential 
for effective management of respiratory tract infections (RTI). PROTEKT 
(Prospective Kesistant Organism Tracking and Epidemiology for the 
Ketolide Telithroniycin) is an international surveillance study of the 
antimicrobial susceptibility of bacterial isolates from patients with conmiu- 
nity-acquired RTI. 
Methods: As part of the global study, isolates were collected at two 
surveillance study centres in Italy fiom patients with pneumonia, acute 
bacterial exacerbation of chronic bronchitis, acute exacerbation of chronic 
obstructive airways direase, sinusitis, pharyngitidtonsillitis or otitis media. 
MICs for 180 isolates (H.  ir$uei?rae, 62; M. catarrhalis, 19; S. aureus, 19; S. 
yneutnowiae, 56; S. py(~pwes ,  24) have been determined to date (October 
2000) at a central laboratory by an NCCLS broth nucrodilution method for 
26 Licensed and developniental antimicrobials. 
Results: Beta-lactamase production was rare among H. iyfluenzae isolates 
(1.6%) but was detected in 100% of M .  catarrhalis isolates. The majority 
(80.4%) of S. prreuinoriiae isolates were susceptible to penicillin. However, 
macrolide resistance levels were 44.6% for S. przeumoniae and 45.8% for S. 
p ) q e n e s .  None of the S. aureus isolates were mecA-positive. The new 
ketolide antimicrobial telithromycin was active against 100% of isolates of 
both H. ir$uerrzae and M. catarrhalis, and > 95% of S. pneumoniae isolates. 
Importantly, telithromycin was also active against the majority of penicillin- 
and erythroiiiyciii-resistant isolates of S. pneumoniae, with mode MICs of 
0.5 nig/L and 0.25 ing/L, respectively, and MICYOs of 0.5 mg/L. Mode 
MIC and MIC90 for S. pneutnorriae (all isolates) are shown in the table for 
telithromycin and antinllcrobials most frequently used in the treatment of 
community-acquired RTI. 
Conclusions: In Italy, a considerable proportion of respiratory tract 
pathogens are resirtant to commonly prescnbed antinvcrobials Telithro- 
mycin has excellent activity, even against penicillin-and niacrohde-resntant 
pathogens, and IS hkely to be '1 valuable new opnon foi the ophmal 
treatment of community-acquired RTI in the face of increasing 
antimcrobial resistance (Table 1) 
v1 Telithromycin has excellent activity against respiratory 
pathogens collected from Germany in the PROTEKT study 
D. Felmingham, I. Harding, M. Mehl 
Lmdon, Cambridgeshire, UK; Berlin, D 
Objective: The emergence of multiply drug-resistant pathogens, including 
those commonly associated with respiratory tract infections (RTI), is a 
major public health concern. PROTEKT (Prospective Kesistaiit Organism 
Tracking and Epidemiology for the Ketolide Telithromycin) is a global 
longitudinal study of the antimcrobial susceptibility of bacterial pathogens 
isolated from patients with community-acquired KTI. 
Methods: Bacterial isolates koni patients with pneumonia, acute bacterial 
exacerbation of chronic bronchitis or chronic obstructive airways direase, 
sinusitis, tonsillitis/pharyngitis or otitis media were collected at 8 study 
centres in Germany and submitted to a central laboratory for analysis. To  
date (October 2000), MICs have been determined for 362 isolates ( H .  
ir!fluenzae, 103; H. parair!fluenzae, 14; M. catarrhalis, 48; S ,  aureus, 42; S.  
pyogenes, 32; S. ynetrmoniae, 123), using an NCCLS broth nllcrodilution 
method, for 26 licensed and developmental antirmcrobials. 
Results: Beta-lactamase production was rare in H. iyfluenzae isolates (1 .9%) 
but more frequent in H. paraicfluerizae isolates (14.3%); 91.7% of M. 
ratarrhafis isolates were beta-lactamase positive. A notable proportion of S. 
prieumoniae isolates were not penicillin susceptible (10.6%). Macrolide 
resistance was evident in 16.3% of S. pneumonia? and 12.5% of S. pyogeries 
isolates. The mecA gene was detected in 9.5% of community S. aweus 
isolates. Based on NCCLS breakpoints, 0% (cefixime) to 100% (telithro- 
mycin, amoxicillin/clavulanate, fluoroquinolones, linezolid, teicoplanin, 
vanconiycin) of S. pneumouiae isolates were susceptible to the antimicrobials 
tested. The table shows results for the most relevant agents for community- 
acquired KTI. Telithromycin was the most potent antipneumococcal agent 
in this analysis. In addition, all H .  ir$crenzae and M .  cafarrhalis isolates were 
susceptible to telithromycin. 
Conclusions: New agents able to overcome beta-lactam and niacrolide 
resistance are urgently needed. Telithromycin is highly effective against a 
broad spectrum of respiratory pathogens, including those that have become 
resistant to conventional therapies. Telithroniycin is therefore an excellent 
choice for the management of community-acquired RTI. 
v1 Activity of telithromycin (HMR 3647) against 
erythromycin-susceptible and resistant isolates of viridans 
streptococci isolated from blood cultures 
H. Mittermayer, C. Jebelean, A. Eocksrucker, L. Binder, M. Haditsch, 
R. Watschiiiger 
Liriz, AT 
Background: Telithromycin (HMR 3647) is a new ketolide with activity 
against Gram-positive and negative bacteria including those with acquired 
resistance to erythromycin. 
Methods: 106 strains of viridans streptococi isolated fiom blood during 
1990-98 were tested for susceptibility to telithromycin (T), erythromycin 
(E), roxithromycin (K), clarithromycin (C) and azithromycin (A) using an 
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agar dilution method. E-resistant strains (MIC > 1 ingiL) were further 
investigated for the presence of iiiacrolide resistance genes (nief, emi and 
ennTR) . 
Results: On a weight basis, T was the most active substance with a MIC50 
and a MIC90 of < 0.015 and 0.12 mg/L. The respective MIC50 and 
MlC90 for E were < 0.12 and > 4; for R < 0.12 and 8; for C < 0.06 aiid 
2; and for A < 0.06 and 2 mg/L. Twenty-four strains (22.6%) were resistant 
to E. Of these, 12 harboured mef genes, 8 enn genes and 2 ermTR genes. 
Even in strains harbouring macrolide resistance genes, telithromycin 
retained its strong activity; the MICs for those strains ranged froni < 
Conclusions: Irrespective of the presence of rnacrolide resistance genes, 
telithromycin was highly active against Austrian strains of vindans 
streptococi. Based on the in vitro data, telithromycin seems to be a very 
promsing antibiotic even in the case of erythromycin resistance. 
0.015-2 mg/L. 
p12581 In vitro activity of the ketolide antimicrobial agent 
telithromycin (HMR 3647) against Staphylococcus aureus strains 
with susceptible and inducible phenotype to macrolides 
P. Gueudet, L. Gazagne, E. Lecaillon, R. Bismuth 
Perpipan, F 
The in v i m  activity of telithromycin (HMR 3647) was compared to 14 and 
1 5-meinbered ring macrolides against 20 clinical strains of methicillin- 
susceptible Staphylococcus anreus (MSSA) and methicillin-resistant Staphylo- 
coccus anreus (MRSA) with susceptible and inducible phenotypes to 
niacrolides. Killing rates of telithromycin were detemned against these 
strains after exposure to 8 x MIC and survival counts performed at 6, 12 
and 24 h. At the same time, viable strains were measured by flow cytonietry. 
KiUing kinetic curves of susceptible strains were compared to those of 
erythromycin aiid clarithromycin. MICs of telithromycin determined by the 
agar dilution method on susceptible strains were comparable to those of 
inducible strains and were not affected by methicillin-resistance. The flow 
cytometric method is more efficient in detecting heterogeneous behaviour 
wthin a microbial population. The bactericidal effect of telithromycin was 
greater on susceptible strains than on  inducible strains and this effect waF 
greater on niethicillin-susceptible strains. The in uitru activity of telithro- 
iiiycin is interesting because of low MICs and a bactericidal effect greater 
than those of erythromycin and clarithromycin 
I P I  259 I Activity of telithromycin and oral comparators 
against 11 701 Canadian respiratory tract pathogens isolated 
from 1997 to 2000 
D. J. Hoban, L. Palatnick, B. Weshnoweski, G. G. Zhanel 
Winnipeg, CDN 
Respiratory tract infections caused by S.  pneumoniae (SPN), H. itzfluenzne 
(HI), M.  catarrhalis (MC) and S. pyogenes (GAS) are commonly treated on an 
outpahent basis with oral, empiric antibiotics. Increases in penicillin G, 
macrolide, TMP/SMX aiid fluoroquinolone resistance necessitates con- 
tinued national surveillance. In this multiyear ongoing sumelllance trial, we 
studied the activity of telithromycin and oral coinparators to 11 701 isolates 
of SPN (4054), HI (4973), MC (1512) aiid GAS (1162). Susceptibilities 
were determined following the microbroth dilution method (NCCLS, 
2000). MIC90 (pg/niL) are shown below for combined ptudy years 1997- 
2000. Telithromycin exhibited significant activity against respiratory tract 
pathogens isolated in Canada since 19'97 including multidmg resistant 
phenotypes. (Table 1) 
m s n  (3 
16 16 0.03 
1 0.25 0.M .03 
0.u 0.u 1 1  
0.12 012 0.5 L5 
1 0.a 0.12 .w 
2 0.M 0.m .03 
2 0.05 0.008 
8 0.12 003 .E 
Telithromycin is highly active against Streptococcus 
pneumoniae isolates - including resistant strains - collected 
from France in the PROTEKT study 
I> Feliiiinghaiii, I Harding 
Londurz, Cambnd&ive, UK 
Objectives: Antimicrobial resistance among respiratory tract pathogens is a 
steadly increasing global problem PROTEKT (Prospective Resistant 
Organism Tracking and Epidemiology for the Ketohde Telithioniycin) has 
been established to study the antimcrobial susceptibility of bacterial 
pathogens isolated froin patients with community-acquired respiratory tract 
infechons (CARTIs) 
Methods: As part of the worldwide study, isolates were collected at 
surveillance Ptudy centres in France from patients with pneumonia, acute 
bacterial exacerbation of chronic bronchus, acute exacerbation of chronic 
obstructive airways disease, sinusitis, tonsilhhsipharyngtis or otitis media 
MICs were detemuned at a central laboratory by an NCCLS broth 
mcrodilution method for 26 bcensed and developniental aiinnmrobials 
Results: For 69 S pnenmoniae isolates tested to date (October 2000). mode 
MIC for macrohde-hncosarmde-streptogramin class antimicrobials ranged 
from 0 015 mg/L (telithromycin) to 128 nig/L (azithromycin and 
erythromycin) Susceptibllity (% of isolates) to antimicrobials tetted, 
according to NCCLS breakpoints, was between 40 6% (penicillin) and 
100% (telithromycin, fluoroqumolones, hnezohd. teicoplanin vancomy- 
cin) The table sumnianses results for the most relevant antimicrobials for 
treatment of CARTIs The majonty of isolates had interniednte or full 
resistance to penid in  (59 4%) and/or inacrohdes (56 5%) The new 
ketohde antimicrobial tehtbromycin, whch has been developed specifically 
for the treatment of CARTIs, was one ofthe moqt active agents tested, with 
modal MIC and MIC90 of 0 015 mg/L and 0 25 nig/L, respectively, 
MIC90 values against penicillin- and macrohde-resistant iqolateq were 0 5 
mg/L All S pneurnoniae isolates were inhibited by 1 mg/L or lesc of 
teirthromycin, irrespechve of penicdhn, niacrolide or multiple resistance 
Conclusions: In France, the majonty of S pfteumontae isolates are rewtant to 
beta-lactam and macrolide anhnucrobids, however, the new ketolide 
antimicrobial telithroinycin showed excellent activity against all the isolate5 
studied, irrespective of resistance (Table 1)  
S. pneumoniae MIC (mglL) Susceptibilky 
(69 isolates) Mode MI% (%of isolates) 
Tellthromych 0 015 0 25 100 
Penicillin 2 4 40.6 
Cefaclor 1 >64 44 9 
Cefwoxime 8 8 53.6 
E~ylhthmmycin 128 >64 43 5 
Clanlhromycln 64 >32 43 5 
Azilhromycin 128 264 43.5 
Cipmloxacin 1 2 Not available 
Levofloxacin 1 1 100 
Moxifloxacin 0 12 0 25 100 
jp1261/ Clinical and bacteriological efficacy of telithromycin 
(HMR 3647) in the treatment of community-acquired RTls caused 
by S. pneumoniae with reduced susceptibility to penicillins or 
macrolides 
M. Rangaraju, B. Leroy 
Romainville, F; Bridgewater, U S A  
The global spread of resistance among respiratory pathogens presents a 
serious threat to public health. Recent results from a prospective, 
international surveillance study (PROTEKT) showed overall resistance 
among 814 isolates of S.  prieuntoniae analysed to date of 33% for penicillin 
(PEN) and > 50% for the niacrolides. All isolates of S pneumoniae were 
inhibited by 1 mgiL o r  less of the new ketolide telithroinycin (TEL; HMK 
3647), irrespective of PEN, macrolide or multiple resistance. In Phase IIIa 
chnical trials, 4142 patients with cormnunity-acquired respiratory tract 
infection (RTI) received TEL (800 mg od, n=2485) or a comparator 
antimicrobial ( n =  1657). Overall clinical cure rates were excellent among 
TEL-trea ted patients for all indications studied (community-acquired 
pneumonia 91.894, acute exacerbations of chronic bronchitis [AECB] 
88%, sinusitir 82%, tonsillopharyngitis 93.6%; per protocol analysis) and 
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compared weU with comparators. Satisfactory bacteriological outcome rates 
for TEL ranged from 80.4% (AECB) to 90.8% (sinusitis). Data !?om the 
Phase IIIa studies (plus studies in which patients received open-label TEL) 
have been used to analyse the efficacy of TEL in patients with PEN- or 
niacrolide-resistant pneumococcal RTI. Of 334 TEL-treated patients with 
S. yrietrmoriiae as sole pathogen or part of a mixed infection, 69 (20.7%) had 
strains with reduced susceptibility to PEN and/or erythromycin (ERY) 
[central laboratory determined MIC]. The clinical cure rate (53157 [93.0%]; 
per protocol) following TEL treatment in these patients was similar to the 
overall clinical cure rate for S.  pneumoniae infections in the Phase IIIa 
programme. The clinical cure rate among the 33/86 (15.1%) pooled 
comparator-treated patients with PEN- and/or ERY-resistant pneumo- 
coccal infection was much lower (7/10 [70.0%]; per protocol; P= 0.06). 
Equivalent results in the ITT analysis were 58/63 (92.1%) for TEL vs. 8/12 
(66.7%) for comparators. Bactenological eradication rates among these 
patients were also higher following TEL treatment than comparators (53157 
[93.0%] vs. 8/10 [80.0%], respectively; per protocol). A stronger trend waF 
evident in the ITT analysis: TEL 59/63 (93.7%) vs. comparators 9/13 
(69.2%). These results support the previous findings that TEL has significant 
activity against key respiratory pathogens, including resistant strains of S .  
yiieunioriiae. TEL therefore provides an effective and reliable option for the 
empirical treatment of community-acquired RTIs. 
lp12621 Telithromycin (HMR 3647) provides faster symptom 
relief than penicillin V in patients with GABHS pharyngitis: 
results from a randomized, double-blind, comparative trial 
J. Chang, J. Stenart, I. Brumpt, D. Conway 
Bridgeiuater, USA; Laval, CDN 
Objectives: Tonsillopharyngitis causes significant discomfort to patients and 
is one of the most frequent reasons for physician consultations and for time 
off work or school. Treatments need to provide rapid relief of symptoms as 
well as effective clinical and bacteriological cure. The new ketolide 
telithromycin (TEL; HMR 3647) has been developed to provide optimal 
therapy for tonsillopharyngitis, with a short-course (5-day), once-daily 
treatment reghen. The objective of these analyses was to assess time to 
resolution of symptoms in patients with tonsillopharyngitis in a randomized, 
double-blind, comparative tnal. 
Methods: Patients: (aged 15-65, t i  = 396) with group A beta-haemolytic 
streptococcus (GABHS) tonsillopharyngitis were randomised to receive 
either TEL 800 ing once daily for 5 days followed by placebo for 5 days 
( t i =  198), or penicillin (PEN) 500 nig three-times daily for 10 days 
(n= 198). Clinical and bacteriological outcomes were assessed at post- 
therapy (Days 16-2 1) and late post-therapy (Days 35-45), Symptoms (sore 
throat, erythema of posterior pharynx, oedema of posterior pharynx, 
exudate, cervical lymphadenopathy, headache) were each scored according 
to severity, on a scale of 0 (absent) to 3 (severe), before, during and at the 
end of treatment. 
Results: At the post-therapy visit, bacteriologd outcome was satisfactory 
in 79.7% and 79.3% of patients and clinical cure was achieved in 85.9% and 
85.8% of patients in the TEL ( n =  198) and PEN ( t i =  197) groups, 
respectively (modified inten-to-treat [mITT] population). Both treatments 
were well tolerated, with coinparable safety profdes. Baseline total symptom 
scores were 10.4 in the TEL group and 10.5 in the PEN group. On- 
treatment, the improvement from baseline in total symptom score was 
statistically significantly greater in the TEL group than in the PEN group (- 
7.7 vs.-7.0; P= 0.042, mITT population), indicating faster resolution of 
symptoms in the TEL group. By the end of treatment, symptom scores in 
the 2 groups were equivalent. 
Conclusions: Treatment of GABHS tonsillopharyngitis for 5 days with TEL 
provides equivalent clinical and bacteriological outcome to a 10-day course 
of PEN. The more rapid syinptom rebef achieved with TEL may suggest a 
faster return to usual activities and fewer days lost from work or school. 
Ths, together with the convenience of once-daily admmistration, makes 
TEL an attractive choice for the treatment of GABHS tonsillopharyngitis. 
(p12631 Population pharmacokinetics support the convenient 
once-daily 800 mg dosage of telithromycin in patients with 
upper and lower RTls. including special populations 
J. Pluim 
Bridpuater, USA 
Telithromycin (HMR 3647), the first ketolide antimicrobial to undergo 
clinical development, has shown efficacy sinular to standard comparators in 
the treatment of community-acquired respiratory tract infections (RTls). In 
Phase I studies in healthy volunteers, oral telithromycin 800 mg once daily 
was rapidly absorbed, reaching peak plasma concentrations (2.0 mg/L) 
withm 1-3 h. Telithromycin achieves sustained plasma levels that 
consistently exceed MICs for relevant respiratory pathogens, and also 
shows profound and prolonged penetration into inflammatory fluid, 
bronchopulmonary and tonsillar tissues and white blood cells. We report 
here pharmacokinetic data from 1590 patients treated for RTIs in the Phase 
111 clinical trial programme. This analysis combined data from 7 studies 
involving 1590 patients (mean age 42.5 years; weight 76.4 kg; male/female 
779/811) treated with telithromycin (800 mg once daily for 5 or 7-10 days) 
for CAP, acute exacerbations of chronic bronchitis, sinusitis or pharyngitis/ 
tonsillitis. Blood samples for telithromycin plasma concentration analysis 
were taken before treatment, on treatment (Days 3-5) and after treatment 
(Days 11-13). Non-parametric, noncompartmental population methods 
were used to estimate pharmacokinetic variables; logistic regression was 
used to identify covariates influencing telithromycin plasma concentrations. 
The phannacokinetic parameters of telithromycin in patients with RTIs 
were sindar to those in healthy subjects. Covariate analysis showed 
telithromycin plasma levels to be slightly increased in elderly patients (aged 
> 66 years) and in patients with decreased creatinine clearance or severe 
infection. They were slightly decreased in male patients, those with body 
surface area > 2.1 m' and in heavy smokers. None of these differences were 
clinically significant and none warranted a dose change. Among 20 
adolescents (13-1 7 years), telithromycin plasma levels were not significantly 
different to those in adults (18-60 years; 17 = 1329). The pharmacokinetics of 
telithromycin in patients with RTIs is sindar to that in normal, healthy 
subjects. No dosage adjustment is required on account of the patient's sex, 
age, body size, renal function, smoking status or infection severity. 
v1 Telithromycin (HMR 3647) does not require dosage 
adjustment in patients with renal impairment 
C. Lippert, S. Andenen, M. Sack, E. Sultan 
Kansas City, Minneapolis, Austin, USA; Romainuille, F 
Objectives: Telithromycin (HMR 3647) is the first of a new family of 
antimicrobials, the ketolides, developed for the optimal oral therapy of 
community-acquired respiratory tract infections. Telithromycin is elimi- 
nated mainly by metabolitm, with minor renal excretion of unchanged 
compound (12% of the dose). The pharmacokinetics of telithromycin was 
assessed in adult subjects (aged 18-70 years) with varying degrees of renal 
impairment in comparison to subjects with normal renal function. 
Methods: Subjects were divided into 4 groups based on 24-h creatinine 
clearance [CL(cnI] values at screening: normal function (n = 10; CL(cll) 
> 80 mL/min); mild to moderate impairment ( n =  10; CL(cR, 41-80 mL/ 
min); moderate to severe impairment (17 = 10; CL(,-,,, 11-40 mL/min); 
end-stage renal failure (ESRF) or anuria (n = 10; CL(c:ic) 10 d i m i n  or 
less). Subjects received a single oral 800 mg dose of telithromycin. 
Telithromycin concentrations in plasma and urine were determined before 
dosing and at regular intervals up to 72 h postdose. Standard pharmaco- 
kinetic parameters were calculated using noncompartmental analysis. The 
relationships between pharmacokinetic parameters (C,,,,,, AUC(,,.,,,,I, 
CL,,,,) and renal function (CL(,-n,) were assessed by linear regression. 
Pharmacokinetic parameters were compared between groups by analysis 
of vanance. 
Results: C,,.,, and AUC(L)_,,,,l were independent of renal function (P= 0.35 
and 0.57) whereas a relationship between CL(LI) and renal function was 
observed (P=O.O09). The pharmacokinetic parameters by group are given 
in the table. C,,,,,, was 1.4-fold higher in subjects with mild to severe 
impairment and AUC was 1.4-1.5-fold higher, as compared to subjects 
with normal renal function. However, the mfferences between the 4 groups 
did not reach statistical significance. When telithromycin was given 2 h after 
dialysis in patients with end stage failure, C,,,,,, and AUC were similar to 
those in the control group. Terminal elimination half-life did not increase 
markedly. Telithromycin was generally well tolerated and no  serious adverse 
events were reported. 
Conclusions: The pharmacokinetics of telithromycin is only moderately 
modified in renal impairment. These moderate changes are in good 
agreement with the minor role of renal elimination of the drug and suggest 
that no dosage adjustment is necessary in patients with renal impairment. In 
haemodialysed patients, telithromycin should be administered after the 
dialysis session. (Table 1) 
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Parametw 
AIJ+q 5s 
( r n g h h )  
Cmax 5s 
( r n g h )  
C& 5s 
i rnyh)  
Mean (%cv) pharmaeokin.tie parameters according to renal funbien (CL,,] 
Cmax (rng/L) 2 29 (38) 3 00 (26) 3 25 (43) 213141) 
14 31 (40) 16 OD (46) 10 75 (57) 
I U  86 (25) / I  41 (13) 12 58 1271 14 64 16a1 
Tman (h) 1 15 (251 130132) 1 lO(19)  I 35 (301 
CLn IUh) 5 31 136) 5 71 (29) 2 63 (58) 
'0.2 
Treatment Mean ("/. CV) Ratio (%p 90% CI 
PAR 30 rng nd 134(?9] 
PAR30rngnd+TEL800mgod 112(211 Y O ?  1OqB 
PAP 311 rnyod 
PAR 30 mg od * TEL son rng od 0 07 (20) 105 9 94 Y I 18 I 
PPR 30 mg od 
~ ~ ~ 2 0 m g n a + ~ ~ ~ 8 n n r n q o d  on31z'i 9 6 3  3 9 6  m i  
0 117 (27) 
0 04 (30)  
lp1268 Telithromycin (HMR 3647) does not interact with the 
CYP2D6 substrate paroxetine 
C. Lippert, P. T. Leese, E. Sultan 
Kansas Ciry, CJSA; Romairzville, F 
Objectives: Telithromycin (TEL; HMR 3647) is the first of a new family of 
antimicrobials, the ketolides, and has been developed to provide optimal 
treatment of community-acquired respiratory tract infectionc using a 
convenient once-daily oral dosage. TEL is primarily metabolised in the 
liver by cytochrome P450 (CUP) 3A4; however, in vitro data indicate that it 
does not form inhbitory complexes with the CYP subfamily, as has been 
reported with other antimicrobials such as the macrolider. Comparison of 
the affinity of TEL for CYP2D6 relative to that of known CYP2D6 
inhibitors also indicates a low potential for interaction. Paroxetine (PAR) is 
a substrate for CYP2D6, being almost exclusively metabolized by this 
pathway, and is a frequently used antidepressant. In ths  study, the effects of 
TEL administration on the pharmacokinetic parameters of PAR were 
determined in healthy adults. 
Methods: Twelve healthy male subjects (aged 18-45 years) took part in this 
open-label, randomized, two-period, crossover study. In each study period, 
subjects received PAR 30 mg once daily for 10 days either alone or in 
combination with TEL 800 mg daily for the last 5 days of PAR 
administration. Treatments were separated by a 2-week washout period. 
Plasma samples for determination of PAR concentrations were collected for 
up to 96 h after administration of the last dose. Standard pharmacokinetic 
parameters at steady state were calculated by noncompartmental analysis. 
Comparisons between treatments were made for PAR pharmacokinetic 
parameters by analysis of variance, from which 90% confidence intervals 
(CI) for the ratio of neatment means (TEL alone being the reference) were 
obtained. Similarity between treatments was defined if the 90% CI fell 
within 70-143%. 
Results: The plasma pharmacokinetic parameters for PAR with (I? = 10) and 
without TEL (12 = 10) are shown in the table. Co-ahnistration ofTEL and 
PAR had no  significant effect on the phamiacokinetics of PAR. The 90% 
CI for the ratios of the adjusted mean AUC and Cmax values at steady state 
vs. PAR alone were within the bioequivalence range (70-143%). Both 
treatments were well tolerated. 
Conclusions: Co-administration of TEL 800 ing once daily with PAR 30 
mg once daily has no significant effect on the pharmacokinetic profile of 
PAR. This lack of interaction between TEL and PAR indicates a low 
potential for clinically relevant pharmacokinetic interactions with other 
CYP2D6 substrates. (Table 1) 
Linezolid 
*Ratio of adjusted rnbans (PAR aioneFAR + E L )  
1 PI269 I Effect of gastric pH on the bioavailability of 
telithromycin (HMR 3647) 
C. Lippert, P. T. Leese, E. Sultan 
Kansas Ciry, USA; Romainoille, F 
Objectives: Telithromycin (HMR 3647) is a new ketolide antimicrobial 
developed for the treatment of community-acquired respiratory tract 
infections. In this three-way, open-label, randomized, crossover study, the 
effectc of intragastric pH altering agents on the pharmacokinetic parameters 
of telithromycin were determined. 
Methods: Fifteen healthy male subjects (18-45 years) received a single 800 
mg oral dose of telithromycin administered alone, or either 1 h after a 300- 
mg oral dose of ranitidine [Zantac"] or 15 *n after a 20-1nL oral dose of 
magnesium aluminium hydroxide [Maalox ] suspension. Subjects then 
underwent 2 hrther treatments, each separated by a 1-week washout period, 
such that each subject had taken all 3 treatment combinations by the end of the 
study. Plasma concentrations of telithromycin were determined before dosing 
and at regular intervals up to 48 h postdose. Pharmacokinetic parameters were 
calculated by noncompartmental analsysis. Comparisons of telithromycin 
pharmacokinetic parameters between treatments were made by analpis of 
variance, &om which 90% coddence intervals (CI) for the ratio of treamient 
means (telithromycin alone being the reference) were obtained. Similarity 
between treatments was defined if the 90% CI fell within 70-143%. 
Results: Telithromycin plasma pharmacokinetic parameters following 
administration of a single dose alone or with Zantac" or Maalox" are 
shown in the table. The 90% confidence intervals (CI) for the ratios of C,,,,,, 
and AUC means for telithromycin + Zantac" vs. telithromycin alone or 
telithromycin + Maalox" vs. telithromycin alone fell within the 
bioequivalence range of 70-143%. All treatments were well tolerated. 
Conclusions: Co-admi*nistration of telithromycin with the gastnc pH 
altering agents Zantac or Maalox' does not affect the bioavailability of 
telithromycin. (Table 1) 
6 61 [34] 
71 Comparative ecological effects of linezolid and 
amoxicillinlclavulanic acid on the normal intestinal microflora 
H. Lode, N. van der Hoh, S. Ziege, K. Bomer, E. Sillerstrom, E. Wahlund, 
C. E. Nord 
Berlin, D; Storkhobn, S 
Adnunistration of antibiotics may cause deleterious effects on the n o d  
microflora such as decreased colonization resistance, overgrowth of 
potential pathogens and emergence of antibiotic resistance. Since antibiotic 
induced ecological disturbances in the normal microflora cannot be 
predicted from in vivo data, ecological studies should be performed in the 
development of new antibiotics. 
Objectives: To study the effect on the normal intestinal microflora of 
linezolid, a new synthetic antibacterial agent belonging to the class 
oxazolidinones, and compare it with that of amoxicillin/clavulanic acid in 
a randomized, cross-over open label investigation. 
Methods: Twelve healthy subjects (6 females and 6 males) 18-40 years of 
age participated in the m a l .  Linezolid was given in tablets of 600 mg bid for 
7 days and amoxicillin/clavulanic acid in tablets of 1000 mg od for 7 days. 
The wash-out period was 4 weeks between the administration of the two 
antibacterial agents. Faecal samples were collected prior to administration 
(day -2 and -l), during administration (day 4 and 8) and after withdrawal of 
administration (day 14, 21 and 35) for microbiological analyses. The samples 
were diluted in prereduced media and inoculated aerobically and 
anaerobically on nonselective and selective media. The different colony 
types were identified to genus level by morphological, biochemical and 
molecular analyses. 
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Results: During the adniinistration of linezolid, enterococci in the intestinal 
aerobic microflora were markedly suppressed while Klebsiella strains 
increased. In the anaerobic microflora, the numbers of bifidobacteria, 
lactobacilli, clostridia and bacteroides decreased strongly while no impact on 
the other anaerobic bacteria was observed. The microflora was normalized 
in all volunteers after 35 days. Amoxic&n/clavulanic acid administration 
caused increased numbers of enterococci and Esilzerichia coli strains in the 
aerobic intestinal microflora while bifidobacteria, lactobacilli and clostridia 
decreased significantly. Clostridiuni d~@iin'l strains were recovered from three 
volunteers. At the last visit, the intestinal microflora of the volunteers had 
returned to normal levels. 
Conclusions: The administranon of linezolid had mainly an ecological impact 
on the Grani-positive bacteria which may be a more favourable profile 
compared to anioxicilliii/clavulanic acid in temis of selecnve decontamination 
and resistance development in the intestinal human nlicroflora. 
v1 Comparative in vitro antimicrobial activity of 
linezolid against Gram-positive clinical isolates from hospitals in 
Kuwait 
KUUMif, K W T  
0. A. Phillips, E. E.  Udo, A. A. M. Ali 
Objectiye of this study was to evaluate the antibacterial activities oflinezolid 
[Zyvox ] in vitro in comparison with vancomycin against Gram-positive 
clinical isolates from four hospitals in Kuwait collected between 1994 and 
1999. 
Methods: Antibacterial activity was determined by measuring the minimum 
inhibitory concentration (MIC) of both antibiotics by agar dilution method. 
A total of 15 1 strains of Gram-positive clinical isolates were utilized for this 
study. The isolates consisted of methicillin-resistant S. aureus (MRSA, 40), 
methicillin-susceptible S. airreus (MSSA, lo), methicillin-resistant coagu- 
lase-negative staphylococci (MR-CNS, 40) and methicillin-susceptible 
coagulase-negative staphylococci (MS-CNS, lo), penicillin-resistant strepto- 
coccus pneumoiiiae (PRSP, 21), vancomycin-sensitive enterococci (Non- 
VRE, 20) and vancomycin-resistant enterococci &WE, 10). These 
organisms were isolated from the throat, wounds, urine and blood. 
Susceptibility testing was carried out by agar dilution method, with medium 
containing dilutions of antibiotics ranging from 0.25 to 512 mg/L. The 
nlinimum inhibitory concentration (MIC, mg/L) was defined as the lowest 
concentration of drug that completely inhibited growth of the organism. 
Results: For Linezolid, MIC ranges of 0.5-4 mg/L for MRSA, and 1-4 mg/ 
L for MR-CNS, and for Vancomycin, MIC ranges of 0 . 5 4  mg/L for 
MRSA, and 0.5-1 nig/L for MR-CNS were obtained. PRSP demonstrated 
MIC ranges of 0.5-1.0 mg/L and 0.254.5 mg/L for linezolid and 
vancomycin, respectively. Against Non-VRE strains MIC ranges of 1.0-2.0 
mg/L and 0 .54 .0  mg/L were obtained for linezolid and vancomycin, 
respectively. However, against VRE strains (lo), linezolid showed MlC of 
2.0 mg/L compared to an MIC range of 8-1024 mg/L for vancomycin. 
Conclusion: Overall, the irt vitro data demonstrated that Linezolid was very 
active against all Staphylococcal, Non-VRE and PRSP strains and its 
activity was comparable to that of Vanconiycin. Against VRE, linezolid 
clearly demonstrated superior antimicrobial activity over vancomycin. 
Linezolid will be a viable alternative in treatment of Gram-positive 
infections that are becoming increasingly intractable. 
Activity of linezolid against important Gram-positive 
cocci isolated from infection sites in Poland 
K. Szczypa, K. Nowak, K. Betlejewska, T. Kamifiska, W. Hryniewicz 
Warsaw, PL 
Objectives: The aim of the study was to investigate the in oitro activity of 
linezolid against Gram-positive cocci isolated from patients suffering from 
the community or hospital acquired pneumonia, complicated and 
uncomplicated skin and soft tissue infections and bacteraemia. The 
susceptibility to linezolid was compared with the susceptibility to other 
antibiotics. 
Methods: The following clinical isolates of Gram-positive cocci were 
tested niethicillin-resistant and methicillin-susceptible staphylococci 
( i i  = 120), penicillin-resistant and penicillin susceptible pneumococci 
(11 = 1 00), vancomycin-resistant and vancomycin-susceptible enterococci 
( r z  = SO), erythromycin-resistant and erythromycin-susceptible Streptococcus 
pyogenes. Strains were collected from 26 centres in Poland. The minimum 
inhibitory concentrations (MlCs) was determined by agar dilution method 
for staphylococcal and enterococcal strains and for pneumococcal and S.  
pyogenes strains by broth microdilution method according to the guidelines 
established by the NCCLS. The strains were subsequently tested for their 
susceptibility to linezolid, vancomycin, teicoplanin and quinupristin/ 
dalfopristin. Linezolid was tested at the concentrations of 0.5, 1, 2, 4, 8 
and 16 mg/L. 
Results: MICs of linezolid for all MRSA strains were in the range of 0.5-2 
mg/L equal to or slightly lower than MlCs for vancomycin, teicoplanin and 
quinupristin/dalfopristin. Vancomycn-resistant entrococci (VKE) of either 
the VanA or VanB phenotypes were inhibited by linezolid with MIC range 
of 0.5-2 mg/L. All clinical isolates of streptococci including penicillin- 
resistant pneumococci and erythromycin-resistant S. pyogenes were 
susceptible to linezolid with MIC range of 0.12-1 mg/L. 
Conclusions: Based on our in vitro results linezolid appears to be a promising 
new antimicrobial agent for the treatment of Gram-positive infections. 
v1 Multicentre evaluation of linezolid antimicrobial 
activity in Europe 
C. Ballow, R. Jones, D. Biedenbach, A. Bolmstroni 
Clarence, North Liberty, USA; Solna, S 
Background Fortyone medical centres 6-om 13 countries in Europe provided 
well-controlled surveillance data for this international study designed to evaluate 
the iii viho spectrum and activity of linezolid, a new oxazolidinone 
Methods: Participants tested the susceptibility of 125 clinical strains of 
enterococcal and staphylococcal species against 13 drugs using reference 
broth microdilution trays or the disk diffusion method. Streptococcal species 
( n  =25) were tested against 6 drugs using E-test (AB Biodisk). Q C  testing 
was conducted using NCCLS recommended strains and verification of 
resistance to linezolid and select other agents was performed by regonal and 
international monitors. 
Results: A total of 5598 strains horn throughout Europe (91 %) compliance) 
indicated that oxacillin resistance occurred in 35.2% and 61.8% of S.  aureus 
and CONS strains, respectively. Vancomycin resistance was reported in 
0.6% and 3.0% of E.-faecalis and E..fapcium, respectively. Penicillin resistance 
occurred in 25.1% of S. pneumoniae; 4.9%) high-level. The MIC90 for 
linezolid was 1 mg/mL for streptococci and 2 mg/mL for enterococci and 
staphylococci. Using the US FDA-recommended susceptible breakpoints 
for linezolid, there were no confimied reports of linezolid resistance (MlC, 
> 8 mg/ id) .  The Occurrence of linezolid MlCs was unirnodal and vaned 
between 0.25 and 1 mg/mL for streptococci (> 90% of isolates), 1-2 mg/ 
mL for staphylococci (> 90%) and enterococci (> 95%). There were no 
differences in linezolid susceptibility in the vancomycin-, oxacillin-, or 
penicdlin-resistant subsets of strains. 
Conclusions: Compared to the North American (NA) component of this 
study, there was marginally less methicillin resistance aniong staphylococci in 
Europe, but substantially less vancomycin resistance among E.fae&m (Europe; 
3.0% vs. NA; 63.4%). While the occurrence ofpenicillin-resistant S. pneumoniae 
in Europe and NA was sinular (25.1 vs. 29.7%), the recovery of high-level 
penicillin-resistant strains was nearly 3-fold higher in NA (4.9 vs. 13.2%). Only 
linezolid was univetsally active against all tested Gran-posinve species. 
v1 In vitro activity of linezolid against coagulase 
negative staphylococci 
M. A. John, C.  Pletch, Z .  Hussain 
Loizdori, CDN 
Introduction: CONS are the third most common bactenal cause of 
nosocon~al infections, particularly in association with the presence of 
foreign bodies. Treatment of these infections often requires intravenous 
vancomycin, as up to two thirds of isolates are resistant to methicillin. 
Linezolid is a new antibacterial of the oxazolidine class that is available in 
bioequivalent oral and intravenous fonnulations and shows good activity 
against Gram-positive bacteria, includmg methicillin resistant strains of 
staphylococci. 
Objectives: To determine the in vitro activity of linezolid against speciated 
isolates of CoNS. 
Methods: A total of 721 nonduplicate isolates of CoNS were collected at 
the University and Victoria canipuses of the London Health Sciences 
Centre, London, Ontario. All isolates were speciated using conventional 
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biochemical tests and cellular fatty acid profiles determined by HPLC. The 
presence or absence of the mec A gene was determined using the polymerase 
chain reaction (PCR). All told 16 species were represented amongst the isolates; 
Staphylococcus epidernzidis (186), S. hominis (76), S. lugderwnsis (51), S. sn'uri urea 
(49). S. schl+vi (45), S. ivarnei (43), S. xylosis (41), S. simulans (39), S. 
haemolyticus (39), S. saprophytims (38), S. caprae (34), S. cohnii (31), S. capitir (29), 
S. auriculans (5) .  S. equortrm (3) and S. lentus (2). MIC's were determined for 
these isolates against linezolid, erythromycin, clindaniycin, oxacillin and 
vancomycin, using the standard agar dilution methodology recommended by 
the National Committee for C h c a l  Laboratory Standarch (NCCLS). 
Results: Overall, Linezolid demonstrated good activity, with only six 
isolates (4 S. cohnii, 1 S.  homiriis and 1 S.  xylorus showing resistance (MIC > 
4 pg/mL). S. haemolyticus and S. caprae were most susceptible with an MIC 
90 of 1 pg/mL. S. hominis, S .  luxdeiieizsis, S. capitis, S. iuarneri and S. simulans 
had an MIC 90 of 2 pg/mL. All the remaining species had an MIC 90 of 4 
pg/mL. In uitro data suggests that Linezolid will be a useful agent for the 
treatment of infections due to CONS. 
/p12741 Linezolid levels in pancreatic abscess 
G. Gopal Kao, A. Steiger 
hIldo17, UK 
Aim: To determine the levels of Linezolid in pancreatic abscess. 
Methods: 2 patients developed pancreatic abscesses caused by methicillin 
resistant Staphylococcus aureus (MRSA). Drains were inserted into the 
abscesses to allow drainage of the pus. Patients were treated with Linezolid 
(600 mg BD for 3 days and 1 week, respectively). Pus from the pancreatic 
abscess and serum levels (predose and postdose) of Linezolid were measured 
by HPLC at Antibiotic Reference Laboratory, Bnstol, UK. 
Results: Patient 1 (3 days' treatment): Post dose serum level increased 
progressively from 6.1 mg/L to 29.0 mg/L. Post dose pancreatic abscess 
levels increased progressively from 0.3 mg/L to 31.6 mg/L. The serum 
predose levels also increased progressively from 0 mg/L to 28 mg/L. The 
pancreatic abscess pre dose levels increased from 0 mg/L to 31.6 mg/L. 
Patient 2 (7 days' treatment): The post dose serum levels increased from 
13.5 mg/L to 17.7 mg/L on 7th day. The corresponding pancreatic abscess 
levels also increased from 3.4 mg/L to 11 mg/L. 
Conclusions: Linezolid is distributed satisfactorily to the pancreas at 
levels higher than MIC for common Gram positive bacteria including 
MRSA. There is progressive accumulation of drug both in the serum and 
pancreatic abscess. 
vl Linezolid activity against resistant Gram-positive 
bacteria in vitro and in vivo 
L. Nielsen, J. A. L. Kurtzhals, C. B. Christiansen, N. Frimodt-Moller 
Copenhagen S, DK 
Objective: To evaluate the in uitro and in uiuo activity of linezolid against G 
+ cocci and the pharmacokinetics of linezolid in nice. 
Materials and methods: Linezolid in uitro MIC was determined against 110 
strains of G + cocci with different resistance patterns by: 1. 
Agar dilution: Linezolid in conc. from 0.063 to 16 mg/L in Mueller- 
Hinton BBL I1 (MH) 5% whole sheep blood. An inoculum of 10E4 
CFU/spot was used. Plates were incubated at 35 "C and read the next day. 
The lowest conc. of linezolid with growth of < 10 CFU/spot was defined 
as the MIC. 2. E-test on Danish blood agar. In uiuo phannacokinetics: One 
mg of linezolid in 0.5 mL saline (equivalent to 1/2 human dose) was 
injected S.C. in 18 CF1 mice at time zero. Blood was drawn from 3 mice at 
time %, 1, 1 %, 2 and 3 h, respectively. Linezolid conc. in serum was 
determined by bioassay on M H  plate floated with S. epidermidis. t1,2 was 
calculated from the serum conc. curve. Time-kdl kinetics within 5 h in uitro 
of linezolid in conc. 0-16 mg/L (0-8 x MIC) was determined against S. 
aureus # 2371 (MIC 2.0) in beef broth. Time-kill kinetics in a mouse 
model: S. aureus # 2371 (0.5 mL of 5 x 10' CFU/mL in 5% mucine in 
saline) was inoculated in peritoneum in 18 CF1 mice at time - 1 h. At time 
zero 1 mg of linezolid was injected S.C. in 9 of the mice. Blood and 
peritoneal fluid were drawn from 3 mice in each group at time 1, 3 and 5 h 
and CFU was detemined. Concentration of linezolid in serum and 
peritoneal fluid was determined as described earlier. 
Results: The MIC for linezolid ranged between 0.5 and 4 mg/L for all 
groups of bacteria with a median of 2 mg/L. The MRSA and VRE had 
MIC similar to the rest of the bacteria. MIC values deduced from the E-test 
were lower than those found using the agar dilution method. T,,,,,, was 12 
mg/L. t l ,*  was approximately 2.5 h. Time-kill kinetics in uitro showed from 
1.5 to 3 log reduction of S. aureus CFU at time 5 h compared to untreated 
control. In the mouse model we found a 2 log reduction of S. oureus CFU at 
time 5 h both in blood and peritoneal fluid compared to untreated control. 
Conclusion: Linezolid is promising for treatment of infections with 
methicillin and van-coniycin resistant gram positive cocci. 
lp12761 Effect of linezolid treatment on S. pneumoniae- 
induced pneumonia in brown Norway rats 
I. Richards, J. Justen, K. Shull, C. Clay, J. Bley, S. Fidler, M. Kuo, 
K .  Zielinsh, M. Shattuck, K. Kolbasa 
Kalamazoo, USA 
Objective: Linezolid is a novel oxazolidinone antibiotic with demonstrated 
activity against gram positive, penicillin-susceptible and penicillin-resistant, 
methicillin-resistant and vancomycin-resistant bacteria. We investigated the 
potency and efficacy of linezolid in a Brown Norway rat tnodel of S .  
przeumoniae-induced pneumonia using two linezolid dosing protocols. 
Methods: Anaesthetized Brown Norway rats were infected by direct 
instillation of S.  pneumoniae, ATCC#6305, 6-8 x 106 cfulrat, into the 
trachea via the oropharynx. The MICs for linezolid for this strain were 
0.25-1 .0 pg/nL. Infected animals were treated with the oxazolidinone, 
linezolid, using two different experimental protocols. 
Experiment a: Dosing with linezolid 1.875, 3.75, 7.5, 15.0 or 30 nig/kg PO 
BID (n=6)  was initiated 24 h after infection and continued for 5 
consecutive days. 
Experiment b Animals were dosed with linezolid 30 mg/kg at 24 h, 36 h 
and 48 h after infection, and killed at 50 h, when blood and lung tissues were 
harvested for detem7lnation of bacterial load and linezolid concentrations. 
Results: In both stuhes, severe pneumonia was confirmed within 24 h by 
X-rays and histopathological assessment of lung tissue damage. Bacteria were also 
recovered &om lungs and blood at 24 h after mcheal instillation of S. pnatinorriae. 
Death occurred w i h  48-72 h in the majority of mfected rats. In Experiment A, 
m o d t y  was 100% in vehicle-ueated mfected rats. Survival was 100% in rats 
treated with 30 mg/kg linezolid BID and 83% in aninds treated with 15 n d k g  
linezolid BID. The ED50 (dose inhibiting niottality by 50%) was 6.0 mg/kg 
(BID). In Experiment B, both blood and lung hsSueS were culture-negative 
following this treatment regimen; levels of linezolid were 19.6 2.6 and 
6.5 f 1.7 microgcam/mL, rcspectively, at 2 hours after the final dose. 
Conclusions: Linezolid proved potent and efficacious in treating S. 
pneumowiae-induced pneumonia in rats. 
v1 Linezolid in vitro and in vivo against three 
Streptococcus pneumoniae strains and one Staphylococcus 
aureus strain 
J. D. Knudsen, N.  Frimodt-Mder, F. Espersen 
Copenhagen, DK 
Introduction: Infections caused by Gram-positive bacteria are worldwide 
emerging problems due to resistance to various antibiotics. New antibiotics, 
especially drugs with h g h  bioavailabilities, are highly warranted. Linezolid, 
an oxazolidinone antibiotic is a new and promising drug with known 
activity towards staphylococci and streptococci among other Gram- 
positives, and without cross-resistance to other antibiotics. Linezolid was 
studied in-vitro and in the mouse peritonitis model with the purpose of 
comparing the activity of linezolid with the activity of other drugs fonnerly 
tested in our laboratory using strains with different susceptibilities. 
Materials and methods: MICs and MBCs in beef broth and human serum 
were determined using the microdilution method. Time-kdl curves were 
performed three times for each of the four strains using the concentrations 
16, 8, 4, 2, 1, 0.5 mg/L. In the mouse peritonitis model, lethally challenged 
mice in groups of five were treated with various doses of linezolid, and the 
50% effective doses, ED50s were calculated. The in uiuo bacterial killing 
effects were studied using doses providing serum-concentrations above the 
concentrations giving maximum killing effect in uitro. 
Results: The MICs and MBCs for all four strains: 1-2 mg/L and 4 nig/L, 
respectively. The in-vitro killing was bacteriostatic for all strains tested, with 
maximum effect achieved at the concentrations 2-4 nig/L. The linezolid- 
ED50 for the staphylococcus was 1.3 mg/kg, and as potent as vancomycin 
and teicoplanin (ED50s 3.8 mg/kg and 2.9 mg/kg, respectively, both 
having MICs of 1 mg/L). The linezolid-ED50 for three pneumococci were 
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9.5 mg/kg, 12.4 mg/kg and 16.1 mg/kg, respectively, and as potent as 
various betalactam antibiotics when using strains with MIC in the level of 
1-2 mg/L in the same model (betalactam-EDSOs, range 1 4 0  mg/kg). The 
in uiuo killing effect was similar to the killing effect in uitro. 
Conclusion: Linezolid was found as effective as traditionally used antibiotics 
against one staphylococcus and three pneumococcal strains when tested in 
v i fro  and in the mouse peritonitis model. 
lp1278/ Systemic and intracerebral infections of mice with 
Listeria monocyfogenes successfully treated with linezolid 
T. Nichterlein, M. Callapina, M. Kretschmar, H. Hof 
Mannheim, D 
Linezolid is an oxazolidinone derivative which is active mostly against 
Grampositive bacteria. In this work its activity against the facultatively 
intracellular bacterium Lisren'a monocytogenes was examined in vitro, in tissue 
culture and in animal models of systemic and intracerebral infection and 
compared with ampicillin which is the antibiotic of choice for treatment of 
listeriosis. All strains of L. monocytogenes were susceptible to linezolid, with 
MIC values detemined by E-test ranging fiom 0.38 to 1.5 mg/L which is 
beyond the preliminary breakpoint of the substance. Linezolid was 
bacteriostatic against listeriae since up to 64 times the MIC did not lull 
the bacteria in 24 h. Linezolid was also bacteriostatic in infected tissue 
culture cells. In animal models of systemic and intracerebral infections, 
linezolid was able to inhibit bacterial growth but was less effective than 
ampicillin given in the same dosage of 2 mg/animal injected intraper- 
itoneally every 12 h. In conclusion, linezolid might be useful for the 
treatment of infections with L. monocytogenes also in humans when 
ampicillin may not be used. 
vl Preliminary microbiology results from the European 
Expanded Access Program with linezolid given intravenously or 
orally in patients with multidrug resistant Gram-positive infections 
G. Pema, M. L. Ferrari, R. Piadena 
Newiano, I 
Linezolid is the first in a new class of antibiotics, the oxazolidinones, 
developed for the treatment of Gram-positive infections. Previous studies 
showed linezolid to be effective against both sensitive and resistant Gram- 
positive organisms. Ths open-label, noncomparative study was performed 
to provide adequate antibiotic therapy to patients suffering from severe 
infections due to Gram-positive organisms resistant to or intolerant of 
standard treatment. Linezolid was given intravenously or orally to adult 
patients at the daily dose of 600 mg bid. Treatment duration was in the range of 
1-127 days (mean duration 20 days). Follow-up was perfomied up to 4 weeks 
afier the end of treamient. Prelinlinary data on 314 clinically evaluable patients are 
here presented. One-hundred-49 patients were also microbiologically evaluable. 
In one-hundred-54 ofthe 174 assessments available (88.5%) there was evidence of 
inicro success (eradication or coloniution); tdure was reported in 6.4% of cases. 
Breakdown for +oses is as follows: skin/sofi ussue iufection (71 patients 
assessed nlicro success 88.3%) hospital or commwty-acquired pneumonia (10 
patients assessed; micro success 81.8%), bacteraemia of unknown origin (16 
pahents assessed; micro success loo%), u""ary tract infections (3 patients asesed; 
micro succes 66.7%), osteomyelitis (6 patients asessed micro success 85.7%), 
endocarditis (2 patients artessed; micro success 50%) central nervous system 
infections (1 patient assessed; micro success 10%) and other infections (24 patients 
assessed; micro success lOG'??). Common pathogens mcluded Staphylocmus aums,  
niethich-resistant Sraphylororcus airreus, Stqforom5 epidmidis, and enterococci. 
Conclusion: Linezolid is an effective therapy for treating patients with 
multiresistant Gran-positive infections or patients unsuitable to tolerate 
standard treatment. 
/p12801 Linezolid treatment of surgical infections: pathogen 
outcome of results from two phase 111 multinational clinical trials 
J Brucs, S Duvall, M McConnell-Mamn 
Kalantazoo, USA 
Introduction: Linezolid (LZD) is the first oxazohdmone to be developed for 
the treatment of skin and soft tissue (SST) infecuons 
Methods: Data from 2 studies evaluating patients with complicated SST 
infections is presented; 1 study compared LZD to oxacilliddicloxacillin; 
and 1 study compared LZD to vancomycin in the treatment of SST 
infections due to mehcillin-resistant Stuphylucoccus spp. Treatment was 7- 
28 days with follow-up 12-21 days post-treatment. Results are presented for 
patients diagnosed with surgical infections and abscesses. 
Results: 1279 patients were treated, 640 LZD and 639 comparator 
recipients. Duration of therapy was comparable between treatment groups 
in each study, mean range 11 .O-13.4 days. Pathogens were isolated in 54 
patients diagnosed with infected wounds with, 93 with skin abscesses, and 
89 with infected surgical incisions. The clinical cure rate in clinically 
evaluable (CE) patients was 83.1% (49/59) for LZD and 77.5% (55/71) for 
comparator recipients. The nlicrobiological success rate in microbiologically 
evaluable (ME) patients was 78% (46/59) for LZD recipients verses 72.2% 
(44/58) for comparator recipients. The microbiological success by pathogen 
was Staphylococcus a u w s  80.9% (38/47) in the LZD-treated group and 
69.5% (41/59) in the comparator-treated group, Sfreptooms agalactiae 
100.0% in both treatment groups, and Srreptococcuspyogenes 72.7% (8/11) in 
the LZD-treated group and 81.8% (9/11) in the comparator-treated group. 
Conclusions: Linezolid is an effective new therapy for treating surgical 
wound infections caused by Gram-positive organisms. 
Ip12811 Linezolid in the treatment of community-acquired 
pneumonia caused by Haemophilus influenzae 
S. Cammarata, K. Hempsall, T. Oliphant, B. Hafkin 
Kalamazoo, USA 
Background Linezolid, an oxazolidinone, has been tested in clinical trials 
for the treatment of community-acquired pneumonia (CAP) including 
infections caused by Haemophilus ir@uenzae. Most strains of H. i$uenzae are 
intermediate in their susceptibility to linezolid. 
Methods: Three studies have been conducted to determine the efficacy of 
linezolid in the treatment of CAP, including patients with H .  it$umnZae 
pneumonia. One trial was a dose escalation study while two trials treated 
patients with either linezolid 600 mg orally or i.v. q12 h vs. cefiriaxone 1 g 
i.v. or cefpodoxime 200 mg PO q12 h. Patients received treatment for 7-14 
days. Follow-up occurred at 15-28 days after end of therapy. 
Results: In these multinational studies, of the 1485 patients enrolled, 1077 
were clinically evaluable (CE). On average the patients received treatment 
for 12 days. The clinical outcome for the CE patients at FU showed 
linezolid to be equivalent to cephalosporins in the treatment of CAP with 
clinical cures (patients with indetemunate and missing outcomes excluded) 
in 519/575 (90.3%) linezolid patients vs. 4121460 (89.6%) cephalosporin 
patients. Of the CE patients 45 had pneumonia caused by H. ir$uenzue. The 
microbiologic outcome for these patients again showed linezolid to be 
equivalent to cephalosporin with pathogen eradication in 17/ 19 (89.5%) vs. 
23/26 (88.5%) cephalosporin patients. 
Conclusion: Despite MICs in the intermediate range, most cases of H. 
influenzae pneumonia appear to be cured by linezolid. While linezolid is not 
the primary choice for known cases of H. i$uerzzae pneumonia, these 
results provide further assurance that empiric use of linezolid in suspected 
Grain-positive pneumonia is warranted. 
p12821 Linezolid in the treatment of patients with 
nosocomial pneumonia: European results 
S. Caiiunarata, E. Rubinstein, K. Hempsall, T. Oliphant, B. Ha&in 
Kalamazoo, USA; E l  Hashomer, IL 
Background: Linezolid, the first in a new class of antibacterials, the 
oxazolidinones, has activity against gram positive organisms, both 
susceptible and resistant. This trial evaluated linezolid, in combination with 
aztreonam, for the treatment of nosocomial pneumonia (NP). 
Methods: This double blinded, randomized study in patients with NP 
compared the efficacy of linezolid (LZD) 600 mg IV q12 h against vancomycin 
(vanco) 1 g i.v. q12 h. All patients received coverage for Gram negative 
organisins with aztreonam 1-2 g i.v. every 8 h. Patients received treatment for 7- 
21 days. Follow-up occurred at 12-28 days after end of therapy. 
Results: A total of 623 patients were treated in this global trial, with 154 
clinically evaluable (CE) patients from Europe. In these European patients, 
LZD clinically cured 75.0% (54/72) vs. 67.5% (54/80) of the vanco treated 
patients (excluding patients with missing and indeterminate outcomes). Ths 
was comparable to outcomes seen in the global population. For those CE 
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patients with a baseline pathogen, LZD provided microbiological success in 
66.7% (20/30) of patients vs. success in 48.8% (20/41) of the vanco treated 
patients. Adverse events were generally mild to moderate in nature, with 
diarrhoea being the most common drug-related event. 
Conclusion: Linezolid with concomitant Gram-negative coverage is an 
effective, well-tolerated agent in treatment of NP. 
/p1283] Hetero-GISA from a case of nosocomial pneumonia 
finally successfully treated with linezolid 
W. Witte, F. Fischer 
Wernigerode, Burghausen, D 
A patient (male, 43 years, alcoholic) admitted to hospital B. and previously 
treated in a neurosurgical centre developed a nosoconlial pneumonia 
(clinical criteria: fever, ARDS). Besides P.  aenrginosa, a MRSA was isolated 
from tracheal secretion. Treatment with vancomycin (2 x 1 g, 11 days) was 
not successful. The S. auveus isolated Gom tracheal secretion exhibited an 
elevated MIC (4 mg/L) when tested by the E-test with high inoculum 
(McFarland 2.0) which was confirmed when retested Gom a fresh overnight 
culture fiom tracheal secretion and applying vancomycin screen test and 
population analysis. The hetero-GISA phenotype revealed as instable in 
further subcultivation. Further resistance traits were PEN, OXA (mecA), 
GEN, ERY, CLI, CIP, MFL, RAM. The strain was susceptible to 
quinupristin/dalfopristin (MIC 0.5 mg/L) and to linezolid (MIC 2.0 mg/L). 
The genomic fingerprint was dzerent from those of epidemic MRSA 
disseminated in Germany and from the few GISA which became known in 
Germany until now. Further treatment of the patient with quinupristin/ 
dalfopristin (3 x 650 mg, 12 days) remained unsuccessful. However, the 
infection finally was cured by linezolid (2 x 600 mg, 19 days). This case 
underlines the need of identification and report of MRSA with reduced 
susceptibility to glycopeptides as an important prerequisite for treatment of 
GISA infections with an appropriate drug such as linezolid. 
Faropenem 
lp12841 Comparison of linezolid and flucloxacillin sodium in 
the treatment of complicated skin infections: a safety analysis 
M. L. Ferrari 
Nerviano, I 
Introduction: Linezolid is the first in a new class of antibiotics, the 
oxazolidinones, developed for the treatment of both sensitive and resistant 
Gram positive infections. This double-blind trial compared the efficacy of 
intravenous (i.v.) and oral linezolid 600 mg BID to flucloxacdhn sodium i.v. 
2 g every 6 h and oral 500 mg every 6 h in hospitalized adults with 
complicated Skin/Soft Tissue (SST) infections. Patients were treated for 7- 
21 days; follow-up (F-U) was 12-21 days after treatment completion. 
Results: 183 patients (96 linezolid, 87 flucloxacillin) were treated. The most 
common diagnoses were cellulitis, erysipelas and infected surgical incision in 
both groups. Common pathogens included Staphylococcus aureus, Streptococrus 
pyogenes, Sheyfococcw agalactiae, and Enterococrusfaecalis. A total of 47.9% (46/96) 
of the patients in the linezolid treatment group and 50.6% (44187) of the 
patients in the flucloxacillin treatment group had 1 or more adverse events. The 
most common (> 5%) study-emergent adverse events in the linezolid group 
were nausea and diarrhoea, while rash, headache and thrombophlebitis were 
the study-emergent adverse events that occurred in > 5% of the flucloxacillin 
group. Serious adverse even& were reported for 4.2% (4196) of patient? in the 
linezolid treatment group and 6.9% (6/87) of the patients in the flucloxacdlm 
treatment group. There was only 1 serious adverse event considered to be 
related to study medication, and it occurred in the flucloxacillin group. One 
patient in the linezolid treatment group and 1 in the flucloxacillin treatment 
group died during the study. There were no dSerences between treatment 
groups in the percentages of patients with substantially abnormal chemistry 
laboratory values; more patients in the flucloxacdhn treatment group than in the 
linezolid treatment group had substantially abnormally high platelet count and 
low RBC count. Conversely, more patients in the linezolid treatment group 
had substantially abnormal high WBC counts. 
Conclusion: Linezolid is a safe and well tolerated new therapy for treating 
complicated skin and soft tissue infections. 
Target affinity and beta-lactamase stability of 
faropenem in Staphylococcus aureus, Escherichia coli, Proteus 
vulgaris and Serratia marcescens 
A. DalhoK T. Nasu 
Wuppertal, D; Tokyo, ] 
Objectives: Faropenem (FAR) is a novel, broad-spectrum antimicrobial 
with activity against Gram-positive and Gram-negative bacteria. Determi- 
nants of the in vitro activity of beta-lactam antibiotics include affinity to 
penicillin-binding proteins (PBPs) and beta-lactamase (BLA) stability. In 
this study, the binding affinity to various PBPs and BLA stability of FAR 
was evaluated. 
Methods: PBP binding affinities were determined by competitive 14C- 
penicillin G displacement. BLA preparations were obtained from sonicated 
late exponential growth phase bacteria. Irreversible inactivation of BLA by 
FAR was assayed by a dilution method, while BLA hydrolysis of FAR was 
assayed by a spectrophotometric method (substrate [cephaloridine or 
bezylpenicillin] = 100 PM). 
Results: In Staphylococclrs aureur, FAR exhibited high binding affinity to 
PBP3, followed by PBP1 and PBP2. In Escherichia coli, FAR showed the 
highest affinity for PBP2, followed by PBPIA, lB, 3 and 4. In Proteus 
uulgmis, binding was highest to PBP4, followed by PBPlA, 2 and 3.  In 
Serratia marcescens, FAR bound preferentially to PBP2 and 4. FAR 
irreversibly and nearly completely inhibited type Va BLA, while irreversibly 
inactivating type 111 BLA by 40% and type l c  BLA by 30%. FAR was highly 
stable against hydrolysis by a number ofBLAs, including TEM-1, extended 
qpectrum TEM-3 and S. aureus BLA. 
Conclusions: FAR shows h g h  binding affinity to PBPs ftom Gram-positive 
as well as Gram-negative bacteria. FAR irreversibly inactivated type Va and 
111 BLA, which are encoded by R-plasmids and are major drug resistance 
factors in Gram-negative bacteria. FAR'S ill vitro profile includes excellent 
stabhty against BLA hydrolysis (by both Gram-negative and Gram-positive 
bacteria), high PBP target specificity, and irreversible BLA inactivation. 
v1 Faropenem demonstrates greater beta-lactamase 
stability and lower emergence of resistance compared to 
cephalosporins 
A. Dalhoff, T. Nasu, K. Okamoto 
Wuppertal, D; Osaka, ] 
Objective: Faropenem (FAR) is a novel, broad spectrum antimicrobial with 
activity against Gram-positive and negative bacteria. This study compared 
FAR to cephalosporins (CEPHs) and imipenem with respect to p-lactamase 
@LA)-stability and emergence of resistance to S. aureus and E. coli. 
Methods: BLA-stability was studied using enzyme preparations from 
sonicated/centrifuged 24 h cultures of E .  coli, E.  cloacae, P.  vulgaris, P. rettgeri, 
K.  pneumoniae, S. aureus, and B .  jagilis grown in the presence of 20 mg/L 
anipican or cephaloridine to induce penicillinase or cephalosporinase, 
respectively. Substrate hydrolysis was quantitated spectrophotometrically. 
Multi-step acquisition of resistance was promoted by growing bacteria in 
broth containing 2-fold ddutions of antibiotic over 10 cycles. Aliquots from 
test tubes with visible growth provided the inoculum for the next series 
of dilutions. 
Results: FAR, as well as other CEPHs tested, was highly stable to 
penicillinase derived from S. aureus and E. coli. However. E. coli- and P. 
vulgari-derived cephalosporinase hydrolysed cephalondine, cefaclor and 
cefotiam considerably, whereas FAR was hghly stable. FAR was highly 
stable against hydrolysis by various BLAs prepared from four B.-fragilis strains 
and the rate of FAR hydrolysis by metallo-BLA was 5-times lower than that 
for imipenem. Additionally, the acquisition of resistant S. aureus strains was 
less pronounced for FAR compared to other agents tested. MlCs rose 8-fold 
after the 10th sub-MIC exposure, while MICs rose 16, 31 and 512-fold for 
cefixime, cefazolin and cefaclor, respectively. E. coli, shifts in MICs were 
moderate for all the agents tested. 
Conclusion: Faropenem is characterized by pronounced BLA-stability 
compared to other CEPHs and imipenem. Furthermore, a lower propensity 
for resistance development with FAR as compared to CEPHs was observed. 
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lp12871 /n vitro activity of faropenem 
I). Felmingham, M. J. Kobbins, I. Mathias, N. Tsa, I. Baker, A. Dalhoff 
Londuri, UK; Wuppertal, D 
Objectives: Faropenem daloxate is a novel broad-spectrum antimicrobial 
with Gram-positive and -negative coverage. 
Methods: In this study we have determined the iri uitro activity of 
faropenem against a wide range of Gram-posinve and Gram-negative 
bacterial isolates using the NCCLS agar ddution method. 
Results: Faropenem was highly active against important respiratory tract 
pathogens, including: penicillin-susceptible, -intermediate and -resistant 
Streptococcus prteumorriae (MIC90 0.008, 0.25 and 0.5 mg/L, respectively), p- 
lactamase positive and negative Haemophilus i @ m m ~ e  (MIC90 1 mg/L) and 
similar p-lactam susceptibility phenotypes of Moravella catawhalis (MIC90 
0.12-0.5 mg/L). Lancefield A, B, C and G serotypes of Streptococcus spp. 
(MIC90 0.034.06 nig/L), Neisseria spp. (MIC90 0.06 mg/L) and 
Corynebactenuni diphthetiae (MIC90 0.12 mg/L) were very susceptible to 
faropenem. Methicdhn-susceptible Staphylococcus aureus (MIC90 0.12 mg/L) 
were very susceptible to firopenem whilst niethicillin-resistant strains were 
not (MIC90 > 64 mg/L). With the exception of Serratia marcesrens (MIC90 
16 mg/L), faropenem was active against species of Eriterobacteriareae: 
Esrherickia coli (MIC90 1 mg/L), Klebsiella pneumoniae (MIC90 0.5 mg/L), 
Citrobacter.fieundii (MIC90 2 mg/L), Eiiterobacter cloacae (MIC90 4 mg/L), 
Salnioriella spp. and Shigella spp. (MIC90 0.5 mg/L), and Yersinia eriterocolitira 
(MIC90 1 mg/L). Faropenem was generally less active than imipenem 
against the Eriterobarferiareae but was sindarly, or slightly more active against 
Proreus spp. (MIC90 1 mg/L), Morgariella morganii (MIC90 2 mg/L) and 
Prouideririo spp. (MIC90 1 mg/L). Faropenem was poorly active against 
Pseudoonionas aeruzinosa and Stenotrophomonar maltophilia (MIC90 > 64 mg/ 
L). Faropenem showed potent activity against a range of anaerobic species 
(MIC90 0.254.5 nig/L) but was less active against C. dficile (MIC90 
4 mg/L). 
Conclusions: These results indicate a potential therapeutic role for 
faropenem in various infections, particularly those of the respiratory tract 
acquired in the community, if its phatmacokinetic/toxicity/side-effect 
profile is favourable. 
v1 In vitro activity of faropenem against 340 isolates of 
antibiotic-resistant Streptococcus pneumoniae 
F -J Schmtz, M Boos, S Mayer, D Milatowc, A C Fluit 
Dusseldo$ D, Utrechf, NL 
Objective: The increasing worldwde incidence of multiply antibiotic 
resistant Streptococcus prreumorziae hay created a need for new, effechve, oral 
agent7 mhich can be used for therapy of adult and paediatnc pneumococcal 
infechons Faropenem (FAR) is a novel investigational antimcrobial with a 
broad cpectruin of activity 
Methods: To evaluate its achvity against genetically charactenzed 
pneumococci with resistance to erythromycin and clindamycm (ernB- 
phenotype, t i  = 166), resistance only to erythromycm (me&-phenotype, 
ri  = 66), resistance to tetracychne (tetM-phenotype, rr = 290), resistance to 
levofloxacin (LEVO) (mutanons in gyrA and parC, combined with efflux 
activity via pmr, n = lo), and resistance to tnmethopnn-sulfamethoxazole 
(SXT) (mutations in sulA, ti = 34), an in uifro study was performed using 
NCCLS rmcrobroth ddution methodology to compare the activity of FAR 
with the acnvity of 26 other oral and/or parented antimcrobial agents 
against recent European chmcal isolates 
Results: FAR exhlbited an excellent in uitro activity with the following 
values for MIC50, MIC90, and range (ug/mL) see Table 
Conclusions: Based on these data, FAR was one of the most potent agents. 
The highest MIC value observed was 0.5 pg/nL. FAR therefore warrants 
further investigation as an antipneumococcal agent. 
I PI289 1 Faropenem susceptibility of isolates of Streptococcus 
pneumoniae, Haemophilus influenzae and Moraxella catarrhalis 
collected from centres in Great Britain and Ireland during the 
1999-2000 cold season 
J. Shackcloth, C. J. Thomson, D. Felmingham 
London, Newbury, UK 
Objectives: Faropenem daloxate is a novel broad-spectrum antimicrobial 
with Gram-positive and -negative coverage. 
Methods: In this study we have determined the iir uitro activity of 
faropenem against isolates of Streprororrus pneumoniae, Haemophilus ir$uenzae 
and Moraxeila rntan.haiis collected from 20 centres spread geographically 
throughout Great Britain (England, Scotland and Wales) and Ireland (N. 
Ireland and Eire) during the 1999-2000 cold season. Isolates were sent to a 
central testing laboratory (GR Micro Ltd, London, UK) where they were 
re-identified and the minimum inhibitory concentration (MIC) of 
faropenem for each isolate determined using the British Society for 
Antimicrobial Chemotherapy @SAC) agar dilution method. The medium 
used was Isosensitest Agar (Oxoid, Basingstoke, UK) containing a final 
concentration of 5% horse blood and, for Haemophihs i@emae only, 20 
mg/L nicotinamide adenine dinucleotide. An inoculum of approximately 
10 000 CFU/1 pL spot was delivered to the surface of the agar plates using a 
niultipoint inoculator. Following inoculation, plates were incubated for 18- 
20 h in air, enriched to 6% C 0 2  for isolates of S. pneumoniae and H. itzfluerrzae. 
Results: Faropenem was highly active against isolates of S. pneumoniae from 
Great Britain (MIC50 0.008; MIC90 0.03; range 0.004-1 mg/L) and 
Ireland (MIC50 0.008; MIC90 0.5; range 0.004-0.5 mg/L). The higher 
MIC90 for isolates from Ireland indicates a greater prevalence of strains with 
reduced susceptibility to penicillin. Faropenem also demonstrated good 
activity against isolates of H. influenzae (Great Britain: MIC5O 0.5, MIC90 
1; range 0.03-16 mg/L; Ireland: MIC50 0.5, MIC90 2; range 0.25-4 mg/L) 
and M. ratarrhalis (Great Britain: MIC50 0.06, MIC90 0.06; range 0.015-0.5 
mg/L; Ireland: MIC50 0.06, MIC90 0.06; range 0.15-0.06 mg/L). 
Conclusions: These results indicate a potential clinical role for faropenem in 
the treatment of various respiratory tract infections caused by these species, 
particularly those acquired in the community 
v1 Comparative in vitro activity of faropenem against 
Streptococcus pneumoniae, Moraxella catarrhalis and 
Hemophilus influenzae isolated in the UK 
F Walsh, S Amyes 
Edinburgh, UK 
Objective: Faropenem (FAR) is a novel broad spectrum antimcrobial and 
potential alternative for the treatment of respiratory infections The in uitro 
achvity of FAR agamst Strepturocrus pneumorziae, Hemophrlus influenzae and 
Moraxella ratawhalis was compared to a macrohde, a beta-lactamase inhibitor 
and two other fluoroquinolones 
Methods: The agar d h t i o n  method was used to determme the 
suscepnbihty of Streptoroccus pneumotiine, Hemophilus iriflnerizae and Moraxella 
ratawhalis to vanous annnucrobial agents (see below) The bactena were 
collected from various regons of the UK The Streptorarcus prieumoriiae (total 
r7=100) were collected from Edmburgh and Leeds, the Hemophilus 
ir$ueiizae (total n =  100) from Edinburgh and Glasgow and the Maraxella 
rutawhalis (total n = 100) from Edmburgh, Lee& and Wales The iri uitro tests 
were camed out in ar incubators The final inoculum for Streptococcus 
pneumoniae was 10 000 cfu per spot whereas Hemophilus inf7uerwae and 
Moraxella catavhahs were both 10 000 Lfu (see Table) 
Results: Streptococcus ptieumorirae was the most susceptible of the three specie5 
to FAR m t h  an MIC90 of 0 25 mg/L For Moraxella catarrhalis and 
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Hernophilux ir@wrae FAR has MIC90 of 0.5 and 1 mg/L, respectively. 
They are both one dilution higher than amoxiclav. For Hemophilus 
ir$uerizae clarithroniycin was poorly active, whereas the quinolones 
exhibited strong activity. Levofloxacin and ciprotloxacin were moderately 
active against S. pneumorziae. 
Conclusions: FAR has low MICYO values for all three bacteria and since 
yuinolones can not be used for treatment of paedatric infections or in 
pregnant women, FAR could be a suitable alternative for treatment of 
respiratory infections caused by Streptococcus ptieumoriiae, Hemophilus 
inflrtenzae or Moraxella cutunhalis, in contrast to beta-lactam. 
v1 Activity of faropenem for 146 fluoroquinolone- 
resistant bacteria 
L. J .  V. Piddock, M. A. Webber 
Birmitigham, UK 
Objectives: To determine the activity of faropenem (FAR) for 146 
fluoroquinolone-resistant bacteria (MIC of ciprofloxacin > = 2 pg/mL) 
with known mechanisms of fluoroquinolone resistance, and compare the 
data for FAR with that of ciprofloxacin (CIP) and imipenem (IMI). 
Methods: The MIC of each agent was determined by the agar doubling 
dilution method. The MIC of IMI was determined for all strains with an 
MIC of FAR > =0.5 pg/mL. 
Results: FAR was very active against E .  coli with an MIC50 of 0.125 pg/ 
mL, and an MIC90 of 0.25 pg/mL. FAR was also very active against S. 
pneumorriae with an MIC50 of < 0.0625 pg/mL and an MIC90 of 0.5 pg/ 
niL. The FAR MIC50 for S. aureus was 0.5 pg/mL and the MIC90 was 16 
pg/nL (8/35 strains required > = 1 pg/mL for inhibition). Enterococci, 
collected from a variety of sources, were resistant to FAR with an MIC50 of 
16 kg/mL and an MIC90 of > 32 pg/nL. Likewise, FAR was less active 
against B.fragilis with an MIC50 of 0.5 pg/mL and an MIC90 of 8 pg/mL 
13/26 strains required > = 1 pg/mL for inhibition). Notably, all bacterial 
strains with an MIC of > 0.5 pg/mL of FAR were also less susceptible 
to 1M1. 
Conclusions: Faropenem is active against certain Gran-negative and - 
positive bacteria (i.e. E. coli and S. prieirrnoiiiae) despite demonstrated 
fluoroyuinolone resistance. 
Susceptibility of multiresistant Fnterobacteriaceae to 
faropenem 
Munich, Wupperfal, D 
A. Bauemfeind, 1. Schneider, A. Dalhoff 
Objectives: The choice of antibiotics for the treatment of infections caused 
by Enferoharferiareae ie remarkably restricted, r.g. by resistance due to the 
production of extended spectrum beta-lactamases (ESBL). Beta-lactam 
antmcrobials stable to these enzymes are of particular importance. 
Faropenem daloxate is a novel ester pro-drug of faropenem sodium, a 
broad-spectrum antimicrobial. This study evaluated the activity of 
faropenem against multiresistant, ESBL-producing Enterobaderiacme in 
comparison with other compounds including major oral beta-lactams. 
Methods: Strains producing various types of ESBL or AmpC type beta- 
lactamases were analysed for their MICs by agar dilution. Clinical isolates 
(n  = 60) of E. coli, K. pneumoniae, K. oxytoca, S. typhimurium, S. paratyphi B, 
P. rnirabilis, M .  moganii, and C. jkwdi  were included. They produced 
either TEM- (one of 17 types), SHV- (one of six types), CTX-M- (one of 
three types), PER- (one of two types) or AmpC- (one of four types) type 
beta-lactamases. 
Results: MICs offaropeuem ranged between 0.5 and 16 mg/L. MIC50s and 
MIC90s were, respectively, 2 and 8 mg/L for faropenem, 16 and 64 mg/L 
for amoxicillin/clavulanate, 32 and 256 mg/L for cefditoren, 128 and 
= 2048 mg/L for cefuroxime, 256 and 1024 mg/L for cefaclor, 128 and 
512 mg/L for cefpodoxime, 32 and 512 mg/L for cefixime and 4 and 512 
mg/L for ceftibuten. Thus, faropenem was the most active drug among 
those investigated. 
Conclusion: Faropenem daloxate may offer an interesting alternative for the 
oral treatment of infections caused by some ESBL or AmpC type producing 
Enterobacferiareae. 
Synergistic bactericidal effect of faropenem with 
host defence mechanisms 
A. Dalho& T. Nasu, K. Okainoto 
Wuppertal, D; Osaka, 1 
Objectives: Antibacterial agents can interact with the host-parasite 
relationship in a variety of ways. Certain antimcrobials can interfere with 
adherence, colonization and dissemination of bacterial. Antibiotics may 
synergize with host defence mechanisms and could potentially affect 
phagocytic activity. Additionally, by altering the morphology and structure 
of bacterial surfaces, antibiotics could promote complement-mediated lysis, 
phagocytosis and/or enhance the susceptibility of bacteria to intraleukocytic 
killing. Therefore, this study was designed to evaluate the morphological 
changes in E.  coIi triggered by faropenem (FAR) and its interaction with 
complement and cultured macrophages. 
Methods: E. ruli K12 was exposed to FAR at 1/8 x , 114 x , 1 x , 2 x and 
4 x MIC. Changes in morphology were evaluated over 4 h of exposure 
using phase-contrast microscopy. The interaction with guinea-pig coniple- 
ment was studied by adding 4% complement to approx. 51og E. cufi NIHJ 
JC-2 and/or FAR (7.5 X MIC = 0.75 mg/L). Bacteria were cultivated at 37 
"C with shaking and viable counts were quantitated at 1, 3 and 5 h. The 
interaction with macrophages was studied by adding 6.71og E. coli to 
adherent macrophages (50-fold the number of macrophages) plus 1/1&1/2 
MIC of FAR. After incubation for 5 h, cells were washed, fixed, stained 
(Giemsa), and examined under a light microscope. 
Results: Exposure of E .  o l i  to 1 / 8  x MIC induced a change in cell shape 
from the nomial rod-shaped form to a spherical form in a time-dependent 
manner. After exposure of E. mli to 1 X MIC for 2 h, bulging-shaped E. coli 
cells were observed and after 4 h of exposure cell-lysis was demonstrated. In 
the presence of 4 x  MIC, spheroplast-like forms and cell lysis were 
observed after only 2 h. The bactericidal activity observed with FAR (7.5 x 
MIC) was increased approx. 10-fold by the addition of complement. 
Likewise, phagocytosis was enhanced by the effects of FAR. Phagocytosed 
E. roli caused a lysis of macrophages in the absence of FAR; however, in the 
presence of FAR (118 X to 1/2 X MIC), more E .  roii were phagocytosed 
hut no lysis of macrophages was observed. 
Conclusions: Faropenem works synergistically with complement and makes 
E.  coli more vulnerable to phagocytic killing by altering the morphology and 
structure of the bacterial surface; faropenem also protects phagocytes &om 
lysis. Thus, faropenem interacts synergistically with host defence mechanisnls. 
In vitro pharmacodynamic activity of faropenem 
against 5. pneumoniae and H. influenzae 
A. Dalhoff, M. Groth, M. Heidtmann, A. Schmidt 
Wuppertal, D 
Objectives: To compare the activity of faropenem (FAR) to anioxicillin 
(AMX) using an in uifro model simulating human phamiacokinetics. 
Method: A modified one-compartment model. was used to mimic human 
serum kinetics of FAR following single oral doses of 150, 300, and 500 mg 
and AMX following single oral doses of 250 and 500 mg. The following 
parameters were simulated for the respective doses of FAR: C,,,,,, = 6, 12, 
and24mg/L; t ,,,,,,, =1.5h;  t l , z=0 .9handAMX:C ,,,, ,,=5.5aiid 11 mg/L; 
t,,,,,y=2 h; t,/2=1.2 h. Two strains of S. pneumoriiae (MICs=0.125 mg/L 
and 1.0 mg/L) and H. influertzae (MICs = 0.25 mg/L and 1 .0 mg/L), equally 
susceptible to FAR and AMX, were tested. 
Results: FAR exerted a dose- and concentration-dependent antibacterial 
effect against both S. pneumoniae strains, reducing their viable counts below 
the Limit ot detection within 5 h. The onset of bactericidal activity of FAR was 
immediate, whereas viable counts only decreased after a lag-period of 1 h 
following addition of AMX. FAR also exerted a concenmation-depeiident effect 
against H. i~jkerizae. Viable counts were reduced by 3 log units within 3-4 h 
only by the 300 and 500 mg FAR regimens and by both AMX regimens; 
however, bacteria re-grew under all experimental conditions after 4 h. Sinitdating 
a twice-daily dosing schedule, FAR and AMX both caused a continuous 
reduction of viable H. i?lfumrae counts during a 24-h exposure period. 
Conclusion: FAR exhibits dose- and concentration-dependent bactericidal 
activity against S. pneumoniae and H. influenzae. Compared to AMX, 
bactericidal activity of FAR was more pronounced against S.  ptieumoniae but 
equivalent against H. irrfluenzae. Twice-daily regimens of either FAR or 
AMX were equally effective against H .  irguenzae. These data suggest that 
faropenem may be dosed hid for the treatment of community RTIs. 
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w1 Influence of concomitant administration of 
probenecid on the safety, tolerability, and pharmacokinetics of a 
single dose of faropenem daloxate 
B. Voith, U. Schuehly, T. Ruf, U. Voigt, G. Wensing, J. Kuhlmann 
Wuppedal, D 
Objectives: Faropenem daloxate (FD) is a novel broad-spectrum anti- 
microbial with Gram-positive and -negative coverage. Faropenem (FAR), 
the active constituent of FD, is predominantly eliminated via the renal 
route. In preclinical studies in dogs, the conconitant adniinisttation of FD 
together with probenecid, an inhibitor of the anion transport carrier at the 
renal tubules, decreased the excretion of FAR thus leading to elevated 
plasma concentrations of FAR and longer half-lives. The objective of t h s  
study was to investigate the intluence of probenecid on the safety, 
tolerability and pharmacokinetics of FAR in humans. 
Methods: The study was conducted in a nonblinded, randormzed, 2-way 
cross over design. FD was given as a single dose corresponding to 300 mg 
FAR. Probenecid was given as total dose of 1500 mg divided in three 
administrations of 500 mg, starting 1 h before FD and repeated 3 and 7 h 
thereafter. Eleven male healthy subjects, ranging in age from 25 to 37 years, 
participated in the study. Safety and tolerability were evaluated by 
monitoring adverse events, vital signs, ECG, and clinical laboratory values. 
Twenty-four hour PK profiles were taken and urine was collected for 
24 h. Samples were analysed for FAR by a validated HPLC method with 
UV detection. 
Results: FD was well tolerated, with no relevant changes in vital s igns ,  
ECG, or laboratory parameters. As expected, AUC as well as t 1 / 2  was 
approximately doubled with concomitant treatment of probenecid, while 
C,,,,,, was only slightly elevated. The amount of dose excreted renally was 
reduced by about 40% (see Table) 
Conclusions: Ac the temnal  half-life of FAR is only 2 3 h when gwen 
together with probenecid, no accumulation of FAR is expected after 
multiple bid dosing of FD As the exposition seen after concomtant 
administration is far below plasma concentrations proven safe in previous 
studles, no safety issue anses Therefore, it can be concluded that this drug 
interaction is not clinically relevant and no dosage adjustment is necessary 
for FD when gwen together with probenecid 
lp12961 Influence of a pre- and cotreatment with MaaloxR 70 
on safety, tolerability, and pharmacokinetics of a single dose of 
faropenem daloxate 
B. Voith, U. Schuehly, T. Ruf, U. Voigt, J. Kuhlmann 
Wuppertal, D 
Objectives: Faropenem daloxate (FD) is a novel broad-spectrum anti- 
microbial. The hydrolysis of FD to faropenem (FAR), the active constituent 
of FD, is pH-dependent. This raises the question whether the concomitant 
administration of FD with drugs altering the intragastric pH will result in a 
clinically relevant drug interaction. The objective of this study was to 
investigate the safety, tolerability and pharmacokinetics of FAR after 
concomitant administration of FD with Maalox 70 R . 
Methods: The study was conducted in a nonblinded, randomized, 3-way 
cross over design. FD was given in a single dose corresponding to 300 mg of 
FAR (treatment A). Maalox 70 was given as 10 mL suspension, containing 
600 mg magnesium hydroxide and 900 mg aluminium oxide, either as one 
single dose five nunutes before intake of FD (treatment B) or four times a 
day after the main meals stamng 48 h before administration of FD and 
continued until the evening of the FD administration, but given 2 h after 
the FD dose (treatment C) 11 healthy male subjects, 25-43 years of age, 
participated in the study Safety and tolerabihty were evaluated by 
momtonng adverse events, vital signs, ECG and chmcal laboratory values 
Pharmacokinetics were analysed m 24 h PK plasma profiles and collecnng 
unne by a validated HPLC method with UV detection 
Results: FD was well tolerated, mth  no relevant changes in vital signs, 
ECG, and laboratory parameters When administered mrectly together with 
Maalox 70, AUC and C,,,,,, of FAR were reduced by 20 and 4096, 
respectwely This effect was much legs pronounced when the two drugs are 
gwen 2 h apart (reduchon by 8 and 25%, respecnvely), although the Maalox 
70 treatment wac p e n  2 days before and 1 day after the FD single dose in 
that treatment The half-hfe of FAR was not changed in any of the 
treatmentc, and the T > MIC was slightly higher in both treatment5 with 
Maalox 70 compared to FD alone 
Conclusions: The concormtant administration of FD together w t h  Maalox 
70 ylelded moderately lower AUC and C max values for FAR As this effect 
was predormnantly seen with direct coadmnistration and not dunng a 
Maalox 70 multiple dose treatment, it is most probably due to absorption 
effects between FD and Maalox 70 and not due to intragastnc pH changes 
However, as T > MIC is not reduced in either of the cotreatments, this 
effect is not regarded to be chmcally relevant (Table 1) 
v1 Investigation of a potential pharmacokinetic 
interaetion between furosemide and faropenem daloxate after 
concomitant single-dose administration 
U. Schuehly, B. Voith, U .  Voigr, J. Kuhlmann, G. Wensing 
Wuppertal, D 
Objectives: Faropenem daloxate (FD) is a novel broad-spectrum anti- 
microbial with Gram-positive and -negative coverage. Faropenem (FAR), 
the active constituent of FD, is predominantly renally eliminated, both by 
glomerular filtration and active tubular secretion. As furosenlide (Fu) is 
mainly excreted by tubular secretion as well, an’investigation was performed 
to evaluate whether the concomitant administration of FD and Fu results in 
a pharmacokinetic interaction. 
Methods: The study was conducted in a nonblinded, randomized, 3-way 
cross over design. Single doses of FD corresponding to 300 mg FAR, and 
single doses of 40 mg Fu were given either alone or conconitantly. 11 
healthy male subjects, 22-46 years of age, participated in the study. Safety 
and tolerability were evaluated by monitoring adverse events, vital signs, 
ECG and clinical laboratory values including profiles of plasma electrolytes 
and excretion of urinary proteins. Amount of urine excreted and 
electrolytes in 24 h collecting urine were analysed. FAR 24 h plasma and 
urine pharmacokinetics were analysed using a validated HPLC method with 
UV detection. 
Results: FD was well tolerated, with no relevant changes in vital signs, ECG 
or laboratory parameters. The amount of urine and electrolytes excreted was 
elevated after Fu intake, with no difference between Fu alone and Fu-FAR 
concomitant administration. AUC and Cmax as well as the amount of dose 
excreted renally were nearly unchanged for both drugs when comparing 
single and concomitant treatment. Terminal half-life was also the same for 
both drugs in both treatments (see Table) 
Conclusions: The concomtant administration of FD and Fu dld not alter 
the pharmacokinetics of either drug in a clinically relevant manner The 
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amount of urine and the excretion of electrolytes after Fu treatment was not 
changed after concomitant ahnis t ra t ion of Fu together with FD. 
Therefore, it can be concluded that both drugs could be given together 
without need of dose adjustment. 
lp12981 Effect of multiple oral doses of faropenem daloxate 
on the normal faecal and oral flora 
U. Schuehly, M. Koch, W. R. Heizmann, B. Voith, J. Kuhlmann, 
G. Wensing 
Wuppertal, Cottingen, D 
Objectives: Faropenem daloxate (FD) is a novel, broad-spectrum 
antimicrobial. This trial evaluated the effect of multiple oral doses of FD 
on both oral and faecal flora in healthy male volunteers. 
Methods: In a double-blind, randomized, group comparison design, FD 
was given in doses of 300 mg or 600 mg or placebo twice daily for 8 days to 
groups of 6 healthy volunteers. Swabs of the oropharynx and faeces samples 
were collected pnor to first administration, at the end of the administration 
period, and one and two weeks after the end of the administration period. 
Samples were cultured under aerobic and anaerobic conditions, and 
bacterial species were quantified and identified. Toxins A and B were 
identified for C. drfticile. 
Results: In both FD dosages, the changes in the oropharyngeal microflora 
were minor. The evaluation of the faeces samples revealed an increase of 
enterococci, mostly E.faecium and a reduction of Clostridiurn spp. C. dificile 
was undetectable in all but one volunteer. This one volunteer was in the 
300 mg dosing group and exlbited C. drflcile and C. dificile toxin before 
treatment and two weeks after the end of treatment, but not during 
treatment. The subject had no complaints of diarrhoea throughout the 
study. Candida spp. &d not show an overgrowth during treatment. N o  
other relevant changes in endogenous flora or overgrowth of P. aerugiiiosa or 
potentially multiresistant Enferobacferiaceae (e.g. Eiiterobacter spp., Senatia spp. 
or Klebriella spp.) were seen. The total count of anaerobic bactena did not 
change in any of the treatment groups. 
Conclusions: Multiple dose FD administration resulted in only minimal 
changes in normal oropharyngeal and intestinal microflora. 
Cephalosporins 
/n vitro evaluation of ceftriaxone activity against 
recent Gram-positive clinical isolates: results from the TSN 
database-USA, 1996-2000 
J. A. Karlowsky, M. E. Jones, D. C. Mayfield, C. Thornsbeny, D. F. Sahm 
Henidoiz, USA; Uirecht, NL; Brenfwood, USA 
Objective: Ceftriaxone (CFTX) is a broad-spectrum cephalosporin that has 
been an important component of hospital formularies worldwide for the last 
16 years; therefore, up-to-date monitoring of its activity is important. This 
study evaluated the current activity of CFTX against commonly 
encountered Gram-positive (GP) isolates from the United States. 
Methods: CFTX data from the TSN Database-USA were analysed and 
compared with the susceptibility profiles of other commonly prescribed 
beta-lactams for S. pneumoniae (SP) (all specimen sources) and blood isolates 
of S. pyogenes (GAS), group B streptococci (GBS), viridans group 
streptococci (VGS), and methicillin-susceptible S. aureur (MSSA). Only 
one result per pahent per idectious episode was permitted for analysis. 
Results were interpreted using NCCLS breakpoint criteria pemnent to each 
year. It is important to note that the oral amoxicillin-clavulanate (A-C) 
NCCLS resistance breakpoint increased to > = 8/4 m g / d  (M100-S10) in 
2000 from > =2/1 m g / d  (M100-S9) in 1999. 
Results: SP results for all specimen sources are summarized below, where n 
is the total number of results available for each year and percentageR is the 
percent of n, resistant to each beta-lactam. For SP, CFTX resistance rates 
were much lower than those of the other beta-lactams and have remained 
essentially unchanged over the last 5 years, in spite of increases in penicdlm 
(15.6% to 23.3%) and cefuroxime (27.5% to 38.3%) resistance. Among 
blood isolates, no GAS with resistance to CFTX ( n  = 244) or penicillin 
(n=706), or isolates of GBS resistant to CFTX (n=374) or penicillin 
(ri = 1975), were identified. CFTX resistance among blood isolates of VGS 
increased slightly (range, 3.4-10.3%) (R = 2755), while resistance among 
MSSA (range, 0.1-0.9Y/o; n=4693) remained < 1%. 
Conclusions: CFTX was the most potent beta-lactam against common GP 
pathogens studied, and it has demonstrated consistent activity over the last 5 
years. CFTX remains a viable and valuable therapeutic resource for treating 
infections caused by susceptible GP cocci. (Table 1) 
1996 1991 1998 1999 2000 
AntmucroLaI n %R N %R N %R n %R N 4' 
pSnrcllhn 2,201 136 3,534 188 5,332 16 I 7,661 m3 6,003 n 3  
Coflrlaione 1,228 6 3  1,843 6 5  3,069 5 1 5,063 3 6  4,210 5 4  
Cefiuoxrme 711 n I 969 284 1,065 31 8 1,684 4 4  1.401 383 
AC 431 155 493 181 - 619 1 8 1  147 T22 701 I1 3 
v1 /n vitm evaluation of ceftriaxone activity against 
recent Gram-negative clinical isolates: results from the TSN 
database-USA, 1996-2000 
D. C. Mayfield, J. A. Karlowsky, D. F. Sahm, C. Thomsberry, M. E. Jones 
Hcmdoti, Virginia, Bnnficmod, Tennessee, USA; Utrctht, NL 
Objective: Ceftriaxone (CFTX) was one of the first potent broad-spectrum 
cephalosporins approved for the treatment of gram-negative infections. 
Given its ongoing use, continued monitoring of CFTX activity is 
important. We present current surveillance data to detemGne its activity 
against important Gram-negative pathogens. 
Methods: CFTX data from the TSN Database-USA (TSN) were analysed 
and compared with the susceptibility profiles of other beta-lactams, 
ciprofloxacin, and trimethoprim-sulfamethoxazole (SXT) for common 
species of Enterobacteriacae and H. iizfluerrzae. TSN is an electronic repository 
for isolate-specific antimicrobial test results and demographic information, 
reported daily to MRL by clinical laboratories throughout the United 
States. Only one result per patient, per infectious episode, was permitted for 
analysis. Results were interpreted using NCCLS breakpoint criteria 
pertinent to each year. 
Results: Isolate results for Enferobacferiarae are summarized below, where n is 
the total number of results available for each species and percentages is the 
percent of n, susceptible to each antimicrobial. CFTX remains highly active 
(%S range, 93.1-99.6%) against all species of Enferobartetiacae studied. CFTX 
was as active as cefepime against E. coli and K. pneumoiiiae, and was the most 
active agent against P. mirabilis. Susceptibility to CFTX remained essentially 
unchanged when the database was trended by year for E. mli (range, 99.3- 
99.6%), K. pneumoniae (94.7-96.2%), K. oxytoca (92.5-93.6%), and P. 
mirabilis (99.5-99.6%). All H. influenzae tested ( n =  7040) over the same 
period were susceptible to CFTX. CFTX was as active as, or more active 
than, ciprofloxacin against all species studied, and was consistently more 
active than SXT. 
Conclusion: Despite 16 years of use, CFTX has retained potent activity 
against the most commonly encountered enteric species (i.e. E. roli, K. 
pneumoniae, K. oxytora, P. mirabilis) and H .  ii&iizae. CFTX continues to 
demonstrate good activity as a first-line agent for the treatment of infections 
arising from important Gram-negative pathogens. (Table 1) 
E ~ $ 4  Kpp-5 K P mrpbj$ 
hhmlcrdbld p %S n %S n %S g %S 
C e h o n e  425.372 994 105,745 95 8 14,647 93 1 60.332 99 6 
Ceftandune 324,646 98 6 91,486 92 5 13,786 Y 5  I 44,161 99 0 
Cefepune 109,374 994 34,342 971 4,593 970 17,214 Y78 
Piperadlm-taobactam 171,145 96 0 47,299 91 0 6,919 88 8 25,039 98 0 
Cipt oflozam 569,383- 97 1- 136,627 94 0 19,067 952 74,018 908 
SXT 675,226 821 159,861 881 22,201 914 88,384 812 
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Klebsiella spp. (409) 02 Z7  3,7 1,2 
Shigella spp. (738) 1.7 03 1 ,& 0.3 
1 
Activity of cefotaxime, ceftazidime and cefepime 
against ESBL producing Enterobacteriaceae 
B. Rybak, K. Przedpelska, E. Dziemaszkiewicz, L. Naumiuk, A. Samet 
Gdansk, PL 
Objectives: The aim of the study was to conipare in vitro activity of 
cefotaxime (CTX), cefiazidime (CAZ) and cefepinie (FEP) against ESBL 
(extended-spectrum beta-lactamase) producing E. coli, Kfehsielta spp., 
Etiterobarrer rloucae, Sensrria marrescens and Cirrobacter freundii. 
Methods: Over one year study (June 1999-June 2000) we isolated 197 
nonreplicate ESBL (+) of above mentioned species. All isolates exhibited 
ESBL phenotype in routine double-disk synergy test (DDS) with CTX, 
amoxicillin-clavulanate (AMC) and CAZ were stored. We performed 
another susceptibility testing to compare E. coli and Klebsiella spp. group 
(EK) to S. rnarcesrens. E. cloacae and Cfreundii  group (SEC). Zone diameters 
of CTX, CAZ and FEP were recorded and analysed by WHONET 5. 
Results: The most active antibiotic in uitro (according to NCCLS) in 170 
EK isolates was FEP (84% susceptible) followed by CAZ (58%) and CTX 
(7%). !n much smaller SEC group (27 isolates) 63% were susceptible to 
CAZ, 55% to FEP and 3%) to CTX. 
Conclusions: The highest resistance to CTX in both groups suggested 
persistence of one or more ESBL enzymes preferentially hydrolysing that 
antibiotic. AmpC together with ESBL production could be responsible for 
lower FEP activity in SEC group. 
v1 Comparative in vitro activity of Cefepime with other 
antimicrobials against nosocomial isolates of Enterobacteriaceae 
E. Chinou, E. Tsiganou, M. Georgouli. Z. Chiolou, N. Trobouki, P 
Goleniati 
Atheris, GR 
Objectives: This study was performed to compare the in vitro activity of 
Cefepime a broadspectrum fourth generation cephalosporin, with that of 
other antimicrobials used in nosoconllal Infections. 
Methods: 486 isolates of Ewterubacteriaceae (386 E. culi, 82 K. pnelrrnoniae and 
18 E. rluacae) were selected tiom various specimens collected from patients 
located in different wards, of the hospital during one and a half year period. 
Antibiotic susceptibilities were determined by standard disk diffusion 
procedure. Antimicrobials tested were: cefepime (FEP), ceftazidime (CAZ), 
cefiriaxone (CKO), anioxicillin/clavulanic acid (AMC), ciprofloxaciu 
(CIP), amikacin (AN) and trimethoprini/sulfamethoxazole (SXT). 
Results: Cefepime showed a broad spectrum and potency inhibited 95% 
80% and 74%, respectively, of E. coli, K. pneumoniae and E. cloacae isolates. 
Cefepinie was more active than CAZ, CRO,  AMC, and SXT. The latter 
agents had resistance rates, for C. coli, K .  p~zeurnurriae and E. cloacae up to 
lo%, 35% and 61% for CAZ, 1576, 51% and 67% for C R O ,  2476, 37% and 
89% for AMC and 45%, 61% and 67% for SXT. 
Conclusions: Cefepime, a new cephalosporin resistant to hydrolysis by beta- 
lactanlases was active against most detected isolates, thus it appears to be a 
promising antimicrobial agent for the therapy of nosocomial infections due 
to Enteruhacteriaceae resistant to third-generation cephalosporins. 
v1 In vitro activity of cefoperazone against 
enterobacteria isolates 
A. Poiata, L. Gngore, I. Badicut, D. Buiuc 
lasi, RO 
The aim of the present study was to compare the in vitro antibacterial activity 
of cefoperazone with that of other third-generation cephalosporins against 
Enterobactenareae strains. 
Materials and methods: Antibiotics: Cefoperazone was provided by Pfizer 
INC., N.Y., U.S.A. Stock solutions of the following were prepared from 
their respective powder forms: cefoperazone (CPZ), cefiazidime (CAZ), 
cefotaxime (CTX), cefiriaxone (CRO). Strains: We tested 2863 clinical 
isolates of Esrhcrichia coli, Klebsiella spp. and Shigella spp. isolated from faeces 
during 1995-2000 period from eastem zones of Romania. Sensitivity study. 
MIC deteniiination was performed by the dilution method in Mueller- 
Hinton agar, according to NCCLS guidelines. Resistance rates are reported 
using the NCCLS breakpoints for the fully susceptible category. Results are 
summarized in the Table. 
% Resistance 
Strains(no) 
E.coli (1716) 
[ P I  304 ] Susceptibility of Gram-negative bacteria to fourth- 
generation cephalosporins in intensive care units and burns 
units in Johannesburg-recommendations for first-line 
empirical therapy 
A. J. Brink 
Johannesbuvg, ZA 
Cefepime or cefpirome is often used as first line emperical therapy for 
suspected Gram-negative infections in ICU’s in johannesburg hospitals. 
Reports have suggested differences in Susceptibility between these two 
antibiotics. To  determine the susceptibility of the fouah generation 
cephalosporins, a 100 consecutive Gram-negative isolates were collected 
from ICU patients in 16 private hospitals in May 2000. To ensure 
representative surveillance only 1 isolate per patient were tested and only 
clinically significant bacteria were included. MIC’s were determined using 
the E-test method according to NCCLS standards. As control strains, P. 
aerqinosa ATCC 27853 and E. coli ATCC 25922 were used. The majority 
of isolates were cultured from blood (32%), unne (15%) or respiratory tract 
aspirates (14%) whilst P. aenrgbtosa constituted 33% of the strains, E. coli, E. 
apglurneraris and K.  pneumoniae represented 21%, 12% and 11% of strains, 
respectively. The MIC 90 for all bacteria for cefepime was 8 pg/ml (range 
< 0.064-32) and for cefpirome 128 p g / d  (range < 0.064-> 256). 
According to NCCLS criteria 90% of isolates were sensitive to cefepime and 
77% to cefpirome. Furthermore, 94% of 2‘. aeruginusa isolates were sensitive 
to cefepime whilst only 74% were sensitive to cefpirome. 
These results confirm results published elsewhere that cefepime has 
increased Gram-negative activity conipared to cefpirome. The use of 
cefepime as first line emperical therapy for suspected Gram-negative 
infections in Johannesburg ICU’s and bums units is therefore endorsed 
whilst antibacterial therapy with cefpirome should probably be restricted to 
directed therapy only when susceptibility testing suggests adequate activity. 
v1 In vitro interactions of aminoglucosides with third- 
and fourth-generation cephalosporins against multiresistant 
nosocomial Klebsiella pneumoniae strains 
A. Dahou, A. Antoniadou, G. Perdikaris, 2. Chrysouli, M. Grammatikou, 
H. Giamarellou 
Athens, GR 
Multiresistant nosocoillid KL strains are among the pathogens implicated in 
dQicult-to-treat nosocomial and ICU infections. The possible effectiveness 
of combination treatment was investigated by the study of the it7 uitru 
interactions of anlikacin (AM) and netilmicin (NT) with ceftazidime (CAZ) 
or cefotaxime (CTX) or aztreonam (AZT) or cefepime (CEF). Twenty- 
seven KL strains (MIC > 32 yg/mL) were studied by the time-kill curve 
technique with 16 pg/mL of each antibiotic (and 8 pg for NT) representing 
the mean obtained blood level during conventional therapy. Synergy was 
defined as the combination of both (a) kihng effect of the combination at 
hour 5 and (b) reduction in bacterial growth of > 2 logs at the same time, 
compared to the effect of the most potent of the drugs (of the combination 
under study). Reduction of < 2 logs was regarded as an additive effect. 
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%D/C 
Courses 
Rash 
Results 
Synerw o r  additive effect('% Ytraim) 
C A Z  + AM 1Y'%b 
c rx  + AM 33% 
A l M  + AM ?'%I 
CEF t AM 33%) 
C A Z  or CTX or ATM or CEF + NT 0 
VC GM CLN CLX CTZ TM CZ CRO 
18,9 14.8 11.7 11.1 6.9 5.7 5.4 1.7 
37 27 77 18 73 53 111 229 
4 6 1  2 1 2  
It ic concluded that combination treatment should not be used empirically 
but only after MIC evaluation to ensure future benefit. 
Fl The investigation of the effect of corticosteroid 
usage on ceftriaxone levels in cerebrospinal fluid in acute 
bacterial meningitis 
C. Duke, C. Cavutoglu, E. Karasulu, G. Karakartal 
Izrnir, TR 
Purpose: The importance of corticosteroids in the treatment of acute 
bacterial meningitis is still controvertial ecpecially in adult age groups. In this 
ctudy it was investigated whether the transition of antibiotics to 
cerebrospinal fluid was adequate or not in patients with acute bacterial 
meningitis and its implication on recovery. 
Materials and methods: Twelve patients between 15 and 65 years of age 
with positive meningeal irritation signs, CSF findings in accordance with 
Adverse effects of antimicrobials 
acute bacterial meningtis were included in this study. The patients wlth 
contraindication of corticosteroid usage, underlying chronic debilitating 
diseases, penicillin and cephalosporin allergy, and pregnancy were excluded. 
A double blind randonuzed study was undertaken. The patients were 
randoidy divided into two groups of six patients and CSF samples were 
microbiologcally studied before the therapy was started. Group 1 received 
ceftriaxone (Rocephin " ) + dexamethasone, and group 2 ceftriaxon 
(Rocephin ') only. Ceftriaxone was administered intravenously 2 g b.i.d. 
for at least 10 days and dexametasone was given intravenously 8 mg t.i.d. for 
the first 4 days. Plasma and CSF samples were obtained on the 24th, 48th, 
72nd, 96th and 264th hours after the establishment of therapy. The 
ceftriaxone levels in the plasma and CSF samples were studied with high 
performance liquid chromatography (HPLC) and microbiological assay. 
The CSF samples were also evaluated biochemically. The signs and 
symptoms such as fever, headache, nausea, vomiting, consciousness, neck 
ngidity, Kermg and Brudzinsky were daily recorded. 
Results: The CSF ceftriaxone concentrations were demonstrated in graphs 1 
and 2. Deafness was detected in one patient in group 1. Ail other patients 
were recovered without any complication. 
Conclusion: Despite the fact that there was no difference between the two 
groups in terms of plasma antibiotic concentrations CSF antibiotic 
concentrations of the ceftriaxon + dexamethasone group was significantly 
lower than only the ceftriaxon given group ( P  < 0.05). The CSF 
concentration of ceftriaxone never detected below MIC level. We 
concluded that the dexametason usage is not contraindicated in adult 
bacterial meningtis. 
v] Adverse effects of intravenous antibiotic therapy 
A. D. Tice, G. Seibold, D. Nathwani, S. Esposito, A. Martel 
Tacoma, USA 
The frequency and type of adverse effects of intravenous antibiotic therapy 
are critical factors in deciding which drug to use yet there is little 
comparative information and limited knowledge of the types of serious 
events that occur. The Outpatient Parented Antimicrobial Therapy 
(OPAT) Outcomes Registry provides this data through 20 sites in 5 
different couiitnes. Outcomes measures include whether an antibiotic was 
stopped early because of an adverse event and the type of event that 
occurred. The data below were gathered from 625 courses of therapy. They 
indicate differences in kequency of serious adverse events. The types of 
reactions also differ with rash the most common, especially with 
clindamycin. Anaphylams and anaphylactoid reactions occurred with 
cefazolin and gentamicin, which reinforces the need for close monitoring 
with OPAT. The OPAT Outcomes Registry will be helpful in decision- 
making about antinlicrobial therapy. Ongoing data collection will allow 
statistically significant results and insight. 
Abbreviations:%D/C = percent stopped eai-ly, Ana = anaphylaxis or ana- 
phylactoid reaction, GI = gastrointestinal, W C  = leukopenia, VC =van- 
comycin, GM = gentamicin, CLN = clindamycin, CLX = c loxach ,  CTZ = 
ceftazidime, TM = tobramycin, CZ = cefazolin, C R O  = ceftriaxone. 
/p13081 Retrospective study of adverse effects of rifampicin 
among patients with Gram-positive cocci infections 
F. Leguay, Y. Hansmann, M. Martinot, V. Remy, D. Christmann 
Strasboug, F 
A retrospective study, which aim was to evaluate nature and frequency of 
intolerance observed among patients treated with rifampicin (20 mg/kg/d) 
in Gram posiuve COCCI infections, was carried out. All patients with clinical 
or biological disorder that appeared after the beginning of rifampicin 
therapy were included in the study. The medical Gler of 36 patients were 
analysed: 23 men arid 13 women. The 38 raised infections were: 10 
osteoarticular infections, 10 foreign body infections, 8 bacteraemias, 7 
endocarditis, 2 pulmonary infections and 1 mediastinitis. The bacteria were 
distributed as follows: 21 Staphylococcus (15 Staphylococcus aureus: 11 nieti-S, 4 
meti-R; 6 other Sruphylococcus: 3 meti-S, 2 meti-R and 1 unknown), 8 
Streptococcus, 4 Enteromccus, 1 Bartonella and 1 Coxiella. All patients had at 
least one other conconlitant antibiotic ordered with nfampicin. Among the 
patients, 25 presented one or more adverse effects (see Table 1). Kifampicin 
has been stopped in 10 patients because of adverse effects: 3 for biological 
hepatic abnormalities, 3 for digestive disorders, 3 for cutaneous eruption and 
1 for drug interaction. Dosage of rifampicin have been decreased in 5 
patients: 3 for biological hepatic abnormalities and 2 for digestive disorders. 
Other actions have been realised in 6 patients (oral administration, stop of 
drug or symptomatic treatment): 3 for veinitis, 2 for drug interaction and 1 
for digestive disorders. In 4 patients, nothing has been realized: 2 for 
biological hepatic abnormalities, 1 for digestive disorders and 1 for veinitis. 
Hepatic disorders appeared in the first 10 days ofrifampicin therapy. Veinitis 
were the most frequent adverse effects, but the other drugs could also be 
responsible. In the study, among the 4 patients with oral anticoagulants 
therapy, 3 had an imbalance of the INK occurs during the 1 0  first days of 
rifampicin therapy. In our study, we have observed 76% adverse effects after 
beginning of rifampicin. In 22% of theses cases, rifampicin therapy have to 
be stopped. A hepatic 'monitoring by regular controls of biological constants 
the first 10 days and a fast adjustment of dosage of rifampicin often make it 
possible to restore the hepatic fimction. In the same way, the nionitonng of 
efficacy of oral anticoagulant is essential during a concomitant nfinipicin therapy. 
Adverse effects IN umber of I) atients 
Veinitis 10 
Digestive disorders 
Nausea 
Nausea armd vomiting 
Nausea. vomiting et diarrhoeas 
gastro-intestinal pans 
Elevation of ASATor ALAT 
Elevation ot hl i rubn 
50 th 
Jnteracbor, with oraJ anticoagulants 
jnteraction with acebutobl 
Hepatic disorders 
Drug interactions 
Cutaneous eruption 
8 
2 1  
3 
2 
I 
I 
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Effect of anti-inflammatory drugs alone and 
combined with quinolones on the respiratory burst of human 
polymorphonuclear leukocytes 
M. Velen, E. Cabrera, J. P. Martinez, E. Canton 
Valenda, E 
Background: The antibacterial activity of PMNs is based on the production 
of superoxide anion (SOA) and hydrogen peroxide (HP) in the respiratory 
burst and can be impaired in different ways. The combination of an 
antibacterial agent and an anti-inflammatory (AI) drug is quite common in 
immunodepressed patients whose respiratory burst of PMNs could be 
impaired thus, it is important to know the effect of drugs to choose those 
that do not interfere with this function. 
Methods: Drugs and concentrations assayed were: grepa5oxacir1, 15 mg/L; 
ofloxacin, and betamethasone, 10 mg/L; dexamethasone, 40 mg/L; 
hydrocomsone, 5 mg/L; acetyl salicilic acid (ASA); 2.5 mg/mL; and 
methylprednisolone, 37.5 mg/L. PMNs were recovered from venous blood 
of healthy donors by dextran sedimentation and Ficoll-Hypaque gradient. 
SOA was measured by the cytochrome C reduction technique and the HP 
production by the oxidation of phenol red. PMNs were pretreated for 30 
min with a combination of a quinolone plus an A1 drug before stimulation 
with phorbol myristate acetate. 
Results: The mean amount of SOA and HP generated by control was 
4.6 f 0.4 and 13.5 f 1.4 n ~ / 2 5 0  000 PMNs/h, respectively. The A1 drugs 
alone decreased the production of HP (except betamethasone and 
methylpredtusolone) and SOA (except betamethasone) between 15 and 
45% depending on the A1 drug. Grepafloxacin alone significantly decreased 
HP (84.26%) while ofloxacin increased the production of SOA 
(120.2 rt 6.7%) (P  < 0.05). The combination of dexamethasone or ASA 
with grepanoxacin decreased the production of SOA to a less extent than 
the A1 drug alone. Grepafloxacin plus niethylprednisolone slightly increased 
the generation of HP. O n  the contrary, with the combination of the A1 
drugs plus ofloxacin the inhibitor effect of the former on the respiratory 
burst of PMNs was neutralized. 
Conclusions: The combination of ofloxacin with AI drugs, at concentra- 
tions reached in plasma, could be beneficial because they neutralize harm 
caused by the A1 drugs on the respiratory burst. 
1 P1310 1 Hyperpigmentation and severe thrombocytopenia 
due to pyrimethamine use 
R. Ozturk, A. Engin, R. Ozaras, A. Mert, F. Tabak, Y. Aktuglu 
Istanbul, TR 
Pyrimethamine, a folic acid antagonist is an antiparasitic agent. It is indicated 
for treatment of toxoplasmosis and prophylaxis of malaria due to susceptible 
strains. Adverse reaction encountered during pyrimethamine use include 
megaloblastic anaemia, leukopenia, thrombopenia, rash, vomiting, and 
diarrhoea. Although hyperpigmentation is observed in very few cases, it is 
not well-documented in any patient. A 29-year-old woman was admitted 
with fatigue, drowsiness, widespread purpuras, and hyperpigmentation. She 
had history of two abortus. When she was admitted to a gynaecologist, she 
was found to have a positivity of Toxoplasma IHA (1/1024) during 
screening and prescribed pyrimethamine (Daraprim 25 mg tablet, twice 
daily). Forty days after the initiation, she noted darkening on the skin 
around mouth and at finger rips and also widespread bruises. After 5 days, 
she admitted to a clinic; and referred to our unit because of 
hyperpigmentation and sever thrombocytopenia (9000/nm3).0n admi- 
sion, she had a generalized hyperpigmentation, but especially on periorbital, 
Antimicrobial usage and resistance 
period, and palatal regions. O n  all extremities, there were many purpuras. 
Hepatosplenomegaly, ascites, oedema, and LAP were absent. Blood pressure 
was 95/50 mmHg, and pulse rate was 108/min. An apical murmur of 2/6 
was heard. Laboratory studies: Haemoglobin 6.9 g/dL, leukocyte count 
5700/mm3 (PNL 51%, lymphocyte 44%, eosinophil 3%, and stab 2%) 
platelets 9000/rnm3, MCV 96 a, reticulocyte 9%, ALT 45 U/L, AST 29 
U/L, ALP 185 U/L (N: 70-306), albumin 3.9 g/dL (total protein 5.8 g/ 
dL), K 3.9 mEq/L, t. bilirubin 0.8 mg/dL, urea 20 mg/dL, creatinine 0.8 
mg/dL, LDH 1878 U/L (N: 24G480). Levels of TSH, T3, T4, iron, iron 
binding capacity, fenitin, basal hydrocortisone, ACTH, and hydrocortisone 
after ACTH (Synacthen depot 1 mg ampule) injection remained normal. 
Bone marrow aspiration revealed hypercellularity, and skin biopsy was 
normal. Pyrimethamme dwontinued, and she was given thrombocyte 
suspension and folinic acid. Mter 15 days, her pigmentation began to 
regress, haemoglobin was 7.3 g/dL, leukocyte 11 500/mm3, and platelets 
138 0 0 0 / m 3 .  Her all clinical and laboratory findings returned normal after 
6 months. This case represent the first well-documented pyrimethamine- 
induced hyperpigmentation. Although very unusual, it may lead to 
hyperpigmentation. After exclusion of more commoner aetiologies, this drug 
should be considered in aetiology of hyperpigmentation in appropriate settings. 
vl Risk factors for nephrotoxicity in elderly patients 
receiving aminoglycosides 
D. Raveh, M.  Kopyt, Y.  Hite, B. RudensLy, M. Sonnenblick, A. M 
Yinnon 
Jerusalem, IL 
Background: Aminoglycosides are the mainstay of treatment for infections 
caused by Gram-negative bacilli. Although once-daily dosing has become 
generally accepted, there remains concern about its safety in the elderly. 
Purpose: To assess the safety of once-daily aminoglycosides in a cohort of 
elderly patients and to evaluate possible risk factors for nephrotoxicity. 
Methods: Prospective surveillance of all patients receiving amino-glycosides 
during a 4-month period. Aminoglycoside toxicity was defined as an 
increase in serum creatinine of 250%. A total of 23 parameten were 
followed during and after completion of therapy. Univariate and logistic 
regression analyses were performed in order to evaluate risk factors for 
nephrotoxicity. 
Results: In the study period, 249 consecutive patients received an 
aminoglycoside: 116 (47%) were male and 133 (53%) female. Mean age 
was 75 & 16. Forty-two patients (17%) received amikacin, 207 gentamicin 
(83%). The majority of patients (237, 95%) were admitted to the medical 
and geriatric departments, the remaining 12 (5%) in surgical departments. 
An increase of >50% in serum creatmne was detected in 31 of the 249 
patients (12.4%); the maxitiial creatinine was 6 2  mg/dL in 16 of 249 
patients (6.4%). 2.1-3 nig/dL in 9 patients (3.6%), and > 3 mg/dL in six 
patients (2.4%). None of the patients developed oliguric renal failure; most 
subsequently experienced significant reduction of serum creatinine prior to 
discharge from hospital. Univariate and logistic regression analysis revealed a 
very significant correlation between renal damage and a high aminoglyco- 
side trough level (> 1.1 mg/mL.)(P < 0.001), and a weaker, but still 
significant correlation with a haemoglobin level < 10 gm/dL ( P  < 0.05), 
and length of hospital admission > 7 days prior to aminoglycoside 
treatment ( P  < 0.005). 
Conclusions: Oliguric and/or lasting renal toxicity appears to be extremely 
rare in elderly patients receiving once-daily aminoglycosides. Trough drug 
levels must be obtained. Calculation of creatinine clearance should be done 
after actually weighing patients, rather than estimating their weight. These 
acnons may reduce the incidence of nephrotoxicity. 
v/ Clinical determinants for the recovery of fungal or 
mezlocillin-resistant pathogens from bile 
B. Ehrenstein, L. Salamon, H.-J. Linde, J. Scholmerich, T. Gliick 
Regetz&p, D 
Objectives: There is a paucity of studies to determine the clinical mpact of 
pathogens cultured &om bile. Better understanding of clinical settings and 
resistance patterns for bile-pathogens are needed to devise precise strategies 
for empiric antibiotic therapy. 
Methods: We conducted a retrospective analysis of all routine cultures from 
bile-specimens collected from January 1995 to December 1999 at our 
tertiary-care hospital. Results of the first positive culture from a patient were 
linked to clinical parameters regarding medical history and initial 
presentation gathered by chart review. Factors associated with the culture 
of Candida spp. or bacteria resistant to mezlocillin, commonly used as 
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empiric therapy in biliary infections, were delineated by uni- and 
multivariate analysis. 
Results: 722 isolates were cultured from 345 out of 454 bile-specimens sent. 
172 (51%) of positive specimens grew more than one pathogen. Overall 
66%, 60% 31%, and 6% of specimens grew Gram-positive, Gram-negative, 
fungi or anaerobic bacteria, respectively. Clinical data were available for 176 
of the 215 patients with positive cultures. Prior treatment with antibiotics 
> 7d (odds ratio (OR) 5.7; 95% confidence interval (CI) 2.3-14.3), severe 
leukocytosis (> 20/nL) on admission (OR 7.8; CI 1.7-23.9), endoscopic 
or percutaneous biliary manipulation in the prior 14 days (OR 2.9; CI 1.2- 
7.0), and being an internal medicine patient (OR 2.5; CI 1.0-6.4) were 
independent factors associated significantly ( P  < 0.05) with recovery of 
Catzdida spp. from bile. Culture of mezlocillin-resistant bactena from bile 
was independently atsociated with specimen collection beyond one week 
after ddniission (OR 3.8; CI 1.8-2.8), no prior performed endoscopic 
biliary drainage (OR 3.2; CI 1.5-6.7), and high (> 72 U/L) serum AST 
levels on admission (OR 2.6; CI 1.1-5.8). 
Conclusion: Prior treatment with antibiotics, severe initial leukocytosis, 
biliary manipulation in the prior 14 days and being an internal medicine 
patient were independently associated with recovery of Candida spp. from 
bile. Specimen collection later than one week after admission, no prior 
performed endoscopic biliary drainage and high serum AST on admission 
were independently associated with culturing mezlocillin-resistant bacteria 
from bile. Further prospective studies are warranted to confirm our finhngs, 
to delineate the clinical impact of these pathogens, and to evaluate 
subsequent risk-adjusted enipiric antibiotic regimens for biliary infections. 
v/ Antibacterial resistance and antibiotic use in 
Lithuanian out-patient clinics 
A. Stefanovic, V. Jurkuvenas 
Vilnius, LIT 
Objective: The aim of the study was to analyse the use of antibiotics and 
antibacterial resistance in outpatient clinics; 
Materials and methods: The study was planned and performed as a 
descriptive epidemiology. Individual charts of 4200 patients from 20 
paedatric and adult outpatient clinics were randomly selected and reviewed. 
The data of 2055 results on the isolates from throat, sputum, urine, wounds 
and their susceptibility to antibiotics were obtained from 7 bacteriologcal 
laboratories of outpatient clinics. 
Results: It turned out that 66.4% of all children and 34.9% of all adults 
visiting outpatient clinics with different health problems receive prescrip- 
tions of antibiotics. While penicillines of wide spectrum (31.6%) and 
macrolides (14.7%) were the most frequently prescribed antibiotics for 
younger patients, tetracyclines (26.1%) and cotrimoxazole (12.8%) were the 
most commonly issued ones for elderly. About 95% of a l l  antibiotics 
prescriptions were issued for upper respiratory tract infections, acute 
bronchitis, urinary tract infection and ear infections. It was found out that 
97% of children and 99.6% of adults receive antibiotics without any clinical 
microbiological tests. Analysed results of bacteria susceptibility to antibiotics, 
established that isolated bacterias from throat were 88.3% Penicillin resistant 
and 34.8% Erythromycin resistant. Most frequently isolated from throat 
were beta-haemolytic Streptoccoci, S .  aureus and Moraxelln rataurhnlis. 
Erythromycin (30,8%) and penicillin with wide spectrum (30.0%) were the 
most frequently prescribed antibiotics for upper respiratory tract infections 
in outpatient clinics. Isolated from urine were 28.5% Trimetoprmi resistant 
and 12.9% Ciprofloxacin resistant. Most frequently isolated &om urine were 
E. coli (67.2%), Ssaprophytims (9.6%) and Klebsiella/Enterobacter (8.1%). 
Ciprofloxacin (37.8%) and trimetoprim (22.6%) were the most frequently 
prescribed antibiotm for urinary tract infections. 
Conclusions: Antibiotics were prescribed for 2 of 3 children and every third 
adult when visiting outpatient clinics for any health problem. Physicians 
prescribe mostly antibiotics of broad spectrum-88.0% in adult outpatient 
clinics and 65.4% in children outpatient clinics. Microbiologcal test were 
performed only for a small part of patients in outpatient clinics. The used 
antibiotics in Lithuanian outpatient clinics do not correspond to the actual 
bacteria susceptibility to antibiotics. 
Molecular epidemiology of Corynebacterium 
ulcerans infections in England and Wales, 1987-99 
K. H. Engler, S. Lai, J. White, G. Mann, A. Efstratiou 
London, UK 
Objectives: To examine the molecular epidemiology of Coryrrebacteiut~l 
ulcerans strains from England and Wales isolated between 1987 and 1999. 
Methods: Fortyseven clinical isolates of C. ulceram of human and animal 
origin, referred to the PHIS Streptococcus and Diphtheria Reference Unit 
(SDRU) between 1987 and 1999 were characterized by biotyping, 
toxigenicity testing and ribotyping. Ten strains of C. ulceratis from the 
Came collection, isolated from humans in Australia, between 1933 and 
1965 were also examined. 
Results: Forty-one of 47 clinical isolates and all isolates from the Came 
collection were toxigenic. The 47 clinical isolates produced seven distinct 
riboypte patterns. The predominant ribotype pattern, U1, was produced by 
18 isolates, including isolates from two siblings, in the UK, where the 
second (asymptomatic) case denied any direct contact with other possible 
sources of infection. This ribotype pattern was also produced by isolates of 
animal origin (otters) with skin lesions. Ribotype patterns. U2, U3 and U4 
were observed amongst 7, 3 and 11 strains, respectively. The isolates from 
the Came collections produced two ribotype patterns, U2 (6 isolates) and 
U3 (4); ribotype pattern U1 was not observed amongst these isolates. There 
was no correlation between toxgenicity and ribotype pattern. 
Conclusions: Riboptyping revealed that there is a predominant clone of C. 
ulrerans circulating within the UK and this was observed amongst isolates of 
both human and animal origin. The isolation of C. ulcerans strains, with 
indistinguishable ribotype patterns, from two siblings in the LJK suggests 
that person to person transmission my be possible. 
I PI315 I Effect of adequate empiric antibiotic therapy on 
outcomes among patients with complicated intra-abdominal 
infections 
J. Burke, J.  Lloyd, R. Evans, E. Alemao 
Salt Lake City, Piscotaivay, USA 
Objective: To estimate the effect of choosing adequate initial antibiotic 
therapy empirically for the treatment of complicated intra-abdominal 
infections on outcomes such as mortality and healthcare resource use. 
Methods: This was a retrospective analysis of computerized patient records 
from a large health care system. Adult patients discharged within the last 10 
years (1990-99) with the following discharge ICD-9 CM diagnosis codes 
were included: 540.0 (acute appenhcitis with generalized peritonitis), 540.1 
(acute appendicitis ul th  peritoneal abscess), 567.2 (other suppurative 
pentomtis), 567.9 (peritonitis of unspecified cause), 569.5 (intestinal abscess 
excluding appendiceal abscess) and 569.83 (perforation of intestine), Patients 
who received less than 48 h of antibiotic therapy were excluded. A patient 
was classified as having received adequate initial therapy if all clinically 
relevant pathogens identified from the patient within 48 h of hospital 
admission were susceptible to the initial antibiotic regimen. A patient was 
classified as having received inadequate initial therapy if at least one 
clinically relevant pathogen was not susceptible to the initial regimen. 
Results: 1306 patients met the inclusion criteria. 620 of them did not have a 
positive culture (no culture or culture negative) and another 227 patients did 
not have cultures with susceptibility data or identified anaerobes. The 
remaining 459 patients were included in the final analysis. 92 of these 
patients (20%)) received inadequate initial therapy empirically. Patients 
receiving inadequate initial therapy had significantly higher mortality than 
patients receiving adequate initial therapy (14.1% vs. 4.9%, P= 0.002, Chi- 
square test). Among surviving patients, those receiving inadequate initial 
therapy had more antibiotic days (median 8.3 vs. 7.3 days) and longer 
hospital length of stay (median 8.8 vs. 8.0 days) although these differences 
did not reach statistical significance. 
Conclusion: Inadequate initial antibiotic therapy was associated with higher 
mortality rate and seems to result in greater healthcare resource use among 
hospitalized patients with complicated intra-abdominal infections. 
Ip13161 Antibiotic use on an acute medical assessment unit 
I. M. Gould, Y. Kumarasamay, 1. A. Gillanden, B. Jappy, R. Laing 
Aberdeen, UK 
Acute medical assessment units (AMAU) are a new development in the UK 
for central reception, evaluation and treatment of acute admissions prior to 
transfer to appropnate wards. They have the potential to reduce continuity 
of medical care and feedback of laboratory results, leading to inappropriate 
use of antibiotics, so an audit of antibiotic prescribing on the AMAU at 
Aberdeen Royal Infirmary was camed out. Of 1304 consecutive admissions, 
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222 were started on empiric antibiotic with a mean delay of 5.4 h 52 were 
in accordance with the Unit Policy. Appropriate cultures were taken in 78% 
of patients and results were positive in 29%). O f  the culture-positive cases, 
51% were on  an inappropriate antibiotic, 60% ofwhom were not changed 
to a more appropriate antibiotic. In 88% of the patients with a negative 
culture. the culture had no obvious effect on treatment with regard to 
duration or type of antibiotic being administered. 85% of results were filed 
appropriately within 1 day. The duration of treatment ranged from 1 day to 
26 days with a mean of 8.4 days. 60% of the patients started on empiric 
antibiotics received it IV. Of the patients started on IV antibiotics, 43'% had 
a negative culture report and 42% a negative sepsis profile. The time to 
change from 1V to oral antibiotics ranged firom 1 to 11 days, with a mean of 
3.5 days. Mortality was 1.5%. In conclusion, there is general under- 
utilization of laboratory results and chest X-rays to direct antibiotic therapy 
and over use of IV antibiotics especially cefotaxime, often in combination 
with clarithromycin for patients with clear chest X-rays. 
(p13171 Evaluation of vancomycin use in in-patients 
C. Kuzucu, M. Ayan, B. Durniaz 
I l lnlntyn, TR 
Objective: Overuse of vanconiycin can lead to the emerging of vancomycin 
resistant enterococci and vancomycin intermediate Staphylococcus aureus. I n  
this study we investigated vaiicomycin use in the definitive, empirical or 
prophylactic setting. 
Methods: During a 2-month period we obtained daily infomiation from the 
hospital phannacy database and we visited patients receiving vancomycin. 
Their medical records were reviewed for clinical and laboratoiy data. Fifty 
hospitalized patients receiving vancomycin were evaluated. Twenty-five 
patients were in Department of Pediatrics, five in Hematology, four 111 
Internal Medicine, two in Neurosurgery, two in General Surgery, two in 
Cardiology, two in Thoracic arid Cardiovascular Surgery, two in 
Neurology, one in Pediatric Surgery, one In Dermatology, one in Urology, 
one in Orthopedics, one in Infectious Diseases and one in Oncology. 
Results: Vanconiycin was used as empirical therapy in 35 patients (70%), 111 
accordance with culture results III 14 patients (28%)) and as prophylactic in 
one patient. Vancoinycin was used as empirical therapy in four patient with 
infective endocarditis, eight with febnle neutropenia, seven with pneunio- 
niae, six with sepsis, four with meningitis, two with wound infection, one 
with catheter infection, one with pericarditis, one with peritonitis and one 
with febrile after dialysis. Vancomycin was used according to culture results 
of 14 patients. Staphylomcciis spp. were isolated in nine patients (eight 
methicillin resistant Staphylococrus spp., 1 methicillin susceptible Sfnphylo- 
COCCUS spp,), €itteroroccus spp. in two, S. aureus in two (one niethicillin 
resistant S. nureus, one niethicillin susceptible S. aureiis) and i n  one 
Coryirebncteriurri jrikeiutti. 
Conclusion: Due to overuse aiid misuse of vancomycin, glycopeptid 
intermediate S. nureus or vanconiycin resistant eiiterococci will be emerge 
more rapidly. Therefore vanconiycm should be used according to 
appropriate criteria. 
/p1318/ Rational choice of antibiotic treatment of infection of 
pressure ulcers in spinal cord-injured patients 
B. Heyni, A. Lortat-Jacob, F. Rimareix, M. Nicolas-Chanoine 
Boulopte, F 
Objectives: Infected pressure ulcers are the most frequent complication in 
spinal cord-injured patients. Because there are many bacterial species 
involved in either colonization or infection, it is difticult to choose 
antibiotherapy reasonably. I n  order to interpret correctly the bacteriological 
results, which is the basis for antibiotic treatment, we analysed tissue 
sampled from surgically unbridled and cleaned ulcers. 
Methods: AU isolates grown from samples were identified and an 
aiitibiograrn (agar disk diffusion test) was carried out. 
Results: In 1999 we received 168 surgical samples &om 101 patients, and 
183 wound drainage samples on the first (Dl) aiid 162 on the fifth (D5) 
postsurgical day. Seventeen of the surgical samples (10%) had a negative 
culture whereas 116 (69%) were positive with one or two species, and 35 
(21%) with a t  least three species. Only 2% of D1 drainage samples were not 
submitted for culturing, but 36% of the D5 drainages. For 48% of D1 and 
56% of D5 drainage samples the culture was negative. One or two species 
were found in 44% of I11 and 40% of D5 drainage samples, whereas at least 
three species were isolated from 8% of D 1 and 4% of DS drainage samples. 
The most kequent species were, in both types of samples, enterobactena 
(Escherichin roli and Proteus mirabilis being the most frequent), followed by 
Staphylocorrus nureus and streptococci. In the case of a negative culture of the 
surgical sample, the drainage samples were also negative in 59%, but positive 
in 36% with one species and in 6% with two species. If one species was 
isolated from the surgical sample, 34% of drainage samples were negative, 
40% positive with the same species as in the surgical sample, and 26% 
positive with a different species. Similar results were found, if the surgical 
sample yielded two or more bacterial species. Overall, in 25% of the surgical 
samples with a positive culture, the subsequent drainage samples were 
negative, and in 56% of the cases the same species was isolated from both 
types of samples. 
Conclusion: Culturing only deep tissue samples taken from the surgically 
cleaned and unbridled ulcer permits to isolate the bacteria which are 
involved in the ulcer infection. Moreover, as the identification of these 
bacteria and their antibiotic susceptibility are available, when the potential 
positive culture of the I)1 postsurgical drainage sample is also available, It is 
easy to choose a targeted antibiotic treatment. 
rmw Sensitivity of pathogens isolated in blood cultures of 
patients admitted to the medical department of a tertiary 
hospita I 
E. Karabatsaki, E. Kalogeropoulou, C. Kakari-Tsiropiiia, E. Vagnkou- 
Voudri, D. Petropoulou-Milona, P. Tsiodra, E. Malaniou-Lada, A. 
Efitratopoulos 
Athens, CR 
Objectives: Tertiary hospitals benefit from regular reviews of evaluation of 
sensitivity and resistance of pathogenc to antibiotics. Our aim was to assess 
the sensitivity to antibiotics of all pathogens isolated from the blood cultures 
of patients admitted in a general niehcal department of a tertiary hospital 
Methods: W e  analysed the results of 124 positive blood cultures, taken in 
the last two years from patients admitted in a medical department, focusing 
on the sensitivity to antibiotics of the microorganisms isolated. 
Results: E .  roii has been isolated in 32 patients (23.2%). All of the strains 
were resistant to ampicilline and 1st generation cephalosporins. There was 
no resistance to ceftriaxone, aminopenicillins, aminoglycosides, kinolones 
or imipenem. In 13% of the cases, the isolate was Pseudomums aerqinusa 
with 28.6% resistance to ceftazidiine, 7% resistance to aminoglycosides and 
14% resistance to aztreonam. All of the strains were sensitive to 
ciprofloxacin, iinipenem and antipseudomonal penicillins. Kkbsiella spp., 
isolated in 8.7?4 of the cases and Pruteus spp., found in 5.8% of the patients, 
did not have any remarkable resistance to antibiotics. In 3.65%, Eiiteroharter 
spp. was the microorganism isolated and it was resistant to aminopenicillins 
arid 40% resistant to ciprofloxacin, but sensitive to imipeiiem and 
anunoglycorides. AU Arirtetobactev spp. isolated (2.2% of bacteraenuas) were 
resistant to aminoglycosides, ceftriaxone and kinolones and sensitive to 
imipenem. S. aureus was the pathogen in 18.6% of the cases and its resistance 
to methicilline was 26%. Four ofthe 18 Staph. coagulase (-) isolated (14.5%) 
were methicillin resistant. Etiterurorcrrs spp. was isolated in 5.8% of the blood 
cultures and there was no resistance to vancomycin. All Strq.  pneurnonine (1.4%) 
were sensitive to oxachi .  One Strep. artqinusus fourid was sensitive to penicilline 
G and one Coryriebmfeiium jeikcium found was sensitive to vancomycin. 
Conclusions: One fourth of the S.  aureus isolated in our department were 
niethicillin-resistant. Nearly one third of the Pseudoniotias aerqirzosa were 
resistant to ceftazidime and sensitive to ciproxin, imipenem and 
antipseudoinonal penicillins. Au Enterorocrus spp. isolated were sensitive to 
vanconiycin. An increased resistance of Ariiietobarter has been observed, with 
the pathogen being sensitive only to imipenem. 
(p13201 Urinary tract infections with fluoroquinolone- 
resistant Enterobacteriaceae 
D. Leca, V. Luca, E. G. Miftode, C. Dorobat, C. Luca, D. Mihalache, A. 
Teodor, T. Turcu 
lasi, RO 
Objectives: To correlate the clinical evolution and characteristic? of patients 
with urinary tract infections caused by Enterubarteriareae of fluoroquinolone 
resistance. 
Material and method: During a 2-year period, 51 patients (1 2 inen and 39 
women), aged between 4 months and 83 years, with urinary tract infections 
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(UTI) by fluoroquinolone resistant Enterobacteriaceae, were studied. Urine 
cultures revealed Esrherischia coli in 31 cases (60.78%), Klebsiella sp in 14 cases 
(27.45%). Eriterobacter cloacae in 7 cases (13.72%) and Citrobacter in 1 case 
(2%). These strains had a susceptibility to thrd generation of cephalosponns, 
betalactanlines-betalactamase inhibitors and carbapenemes, varying &om 
one patient to another. Three patients developed, during hospitalization, 2 
successive UTI with different fluoroquinolone resistant Enterobacteriaceae. In 
15 cases, UTI occurred on immunocompromised patients. These infections 
occurred during another bacterial infection treated with fluoroquinolones (5 
cases), or after it had been healed (7 cases). Favouring factors consisted of 
genital diseases (13 cases), renal diseases (8 cases), diabetes meUitus (2 cases) 
and indwelling urethral catheter (7 cases). 16 patients previously had 
iterative UTI treated with 5uoroquinolones. Dunng hospitalization, 36 
patients from our trial were treated with fluoroquinolones (in mono- 
Beta-lactamases 
therapy-22 cases or associated with synergic antibiotics). 10 patients with 
betalactanune-betalactamase inhibitor and 5 patients with third generation 
cephalosporins. The average time of treatment was 8.25 days. 
Results: Patients treated with fluoroquinolones had a favourable clinlcal and 
bacteriological in 12 cases, only clinically favourable evolution in 4 cases, 
only initial clinically favourable evolution with recurrence of symptonls 
during (6 cases) or a few days after the treatment (5 cases), requxing therapy 
change. For those treated with other antibiotics, evolution was favourable in 
6 cases. 
Conclusions: ITU with fluroquinolone resistant Enterobactenacefae occurred 
on immunocompromised patients, those with ninltiple hospitalizations, 
being favoured by empirical and frequent use of these annbiotics for 
bacterial infections therapy, and having a severe evolution in most cases. 
Comparison of different methods for detection of 
extended spectrum p-lactamases in Klebsiella pneumoniae, 
Klebsiella oxytoca and Escherichia coli strains 
M. Fincanci, R. Uluturk, G. Eren, C. Konukal, F. Soysal, S .  Sander, 2. Uoztas 
Istanbul, TR 
Objective: To compare four different methods designed for detection of 
extended spectrum p-lactamase (ESBL) production in K. piieuriiorriae, K. 
oxytoca and E. mli strains. 
Methods: Eighty-nine K. pneumoniae, 7 K. axytoca and 63 E. coli strains 
isolated from the clinical specimens of anibulatory and hospitalized patients 
were studied to identify ESBL production by (a) evaluating the resistance 
patterns of ceftazidime, aztreonam, cefotaxime and ceftriaxone on disk 
diffusion test (RP); (b) comparing disk diffusion zones of the5e antibiotics 
(ZC); (c) double disk synergy test (with 25 tnm and 30 mm disk distances) 
(DDS-25 and DDS-30); and (d) E-test (for Klebsielfa spp. only). 
Results: The highest rate for ESBL production was observed in K. 
prieumoniae strains (79%) and by ZC method, with no significant difkrence 
between ambulatory and hospitalized patients (P= 0.05). ESBL production 
was less frequent in E.  coli strains by this method (11%) ( P  < 0.001). 
Spearman correlation test revealed very good correlation between KP and 
DDS-25 (r=0.77), moderate correlation between ZC and E-test ( r =  0.40) 
and good correlation between RP and ZC (r=0.74), Z C  and DDS-25 
(r=O.64), R P  and E-test (r=0.65), DDS-25 and E-test (r=0.57). 
Conclusion: DDS-25 test in combination with R P  or ZC tests appears to be 
most suitable for routine detection of ESBL production which stands as a 
major problem especially in K. pneumoiiiae strains. 
Mechanisms causing decreased susceptibility to p- 
lactam antibiotics in a Bacteroides thetaiotaomicron strain 
H. Fang, C. Edlund, M. Hedberg 
Stockholm, S 
Objectives: To elucidate the mechanisms causing decreased susceptibility to 
p-lactam antibiotics in a B. thetaiotaomicron strain isolated from faeces. 
Methods: The antinlicrobial susceptibilities of antimicrobial agents were 
detemlined by the agar dilution method. The strain was cultured in 
prereduced BHIS broth, harvested by centrifugation, and then disrupted by 
sonication. The supernatant fraction obtained &om the sonicated cells was 
assayed for 6-lactamase activity and used for inhibition studies. The p- 
lactamase activity was measured spectrophotometncally with nitrocefin as 
the substrate. The method of biotinylated p-lactam and chedunlinescence 
was employed for study of the penicdhn-binding proteins (PBPs). The 
affinity of the PBPs for specific p-lactam antibiotics was investigated by an 
antibiotic competition assay. The outer membrane protein (OMP) profile 
was examined by differential solubilization and subsequent SDS-PAGE. 
Results: Bacteroides thetaiotaomicron 2877 was susceptible to imipenem, but 
showed resistance or decreased susceptibility to ampicillin, p i p e r a c h ,  
cefoperazone and cefoxitin. The ampicfin resistance was reversed by 
addition of clavulanic acid. The specific 0-lactamase activity was 0.13 U/  
mg. The enzynie activity was inhibited by clavulanic acid, but was not 
influenced by EDTA. The PBP profile of B. thetaiotaomicron 2877 slightly 
differed from that ofthe type strain B.  thetaiotaomicroii CCUG 34778, whch 
was used as a reference. The PBPl had a higher molecular weight in strain 
2877 than in the reference strain. However, the affinity of cefoxitin and 
piperacillin for PBPl was not decreased in strain 2877 as compared to the 
reference strain. Bacteroides thetaiotaorninon 2877 presented an altered OMP 
profile, which was mainly manifested as the absence of an approximately 37 
kDa OMP at the region of 37-40 kDa, as compared to the reference strain 
and most other B. thetaiotaomicron isolates investigated. Betides, other 
alterations as band intensity and band shift were also observed. 
Conclusion: The p-lactam resistance of the faecal isolate B.  thetaiotaomicrori 
2877 was shown to be mediated by production of p-lactamase and alteration 
in the OMP profile. No reduction of the PBP-affinity for cefoxitin and 
piperacillin could be demonstrated. 
vi Conjugative resistance to ceftazidime among 
nosocomial Klebsiella pneumoniae 
F. Coskunkan, 0. Tansel, S .  Cetiri Akhan, H. Vahaboglu 
Istaiihul, TR 
Objective: To demonstrate the genetic location and enzymatic character- 
istics of ceftazidime resistance in extended-spectrum p-lactamase (ESBL) 
producing nosocomial klebsiella isolates. 
Methods: Transconjugation experiments were studied on agar media and 
the recipients were selected on Mueller-Hinton agars supplenmited by 
nfampicin plus ceftazidime. Isoelectric-focusing were acheved on acryla- 
nlidlbis-acrylamide gels having ainpholytes with PI range of 3-10. Minimal 
inhibitor concentrations of antibiotics were determined by agar dilution 
method. SHV genes from the isolates were amplified by polymerase chain 
reaction. 
Results: A total of 70 ceftazidime resistant K. prieumoriiae from different 
hospitals were studied. From these, we obtained 44 transconjugates resistant 
to ceftazidime. An enzyme with PI  point of 8.2 was common to all 
ceftazidime resistant isolates. All of these were biaSHV positive by PCR 
experiments and the sequence of one of these was identified as SHV-5. 
Conclusion: SHV-5 is responsible from the conjugative resistance of ESBL 
producing K. pnenmoriiae to ceftazidime in Turkish hospitals. 
v1 Relationship between carbapenems activity and p- 
lactamase production, outer membrane protein and penicillin- 
binding protein profiles in clinical isolates of Acinetobacter 
baumannii 
F. Fernandez, A. Pascual, L. Martinez-Martinez, M. C.  Conejo, J.  Ayala. 
E. J .  Perea 
Seville, Madrid, E 
Objective: To evaluate the role of p-lactaniase production (BLS), outer 
membrane protein (OMP) and penicdin-binding protein (PUP) profiles in 
the activity of carbapenems (CBP) against clinical isolates of Acirtetobacter 
bauinannii (Ab). 
Methods: Twenty-six isolates of Ab representing different antimicrobial 
susceptibility, pulsed field gel electrophoresis (PFGE) and biochemical 
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patterns were studied. MICs of imipenem (IMP) and nieropenem (MPM), 
alone or combined with cla&c acid (CV; 2 mg/L) or BRL 42715 (BRL; 4 
mg/L) were determined by microdilution (NCCLS). supernatants of sonicated 
cells were used for the determination of the isoelectric point (PI) of BLS. 
Hydrolysing activity of BLS against cephaloridine (CFL), IMP, MPM and 
oxacdhn (OXA) was detemlined by spectrophotometry. OMPs were resolved 
by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). PBPs were labelled 
with 1251-ampicfin (AMP*) and separated by SDS-PAGE. 
Results: Seven PFGE patterns and 5 biotypes were obterved. In the 
presence of BFC (but not CV) MIC90s of IMP and MPM decreased from 
16 to 0.5 mg/L and from 8 to 4 mg/L, respectively. Hydrolysing activity 
(nnioles/nlin/mg) of bacterial supernatants against CFL ranged 18.8-552.3 
for Ab type I (MICs of IMP 2 mg/L). which expressed only BLS of pI 2 9, 
and 12.3-1543.5 for Ab type I1 (MICs of IMP 3 4 mg/L), which expressed 
BLS of 2 9 ,  6.3 and 7, respectively. Hydrolysing activities of type I1 isolates 
against, MPM and OXA were higher than those observed in type I isolates. 
Five OMP profiles were observed: A1 ( ) I =  14), A2 (ft=4), B (n=5),  D 
( t i  = 1) and E ( 1 1  = 2). The five isolates with OMP-profile type B (absence of 
a 22.5-kDa-OMP band) were resistant to MPM and/or IPM. Fifteen highly 
complex patterns of PBPs were observed. PBP patterns of type I1 isolates 
were charactensed by the absence of one band of 73.2 kDa (PBP 2a). For 8 
type I1 isolates for which the hghest MICs of IMP and MPM were obtained, 
another band of 70.1 k D a  (PBP 2b) was also absent. 
Conclusions: Resistance of Ab to IMP, but not to MPM, is reversed by 
BRL. Decreased activity of CBP against Ab is associated with BLS ofpI 6.3 
and 7.0, reduced expression of PBP2 and, in some isolates, loss of a 22.5- 
kDa OMP. 
vl Extended spectrum p-lactamases from Escherichia 
coli and K/ebsie//a pneurnoniae isolated from coastal marine 
waters of Northern Portugal 
A. Figueiredo. J. Sousa, L. Peixe, H. Ferreira 
Porto, P 
Objectives: Screening of E. rol i  and K .  pneurnoniae producing extended 
spectrum p-lactanuses (ESBL) in Oporto marine waters. 
Materials and methods: Saniples of seawater were collected monthly from 
3 beaches of Oporto urban area. Strains were isolated using the membrane 
6ltration technique. Filters were placed on MacConkey with ceftazidime (5 
pg/mL), or cefotaxime (2 pg/mL), or  nalidwc acid (50 bg/mL), or 
amoxicillin (100 pg/nL). Bacterial colonies selected were identified by 
classical biochemical testy and API 32 GN System. Antibiotic susceptibilities 
were determined by the disc diffusion method, according to the NCCLS. 
The strains were screened for the production of ESBL by using the double 
disc synergy test and the E-test method. The p-lactamase PI was deterrmned 
by isoelectric focusing. Conjugation and transformation assays were 
perfomied with strains producing ESBL. 
Results: Fe-eight E. coli and 4 K. pneumoniae producing ESBL, were isolated. 
fichekliia coli s& showed similar antibiotic susceptibility and PI of elactamases 
(5.4 and 5.9). The K. pimmiorriae strains showed two p-lactamase bands, one 
strain showed bands of PI 7.6 and 8.2, one 5.4 and 7.6, and the other two, 
showed ban& of pl 7.0 and 8.2. Conjugation assays of E. coli denionsmted that 
the ESBL of PI 5.9 was associated with conjugative plasm&. 
Conclusions: Extended-spectrum p-lactamases analogous to the previously 
described in clinical mains were found in strains of environmental sources. 
The presence of these strains in the absence of antibiotic selective pressure, 
in a somewhat hostile environment (marine water), seems to suggest 
contamination of marine waterj by urban wastewater, including that from 
hospitals. Furthemiore, this fact could be of great concern, since these 
bacteria can cause infection by ingestion, inhalation or contact, during 
recreation in such waters and concentration by filter feeding shellfish in 
sewage polluted bathing waters. Additionally, the transferability of the 
extended spectrum p-lactamase genes allows the dirtenlination to other 
species, including commensal bacteria of human host and fish. 
jp132q Isolation of a Salmonella typhimurium carrying an 
integron-encoding OXA-30 p-lactamase 
J. Ruiz, F. Gallardo, T. Jimknez de Anta, J. Vila 
Barceloita, E 
Objective: Characterization of a p-lactamase present in a clinical isolate of 
S .  ryphirnununr. 
Methods: A S. typhirnuriuin strain isolated from a stool sample of a patient 
with acute gastroenteritis was studied. The presence of p-lactamases was 
show by isoelectrofocusing. PCR with specific primers was perfomled to 
identified the type of 0-lactamase and the amplified product was sequenced 
to identify the exact P-lactamase present. PCR crossing the aforementioned 
primers and primers specific for integron type 1 was performed to locate the 
p-lactamase. 
Results: A p-lactamase with PI c. 7.3 was found in a clinical isolate of S. 
typhimurium. A positive result was obtained when a PCR with a consensus 
primers for p-iactamases Om-1, OXA-4 and O m - 3 0  was perfomled. 
The sequence of the amplified fragment show the presence of the OXA-30 
plactaniase. This p-lactamase was located in a type 1 integon together an 
aadAla gene. 
Conclusion: To our knowledge this is the second report of the OXA-30 0- 
lactamase (the first was in chinesse Shigella Jexiieri isolates), being the first 
time that this p-lactamase is found in S. typhiinurium. These results show the 
ease as p-lactamases located on integrons spread among different bacterial 
species and the loss of the geographical bamers which facilitates a worldwide 
diffusion of resistance genes. 
v] Detection and typing of extended-spectrum p- 
lactamases in clinical isolates of the family Enterobacteriaceae in 
a medical center, Turkey 
R. Durmaz, B. Durmaz, M. Koroglu, M. S. Tekerekoglu 
Maratya, TR 
Objectives: In order to determine and type the extended-spectrum p- 
lactamases (ESBLs) among the fanlily Ei~ter~~bacteriaceae in a medical center. 
Methods: A total of 668 clinical isolates were screened. Of the 668 isolates, 
the 80 strains were presumptively defined as ESBL producers according to 
the result of disk method using ESBL marker antibiotics (aztreonam, 
ceftazidime and cefoxitin). These 80 strains were retested with double-disk 
synergy test (DDST), the E-test ESBL strip, a 5 rmcrogram ceftazidime disk, 
and agar dilution MICs of ceftazidime with and without clavulonic acid. 
Isoelectric focusing was performed to confimi ESBL production and type 
the p-lactamases. 
Results: By evaluation of the results of all texs used for ESBL detection 
together with isoelectric focusing, 33 (4.9%) of the 668 isolates were 
described as ESBL producer. The positive results of the agar dilution test, 
DDST, the E-test strip, and 5 microgram ceftazidime disk were 32, 26, 27, 
and 26 of the 33 strains, respectively. ESBL positivity was 48.8% in Klebsiella 
species, 15.4% in Citrobacter species, 4.9% in Enterobactrr species and 1.1% in 
Escherirhia coli mains. The ESBL enzymes fiequently detemiined were 
SHV-2/6-like (PI 7.6), SHV-5-like (PI 8.2), SHV-4-like @I 7 4 ,  and 
SHV-3-like (PI 7). SHV-derived enzymes were comnionly observed in 
Klebsiella spp. while TEM-related enzymes in E. col i  strains. 
Conclusion: The results of this study indicated that SHV-derived ESDL 
expression among the isolates of the family Entembacteriaceae is an important 
problem in our medical center. 
v1 Resistance to p-lactams among clinical strains of P. 
mirabilis isolated in Poland 
E. Literacka, A. Baraniak, W. Hryniewicz 
Warsaw, PL 
Objectives: A notable increase in the frequency of p-lactam-resistance 
among P. mirubifis clinical strains has been observed over the last decade. It 
may be, among others, attributed to the constant growth of newer p-lactams 
consumption. The aim of the project was to evaluate susceptibility of 
climcal P. mirabilis strains isolated in Poland to expanded-spectrum p-lactam 
antibiotics and to study the hversity of their p-lactamases. 
Material and methods: The study was camed out on about 200 P. wlirabilis 
isolates collected from different Polish hospitals by the Sera and Vaccines 
Central Research Laboratory in 1999-2000. Most of the isolates were 
derived from urine samples. Species identification was performed by the 
ATB ID 32E test (bioMkrieux). Susceptibility to various antimicrobials was 
evaluated by the disc-diffusion method accordmg to NCCLS and the ESBL 
detection was performed by the double-disc synergy test (DDST). p- 
lactamase content of the isolates was examined by isoelectnc focusing (IEF) 
and the abhty of the enzymes to hydrolyse expanded-spectrum cephalos- 
porins was tested by the bioassay approach. 
Results: More than 32% of the P. mirabilis isolates were found to be resistant 
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to amoxicillin/clavulanic acid, cefotaxime and ceftazidime. The IEF analysis 
of p-lactamases extracted from resistant strains revealed the presence of 
enzymes with a PI of 5.4 or 5.6 and of approximately 9.0. All the isolates 
were DDST-negative. p-lactamases with a PI of i. 9.0 were able to 
hydrolyse cefotaxime and ceftazidune in vitro. 
Conclusion: Results of the study revealed a h g h  prevalence of P.  mirabilis 
strains resistant to newer generation p-lactam antibiotics in Polish hospitals. 
Isolates resistant to cefotaxime and ceftazidime showed a relatively low 
degree of diversity of p-lactamases produced. The observed resistance to 
expanded-spectrum p-lactams may be attributed to expression of p- 
lactamases with a PI of about 9.0. 
Spreading of integron borne metallo-p-lactamase 
gene among Gram-negative bacilli in Korea 
K. Lee, J. Yum, D.  Yong, J. Kim, Y. Chong, G. Rossolini 
Seoul, KOR; Siena, I 
Objectives: We reported presence of VIM-2 metallo-p-lactamase (MBL)- 
producing P. aeruginosa, P. putida and A. baumannii in Korea. It is to report 
the characteristic ofVIM-2 gene of P. putida, and detection of other species 
of MBL-producing Gram-negative bacfi. 
Methods: Imipenem-resistant clinical isolates at a tertiary care hospital in 
Korea were screened for MBL production by modified Hodge and EDTA- 
disk synergy tests. EDTA synergy-positive isolates were charactenzed for 
imipenem hydrolysis, possession of carbapenemase gene by PCR. P C R  
product of primers 5 CS and 3 CS of integron was used to sequence MBL 
gene. Transferabdity of the gene was tested by filter mating using P. 
aeruginosa P A 0  4089 as a recipient. 
Results: Besides previously reported P. putida isolates mostly from urine, 
one S. marcescens isolated in 2000 from urine was found to produce VIM-2 
enzyme. The sequence of these genes (Acession No. AF 291438 for P.  
putida) were identical to the previously reported one in France. One 
imipenem-resistant A .  baumannii isolated in 1998 kom urine produced IMP 
MBL. It is the first IMP producer in Korea. The sonicate of the IMP- 
producing A .  bauwrannii hydrolyzed imipenem more efficiently than that of 
VIM-2 producer. Imipenern resistance was transferred from 2 of 9 Vim-2- 
producing P. putida isolates by conjugation. The VIM-2 gene cassette of P. 
putida was present in an integron of approximately 3.0 kb. Other gene 
cassettes found were AACA7 and AADAl. 
Conclusion: Emergence of various species of MBL-producing Gram- 
negative bacilli indicate that MBL-genes are spreading among aerobic 
Gram-negative bacdh in Korea, which could compromise usefulness of 
carbapenem for treatment of Gram-negative bacilli infection. Presence of 
conjugatively transferable VIM-2 gene in P. putida indicate that this 
clinically less significant species can play significant role in transferring the 
resistance to other more virulent species, such as P.  aeruginosa. 
I PI330 1 Extended spectrum 0-lactamase production of 
Salmonella and Shigella spp. 
R. Karakus, F. Yetkin, C. Kidah, E. Senol, K. Caglar 
Ankara, TR 
Objectives: To investigate the presence and frequency of extended 
spectrum p-lactamase (ESBL) production of Salmonella and Shigella spp. 
isolated in adults. 
Methods: F o q  two Salmoirella spp. and 26 Shigelh spp. isolated from stool 
cultures of adults between March 2000 and September 2000 at the Gazi 
University Faculty of Medicine were taken into study. AU of the strains that 
were taken into study were isolated froin community acquired infections. 
ESBL production was investigated by double-disk synergy method using 
anioxicih-clavulanate (AMC), ceftazidime (CAZ), cefotaxime (CTX), 
cefepime (FEP) and aztreonam (ATM) disks according to the criteria of the 
NCCLS. The ESBL producing strains were checked for serogroups with 
BBL Crystal Identification (EnteridNan-Fermenter ID) kit. The results 
were independently read by two investigators. 
Results: Among the tested 42 Salmonella spp. and 26 Shigella spp. ESBL 
production was observed in six (14%) and two (7.7%) strains, respectively. 
Three of the six ESBL producing Salmonella isolates belonged to serogroup 
A, two to the serogroup D and one to the serogroup B. The shigella strains 
that demonstrated ESBL activity were identlfied and double checked as 
Shigella sonnei. Both of the Shigella sonnei isolates showed the same 
antimicrobial susceptibility patterns. 
Conclusion: ESBL production in salmonella strains is relatively a new 
phenomenon reported in our country. In our investigation we observed 
that six out of 42 (14%) Salmonella spp. with the majority belonging to 
serogroup A showed ESBL activity. Our finding is somewhat higher than 
the results of two studies (8% and 4.8%) reported in sporadic cases from our 
country at the 10th ESCMID meeting. ESBL producing strains among 
Salmonella and Shigella spp. alerts for periodic screening of these bacteria for 
ESBL activity. The results of our study &splay to be the first report of ESBL 
producing shigellu strains from our country. 
Clinical strains of Acinetobacter baumannii-genetic 
characterization and prevalence 
E. Stefaniuk, A. Baraniak, W. Hryniewicz 
Warsaw, PL 
Introduction: Gram-negative nonfermentive rods of Aiirtetobacter spp, are 
responsible for the increasing number of nosocomial infections. More and 
more of these are caused by strains that are resistant to many antimicrobials 
including p-lactams. p-Lactam-resistance may be mediated by different 
mechanisms, such as: a-lactamase production, PBP alterations and reduction 
of the outer membrane permeability. 
Objectives: The aim of our study was to perform the epidemiological 
analysis of A .  baumannii strains that were responsible for infections in a 
speciahed bum hospital in the south of Poland in 1999. 
Methods: Seventeen A .  baumannii clinical isolates were collected from 
patients hospitahsed in the Centre of Bums Therapy in Silesia between July 
and October 1999. MICs of various antimicrobials were evaluated by the 
microdilution method according to NCCLS. Strains were typed by REP- 
PCR and RAPD using ERIC1, RAPD-7 and RAPD-1283 primers. p- 
Lactamase content of the isolates was studied by isoelectric focusing (IEF). 
Results: All the A .  baumannii isolates were multiresistant with nine isolates 
that were resistant also to carbapenems. The PCR-based typing has revealed 
altogether six distinct types of the isoiates and two of these appeared 
predominant (type A-5 isolates, type B-7 isolates). The IEF approach 
demonstrated a high diversity of p-lactamases produced by the isolates 
reveahg enzymes with PIS of about 6.0. 6.5, 6.6 and more than 9.0. 
Conclusions: The results suggested that A .  baumannii infections that 
occurred in the hospital &om July to October 1999 were caused mainly 
by two distinct multiresistant strains. Their broad resistance to p-lactam 
antibiotics could be, at last partially, attributed to the production of various 
p-lactamases. 
lp1332/ Detection of the frequency of extended spectrum p- 
lactamases amongst Klebsiella spp. and E. coli from nosocomial 
infections and typing by the IEF method 
K. Loker, B. Besirbelhogh, 0. Kisa, H. Aydogan, U. Dizer, A. Pahsa 
Ankara, TR 
Extended spectrum p lactamase (ESBL) type of resistance is an important 
problem in the treatment of nosocomal infections especially where K. 
pneumoniae and E. coli is an infection agent. In h s  study, in 143 E. mli and 
47 K. pneumoniae strains, which are nosocomial infection agents, ESBL 
production was determined with the double disc synergy method and the 
frequency of the ESBL were found 3.1% and 42.6% respectively. Then, 
lactamase types were estimated by evaluating both the susceptibility of these 
ESBL producer strains to @lactam antibiotics and the PI values of the 
produced ESBLs. The dispersion of ESBL positive bacteria according to 
their date of isolation is as follows: the ESBL positivity rate of K .  pneumoniae 
species that are isolated in July-December 1999 was 47% and is decreased to 
37% in January-June 2000. In the comparison of the percentages of the 
ESBL positivity ofbacteria among clinics, neurosurgical clinic was at the top 
of the list. It was followed by burn unit, physical medicine and rehabilitation 
pediatry, general surgery, urology, internal medicine, and nephrology 
clinics. PI values of the ESBL were determined by using the IEF method. In 
92% of the species investigated in our study a band of 7.6 PI was found. This 
band may belong to SHV-1 or SHV-2. The second frequent band we found 
had a PI of 5.4 in 56% of the strains. This band is in accord with the TEM-1. 
The third frequent band with a PI of 7.0 has a rate of 24% of the species and 
is in accord with SHV-3. A band with a PI of 5.5 is found in 16% of the 
species whch may belong to either TEM-5, TEM-10 or TEM-26 enzyme. 
Other results were as follows: a band with a PI of 5.25 and with a rate of 
12% may belong to TEM-12 enzyme, a band with a PI of 6.6 with a rate of 
284 Abstracts 
8% may belong to TEM-25 enzyme, a band with a PI of 8.0 may belong to 
either SHV-4 or SHV-5, a band with a PI of 5.7 may belong to TEM-11 
enzyme. As a result, in our opinion to evaluate PI values of P-lactamases 
together with antibiotic susceptibility may be useful in the following studies; 
observation of antibiotic resistance changes, determining antibiotic 
resistance mechanisms, formation of an antibiotic usage policy, and in 
epidemiological studies. 
Distribution of the Klebsiella pneumoniae biotypes 
among the ESBL+ and ESBL-strains 
opoc, PL 
K. Burdynowski 
Objectives: To study the distribution and correlation between biochemical 
properties and ESBL production among the strains K. pneumoniae. 
Methods: One hundred and ninety-one strains of K. pneumoniae &om 
patients hospitalised on disparate wards in the period of 01.02.1999 to 20.10 
2000 have been analyzed. The average age of a patient was 21.7 yean (range: 7 
days to 86 yeas), of 191 patients were 73 female and 118 male. The 
investigated s w s  were isolated as following: faecal specimens-71 (ESBL-, 50; 
ESBL+, 21). blood and catheter tip-14 (3; 11, respectively), urine-46 (26 20), 
pus specimens-9 (4; 5 ) ,  resplratoIy tract and throat-51 (25; 26). Among the 
examined strains, 83 of them produced the ESBL. The idenhfication of the 
biotype and ESBL production was perfomied using a VITEK system 
(bioMerieux), with a use of the GNI+ and GNS 650 cards, respectively. 
All of the detections were made according to the tests’ manufacturer’s 
instruction. Statistical analysis was performed by using Ch-square test. 
Results: T h q - t h r e e  biotypes were obtained. A l0-digt number 
representing the biochemical properties, corresponding to an algorithm 
acquired by the tests’ manufacturer, described them. The biotype number 
6674773631 characterised 41.36% of all the strains analyzed, besides there 
were 44.44% of the strains with that biotype in the ESBL-strains group, and 
37.35% in the group of the ESBL+ strains. The 6674771631 biotype, found 
in 7.33% of the analyzed strains, was noticed in 9.26% ESBL-and 4.82% 
ESBL-. Biotypes 6274773631 and 6674771630 occurred only among the 
ESBL+ strains (correspondingly 7.23% and 4.82%). The 6234773631 
biotype was found in the 4.63% of the only ESBL-group. 
Conclusions: An observation was made that the two most common biotypes 
(48.69% of the analyzed strains), differing from each other in only one 
biochemcal characteristic (the abihty of adonitol fermentation), are more 
popular among the K. pneumoniae with no ESBL production. Also a higher 
frequency of urea hydrolysis and lysine decarboxylation was observed in this 
group. Inositol was fermented more often by the ESBL+ strains. The 
research of the correlation between production of the ESBL and the K. 
pm~nzoniae biotypes should be continued on a bigger number of strains. 
I - f l 3 7  Detection of extended spectrum p-lactamase with 
double disk diffusion test and E-test ESBL method 
F. Korkmaz, B. Bayraktar, A. Eren-Sensoy, J. Aytaq, E. Seber 
Istanbul, TR 
Objectives: Nosocomial strains of Klebsiella spp, and E. coli that produce 
ESBLs are becoming more common. Accurate and rapid detection of this 
isolates IS important since it may result in treatment failure with 
cephalosporins and monobactams. In this study two phenotypic confirma- 
tion methods for ESBL detection, the double disk diffusion and E-test 
ESBL, was compared with each other. 
Methods: The bacteria were collected &om intensive care units and wards at 
Sisli Edal Hospital. Sixty-four clinical isolates (53 K. pneumoniae, 6 E.  coli, 2 
K. oxytoca, 3 E.  aerogenes) were considered a potential ESBL producer on the 
basis of disk diffusion screening test performed with ceftazidime (CAZ) and 
cefotaxime (CTX) disks according to NCCLS M100-S9, 1999. For double 
disk diffusion test CAZ. CTX plus amoxic ih  + clavulanic acid (AMC) 
disks were used. Enhancement of inhibition zone or so-called ghost zone 
indicated presence of ESBL in certain strain. Both of the E-test ESBL strips 
(AB Biodisk), ceftazidime (TZ), ceftazidime f clavulanic acid (TZL) and 
cefotaxime (CT), cefotaxime + clavulanic acid (CTL), were used. If the 
MIC ratio (TZ/TZL, CT/CTL) was equal or higher than 8 or there was a 
phantom zone, strain would be considered as ESBL producer. Data analysis 
were done by chi-square test and P < 0.05 was accepted significant. 
Results: The presence of ESBL was confirmed by at least one of the 
methods in 52 of the strains. Forty-two strains were ESBL positive by TZ/ 
TZL and/or CT/CTL E-test strips. Enhancement of inhibition zone was 
detected 39 of the strains with double disk difusion method AMC-CTX 
and/or AMC-CAZ. AMC-CTX alone detected 38 strains as ESBL positive 
while AMC-CAZ detected only 27. Eight strains remained not determin- 
able (ND) with E-test and showed no enhancement of inhibition zone with 
double disk difhsion test. 
Conclusions: We demonstrated that our hospital strains had ESBLs with a 
substrate preference for cefotaxime. Although E-test ESBL strips detected 
two more ESBL producer strains than double disk diffusion test, this was 
accepted statistically insigmiicant. Beside that double disk diffusion test is 
cheaper and easier to perform. 
Comparative value of the different methods used for 
detection of staphylococcal methicillin-resistance 
B. Kowalska-Krochmal, I. Doha, J. Ruczkowska 
Wroclaiv, PL 
Objectives: Identification on methicdlin resistant staphylococci has a great 
clinical implication and significant impact on antibiotic therapy. The aim of 
our study was to compare the disc-diffusion method with agar dilution 
method, E-test and agar screen test. 
Methods: Ninety selective clinical strains of staphylococci (13 S. aureus- 
MRSA, 77 Coagulase Negative Strains-MRCoNS) determined as 
methcillin resistant (MRS) by disc-diffusion test were enrolled in this 
study. These strains were also resistant to one (erythromycin-E, 
doxycycline-D, gentamycin-GM, ko-trinioxazole-SXT, ciprotloxacin- 
CIP) or two antibiotic (E,D; E,SXT; E,GM; E,CIP; D,SXT; GM,SXT). 
Disc-difhsion method (DDM) was performed with oxaciUin (1 pg/mL) on 
Mueller-Hinton agar-MHA (Becton Dickimon) without NaCL Agar 
dillution test (ADT)-oxacillin was added to MHA with 2% NaCl to final 
concentrations 0.25 pg/mL-1024 pg/mL. E-test -A€? Biodisk-was 
performed by applying the strips with methicillin on MHA with 2% NaC1. 
Oxacillin agar screen test (0AST)-was performed on MHA with 4% NaCl 
and oxacillin 6 p g / d  (according to NCCLS) and with modifymg 
concentration of oxac1Uin4.6 pg/mL only for CoNS according to Kohner 
P et al. suggestions. More than one colony growing on the plate indicated 
oxac&n resistance of the tested strains. The plates were inoculated by 
swabbing the surface with staphylococcal suspension (0.5 McFarland) and 
incubated in 30 C (DDM) or 37 C (ADT, E-test, OAST) for 24 h ( S .  
aureus) or 48 h (CoNS). Strains were classified as M R S  (positive) in 
accordance with NCCLS (1999). 
Results: In the group of 90 MRS strains detected by DDM, positive results 
were as follow: E-test in 82 (1 1 S. aureus, 77 CNS), ADT in 87 (13 and 74), 
OAST-6 pg/mL in 55 (9 and 46), OAST-0.6 pg/mL in 70 among 77 
MRCoNS. Agreement between the DDM, E-test, ADT,OAST-6 p g / d  
was 61% (55/90), between DDM, E-test and ADT was 91% (82/90) and 
between DDM, E-test, ADT, OAST-0.6 pg/mL was 91% (70/77). 
Conclusions: Despite discrepaciens between methods, DDM seems to be 
sufficient for routine MRS screening. We found Kohners et al.’s method 
(OAST-0.6 pg/mL for CoNS) worth recommending. 
lp13361 Critical appraisal of E-test and Oxoid Combination 
disk for the phenotype detection of extended-spectrum 
P-lactamases 
M. Kcrawala, T. Saleh, P. Lee, Y. Drabu 
London, UK 
The rapid emergence of Enferobacteriaceae harbouring extended-spectrum p- 
lactamase (ESBL) enzymes continue to pose a serious threat and provide a 
therapeutic challenge to clinicians. 
Objectives: A number of screening methods for detection of ESBL are 
commercially available. The objective of the study was to evaluate the 
ability of ESBL E-test strips and Oxoid Combination d i s h  to detect ESBLs 
in comparison with double &sk synergy (DDS) test. The study also 
determined the in uifro activity of piperacillin/tazobactam (PTC), 
meropenem (MP) and mecillinam (MM). 
Methods: The ESBL E-test strips [ceftazidmie (TZL) and cefotaxime (CTL) 
with clavulanic acid] and Oxoid Combination disks [cefpodoxime (CDOl), 
ceftazidime (CD02) and cefotaxime (CD03) with clavulanic acid] were 
evaluated and compared with conventional DDS test using ceftazidime (30 
pg), amoxycillin/clavulanic acid (20:lO mcg) and cefotaxime (30 pg). The 
MlCs of PTC, MP and MM were determined by E-test. 
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Results: Eighty-two multiresistant Gram-negative clinical isolates were 
tested for ESBL. The 22 strains (27%) found to harbour ESBL by the DDS 
test method were: Enterobacter (8), Klebsiella (7), E. coli (5), Acinetobacter ( I )  
and Mogartellu (1). Majority of the ESBL-positive isolates were correctly 
identified by CD03 (20/22; 91%) followed by CD02 (18/22; 82%). Whilst, 
CDOl and CTL E-test perfomied equally well (11/22; 50%), TZL E-test 
performed poorly (9/22; 41%). Enterobacter produced most hscrepancies 
with both E-tests and CDOl. The MIC values of all eight ESBL-positive 
enterobacter were outside the test ranges and interpretation was not 
determinable; hence ESBL producen were not identified by these methods. 
Of the 82 isolates, 25 (31%) were PTC-resistant (MIC 2 32 mg/L) and 33 
(40%) were MM-resistant (MIC > 16 mg/L). AU isolates were susceptible 
to MP (MIC < 4 mg/L). 
Conclusions: Our data suggests that the ease of use and reliability of 
combination discs (CD02 and CD03) make them an attractive option for 
use in a routine diagnostic laboratory. In conclusion, meropenem remains 
the drug of choice for empirically treating multiresistant Gram-negative 
infections, including ESBL-producing strains. 
v1 Extended-spectrum p-lactamases frequency amongst 
100 nosocomial Gram-negative bacilli isolated consecutively in a 
teaching hospital, Turkey 
E. Titizler, N. Elaldi, I. Dokmetas, M. Bakir, M. Z .  Bakici, M. Turan 
Adiyumun, Sivas, TR 
Objectives: To evaluate the frequency of ESBLs in 100 nosocomial Grarn- 
negative isolates and their irt vitro susceptibility to antimicrobials at our 
hospital. 
Methods: This study was performed between December 1998 and October 
1999. In this 11 month follow up period 100 nosocomial infections caused 
by 100 Gram-negative bacilli isolates were separated. Nosocomial infections 
were defined by CDC criteria. Isolates were identified using Uecton 
Dickinsoii Autosceptor and were tested by the disk diffusion method to 
different antimicrobials according to NCCLS recommendations. ESBLs 
were detected by the double-disk synergy test (DDST). 
Results: Escherichia coli (37%), Pseudomonas aeruginosa (25%) and Klebsiella 
pnerrntorziae (13%) were the most responsible microorganisms for nosocomial 
Gram-negative bacillary infections, respectively. Twelve percent of all 
isolates were producing ESBLs and included four different species. Six K .  
pneurnoniae (46%), 3 E. coli (8%) and 2 P. aerugirzosa (8%) strains were ESBL 
positive. Seven (58%) isolates which were producing ESBLs recovered from 
surgical intensive care unites (ICUs). AU the patients infected with ESBLs 
producing isolates received different aiitibiotics before the diagnosis of 
infection. Against ESBLs positive sti-ains meropenem, amoxicillin-clavula- 
nate and cefepinie were the most active agents with 100%. 83% and 67% 
susceptible strains, respectively. 
Conclusions: These observations suggest that especially in our ICUs ESBLs- 
producing Gram-negative bacilli is a problem and against these micro- 
organisms meropenem is the most active agent in our hospital. 
I PI338 I Antibiotic susceptibility and p-lactamase activity of 
Enterococcus isolates 
Y. Karaca, H.  Pullukcu, S. Aydemir, A. Tunger, F. Ozkan, M. A. Ozinel 
Irmir, TR 
Enterococci are inicroorganisnis that can cause severe infections especially 
in patients who are hospitalized for a long time and treated with wide 
spectrum cephalosporins. We have serious difficulties in the therapy of their 
infections because of their unique antibiotic susceptibility pattern. In this 
study we aimed to investigate the p-lactamase production and susceptibility 
of enterococcus isolates to some antibiotics. Study group consisted of 69 
enterococcus strains isolated from the hemocultures of the patients 
hospitalized in Ege Univenityity Medical Faculty Hospital between 1999 
and 2000. We used API system (20 Strep, BioMerieux) for bacterial 
identification, E-test (AB Biodisk) for ampicifin, gentamycin, streptomycin, 
teicoplanine and vancomycin susceptibility and nitrocefin method (Oxoid) 
for !3-lactainase activity. Forty of the isolates were identified as Enrerococcur 
fueculis and 29 as Enterococ~cus.fuecium. Among the E. .faeculis isolates high level 
aminoglycoside resistance was detected for streptomycin in 12 (30%) and for 
gentaniycin in 7 (17.5%) strains. These ratioc for E..faecium were found to be 
10 (34.5%) and 19 (65%), respectively. All isolates were found to be 
susceptible to vancomycin (for E. jiecalis MIC50 = 3 nig/mL, MIC90 = 4 
mg/mnL,; for E .  faecium MIC50 = 2 mg/nlL, MIC90 = 2 nig/nL) and 
teicoplanine (for E. faecalis MIC50 = 0.5 mg/mL, MIC9O = 1 mg/nL; for 
E. jaecium MIC50 = 1 mg/mL, MIC90 = 2 mg/mL). Among 40 E. .faecalis 
isolates 39 (97.5%) (MIC50 = 0.5 mg/mL, MIC90 = 8 mg/mL) and among 
29 E.fueciuwz isolates 11 (37.9%) (MIC50=32 mg/mL, MICYO= 128 mg/ 
mL.) were found to be susceptible to ampicillin. Twenty (50%) E.  jaesalis 
isolates (MIC50=4 mg/mL, MIC90=32 mg/mL) and 12 (41.4%) E. 
faeciunr isolates (MIC50 = 16 nig/mL, MIC90 = 32 mg/nlL) were suscep- 
tible to levofloxacin. p-lactamase production was not detected 111 any of the 
isolates. It IS concluded that gIycopeptide resistance is not yet a n  important 
problem for enterococcus isolates in our region. However, we observed that 
high level aininoglycoside resistance reached to a high ratio which diables 
the use of traditional combination therapy. 
vl Antibiotic susceptibilities of Gram-negative bacteria 
producing extended spectrum p-lactamase and inducible 
p-lactamase 
A. E. Aktas, A. Ayyildiz, N. Yigt, U. Altoparlak, F. Al 
Errurum, TR 
In this study, a total of 212 Gram negative bacteria (104 Esrherichia coli, 24 
Klebsiella pneumuniae, 70 Pseudomortas aeruginosa and 14 Aciriefobacter 
baumannii) isolated from clinical samples as a causitive agent were researched 
for the presence and frequency of extended spectrum P-lactamase (ESBL) 
and inducible p-lactamase (IBL). The strains were then tested for their 
antibiotic sensitivities against 11 different drugs (Aztreonam, Imipenem, 
Ceftriaxone, Cefotaxime, Ceftazidime, Cefoperazone, Ampicillin, Cefe- 
pime, Gentamicin, Trimethoprim-Sulfamethoxazole, Ciprofloxacin). The 
double disc synergy method was camed out for deternining the presence of 
ESBL, and direct induction method for IBL. As for the sensitivity test, disk 
diffusion method was applied and evaluated according to the NCCLS M2 
A5 criteria. At the end, ESBL was determined in 24 out of 104 E .  coli strains 
(23.0%). 10 out of 24 K. prteumoniae strains (41.6%); and also IBL was 
detemuned in 56 out of 70 P. aerugirroso strains (80.0%) and 1 ouc of 14 A .  
baumnnnii stran< (7.1%). The most effective antibiotics for P. aeriyiitosa were 
imipenem (1 00%) and cefepime (100%). Similarly cefepinie and imipeneni 
were found to be the most effective antibiotics for E.  coli (lOO%), for K .  
pneumoniae (100%) and for A .  balrmannii (100%). O n  the other hand, the 
most ineffective antibiotics for the tested bacteriae were as follows: For E. 
coli, ampicillin (22.2%) and Trimethoprim-Sulfamethoxazole (40%); for K .  
pneumoniae, ampicillin (0%); for A. baumanni, ampicillin (0%) and 
Trirnethopnm-Sulfamethoxazole (0%). One another important finding 
resulted 6om the study was that the strain< producing ESRL and/or IBL 
were more resistant to antibiotics than the others. 
1 PI340 I Application of modified Hodge test for screening 
CMY-1-producing strains of Escherichia coli and Klebsiella 
pneumoniae 
Y. Chong, D. Yong, J. Yum, H. Park, H. Lee, K. Lee 
Seotrl, KOR 
Objectives: Increase of plasmid-mediated AmpC P-lactamase-producing E. 
coli and K. pneumoniae is a womsome phenomenon as they coufer resistance 
to a wide variety of P-lactams and may transfer the resistance. The aim of 
this study was to determine applicability of the modified Hodge test for the 
screening of CMY-1 e-lactamase-producing strains. 
Methods: Consecutive isolates of 100 E. ioli and 50 K.  prreurnorriar were 
collected in 1999. Susceptibility to cefoxitin was tested by NCCLS disk 
method. PCK was used to detect blaCMY-l gene from cefoxitin- 
nonsusceptible strains. For modified Hodge test, Mueller-Hinton agar was 
inoculated with cefoxitin-susceptible E. coli (ATCC 25922) and a 30 nicg 
cefoxitin disk was placed. A cefoxltin-nonsusceptible test strain was streaked 
heavily from the edge of the disk to the periphery of the plate. After 
incubation, reduction of inhibition zone was measured. Three dimensional 
extract (3-D) method was used for comparison. For the 3-D method, p- 
lactamase was released by sonication instead of freezing-thawing. For 
modified Hodge test-equivocal isolates, cefoxitin hydrolytic activity of cell 
sonicate and minimuni inhibitory concentratiou of cefoxitin were tested. 
Results: Of the 150 isolates tested, 33 E. coli and 9 K. pneunioriiae showed 
cefoxitin zone diameter of less than 19 mm (I or R). Among the 42 
cefoxitin-nonsusceptible isolates, CMY-1 gene was detected from 29. 
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CMY- 1 gene-positive isolates showed reduction o f  inhibition zone by 3-10 
mm, while the gene-negative isolates 6 3  mm by the Hodge test. 
Reduction of inhibition zone of 3 nun clearly distorted the shape of zone, 
while reduction by 2 mm did not distort the zone and easily interpreted as 
negative. Among the 31 Hodge test-positive isolates, 2 were CMY-1 
negative, resulting false positive rate of 6.5%, if over 2 mm is interpreted as 
positive. AII of the CMY-1 gene-positive isolates showed 3-10 mm 
reduction of inhibition zone by 3-D method. The Hodge test does not need 
to release p-lactamase while 3-D method needs repeated freezing-thawing. 
Limitation of this study is that among the AmpC p-lactamase-producing 
strains, only CMY-1 producen were tested. When the reduction is 3 mm 
by the Hodge test, additional test is required for confirmation. 
Conclusion: Modified Hodge test using background lawn of E. coli ATCC 
25922 and cefoxitin disk is simple to screen CMY-1 p-lactamase-producing 
E. coli and K. pneumoniae. 
Extended spectrum beta-lactamases 
I P1341 1 High frequency of quinolone resistance in extended- 
spectrum-p-lactamase producing €. coli but not in K. 
pneumoniae isolates from a Spanish hospital 
R. Cantbn, T. M. Coque, M. C. Varela, A. Oliver, J. C. Ptrez-Diaz, 
E. Loza, F. Baquero 
Madrid, E 
The report of the increasing frequency of fluoroquinolone resistance among 
extended-spectrum-p-lactamase (ESBL) producing isolates has been 
recently focused in K. pneumoniae but not in E .  coli isolates. A total of 
165 K .  pneumoniae and 104 E. coli isolates recovered from 131 patients 
attended in our  institution from June 1988 to October 2000 were identified 
as ESBL-producing isolates. Different ESBL belonging to TEM-(52%), 
SHV-(l9%) or CTX-M-(29%) families were characterised by PCR and 
sequence amplification. Nalidixic acid and ciprofloxacin susceptibility 
testing (standard NCCLS agar dilution) revealed that 26.9% of E. coli 
isolates were resistant to ciprofloxacin. The corresponding value for 
nalidixic acid was 40.4%. Resistance to quinolones dramatically increased 
in ESBL-producing E. coli isolates along the 1996-2000-year period. 
During this period, n&dwc acid and ciprofloxacin resistance rates were 
59.1 and 37.9%, respectively. On the contrary, these resistance rates were 
7.9 and 7.9%, respectively, during the 198&95-year period. To note that 
quinolone resistance was frequently observed in CTX-M-ESBL-producing 
E.  coli isolates (54%) and at a lower rate in those producing TEM-ESBL 
(32%) or SHV-ESBL (14%) enzymes. All these quinolone resistant ESBL- 
producing E. coli isolates were recovered from adult patients. Contrary to E. 
coli, only 1.2% and 3.6%) of ESBL-producing K. pneumoniae isolates were 
resistant to ciprofloxacin and nalidixic acid, rrspectively. Quinolone resistant 
ESBL-producing K.  pneurnoniae isolates were randomly distributed along the 
studied period and with the exception of a Cystic Fibrosis patient, all these K. 
pneumoriiae isolates were also recovered from adult patients. In our hospital, the 
increasing frequency of quinolone resistance in ESBL-producing E. coli isolates 
is of pardcular concern but not in ESBL-producing K. pneumoriiae isolates. This 
situation should be also monitored in other instituhons. 
isolates (35.6%, n= 65/180) (P < 0.02). Furthermore, the prevalence ofthe 
0 1  serotype among serum resistant strains of both ESBL and non-ESBL- 
producing isolates (75%, n = 25/33; 76%, n = 18/24, respectwely) was 
significantly higher than that among the serum sensitive strains (57%, 
n=32/56; 27.2%, n=40/147) (P  < 0.02). 
Conclusions: The results suggest that ESBL-producing strains are more 
virulent than non-ESBL-producers. This notion requires the examination of 
the clonality of the isolates to exclude the possibility that the isolates belong 
to few individual clones to permit statistical evaluation. 
ESBLs producing enterobacteriaceae from APUA- 
Bulgaria Chapter survey 
E. Keuleyan, M. Sredkova, D. Ivanova, 1. Haydoushka, R. Marrkovska, 
N. Hadjieva, T.  Strateva, I. Mitov 
Sgfia, BG 
Objective: To survey the incidence of ESBLs producing strains during 
APUA-Bulgaria Chapter survey, conducted for 3-6 months during 19991 
2000 in 5 University hospitals. 
Methods: Double disk synergy (DDS) method by V. Jarlier et al. E-test 
ESBL (ceftazidime) (AB BIODISK, S o h ,  Sweden), cefpodoxime (CPO) 
disk and conjugation plasmid transfer to E. coli W33 10 Rif lac-, E. coli J 62 
Nx lac- and E. coli W3110 Nx lac + were applied. 
Results: ESBLs producing strains have been detected from 3 different 
University hospitals-in Pleven, Sofia and Plovdiv. They represented 40 
Klebsiella spp., 8 E. coli, 4 C.freundii, 4 E. cloacae and 2 S .  marcescens. DDS, 
E-test and CPO-methods showed complete agreement. Conjugation 
plasmid transfer of genes encoded for ESBLs was successful in 8 of 8 E. 
coli, 5/51 K. pneumoniae and 1/2 E. cloacae strains. 
Conclusions: ESBLs producing strains, commonly encountered in other 
European countries, as well as in many other parts of the world, are now 
emerging in Bulgaria and may represent a significant challenge for both 
laboratory and clinical practice. Further investigations will be necessary to 
characterize the type of ESBLs and the epidemiology of strains. 
11)13421 Association between extended spectrum p-lactamase 
production, 0-serotypes and serum resistance properties in 
Klebsiella isolates from different European countries 
H. Sahly, H. Aucken, V. J. Benedi, C. Forestier, D. S. Hansen, K. Krogfelt, 
T. Oelschlaeger, R. Podschun, D. Sirot, J. M. Tomis, U. Ullniann, I .  Ofek 
Kid, D; London, UK; Palrna de Mailorca, E; Cfermont-Fenartd, F; Copenhapi ,  
DK; Wurzbq, D; Barcelona, E; Tel Aviv, il 
Objective: T o  evaluate the possible association between serum resistance 
properties, 0-serotypes and the production of extended spectrum p- 
lactamases (ESBL) in Klehsiella strains from different European countries. 
Methods: One hundred and eighty non-ESBL producing and 80 ESBL- 
producing Klehsiella pneumoriiae isolates from five European countries 
(Denmark, England, France GL I many, and Spain) were 0-serotyped by 
ELISA using 0-type specific rabbit antibodies and tested for their ability to 
resist killing by nomial human serum. 
Results: The frequency of serum resistant strains was significantly higher 
among ESBL-producing Klebsiella strains (30%, N = 24/80) than among 
non-ESBL-producing strains (18.396, n =  33/180) ( P  < 0.02). Although the 
01-serotype was the most frequent 0-serotype among all Mebsiella isolates 
(30%-70%), its frequency among the ESBL-producing strains (62,3%, 
I J  50/80) was significantly higher than among the non-ESBL-producing 
v1 Detection of expanded spectrum plasmidic p- 
lactamases: results of an external quality control programme 
J. L. PCrez, C. Gimeno 
Madrid, E 
Introduction: ESBL-producing clinical strains have became a major problem 
in some European hospitals, causing severe infections difficult to treat. 
Because MlCs for some p-lactam antibiotics are wthin the succeptibility 
range, it is very important that clinical laboratories were able to recognize 
this resistance phenotype. External quahy control programmes might help 
in this way by sending control strains and by implementing continuous 
education activities around these controls. 
Methods: In April 1997, an ESBL-producing Kkbsiella prieumonioe clinical 
strain was sent to 242 laboratories participating in the nation-wide Quality 
Control Programme sponsored by the Spanish Society (SEIMC). MIC for 
cefotaxime (CTX) obtained by the reference laboratory for ths  strain was 4 
mcg/mL, and reported as resistant because of phenotypic characterization 
(MIC in presence and absence of  clavulanate, double disk-diffusion test, 
etc.). The same strain was sent to 309 participants in 1999. 
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Results: A total of 186 laboratories returned a response in 1997. Of these, 
only 45 (24.2%) reported specifically that the strain produced ESBL. 
Moreover, only 57/149 responses (38.3%) from laboratories performing 
CTX susceptibility tests reported resistance to this p-lactam antibiotic. 
Conversely, in 1999, 155 out of 282 (55.0%) participants that sent results 
recognize the presence of an ESBL, and 69.2% informed the strain to be 
resistant to CTX (139/231 laboratories doing CTX susceptibility). In the 
1999 control, a subset of 94 laboratories were participants not registered in 
1997. When excludmg them from the analysis, 133/188 (71.3%) were able 
to detect an ESBL, a figure that compares favourably with the percentage of 
1997. Moreover, 80.1% of the ‘old participants’ informed resistance to 
CTX, in comparison with the 40.0% of the new members. When analysis 
was focused on those laboratories detecting the ESBL phenotype, 89.3% and 
91.9% reported resistance to CTX in 1997 and 1999, respectively. 
Conclusions: (a) An increase in laboratories detecting the ESBL phenotype 
in the control strain was observed along the two-year period; (b) external 
quality control programmes may be a valuable tool for continuous technical 
improvement in the clinical microbiology laboratories. 
/p13W1 Antimicrobial susceptibilities of Enterobacteriaceae, 
Pseudomonas spp. and Acinetobacter spp. isolated from an 
Algerian hospital 
N. Ramdani-Bouguessa, F. Slimam, A. El Ksouri, R. Denine 
Akiers, DZ 
Objectives: To evaluate the prevalence of antimicrobial resistance among 
the most common Gram negative rods isolated from inpatients between 
1998 and 2000. 
Methods: Eight hundred and eighty-four Enterubacteriaceae (428 E. roli, 196 
Klebsiella, 77 Proteus, 72 Salmonella, 64 Enterobacter, 28 Serratia, and 19 
others), 149 Pseudumonas aeruginosa, 30 Pseudomonas spp. and 106 
Acinetobacter spp. were studied. Susceptibilities were tested by disk difision 
method according to the NCCLS guidelines. Screening for detection of 
extended spectrum p-lactamases (ESBLs) &om Enterobactericeae was used by 
the double-disk synergy test (DDT). DDT-positive results of 118 selected 
strains were tested to ceftriaxone by MIC. 
Results: 610 (69%) of Enterobarteriaceae and all Pseudomonas and Aritietobarter 
were collected from nosocomial infections, rates of nosocomial septicemia 
caused by these strains were, respectively: 68.6%, 17.3% and 37.7%. Among 
the Enterobactericeae 22.5% were resistant to cefotaxime, ESBL production 
was observed in 32.7% of nosocomial strains, the highest rates were for 
Salmortella (81%) and Klebsiella (49.3%) and the lowest for Pruteus (3.7%). 
Resistance to other drugs was as follows: cefoxitine 1296, gentanllcin 45%, 
amikacin 18%, ofloxacin 10% and 0 to imipenem. MIC50 and MIC90 of 
ceftriaxone were, respectively, 64 and 256. Resistance of Pseudomunus and 
Acinetobacter were, respectively: ticacillin 12% to 72%, piperacfin 17% to 
84%, ceftazidini 6% to 57%. imipenern 4% to 3%, gentamicin 36% to 75%, 
amikacin 6% to 51% and otloxacin 18% to 37%. 
Conclusions: ESBLs appear to be widely disseminated in our hospital and 
indicate the overuse of third generation cephalosporins, in addition the 
stralns of Acinetobacter show a rnultidrug resistance. Prevention of 
nosocomial infections is needed by implementation of control measures 
and the rational use of antibiotics. 
Prevalence of ESBLs producing isolates among 
En terobacteriaceae 
R. Vatcheva-Dobrevski, P. Pencheva, E. Savov, T. Chalashkanov 
S&, B G  
The aim of this study was to comprise the frequency of ESBLs in two big 
hospitals in Bulgaria for 1 year period. A total of 3567 isolates of 
Enterubacteriaceae were investigated by the Mini API system (Bio Meneux, 
France). ESBL detection was performed with the double disk (DD) test and 
ATB BLSE (Bio Merieux, France). MIC patterns were detected by E-test 
(AB Biodisk,Sweden). The 205 (5.74%) ESBL producing strains were 
isolated from urine (38%). endotracheal aspirate (36.6%), surgery wounds 
(17.6%), blood (6.3%), etc. (1.5%). Amongst ESBLs strains Klebsiella 
pneumoniae showed higher production (76.2%). ESBLs positive strains were 
isolated more frequently from ICUs (59.3%); Urology (19.6%); Surgical 
words (14.5%). The obtained results confirm a relatively high incidence of 
ESBL production among Enterubacteriareae. The DD test seems to be a 
practical method to discriminate ESBLs. Semiautomated ATB-BLSE 
method is more sensitive. Preliminary results on the antibiotic susceptibility 
profiles of ESBLs producers show that all strains has completely 
susceptibility to carbapenems. Optimisation of antibiotics use based on 
microbiological surveillance is the way to mininllze resistance problem. 
w1 Occurrence of extended spectrum p-lactamases at 
the university hospital of Thessaly (Central Greece) 
P. Petinaki, F. Hatzi, A. Maniatis 
Larissa, GR 
Objectives: The occurence of prevalence of ESBL among Escherichia coli 
and Klebsiella pneumoniae in the district of Thessaly, was the purpose of 
this study. 
Methods: Six hundred and sixty non-replicated isolates of E. culi (580) and 
K. pneumoniae (80), collected during a six month period from clinical 
specimens at the University Hospital of Thessaly were studied. Anti- 
microbial susceptibility to p-lactams antibiotics, aninoglycosides, quino- 
lones, tetracycline and trimethoprim-sulphamethoxazole was performed by 
Kirby-Bauer method and by ATBG-System. Determination of MIC to 
ceftazidime, cefotaxime, ceftazidime-clavulanic acid and cefotaxinie- 
clavulanic acid was performed by agar dilution method. All the strains 
demonstrating reduced sensitivity to ceftazidime and cefotaxime or both 
abtibiotics were tested by Double Disk Synergy Test (DDST). 
Results: Twenty-two (10 E. culi, 12 K. pneumoriiae) out of 660 isolates 
produced ESBL. The DDST was found positive in all ESBL-positive 
isolates. The majority of the isolates (81%) had reduced sensitivity to 
cefotaxime, while were hghly resistant to ceftazidime. Resistance (70%) has 
been observed only to aminoglycosides. 
Conclusions: The overall prevalence of ESBL producing E. ruli and K. 
pneumoniae in our institution was 3.3%. This prevalence rate seems currently 
to be amongst the lowest in Europe. Perhaps, resistance is due to the 
expression of SHV-5 type p-lactamase, an enzyme which is prevalent in 
Greek ceftazidime-resistant isolates. 
lp1348/ A multicenter survey of the various antibiotics ability 
to detect ESBL-producing Klebsiella spp. and E. coli 
D. Roe, L. Van Pelt, E. Baron, P. Coudron, G. Hall, J. Hindler, V. 
LaBombardi, S. Mirrett, S. Munro, D. Paterson, M. Weinstein, B. Z m i e r  
West Sacramento, Palu Alto, Richmotid, Clevelaiid, Lus Atigeles, New Yurk, 
Durham, Pittsburgh, New Brunswick, U S A  
A multicenter survey was conducted to compare the ability of five screening 
antibiotics to identify isolates of E. culi and Klebsiella spp. that were 
subsequently shown to be ESBL produces using phenotypic confirmatory 
tests. NCCLS M100-SlO recommendations were followed for all testing 
using MicroScan Dried Overnight Panels that were previously shown to 
perform comparably to frozen reference panels. A total of 822 clinical 
isolates (494 E. culi, 202 K. pneumuniae and 126 K. uxytura) were collected 
between 7/98 and 2/00 &om nine geographcally distinct institutions. A 
total of 114 isolates (51 E. ruli, 33 K. pneumuniae and 30 K. uxytoca) were 
screen positive for at least one of the five antibiotics tested, including 102 
(89%) for cefpodoxime (Cpd), 79 (69%) for aztreonam (Azt), 71 (62%) for 
ceftriaxone (Cax), 68 (60%) for ceftazidime (Caz) and 66 (58%) for 
cefotaxime (Cft). The frequency of screen-positive results was greatest for 
Cpd at all sites except VA, where Azt led. Of the 114 isolates that were 
screen positive, 55 (48%) were also positive with the NCCLS ESBL 
confirmatory test and included 24 K. pneumuniae, 19 K. oxytora, and 12 E .  
culi. The likelihood of detecting an ESBL-producing strain with only one 
screening drug was greatest for Azt (95%), Caz (89%), Cpd (89%), Cax 
(85%) and Cft (82%). Of the 24 ESBL-producing K. pneumuniae, 22 (92%) 
were screen positive with all five antibiotics and an additional two isolates 
were screen positive with only one agent. For the ESBL-producing E. roli 
(M = 12) and K. oxytura ( i i  = 19), only 7 (58%) and 12 (63%), respecuvely, 
were positive with all five screening drugs. The prevalence of screen- 
positive isolates varied depending on institution and the species. Among the 
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822 isolates, the incidence of positive results for one or more screening 
antibiotics vaned by institution and ranged from 2 to 65% for E.  coli, &72% 
for K. przeunioriiae and 0-67% for K .  oxytoca. The incidence of confirmed 
ESBL producers also vaned by institution with a range of O-29% for E. coli, 
0 4 4 %  for K. yneumoniae, and G33% for K. oxytoca. The most sensitive 
antibiotic or combination of antibiotics for screening for ESBL production 
may be institution specific. 
vl Ability of different methods to detect extended- 
spectrum p-lactamases in Enterobacteriaceae 
Z.  Gulay, M. Bicnien, S. G. B. Amyes, N.  Yulug 
k m i r ,  TR; Edirihurgh, UK 
Objective: Different procedures for the detection of ESBLs were compared 
by using a set of 17 positive control strains including 14 TEM and 3 SHV 
type ESBL producers and 3 negative controls which consisted of one TEM- 
1, one TEM-2 and one SHV-1 producer. 
Methods: Positive and negative control strains and 50 clinical isolates (43 
K/ebsiella prieunioiiiae and 7 Esc/wichia rob] isolates identified as resistant to at 
least one ESB-lactani agent in the routine laboratory were screened for 
ESBL production by 6 methods: (1) Double disk synergy test (DDS); (2) 
L k k  diffusion test (DDQ with ceftazidime (CAZ), cefotaxime (CTX), 
aztreonam (ATM) and cefoxitin (ATM); (3) Microdilution (MD) method 
with CAZ and CTX either alone or in combination with clavulanate; (4) A 
MD test with the same antibiotics but with increased inocula of 5 x lo6 and 
5 x lo7 C F U / d ;  (5) E-test ESBL screen strips with CTX(CT/CTL) and 
CAZ(TZ/TZL); (6) VITEK automated system (GNS 112). P-Lactamases 
were also identified by iso-electnc focusing. 
Results: The sensitivity of different methods for positive control strains 
were as follows (highest percentages are given): DDS method (88%); 
DDf (64.7%); MD (82%)); MD with higher inoculum 94%); E-test 
screen (76.5%); GNS-112 cards (64.7%). The specificity of all methods 
except MD with higher inoculum, was 100%. The specificity of the latter 
ranged between 10 and 70%. DDS test was positive for 33 clinical isolates. 
IEF revealed that these isolates mainly produced PI 7.6 or 8.2 etizymes. 
Overall, all methods except the MD method performed with higher 
inocula, were in good correlation with each other for ESBL detection in 
clinical isolatec. 
Conclusion: UDS is easy to perform and interpret and relatively cheap. We 
recommend the use of DDS in conjunction with a susceptibility test (Ddf, 
MD or VITEK) for the detection of ESBLs in die routine laboratory. 
I PI350 I Detection of extended-spectrum p-lactamase in 
fnterobacter cloacae by cefepime, ceftazidime and amoxicillin- 
clavulanate 
L. Nauniiuk, A.  Samet, E. Dziemaszkiewicz 
Gdaiisk, PL 
Objectives: To study thc prevalence of ESBLs by double-disk synergy 
(UDS) in Elirerobacfer cloacae. 
Methods: From January to July 2000 we collected 189 E. cloacae from 
patients. Routine DDS with ceftazidime (CAZ), amoxicillin-clavulanate 
(AMC) and cefotaxime (CTX) was ofno help with 102 nonreplicate isolates 
of E. doacae which were resistant to CTX and CAZ probably because of 
AmpC derepression. We used modified DDS with cefepime (FEP) which is 
stable against AnipC enzyme, AMC and CAZ instead. Zone diameters for 
CAZ and FEP and other relevant information were recorded and analyzed 
by WHONET 5. 
Results: We detected ESBL activity in 23 CAZ resistant E.  cloacae, 70 CAZ 
resistant were ESBL(-), another 9 isolates were undetermined due to only 
slight increase of ~nh~bit ion zone between FEP ad AMC. 8/23 ESBL(+) E. 
cioaiae were resistant to FEP, 5 intermediate and 10 susceptible. In ESBL 
negatives the numbers were 2, 1 and 67, respectively. All strains with 26 
nim zone around FEP were ESBL(-). 
Conclusions: Inclusion of FEP disk in DDS is the easiest way for ESBL 
detection in AnipC derepressed E.  cloacae which are not usually suspected of 
producing ESBLs. Other methods like PCR and isoelectrofocusing are 
costly and labour-intensive. 
vl Evaluation of different methods to detect ESBLs 
and prevalence of ESBLs among Klebsiella and F. coli in 
Belgian ICU 
M. Ieven, E. Vercauteren, C. Sanders, H. Goossens 
Edegem, B; Omaha, USA 
Background: Extended spectrum p-lactamase (ESBL) producing entero- 
bacteriaceae have rapidly emerged as major pathogens around the world and 
have compromised therapy with newer generation cephalosporins, 
penicillins, and monobactams. Therefore, accurate detection of and 
surveillance for ESBLs remains essential. The objective of this study was 
(1) to evaluate the sensitivity and specificity of different niethods to detect 
ESULs and (2) to study the prevalence of ESBLs in Klebsieth and E. coli in a 
national prospective study in 1997 and 1998. 
Methods: Eighteen acute care hospitals in 1997 and 11 in 1998 collected 
373 and 305 E. coli and KIebsiella consecutive nonduphcate strains from 
hospitalized patients of which 85 and 55, respectively, were sent to our 
laboratory for confirmation of ESBL production. On a set of 27 of well 
characterized and genotypically confirmed ESBLs among these strains 
different methods were evaluated the double disc (DD) test using 
ceftazidime (CAZ) and ceftriaxone (CTR) placed on 2 cni or 3 cm 
from the clavulanic acid (CLV) disk, disk &ffusion test with both 
cefpodoxime (POD) paper discs and Roxotablets, MIC values for CAZ, 
C T R  and aztreonan (AZT) and ESBL E-test. Prevalence of ESBLs in 
Belgian hospitals was calculated based on the most sensitive and specific test 
from this evaluation. 
Results: Best results were seen with DD CTK 2 cm, DD C T Z  2 cm and 
ESBL E-test with sensitimties of 93% for all three methodt and specificities 
of 97%, 100% and 100%, respectively. POD paper disk diffusion was 100% 
sensitive but only 76% specific. Prevalences of ESBL+ strains were: for E .  
coli 2/231 (0.9%) and 2/196 (1.0%), K.  piieumoniae (19/82 (23.2%) and 14/ 
65 (21.5%), K .  oxytoca 6/59 (10.2%) and 6/40 (15.0%), i.e. overall 27/373 
(7.2%) and 22/305 (7.2%) in 1997 and 1998, respectively. 
Conclusions: (1) POD disk diffusion is too sensitive resulting in false positive 
results; the best strategy for the detection of ESBL+ strains is screening by 
POD discs and confimiation by DD C T R  or CTZ 2 cm test or ESBL E- 
test; (2) the number (“A) of ESBL+ strains has not increased in 1998 
compared to 1997; (3) the percentage of ESBL+ strains remains highest 
among K. pneumoiiiae. 
Surveillance of Pseudomoms aeruginosa harbouring 
O M - 1 0  derivatives in a university hospital 
S. Kocagoz, B. Altun, P. Zarakolu, D. Ozcan Inan, M. Akova 
Ankara, Antalya, TR 
Extended-spectrum p-lactamases (ESBLs) are an increasing cause of 
resistance among Enterobacteriaceae and in certain circumstances in P. 
aeuruginusa. In 1991 OXA-11, a mutant ofOXA-10 (PSE-2), was isolated in 
P. aenginosa isolates in our hospital and several other mutants therafter. We 
conducted a surveillance study to evaluate the colonization rate of P. 
aemxinosa harbouring these enzymes in our hospital. Surveillance cultures 
(throat and fecal swabs) on days 3,  5-7 and 15-21 were taken !?om all 
patients who were admitted to medical intensive care, burn and plastic 
surgery units of Hacettepe University Hospital, Ankara, Turkey between 
1996 and 1999. A total of 483 cultures were collected €-om 281 patients. 
Isoelectric focusing was pe*ormed to isolates with ceftazidmie MIC value 
> 32 mg/L for P. aeruginosa. Thirteen isolates of P. aerugiriosa had extended 
spectrum P-lactamases and only two of them were shown to have a 
common720 bp hgment  ofthe O M - 1 0 ,  17, 11, 14 and 16 genes with dot 
blot hybridization and with PCR. Both were cleaved to two fragments (408 
and 312 bp) with PvuII and to three fragments (284, 240 and 196) with 
HaeII, and was interpreted to be as blaOXA-10 or blaOXA-17 type. All 
isolates were characterized by pulsed-field gel electrophoresis of XbaI 
chromosomal digests. When compared to our hospital’s major intensive care 
outbreak clones, no obvious clustering of patterns were observed among 
these colonizing isolates. Our results indicate that P. aemgirma with O M -  
10 derivatives are not a major problem in our hospital during the 
surveillance period. 
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Group A streptococci 
vl Group A p hemolytic streptococcus among patients 
with upper respiratory tract infections 
K. Giines, E. Seber, B. Cetin, A. Giindiiz 
Istanbul, TR 
Objectives: To evaluate the reliability of bacitracin and sulfamethoxazole- 
trimethoprim tests performed with streptococcal colonies isolated from 5% 
sheep blood agar as a conventional method for the identification of Group A 
p hemolytic streptococcus and to estimate the incidence of Group A 0 
hemolytic streptococcus in throat samples among patients with upper 
respiratory tract infections. 
Material and methods: From November 1999 to June 2000, 200 patients 
admitted to the outpatient clinics of Sisli Etfal Hospital and who had upper 
respiratory tract infection were investigated for group A !3 hemolytic 
streptococcus. 100 persons who dld not have any complaints were used as a 
control group. Throat swabs were plated onto 5% sheep blood agar in 5% 
COr-enriched environment for 24 h of incubation. After the incubation p 
hemolytic colonies were selected and gram staining and catalase test were 
performed. Bacitracin (0.04 U; OXOID) and sulfamethoxazole-trimetho- 
prim (25 microgram; OXOID) tests were performed with gram positive, 
catalase negative p hemolytic streptococal colonies. These colonies were 
grouped by using latex agglutination test (Streptococcal Grouping Kit, 
OXOID). API 20 S identification system (BioMerieux; France) was used for 
definitive identification. 
Results: Group A p hemolytic streptococcus was detected in 38 (19%) out 
of the 200 patients with upper respiratory tract infections admitted to the 
outpatient clinics of Sisli Etfd Hospital. We had only 2 (2%) patients with 
Group A p hemolytic streptococcus in the control group. The difference 
between the throat culture samples of the patients with upper respiratory 
tract infections and the control group was statistically significant ( P  below 
0.05). All these strains were susceptible to bacitracin and resistant to 
sulfamethoxazole-trimethoprim and were classified as Group A p hemolytic 
streptococcus. Using API 20 S identification system which contains 
diferrent biochemical reactions all of these 38 p hemolytic streptococcal 
strains were identified as S.  pyogenes (Group A). 
Conclusion: When untreated Group A p hemolytic streptococcus may lead 
to serious complications, so we finded that it is often isolated as a causative agent 
in upper respiratory tract infections and in throat culture saniples he performance 
of bacitracin and sulfamethoxazole-trimethoprim tests with catalase negative 
colonies isolated &om 5% sheep blood agar is reliable as a conventional method 
for the idendcation of Group A p hemolytlc streptococcus. 
ones. Thus, RO could be an efficacious alternative among iMLSb and M- 
pnenotypes ER-resistant strains, when macrolide therapy is preferred to p- 
lactamics, for avoiding reported tolerance particularly. 
v1 T-serotyping amongst erythromycin resistant group 
A p haemolytic streptococci strains from paediatric population in 
Greece-patterns of resistance to antibiotics 
L. Zachariadou, G. Chronopoulou, N. Petropoulou, M. Xyptera, A. Pangalis 
Athens, GR 
In our attempt to study the epidemiology of erythromycin resistant GAS in 
the paediamc population in Greece we performed detection of opacity 
factor (OF) and T-serotyping on  73 strains isolated from pharynx (48), ear 
(5), nose (5). cervix (l), peritonsillar abscess (2), pus (5), skin lesions (5). and 
CSF (1) of hospitalised and outpatients, during the period 1997-99. 
Susceptibility to penicillin, clindamycin, tetracycline, rifanipicin, chloram- 
phenicol and vancomycin, was tested by the Kirby-Bauer disk diffusion 
method and MICs determination by E-test following NCCLS recommen- 
dations. Three strains resistant (R) and 4 intermediate resistant (IR) to 
clindamycin as well as 18 (R) and 4 (IR) to tetracycline were found. Seven 
out of 73 strains resistant to erythromycin (9.6%) exhlbited inducible 
resistance to clindamycin by the double disk diffusion method. Fifty-seven 
(78%) strains were OF positive. As for T-serotyping 25 (34.3%) strains, most 
of them from pharynx (17/25), were T8/25/imp19; 12 (16.5%) were T12 
with 5/12 isolated from s h n  lesions; 11 (15%) were T4; 6 (8.2%) T28; 5 
(6.9%) T13; 4 (5.5%) T3/B3264; 2 (2.8%) T6 and T13/B3264 and the 
remainder belonged to other serotypes. All 5 OF positive T12 strains were 
R to tetracycline and 4 of them exhibited inducible resistance to 
clindamycin. However, OF positive T13 strains were R (3/4) or IK (1/ 
4) to tetracycline but sensitive to clindamycin. It is worthwhile to mennon 
that about one third of the erythromycin resistant strains belonged to T8/ 
25/imp19 OF positive serotype. Further typing of erythromycin sensitive 
strains is in progress in order to evaluate this result as well as to acquire a 
complete figure of the distribution of OF/T serotypes. 
I P I  354 I Prevalences and phenotypes of macrolide-resistant 
Streptococcus pyogenes during 2000 in Perugia, Italy 
D. Crotti, G. Fouzo, M. D’Annibale, M. Medori 
Perugia, S. Sisto, I 
Objectives: To investigate prevalences and phenotypes of macrolides- 
resistant S. pyogenes (GAS) in our area. 
Materials and methods: Between January and October, 2000, we processed 
249 strains of GAS isolated from throat swabs (of whom 164 acute 
pharyngytis), over all chddren. Sensitivity test was performed with agar 
diffusion system on 5% sheep blood agar (Mueller-Hinton). We determined 
the macrolides-resistence phenotypes using a double-disc test with 
erytromycin (ER) and clindamycin (CL). We tested also rokitamycin 
(RO), 16-C macrolide, and penicillin, cefaclor, and a m o x y c h  plus 
clavulanate. 
Results: Observed resistances were 30.9% (31.6% among pharyngytis group) 
to ER, 13.3% (14.1%) to CL, 1.6% (2.2%) to RO. No resistances were 
reported to p-lactamics. Among 77 ER-resistant strains of GAS, constitutive 
MLSb represented 36.4% of cases (36.2%), inducible MLSb 32.5% (29.3%), 
phenotype-M 31.1% (34.5%). Among ER-resistant strains only 4 (5.2%) 
showed ‘in uirro’ resistance to RO. RO-resistant GAS were observed only 
among cMLSb phenotype. 
Conclusions: About 30% of GAS strains are now resistant to ER, but less 
than 5% to RO. Anyway, cMLSb phenotypes are about one third of these 
1 P I  356 I M-serotyping and antimicrobial susceptibility 
patterns of invasive group A p haemolytic streptococci in Greek 
paediatric patients 
L. Zachariadou, N. Petropoulou, K. H. Engler, A. Efstratiou, 
G. Chronopoulou, A. Pangalis 
Athens, GR; London, UK 
The severity of GAS infections during the 1990s emphasises the importance 
of microbiological survedance and serotyping. A total of 20 GAS strains 
isolated €-om blood cultures and one &om CSF during 1996-2000, were 
examined. There was only one fatal case from STSS. Antimicrobial 
sensitivities to penicillin, vancomycin erythromycin, azithromycin, clari- 
thromycin, rifamphicin, tetracycline, clindamycin and chloramphenicol was 
determined by the dlsk diffusion Kirby-Bauer method according to NCCLS 
recommendations. MICs to erythromycin were also determined by the E- 
test methodology. T-serotyping, determination of opacity factor and M- 
serotyping were also performed. Resistance to erythromycin but not 
clindamycin was found in 4 strains (19.04%). Two strains (9.52%)were 
resistant to tetracycline. As expected, resistance to p e n i c i h  and 
vancomycin was not found. Six strains were of serotype M1; four were 
M12; three M89; two M77; two M4 and the remainder belonged to other 
serotypes. In conclusion, M1 and M12 predominate amongst invasive 
paediatric GAS infections in Greece. The case of fatal STSS was a mucoid 
M75 strain resistant to erythromycin. Erythromycin resistance (19.04%) 
amongst these strains was found to be lower than in previous studies 
amongst non invasive strains (25%). 
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Molecular typing of Streptococcus pyogenes with 
emmlZ isolated from patients with severe infections 
C. M. Brandt, B. Spellerberg, R. Holland, R. Liitticken, G. Haase 
Aachen, D 
Objectives: Slreptococrlrs pyogenes with emml and e m 3  are predominantly 
responsible for invasive streptococcal infections, however, severe S. pyogenes 
infections caused by isolates containing emml2 have been reported. The 
purpose of this study was to determine the genetic polymorphism of 
distantly related streptococcal inhibitor of coniplement-genes (Drs) among 
invasive S. pyogenes isolates with e m 1 2  and to evaluate Drs as an 
epidemiological marker for the investigation of nosocomial infections 
and outbreaks. 
Methods: Two S. pyogenes isolates with e m 1 2  recovered from 
epidemiologically related nosocomial invasive infections and 10 isolates 
with emml2 from epidenfiologically unrelated severe infections were 
compared by random amplified polymorphic DNA (RAPD) analysis and 
sequencing of Drs. 
Results: RAPD analysis did not discriminate substantially among isolates 
studied and suggeted that invasive isolates with emml2 in this study 
are genetically related. Sequencing of Drs revealed distinct Drs-alleles for 
the 10 epidemiologically unrelated isolates studied, while the two 
epidemiologically related isolates contained identical Drs-alleles. Results 
of Dn-sequencing corresponded with the epidemiological association of 
the isolates. 
Conclusions: The identification of multiple distinct Drs-alleles and the 
identification of novel Drs-alleles suggest that Drs-genes exhibit a substantial 
level of genetic polymotphism among S. pyogenes with emml2 s i d a r  to 
that ofsic among S. pyogenes with emml. Sequencing ofDrs may contribute 
to the investigation of nosocomial infections or outbreaks and provide 
further insights into the mechanims leading to the emergence and 
reemergence of severe S .  pyogenes infections. 
lp13581 Isolation and antimicrobial susceptibility of 
Streptococcus pyogenes from acute pharyngitis 
B. Orden, R. Martinez, F. Caballero, G. Strepto 
Madrid, E 
Objective: To detemline the current fiequency of S. pyogenes in acute 
pharyngotonsillitis in our district and the frequency and phenotypes of 
niacrolide-resistant strains. 
Methods: A cross-sectional study, with a temporal-clusters sample of 
1252 outpatients in a sanitary district of Primary Care in Madrid (Spain), 
with 240,000 people. The study was conducted over a 5-month period 
(January to May 1999). The study included patients (age range, 1 month to 
99 years) with symptoms of acute pharyngotonsillitis and had not received 
antibiotic therapy in the preceding 4 weeks. Clinical status, epidemiological 
data and throat swab were recorded for each outpatient. The isolates were 
identified according to standard laboratory techniques. Susceptibility testing 
(MIC) was perfomied according to the NCCLS by using a broth 
microdilution automated method. Penicillin, erythromycin, clindamycin, 
tetracycline, ofloxacin, rifampin and vancomycm, were evaluated. The 
breakpoints used were those recommended by NCCLS. The phenotypes of 
the erythromycin-resistant strains were determined by the double-disc 
induction test. 
Results: Of the 1252 patients enrolled in the study 107 (8.5%) had a positive 
culture with S .  pyogenes. All isolates were uniformly susceptible to penicillin, 
rifampin, and vanconiycin. Overall, 31 isolates (29%) showed a MIC for 
erythromycin greater than, or equal to, 0.5 mcg/mL. Clindamycin 
resistance was not seen among the erythromycin-susceptible strains, but 4 
of the 31 erythromycin-resistant strains were also resistant to clindamycin 
(constitutive resistance). An additional 2 strains showed resistance to 
clindamycin when exposed to an erythromycin &k in the double-disk 
diffusion test (inducible resistance). More than 10% of the strains were 
resistant to tetracycline. Five isolates (4.6%) tested showed a MIC for 
ofloxacin equal to 4 mcg/mL. 
Conclusion: Penicillin seems to be an excellent antibiotic for S. pyogenes. 
The incidence of erythromycin-resistant strains in acute pharyngitis is high. 
Clindamycin is an alternative for treatment in penicillin-allergic patients. 
Acknowledgements: Part of this study was carried out with a research grant 
(98/0717) 6om the Fondo de Investigaciones Sanitarias, Ministerio de 
Sanidad y Consumo, Spain. 
(p13591 Clinical predictors of streptococcal pharyngitis in 
adults 
dfula, IL 
B. Chazan, R. Colodner, R. Raz 
Introduction: Streptococcal pharyngitis is one of the most common illnesses in 
primary care. Throat culture is the 'gold standard' for dlagnosis, but when 
not available, simple clinical guidelines are useful. There are clinical 
guidelines for the diagnosis of S. pharyngitis in children, but not for adults. 
Objective: To investigate signs and symptoms associated with S. pharyngitis 
in adults, and point out simple clinical predictors. 
Methods: During winter 1999/2000, 207 consecutive adult patients, 
presented with acute sore throat, were enrolled in the study. Demographic 
data and clinical signs and symptoms of pharyngitis were recorded. Throat 
cultures were taken. 
Results: 207 patients, aged 16-80-year-old (mean 32.6 + 12.8) were 
enrolled: 46.9% females and 53.1% males; 50 patients (24%) had a positive 
throat culture for group A hemolytic streptococcus (GABHS). Patients 
with positive cultures were significantly younger. Symptoms of chills, 
absence of cough or rhinitis, pain in swallowing, headache and vomiting, 
and signs of tonsillar exudate, oral malodor, fever > 38°C. trismus, voice 
change and sweat, had a h g h  sensitivity but a low specificity for S. 
pharyngitb. By univariant analysis we found that among symptoms, CMS had 
the greater predictive value for a positive throat culture ( P  0.044, OR 2.45, 
95% CI 1.03-5.87). Among signs, presence of pharyngeal exudate showed 
the hghest predictive value (P  0.001, OR 5.49, 95% CI 1.97-15.3). By 
multivariate analysis, the unique significantly factor predictive for a positive 
throat culture was presence of pharyngeal exudate ( P  > 0.00, OR 4.54, 
95% CI 1.84-11.20). 
Conclusions: In our adult population we found a relatively high prevalence 
of GABHS among patients with sore throat and the clinical presentation 
differed &om pediatric population. Large prospective studies should be carry 
to venfy if presence of pharyngeal exudate in adults exclude the need of 
throat culture for accurate diagnosis of S. pharyngitis. 
Severity of Streptococcus agalactiae endocarditis 
Y .  Douadi, X. Lescure, A. Mirode, D. Thomas, F. Daoudi, G. Laurans, 
S. Redeker, F.  Eb, C. Tribouilloy, J. -L. S c h t  
Amiens, F 
Background: Group B streptococcus (S. agalactiae) bacterienlia in adults has 
been shown to be a major cause of postpattum infection. It is an occasional 
cause of endocarditis. In the last 20 years only several patients were found to 
have an endocarditis. 
Objective: To describe clinical characteristics, treatment and outcome of 
group B streptococcal endocarditis in nonpregnant adults. 
Methods: We included all cases of S. agalactiae endocarditis diagnosed 
according to the Duke criteria between 1995 and 1999 in our hospital, 
where a prospective survey of all cases of endocardids is regularly performed. 
Results: There were 6 cases of S. agalartiae endocarditis out of 115 infectives 
endocarditis during the study period. They occurred in 4 males and 2 
females with an average age of 52 years (33-72 years). Three patients had 
underlying disease (diabetes mellitus, liver disease or both) and one had been 
previously diagnosed as having valvulopathy. There were no case of 
prosthetic valve endocarditis. All strains were susceptible to penicillin. 
Despite appropriate antibiotics three patients died and two underwent 
valvular replacement. 
Conclusions: The group B streptococcus should be considered as a pathogen 
capable of causing severe acute endocarditis in patients with underlying 
diseases. Cardiac surgery may be necessary due to the rapid destruction of 
the valves which occurs, in spite of the fact that the organisms are usually 
susceptible to peniciUm. 
Clinical Microbiology and Infection, Volume 7, Supplement 1, 2001 291 
/p1361j streptococcus agalactiae infections in nonpregnant 
adults: single center experience of a growing clinical problem 
I .  Avramopoulos, C. Gatsiou, C.  Nikolidaki, K. Geromenati, N.  Vakalis, 
A. Achimastos, G. Nasioulas, M. E. Falagas 
Athens, GR 
Background: Group B a-haemolytic streptococcus (S. agalactiae) has been 
traditionally considered a major pathogen in neonates and pregnant women. 
However, there is accumulating concern about its significance in 
nonpregnant adults too. 
Methods: We analyzed retrospectively collected data from patients 
(nonpregnant adults) with S. agalactiae isolates who received care in our 
354-bed hospital either as inpatients or as outpatients during the period 01/ 
01/1995-31/12/1999. Data were retrieved, using specially designed case 
report forms, by reviewing patient medical records and Microbiology 
laboratory databases. 
Results: Sixty-nine S. agalactiae strains were isolated from specimens of 65 
nonpregnant adults (42 women and 23 men). Thirty-four of them were 
managed as inpatients and 31 as outpatients. Mean age was 57.7 (range: 18- 
84) years. Classification of isolates by specimen type and sex was: urine 38 
(32 women + 6 men), blood 7 (5 + 2) ,  prostate fluid 3 (0 + 3), vaginal fluid 
4 (4 + O), pus 7 (0 + 7), semen 2 (0 + 2), urethra fluid 1 (0 + l),  sputum 1 (0 
+ l), ear discharge 3 (2 + 1). and other sterile fluid 3 (2 + 1). S. agalactiae 
grew from mixed cultures (with at least one more microorganism) from 11 
specimens. Resistance of isolated strains of S. agaladiae was 0% (0/54) to 
ampicillin, 5.4% (2/37) to vancomycin, 5.8% (3/52) to ciprofloxacin and, 
20% (10/50) to erythromycin. Underlying conditions of 34 inpatients 
possibly predisposing to S. agalactiae infection were neoplasia in 8 patients 
(23.5%). diabetes mellitus in 7 (20.6%), splenectomy in 1 (2.9%). heart 
disease in 9 (26.5%), and corticosteroid treahnent in 2 patients (5.9%). 
Nineteen (17 women and 2 men) of 34 inpatients with S. agalactiae had the 
organism isolated from urine. Thrteen of these 19 (68.4%) patients had 
clinical evidence of urinary tract infection (UTI). Besides those inpatients 
with an UTI, 2 had bacteremia of unknown origin, 2 pneumonia, 2 
erysipelas, 1 spondylodiscitis. 1 peritonitis, 2 prostatitis, 1 perirectal abscess, 
1 testicular abscess, and 1 diabetic foot infection. 
Conclusion: In keeping with results from other recent studies S. agalactiae 
was isolated more frequently than previously believed from nonpregnant 
adults in our center. However, the organism was isolated from a relatively 
considerable number of urine specimens of nonpregnant women, the 
majority of whom had evidence for symptomatic UTI. Our data suggests 
that S.  agalactiae may be an underestimated cause of UTI in nonpregnant 
women. 
E coli and Ktebsielia 
/p13621 Recurrent soft tissue infections due to intermediate 
group streptococci: Streptococcus constellatus 
B. Taser, S .  O z e ,  0. Ak, M. Uzel, H.  Acar, N. Benzonana 
Istanbul, TR 
Although group A streptococci and staphylococci are responsible for 
majority of cases of soft tissue infections, intermedious group streptococci 
are rarely identified the causes of soft tissue infections, invasive pyogenic 
infections, perirectal and perianal abscess. A 50 year old male patient with 
multiple fistullated abscesses over the gluteal, sacral, back of the left femoral 
and perianal regions was accepted to our depamnent. The patient stated that 
he had first applied to a university hospital in Istanbul 6 years ago with the 
same complaints and had been admitted to a general surgery department; 
abscess drainage, excision of the necrotic tissues and autogenous split 
thickness dermal graft had been performed. Although margins of the graft 
attached properly, recurrent abscesses occurred at the central region up to 
date. C T  scanning revealed multiple microabscesses fistulated to the 
subcutaneous tissues around the left hip joint and in the muscles of gluteus. 
Deep tissue specimens were aspirated and Streptococcus constellatus was 
cultured purely from the specimens. These abscesses resolved with 
Ceftriaxone 2 g/day therapy for 14 days and colostomy perfomied to 
prevent reinfections. Intermedious group streptococci previously referred to 
as the 'Streptococcus anginosus-milleri' (S. interntedius, S. arzginosus, S. 
constellatus), colonizes the oropharynx. intestinal tractus, predisposes to oral- 
maxillofacial infections, CNS, lower respiratory system, inti-a-abdominal, 
bone-joint-soft tissue infections, perirectd-perianal abscesses. These infec- 
tions respond well to third generation cephalosporin therapy in addition to 
surgical drainage as in our case. 
lp13631 Streptococcus zooepidemicus bacteremia 
E. Prieto, M. Trevifio, A. Cid, M. -J. Lopez, M. -C. Rajo, E. Leon, L. 
Rguez-Otero, A. Garcia-Zabarte 
Santiago de Compostela, E 
Streptococcus zooepidemicus, hemolytic group C streptococci, is a vetennary 
pathogen and uncommon human infectious agent. Streptococcus zooepidemicus 
was isolated from human pharyngitis, glomerulonephritis and septic arthritis. 
The organism usually is acquired by the consumption of unpasteurized mdk. 
We report a case of S. zooepidemicus hacterenlia in a 28-years-old man with a 
12-h history ofgeneralized abdominal pain, high fever, nausea and vomiting 
was admitted to hospital. He lived in a rural area. His aunt presented similar 
symptoms. For these reasons we suspected that the homemade fresh cheese 
was the source of the infection. Blood cultures obtained from the patient 
before the institution of antibiotic therapy with ciprofloxacin, yielded S. 
zooepidemicus, which was isolated also from the aunt's stool and in the 
suspect milk. In view of this results, ciprofloxacin was suspended and 
replaced by 16 d o n  units of penicillin G dayli for 10 days. Blood cultures 
obtained at the end of the treatment were sterile. 
(p13651 Severe infections with Escherichia coli and Klebsiella 
E. G. Miftode, V. Luca, D. Leca, D. Mihalache, M. Radu, C. Anuta, S. 
Dimitriu, T. Turcu 
Iasi, RO; Vienna, AT 
Objectives: To correlate the clinical evolution and Characteristics of patients 
with severe infections due to E. cdi and Klebsiella spp. with antimicrobial 
resistance patterns. 
Methods: A retrospective analysis of the data obtained from medical records 
of patients with sepsis, meningitis, and pneumonia hospitalized in the 
University Hospital of Infectious Diseases Iasi between 1996 and 2000. 
Results: Escken'chia coli and Klebsiela spp. were etiological agents in 54 cases 
and 20 cases, respectively, of sepsis, meningitis, and pneumonia. The origin 
of isolates were: blood 62%, pus 13.5%, CSF 11%, organs 11%, sputum 
5.4%, catheters 7%, and pleural effusion 3%. Esrkerichia coli and Kkbsiella spp. 
showed a multiresistance pattern in 34 cases (63%) and 13 cases (65%). 
respectively. The 47 patients with severe infections determined by 
multidrug resistant E.  coli and lcnebsiella had the following characteristics: 
in 28 patients (67%)) among 37 with sepsis due to multidrug resistant 
organisms were noted at least two secondary sites of infection (kdney-15c, 
lungs-8c, liver-7c, meninges-5c endocardium-4c); 34 patients (72%) had an 
immunossupressive condition (chronic liver disease, diabetes, neonates, 
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elderly); 22 patients (47%) had septic shock; for all patients the initial 
antibiotic therapy was changed, and 15 patients (32%) died. The overall rate 
of mortality for the 74 patients with E. coli and Klebsiella spp. severe 
infections was 20%. 
Conclusions: In this study we observed a high rate of resistance among E. 
mli and KIebriella spp. isolated from severe infections. Infections with a 
multidrug resistant strain was an important risk factor for developing more 
than two sites of infection in sepsis, with a severe course of the disease and 
recurrences of meningitis. 
p13661 A 5-year survey of emerging antimicrobial resistance 
among Klebsiella pneumoniae and Escherichia coli isolates at a 
teaching hospital in Turkey 
0. Ozgenc, A. Urbarli, M. Sungur, E. Unal 
kmir,  TR 
The incidence of ESBL-producing K. pneumoniae and E. coli has been 
increasing and becoming a serious therapeutic problem around the world. 
The objective of this study was to evaluate the dissemination of extended- 
spectrum 0-lactamase (ESBL)-producing strains and to demonstrate their 
relation to multidrug resistance. A total of 2065 K. pneumoniae ( n  =391), 
and E. coli (17 = 1674) isolates from clinical specimens through years 1996- 
2000 were investigated. All strains, which exhlbited a positive double-disk 
synergy test, were identified as putative ESBL-producers. For 150 multidrug 
resistant isolates, the Etest ESBL screen was, also, performed for agreement 
of the results of the two tests (P > 0.05). The standard disk diffusion test 
was used to test the susceptibility of the isolates to at least 20 antibiotics. 
ESBL-producing strains of K. pneumoniae and E. coli were found 40.9%, and 
1.4%, respectively. The inhibition zone diameters of ceftazidime (9.8 f 5.3 
mm), cefotaxime (16.3 k 4.4 mm), and aztreonam (9.5 5.7 mm) for 
ESBL isolates were calculated. All K. yneumoniae strains, and 64.5% of E. coli 
strains were ampicillin resistant. Resistance to at least one aminoglycoside 
was detected in 90.0% of ESBL-producing K. pneumoniae isolates, compared 
with 12.9% ofESI3L nonproducers. The high proportion ofresistance in K. 
piiewioniae and E .  o l i  strains was found to tobramycin (43.5%, 11.9%) or 
gentanucin (35.6%. 18.4%). while the least reduced susceptibility was found 
to amikacin (27.5%, 1.4%) with both strains, respectively. Whde the total 
fluoroquinolone (FQ) resistance ratio was 8.2%, ESBL production was 
detected in 78% of FQ-resistant K. pneumortiae isolates. Emerging FQ- 
resistance in E. coli strains was noticeable in recent years, and the resistance 
ratio was 23.2% over 5 years. The overall mmethoprim/sulfamethoxazole 
resistance was 52.4%, and 54.1% in K. ptzeumorziae and E. coli isolates, 
respectively. Amoxicillin-clavulanate resistance ratio was found 16.7% in 
both strains. Cefoxitin resistance was observed to be 1.2%, and 1.4% for 
these bacteria. All strains were susceptible to carbapmems. The results 
indicate that coresistance patterns produced evidence of potential 
nosocomial dissemination of K .  prieumonine strains. Dramatic increase in 
the resistance of E. C C J ~ ~  to fluoroquinolones might be attributed to the 
fkequent use of these antimicrobials at this medical center. 
/p13671 Susceptibility of Escherichia coli and Klebsiella 
pneumoniae Isolated in Lebanon between 1991 and 1999 
Z .  Daoud, J. Mokhbat, G .  Kayali, N. Hakime 
Beirut, R L  
Background and objective: Resistance to antimicrobial agents is an 
emerging problem where drug-resistant pathogens are a growing menace 
to all people, regardless of age, gender, or socio-economic background. 
They engender people in amuent, industrial societies, as well as in less 
developed nations. The high incidence of E. coli and K. pneumoniae and the 
resistance constantly reported of rrzterobacteriaceae to antibiotics as well as the 
fact that strains with Expanded Spectrum 0 Lactamase (ESBL) have been 
observed niainly among E. coli and K. prieumoniae motivated us to do this 
study where our aim is to determme and compare the patterns of 
susceptibility of the strains of these two genera isolated between January 1, 
1991 and January 1,2000. The strains susceptibilities were determined using 
the method of agar dissusion (Ku-by-Bauer). The ESBL strains were 
detected using clavulanic acid discs. 
The results are shown in the table. 
1991 1993 
Esclien'drio coli 
No. strains 
Ampicillin 
Augmantin 
Caphalothin 
Cafuorxime 
Cafotaxinie 
Cafoxitin 
Caitriaxone 
Astronam 
Ceftazidime 
Piperacilla 
lriipelern 
Geltamicia 
Tobramycia 
Amikacia 
Tctracycline 
Nallditic acid 
Nodoxaria 
Ofloxacia 
Pefloxacia 
Nitrotrablc 
Trit iieth/SaJtra 
ESBL (x) 
Kfeb~iPlla prreirnrotrm 
No. strains 
Ampicillin 
Augniantin 
Caphalothin 
Cafuorxiine 
Cafotaxnne 
Cafoxitlll 
Caftnaxoiie 
Astronam 
Cefiazidime 
Pipcracilla 
Impelem 
Gcltamicia 
Tobramycia 
Amikacia 
Tetracyclmc 
Nallditic acid 
Norfloxacia 
Ofloxacia 
I'eiloxacia 
Nitrotrable 
Trinieth/Saltra 
ESHL (96) 
508 
40 
61 
58 
99 
97 
100 
to0 
100 
100 
48 
100 
98 
100 
I00 
47 
93 
96 
92 
92 
100 
ND 
ND 
32 1 
0 
70 
69 
87 
91 
91 
91 
91 
91 
32 
100 
98 
98 
100 
83 
86 
91 
93 
91 
51 
87 
ND 
850 
43 
67 
59 
91 
100 
98 
I 0 0  
100 
100 
49 
100 
98 
98 
I00 
45 
96 
99 
92 
88 
97 
45 
ND 
300 
0 
73 
75 
86 
91 
91 
94 
83 
83 
14 
100 
91 
91 
96 
80 
89 
89 
86 
86 
36 
81 
ND 
1996 
~ 
8 
42 
65 
57 
95 
98 
97 
99 
100 
95 
45 
100 
95 
95 
100 
45 
90 
97 
90 
88 
95 
65 
0 32 
3( 10 
0 
75 
66 
81 
90 
90 
93 
75 
82 
10 
100 
89 
89 
93 
79 
82 
80 
82 
82 
40 
77 
I 78 
1997 
771 
39 
60 
57 
90 
98 
95 
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Conclusion: Our data show a clear decrease in the susceptibility of the strains 
of E. coli and K. pneumoniae between 1991 and 1999. This decrease is 
observed with almost all the classes of antimicrobial agents with the only 
exception of Imipenem (100%). The maximum of resistance is observed 
with the Quinolones. The 2nd and 3rd generations of 0-lactams are found 
to be less effective year after year and the activity of the broad-spectrum 
antibiotics is affected. The emergence of ESBL strains is rapidly observed 
mainly with K .  ptieumoniae. The misuse and abuse of antibiotics is 
responsible of the emergence of resistant strains. A strict policy concerning 
this matter should be adopted. 
lp1368 Differences in virulence of Escherichia coli strains 
causing pyelonephritis in women and prostatitis in men 
J. Ruiz, K. Simon, J. P. Horcajada, M. Velasco, M. Barranco, A. Moreno. 
M. T. J imhez  de Anta, J. Mensa, J .  Vila 
Barcelona, E 
Objective: To investigate if the E. coli strains causing pyelonefiitis in women 
and those causing prostatitis in men show different virulence factors. 
Methods: Eighteen isolates causing women pyelonepritis and 21 causing 
men prostatitis were selected. Presence of cnfl, hly, pap and aer genes was 
determined by PCR. While presence of fimbnae type 1, and haeiiiolysin 
activity was determined by agglutination and growing on blood agar plates, 
respectively. Statistical analysis was performed by the chi square method. 
Results: All strains presenting haemolysin gene showed haemolysin activity, 
and all haemolityc strains possessed the cnfl gene, while no nonhaemolytic 
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strain presented the cnfl gene. Among E. coli isolates causing pyelonefritis, 
100% showed the fimbriae type 1, 72% the papoperon, 61% aer gene, and 
50% haemolysin and the cnfl gene. While 81% of the E. coli isolates causing 
pyelonefritis presents the fimbriae type 1, haemolysin and the cnfl gene, a 
76% the papoperon and 52% aerobactin. Haemolysin and necrotizing factor 
were detected more significativrly in E. coli causing men prostatitis. 
Conclusion: Haemolysin and necrotizing factor type 1 are two important 
causes of men invasive UTI associated with E. cooli. 
lp13691 Antibiotic sensitivity of isolated Sbigella spp. from 
Gom province (Iran) 
M. Mahzounieh, M. M. Attarpour Yazdi, F. Skandarian 
Shahrekord, Tehran, IR 
Shiplola species are the cause of acute infectious diarrhea. Approximately 40 
million cases of shigellosis with 600,000 deaths are reported annually 
throughout the word. The highest incidence of ksease occurs among young 
children from 1 to 5 years of age. There are four species of shigeh:  S. 
dysenteriae, S .  flexneri, S. boydii and S .  sonnei. with few exceptions the 
shigelhe are harbored by humans and transferred by the fecal-oral rout. As 
many Shigelh species show multiple antibiotic resistance markers on 
plasmid, $antibiotic therapy is undertaken, it is advised that isolated species 
should be subjected to in vitro antibiotic susceptibiltty test. In this study fecal 
specimens of suspected diarrhea cases of four hospitals (Beheshti, 
Golpaiegani, Koodakan 81 Nekoi) of Gom province (central area of Iran) 
cultured by plating on various selective or diflerential media, from March 
1999 to April 2000. Isolated samples then subjected to specific biochemical 
tests. Species that non motile, didn't ferment lactose and produce no gas 
fiom carbohydrate and fail to produce hydrogen sulfide confirmed by 
serological testing. Results analyzed by chi-square and t-test. Out of 80 
suspected dysenteric cases (male and female) 60 Shigella spp. Were isolated 
with included S. flexneri 38.3% (n=22), S. dy~enrenae 31.7% (n = 19), S. 
boydii 5% (n = 3) ,  S. sonnei 25% (n=  15).  Results showed that S.flexneri and 
S. dysenteriae were dominant serotypes (70%). There was no significant 
difference between male (53.3%) and female (46.7%) ( P  < 0.3). the 
most cases were found in summer (45%) and the least in spring (8.31). 
Most of the isolated strains were sensitive to ceftriaxone and ceftizoxime 
(96.7%), ciprofloxacine (93.3%) and nalidixic acid (90%). They showed 
resistance to ampicfine, amoxicfine, furazolidone, sxt, tetracycline and 
neomycine. 
(p13701 Import and spread of a Klebsiella pneumoniae strain 
producing the plasmid-mediated cephalosporinase ACC-1 in a 
French hospital 
V. Leflon-Guibout, C. Lawrence, C. Wipff, B. Heym, E. Ronco, A. 
Philippon, J. Gaillard, M. Nicolas-Chanoine 
Boulogne, Garches, Pans, F 
Objective: Between September 1999 and Apnl 2000, 7 patients hospitalised 
in the same rehabilitation unit of R. Poincare hospital were infected 
(urinary tract infection: N= 5 )  and/or colonised (digestive tube: N= 5) by 
Kp isolates for which MICs (mg/L) of p-lactams were as follows: 
cefiazidime: 32-64, cefotaxime: 8, cefoxitin: 4, cefotetan: 2,  aztreonam: 
1-2, and cefepime: 0.25-0.5. Moreover, the addition of 2 mg/L of 
clavulanate did not restore the activity of third generation cephalosporins. 
Faced with such a particular 0-lactam resistance phenotype and an 
important number of cases, we determined the 0-lactamase contain and 
the clonal relatedness of the isolates (N= 12). 
Methods: MICs were determined by the agar ddution method. p- 
Lactamases were studied by PCR and sequencing. Isolates were typed by 
using the random amplified polymorphic DNA (RAPD) method. 
Results: All the isolates produced the p-lactamase TEM-1 and the plasmid- 
mediated cephalosporinase ACC-I, which was in good accordance with the 
p-lactam resistance phenotype. However, if all the isolates displayed the 
same p-lactam phenotype, an aminoglycoside phenotype of AAC(3)-II, and 
a low level of resistance to fluoroquinolones, they ditfrred from each other 
by the susceptibility to kanamycin (K), tetracyclines (TC) and trimethoprim 
(TP). Two isolates (1 patient: the index case) were susceptible to the 3 
molecules, 1 isolate (1 patient) was susceptible to K and resistant to T C  and 
TP, and 9 isolates (7 patients) were resistant to the 3 molecules. The 12 
isolates displayed the same or very similar RAPD profiles which were 
completely different from those of other Kp isolates obtained from patients 
in the same unit during the study period. Ths strain was introduced into the 
unit by a patient transferred from Tunisia, who was shown to be digestive 
carrier of this strain at his admission at the French hospital. Six out of the 7 
patients have had long overlapping sojourns whereas the remaining patient 
stayed only 1 week in the concerned unit, and was detected as carrier in 
another unit. 
Conclusion: T h s  study shows that, although stdl rare in France, Kp isolates 
producing plasmid-mediated cephalosporinases can spread rapidly and 
moreover acquire resistance to further antibiotic families. 
[-I Novel plasmid is determining SlgA-protease of K. 
pneumoniae 
V. Bondarenko 
Moscow, RUS 
Plasmids of 360 nosocomial K. pneumoniae strains involved in suppurative 
infections and septicemia in patients were stuked. A three types of virulence 
plasmids are detected. A nonconjugative pAdh-55,controlled aggregative 
adherence of K. pneumoniae and two different conjugative R-plasmids: 
PSI$-100 controlled the capacity of inacnvating SlgA, and pAlz-60 
involved in antilysozyme (Ah) activity of bacteria. The results of i t i  vitro 
experiments revealed that the strains containing pSIgA and pAlz plasrmds 
were cytotoxic with respect to HEp-2 cells and more resistant to the 
digestive action of enzymes produced by the phagolysosonies of guinea pig 
peritoneal ceh.  The study of SIgA-proptease and Alz-activities of 
intrahospital K. pneumoniae strains circulating among patients with a view 
to the detection of clones causing the development of persistent infection 
was shown to have good prospects. Evaluation of signs connected with a 
virulence of nosocomial pathogens is very important and can help to 
determine etiological role of the isolated strains and a prognosis of the 
infection course. Some of those signs may be recently observed an 
SIgA-protease, aggregative adhesive, and an antilysozyme activities of 
bacterial cells. 
-1 Epidemiological typing of Klebsiella pneumoniae 
strains responsible for urinary tract infections in Children's 
Memorial Health Institute, Warsaw 
A. Pawinska, W. Kaminska, D.  Dzierzanowska 
Warsaw, PL 
Urinary tract infections remain the most common hospital-acquired 
infections, accounting for 32% of the total number of all nosocomial 
infections in the Children's Memorial Health Institute in 1999. We 
observed a progressively higher frequency of urinary tract infections caused 
by K. pneumonine: 10% in 1997, 18% in 1999, and 22% in 2000 
The aim of our study was to characterise (phenotypically and 
genotypically) K. pneumoniae strains isolated from children with urinary 
tract infections in 1999. We used pulsed field gel electrophoresis (PFGE) 
typing to show if the strains were transferred between patients. 
A total of 7626 urine specimens were bacteriologically tested. 1307 
(17.1%) cultures were defined as a positive. The pathogens isolated were: E. 
cdi (37%), K. pneumoniae (18%), Droteus sp. (ll%), Pseudomonas sp. (lo%), 
Enterococcus sp. (9%), Enterobacfer sp. (5%), S.  epidemidis (3%), Candida sp. 
(3%). Above 50% of K. pneumoniae strains were resistant to the I11 
generation of cephalosporins and aminoglycosides. PFGE typing has shown 
that K. pneumoniae strains were moved between children at the time of 
the study. 
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Pseudomonas and Acinetobacter 
vl Comparative activity of 14 antimicrobials against 
clinical Pseudomonas aeruginosa strains 
J. Van Eldere, J. Verhaegen 
Leuven, B 
Objective: To assess the antibiotic susceptibility of Pseudomonas aeruginora 
(Psae) isolates Gom clinically significant samples. 
Methods: In 35 hospitals throughout Belgium, from 20 to 50 Psae isolates 
were collected between A p d  and November 99. AU isolates were Gom 
clinically significant samples and only one isolate per patient was included. 
MIC testing was performed with agar dilution or E-test (FQs) at a single 
central site. 
Results: Seven hundred and fifteen isolates were included. 47% of isolates 
were Gom respiratory samples, 24% from urinary samples and 5% from 
blood. Patients were from ICU (44%), general medicine wards (25%), 
surgical wards (1 4%) or haeniatology-oncology wards (7%"). The 
prevalence of multiresistant Psae isolates Mered greatly between hospitals. 
Overall results are given in the table. 
Ofloxacin 
Lcvofloxacin 
Ciprotloxacin 
Centaniicin 
Tobramycin 
Isepam~cin 
Amikacin 
Piperarilli n 
Pip/tazobactam 
Ticar/clavul 
Aztreonam 
Cefiaz~dinie 
Cefepiine 
Merooenem 
96 FUS 'YO res 
54 32 
71 20 
79 19 
67 24 
80 20 
81 12 
85 11 
76 24 
83 18 
63 37 
18 56 
59 29 
i l  30 
82 10 
MICsii 
0 75 
0.19 
4 
I 
8 
8 
32 
16 
64 
32 
8 
8 
2 
7 
MICv,, 
> 32 
> 32 
> 32 
256 
256 
128 
128 
> 256 
> 256 
> 256 
> 256 
128 
128 
16 
v) In witro activities of various antibiotics, alone and in 
combination with amikacin against Pseudomonas aeruginosa 
B. Karakoc, A. Gerceker 
Istanbul, TR 
The in vitro activities of various antibiotics, either alone or in combination 
with amikacin were assessed in clinical isolates of P. aeruginosa. The 
minimum inhibitory concentrations (MIC) of these antibiotics were 
determined by nllcrobroth dilution method against 50 clinical strains. 
According to the MIC values, 96%, 94% and 74% of the isolates were found 
susceptible or moderate susceptible to amikacin, meropenem and 
ceftazidime, respectively. The in vitro activities of ceftazidime and 
meropenem in combination with amikacin were determined by inicrobroth 
chequerboard technique and results were interpreted by Gactional 
inhibitory concentration (FIC) index. With a FIC index of less than or 
equal to 0.5 as borderline, synergistic interacnons were more frequent with 
ceftazidime (70.8%) than with meropenem (40%). No antagonism was 
observed. Pseudomonas ueruginosa continues to be as one of the most 
important nosocomial pathogens, which is a leading cause of moaahty, 
particularly among patients with immunosuppression, malignancy, cystic 
fibrosis, bum or traumatic wounds. Since P. aeruginosa infections often 
progress rapidly in these patients, optimal result can only be achieved when 
timely administration of an effective antimicrobial therapy is ensured. O n  
the other hand, emergence of resistance has been observed when any of the 
newer antipseudomonal antibiotics is used alone against this organism. For 
these reasons, P. aenrginosa has been an important consideration in 
development of effective combination therapy, in order to produce rapid 
enhancement of bactericidal activity and to help prevent or delay the 
emergence of resistance. Because animal and human data are difficult to 
obtain, decision about the selection of optimal combinations are based on 
in-vitro dormation. Using microbroth chequerboard technique we studied 
the in vitro activities of ceftazi&me and meropenem in combination with 
amikacin against clinical isolates of P. aeruginosa. 
Conclusion: In comparison to earlier studies, there was a loss of activity in a l l  
antibiotic goups. Ciprofloxacin remains the most potent anti-Psae FQ. 
Amkacin, isepamicin and tobramycin also retain good anti-Psae activity. In 
the p-lactam group, meropenem is most active, followed by ceftazidime and 
piperacillin. There were no significant differences between isolates from 
ICU patients and other patients. In general resistance levels were higher in 
urinary isolates. 
v1 In vitro activity of eight antibiotics against clinical 
isolates of Pseudomonas aeruginosa 
S. Genqer, N.  Benzonana, 0. Ak, A. Batirel, S .  Ozer 
Istanbul, TR 
Background: Pseudomoms aeruginosa is an important bacterial pathogen most 
frequently responsible for nosocomial infections and infections in 
immunocompromised patients. 
Objectives: T o  study the current level of susceptibility to widely used 
antipseudomonal antibiotics against P .  aeruginosa. 
Methods: A total of 50 ctinical isolates of P. aeruginosa were investigated. 
MICs for inlipenem, meropenem, ceftazidime, cefepime, piperacdhn/ 
tazobactam, ciprofloxacin, tobramycin, amikacin were determined by the 
E-test method. Breakpoints were interpreted according to the NCCLS 
guidelines. Also, the prevelaiice of inducible p-lactamases was investigated 
by using imipeneni (10 mg) and ceftazidinie (30 mg) disks. 
Results: The percentages of susceptible isolates were meropenem 84% 
( t i  = 42), imipenem 82% ( f i  = 41), ciprofloxacin 80% (n = 40). piperacillid 
tazobactam 76% ( n  = 38). cefepime 72% (n = 36). ceftazidime 68% (n = 34), 
amikacin 66% (fi = 33) and tobramycin 58% (n = 29). 60% (n = 30) of all 
isolates were pOSihve for inducible f3-lactamases. 
Conclusions: Carbapenems seem to be the most active agents against P. 
aerugirima followed by ciprofloxacin in our unit. 
/p1376j Biofilm formation on collagenous substrata by 
twitching and nontwitching Pseudomonas aeruginosa strains: 
the influence of ciprofloxacin and pefloxacin 
E.-A. Trafny, A. Kocik 
Warsaw, PL 
Objectives: To determine the inhibitory effects of ciprofloxacin and 
pefloxacin on the process of biofihn formation on collagenous substrata by 
twitchmg and nontwitchmg P. aeruginosa strains. 
Methods: The ability of 54 strains of P. aeruginosa to form biofilm was 
evaluated in the wells of microtitre plates coated with collagen type I. To 
quantitatate the biofilm formation the microcolonies were stained with 
crystal violet, dmolved with ethanol and the absorbance was determined at 
595 nm. Biofilm formation was assessed in the presence of subinhibitory 
concentrations of ciprofloxacin and pefloxacin. Twitching and swarming 
motility of the strains were observed on LB agar (1%) or Nutrient 
agar (0.5% supplemented with 0.5% glucose) plates, with or without 
antibiotics, respectively. Biofilm on collagen membrane was developed by 
incubating the pieces of biomaterial for 24 h in the Luria Broth inoculated 
with 105 CFU/mL of the strains tested. The number of attached cells 
was quantified by plating of the bacteria released to the medium after 
sonication of membranes. Biofilms grown on the collagen membrane were 
treated with ciprofloxacin at the concentration equal to 20 times of the 
MBC. The number of the cells that survive in the presence of antibiotic 
was determined. 
Results: Thnteen of the 54 strains tested do not express twitchmg motility 
(T-); three of them do not form biofilm. Five of 41 twitching strains (T+) 
do not form biofilm on the collagen gel. Six T +  and four T-strains, which 
develop thick biofilms, were assayed for their ability to grow in 
microcolonies and to express twitching and swarming motility in the 
presence of subinhibitory concentrations of two fluoroquinolones. 
Twitching motility of these strains was inhibited at lower concentrations 
of antibiotics than was the process of biofilm formation. Swarming motility 
was not completely inhibited by antibiotics at concentration below the MIC 
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values. Pefloxacin generally inhibited biofilm formation at two times lower 
subinhibitory concentrations than ciprotloxacin. There were no statistically 
significant differences between T+ and Tstrains neither in the number of 
cells attached to the collagen membrane nor in the susceptibility of these 
cells to ciprofloxacin at bactericidal concentrations. 
Conclusion: Pefloxacin at lower subinhibitory concentrations than cipro- 
floxacin can inhibit biofilm development by twitching and nontwitching P. 
aeruginosa strains on the surface of collagenous substrata. 
Investigation of synergism of meropenem and 
ciprofloxacin against Pseudomonas aeruginosa and 
Acinetobacter strains isolated from intensive care unit infections 
S. Ermertcan, M. Hosgor, 0. Tunger, G. Cosar 
Izmir, Manisa, TR 
Gram-negative, nonfermentative rods are increasingly implicated as 
causative agents in intensive care unit infections. Infections caused by 
nonfermenters are often difficult to treat and usually require a combination 
of two antimicrobial agents for effective treatment. In this reason, the aim of 
this study was to determine synergistic effects of meropenem and 
ciprofloxacin against P. aeruginosa and acinetobacter strains isolated from 
intensive care unit infections. A total of 18 P. aeruginosa and 17 acinetobacter 
strains were tested. Strains were all identified by conventional methods. 
MICs were determined by broth microdilution method as recommended by 
National Committee for Clinical Laboratory Standards. The synergy was 
investigated in glass tubes containing a total volume of 2 mL. The antibiotics 
were assessed alone and in combination for their synergistic effect at 0.5 and 
1 x the MIC, respectively. Viability counts were made after 24 h of 
incubation at 37°C by plating 10 pL from each tubes onto blood agar plates. 
A synergistic effect was defined as a 100-fold fall in the numbers of CFU per 
mL induced by the drug combination relative to the value obtained with the 
single most effective antibiotic in combination. Susceptibility rates of P.  
aeruginosa strains to meropenem and ciprofloxacin were as follows: 11% and 
22%. The synergistic effect of meropenem and ciprofloxacin in combination 
were found to be 22% at 0.5 x the MIC, and 61% at 1 x the MIC. Two 
strains (11%) showed synergy at both 0.5 x and 1 x the MIC. Out of 18 P. 
aeruginosa strains 1 (6%) did not show synergistic effect neither in 0.5 x the 
MIC nor in 1 x the MIC. Susceptibility rate of Acinetobmter strains to 
meropenem was 77% and to ciprofloxacin was 24%. Meropenem was an 
effective agent against Acinetobacter strains. The synergistic effect of 
meropenem and ciprofloxacin in combination were found to be 29% at 
0.5 x the MIC, and 18% at 1 x the MIC. One strain (6%) showed synergy 
at both 0.5 x and 1 x the MIC. Out of 17 Acinetobacter strains 8 (47%) did 
not show synergistic effect neither in 0.5 x the MIC nor in 1 x the MIC. 
Accordmg to these results of the study, in intensive care unit infections due 
to P .  aeruginosa strains, antibiotics combination is more effective than only 
the antibiotic. 
m] Comparison of disk diffusion and agar dilution 
method for susceptibility testing of Pseudomonas aeruginosa 
isolates from ICU 
M. Mueller-Premru, M. Gubina 
Ljubljana, SLO 
The aim of the study was to detect whether disk diffusion method 
corresponds to agar dilution method in P. aeruginosa. Susceptibility of 32 P. 
aeruginosa isolates from blood, catheter tips, wounds and tracheal aspirates of 
ICU patients was determined to imipenem, ceftazidime, ciprofloxacin, 
gentamicin and amikacin with disk diffusion and agar dilution (E-test) 
method according to NCCLS recommendations. In addition, piperac&n/ 
tazobactam, which was not yet used in our country, was tested with agar 
dilution method only. In agar dilution method 22 isolates (68.7%) were 
susceptible, six (18.7%) resistant and four (12.5%) intermediate to 
imipenem. Twenty (62.5%) were susceptible, seven (21.8%) resistant and 
five (15.6%) intermediate to ceftazidime. Twelve isolates (37.5%) were 
susceptible and 20 (62.5%) resistant to ciprofloxacin. Fourteen (43.7%) were 
susceptible and 18 (56.3%) resistant to gentamicin and 26 (81.2%) 
susceptible, one (3.2%) resistant and five (15.6%) intermediate to amikacin. 
Twenty-three (71.8%) were susceptible, four (12.5%) resistant and five 
(15.6%) intermediate to piperacdndtazobactam. Five isolates were multi- 
resistant. Disk dihsion results were in accordance with agar dilution results 
except in some cases. Three isolates which were imipenem intermediate 
were interpreted as resistant in &sk difksion and one resistant isolate as 
susceptible. For ceftazidime one intermediate isolate was interpreted as 
resistant and one resistant as intermediate. For ciprofloxacin four resistant 
isolates were interpreted as intermediate and one resistant as susceptible. For 
gentamicin and amikacin results matched completely. Resistance of P. 
aeruginosa in ICU is high. Disk a s i o n  method corresponded with agar 
dilution method best for aminoglycosides and less good for other antibiotics. 
/p1379/ Comparison of imipenem and ceftazidime activity 
against mucoid and nonmucoid strains of Pseudomonas 
aeruginosa isolated from patients in Iran 
M. Ahangarzadeh Rezaee, Q. Behzadiyan-Nejad, S. Najar-Pirayeh, P. Owlia 
Tehran, IR 
From April to September 2000, one hundred and thirty-three P.  aeruginosa 
were isolated &om hospitalized patients in Tehran. In t h ~ s  tudy, in admtion 
to determine the MICs of two anti-Pseudomonas antibiotics, ceftazidime 
and imipenem, on these isolates; mucoid strains were selected by capsule 
staining and precipitating of algmate in cold ethanol. The results showed 
that more than 95% of the strains were sensitive to imipenem. T h s  
antibiotic irhbited most strains with an MIC equaling 4 pg/mL. However, 
more than 65% of strains were resistant to ceftazidime and only 
concentrations equal to 128 pg/pL or more inhibited their growth. 
Statistical analysis of the results showed that there is a significant relationship 
between alginate capsule and resistance to ceftazidime, but about imipenem 
there was no such relation. 
Ip138Ol In vitro susceptibility of Pseudomonas aeruginosa 
from cystic fibrosis patients in Southern Germany, 1998-99 
T. Schiilin 
Freiburg, D 
Pseudomonas aeruginosa is the most common colonising pathogen in the lung 
of CF patients. Repeated exposure to antimicrobial agents and emergence 
of resistance makes treatment of P. aeruginosa infections difficult. In this 
study we investigated the in vifro susceptibility of CF-pathogens to several 
antipseudomonas agents for iv as well as for inhalative treatment. 90 unique 
strains of P. aeruginosa (30 mucoid and 60 nonniucoid) from 50 CF patients 
were collected from 8/98 to 2/99. Agar-dilution test was performed on 
MH-11-agar. Results were as follows (MIC mg/L: vertical lines mark 
NCCLS breakpoints where available; numbers indicate number of isolates) 
Antibiotic <0.25 0.25 0.5 1 2 4 8 15 32 64 128 > 128 U susc 
Crftazidimr 4 2 5 16 25 10 9 4 2 5 4 4 h X Y  
Ciprofloxacin 16 5 12 15 18 14 7 2 0 1 0 0 53.3 
Colistin 7 3 29 34 8 1 0 0 0 0  I 7  43.3 
Forfomycin 0 0 0 1 3 2 7 5 13 23 18 18 
Mrropenem 14 17 17 1 1  13 4 8 5 1 0 0 0 80 
Piperacillin 0 1 2 4 8 12 20 12 8 7 5 I 1  30 
Tobramyan 0 8 6 9 20 17 I3 5 I 1 4 6 25.6 
The MICs compare favourably to those published elsewhere, but are higher 
than for P. aeruginosa &om non-CF patients. MICs for mucoid and 
nonmucoid strains did not show significant differences. Meropenem was the 
most potent agent, followed by ceftazidime. Fosfomycin MICs are generally 
high and their clinical relevance remains to be tested further. 43.3% of 
strains were susceptible to colistin and only 25.6% to tobramycin. However, 
those MICs may need to be interpreted differently from the NCCLS 
breakpoints, since the agents are used aerosolised, and the concentration in 
the lungs will be hgher than the achevable serum concentrations. 
Therefore, this agents may play a crucial role in therapy. 
v1 In vitro activity of a new aminoglycoside-lsepamicin 
against Pseudomonas aeruginosa 
A. Karadenizli, M. MeriC, F. Kolayli, S. KeGeli, A. Willke 
Kocaefi, T R  
Pseudornonas aerlrginosa is one of the most isolated microorganisms from 
hospital infections. Aminoglycosides are the drugs of choice in the treatment 
of the infections caused by resistant strains to many antibiotics in hospital 
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environment. In this study, the effect of a new aminoglycoside (Isepanicin) 
was investigated in P. aeruginosa strains isolated from our clinical laboratory. 
Antibiotic susceptibility was tested by disk diffusion and agar dilution 
method according to NCCLS M10049. In disk diffusion method, of totally 
90 strains, 85 (94.44%), 69 (76.66%), 43 (47.77%) and 37 (41.11%) were 
found to be susceptible to amikacin, isepamicm, tobramicin and gentamicin, 
respectively. Whereas in agar dilution method, rates were determined as 91 
(87.50%), 74 (71.15%), 43 (41.34%) us. 39 (37.50%), respectively. Thus, 
using both methods showed that the effect of isepamacin was hgber 
compared to tobnmycin and gentanlicin ( P  < 0.01). However, it was less 
effective when compared to amikacin (P < 0.01). 
jp1382/ In vitro antibiotic sensitivity of Acinetobacter spp. 
strains isolated as the nosocomial infection agents in medical 
intensive care units and identified in the microbial identification 
system (MIS) 
0. Aktas, A. Ozbek, R. Kesli 
Erzurum, TR 
Objective: To investigate antimicrobial susceptibility for nosocomial isolates 
of Acinefobarter spp. in intensive care unit, surgical and reanimation 
departments. 
Methods: Fifty Acinetobacter spp. strains isolated from various specimens of 
patients in intensive care unit, surgical and reanimation departments were 
identified in the Microbial Identification System (MIS) by gas-chromato- 
graphy method as well as by routine diagnostic methods. The antimicrobial 
susceptibllities of a total of 50 strains (45 of which were Acinetobacter 
baumanii, 3 were Acinetobacter calroaceticus and 2 were Acinetobacter iwqff;) 
against 16 antimicrobial agents were investigated by disc diffusion method 
according to NCCLS guidelines used as the reference method for 
antimicrobial susceptibility testing. 
Results: Of the antimicrobial agents tested imipenem was the most active 
against A. baurnanii strains (95.6% susceptibhty), nieropenem and netilrmcin 
presented tnodareted activity (86.7%, 79.8% susceptibility). Most of A. 
baumanii strains were resistant to otloxacin and cefoperazone-sulbactaui 
(53.3%suscepnb~lity), ciprofloxacin (44.5% susceptibility), amikacin (35.6% 
susceptibhty), ticarcillin-clavulanate (31 .I% susceptibility), ceftriaxone and 
ampicih-sulbactam (24.5% susceptibility), ceftazidime (22.2% suscept- 
ibility), mmethoprim-sulfamethoxasole and cefepime (28.9% susceptibdity), 
amoxocillin-clavulanate (20.0% susceptibility), ampicillin (15.6% suscept- 
ibility), aztreonam (11.1% susceptibility). All o fA.  calcoaceticus and A. iwofl; 
strains were sensitive to imipenem, meropenem and netilmicin, but the 
other antibiotics were not. 
Conclusion: Antimicrobial resistance of Arirtetobarter spp. strains was found 
in a high range in our hospital. To prevent the spread of Acinetobacter spp. 
strains in a hospital, the control of extensive cleamng and disinfection of the 
entire ward and of antimicrobial usage is necessary. 
lp13831 Antibiotic susceptibility of multiply resistant bacteria 
from Scottish cystic fibrosis patients, 1999-2000 
I. M. Gould, K. Milne, J. Legge, F. M. MacKenzie 
Aberdeen, UK 
In 1999 the Common Service Agency of the Scottish Government funded a 
National Referral Centre for the study of multiply resistant isolates from 
cystic fibrosis (CF) patients. Over a 19-month period, 125 isolates were 
forwarded for analysis comprising 65 P. aeruginosa, 24 B.  repacia, 16 
Pseudomonas spp., 16 Stenotrophonionas maltophilia and 4 Alcaligenes spp. 
Susceptibility testing methods were NCCLS agar disc diffusion and NCCLS 
microtitre broth dilution. A total of 1420 disc di€fusion susceptibilities and 
1517 MICs were carned out, MIC 50, MIC 90 and percent susceptible 
were calculated. Mean numbers of M y  active agents per species were: P. 
aerugiriosa 2.8, Pseudomoms spp. 2.9, B. cepacia 0.7, S. maltophilia 2.5 and 
Alcaligenes spp. 5. There were 160 major and 39 minor errors in the agar disc 
dihsion testing. Colistin was the most active agent against P .  aenrginosa 
(63.5%) and Pseudomonas spp. (91%) followed by tobraniycin (43.7% and 
50%, respectively). Minocycline waF the most active agent against B. cepacia 
(25% susceptible) and S .  maltophilia (70% susceptible) followed by 
cotrimoxazole (14%) for B.  cepacia and rifampicin (36.5%) for 5'. maltophilia. 
Several broad-spectrum p lactams were fully active against Alcalkiner spp. In 
conclusion, improved methods for susceptibility testing of clinical isolates 
need to be employed in Scottish laboratories. Levels of resistance in referred 
isolates are very high and simdar to those already described from a referral 
laboratory in the USA. 
lp13841 PER-I and OXA-10-like p-lactamases in pseudomonas 
strains isolated from intensive care unit patients 
2. Aktas, L. Poirel, M. Salcioglu, C.  Bal, 0. Ang, P .  Nordmann 
Istanbul, TR; Paris, F 
PER-1 p-lactamase was first detected in France from a Turkish patient and 
was reported later in several studies from Turkey. In this study antibiotic 
resistance and presence of extended spectrum p-lactamases in general and 
PER-1 and OM-10-like P-lactaniases in particular were investigated in 
pseudomot~as strains isolated from patients hospitalized in the intensive care 
unit of the Medical Faculty of Istanbul. The disk diffusion method was used 
to determine resistance to antibiotics. Resistance rates of 63 pseudomoriar 
strains to ceftazidime, imipenem and aztreonam were found as 76%, 92% 
and 73%, respectively. The double disk synergy test was used to determine 
the presence of extended spectrum P-lactamases (ESBL) and 28% of the 
strains were found to harbour ESBL. PER-1 gene was found positive in 42 
strains, and of these, 26 strains were found positive for the OM-10-like P- 
lactamase gene by PCR. The AP-PCR method was employed to 
investigate any epidemiological relatedness among the isolates but 16 
different types were detected. Information on p-lactamases will help 
improving antibiotic treatment and epidemiological tracking. 
lp13851 Ralstonia pickettii traced to blood culture bottles 
N. Boutros, N. Gonullu, A. Casetta, M. Guibert, V. Gautier, H. Coudol, 
D. Ingrand, L. Lebrun 
Istanbul, TR; Clamatt, F 
Between March and November 2000, 14 strains of R. pickettii were isolated 
from various biological samples cultured in enrichment broth (5 pleural 
fluids, 3 ascitic fluids, 3 pus samples, 2 biopsies and one blood culture) and 
originated &om patients hospitalised in Merent  units of our hospital. All 
these strains were detected in the same broth (Vital BioMerieux, France) 
generally used for blood cultures and the presence of this microorganism did 
not correlate with the clinical status of patients. Our aim was to investigate 
the origin of this probable contamination using biotyping, antibiotyping, 
and molecular typing. Strains were identified using Api NE identification 
system. Antibiotic resistance profiles were done on Muller-Hinton agar and 
interpreted according to CA-SFM standards. Molecular studies were 
performed using random amplified polymorphic DNA (KAPD) and pulsed 
field gel electrophoresis (PFGE) using SpeI restriction enzyme. Antibiotic 
testing showed sirmlar susceptibility patterns for all strains. PFGE performed 
for 11 strains revealed four different clusters A, U, C and D. The A and B 
clusters contained six and three strains, respectively. The two remaining 
strains constituted clusters C and D. However, all clusters were closely 
related (different by less than four bands) A source of a contaminated 
parented or antiseptic solution as has been previously described, could not 
be incriminated. For this reason, culture on chocolate agar of 15 unused 
Vital bottle caps chosen at random was undertaken. After 48 h of incubation 
at 30:C, seven of these caps yielded a confluent growth of R. pickettii, 
corresponding to interior surface of the cap and showing the same biotype 
and the same antibiotic susceptibility pattern. Further studies are in progress 
to correlate the four molecular profiles to serial numbers of Vital blood 
culture bottles. 
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lp13861 Tuberculin skin test reactivity and booster effect 
among elderly in nursing home settings 
R. Karakus, I. Maral, K. Hizel, F. Aktas 
Ankara, TR 
Objectives: To determine the baseline prevalance of positive tuberculin skin 
test (TST) reactions and boosting effect among the elderly 
Methods: In two nursing home settings in different provinces ofAnkara 189 
people aged 60 and above were enrolled in this study. It was carried out 
prospectively between July August 2000. A questionaire was held for past 
medical history and previous personal hstory of tuberculosis (TB) or of 
exposure to TB. BCG scars were noted for each patient. The tuberculin 
tests were prepared indoors of each nursing home just prior to 
administration. 0.1 mL of tuberculin was administered by a specialized 
doctor to all of the enrolled people using the Mantoux method. The 
diameter of induration was read 72 h after the administration. TST 
reactivity equal 10 mm or above was considered as positive. For those < 10 
mm induration a second tuberculin of 0.1 mL was placed 7 days later. The 
results were read again 72 h after the second placement. Boosting effect was 
considered as an increase to 10 mm or above after the second placement. 
Results: In our study we found the mean induration diameter 8.7 mm (SD 
6.7). One hundred of the attendees were considered as negative, and 89 
were considered as positive after the initial reading. Among the initially 
negatives, 18 became positive after the second dose. Any statistically 
significant difference between sex, age groups, previous personal history of 
or exposure to TB, number of BCG scars and TST positivity could not be 
detected. 
Conclusion: In our study we could not find any relation between BCG scars 
and TST positivity. This result is suggestive of that community exposure to 
mycobacteriae is frequent in our population. We also observed a boosting 
effect of 25.7% suggesting that a definite TST should be reported after a 
second testing among the elderly. 
v1 Primary tuberculosis cases presenting with Erythema 
nodosum 
A. Mert, F. Tabak, R. Ozaras, R. Ozturk, Y. Aktuglu 
Ltanbul, TR 
Erythema riodosum (EN) due to tuberculosis (TB) is seen only in primary TB 
form of tuberculous diseases. O n  the other hand, primary TB is the most 
frequent etiology of E N  in developing countries. We aimed to evaluate 
clinical features and prognosis of primary TB cases of our clinic presented 
with EN during last 20 years in our country where TB is endemic. We 
retrospectively studied files and outpatient clinic data of our all TB cases 
hospitalized during last 20 years, from 1980 to 2000. We divided patients 
according to clinical forms. Clinical features, diagnosis, treatment, and 
prognosis of the patients diagnosed as primary TB were further studied. We 
found that 270 patients were diagnosed as TB during last 20 years. Fifty-five 
(20%) had pulmonary and 215 (80%) had extrapulmonary TB. Eight 
(14.5%) of pulmonary TB were primary TB. Ail were presented with EN. 
Meanwhile, 40 patients with EN were diagnosed and followed during last 7 
years, the etiology was detected in half Primary TB was the most frequent 
etiology (19%). These patients were prescribed 4 anti-TB drugs (isoniazid 
[INH], rifampin [RMP], pyrazinamide [PZA], and ethambutol PMB]) and 
clinical response was obtained within 3 weeks. PZA and EMB were given 2 
months, INH and RMP were given at least 6 months. E N  seen during the 
course of primary TB results from a delayed type hyperreactivity against 
tuberculoproteins. It is generally seen 4-8 months after the entry of bacilli 
when tuberculin skin test becomes positive. For this reason, it is generally 
seen in ages which pnmary TB is fiequent (childhood and adolescence; 
< 20 years). TB became an important health problem after 1985 all over the 
world. Ten million new TB cases are encountered annually with 95% from 
developing countries. It can be easily estimated that EN due to TB beside 
the other clinical forms of TB will be seen more especially in developing 
countries. Some studies revealed that primary TB is one of the leading 
etiologies ofEN in developing countries, but this etiology is less frequent in 
developed countries. In conclusion, primary TB should be considered in 
cases presented with EN especially in developing countries. 
lp1388( Tuberculous lymphadenopathy: a review of 35 cases 
A. Mert, F. Tabak, R. Ozaras, R. Ozturk, H .  Aki, Y. Aktuglu 
Istanbul, TR 
Tuberculosis (TB) is endemic in Turkey. There is a tendency to increase in 
TB cases during recent 15 years due to several factors worldwide. TB LAP is 
one of the most frequent form of extrapulmonary TB. We reviewed several 
aspects of 35 cases of TB LAP and Mycobwerium tuberculosis DNA was 
studied by PCR in available hepatic granulomas. During last 20 years, 270 
cases with TB have been followed-up; 20% were pulmonary and 80% were 
extrapulmonary. TB LAP constituted 13% of all (1x35, 10 male, 25 female, 
mean age 33 + 17). Of these patients, 34% (n:12) were admitted with 
enlargements in lymph nodes, 9% (n:3) with LAP with fomiation of fistula, 
and 57% (n:20) with both enlargements in lymph nodes and systemic 
complaints. Mean duration from emergence of LAP to admission was 
6.3 + 7.3 months (2 weeks-24 months). The leading localization of LAP 
was cervical (77%). The sizes of LAPS were 1.5-4.5 cm and their numbers 
were 2 4 .  Abnormal findings on chest X-ray were present in 23% (8/35), 
and in 5, these findings were verified by CT. Five had primary, and 3 had 
postpriniary pulmonary TB. Erythrocyte sedimentation rate (ESR) was 
<20 mm/h in 36% (5/28), 20-50 mm/h in 38% (10/28), 50-100 mm/h in 
21% (6/28). and >lo0  mm/h in 25% (7128). While all the patients in the 
first group were asymptomatic, a!.i in the last were symptomatic. Tuberculin 
skin test was positive in 91% (21/23). The diagnosis was established by 
biopsy in 32 (91%, granulomatous LAP; caseating necrosis in 28, without 
necrosis in 4), by fine-needle aspiration in 2, by detecting acid-fast bacilli 
(AFB) in fluid from fistula in 1. All were given anti-TB treatment (INH + 
RMP + PZA + EMB for 20 and INH + RMP + PZA or EMB for the 
remaining). Surgical excision was needed for 2. Clinical improvement was 
achieved within 3 months and ESR returned to normal within 5 months. 
The overall tolerance to the drugs was good. 22 of the patients were 
followed-up for a duration of 3 k 2 years (1-7 years) and no recurrences 
were noted. AFB was detected in none of the paraffin-embedded materials 
of TB granulomas. M. tuberculosis DNA by PCR was positive in 6 /  18 (33%). 
In conclusion, TB LAP is generally presented with painless, 1.5-4.5 cm in 
size, few and slowly growing lymph nodes. Epidemiological data, history, 
clinical presentation, chest X-ray, and tuberculin skin test may contribute to 
the correct diagnosis in majority of the cases. The exact diagnosis should be 
based on tissue sampling. 
Primary tuberculosis of the parotid gland 
A. Mert, R. Ozaras, M. Bilir, Y .  Cicek, F. Tabak, V. Tahan, R. Ozturk 
Istanbul, TR 
Tuberculosis of the parotid gland is rare even in those areas where the 
disease is endemic. It may result from the involvement of intraparotid lymph 
nodes (the localized form) or the infection of parenchyma either primary or 
secondary to nodal disease (the diffuse form). We present a patient with a 
parotid mass which was thought to be a malignancy but diagnosed to be 
tuberculosis of intracapsular lymph nodes after surgery. A 66-year-old 
woman was admitted with one month history of increasingly swelling at the 
angle of the jaw on the right side. Systemic examination was normal except 
for a 4 x 2 cm, mobile, rubbery, nontender mass in the right parotid region. 
All the haematological findings (a white cell count of 7000/mm3, and a 
lymphocyte count of 1600/mm3), biochenlical data, ESR and CKP were 
normal. The chest X-ray was normal. A tuberculin skin test was positive (an 
enduration of 30 x 32 mm). Anti HIV 1 and 2 antibodies were negative. 
With ultrasonography, an anechoic mass measuring 36 x 16 x 18 mni was 
detected. Computed tomography of this region revealed a 35 x 25 mni 
homogenous mass extending from superficial lobe to inferior border of the 
parotid gland. Surgical exploration of this region revealed a yellow-pink, 
firm, nodular mass. The mass is completely removed surgically. Histological 
examination demonstrated a caseating granuloma in the intracapsular lymph 
nodes. Acid-fast bacilli (AFB) were found in the aspiration fluid of the 
lesion. The culture of this fluid for Mycobacte~um tuberculosis was negative. 
M. tubercutosir DNA in the tissue with caseating granuloma remained 
negative by PCR. After surgery, she was prescribed a 6-month course of 
INH, RMP, EMB, and PZA. EMB and PZA were discontinued after 2 
months. At a 12-month follow-up, the patient was doing well. Because of 
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difficulty in differential diagnosis, a mass in the parotid gland needs a carefbl 
investigation and although it is rare, tuberculous parotitis should especially 
he considered in an  endemic area and parotid gland biopsies should be sent 
for microbiologcal as well as histological examination. 
I PI390 I Multidrug-resistant tuberculous spondylodiscitis: 
growing evidence for the need of aggressive management of 
spondylodiscitis and drug susceptibility testing of 
Mycobacterium tuberculosis isolates 
I. Avramopoulos, N.  Vakalis, G. Sapkas, M. Christopoulou, J. Xinotroulas, 
C. Nikolidaki, A. Achimastos, M. E. Falagas 
Athens, GR 
Muladrug resistant tuberculosis is an emerging threat to human health. 
Resistance to isoniazid and rifampin of M. tuberculosis becomes gradually 
more common worldwide. A 49-year-old woman complaining of thoracic 
spine pain for 18 months was admitted to the hospital for evaluation. 
Erythrocyte sedimentation rate (ESR) was 86 mm (first hour). Chest X-ray 
showed destruction of the lower part of the body of the eighth thoracic 
vertebra. Magnetic Resonance Imaging of thoracic spine showed 
spondylodiscins of the T8-T9 intervertebral disk. Computed tomography 
scan-guided fine needle aspiration of the affected area was performed. Gram 
stain and culture of the obtained specimens for common microorganisms 
and Brucella species were negative. Serology tests for brucellosis were also 
negative. In addition, Ziehl-Neelsen stain, polymerase chain reaction 
(PCR), and culture for Mycobacteria were negative. Because of continuing 
symptoms and lack of diagnosis the patient underwent a vertebrectomy and 
substitution of the eighth thoracic vertebra with Moss titanium cylinder 
filled-up with auto-bone grafts. The stabilization was completed using the 
Kaneda system. Culture of the extracted bone grew M.  tuberculosis, which 
was resistant to isoniazid and rifampin. The patient was treated with 
pyrazinaniide IS00 mg, ethambutol 1200 nig, streptomycin 1 g, ofloxacin 
800 mg, cycloseririe 750 mg and vitamin A6 62.5 mg/day. Her symptoms 
gradually receded. Streptomycin was discontinued after 2 months of 
treatment. The rest of antituberculous agents were discontinued five months 
after initiation of treatment due to severe drug-related hepatotoxicity and 
psychosis. Afler treatment discontinuahon nl l  adverse reactions subsided. 
Twenty-two months later the patient continues to be free of symptoms and 
with nomial ESR without taking any medications. In conclusion, a 
conservative management strategy would have clearly led to therapeutic 
failure in our patient. Persistent and even invasive diagnostic work up is 
needed for the proper and prompt management of patients with 
spondylodiscitis. It? uitro drug susceptibility testing may be necessary for all 
M .  tuberculosis isolates due to the increasing incidence of multidrug resistant 
strains worldwide. An initially five-drug combination regimen (based on 
iri v i m  drug susceptibility testing) and used for a shorter period than 
previously thought may successfully treat multidrug-resistant tuberculous 
spondylodiscitis. 
(p1391/ Genotyping of Mycobacterium tuberculosis and 
nontuberculous mycobacterium by infrequent-restriction-site 
amplification 
T. Choi, J. Kang 
Seoul, KOR 
We stumed the use of infrequent restriction site amplification (IRS-PCR) 
to characterize M. tuberculosis and nontuberculous mycobacteria (NTM). 
IRS-PCR is a method of amplifying DNA sequences, which flank an 
infiequent restriction site, and produces a strain-specific electrophoretic 
pattern from crude bacterial lysates. One hundred and sixteen M. tuberculosis 
and nine NTM isolated from different geographic areas, Inchun and Seoul, 
in Korea were used in this study. IRS-PCR using AH1 and PX-G primers 
produced a unique pattern for reference strains, M. tuberculosis H37Rv, M. 
bovis BCG, M .  kansasii, M. auium, M. intracellulare, M. fortuitum, and M. 
szulgi, respectively. Reference strains M.  tuberculosis H37Rv, M. bovis, M. 
uficarium, and all isolates of A t .  tuberculosis show sindar IRS-PCR patterns 
consisting of 11-13 hands. We could differentiate these similar patterns by 
combination of results using other primers (AH1 and PX-N). The patterns 
generated by IRS-PCR of M .  tuberculosis show no relationship between 
patient place of residence or drug susceptibility. The patterns generated with 
multiple isolates of M. tuberculosis from the same patients were essentially 
identical. IRS-PCR using AH1 and PX-G produced a unique pattern for 
each of the three M. au~um, four M. intracellnlare. and two M .  fortuitum 
isolates when compared to the reference strains, respectively. We conclude 
that IRS-PCR is a potentially powerful and easy epidemiological tool for 
M .  tuberculosis and NTM. 
-1 T and B cell irnmunogenicity of SA-SK. a secretion 
antigen of Mycobacterium tuberculosis, in healthy subjects and 
in tuberculous patients 
S. Esin, G. Batoni, W. Florio, D. Bottai, M. Pardini, G. Maisetta, 
A. Boschi, M. Campa 
Pisu, I 
Objectives: We recently identified and cloned a novel 8.3 kDa secretory 
antigen of M.  fuberculosis (MTB) and M .  bovis bacillus Calmette Guerin 
(BCG) called SA5K. In the present study, recombinant SA5K containing a 
hstidine hexamer (rSA5K) was expressed in E.  coli, purified, and utilized to 
establish whether it was immunogenic for healthy BCC-vaccinated and 
nonvaccinated human donors and for tuberculosis (TB) patients. 
Methods: Enriched T-cell populations were obtained by passage of PBMC 
through a nylon wool column and stimulated in vitro with BCG culture 
filtrates (CF), rSA5K, Neg-SA5K (negative control) and PHA. Cultures 
without stimulus were set up as negative control for cell reactivity. 
Proliferative responses were evaluated by flow cytometric determination of 
bromodeoxpridine (BdU) positive cells in the well after 6 days of in vitro 
stimulation. Recognition of rSASK by human serum antibodies [Ab) was 
investigated in Western blot experiments with sera obtained from 22 TB 
patients and 27 healthy donors. 
Results: A statistically significant difference was observed between healthy 
vaccinated and nonvaccinated donors in response to rSA5K (P=0.02) as 
well as to CF (P=0.03). Analysis of the cell populations responding to 
rSA5K revealed a predominant proliferation of CD4+ T cell subset. Out of 
7 TB patients tested only 1 was responding well to rSA5K with a 
proliferation value more than 5 times the corresponding value for Neg- 
SA5K. Recognition of rSA5K by serum Ah was generally low in all subject 
categories. However, at relatively low serum dilution (1 :20), 10/13 sera 
from healthy BCG-vaccinated subjects and 7/ 13 sera from nonvaccinated 
subjects (at least 2 of them were PPD+) exhibited a positive recognition of 
rSA5K. 12/22 sera from TB patients also recognized rSA5K to certain 
extent. Reactivity of serum Ab to rSA5K was investigated in 11 TB patients 
over the course of therapy. All of the patients which were positive reactors 
at the time of the first sampling (3/11) tumed into negative during the 
course of therapy. 
Conclusions: While T and B immunogenic potential of rSA5K is generally 
low in patients with pulmonary TB, vaccination with BCG seems to elicit 
significant T cell responses and, in a certain extent, B cell responses to 
rSA5K. Ab titers in TB patients’ sera drop during the course of therapy 
suggesting that production of SA5K by live bacilli is a necessary stimulus for 
the maintenance of detectable titers of serum Ab specific for SA5K. 
v/ Low level of compliance with tuberculosis treatment 
A. Palanduz, D.  Gultekm, E. Erdem, M. Arapoglu, L. Telhan, N. Kayaalp 
Istanbul, TR 
Objectives: Compliance with therapy is important in respect of disease 
control and development of drug resistance. We measured patient 
compliance by detection of antituberculous drugs in urine. 
Methods: The second urine of the day was collected goom a total of 218 
cases. Group 1 included the 158 outpatients receiving 1-3 antituberculous 
drugs. The positive controls (Group 2) were the 20 hospitalized patients, 
supervised to receive INH, rifampicin and pyrazinamide. Group 3 consisted 
of 20 healthy nonsmokers and Group 4 included 20 healthy smokers. The 
urine was tested for INH, RIF and PZA. The tests were performed by a 
physician who was blind to the treatment regimens. 
Results: Among the 158 study patients, only 68% were found to he takmg 
the appropriate treatment and 8% received none. All of the patients in 
Group 2 had positive test results, while none of them in Group 3 had so. 
The urine of 20 smokers in Group 4 showed a false positive test for INH, 
but t h ~ ~  was easily distmguished &om the hue positives by the color of the urine. 
Conclusion: A remarkable number of patients were found to be 
noncompliant with the treatment. Patient compliance should be ensured 
in an effective tuberculous control program. The detection of antitubercu- 
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lous drugs in the urine is a quick, simple and inexpensive means of 
measuring adherence. 
vl Drug resistance pattern of Mycobacterium 
tubercu/osis complex strains in a faculty hospital in Istanbul 
M. Uzun, D. Satana, 2. Erturan, Y. Yegenoglu 
Istanbul, TR 
The modem era of tuberculosis recently has been characterized by a rise in 
the number of cases of infection with multiple-drug-resistant (MDR) M. 
ruberrulosis. The rising prevalence of MDR strains has resulted in outbreaks 
and individual cases that are only marginally treatable and often fatal. In this 
study, 9334 clinical specimens were collected during five years period 
(1996-2000) and 771 M. tuberculosis complex strains (8.5%) were isolated by 
the Bactec TB 460 system. Susceptibihties of these strains to four major 
antituberculosis drugs were detemsned with the same system. Resistance to 
at least to one or more of the drugs was 34%, and MDR-TB strains was 
18.8%. The most common resistance type was I + R +  E among M .  
tuberrulosis complex strains. 
(p13951 Susceptibility of Mycobacterium tuberculosis strains 
isolated in a Spanish hospital 
A. Rico, G. Ruiz, M. L. Guem, M. Jimenez, J. Garcia 
Madrid, E 
Objective: To know the susceptibility patterns of M .  tuberculosis strains 
isolated in our hospital in the last year to the first line tuberculostatics drugs. 
Methods: The susceptibility of 140 strains of M. tuberculosis isolated from 
140 patients between April 1999 to November 2000 was studied using the 
proportions method. The drugs tested were isoniazid (INH), rifanipin 
(RMP), ethambutol (EMB), streptomycin (S) and pyrazinamide (PZ). 
Results: Susceptibility to all five drugs: 128 (91.4%). Resistance: INH, 3 
(2.1%); RMP, 2 (1.4%); EMB, 0; S, 1 (0.7%); PZ, 0; MDRTB, 3 (2.1%). 
[MDRTB: Resistance to INH and RMP at least.] Primary resistance 
was found in 5 strains, 2 were MDRTB and the others were only resistant 
to one drug. Secondary resistance was found in 4 strains. Only one was 
MDRTB. There were not differences between positive and negative 
HIV patients. 
Conclusions: The rate of resistance was low. Most resistant strains were 
found in patients previously treated (secondary resistance) regardless of the 
HIV serology. 
Study of primary drug resistance of Mycobacterium 
tuberculosis in a tertiary hospital in the Canary Islands: a 
10-year survey 
M. Lecuona, I. Gonzalez, R. Alvarez, I. Montesinos, J. A. Gullon, M. 
Cuervo, A. Sierra 
La Lagurta, Tenenye, E 
Objective: To study the primary drug resistance for M. ruberrulosis isolated in 
our laboratory, in order to evaluate its evolution throughout these past 10 
years (1990-99) in our island. 
Method: We have study the sensitivity pattern of the 456 strains of M. 
ruberrulosis complex collected from equal number of patients (76.1 males, 
mean age: 40 & 16.8 years) with different clinical forms of tuberculosis 
(10.9% pulmonary samples), diagnosed between 1 January 1990 and 31 
December 1999. We have used the proportion method described by 
Canetti et al .  for the drug sensitivity study. To  determine primary resistance 
for resistance strains, we have selected patients who had not previously 
received antituberculosis treatment by means of personal interviews and 
patient’s charts. 
Results: Sixty-six (14.5%) strains of the 456 isolates were resistant to one or 
more drugs; nevertheless among these, 42 had not previously received 
antituberculosis treatment, then the rate of primary resistance in our study 
comes 9.2% (81% males, mean age: 37.7 15.4 years, 11.9% extra- 
pulmonary forms). Within the 42 isolates with primary drug resistance to 
one or more drugs, 33 (78.6%) were from HIV negative patients and 9 
(21.4%) from HIV positive. Among the 389 sensitive isolates, 340 (87.4%) 
came from HIV negative patients, whereas 49 (12.6%) came &on1 HIV 
positive patients ( P =  0.1). Isoniazid (INH) was individually at the forefront 
of primary drug resistance (4.8% of the total strains), followed by Rifampin 
(RMP) (4.4%). 17 strains (40.5%) showed resistance to two or more drugs. 
23.8% of the resistant isolated were resistant to INH plus streptomicin (SM) 
and in particular, the appearance of five cases of resistance to three drugs and 
four cases to four drugs. Eight ofthe 42 strains (19%) showed niultiresistance 
pattern (INH + RMP); this represents 1.7% of the total isolates. Three of 
these eight cases of multirresistance came from HIV positive patients. 
Conclusions: Primary drug resistance of M. tuberrulusis in our island has 
stayed in relation to previous studies and we have a low incidence of 
multiresistance. There is not a direct causal relationship between the HIV 
epidemic and primary resistance tuberculosis rate. 
v1 Outcome and management of HIV-1 pregnant 
women with multidrug resistant tuberculosis in Durban, South 
Africa 
M. Khan, T. PiUay, A. Ramjee, N. Padayatchi, J. Moodiey 
KwaZuEu Natal, ZA; Oxford, UK 
Background: KwaZulu Natal is being ravaged by the tuberculosis (TB) and 
human immunodeficiency virus (HIV-1) epidemics, with Durban at the 
epicentre. The current rates for multidrug resistant tuberculosis (MDK TB) 
is 10.2% and similar rates of HIV-1 coinfection have been reported 111 
patients with MDR TB as in patients with drug sensitive TB. 
Method: We wish to focus on the management, pregnancy- and neonatal - 
outcomes of mothers with M D R  TB in KwaZulu Natal for the period 
Results: Five women with MDR TB are described, two of whom were 
HIV-1 infected. The mean age, parity and gravidity of these women was 
30.8, 2 and 2.6, respectively. The mean time period for diagnosis of MDR 
TB was 8.5 mouths prior to conception. Of the HIV-1 infected women, 
one elected to terminate her pregnancy and the other delivered a 2.8-kg 
tern1 baby. Ofthe three HIV-1 uninfected women, two camed to term (3.2 
kg and 2.5 kg babies). We review the current dilemmas in the management 
of MDR TB in pregnancy, prophylaxis and management of exposed 
neonates. 
Conclusion: This is the first reported case of HIV-1 associated MDR TB in 
pregnant women and their exposed neonates. In areas endemic for these 
diseaces, management options must be highlighted. 
1997-2000. 
lp13981 Evaluation of drug resistance in TB disease in 50 
urinary and respiratory samples 
A. De Santis, A. Simone, M. Rutighano, V. De Lettenis, M. Schiralli, 
V. Giorgio 
Bari, I 
Introduction: In a population of 50 patients with active TB disease (urinary 
and pulmonary TB disease) in the Tisiatric Ward in San Paolo Hospital Ban 
(Italy), the drug resistance has been evaluated of 4 antibiotics commonly 
used for TB therapy (H, R ,  E, S). The species isolated and considered in the 
study have been TB complex only. 
Method: The 50 positive samples were isolated from several urinary and 
respiratory materials as shown in the table below: 38 sputum, 3 urine, 7 
bronchial lavage and 2 pleuric fluid. Each sample collected belonged to a 
single patient from the Tisiatric Ward and the trial started at the beginning 
of January 2000. The TB complex species were isolated with liquid broth 
7H9 using the instrument MGIT 960 of Becton Dickinson and the method 
utilized for testing drug-resistant tuberculosis was MGIT fluorescence test of 
Becton Dickinson. 
Result: The results of drug-resistant tuberculosis are shown in the table. 
Total sample5 50 1 OO%, 
Total sensitwiry 16 3% (S, H. E, I<) 
Mono-resistant strains 
S 18 36% 
H 9 1 ti%> 
E 31 6 2 1  
R 1 2% 
Multi-resistant stram\ 
H, R, E 1 296 (MDR) 
E. S 1 0 20% 
H. E 2 4% 
H. E, S 5 10% 
H, s 1 2% 
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Conclusion: The study hghlights a general increase in drug-resistance for 
Mycobacterium Tuberculosis complex, and in particular there is an increase in 
drug-resistance for Etambutol. The MDR (Multi Drug Resistance), on the 
contrary, has an average as reported in literature. 
(p13991 Isolation of Mycobacteriurn elephantis in sputum: a 
mystery? 
D. Potters, M. Seghers, G. Muyldermans, D. PiCrard, A. Naessens, 
S. Lauwers 
Jetfe, B 
A 79-year-old man was hospitahsed having watery diarrhoea (blood and 
mucus absent) and palpitations. In his recent medical history an empirical 
treatment in an ambulatory setting for an upper respiratory tract infection 
with cipro5oxacin was noted. A diagnosis of enteritis (no pathogen isolated) 
was made and the cardiovascular evaluation demonstrated ventriculadextra- 
ventricular extrasystoles and nlitral valve insufficiency. A mycobacterium 
strain (S2257) was isolated from sputum and referred to our lab for 
identification and susceptibility testing. S2257 was inoculated on Low- 
enstein-Jensen, Ogawa and Middlebrook 7H10 medium and incubated at 
35°C in CO? atmosphere. S2257 took more then 3 days to grow on our 
isolation media, was acid-fast (Auramin-0-stain) and nonchromogemc. 
These characteristics and the presence of catalase activity (semiquantative), 
production of urease, nitrate reduction and Tween 80 hydrolysis suggested 
this strain belonged to the Mycobactenurn triviale-nonchromogenic-terrae- 
complex. However, gas liquid chromatography (GLC) repetitively 
suggested Myrubacfen'um auium-intracellulare (similarity coefficient 0.406- 
0.655). The antibiotic profile pointed against this complex (susceptible to 
the highest concentration of isoniazide, streptomycine, kanamycine, 
capreomycine, cycloserine and clarithromycine). Because of the contra- 
dictory results a sequence analysis of the 16SrRNA gene of S2257 was 
performed. There was a 99.8% similarity to M .  elephantis. The patient had 
not had any contact with elephants, the only known source of this species 
until now. There was however, a history of respiratory tract infection and of 
enteritis. We conclude that further studies are required into the origin, 
infectiveness and clinical significance of M .  elephantis and that molecular 
techniques will be a valuable tool in the identification of mycobacteria not 
readily identified with standard methods 
[p1400/ Typing of 186 clinical isolates of M. kansasii, isolated 
in the area of Bilbao, Spain by PCR-RFLP of the Hsp65 gene 
A. Gaafar, M. J. Unzaga, P. Velasco, A. Martinez, B. Amezua, R. Cisterna 
Bilbao, E 
Background In the last few years, infection by M .  kansasii has been 
increasindy reported in the area of Bilbao, with an annual rate in 1998 of 
8.33 per 100 000 in the general population. 
Objective: The aim of this study was to determine the subtypes responsible 
for the unexplained augmentation of the infection rate in the area of Bilbao 
in the last decade as a part of an epidemiological study to trace the source of 
the infection. 
Material and methods: Isolates: 186 clinical isolates of M .  kaurasii isolated 
from 162 patinas. All clinical isolates were identified as M.  kansasii by using 
DNA probe (AccuProbe). 5 strains belonging to the 5 known genotypes of 
M. kansasii have been included as positive control (provided by Dr V. 
Vincent, Institute of Pasteur, Paris). PCR-KFLP: DNA was obtained as 
follows: One loopful of bacteria was suspended in 300 mL of distilled water, 
subjected to sonication for 15 min, boiled in water bath for 15 min, and 
centrifuged for 10 min at 13 000 revlmin 5 pL ofthe supernatant were used 
for PCR. The composition of the of the PCR m t u r e  (50 pL) was 50 mM 
KCl, 10 mM Tris-HC1 (pH 8.3). 1.5 mM MgCL, 10% glycerol, 200 pmol 
(each) deoxynucleoside triphosphate, 0.5 pmol (each) primer (Tbl l  and 
Tb12), and 1.25 U of Taq polinierase. The reaction was subjected to 45 
cycles of amplification (1 min at 94"C, 1 min at 60"C, 1 min at 72'C); this 
was followed by 10 min of extension at 72°C. For restriction Gagmenr 
analysis, 20 microliters of the PCR product was digested by 5 U of either 
BstII for 60 min at 60 "C, or with HaeIII for 60 min at 37"C, with 2.5 pL of 
the corresponding buffer (5X). The digestion product was loaded onto 4% 
agarose gel and the fragments were visualized by ethidium bromide staining 
and W light. 
Results: The PCR-RFLP analysis of the 5 control strains generated five 
different patterns typical to that of the published data. All the clinical isolates 
had the typical pattern of type I except only on isolate, that had a pattern 
typical to that of type 11. 
Conclusions: The results of this study do not discover any heterogeneity 
among our collection; nevertheless, it may confirm the clinical importance 
of these isolates being corresponding to type I, the type mostly isolated 
clinically. It may be necessary in the future to subject our collection to more 
discriminating typing methods as LRF-PFGE, in order to outline the source 
of this infection. 
v1 An emergent infection by M. kansasii among HIV 
negative patients in the area of Bilbao, Spain 
M. V. Leal, A. Gaafar, F. Garcia, M. J. Unzaga, J .  A. Crespo, R. Cisterna 
Bilbao, E 
Background: M. kansasii has been increasingly reported as a pathogen 
among HIV negative population during the last decade in the area of Bilbao. 
Such increase has not been reported in the adjacent areas. 
Objective: Retrospective study including: (a) analysis of the clinical history 
of 60 HIV negative patients hom whom M .  kansasii had been isolated 
during the period between January 1998 and June 1999 in the hospitals of 
Basurto and Santamarina, which cover the urban area of Bilbao; and (b) 
molecular typing of the 37 viable isolates from these patients. 
Material and methods: (a) Review of the medical records to fulfil the 
criteria of pulmonary disease according to ATS (the American Thoracic 
Society). (b) Molecular typing of37 viable isolates was performed by PCR- 
RFLP analysis of the hsp65 gene in which a 439-bp segment was amplified 
using 2 primers (To1 1 and Tb12) and the PCK product was digested using 
2 restriction enzymes (BstEII and HaeIII). Restriction fragments were 
separated by gel electrophoresis and were visualised by staining with 
e h d i u m  bromide. 
Results: Because the information available for 16 patients was insufficient, 
these patients were eliminated Gom further analysis. Only 34 completed 
typically all ATS criteria and received antituberculous treatment. The 
clinical presentation was productive cough (60%), fever (26%), hemoptysis 
(18%), and constitutional manifestations (15%). Chest X-ray revealed 
cavitary lesion in 65% and acid fast bacilli were recovered in 31.6%. Many 
predisposing factors were outlined COPD (18%), smoking (16%), prior 
tuberculosis (14%), alcohol abuse (8%) silicosis (4.1%), chronic hepatopathy, 
bronchogenic carcinoma and other malignancies. Geographically, the 
peripheral districts of Bilbao showed higher incidence (23 per 
100,000).The vast majority were males (57 of 60 pahents) with a mean 
age of 57 years. The PCR-RFLP of 5 control strains belonging to the 
known 5 types of M .  kamasii generated five different patterns while all the 
clinical isolates had the typical pattern of type I .  
Conclusions: The patients were characterised by a very high male 
predominance (95%), a mean age of 57 years, underlying disease, and most 
lived in peripheral districts. Type I was the only type detected by PCR- 
RFLP. It may be necessary in the future to use a more discriminative typing 
method; nevertheless, this result may confirm the clinical importance of 
our isolates. 
v1 Evaluation of PGL-I ELISA as a serodiagnostic method 
in leprosy 
A. Rafi 
Tabnz, IR 
Serum samples Gom the lepromatous leprosy patients were tested by 
indrect ELISA to determine the level of IgG antibody against phenolic 
glycolipid-I (PGL-I) specific antigen of M. leprae. The results correlated very 
well with the previous molecular findmgs and 96% of the leprosy PCR- 
positive patients could be confirmed with PGL-I ELISA. The sensitivity and 
specificity of PGL-I ELISA for leprosy PCR-positive patients reached 
85.6% and 94.4%, respectively. The high specificity of PGL-I ELISA 
obtained in this study together with correlation of molecular findings 
confirm the effectiveness of this technique for the serodiagnosis of 
leprosy patients. 
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Bone and joint infections 
vl Evidence-based antibiotic therapy for bone and joint 
infections: results of a meta-analysis 
D. Stengel, K. Bauwens, J. Sehouli, A. Ekkemkamp 
Bedin, Greifiwald, D 
Background: Patients undergoing surgical treatment for bone and joint 
infections routinely receive antibiotic therapy. The purpose of ths  meta- 
analysis was to evaluate the clinical e5cacy of individual antibiotic agents for 
this difficult to treat condition in adults. 
Methods: Published and unpublished controlled clinical trials reported 
between 1966 and 2000 were eligible for analysis if they involved any 
random allocation to systemically applied antimicrobials or local antibiotic 
therapy for osteomyelitis and septic arthritis. Sunlmary measures of 
effectiveness were expressed as odds ratios with the use of fixed effects or 
random effects modelling where appropriate. Quiescence of infection after 
one year follow-up was defined as the primary measure of outcome, 
whereas clinical cure and improvement at end of treatment, adverse events, 
and bacteriological eradication served as secondary endpoints. Numbers 
needed to treat (NNT) and nuniben needed to harm (NNH) were 
computed to give a clinically sound idea on effort and yield of therapy. 
Results: More than 200 citations were identified. After dropping the vast 
majority ofstudies from final evaluation for methodological reasons, 19 trials 
containing 677 patients were included in the final model. Kifampin 
combinations showed advantage over mono-therapy in chronic staphylo- 
coccal bone infections (OR 9.94, 95% CI 2.62-37.65, P < 0.001), while 
ticarcfin was favourable comparing with other IV antibiotics in 
osteomyelitis caused by Gram-negative bacilli (OR 5.70, 95% CI 1.18- 
27.42, P= 0.03). Severe protocol violations biased the results of one of three 
available trials comparing local with systemic antimicrobial therapy. 
Artificial benefits of parenterally applied antibiotics derived from intention 
to treat analysis diminished, when per-protocol results (i.e. systemic 
antibiotics vs. PMMA bead chains alone) were evaluated (OR 1.03, 95% 
CI 0.48-2.20, P =  0.936). More adverse events occurred in the parented 
group (OR 2.52, 95% CI 1.22-5.18, P=0.012). The remaining absolute 
risk difference of 3% for the benefit of parented drugs will be paid by an 
absolute risk increase for adverse events of 22%, indicating a likelihood of 
being helped us. harmed of 1:7 against systemic antibiotic therapy. 
Conclusions: The available data does not support the preference of a 
particular drug schedule over another for the treatment of bone and 
joint infections. 
Diagnosis of prosthetic joint infection with 99mTc- 
ciprofloxacin (Infecton) 
D. W. Wareham, S. Das, K. Solanki, K. Britton, H.  Aniaral, J. Malamitsi, 
V. Soroa, A. Padhy 
Londuir, UK; Santiago, RCH; Athens, GR; Burnos Acres, RA; Vienna, A 
Objectives: Diagnosis of prosthetic joint infection is a challenging clinical 
problem. A definitive microbiological diagnosis can only be made with 
invasive samphg and meticulous laboratory processing of specimens. Other 
parameters, e.g. CRP, ESR, WBC and imaging techniques, e.g. X-ray, CT, 
MRl often employed, lack both sensitivity and specificity. We assessed the 
ability of a recently described radiolabelled antibiotic, imaging technique, 
using 99mTc labelled Ciprofloxacin (Infecton), to reliably detect sites of 
prosthetic joint infection. 
Methods: 190 patients with suspected prosthetic joint infection were 
referred for Infecton imaging. The infections were classified as infected or 
not infected according to the CDC criteria. Each patient received 2 mg of 
99mTc radiolabelled (300-400 MBq) ciprofloxacin intravenously. Whole 
body images were taken 1, 4 and sometimes 24 h later. Each image was 
reviewed by three nuclear medicine physicians, blinded to the clinical 
information, and declared positive or negative for infection. Several patients 
also underwent serial scanning. 
Results: 190 images were produced, there were no adverse reactions. These 
included 150 true positive and 33 true negatives. There were 6 false 
negatives and 1 false positive, thus Infecton imaging has a sensitivity of 
96% and a specificity of 97% for detecting prosthetic joint infections 
with respect to the CDC criteria. In 63 patients infection was confirmed 
by microbiological analysis, in all of these patients Infecton imaging 
was positive. Scans were seen to revert from positive to negative with 
successful chemotherapy and clinical cure in several patients undergoing 
serial scanning. 
Conclusions: Imaging with radiolabelled ciprofloxacin can accurately 
predict infection in prosthetic joints. As well as aiding diagnosis this 
technique may be helpful in assessing the response and requirement for 
antimicrobial chemotherapy. 
v1 Successful reimplantation of a total knee prosthesis 
after Candida parapsilosis infection 
P. Kotilainen, H.  Aro 
Turku, FIN 
Although fungal infections complicating total joint arthroplasties have been 
uncommon, they provide a demanding challenge to orthopedic surgeons 
and infectious diseases specialists. Prosthesis removal is usually required to 
cure the infection, and there has been reluctance to reimplant these patients. 
We are aware of only thee  patients who have undergone successful 
reimplantation of a total joint arthroplasty after candidal infection; all 
involved hip prostheses. We describe here a successful reiniplantation of a 
total knee prosthesis after infection with C. purapsilorir. Our patient, a 72- 
year-old male, underwent a right knee replacement for osteoarthrosis in 
September 1995. A week after the discharge, he started to suffer from low- 
grade fever, and the replaced knee became tender and swollen. Joint 
aspiration in the open care yielded nonpumlent fluid, which was not further 
analyzed. Five days later, the patient was admitted to our hospital for 
increasing pain and swelling of the joint. Aspiration yielded 55 mL of 
slightly purulent fluid, all four separate cultures of which grew C. 
parapsilosis. Antifungal treatment with amphotericin B was started, and the 
patient underwent imgation and debridement of the right knee. Gram 
staining of the synovial tissue samples taken during the operation revealed 
yeast cells, and C. parupsilosis was cultured from all tissue and fluid samples 
taken. Due to the elevation of the serum creatinine value, aniphotericin B 
therapy was soon switched to liposomal amphotericin B. In the end of 
October 1995, the patient again underwent imgation and debridement. 
When the samples taken were s t i l l  positive for C. parapsilosis and radiographs 
revealed loosening of the tibial component, the prosthesis was removed. 
Liposomal amphotericin B was continued untd the end of January 1996, 
when the total additive dose of aniphotericin B was 5200 mg. The patient 
received peroral fluconazole until April 1996; the drug was then 
discontinued before samples were obtained for microbiological and 
histological examination. When no evidence of infection was observed in 
these specimens, a total knee prosthesis was reimplanted at the beginning of 
May 1996. The patient subsequently received suppressive peroral 
fluconazole for 2 years. During the follow-up, he has remained infection- 
free. This case provides further evidence on a successful two-stage exchange 
arthroplasty for fungal infection of a total knee arthroplasty. 
1p14o61 Prosthetic osteomyelitis: epidemiology and clinical 
presentation: a 7-year prospective study 
J. Gbmez, M. Rodriguez, V. Bafios, J. Ruiz, L. Martinez, E. Siniarro, 
J. Medina, M. A. Claver, M. Clavel 
Murcia, E 
Objectives: To determine epidemiological characteristics, microbiological 
patterns and clinical course of osteomyelitis associated to prosthetic materials 
and autogenus bone grafting. 
Patients and methods: During the period of study between 1992 and 1997, 
110 patients with prosthetic osteomyelitis were prospectively evaluated. 
Identification of bacteria and susceptibility tests were perfomied with usual 
procedures. Osteomyelitis was diagnosed according to standard nlicro- 
biological, clinical and radiological criteria. The patients were evaluated at 
least quarterly with a minimum follow-up of 1 year after the end of 
antibiotic treatment. 
Results: Mean age was 60 years (range 18-79) and the majority of patients 
(63, 57%) were female. Forty-two (38%) suffered a total knee repIacement, 
29 (26%) a total hip replacement, 1 (1%) shoulder replacement and 38 (34%) 
autogenous bone grafting. In 25 patients (23%) a previous chronic disease 
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had been diagnosed (diabetes, neoplasia, rheumatoid arthritis). During the 6 
weeks before diagnosis An etiological diagnosis was reached in 66 patients 
(60%). Staphylococcus sp. was isolated in 37 patients (56%), Gram-negative 
bacilli in 23 (35%), anaerobic flora in 5 (8%). and enterococcus 1 (1,5%). All 
the patients had local pain and flogotic signs as initial findings, whereas 46 
(42%) developed osteocutaneous fistula and only 5 (4, 5%) presented with 
fever. Previous use of antibiotics (considered 6 weeks before presentation) 
was detected in 58 patients (51%), being ciprofloxacine the most frequently 
used (32, 30%) followed by p-lactamics and aminoghcosides. 
Conclusions: 1. Osteomyelitis is a frequent complication after articular 
replacement. 2. Gram-positive cocci predominate as ethiological agents. 3. 
Sisteniic clinical manifestation are uncommon. 
Chronic osteomyelitis in Greece: clinical and 
therapeutic considerations 
A. Papadopoulos, A. Dafnou, K. Kanellakopoulou, E. Papadimitriou, 
L. Karnesis, E. Giannitsioti, E. Dounis, H. Giamarellou 
Atlzens, CR 
Objective: To present clinical, microbiological and therapeutic features of 
patients with chronic osteomyelitis. 
Methods: A cohort of 109 patients with chronic osteomyelitis, were 
retrospectively studied, 80 men and 29 women, mean age 50 years. They 
were treated and followed up in our infection outpatient clinic from 1995 to 
2000. Patients (pts) were dwided into 2 groups, according to treatment (Rx) 
duration: group A (n = 54) with 6 months of Rx and group B (n = 55) with 
12 months of Rx. Long-term follow up was recorded in 59 pts. The disease 
outcome and the relapse rate were studied taking into consideration the Rx 
duration, the existence of foreign bodies and the causative microorganisms. 
Pts with prosthetic joints were excluded. 
Results: In group A the response rate was 76% us. 85% in group B (P=NS). 
Relapses were more frequent in group A (5/26, 19%) vs. 2/33 (6%) in 
group B (P' 0.1). Pts with foreign bodies ( n  = 60) had response rate of 80% 
vs. 81% of pts without foreign bodies (P=NS) Foreign bodies were 
removed in 38/48 (79%) of responders compared to 9/12 (75%) of patients 
with failure. (P' NS). The former presented 3/25 (12%) relapses vs. 2/8 
(25%) of the latter ( P O . 1 ) .  One hundred and fourteen pathogens were 
isolated 77 Gram(+) cocci (67%), m a d y  Staph. aureus and Staph. CNS and 
37 Gram(-) bacteria, mainly Ps. aeruginosa. The response and relapse rate in 
pu with Gram(+) cocci was 82% and 14%, respectively, and the 
corresponding rate in the pts with Gram(-) bacteria was 78% and 10%. 
Conclusions: (1) The disease outcome is not related to the duration ofRx (6 
vs. 12 months) hut there is a tendency for fewer relapses to occur in pts with 
12 months Rx. (2) The existence of foreign bo&es does not seem to 
influence the response rate, but fewer relapses tend to occur in pts who have 
the foreign bodes removed. (3) Long-term prospective clinical studies in 
higher number of pts with more prolonged follow-up are required. 
jP1408/ Spondylodiscitis: an unusual complication after 
lumbar myelography 
E. Kotilainen, P. Sonnmen, I?. Kotilainen 
Turku, FIN 
Many infectious complications, e.g., bacterial meningitis, secondary to 
metrizamide niyelography in the diagnostics of spinal diseases are well 
documented. T o  our best knowledge, however, the development of 
spondylodiscitis after myelography has not been previously reported. We 
describe here a case of meningitis and bacteremia caused by Streptococcus 
viridans after metrizanide lumbar myelography. The disease was compli- 
cated by development of spondylodiscitis, leading to severe lumbar 
instability. Our patient, a 56-year-old female, had undergone a successful 
lumbar laminectomy one year precedingly. Because of the recurrence of 
low back pain and radiating pain, she was re-examined by lumbar 
myelography. Twelve hours after the myelogram, the pahent started to 
sufier from severe headache and vomiting. She had high fever, and physical 
examination revealed rmld stfiess of the neck. The peripheral white blood 
cell (WBC) count of the patient was 16.9 x lO'/L; the hemoglobin value, 
121 mg/L; and the serum C-reactive protein (CRP) value, 169 mg/L. The 
WBC count of the cerebrospinal fluid (CSF) was 16 600 x 1O"/L with 94% 
of polymorphonuclear leucocytes. Gram staining of the CSF showed no 
microbes and the CSF cultures remained negative, but two blood cultures 
yielded Streptororcur viridans. The patient was treated with vancomycin and 
ceftriaxone for 2 weeks intravenously. Unexpectedly, the finding of the 
magnetic resonance imaging (MRI) of the lumbar spine was indicative of 
spondylodiscitis at the previously operated disc level L3-L4, with highly 
increased signal intensity of the disc on T2-weighted images. The initial 
response to antimicrobial therapy was considerably good, and the patient 
was discharged after 2 weeks of hospital treatment, still suffering from mild 
low back pain and radiating pain into the right leg. Within 1 year, she 
developed severe low back pain, with symptoms suggestive of lumbar 
segmental instability. When consenrative treatment failed, the patient was 
treated surgically with lumbar spondylodesis. The postoperative outcome 
was successful, and she returned to work after a sick leave of 5 months. This 
case provides further data on severe infections complicating myelography, 
rendering it inferior to MRI also in this respect in the diagnostics of 
spinal diseases. 
(p14091 Pyogenic and tuberculous vertebral osteomyelitis: a 
descriptive and comparative study of 39 cases 
B. Kilani, L. Amari, H. Tiouiri, A. Goubontini, F. Kanoun, F. Zouiten, 
T. Ben chaabane 
Tunis, TN 
Objective: To analyze and to compare clinical, rad~ological features and 
outcome of pyogenic spondylodislutis (PS) and tuberculous spondylodishtis 
(TS) in order to find criteria to distinguish between them. 
Methods: Retrospective study of 39 cases of bacterial spondylodiskitis, from 
January 1989 to December 1998. Inclusion criteria were (1) clinical 
symptoms with radiological signs (2) microbiological diagnosis. Statistical 
study: chi-square test. 
Results: During the study period, we collected 13 patients (33.3%) with PS 
and 26 patients (66.7%) with TS. The mean age was 44 years. The delay in 
diagnosis was much longer in TS (8.4 months) than in PS (2 months). 
Diagnosis was certain in 6 cases (46%) of PS and 12 cases (46%) of TS. 
Vertebral levels afCected: cervical 7.7%, dorsal 51.3%, lumbar 46%. 
Paravertebral abscesses and neurological complications were significantly 
more frequent in TS than in PS (53.8% vs. 15.3%). Diagnosis of 
spondylodiskitis is based on the imaging techniques, especially MRI whch 
is more sensitive than C T  scan. Causal agents isolated in PS: S. aureus 5, E.  
coli 1. Mycobacterium tuberculosis was isolated in 9 patients after bone biopsy 
culture, or culture of.other samples. Treatment was based on specific 
medical antibiotics, with corticosteroids if neurological complications. 
Morbidity was 20%, especially in TS. 
Conclusion: Tuberculous spondylodiskitis was more frequent than pyogenic 
spondylodiskitis in this series. Risk factors, duration of symptoms, the 
vertebral level affected and the presence of neurological symptoms may lead 
to distinguish between TS and PS. 
Spinal tuberculosis 
J .  D e  la Fuente, A. Nodar, M. Rubianes, M. Seijas, A. Lbpez, €3. Sopeiia, 
C. Martinez, R. Zugasti 
Vigo, E 
Objectives: To define the clinical characteristic, imaging data, diagnostic 
procedures and treatment of spinal tuberculosis at our sanitary area. 
Patients and methods: We retrospectively reviewed the medical charts of 
a l l  consecutive patients in whom spinal tuberculosis was diagnosed in our 
hospital during the last 10 years. Inclusion criteria were (1) identification of 
Mycobacterium tuberculosis in skeletal specimens; (2) the presence of 
tuberculoid granulomas with caseating necrosis in histological studies; and 
(3) active tuberculosis disease elsewhere associated to radiological evidence 
of vertebral involvement. 
Results: Twenty-one cases (12 males) were identified. The median age was 
51 years (16-82). Eight patients (38%) had any predisposing condition or 
previous tuberculosis. Back pain (95%), fever (48%), spinal cord compres- 
sion (28.6%) and nonspecific constitutional symptoms (28.6%) were the 
most frequents complaints. PPD skin test was positive in 67%. The median 
time to diagnosis was 135 days (8 days to more than 1 year). The 
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erythrocyte sedimentation rate was increased in 71%. The sites of spinal 
involvement were: thoracic (9), lumbar (6). thoracolumbar (5) and cervical 
(1). MRI was performed in 13 patients and no false negative result was seen. 
The pattern of spinal involvement was spondylodiscitis in 85.7% and 
spondylitis in 14.3%. Diagnostic procedures were: surgical biopsy (71.4%), 
fine needle aspiration (9.5%) and percutaneous needle biopsy (4.8%). 
Treatment consisted in administration of antituberculous drugs by a mean of 
13.6 months (11-18) and surgical procedures in 71.4% of patients. Five 
patients were lost to the follow-up. No fatahties or recidives were seen. 
Conclusions: Spinal tuberculosis continues to be an important infectious 
disease of spine. In our experience the diagnosis is unfortunately delayed and 
associated to an advanced bone destruction, spinal deformity and occasional 
signs of spinal cord compression requiring surgical treatment. MRI proved 
to be the best imaging procedure for spinal tuberculosis. A year of 
antituberculous therapy appears to be a reasonable therapeutic regimen. 
(p14111 Incidence of anaerobic bacteria isolated from 
diabetic patient's foot ulcers 
H. Bahar, M. Mamal Torun, M. Altintas 
Istanbul, TR 
Objectives: The aim of this study was to identlfy the anaerobic bacteria 
isolated 6om diabetic patient's foot ulcers to find out their frequency on this 
flora. 
Methods: The population studied was 180 diabetic patients having foot 
ulcers with extensive surrounding cellulitis. Specimens were obtained by 
scraping the ulcer base or the deep portion of the wound with a sterile 
curette and were immediately put in fluid thoglycolate medium as transport 
media. Blood agar, phenil etil alcohol blood agar and kanamycin 
vancornycin blood agar prepared with Schaedler agar and enriched with 
vitamin K1 were used for the cultivation of anaerobic bacteria on jars in 
anaerobic conditions for at least 7 days. AE'I 20A (BioMerieux SA, Marcy 
YEtoile France) was used for the idendcation of anaerobic bacteria. 
Results: From 180 specimens a total of 441 anaerobe isolates were found. 
From these 117 were anaerobic Gram-negative bacteria. 47 (10.6%) ofthem 
were Bacferoides jagilis, 11 (2.4%) were B .  thetaiotaominon, 17 (3.8%) were 
Prevotello melaninogenica, 14 (3.1%) were Porphyromonas asauharolyfica, 19 
(4.3%) were Fusobacterium nucleatum and 9 (2%) were Weillonella parvula. 
From 324 anaerobic Gram-positive bacteria 72 (16.3%) were Peptosfrepto- 
coccus anaerobius, 37 (8.3%) were P.  u.sarchnrolyticus. 18 (4%) were P. magnus, 
87 (19.7%) were C[oztridium innocum, 57 (12.9%) were C. ramosum, 21 
(4.7%) were C. perjhgens, 19 (4.3%) were Propionibacterium acnes, 8 (1.8%) 
Maternal & neonatal infections 
were P. granulosum and 5 (1.1%) were Eubactenum lentum. 
Conclusion: We concluded that because of their presence in h g h  
percentages in diabetic patient's foot ulcers, the strains of B.  jagilis, P. 
anaerobius, P. ataccharolyticus, C. innocum and C. ramosum may be potantial 
pathogens in the formation of deep tissue infections. 
vl A case of Bademides fragilis bursitis 
D. Potters, K. Vandoonlaer, P. Rosseel, D. Pihard, A. Naessens, S .  
Lauwers 
Jette, B 
A 56-year-old man was hospitalised with an abscess at his  right elbow and an 
oedematous right underarm and hand. As clinical diagnosis bursitis and 
sepsis was put forward. The abscess was drained, swabs and bloodcultures 
were taken. Empirical flucloxacillin treatment was started (IV, 2 g, every 8 
h). Initial aerobidanaerobic bloodcultures remained negative. In the first 
and second set of swabs a p-haernolytic streptococcus group B was isolated. 
No anaerobic culture was requested. Antibiotic treatment was changed to 
Penicillin G (IV, 1 000 000 IU, every 4 h). One week after admmion new 
bloodcultures were drawn and pus from the abscess obtained per- 
operatively (fasciotomy, carpal tunnel release), was sent for aerobic and 
anaerobic culture. One anaerobic bloodculture bottle (BACT/ALERT 3D, 
Fan Anaerobic Culture Bottles, Organon Teknika Corp.) became positive 
after 2 days incubation. Both from blood and pus an anaerobe Gram 
negative bacillus was cultured and identified as B. jagi l is  with standard 
biochemical tests. Antimicrobial susceptibility, performed with E-test, 
showed sensitivity to amoxycillin/clavulanate, clindamycin, metronidazol 
and meropenem. Based on these results clindamycin was added (IV, 600 
mg, every 8 h) and after 2 weeks of positive chical evolution a skingraft was 
done. After rejection (unknown reasons) and local treatment, the patient 
received a second graft 2 weeks later. He regained complete function of his 
fingers and arm. In the literature we could not find a case of bursitis caused 
by B. jagi l is  (search engine: www3.idotrieve.com/medline/infomeve; 
years 1966-2000). However the microorganism has been known to be 
present in a variety of cultured specimens and has been implied as pathogen 
in several infections (aspiration pneumonia, lung abscess, salpingitis, tubo- 
ovarian abscess, chronic osteomyelitis, . . .). Bacferoides jagi l is  is still 
susceptible to most commonly used antibiotics to treat anaerobic infections. 
Although identification is relatively easy, it is important to immediately 
request anaerobic culture to avoid a prolonged and complicated coune 
of disease. 
v1 Listeriosis in a pregnant HIV-1 positive woman 
U. R. M. Bohr, J. Rotthauwe, U. Peitz. G. Treiber, P. Malfertheiner 
Magdeburg, D 
List& monocytogenes is an intracellular pathogen which primarily causes 
illness in persons with deficient cell-mediated immunity. Here we describe 
listeriosis as a rare case ofpregnancy complication in a HIV positive patient. 
The 30-year-old woman who migrated 3 months before from Angola to 
Germany was referred to our department after HIV infection was newly 
diagnosed during pregnancy. When the diagnosis was made the patient 
already was classified as A3 according to CDC. At admission she presented 
with mild nausea only and reported fever of about 39 "C once the day 
before. No clinical focus could be detected explaining these symptoms. Five 
days thereafter temperatures recurred. Empirical therapy with ampicillin/ 
sulbactam was initiated and biood cultures were taken. Despite antibiotic 
therapy immature labor onset occurred. One day later the results of the 
blood cultures revealed Listeria monocytogenes. After infected abortion on 
day eight the patient recovered rapidly continuing the initial antibiotic 
therapy, Listeriosis is a very rare complication during pregnancy in HIV 
positive patients. To  our knowledge this is the third case reported in the 
world literature. 
1 PI414 I Human T-cell lymphotropic virus-I associated adult T- 
cell leukemiallymphoma presenting as rapidly progressive 
mononucleosis-like syndrome during pregnancy 
A. Safdar, N. Johnson, J. Stephens, D.  Meitinger, S .  Stinson 
Columbia, New York, USA 
Human T-lymphotrophic virus-I associated ATLL is a rare malignancy, and 
two cases reported during pregnancy were subacute. We report a case of 
HIV-1 seronegative 23-year-old Afiican-American female with a 7-day 
history of sore throat, fever, and progressive fatigue during the 26th week of 
gestation. She was in modest distress on examination and markedly enlarged 
exudative tonsatis was accompanied by extensive, tender, enlarged lymph 
nodes in the head and neck region. A 20-cm nontender spleen was 
continned on ultrasonography. The intrautrine fetus was in good health. 
Her WBC was 55 900 cells/mm3 (74% unclassified cells), HgB 11.0 &, 
Pfateles 147 OOO/pL, ALT 31 U/L, AST 30 U/L, T. bili 2.3 rng/dL, and 
Alkaline Phosphatase 151 U/L. A negative work up included monospot 
test, A S 0  titer, EBV IgM, CMV IgM, and Toxoplasnia gondu IgM and 
IgG. HIV 1 & 2 plasma RNA was undetectable. Patient received supportive 
care, and empiric antibiotic were withheld. O n  day-4, her WBC increased 
to 75 000 cells/mm3, serum calcium 20.2 mg/dL and LDH 7056 U/L. 
Bone marrow biopsy revealed marrow d t r a t i o n  with 34% atypical 
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intermediate-size lymphocytes and peripheral blood flow cytometery 
showed CD3+ 4+ and CD3-25+ monocolonal lymphocytic expansion. 
Hydroxyurea (1 9) was initiated on day-5 as her WBC rose to 132 000 cells/ 
mm’ and the following day she received combination chemotherapy 
(CHOP). Patient had serologic evidence of prior HTLV-I infection. The 
following week she developed respiratory failure and succumbed to 
polymicrobial sepsis and multisystem failure. This case emphasizes the 
importance of noninfectious etiology of clinical syndrome that may initially 
suggest mononucleosis-like dlness in an otherwise healthy individual and 
illustrates the course of this rare, highly aggressive hematological malignancy 
in pahents with a very low likelihood of HTLV-I infection. 
v] Influence of prematurity and low birthweight on 
materno-foetal transfer of antibodies in Gambia 
J. B. Okoko, L. H. Wesumperuma, A. C. Hart 
Banjul, WAG; Luerpool, UK 
The inhence of prematurity and low birth weight on transplacental 
antibody transfer was assessed in 213 mothers and their neonates from The 
Gambia. Paired maternal and cord serum samples were tested for specific 
IgG antibody titres for measles virus (MeV), herpes simplex virus type 1 
(HSVl), respiratory syncytial virus (RSV), varicella-zoster virus (VZV), 
tetanus toxoid (TT) and diphtheria toxoid (DT) antigens using enzyme 
linked immunosorbent assay (ELISA). Prematurity was significantly 
associated with reduced placental antibody transfer for MeV, HSVl, TT, 
DT, RSV and VZV. In addition, a significantly lower cord/matemal 
antibody transfer for MeV, HSV1, TT,  DT, RSV and VZV was observed in 
neonates with a low birth weight, compared to the antibody transfer in 
those with adequate birth weight. Materno-fetal transfer of these antibodies 
is impaired in prematurity and low birth weight babies in this Gambian 
population. This reduction in antibody transfer may further predspose these 
already vulnerable neonates to bacteria and viral infections. Therefore, 
alternative vaccination strategies, including earlier vaccination schedules 
may be needed to provide better protection to these young infants. 
1p14161 A proposed method for the assessment of bacterial 
colonization of the cervix during assisted reproduction 
technique procedures 
R. Colodner, R. Salim, I. Ben-Shlomo, Y. Keness 
Afula. IL 
Vaginal overgrowth of bacteria is known to caused increased risk of late 
miscarriage, preterm labor, postpartum endometritis and low birth-weight. 
Despite significant advances, conception rates in assisted reproduction 
technology treatments remain frustratingly low. A number of studies were 
conducted recently assuming that invasive techniques, like vaginal oocyte 
retrieval or vaginal embryo transfer can introduce vaginal flora into the 
endometrium and affect the success of conception. In the present study, a 
method for the assessment of bacterial colonization of the uterine cervix 
during assisted reproduction techniques is proposed, and results of the 
sampling and bacteriological culture of the cervical canal of 204 patients 
who underwent embryo transfer are presented. Conception, as defined by 
the presence of intrauterine gestation, was correlated with bacterial type and 
colony count. The employemelit of the method proposed herein can help 
in establishmg the quantity and quality of the colonizing flora of the cervix 
during assisted reproduction and establish its influence on the success rate of 
conception. Antibiotic susceptibility testing of this flora can further be 
applied for establishing treatment protocols to be implemented before 
vaginal embryo transfer. 
Changes in toxoplasma seroprevalence and risk 
factors in infected pregnant wOmen in the Poznan region of 
Poland 
M. Paul 
Pozltan, PL 
Aim: To d e t e m e  the rate of Toxoplasma gondii seropositivity in the 
pregnant women population and presumable local sources of infection for 
mothers who delivered congenitally infected children. 
Materials and methods: Neonatal blood samples collected at birth were 
used for an evaluation of the Toxoplasma seroprevalence in pregnant 
women at delivery. The filter-paper spots were tested for T. gondii-specific 
IgG by a direct agglutination assay. Mothers whose babies were identified to 
be infecced through regional newborn screening based on the detection of 
specific IgM and IgA were examined by a standard questionnaire, including 
details of the diet, cat or kitten ownership, gardening during pregnancy and 
professional contact with meat or ammals. 
Results: The 2684 filter-papers &om neonates born alive in 1998-2000 
were analyzed for anti-T. gondii IgG or 2656 gravidae (28 twin pregnancies). 
The proportion of samples originated from urban ( n =  1423) and rural 
( n =  1261) areas was comparable. The mean seropositivity rate was found to 
be 43.7%, and it was lower in urban agglomerations than in rural 
communities, and in Poznan city when compared to other localtties. The 
Toxoplasma seroprevalence in gravidae was 43.8% in 1998, 41.5% in 1999 
and 45.8% in 2000. The population of seronegative pregnant women was 
increased &om the early 1990s, when 58.9% ofgravidae were immune to T. 
gondii. Thirty-five mothers of congenitally infected children (mean age of 
25.2 years) were qualhed to the epidemiological analysis; 4 of them had 
medically oriented professions, and 15 mothers had delivered more than one 
chdd (42.9%). The proportion of women living in rural (n=9) and urban 
(n=26) areas was 1:3. Six women achieved a high level of university 
education and 24 completed college or professional school. The potential 
risk factors were revealed in 31 mothers: eating or testing raw pork was the 
main source of infection in 24 women, 8 patients lived in a household with 
kittens, 4 were accustomed to eat unwashed h i t  or vegetables; 15 of them 
had more than one source of infection. 
Conclusions: Poznan region of Poland can be considered a hgh  risk area for 
T. gondii infection. In the high seroprevalence population, the application of 
hygienic measures to susceptible pregnant women seems to be unsatisfactory 
to prevent congenital infection in their offspring and could be associated 
with other preventive strategies like pre or neonatal screening programmes. 
/p1418( Is Western blotting useful to characterize naturally 
immunoglobulin M antibodies to Toxoplasma gondii during 
pregnancy? 
R. Ceccarelh, F. Toscanini, M. Feasi, N. Bobbio, R. Frulio, C. Palmero, 
S.  Ratto, D. Bassetti 
Genoa, I 
Objectives: Primary infections with T. gondii during pregnancy can result in 
fetal infection with serious sequelae for the unborn if not treated properly. 
Naturally occurring immunoglobulin (Ig) M antibodies (Ab) to T. gondii 
was evaluated to be about 3% during pregnancy. The aim of our study was 
to define the role of Western blotting (WB) to characterized anti-T. gondii 
Ig M false-positives and to evaluate possible confounding factors. 
Methods: We considered all pregnant women with suspect primary 
Toxoplasmosis, coming to our Day-hospital between June 1999 and June 
2000. We performed the following serological tests to confirm Toxoplasma 
infections: ELFA IgG and IgM (BioMerieux, F) ISAGA IgM and IgA 
(BioMerieux, F) ETI-Toxo IgA (Sorin Biomedica IT). We evaluated 
patients with persistent anti-T. gondii ELFA Ig M and/or ISAGA positivity 
but without evidence of infection (ELFA IgG negativity in two consecutive 
samples taken at least 3 weeks apart). In these women we investigated: 
Westem Blot (Bioline Dg. IT), serum Ig dosage, rheumatic factor, 
electrophoresis, C3, C4, CH50, anticardiolipine IgG and I@, ANA, 
ENA, ASMA, LKh4, antithyroglobulin Ab, antiperoxidase Ab, Widal- 
Wright reaction, blood cells count. 
Results: Among 537 patients we found 14 anti-T. gondii IgM false positive 
women (2.06%). Seven patients out of 14 were lost during 12 months of 
follow-up. Between studied patients 3 were positive only for ISAGA IgM 
(Index > 9) (Group 1) and 4 only for ELFA IgM (Index > 0.65) (Group 
2). Widal test was positive (> 150)  for flagellar antigen in 5/7 patients, and 
an increased level for al, ~ 2 ,  p l ,  p2 was documented, respectively (mean 
f SD) 4.7 f 0.7, 13.2 f 2, 5-10.2 & 1.0, 8.2 f 1.8. Six out of 7 were 
negative for lymphocytes proliferation test with toxoplasmic antigens and 
the percentage of CD3-/CD16-56 + ranged between 5.1 and 6.7% in all 
patients. Others laboratory abnormalities or clinical findings were not 
documented. In the Group 1 WB showed only the next bands: 88-94-1 10 
kDa and 70 kDa. On the contrary in the Group 2 WB revealed only 88-94- 
110 kDa and 67 kDa. 
Conclusions: Western blotting analysis revealed that natural IgM antibodies 
were directed to multiple and aspefic antigen molecules. The WB recognition 
pattern was Nerent in the two studied groups for 67 and 70 kDa. 
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Ip1419/ lgG toxo avidity in serodiagnosis of acute 
toxoplasmosis 
B. Sobieszczanska, A. Przondo-Mordarska 
Wroclaw, PL 
Objective: The aim of the study was to estimate the avidity of specific IgG 
Toxoplasma gondii antibodies in serodiagnosis of acute toxoplasmosis in 
patients with lymphadenopathy and pregnant women. 
Methods: The presence of specific to T. gondii antibodies was determined 
using VIDAS system: screening test, test for screening IgM and IgG specific 
antibodies and IgG toxo avi&ty test (bioMerieux). 
Materials: Sera of 20 patients (mean age: 16 years) with lymphadenopathy 
hospitalized in Clinic of Hematology of Wroclaw and 5 sera of pregnant 
women containing specific to T. gondii IgM antibodies. 
Results: In all cases the screening test was positive as well as the presence of 
IgG antibodies. In 14 (70%) sera of patients with lymphadenopathy there 
were present specific IgM antibomes. In 12 (60%) sera the avidity of IgG 
antibodies was low (<0.200) indicating that infection of T. gondii took 
place during the last 4 months. In 2 (10%) examined sera besides ofpresence 
of specific IgM antibodies the avidity of IgG was high (> 0.200) indicating 
past infection (chronic infection). In the rest of 20 sera of patients with 
lymphadenopathy there were no IgM antibodies and the avidity of specific 
IgG antibodies was high so infection of T. gondii as a cause of 
lymphadenopathy was excluded. In 5 sera of pregnant women, in one 
serum only the low IgG avidity and the coincident of IgM confirmed the 
acute toxoplasmosis. In 4 sera, besides of presence of specific IgM 
antibodies, avidity of IgG was high indicating that the IgM antibodies 
were unspecific. That results were confirmed in the second examination 
after 2 weeks. The acute toxoplasmosis in these cases was excluded. 
Conclusion: IgG toxo avidity allows to confirm or exclude the acute 
toxoplasmosis in patients with lymphadenopathy and pregnant women. 
vl Clinical and evolutive aspects of toxoplasmosis in adults 
D. Kraja, N. Como, E. Cani 
Tirana, A L  
Objectives: Study of the manifestations and development of toxoplasmic 
infestation in adults. 
Methods: The manifestations of toxoplasmosis, classified in clinical- 
biological syndromes, observed in 164 patients of ages 14-61 years 01, 
followed up by us during the period 1984-2000. We grouped the cases in 
accordance with the evolutive classification of this pmtozoose. Diagnosis was 
verified by positivity of specific IgM and IgG in the IFA-IgM and IFA test. 
Results: From the clinical-biological viewpoint, we distinguished the 
following underforms of toxoplasmosis: Lymphadenopathia ~zfibn’lis-48 cases, 
29.26% [/aterorervicalis-25%, rervica/i~-refrooripitalis-20.8%, cervicalis-submandi- 
bulari-16.6%, ~eervira/is-supratrape~oida/is 4.1%, systemic-33.3%]; Imyphade- 
nopathia febn’lisasthenic-22 cases, 13.41%; lymphadenopathy with acute 
hepatopathy 8 cases, 4.87%; lymphadenopathia with liverspleen syndrome6 
cases, 3.65% mononucleosis syndrome18 cases, 10.97%; recurrent fever 
syndrome10 cases, 6.09%; lymphadenopathy with polymyosite-6 cases, 
3.65%; lymphadenopathy with dermatoses-14 cases, 8.53%; spontaneous 
abortioii-with stillbirth4 cases, 2.43%; ocular forms-16 cases, 9.75% [with 
unilateral blindness4 cases-25%, bilateral blindness-1 case, 6.25%]; oculo- 
nervous forms-8 cases, 4.87% systemic lymphadenopathy with a l o p e r i ~ 2  
cases, 1.21%; ‘oportunistic’ meningo-encephalitic toxoplasmosis accompa- 
nying AIDS-4 cases, 2.43%. According to the evolutive stages we 
distinguished these forms: acute, 29 cases, 17.68%; subacute74 cases 
45.12%, chronic-41 cases, 25%. 
Conclusions: We saw 13 clinical (under)forms of toxoplasmosis in adults; 
the prevailing of the subacute and chronic forms in our contingent, shows 
that early diagnosis of this protozoois is still much delayed. 
vl Toxoplasmic pneumonia-a case report 
D. Mihailovic, V. Mihailovic 
Nis, W 
Toxuplasma gondii, an obligate intracellular parasite, is the causal agent of 
significant morbidity and mortality worldwide. In the presence of a normal 
immune response, the pathogen becomes latent and the immunocompetent 
host remains chronically infected throughout life, often without clinical 
disease. During the past decade the incidence of toxoplasnia pneumonia has 
increased in immunocompromised patients and as a result, it has become 
essential that clinicians include t h ~ ~  infectious agent in the &agnostic testing 
and differential diagnostic of pneumonia. We report a case of fatal 
pulmonary toxoplasmosis in a premature baby boy weighing 11 00 g and 41 
cm long, which left 21 days. Clinically, the main features were hypotrophy, 
shortness of breath, and cough. Chest roentgenographs revealed bilateral 
pneumonia of unknown case. Serological findings were not suggestive of 
active toxoplasmosis. At a postmortem study, lytic toxoplasmic pneumonia 
was found. Alveoles were occupied with serofibrinous exudate with many 
free parasites and pseudocistes. Thymus was hypoplastic and there was 
evidence of disseminated mfection. Respiratory infections in young infants 
are common and can cause significant morbidity and mortalty. The 
etiology of pneunionia in the neonate varies widely because of several 
modes of acquisition of infecting agents. Toxoplasmosis encompasses a variety 
of clinical conditions. Serious seqnelae and death are seen in congenital 
toxoplasmosis and in infections of the imniunocompromised host. 
)p1422( Determining IgM and IgG type antibodies against 
TORCH in the child-bearing years of 15-35 in Mersin, Turkey 
C. Oztiirk, N. Deliahogln 
Mersin, TR 
Whiie CMV generally develops asymptomatically in childhood, infections 
such as Rubella and Toxoptasma guiidii lead to intrauterin einfections, 
particularly in pregnant women, causing considerable mortality and 
morbidity. Therefore, in the child-bearing years of 15-35, the examination 
of the prevalence of antibodies against T O R C H  agents is important in terms 
of seroepidemiological evaluations in the community. This study was 
planned with the aim of determining IgM and IgG type antibodies against 
TORCH agents in women of child-bearing age. Blood samples were taken 
from a total of 676 female patients between 15 and 35 years of age attending 
the gynecology and obstetrics policlinic of Mersin Universityity Faculty of 
Education’s Research and Practice Hospital andanalyzed for antibodies 
against TORCH agents by ELISA (AXSYM, Abbot). In 9 of the 676 
patients (1 -33%) Toxoplasma IgM antibody positivity was found, and in 683 
of 247 patients (52.26%) Toxoplasma IgG antibody positivity was found. 
669 out of 686 patients (97.52%) were found to be positive for Rubella IgG; 
714 out of733 (97.4%) were found to be positive for CMV IgG antibodies; 
and 11 out of 682 patients (1.61%) were found to be positive for CMV IgM 
antibodies. These results show that these three agents are encountered in a 
majority of women in the community. 
/p14231 Combined serological screening for congenital 
cytomegalovirus infection based on neonatal filter-paper blood 
specimens 
M. Paul, J. Szczapa, I. Wojsyk-Banaszak, A. Jaworska, I. Chudzicka- 
Strugala 
Pornnn, PL 
Objectives: We determined the value of the new combined immunodiag- 
nostic assay detecting cytomegalovirus (CMV)-specific IgM, IgA and IgG 
antibodies at birth adapted for mass neonatal screening. The seroprevalence 
of CMV in the population of pregnant women at delivery and the risk of 
the congenital disease in their offspring were studied. 
Materials and methods: The neonates born in maternity departments of the 
University Clinic in Poznan and 8 district hospitals were included into the 
pilot screening study. Peripheral blood was collected on Guthrie cards using 
a noninvasive heel-stick method during the first 3 days of life. The 3.2-mm 
filter-paper blood spots were tested for anti-CMV antibodies by a 
noncommercial ELISA. The technique was based on early and late AD- 
169 strain antigens tiom in v i m  culture in MRC-5 cells, rabbit antihuman 
IgM, IgA, IgG secondary anhbody labelled with alkaline phosphatase, and 
p-nitrophenyl phosphate/diethanolamine as an enzyme substrate. When the 
screening result exceeded 70% of a positive control, serum samples from the 
suspected infant and the mother were required for a confirmatory analysis. 
Paediatric, imaging, audiologic and ophthalmic follow-up was conducted 
for CMV-positive children. 
Results: Altogether, 513 dned blood spots from neonates born in March- 
April 2000 were screened and CMV-specific antibodies were found in 403 
filter-paper eluates (78.6%). Seventy-four high positive infants were 
followed and 13 of them were strongly suspected as congenitally or 
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perinatally infected (2.5%). The incidence of CMV infection diagnosed by 
serological screening alone was 1 per 40 children born &ve or 1 per 31 
infants at risk born to CMV-positive women. Mothers of infected children 
were strongly Igt-positive when re-tested after delivery but only 3 of them 
had specific IgM. Three of the 13 infected infants were IgM-positive at 
adrmssion, 7 children had a significant increase in a level of specific IgG, and 
2 others had higher IgG titres than their mothers. In one infant, who had a 
transitory negative serology, an immunological rebound was observed at 6 
months. The CMV infected children were all symptoms-free at birth and 
during the follow-up period. 
Conclusion: The combined IgM-IgA-IgG assay showed good diagnostic 
sensitivity to detect asymptomatic congenital CMV infections at birth and 
could be considered a preventive option against the clinically overt disease 
in nation-wide screening programmes for newborns. 
v l  Detection of human cytomegalovirus in 
cerebrospinal fluid of newborns by DNA-RNA hybridization and 
nested PCR 
D. Dzierzanowska, E. Witkowska-Vogtt, U. Lopaciuk, B. Milewska- 
Bobula, D.  Dunin, A. Dobrzaiiska, E. Swiatkowrka 
Warsaw, PL 
The utility of amplification of human cytomegalovirus (HCMV) DNA in 
cerebrospinal Quid (CSF) for the diagnosis of HCMV central nervous system 
(CNS) disease in newborns was studied. CSF specimens from 50 patients 
with neurologic dysfunction were assayed by DNA-RNA hybridization and 
nested PCR, and the results were correlated with serology. DNA-RNA 
hybridization results were positive in 7 patients. Three patients were 
positive by nested PCR. CMV IgG titers were positive in 31 patients, and 
negative in 3 patients; CMV IgM titers were positive in 6 patients and 
negative in 28 patients. In 16 cases CMV serology was not available. In 
control studies, cells infected with other members of herpes virus family 
were negative with these methods, which suggests that specific amplification 
by DNA-RNA hybridization is sensitive and can be used for rapid detection 
of HCMV DNA in cases with CMV infection. 
/p1425/ Is it worthwhile using the CMV viral DNA 
quantitative test for amniotic fluid? 
M. Rostagno, L. Balbo, F. Albano, M. Liewe, G. Lucania 
Turin. I 
Objectives: To evaluate the possible correlahon between viral load and fetal 
risk by means of a semiautomatic quantitative test of CMV viral DNA 
(Cobas Amplicor CMV Monitor) in amniotic Quid. 
Methods: 16 amniotic Quid samples (A.F.) collected between 16th and 22nd 
week of gestation were studied; 5 prenatal diagnosis (PND) were performed 
because of suspected CMV infection (positive IgM antibody) and 11 owing to 
problem3 different &om CMV infection (5 out of them without IgG and IgM 
and 6 with IgG but not IgM) The CMV viral DNA quantitative test was 
camed out using the Cobas Amplicor CMV Monitor with the same previous 
preparation step from ‘in toto’ amniotic fluid as used for plasma samples. 
Results: All samples from IgM negative women (11) showed a viral load 
lower than linear range of the assay (< 400 copies/mL). In the group of 5 
suspected mfections, 3 AF showed negative results and 2 had a viral load of, 
respectively, 9.93 and 5 . 9 8 ~  100 000 copies/&, these 2 foetuses were 
severely damaged. Six newborns did not show any CMV infection sequelae 
and 8 pregnancies are still being. 
Conclusions: This method turned out as standardized and suitable to 
amniotic fluid samples, that can be processed in the usual working run and 
at the same time of other biological specimens, thus makmg the best of 
laboratory instrumentation. 
The carriage of group B streptococci in pregnant 
women in Turkey and its tranmission rate in newborn 
N. Unal, A. Topkaya 
Istaribul, TR 
Group B streptococci (GBS) is an important reason for severe newborn 
infection which have been developing sepsis and meningitis since 1960s. 
GBS is acquired by vertical transmission during birth or nosocomial or 
community acquisition in infants. Maternal carriage of GBS in women 
depends on the geographic and social factors. This study was planned to 
maintain the necessity of intrapartum antibiotic prophylaxy and vaccine 
application which are known to be important to prevent newborn infant 
infections. Because of that reason 500 pregnant women who gave birth to 
their children in Zeynep Kamil Women and Birth Hospital from May to 
July 2000, was included to t h ~ s  tudy. Vaginal and rectal swabs were taken 
from mother before birth and umbilical and throat swabs fiom their infants 
in the first 24 h after the birth. All these samples were inoculated into the 
selective medium. GBS chagnosis was done by conventional methods. GBS 
was found positive in 46 (9.2%) women from 500, 8 (1.6%) from the infants. 
Seven (87.5%) of infants born to colonized mothers and one (12.5%) born 
to noncolonized mother had GBS isolated. In this study we found h g h  rates 
of maternal camage for GBS and vertical transmission in Turkey. By this 
way we will have more clear data for the camage rate an the GBS frequency 
in newborn sepsis and meningitis in our country. Besides that if we 
determine serotype distribution of isolates, we can decide the necessity of 
intrapartum antibiotic therapy or vaccination of GBS positive pregnant 
women in Turkey. 
/p14271 Evaluation of Granada medium in the early detection 
of group B streptococcus colonization in genital specimens 
S. Haider, W. M. Dunne Jr, E. M. Burd, L. Ross 
Detroit, USA 
Background: Group B streptococcus (GBS) is a major cause of neonatal 
morbidity and mortality worldwide. Intrapartum prophylaxis of colonized 
women depends on effective GBS screening. For GBS screening, we 
currently inoculate genital specimens to a neoniycin and nalidixic acid 
(“A) agar plate and selective broth medium (SBM). This combination has 
high sensitivity and specificity but is labor intensive and requires 48-72 h for 
confirmation. We evaluated Granada medium that relies on orange-red 
pigment production for early detection of GBS. 
Methods: We evaluated 285 consecutive specimens (85 vaginal, 23 vaginal- 
rectal, 112 cervical, 32 rectal and 33 unspecified genital specimens). A single 
swab was inoculated to an NNA agar plate and a Granada agar plate and 
then submersed into SBM. The order in which the NNA agar and Granada 
agar were inoculated was altered between shifts. All plates were read the 
next morning. On NNA, catalase-negative, beta-hemolytic or nonhemo- 
lytic colonies were confirmed as GBS by CAMP test. If the NNA did not 
show GBS, the corresponding SBM was subcultured onto a blood agar plate 
and incubated for 18-24 h. All SBM subcultures were examined for GBS 
and confirmed as above. The Granada plates were examined for orange 
pigmented colonies which were confirmed as GBS with a CAMP test, 
whde blinded to the results of the NNA/SBM cultures. Negative cultures 
were finalized at 48 h. 
Results: GBS was recovered in 771285 (27%) of genital specimens by the 
combination of NNA agar and SBM. Granada agar grew orange-red 
colonies in 63/285 (22%) of genital specimens, confirmed as GBS by positive 
CAMP in all cases. The sensitivity and specificity of Granada medium 
compared to NNA/SBM were 83% and 100%. Earliest time to confirmation of 
GBS colonies using NNNSBM was at least 48 h after inoculation whde 
positive resulh on Granada agar were obtained at a mean of 19.6 h. 
Discussion: Studies support screening combined vaginal and rectal speci- 
mens for GBS using both a solid agar and broth medium for maximum 
sensitivity. Because of the high specificity of orange pigment production on 
Granada agar, confirmation is not necessary, allowing for earlier time to final 
positive results. Due to lower sensitivity of Granada agar compared to agar/ 
broth combinations, and because Granada agar would miss the 2-5% of 
pathogenic GBS colonies that are nonhemolytic and do not produce orange 
pigment, Granada agar would not ideally be used alone. 
/p1428/ lrnmunoprophylaxis of neonatal infections using 
intravenous immunoglobulin 
0. Milovidova, V. Anastasiev, L. Timofeeva, T. Korotkova 
Nizhny Novgorod, RUS 
Objectives: Immunoprophylaxis of neonatal infections using intravenous 
immunoglobulin. 
Methods: We have determined the group of preterrn infants needing 
iinmunosubstituting therapy (deep prematurity, intrauterine infection, 
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prenatal hypotrophy, infectional diseases). In nursing pretem infants the 
home human normal immunoglobulin for intravenous infusion (WIG) 
(Enterprise ‘ImBio’, N.Novgorod) was included as a inrmunocorrecting 
agent in the therapeutic complex. Indication, dose and ratio of infusing 
preparation with allowance for severity of acconlpanying pathology and 
degree of disturbance of the neonate immune protection have been 
developed. 532 infants with birth body weights from 700 gm to 2000 gm 
have received the preparations in the doses of 375-500 mg/kg body 
weights. The preparation dropped with 5% glucose intravenously in 48-72 
h on 2, 3 or 4 day and 2-3 week of life no less than 2-3 times. 
Results: The diseases were arrested in 1.9 times quicker, a septic infections 
were not determined. Improving clinical results were followed by the 
reliable increase of the humoral protective factor (IgG were increased at an 
average 2.5 times, phagocytic activity 1.8 times) without the negative 
influence on the cell-mediated immunity. The adverse reactions to the 
preparation infusion were not observed. 
Conclusions: Including the WIG in the therapeutic complex of nursing 
premature infants allowed one to decrease the infectious morbidity of 
premature babies at the first year oflife in 2.9 times and to obtain the figures 
decreae of the &tile m o d t y  in 1.3 times over a period &om 1993 to 1996. 
v1 A survey of microbial strains isolated from a neonatal 
intensive care unit during a 4-year period 
E. Gesouli, D. Papamihail, C. Pappa, E. Themeli, N. Krallis, S. Levidiotou- 
Stefanou 
luannina, GR 
Objective: The aim of ths  survey is the retrospective study of the microbial 
strains isolated &om the Neonatal ICU of Ioannina University Hospital 
(NW Greece) during the 1996-99 period and their resistance to antibiotics 
as well. 
Materials and methods: A total number of 233 strains was studied, isolated 
from cultures of various cluucal specimens and implicated in neonatal 
infections: 87 strains (37.33%) &om blood, 14 (6.0%) &om CSF, 60 (25.75%) 
tiom skin lesions and 72 (30.900/0) hom suprapubic aspirations. Identification 
was performed with the standard bacteriological and biochemical procedures. 
They were further identified by the use of the API and PASCO-ID systems. 
Antimicrobial Susceptibility testing was performed with the disk diffusion 
method, according to the NCCLS guidelines. M.1.C was determined with the 
PASCO-MIC and with the E-test system as well. 
Results: One hundred and thirteen (48.49%) of the isolated strains were 
identified as Gram (+) bacteria, 111 (47.63%) as Gram (-) bacteria and 9 
(3.86%) as Candida spp. More specifically, CNS were the predominant 
strains in blood cultures (42.52%) and were evaluated only in late-onset 
infections, S. aureus in skin lesions (68.33%) and enterubacetiaceae in urine 
samples (97.22%), as expected. Group B streptococci were isolated at a 
percentage of 7.92%. None of the staphylococcal and enterococcal strains 
was found resistant to Vancomycin. No strain of Group B Streptococcus 
was found Penicillin or Cehaxone resistant. The 22.91% of S. aureus and 
64.28% of CNS strains were MRSA and MRCNS. No strain of Enferucuccus 
spp. demonstrated h g h  level Gentamicin resistance. None of the tested 
Gram (-) rods was found resistant to Imipenem. Five per cent of E. culi 
strains and 57.14% of Klebsiella spp. strains were ESBL producers. The 3 
most predominant GNR demonstrated the lower percentage of resistance to 
Amikacin among ammoglycosides: E. ruli (5%), K. pneumuizine (19.04%) and 
Enterohacter spp. (5.71%). 
Bacteraemia in neonatal intensive care unit: 
microbiology and antibiotic susceptibility 
M. Ellabib, M. Al-Sagher, N. Elhamli 
Tripoli, LY 
Setting: Microbiology Section, Central Laboratory, TMC. 
Objective: To determine the most common important causative agents of 
bacteraemia in NICU and their antibiotics susceptibility during a 3 year 
period &om 31 November 1996 to 31 November 1999. 
Methods: During this period 981 oxoid signal blood culture sets were 
obtained &om 716 neonatal patients with suspected bacteremia. Conven- 
tional methods and API 20E and API 20NE (bioMerieux) were used to 
identlfy the isolated bacteria. The Kirby-Bauer disk diffusion method or 
break point was carried out for the susceptibility testing in accordance to 
NCCLS standard. 
Results: Over the period of this study (54.9%) of all BC was positive, in 
which (539 isolates) have been identified. The niost frequent isolates were 
Serratia tnarcescens (205 strains), S. liqufacirns (130 strains), Klebsiefla spp. (70 
strains), Eiiferubacter spp. (53 strains) and Staphylococcus epidermidis (40 strains), 
other Gram-negative rods (29 strains), Gram-positive cocci (1 0 strains) and 
Candida spp. (2 strains). Among Serratia spp. ceftazidime (97.6%), imipenem 
and ciprofloxacin (99.7% each), and trimethoprim-sulfamethoxazole (74%) 
were the most effective antibiotics. Among Klebsiella spp., the majority of 
isolates were susceptible to ceftazidime (91.4%), imipenem and ciproflox- 
acin (100% each). 100% of Enferobader spp. were susceptible to imipenem 
and ciprofloxacin (83%) to Amikacin (75.5%) to ceftazidime. Percent of 
susceptibility of strain of S. epidermidis to Amoxicillin/clavulanic acid was 
75, to imipenem-72.5 and to ciprofloxacin-80. 25% of all S.  epidennidis 
strain were found to be methcillin resistant (62.4%) have shown border 
line-oxacdhn resistant and over (75%) been unsusceptible to other 
commonly used antistaphylococcus antibiotics. 
Conclusions: In our study S. marescens, S. liqfaciens with other above- 
mentioned organisms are most the most important pathogens of bactereanlia 
in NICU. Although most Gram-negative rods remain sensitive to the new 
powerful antibiotics, however, the emergence of resistant strains cannot 
excluded in the near future. New strategy and antibiotic monitoring are 
needed to overcome the increasing incidence of S. epidermidis resistant to 
most usable drugs. 
w1 Antibiotic therapy for reduction of infant morbidity 
after preterm premature rupture of the membranes-a 
randomized controlled trial 
G. Halis, V. Ragosch, S. Hundertmark, H. Weitzel, H. Hopp 
Berlin, D 
Background and objectives: About one thrd of births before 37 weeks is 
associated with preterm premature rupture of membranes (pPROM). This 
is thus an important problem, which places both mother and chdd at risk of 
infection, preterm delivery and the complications of prematurity. 
Intrauterine infections thought to be one cause of pPROM. Antibiotic 
therapy has been shown to prolong pregnancy, but the effect on infant 
morbidity has been inconsistent. The aim of the trial was to determine if 
antibiotic treatment during expectant management of pPROM will reduce 
infant morbidity. 
Method: Design: Randomized, double-blind, placebo-controlled multi- 
center-study. Patients: A total of 105 gravidas with pPROM between 24 
weeks’ and 0 days’ and 32 weeks’ and 6 days’ gestation who where 
considered candidates for pregnancy prolongation and had not received 
antibiotic treatment or corricosteroids for fetal maturation within 1 week of 
randomization. Interventions: Intravenous mezlocillin (2-g dose every 8 h) 
for 7 days us. a matchmg placebo regimen. Group B streptococcus carriers 
were identified and treated. Tocolysis and corticosteroids were given in 
both groups. Outcome measures: The composite primary outcome included 
pregnancies complicated by at least one of the following: respiratory distress 
(RDS), severe intraventricular hemorrhage (IVH), stage 2 or 3 necrotizing 
enterocolitis (NEC), or neonatal infection. These perinatal morbidities were 
also evaluated individually and pregnancy prolongation was assessed. 
Results: In the total study population a significant pregnancy prolongation 
was seen with antibiotics ( P  < 0.01). The primary outcome (19.1% us. 
39.7%), respiratory distress (14.9% vs. l8.9%), neonatal infection (12.1% us. 
2.1%), IVH (0 us. 3.4%) and NEC (2.1% us. 5.3%) were less frequent 
with antibiotics. 
Conclusions: We recommend that women with expectantly managed 
pPROM before 33 weeks’ gestation receive antibiotics to reduce infant 
morbidity. 
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lp1432/ Resistance to fluoroquinolones marking the origin of 
human Campylobacter infections in the Netherlands 
W. van Pelt, E. Talsma, A. de Neeling, A. van de Giessen, J. Lambers, G.  
Rotgers 
Bilthouen, Komhom, Zeist, NL 
Background: It is unclear if poultry is the predominant source of 
Campylobacterjejuni infections in humans. Case control studies fail to show 
a predominant role of poultry meat and in some countries, reduction of 
Campylobacfer in poultry has not resulted in a similar reduction in humans. 
Typing methods so far fail to differentiate between strains from dlfferent 
sources. Treatment of broilers with fluoroquinolones strongly increased 
the resistance of Campylobacter spp. in poultry and humans. This is a 
descriptive study of temporal, regional and demographic variations in 
fluoroquinolone resistance as a marker for the role of p o d b y  derived 
campylobacteriosis in humans. 
Methods: Data on fluoroquinolone-resistance of C. jguni  in humans were 
obtained, &om 2 public health laboratories (PHL), 1992 onwards. Numbers of 
campylobacteriosis came from another 12 PHL.. Infection percentages of 
poultry were derived from a national monitoring p r o w  sampling 30 000 
flockdyear. Data on fluoroquinolone treatments came &om 3 slaughterhouses. 
Results: Human campylobacteriosis is 3-6 times more frequent in the 
summer as in the winter whilst resistance to fluoroquinolones is >6 times 
lower in the sumnier. In poultry the increase of Canrpyloburter started 2 
weeks earlier and decreased 2 weeks later than in humans. In rural areas 
campylobacteriosis incidence is half that found in urban areas whilst 
resistance to fluoroquinolones is 2 / 3  of that found in urban regions. 
Resistance in adults over 20 years is higher than in children, being 2/3 of 
the adult level in the youngest children. In 1999, about 17% of flocks were 
treated with a fluoroquinolone, equally throughout the year. In humans, the 
seasonal increase in resistant strains appeared 3 weeks after that of the 
sensitive ones. 
Conclusions: The results suggest that in people infected in the summer 
months, young people, or people living in rural areas a large fraction of 
human C.  jejuni infections originates from other sources than poultry. 
Seasonal increases of infected flocks may be related to increased 
environmental infection pressure with sensitive Compytobarter as well. 
Additional results on resistance and species distribution wdl be presented of 
a monitoring programme started in May 2000 of 25% of all broilers 
slaughtered in the Netherlands. Knowing the level of resistance in broilers 
from week to week in parallel to that in humans the approximate fraction of 
human campylobacteriosis associated with poultry can be calculated. 
lp1433/ Travel-associated Campylobacter infection 
C. Swift, J. Frost, I. A. Gdlespie, S. J. O’Brien 
Landon, UK 
In recent years Campylobacter has been recognised as a major cause of human 
gastroenteritis in many indusmahsed countries, and since 1981 it has 
become the most commonly referred gastroenteritis pathogen in England 
and Wales, with approximately 55 000 cases being reported to the PHLS 
CDSC during 1999. The majority of these cases are not speciated, but 
where species data are available approximately 90% are identlfied as C. 
jejuni, with most of the remainder of the infections being caused by C. coli. 
Despite its prevalence, the epidemiology of Campylobacter infection is still 
poorly understood. To gain a greater understanding of Campylobactev 
epidemiology in England and Wales campylobacter surveillance now 
focuses on a sentinel system covering selected Heath Authorities, 
encompassing a population of 12 million people. The aim is to provide 
epidemiological data to support the microbiological typing data supplied by 
the Campylobarter Reference Unit a t  CPHL, so that detailed analysis of 
sources and routes of campylobacter infection in humans can be generated. 
In addition to this the system also provides a focus for detailed studies on 
specific food, environmental and cultural issues affecting campylobacter 
epidemiology. The sentinel system is based on a standard risk factor 
questionnaire, which is administered to patients presenting with Campylo- 
barer  infection. The scheme has been in place since May 2000 and 
preliminary data analysis has shown the significance of travel away from 
home as a risk factor for Campylobacter infection. Of those individuals 
presenting with campylobacter infection 18% had travelled abroad within 2 
weeks before onset of symptoms and 16% had travelled away from home 
within the UK. Of those travelling abroad, Spain was the most common 
destination, followed by: Portugal, France, Pakistan, Morocco, Ireland, 
Greece and Germany. This reflects the most popular holiday destinations for 
UK travellers during the summer. The serotypes HS9, 18 and 37 were 
isolated at a significantly higher incidence, and HS2, and 50 at a significantly 
lower incidence, &om travellers returning from foreign destinations than 
&om home-acquired infections. O f  those travelling within the UK 18% 
used hotel accommodation, 6% were staying in a Holiday camp, 17% were 
camping and 12% used private accommodation. These data highlight the 
important contribution of travel to campylobacter infection in the UK both 
from overseas travellers and from those travelling locally. 
(p14341 Campylobacter infection in Italy: a laboratory based 
surveillance 
C. Pezzella, A. M. Dionisi, I .  Luzzi, D. Crotti, M. J. Gomez Miguel 
Rome, Perugin, 1 
Introduction: Campylobacter is one of the most common agents of acute 
enteritis in Italy too, in children particularly. Some clinical aspects are 
mandatory for its prompt identification. In addition, some increased 
antibiotic resistances (e.g. to quinolones) indicate the need for a suitable 
surveillance of these mfections. In the aim to verify the possibility of a future 
establishment of a nationwide surveillance, we performed a 1 year pilot 
laboratory based surveillance on Campylobacter infections in Italy. 
Patients and methods: The type ofsurveillance system was sentinel, passive, 
voluntary, speclfic and confidential. A case was defined as an Italian resident 
with laboratory confirmed Campylobarter infection. Anamnestic, clinical- 
epidemiological information of the case together with microbiologic results 
have been recorded in a form similar to that used in Enter-net Survedance 
(European Surveillance of Enteric Pathogens). Campylobacter isolates have 
been sent, together with the forms, to the CAMPYG coordinating Center 
(Perugia) and to the National Center for Enteric Pathogens (Rome) in order 
to type or confirm the typing of the isolates, to collect clinical isolates, to 
elaborate and to report the data. 
Results: About 300 strains of Campylobacter have been isolated from the 
beginning of the surveillance uanuary 2000). Most of the isolates (about 
80%) were C. jejuni biotype 1. The antimicrobial resistance was high for 
fluoroquinolones (more than 48%) whereas only 8% of isolates showed 
resistance to erythromycine. 
Conclusion: There is the need and the possibility to establish a nationwide 
survedlance in Italy where, as in most of the indusmalized world, Campylobacter 
are among the most impottant bactenal agents of acute diarrhoea. In some 
European countries Campylobarter infections exceed the number of salmonella 
mfections, which indicates a major public health problem in the whole 
European Community. Collaboration with other European study groups and 
interaction with veterinary area for better understanding the epidemiology of 
this zoonosis in OUT country will be further aims of our study. Molecular 
typing will be developed for this purpose. 
v1 Campylobacter enteritis in Ireland 1999 
D. Whyte, D.  Igoe 
Dublin, I R L  
Objective: There has been increasing concern internationally at the level of 
illness caused by Campy/obacter spp. Commonly, Campybibacfer jejuni and 
Campylobacter coli infection is a zoonosis and manifests as a severe enteritis. In 
1999, there were concerns expressed about the rising number of 
Campylobacter isolations being made, in comparison to other years. In 
March 2000, the National Disease Surveillance Centre (NDSC) conducted 
a national review to ascertain more dormation on the epidemiology of 
laboratory-confirmed C. enterilk in Ireland. 
Methods: At present there is no national electronic surveillance of Campylobucfer 
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infection in Ireland. NDSC asked laboratories and/or public health doctors, in 
all eight health regions, for disaggregate information on all laboratory-confimled 
cases of C. enterifis diagnosed in 1999. A nlinimum dataset was requested. 
Duplicates were removed where detected. Analysis was carried out using Access 
and STATA. Direct methods of standardization were applied. 
Results: Information on Campylobactev was obtained from all regions. Data 
was missing on age in 12% of cases and on sex in 0.7% of cases. In total, 
2085 cases of laboratory-confirmed cases of C. eriteritis were reported in 
1999. The crude incidence rate and age standardised rate varied widely 
according to health region. It was found that the age-specific incidence rate 
for children under 4 years was very high, relative to other age groups. A 
second peak was found in the 25-34-year-old age group. 
Conclusion: The data reveals a crude incidence rate of 57.5 cases per 
100 000 persons making it the single biggest cause of bacterial food 
poisoning in Ireland. The true burden of illness is from Campylobacter is 
far greater, given that these are only laboratory-confirmed cases. The 
rate is similar in Northern Ireland and half that seen in Scotland and 
England & Wales. Further work needs to he done to examine the 
reasons for the high incidence in children under 4 years. This may 
facilitate appropriate preventive strategies to reduce the significant 
morbidity associated with campylobacterosis. 
/p14361 Antimicrobial resistance in Campylobacter jejuni and 
Campylobacter coli strains isolated from human stool samples in 
Bosnia and Herzegovina 
S. Uzunovic-Kamberovic 
Zenica, BJH 
Objective: To establish antimicrobial resistance of C. jejuni and C. coli 
strains, to eight antimicrobials. 
Methods: In Laboratory for clinical and sanitary microbiology of Canton 
Center for Public Health in Zenica (Bosnia and Herzegovina) a total 
number of 88 C. jejurri and C. coli strains were isolated from human stools 
during 1998. The strains were identified using the standard microbiological 
methods and were tested by disc diffusion method to eight antimicrobials: 
ciprofloxacin, nalidixic acid, erytromycin, azitromycin, tetracycline, 
ampicillin, gentamicin and nitrofurane, using bioDiscs (bioM&rieux, France) 
and Muller-Hinton agar (Oxoid, U K ) ,  supplemented with 5% sheep blood, 
according to NCCLS recommendations. 
Results: The frequency of resistance was: ciprofloxacin 13.8%, nalidixic acid 
18.296, erythromycin 21.6%. azitroinicin 23.9%, tetracychn 14.8%, 
ampicillin 20.5%, gentamicin 12.5%, nitrofurane 8.6%. The overall 
susceptibility rate to all eight antibiotics was higher for C. mli strains, 
62.5%. than for C. jejuni strains, 34.4%. C. jejuni strains showed twice 
higher resistance to ciprofloxacin and nalidixic acid, 15.9% and 20.3%, than 
C. coli strains. The resistance to tetracyclin reached 29.2% in C. culi strains. 
The urban isolates showed approximately twice higher resistance then rural 
one for all tested antibiotics except tetracyclin. More than half, 53.4% of the 
isolates, were from chlldren up to 6-year-old, and resistance to ciprofloxacin 
in this age group was equal to adult age group resistance, 13.6%. There was 
apparent dlfference between antibiotic resistance and the age in case 
tetracyclin, ampicillin and nitrofurane: 6.8%, 11.9% and 5.7% in children up 
to 6-ye~r-old, and 30.4, 30.4% and 13.6% in adult age group. 
Conclusion: The Institute of Statistics, Federation of Bosnia and 
Herzegovina reports that 75-90% decrease in livestock resources was 
recorded between 1990 and 1998. Consequently, far less milk, meat and 
products derived from them were consumed during the war and in the 
postwar penod. Yet, as the use of quinolones is restricted in children, still, 
the resistance rate to ciprofloxacin remains high and unexplainable. Also, as 
the resistance rate of Cumpylobacter strains in this region to erythromycin 
appears too high, it is necessary to peiforni the routine test of susceptibility 
of C .  jejuni/oli strains to antibiotics. 
v/ Epidemiological study of children's shigelloses in 
Plovdiv's region 
Y. Stoilova, P. Vassileva, N. Popivanova 
Ploudiv, BG 
Objective: Children's shigellosis registered in Plovdiv's region during 1993- 
97 period were epidemiologically studied to assess epidemic situation in 
light of morbidity rate, dynamics, risk factors and efficiency of measures 
against this pathology. 
Methods: Prospective epidemiological study was carried out of 1451 
children with shigellosis, G I 4  year of age, 696 hospitalized in In6 Clinic, 
Med. Univ. The study analyzes morbidity, lethality, etiological structure, 
age, gender, demographc structure, town/village, clinical course, etc. 
Complex epidemiological methods-epidemiological survedlance, investiga- 
hon, routine clinical and statistical methods were employed. 
Results: Annual shigelloses morbidity among k 1 4  year age children is high, 
varying between 158.8%0 (1993) and 287.74%0 (1994) but the trend is to 
decrease - 172.19%0 (1997). Adult morbidity rate is many times lower - 
from 31.36%0 to 41.96%~~ According to age risk groups are 0-1 and 1-3 
years presented by annual morbidity from 872.09Ym to 1702%0 and from 
276.85% to 611.02%0, respectively. Sh..flexnery was isolated from 80.25% of 
patients, Sh. sonnei fiom 18.23. Seasonality is usual - summer. The cases 
were with sporadic registration. Cases with moderate clinical course are 
statistically significant taking largest share - 45.84% compared to those with 
grave clinical course-27.95% and light clinical course - 26.21% 
Conclusion: Regional epidemiological studies are necessary to determine 
measures for effective control. 
v( Epidemiology of Shigella - associated diarrhea in 
rural Egyptian children 
K .  Abu-Elyazeed, T. Wierzba, M. Kao, S. Savarino, K .  Frenck, K. Kamal, 
L. Peruski, I. Abd-El Mess&, S .  El-Alkamy, A. Naficy, J. Clemens 
Cairo, ET; Bethesda, USA; Seoul, KOR 
Shigefla associated diarrhea is important cause of morbidity and a major cause 
of chddhood mortality in the developing world. In the current study, we 
describe the epidemiology of Shigella diarrhea in a cohort of children less 
than 3-year-old resiclng in two rural villages of the Nile Delta of Egypt. 
Between February 1995 and February 1998, 397 children under 36 months 
of age were enrolled and under surveillance for diarrhea. Twice weekly, 
children were visited in their homes and a rectal swab and a fecal specimen 
were collected from any child reported to have diarrhea. Specimens were 
cultured for Shigella and other entenc pathogens using standard nlicro- 
biological techniques. The incidence of all diarrhea and Shigeh related 
diarrhea were 5.5 and 0.2 episodes per cud-year, respectively. S. jkxt ter i  
was the most commonly isolated species (55%) followed by S. sottnei (22%). 
Shigella was more frequently isolated during the warm months (April- 
October) ( P  < 0.05) and among children between 12 months and 23 
months old (0.3 episodes per chdd/year). Breast-feeding was protective for 
Shigella associated diarrhea ( P  < 0.05). Children with Shigella associated 
diarrhea were ill for a mean of 3.8 days and passed a mean of 6.2 stools per 
day. Symptoms commonly associated with the infection included fever 
(35%), vomiting (19%) and dehydration (16%). However, dysentery, with 
visible blood in the feces, was documented in only 11% of the cases. These 
data suggest that Shigella associated diarrhea is common among young 
children but breast-feeding may reduce the incidence of disease. This study 
site could be utilized to test candidate Shiplla vaccines. 
v] Antimicrobial susceptibility patterns of Salmonella 
and Shigella spp. isolated from community-acquired infections 
in adults 
F. Yetkin, R. Karakus, C. Kulah, E. Senol, K. Caglar 
Ankara, TR 
Objectives: To investigate the in uitro antibiotic susceptibility patterns of 
Salmonella and Sh&ella spp. isolated h m  community acquired infections in adults. 
Methods: Foq- two Salmonella and 26 Shigella spp. isolated from stool 
cultures between March and September 2000 were taken into study. The 
isolates were identified by conventional microbiological methodr. Anti- 
biotic susceptibility tests were performed by Kirby-Bauer disk diffusion 
method using the azithromycin (AZM), levofloxacin (LEV), ampicillin 
(AMP), chloramphenicol (C), trimethoprim/sulfamethoxazole (SXT), 
ampicillin/sulbactam (SAM), ciprofloxacin (CIP) and ceftriaxone (CKO) 
disks accordmg to the criteria of the NCCLS. 
Results: Nineteen (45.2%) of the Salmonella spp. belonged to serogroup A, 7 
(16.7%) to serogroup B, and 16 (38.1%) to serogroup D.  Two (7.7%) ofthe 
Shgella spp. were identified as S. boydii, 4 (15.4%) as S. dysetiteria, 9 (34.6%) 
as S. JTexneri, and 11 (42.3%) as S. sonnei. All of the isolates were susceptible 
to LEV, CIP and CRO.  Twenty-four (57.1%) of the Salmonella spp. and 3 
(1 1.5%) of the Shigella spp. were susceptible to all antibiohcs tested. On the 
other hand 3 (7.1%) of the Salmonella and 1 (3.9%) of the Shigdla spp. were 
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found as niulti drug resistant (MDR-resistant to AMP, C, and SXT). AU of 
the Salmonella spp. were susceptible to AZM whereas 3 (11.5%) of the 
Shigella spp. were resistant. Among the M D R  Salmonella isolates all were 
susceptible to AZM and LEV. The overall resistance of the Salmonella spp. 
to SAM, SXT, C and AMP was 14.3%, 6.6%, 28.6%. and 14.3%, 
respectively. The overall resistance of the Shigella spp. to SAM, SXT, C and 
AMP was 34.6%, 50%, 19.2%, and 34.6%, respectively. 
Conclusions: Though we did not observe any resistant strains in Salmonella 
and Shigella spp. to CIP and LEV, the resistance patterns in general is 
alerting for rational antibiotic use in salmonellosis and shigellosis. In uitro 
activity of AZM and LEV are found to be superior to SAM, SXT, C and 
AMP in our study but clinical studies are needed to determine the in uiuo 
activity of the former antibiotics. 
[p14401 Virulence factors, antimicrobial resistance and 
plasmids of Salmonella serotypes isolated in Edirne, Turkey 
E. Ozkan, M. Tugrul, M. Tatman-Otkun, D. Oztiirk, 0. Tansel, M. 
Otkun, F. Akata 
Edirne, TR 
Objective: Detection of virulence factors, antimicrobial resistance rates and 
plasmid profiles of nontyphi Salmonella serotypes. 
Methods: Salmonella serotypes isolated clinical specimens between January 1995 
and July 2000, were studied. Fimbria were detected by hemagglutination (HA) 
with sheep and human erythrocytes in the presence and absence of mannose. 
Rabbit and human sera were used in the tests of lethal effect of serum. 
Antimicrobial susceptibility tests were done by disk diil%sion and agar dilution 
methods according to NCCLS recommendations. Extended-spectrum p- 
lactamases (ESBLs) were screened by double disk synergy method. Plasmids 
were extracted by alkaline-lysis method and visualised by gel electrophoresis. 
Results: A total of 125 [90 S. enteritidir (SE) and 35 S.  typhimurium (STM)] 
isolates obtained from sporadic cases except 34 SE which were isolated from 
two different gastroenteritis outbreaks, were studied. Of these, 119 were 
cultured from stool, four from blood, and one from cerebrospinal fluid. 
Mannose-sensitive H A  rates were similar in both serotypes, but mannose- 
resistant HA was more frequent in STM (P < 0.05). All isolates were resistant 
to lethal effect ofserum. Resistance rates to ampic&, amoxich-clavulanate, 
cefazolin, cefoperazone in SE and STM isolates were detected as 5% and 63%, 
4% and 34%, 2% and 14%, and 19% and 63%, respectively (P < 0.05 for all). 
No ESBLs were detected in any isolate. Cefotaxime, cefinaxone, cebzldinie, 
imipenem, ciprofloxacin, amikacin and netllrmcin were effective for all 
isolates, however, two STM were resistant to gentamicin and tobramycin. 
Plasmids were not detected in two SE and six STM isolates. A > 100 MDa 
plasmid and a 90 MDa plasmid were detected in seven and 58 SE, respectively, 
in addition to some smaller plasmids. Plasmid profiles of outbreak isolates were 
similar. Twenty-six STM contained a > 100 MDa plasmid, while two 
contained a 70 MDa and one contained a 24 MDa plasmid. 
Conclusion: Antimicrobial resistance and nontype 1 fimbria were detected 
more frequently in STM isolates. The presence of virulence facton and 
antimicrobial resistance were not associated by a particular plasmid profile. 
/p14411 Antimicrobial resistance among clinical isolates of 
Salmonella spp. in Kayseri, Turkey 
D. Esel, M. Telli, B. Sumerkan, N. Karaca, B. Aygen 
Kayseri, TR 
Objective: The aim of this study was to evaluate the in vitro activity of some 
antibiotics against the clinical isolates of Salmonella spp. 
Method: Seventy-eight clinical isolates of Salmonella spp. isolated from stool 
(1t=63), blood ( n =  12), urine (n=  l), bone-marrow ( n =  l),  and intra 
abdominal abscess ( w  = 1) in the period between 01.01.2000 and 01.1 1.2000 
were tested for the susceptibility to ampicillin, chloramphenicol, trimetho- 
prim-sufhamethoxasole (TMP/SMX), ceftriaxone, ciprofloxacin, and 
nalidixic acid. Susceptibility tests were performed using disk difision 
method according to the standard? of NCCLS guidelines. 
Results: Sa/mone/lu typhimurium (60%) was the predominant species, 
followed by S.  enteritidis (21%). and S .  typhi (15%). Serotypes of 3 (4%) 
strains could not be determined. The resistance to ampicillin and 
chloramphenicol and nalidixic acid were detected in 63%, 58%, and 8% 
of the salmonella isolates, respectively. All strains were susceptible to 
cefiriaxone, TMPISMX, and ciprofloxacin. Nalidixic acid resistance were 
observed only in strains of S. enteritidis. 
Conclusion: Ampicillin and chloramphenicol cannot be considered useful 
for the empirical treatment of salmonella infecaons. TMP/SMX, third 
generation cephalosporins and quinolones may be more prudent for the 
empirical treatment of suspected salmonella infections in our region. 
Nevertheless, MIC for ciprofloxacin should be determined in the caSe of 
nalidixic acid resistance. 
vl Antimicrobial susceptibility of Salmonella and 
Shigella strains isolated from stool samples against ampicillin, 
cotrimoxazole, chloramphenicol and ciprofloxacin 
F. Albayrak, S. Cesur, S. Birengel, 0. MeCo 
Ankara, TR 
Objectives: Between 1997 and 1999 years a total of 107 Salmonella and 
Shigella spp. were isolated &om stool samples in our laboratory. We aimed to 
detect antimicrobial susceptibility of these isolates against ampicillin, 
cotrimoxazole, chloramphenicol and ciprofloxacin. 
Methods: We used the Kirby-Bauer disk &sion method in Mueller 
Hinton agar according to NCCLS recommendations. 
Results: Among 75 Salmonella strains; 31 was S. typhi and the rest 44 was 
nontyphi Salmonella spp. (36 was group D, 5 was group C,  3 was group B). 
Among 32 Shigella strains; 13 was S.jlexneri, 7 was S. sonnei, 7 was S. boydii, 5 
was S. dysentetim. Antibiotic susceptibility ofthe isolates was shown in Table 1. 
Table 1 Antibiotic susceptibility of the Salmonella and Shigella strains 
S. typlri Nontyphi Snli~tnriclla S/r@lln spp 
(17 = 31) (17 44) (11 = 32) 
Ampicillin 18/31 (5S.lW) 5/44 (11.4%) 7/32 (21.9%) 
Cotrirnoxazole 4/31 (12.9%) 4/44 (9.1%) 4/32 (12.596) 
Chloramphenicol 7/31 (22 6x1) 8/44 (18.2%) 8 /32  (25.0%) 
Ciprofloxacin 31/31 (100%) 4+/44 (100%)) 32/32 (ll)O'%~) 
Conclusion: As years passed, we observe an increase in resistance of Salmonella 
and Shigella spp. to ampicillin, chloramphenicol and cotrimoxazole. No 
resistance observed against ciprofltoxacin. So we should use quinolones for 
the treatment of infections caused by Salinonellu and Shigella species. 
v] In vitro effects of cefotaxime and ceftriaxone to 
Salmonella typhi within human monocyte-derived macrophages 
B. Ekinci, A. Y. Coban, A. Birinci, B. Durupinar, M. Erturk 
Samsun, TR 
Objectives: The main objective of this study was to asses in in-vitro 
conditions the effects of cefotaxime and ceftriaxone in curing S. typhi 
infected human macrophages. 
Methods: Human monocyte derived macrophages isolated from peripheral 
blood of human volunteers were cultured in uitro for macrophage 
differentiation and subsequently infected w t h  S. fyphi strains (a clinical 
isolate and a standard strain TA-42) at a cell ratio of 10:l. MICs of 
cefotaxime and ceftriaxone were determined by broth microdilution test 
and included into the culture medium at one and five times their MIC 
values. Samples of cell culture medium taken at 0, 3, 6 and 24 h of 
incubation were cultured for growth of S.  typhi using nutrient agar. 
Gentamicin (10 pg/mL) was included each well except control wells in 
order to prevent extracellular growth of S.  typhi. 
Results: Both antibiotics showed good in vifro antibacterial effects against S. 
typhi strains. There was no statistically significant differences between 
extracellular and intracellular effects of antibiotics with regard to elimination 
of the bacteria. Their maximum effects were observed at 6th hour 
continuing for at least 24 h time, albeit without complete removal of all 
bacteria fiom medium. Gentamicin (10 pg/nL) used as the control 
antibiotic, did not exhibit any significant antibacterial effect. 
Conclusions: Cefotaxime and ceftriaxone are highly effective against 
extracellular bacterial growth. The results of our in uifro experiments 
suggest that cefotaxime and ceftriaxone inay also be used routinely against 
susceptible intracellular pathogens such as S .  typhi. 
m] Effects of subinhibitory concentrations of antibiotics 
on the viability of Salmonella typhimurium in host cells 
Q. Behzadiyan-Nejad, R. Keshnuri 
Tehran, IR 
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Our hypothesis was that pretreatment of S. typhimun'um with subinhibitory 
concentrations (subMICs) of antibiotics enhances the susceptibility of the 
organisms to killing by murin peritoneal macrophages. The antibiotics 
used were representative of variety of classes, including chloramphenicol, 
tetracycline, ampicillin and cotrimoxazol. Bacterial uptake and killing 
were measured by colony count method. Pretreatment of S. typhimun'um 
with all drugs showed significantly enhanced killing and uptake of bacteria 
by macrophages. 
(p14451 In vitro and in vivo study of Iranian garlic on 
Salmonella typhimurium 
R. Gharebaghi, H. JaEari, M. Niakan, N. Fallah, S .  Mansorii 
Tehran, G a m i n ,  IR 
Objectives: Sahonellosis is considered as a major hazard to the health of the 
world and food poisoning is one of the most commonly related by S .  
typhimun'um. In this study we survey in uivo and in uitro effects of aqueous 
extract of Iranian garlic (from Hamadao) on S. typhimun'um. 
Methods: The aqueous extract of garlic has prepared with the concentration 
of 20 g/L. After prescription of a concentration of 10"' of S. typhimuium 
per 1 mL of culture media to 60 Dutch polish rabbits, the symptoms such as 
fever and diarrhea were developed. Treatment of involved rabbits by garlic 
three times in the day for a duration of 6 days is done. After sampling from 
stool of animals in times:-24, 0, 24, 48, 72, 96, 120 and 144 h, bacterial 
colonies were counted in culture media. In other part of this study the zone 
inhibition of garlic were measured. 
Results: The statistical analysis by ANOVA showed that aqueous extract of 
garlic can decrease bacterial colonies in culture media (P < 0.05). In 
addition garlic decreases the body temperature of rabbits by 2'C and 
completely prevent diarrhea. Results showed that the mean of zone 
inhibition of garlic was 17 mm according the in uitro study. 
Conclusion: We concluded that the aqueous Iranian garlic extract is effective 
on salmonella typhimu&m in rabbits according the in uiuo and in uim srudy. 
/p1446 I In vitro effect of antibiotics on Salmonella enterica 
serovar typhimurium DT104 
L. Majtanova, V. Majtan 
Bratislava, SK 
Objectives: T o  evaluate the antibacterial activity of both fluoroquinolones 
(ciprofloxacin, enoxacin, nortloxacin, ofloxacin, pefloxacin) and aminogly- 
cosides (ainikacin, gentamicin, netilmicm, tobramycin) as well as influence 
of these antibiotics at sub-MIC on the surface hydrophobicity and motility 
of S. thyphimutiurn DT104 strain (a clinical isolate resistant to ampicillin, 
chloramphenicol, streptomycin and tetracycline). 
Methods: The hydrophobicity was determined on the basis of salt 
aggregation test with ammonium sulphate (SAT), by the method of 
bacterial adherence to polystyrene and by the method of Congo red 
binding. The assay of motility was performed on the semisolid swarming 
agar medium (0.35%). 
Results: Antibiotics studied were highly effective on the tested strain. From 
fluoroquinolones, the most effective was ciprofloxacin (MIC - 0.09 pg/mL) 
and of aminoglycosides ne t ihc in  (MIC - 0.39 pg/mL), respectively. The 
hydrophobicity of tested strain evaluated in the SAT test was decreased after 
the sub-MICs (1/4, 1/8, 1/16 of the MIC) of all antibiotics under study. 
The adherence to polystyrene was moderately and inhibited after the effect 
of fluoroquinolones and gentamicin at 1/4 and 1/23 of the MIC, 
respectively. The Congo red binding was influenced only by ciprofloxacin, 
nortloxacin and pefloxacm. The motility was expressively suppressed to 16 
and 25% against the control by amikacin at the whole concentration range. 
Conclusions: The results obtained indicate that the subinhibitory concen- 
trations of fluoroquinolones and aminoglycosides are capable of blocking 
the pathogenic mechanisms of S .  typhimurirm DT104. 
Serogroups and antimicrobial susceptibility of 
Salmonella and Shigella clinical isolates: 3 years experience 
E. Trikka-Graphakos, M. Nepka, C. Pappa, C.  Kotroni, M. Pantelaki, F. 
Ioannidou 
Athens, GR 
Objectives: To determine the trend in the prevalence of the serogroups and to 
analyze the distribution and the antibiotic resistance pattern of Salmonella spp. 
Methods: One hundred and ninety-eight Salmonella clinical isolates mainly 
from children with gastroenteritis were isolated from stool cultures (182) 
and blood cultures (17) in our department during 1997-2000. AU the 
isolates were identified and serogrouped by conventional methods. 
Minimum Inhibitory Concentrations (MICs) of several antibiotics against 
the clinical isolates were determined by broth microdilution technique 
using the Sensititre dried microtiter panels. 
Results: Twenty different salmonella serotypes were isolated. S. enteritidis was 
the predominant isolate (51.9%), followed by S. fyphimurium (28.8%), S. 
hadar (4.4%), S. Mbandaka (3.6%), S. ryphi (1%). S. blocklev (1%) and other 
less common serotypes (9.3%). The resistance pattern after MIC 50.90 
determination was as follows: ampicillin (16, > 16 pg/mL) cotrimoxazole 
(< 025/4.75 pg/mL) cephalothin (4.8 pg/mL) choramphenicol (< 4.8 
pg/mL) tetracycline (2.4 pg/mL). Thirty-two per cent of the strains were 
resistant to ampicillin, 3.9% to cotrimoxazole, 1.9% to cephalothin and 
1.8% to chloramphenicol. S. enteritidis was more resistant to ampicillin than 
S .  typhimurium. The commonest resistance pattern of S .  typhimuriutn was 
ampicillin/mezlocillin/piperacillin/chloramphenicol/tetra~cline. Reduced 
susceptibility of S.  typhimun'um to ampicillin/clavulanic acid and tirarcil- 
lin/clavulanic acid was also observed in almost all isolates. All strains were 
susceptible to aminoglycosides 2nd and 3rd generation cephalosporins 
and ciprofloxacin. 
Conclusions: (1) S. enteritidis continuous to be the most common clinical 
isolate. (2) S .  enteritidis was found to be more resistant to ampicillin while S. 
typhimun'um was more resistant to cotrimoxazole. (3) Antimicrobials with 
low demonstrated resistance such as 2nd and 3rd generation cephalosporins, 
quinolones and cotrimoxazole should be considered in patients when 
treatment is necessary. 
I PI448 I Acute gastroenteritis: clinical and laboratory findings 
in an emergency service 
J. Guardiola, J. Montiel, E. Francia, 0. Torres, A. Mauri, M. Barcelo, E. 
Coma, M. Gurgui, P. Domingo, J. Ris, G. Vazquez 
Barcelona, E 
Objectives: To speclfy the pathogens and to evaluate clinical and laboratory 
findings in patients admitted for febrile gastroenteritis in a emergency service. 
Methods: This is a prospective study of all patients with AG attended in our 
ES during summer of 1999 and 2000. WBCs, stool microscopy examination 
and culture results were evaluated for all patients. 
Results: One hundred and forty patients were attended (97 in 1999 and 40 
in 2000). Mean age was 43.5+20.3 (18-93) 51% were female. Mean 
number of depositions were 7.3 + 4.5 (4-20). Fever was present in a 59.8% 
of patients. Abdominal pain was present in 84.5%. Leukocyte count were 
8.5 + 3.6 x 10"/L 40.1% of patients had positive stool culture. Salmonella 
spp. was the pathogen in 69.2% ofthe positive stool cultures. Antibiotic was 
prescribed in a 45.4% of patients (predominantly ciprofloxacine and 
cotrimoxazol). Only a 8% of patients need hospital admission. The 
evolution was satisfactory in all patients. 
Conclusion: The most frequent symptoms were diarrhea, fever and 
abdominal pain. More than one third of all patients admitted with febrile 
gastroenteritis have positive stool culture. The commonest isolated 
pathogen was Salmonella spp. Antibiotic prescription was performed only 
in 45% of cases. The evolution of AG was satisfactory. 
vl Incidence of E. coli 0157H7 in a Turkish hospital 
C. Guney, H.  Aydogan, M. Saracli, A. Basustaoglu 
Ankara, TR 
The aim of ths  study was to determine the prevalence of E. coli 0157:H7 in 
pediatric patients with acute gastroenteritis. A prospective epidemiological 
study was performed in cases and controls to detect the germ in fecal 
samples of 649 children (0-7-year-old) with acute gastroenteritis, in Ankara, 
Turkey. The stools were inoculated to Sorbitol MacConkey agar (SMAC). 
The sorbitol negative colonies were biotyped and seroagglutinated with a 
specific antisera (Difco, USA) for E. coli 0157:H7 and also researched the 
production of verotoxins in Vero cell culture. Of the 649 stool specimens 
23 (3.54%) sorbitol negative E. coli strains showed the presence of low titer 
agglutination with 0157:H7 antiserum. However, these strains were 
negative for verotoxin production. False-presumptive-posiuve results were 
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observed with strains of E. coli when isolated by the culture method and 
when using a commercially purchased antisera. Ths false presumptive 
positive results can be reduced by detection of verotoxin production at these 
strains. As a result of this study we believe, that we are in a low rate of 
infection area for E. mli 0157:H7 and also accordingly do not recommend 
routine screening of this pathogen by only using Sorbitol MacConkey agar 
and antisera. 
Ip1450 Isolation of enteroaggregative strains of Escherichia 
coli from children with diarrhoea 
B. Sobieszczanska, R. Gryko 
Wmclaw, Pulaicry, PL 
Introduction: EAggEC are newly recognized strains of E. coli which are 
responsible for diarrhoea in developing country. The virulence factors of 
these strains are still unknown as well as the serogroup? belonging to that 
group of pathogenic E. coli strains. 
Objective: Determination of virulence factors of 25 enteroaggregative 
strains of E. roii isolated from children with diarrhoea (mean age: 3.5 
months). 
Material: Twenty-five strains of EAggEC isolated from 43 stool samples on 
the basis of the characteristic aggregative (AA) adherence pattern. 
Methods: Adherence assay was performed on HEp-2 cell line. All strains 
were tested biochemically by ID GN32 test. In the strainc which showed AA 
adherence were exanlitied fimbriae by henlagglutinadon of guinea pig and 
human A and 0 group of erythrocytes. In all strains there were detemined the 
ability to producing of hemolysins on blood agar medium contained washed 
sheep erythrocytes and verotoxins on Vero and HeLa cell lines. All 23 isolates 
were examined with enteropathogeiuc and 0157 antisera by slide agglutination 
method. Plasmid analysis was performed after gel electrophoresis. 
Results: None of the examined strains produced verotoxins. Only 2 strains 
were produced hemolysin-alpha. the rest of the strains were not hemolytic. 
The 3 o f  23 examined isolates did not showed agglutination with guinea pig 
or human erythrocytes. Most of the strains showed the presence of 
mannose-sensitive finibriae and 8 of these strains had mannose-resistant 
fimbriae. In the most of the isolates plasmid analysis showed the presence of 
high molecular weight plasmid about 40 MDa. Serotyping revealed one 
strain 0 1  19, 3 strains 025 ,  2 strains 018,  one strain 086,  One strain 0125 
and one strain 0126. 5% examined strains were rough and the rest strains 
were did not agglutinate with the used antisera. 
Conclusion: EAggEC were isolated from children with diarrhoea in Poland. 
They belonged to the different serogroup but they did not produced 
heinolysins or cytotoxins on Vero or HeLa cell lines. Most of isolates 
showed the presence of about 40 MDa plasmid. 
(p14511 Molecular epidemiology of Norwalk-like human 
caliciviruses in outbreaks of acute gastro-enteritis on hospital 
wards in the Stockholm area in 1996 
M. Billgren, B. Cluistenson, K .  Hedlund, J. Vinjk 
Srockholnl, S; Bilthouen, hTL 
Background: Outbreaks of gastro-enteritis associated with Norwalk-like 
human caliciviruses (NLV) have been an increasing problem on hospital 
wardc. To  monitor the epidemiological and clinical significance of NLV- 
associated outbreaks in hospitals in the Stockholm area, epidemiological data 
and stool samples were collected in an intervention study in 1996. 
Methods: Ten hospitals, representing 66% of the hospitals in the Stockholm 
area, participated. Altogether 211 wards for adults were included; from 
these, 18 wards were selected as controls. The inclusion criterion was acute 
gastro-enteritis in at least three persons during one week. Questionnaires 
were distributed and contacts made in hospital units which participated in 
the survey. Wards that had reported outbreaks in 1996 were also 
investigated for the occurrence of outbreaks of acute gastro-enteritis 
between 1991 and 1999. A total of 253 stool samples were analyzed in 1996 
by electron microscopy (EM) and by reverse traiiscriptase ((RT)-PCR) for 
NLV. The genetic variation of the outbreak strains was determined by 
sequencing specific RT-PCR products. 
Results: A total of 4326 patients and 11 19 staff were exposed on the 43 
wards which reported outbreaks in 1996. The real number was considered 
to be much higher, as ongoing outbreaks were not reported. The attack rate 
varied between 7%) and 65% among patients and between 2% and 57% 
among staff. Hospital admission was stopped for 3-7 days on 56% o f  the 
outbreak wards. The risk of an outbreak was significantly higher on wards 
that had reported outbreaks in the previous year. All hospital outbreaks were 
closely associated with an NLV strain, Grimsby, genomic group Lordsdale, 
that had been reported in other countnes. 
Conclusions: Outbreaks of calicivirus caused considerable interruption in 
care. Wards with an outbreak in one year had a significantly higher risk of 
an outbreak in the following year. Environmental contamination and 
airborne spread have been underestimated as causes of outbreaks and in 
maintaining spread. Phylogenetic analysis indicated that mainly one NLV 
strain at the time causes the epidemic of gastro-enteritis. 
An outbreak of neonatal diarrhoea caused by 
emerging rotavirus genotype P[6]G9 in an incubator ward 
M.-A. Widdowson, G. J. J. van Doomum, W. H.  M. van der Poel, A. S. de 
Boer, U. Mahdi, J. L. Kool, M. Koopnians 
Bilthouen, Amsterdam, N L  
Introduction: Rotavirus generally does not cause symptomatic disease in 
neonates. On 13 September 1999, an outbreak of acute watery diarrhoea 
started in neonates in a hospital incubator ward, and rotavirus diagnosed by 
latex agglutination and genotype P[6]G9 was detected and typed by reverse 
transcriptase PCR. Until this time, P[6]G9 infection had been reported as 
emerging worldwide but only as sporadic cases in surveillance data. 
Objective: To describe this outbreak of rotavirus and to identify tisk factors 
for illness for implementation of control measures. 
Methods: A descriptive study of all cases in the incubator ward was carried 
out followed by a case-control study. Cases were neonates with diarrhoea in 
the incubator ward with a rotavirus infection diagnosed by latex agglutination 
between 19 October and 31 December 1999 ( ~ ~ 2 3 ) .  Controls were all the 
healthy babies that spent at least 3 days in the incubator section in the same 
period (n = 26). In cases, exposures in the 3 days before date of onset were 
documented from medical reports and included birthweight, maturity at 
birth, type of feeding/food, room, type of incubator/bed and medical 
interventions. In controls, the same exposures were documented for a 3-day 
period randomly selected from the period of stay. 
Results: Fortyseven cases of clinical rotavirus illness in neonates were 
diagnosed by latex agglutination out of 11 8 neonates exposed during the 5 
months of the outbreak (attack rate 40%). All cases recovered within a 
week. Rotavirus P[6]G9 was found in all of28 faecal samples tested by RT- 
PCR. Significantly associated with illness in univariate analysis were low 
birthweight (< 2500 g, OR=6.1), prematurity (< 36 weeks, ORz5.1) 
and increased nasogastric feeding (> 10 times in 3 days, OR = 9.0). In 
multivariate analysis of the same variables, only nasogastric feeding remained 
significant (Adj OR =4.9, 95%CI 1.1-22.5). 
Conclusions: This first reported outbreak of rotavirus P[6]G9 shows that this 
genotype can cause serious nosocomial outbreaks of dness in neonates with 
high attack rates. The association with nasogasuic feeding may possibly be 
because sterile gloves were not worn for this procedure and highhghts the 
difficulty of controlling nosocomial rotavirus outbreaks. Current rotavirus 
vaccines containing the four main rotavirus genotypes may not protect 
against this genotype whose emergence emphasises the need for surveillance 
of rotavirus strains before introduction of a vaccine. 
Clinical course and treatment of enteral infections in 
children with malnutrition 
V. Tzaneva, M. Dimitrova 
Stara Zagora, R G  
The purpose of this study is to analyze the clinical, laboratory results and 
therapy in 7 children with severe forms of enteric infections and to indicate 
the contributing factors for this severe clinical presentation with fatal 
outcome in 3 of the children. We studied the clinical course in 7 children 
aged from 2 months to 1 years. In 4 the causative microorgarusni of the 
enteric infecuon was S..flexneri, in 1 k7ehriella pneiimoniae was isolated and in 
1 Ps. aewginosa. The clinical course was characterised with severe and 
protracted diarrhea and dehydration, development of complications like 
pneumonia, sepsis, keratitis and disseminated intravasal coagulopathy. The 
conducted etiological treatment included cephalosporins third and fourth 
generation, aminoglucosides, carbapeuems, active parented rehydration, 
correction of the metabolism and other disorders that occurred. The severe 
clinical course and fatal outcome in 3 of the children is associated with 
underlying factors like age, malnumtion, reduced weight and secondary 
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anaemia, factors from the f a d y ,  concerning the cultural and educational level 
of the parents, unemployment and number of children. The reason of the btal 
outconie was the development of cerebral oedema, sepsis, ileus and DIC. 
Ip1454/ Analysis of genetic polymorphism on the levels of 
genome and alpha toxin gene in Clostridium perfringens strains 
isolated from clinical cases in Poland 
E. Augustynowicz, A. Gzyl, J. Slusarczyk 
Warsaw, PL 
The goals of the work were to determined a profile of synthesised toxins 
and an examination of polymorphism on the levels of whole genome and 
gene encoding alpha toxin in C. pe$ringem type A strains isolated from 
clinical cases in Poland. Collection of analyzed strains was genotyped by 
multiplex P C R  with application of primers designed for genes encoding 
main toxins. For genotyping on the whole genome level, RAPD technique 
was applied and 18 different arbitrary primers were tested. Most informative 
profiles were obtained with use of a short (10 bp) primer 1254. It was 
performed to classify isolates into related and unrelated groups. RAPD 
differentiated among 26 examined isolates 14 patterns of closest similarity. 
We found among them 4 spatiotemporal clusters and 10 unrelated isolates. 
Clonal relatedness may thus exists among toxigenic groups recovered from 
temporally and locally unrelated outbreaks. Sequencing of PCR products of 
plc gene of 20 clinical strains showed weak polymotphism of tested region. 
Our findings may be indicate that among toxigenic C. pef?ingens strains of A 
type there are present some more widely spread and genetically stable 
strains. Localisation of some point mutations strongly suggest that, in several 
Intra-abdominal infections 
instances sharing staff and/or transfer of patients between health care 
institutions can create a significant risk for C. perjkngens dissemination. 
v/ Distribution of Clostridium perfingens in condensed 
water collections 
A. Tsiotsias, C. Voidarou, E. Bezirtzoglou 
Athens, Gr 
In order to fulw epidemiological investigations and trace the source of water 
contamination, C. yefiingens was used as a specific indicator in water 
collections coming from condensed steam in the Greek Company of 
Electricity. Determination of C. perjiringens numbers was done by using a 
new medium, lactose-sulphite (LS) broth, suggested for rapid enumeration 
and identification of C. petfn'ngens. Duplicate samples were collected at each 
one of the selected sites of the water collections. Membrane filtration 
equipment was used. All samples were alternatively passed through a 
membrane filter (porosity 0.45 pm) for retention of C. pefnfn'rigens. 
Membranes were placed into the first tube of 10-fold dilutions from 101 
to 104 and incubated aerobically in a waterbath at 460 C for 24 h. The 
numbers of C. pefingens fluctuated dependmg on the proximty of the 
sampling site to the areas of human activities or industrial activities at the 
Company. C. pe$iingens varied tiom 0 to 46.67% in samples at 101 and kom 
0 to 13.33% in samples at 102. Sporulated forms found varied &om 0 to 
26.67%. Vegetative forms were significantly more common in sampling 
stations situated by industrial or human activities, and sporulated were 
isolated mainly Gom sampling sites more distant from human contact zones. 
This last fact contribute as an argument to the detection of C. &ingens as 
fecal pollution indicator of remote origin. 
Spectrum of pathogens and resistance in peritonitis 
J. Focht 
Moers, D 
Severe mtra-abdominal infections are associated with a high mortality rate. In 
addition to risk factors in the patients, the casual pathogens and the selection of 
appropriate therapeutic procedures play an essential part in the course of these 
conditions. In the majority of intra-abdominal infections mixed aerobic/ 
anaerobic infections, mostly with some mvolvement of enterobactetia and aka 
of enterococci and staphylococci can be demonstrated. In addition to surgical 
intervention a calculated antimicrobial initial treatment of intra-abdominal 
mfections with an antibiotic with an adequate effect to combat the pathogen 
concerned can contribute to improving the patients prognosis. A calculated 
antibiotic treatment can only be effectively and reliably carried through if the 
kequency of the pathogen and the resistance situation are known. Retro- 
spective evaluation of the data on the sensitivity and kequency of pathogens 
from a defined goup of subjects allow conclusions on the epidemiological 
situation in a particular catchment area or in a medical sector and thus make it 
possible to calculate the appropriate therapy for infectionc. In the years 1996-98 
a total of 5126 bacterial isolates &om the intra-abdominal infection sector were 
examined: 1770 (34.5%) Enterobacteriaceae, 876 (17.1%) Gram-positive cocci 
and 2480 (48.4%) a e r e n t  anaerobic bacteria. The most kequently encounted 
species were Baaeroides spp. (B.fragilis and B. thetaiotaominon together accounted 
for 40.5% ofall isolates), E. coli (23.7%) and enterococci (7.9%). The antibiotics 
tested were piperaciWtazobactarn, mezlocdlin, ceftazidme, cefotaxime, 
ceftriaxone, imipenem and ciprofloxacin or (for anaerobes) cefoxitine, 
clindamycin and metronidazole. The idenscation of the Gram-negative 
strains was carried out by using 27 diflerent biochemical reactions. The MICs 
were determined by microdilutio? test according to DIN 58940 part 8 and part 
1 using an inoculum of 2 x 10' c f i ~ / m L .  Overall resistance to piperacillin/ 
tazobactam was 3.8% among Gram-negative strains, 10.5% among Gram- 
positive strains and 0.2% among anaerobic. In Gram-negative rods cefipime, 
ceftazidime and piperacillin/tazobactam were the most active drugs, ceftazidime 
and piperacddtazobactam were more active than all other antimicrobial tested 
against P. amginosa. In anaerobes piperacillin/tazobactam and imipenem 
showed the highest acuvity. 
v1 Spontaneous bacterial peritonitis and neutrocytic 
ascitis: clinical characteristics, pathogens and outcome 
E. Karabatsaki, E. Kalogeropoulou, E. Vagiakou-Voudri, D. Petropoulou- 
La&, P. Tsiodra, E. Malamou-La&, A. Efstratopoulos 
Athens, GR 
Objectives: To study the clinical and laboratory findings of patients 
diagnosed with spontaneous bacterial peritonitis (SBP) and neutrocytic 
ascitis (NA). 
Methods: Case records ofall patients diagnosed with SBP and NA in the last 
3 years, were reviewed. Of the 18 patients included in the study, 10 had 
more than 500 polymorphonuclears (PMNs)/-' in their ascitic fluid and 
a positive ascitic fluid culture (SBP, group A) and eight patients had more 
than 250 PMNs/mm' in their ascitic fluid and a negative fluid culture (NA, 
group B). The results of ascitic fluid cultures, blood cultures and urine 
cultures were analyzed. 
Results: Eleven of the patients were male and seven female, of a mean age of 
57.7 years (standard deviation 12.25 years). The cause of cirrhosis was 
alcohol abuse in 11 cases, viral in 6 and cardiac in one patient. Five of the 
patients in group B were asymptomatic. The predominant symptoms in the 
remaining seven patients were fever and abdominal pain. The pathogens 
isolated in the ascitic fluid cultures were: E .  coli 50%, Klebsiella pneumoniae 
20%, S.  aureus lo%, Strep. pneumoniae 10% and Listeria monorytogenes 10%. 
The isolated S. aureus was methicdlin resistant. The isolate of the ascitic fluid 
has been found in the blood cultures as well in two cases (E.  o l i  and Sfrep. 
pneumoniae). The urine cultures were positive in two cases. In the first case, 
the pathogen in the urine was the same as that in the ascitic fluid (Strep. 
pneumoniae) and in the other case, the isolates were different (Proteus mirabilis 
in the urine, Listeria monocyfogenes in the ascitic fluid). Three of the five 
patients that died, had SBP (mortality 27.8%). Sixty percent of the deceased 
had developed serious complications (2-hepatic encephalopathy, 1- 
hepatorenal syndrome). 
Conclusions: The majority (80%) of the pathogens isolated in patients 
with SBP were Gram negative and E .  coli in particular. Spon- 
taneous bacterial peritonitis IS a potentially lethal condition, with a 
30% mortality. 
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lp14581 Outcomes of empirical antibiotic therapy for hospitalized 
patients with community-acquired intra-abdominal infection 
P. Cattan, N. Kotman, D.  Houssin, J. Benichou, P. L. Fagniez, E. Sarfati, 
A. DesnC, D. Yin, R. Lyu, M. de Zelicourt, F. Fagnani 
Pans, Cdteil, Bobigny, F; Whitehouse Station, Piscatarvay, USA; Bourg La 
Reine, F 
Objectives: Parented antibiotics are often used empirically to treat 
hospitalized patients with intra-abdominal infections before pathogens are 
identified. The objectives of this study are to estimate healthcare resource 
use and to assess the relationship between outcome of empiric antibiotic 
treatment and resource use. 
Methods: Patients with community acquired intra-abdominal infections 
were retrospectively identified at four acute hospitals in France using ICDlO 
codes. Medical records were reviewed to confirm intra-abdominal infection 
and to collect data. All patients had surgical control of infection in addition 
to antimicrobial therapy. Patients with nosocomial infections were 
excluded. Enipiric therapy was defined as successful if the index infection 
was resolved without additional surgical intervention or parenteral 
antimicrobial therapy. 
Results: Three hundred and thutyeight of the 400 identified patients had 
con6rmed. community-acquired intra-abdominal infections without exclusion 
critena and 336 had complete data for analysis. Mean panent age was 
52.1 f 20.9 years; 42.1% were female. The most common types of intra- 
abdominal infecaons included bacteria peritonitis (11 = 139), intra-abdominal 
abscess (108) and appendiceal pe6oration and abscess (78). Pathogens were 
identified in 218 (65%) of the patients; most kequently identified pathogens 
included E.  coli (120 isolates), streptorocri (45), and obligate anaerobes (44, 
including 26 Baaemides jagilic isolates). On average 1.7 pathogens were 
identified per patient. The most fiequently used empirical antibiotic regimens 
were anioxich/clavulanate 1V alone (75 patients) or in combination (94, 
piperacillin/tazobactam alone (24) or in combination (57). A total of 16 
patients (4.8%) died due to infection, 11 (3.3%) patients required reoperation 
to control infections and 121 (35.8%) required a change ofempirical antibiotic. 
Patients with unsuccessful empiric antibiotic therapy (N=148, 44%) had 
significantly more antibiotic days (median 10 vs. 6 days, P < 0.0001 Wilcoxon 
test) and longer hospital length of stay (14 vs. 10 days, P < 0.0001 Wilcoxon 
test) compared to patients with successful empirical antibiotic therapy. These 
differences renlained statistically significant after adjusting for patient age, 
comorbid conditions, and other risk factors. 
Conclusion: Unsuccessful initial antibiotic treatment was associated with 
significantly more antibiotic days and longer length of stay. 
vl Treatment of complicated intra-abdominal infections 
with sequential ivlpo ciprofloxacin + metronidazole vs. 
ceftriaxone + metronidazole: a randomized trial of the IAl Study 
Group 
H. Wacha 
FrankJurt/Main, D 
Intra-abdominal infections result in substantial morbidity and costs. 
Antimicrobial therapy on average takes 8-10 days. The properties of 
ciprofloxacin allow an initial intravenous therapy followed by oral therapy. 
The objective of this prospective, randomized double-blind trial was to 
compare the eficacy and safety of sequential CIP (iv/po) +MET (ivlpo) 
vs. CEF (iv) + MET (iv/po). Patients with clinical signs of sepsis or diffuse 
peritonitis were included. Most frequent sources of infection were: 
appendix (33.1% of patients), biliary tract (20.4%), colon (19.6%), small 
bowel (10.9%). and stomach/duodenum (14.7%). After clinical response 
to initial intravenous treatment a switch to oral medication was intended at 
day 3 or later. Patients were evaluated at end of treatment (EOT) and after 
4-6 weeks follow-up (FU). The primary endpoint was clinical response at 
EOT for patients that could be switched from intravenous to oral therapy. 
A total of 531 patients were enrolled by 32 centers, 475 patients (235 
CIP +MET and 240 CEF + MET) were evaluable for efficacy analysis 
(mean Apache I1 score: 7.4), 327 had a bacteriologically documented 
infection. 78% of patients in the CIP +MET group and 81% in the 
CEF +MET group could be switched to oral treatment after 4.8 days on 
average. Total duration of treatment was 8.6 days for switched patients and 
8.1 days for intravenously treated patients. Clinical and bacteriological 
response rates of the CIP (iv/po) +MET (iv/po) and CEF (iv) + MET (iv/ 
PO) treatment groups were equivalent. In patients infected with 
enterococci the combination of CIP +MET was proven statistically 
superior with respect to clinical response ( P =  0041) and bacteriological 
eradication ( P =  0.03). In conclusion sequential therapy with iv/po 
CIP+MET is as effective as intravenouc therapy in patients with 
complicated intra-abdominal infections. Sequential therapy may reduce 
the incidence of complications associated with intravenous drug admin- 
istration and reduce treatment costs. 
Ip14601 Results of a prospective, randomized, triple-blind 
study of ettapenem vs. piperacillinltazobactam for complicated 
intra-abdominal infection 
J. Solo&, K. Choe, N. Chnstou, E. Dellinger, 0. Malafaia, 0. Rotstein, 
J. Tellado, A. Yellin, B. Deyi, V. Satishchandran, H. Teppler, Protocol 017 
Study Group 
Cindmati, USA; Montreal, C D N ;  Seattle, USA; Curitiba, BR; Torotito, 
CDN; Madrid, E; Los Aqeles ,  Blue Bell, USA 
Objective: ETP is a novel carbapenem with a half-life that allows once-a- 
day dosing, and activity suited for community acquired polymicrobial 
infection, including IAI. To examine its clinical efficacy in this setting, we 
performed a triple-blind, randomized, prospective trial companng ETP (1 g 
qd) with P/T (3.375 g q6 h) for complicated IAI requiring operative or 
percutaneous intervention. 
Methods: Patients (ps) were stratified at the time of enrolment by primary 
site of infection and APACHE II score. The primary analysis was performed 
on the microbiologically (micro) evaluable (eval) population. Additional 
analyzes were performed on the clinically eval and the microbiological 
modified intent-to-treat (MITT) population. Prior to unblinding the data, a 
formal peer review verified the adequacy of source control in ptc deemed 
failures or having additional procedures. 
Results: Table 1 provides the number of pts enrolled and outcomes (% 
success) in each tier of the analysis. For all 3 analyzes, the lower h i t s  of the 
95% CI about the difference were not less than -15.0% meeting the 
predefined criteria for equivalence (noninferiority) of ETP. The following 
demographic information refers to the micro eval population. Patients with 
a wide range of infections were enrolled, with perforated or abscessed 
appendicitis most common (about 60%). Overall about 40% of pts had 
abscess(es). The microbiology encountered included 83% of pts with 
facultative and aerobic Gram-negative rods, 68% with anaerobic Grain- 
negative rods, and 85% with polymicrobial infection. In total, there were 63 
failures: 1 death related to IAI, 23 recurrent or persistent IAI requiring 
reintervention, 22 wound infections, 10 undocumented IAI with additional 
antibiotic treatment, and 7 others. Safety was assessed in all pts who received 
at least one dose of study therapy. The most common drug related clinical 
and laboratory A E s  were: diarrhea, phlebitis/thrombophlebitis, increased 
ALT, AST, and alkaline phosphatase. These were seen at sirmlar rates in 
both treatment groups. Drug-related adverse experiences that were serious 
or that led to discontinuation were uncommon in both groups. 
AnalysisGroup N ETP N PIT Differmce(95Yo CJ) 
MrrT 264 81.% 259 77 0% 4.8 ( -23 , l l . g )  
ClinicalEval 230 16.8% 225 83.1% 3.7 (-3.2,107) 
UcroEval 203 86.7% 193 81.2% 5.5 (-2.2,13 1) 
Conclusions: This study clearly demonstrates the efficacy of ETP in the 
treatment of a range of IAIs. ETP was generally well tolerated ~fl this study. 
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Nosocomial infection (11) 
v1 The nosocomial infections in a teaching hospital 
internal medicine care unit 
0. Oncul, Y. Kucakardali, E. Goncuoglu, M. Danaci, S .  Cavuslu 
Isfaribul, TR 
Purpose: Nosoconual infections are important health problem in worldwide 
and one of the major causes of mortality, morbidity and high cost in 
hospitalized patients. In this study, the aim is to determine the nosoconllal 
infection incidence and the mortality rate in internal Medicine Care Unit of 
GATA Haydarpasa Teaching Hospital. 
Material and methods: The study is perfoimed between 1 March and 1 
September 2000 prospectively. Nosocomial infection was defined as one 
that was neither present, nor incubating at the time ofpatients admission but 
had its onset during hospitalization. 
Results: The nosocomial dection incidence rate was found 10.2% (27/265). 
Major underlying dxeases causing hospidmtion were cardm diseases (41%), 
malignity (33%). diabetes inellitus (3%) and chronic renal diseases (30%)). 
Percutaneous venous catheter (loo%), urine catheter (10oo/o)), insogastric hibe 
(40%) and haemodyalis (33%) were most comnion applications. The nosocomial 
ufections were uiinary tract infection7 44% (1 2/27), intravenous catheter 
iniections 7% (2/27) and bacteraemia 11% (3/27). A total of 47 culture specimens 
were taken fiom 27 patients and 34 culture positivity was found in 26 of them. 
The most conmion rmcro-organism identified &om culture were S. anrrns (41%) 
(14/34), Eiterobacf~ spp. (18%) (6/34) and P. amginosa (15%) (5134). Mortality 
ntes for our groups which constituted all patients and nosocomial infected 
patients were 17% (45/265) and 44% (12/27), respectively ( P  < 0.01). 
Conclusion: Our results pointed out that the nosocomial infections increase 
the mortality rates in intensive care units. So, infection surveillance and 
control programs are necessary to reduce the morbidity and mortality in 
intensive care units. 
plal Nosocomial meningitis in a teaching hospital in 
Turkey: evaluation of 33 cases 
N. Elaldi, M. Bakir, I. Dohetas, M. Goksel, 0. Karadag, M. Z .  Bakici, A. B h c  
Sivas, TR 
Objectives: To evaluate the clinical, laboratory findings, aetiological and 
therapeutic features of patients with nosocomial meningitis (NM). 
Methods: Patients developing NM in the Department of Neurosurgery at 
Cumhuriyet University Hospital between June 1998 and October 2000 
were included. The diagnosis of NM was made by using the Centers for 
Disease Control (CDC) cnteria. 
Results: In this 29 month follow-up period using the CDC criteria 33 
patients with N M  were diagnosed and followed by hospital infection control 
team. Ten (30%) of them fende were and 23 (70%) were nlale. Eight (24%) 
patients were paediatric ageing group (32 days to 16 years) and 25 (76%) were 
adults (17-68 years). Hydrocephalus (11 cases), tumoui-s (8 cases), cerebral 
haemorrhage (7 cases) and head injury (5 cases) were the most common 
underlying diseases. Craniotomy (1 5 cases), external ventricular drainage 
system (13 cases) and cerebrospinal fluid (CSF) leak (8 cases) were the most 
common associated factors of the patients. CSF Gram stain in 25 (76%) cases, 
CSF cultures in 30 (91%) patients were positive and identified 34 causative 
nucroorganisms. Coagulase-negative staphylococci (CNS) 19 (55.9%) and 
An'netobaner baumannii 6 (17.8%) were the most responsible microorganisnls, 
respectively. Seven (37%) strains of CNS were niethicillin-resistant. The 
patients were treated with reginlens including vancomycin, meropenem, 
cefepime and amikacin: 23 (70%) patients were recovered. Attributable 
mortality of N M  15% and overall momlity was 30%. 
Conclusion: CNS and A. baumannii is the commonest causing microorgan- 
isms of NM and in spite of new generation of antimicrobial agents it leads 
important mortality at our hospital. 
/p1463j Nosocomial meningitis - considerations concerning 
88 cases 
D. Mihalache, C. Corcaci, V. Luca, R. Scurtu, D. Leca, M. Hurmuzache, 
C. Luca, A. Teodor 
Iasi, RO 
Objectives: Clinical, bacteriological and therepeutical study of 88 cases of 
nosocomial meningitis. 
Methods: Retrospective study of 88 cases of nosocoinial meningitis 
admitted in the Clinic of Infectious Diseases Iasi between Jaii~Iary 1990 
and September 2000. 
Results: 2000 was the year with the most high incidence of nosoconual 
meningitis (21 cases), all of them occurring after neurosurgical treatment. 
From the total of 42 meningitis after neurosurgical interventions in 26 of 
them the first clinical sign was observed in first 10 days. For 4 patients 
meningitis occurred after rachianesthesia, in other 4 cases after ORL surgical 
act in the rest of 38 cases the cranial trauma being involved. Clinical signs 
were mild, represented by the persistence of fever or re-appearance after a 
period of afebrility (S5%), psychiatrical disorders (26%)). convulsions 
(20.4%) and neck stiffness in all cases. Microorganisms were isolated 111 
CSF cultures in 20 cases: Staphylococci (8 cases), Gram-negative bacteria (8 
cases), gram-negative bacteria + anaerobic (2 cases), nontypable strepto- 
coccus (1 case). The most active antibiotics according to the antihiograma 
were represented by the thrd cephalosporines generation m d  by the 
systemic fluoroquinolones. The global mortality was 4.54%. 
Conclusions: Diagnosis and therapy of nosoconual meningitis always cause 
ditticulties in the clinical evolution of the surveyed patients. 
1 p1464/ Aeromonas meningitis from medicinal leech therapy 
J. Ouderkrk, G. Turett, D. Bekhor, J. Kislak 
N e w  York, USA 
Recently, therapy with leeches has been used more frequently to decrease 
venous congestion with replantation or flap surgery. AerOMiorias species, 
especially A .  hydropophila, are normal components of leech flora and aid their 
digestion. Up to 20% of patienn undergoing leech therapy will have their 
course complicated by gram negative infection, especially with Aeroriioizas. 
Mild wound infection is the most common presentation; niyonecrosts, 
bacteraemia, and sepsis occur less frequently. Prophylactic antibiotics are 
recommended for patients with leech treatment. Aeronrorins meningitis is a 
rare entity. Only 5 adult cases of Aeromonar meningitis have been described, 
none related to leeches. A 40-year-old male had a right temporal glonius 
tumour removed. The lesion was described as a 'large tuniour arising from 
petrous bone extending into the cerebellopontine angle'. The patient 
initially underwent am angiograni and enibolization with good reduction in 
vascularity. This was followed by tunionr resection and construction of a 
flap. A dural defect leaking CSF was noted during the operation and was 
sealed. Leech therapy was begun 2 days after surgery, without prophylactic 
antibiotics, to salvage a then-congested graft. Three days later, serous fluid 
was noted to be leaking kom the wound requiring insertion of a CSF drain. 
The same day, the patient had a change in his  mental status, meningeal signs, 
and fevers to 40°C despite steroids. A lumbar puncture showed cloudy, 
yellow fluid with 1728 leukocytes (100% neutrophils), 150 erythrocytes, 
1394 protein, and 35 glucose. Gram stain revealed leukocytes with no 
organisms. Cultures of CSF and the wound grew many A.  sobria. Blood 
cultures failed to reveal Aeromonas sp. Leech body fluid yielded both A. 
hydrophila and A. sobria. The patient was treated with ceftriaxone and 
tobramycin for a total of 21 days with rapid normalization of CSF and good, 
albeit gradual, clinical response. He was later discharged to home in good 
condition. Meningitis secondary to Aeromonas has been described previously 
in only 5 adult patients. Ths is the first case of Aeromorias meningitis as a 
complication of leech therapy. Leeches have an expanding role in plastic 
surgery, but this case emphasizes the importance of prophylactic antibiotics 
to avoid potential associated infectious complications. 
v] Nosocomial meningitis - clinical study January 1990 
to September 2000 
D. Mihalache, V. Luca, C.  Corcaci, R. Scurtu 
Iasi, RO 
Objectives: Clinical, bacteriological and therepeutical study of 88 cases of 
nosocomial meningitis. 
Methods: Retrospective study of 88 cases of nosoconual meningitis 
admitted in the Clinic of Infectious Diseases Iasi between January 1990 
and September 2000. 
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Results: 2U00 was a year with the most h g h  incidence of nosoconrial 
meningitis (21 cases), all of thein occumng after neurosurgical treatment. 
From the total of 42 meningitis after neurosurgical interventions in 26 of 
them the first clinical sign was observed in first 10 days. For 4 patientc 
meningitis occurred after rachianestheTia, in other 4 cases after ORL snrgical 
act in the rest of 38 casec the cranial trauma being involved. Clinical signs 
were n d d  represented by the persistence of fever or re-appearance after a 
period of afehrility (85X), psychiatncd disorders (2h%), convulsions 
(20.45%) and neck ctiffiiess in all cases. Microorganisms were isolated in 
CSF cultures in 20 cases: Stapliylomcci (8 cases), Gran-negntive bacteria (8 
casec), gram-negative bacteria + anaerob (2 cases), nontypable streptococcus 
(1 case). The most active antibiotics according to the antibiograma were 
represented by the third cephalosporines generation and by the rystenric 
fluoroquinolonec. The global niortality was 4.54%. 
Conclusions: Diagnosis and therapy of nosoconiial meningitis always cause 
difficulties in the clinical evolution of the surveyed patients. 
Results: The strains tested were represented by two clones named A and B. 
Clone A contained 19 Eiiterobaeter doarae isolates from 17 patients, and clone 
€3 10 isolates from 8 patients. The remaining 7 strains were not related to 
clonal strains and differed from each other. The strains of clone A and B 
were responsible for UTI in 25 patients hospitalized during 1994-98. We 
confimied gastrointestinal tract colonisation of patients before UTI. 
Conclusions: I'atients after renal transplantation are at a higher nsk of U T I .  
Their gastrointestinal tract is often colonised by the multidrug-resistant 
strains of Gram-negative rods selected by uncontrolled broad-spectrum 
antibiotic therapy or prophylams. Immunosuppressed patients become 
chronic carriers of these strains, which can cause UTI. E~tembartrv cloacae is a 
stable gastrointestinal conmiensal, which has been responsible for UTI in 
renal transplant patients for several years. I t  h a  been necessary to perfomi 
environmental study to search for Enrerobatrer cloacae strains as endemic 
nllcroflora in DT. Differences between Eureroohacter cbiacae isolates can only 
be revealed on  a genoniic level by using genetic typing methods. 
vl Aetiological spectrum and antimicrobial 
susceptibility in hospital urinary tract infection 
Nosocomial urinary tract infections: aetiology and 
susceptibility patterns over a 3-year period 
M. Gaya, J. de Otero. L. Ferrer, S. PareJo, S.  Elia, F. Ferrer-Riiscalleda 
Barcrloiia, E R. Paberza. A. Zilevica 
Riw, LET 
Objectives: (1) T o  establish the aetiology of hospital acquired urinary tract 
infectiom. (2) To  find out the freyuency and antimicrobial susceptlbihty of 
uiinary pathogene. (3) T o  an.ilyce changes of antinricrobial susceptibility 
over 3 years. 
Methods: Bet%veen March 1997 and February 2000 all unne isolates from all 
hoepitalized patients in Hospital Creu Roja were collected. In each patient, 
pretence of unnary tract obstruction, bacteraeiilla, other underlying diseases 
and relation to indwelling catheter5 were analysed. Antiuucrobial suscept- 
ibility patteins (dirk hiiusioii method, according to NCCL standards) were 
compared along different periods of time. 
Results: 963 urine icolates were analysed. 274 (28.5%) were hospital 
acquired infections (93 in 1997, 89 in 1998, 72 in  1999 and 20 in 2000). 
Mean age of patients was 78 (31-98) years and 68,6'% were men. The 
predonlinant species \vae E. mli reprecenting 150 (54.7%) of the isolates, 
followed by Klcbsiella spp. (10.9%), Psetidoi~ir~r~ns neru<giirosn (9.9%). Profeus 
spp. (9,5'%1) and E. jaeculis (7.3'%). Frequencies were cimilar over the study 
periods. We identify the cusceptibility rate to arnoxicillin-clavulanate, 
ciprofloxacin, norfloxacin, 2nd and 3rd generation cephalocporins, 
piperacillin and aztreonam. We observed a progressive increase of 
susceptibility of E. nili for amoxicillin-clavulanate from 44% in 1997 to 
100% in 2000. The rate of resictance of enterobacteria against quinolonec 
was increating from 37 to 50% in 1997 to 58-66's in 2000. Surprisingly, we 
observed an increase of susceptibility of Pseudornorias nerugirrosa to quinolones 
from 75% in 1997 to 100% in 2000. There were no differences of 
susceptibility bemeen ciprofloxacin and nodoxacin. 
Conclusions: The nioct conmion pathogen among isolatec from urine 
cultures in our Hospital was Escherrrliia ciili. Overuse of quinolones in 
nosoconiial infections could explain the global increase of resistance in 
hospitd acquired urinaiy tract infections in turn of the increase of 
antimicrobial susceptibility to beta-lactamz. The spread of a donllnaiit 
ciprofloxacin-censitive strains of Psrimdoiiiorius aerirgiricm in our hospital could 
cxplaiii the increasing susceptibility to quinolones observed. 
Objectives: To establish the aetiology of acute lower uriiiary t r x t  infectiom 
(UTI) in hospital and the antimicrobial susceptibility of l\olated urinary 
pathogens. 
Methods: All bacterial isolates from urine cultures were collected from 
departments of two hospitals in  Riga in the period from January to October, 
2000. Cultures of urine samples were perfomied by conventional methods. 
Isolates were identified to the species level using the Sceptor and Crystal 
systems. Antimicrobial susceptibility tects to niore than 20 antibiotics were 
perfomied using the Ask diffusion method (BBL) and interpreted accordmg 
to NCCL standards and the E-tect (AU Uiodisk). The cefinase test was uced 
for detection of beta lactamate activity. 
Results: 147 isolates from urine cultures were analysed. There were 3 
group' of causative agents: (1) Granl-positive cocci-52, from them the S. 
epidermidis group-14, S. sapr~ipliyticiis-1. E.  . / k1 lL-26 ,  E.  .jaecium-'l, 
E.achn-I, S. pyqcries-1; (2) Gram-negative rods-79, 1.e. the fanllly 
eriterobactcriarrae: E .  ciili-42, Klebsiella yrreumoriiac-6, K. ii.uytocc-2, Ghibarter 
fieuiidii-5, Serratia niarcesceiis-3, Proreus i/ulpris-2, Providenda vertferi-1, 
Ewiu~ella anien'carla-1; (3)  Gram-negative noiifennenters-16. from them 
17. neruginzosa-1 1, I? putida-3, Xa~i thorno~rn~  i talfophilc-I, Shrrrmclla 
purrificaris-1. The susceptibility of isolated ctrains to antibiotics wac a$ 
follow-s: 50 strains (38.9%) were polyresistant, from them 12 strains were 
gram-positive cocci, 38-Gram-negative rods. Polyresistance was mainly 
registered in the genus Euterococcus and P~eudoirtotios. The antinlicrobial 
cusceptibility of 97 strains varied widely aniong hospitals and departments. 
N o  resistance in Staphylococci to vanconiycin was registered. 
Conclusions: In hospitalized patients, the predominant cultwe agent of 
hospital UTI was Escherirlua coli, followed by Euteiocoiciu and coagulase 
negative Staphylococci other than Sr~phyloi~icctts sapiqh yticus. Polyresistancc 
anioiig causative agents of UTI was increased in comparison with that in  the 
previous years. 
vl Evolution of nosocomial bacteraemia in a new hospital 
K Cid, E. Maun, M Sierra, A Vild, L Ortega, J. Martinez 
Baneloria, E 
1p1467I Nosocomial Fnterobacter cloacae urinary tract 
infections in dialysis and transplantation units 
W .  Kaniinska, D. Dzierzanowska 
W a r s a w ,  PL 
Background: Urinary tract infections (UTI) are the most conunon 
infections 111 patientc following renal trausplantation in our Dialysis and 
Transplantation Units (DT). The patients who were given cephalosporin 
antibiotics in the past as a prophylactic in the preoperative period, 
developed infectionc caused by antibiotic-resistant microorganisnic. The 
most coninion pathogen was multidrug-resistant Enferi~barter tioncar. The 
purpose of this study w-as 1: to investigate the persistence of niultidrug- 
resistant Eiitembacfrr rloocnr strains in uriiie and stool of renal transplant 
patients in our DT, 2:  to establith if these strains were clonal, and 3: to 
evaluate gastrointestinal tract colonization prior to UTI. 
Methods: For genetic typing the following methods were used: (1) PCR- 
baced random amplification of polymorphic DNA (KAPD). (2) Pulsed-field 
gel electrophoresis (PFGE). 
Objective: The clinical, epidemiological and nucrobiological characteristics 
of nosoconrial bacteraemia (Nu) in a 321) beds general hospital whose 
activity started in 1990 were studied. Comparisonc were made between the 
periods of 1990-91 and 1998-99. 
Methods: AU the episodes previously registered as NB(103) in adult patients 
(older than 15) during these periods were mcluded, and the clinical cham revised. 
Results: In the firct period 30 incidence of 1 , 7 / 1 0 0 0  adniiccions wac found 
since 33 NB (20 male) were detected. The median age was 64 and the 
median of admission days previously to NU was 16.  The focus of NB was 
abdonlinal in 10,  intravenous catheter in 9 ,  unnary in 7.  infection of surgical 
wound in 1 and unknown in 6 patients. The tnicroorganisms isolated were 
8 E. coli, 1 S.  rnarcescem, 3 S. euteritidis, 1 E. cloacae, 1 P. aeru~qiriosn, 7 S. 
auieiis, 3 S.  epiderntidis, 3 S.  niitis and 2 E.-jaeculis, 3 Bacteruides spp. and 1 C. 
albicaits. Using the McCabe classification for underlying diseases, 19 patients 
were McCabel, 8 McCabe2 and 5 McCabe3. 22 patients had undertaken 
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previous surgery and 21 had received antibiotics therapy. The deaths related 
to the NB were 3. In the second period an incidence of 1.7/1000 
adniissions was found since 70 NB (44 male) were detected. 8 were 
polyniicrobial. The median age was 66 and the median of admission days 
previously to NB was 16. The focus of NB was abdominal in 10, 
intravenous catheter in 25, urinary in 12, infection of surgical wound in 2, 
other focus in 7 and unknown in 14 patients. The nlicroorganisms isolated 
were 15 E. coli, 2 C. d i m ,  2 E. cloacae, 2 Klebsiella sp.,l Proferrs sp., 2 S. 
nrnrrescerrs, 1 S. Ptiteriticiis, 6 P. aevtrgiiiosa, 1 A. baurnaiiii, 1 Aevomona sp., 2 H. 
in fhwrae ,  12 S. aureus (1 SAKM), 12 S.  epidermidir, 2 Streptomrcus cp. and 2 
Eritevociicrus sp., 3 Bmferoides spp., 1 Closfridiurn sp. and 2 C. dhicam. There 
were 27 patients McCabel , 19 McCabe2 and 24 McCabe3. 38 patients had 
undertaken previous surgery and 33 had received antibiotics therapy. The 
deaths related to the NB were 7. 
Conclusions: The incidence of nosoconual bacteraemia has not been 
modified despite the increace in number of admissions. There are more 
patientc with underlying rapidly fatal disease. The increase of infection due 
to a high-risk microorgmisin is outstanding. Nonetheless related mortality 
has not men. 
ml Nosocomial infections in Pamukkale University 
Hospital, Turkey 
C. U. Cetin, A. N.  Yalcin, H. Turbvt, M. Zencir 
Deiiizli, TR 
Objective: Determination of the nosocomial infections and the antmiicro- 
bial susceptibility rate in our hocpital within years. 
Method: Adults patients which were hospitalized between April 1997- 
October 2000 were examined for nosoconllal infections by clinical visits and 
6om the records of microbiological laboratory. 
Result: 524 nosocomial infections were detennined in 367 adult patients 
which were hospitalized between April 1997-October 2000. Highest rates 
of hospital infections were observed in intensive care unit, internal medicine 
and general surgery. The most common infection site was lower respiratory 
tract and Pseudoniorias cpp. (26.9%), Atirietobacler spp. (14.3%), S .  aureus 
(14.3%) and Hcbsiella qpp. (9.5%) were determined as the most coiniiion 
isolated microorganisms. The resistance to the antimicrobial agents had been 
increased within years and imipenem and ciprofloxacin were shown as the 
most effective drugs for the gram-negative bacdli infections. 
Conclusion: Nosocomial infections and antimicrobial resistant pathogens 
are a major problem in our hospital. In order to control the emergence 
and spread of these recistant pathogens, effective preventive measures 
have to be applied. 
rP1-1 Nosocomial infections in the medical department of a 
tertiary hospital 
E. Karabatsaki, E. Kalogeropoulou, C. Kakari-Tsiropina, G. Ganteris, A. 
Strouza-Koutsougera, D. Petropoulou-Milona, P. Tsiodra, E. Malaniou- 
Lada, A. Efstratopoulos 
Atlzeiis, CR 
Objective: To study nosocomial infections and their frequency, in patients 
admitted in a general rnedcal department of a tertiary hospltal and to 
determine the conmonest isolated pathogens. 
Methods: This has been a retrospective study of 3095 cases, in the last 3 
years. The diagnosis of infection, afrer the first 72 h, was based on the 
clinical manifestations, with the contribution of haematologcal, micro- 
biologic and medical imaging findings. All results of blood, urine and 
bronchial secretions cultures were evaluated and analysed. 
Results: A nosoconiial infection was observed in 324 patients (10.5%), 147 
men (45.4%) and 177 women (54.6%) of a nieaii age of71.7 years [standard 
deviation (SD) 14 years]. Nosocomial respiratory tract infection has been 
developed in 25.3% of the patients, 41 niale and 41 female of a mean age of 
75.2 years (SD 16.7 years). The commonest pathogens isolated in the first 7 
days after admission, were: Haemophilus spp. 28.6%, Strep. yneurnoniae 
23.8%, KIebsiella spp. 23.8%, Aririetobarter baurnanii 9.7% Pseudomonas 
aercrgiriosa 9.5% and S. aurerrs 4.76%. A nosoconiial urinary tract infection 
was observed in 161 patientc (49.7%). 63 men and 98 women of a mean age 
of 72.9 years (SD 10.9 years). The most frequently observed pathogens, 
were: E. roli 38%, Pseudomonos aeyqinosa 20.5%, Klebsiella spp. 14.3% and 
Proteus mirabilix 10.7%. A nosocomial bacteraemia was found in 24.1% of the 
patients, 42 men and 36 women of a mean age of 69 years (SD 14 years), 
with the conlmonest pathogens being: S. aureus 24.3'%, E. roli 19.2%, Stqdr.  
coagulase (-) 14.196, Pseud. aeruginma 10.25% KIchsiella spp. 10.25% and 
Pvoteus spp. 9%. 
Conclusions: (1) One tenth of the patients adnlltted in a general medical 
department of a tertiary hospital, develops a nosocomial infection and, in 
particular, a urinary tract infection, in half of the cases. (2) The mortality of 
the patients with a nosocornial infection is 9.8%. The iiiost serious is 
bacteraemia, with 21.8% mortality and respiratory tract infections follow 
with 12% mortality. (3) Gram negative bacteria consist 79% of the isolated 
microbial strainc. 
1 Risk factors for acquisition of nosocomial infections: 
a prospective cohort study in a Turkish university hospital 
Y. Babiir, Y. Cetinkaya, M. Hayran, I .  Sayek, S. Unal 
Ankara, TR 
Objective: To evaluate risk factors for acquisition of nosoconiial infections 
in the Department of General Surgery in Hacettepe University Hospital. 
Setting: Three wards and intensive care unit of the Department of General 
Surgery. 
Methods: The study was conducted between 20 October 1997 and 19 August 
1998. The sample size was calculated as 1028. All patients hospitalized in the 
study units were followed daily by the researcher until the sample size was 
reached. Data were collected 6om medical recordc and nursing records 
Diagnoses of nosocomial infections were made by the same consultant 
physician from the Section of Infectious Diseases (ID) by using the Centers for 
Disease Control and Prevention (CDC) criteria. The researcher consulted all 
the patients with the ID doctor three times a week. Patients included in the 
study were followed untd discharge or death. Chi-square test and logistic 
regression analysis were performed for statistical analysis. 
Results: The incidence of nosoconiial infections was calculated as 1 1.8%. 
The most common nosocomial infection was surgical site infection (6.4%). 
Median duration of hospitalization was eight days (nlin-max: 1-1 43). 
Logistic regression analysis revealed two different models which were 
presented in Table 1. 
O,O.l,7 
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Discussion: Duration of hospitalization and admission to an intensive care 
unit are well-known risk factors for nosocoinid infections. Logistic 
regression analysis revealed the presence of a central venous catheter or a 
chest tube as an independent risk factor for nosocomial infections. Each of 
these interventions was found to be associated with an at least two fold 
increase in the risk of nosocomial infection. This might be related to breaks 
in infection control measures during insertion or daily care. Reconiinenda- 
tions were made to shorten the duration of hospitalization and importance 
of infection control practices was emphasized. 
lp1473( Aortic bypass graft infection due to Aspetyillus flaws 
M. Marroni, P. Cao, A. Repetto, L. Prattichizzo, G. De Socio. M. Fiorio 
Percrgia, I 
Fungal infections of intravascular grafts are rare, and to our knowledge, only 
11 cases of Aspergillus infections have been reported 6oni 1981 to the 
present. In March 2000 a 64-year-old man was admitted to our hospital 
because of unendurable pain in the abdomen and lower hack. Three year 
earlier, he underwent aortobi-iliac Dacron bypays graft for an asymptomatic 
abdominal aortic aneurysm at a different Institution. Six months after 
surgery the patient experienced mild abdominal pain. Physical examination 
was unremarkable but the erythrocyte sedimentation rate was 98 mm/h. 
Eight sets of blood culture were all negative. Abdonlinal computed 
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tomographic scan, magnetic resonance imagmg and arteriograms visualized 
a patent aortic graft with an aortoprostetic false aneurysm associated with a 
partial thrombosis of both renal and external iliac arteries. The patient was 
taken to the operating room under antibiotic therapy with teicoplanin and 
inupenem/cilastatin without evidence of systemic infection. At surgical 
exploration, a poorly incorporated aortic graft, with partial anastomotic 
disruption and no perigraft fluid was found. Given no clear evidence of 
prosthetic infection and involvement of the iuxtarenal aortic tract by the 
pseudo aneurysm, removal of the old graft and in situ reconstmction with an 
aortoiliac Dacron graft was performed. Culture of the removed graft and 
thrombohc material revealed Aspergillus.pavLis. Immediately after surgery the 
patient had irreversible renal failure and underwent haeniodyalisis. Despite 
amphotericin B lipid complex (ABLC, Abelcet) treatment (150 mg/day, 
total dose of- 1500 mg), the patient experienced septic shock with multiple 
organ failure and died 10 kiys after surgery. This case, in line with previous 
reports illuctrates that Asperfillus Javus may cause severe vascular graft 
infection. Optimal treatment of graft infections due to Aspergillus seems 
related to removal of infected prosthetic material and placement of a new 
prosthesis in a noninfected field. Amphotencin B, if associated with this 
surgical approach, appears to be effective. 
Study of relationship between duration of operation 
in cesarean section (ds) with wound infection incidence 
S.  Rabiee, M. Zamani 
Haiiradair, IR 
Cesarean wction (c/s) is a life-saving operation for fetus and mother. 
Wound infection in c/s is a common complication of operation. The 
duration of operation (DO) may be is an important factor in producing 
wound infection. This case-control study evaluated the relationship 
between the duration of operation and the incidence of wound infection 
in the patients admitted to Fatemieh Hospital in Hamadan, Iran, in 1997. 
In this study wound infection regarded as existing fever, erythema, 
tenderness, and purulent discharge. A total of 200 c/s with duration of 
operation longer than 1 hour compared with 200 cases of c/s shorter 
than 1 hour in relation to wound infection. A total of 1200 c / s  were 
studied and wound infection were found in 72 cases (5.7%). From 400 
cases eligible for this study, 200 cases with DO longer than 1 hour had a 
total of 14 cases (56%) infection. In contrast, 200 cases with D O  shorter 
than I hour indicated only 11 cases (44%) wound infection. The 
incidence of wound infection was not significantly different between 
two groups. In conclusion, the duration of operation has not an 
important role on the wound infection incidence in this teaching 
C. difficile 
hospital. In spite of difference between two groups without statistically 
significance, may be other factors has more influence in producing 
wound infection in cesarean sections. 
lp1475/ Stenotrophomonas maltophilia: an emerging 
nosocomial pathogen in a children's hospital in Turkey 
A. Kara, G. Kanra, G. SeCmeer, M. Ceyhan, B. Kanra, A. B. Cengiz, D 
Cur 
Ankara, TR 
Objective: Stenotrophornorias maltophilia is an aerobic Gram-negative bacillus 
that is being isolated from clinical specimens with increasing frequency. The 
prevalence of infections caused by S.  maliophifia, the contribution of 
underlying disease conditions toward isolation of S. maltophilia, and 
influence of antibiotic exposure resulting in S. wzahphilia infection are 
largely unclear. The purpose of this study was analyse the epidemiology, 
clinical characteristics and outcome of S. nraltopphilia iufection in a tertiary 
children hospital. 
Methods: The study was a prospective follow up of patients in Hacettepe 
University Ihsan Dogramaci Children's Hospital (a 240-bed hospital with 
one paediatric and one neonatal intensive care unit). S. maltophilia isolation 
from any clinical specimens between January 1999 to June 2000. 
Subsequent isolates from the same patient were not included in the analysis. 
Patient characteristics reviewed include age. sex, overall duration of stay in 
the ICU, underlying illness, immunosuppression, neutropenia, steroid use, 
recent surgery, duration of mechanical ventilation. Assessment was made at 
the time of the first positive culture. 
Results: Over a 1 8-month period there were 23 patients with S.  maltophilia 
isolation. Most isolates from blood culture (In), 9 were from the respiratory 
tract and were part ofpolymicrobial culture in 3 of them, and one from urine 
specimen. Three of the panents were newborn at neonatal ICU, and mean 
age of the others were 6.5 years. Three patients had been immunosuppres- 
sion, one waF AIDS, four patients had been neutropenic. Three patients had 
cystic fibrosis. One had been intra-abdominal operation, and the other three 
were on steroid treatment. 12 of them had received mechanical respiratory 
support (mean 5 days). All the patients were hospitalised more than 10 days 
and also all had antibiotic treatment. 21 out of 23 had received imipenem or 
meropenem previously. Six of the patients died. 
Conclusion: S .  rnaltophih is emergmg as an important cause of nosocomial 
infection with high monality even in paediatric patients. Underlying 
disease, immunosuppression, mechanical ventilation and especially previous 
broad spectrum antibiotic therapy seems to be nsk factors. Trimethoprim- 
sulfamethoxazole remains the drug of choice. 
v/ Evaluation of diagnostic methods for the detection 
of Clostridium difficileassociated diarrhoea 
C. NonhofT, M. Nesterenko, M. J. Struelens 
BrusseL, B 
Objectives: To compare the accuracy of several methods for the diagnosis of 
CDAD: sequential ethanol shock-taurocholate treatment for selective C. 
d@rile stool cultures and C. difficile toxin immunoassays (Toxin A test- 
Oxoid, CdToxA OIA-BioStar, ImmunoCardToxinA and PrimerToxins A 
& B-Meridian Diagnomcs) as compared with ceU culture cytotoxin assay. 
Results: Over a 3-month period, stools &om 226 hospitalized adult patients 
were analysed. Based on chnical data and detection of ctool cytotoxin and/or 
positive culture, 17 (8%) patients had confirmed C. d@ile-associated 
diarrhoea (CDAD) and 5 (2%) had probable CDAD. Ethanol + taurocholate 
treatment increased twofold the yield of C. d$de  isolation from 11 
(sensitivity: 50%) to 22 cases (sensitivity: 100%) (P  < 0.025). The specificity 
ofthis culture method was only 70% (137/197) for all C. difficile isolates but 
99% (1 95/196) for toxigenic C. d@ik isolates. Detection of toxin($ in stool 
by inimunozsays showed 62-71% sensitivity vs. 45% for cell culture assay. 
There was > 95% concordance for toxin detection in C. dflci le  isolates by 
immunoassays, cell culture assay and PCR for toxin A and B genes. 
Conclusions: Ethanol + taurocholate treatment of stool increased significantly 
the sensitivity of C. dificile selective culture. Isolates must be tested for toxin 
gene/production if no cytotoxin is detected in stool. Immunoassays and 
cytotoxln assay gave comparable results for direct toxin detection. 
v/ Prevalence and genetic characterization of toxin A- 
negative, toxin &positive Clostridium difficile strains among 
adults and children with diarrhoea in France 
F. Barbut, V. Lalande, B. Burghoffer, N. Hidn, H. Vu Thien, E. Grimprel, 
J.-C. Petit 
Pans, F 
Objectives: Clostvidium d @ d e  is responsible for 1 &25% of antibiotic- 
associated diarrhoea and for virtually all cases of pseudo-membranous colitis. 
Toxigenic strains usually produce two toxins (A and B) which are involved 
in the pathogenicity of this organism. Recently, toxin A-negative toxin B- 
positive strains (referred as A-B +strains) have been described in 
asymptomatic children in France and in symptomatic adults in Japan and 
USA. These strains lack parrs of the repeating sequences of the toxin A 
gene. However little is known regarding their clinical significance, 
prevalence and genetic backgrounds. Here, we report the prevalence of 
A-B +strains determined by PCR that amplifies the repeating segment of 
toxin A in patients with C. d @ d e  associated diarrhoea in France. 
Methods: 324 C. dificile strains &om 293 adults with antibiotic-associated 
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diarrhoea and 43 strains from chddren with marrhoea were isolated on a 
selective media (TCCA). All these strains were toxin B-positive by cell 
culture assay on MRC-5 cells. The repeating segment of toxin A gene 
(1200 bp) was amplified by PCR using the primers NK9 and NKl1 (Kato 
H., JCM 1908, 36, 2178-82). Strains with amplified fragments of 
unexpected size were serotyped according to Delmhe’s method and 
genetically characterized by pulsed-field gel electrophoresis (PFGE) and 
PCR-ribotyping. Tomn A was detected by an enzyme-linked i tmuno- 
sorbent assay (Triage, Biosite, USA) 
Results: A deletion of 500 bp was observed in 6 strains (5 patients). All these 
strains belonged to the serogroup F and they were characterized by the same 
pulsotype and the same PCR-ribotype. These strains were negative for 
toxin A by ELISA. One strain (serotype H) has a longer amplified fragment 
(1400 pb) and was positive for toxin A by ELISA. No fragment was 
amplified in strams from 3 patients. Two strains out of 3 were toxin A- 
negative by ELISA. The last 4 strains exhibited different PFGE and PCR- 
ribotyping patterns. 
Conclusion: Toxin A-negative toxin B-positive strains identified by PCR 
account for 2.7% in adults with C. dijicile antibiotic-associated diarrhoea 
and for 2.3% in children with diarrhoea. Diagnosis of C. dI@& diarrhoea 
would have been nlissed in 7 patients (2.1%) by laboratones screening the 
stools only for the presence of toxin A. 
v1 Detection of toxigenic Clostridium difficile and its 
toxins in stool samples of patients with diarrhoea 
S. Wongwanich, P. Sawanpanyalert 
Nutithabun’, T 
Objectives: To determine the prevalence of Clostridiirrw dificile strains with 
toxin A and toxin B genes positive; and its toxins in stool samples collected 
&om adult patients with suspected antibiotic-associated and nonantibiotic 
associated diarrhoea. 
Methods: Stool samples from 151 patients with suspected antibiotic- 
associated and nonantibiotic associated diarrhoea were examined for C. 
&fici/e by Cycloserine Cefoxitin Fructose Agar culture. The presence of C. 
d@cile toxin A and toxm B genes was determined by specific PCR method. 
All stool samples were subsequently examined for the presence of toxin A 
and B by commercially available EIA (Premier Cytoclone A + B, Meridian 
Diagnostics, Inc.). 
Results: The C. d@rik strains were found in 34 (22.5%) patients. Of these, 
only 20(13.25%) strains were toxin A and toxin B genes positive by PCR. 
C. dijicile toxin A + B was detected in 28 (18.54%) patients. 
Conclusions: The frequency of detection suggests a higher prevalence for C. 
d @ d e  toxins than tomgenic C. d@de isolates. 
Detection of toxin production in Clostridium difficile 
strains by three different methods 
M. Yiicesoy, J. McCoubrey, R. Brown, I. R. Poxton 
Izmir, TR; Edinbugh, UK 
It is important to be able to detect the production of toxins in isolates of C. 
d@de to help in the diagnosis of C. dificile associated diarrhoea. In h s  
study, toxin production was investigated in 42 C. d@cile strains of various 
serotype, ribotype and S-protein type. These included strains from our 
laboratory collection, strains freshly isolated &om stool specimens of patients 
suspected of suffering from C. d@cile-associated disease, and one NCTC 
strain (NCTC 11223). Toxin was assayed by (i) a rapid slide immunoassay 
(C. diflcile toxin A test, Oxoid) (ii) an enzyme-linked microplate 
immunoassay (C. d@le toxin A/B-test, Techlab) and (iii) a tissue culture 
assay. The rapid slide assay and the enzyme inununoassay were performed 
according to the manufacturers’ recommendations. The tissue culture assay 
was done using Vera cells. Thirty of the 42 strains (71%) were shown to be 
positive for toxin A by the slide immunoassay and 34 of the strains (81%) 
were found to be toxin A/B producing by the enzyme immunoassay. The 
same 34 strains that were positive in the enzyme immunoassay also 
produced toxin B (cytotoxin) in the tissue culture assay. The sensitivity, 
specificity, positive and negative predictive values for the rapid slide 
immunoassay method were calculated to be 88.2%, 100.0%, 100.0%, 66.7%, 
respectively, when compared to tissue culture assay results as the reference 
method. These values for the enzyme immunoassay method were all 
100.0%. In this study 8 strains were found to be nontoxin producing by all 
methods. It is possible that there were 4 strains that only produced toxin B 
(A-B+), and were missed by the rapid A-only assay. As a result we can 
recommend the use of the enzyme immunoassay for the detection of toxin 
production of C. d @ d e  strains because of its high sensitivity, specificity, its 
easy use and its capability of detecting both A and B type toxins. 
(p14801 Comparison of a novel phenotyping method for 
Clostridium difficile with PCR ribotyping 
J. McCoubrey, J. S. Brazier, I. R. Poxton 
Ediribuyh, Cordifi UK 
Clo&dium d@& expresses two major cell surface proteins, known as surface- 
layer (S-layer) proteins. The molecular weight of these proteins has been 
shown to be highly variable between strains, thus having the potential as a 
useful marker for phenotyping. To date 11 C. d@cik isolatec collected &om 
patients in a geriatric unit were phenotyped on the basis of the molecular 
weights of the two S-layer proteins and their ability to produce toxin i r i  r h o .  
The S-proteins were extracted by treatment with guanidine hydrochloride 
and the extracted proteins were visualized on SDS-PAGE. The protein 
protiles were analysed using Phoretix 1-D software. Toxins A and B were 
detected in brain-heart-infusion broth cultures by ELISA. The S-layer 
method revealed seven Merent types. When the isolates were subsequently 
ribotyped, seven different ribotypes were identified. However, comparison of 
these two typing methods showed that within a designated ribotype, there 
were different phenotypes. Conversely, isolates of one phenotype could be 
divided into two different ribotypes. These data suggest that within one 
ribotype there may be dstinct phenotypes. The location of the S-layer 
proteins on the cell surfice makes them likely candidates for host-pathogen 
interactions and hence, they may have a role in virulence. This phenotypic 
characteristic may therefore be indicative of outcome of infecnon. 
Ip14811 Characteristic of Clostridium difficile strains isolated 
from asymptomatic individuals and from diarrhoea/ patients 
S. Wongwanich, P. Pongpech, C.  Dhraputra, S. Huttayananont, P 
Sawanpanyalert 
Noathaburi, Bangkok, T 
Objectives: To characterize genotypes of C. d[@rile strains isolated from 
asymptomatic individuals and patients with diarrhoea. 
Methods: Faecal specimens from 235 asymptomatic infants < 12 months, 76 
asymptonutic children 1-11 years and 132 adult patients with antibiotic 
associated and nonantibiotic associated diarrhoea obtained from Siriraj hospital, 
Bangkok during October 1998-April 1999 were examined for C. d @ d e  by 
Cycloserine Cefoxitin Fructose Agar culture. Presence of C. d@ik toxin A 
gene was determined by spec& PCR with the use of primers: 5-CCC AAT 
AGA AGA TTC AAT ATT AAG CTT-3 and 5-GGA AGA AAA GAA 
CTT CTG GCT CAC TCA GGT-3. All C. d @ d e  isolates were 
subsequently genotyped by Pulsed-Field Gel Electrophoresis (PFGE). 
Results: The C. d @ d e  strains were found in 28 (11.9%) asymptomatic 
infants, 16 (21.1%) asymptomatic children and 33 (25%) adult patients. A 
total of 14 PFGE types and 8 subtypes designated as type A, B, C,  D, E, F, 
G, H, I, J, K, L, M, N and A1 A2, A3, A4, Bl ,B2,  B3, E l ,  respectively, was 
identified. Only 2 isolates from infants and 18 isolates from adult patients 
were toxin A gene positive by PCR. Both isolates of enterotoxigenic C. 
&@rile from infants in the same ward were PFGE type B. PFGE type A was 
the predominant type among all enterotomgenic isolates (9 out of 18 
isolates) fkom adult patients. The other PFGE types of enterotoxigenic C. 
di@cile foundin adult patients were type AI, 1 isolate; A2,l; B,4; B1,l; C,1; 
and D,1. Type B2 and U were identified in 38.5% and 46.2% of the toxin A 
gene negative isolates of C. d@de from infants. 
Conclusions: These results revealed the occurrence of three distinct clusters 
from the different wards in Siriraj hospital. The enterotoxigenic C. dificile of 
PFGE type A and related subtypes was a predominant infective clone in 
adult patients. Whereas nonenterotoxigenic C. d@cicile type B2 and D were 
encountered in asymptomatic infants. 
11)14821 Molecular typing and MLS resistance genes in 
Clostridium difficile nosocomial strains 
P. Mastrantonlo, P. Spigaglia, R. Cardines 
Rome, I 
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Thirty-two related and 68 unrelated C. difficile strains, isolated from 1987 to 
1999 in different Italian hospitals, were analysed by Pulsed Field Gel 
Electrophoresir (PFGE) to investigate their genetic relatedness. The strains 
were classified into 28 groups and a single clone, PFGE group 1, was 
recognized as the cause of three geographically and chronologically distant 
outbreaks. Among the 60 unrelated strains, PFGE resolved 27 groups with 
the majority of the strains belonging to group 1 and 4. The comparison of 
the results In relation to time period showed that the group 1 was 
predominant from 1987 to 1990, and group 4 from 1996 to 1999. Cluster 
analysis showed that these two clonal groups had a common origin. A 
recent study has demonstrated that the use ofclindaniycin was significantly 
higher among patients with diarrhoea due to an epidemic strain of C. 
d@ci/r, compared to those with diarrhoea caused by nonepidemic strains. 
The epideimc strains were highly resistant to cliiidamycin and showed 
more than one copy of the MLS resistance emi(B) gene. We examined all 
the strains isolated from outbreaks in this study for MLS susceptibility and 
the results showed they were highly resistant to clindamycin. Thirty 
percent of the strains, analysed by hybridization and P C R  assays to detect 
the em@) gene, showed a Hind111 hybridizing band at 7.3 kb and gave the 
expected PCK product of 440 bp. The sequencing of the complete ErmU 
determinant of a prototype strain showed the presence of one copy of the 
gene, indicating that the number of erm(B) gene copies in epidemic strains 
niay be variable and not proportionally linked to increased levels of 
clindamycin resistance. 
CDAD in hospitals are antibiotic use. particularly 3rd generation 
cephalosporins, and exposure to the bacterium, usually as spores. 
Attention to infection control and antibiotic prescribing behaviour are 
obvious approaches to control and prevention of CDAD, however, 
recent outbreaks in the UK and the endemic persistence of the infection 
in all hospitals highlight the need for continued vigilance regarding these 
approaches. An earlier study in  our hospital indicated a direct correlation 
between CDAD and 3rd generation cephalosporin usage. Likewise, 
hospitals in the UK and USA have reported CDAD outbreaks following 
changes in antibiotic policies that resulted in increased 3rd generation 
cephalosporin use. CDAD rates have been monitored closely in our 
hospital since the early 1980s. A steady rise in incidence was observed 
during the 1980s that plateaued during the early 1990s with about 50 
cases/100 000 occupied bed days annually thereafter. In I998 a review of 
antibiotic prescribing by the hospital’? Drugs and Therapeutics Commit- 
tee resulted in an almost total ban of ceftnaxone use in the hospital from 
December that year. Accordingly ceftriaxone use (measured by annual 
cost) fell substantially from A9250 000 in 1998 to A$32 000 in 1999. This 
policy change was subsequently followed by a 50%) drop in the number of 
nosoconial CDAD cases in 1999, a decrease that persisted into 2000. 
These findings suggest that it is possible to control CDAD by regulating 
antibiotic prescribing in the hospital tetting. 
p14831 Saccharomyces boulardii for the treatment of 
recurrent Clostridium difficile-associated diarrhoea 
T.  V. Riley, C .  L. Golledge 
Prrtlr, ‘4 US 
Closfridiiirrt d!fficile-associated diarrhoea (CDAD) IF a serious hospital- 
acquired infection that costs the healthcare system nllllions of dollars 
annually. The pathogenesis of CDAD involves disruption of the gut 
microflora, usually by antibiotics, followed by infection with C. d@de, 
usudly acquired from the hospital erivironnient. Although poorly under- 
ctood, diarrhoea is thought to be due to the effects of an enterotoxin (toxin 
A) and a cytotoxin (toxin B). Treatment with vancomycin or 
nietronidazole is not always successful and the relapse rate is high. 
Sarrlraruniym houhrdii is a nonpathogenic yeast that has been used to treat 
CDAD and prevent relapses. I t  survives gastric acidty and establishes in the 
colon, is not inhibited by antibiotics, does not impact on normal flora and 
has a good safety profile. S. boulardii produces a protease that digests toxins 
A and U, and this may partially explain its efficacy. Over the past 5 years we 
have treated 22 panents with recurrent CDAD with S. boulardii (500 mg 
twice daily for a month) as an adjunct to conventional therapy. Ofthese, 18 
had an uneventful recovery without further relapses, 3 are still being treated 
and 1 failed to comply with therapy, had one positive follow-up specimen 
and was then lost to follow-up. There is great debate currently about the 
taxonomy of S.  boulnrdii in relation to its use as 3 therapeutic agent. Is S.  
boulardii really S. boiihrdii, or is it S. cereuiciae? W e  have compared our strain 
of S. boulardii with other S. boulardii strains. as well as S. crrruisiar, Baker’s 
yeast and Brewer’s yeast, for their ability to degrade C. d@ci/e toxins. Only 
the clinically effective Sh-ain of S. houlardii reduced toxin htres iir uifru. 
Using pulsed field gel electrophoresis there were significant differences i n  
banding patterns between strains suggesting that the therapeutic effect niay 
be strain specific. 
(p1484j Control of Clostridium difficile-associated diarrhoea 
by regulating antibiotic prescribing 
C. Thonias, C.  L. Golledge, T. V. Riley 
Perrlr, .4US 
Clostridiurri d!fficilr-associated diarrhoea (CDAD) is the most common 
fonii of infectious hospital-acquired diarrhoea. The main risk factors for 
1 PI485 1 Toxinogenicity status of Clostridium difficile 
R. Dei, A. Ciapini, L. Serrai, C.  Sacco 
Flomirre, I 
Background: CIostridium d f i c i l r  produces two toxins (A and U) ,  which 
are responsible for gut pathology: their genes, tcdA and tcdB, are part of 
a pathogenicity locus (PaLoc) shared by all toxinogenic strains. Non- 
toxinogenic strains are considered tion pathogenic and do not present the 
PaLoc. C. dtficile was thought to produce both toxins (toxin A + B +) or 
none (toxin A-B-), until toxin A-B+ strains, associated with disease, 
have been reported in the last years; genetic studies on thote strains 
revealed a defective PaLoc. Because of the diagnostic implications, it is 
important to know how frequent these nonclassical toxinogenic wains 
might be. 1,2 
Aims: To evaluate toxin A activity and carry out genetic analysis on our 
large collection of C. d@cile isolates. 
Materials and methods: From 1983 to early this year a 600 odd C. d @ d e  
were isolated €ram vanous sources in our region (Tuscany, Italy); all were 
characterized for cytotoxin (toxin B) production, and stored frozen. 
Selected on the basis of epidemiologcal unrelatedness; the study included 
human (50 adults and 14 children), animal (seven) or environmental (three) 
isolates plus 17 reference strains. Overall, 21 were cytotoxin negative. Toxin 
A production war assessed with the C.  Dificile Tox-A test (TechLab, 
Blacksburg, VA, USA). DNA was extracted by a rapid boiling method from 
three-day subcultures in BHI broth. A multiplex PCR for tcdA and tcdB 
(primers YT-28 and YT-29, and YT-17 and YT-18, respectively) and a 
multiplex PCK for tcdC, tcdD, tcdE, cdu-2, and cdu-3 were camed out as 
described by Cohen et al. 
Results: None of the 20 cytotoxin-negative C. ditficile strains showed toxin 
A activity: of the 71 cytotoxin-positive. 70 showed toxin A activity, and 
one, a clinical isolate, gave an indetemllnate reaction. A complete PaLoc 
was preseut in 69 of the toxin A + B + strains and also in the clinical isolate 
with borderline toxin A activity, and it was absent in 19 of the 20 toxin A- 
B-strains. Two strains showed a defective PaLoc: a toxin A-B-reference 
strain, and a toxin A + B + isolate from adults. 
Conclusions: C. dfir i le  with nonclassical toxinogenic profile would seem 
quite rare in our region: our only one toxin A-B + isolate was in fact 
questionable; on the other hand, genetic analysis revealed two further, 
possibly interesting, strains. 
References 
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Pathogenesis & animal models (11) 
vl 
by thalidomide 
H. Poulaki, E. J .  Gianiarellos-Bourboulis, N. Kostonlitsopoulos, I. Dontac, 
H. Giamarellou, P. Karayiannakos 
Atheirs, GR 
Objective: To define the inmunomodulatory role of T in the therapy of 
Grani-negative sepsis. 
Methods: Gram-negative sepsis was established in 33 Wistar rats after the 
intraperitoneal injection of a 5 x 10‘ CFU/mL log-phase inoculuiii of 
Esrken’rlria culi. T dduted in castor oil was administered orally at a dose of 100 
mg/kg in 13 rats 30 nlln before the intraperitoneal injection of E. ro l i .  
Twelve rats served as controls and castor oil was adniiniftered orally 30 niin 
before the intraperitoneal injection of E. i d i  in eight rats. Establishment of 
sepsis was based in controls at 6 h on leukocytosis or leukopenia along with 
elevation of rectal temperature or of heart beats or of number of breaths. All 
animals were killed 6 h after the intraperitoneal injection of E. roli and 
concentrations of TNFz and IL-6 in blood were determined by an 
enzymoinmiunoatsay and of endotoxins (LPS) by the LAL QCL-1000 
chroniogenic assay. 
Results: Blood cultures were positive in all animals. Me311 values (k SE) 
of white blood cells of rats fed T, of rats fed castor oil and of rats controls 
were 8150 f 498, 1725 f 313 and 4964 f 1419/ktL, respectively ( P  
< 0.001). RespeCtiVK TNFa values were 96.3 f 32.6, 165.6 f 18.7 and 
53.9 & 17.1 pg/mL (P0.017), IL-6-values 210.2 k 117.4, 44.5 k 20.7 and 
0.42 k 0.23 pg/mL ( P  0.001) and LPS values 42 f 23, 223 k 19 and 
134 f 29 n g / d  (P  0.08). 
Conclusions: T was effective in the in~niunomodulation of Gram-negative 
sepsis both by inhibiting production of TNFa and of IL-6. 
lmmunomodulating therapy of Gram-negative sepsis 
rp481 Fimbrial and HMW adhesions in nonencapsulated 
Haemophilus influenzae isolated from invasive disease 
M. Cerquetti, K. Biunetti, P. Spigaglia, P. Mastrantonio 
ROWIP,  
Harmophilns ir!fluerrzar invasive disease (meningitis, septicaemia, epiglottitis, 
septic anhritis) is usually caused by a minority of virulent strains possessing 
the type b capsule (Hib), but nonencapsulated strains have also been found 
responsibk. With the implementation of Hib vaccination, the serotype b 
disease has declined in many industrialized countries. It has been speculated 
that nonencapsulated strains would become relatively more important. 
Several adhesins have been identified among suiface antigens of none- 
ricapsulated H. ir!fluerizae, including the HMW 1 /HMW2 proteins and the 
haemagglutinating fimbriae, but few data have been reported 011 their 
prevalence among nonencapsulated isolates from systenlic sites. Forty-five 
nonencapsulated H .  ir!fluenzae strains isolated &om cases of invasive d i s e a s ~ s  
in Italy, were characterized. The presence of hi€4 gene, which encodes the 
niajor subunit of the fimbriae, and hniw genes were determined by PCK. 
To mess the expression of genes, haemagglutination assay and Wectern 
blotting with specific antisera were used. The nonencapsulated isolates were 
a170 tested for beta-lactamase production and intrinsic ampicillin resistance. 
The hifA gene was found in 8 strains (17%), whereas 14 strains (31%) 
contained hmw genes. Twenty-three strains harbour neither. Contrary to 
Hib strains, finibnae were expressed by all the positive hifA strains. Only 
O I ~ K  strain produced beta-lactamase. 2 isolates were not susceptible to 
ampicdin. Our results show that the distribution of adhesins in none- 
ncapsulated H .  ir!flueriae isolates from invasive disease is different from that 
observed in lion invasive strains, in which the HMWl/HMW2 proteins are 
widely represented. A low level of ampicillin resistance was observed, even 
if beta-lactamase-negative ampicdin resistant strains may be recovered 
among invasive isolatec. 
Ip14881 Effects of sulfur mustard on appearance of 
Pneumocystis carinii in rat and comparison of this with 
corticosteroid effects 
A. Mahmoodzadeh, A. K. Kuzbehani 
T~hratt, IR 
It has been shown that sulfur mustard has so many adverse effect on human 
body, one of which is its inmiunosupressive action. P. rariii ir is an 
opportunistic organism which can grow In iiiimunoconiprotniztd human 
body. In this study 7Y NMKI rats weighing at least 150 g and in the age of 
3 months were randomly selected and divided into eight groups. One 
group (as a negative control) received Tyrod’s buffer and two groups 
received 2.5 and 5 mg/kg of SM solution intraperitoneally. Two groups 
received Betamethasonel 0 and 20 mg/kg subcutaneously. Two groups 
received subcutaneous Prednisolone, 40 and 80 nig/kg. The last group 
received Hydrocortisone 25 mg/kg, as above. following 8 weeks of 
treatment, rats were killed, smears obtained from lung tissues and stained 
with Gienisa, and finally were studied under light nllcroscopy. The results 
showed that there was no contanlination with P. iaviriii within groups 
receiving SM and Hydrocortisone. However, the animals in the 
Prednisolone groups (80 nig/kg) were significantly contaminated with P. 
m h i i  in comparison with other corticosteroids. 
lp14891 influence of melittin expression on M. horninis 
infection in cell culture 
V. N. Lazarev, V. M. Govomn, K. T. Momynaliev, N. M. Alexandrova, T. 
M. Padenova, T. A. Akopian 
Mosrorri, RUS 
Objectives: To study the influence of nielittin rxpressio~i on the M .  h o r r i i r i i j  
infection in cell culture. 
Methods: HeLa cell line transfection, iti~iuiiofluorescence. cloning, PCR. 
Results: For study of melittin influence on intrxxllular parasites (such as 
Myr~ip/asma /ionriiris) the melittin gene was cloned in the plastiiid vectors 
under control of early human cytoniegalovinis (CMV) promoter and 
tetracycline-responsive CMV promoter. The level of inhibition of infection 
(about 70%) was detemlined by itnniunofluorescence with polyclonal serum 
(tagged with FITC) against membrane fiaction of M .  Irorrwlir  after 
transfection of the infected HeLa Tet-Off (‘Clantech’) cell line with 
recombinant construction. 
Conclusion: The inhibition of M .  Iiorrririis infection after adm~nistr~itioti of 
recombinant plasmid vectors, expressed the melltnn gene was shown. The 
further investigations will be directed on study of nielittiii effect on M.  
homirii.r on in vivo model. 
v1 Massive bacterial load and in vivo expression of 
superantigen in patients with severe tissue infections caused by 
group A streptococci 
P. Thulin, 1). E. Low, B. S. Gan, A. McGeer, M. Koth, J. Atiden~oii, A .  
Norrby-Teglund 
Storkholm, S; Toronto, CAN; Memnplris, USA 
Background Superantigens (Sag) have been suggested to play a central role 
in the pathogenesis of GAS direases. Here we aiialysed i r r  rlivo bacterial load 
and SAg expression in context of severity of GAS tissue infectioii. 
Methods: Snapfrozen tissue biopsies from patients with necrotizing fasciitis 
(n  =4), and from the less severe forms of Infectioii, cellnlitis ( 1 1 ~ 2 )  and 
inyositis (n= 1) were sectioned, fixed and stained for GAS and SpeF using 
specific antibodies. SpeF was used as a marker for SAg since it IS precent in 
d GAS strains. Immuriostaining was used to detect the antigen and 
semiquantitative analysis was achieved by computerized image analytic. 
Results: High amounts of extra-and iiitracellulai- GAS, and SpeF could be 
detected in tissue from all patients There was a correlation brwerrr higher 
bacterial load in tissue more severely involved as compared to ltis affected 
tissue biopsies (I3= 0.04). Conristently high amounts of GAS and SprF could 
be detected in biopsies taken several days (3-20) after disease onset and there 
w3s a correlation between the amount of GAS and amount of SpeF 
( P =  0.002). Dual staining revealed co~oC&Z3hOn of GAS and SprF with CD 
68 + cells, but also with other as yet unidentified cells. Intracelluhr locahzanon 
of GAS wa associated with hgh  levels of mtracellular SpeF, whereas only low 
amounts of SpeF could be seen with high extracellular GAS. 
Conclusion: High bacterial load and excessive iii viva SAg production 
contribute to the inflammatory responses seen in these patients; however. 
the data suggest that also host factors are involved in regulating the level of 
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response and consequently the severity of disease. The study indicates that 
there may be a relation between localization of GAS and SAg expression. Of 
major clinical iniportance is the finding that SAg expressing GAS can be 
found in tissue even after prolonged i.v. antibiotic therapy, which suggests 
that novel therapies may be required. 
ml Serum markers and mediators in experimental 
endotoxaemia in humans: calcitonin precursors persist for 7 days 
K. L. Becker, H. L. Preas, R. H. Snider, E. S. Nylen, J. C. White, A. F. 
Su&edini 
Washiri~ron, Bethrsdu, USA 
Objective: Calcitonin precursors (CTpr) are excellent markers for systemic 
infections, often correlating with severity and outcome. Furthermore, the 
prohormone itself (ProCT) is toxic to the host. In this study, we wished to 
compare the duration of CTpr responte to that of acute-phase cytokuies. 
Methods: Serum CTpr levels were studied in 4 subjects during the acute 
inflammatory response to intravenous endotoxin (4 ng/kg, E. coli 0: 113). 
Blood was  obtained a t  baseline, 3, 6, 8, and 24 h and 2, 3, and 7 days. 
Results: CTpr increased by 3 h and attained peak values at 24 h (995 +_ 223, 
mean & sem, hiol /nL)(P < 0.001). Subsequently, values progressively 
declined. Importantly, at 7 days all volunteers exhibited levels which were 
above nomial (45.3 17.7 finol/mL (nomlal range 5.6 k 2.7 fmol/mL). 
Levels normalized by 1G14 days in 2 subjects. 
Discussion: In contrast to the above results, in a previously published study 
lt!fert Dis 1999; 179: 1278), 4 subjects were administered identical doses of 
endotoxin and proinflammatory cytokines measured for 24 h. Seruln levels 
of TNF-alpha conunenced increasing at 1 h, reached a peak at 1.5 h 
(2898 & 970 pg/mL), and had normalized by 24 h. IL-Ira: Ininal increase at 
1.5 h, peak at 3 h (477 & 136 ng/mL), and normalization by 24 h. IL-6: 
initial increase at 1 h, peak at 4 h (8.05 & 5.21 ng/mL), and normahzation 
by 24 h. 
Conclusion: While the acute-phase cytokines are transient in nature, CTpr 
are elevated for prolonged periods. Moreover, the prolonged elevation of 
CTpr (for as long as 7 days after a systemic inflammatory response) suggests 
that they may have advantages as a marker of inflammation and may be a 
potential target for immunoneutralization several days after the onset of 
septic shock. 
lp1492) Development of experimental murine infections 
caused by H. influenzae and H. parainfluenzae 
V. Berry, M. C. Ferreira-Cornwell, C. Singley, G. Woodnutt 
Collegeville, USA 
Objective: To develop experimental infections of H. influenzue and H. 
parair!flirenzue in nice to assess the therapeutic effects of antibiotics. 
introduction: H. in jhemue is a commonly occumng pathogen in a variety 
of conlmunity acquired respiratory infections including otitis media, 
sinusitis, bronchitis and pneumonia. However, there are no well-established 
murine models for Hapmophihis spp. Here we describe the developnient of 
models to examine chemotherapy against H. injuenzae and H. paruinfluenme 
and provide initial data on the effects of antibacterial agents. 
Methods: Bacterial inocula were prepared by harvesting growth of H. 
influeiizae (BLA + and BLNAR) and H. paruinfluetizue from chocolate agar 
plates and suspending in PBS. Ten-fold dilutions were prepared in cooled 
(41 C) molten nutrient agar. Mice (approx 5 weeks CD1 male, Charles 
River)were anaesthetised with 3% isoflurane + 1 L/min oxygen and infected 
by innabronchial instillation of 50 pL via nonsurgical intubation (approx 6 
log10 CFU/mouse). T o  validate the infection model, oral therapy with 
amoxican & clavulanate (AMX/CA) and gemifloxacin (GEM) was 
administered at 1, 5 and 24 h post infection. Approximately 24 h after 
cessation of therapy the animals were killed and the lungs excised for the 
recovery and enumeration of viable bacterial numbers. 
Results: Following infection with H. infllrmzae H128 @LA+) bacterial 
numbers in the lungs of mice at 48 h post infection were 6.1 & 1.1 log 10 
CFU/lungs. Therapy with oral AMX/CA (350/50 mg/kg) and GEM (200 
mg/kg) reduced bactenal numbers to 3.1 t 1.6 and < 1.7 log10 CFU/lungs, 
respectively (P  < 0.01). Bacterial numbers obtained &om the lungs of an inds  
infected with H. injunizae Chesterfield (BLNAR) and H. parainfluenzae 
R3697 were 6.4 + 0.4 and 4.9 f 1.1 log10 CFU/lungs, respectively. 
Conclusions: A technique involving intubation of mice with H. injuenzae 
and H. paruinfluenme to produce respiratory infections suitable for 
exanllning the effect of antibiotics has been developed. The method 
employed is inexpensive, easy to use and results in a reproducible infection 
with low mortality. In addition, it offers advantages over existing M. 
inj7uenzae models for exanirung novel chemical entities in ternLC of 
compound requirements whdst maintaining excellent reproducibility. This 
is also the first description of a model utilismg H .  purui$uenzae. 
[mi Phenotypic markers of virulence and 
enteropathogenicity in Aeromonas hydrophila clinical isolates 
D. Ottaviani, L. Masini, S. Bacchiocchi, I. Bacchiocchi. M. Gianmarioli, 
A. Canxturo, G. Sbaraglia 
Ancona, Perugia, Avellino, I 
Objectives: To evaluate the virulence of A. hydrophila clinical strains testing 
m o u e  pathogenicity and correlating the human enteric diseases with 
virulence-associated phenotypic markers as suicidal and haeinolytic actwities 
(Namdari H et al.].Clin. Microbiol. 1988; 26: 2615-9). 
Methods: The 60 A. hydrophila strains tested, recovered from the stools of 
patients with diaithoea, in absence of others pathogenic microorganism, 
were identified at the genospecies level (Abbott et ul.]. Clin. Microbiul. 1992; 
30: 1262-6). To assess virulence, five nuce/stnin were inoculated 
intraperitoneally with 107 cells of A. hydrophila strains. The enteropatho- 
genicity was stumed by oral adnunistration of A. hydrophila strains (108 cells, 
in skim miuc) to three nllce/strain and assessing diarrhoea and intestinal fluid 
accumulation. The suicidal capacity of each isolate was determined by the 
inoculation of duplicate tubes of nutrient broth containing 0.5% glucose 
followed by the incubation of individual tubes at 37°C for 24 h. Strains 
showing the suicide activity spontaneously pelletted, while those without 
this characteristic showed uniform broth turbidity. Suicidal activity was 
further confirmed subculturing the pelleted organisms to trypticase soy agar. 
Haemolytic activity was assayed on sheep blood agar at 37°C for 24 h in 
overnight nutrient broth culture of each organism. 
Results: Diarrhoea and fluid accumulation were present in all mice 
challenged orally with pathogenic A. hydrophila isolates (17%); the same 
strains, when inoculated intraperitoneally, lulled all mice 24 h after 
treatment. Necropsy cultures performed on dead mice were positive for the 
challenged strains. All the pathogenic strains were nonsuicidal and 
haemolytic, while the avirulent strains were suicidal and nonhaemolytic. 
Conclusions: The presence of both human enteropathogenicity and animal 
virulence propemes in some stool isolates, in absence of others pathogenic 
microorganisms, suggest that A .  hydrophila could be related to human 
enteric diseases in these patients. Besides, the suicide phenomenon and 
haemolytic activity can be considered significant phenotypic markers of 
virulence. These activities are reproducible, easily demonstrated and allow a 
rapid assessment of the clinical significance of an isolate. 
p 4 1  Receptors to extracellular matrix proteins in 
Enterococcus spp. clinical isolates 
R. Di Rosa, L. Bertuccini, M. G. Animendolia, A. Penni, G. Gherard, G. 
Dicuonzo, M. Venditti, L. Baldassam 
Rome, I 
Objective: To evaluate the expression of receptors to extracellular matrix 
proteins in Erzterucuccus spp. clinical isolates. 
Methods: Enferococcal strains isolated &om patients hospitalised in diff&ent 
hospitals in the Rome area were collected in a 2-year period and identified 
at species level. Strains were grown overnight in trypticase soy broth (TSB) 
or Todd-Hewitt broth (THI) at 37°C or 46°C. Adhesion to fibrinogen 
(FBG), fibronectin (FN) and collagen type 1 and IV (CI-Iv) absorbed onto 
polystyrene microtitre plates, was tested by evaluating the absorbance at 405 
nm of protein-conditioned against BSA-conditioned wells. 
Results: Strains isolated were 50 E.  f a e r u h ,  23 E. fueciurn, and 14 belonging 
to other species (E.  hiroe, 8, E. uviurn, 2, E. raasscfjflavus-guilinavum, 2, E.  
duruns, 2). Receptors to FBG, FN and CI-IV were expressed by 19.3%, 
11.4%, and 35.2%, respectively, when strains were grown in TSB at 37°C. 
The maximum increment of adhesion was 75-fold for FBG, 62-fold for FN, 
and 288-fold for CI-IV. Adhesion of E.faecalis to collagen was enhanced by 
growth in THB (44.3%); further increment in expression of receptors was 
obtained by growth at 46"C, where 40.8% ofstrains negative in THB/37"C 
became adherent to collagen in THB/46 "C.  All condition considered, 
adhesion to CI-IV of E. faecalis reached up to 84%, while for E .  jzecium and 
other species was 57.2% and 28,6%, respectively. 
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Conclusion: E. Jaeralis expressed receptors to all  proteins more frequently 
than other enterococcal species. Adhesion to collagen only was a common 
property among all enterococcal isolates regardless of species. 
the Mbrio cholerae non01 strains found in natural, eastern border of Poland 
water are potentially pathogenic for humans and that in foster circunistancer 
might be able to start epidemy of intestinal infections with ctrong diaiihoeal 
symptoms (among swmiers ,  campen, a.s.0). 
1 P I  495 I Effect of human chorionic gonadotrophin on the 
growth and morphology of Sfenofrophomonas maltophilia, 
Lisferia monocyfogenes and Strepfococcus agalactiae 
U. Siddiqui, L. Mooney, M. Denton, K. Ken 
Leeds, UK 
Background S. maltophilia possesses recepton for human choiionic 
gonadotrophin (hCG) and this hormone may have a paracrine effect on 
this bacterium, as exposure to hCG results in increased numbers of bacteria 
entering the stationary phase of growth as well as marked changes in cellular 
morphology when compared with untreated controls. As hCG levels are 
raised in pregnancy, we investigated the effect of hCG on two pathogens of 
iniportance in this setting; L. monocytogenes and S. aplrrorae. 
Materials and methods: S. maltophilia (NCTC 10257), an isolate of L. 
morzocytogenes from the blood cultures of a patient with pregnancy associated 
listeriosis and an isolate of S. azalactiae from the blood of a patient with early 
onset neonatal sepsis were used. Bacteria were grown in nutrient broth with 
or without hCG (250 ng/mL) at 37°C for 48 h. Ahquots removed at 0, 
2.5.5, 24, 29 and 48 h postinoculation were decimally diluted before plating 
onto Iso-sensitest agar. At these times, bacteria were also Gram-stained and 
photomicrographs taken. Experiments were performed in quadruplicate on 
four occasions 
Results: At T29 and T48, the mean cfu/mL of S. maltuphilia was 
sipficantly higher ( P  less than 0.05) for the hCG-supplemented broths 
than controls. In addition, Gram stains at these times showed longer, 
thicker, more intensely staining bacteria in the hCG-treated bacteria. In 
contrast, growth curves of both the other isolates manifested no significant 
differences, as did Gram-stain morphology. 
Conclusions: At the concentration (250 ng/mL) studied, hCG appears to 
have no trophic effect on L. monocytogenes and S. ogalartiae. Although an 
investigation involving a larger number of strains is warranted, it would 
appear that a paracrine effect of hCG does not explain the association of the 
latter bacteria with sepsis in pregnancy and the peripartum. 
jp14961 Research on pathogenic activity of Vibrio cholerae 
strains isolated from the Bug River in Poland 
K. Pancer, H.  Stypulkowska-Misiurewicz, Z .  Jarzabek, 2. Kudelslu 
Warsaw, PL 
Vibrio cholerae nonOl strains were isolated fioin Polish-Ukrainian border- 
line river water tiom 1994 to 1998. The strains were presented in the Rug 
River water for all year, even in winter, in several places along the border. 
Most of the 141 strains produced extracellular substances known to be 
connected to pathogenic activity of bacterial strains: proteases, neuramini- 
dases, haemolysins and cytolysms. Cytotoxic activity of filtrates of 90 strains 
cultured in Syncase Broth medium has been measured on 3 established cell 
lines: CHO, HeLa and Vero and on 3 diploid cell cultures: PZ, MRC-5 and 
WI-38. The majority (73.3%) of exanuned V. rkolevac non0l strains 
produced cytotoxin for one, two or three contmuous cell lines in 
companson to only 41.2% positive strains on human diploid cell lines. 
Human diploid cell lines were less sensitive to crude preparations of V. 
choierae toxic products than the continuous cell lines. According to the 
expectations the majority of strains showing high level of toxicity on 
continuous cell lines also were damaging to diploid cell lines. Nevertheless it 
was not a rule. Cholera toxin (CT) has not been found neither by 
immunological nor by genetic tests as well as Ship-like toxin. The 
production of heat-stable toxin immunologically related to E. coli ST toxin 
was found in 41% tested strains of V. rholerue nonOl culture filtrates examined 
by commercial iinmunological EIA test. Haemolytic activity was denion- 
strated by 13 out of 15 tested strains. The range of 1 H U  (haernolytic unit) 
titre was from I to 512, median 28. The correlation between haemolytic 
activity and toxic effects was found. The ligated rabbit ileal loop was used for 
confimiation of the toxic activity of 28 chosen strains. In the biological test 
on ligated rabbit ileal loop 8 strains show accumulation of fluid secreted into 
ligated part of intestine, and 3 strains show intensive mucus production. The 
lack of correlation between reactivity on ligated rabbit ileal loop and the 
cytotoxicity on  cell lines was found. Probably these different models are 
showing presence of different toxinc. O n  the our data base we consider that 
v) Serotype related differences in cytokine kinetics 
during experimental pneumococcal meningitis in rabbits 
C .  Bstergaard, T. Benfield, N. Frimodt-Moller, F. Espersen, J .  L). 
Lundgren 
Copenhagen, Hvidovre, DK 
Background: Serotypes-related differences in CSF WBC and TNF-alpha 
levels occur in pneumococcal nieningitis. However, the kinetics of these 
changes as well as the study of IL-1 and IL-8, important cytokmes in the 
regulation of the neutrophil pleocytosis, remains to be defined. 
Methods: Rabbits were inoculated with 10(5) CFU of pneumococci 
(serotype 1, 3, 9 V, and an uncapsulated strain) in groups of 6, 15, 6, and 6 
rabbits, respectively. CSF samples were taken every second hour during a 
16-h study period. 
Results: Significant differences among groups were found for WF3C at 8-1 4 
h, IL-8 a t  &16 h, TNF-alpha at 8-16 h, and 1L-1 at 8-10 h. 3 was the 
serotypes with the highest WBC and IL-8 levels, 9 V was the serotype with 
the highest TNF-alpha levels, whereas serotype 1 was the serotype with 
highest IL-I levels in the CSF. The uncapsulated strain had low CSF 
cytokine levels as compared to the capsulated strains. 
Conclusion: Serotypes related differences in cytokine kinetics occur during 
experimental pneumococcal meningitis. 
/p1498] Mixed infection of lxodes ricinus with three Borrelia 
burgdorferi sensu lato genospecies 
K. Schwarzova, D. Postic, I. Ciznar 
Bratislava, SK; Paris, F 
Isolates from midgut content of Ixvdes ricinus collected in Slovakia were 
analysed by PCK. AU the isolates revealed the phenotypical charactenstic of 
spirochetal morphology in dark field nlicroscopy. Spirochetes. with 
characteristic morphology in dark-field and electron nucroscopy were 
identified using the unique structure of ribosomal genes in B. hiqioderi  s.1. 
Restriction fiagment length polymorphism analysis (KFLP) of PCR 
products (using primer 1: 5’-CTGCGAGTTCGCGGGAGA-3’ and pnrner 
2: S‘-TCCTAGGCATTCACCATA-3’) by MseI endonuclease led to 
different patterns specific to B. garinii, B. afielii and B .  hiru&rjeri s .s . .  
recognizable on a polyacrylamide gel. Bowelia DNA was amplified by PCK 
in ML1-96 isolate from the unfed I .  ricinns male from Western Slovakia. 
Duiing the RFLP analysis of this isolate we observed that the presence of 
the restricted DNA was too low for a species specific characterization. 
therefore we used more concentrated P C R  ML1-96 products. The RFLP 
identification in PAGE electrophoresis revealed a band pattern correspond- 
ing to the presence of aU three genospecies in the same sample. Thus the 
pluri-infection of I. ricirrus with B .  buixdolfPri s.s., B .  p i i r r i i  and B. &lit was 
recponsible for this result. 
p m /  Standardization of a mouse peritonitis model of 
glycopeptide intermediate 5faphylococcus aureus infection 
A. Domenech, S. Ribes, C.  Cabellos, M. Dominguez, A. Montero, J .  Ariza, 
J. Lifiares, F. Gudiol 
Barcelona, E 
In recent years, the description of GISA has been of great concern. Their 
clinical relevance is unknown but the iinportance of these findings in senous 
infections has led to the search of therapeutical alternatives. 
Objective: In order to study these alternatives we have developed a mouse 
peritonitis model due to GISA. 
Methods: Two mice strain (Swiss as outbred and C57BL/6 as inbred) were 
tected. Two different staphylococcal strains were uted: Strain A MIC 
oxacillin (OXA) 0.25 pg/nL,  vanconiycin (VAN) 1 pg/inL, teicoplanin 
(TEI) 0.5 pg/mL and strain B: OXA > 256 pg/niL, VAN 4 pg/mL, TEI 8 
pg/mL. Inoculum size 10 E6 and 10 E7 cfu/mL were tested. Peritonitis 
model consisted of intrapentoneal injection to several groups of mice of 0.5 
n L  of a suspension containing one of the strains at different inoculum size 
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with mucin 1: 1. At 4, 8, 12, 16 and 24 h survival was assessed. At the same 
time points, different groups of n ice  were anaesthetized, 2 mL of saline 
were instilled intraperitoneally and external abdominal massage was 
performed. Immediately, 0.1 n L  of blood was withdrawn by cardiac 
puncture and animals were killed by cervical dislocation. Abdominal cavity 
was opened and w-ith aseptic technique peritoneal fluid was recovered and 
used to perfonii direct and 10-fold dilution cultures. Blood sample was 
instilled in 10 mL of TSB to perform blood culture. 
Results: Survival of Swiss inice at 16 h was 100% vs. 33% for C57BL/6 mice 
for the same strain and inoculum size. With C57BL/6 mice, use of strain A 
at different inoculuni size resulted in 0% survival for 10 E7 and 65% survival 
for 10 Eh. 
Bacteraemia: With C57BL/h, bacteraemn was 100% using both strain A 
and B and different inoculuni size. For C57BL/6 with both staphylococcal 
strains bacterial concentration curve in peritoneal fluid was stable at 4, 8, 12 
h of inoculation in the order of 7-8 log cfu/mL. Bactenal concentration 
with Swiss inice showed a wide dispersion ranging tiom 3 to 7 log cfu/mL. 
Conclusion: C57BL/6 mice showed more homogeneous results. Based on 
bacteraemia and survival results a inoculum size of 10 E6 seems adequate to 
study therapeutic regmens. Final schedule includes start of therapy at 4 h of 
inoculation and tacrifice of groups of mice at 0, 4, 8. and 24 h of therapy. 
Mouse peritonitis model may be a good model to test therapeutic 
possibilities for GISA infections. 
I PI 500 I The effect of a variety of agents on the intoxication 
process caused by Yersinia pestis 'murine' toxin 
M. B. Mishankin, G. 1. Vasilieva, V. N. Kozlovsky, 1. V. Kyzhko, B. N. 
Mishankin 
Rosrov-i~ri-Durr, RUS 
Objective of the study was to estimate influence ofthe variouc agents on the 
lethal activity of Yeniirra yestic 'murine' toxin (MT). MT was obtained from 
the recombinant Ersheriihin mli DHS-alpha ctrain, carrying plaslrud pMB 188 
with the cloned M T  gene. Mouse mean lethal dose (LD50) of the toxin was 
1 .64 .5  mkg. Our recent experiments with purified (99%) toxin showed 
that it possesses several enzymatic activitm iri vitro (phosphatase, autokulase, 
phosphodiesterase, phospholypase, deaiiunase, NAD-glycohydrolase) and 
superantigen properties (T-mitogenic activity and inductlon of IL-1,-2, 
TNF-alfa). Addition of the 1'. pc.clic GroEl-protein as well ac envelope 
antigen fraction 1 to the MT enhanced iiuce lethality. Possible protein- 
protein interactions also increased M T  stability in the solutions during 30 
days. Inhibitors of a phosphatase activity ammonium rnolibdate, ZnSO, 
(but not NaF) were able to provide significant increasing of M T  LD50. 
Nicotinamide affected the intoxication process in the same way, whereas 
nicotitlic acid enhanced lethal activity of MT. Pnor incubation of the toxin 
with the 4 monoclonal antibodies (MABs) to M T  did not affect lethality, in 
spite of 2 of these MABs revraled pronlinent theraupeutic activity in the 
experimental plague caused with the 1000 LD50 Y. pestis 231 strain. M T  
treatment with the trypsin d ~ d  not modify lethality and T-mithogenic 
activity. However addition of the SH-group reducers to the enzymatic 
hydrolysate significantly affected its lethal activity. Our data have shown that 
the tertiary structure and enzymatic activities of M T  could mediate such 
biologcal effect as toxin lethal activity. 
Ackowledgernent: Grant Support: Russian Foundation for Basic Research 
N99-04-48433 
p1m1 Electroencephalographic characteristics of 
imipenem/cilastatin-induced seizures 
I). Zivanovic, V. Suac. 0. Stanojlovic, J. Stojaiiovic, N. Rajsic 
B e l p d e .  W 
lmipeneni is a broad spectrum antibiotic which is reported to induce 
ceizuret both in patient? and expenmental animals. The purpose of present 
study was to characterize iniipenein/cilastatin (ImYCiI) evoked electro- 
encephalographic (EEG) changes by continuous spectrum power analysis, 
and to correlate the EEG changes to specific convulsive behaviour. Under 
intraperitoneal thiopental anaecthesia (40 mg/kg, i.p.) adult male Wistar rats 
were implanted with electrodes over frontal, parietal and occipital cortices 
and cannulas were placed into lateral ventricle. Groups of eight rats were 
injected intracerebroventricularly (i.c.v,) with Inii/Cil in doses of 10/10, 
25/25, 50/50 and 100/100 pg. Power spectral analysis were provided by 
FFT (Fast Fourier Transfoiination). Behavioural seizures were scored 
according to the descriptive scale: 0-normal behaviour, 1-twitching, 2- 
forelimb clonus and head nodding, 3-kangaroo posture and f d n g  back, 
and &jumping, clonic and tonic convulsions. Incidence and severity of 
Imi/Cil-induced seizures increased in a dose-dependent manner. After the 
highest dose eniployed all aniinals displayed severe clonic-tonic convulsions 
and died 13 f 2 rnin aker the injection. The EEG signals before Inii/Cil 
adnlinistration in all animals were characterized by low spectral powers. 
I n d C i l  injection provoked paroxysmal discharges and increase in power 
spectra. Epileptifomi activity induced by Inii/Cil characteristically corre- 
sponded to clinical manifestations. Twitching was associated with Isolated 
spikes. while dunng head noddmg short-lasting bursts of spikes were 
recorded in the EEG. Kangaroo posture was accompanied by hgh-voltage 
rhythmic spikes which lasted for 10-1 5 s. Clonic-tonic seizures were 
characterized by unintenupted bursts with high aniplitude and hlgh 
frequency (5-7 Hz) spikes. The present results extend previously published 
reports of an convulsant action of iniipenem/cilastatin and correlates 
respective EEG changes to seizure behaviour. 
v1 Disbiosis as a criterion for experimental model of 
Candida infection in rats 
S. Kuznecovs, G. Kuznecova 
Riga, LET 
Objectives: With focus on optimal expenmental model of chronic candidasls 
we are studying in white rats the mechanism of Caridida infection. 
Methods: The experimental group (17 = 20) was gwen nucroorganisnlr in 
definite dosages for a period ofone month by two ways: per 0 s  and inhalations. 
The conteiit of large intestine and parietal microflora of <mall intestine were 
studed. The suspension made in phosphate buffer was diluted to have 3 
dilution of 0.01-1.09. The number of anaerobes, aerobes, lactobacih, colon 
bacilli, staphylococci, protei and bacteroid was determined. 
Results: Under the influence of Cmdidn &ram the ditbiosic of intestines 
was more marked when the inhalations were adnlinistered. Cmdida wzaftorn 
induced changes were more distinct when the preparation administered 
intragastrically. Cur7dida alhiram caused the decrease of the total number of 
anaerobes and lactobacilli. Candida rtralroia caused the increase in the 
amounts of bacteroides and staphylococci. Carididu spp. cause the decrease 
in the quantity of anaerobe flora that testifies of the decrease of 
immunoreactivity of the body. At the same time there is an intensified 
propagation of relatively pathogenic microflora, which due to reduced 
immunity can cause various kin& of abnormalities. A proportional gain of 
bacteroides is related to the processes of the sensibilizatiori in the body. 
Conclusions: A hamiful effect of Carrdida spp, ic determined by a strain and 
the way of administration. The critenon for the present experimental model 
is the level of disbiosis. If the difference between the experimental and 
control group exceeds 1 log/g the dose is considered to cause the disease. 
v/ Dietary supplementation with Lactobadus crispatus 
reduces severity of dextran sodium sulfate (DSS)-induced colitis 
in mice 
I. Castagliuolo, F. Galeazzi, A. Cavaggioni, G. Sturniolo, C. De Ros, D. 
Tormen, G. Pozzi, G. Palii 
Paduu, Sieria, I 
The disruption of the homeostasis between endogenous intestinal flora and 
host inunune system is considered a trigger of inflanunatory bowel disease. 
Colonic microflora nlanipUhhOIi through antibiotic therapy or  dietary 
supplementation with nonpathogenic intestinal niicroorganisnis influence 
the severity of colitis. Here we assessed the effect of Lurtobaciflus crispatus, 3 
newly identified Lartohacillirs from healthy human colon, on dextran sodium 
sulfate (DSS) induced colitis and its effect on intestinal epithelial cells 
response to inflammatory stimuli. Oral administration of L. rri.cpatus., but 
not of medium alone or spores of Bnrltemides jkgilir. one day after the 
induction of DSS colitis dose-dependently reduced the body weight loss 
associated with colitis. Furthermore, 108 L. crispatus significantly ( P  < 0.01) 
inhibited mucosal neutrophil infiltration (assessed by myeloperoxidase 
activity) and colonic inflammatory damage (evaluated by a seniiquantitative 
histological score), whereas lower doses had no significant effects. 
Furthermore, protective effects were absent in animals receiving heat killed 
or adhesion deficient bacteria. In addition, preincubation of colonic 
epithelial cells (HT-29) with L. cr iprus  significantly reduced IL-lbeta 
induced IL-8 release in vitro. In  summary, dietary supplementation with live 
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L. cn’spatus reduces the severity of DSS-induced colitis and IL-1 beta 
induced IL-8 release from intestinal epithelial cells, possibly via a direct 
iimnuno-niodulatov action on intestinal niucosa. 
/p15041 lmmunochemical analysis of lipopolysaccharide - like 
component extracted from Borrelia garinii 
K. Schwdrzova, I. Ciziiar 
Bvatislava, SK 
Lipopolysaccharide (LPS) is the important coniponent of a bacterial cell 
contributing to the pathogenic process in a host. Its role and contribution to 
pathogenicity of Borrelia burgdoferi s.1. has not been clanfied. The discussion 
Laboratory diagnosis of bacteria 
has been carried on, whether such component is a permanent moiety of 
Borvelia burgdoferi s.1. cell envelope. We have applied irmnunoelectrophor- 
esis for analysis of lipopolysaccharide extracted from Borrdia gariiiii strains 
K2.4 and K48 isolated from Ixodes ricirius in Slovakia and one control strain 
Borrelia buydo+ti sensu stricto B31. A modification of the hot phenol-water 
method was used for isolation of LPS. Inmiunoelectrophoresis. crowd 
immunoelectrophoresis (CLE) and double diffusion of LPS with polyclonal 
rabbit antisera revealed pattern and properties partially similar to LPS froin 
other Gram-negative bacteria. Borrelia gaririii LPS fomied in CIE difhced 
band extended from the start to the anode. Sinularly, the shape and position 
of the band in standard irmiiutioelectrophoresis did not show major 
differences from SDS-PAGE of the extracted LPS. However, it showed 
bands only iii the higher molecular weight regions of approximately 36-60 
ma, thus indicating that its structure is more K-than S-type. 
vl Clinical laboratory accreditation in Germany 
E. Schmidt-Marttila 
Ruessdsheirn, D 
Accreditation of clinical pathology laboratory in Gemiany today is possible 
by meeting the requirements of the European nom1 45001. In Germany the 
accreditation procedure consists of a check on the spot considering EN 
45001 as well ac the I S 0  9000 series, after ful6hng a review of documents 
based on detailed questionnaires dealing with analytical competence, issued 
by the Gennan ZLG, AML et al. representing the national scientific societies 
concerned. After a self inspection step in 1997 we developed in a bottoni-up 
process a quality management handbook. Subjects of this manual were 
arranged as structural quality sections like penonnel and hardware 
configuration, instrumentation and reagent validation procedures, quality 
policy or staff training, process quality sections refemng to document 
control, contract review, identification and traceabdty, process control, 
internal and external analytical quality control procedures, complaint and 
correction management, finally result quahty sections like technical records, 
test reports and electronic data processing. After a short validation period we 
decided, as the first hospital laboratory outside m e d d  schools to apply for 
accreditation, including our microbiological branch. Since the first successful 
audit in early 1998 we decided to focus personnel attendance more and more 
on process quality, thus aspiring to Total Quality Management. 
Ip15061 European comrhittee for External Quality 
Assessment programmes in Laboratory Medicine (EQALM) 
T. Ctucitti, J. Libeer 
Brussels, 8 
Why?: Participation in External Quality Assessment (EQA) schemes by the 
clinical laboratories is becoming very important in the actual context of 
laboratory accreditation. In some countries this participation is mandatory. 
I S 0  and [LAC guidelines describe quality management for proficiency 
testing, but some issues such as for example education are not handled in 
these guidelines. 
Who?: EQALM is a newly fornied European group of organisations for 
External Quality Assurance progranls in laboratory medicine. EQALM 
provides a forum for co-operation and exchange of knowledge about 
quality related matter with regard to external quality a~sescment/ac~~raiice 
programs. The first meeting was held in 1989. Three working groups were 
set up. These working groups discuss sample preparation, quality concept 
and reference niethods. Results are published in internattonal journals. A 
periodcal EQAnews was launched in 1990. Later on a workmg group in 
haeniatology and in microbiology (bacteriology, parasitology and virology) 
was created. 
What? EQALM ainls to search contact with EQA organkttions in the field 
nicrobiology. In this workmg group discus.iorls on scheme design, sample 
preparation and validation, statistical evaluation and qudiry management. These 
discussions ~hould result in practical guidelines. The working group should offer 
an opportunity to exchange experiences in a matter for which literature is 
almost not existmg, to sharr domiation on paiucular EQA related problem, 
and to make contacrc with European and worldwide EQA organizen. 
1 P I  507 I The future of external quality assessment for 
microbiology-the stakeholders’ perspective 
C. Walton 
Lmidori, U K  
There are many national External Quality Assurance (EQA) schemes, but 
few are international in scope. The United Kmgdoni National Extenial 
Quality Assessment Scheme for Microbiology (UK NEQAS) has 30 years‘ 
experience in this field. The Scheme was provided initially for the benefit of 
UK clinical microbiology laboratories but participants in other countries 
have found the scheme useful and currently 22 countnee are represeilted 
including, from Europe:-Republic of Ireland, Denmark, Finland, Italy, 
France, Netherlands, Switzerland, Austria, Cemiany. Sweden, Norway, 
Portugal and the Slovenia. A measure of international comparabhty is thus 
provided. Increasingly, the environment surrounding the routine clinical 
diagnoxic microbiology laboratory is becoming inore coinplex, and 
dynamic changes are occurring in the healthcare market and iti 
technological development in laboratory medicine. Representatives’ from 
12 key stakeholder goups of UK NEQAS took part in a survey to gather 
evidence and expert opinion on the future direction of clinical diagnostic 
microbiology, and any changing requirements for EQA. Participants from 
the UK and from nlainland Europe, together with a collaborating national 
EQA scheme, UK NEQAS Steering Committee and a Virology workmg 
group were just some of the stakeholder groups represented. The results of 
the survey are presented. AU stakeholders’ identified the expansion of 
molecular methods in routine clinical diagnostic iiiicrobiology laboratones, 
as a conuriuing future trend. External quality awssinent schenir~ will 
provide a valuable assessment of the quality of a laboratory’s PCK 
procedures and diagnostic ability. One of the major changes in recent years 
has been the role of accreditation, with a growing emphasis on the 
assessment of objective perfomunce standards. Third parties such as national 
accreditation bodies, regulatory authorities and c ~ ~ t o n i e r s  are incremngly 
using proficiency testing results. Many UK stakeholders agreed that large- 
scale automation, rationalisation of services, point-of-care testing (PoCT) 
and rapid detection devices were likely to be significant issues in the future. 
(p15081 Cloning vector system that guarantees PCR products 
to insert to right frame 
0. Koseoglu, T. Kocagoz 
Ankara, TR 
The use of cloning vectors has revolutiotuzed molecular biology. Any 
vector with appropriate sites can be used to clone a wctioii of DNA and 
polymerase chain reaction (PClI) i q  a useful method for producing inserted 
DNA hagmenu. When Tnq polyn~erase is used for polymerisation, thr 
enzyme adds an extra adenocyl (A) nucleotide to the 3’ end of an extended 
strand in a template independent manner. T-cloning vectors are created by 
adding a thynudine (T) residue to the digested blunt ends of the cloning rite. 
This aids ligation with PCR products possessing an extra A, creating a sticky 
end. In this study, we prepared a T-cloning vector rystein, which guarantees 
insertion of open readmg frames to the right position for expression. W e  
modified the Xa expression system (~romega)  which constitutes of three 
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types of plastnid Xa1,2, and 3, differing by a single nucleotide a t  the cloning 
site. Xa-2 has one and Xa3 has two extra nucleotides compared to Xal. All 
Xa plasmides were restricted with the eruynie EcoRV w h c h  creates blunt 
ends. They were incubated with Taq polymerase and T at 72 " C  for 45 min 
and thus Ts were added to 3' ends. After purification of vectors, PCK 
products were ligated mto the vectors by adding ATP and DNA ligase. The 
presence of successfully cloned inserts was controlled by transformation and 
analysis of the plasmids. This method provides an easy way of cloning P C R  
products assunng at the same time in frame insertion. 
A new automated system for nucleic acid isolation in 
the clinical laboratory 
P. van Deursen, A. Verhoevm, B. Deimin, P. Sillekens, H. Kreuwel 
BoxIPI, h'L 
Objectives: To develop a generic and automated system for nucleic acid 
(NA) isolation in a clinical laboratory. 
Methods: A new sample preparation system is presented that combines the 
advantages of the Boom method for icolating nucleic acid from biological 
samples with the convenience of magnetic bead technology. In contrast to 
probe based niethods, it does not use target specific reagent%. The system 
wac designed a? a flexlble and automated bench top instrument for use as a 
general fiont-end module for a vaiiety of NAD assays. It uses an innovative 
method for manipulating magnetic shca particles to obtain fast and efficient 
waching of the beads and recovery of the NA target. 
Results: The system's potential as a universal saniple preparation module for 
NAU testing is illustrated &om the following successful applications. In 
conibination with NucliSens assays for HIV-1 viral load detection in plasma 
samples a supenor assay performance was obtained. Next, it was linked with a 
NucliSens assay for detection of CMV-KNA in whole blood samples to 
screen for active cytoniegalovirus infections. Furthermore, the magnetic slltca 
method was applied in a new NucliSens assay for monitoring HBV DNA 
levels in s e m n  as well as for the detection of enteroviruses in stool ramples. 
The cystnn shows to be highly productive for various sample throughput 
scenarios. Typically, it completes 48 sample preparations in 90 min. 
Conclusions: We have shown that the use of magnetic silica beads in the 
Boom method results in a convenient and productive system for detection 
of viral targets in various sample typec. 
1 PI510 1 Evaluation of RAPD-PCR analysis for identification of 
enterococci 
C. Lanuiiens, P. Descheeniaeker, S. Chapelle, M. Wijdooghe, P. 
Vandanmie, H.  Goossens 
Edegetn, BruEe, Gent, B 
Objective: We described a novel method for the identification of the most 
frequently encountered enterococcal species in human infections (Znl. J.  
S p t .  Bucreriol. 1997: 47: 555-561). In the present study we evaluated the 
applicability of this method for the routine identification of a large number 
of euterococcal isolates. 
Methods: The method is based on the analysis by oligonucleotide D11344 
pnmed RAPl)-PCR and proved to be equivalent to SDS-PAGE for the 
identification of these species. DNA was prepared from 4399 enterococcal 
strains from human and aninial origin and subjected to D11344 primed 
RAPD-PCR analysis. 
Results: 97.4% of the strains could be identified and belonged to the 
following species: E .  .faeciuift (2235 strains), E. faecalis (1346 strains), E. 
plliirarum (250 strains), E dirrniis (218 strains), E .  r a s s e l ~ f 7 u i ~ ~ ~ s ~ ~ ~ ~ e s c e n s  
(153 strains) and E.  hirae (83 strains). The remaining 114 strains (2.6%) 
were further characterized by SDS-PAGE and belonged to the above 
mentioned species as well as to E. auizrm (6 strain?), E. malodoratus (4 
strains), E .  dispar (2 strains), and E. tnumftii (1 strain); 20 strains represented 
nonenterococcal isolates ( Weissplla, Lartobacillus, Lactococcus and Pediococcus 
specie?). Examination of E. auirrrn and E. malodoratus reference strains by 
means of RAPD-I'CR revealed unique profiles. The P C R  based 
identification procedure allowed to identify field isolates of these 
additional species as well; identification of E .  &par and E inurtdtii by 
this approach was not straightforward. 
Conclusions: Our PCK based identification technique proved to be a quick 
and reliable alternative for the identification of 9 tiequently recovered 
eiiterococcal species. 
vl Evaluation of a triplex polymerase chain reaction 
assay to discriminate Staphylococcus aureus from coagulase 
negative Staphy/ococcus and determine methicillin resistance 
from blood cultures 
J. Magdalena, S. Rottier?, N .  Mars, Y. De Gheldre, M. J. Stmelens 
Brussels, B 
Objectives: T o  evaluate the performance (sensitivity, specificity, time of 
detection) of a in house tnplex PCR assay aimed to differentiate 
Staphylococcus aureus &om CNS and to detect metkcillin 1-esistance directly 
from blood cultures in comparison with conventional techniques. 
Materials and methods: Blood cultures were performed using BACTEC- 
Plus aerobic and anaerobic bottles (Becton Dickinson). PCK was evaluated 
on positive blood culture specimens with dxrect examination showing Gram 
positive cocci in tetrads and on colonies growing from these blood cultures 
after overnight incubation on blood agar platec. 1: 1011 diluted blood 
cultures were incubated in nutrient broth at 35 "C for 45 n ~ n .  Bacteria were 
recovered by centnfugation and washed several times prior to DNA 
extraction. Bacterial DNA was extracted (from the sediments and from the 
colonies) using a 3-step procedure including sequentially incubations with 
lysostaphin, and proteinase K and subsequent boiling. A triplex P C R  was 
peiformed using 3 set? of primers for the aniphfication of gene fragments 
encoding for: (1) Staphylococcal 16s rRNA (2) the PBP2a protein 
conferring resistance to methicillin among staphylococci (mecA) and (3) a 
therniostable nuclease specific of S. aureui (nuc); the expected cize of the 
amplified DNA 6agments is, respectively, 750 bp, 533 bp and 267 bp. The 
P C R  perfonned directly on blood cultures takes seven hours in total. PCR 
results were compared to conventional techniques of identification 
(detection of coagulase and latex agglutination) and oxacillin susceptibility 
testing (Oxascreen agar plates). 
Results: W e  evaluated blood cultures from 18 patients with bacteraemia. 
Gram positive cocci were identified by conventional techniques as: 
niethicillin resistant CNS (n  = 11). niethicillin susceptible CNS (. = 3), 
methicillin susceptible S. acoreirs (n = 3) and Enterococcirs faecaiis (n = 1). N o  
methicillin resistant S.  aweus was detected. Identical results were obtained 
with the 16s rRNA-merA-nuc tnplex P C R  performed on the DNA 
extracted directly from the blood culture and on the DNA extracted from 
the corresponding overnight grown coloiiies. 
Conclusion: The 16s rRNA-mecA-nuc triplex P C R  was shown to be a 
reliable tool for the rapid (same day) diagnosis (100%~ specificity aiid 100% 
sensitivity) of staphylococcal bacteraenlia aiid methicillin susceptibility. 
Further evaluation of the cost-effechveness of this rapid diagnosis on patient 
management is justified by these encouraging results. 
v1 Staphychrom, a new specific staphylocoagulase test 
using a fluorogenic substrate 
A. Treny, M. G s ,  N. Fonsale, A. Canicajo. M. E. Reverdy, A. M 
Frrydiere 
Lyon, St.-Etienne, F 
Objectives: T o  comparatively assess the peiformance of Staphychrom 
(International Microbio, France), a 2-h fluorogenic staphylocoagulase test 
using a human prothrombin and several protease inhbitors, with (i) a 
reference tube coagulase test and (ii) the latex agglutination test Pastorex 
Staph Plus (Bio-Rad, France) for the rapid identification of S. aweus. 
Methods: 264 S. aur~us trains and 33 S. noii-aureus strains were used. The 264 
S.  aureus strams encompassed 158 Methicillin Resistant Staphylocucrus aureus 
(MRSA) and 102 Methicfii Sensitive Slaphylococcus aureus (MSSA) and 4 
selected atypical S. aureus s t r a i n s  (1 coagdase-negative and 3 selected for their 
inabdity to produce a positive reaction with one or several Latex agglutination 
tests). For the 33 S. non-aureus strains belonging to 17 species, several of them 
were selected for their ability to give false-positive results either with the tube 
coagulase test or with one or several Latex agglutinahon tests 
Results: Staphychroin yielded a positive test with 263 S. aurem strains 
including the 3 false-negative clumping factor strains (sensitivity of 99.6%) 
and a negative staphylocoagulase test with the atypical coagulase-negative S. 
aureux strain. An equal sensitivity of identification was observed for the 
MRSA and the MSSA strains. These results are in complete agreement with 
those obtained with the tube coagulase test. In contrast, Pastorex Staph Plus 
yielded a uegative agglutination test with 3 S. a u r a s  strains, 2 ofwhich were 
MRSA. Staphychrom yielded a negative test with the 33 S. non-aureus 
strains (specificity 100%) whereas the tube coagulase test yielded a falre- 
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positive test with 3 S. sclile!fefeui srp. iuaplans, 3 S. intermedius and 1 S.  de/pAirri 
strains. The Pastorex Staph Plus test yielded a false-positive agglutination 
test with 3 S.  schlejfiri ssp. cuagulanc, 4 S. schle$ri subsp schleifiri, 4 S. 
iritennedius, and 3 S. lirgdurtensis strains. The Staphychrom test required only 
one to two colonies fiom solid medium, eliminating the need for broth 
cultures. Result were available between one to two hours. 
Conclusion: Staphychrom is more specific, more rapid and as sensitive as the 
tube coagulase test. Staphychroni is more specific, niore sensitive but less 
rapid than the Pastorex Staph Plus test. 
jp1513/ Comparison of selective broth culture and selective 
blood agar culture for detection of group B streptococcal 
colonization 
S. Kurutepe, B. Altinrik, I. Tosun, B. Ozbakkaloglu 
Manisa, TR 
Objectives: The objective of this study is to compare the sensitivity of 
Todd-Hewitt medium with gentamicin and nalidixic acid (SUM) with 
blood agar medium containing gentainicin and nalidixic acid (SBA) for 
detection of group I3 streptococcal (GBS) colonization in pregnant women. 
Methods: A total of 340 vagmal and rectal specimens submitted for the 
detection of GBS were entered into the study. Saniples were collected on 
swabs and were transported Stuart's medium. All specimens were inoculated 
into Todd-Hewitt broth medium and selective broth medium (Todd- 
Hewitt broth supplemented with 8 mg of Gentamiciii per litre and 15 nig of 
NaLdutic acid per litre). Both media were incubated overnight at 35 "C, 
with 5% COz. After 18-24 h of incubatlon, the selective broth cultures 
were subcultured onto a blood agar plate and Todd-Hewitt broth cultures 
were rubcultured onto selective blood agar containing 8 nig of gentanlicin 
per litre and 15 nig of nalidixic acid per litre (SBA). All cultures were 
incubated for 18-24 h at 35 "C, with 5% COz prior to examination. AU 
selective broth subcultures and telective blood agar cultures were examined 
for colonies typical of GBS, and the colonies were identified by gram 
staining, catalate reaction, and either CAMP tert or a particle agglutination 
assay (Staphytect plus, Oxoid dry spot). 
Results: GBS were recovered from 41 ofthe 340 specimens (12%) processed 
during the study period by one or both culture techniques. Of these, GBS 
were recovered &om 22 specimens by both selective blood agar cultures and 
the selective broth cultures. GBS were isolated SBA only for 12 specmens, 
while only SBM was positive for GBS for 9 specimens, for calculated 
sensitivities of 83%) and 71%, respectively. 
Conclusion: Based these findings; selective blood agar is more sensitive than 
selective broth medium for detection of group B streptococcal colonization 
in women. 
rmw Performance of wider 1 W MlC panel compared to 
reference laboratory method for Neisseria rneningitidis 
susceptibility 
D. Fontanals, M.  Sim6, F. Salceda, J.  Hernindcz, M. Morera, I. Sanfehu 
Sabadell, Terrassa, E 
Objective: To evaluate the performance of a new broth nlicrodilution dried 
oveinight panel, WIDER 1 W MIC (Francisco Soria Melguizo SA), for 
Neisreria iueriirigitidis surceptibility. 
Methods: We compared the results of WIDER 1 W MIC broth 
niicrodilution panels with the results of National Reference Laboratory 
for Neisseria susceptibihty method, against 33 strains isolated from invasive 
disease samples plood (20) and cerebrospinal fluid (13)] between October 
1999 and September 2000 in Corporacii, Parc T a d  of Sabadell and 
Hospital of Terrassa. Panels were inoculated according to the instructions of 
the manufacturer and the final panel inoculum density was approximately 
5 x 10' CFU/nL. 
Results: Overall agreement for Neisseiia meuit?gitidis at 5 1 log2 dilution was 
98.8%. Agreement between the two methods was higher for penicillin 
(lOO%), cefotaxlme (100%), rifanipin (loo%,) and ciprofloxacin (100%) than 
ampicillin (97%). We detected 4 minor errors [3 (9%) in ampicillin, 1 (3?4) 
in penicillin] 
Conclusion: The performance of WIDER 1 W MIC panel for susceptibility 
testing of Neicseria meningiridis, deniosmtes good correlation in comparison 
to Reference Laboratory susceptibility method. 
vl Evaluation of the performance of new Phoenix 
Automated Microbiology System on Gram-negative rods 
M. G. Menozzi, S. Covan, S .  Rossi, M. Benecchi, L. Bertoncini, P 
Sonienzi, C. Chezzi, G. Dettori 
P a m a ,  I 
Objectives: Evaluation of the performance of the I'hoeilixTM Automated 
Microbiology System (BD Diagnostic Systems-BUDS, Sparks, USA) for 
identification (ID) and antimicrobial susceptibihty testing (AST) of Grani- 
negative rods in comparison with approved standard methods. 
Methods: 302 Gram-negative rods were tested, including 229 E~rtertibacter- 
iaceae and 75 strains of Pseudotnonas/Others spp. (Non-Fennenton); 192 
strains were kesh clinical isolates and 110 were challenge strains. The results 
of the ID were compared to routine laboratory methodr, such as Vitek 1 
(bioMPrieux, Saint Louis, USA), ATB (bioM&rieux, Lyon, France) and 
Autosceptor (BDDS). Discrepant ID results were repeated in duplicate and 
remaining discrepant isolates were sent to the BDDS Lab. The AST were 
performed according to NCCLS recoinmendations and the results were 
compared to the NCCLS recommended standard broth nlicrodilution 
method. Several drug-classes/dnigs were evaluated: 5-Fluoroquinolone (9 
drugs), Aminoglycoside (5), Penicillin (4), Beta-lactani/brta-lactaniaset 
inhibitor (4), Carbapenems (2), Cepheni (17), Folate antagonist ( 2 ) ,  
Aztreonam, Chloramphenicol, Nitrofurantoin. Nalidixic acid, Tetracycline. 
Discrepant AST results were repeated in duplicate. Data were evaluated as 
defined by the NCCLS ides for essential agreement (EA), category 
agreement (CA), very major error (VME), major error (ME), and minor 
error (MIE) rates. 
Results: Overall correct ID was obtained to the species and genus level in  
95.7% and in 97.4%, whereas among clinical isolates the correct ID was 
reached in 96.9% and in 98.4%, respectively. Out of the total 12 539 
single values for the AST, 11 925 (95.1%) EA and 12 262 (97.7%) CA 
were obtained, raising to 97.1% (EA) and 98.1% (CA) among Non- 
Fermentors. The instrument performance has shown a VME rate of 
1.5696, a ME rate of 0.33% and a MIE rate of 1.56%; the highest rates 
were observed among clinical isolates with 1.95% (VME), 0.25% (ME) 
and 1.62% (MIE), respectively. 
Conclusion: The PhoenixrM system showed an excellent performance for 
ID and AST when applied to Gram-negative rods. 
Work-flow analysis of the Vitek 2 automated 
identification and antimicrobial susceptibility testing system in a 
British clinical microbiology laboratory 
I. Hosein, M. Heginbothom, A. Paull 
Cardijtf; UK 
Introduction: The Vitek 2 '' System (bioM6rieux) for automated identifica- 
tion and susceptibility testing is the latest version of Vitek and may afford 
even faster results than its precursor. This would be of potential benefit in 
antimicrobial rationalisation at the bedside and thereby help both with a n  
expected better patient outcome and reduction of the potential for 
multiresistance. Purported benefits of any new system for clinical laboratory 
use need to be assessed against standard approacher. This study evaluated the 
work flow and accuracy of Vitek 2 against standard methods for 
identification (Crystal system, BBL) and susceptibility testing (BSAC 1998). 
Methods: 349 routine, sequential isolates from cultures of urine. blood and 
wounds were subjected to postisolation testing by Vitek 2, BSAC disk 
difision susceptibdity testing and identification by the Crystal system. All 
steps in the processes to result generation were timed with a stop watch by 
an independent observer. 
Results: Isolates studied included 174 Gram-negative bacilli (70 E. d), 44 
enterococci and 131 staphylococci. Concordance in both identification (Id) 
and susceptibility (Susp) results was above 95% and times to result in hours 
(h) were as follows-VITEK 2 Id-2-3 h, VITEK 2 s11Sp.-9.6 h (6.3 h for E. 
coli], Cryctal Id-18-24 h, BSAC Susp. 18-24 h. 
Conclusions: The Vitek 2 System results had an acceptable level of 
concordance with standard methodt for both identification and suscept- 
ibility testing. Times to generation of final result were less than 10 h which 
could mean same day availability with appropriate laboratory work 
schedules. Saniple preparation was simple and the evaluating staff who 
were regular 'bench' staff felt that Vitek 2 could be easily incorporated into 
the clinical laboratory wtting in the UK. 
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[MI Use of VITEK-2 system in performing teicoplanin 
susceptibility in coagulase-negative staphylococci 
A. Torres-Lana, C. Revert, M.-J. Ranios, M.-I. Montesnios, M. Lecuona, 
M. Cuervo, A. Dona, A. Sierra 
LA Lcquiia, E 
VITEK-2 1s a new automated system that calculates MICs of several 
anribiotics. The aim of this study was to evaluate this system in perfonming 
the susceptibility of coagulase-negative staphylococci (CNS) against 
teicoplanin. A total of 84 CNS (49 S. epiderinidis, 16 S. haemolytienr and 
19 other CNS) from clinically significant isolates from blood cultures were 
ctudied, including 24 resistant, 12 intennediate strains and 49 susceptible. 
We used €-test as reference method. 44 isolates showed the same MIC in 
both methods (51.8%). 24 isolates had 1 log of difference (28.6%) and 16 
showed 5 2 or plus log of discrepancies (19.6%). Overall, there was a 80.4% 
of ecsential agreenient (MIC wi thn  one two-fold dilution) between the two 
methods. 111 conipanng species, S. rpiderinidis and S. I1aemolyticus had 89.8% 
and 68.7% of essential agreement, respectively. When analysing the data in 
categories (resistant, intermediate and susceptible) we found one very major 
error (one S .  epiderinidi.v was resistant with E-test and susceptible with 
VITEK-2). 4 niajor emors (two S.  liueitiofyfici.~s. one S. epideniiidis and one S. 
rrJariieri were resistant with VITEK-2 and susceptible with E-test) and 18 
minor errors (from resistant or susceptible with one method and 
intermediate with the another). We did not measure the mean time 
VITEK-2 required to show results, but all were over in less than 8 h. W e  
conclude that VITEK-2 system is correlated wlth Gtest when testing 
teicoplanin in CNS. The system is rapid, accurate and easy to perform. 
p m ]  Day to day Vitek 2 
J. Lopez-Hontangas, A. Valentin, J. Cano, M. Goberriado 
Valeticia, E 
Background Vitek 2 perfonns automatic identification ofbacteria. We have 
evaluated Vitek 2 in the daily routine for identification de clinically relevant 
bacteria and yeast. 
Methods: A total 1821 clinical isolates were evaluated, the preliniinary 
identification was perforiiied with nianual methods laboratory or/and API 
(BioMenenx). We managed Vitek 2 (BioMerieux) according the 
manufacturer's instructionc, except prieuniococci in which case the 
McFarland was 0.7-0.8. 
The strains tested were: 157 Gram-positive cocci (138 Stapliylomrcus), 133 
SlrFpfoiorCrlz (22 S .  piiarirtioiiioe, 64 S. aplaeriop), 248 E n f e r ~ r o r c i ~ s  (203 E. 
facin/i.r, 20 E. &eciiriri), 774 Eiireruboiteria~-eae (365 E. co/i), 80 Aeroinoim, 5 
Ptisrcirvrh spp., 226 Gram-negative bacilli not ferment (95 P. aerugiriosn, 62 
Aciiir~obacfev spp. 30 S iiia/f~ip/ii/ia) and 198 yuast. 
Results: Vitek 2 identified 196 (98.98%) of isolates yeast. Vitek 2 identified 
1505 (92.7%) of isolatec bacteria, not identified 118 (7.3%1), 30 Gran- 
positive cocci, 9 Eiikriicoiciis, 21 Streprococcus vividails group. 38 Eiirerohacter- 
inreor and 20 Gran-negative bacilli not feinient. Vitek correctly identified 
1336 (82.3%) of isolates bacteria to the ypecies level. Not  discrimination 
between severd species 169 (10.4%), not differentiate between A .  
/i)~Ar~y/iila/.4. iaiiiae, S. aeidoiiiiiriiiirrslS. piteiriiioiiiae, S .  nritis/S. oralis/S. 
piieiiitioiiior~, K.  piieiiiiioiiiar/E. cloacae, S.  /miitiiiis/S. mpifis. E.  ga//iworuni/€. 
i-msd&wiu. not feniient-VNFGN. 
Conclusions: Vitek 2 showed adequate accuracy for same day identification 
of clinical isolates conlnionly isolated i n  our population. 
v] Study of performance for direct identification and 
susceptibility testing with Vitek 2 using positive Vital blood 
culture bottles 
1'. Brunet, C.  Casado 
M2.lnrwii/e, Lyw, F 
This work has been pelfomied to evaluate the feacibility of identification 
and susceptibility testing, with VITEK 2 directly using broth froni positive 
VITAL AER blood culture bottles. Results obtained with this direct 
technique were compared to the laboratory reference technique, i.e. using 
coloniec obtained after culture on solid media. 10 n L  of positive broth 
underwent double washing with saline solution and the pellet of 
nncroorganisim was w e d  firstly to onent bacterial identification (Gram 
staining, catalase, oxid,w. ctreptococci grouping), and then used to prepare 
an inoculum of 0.6 Mc Farland to inoculate the appropnate VITEK 2 card. 
The results obtained using the two methods were compared for both 
identificanon (genus and species) and susceptibility testing (MICs, 
categories). A total of 300 positive VITAL AER bottles representing 160 
patients were analysed between March and October 2000. The bacteria 
detected were classed as follows: 133 Gram + cocci (GNB) including 117 
staphylococci, 12 Group B streptococci, 4 enterococci, 167 Gram-bacilli 
(GNR) including 153 Enfemhacteiiaceae, 14 nonfermenterc. Discrepancies 
were defined for identification as being minor (same genus, different species) 
and major (different genus) and for susceptibility testing as nlinor, major and 
very major errors. For GNU: identification was shown to have 86.8%) of 
complete concordance, 9.6% of discrepancies (7.2% nlinor and 2.4% major) 
and 3.6%) of iion identifications (no growth). The susceptibility tests were 
shown to be concordant in 98.1% of cases. Analysis of organism-antibiotic 
combinations showed 1.8% minor errors, 0.03'% major errors and 0.07% 
very major errors. For GPC, identification was shown to be conipletely 
concordant in 63.2% of cases and 18.8% of discrepancies (17.3'Xr minor 
errors and 1.5% major errors) and 18% of iion identifications. The 
susceptibility tests were fourid to be concordant in 95.6% of cases. Analysis 
of organism-antibiotic combinations showed 2.7% minor errors, 0.8% niajor 
errors and 0.9% very major errors. 
Conclusion: This standarkzed prehninaiy study shows that VITAL positwe 
bottles can be analysed using VITEK 2. Results for GNl3 can be obtained 
with a low risk oferrors between the sixth and eighth hour after bottles have 
been signalled positive given that the interpreted phenotypes led to only 
two discordant expertized result?. For Gram + cocci, the interpretation is 
more difficult depending on the number of discrepancies observed. 
v/ Use of VITEK-2 system in evaluating coagulase- 
negative staphylococci to vancomycin 
A. Torres-Lana, M. -J. Ramos, C .  Revert, M. -I. Montesinos, M. Lecuona, 
M. Cuervo, A. Dorta, A. Sierra 
IA Lagum, E 
VITEK-2 system is a newly automated system that provides susceptibility 
results for several antibiotics. Tha purpose of this study is to evaluate the 
ability of the system in per fomng accurate susceptibility tests of coagulase- 
negative staphylococci (CNS) againrt vanconiycin. 4'1 clinically significant 
isolates from blood cultures were studied: 21 S. epideriiridis, 1 1  S. 
liaeiiiolyficus and 17 other CNS. E-tect was used as reference method. All 
strains were susceptible to vancomycin. We found 31 cares of total 
agreement (same MIC) between the two method7 (63.2'%), 17 cases 
with I log of difference (34.7%) and only one strain showed + 2 log of 
difference. Overall, the essential agreement (MIC within one two-fold 
dilution) was 97.9%. If we analyse the results according category agreement 
we only found one nunor error: one S. cpidennidis strain was intermediate 
with VITEK-2 and susceptible with €-test. VITEK-2 showed all 
vanconiycin results within our workday. We conclude that VITEK-2 
appears to be a rapid and easy to perform method to test sutceptibility of 
varicoiiiycine in CNS and has a high MIC correlation with E-test. 
/p15211 An impedance test-Bactometer-for microbiological 
screening of pharmaceutical products 
T. Zari.ba 
Warsaw, PI. 
Introduction: The microbial content testing in pharmaceutical raw 
inatenals, bulks and finish products has been considered time-consunung. 
Staridai-d procedures require usually more than 5 days, therefore the rapid 
method based on impedinietnc procedure was developed. Bactotneter 
(Vitek System, bioMerieux, USA) method is based on the principle that 
when bacteria grow and metabolize. the conductivity of a cultrvation 
iiiediuni increases. The  time which takes a bacterial population to create a 
detectable conductivity change in medium is usu.ally proportional to the 
initial bacterial population. The aim of the study was to estiniate usefulness a 
new, alternative to pharmacopoeia1 method in microbiological testing of 
pharmaceutical products. 
Material and methods: The study was conducted with pharmaceutical 
products without or contaminated with standard strains used for test 
validation, as follow: Escherichia coli ATCC 87739, Psrudomoiias aerqiirosa 
ATCC 9027, Staphyloroccus aureus ATCC 6538, B a d u s  si ihf i l is  ATCC 6633. 
Throughout the study, 100 pL of diluted product was inoculated into the 
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wells of the module. All procedures conducted in Bactometer were verified 
by parallel method reconmended by Pharmacopoeia. For quantitative 
analysis the product samples were preincubated and then transfer into 
module with selective niedia. The appearance of conductance $ignal was 
defined as detection. 
Results: In the measurement of the total bacterial count carried out with 
bacterial suspensions mixed with equal volumes, the time of detection 
varied from 2 h for concentration one million CFU/mL to 28 h for 10 
CFU/nL.  Mixed cultures exhibited curve closely resenihling that of E.  coli. 
The Gram negative bacteria concentrations of 10 CFU per 10 g of 
phannaceutical preparation were detected within 36 h including 18 h 
preincubation time. The conductance signals were generated after 7 h for E. 
roli and 14 h for P. aeruginosa and not detectable for S. a l r r a . ~  and B. slrbtilis 
when tested with Gram negative bacteria media. 
Conclusions: The studies indicated a positive correlation between standard 
plate count results and impedance readings. Mixed cultures exhibited 
impedance similar to the more rapid growei-. The use of selective media 
enable to detect the presence of undesirable rmcroorgannnis. Total test time 
of the impedimetric procedure takes 2 4 4 8  h in comparison to minimum 
72 h when carried out with standard procedure. 
/p1522] Evaluation of the new automated PhoenixTM 
microbiology system for Gram-positive cocci 
U. Eigner, A. Caganic, M. Armbrust, U. Wild, A. Fahr 
Heidelberg, D 
Objectives: The performance of the Phoenix' System (BUDS, Sparks, 
USA) with regard to identification (ID) and antimcrobial succeptibility 
testing (AST) was evaluated for Gram positive cocci. The results of the ID 
were compared to standard methods, the results of AST were conipared to 
the reference broth microdilution method according to NCCLS standards. 
Methods: 200 clinical isolates of Gram positive cocci were tested, including 
107 ctrains of Staphylococci, 78 strains of Enterococci and 15 strains of 
Streptococci. The ID results were compared to API 20 Staph and API 20 
Strep (bioMerieux, Lyon, France). Discrepant results were repeated in 
duplicate and remaining discrepant isolates were sent to the BDLS 
laboratory. For AST results the following drug classes (drugs) were evaluated 
in comparison to the NCCLS recommended standard broth microdilution 
method: Aminoglycosidec (7), Beta-lactam antibiotics (6). Beta-lactam/ 
beta-lactanuse inhibitors (4), Carbapeneins (2), Cephenis (1 7), Folate 
antagonists (3), Quinolones (1 0), Glycopeptides ( 2 ) .  Macrolides/Lincosa- 
mides (6). Others (5). Diccrepant results were repeated in duplicate, all data 
were evaluated as defined by the NCCLS rules. 
Results: Correct ID to the specie7 level was obtained in 98.0%, 4 isolates 
(2.0%) showed incorrect ID at the species level, but were correct at genus 
level. With 7900 single tests perfomied for AST, ecsential agreement (EA) 
was 93.0% and category agreement (CA) 96.9%~ For the mstruiiieiit 
performance the very major error rate (VME) was 0.7%, the major error rate 
(ME) 2.1'%, and the nllnor error rate (MIE) 1.6%. 
Conclusions: The new automated Phoenix(TM) system showed excellent 
perfomiance for ID and AST when tested with Gram positive cocci. 
vl Microbial identification using matrix assisted laser 
desorption ionization time of flight mass spectrometry (MALDI- 
TOF-MS) 
C. J .  Keys, H. N. Shah, S. E. Gharbia, D. Dare, T. McKenna 
Luridoil, Maridiester, UK 
Many atypical and nonfernientative taxa lack pheiiotypic markers to 
distinguish between species and consequeutly remain poorly studied. The 
aim of this study was to investigate the potential to discriminate such species 
using MALDI-TOF-MS. This form of mass spectrometry utilises a gentle 
ioiiisation process and is suitable for analysis of larger biomoleculec. In  
practice a portion ofa single bacterial colony is placed on a sample grid and a 
matrix solution added and allowed to dry. The resultant crystf i le  complex 
is then ionised when a laser is fired at it. The ensuing plume of ions is then 
separated by molecular mass along a time of flight tube and a spectral profile 
ofthe ionised components is obtained. With intact bactenal cells the spectral 
fingerprint obtained represents the ionizable components of the cell surface. 
Cluster analysis using vanous algorithms enabled visual display of the 
simllarity between taxa. In this study, representative species within the 
~cittetebaetei ' ,  Kiiiplla and Moraxella complex. and a wide range of atiaeroblc 
genera such as Bacteroides, Preuotella, P~irpl~yrortror~ns, Trepoifeim and 
Peptostreptococcus were tested. Results showed separation at the genus and 
species level of representative species from the genera Acirreteborter, Kinplla 
and Moroxe/io with the exception of Aciiirtebacfer jurii i  NCTC 10307 and 
Aririetebacter junii N C T C  12153 which were atypical and clustered within 
the &loraxella region of the dendrogram. For the anaerobic genera 
charactenstic mass spectral profiles were found with the mass range 500- 
5000 Da. Distinct peaks in the ranges 1400-1600 Ila and 2400 12-2600 I)a 
in Preuorella u(psceiis differentiated this species froni the closely related 
Preuotella ififerinedia while the two morphotypes of Pepfostr~ptiic~~rrr,r micros 
were recovered in two different clusters of the dendrogram. The results of 
this study indicate that MALDI-TOF MS is a powerful tool for the rapid 
characterisation of many atypical and poorly defined tax3 which are 
otherwise difficult to delineate. 
1- Glutamate dehydrogenase, a potential new 
diagnostic marker for classification and identification 
11. Rajendram, H.  N. Shah, S. E. Gharbia 
Lirido~i, UK 
Classification of Gram-positive anaerobe P~yr,isfreptoioc(-rrs has long been 
hampered by the lack of reliable species markers contributing to the poor 
understanding of these organisms in human health and disease. Most species 
are asaccharolytic, grow poorly and in general lion reactive to most 
conventional biochemical tests. In this study the molecular investigation of 
glutamate dehydrogenase (GIIH) encoding gene was undertaken as a tool 
for studying genetic diversity in parallel with I6SrDNA sequence analysis. 
GDH is a NAD/P dependent dual functional enzyme involved in  the 
catabolism of glutamate which is a major source of energy aiiiong 
peptostreptococci. A 330-bp conserved region of the gdh encoding gene 
was amplified using degenerate primers constructed by the multiple 
ahgnnient of amino acid sequences of fainily I1 GDHs. The PCK fragments 
were cloned and sequenced. The sequence data were translated and the 
predicted aiiiino acid sequences were compared and aligned to sequences in 
databanks using BLAST and Neighbour Joining algorithms Clustal W. A 
phylogenetic tree constructed using the partial amino acid sequences of 
Peptostreptororeus species delineated 4 clusters. Sequence data revealed all 
Peptostreptococrus species belong to fanllly I1 GDHs and clustered closely to 
the gdh of Clorfvidiurti d@cile. The homology among Peptostreptoeortiis GDHs 
with those belonging to family I was less than 25% w-hde similarities of 40- 
100% were calculated among species of Pepfostreptoeorclrs. The type cpecier P. 
nnaerobiiu showed an 82% similarity to Cl~xtridium dif7irile and lower 
simllarity values to other Pcptmtreptococctrs species indicating the hetero- 
geneity among this genus. P. asocciinrolyticus, P. iridulirirs, P. i twiriwiix and P. 
harei clustered into one g o u p  with a siiilllarity score of 93% between P. 
asncc/iorolyricrrs and P. iiidulicrrs. P. uagittalis and P .  p r e i ~ d i  gdi are 100'% 
identical and cluster within a distinct branch of the phylogenetic tree along 
with P. kydrogenalis and P. lartolyticus while P. itiicms and P. riinyiiirs clucter 
into a separate group. The gdh sequence alignment of this clurter parallels 
the 16SrRNA tree and indicates that this enzyme is a usehl marker for some 
species of the genus Peptostreprococcus and may be a useful new diagnostic 
marker for classification and identification of other species. 
lp1525( Evaluation of ID 32 E identification system for the 
identification of members of the family Enterobacteriaceae and 
some other Gram-negative, glucose fermenting bacilli 
wnrsaiu, PL 
We evaluated the I D  32 E identification system (Bio-Merieux) for its ability 
to correctly identify 262 wains of members of the family, Eittr,robarreriaseoe 
and 8 strains of members of the family, Vibnoimreae. Furthemiore we 
detennined its ability for distinguishing of new taxons-genoiiiospecies 
within the genus Citrobacrer and Eftterobacter. All tested strains were taken 
from a stock collection and passed two tiines prior to examinations. Testing 
was done according to the nianufacturer instruction and tests were repeated 
in duplicate when errors occurred. Mini API software (Uio-Mrrieux) was 
used for identification. The identification results were compared wtth 
identification obtained by using reference biochenucal tests as performed at 
the National Institute of Hygiene according to Uergey's Mitnuaf The I D  32 
E 5ysteni correctly, identified at the genus level 97.1% and a t  the spccles 
level 94.1% of the total strains. The reliability level of identlfic'ition of 
S.  Kaluewski, J. Szych, A. Cieatlik, R. Gierczyiiski 
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accurately identified strains was evaluated as: perfect-93, very good-56, 
good-24 or questionable-28. Forty-three strains were correctly recognised 
at the genus level showing the accuracy identification of species. The 
remaining strains of those correctly identdied were recognised with low 
level of distinguish. Despite the relatively high rate of strains correctly 
identified, few strains of Snlmortella and Shigella were inaccurate distin- 
guished at the genus level and some of Yersiiiia rods were fmlty identified at 
the species level. I n  such cases, after the additional tests suggested by 
software were perfonned. idenufication results were not improved. The 
possibility to identi@ genomospecies within Enterobacter genus is an 
advantage of the evaluated test. Moreover, the evaluated ID 32 E system 
showed about 25% enhancement of reliability of idenhfication at the genus 
level when comparing with the previously tested Rapid ID 32 E. We 
conclude that ID 32E system may be helpful for the clinical nucrobiology 
laboratoriec especially if classical-reference biochermcal tests are not 
approachable. 
[p1526] Direct bacterial identification and susceptibility 
testing from positive Bact/Alert bottle cultures using WIDER 6 W 
ID/MIC and 3 W ID/MIC panels 
F. Salceda, J. Hernandez. D. Fontanals, 1. Saiifeliu, I. Pons 
Sobadell, E 
Objective: T o  evaluate the performance of direct inoculation of the two 
new WIDEK 6 W ID/MIC and 3 W ID/MIC Dried Overnight Panels 
(Francisco Soria Melguizo SA), from positive Bact/Alert culture bottles. 
Methods: We compared the accuracy of WIDER 6 W and 3 W panels 
inoculated drectly from positive culture bottles for performance identifica- 
tion and susceptibility testing according to NCCLS (for Ettterobarteriaceae, 
nonfermenters and Stnpliylonicci’), with inoculation of corresponding panels 
with a standardized bacterial suspension obtained following subculture to 
agar. One hundred and eleven positive culture bottles (7 biological fluids 
and 104 bloods) that appeared unimicrobic and Gram-negative rods on 
initial Gram stain were evaluated by 6 W ID/MIC panels. Twenty-five 
positive culture bottles that appeared Staphylococci on initial Gram stain 
were evaluated by 3 W ID/MIC panels. 
Results: For species identification, WIDER 6 W and 3 W panels showed 
complete agreement with the standard method 98.2% and 9694, 
respectively. For susceptibility testing, essential agreement i 1 log2 
between the two methods was 98.9% and 97.5% by WIDER 6 W and 3 
W, respectively. For Gram-negative rods the ininor error, the mayor error 
and the very mayor error rates were 2.294, 0.4% and 0.15%, respectively (the 
very mayor errors were presented in Amoxicillini/Clavulaiiic acid and 
Cefazolin antimicrobials agents). For Stap/iylococci the minor error and the 
mayor error rates were 0.9% and 0.3%, respectively (no very major errors 
were presented). 
Conclusion: Overnight gram-negative WIDER 6 W and Gram-positive 
WIDER 3 W panels inoculated directly from posiuve Bact/Alert bottles 
provide a n  acceptable bacterial identification and susceptibility testing, yield 
results comparable to standard methods arid allow reporting of results 18- 
24 h sooner. 
r P W 1  Comparison of Bactec LytidlO anaerobic/F medium 
and BacTlAlert FAN anaerobic medium for detection of 
Bacteroides fragilis, Clostridium perfringens and 
Peptostreptococcus anaerobius strains 
P. Ceniiak, M. Kolar, T.  Latd 
Hrfidei Kralove, Oloinouc, CZ 
Objectives: T o  compare ability to cultivation anaerobic bactenal strains 
from hospitalised patients in the Bactec Lytic and BacT/Alert FAN 
Anaerobic systems. 
Methods: From anaerobic bacterial strains (Bacferoides jagilis, Clostridiww 
pefriitgeris and Pe~~fostrepton,ccus artaerobius-clinical isolates) were prepared 
suspensions with descended concentrations of CFU. Every suspension was 
inoculated on the solid VL agar medium (0.1 n L  on the plate) and in the 
Bactec Lyric mid BacT/Alert FAN Anaerobic bottles (0.2 n L  in the bottlc). 
The bottles were cultivated in the Bactec 9240 and BacT/Alert 240 systems. 
Tinie to detection of positivity (TTD) was observed. VL agar plates were 
cultivated in the Oxoid anaerobic jar. The number of CFU was counted 
after 48 h cultivatioti. 
Results: T T D  depends in both systems on the number of inoculated CFU. 
Bacteroides jagilir grows much more faster in the Bactec Lytic bottles. 
Average T T D  was in BacT/Alert system 55.5 h and in Bactec qystem only 
17.1 h. T T D  (BacT/Alert)/TTD (Bactec) rate varied from 2.8 to 3.4. 
Clostridiutit pefiityeus had similar results. Average T T D  was in BacT/Alert 
system 23.7 h and in Bactec system l6,7 h. T T D  rate vaned from 1.2 to 2.7. 
Four suspensions of Closrridiutn yPfrittger7ern were positive in Bactec and on VL 
agar and negative in the BacT/Alert. Both systems failed in cultivation of 
Peptostreptococcus arzaerohius. This strain was cultivated only on the solid VL 
agar medium. Growth in the Bactec Lytic and BacTIAlert FAN Anaerobic 
systems was not detected even in the case of inoculation 10 000 CFU into 
the bottle and 7 days cultivation-all subcultures were negative. 
Conclusion: The Bactec Lyhc system is better defined for detection of 
anaerobic bacterial strains than BacT/Alea FAN Anaerobic system. Culnvation 
in this system IS shorter and probabllity of detection anaerobic stram is higher. 
Both system can tided in the detection of Peptosneptocuccus arraerobius strains. 
1 P I  528 I Usefulness of GNI+ cards for identification of Gram- 
negative rods isolated from blood cultures 
M. Bronk, A. Saniet, M. Kochowska-Bronk 
Cdaiisk, PL 
In the beginning of the year 2000, the card GNI + (for Gram-negative 
roods identification) was introduced in the Department of Clinical 
Bacteriology of Clinical Hospital no. 1 in Gdansk. In the period of 6 
months from January to June 2000, 5500 blood cultures were performed. 
Out of which 785 microorganimis were isolated. Gram-negative roods 
accounted for 206 isolates. They were identified by GNi + cards as: E. mli 
(69), Enterobacter cloacae (32), Klebsiena prteumoriiae (28) ,  Klebsiella oxytocn 
( is) ,  Proteus mirabilis (17), Sewaria tiiarcescem (7) ,  Proteus uu/garis (7). 
Aiirietobacter baumatinii (4), Morgattella morgarirtii ( 2 ) ,  Citrubacter-lueurtrlii (2). 
Pseudoitionas aemginosa (3) .  Stenotrophornoim maltophiLia (3). unidentified 
microorganism3 (16). The microorganisms were identified in 2-12 h. Mean 
time for identifications was 6.5 h. It way shorter for ~riterobaneviaceae-5 h 
than for nonfermentative rods-8 h. O u t  of.206 Gram-negative roods 16 left 
unidentified (7.76%). Introduction of GNI cards reduced time for 
identification and improved its reliability. 
v/ Novel genus-specific PCR for rapid identification of 
Nocardia based on 165-235 rDNA spacer sequences and 
restriction endonucleases 
S.  Andrees, A. Roth, U. Reischl, 11. Harmsen, R. M. Kroppenstedt, H 
Mauch 
Berlin, Regetzsburg, Wtirzhug, Braurisc/tiiw<c, D 
The genus Noiardia forms a heterogeneous group of 17 validly descnbed 
species. Some of these cause clinical diseases in huniam and miniah. 
Conventional species identification is difficult and time consuming and the 
taxonomical status of some species remains unsettled. This prompted us to 
develop slrnpler and faster methods for the identification of hbcardia to the 
rpecies aiid strain (biotype) level, such as restiiction fragment polymorphism 
(RFLP) or hybridisation with probes. These methods are not well suited for 
the highly conserved 16s rDNA which is to homogeneous in this bacterial 
genus. Therrfore, we used the heterogeneous 16s-23s rDNA intenidly 
transcribed spacer (ITS) for developing genus specific primers and an 
identification scheme by RFLP. A total of 75 reference strams and 14 patient 
isolates comprising 16 Norardia taxons were used. Among these, 80 strains 
were sequenced in the 16s rRNA gene. The complete ITS was cloned and 
sequenced. Partial ITS-23s sequences were also generated from closely related 
genera for the accurate design of the 23s-flanking genus-specific primer. The 
new primers were evaluated by wting all hbcavdia strains and additional 324 
strains from 27 other closely related genera. AU Nacardiar were amplified by the 
new primers, whereas none of the strains &om other genera were amplified 
The obtained sequences were scanned for suitable restnction sites and a 
diagnostic RFLP scheme wa~ developed that uses 2 restriction enzymes. 
Conclusions: This study showed that the ITS represents a powerful target 
for accurate discrimination between closely related Nocardin species. I n  
contrast to the 16s rRNA gene, it offers the possibility to identify these 
organisms to the strain or biotype level using RFLP with 2 endonucleases. 
The new niethod uses highly genus-specific primers and may be suitable for 
rapid and cost-effective identification of Noiardia both to the genus and the 
subspecies level without the need for sequencing. 
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Helicobacter pylori 
v1 Epidemiology of Helicobacter py/ori infection in a 
town in Northern Italy 
K. Bandettini, A. Della Rocca, K. Monacelli 
Gerioa, I 
Objectives: The aim of this study was the evaluation of Helirobarter pylori 
seroprevalence i n  adults living in a district of Genoa. 
Methods: Senmi samples were collected from 1930 adults ( I  144 females, 
786 males, age range 31-80, mean age 54.6). IgG antibodies against 
Hrlirobar~erpylori were detected by a micro ELISA method (Helori-test IgG- 
Eurospital), 
Results: Of the 1930 adults, 1223 (63.4%) were reactive, 35 (1.8%) 
borderline and 672 (34.8%) negative. In particular of the 786 males, 509 
(64.7%) were reactive, 13 (1.7%) borderline, 264 (33.6%) negative and of 
the 1144 females, 714 (62.4%) were reactive, 22 (1.9%) borderline and 408 
(35.7%) negative. Betides, of the 1223 poritives, 157 (12.8%) (93 females 
and 64 males) received a therapy cycle and were re-tested six months after 
the end of treatment with the following results: 31 (48.4%) males and 51 
(54.8%) females (82; 52.2%) responded to the therapy (IgG decrease > 
30%), 23 (36.0%) males and 36 (38.7%) females (59; 37.6%) were 
nonresponders, 16 (10 males and 6 females) dropped-out. 
Conclusion: Helicohacter pylori infection induces the immune system to 
produce specific antibodiet that do not seem to have any influence on  the 
disease or a protective effect. The titration of specific IgG is useful for 
epidemiological studies and for the screening of infection. In this view, we 
evaluated the data obtained in our study. The values shown in the first part 
of our study reflect the data reported in literature. The second part shows a 
52.2% of success of the therapy and a 37.6% of unsuccess that may mean 
drug resistance or patient nonconipliance. 
/p'15311 Helicobacter py/ori infection in Venezuela 
M. E. Cavazza, M. Correnti, M. I .  Urrestarazu. J. V. Vivas, M. Perrone, N.  
Serrano, M. Avila, D. Ortiz, V. Lecuna, R. Piiiero 
Caracas, YV 
Introduction: Few national survey studies has been reported and is no 
enough epidemiological infomiation of H. pylori infection in Venezuela. 
The aim of this work was to study the seroprevalence of H .  pylon' infection 
in patients with gastroduodenal Fymptomr, asymptomatic population and 
children of different areas of our country. 
Method: Serum samples were obtained duniig a National survey from 
November 1998 to March 2000. The seruni of 416 patients with 
gastroduodenal diseases, 190 blood donors, 220 healthy children under 10 
years and 90 teenagers from Tichira (Endemic stomach cancer state) were 
collected for ELISA. The soluble antigen material for imniunoenzyniatic 
assay was prepared by sonication of five H. pylori strains isolated from 
duodenal ulcer patients (cut off > 500 DO). 
Results: The group of patients with gastroduodenal diseases coinpnsed 339 
(82%) culture-positive and also IgG anti-H. pylon' positive, only 77 patients 
(18%) were seronegatives and culture negative. The group of Asymptoinatic 
population showed 144 (76%) individuals with IgC anti-H. pylori positive 
and 46 (24%)) were seronegative. In the children group we observed 109 
(50%) individuals were seronegative and 11 1 (50%) had IgG anti-H. pylori 
antibodies. In the teenagers group from endemic stomach cancer area we 
observed the highest seroprevalence of IgG antie H .  pylori antibodies 
(96.7%). 
Conclusions: Helirobnrterpylori infection is highly seroprevalent in Venezuela 
particularly in Tichira State with elevated prevalence of stomach cancer 
population. The acquisition of the infection of H. pylori in our country 
occurs early in life. 
Acknowledgements: This study was support by CONICIT grant S1- 
9600 1408. 
/p1532] Change in the prevalence of Helicobacter py/ori 
infection in Turkey during last 10 years 
A. Ozden, G. Bozdayi, 0. Koc, K. Kose, H. Cetinkaya 
Atikara, TR 
Prerence of IgG antibodies in Helitobacter pylon' (Hp) infection is accepted as 
main parameter for the diagnosis of infection. Hp-IgA antibodies have no 
importance in the diagnosis and Hp-IgM antibodies show acute infection. 
Aim: To compare the rmult. ofHp IgG positivines in the sera of pnnury school 
students (age 7-14) fiom the same school, handled in 1990 and 2000 years. 
Materials and methods: In this study; 219 students (ages 7-14; 109 female, 
110 male) in year 1990, 184 students (ages 7-14; 90 female, 94 male) in year 
2000 fiom Ankara, Argentina primary school were included. Hp IgG 
antibodies were tested by EIA (IBL. Hamburg, Gemiany) in the sera of all 
students. Chi square and Fisher exact test were used for statistical analysis. 
Result: Table: Hp IgG antibody positivity arid comparison the results in year 
1990 and 2000. 
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Conclusion: The prevalence of Hp infection srens to be decreasing during last 
10 years in Turkey, parallel to socioeconomic development in the country 
v1 Comparison of ELISA and Western blot techniques in 
the diagnosis of Helicobacter pylori infections 
G. Arlan, M. Ulukanhgrl, A. Seyrek, Y. Nazligul 
Mersiii, Sarilirrlfa, TR 
Helicobacter pylori infection is one of the most comn~on nifecnous diseases in 
the world, whereas a gold standard for identifying its infection has not yet 
been established. Hardly any other bacterial infection can be diagnosed with 
a similar variety of noninvasive and invasive tests as infection with H. pylori. 
The purpose of this study was to evaluate and compare serological methods 
used to detect the expression of H. pylori antigens. A potential vinilence 
determinant of Helicobacter pylon' is the cagA gene product. 
The relevance of the expression of CagA is determined to the clinical 
picture and outcome ofH.  pylon'infection. In the patient with terious gasmc 
pain, H. pylori IgG antibody in sera and histopathological examination in 
gastric biopries were evaluated. In H. pylori IgG positive patlents, IgG and 
IgA anti Cag A anti Vag A antibodies were investigated by Western blot 
method. 50% of ELISA IgG positive patients was found positively with IgG 
anti Cag A anti Vag A antibodies and 18.7% them with IgA anti Cag A and 
anti Vag A antibodies by Western blot technique. 
/p15341 Detection of Helicobacter pylori by serological 
methods 
M. Ang-KuGuker, 0. Biiyiikbaba-Bod, G. Aktas, 0. Ang 
Istaribul, TR 
Helicobacter pylori (Hp), a spiral shaped bacterium, colonizes the stomach in 
humans and has been identified as the cause of chronic gastritis, peptic ulcer 
disease, gastric cancer and niucosa-associated lymphoid tissue lymphoma. 
Several virulence factors such as the vacuolating cytotoxin (Vac A) and the 
cytotoxin-associated protein (Cag A) have been recently identified. Since 
332 Abstracts 
Cag A is immunogenic. individuals infected with C a  A exprescing stram 
generally develop sycteiiiic and iiiucosal antibodies to this protein. 
Therefore, antibodies to Ca A reflect an underlying infection Lvith Ca A 
expressing Hp strain and serologic methods for detecting of Ca A-antibodies 
can be used for diagnostic purpose. Detection of Ig G-antibodies by EIA is 
also rapid and inexpensive. However, after a patient hac become infected 
with Hp, antibodies reiiiain in the serum for an indefinite period. This 
serologic testing cannot be used to confinu eradication of Hp infection or to 
test patients who have previously been infected For this reacon a positive 
result is not proof of active infection. Faecal antigen testing EIA is a rapid, 
nomnvasive method for detecting Hp infection. Faecal antigen tecting 
indicates active infection not just exposure. In this study stool samples from 
68 patients (40 children, 28 adults) and blood saniples from 35 (16 chddren 
and 19 adult?) of these 68 patients were examined. Stool samples were 
examined for H P  antigen (HpSA) by an ELISA method (Prenliuni Platinum 
HpSA, Meridian Diagnostics) according to manufacturers instructions. 
Seruni sample? were examined for Cag A-Ig G by an EIA method (Cag A- 
Ig G EIA WELL, IIADIM) and for IgG also by an EIA method (H.  pylori 
IgG EIA WELL, RADIM) according to manufacturers instructions. In 23 
(14 children, 9 adults) of 68 stool samples HpSA was positive. Cag A-IgG 
was found to be positive in 22 (5 children, 17 adults) of 35 seruiii samples 
and 31 (9 children, 25 adults) of 35 serum samples were positive for IgG. O f  
17 serum samples obtained from patients with HpSA positive (8 children 
and 9 adults) 12 (5 children and 7 adultc) were positive for Cag A-IgC and 
12 (5 children and 7 adults) were positive for IgG. whereas of 17 cerum 
samples (8 children and 9 adults) obtained from patients with negative 
HpSA 5 (adults) were positive for Cag A-IgG and 9 (1 child and 8 adults) 
were positive for IgG. Our data indicate that serodiagnostic could be used 
for epidemiological studies, eventually before endoccopy, however, culture 
remain as gold standard. 
vl Noninvasive serological tests in diagnosis of 
Heficobater pylori infections 
M. Chnliela, M. Wisniewcka, L. Uak-Ronianiszyn, I. Planeta-Malecka, A. 
Covacci, W. Rudiiicka, B. K6zalska 
Ldz, PL; Sierrn, I 
Objective: The diagnostic 'gold ctandard' procedure in H. pylon' infections 
needs endoscopy. Iiivasiveness, low accessibility of endoscopy and high (50- 
90%) prevalence of H .  pylori infections demand developing of noninvasive, 
sensitive and specific dlagiiostic techniques. 
Methods: W e  were evaluating utility of three commercial noninvasive 
cerological tests: fast qualitative IinmunoCARD H .  pylori kit (Meridian 
Diagnostic), MileniaULOT (DPC Biernian GmbH) and Premier Platinum 
HpSA (Meridian Diagnostic), the last one permitting detection of H. pylori 
antigens in ctool. In parallel, a noninvasive urea breath test (UBT) with 
13C-urea and quaiihtative ELISA with a home made glycine extract (GE) of 
H .  pylon' CCUG 1 7874, a recombinant immunodominant CagA fragnent 
(rCagA) and full length CagA (flCagA) were conducted. 
Results: The sera from all individuals classified as H .  pylon' infected-H.p (+), 
by endoscopy with rapid urease and histological exariiiriation or UBT test, 
were positive for anti-GE IgG (ELISA) and MileniaBLOT IgG. The sera 
from 86% and 80% of such individuals, respectively, were also positive for 
anti-GE IgA and MileniaBLOT IgA. ImniunoCAKD test was less sensitive 
and less specific as well as Preiiuer Platinum HpSA detecting H. pylon 
antigens in the stool samples from 50% of H.p (+) individuals. The ELISA 
conducted with rCagA. flCagA and MileniaBLOT IgG allowed to detect an 
infection nith CagA positive H. yylori strain in 60%. 65% and 80% H.p (+) 
individuals, respectively. 
Conclusions: A set of serological tests may give more precise evaluating of 
H. p y h i  infection than one test detecting specific antibody o r  bacterial 
antigen. 
Acknowledgements: Supported by The Polith Research Committee, Grant 
4 P05E 11718. 
p1536) Rapid disk urease test compared with different other 
methods for detection of Helicobacter pylori infection 
K. Iv'inova, M. Marina, I3. Vladiiiiirov, J. Churchev, I .  Tersiev 
S<?fia, BG 
Introduction: The ditfrrent methods used to detected Helicohncter pylori are 
either invasive (histology, culhli-e, PCK) or noninvasive (serology, urea 
breath test). Kapid urease tests are widely used to determine the presence of 
H. pylori directly in gastnc biopsy specimens in the endoscopy room. The 
aim of this study was to compare the accuracy of the Rapid disk urease test 
(from 1 min to 1-h reading the results) with different other inethods- 
histology, culture and serology. 
Methods: 172 patients subnlltted to endoscopy because of different 
gastrointestinal disorder? were ytudied. Two biopsy specimens for each 
petients were taken from gastric antrum and corpus and were tested for H .  
pylori  by the Rapid disk urease test, culture and histology. The serological 
test was carried out for all 172 patients. 
Results: 108 (62,8%) of all patients were infected with H .  pylovi, using 
culture and/or histology 3s a gold standard. The sensitivity, qpecificity, 
predictive positive value, predictive negative value and diagnostic accuracy 
ofthe tects were as follows: Kapid disk urrase tezt-93.8%; 100%; 100%; 82% 
and 94.3%; histology-81.1%; 100%; 100%; 70% and 82,5'%,; culture-76.9'X; 
100%); 100%; 75% and 78.6%; and serology-88.2V~; 88.2%; 100%; 57% and 
86.8%. N o  statistically significant difference was found when comparing the 
results obtained from the Rapid disk urease test and histology, using 
McNeniar's related samples x2 test (xz=42.45; P < 0.05). The 
concordance between the two tests was 96% (1 65 out of 172). 
Conclusion: The results show that the Kapid dick urease test is an 
inexpensive and quick test with good sensitivity and good specificity and 
accuracy for detection of H. pylori infection in upper gastrointestiiial 
biopsies. 
/p15371 Direct detection of Helicobacter pylori in clinical 
samples by in situ hybridization 
Y .  Moreno, M .  A. Ferms, E. Medina, A. Jimenez, M. Martinez, J 
Hernandez 
Valentia, E 
Objectives: W e  have developed a comparison assay for evaluating the use of 
cultural methods and fluorescent in sifu hibndization (FISH) technique for 
the detection of HPiicobnrter pylon' from infected patients biopsies. 
Methods: Nineteen samples of gastric biopsies obtained froni ulcer-patients 
were used for this study. The samples were homogenized in 2 mL of Dent 
Selective Enrichment Broth. A 100 FL al~quot was spread and cultured onto 
Pylori Selective Agar (PSA), and the remaining broth was incubated under 
iiiicroaerophilic conditions for 48 h. An amount of 500 pL of enriched Dent 
Broth was used for FISH detection and 100 pL were spread onto PSA, and 
incubated for 5 days under microaerophllic conditions. Presumpt~ve 
colonies were identified by Gram stain, urease test arid a PCK assay. 
Two specific primers which amplify a 2400-bp fragment froiii H .  pylori 
urease gene were used. 16s rRNA sequence data was used to develop an 
oligonucleotide probe for FISH analyses. 
Results: Helicohnrterpylort strains were recovered from 10 out of 19 samples. 
Enriched Dent broth was not suitable for isolation, due to massive growth of 
contanlinating bacteria. FISH detection yielded positive results in  13 
samples. In no case, a negative FISH result was obtained from 3 cultural 
positive sample. 
Conclusions: FISH techiuque is a rapid, sensitive and specific method to detect 
and identifi Hrliobalterpylon' in clinical samples, and could be an excellent tool 
for detecting this bacteria in poorly contammated environments. 
v] I g t  and IgA antibodies against Helicobacterpylori in 
serum, saliva and gastric juice of patients with gastroduodenal 
disease 
Wroclnro, PL 
G. Gosciniak, A. Przondo-Mordarska, B. Iwanczak, E. Poniewierka 
Objective: The aim of the study was to determine the titres of IgG and IgA 
antibodies to H .  pylon' in serum, sahva and gastnc juice. 
Methods: Samples for bacteriological and serological examination came 
from 397 patients. The culture was positivr in 196, and negative 111 201 
patients. The levels ofspecific antibodies in sera, sahva and gastric juice were 
deteimined by ELISA test. The sonicate from the reference strain H .  pylon' 
N C T C  11 637 was wed as antigen. Serum samples were diluted 1:400 for 
IgG and 1:100 for IgA. Neutralized gastric juice and saliva samples were 
centrifuged and diluted 1: 10 for IgA and IgG. 
Results: Increased levels of H. pylon specific IgG antibodies were niore 
frequent ( P  < 0.01) in the serum 96% than in the saliva samples 77%. 
Elevated IgA levels in the saliva 82%) and serum 80'% saiiiples occurred in a 
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sindar proportion. No increase of IgG antibody titre was found in the 
gastric juice froni adults, but there was such increase in 22% of the children 
patients. IgA antibodiec were prevalent in gastric juice samples. Serum and 
salivaiy anti H. pylori IgG and IgA antibody titres were higher in H. pylori 
positive than in H .  pylori negative patients. The titres of serum H. pylori IgG 
were higher than of serum specific IgA. In all patients, the level of IgG 
antibodies were very low in gastric juice. 
Conclusion: Our results inkcate that there is a correlation between the presence 
of H. pylori m gasmc inucosa, the occurrence of IgG and IgA antibodes against 
H. pybri in serum and saliva and the presence of IgA antibodies in gastric juice. 
The detecnoii of IgG antibodies in the serum samples and IgA antibomes in 
gastric juice is of sipdicance in terms of diagnostics. 
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Evaluation of antibody against Helicobacter py/ori 
CagA in patients with dyspeptic and acute coronary syndrome 
K. Thenieli-Digalaki, E. Orkopoulou, N. Ntiniakos, D. 
Graiimiatikopoulou, C.  Koutsia-Carouzou 
Aflreris, GR 
Objectives: to evaluate the detection of IgG antibody to He/icobarter pylori 
CagA IgG protein in patients with peptic ulcer, gastritis and acute coronary 
syndrome. 
Methods: Sera from 105 patients were sex and aged matched with 
asymptomatic controls. The patients were subdivided in three groups. 
Group 1:38 with gastric symptoms. Group 2:52 with acute coronary 
syndrome. Group 3: 15 asymptoniatic controls. The enzyme iiimiunoassay 
(EIA) for detection of IgA and IgC anti-Helicobact~r antibodiec was used. 
The CagA IgG specific antibody was determined by EIA. 
Results: The Cag IgG was found in 34 patients (32.3%). Subgroup analyci? 
showed a significant increare in Group 1 47.3%, while in Group 2 was 
found in 30.7%. The detection of the CagA IgG was found in about the 
50% of the dyspeptic patients with positive IgG, but none in Group 3. 
Conclusions: The detection of the CagA IgG, is an additional tool to 
identify patients with a predict increased risk for gastric cancer, and iiiay be 
useiul i n  therapentic decisions. 
vl Differences in serological response against CagA and 
VacA in patients with chronic gastritis and duodenal ulcer 
Wvoclaw, PL 
G. Gosciniak. A. Przondo-Mordarcka, B. Iwanczak, E. Poniewirrka 
The aim of the study was to determine the frequency of appearance of anti- 
VacA and CagA antibodies in the serum of patients with chroiuc gastritis 
and duodenal ulcer. 
Methods: 196 strains of H .  pylon isolated from the gastric mucosa of patients 
(aged 1&50 years) with chronic gastntis (165) and duodenal ulcer (31) were 
investigated for the production of vacuolating cytotoxin. The cytotoxic 
activity of H. pybrt was tested on Intestine 407 cells (human embryonic 
intestine cells). The resultc were regarded as positive when a t  least 50% of 
the cells were vacuolated after 24 h. Antibodies to VacA and CagA were 
detected in 196 sera saniples (of the same patient group) by Western Blot lut 
(Hel~co Blot 2.0. Genelab? Diagnostics, Singapore). 
Results: 71% of H. yylori strain? icolated from patiente with duodenal ulcer 
and 35.2% of strains kolated from patients with chronic gastritis expressed 
vacuolatiiig cytotoxic activity. The detection of antibodies to CagA and 
VacA was more frequent found in the serum samples of patient? with 
duodenal ulcer with from chronic gastritis. Antibodiec to CagA were 
detected in 97.5% of the reruni samples from patients infected by H .  pylon 
strain? which produced vacuolating cytotoxin (Tox +) and in 36.2% of the 
seruni saniples from patients infected by H. pylori (Tox-) strains. Anti-VacA 
antibodes were found in 100% and 18% of the serum samples, respectively. 
Conclusion: The presence of antibodies to VacA and CagA proteins 
correlates with infection by H .  yylori strains which produce vacuolating 
cytotoxin. They are more fkequently detected in duodenal ulcer patients. 
vl Association of other serological markers than CagA 
and VacA in H. pylori related diseases 
N. Camino, C .  Toro, 1. Casado, J. Garcia Samaniego, T. Alarcbn, A. 
Enriquez 
Madrid, E 
v1 He/icobacter py/ori infection and peptic ulcer disease 
in patients with liver cirrhosis 
Z. Petrovic, D. Daiiijanov, Z. Savic 
hboi  Sad, W 
Background and aims: Although H .  pylor i  is strongly associated with peptic 
ulcer disease, several studies showed no relationship between H. pylon' 
infection and gastroduodenal ulcer in liver cirrhosis. The aini of this study 
was to investigate the appearance of peptic ulcer in patients with liver 
cirrhosis and the role of Helicohacter pylori infection. 
Materials and methods: The severity of cirrhosis was ascecsed by Child 
grading. Number ofpatients was 180 and consisted of60 patients of grade A 
(42 men; 16 women; mean age, 43.2 2.3 years), 68 of grade B (48 iiieii; 
20 woman; niean age 47.4 i. 1.8 years) and 52 of grade C (41 men; 11 
woman; mean age 54.8 f 2.8 years). None of the patientc received 
antibiotic5 for at least 3 months prior to exanunation Ln all patients, 
diagnostic upper endoscopy was performed, and gastric biopsies were taken 
from antiuin and corpus (n= 4) for histological exannnation and dingnoris of 
H. pylon'. If patients were H. pylori positive. H .  pylori  infection was 
determined by anti-Helicohacter pylori IgG titre before and after treatiiient.- 
They were treated 2 weeks with aiiioxicillin (3 x 500 ing) aiid onieprazole 
(2 x 20 nig). 
Results: According to Child grading, 21.67% ofgrade A, 17.65% o f p d e  B 
and 19.23% of grade C had duodenal ulcer. Gastric ulcer had 10.00% 
patients of grade A, 35.29% of grade B and 44.23% of grade C. The H. p ) h i  
prevalence revealed no difference among cirrhotic? with Child A 
(78.3%),Child B (72.06%) and Child C (78.8%) (P=O.$).Thrre also was 
no difference in the H. pylori prevalence between cirrhotic patients with and 
without peptic ulcers (84.1% vs. 69.6% P=0,09) or with and without 
congestive gastropathy (77.9% vs. 73.1%). P z 0 . 8 ) .  After six month of 
treatment anti-Helifoharterpylori IgG titre was not significantly lower (Child 
A 33.1%; Child B 22.8%; Chdd C 19.8%). 
Conclusions: We conclude that peptic ulcer disease in our cirrhotic patiriitr is 
very 6equent. The association between H. pylon' infection and peptic ulcer 
diseare is weak in liver cirrhosis. Reduced gastric mucoral defence may 
account for the pathogenesis of gastrointestinal lesions. We cuggest that thrre is 
no need for routine eradication of H. pylon infection in cirrhotic patients. 
vl Helicobacter pylori infection and the normal 
microflora of the stomach 
K. LBivukene, H.  Kolk, H.  Maaroo?, M. Mikelsaar 
Tonu, EE 
Objective: To charactenze the microflora of the stoinach qualitatively and 
quantitatively in comparison with the colonisation rate of H. pylon. 
Methods: 64 adult patients with gastritis ( 5 )  and peptic ulcer (59) were 
included concecutively. For nllcrobiological investigation one biopsy sample 
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from the antrum and one from the gastric corpus were obtained and placed 
uito Stuart Transport Medium. H. pylori was isolated on the Columbia Agar 
Base supplemented with 7% horse blood and 1% Isovitalex. The plates were 
incubated for 3 4  days at 37°C under nlicroaerophilic conditions 
(CanipyGen Oxoid). H .  pylon was identified by Grain staining and by 
oxidase, catalase and urease reactions. Aerobes were isolated on Blood Agar 
plates, incubated under aerobic conditions for 1-2 days and identified using 
standard methods. The lactobacfi were isolated on MKS agar, incubated by 
CO2 for 3 days and identified according to colonial and cellular 
morphologies and negative catalase reaction. The anaerobes were isolated 
on Wilkin-Chalgren Agar supplemented with 5% horse blood and 
incubated in anaerobic glove box (Sheldon Manufacturing Inc.) for 2-4 
days. The anaerobes were identified by colonial and cellular morphologies 
and biochemical properties. The degree of colonisation was scored from 
low (1) to high (4). 
Results: D ~ e r e n t  groups of nlicrobes (streptococci, enterococci, staphylo- 
cocci, lactobacilli, enterobactena, yeasts, anaerobic cocci and rod) were found. 
On the stomach niucosa aerobic Gran-positive cocci were the predominant 
colonizers. In 10 cases, no growth was established. In H. pylon negahve cases 
(29) the mean colonisation rate was 2.8 in anhum and 2.6 in corpus vs. 1.2 in 
antrum and 1.1 in corpus in H. pylon positive patients. The presence of H. 
pylon' decreased significantly the growth of other nlicrobes ( P  < 0,001) both in 
antrum and corpus. In only H. pylon positive cases (11) mean values were 2 in 
antrum and 1.5 in corpus vs. 1.6 and 1 with the presence of other microbes. 
No statistically siginficant differences were found between the colomsation rate 
of H. pylmi with and without the other nlicrobes. 
Conclusions: Aerobic grain-positive cocci were predominant coloiusers ni 
H. pylon positive and negative patients. The colonisation rate of H. p y l w i  
was not influenced by the other nlicrobes yet, H. pylori suppressed 
significantly the intensity of mucosal colonisation with aerobes and 
anaerobes. Thus, in gastnc ecology H. pylon' seenis to outcompetr the 
microflora of the stomach. 
lp'1544/ Evidence that Helicobacter py/ori belongs to the oral 
microflora of humans 
G. Bode, G. Adler, Q. Song, A. Spahr 
Ulm, D; Atlortra, USA 
We recently could show, that only the primer pair EHC-U/EHC-L, 
directed to the 860-by DNA of H. pylon', revealed a high specificity and 
wnsitivity for detecting H. pylon' in the oral cavity. Using this primer and 
nested PCR as well as Southeni hybridization, we have evidence, that H .  
pylon' belongs to the oral nlicroflora of humans: (1) H .  pylon' is present in all 
oral samples of patients (168/180), except in patients (11 = 12) recently 
treated with antibiotics and/or in smokers (< 15 cigarettedday). (2) The 
C-urea breath test performed in 129 patients (n=39  H. pylon' positive; 
30.2%) shows, that the prevalence in the oral cavity is independent from the 
infection in the stomach. (3) The prevalence of H. pylon' showed a 
characteristic distribution in dental plaque from molars (82%~)~ premolars 
(64%), incisors (59%), and in saliva (55%), and is therefore not random. (4) 
Quantitation of H. pylori in dental plaque samples by competitive PCR, 
thawed in most saniples (79%) less than 50 H. pylori organisms in 1 mg of 
dental plaque. The number of H. pylon' is negatively correlated with the 
smoking status. (5) DNA sequencing of the nested PCR products 
demonstrated that all tested PCR products of the expected size from the 
oral saniples have more than 97% identity with that froni H. pylori type 
Strdln ATCC 43629. Furthennore, sequences differed in oral saniples from 
different subjects as well as between different oral locations. Therefore, the 
oral cavity may be a permanent reservoir for H. pylori and can harbour 
inultiple strains at the same time. These results confimi the possibility that 
H. pylori belongs to the oral microflora of humans. 
I3 
Detection of Helicobacter pylori DNA in the mouths 
and stomachs of a Venezuelan population using PCR 
A. Berroteran, M. Perrant., M. Correnti, M. Cavazza, C. Tombazzi, R. 
Goncalvez 
Caracas, YV 
Helicobarter pylon' is one of the most comnion bacterial infections worldwide. 
I t  is associated with chronic gastritis, ulcer disease and is a risk factor for 
gastric cancers. The nlicroorganism may be transmitted orally and has been 
detected in dental plaque, saliva and faeces, but the hypothesis that oral 
microflora may be a permanent reservoir of H. pylon' is still controversial. The 
aim of this study was to determine the presence of Helicobacfer pylon' in the 
gastric anhuni and dental plaque of a Venezuelan population by PCR. 
Thirty-two patients from the Clinical Hospital Umversity, Central University 
of Venezuela attending for routine gastroscopy and 20 asymptonlatic subjects 
(control group) were evaluated. Gastric antrum biopsies were taken for 
histological examination and Polymerase chain reaction (PCR). Supragingival 
plaque were collected prior to undergoing endoscopy. The samples for 
detection by PCR were stored at -20 "C prior to specimen processing. H .  
pylon was detected by PCR of gastric biopsies in 24/32 (75%) patients all of 
whom had chronic gastritis. This organism was also recovered by PCR of 
dental plaque in 12/32 (37.5%) of the patients. In the 58% (7/12) of the 
subjects we identified H. pylon' in the gastric biopsy too. In the control group 
we identified H. pylon DNA in 3/20 (7.5%) of the subjects evaluated. We 
concluded that the oral cavity may be an important resexvoir for H .  pylon' and 
the detection of this bacteria at various sites in patients with gastritts indicates 
that oralspread is a potential route of transmission. 
/p15461 Reliability of H. pylori detection in faeces in the 
elderly 
M. J. Gomez Miguel, A. Pietroiusti, S. Mariotti, M. Fini, G. Palniieri, I .  
Luzzi 
Rome, I 
An enzyme immunoassay for H. pylori antigen detection in stools (HpSA) 
has been proposed as a reliable, non invasive test for the detection of H .  
pyloi?' infection. Available data report high levels of sensitlvity and specificity 
of the test in adults and children, and suggest that HpSA is as reliable as urea 
breath test in detecting H. pylon' infection in adult dyspeptic patients. 
However, studies focusing on elderly dyspeptic patients are not available a t  
present. Aim of this study was to evaluate the reliability of the test In this 
later population. It has also been used to analyse the association between H. 
pylori infection and gastroduodenal lesions in elderly patients in conipanson 
to younger ones, to evaluate its possible use as pre-endoscopic screening test 
for the identification of elderly patients at risk for duodenal lesions. Stools 
specimens from 53 patients older than 64 years (group t), and from 60 
patients younger than 65 years (group 2) were tested. From each patient, six 
endoscopic biopsies were taken for histology and H. pylon' detection 
(Gienisa, culture and rapid urease test). Panents were defined as infected if 
histology and urease test were positive, or if culture was positive. The 
sensitivity and specificity of the test were 84.4% and loo%), respectively, in 
group 1, vs. 89.7% and 76.9%, respectively, in group 2. In group 1, the test 
was positive in 11/23 (47.8%) patients with endotcopic lesions, and in 20/ 
30 (66.7%) patients without endoscopic lesions (P= NS). When gastric 
atrophy and/or metaplasia were considered, 12/17 (70.6%) and 19/36 
(52.8%) patients having or not these histological findings, respectively, were 
positive for the HpSA. In group 2, the test was positive in 18/25 (72%) 
patients with endoscopic lesions, and in 15/35 (42.9%) patients without 
endoscopic lesions ( P  < 0.05). In this group, HpSA test was positive in 10/ 
12 (62.5%) and in 22/42 (52.5%)) patients with or without gastric atrophy 
and/or metaplasia, respectively ( P =  NS). 
Conclusions: HpSA test is adequate in detecting H .  pylori infection in elderly 
patients. However, it cannot be reconmended a$ a pre-endoscopic 
screening test in this population. 
lp1547/ Short-term (6 weeks) evaluation of Helicobacter 
pylori serology of patients given antibiotic treatment 
E. Baktir, H. Yerci, T. Unal, A. T. Erten, Y. Acar, A. E. Karakoq, N. Acar 
Aizkara, TR 
Although Helicobarter pylon' serology, in particular enzyme-linked imiuno-  
sorbeiit assays for the rnrasurenient of immunoglobulin G (Ig G) antibody 
titres is accepted as an accurate means of diagnosing H .  pylon' infection in 
patients before treatment, they are of limited value in inonitonng treatment 
because of the slow decline in antibody titres. On the other hand since Cag 
A protein relates to differences in virulence among H .  yylori strains, 
antibodies against this protein have been investigated in relation to the 
clinical presentation and clinical outcome of H. pylori infections. In the 
present study we aimed to assess the decrease in H. pylori Ig G and Cag-A Ig 
G antibody levels after treatment and to determine the sensitivity of a 20% 
decline in antibody titres for determining H. pylori eradication. Serum 
samples of 68 patients with dyspeptic complaints and H. pylon' colonization 
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were tested with the ELISA technique (RADIM) for H. pylori Ig G and 
Cag-A Ig G antibodies before therapy and 6 weeks after therapy. Fourteen 
of 68 patient5 (20.6%) developed no systemic immune response to H. pylori. 
The initial diagnosis of H. pylori dec t ion  had been made by hstology and 
culture of the endoscopic biopsy specimens; Eradication of infection was 
confirmed in 44 of 68 patients (64.7%) using hstologic examination and 
culture of a repeat biopsy specimen 6 weeks after therapy. ELISA antibody 
titres kom H. pyluri Ig G had decreased &om a median value of 41.5-33.0 
units ( P  < 0.001), and Cag A Ig G antibody titres from a median value of 
39.5-20.5 units ( P  < 0.001). Regarding seroreversion none of the patient 
samples reverted to ‘negative’. The sensitivity of a 20% decline in anti-H. 
pylori Ig G was found to be 82.9% whereas same value for anti-Cag A Ig G 
was 75.9%. In conclusion serology, in particular anti-H. pylon’ Ig G, taking 
into consideration a 20% decline after a 6-weeks interval is an alternative to 
endoscopy in monitoring patients after H. pylori treatment; yet without 
elinlinating the need for a biopsy specimen for culture and histology. 
(p15481 Detection of Helicobacter pylori antigen in stool 
specimens taken from infected patients before and after 
treatment 
G. Gosciniak, A. Przondo-Mordarska, B. Iwanczak 
Wrorlutu, PL 
Objectives: Detemlination of Helicobacter pylori eradication raises problems. 
Currently, use is made of endoscopy with biopsy or of the urea breath test. 
The aim of the study was to assess the diagnostic value of the HpSA test 
before and after eradicating therapy. 
Methods: Our study included 42 H. pylon’-positive chddren with dyspeptic 
symptoms who were examined by upper gastrointestinal endoscopy. H. 
pylori infection was diagnosed by culture of gastric niucosa before treatment 
(clarithroniycin, amoxicillin, onieprazole for 7 days) and after 3 months 
following treatment. Stool samples were taken at the time of biopsy. They 
were stored in -20°C until they were tested by HpSA (Prenlier Platinum, 
Meridian Diagnostics, Inc, Cincinnati, USA). Sensitivity and specificity of 
HpSA were calculated 011 the basis of culture results. 
Results: Before therapy, stool antigen was detected in 37 out of42 H. pylori- 
positive patients, which indicates that the sensitivity of the test was 88.1%. 
After therapy eradication was obtained (and confinned by culture) in 35 out 
of 42 subjects. When use made of the HpSA test, the proportion was 34 out 
of 42. Sensitivity, specificity, PPV and NPV of HpSA were 85%, 94.4% 
77.8% and 97.1%, respectively. 
Conclusion: The accuracy of the HpSA test for the detection of H. pylori in 
human stool 3 months after treatment is comparable with the accuracy of 
the culture results. 
v/ Development of antibiotic resistance surveillance for 
Helicobacter pylori infecting dyspeptics in south-east England-a 
review of progress 
N. C. Elviss, R. J. Owen, E. L. Teare, A. Breathnach, N. Shetty 
Loridort, Ckelmsford, UK 
Objective: First line therapy for treatment of Helicobacter pylori infections of 
the gastric mucosa use triple therapy comprising a proton pump inhibitor, 
clarithromycin and ainoxycfin or metronidazole. The development of 
antibiotic resistance is a key contributing factor to treatment failure in 
approxiniately 10% of patients. Our aim was to develop surveillance to 
identify trends in resistance of isolates from patients undergoing routine 
endoscopic investigation at three centres in SE England. 
Methods: Gastric antral biopsies were despatched in Helicobacter transport 
medium to amve at CPHL within 24 h (about 18/week). Each sample, 
where possible, was accompanied by a specially designed form, completed 
by the gastroenterologMmicrobiologist, to provide relevant background 
clinical details. Biopsies were cultured inmiediately and H. pylon’ isolates 
were tested for susceptibility to clarithromycin and metronidazole using disc 
diffusion and E-test. 
Results: T o  date the average isolation rate is 25%. For the London centres (9 
month period), 61.4% of isolates were resistant to at least one of the 
antibiotics with 51% resistant to just metronidazole, 3.1% resistant to just 
clarithromycin and 7.3% showed dual resistance. Resistance rates were 
markedly higher for individuals born outside the UK. For mid-Essex (5-year 
period) the rates were lower at 38.8%, 34.6%, 1.7% and 2.5% respectively, 
and rates were relatively stable over the surveillance period. 
Conclusions: Resistance to nietronidazole was the most distinctive feature 
of the H. pylori isolates with a marked difference between resistance levels 
in mid-Essex and in London (38.8% vs. 61.4%). A small trend indicating 
dual resistance to both metronidazole and clarithroniyciri in some strains 
needs to be closely monitored as it effects the efficacy of first-line therapy. 
Birth outside the UK was identified as a major risk factor for infection 
with a metronidazole resktant strain irrespective of gender. Age appeared 
to have no significance in relation to antibiotic susceptibility. Our 
findings highlight the importance of continued surveillance of resistance 
in local communities. 
v1 In vitro resistance of H. pylori to metronidazole and 
clarithromycin: a quadrennial retrospective investigation on the 
impact of age, gender, secondary resistance and resistance 
stability of clarithromycin 
M. Zanetti, 0. Pieramico, R. Vendramin 
Meruno, I 
The prevalence of in uitro resistance to metronidazole (MTR) and clarinoniycin 
(CLA), which are widely used in association with a proton pump inhibitor for 
cure of H. pylon (HP) infection, Mers according to the geographical area and 
may have an important impact on the efficaq of therapy. 
Aim: to investigate the prevalence of M T R  and CLA resistance in HP 
infected patients and its relationship to gender, age, onset of secondary 
resistance over a 4-year period. 
Patients and methods: A total of 711 patients with HI’ itlfection (381 M, 330 
F, range 1&75 years, mean age 46.5 years) were included. HP infection was 
assessed by histology, rapid urease test, and culture (antrum and corpus) before 
and 6-10 weeks after eradication therapy. Culture was performed using a 
selective blood-€-re agar (pylon-agar) and then HP-positive cultures were 
tested for MTR and CLA resistance with the disk-&sion t e c h q u e  with 
break-points according to the most recent literature. 22 cultures with CLA 
resistance were further subcultured (20-25 tinies) in agar Midler-Hinton with 
5% (sheep) blood in order to evaluate the stability of CLA resistance. 
Results: Prevalence of MTR resistance was higher in women (36.4%) than 
in nien (28.6%); CLA resistance was 19.1% in women and 14.7% in nien. 
The distribution of M T R  and CLA resistance according to age groups 
showed two peaks in patients between 35 and 50 years and in patients > 65 
years; secondary resistance was observed in Y patients (36.9%) being 15.8% 
(3/19) for M T R  and 21.1% (4/1Y) for CLA. Resistance to CLA was stable 
in 13/22 (59.1%)) of cultures and reversible in 40.9% (9/22). 
Conclusions: (1) prevalence of M T R  resistance is almost twice higher than 
CLA resistance in our region; (2) M T R  resistance is more Gequent in 
females; (3) prevalence of M T R  and CLA resistance is higher in age groups 
between 35 and 50 years and > 65 years; (4) secondary resistance develops 
in 36.9% of positive cultures after therapy; (5)  in uitro resistance to CLA is 
stable in almost 60% of cultures. 
1 P I  551 I Clarithromycin resistance detection of Helicobacter 
pylori with PCR-restriction fragment length polymorphism 
J. 0. Kang, K. S. Kim, D. Han, I. K. Park, T. Y. Choi 
Kuri, Seoul, KOR 
Objective: Resistance to clarithromycin is a major cause of treatment failure 
of peptic ulcer disease infected with Helicobacter pylon’. Clarithromyciu 
resistance is associated with single base mutations withiii the peptidyl- 
transferase-encoding region of the 23s rRNA gene. In Korea, there have 
been few reports on the point mutation study for the detection of 
clarithromycin resistance. 
Method: We examined 9 resistant (MIC 61 mg/L) and 14 sensitive (MIC 
< 0.5 mg/L) strains of H. pylon’. Genomic DNA was extracted and 
amplified for the peptidyltransferase region of the 23s rRNA (GenUank 
accession no., U27270). Forward primer from position 1820-1839 and a 
reverse primer from position 2244-2225 were used to amplify a 425-bp 
fragment. Ten uL of the aniplicon were treated with restriction enzyme Bsa 
I (2144 A al&) or Bbs I (2143 A alleG) and separated by electrophoresis. 
Result: AU 23 strains were I’CK positive. Among the 9 resistant strains, 6 
strains were found to have A to G mutation at position 2144, but 3 strains 
were not restricted with both enzymes. 
Conclusion: We confirmed the nutations of A a l z G  at position 2144, but 
2143 A a l &  mutation was not found. The new NCCLS, USA, guideline 
of clarithroniycin MIC for resistance (alAl mg/L) found to be reasonable. 
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(p15521 Suggestion of modified broth microdilution method 
as a routine method for antimicrobial susceptibility testing of 
Helicobacter pylori 
J. 0. Kang, K. S. Kim, D. Han, I. K. Park, T. Y. Choi 
Kuri, Seoul, KOR 
Introduction: Aiitinlicrobial resistance among Helimbarter pylori (H. pylon) 
strains results in the increased incidence of treatment failure of peptic ulcer 
diseases. Therefore, reliable methods for detemining the susceptibdity 
testing are very important. In 1999, NCCLS of USA proposed the agar 
dilution method ac a reference method. But this method is tmie-consuming 
Candida spp: pathogenesis and clinic 
and tedious, not adequate for a few clinical isolates. We developed a 
modified broth microdilution method for routine susceptibility testing and 
compared it with the NCCLS method. 
Methods: With 43 clinical itolates of H. pyluri, antimicrobial suqceptibility tests 
for nietronidazole were perfomied by modified broth microdilution method 
and compared with the reference agar dilution method (NCCLS, 1999). 
Results: Withiti-1-dilution agreement in MIC was 93.0% and agreement of 
susceptibility categories was 95.3% between the two methods. 
Conclusion: The correlation of niodified broth nlicrodilution and the 
NCCLS agar dilution method is high enough, so it could be recommended 
for routine nietroiidazole susceptibihty testing method for clinical isolates 
of H. pylori. 
(p15531 Molecular typing of Candida parapsilosis isolates 
from patients and healthcare workers by pulsed field gel 
electrophoresis 
J. H. Shin, D. H.  Shin, J. W .  Song, S. J. Kee, S. 1’. Suh, D. W. Ryang 
KiiiaiiyjrJ, KOR 
Cairdidu ynrupsiiosis has become iiicreaslligly important as a prevalent yeast 
species in catheter-related bloodstreani infections. The epidemiology of 
nosoconlial C. parapsikicir is sd undefined and may involve sources such as 
hospital enviromient and hands of health care worken (HCWs). W e  
perfomied the molecular typing of C. parapsikisis isolates from patients with 
blood5aeam infections and from hands of HCWs at the same hospital and 
compared them. A total of 63 C .  pavapsilosis strains including blood ( n  = 20) 
and catheter ( 1 1  = 20) isolates &om 20 patients and isolates from hands of 18 
HCWs (ii = 23) were analyzed. All isolates were collected between May 1998 
and Apnl 2000. Isolates from hands of HCWs were obtained from three 
surveillance culture5 at the hospital during the study period. Molecular typing 
was pedomied by electrophoretic karyotyping plus restriction endonuclease 
analysis with Sfil followed by pulsed-field gel electrophoresis (PFGE). PFGE 
separated 63 itolates into 34 distinct types. For blood isolates, a total of 17 
different DNA types were identified among 20 isolates &om 20 patient?: one 
saairi type (pattern A) was shared by 4 isolates from 4 patients (20%). The 
catheter strain koni each patient exhibited the same PFGE pattern with the 
blood isolate. Of23  manis from 18 HCWs, a total of 17 ditferent DNA types 
were identified and 4 DNA types were shared by 9 isolates from 9 HCWs 
(39‘3,). All isolates from HCWs showed different PFGE patterns from blood 
isolates except oiie: the same ‘ A  pattern wac found in one isolate from the 
hand of a HCW. These results suggest the apparent intrahospital spread of C. 
parquilorir among HCWs, and between patients and HCW. 
v/ Emergence of Candida parapsilosis fungaemia as the 
dominant non-albicans Candida species blood stream infection 
at a cancer centre in New York 
A. Safdar, D. Perhn, D. Aniistrong 
Colirrtihia, Neiu Yo&, US4 
Introduction: Nosocomial fungaenlia in patients with an underlying 
malignancy are frequently associated with higher morbidq  and mortality 
coinpare to bacteraemia. Cariifida alhitarrs and C. frupitalir are highly 
virulence species and recently fungeinia due to C. krusei and C. glabrata were 
observed to cignificantly compromised host survival. 
Objective: T o  assess interval distribution of Caiidida species associated with 
blood stream infections in patients with cancer. 
Methods: Retrospective review of Caridida species isolated from blood 
culture specimens was performed from 1 January 1 1993 to 31 December 31 
1998 ‘A’ a t  Memorial Sloan-Kettering Cancer Center (MSKCC), New 
York. Thew results were conipared with pnor studies during 1978-82 ‘B’ 
Results: I h n i i g  1993-98, 569 blood culture specimens grew Caridida 
species, and overall prevalence of C. albiraris was 40.596, 44.5%, 38.9% for 
the study peiiods ‘ A ,  ‘B’ and ‘C’, reypectively. Candidu species other than 
C.  nlhiimrs was 59.4%1 (A), 55.5% (B) and 61.1% during 1974-77. Caridida 
fropiiolis was the predominant Caridida species in the non-albicaris group at 
and 1974-77 ‘c’. 
our center until 1994 (‘B’ 45.9%; ‘C’ 34.9% and ‘1994’ 36.3%). A tignificant 
change was observed since 1995, when C. pavupsilosir (59.4%)) emerged 3s 
the most conmon species in this group (P= < 0.00 1). A significant decline 
in C. frupicalis fungaemia was also noticed from 1974 to 82 (41.2% to 26.6‘%, 
during 1993-98)(P= < 0.001). 
Conclusions: The underlying mechanisnis for this shift in the non-C. 
albiraris species are uncertain. W e  suspect that widespread use of indwelling 
intravascular devices and routine use of aniphotericin B for enipiric; 
preemptive antifungal therapy at MSKCC niay have positively influenced 
this shift towards less virulent Caridida species. 
v1 Impact of Candida species colonization on mortality 
in patients with cancer 
A. Safdar, D. Perlin, D. Armstrong 
Coluinbia, New Yo&, USA 
Introduction: The invasive yeast infections invariably anse from patients 
endogenous nlicroflon wch as gastrointestinal tract, genitourinary tract and 
the integument. The degree of Caridida colonization IF recognized as an 
important predictor for systemic infection in the susceptible host. 
Objective: T o  determine the relationship between heavy colonization with 
Carrdida species in patients with malignancies and impact on short-term 
survival. 
Methods: W e  performed a prospective evaluation during the later half of 
1998 a t  a tertiary cancer center in New York City. Heavy Caridida species 
colonization was defined as > 50 yeast colonies from a noiisterile site. 
Results: All 223 patients were followed for 14 weeks after cultures were 
obtained. Ten patients had AIDS, 13 benign conditions and 210 had an 
underlying cancer. Among patients with cancer 138 had solid organ 
malignancy and 53 hematologic cancer and in 21 blood or marrow 
transplantation recipients, 18 received allogeneic grafts. Overall 59 patients 
died, 53.4% with haematological cancer, 55.5% marrow transplant 
recipients, 36.2% with organ malignancy. No deaths were observed in 
patients with AiDS and oiie patient (7.6%) expired in noninmiunoconi- 
promised group. The highest death association with CatidIda species 
colonization wac observed among patients with non-Hodglun’s lymphoma 
(62.5%), multiple myeloma (80%), myelodysplastic syndrome (75%) and 
CML (60%). Lung cancer (80%), Breast (76.5’%), and colorectal (72.3’3)) 
patients had better short-term survival in this setting. 
Conclusions: This casual relationship between high-level Caridida species 
colonization and markedly compromised short-tenn survival in patients 
with haematological cancer may suggest as an important predictor of near- 
future systemic candidiasis among the highly susceptible patient population. 
jP15561 Reidentification of Candida dubliniensis isolates 
among C. afbicans strains isolated from debilitated or 
immunocompromised patients in a Turkish university hospital 
A. S. Kantarcioglu, A. Yucel 
Isfarihul, TR 
This study was undertaken to reevaluate C. nlhirans strains of clinical ongin 
for the presence of C. dubliniensis isolates among them. 129 C. nlbirarrs 
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strains isolated from oral cavity ( f z =  31), respiratory tract (ti = W), vagina 
(n = 27) and feces (ri = 12) were previously identified based on their ability 
to produce germ tubes and chlamydoconidia.The isolates were obtained 
from debilitated and immunocompromised patients due to various causes, 
i.e. malignancy and corticosteroids, neutropenia, extensive surgery and 
previous antibiotic usage, diabetes mellitus and others; whose HIV status 
were unknown except two HIV-seropositive ones. Six methods each 
proposed as a reliable for the daerentiation of the two species were used 
together. O n  Staib agar 19 of 129 isolates formed rough colonies the others 
produced smooth ones. O n  cornmeal Tween 80 agar abundant chlaniy- 
doconidiuni production in unusal configurations was seen in 17 of them 
(17/129). On methyl blue Sabouraud agar 116 of 129 isolates fluoresce under 
Wood's light and others (13/17) f d  to fluoresce. N o  growth occured at 45°C 
degrees in 10 of 13 strains (10/129). Wickerham medium with carbohydrates 
and bromcresol purple indicator was used for assimilation tests which were all 
positive for glucose, maltose, galactose and negative for lactose, melibiose, 
cellobiose, inositol, rafinose and dulcitol. Only one isolate was sucrose 
negative and the others wac positive. Trehalose assimilation u-as negative in 
five of the 10 (3129) and xylose utilisation was negative in three isolates (3/ 
12'9) and was positive in all the rest. Three C. albicans strams isolated two from 
oral cavity, one from sputum were reidentified as C. drrb/inietzsis. The sucrose 
negative isolate was assessed as C. stellufoidea vanant. Testing by NCCLS 
M27-A macrodilution method isolates were all susceptible in vim to 
amphotencin B (MIC range 0.125-0.5 pg/mL), resistant to fluconazole and 
ketoconazole (MICs > 64 and > 16 inkg/mL, respechvely), dose dependent 
to itraconazole (MIC range 0.25-0.5 pg/mL) and susceptible to flucytosine 
(MIC range 1-4 pg/nL). One of the oral cavity strains and that koni sputum 
were obtained at intervals &om the same patient with AML, the other oral 
cavity strain was obtained from a patient who have previously been irradiated 
for a laryngeal malignancy. This results indicated the need for further 
investigations into the prevalence and pathogenesis of C. dublittiensis including 
HIV negative patients with ininiunsuppression. 
p15571 Survey of candidosis in three representative tertiary 
care Greek hospitals: a preliminary report 
E. Fannaki, P. N.  Panagopoulou, A. Kanta, M. Anatoliotaki, E. lioilides, 
G. Petnkkos, G. Samonis, for the Greek Invasive Mycoses Study Group 
Thessaloniki, Atheris, Hcraklion, CR 
Objective: T o  study the incidence and epidemiology of invasive Cuitdida 
infections (IC) in 3 tertiary care Greek hospitals. 
Methods: A 10-month prospective survey was performed in 3 geographi- 
cally diverse hospitals (Thessaloniki, Athens, Heraklion). Cases of IC were 
recorded through active surveillance in each hospital from Jan to Oct 2000. 
Patient characteristics, underlying conditions, risk factors and outcome were 
obtained by reviewing their medical records. 
Results: During the study period, 37 patients (8 premature neonates, 7 
children and 22 adults) developed equal number of documented IC with an 
incidence ranging from 0.26 to 0.45/1000 admissions among the 3 hospitals. 
There were 28 cases of candidaemia, 4 of pneumonia, 3 of peritonitis and 2 
of pyelonephritis Among 37 isolates, the most frequent Cavdida spp. were 
C. albicatis in 46%. C. parapsilosis in 27%, C. tropicalis and C. glabrata in 11% 
each. There was considerable variation of species isolated in different patient 
groups. Thus, C. parapsihis was found to be the predominant isolate in 
neonates and chddren (47% vs. 14% for adults, P =  0.056) and C. flabrota in 
haematology/oncology patients (37.5% vs. 3.4% for other patients, 
P= 0.026). Underlying conditions were prematurity (22%), haematologi- 
cal/oncologc disorders (19%) and other diseases consisting mostly of severe 
abdominal diseases/surgery and diabetes mellitus (59%). Approximately 50% 
of these infections occurred in NICU or ICU. Other risk factors were 
immunosuppression, corticosteroid and broad spectrum antibiotic use, total 
parenteral nutrition and major surgery. The overall attributable mortality 
rate was 21% with some variation between neonates and patient$ with 
hematologic disorderc (0/8 vs. 3/6, respectively, P =  0.05), but not among 
different Candido spp. A higher incidence of infections due to C. parapsilusi.v 
was observed in Thessaloniki (45% of Catidida spp. isolated) possibly due to 
increased hequency among neonates (37'%) and patients with abdominal 
diseasedsurgery (86%). 
Conclusions: IC was not limited to inlmutioconipromised hosts as more 
than half of the patients were imniunocompetent. While C. albicans 
continues to be leading cause of Catidida infections, non-albicans spp. 
predominate in paediatric and haeniatological patients. Vigorous surveil- 
lance is needed for new trends in aetiology and host susceptibility of IC. 
Support: PENED'99 no. 99ED14 
lp1558) Virulence factors of Candida spp. and persistence of 
candiduria in patients with urinary catheters 
H. Akahn, U. Enrr, F. Kahveci, S. Akpglar, S .  Gurcan, 0. Tore 
Bursa, TR 
I n  this study, the patients who had developed candiduria in the intensive 
care unit (medical and surgical) (ICU) were followed prospectively for 
persistence of candiduria after changed of indwelling urethral catheter and 
the correlation between persistence and virulence factors such as proteinase 
enzyme activity, epithelial adhesion were investigated. Inclusion criteria of 
the study were; presence of indwelling urethral catheter, received broad 
spectrum antibiotic therapy during candiduria. not received .intifungal 
therapy before enrolment, not received corticosteroid and imniunosupres- 
sive therapy, absence of HIV infection and neutropenia and absence of 
SIRS. Candiduria was defined as the presence in cultures of 2 10' cfu/mL. 
When the candiduria was detected, catheter was changed and a second urine 
culture was performed within 24-72 h. The clearence was defined as the 
absence of the growth in second urine culture and persistence was defined ac 
the presence of the growth of the same Carrdida spp. (persistence of 
candiduria) in second urine culture. This study was conducted from January 
1997 to December 1998 and 459 patients who were hospitalized in ICU 
were followed prospectively. O f  the 459 patients, 53 had candiduna (1 1.5%) 
and 4 of the 53 patients who had candiduria developed candidaenua (7.5'59. 
Thirty-four patients with candiduria who met the inclusion criteria of the 
study were included. There were 16 females and 18 malec with a mean age 
of 58 years. Candiduria persisted in 19 of 34 patients(56%)(group 1) and 
cleat-ed in 15 of 34 patie1its(44%)(group 2) after urinary catheter was 
changed. When we coinpared for epithelial adhesion, proteinase activity 
and distribution of Candida spp., no statistically significant difference7 were 
found between two groups (Table 1). The persistence was significantly 
higher in niales than females (14/18 vs. 5/16, P < 0.05). In conclusion, the 
correlation between virulence factors of Cmdida spp. and persistence or 
clearence of candiduria was found to be statistically not significant in thic 
study. However, we need further studies because of the limited number of 
patients who included in our study 
(p1559/ Characteristics of a patient population with funguria 
in a general medical department 
E. Karabatsaki, E. Kalogeropoulou, C. Kakan-Tsiropina, G. Ganteris, A 
Strouza-Koutsougera, P. Tsiodra, E. Malaniou-Lada, A. Efitratopoulos 
Atliens, GR 
Objective: To study the characteristics of the patients that, while ti-eated in a 
general medical department, were found to have fungal growth in their 
urine cultures. 
Methods: After reviewing the results of urine cultures of all patients 
admitted in our department in a three-year period. we studied the records of 
those found to have fungus isolated in their urine cultures and analyzed their 
clinical and laboratory findings. 
Results: Fungal growth was present in 41 of the 1250 urine cultures (3.3%)). 
Fifteen of the patients were male (36.6%) and 26 were teniale (63.4%), of a 
mean age of 72.7 years (standard deviation 11.75 years). Funguria was 
associated with fever in 3 cases (7.3%). Dysuria was reported by 4 patients 
(9.7%). Urinalysis revealed pyuria [more than 5 WBCs per high power 
field (HPF)] in 30 cases (73.2%) and 9 patients had more than 50 W C s /  
HPF. Haematuna (more than 5 RBCs/HPF) was noted in 2 cases (4.87%). 
Of the total of patients with funguna, 28 have been receiving antibiotics 
(68.3%), 27 had a urinary catheter (6S.85%), 17 had an infection of another 
system (41.46%). 15 had a niahgnancy (36.55%), 14 had diabetes mellitus 
(34.15%), 4 had been receiving steroid therapy (9.76%1) and 1 had liver 
cirrhosis (2.43%) Cattdida albirarts has been isolated in 60% of the cases. Six 
of the patients with funguria died (14.6%). 
Conclusions: Funguria is present in less than 5% of the patients in a medical 
department and it can be asyniptoinatic in the majority of the cases. The 
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most important factors predisposing to funguria are antibiotic treatment and 
bladder catheterisation. 
Fungaemia in elderly patients 
G. Kovacicova, K. Babela, M. Lovaszova, 1. Svetlansky, M. Gogova, V. 
Krcmery 
Bratislava, SK 
Introduction and objective: There is little published about fungaemia in 
elderly, despite geriatnc patients are known to have different clinical course 
and worse prognosis of various infections. Here we present an experience 
on aetiology, clinical characteristics, risk factors and outcome of 
candidaeinia in 20 patients who were 70 and more years old selected from 
a 10-years survey on  fungaemia in Slovakia. 
Results: Eight of 20 cases (median age 73.2) had cancer, 10 diabetes and 14 
abdominal or thoralic surgery as underlying disease and 18 of 20 were 
pretreated with broad spectrum antibiotics, 16 of 20 had central venous 
catheter inserted and 12 of 20 stayed on ICU more than 5 days. C. albirans 
caused fungaenua in 12  and non-albicans Carrdida spp. in rest 8 patients (4 C. 
paropsilosis and 4 C. &hrata), and 5 were infected with Carzdida spp. resistant 
to at least 1 antifungal tested. Fluconazol (FLU) was used in 10 and 
ainphotencin B (An@ in 2 cases. 8 patients were not treated at all (6 of 
them died) either because of nialpracnce (mainly in patients after abdominal 
surgery, many surgeons in our country did not consider isolation of Candida 
spp. as indication for systemic antifungal therapy). Overall mortality was 
55%, 30% of elderly patients died on infection (attributable mortality) and 
25% on underlying disease accompanied fungaemia.Concerning risk factors, 
previous surgery (70.0 vs. 21 .O, P < 0.001), C. tropicalis (20.0 vs. 3.4%. P < 
0.01), C. glabrata (20.0 vs. 2.0%, P < 0.002) and absence of antifungal 
therapy (40.0 vs. 17.3%, P < 0.02) were significantly associated with 
fungaeniia in elderly patients in comparison to other patient population. 
Also outcome was mferior-only 45% of elderly patients survived (55% 
overall mortahty) and 30% died on fungaemia (attributable mortality). 
Conclusion: Because of relatively high overall (55%) and also attributable 
mortality (30%) special attention should be given to elderly patients, mainly 
in those with diabetes and after surgery, who show positive blood cultures 
for Carrdida spp. or who do not respond on broad spectrum antibiotic 
therapy and have central venous catheter imerted. Early therapy with FLU 
(which is less nephro-and hepato-toxic as A d )  in those patients should be 
administered as soon 3s possible and vascular catheter (if suspected as source 
of fungaeniia) rapidly exchanged. 
vl Candida spp. and accompanying bacterial flora in 
specimens from patients after surgery 
E. Krzeniinska-Jaskowiak, W. Michalska, Z .  Cybulski, J. Chylak, M. Paul 
PllZllAll, PL 
Objectives: W e  detemiined the incidence of Carrdida spp. strains in 
specimens obtained froin surgically treated patients and analysed the 
accompanying bacteiial aerobic and anaerobic flora. 
Materials and methods: Peritoneal fluid samples (n=Y6)  and colon or  
rectum bioptates ( 1 1  = 73) originated from patients operated on colon or  
rectum cancer were compared with biopsy materials ( n  = 51) obtained from 
patients after a surgical treatment of larynx carcinoma. Other analysed 
specimens from these 2 groups of patients were: pus ( n  = 32), blood (n = 22), 
and wound swabs (11 = 8). The inaterials (except blood) were placed into 
transport media (Biomed) and sent to the nlicrobiological laboratory for 
testing. All specimens were cultured in media selective for isolating of 
aerobic or anaerobic bacteria or C a d i d o  spp. The biochemical typing was 
assessed using the computerized API system (bioMerieux). 
Results: Altogether, 261 various clinical specimens from 165 patients were 
analysed. and 41 Candida spp. 
Strains were isolated: 39 strains of C. albicans and 2 strains of C. tropicalis. In 
2 0  of 41 Catidida spp. infected specimens (48.8%) the coinfechon with 
bacterial aerobic flora was found. In 10 of them (24.4%), the fungi were 
isolated together with aerobic and anaerobic bacterial flora, whereas in 2 
specimens (4.9%) the anaerobes and Candida albicaris were diagnosed. The 
remaining 9 samples showed only the presence of Candida spp. (21.9%). 
Ei?terororrir.~ spp. strains ( n  = 17) and Gram negative rods from Enterobacter- 
iarene family ( 1 1  = 13) were the most frequently isolated as aerobic bacterial 
flora. The bacterial strains of Streptococrns spp. (n = 5), Pseudomonas spp, 
( n =  3 ) ,  Staphylorocrus spp. and Corytrebacterium spp. (2 strains, both) were 
rarer identified. Barteruides spp. were the most frequent members of bacterial 
anaerobic flora (M = 11). Other isolated anaerobic bacteria were classified as 
Fusobacterium spp. or Peptostreptocurcur spp. (1 strain each). E. coli and 
Enterococcus spp. strains of aerobic bacterial flora were more frequently 
isolated together with Candida spp, 
Conclusions: (i) Mixed bacterial flora was the most frequently isolated from 
specimens obtained from the patients after surgery, who were infected with 
Caridida spp. (ii) Candida spp. were more frequently found together with 
aerobic bacterial flora. (iii) However, Candida spp. alone or Candidu spp. 
with anaerobic bacteria were rarely observed in the examined specimens. 
/p15621 Non-albicans Candida spp. fungaemia in a 
hematology unit 
J. Ndewajska, A. Samet 
Gdarisk, PL 
Objectives: The aim of this study was to analyse the epidemiology of non- 
albiravrs fungaemia in a Hematology Unit in the tertiary care hospital. 
Methods: The study involved the patients hospitalized at Hematology Unit 
over the period from 1 January 1997 to 31 December 1999. AU 7078 fungal 
blood cultures were examined using BacT/Alert System (Organon 
Teknika). The identification of Candida species was done with the VITEK 
YBC card (bioMerieux). 
Results: In total, 1438 blood cultures were positive, including 56 fungal 
isolates from 21 patients. The  most common Cantlida species was C. 
parapsilosis (26 strains). During the study period, the proportion of C. 
parapsilosis fungaemia increased from 6 in 1997, to 17 in 1999. It was 
responsible for over 46% of all fungaemia. The incidence of other non- 
albicans species was following: C. glabrata-8, C. krusri-7, C.  lawrhira-4, 
C. rupsa-4 and C. tropicalis-3, T. bekellii-3, comparing to 19 isolates of 
C. albicarzs. 
Conclusion: This study demonstrates the increase in the frequency of non- 
Caridida albicans infection over the past 3 years, in Hematology Unit. C. 
parapsilosis was the leading pathogen which could suggest catheter infections 
as a source of fungaenlla. 
v1 Biotyping and genotyping of Candida albicans strains 
isolated from the oral cavity in HIV-positive patients 
A. Bart, Ab Macura 
Krakow, PL 
Objective: The objective of the study was an evaluation of the enzymatic 
activity and detailed genetic charactenstics of the fungi isolated from HIV- 
positive patients. Those fungi were abundant in the patients' oral cavity. 
The features of these strains were compared with those of the strains isolated 
from healthy volunteers. 
Materials and methods: The hydrolytic activity of 50 C. albicarrs strains 
was evaluated by using an API ZYM test (Bio-Merieux), containing 
substrates for the identification of 19 hydrolases. Biotyping of the strains 
was carried out according to the classification by Williamson and 
Kurnatowska. The genetic characteristics was analysed by using a PCR-  
fingerprinting test. 
Results: There were found some differences between the enzymatic 
activity of the 35 C. albicans strains isolated from the HIV-positive patients, 
and 15 strains originating from healthy persons. The maximum activity was 
found in leucine arylamidase, estarase lipase, and naphtol esterase and 
phosphohydrolase. The biotypes L and M were found most frequently both 
in HIV-positive patients and in the control group. The biotype M in the 
strains originating from HIV-positive patients predisposed to oral 
candidiasis manifestations which was statistically significant ( P  < 0.001). 
A new biotype was described. It was named biotype S. This biotype had 
not been described yet. 
Using PCR-fingerprinting, six genotypes were found in the 2 4  strains 
isolated from HIV-positive patients with symptomatic oral candidiasis; each 
of them concerned more than one strain. The genotypes of 1 1  C. albicans 
strains isolated from healthy volunteers differed from those isolated from 
HIV patients. Four genotypes were found in this group; each of them was 
represented by more than one C. albiram strain. 
Conclusions: (1) The enzymatic activity of the strains originating from HIV 
+ and HIV-patients was comparable. Additionally, biotype S was described 
in the HIV + group. (2) The analysis of C. albicans genotypes revealed a 
considerable variability of the genetic material in both of the groups. 
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[p1564/ Nosocomial candidaemia: a 3-year prospective study 
M. Christofidou, V. Stamouli, A. Svolis, G. Dimitracopoulos 
Patras, GR 
The isolation rate of Carzdida spp. in blood cultures was investigated during 
a period of 3 years. The susceptibility of isolates to antifungal agents was 
determined. 
Methods: Positive blood culture vials (BacT/Alert, Organon Teknika) were 
examined nllcroscopicaly for yeast cells or pseudohyphae and were cultured 
on Sabouraud agar (Difco).The isolates were screened at first by germ hibe 
test and were identified according API 20C AUX (Uiomerieux).The 
susceptibility test (M.1.C) to antifungal agents was carried out by E-test (AB 
Biodisk) for amphotericin B, 5-fluorocytocine, itraconazole, ketoconazole, 
fluconazole. 
Results: From 1998 to 2000, 2604 blood culture samples were positive in 
our hospital including 44 fungal isolates from 38 patients (1.7%). The above 
patients were immunocompromised, having haematological diseases or solid 
tumour. Some of them developed neutropenia as a complication of their 
therapy. 
Causative pathogens were: C .  albicans 25 strains (66%), C. tropicalis 6 
(16%), C. parapsilosix 2 (5%), C .  guillermoridii 2 (5%), C. stellatoida 1 (2.5%), 
C. lipolytira 1 (2.5%), C. humicola 1 (2.5%). Catdida strains developed 
different susceptibility profiles to five antifungals agents, amphotericin B, 5- 
fluorocytocine and ketokonazole, itraconazole, fluconazole (azoles). 
Twenty (20) strains of C. albicans and five (5) strains of Catidida non- 
albicans were sensitive to all five antifungal agents. Four (4) C. albicatis strains 
were sensitive to amphotericin B, to 5-fluorocytocine and to fluconazole, 
another strain was resistant to all five antihngal agents, which were used. 
Two (2) strains of Candida non-albicans were sensitive only to azoles, four 
(4) strains were sensitive to amphotericin B and to fluconazole and two (2) 
strain5 were sensitive only to amphotencin B. 
Conclusions: Candidaemia is caused predominantly by C. albicans (66%). A 
strain of C. albicans was resistant to amphotericin B, to 5-fluorocytocine as 
well as to azoles. The frequency ofcandidaenlia due to Candida spp. is quite 
high (34%). The highest degree of resistance of Candida was observed to 
ketoconazole and itraconazole. 
lp15651 Persistent candidaemia may not be associated with 
increased mortality in neonates 
I. Levy, S. Ashkenazi, L. Sirota, Y. Kogan, N. Linder 
Petah Tikvah, IL 
Background: Candidaeinia is a major risk for morbimty and mortality in 
neonates. The duration of candidaemia is relatively prolonged. However 
few studies have addressed the the risk of death or comlications associated 
with pesistent candidaemia in neonates. It might be predicted that Candida 
spp. as a slowly replicating organisms, will succumb slowly to antifungal 
agents without increasing the risk for mortality or comlications. 
Methods: All neonates with candidaemia between January1 1996 and 
December 30 1999 were identified Gom the mycology laboratory records. 
Upon diagnosis of candidaemia (any positive blood culture for Candida) the 
patients had their central venous catheter (CVC) removed. They also had a 
daiiy blood culture to document sterilization of the blood, urine, CSF and 
tracheal aspirate cultures for candida as well as complete work up for 
dissemination includmg cardiac echocardiography, eye hndoscopy, and 
ultrasonographic examination of the hdneys liver and spleen. Neonates 
were d e h e d  as persistently candidaemid if blood cultures remained positive 
for 6 or more days (PC). The persistent and nonpersistent (NF'C) groups 
were compared for gestational age, birthweight, presence of CVC or 
umbhcal catheters, congenital anpmalies, necrotizing enterocolitis or 
bronchopulmonary dysplasia. 
Results: During the study period, 56 neonates had candidemia. Forty- 
seven had C. albicans and 9 had non-albicans candidaemia. Twentyseven 
patients had PC, and 29 patients had NPC. The PC and the NPC groups 
were not significantly different for the above paarmeters. Nine patients 
died (16%) and 2 of them died within 24 h of the diagnosis. Of the 9 
patients who died, 5 had P C  and 4 had NPC (P-0.7429). Five patients had 
echocardiographic findings compatible with endocarditis. All five patients 
with endocarditis had PC. Except for one case of Candida uveitis, no other 
focal complications (meningitis, arthritis, renal involvement or dermatitis) 
were dignosed. 
Conclusions: Persistent candidaemia in neonates may not be associated with 
increased risk for mortality, but may increase the risk for fungal endocarditis. 
1 P I  566 1 Candida dubhiensis found in a prospective study in 
Romania 
S. Alecu, C. Defta, S. Dumitriu 
Bucharest, RO 
Candida dublinierisir, described in 1995, was recovered for the first time in 
Irish individuals with oral candidosis. The worldwide distribution of C. 
dnblirtietzsis was suggested since the presence of the yeast has been reported 
in several countries. Because C. dublirrierisis phenotypically resembles 
Caridida albicans in nuny respects, it could be easily nnsidentified as such. 
The purpose of the present study was to prospect for the presence of C. 
dubliniensis among clinical isolates recovered &om oral specimens sampled 
from 10 human immunodeficiency virus (HIV)-seropositive patient$. The 
isolates were screened for C. dublinierzsis by colony colour on 
CHROMagar Carzdida medium, by use of tests for gemitube and 
chlaniydospore production and by the results of a sugar assinlilation test 
with API 20 AUX yeast identification system. One isolate was identified as 
C. dubliniensis. This patient harbouring C. dlrbliriierisix was also cultured 
positive for C. albiruns. The C .  dnblinirrisir isolare was assessed for 
antifungal susceptibility using ATB Fungus method (Bionierieux com- 
mercially available kits) and Etest method for fluconazole. The suscept- 
ibility patterns were as followr: minimal inhibitory concentration (MIC) 
for fluconazole was 0.25 nig/L, flucytosine (MIC =0.25 mg/L), 
amphotericine (MIC = 1 mg/L), and also susceptible to nystatine, 
miconazole, econazole, ketocotiazole (only qualitative evaluation). These 
results confirm the presence of this interesting species in Romania and 
support the need for further investigations into the prevalence of C. 
dublittiensis in our population. 
lp15671 Isolation of yeasts from patients hospitalized in a 
public hospital 
A. Samet, J .  Nalewajska 
Gdarirk, PL 
Objectives: To determine the incidence of fungi in clinical specimens from: 
haematology, intensive care, surgery, pediamc and internal medicine 
patients. 
Methods: Over 3 years &om 1997 to 1999 we analysed 87 175 records. 
Fungal strains were identlfied to the species level with VITEK System YBC 
card (bioMerieux). 
Results: During the time of study we isolated 2575 yeasts from clinical 
specimens. The incidence of fungi increased from 5.9%) in 1997 to 9.9% 
in 1999. The frequency of isolation during 3 years was as follow: C.  
albicans 62.896, C .  gfabrata 16.3% C. krrrsei 3.7%. C. parapsifixis 2.6%,C. 
tropicalis 2.5%, C. lambica 2.2% Candida spp. 7.6%, Trirhosyororz beiyellii 
0.7%, C. pseudotropicalis 0.5%. other Catidida 1.1%. They infected/ 
colonized patients' urine (804), respiratory tract (577), wound aspirates 
and swabs (310). blood (132), other sterile body fluids (107). Incidence 
of C .  albicatis among other candida decreased in all specimens from 7 1.5%) 
in 1997 to 56.5% in 1999. C. glabrata increased from 8% to 23.4% 
over the study period and was frequently recovered from unne and 
wound aspirates. 
Conclusion: The most common yeast from clinical specimens was C. aibicans 
followed by C. glabrata and C. krusei. We observed a steady decrease of C .  
albicans in clinical specimens Gain our patients. 
Ip15681 Impairment of phagocytosis following mycelium 
formation by Candida spp 
A. Gonplves Rodrigues, C.  Pina-Vaz, J. Ramos, P. Mardh, J. Martinez-de- 
Oliveira, A. Frietas da Fonseca 
Porto, P; Lund, S 
Germ tube formation by C a d i d a  spp. is assumed to be an important 
virulence factor by promoting adherence to host cells and for tissue 
invasion. We evaluated impairment of the phagocytosis capabikty of 
polymorphonuclear leukocytes after germ tube formation, by testing their 
oxidative potential in the presence of Cundida strains which had and had 
not formed germ tubes. Heparinized human whole blood, Gom different 
donors, used iinmemately after collection, was incubated with each of five 
Candida clinical strains in the presence of a fluorescent marker (rodamine 
1,2,3). The intensity of fluorescence was evaluated by flow cytometry. 
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Yeast cells that had not foriiied germ tubes evoked a greater oxidation 
potential than blastoconidia, suggesting the latter to be more prone to 
phagocytosis than cells with gemi tubes. Retistance to phagocytosis in the 
test population, measured as iriipaimient of oxidation potential, increased 
with increasing rate of germ tube formation and also with length of the 
germ tubes. 
Grant sponsor: Conuss5o de Foment0 de Invesitrga@o em Cuidados de 
SaGde, Miilisttrio da Salide. Project no. 79/95 
jP15691 Extracellular matrix proteins influence 
morphogenesis and pathogenesis of Candida albicans 
A. Concalves Rodrigues, C.  Pina-Vaz. 1’. Mardh, S.  Costa-de-Oliveira. 
A. Freitas da Fonseca, J. Martinez de Oliveira 
Porro, P; Lurid, S 
Adherence of C. albicaiis to extracelular matrix may he critical in 
pathogenesis. C. dbi tai is  strains recovered from the vagina, respiratory 
tract and blood cultures were investigated for binding capacity to 1251- 
labelled fibronectin (Fn). vitronectin (Vn) and collagen (Cii) as well as for 
their effect on  germ tube formation. All strains tested bound Fn and Vn, 
more efficiently after producing germ tubes and mycelium ( P =  0.006); 
they bound poorly native and denatured Cn.  An excess of uidahelled Fn 
and its aniino-temiinal 2!, kDa fragment competed for binding, whereas 
bovine albumin and orosoiiiucoid did not. Lowering the p H  from 7.2 to 
4.U increased significantly the binding capacity. Fn also showed a 
significant dose-dependent inhibitory effect on  germ tube forniation (up 
to 96.7’%~), pH-independent. None of the Fn fragments, Vn and C n  
shmved similar effect. O u r  results show that Fn may influence 
morphology and pathogenic behaviour of C. albiraiis and thereby tissue 
invasion and dissemination. 
/p15701 Proteolytic activity and SAP gene expression in 
Candida albicans strains having different karyotypes 
A. Tavaiiti. A. Lupetti. E. Ghelardi, M. Campa, S .  Senesi 
Pica, I 
Objectives: The aini was to evaluate whether Catididn albiraiis strains having 
different karyotypes possess a difhent  degree ofvirulencr by studying the in 
i h m  expression of secreted-aspartyl-proteinase genes (SAP1-7) and the 
production of the encoded proteolytic activities. 
Methods: Karyotyping of C. albicaris strains isolated from the oral cavity of 
healthy camers and froni HIV-seropositive and seronegative individuals 
suffering fiom oral caiididiasis was performed by pulse field electrophoresis 
on agarose gel. I’roteolytic activity of all the strains was measured by a 
quantitative spectrophotometric evaluation of the amount of serum bovine 
albuniin hydrolysed. The reverse transcription-PCK protocol was used to 
evaluate the expression of SAP genes (SAPI-7) in C. albicaiis strains under 
laboratory conditions. 
Results: Two karyotypes (b and c) within the teven identified resulted to 
he the iiiost frequently isolated from healthy carriers, HIV seropositive and 
seroiiegative syniptoiiiatic patients. Although the highest isolation 
frequency of karyotypes b and c in symptomatic candidiasis reflects their 
prevalence as commensal strains, type b was the most Gequently isolated 
6-om itnniunocoiiiproniised patients (38.3%), while type c was mostly 
isolated from symptomatic HIV seronegative patients (51 .I%). Proteiiiase 
activity produced by strains isolated from healthy carriers was significantly 
lower than that detected ill isolates from symptomatic patients (P < 0.05). 
However, in the healthy carriers, the proteolytic activity of type c strailis 
resulted significantly higher than that detected for type b isolates (P < 
0.05). The in v i m  expression of SAP genes (SAP 1-7) led to the 
demonstration that nlKNA of  all the seven SAP genes is expressed under 
laboratory conditions: in particular, in strains collected from healthy 
carriers, SAP1 and the SAP4-SAP6 subfamily were the predominant 
proteinase genes expressed by strains sharing type b, while the type c 
strains were found to express almost all the seven SAP genes. Expression of 
SAP genes in C. olbiraris strains isolated &om all the symptomatic patients 
revealed that the type c expresses all the seven SAP genes more frequently 
than the type h. 
Conclusions: This f in lng  suggests that karyotyping could represent a useful 
method to cluster C. afbimls strains characterized by a lfferent proteolytic 
activity, thus indicating that defined genotypic profiles are putatively 
associated with a differential expression of individual SAP genes. 
Detection of phospholipase and protease production 
in clinical isolates of Candida species 
A. S .  Kantarcioglu 
Istaribul, TR 
The present study aimed at determining iii vilro phospholipase and protease 
activitiec in 95 clinical isolates of various Caridida cpecies (C. albicaris. C. 
glabrara, C. guilliemrondii, C.  kefjv, C .  knrsei, C. lipolytica, C. lusitnrzine, C. 
purapsilosis, C. UXIJ.W and C. tropicalis). The phospholipase production of the 
isolates was assayed using the egg yolk agar plate method of Price ef a/.  
Determination of protease production was peifomied accordmg to the 
method of Aoki et a / .  using bovine serum albumin agar medium. Enzyme 
activities were measured and calculated (as Pz values) in temu of the ratio of 
the diameter of the colony and that of the colony plus precipitation zone. 59 
(62.1%) of the strains were phospholipase positive and 75 (78.9%) were 
protease positive. 56 (93.3%) of C. albicaris isolates was phospholipase 
producers whereas only a few strains of C. glabrara and C. k fy r  did so. None 
of the other isolates was able to produce this enzyme. Protease activity was 
detected in 57 (95%) of C. nlbicaans strains tested and a few strains of C. kejjv, 
C. lkolytica, C.  parapsilosic, C. tropiralis were protease pocitive and the others 
were negative. 56 of 6O strains of C.albicans and 2 of 4 ttrains C. kcfyr tested 
produced both phospholipase and protease, the other strains found lack the 
capacity to produce one of the enzymes assayed. The Paired Samples test for 
phospholipase and protease activity showed a high significant difference 
between Pz values obtained in C. albiraiis and noii-albims Catidida species 
(p is less than 0.001 and 0.001respectively); and between oral cavity, 
respiratory tract and urogenital system strain? (P is less than 0.001, aiid 
0.001, and 0.001, respectively). The One Way ANOVA test was not 
significant for phospholipase and protease among the sites of infections (p is 
greater than 0.05). The Wilcoxon Signed Ranks test was significant for 
phospholipase positive Caridida species in  relation with the localisations 
when oral cavity, respiratory tract and urogenital system compared (Pis less 
than 0.008, and 0.006, and 0.004, respectively). Regarding to the results of 
previous works and that obtained m Department of Microbiology and 
Clinical Microbiology, Cerrahpasa Medical Faculty, we conclude that 
further investigations should carry on phospholipase and proteare activity in 
noxi-albirans Candid0 species isolated different anatomic sites to clan+ their 
contribution to fungal virulence associated with invasive mycosis. 
r g  In vivo pathogenicity of eight medically relevant 
Candida species in an animal model 
M. Arendrup, T. Horn, N. Frimodt-Moeller 
Copetihagrci, Herlev, DK 
Background: Differences in pathogenicity among Caridida species may be a 
factor influencing the frequency and outcome of chnical infection. Here, we 
compare the pathogenic potential of 8 medically important C. sprciec, in an 
i.v. mouse model. 
Methods: Seventeen isolates were included, two isolates of C. albiruiis, C. 
glabvata, C. tropiralis, C. lusitaniae, C. parapsilosi.c, C. kPfi‘r and C. g i i i l l i ~ r r w r i i f i i  
and three C. krusei isolates. Mice in groups of 3 or 4 were inoculated with 
10’ and 107 CFU, respectively. Day 2 and 7 kidneys were removed. 
weighed and CFU/g kidney determined by the cpot-technique. Histolo- 
gical changes of ludneys aiid eyes were exanlined for selected species. 
Results: Mortality was only observed in mice inoculated with C. albiraris 
and C. tropicalis. Kidneys without detectable infection day 7 were found 
from nice  inoculated with 10’ CFU C. knrsei, C.  pm~pcilotis and C. 
p i l l i e rmi id i i .  Inoculated with 10’ CFU C. tropiralis, C. &hrafa, C. kcfyr, C. 
lusitariiae, C. parapsiloris, C. krusei and C. ,guillierinoiidii the median log 
CFU/g kidney was cignificantly different 6.0, 6.0, 6.4, 7.0, 3.7, i 2 and < 
2, respectively (P  < 0.0001). Eye infection and histological changet of 
kidneys were exanlined for C. albirnm, C. ruopiralis, C. glabvata and C. krusei 
infected mice. Weight-loss, kidney weight, kidney inflamniatioii and 
infection, and number of eyes infected decreased with the pathogenicity of 
the four species. 
Conclusion: The virulence of the Carrdida spp. investigated was highly 
different illustrated by a 7-log difference in CFU/g kidney, a span of 0- 
1(l0% mortality and histological changes in kidneys ranging from discrete to 
serious. The C. spp. could be divided in 3 groups with decreasing virulence: 
(1) C. albicaris and C. tropicalis (2) C. glabrafa, C.  kcfir  and C .  lucitatiine and 
(3)  C. parapsilosir, C. krusei and C. pill iermmfii .  Knowledge of this 
difference iii pathogenicity is also important in testing of ailtifungal drug  in 
the mouse niodel. 
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In vitro activity of antifungals (11) 
(p15731 Determination of MICs of antifungal drugs at 
different growth stages of filamentous fungi 
J .  Meletiadis, E. A. H. Kramer, J. F. G. M. Meis, J. W. Mouton, P. E 
Venveij 
Nijrnegen, NL 
Background: MICs of antifungal drugs are elevated during prolonged 
incubation, which may be related to the different growth phases of fungi. 
The various growth phases are apparent after different incubation periods in 
various nutrient media. The MICs ofamphotericin B (As), itraconazole (IT) 
and terbinafine (TB) against 5 strains of Aspergillus-lum~~atcrs, Rhizopcrs oryzae 
and Scedusporium prolijkans were determined in antibiotic medium 3 ( A M 3 ) ,  
yeast nitrogen base medium (YNB), liquid Sabouraud (SAB) and RPMI- 
1640 (RPMI) at various growth phases during the growth of these fungi. 
Methods: Conidia and spores at a final inoculum of 10' CFU/mL were 
incubated in two-fold serial dilutions of AB (164.015 mg/L), TI3 and IT 
(32-0.03 nig/L) in AM3, YNB, SAl3 and KPMI. MICs were detemined 
during the first transition period, the log-phase, the second transition period 
and the stationary phase after 14, 20, 24, 48, and 72 h of incubation at 37" C 
in 96 flatbottom nucrotitration plates. The geometric mean of the MICs 
(GM-MICs) were calculated for each growth phase and nutrient medium, 
and the differences of second logarithm of the MICs were analysed by 
ANOVA (repeated measures test). 
Results: Statistical significant dhkences between the MICs of antifungal 
drugs at different growth phases were found in the four nutrient media for 
all species ( P  < 0.05). N o  statistical significant differences were found 
between the MICs after 24, 48 and 72 h of incubation when A ,  &ziyatus 
was tested against IT in AM3 and SAB ( P  > 0.08) and between the MICs 
after 14, 20, and 24 h of incubation when R. oryzar was tested against AB 
and IT in  all media. Up to 3-fold increase of GM-MICs were observed 
when the growth control was reached the stationary phase (after 48 h 
incubation for A. &migatus and after 24 h for R .  oryzae). 
Conclusions: MICs of antifangal drugs depended on the growth stage of 
filamentous fungi. High reproducibility in MIC determination of antifungal 
drugs can be generated by reading the MICs before the growth control reaches 
the stationary phase, i.e. before 24 h for R. oryzae and 48 h for A. &migatus. 
This study was supported by the EC-TMR-EUROFUNG network 
(ERBFMXK-CT970145). 
v1 Standardization of inoculum preparation for 
antifungal susceptibility testing of emerging filamentous fungi 
E. Petrikkou, A. Goniez-Lopez, A. Aberkane, M. Cuenca-Estrella, 
J. Mosquera, I. Georgopoulos, J. L. Rodriguez-Tudela, The Eurofung 
Network 
A4ajadahonda, E; Manchestrr, UK; Athens, GR 
Background: NCCLS document M38-P suggests inoculum preparation by 
spectrophotometric procedure. Colour and size of spores which are species 
dependent influence the OD values. Alternatives as spore enumeration 
could be more appropriate. 
Methods: A total of 156 isolates belonging to 8 different species were tested. 
Inocula suspensions were prepared in sterile distilled water or Tween 20 
(0.1 %) for Aspegillus inocula (previous unpublished studies indicated that 
higher concentration of Tween 20 effects antifungal MICs). Inocula were 
adjusted between 1 and 5 x 10" CFU/niL by spore enumeration with 
Neubauer improved chamber (NB) and quantified by plating ahquots onto 
Sabouraud (colony-counting: CC). OD of the inoculum was measured at 
530 nni (SP). Data were transformed to logarithmic values and statistical 
analysis was perfomled (see Table 1 below). 
Results: Table shows by rpecles the range of CC, NB and SP, the 
correlation Index (r) of NB and SP with CC,  the intraclass correlation 
coefficient (ICC 95% IC) of C C  and NB and the O D  proposed by NCCLS: 
Conclusions: (1) The range of O D  units obtained was very broad for all 
species analysed. Thus, spectrophotometric methodology cannot be 
recommended as an appropriate procedure for inoculum preparation of 
filamentous fun@. In addition all r-values were < 0.5. (2) Enumeration of 
spores by mean of a Neubauer improved chamber IS an adequate and 
universal procedure for inoculum adjustment of tilamentous fungi. All CC 
obtained were between 1 and 5 x 10" CFU/nlL except for 6 strains. In 
addition all r-values were above 0.5 except for A. Javirs. The ICC value? 
were appropriate but with a variable range of 95%) IC (interval coetLient) 
especially for A. Javus. (3) A higher sample size will increase the power of 
this expenment. 
(p15751 Activity of four antifungal agents against human 
pathogenic filamentous fungi 
A. Aberkane, E. Petrikkou, A. Gbmez, A. Monzbn, E. Mellado, 
I. Georgopoulos, J.-L. Rodriguez-Tudela 
Majadahonda, Madrid, E; Athens, GR 
The in oitro activity of amphotericin B (AMB), itraconazole (IZ), 
voriconazole (VZ) and terbinafine (TB) against 68 clinical isolates of 
filamentous fungi was assessed using a modification of the NCCLS M38-P 
microdilution reference method. The fungal isolates belong to the following 
genera: Aspevi l lus ,  Scedosporium, Fusariurn, Paecilornyres, Perricilliunr, Muor 
and Rhizopus. The inoculuni was prepared by adjuting the nuniber of 
spores to a concentration of 1 x 106 CFU/niL to 5 x 10" CFU/mL in a 
Neubauer improved chamber. Colony counting on PDA Petri plates was 
performed to check the size of inoculum. The medium employed was 
RPMI 1640 broth with 2% glucose. The final inoculum size was 0.5- 
2.5 x 10' CFU/mL. The plates were incubated at 35 "C for 48 h and read 
macroscopically with a mirror. The MIC was defined a? the lowest 
concentration of the antifungal agent that completely inhibited fungal 
growth. For Aspeaillus species, there were higher MICs for AMB against A. 
ferreiis and A. flauus than against A .  .funrigatus (0.5-4 mg/L for A. trrreus, 
0 . 2 5 4  mg/L for A. ~fluuus and 0.12-0.5 mg/L for A.  f u i ? ~ i g a ~ u z ) .  while IZ, 
VZ and TB had a good in  uitro activity against Arpetgilhrs. Srrdospori~nr~ 
prolificam isolates exhibited in v i m  resistance to all antifungalc. Srrdosporitrnr 
apiospennum is considered intrinsically resistant to AMB: all MICs were 
between 2 and 8 mg/L. MICs of IZ were variable but all oftheni werc > 1 
mg/L. VZ showed a better in vitm activity and all icolates were inhibited by 
concentrations of 4 mg/L. TB did not show in vifro activity against this 
species. Fusarium isolates showed elevated MICF of all tested antifungals 
except F. vpvtitillioides strains which exhibited lower TI3 MICs (0.12-0.5 
mg/L). These data also show a difference between the susceptibility patterns 
of Paecilomyces variotii and P.  lilacinus, since P. variofii exhibits MICs ranging 
from 0.06 to 0.5 mg/L for AMB whereas P. lilacinus MICs were I6 ing/L. 
Further in ihro and in vivo experiments are needed to achieve a better 
knowledge of the susceptibility patterns of filanientous fungi and their 
correlation with therapy. 
lp15761 Cytocidal activity of the new polyene derivative SPK- 
843 against fungi and protozoa 
F. D. D'Auna, M. Tecca, A. Callari, L. Laino, V. Strippoll 
Roma,  I 
Opportunistic fungal infection? cannot always be treated with azole and 
triazole drugs as an alternative to polyene derivatives, because the latter may 
be indispensable in serious pathologic conditions, like deep-seated 
infections. This justifies the number of studies performed to find new 
low-toxicity polyene derivatives. SPK-843(N-dimethyla1ninoacety-partri- 
cin A2-dimethylamino ethylamide diascorbate) is a water soluble polyene 
derivative of partricin A.It possesses unusual stability and hlgh activity 
against sensitive fungal isolates in comparison with aniphotericin B 
(AMB).We investigated the activity of SPK-843 compared with AMB 
against yeasts (Candida albiraris, C. tropicalis, C. glabratn, C. guillirrmondii, C. 
knisei, C. hcrmicoin, C. internre&, Cryptococrcrs tiec$mnam, Trichospomrr 
crrtaneurn), filamentous fungi (Aspetgillus &tigatus, A. ti@, A. terreus, 
Syrrcephalartrunt racernosum) and protozoa (Tridrornonas uaginalis, Leishrwarria 
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ir!farrfurir). Cytocidal activity was evaluated by contact tests and by potassium 
ions (K) release tests. The contact tests were performed by the direct contact 
of cell suspensions with the drug (between 10 and 100 mg/L) and colony 
forming units after 48 h of incubation at 37 "C and the killing times were 
reported. K release was evaluated with a Microion electrode (2008 Cryson) 
after a time contact (1-20min.) between cell suspensions and drug 
concentrations (I 0-100 nig/L). T. uagirialis tests were performed in 
cysteine-pepton-liver-maltose medium plus drug; MICs were read by 
microscope observation (Carl Zeiss X320)after 48 h at 37 "C. Our recults 
demonstrated a remarkable cytocidal activity with a killing time (100% 
inhibition) ranging between 3 min to 10 min for Caridida spp. and 15- 
30min for filamentous fungi. The SPK-843 cytocidal activity was very 
marked against Carrdida spp. with a complete K release within 3 min (10 
mg/L drug concentration). MICs for T. rqiitalis and L. ir@nfum were of3.2 
mg/L (AMB 7.4 nig/L) and 0.015 mg/L, respectively. The killing time 
(100% inhibition) was measured within 10 nlin for a l l  the protozoa tested at 
SPK-843 concentration of 0.03 nig/L. In conclusion SPK-843 presents a 
highel- cytocidal activity irr vitru with respect to AMB. This activity seems to 
be related to the induction of the greater cellular damage with accelerated 
leakage ofK ions. Data show a SPK-843 wide spectrum extended to yeasts, 
filamentous fungi and also to protozoa. These results and drug low toxicity 
make it a suitable potential alternative to amphotericin B. 
v] A dose-dependent antifungal effect of protamine on 
Candida spp 
A. GonFalves Kodrigues, C. Tavares, S.  Costa-de-Oliveira, C.  Pina-Vaz, 
P. Mardh, J. Martinez de Oliveira, A. Freitas da Fonseca 
Porto, P; Lund, S 
The growing emergence of antifungal resistance among Caudida spp. stresses 
the need for alternative or complementary medications. 
Objectives: To evaluate an hypothetical antifungal effect of protamine, 
either fungistatic or fungicidal, estimated as the minimal inhibitory 
concentration (MIC) and nuninial lethal concentration (MLC), on the 
most coinmonly pathogenic Carufida species. 
Methods: Twelve clinical isolates of Cardida (2 C .  albicans, 3 C. krusei, 3 C. 
glabrafa, 1 C. tropicalis, 3 C .  guillierinoudit] were tested (according the 
NCCLS protocol M 27-A for susceptibility testing) at serial concentrations 
of protamine sulphate (Roche). The MIC for fluconazole was also 
detemuned for each strain. Germ tube formation by 6 strains of C. albicarrs 
was assessed in the presence of siniilar concentrations of levobupivacaine. 
Results: MIC ranged between 0.25 and 1 U/mL. In most strains MIC 
corresponded to MLC; MLC was 2-4 times higher the corresponding MIC 
in the renlaining 4 strains. No correlation was found, respectively, between 
MIC or MLC and the susceptibility pattern to fluconazole. At concentra- 
tions below and around the MIC, protamine produced a dose-dependent 
inhibition of gem1 tube formation. 
Conclusions: Protamine showed a marked, dose-dependent, antifungal 
effect on Carrdida species, either sensitive or resistant to antifungals. 
lp1578 Investigation of different methods for susceptibility 
testing of Candida strains to fluconazole 
S. Kustiniur, A. Kalkanci, H. Mansuroglu, K. Senel 
Ankara, TR 
Over the past decade, sigdcant progress has been made with standardization of 
the testing method in the field of antifungal susceptibility testing. We compared 
the results of standard macrotube dilution reference method; two different 
microdilution methods and disc difhsion method for testing the susceptibility of 
150 Candida strains includmg two reference strains to fluconazole. Candida 
prapsilosis ATCC 22019 (Kukens, Istanbul) and Candida kmk ATCC 6258 
(Groupe Hospitalier Pitie SalPehiere, Unite de Mycologie, Paric) were used as 
control strain.. . 148 clinical isolates were 50 C .  albicaus, 31 C. kmsei, 19 C. 
prapsilosis, 16 C. k&, 15 C. hupicalis, 10 C. glabrara, 3 C. rugosa, 2 C. lusitaniae, 1 
C..fa~mia, 1 C. dublininlcis. Macrodilution method was performed as described in 
NCCLS document M27-A with RF'MI 1640. In the procedure of microdilution 
method, Yeast Nitrogen Base Broth (YNBB) and RPMI 1640 mediums were 
used and the Minimal Inhibitory Concentration (MIC) results were compared. 
Disc m i o n  testmg was performed on the plates of Yeast Nitrogen Base Agar 
(YNBA) and Sabouraud Dextrose Agar (SDA) by using 25 pg (microgram) and 
50 mg fluconazole containing discs. All statistical analysis were calculated by the 
help of the computer program, SPSS 9:01. Inhibition zone diameters and MICs 
were determined after 24 h incubation. 81% ofthe 150 strains were susceptible to 
fluconazole with macrodilution method. 85% of the 150 r&c were susceptible 
with microdilution using RPMI 1640 mediuni. 79% of them were susceptible 
with microdilution using YNBB. When we compared these three methodc in 
term of their MIC results, overall correlation was 86% between them (P > 
0.05). All isolates grew but the quality of growth after 24 h incubation was 
variable on the two different solid me& for the dsc dif&sion procedure. 
Majority of the isolates showed no inhibition zone on the SDA. Fluconazole 
inhibition zone diameters were measured easily on the YNBA. 21 of the 150 
isolates (14%) were found to be revstant to fluconazolr with disc difhsion on 
YNBA. There was no si@cant Werence betwecn 25 mg and 50 mg 
fluconazole containing discs. Due to the fact that there was no difference between 
the susceptibility results of Candida strains with disc &ion and macroddution 
tests, we tend to believe that; disc diffusion test was low-cost, reproducible as a 
screening procedure for the determination of susceptibility. 
Comparison study of ATB fungus and NCCLS 
reference broth macrodilution methods 
A. S. Kantarcioglu 
Istanbul, TR 
The ATB Fungus (ATBF) is an alternative method for determination of the 
susceptibility of yeasts to antifungal agents. The purpose of this study was to 
compare the conipatibility of ATBF with National Committee for 
Laboratory Standards (NCCLS) reference broth macrodilution method. In 
uitro susceptibility of 82 clinical Candida strains (63 C. albicarzs, 5 C .  glabrata, 
5 C. krusei, 5 C. parapsilosis, 4 C. tropicalis) isolated from oral cavity ( r i =  19), 
respiratory tract (n = 49) and vagina ( n  = 14) and 5 ATCC reference strains 
of related species against amphotericin B (ampB), 5-flucytosine (5-FC), 
ketoconazole (KTZ), miconazole (MCZ), econazole (ECZ) and nystatin 
( N Y S )  was examined commercially available ATBF strips (Bio Merieux, 
Spain). The NCCLS reference macroddution method (M27-A) were also 
performed to compare the compatibility of two methods. ATBF was 
performed according to the manufacturer's instructions. Number of isolates 
classified by ATBF and macrodilution methods, respectively, against 5-FC 
within the susceptible (S): C. albicans 45 and 44, C. glabrata 4 and 2, C. krusei 
1 and 4, C. parapsilosis 2 and 2,  C .  tropicalis 3 and 2; within intermediate (I): 
C. albicans 13 and 2, C. glabrata 1 and 1, C. krusei 2 and 1, C. parapsilosis 3 and 
0, C. tropicalis 0 and 0; within resistant (R): C. albicans 5 and 4, C. glabrata 0 
and 1, C. krusei 2 and 0, C. parapsilosis 0 and 0, C .  tropicalis 1 and 2. Number 
of isolates classified by ATBF and inacrodilution methods, respectively, 
against anipB within S :  C. albiians 23 and 12, C .  glabrata 3 and 2,  C. knrsei 1 
and 0, C. parapsilosis 4 and 1 ,  C. tropicalis 3 and 0; within R: C. albiiaris 21 
and 30, C. glabrata 2 and 2, C. krusei 4 and 5, C. parapsilosis 1 and 0,  C. 
tropicalis 4 and 4. ATBF allows the categorization of each strain as S, I, R to 
all antifungals tested and 5-FC and ampB MIC determination. However the 
results of ATBF method is comparable with that of M27-A method only for 
5-FC. Due to different criteria (the lowest drug concentration and limited 
dilution ranges) for amp B it is hard to evaluate comparatively. Testing 
guidelines for ECZ and N Y S  are not included yet to, and for KTZ 
susceptible and resistant strains can not be classified (S, I, R) by the reference 
method and there is no available data to assess. Thus, the classification of 
ATBF method seems self-specific. In this study it was revealed that ATBF 
method is required sonie more improvement for comparison with the 
NCCLS approved reference method to de temne its validity. 
I P I  580 I The effect of fluconazole preexposure to the 
susceptibility of Candida albicans strains to amphotericin B 
M. Yiicesoy, M. A. Oktem, N. Giildas, N. Yulug 
Izmir, TR 
Consideration of the interactions between azoles and amphotericin B has 
become clinically significant in recent years. In this study we investigated the 
in vitro effect of fluconazole preexposure to the susceptibility of Candida 
albicans strains to amphotericin B. 52 Clinical isolates and one control strain 
(ATCC 90028) of Candida albicans with low nlinimal inhibitory concentra- 
tion values for both fluconazole and amphotencin B were included. First, the 
effect of different concentrations of fluconazole preexposure for various time 
periods on the susceptibility of the ATCC C.albicans strain to amphotericin 
B were searched. It was found out that 2G50 pg/mL fluconazole exposure 
for 4, 6, 14 h generated a subpopulation of cells that were not affected by 
amphotericin B for 4 ,8 ,24 h. After this preliminary study, 51 clinical isolates 
of C. albicans were investigated by using 50 pg/mL fluconazole for 4 and 14 
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h. 7, 5 and 3 of these isolates which were preexposed to fluconazole for 4 h 
had cells which were resistant to amphotencin B after 4, 8 and 24 h, 
recpectively, while these strainc showed no growth after amphotericin U 
incubation when they were not allowed to expose fluconazole. Various 
percentage of cells of 6, 2, 1 of the strains that were preexposed to 
fluconazole for 14 h were resistant to aniphotericin B after 4, 8 and 24 h. 
These findings which might result Loin prior exposure to fluconazole in 
vitro. nlight have important clinical implications. 
p15811 /n vitro activity of fluconazole and amphotericin B 
against hospital isolates of Candida spp 
M. Ozalp, M. Ekizoglu, D. Giir 
Ankara, TR 
Fungal idections are important causes of morbidity and mortality in 
iinniunocompronused patients and Cundidu spp. are the leading pathogens in 
these infecaons. Emergence of resistance against antifungal agents necessitares 
the use of antifongal susceptibility testing. E-test is a well standarhzed test 
which can be applied for these organism. The aim of this study was to evaluate 
the susceptibilities of nosocoinial isolates of Cundida spp. to fluconazole and 
amphotencin B using the E-test. A total of 46 clinical isolates of Candidu spp. 
which were isolated Loin blood, tracheal aspirate and pus samples of children 
with fungal infections hospitalized in Hacettepe University Children’s Hospital 
were included in the study. Cundida species were identified by chromagar (Mast 
Uiagnostica) and API 20C (BioMeneux) systems and were C. ulbicum (33), C. 
knrsei (1 1) and C. tropicalis (2). The E-test (As Biodisk, Sweden) was perfoimed 
according to the manufacturer’s recommendations on RPMI 1640 agar 
supplemented with glucose. The range of tluconazole MIC‘s for C. albicanr, C. 
krusei and C. tropicalis were 0.125-> 256, 0.25-> 256 and 2 4 4  mg/L, 
respectively. Fluconazole had an MIC of > 8 mg/L in 11 isolates of which 6 
were C. albicans, 4 were C. krusei and 1 was C. tropicdlir. MIC ranges for 
amphotericin B were 0.032-0.75 mg/L in C. ulbicans and 0.0324 mg/L in C. 
krusei. For both C. tropicalis strains, MIC was 0.19 mg/L. There was only one 
smin of C. dbirans and one strain of C. krusei for which the amphotericin MIC 
wac above 0.5 mg/L. These results indicate that resistance to antifungal agents 
are present m our isolates and rouhne antifungal susceptibility tests should be 
performed in hospital isolates of Candidu spp. 
p1582/ Reversion of resistance of Candida spp. to 
fluconazole by efflux pump blockers 
R. Vitale, J. Afeltra, J. F. G. M. Meis, J. L. Rodriguez Tudela, L. Rodero, 
P. E. Venveij 
Nijmegen, NL; Maiadahonda, E; Buenos Aires, RA 
Multidrug resistance in pathogenic yeast has been related to efflux pumps 
that export the drugs, therefore reducing their toxicity. Some compounds 
have the capacity to block these proteins. 
Aim: to evaluate the capacity of efflux pump blocker to revert FCZ 
resistance in Candidu spp. 
Materials and methods: 7 resistant and 13 susceptible dose dependent 
isolates of Cundida spp. were incubated in Sabouraud liquid media with 
subinhibitory concentrations of nifedipine (80 mg/L), verapand (80 mg/L), 
lansoprazole (80 mg/L) and andoride (80 mg/L) all from Sigma. MIC 
values to FCZ alone and in combination to each blocker were determined 
by NCCLS methodology (M27A). 
Result: MIC’s for 12 strains decreased when FCZ was associated with 
different blockers and other strains showed no significant MIC change. 
(Table 1) Some isolates showed no effect from all efflux pump blockers 
suggesting that resistance was due to other mechanisms. 
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Conclusion: Most of the resistant strains tested seem to have efflux pumps 
that are blocked by the coinpounds used, reverting the resistant phenotype. 
For 10 strains the mechanism of resistance appears to be different. 
Combmation of FCZ and efflux pump blockers might be useful in the 
clinical candidosis. 
/p15831 Levobupivacaine inhibits germ tube formation by 
Candida albicans 
A. Gonplves Rodrigues, C.  Tavares, S. Costa-de-Oliveira, C. Piiia-Vaz, P. 
Mardh, J. Martinez-de-Oliveira, A. Freitas da Fonseca 
Porto, P; Lund, S 
Local anaesthetics (LAs), e.g. lidocaine and bupivacaine, are known to 
inhibit germ tube formation by C. albicunr.’.’ This study was planned to 
claiify the in vitro effect of the recently available LA drug levohupivacaine 
(an isomer of bupivacaine) on germ tube fonnation by C. ufbiruru. Thereby, 
germ tube formation by 7 strains of C. ulbicurrs (6 clinical isolates and ATCC 
type strain 10231) was assessed in the presence of serial concentrations of 
levobupivacaine (0.0354).15%). After 3 hours’ incubation at 37 “C, 200 
yeast cells were studied in a Burke’s chamber at 400 x magnification. All 
tem were run in duplicate. Levobupivacaine produced a marked, dose- 
dependent, inhibitory effect, pH-independent, upon germ tube formation 
by C. ulbicuns. Considering the potential use of LAs in antifungal therapy, 
levobupivacaine opens the perspective use of a novel potent local 
anaesthetic devoid of systemic toxicity, in comparison to other compounds 
exhibiting a similar effect, namely bupivacaine. 
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lp15841 Fluconazole disk diffusion for determining 
susceptibility of Candida species 
A. Valverde-Conde, M. D.  Morilla, M. C .  Serano, R. Claro, E. Martin- 
Mazuelos 
Seuille, E 
Objectives: To evaluate the disk dithtsion test for determining susceptibility of 
Candida spp., using two a e r e n t  concentrations of tluconazole and two medium. 
Methods: We studied 71 Candida spp. strajns (44 C. ulbicms, 10 C. glubrutu, 8 
C. tropicalis, 5 C. parupsilosir and 4 C. knrsa] isolated from c h c a l  specimens of 
HIV(+) patients. Susceptibility test to fluconazol was made by agar difhsion 
method using disks with 25 and 50 pg. On RPMI 1640-glncosa agar (RPMI) 
(Difco, Spain) and Buffered Shadomy Agar (BSA) (Rosco. Denmark). The 
tests were read after 24 and 48 h of incubation at 35°C. The reference method 
was the broth microddution method(MDB)(NCCLS,M27-A document). The 
MICs (ing/L) were read after 24 h. 
Results: O n  RPMI media, with 25 and 50 pg fluconazole disks, 40 of the 47 
strains(85%) susceptible by MDB method (MIC < = 8 mg/L) had an 
inhibition zone diameter of > = 20 mni and > = 26 mm, respectively, at 24 
and 48 h.  On BSA media with 25 and 50 pg fluconazole disks, 39 of the 47 
strains (83%) susceptible by MDB method had a inhibition zone danieter of 
> = 22 and > = 28 mm, respectively, at 24 h. At 48 h the inhibition zone 
diameter were > = I 9  and > =25 mni, respectively. All strains that had 
dose dependent susceptibility (DDS) (MIC of > 16 mg/L and < 32 nig/L) 
and resistant(R)(MIC > =64) by MDB had smaller zone of inhibition. 
Conclusions: (1) The higher correlation was with RPMI at 24 h and w t h  
BSA at 48 h using 25 and SO pg fluconazol disks. (2) The disk test did not 
adequately separate fully resistant strains from those with DDS. (3) 
Additional quantitative tests are needed. 
Evaluation of €-test method for testing 
susceptibilities of clinical trial isolates of Candida and Aspergillus 
species to voriconazole: a comparison with NCCLS methods 
A. Espinel-Ingroff 
Richmond, U S A  
344 Abstracts 
Objectives: With the increased incidence of severe fungal infections and 
number of new antifungal agents, the laboratoiy's role in selection and 
nionitoniig of antifungal therapy has become more important. The NCCLS 
tests for yeasts and moulds (M27-A and M38-P documents, respectively) are 
time-consuming and cumbersome. Earlier evaluations have demonstrated 
that E-test MICs of established agents have been comparable to NCCLS 
MICs for both yeasts and moulds. The purpose of this study was to compare 
M27-A and M38-P to E-test MICs of the novel triazole, voriconazole, for 
Cutrdida and Aspe@/us species recovered &om voiiconazole clinical tnals. 
Methods: Broth microdilution NCCLS and Etest MICs were performed 
against 50 isolates of C. ulbicans, C. glubruru, C. krusei, C. purupsilusis, and C. 
tropicu/i.~ and 60 isolates ofA.j7avus, A..futn(pnftrs, A. nidulurts, A .  ri&cr, and A. 
rrweirx. Etest MICs were detemlined on solidified (1.5% agar) RPMI-1640 
(2% dextroce) at both 24 and 48 h. NCCLS MICs were the low-est drug 
dilutionc that showed 100% (Aspt@llus spp.) and 50% inhibition (Curididu 
spp.) at 48 h. 
Results: The agreement (percent of MIC pairs within a 2-dilution range) 
between 24 and 48 h Etest and M38-P MICs was 95.2% for Arper$lus spp. 
The agreement between E-test and M27-A MICs was 90-92% at 24 and 48 
h, respectively, for Curididu spp. Overall, €-test MICs were usually lower 
than NCCLS rewlts for Aspe@lur spp., while E-test MICs for Cundidu spp. 
were either the same or 1 to greater than 2 dilutions higher than those by 
the M27-A method. 
Conclusion: This study suggests the potential utility of the E-test method ac 
a convenient alternative for testing the susceptibilities of Aspetgillus spp. and 
Currdidn spp. to voriconazole. The clinical value of these in v i m  results 
should be detennined 111 clinical trials. 
lp15861 Effects of neem (Azadirachta indica A. juss) leaf and 
seed aqueous extracts on growth and aflatoxin production in 
Aspergillus parasiticus 
M. RazzaghiLAbymeh, A. AUameh, M. Sham 
Te!lrufr, IR 
Objective: The antifungal effects of neem extracts on aflatoxin-producing 
strain of Aspetgi/lus puracirirtrs have been studied. Furthermore, investigation 
on the mechanisni(s)of neem mediated inhibition of aflatoxin synthesis was 
perfomied. 
Methods: Neem leaf and seed aqueous extracts were prepared according to 
I3hatnagar ct a/. (1.40CS 1988; 65) and Razzaghi et u / .  (PhD thesis), 
respectively. Different concentrations of these extracts were added to 
cultures of A .  yurnsirirus on sucrose low saltc (SLS) medium and incubated 
on a shaker incubator (150 r.p.m.) at 28C for 4 days. Mycelia and media 
were extracted with chlorofomi and analysed by TLC. Furthermore, a 
portion of mycelia was homogenized for assay of cytosolic fatty acid 
synthase (FAS), isocitrate dehydrogenase (IDH) and gluthatione S- 
transferase (GST) enzymatic activities. 
Results: Fungal growth was only inhibited by seed extracts with a maximum 
level of 50% at a 100% concentration of extract. Dose-dependent inhibition 
of afldtoxin syntheG was observed for all major types, i.e. B1, B2, GI and 
G2. This inhibition for certain concentrations (12.5-50%1) was accompanied 
with remarkable decrease in cytosolic FAS specific activity. 
Conclusion: This is the first report on the possible mechanitm of neeni- 
mediated suppression of aflatoxin synthesis via inhibition of FAS, an 
important enzyme directly involved in aflatoxin biosynthesis. 
Ip15871 In vitro interaction of itraconazole and nifedipine 
against clinical isolates of Aspergillus fumigatus susceptible and 
resistant to itraconazole 
J. Afeltra, R. Vitale, J .  F. G. M. Meis, P. E. Verwed 
Niitnepr, NL 
Multi-Dmg Resistance pumps in C. ulbicutts modulate their suscepnbdity to 
many antifungal agents but there is hrnited data about the mechanism of 
resistance in filamentous fungi such as Aspergillus species. 
Aim: To evaluate the activity of itraconazolr (ITZ) in combination with 
nifedipine (Nit) against 16 clinical isolates of A. j r t n i p m 4 ~ .  
Material and methods: 8 strain$ were susceptible to itraconazole and 8 were 
resistant. The susceptibility test was used by broth microdilution method 
according to NCCLS guidelines (M38P). ITZ and Nif were dissolved in 
DMSO. Volumes of 50 pL of each drug at a concentranon of four times the 
final concentration were dispensed in the wells to which 100 pL of 
inoculum was added. Final concentration ranged for 164 .03  pg/tnL for 
ITZ and from 80 to 0.6 pg/mL for Nif The nucrotitre plates were 
incubated for 48 h. The MICs were determined as the lowest concentration 
of the drugs (alone or in combination) that showed 50% inhibition of 
growth compared with the drug-free control. Drug interaction effects were 
defined on  the basis of fractional inhibitory concentration index (FIC) as 
follows: synergistic, < 0.5; additive, > 0.5 but < 1; indifferent, > 1 but 
< 2; antagonistic > 2. 
Results: From 16 strains tested, 14 were susceptible to Nifalone (geometric 
mean: 14.14; range: 5-80 pg/mL). The combination of ITZ and Nif was 
active and showed synergistic action against A. jiwt@rus resistant to ITZ. 
(Table 1) 
Conclusion: The interaction between ITZ and Nif was additive for 
ITZ-susceptible strains and synergstic for ITZ-resistant strains. This 
suggest that efflux pumps could be involved in the mechanism of resistant 
in these strains. 
lp15881 In vitm activity of amphotericin B, fluconazole, and 
itraconazole against bloodstream yeast isolates in Hacettepe 
University Hospital, Turkey 
S. Arikan, S. Arslan, G. Hasselik 
Atiknvu, TR 
Objectives: This study was designed to determine the susceptlbility profile 
and irt vitro efficacy of amphotericin B (AMB), fluconazole (FLU), and 
itraconazole (ITRA) aginst yeasts isolated from blood cultures in Hacettepe 
University Hospital. 
Methods: Fungal strains (ti = 107) isolated from blood cultures within the 
time period of February 1996 to November 2000 were included in the 
study. The strains were identified by standard mycological methods. 
Antifungal susceptibihty tests were pexfonned and interpreted in accordance 
with the microdilution method recommended by NCCLS (M27A). The 
MIC (pg/nL) results were read after 24 and 48 h of incubation. FLU and 
ITRA resistance rates of Candidu spp. were determined according to the 
breakpoints proposed by NCCLS. C. krusci isolates were accepted to be 
FLU-resistant, regardless of their FLU MICs. 
Results: Curididu ulbicutrs constituted the most common species, followed by 
C. tropicalis and C. purupsilusis. Overall. 48 (44.9%) of the isolates were of 
non-ulbicuns Cundidu spp. MICs at 48 h were within 2 two-fold dilutions 
with the 24 h MICc for most of the isolates. At 24 h, except the FLU- 
resistant C. krtrsei, none of the Cutidida isolates were resistant to FLU or 
ITRA. Two (C. ulbicarts, C. tropiiubs) and 8 (C. ulbiruns, C. tropicalis, C. 
guil/iermowdit] of the isolates were susceptible-dose dependent (S-DD) to 
FLU and ITRA, respectively. 
Conclusions: (1) Nan-ulbicans Cutzdida spp. are a significant cause of 
fungaenlia in our hospital. (2) AMB MICs are scattered iri a narrow 
range, incapacitating the discriniinatlon of resictant isolates. (3) Except 
for FLU-resistant C. krusei, resistance to FLU or ITRA is not obcerved 
among our Cuirdidu isolates. However, S-DD isolates 3re rare but likely 
and should be of concern in cases with unexpected clinical failure with 
regular doses. 
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Malaria and Kala-azar 
lp15891 lmported malaria in patients who had been treated 
with correct malaria prophylaxis 
M. Lago, J .  Verdejo, M. Subirats, J. Villota, M. Perez-Jurado, S. Puente. 
J. Gonzalez-Lahoz 
Madrid, E 
Objective: To evaluate the chmcal and epidemiological characteristics of 
imported malaria in travellers after correct malarial prophylaxis. 
Patientslmethods: We studied retrospectively 113 patients with malaria 
who were admitted in our unit from January 1999 till October 2000. All the 
patients had been treated with correct malaria prophylaxis: 4 patients with 
Cloroquine plus proguanil (3 from Ecuatorial Guinea arid 1 from Ghana), 
and cwo with meflocluine (1 from Mozmibique and 1 from Cameroon). W e  
excluded travellers with none or incoi-ect prophylaxis. Diagnosis was made 
by detecting the parasite in blood smears by optic microscopy. Other 
procedures as P C R  were considered as complementary techniques. 
Results: We studied 6 patients with malaria coming from tub-Saharan Afirica 
who had been treated with correct iiialarial prophylaxis: 4 patients with 
Chloroquine plus proguanil (Group CP) and 2 with mefloquine. (Group 
M). Patients of Group CP were diagnosed of malaria by Pl..fakiparunr within 
the first 8 days after their return. They presented fever, chiUs, headache and 
arthronrialgias, Hb: 12.7-14.7, leukocytes: 2.700-4.700, plateletc: 97.000- 
180.000. We treated them with quinine plus doxicline. Patients of group M 
were diagnosed of malaria by PI ouale and a nixed parasitation by PI wale  
plus P/ vivax, 4 and 6 months after they had come back. They presented 
fever in altmiate dayc, Hh: 12.3-13.6, leukocyte?: 2.800-6.400, platelets: 
76.000-1 11 000. We treated them with cloroquiiie plus primaquine. Both 
groups presented n d d  haematological alterations and the evolution was 
satisfactory with no complications. 
Conclusions: Protection against nlalana after a correct prophylaxis is 
iiot 100%). Malaria by P/astnodJum .falripryarum was diagnosed in patients of 
Group C P  but none in Group M. Malaria by Plazrriodiurrr ooalp and 
Plasmodium ~ I I U Z X  was diagnosed in patients of Group M (Mefloquine does 
not protect againtt intrahepatic forms of Plasmodium vivax and ovale) but 
none in Group CP. Malaria must be considered in all travellers with fever 
despite of a correct prophylaxis. 
vl Jmported cases of malaria in Constanta, Romania 
V. Florea, I. Duiuitru, E. Goniii, M. Codarcea, C .  Rugina 
Constarita, RO 
Background: The eradicatioii of malaria in Romania was camed out in 
1961 and after that, all cases originated from different Afncan countries 
(Camerun, Nigena, Ghana, Uenin, Angola), India and Turkey. 
Objectives: T o  analyse the epidenmiologcal, etiological and chlllcal aspects 
of the iiialaria cases on the Black Sea area, Romania. 
Materials and method: We per toned  a study on 38 patients with malaria 
hospitalized 111 Department of Infectious Diseases in Constaiita, between 
January 1906 and Noveiiibei- 2000. The puasitologic aiialysis of dense drop 
and smear of peripheral blood were significant for positive magnosis 
of malaria. 
Results: Most of these patients were Romanian citizens worhng in these 
countries. Plasmodiurti $/riparum was the cause of ndaria in most of them 
(63.2%); the rest of p:itients had malaria with P/asrrrodiurn uiuax. Typhoid 
fever was associated in 11 cases (29%). While 31 patients were a t  their first 
diagnosic of malaria, 7 (18.6%) patients pi-eseiited with a relapse (6 with 
PIasr.nodiuiJi.falriyryarum, 1 w t h  PIasmodium  wax infestation). A number of 30 
patients took a prophylactic treatment with Cloroquine (only 26 were 
compliant with the correct administration). 8 patients ignored antimalaric 
prophylaxis. The most frequent complications were anaenlia and trombo- 
cytopenia; one case had severe haeniolytic anaemia and acute renal failure 
and another case developed mucocutaneous bleeding and coma. The last 
patient med after 5 days of treatment with Chinine and Fanridar. 111 both 
cases, Plasmodium &/[- ipr i~in was the etiologic agent. 
Conclusions: Malaria remains a great problem in Romania, especially 
malaria caused by Plasmodiumfak~aruni. A significant nuniber of cases were 
associated with typhoid fever. Concerning the serious problem of therapy 
for malaria resistant to Cloroquine (68.4% in our patients) the important 
role of chemoprophylaxis with other antinialaric agents is emphasized. 
v/ Retrospective evaluation of malaria patients 
S. Goksel, B. Arda, T. Yamazhan, D. Gokengin, S. Ulusoy, E. Erteni, 
D. Serter 
Izmir, TR 
Objectives: To evaluate tlialaria cases with respect to their epidenliologicd 
and clinical aspects. 
Materials and methods: Forty-five malaria patientc who were hospitalized 
in the Departnieiit of Clinical Microbiology and Infectiouc Diseases in Ege 
University School of Medicine, during the years 1991-2000 were included 
in the study. The patients were analysed retrospectively and their 
epidemological data, clinical manifestations, treatment regimens and 
complications were noted. 
Results: O f  the 45 patients, 20 were female and 35 male. Twenty-five of the 
included cases indicated urban residence and 20 rural. A total of 24 patients 
(17 of the urban residents and 7 of the rural residents) had a history of travel 
to an endemic region. The diagnosis was made by direct microscopic 
exanination of Gienisa preparations of peripheral blood smears in 44 
patients and of bone marrow aspirate in 1 patient. Plasrnodiir~ri uiv0.u was the 
causative agent in 39 cases and P. jdiipauum in 6 patients. While a high 
proportion (38.4%) of the P. viuax patients gave a history of travel to the east 
and south-east regions of Turkey, 5 ofthe P,-filiiparurti casec hzd travelled to 
African, South Asian or Middle Eastern countrirc. The iiioqt com~iioi~ 
complaints were fever (100%), chills (84.4%), nausea and vonliting (46.6%), 
headache (31.1%), abdominal pain (15.5%) and change m the state of 
consciousness (6.6%). When evaluated with respect to the physical findings, 
38 patients (84.4%) had splenonniegaly, 29 (64.4%) hepatomegaly. 5 
(11.1'%) ictertrr, 4 (8.8%) herpes labialis, and 2 (4.4%) petechiae. P. vir~as 
malaria patients were treated with a standard regimen of priniaquitie for 14 
days and chloroquine for 3 days. Cases with P. j&ipnrir in nlalaria received 
various combinations of niefloquine, quinine, doxycycline, and primetha- 
mine + sulphodoxine. The complications rioted were severe pancytopeilia in 
two patienn and epistaxis in one patient. One patient died due to ~eptic thock. 
Conclusion: Malaria is still a niajor health problem iu come developing 
countries amongst which is Turkey. Especially the easteni and south-eastern 
regions of Turkey are endenltc for malaria. The fact that malaria was 
magnosed in some cases residing in the urban parts of the country and with 
no history of travel iudicates that preventive measures are rtdl insufficient to 
eradicate the disease even in the developed areas of the country. 
vl Halofantrine for treatment of malaria in children 
M. Garcia-Lopez, M. Mellado, J. Villota, M. Suhirats, M. Perez-Jurxio, 
1'. Martin-Fontelos 
Modrid, E 
Objectives: To study the efficacy of treatment with halofmtrine in children 
infected by P. .falcipanrrw-resistant to chloroquine and to describe the cide- 
Methods: between January 1991/July 2000, we studied 16') children aged 8 
months to 14 years, with malaria in our Pediatric Tropical Unit. conling 
from an endemic area of malana (Guinea) where P .  J&ipntr,t is usunlly 
resistant to chloroquine. A full haematological exanunation including a 
blood smear for malarial parasites were made to all the childreii at entiy and 
24 and 72 h afier treatment. Previously to treatnient we made an 
electrocardiogram to all of them. They were treated with halofantrine by 
oral route, 8 nig/kg/dose, 3 doses every 6 h. When parasitaemia war > 1x0 
after treatment, a 2" cycle of halofantrine was given a week latcr. 
Results: At the entry in oui- Unit: 114 chldren (68%) had fever > 38.5 "C. 
21 caws (1.3%) presented an OKL focus and 22 chddren (13%) complained 
of abdominal pain, vomiting and diarrhoea; 147 children (88%) had spleen 
enlargement and 92 (55%) liver enlargement, 25'% presented maenua and 
75% malnutrition. Parasitaeniia ranged between 0.1% to 3.2%. Plasrriodiriiii 
jdiiparunt was found in 130 cases (77%), P. o i d r  in 14 children (8.2%)) and 
mixed parasitation by P. j i l r i p a m ~ i  + P. vivax or P. ~fali.iparnrir + P o i d e  i n  6 
children (3.5%). In 19 (11.3%) case3 the smear was informed as P. sycsie. 
Fever disappeared 24-48 h after treatment in 99% ofthe children. Sixty-five 
per cent of the patients persisted with positive blood smear for Plasriiodiirrrr 
24 h after treatment and becmie negative, in the 99% of them, 72 h 
postreatnient. One child presented clinical resistance to halofanti-ine and at 
last was cured with quinine by oral route. Tolerance to halofantrine was 
rfiects of this dug. 
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escellent in 164 children (96%) and five cases (2%) presented transitory 
hepatic citolysis. None of them presented cardiac conduction abnomialities. 
The niean time in hospital was 4 days. A new exanlination one month later 
of discharged from hospital was made in 133 children (SO%)), and all of them 
were cured. 
Conclusion: (1) Halofanmne is an effective drug of easy management in 
clddren with P.~falc~~arum-chloroquine resistant with this drug. (2) N o  side- 
effects were observed in our children. (3) In spite ofpositive smear 24 h after 
treatment, it does not meant therapeutic failure. (4) Incidence of clinical 
resistance to halofantrine has been about 0.5%. in this cases we obtained 
good results with oral qu~nine. 
)p15931 Studies on the Plasmodium fakiparum pfcrt K76 
polymorphism in relation to chloroquine resistance 
D. Lopes, F. Nogueird, C.  Casimiro, V. do Rosirio, P. Gil 
Lirhori, P 
The identification of the chloroquine transporter resistance gene (pfcrt) ha5 
been identified and reported through a genetic cross between 2 clones of 
Plarinoniinni.falriarur~~. A mutant, T76K. has been consistently associated to 
chloroquine resistance in epidemiological studies, as well as in vitvo 
transfection based experiments. I" We have assessed the presence of this 
mutation in clones and isolates from diverse geographical origins, including 
Africa (S. Tom6 and Principe, Guinea Bissau, Angola), South America 
(Brazil) and South-east Asia (Thailand), in order assess its frequency through 
molecular genotyping methods. All samples tested were characterized 
concerning chloroquine susceptlbility (WHO microtest guidelines). The 
presence of the T76K mutation was confirmed through nested PCR-RFLP 
methods, as the AAA to ACA single nucleotide polymorphism (SNP) leads 
to the elimination of an ApoI restnction site. Results show a high degree of 
correlation between the 76K variant and chloroquine resistance (60.45%), 
although several exceptions were identified in African and Asian samples. 
The wnples of South American origin show a 100% correlation between 
the presence of this allele and chloroquine resistance. These results reinforce 
the concept of other genes being associated to chloroquine resistance, these 
studies being undertaken. 
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vl Diagnostic dilemmas of imported Kala-azar infection 
in a nonendemic country 
J.  Iqbal, P. Hira, G. Saraj, F. A-AIi, S. Frank 
Kuiruif, KWT; Atlatifa, USA 
A diverse spectrum of clinical presentation of visceral leishmaniasis (VL) in a 
tionendemic country may pose &agnostic dilemmas and thus may lead to 
delay in diagnosis. In this study we present 12 cases of imported VL in the 
Tissular parasitic infections 
migrant workers diagnosed in Kuwait, a nonendemic country. All VL 
patients had been in Kuwait for a substantial period of time before they 
presented chnically. The clinical presentation and/or coinfection of other 
relatively more common endemic infections in some of the cases also 
delayed clinical suspicion or laboratory investigation for VL. Our results 
indicate that indirect haemagglutrnation assay correlates well with the VL 
infection and is a suitable &agnostic assay for screening all suspected VL 
cases. The cutaneow leishmaniasis was caused by Leirhmarria fropica rniiior and 
is endenllc in Kuwait. In view of the presence of a large number of nugrant 
workers &om endenllc areas. changing epidemiological environment and 
the presence of an eflicient vector, there is a distinct need to maintain and 
be vigilant on the surveillance and focus on the diagnosis of VL cases 
in Kuwait. 
Acknowledgements: This study was funded by Grants from Kuwait 
University (MI 113 8r MI 098). 
Identification of two visceral Leishmania strains 
isolated in Tirana, Albania 
Tiratla, AL 
Objectives: Visceral Leishnlaiiiasis is a parasitlc disease which cause a big 
probleni of Public Health in our country, Albania. The nuiriber of new 
cases per year is estimated as approxiniately 200. More than 58%1 of all cases 
affected belong to group age &om one to four years old. We tried to isolate 
visceral Leishmania strains from different patients and dogs for about three 
years. Our presentation aims to give the results of identification of two of 
these strains which have been isolated: one in a young infected boy and the 
other in a sick femde dog. W e  also confirm the zoonotic character of 
Visceral Leishmaniaris in Albania because of the same strain found in 
humans and dogs as reseivoir of infection. 
Methods: Two isolates of Leishrnarria, obtained from: one human case and 
the other from animal during epidemiological investigations, were studied. 
Human isolate (March 2000) w-as from bone marrow aspiration, while the 
canine one (May 1998) was &om spleen. Both of them were made firstly, in 
N.N.N. medium. W e  used modified Tobbias-Evans medium and RPMI 
1640, for further cultivation. Biochemical characterizations were carried out 
by the isoenzymatic technique using starch gel electrophoresis, in two 
specialized laboratories: (a) Laboratoire d'Ecologie Medicale et Pathologie 
Parasitaire, MontpeUier. France (human strain) and (b) Laboratory of 
Parasitology of Istihito Superiore di Sanita, Roma, Italy (canine strain). The 
reference strains used were: MHOM/FR/78/LEM75 (L.  it$mfum 
zymodeme MON-I) ,  MHOM/TN/80/IPT1 (L. infanfum zymodeme 
MON-1), MHOM/IT/86/ISS218 (L. ir!fanrum zyniodeme M O N  72). 
Results: Both of our identified strains belonged to taxonomic complex of 
Lrishtnanin infanturn, zyniodeme MON-1. Their codes are: MHOM/AL/ 
2000/5 16LEZH and MCAN/AL/98/C78L574. 
Conclusions: Visceral Leishmaniasis in Albania is caused from strains of 
Leishrnnrzia infanturn. This parasitic infection is a zoonosis in our country, like 
in other countries of Mediterranean region. 
E. Cani, R. Petrela, T. Myrseli, L. Fuga, P. Minarolli, M.  Hyskaj 
jP15961 Efficacy of medical treatment in hydatid disease ultratonography-guided puncture of the cyst with fluid aspiration followed 
V. Florea, I. Dunlltru, E. Gorun, E. Dunitru, M. Codarcea, 
E. Muja 
Cotmanta, RO 
Objective: T o  analyse the efficacy of medical treatment for hydatid disease 
in patients admtted in our hospital. 
Patients and methods: W e  perfotmed a study on 20 patients admitted in 
the Department of Infectious Disease, Municipal Hospital in the last 2 years 
(1998-2000). The diagnosis was based on history and epidemiological data, 
laboratory analysis (ELISA reaction for Echinococrus gmrzulosus), chest X-ray, 
ultrasonography and computed tomography. Treatment involved Albenda- 
zole in doses of 800 mg/day for 28 days, minimum 3 cures separated by 2- 
week intervals. 4 patients used t h s  treatment after surgical intervention for 
liver or p ~ l m o ~ r y  cysts as a prophylaxis of possible relapses. In another 
cases with a giant liver cyst (12 cm) we performed a percutaneous 
by medical treatment. 
Results: Echinococcosis had different locations: liver cysts (8 cases), 
pulmonary cyst (3 cases), renal cyst (1 case), splenic and peritoneal (1 case), 
muscular (1 case) and bone cyst (1 case). Secondary hydatidosis was reported 
in 2 cases and multiple cysts were found in 5 cases with liver cysts. At the 
beginning of therapy all the cysts had less than 7 cm in dimension. After 
medical treatment we notice a regress of the cysts dimension or cysts walls 
calcification in liver, pulmonary, renal, splenic and peritoneal cysts and no 
relapses after surgical treatment. After 3 months of medical treatment, no 
significant changes were observed in muscular and bone cysts requiring 
surgical intervention. 
Conclusions: The medical treatment with Albendazole was the best choice 
in most cases. Albendazole therapy could prevent relapses after surgical 
intervention. Only in 2 cases (muscular and bone cysts) surgical intervention 
was required. 
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/p15971 Hydatid antigen-specific dot immunobinding assay 
increases the detection of liver echinococcosis in nonendemic 
areas 
M. Paul, J. Stefaniak 
POZnQn, PL 
Objectives: The serological evidence of Echinococrus infections in humans 
using traditional methods remains rather inadequate in nonendemic areas 
when single cysts of low immunogenicity are diagnosed in the liver. We 
evaluated the dot immunobinding assay for the detection of hydatid 
antigensspecific antibodies (HA-DIA) in patients suffering from cystic or 
alveolar echinococcosis. 
Materials and methods: Serum samples from 32 patients with E .  granulosur 
(CE) or E. multilocularis (AE) dections were analysed by HA-DIA in 
comparison to two commercially available ELISA kits. CE was confirmed in 
30 patients by the presence of parasite protoscoleces and/or hooks or 
specific antigen 5 (‘sterile’ cysts) in cyst fluid samples obtained by the fine 
needle aspiration biopsy (FNAB) or surgery. AE which occurred 
sporadically in Poland was additionally diagnosed in 2 patients by 
the detection of E. multilocularis-specific Em2plus ELISA and Em18 
Westem blot serum antibodies and finally confirmed by postoperative 
hiatopathology. 
Results: The HA-DIA based on E. granulosus antigens of bovine cyst origin 
showed a high sensitivity in serum samples from CE patients. Specific 
antibodies were found in 29 of 30 CE cases (96.7%), including 5 patients 
with ‘stenle’ echinococcal cysts without protoscoleces/hooks in a biopsy 
matenal diagnosed by immunological methods alone (Ag5). One negative 
result was observed in a patient 3 years after a radical surgery with a 
subsequent albendazole (Zentel) chemotherapy. The Dialab Diagnostic lut 
was positive in 23 CE patients (76.7%). The correlation between the HA- 
DIA and the Dialab ELSA was statistically signdcant (r= 0.96). By contrast, 
the commonly used Bordier Afinity Products kit gave unsatisfactory results 
being positive in only 12 of 30 CE patients (40%). Sera Gom two AE 
patients showed a cross-reactivity in all three methods analysed in the study. 
Conclusions: The high diagnostic sensitivity and a faster one-step procedure 
when compared to conventional enzyme immunoassays, make the HA-DIA 
a very useful complementary t e c h q u e  for the diagnosis of CE in 
nonendemic areas, especially in a case of small or degenerating lesions, 
‘sterile’ Echinococcus cysts with a low antigenic activity, and early recurrences 
of the disease. The positive serology for CE fiequently requires additional 
differentiation with E. multilocularis-specific antibodies. 
lp15981 Our experience in the chemotherapy of human 
echinococcosis 
N. Andreeva, I. Manchev, V. Blagoeva, A. Massarlieva, E. Tcholakova, 
V. Andonov, K. Chepileva 
sofa, BG 
Introduction: Between 1990 and 1999 statistical estimates of human 
echinococcosis in Bulgaria show an increase in its morbidity rate. This 
upward tendency is even stronger in the second part of the decade. A recent 
uprising in the number of inoperable cases has also been observed due to the 
multiple previous surgical interventions resulting in a marked reduction of 
organ fbnctional parenchyma and severe adhesions. 
Objective: The aim of the present study was to evaluate the effect of 
albendazole treatment in patients with echinococcosis. 
Materials and methods: The study included 18 patients with echmococ- 
cosis (aged 19-72). Of them 14 had liver cysts, 2 had lung cysts and 2-multi 
organ echinococcosis (lung and liver). According to the manufacturer’s 
instructions (SKL) and the W H O  recommendations Zentel was given 
at a dose of 10 mg/kg in 4 cycles of 28 days separated by 14 days 
without treatment. 
Results: Two patients were excluded because of significant dlsturbances of 
liver enzyme activities. The efficacy of chemotherapy was evaluated by US 
and C T  scanning in the c o m e  of treatment and during the 6-month 
follow-up. A successful response to chemotherapy was observed in 14 
(87.5%) of the patients-reduction of the cyst size, increased density of the 
cyst fluid and calcifications of the cyst wall. Only two patients remained 
with unchanged cyst size. 
Conclusion: Our experience although limited shows that albendazole is a 
reIiable alternative in the treatment of echinococcosis in cases in which 
surgery in contraindicated. 
vl Comparison of two methods on experimental cystic 
echinococcosis in Balb/C mice 
M. Hokelek, K. Erzurumlu, Y. Uyar, A. Guvenli 
Samsun, TR 
Objectives: In vitro and in vivo researches on echinococcosis have been 
intensity done. In this study two different experimental methods on mice 
trying to be compared. 
Methods: Thirty-three Balb/c mice were used in the study. Nine of them 
were parted as control group. The cattle liver with cyst were opened under 
sterile conditions. Daughter cysts whose diameter reached between 0.5 and 
1 cm and which were taken Gom the big cyst: were washed with sterile 
physiological saline. Two of these cysts were put in the peritoneal cavity of 12 
mice (Group A). Other 12 mice (Group B) were injected with 0.1 mL of the 
protoscolices solution washed with physiological h e  mtraperitoneally. Three 
mice from Group A were opened after three week and it was seen that daughter 
cysts were fixed on to the walls of the abdomen. Three months later, all the mice 
from all groups were sacrificed and the cyst sizes were compared. 
Results: It was seen that, while in Group A the cysts which were placed in 
periton was reached 1.5-2 cm diameter as unilocular; in Group B intra- 
abdominal cysts the biggest of which has got 3 mm diameter were seen. 
Conclusion: It was found that model of experimental echinococcosis, 
placement of daughter cysts intraperitoneally was considered as favourable 
method. Moreover, it can help to save time in such studies and also that is 
possible to study on unilocular cysts. 
1p1600( Consideration about the treatment with albendarole 
in the hydatic disease 
C. Apostolescu, R. Cemat 
Bucharest, RO 
Hydatidosis still represent a cause of morbidity in Romania, despite of 
several measures taken to eradicate the infection with Taenia echinococcus in 
animals. Even the disease is known for a very long time, the treatment is not 
satisfactory until today 
Objectives: This work try to evaluate the efficacy of treatment with 
Albendazole in human infestation with T. echinococcus, also its frequency 
and severity. 
Method: We used the statistical retrospective method over 54 patients 
admitted in National Institute of Infectious Diseases ‘Prof. Dr M. Bals’, 
Bucharest, between 1 January 1999 and 31 October 2000. The diagnosis 
was made by ultrasonography and specific serology 
Results: The locahzation of cystic was: hepatic-44 (81.4%), pulmonary4 
(14.8%), renals-4 (7.4%). splenic-2(3.7%), and mesenteric-1 ( I  35%). Some 
patients had many cysts as follows: 42 had a single cyst (77.8%), and 12 
(22.2%) had more then one, and 4 of them had cysts in many organs (her + 
lungs, liver + kidney, liver + lungs + mesenterum). 
The treatment was made with Albendazole 600-800 mg/day, 28 days, 
with a success ratio of 62.9% (considerate by dlminution of cysts at 
ultrasonography investigation or by negativation of specific serology). The 
failure of initial treatment called for a second or for a third cure, or for 
surgical act (only for a single cysts). 
Conclusion: A single cure of Albendazole is not enough to cure hidatidosis 
and cannot replace the surgical treatment, only to complete it. 
(p16011 Praziquantel in combined treatment of hydatid disease 
S .  Dautovic, J. Huskic, S .  Mulic, D. Cengic, S. Dizdarevic, S .  Guska, 
S .  Beslic 
Sarajevo, Konjic, BJH 
Aim of the study: The present study was designated to evaluate the 
efficiency of praziquantel combined with the operative treatment of hydated 
disease. From October 1996 to October 2000, we have had 136 patients that 
were surgically treated, 26 of whom (19.2%) were treated involving 
praziquantel. 19 of these patients (73%) had primary echinococcosis, and seven 
(27%) were relapses. The therapy was applied in hospital with praziquantal in 
the 14-day period and with therapeutic dose of 25-50 mg/kg. After the 
therapy, patients were monitored in outpatient department: clinically, using 
biochemical methods, ultrasonographical, and X-ray examination. 
Results: In a group of patients that were treated only surgically, we have had 
only 12.6% relapses. In a group of 26 patients, there were no relapses. 
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Conclusion: This study confirms that combined treatment with praziquantel 
is therapy of choice with patients suffering from human echinononnosis. 
p1602) Fasciolasis among clinically suspected hydatid cyst 
patients 
D t n i r ,  TR 
Objectives: Although it is a common parasite of herbivores, human 
fasciolasis cases are very rarely reported in Turkey. Because of its unspecific 
signs and symptoms like; eosinophilia, right upper quadrant pain and 
hepatomegaly, F. hepatica is mostly underestimated and these symptoms are 
mostly attributed to other parasitic diseases. This study aimed to investigate 
the presence of fasciolasis among clinically suspected cyct hydatid cases 
referred to Parasitology Laboratory. 
Methods: E-S ELISA, which ha. been developed in our laboratory and 
considered to be a useful technique for the diagnosls of hciolasis, has been 
perfonlied to investigate anti-Fadola \.p.tica IgG antibodes. Sero-positive cases 
were fuaher evaluated both radiologically and pamitologically. The definitive 
diagnosk was established following the demonshation ofparasite ova in the faeces. 
Results: Antibodies against fasciola were detected in 3 of 226 cases (1.3%) by 
ELISA. Radiological findings strongly suggested the infection and eggs of F. 
hepatica were found in the stool of two of three patients. 
Conclusion: Human fasciolasis is found to be more common than estimated 
in our country and ELISA is found to be a useful diagnostic test for 
screerung and epidemiological studies. Moreover, fasciolasis should be 
considered a t  the presence of eosinophilia, abdominal pain and liver lesions. 
M. Demirci, M. Korkmaz, N. Sakru, U. Z. Ok, A. Kuman 
v\ Thirty-two cases of fascioliasis in Antalya and i t s  
surroundings 
R. Saba, L. Mmkoglu,  M. Korkmaz, D. Inan, G. Erdaloglu, A. Kabaalioglu 
Antalya, D m i r ,  TR 
Fasriola hepatica is a trematode which especially idects sheep, goats and 
cattle. Humans act as an accidental host and infection is rare. W e  diagnosed 
32 cases of human fascioliasis between 1998 and 2000 (20 acute, 4 latent and 
8 chronic infection). Demographic and laboratory findings and diagnostic 
methods are shown in the table. (Table 1) 
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Previously only few cases has been reported from Antalya and its 
surroundings and we think fascioliasis is not uncommon and can easily be 
diagnosed by radiologic and serologic tests and all patients who has 
eosinophilia must be evaluated for Farciola hepatira. 
Ip16041 Seroprevalence of toxacariasis in psychiatric patients 
M. Kaplan, K .  Demirdag, S. Kuk, M. Ozden, A. Kalkan 
Elazig, TR 
Infection of man with Toxocara ssp., the common roundworm of dogs and 
cats, causes the clinical syndrome known as visceral larva migrans syndrome. 
Transmission of this clinical syndrome to human occurs by oral intake of its 
eggs. Migration of larvae to variety of tissues causes development of this 
disease. Contamination of environment with faeces of infected dogs is 
important factors in transmission of toxacariasis. The  prevalence of this 
disease is higher in lifestyles involving intense interference wtth soil. 
Therefore, the toxacariasis fiequency is higher in childhood period of dog 
keeping families and members of families involved in farming. Because of 
inappropriate personal hygiene and oral contamination, probably, the risk of 
toxacariasis increases in mentally retarded and psychiatric patients. W e  are 
not aware of any study regarding the prevalence of toxacariasis, a parasitic 
zoonosis which invades nervous system, mainly in central nervous system 
and leads to neurological disorders in mentally retarded and psychiatric 
patients of Turkey. This study was perfomied on 140 subject involving 
mentally retarded, deaf and severe psychiatric patients to determine the 
prevalence of toxacariasis prevalence in Elazig province using Toxocara ranis 
IgG/M ELISA kit (Novum diagnostica, Germany). The seropositivity 
aniong mentally retarded, deaf and psychiatric patients was 22.2%, 26.3% 
and 44.7, respectively, a total of 39.3% in studied population. In conclusion, 
the prevalence of toxacariasis is much higher in these three populations 
coinpared to prevalence in healthy population in this region in 1999. 
(p16051 A seasonal outbreak of human parasitation by 
chiggers in La Rioja (Northern Spain) 
S .  Jimenez, I. Gaston, A. Perez, J. A. Oteo 
L g o r i o ,  E 
Chiggers, also known as harvest mites, is a worldwide acari which may be 
free living or may parasitize plants, insects, animals, or humans. In Europe, 
human parasitation by chiggers produce pruritic erythematous skin lesions that 
may be di6cult to diagnosed. So fir in Spain no cases has been described. Now 
we communicated a seasonal out-break of pruritic erytheniatous skin lesions in 
legs in outdoor worken of the woods of La Rioja (North of Spain). At least, 
during the last 7 years at the end of the summer and first of autumn, outdoor 
workers whom developed his job in the mountains of Natural Park of 
Cebollera presented pruritic erytheinatous (maculo-papules) skin lesions in legs. 
Now (September 2000), we have observed inside of the skin lesions the 
presence of Trombicula automnalis in all 11 foresters (100%) who developed his 
job in the citated area. None of the patients have evidence of clinical rickettsial 
disease. W e  presented illustrations of the chiggers and the sku1 lesions. 
vl Aetiological, clinical and therapeutic aspects in 
hepatobiliary parasitoses 
D. Kraja, N. Como, E. Cani 
Tirana, AL 
Objectives: Identification of the parasite type, frequency; clinical-biological 
syndromes and therapeutic tactics, on  100 persons of age 1 4 6 8  years old, 
affected by hepatobiliary parasitoses hospitalized in our service during the 
period 1984-2000. 
Methods: W e  identified the parasite [through direct parasitical examinations 
of biliary liquid and excrement or immunoserological tests for Echinococrus, 
Leishmania, Toxoplasma and Erztamoeba]. The sick persons have completed 
biochemical and paraclinical investigations [abdoimnal echography or CT, 
hepatic biopsy]. 
Results: The etiological structure has been: Cardia laniblia-61%, Ascan's 
lumbricoides-lS%, Echirioroccus gvanu/osids-8%, Leishmarria dorzovniri-7%, Tm- 
oplasma gondii-S%, Eiitamoeha hisfoZitica-2%, Fasriola hepatice2%~ The 
biochemical-clinical syndromes were: Anicteric hepatitis-25%, Icteric 
hepatitis-4294, cholostatic hepatitis-%, jaundice-16%, Febrile icteric 
syndrome-8%, Hepatic cysts-14%,, Cholecystitis 58%. Cholangiocholecys- 
titis 22%, Biliary colic 20%, Hepatolienalsyndrome--16%. 
Therapeutic tactics: 88% of these sick persons were cured with antiparasitics 
[Metronidazole, Omidazole, Albendesole, Praziquantel, Pyrometamine- 
Sulfadiazine, Chloroquine, Glucantime, Dihydroemetine] and one helper; 
in 12% of cases surgical intervention was needed to resolve the problem 
[Echinococcosis-6 cases, Hepatic Accaridosis-2 cases, Cholecystic Ascaridosis- 
2 cases, Ascandosis of Choledocus-1 case, Glardial Biliary Colic-1 case. 
Conclusions: The aetiological and clinical structure of hepatobiliary 
parasitoses in our country is complex. The drug treatment was successfully 
reahzed in 88% of cases. 
Ip16071 Clearance of microfilaraernia and red blood cell 
glutathione peroxidase (GPX) levels in asymptomatic 
microfilaraemics after single dose and 14 days' treatment with 
diethyl carbarnazine citrate (DEC) 
R. Premaratna, T. G. A. N. Chandrasena, W. Abeyewickreme, N. R. de 
Silva, L. G. Chandracena, H. J. de Silva 
Rapma,  CL 
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Background Single dose and 14 day treatments with DEC have been found 
to have similar nlicrofilaria clearance rates. Although the microfilaricidal 
action of DEC is not clearly understood, stimulation of platelets by the drug 
to release free radicals, especially those related to GPX, seem to play a role. 
Aim: T o  study the clearance of microfilaraenlia and changes in red cell GPX 
levels in asymptomatic microfilaraemics after single dose and 14 day 
treatment with DEC. 
Methods: 22 asymptomatic microfilaraemics were block randomized to 
receive either a single dose (300 mg), [ n  = 1 1 (5 males), mean age 34 years 
(range 15-59) or 14 days treatment (total of 4.2 g) [n = 11 (6 males) mean age 
29.8 years (range 16-57) with DEC. Baseline and one month post treatment 
microfilaraemia was assessed by Nuclepore '' membrane filtration using 1 
mL of heparinized venous blood obtained between 9 and 11 pm. Red blood 
cell GPX levels were analysed using spectrophotometry before and on the 
3rd, 7th, 14th and 30th days after commencement of treatment using 2 mL 
of venous blood collected into an EDTA bottle between 8 and 9 am on 
each day. Assays were done within 6 h ofblood collection. Blood was stored 
a t  80C until analysis 
Results: 
c h a n g e s  m microf i laraemia a n d  G P X  
l eve l s  with R x  
A gradual and significant increase in GPX levels was observed up to day 14 
in both treatment groups (day 3, 7, 4 P < 0.03) and the started to decrease. 
There was no sigmficant difference in reduction of wtfcounts (P=O.31) 
or in GPX levels on day 14 (P=0.12) and day 30 (P=0.06) between the 
two treatment groups. 
Conclusions: The 14 day course does not offer a significant advantage over a 
single dose of DEC in  reducing microfilarial counts and inducing the 
participation of GPX related her radicals in microfilarial clearance. 
CNS viral infections 
Ip16081 Red blood cell antioxidant levels after treatment 
with diethyl carbamazine citrate in persons with asymptomatic 
microfilaraemia 
R. Premaratna, T. G. A. N.  Chandrasena, W. Abeyewickreme, N.  R. de 
Silva, L. G. Chandrasena, H. J. de Silva 
RaXama, CL 
Background The mcroiilaticidal action of DEC is poorly uiiderstood. B r  v i m  
studies have shown that, DEC stimulates platelets to release unspecified free 
radicals, whch have microfilancidal effects. In amicrofilaraemics living in endemic 
areas, red cell glutathione peroxidase (GPX) levels are sigdicantly hgher than in 
asymptomatic microfilaraemics. Catalase and superoxide dismutase (SOD) levels 
between these two populations are not Merent. This suggests a possible role for 
GPX related free ndical species in the clearance of microhenl la .  
Aim: To study, in uivo, the changes in red cell GPX, catalase and SOD in 
asymptomatic microfilaraemic patients after treatment with DEC. 
Methods: Ten patients [(6 males), mean age: 29.8 yean (range 16-57)] with 
asymptomatic microfilaraemia were tested for red cell GPX, catalase and 
SOD levels using spectrophotometry before and on the 3rd, 7th and 14th 
day during a 14-day course of DEC. 2 mL of venous blood was collected 
into an EDTA bottle between 8.00 and 9.00 am on each day. Assays were 
done within 6 h of collection. Blood was stored at 8" C until analysis. 
Results: 
Changesin antioxidant lev& with Rx 
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A gradual and significant increase in GPX levels was observed up to the 14th 
day of treatment. (day 3, 7 and 14 P < 0.01). A dower and nonsignificant 
increase in catalase and SOD were also observed during treamient up to day 7. ( P  
> 0.05) and on day 14 the catalase level was significantly a e r e n t  ( P  < 0.01). 
Conclusions: The early and significant rise of GPX levels suggest a rapid 
increase in GPX related oxidant species in blood in response to DEC 
treatment. The late rise in SOD and catalase levels could be due to 
stimulation of immunological pathways by dead parasite antigens, as these 
two antioxidants are known to participate in the IgE mediated 
immunological pathway of the host parasite relationship. 
/p16091 An outbreak of aseptic meningitis in Vojvodina 
G. Canak, J. Jovanovic, K. Doder, J. Vukadinov, N. Samardzija, V. 
Turkulov, M. Aleksic Djordjevic 
Nuui Sad, W 
Aim of the study: To investigate frequency and clinical mainfestations of 
aseptic meningitis (AM) during the outbreak in Vojvodina, from the end of 
July till the end of October 2000. 
Material and methods: 201 patients with signs of acute viral CNS infections 
treated at the Clinic for Infectious Diseases in Novi Sad were enrolled in the 
study. Data were collected from medical records of hospitalized patients. 
Diagnosis of AM was based on cyto-biochemical characteristics and negative 
bacterial culture of CSF, epidemiological data and typical course of the 
disease. Aetiological diagnosis was confirmed only in one patient, in whom 
rectal swab was negative, by isolation of enterovirus ECHO 30 from the 
culture of CSF. As the outbreak of AM occurred in late sumnier and the 
course of disease was inild, it was presumed that entero/ECHO viruses 
accounted for most of the cases. 
Results: Among 201 patients with acute viral infection of CNS, 193 were 
diagnosed as AM and 8 as acute ineningoencephalitis. The patients were from 2 
to 54 yean old. Majority of them were less than 15 years of age (156 or 82.3'%), 
with the highest attack rates in children aged 4 and 12, respectively. The male to 
female ratio was 1.5:l. Monophasic course of AM was predominant (161 
patients or 83, 42%), though 16, 58% (32) had biphasic course of disease. CSF 
cell count ranged from 10 to 2960/nun' and in most cases (123 or 63, 40%) 
was 10-50O/mm'. Predominance of granulocytes in CSF was noted in 99 
patients (51.3096) and ranged between 5(k90%; protein concentration level in 
CSF was hgher than 0.5G-2.8 g/L in 41 patients (21.24%). CSF/blood glucose 
ratio ranged between 0.36 and 0.48 mmol/L in 19 patients (9.84%). 
Leukocytosis in peripheral blood was found in 37.31% (72) patients, and 
ranged from 10.2 to 34.0 x 10". Neutrophilic granulocytosis in WElC was 
registered in 95.83% of patients on admisson to the hospital but 24 h latq, 
leukocytosis was found only in 5.70% (1 I) of them. ESR higher than 20150 
was found in 41.45% (80) of patients. Milder form of meningoencephalitis was 
regstered in 8 cases. Mild hemiparesis as a complication was noted in 2.49% (5) 
cases. It occured at the end of hospitalization or during covalescence period. 
The outcome of disease was favourable in all patients. 
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Ip16101 Eradication of polio in Kosova: is it possible? 
L. Gashi, N .  Raniadani, A. Kdaveshi, M.  Reinicke, M. Kocinaj 
Priskfina, A L  
Goal: Presentation ofpoliomyelitis course in Kosova, of the success of active 
AFP survedlance, possibilities for stopping circulation of polro virus until the 
year 2000 and preparation for eradication of the disease until the year 2003 
with successful implementation of the immunization. 
Method: Epidemiological assessment by using descriptive component, the 
retrospective observation of the phenomenon by time, reporting data from 
active AFP surveillance. communicable disease surveillance and Immuniza- 
tion coverage report of the Institute for Epidemiology and clinical and 
laboratory were collected. 
Results: Since 1990 through 1999, 54 suspected cases of poliomyelitis have 
been registered in the territory of Kosova with two lethal cases. The highest 
number of cases was noticed dunng 1996 (25), with morbidity of 1.16 and 
lethality of 4.0. Last four years no cases of poliomyelitis have been 
registered. Type I, 11. I11 of 'wild virus' of polio was isolated in 12 cases. 9 
cases were negative and other three were not typified. Lart four years no 
case of poliomyelitis was recorded. During sub-NID in Kosova, which was 
iniplemented in 6 rounds in the year 1996 in the age-group 0-5 years with 
polio immunization were covered 97% of the children, in 1997 (93%) and 
1998 (80%). During this period 80% of the children's have been completely 
covered with immunization. 
Conclusions: Having in mind that no cases of poliomielitis have been 
registered within the last three years, it is foreseen that by the end of 
year 2000 the transnllssion of wild polio virus can be interrupted and 
the ground set €or the eradication of the disease by the year 2003, the goal 
set up by health authorities In Kosova. To accomphsh it, an active 
surveillance of polio has been undertaken as well as a vaccination targets 
established for the next year years. It IS expected that the percentage of the 
population to be vaccinated will be of 80% in 2000, 90% by 2001 and 95% 
in 2002. 
Ip16111 Determination of virus DNA load in cerebrospinal 
fluid of patients with AIDS-associated progressive multifocal 
leukoencephalopathy by lightcycler PCR 
M. Kahraman, M. G. De Goer, JC Delfraissy, J. Gasnault, Y. Taoufik 
Pans, F 
Background: The human polyomavirus J C  (JCV) is responsible for a l p c  
infection of oligodendrocytes that lead to a severe and rapidly fatal 
demyelinating disease named Progressive Multifocal Leukoencephalopathy 
(PML). PML generally occurs in patients with marked cellular immuno- 
deficiency especially Acquired Immunodeficiency Syndrome (AIDS) 
patients. JCV DNA detection in cerebrospinal fluid (CSF) is a reliable 
diagnostic marker of PML. Here, by using Lightcycler (Roche) PCR, we 
investigated JCV load in CSF of AIDS-associated PML patients. 
Patients and methods: We determined JCV load in CSF of 17 patients with 
AIDS-associated PML. PML was diagnosed on the basis of clinical, 
radiological and virological criteria. AU patients tested had a positive 
quahtative JCV PCR in CSF. DNA was extracted kom 140 pL of CSF by 
using a Qiagen procedure. JCV DNA quantitation was performed by using 
the Lightcycler apparatus that allows the monitoring of P C R  in real time. 
JCV P C R  products were detected by using two hybridization probes 
labelled with FITC and Red 640, respectively. The detection was based on 
generation of a fluorescent signal by fluorescence resonance energy transfer 
(FRET). To quantify JCV PCR products, an external scale of serially 
diluted JCV DNA was used. To correct for variations on DNA recovery, a 
known amount of a plasmid control was added to CSF samples before DNA 
extraction then quantified by using the same procedure than JCV DNA. 
Results: The assay was linear over a 5 log 10 range (0.001-100 femtograms 
ofJCV DNA per P C R  corresponding to 376-37600000 JCV copies per ml 
ofCSF). Among the 17 patients tested, JCV load in CSF ranged &om 376 to 
113000 JCV copies per mi of CSF. In our series, alI PML patients JCV load 
was correlated to survival (Spearman test ?=0.38, P = O . O l ) .  A negativation 
ofJCV load in CSF was observed in 9 (52%) patients taken on highly active 
antiretroviral therapy (HAART) after PML. diagnosis. 
Conclusion: Ths Lightcycler based procedure used allows fast (2 h from 
extraction to final results) accurate and reproducible JCV DNA quantitation 
over a large dynamic range. Moreover, our results suggest that the assay of 
JCV load in CSF may be useful in evaluating the prognosis of PML patients 
and for their virological monitonng. 
Ipi6121 Evaluation of extraction methods for PCR detection 
of JC virus DNA in cerebrospinal fluid samples 
A. Mielnichuk, C. Polo, S. Cardona, P. Pkrez, J. L. PPrez 
Llobrept, E 
Introduction: JCV is the aetiological agent of progressive niultifocal 
leukoencephalopathy, a fatal demielinizatiiig disease. PCR detection of 
JCV in CSF offers the possibility of a faster and less invanive diagnosis than 
brain biopsy exanllnation. However, sensitivity of PCR detection in CSF 
is limited. In order to improve it, different DNA extraction methods 
were assessed. 
Methods: Study (A): In the first part of our study, 50 CSF samples from 
50 patients with a clinical picture compatible with PML were obtained. 
PCR amplification v Clin Microbiol 1989; 27: 1174-9) for JCV sequences, 
followed by immunoenzyniatic detection of PCR products were performed 
over two different 5 pL aliquots of each specimen, one used directly 
and the other after boiling it for 10 min at 100 "C. Study (B): As a 
consequence of the results of study A, 50 additional CSF specimens from 49 
patients were analysed. Detection of JVC was carried out by a multiplex 
PCR method u Virol Methods 1999; 82: 13744)  in duplicate: one adding a 
5 pL aliquot of boiled CSF (as described above), and the other after 
extracting a 50 pL aliquot of the CSF with a guanidinium thiocyanate-based 
procedure (5 pL final input, 10-fold concentrated) Virol Methods 1995; 53: 
Results: Study (A) A total of 14/50 samples were positive for JCV. Of these, 
only 4/14 were positive by both heat-treated and untreated CSF specimens. 
The remaining 10 were only detected after boiling CSF samples. Differences 
were statistically significant (McNemar test, P < 0.005). Moreover, in the 4 
positive specimens by both preparation methods. higher absorbance values 
were obtained by the immunoenzymanc reaction with boiled heat-treated 
samples. Study (B) In spite of a 10-fold higher CSF input used with the 
guanidinium thiocyanate extrachon method in comparison with the heat- 
treated specimen, a total coincidence of PCR results were observed: of 50 
specimens tested, 12 showed JVC specific sequences. 
Conclusions: (a) Boiling samples improves JCV detection in CSF by PCR. 
(b) Taking into account that a more rapid diagnosis of PML is desirable, and 
that no Merences between heat treatment and guanidinium thiocyanate 
extraction were found in this study (although the higher volume of the 
input sample used by the later), we recommend boiled CSF samples as a 
faster and simpler preparation procedure for PCR. 
25-36). 
v1 Coxsackie B serous meningitis 
M. Zezoski, J. Jordanoski 
Prilep, MAK 
Objective: Enterovirosys are acute febrile season epidemic diseases with 
various clinical manifestations. We present our results fkom our investigation 
of Coxsackie B serous meningitis. 
Materials and methods: Between May 1999 and August 1999 we received 
35 patients with serous meningtis in our department. Diagnosis was made 
with standard clinical, biochemical (CSF finding) and serological (RVK and 
PCR) analyses. 
Results: There were 34 children and one adult, aged among 1-33 years. 31 
of them (88.6%) were less than 10 years old. 24 were male and 11 female. 
94.3% or 33 lived in towns and only 2 in villages. In 94.3% there were 
epidemiological conection. The highest number of diseased people were in 
July, 54.2%. Among clinical findings, we noticed headache in 91.5%. high 
fever in 88.6%, vomiting in 54.3%, positive meningeal signs in 84.3%, tush 
in 11.4%, spastic paraparesys in 8.6%. Very rare we found respiratory and 
digestive symptoms. 
Csf investigation showed: WBC count was 15-560/mm3 at reception, 
with Ly donllnation in 71.4% and PMN domination in 28.6%. increased 
protein concentration in 62.8%; decreased glucose concentration only in 
14.3%. There were normal CSF finding until 20 day of reception. With 
.RVE we found four time-increased titre for enteroviruses, and with PCR 
we detected Coxsackie B, type 6. 
Conclusion: City children, up to 9 years are the most frequent diseased 
group. C h c a l  outcome was good in all patients, without early and late 
complication. 
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1 PI614 1 The epidemiology of enteroviral CNS infections in Crete 
S .  Maraka, A. Tsdimgaki, G. Zanipetakis, S. Stefanaki, A. Schinaki, 
T. Tsekoura, E. Kokori, E. Galanakis 
Heraklioii, GR 
Objectives: Nonpolio enteroviruses (EVs) account for 80-92% of the cases 
of aseptic meningitis for which an aetiological agent is indentified. The 
differentiation between bacterial and aseptic meningitis is often difficult on 
clinical grounds alone. The exact epidemiology patterns of aseptic 
meningitis in Crete has not been investigated yet. 
Population and methods: All children aged &om 30 days to 14 years, who 
were hospitalized in the General Hospital of Heraklion for aseptic 
meningitis from 1/1/1999 to 31/10/2000, were included. Cases of aseptic 
meningitis were defined as patients with cerebrospinal fluid (CSF) 
pleocytosis of a t  least 20 WBC/mm-’, negative Gram stain and bacterial 
antigen detection, and the absence of bacterial growth on CSF and blood 
cultures. Stool viral cultures were performed at Pasteur Hellenic Institution 
in Athens. 
Results: Sixty-eight cases of aseptic meningitis were reviewed. The patients’ 
age ranged from 31 days to 14 years (mean, 5.5 years). Fifty-one per cent of 
the cases occurred in boys. Stool specimens were collected from 47 children 
and EVs were isolated from 18 (38%). I n  the majority of these children, 
acute phase serology was positive for Coxrarkie or Echo viruses. A greater 
incidence of the disease was observed in the summer and fall. Thirty-four 
children (50%) were hospitalized during 4 clustering. The first occurred at 
the end of October 1999 ( 1 1 ~ 8 )  and the second at the first weeks of 
December 1999 ( n = 8 ) .  The third clustering occurred in July 2000 ( t i =  10) 
and the fourth at the first weeks of October 2000 ( n = 8 ) .  In 2 families, 3 
children were simultaneously affected. Positive cultures were more 
common during the clustering. Forty percent of the children had fever 
> 38.5”, while meningeal signs were found in 56%. Vonliting occurred in 
72%. while 87%) of the children > 2 years coniplained for headache. The 
mean WBC count of the CSF was 182 cells/mni-’ (range, 20- lOOO) ,  the 
mean glucose value 63.9 mg/dL (range, 38-90) and the mean protein value 
40.1 mg/dL (range, 15-140). 57% of the children had more than 50% 
polymorphonuclears in their CSF cell count.35% had > 15 000 WBC/ 
nmi” and 84% had a left shift in blood smear. The ESR was > 30 mm/h in 
32% of the cases. The outcome was excellent in all cases. 
Conclusions: Enteroviral meningitis is frequent in Crete, presenting with a 
ceasonal distribution. Culture of the virus is useful, but is expensive, has low 
sensitivity and is not helpful during the acute phase of the disease. 
[p16151 Charactheristics of cerebrospinal fluid in enteroviral 
meningitis 
D Naunova Jovanovska 
Skupje, MAK 
Aim: To study cerebrospinal fluid (CSF) finding., in patients with enteroviral 
meningitis. 
Material and methods: In the period from June to November, 2000, 58 
patients with meningitis caused by enterovirus were treated on the Clinic. 
Lumbal puncture was done to every patient with positive meningeal 
syndrom, and CSF were examined cithological, chemical and bacteriolo- 
gical. Serological tests were done m blood and CSF. 
Results: 91% of CSF were clear, Pandy reaction was positive a t  44, 4%, and 
every ninth patient had high CSF pressure. The number of leukocytes in 
CSF was in range of 37-829/m3,  middlr-195/mm3, and almost 2/3 of 
patients had 37-200 Le/mm3. Lymphocytes were doniinat (52-9S% of Le 
in CSF) at only 57.8% of patients. The level of proteins in CSF was normal 
at 63%). from 0.4 to 0.6 g/L had 18.5% and 0 . 6 4 . 9  g/L had 18.5%. Low 
level of glucose in CSF (less than 50% of glycemia) had only 4.4% and lactats 
were higher than 2.1 (up to 3.8 mg% at 13.3%. All CSF were 
bactermlogcally sterille. 
Conclusion: Enteroviral meningitis show clear CSF and normal pressure, the 
number of Le in CSF was up to 2 0 0 / m z  and with dominant Ly and 
chemical analysis showed normal values of proteins, glucose and lactats. 
/p16161 Clinical characteristics of enteroviral meningitis in 
2000 
D. Naunova Jovanovska 
Skopje. MA K 
Aim: To examine clinical parametres in patients with enteroviral meningitis. 
Matherial and methods: In the period from June to Noveinber there were 
58 patients with enteroviral meningitis treated on the Clinic. 
Results: The patients were in age from 1 to 43 years. 91% of them were in 
age up to 15 years and more than half of them children up to 7 years. 
Distibution in sex was equal. Most of the cases were in Spternber aiid 
October (33/58 patients). Dominant symptoms were haedache at 99%, 
vomiting 99% and temperature at 98%. but some of them had pain in 
stomach 12%, diarrhoea 4, 4%, exanthema corporis 4, 4%, pharingitis 86, 
6% and photophoby 11%. Meningeal signs were positive at 99% stiff neck 
at 98% and only 4% had convulsiones and 12% were somnolent. Most of the 
patients 80% were febrile (37.6-39.5’C), and only 6% were afebrile. The 
febrile period lasted 2-4 days at 73%, and meningeal signs lasted 5-10 days at 
90% ofthe patients. There was no  lethal exit. Patients admitted to the Clinic 
1-7 days from the bigining ofsymptoms, but 75% ofthem the tirst two days. 
Conclusion: Enterovlral meningitis due at children, donlinant symptom? and 
signs were headache, vomiting and temperature, meningeals signs and stiff 
neck. Patients admit to Clinic the first two days from the biginitig and has 
good prognosis. 
[ PI617 I 10-year study on nonbacterial inflammation diseases 
of the nervous system 
P. Vassileva, N.  Popivanova, G. Toshkina, Y. Stodova, 0. Boikinova, 
E. Ivanova. C. Venchev 
Plovdiv, BG 
A retrospective follow up encoinpassing the last 10 years (1990-99) was 
done on 375 patients with nonbacterial infection of the nervous system in 
the department of Infectious Diseases at Medical University-Plovdiv. A 
study on the season ability, age, aetiology, sex, severity of the clinical course 
and the outcome of the disease was performed. There was 110 tendency for 
decrease of morbidity observed. The number of cases increased in the years 
of epidemic spreading ofpoliomyelitis (1 992) and parotitis ( I  998 aiid 1999). 
The aetiology was specified by coriventional virological aiid serological 
methods in 44.26% of the cases. Parotitis neuroinfrctions were the highest 
relative portion (9.06%), followed by enteroviruses (5.33%). The morbidity 
increased in the summer, from June to September. The age distribution was 
as follows: chddren from 8 to 14 years old-24.53%; young adults from 15 to 
45 years-36.26%. In 42.40% of the cases the disease had hght course, iii 
41.81% it was average and heavy in 15.73%. The lethality was 2.93%, with 
residual manifestations discharged in 16.27%. Meningitis was isolated in 68% 
of the cases, nieningoencephalitis in 13.6%. encephalitis in 6.06%. and 
inflammation of peripheral nerves in 3.86%. The main reacon for the 
incresed interest of many specialists in this group of diseases is the wide 
dissenlinatioii of nonbacterial inflammation diseases of the nervous system, 
their abrupt increase during epidemic, the age intluence 011 children and 
young adults, as well as the heavy course of the infection. 
v/ Lymphocytic choriomeningitis in Georgia 
N. Tsereteli 
Tbilisi, CEO 
Georgia is a newly independent repubhc situated between the Caucasus 
Mountains and the Black Sea. The climate. nature and large number of small 
mammels create the desirable conditions for the citrculation and the spread 
of virus of Lymphocytic choriomeningitis in Georgia. New data on the 
epidemiology of Lymphocytic chorionieningtis and 011 their role in 
infectious diseases of man have been otained in Georgia. Clinical, 
virological and Ferological (immunofluorescent antibody, neutralization 
and immunoawy tests) examinations of patients, immune layer of 
population and small mammals. Lymphocytic choriomeningtis was 
diagnosed 78 patients. Human contanlination with the Lymphocytic 
choriomeningitis virus was mostly conducted by alimentary way. One case 
of Lymphocytic choriomeningitis virus transplacental transmssion was 
registered-from pregnant woman to fetus, which became the reason for 
inherent hydrocephalia. Lymphocytic choriomeningitis characterized by 
marred seasonal prevalence. 94, 6% of cases are registered at the end of 
spring and in early autumn. The  Lymphocytic choriomeningitis virus was 
detected in small manmals of different species Rattus rattus, Rattus norvegkus, 
Mu5 niusrulus, Apodemus silvatimr and Crocidura lor~gicaudata. The detection of 
Lymphocytic choriomeningitis virus antigen in small mammals, Immune 
layer of population and the detection of patients with Lymphocytic 
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choriotneningitis indicate, that the Lyniphocytic choriomeningitis virus 
circulates in Georga. 
/p1619) Biological analysis of Arctic fox rabies isolates 
V. Nedosekov, U. Romanova, S .  Timoshenko 
Pokmtj, RUS 
Objective: Rabies virus is a single-stranded negative-sense RNA virus 
belonging to the Lyssavivus genus of the Rhabdouiridae family in the order 
Mttnirrirpvirairs. Rabies virus is iniporrant hunian and animal pathogen that 
causes usually fatal infections. Arctic fox rabies viruses belonging to the 
genotype 1 of rabies virus and its are prevalent among arctic foxes in regions 
of Northern Russia, especially Yakutia, thus the isolates derived from 
Yakutia region for analysis of general biological data were used. 
Materials and methods: Arctic fox rabies viruses were isolated in nice, and 
idended by virus neutralization test in nllce with antirabies inmunoglobulins, 
DAS-ELISA and ELIFA with monoclonal antibodies to NP of rabies virus. 
Arctic fox rabies viruses were identified by RT-PCR with primen to NP of 
arctic fox rabies virus and restriction analysis of the aniplicons was perfomied. 
Hepatitis B virus (11) 
Results: In this report, we presented of 12 rabies viruses that were isolated in 
mice, but characterization of the isolates by RT-PCR showed that it was an 
arctic fox viruses. Infectious activity of the isolates in nlice test was of O-2.5 
Ig MLD50i0.03 cni’ (at average 1-1.5 lg) and virus titres edges during re- 
passages. At first of the passages the lasting of incubation period was 14-35 
days and it was decreased to 12-23 days at second and third of the passages. 
Non of the isolates affected mice through hypodemlic route of virus 
inoculation. Interestedly, at intracerebral route of inoculation of arctic fox 
rabies viruses in rabbits the incubation period was 10-15 days for all isolates 
while a t  same route ofinoculation of the isolates in mce  the period was 14- 
28 (sometmies to up 44 days) and from 12 virus samples only 10 samples 
were positive in the mice test. 
Conclusion: Arctic fox rabies diagnosis is essential for control of the 
infection and management of surveillance systems and requires of significant 
research on biology and evolution of arctic fox rabies. The isolates of arctic fox 
rabies have low pathogenicity at intracerebral inoculation and have no pathogenic 
at hypodermic injection in mice, but the isolates have stronger ui rabbits. 
Apparently, the isolates are branch of natural selection of arctic fox rabies virus 
and it differences koni isolates that early characterized elsewhere. On exanllnatlon 
of the 12 isolates, it was clear that natural mfection cycles of the arctic fox rabies 
virus in Yakutia have tended to be maintained endemically. 
rP16201 Modes of transmission for hepatitis B, C and D 
C. Drakoulis, L. Karasavidou, S .  Konstantopoulou, N.  Iliopoulos, A. 
Loukopoulos, M. Savalla, D. Katsadoroc 
At/icriz, CR 
Objective: We studied the transmission ofinfection with hepatitis type B, C 
and D in patients who were referred to our Hospital’s Outpatients’ 
Hepatological Depamnent from 1994 until 2000. 
Material and method: Our material constituted of 292 hepatitis patients. 
From them, 163 with chronic hepatitis B (92 men and 71 women with 
mean age 42.6 years), 127 with chronic hepatitis C (81 men and 46 women 
with mean age 45.7 years), one nian with hepatitis B and C and another one 
with hepatitis B, C and D. 
Results: (1) For patients with hepatitis B. The niost of the patients, 103 
(63.16%), were infected via unknown way (a sipticant number of thete 
paoents (24) were Greek from ex URSS or North Epiros), 18 (11.64%) 
were infected via intrafamiliar transnlission, 15 (9.2%) via sexual contact, 12 
(7.36%) via blood or blood products transfusion, 6 (3.68%)) via intravenous 
drug use and 9 (5.51%) via surgical or dental operatiom. (2) For patients 
with hepatitis type C. Via unknown way were infected 54 (41.96%) patients 
(1 1 patients originated from ex URSS or North Epiros), via intravenous 
drug use 32 (25.19%), via blood or blood products transfusion 25 (19.68!%), 
via sexual contact 8 (6.29%) and via intrafandiar transniission 5 (3.59%). 
Transnussion was not related with surgical operation except of 3 (2.36%)) 
persons who had been submitted to tattoo. (3) The patient with coexistent 
hepatitis B and C had been infected via blood transfusion and the patient 
with coexistent hepatitis B, C and D was intravenous drug abuser. 
Conclusion: The way of transnlission at most of the patients with chronic 
hepatitis B and C was unknown. The patients’ origin, the intrafamihar 
spread and the sexual contact are significant factors for the prevalence of 
hepatitis B. Transfusions and use of intravenous drugs play a ugnificant role 
in the transmission of hepatitis C. 
Ip16211 HBV genotypes in children with chronic hepatitis B 
K. Dzierzanowska, P. Jozwiak, K. Madalinqki 
Warsaw, PL 
introduction: Vanability in hepatitis B virus DNA allowed its classification 
into seven main genotypes (A-G). The pattern of HBV genotypes vary 
depending on the geographical region and it has been speculated that 
the viral genotype can influence the clinical course of the disease in 
infected patients, 
Objectives: The aim of our study was to detennine HBV genotypes in 
children with chronic hepatitis B. 
Patients and methods: Fifty children (aged 3-17 years) wlth histological 
and serological evidence of chronic HBV infection were included into the 
study. Genotyping of HBV was performed by length polymorphism analysis 
of the core gene and the pre-S1 region by use of two separate PCRs which 
allowed to distinguish the genotypes A, D and non-A, non-U. 
Results: Genotypes A and D were found in 82% and 12% of children with 
chromc hepatitis B, respectively. In 3 patients (6%) genotypes non-A, non- 
D were identified. 
Conclusion: The most prevalent genotype in chlldren with chrotuc hepatitis 
B was the genotype A suggesting that that particular genotype could be 
associated with chronic outcome of HBV infection. 
1 P I  622 I Improvement of sensitivity towards HBsAg mutants 
and wild type HBsAg with the new VIDAS HBsAg ultra assay 
M. Lesenechal, F. Forge, A. Dugua, E. Suiphon, M. Jolivet 
Marry /’Eroi/e, F 
Since the first identification by CamIan r f  nl .  (1990) of a substitution from 
glycine to arginine occurring at amino acid (AA) position 145 (G145R) of 
the Hepatitis B surface antigen, several mutations in the a detemlinant of 
HBs antigen have been reported worldwide. There is evidence that some 
HBV surface antigen mutants may not be detected by all ofthe current tests, 
particularly those which are based on nionoclonal antibodies. We have 
developed a new generation of HUsAg assay, called VIDAS HUsAg Ultra. 
This test is based on a sandwich principle. It presents two anti-HBs 
monoclonal antibodies as the capture phase and one goat polyclorial 
antibody anti-HBs as the detection phase. thus ensuring an efficient binding 
of several mutations. We used the new VIDAS HBsAg Ultra assay to assess 
the sensitivity toward HBs mutants. A panel of 16 recombinant H l 3 s  
proteins whch cover the majority of reported mutations was tested. The 
assay was able to detect 14 out of the 16 mutations tested, including, the 
G145R which is the most frequent mutation reported to day. The first 
undetectable mutation presented an exchange of one arginine to a cysteine 
at AA position 124. The second undetectable mutation presented an 
insertion of two AA at position 122. Both of these occurrences could have 
altered their expression and secretion, posribly explaining a negative result. 
The sensitivity towards the wild type was evaluated by testing the French 
subtype panel of the ‘Socibt; Nationale de Transfusion Sanguine FranCaise’ 
(SNTS). The analytical sensitivity was also tested using three reference 
standards: (1) PEI HBsAg ad and ay standards (2) SNTS tenqitivity panel and 
(3) the second NIBSC monitor sample. The analytical sensitivity w ~ s  shown 
to be lower than 0.02 UPEIinL using the ad or ay subtypes, and lower than 
0.15 n g / d  using the SNTS sensitivity panel. Moreover the second NIBSC 
iiionitor sample (0.125 IUimL) was clearly positive at a ratio (signal/cut on) 
higher than 4. The clinical sensitivity wac tested with 13 seroconversion 
panels. VIDAS HBsAg Ultra was able to detect HBsAg either earlier than, 
or equal to the other assays. The speclficity was carried out on 1009 blood 
bank samples, showing no false positive result. 
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Conclusion: The VIDAS KBsAg Ultra reagent is one of the most sensitive 
and specific tests for HBsAg detection. Its ability to detect HBsAg mutations 
was demonstrated on 14 different mutations, which meets scientific 
expectations. 
p m ]  Sero-epidemiology of hepatitis B in Kosova 
N. R. Ramadani, L. G. Gashi, A. K. Kalaveshi 
Prirltrina, W 
Viral Hepatitis B is a serious global infection. In Kosova, this infection has 
been a continual socio-medical, epidemiological and economic problem. 
The discovery of various HBsAg hosts among healthy populations, and 
HBs-antigenemy among risk groups, will enable the creation of an adequate 
program for the elimination of Hepatitis B in Kosova and the immunization 
of risk groups in order to eradicate Hepatitis B. A survey ofthe course of the 
disease, immunity and HBs antigenemy has been obtained &om the research 
of five population groups, whence 40 cases (9.04%) out of the 442 
examined, have been concluded to be HbsAg positive. (a) In Prishtina 10 
cases (9.17%), out of the 109 with HBsAg, are positive. The greatest 
number ofHBsAg (+) cases, five cases altogether (14.28%), have been found 
within the age group of 30-39 years old, The examined group includes 
individuals of various professions, nonetheless the larger number are 
labourers (38.5%) out of which 7 cases (18.42%) are HBsAg (+). (b) In 
Malisheva 92 individuals have been examined out of which 8 cases (8.69%) 
are HbsAg (+). The greatest number of HBsAg (+) cases, 37.6% or 3 
individuals, are within the age group of 40-49 years old. (c) In Shcinie 95 
individuals have been examined, out of which there are 11 cases (1 1.57%), 
of HbsAg (+). Most are within the age group of 20-29 years old 5 cases, or 
45.5%. (d) From the 95 pregnant women examined there were 7 cases 
(7.4%) of HBsAg, most of which, 5 cases (71.4%), were from the age group 
of 20-29. (e) From the 51 newborns 4 cases (9.04%) of HbsAg (+) were 
detected. Viral Hepatitis represents a serious infection in Kosova. According 
to the CDC, Atlanta (USA), definition, HBsAg has been grouped in three 
zones according to the geographical prevalence of HBsAg. According to this 
categorization Kosova belongs within a high endemic zone, with a high 
prevalence rate of 7.4%-12.5% of HBsAg. This places Kosova in a group 
with other states and regions such as: South-east Asia, China, Sub-Saharan 
Africa, Amazon, Saudi Arabia, United Arab Emirates, Yemen, Jordan, 
Egypt, Greece. Thus, there is a great need to create and implement a 
program which would eliminate Hepatitis B in Kosova, and include 
immunization through vaccination against Hepatitis B of all risk groups. 
p m \  Interest of a highly sensitive and quantitative 
detection of anti-HBc IgM immunoassay (VIDAS HBc IgM II) 
towards chronic hepatitis B patients 
M. Lesenechal, J. Ritter, B. Riou, E. Suiphon 
Marry L’doile, Lyon, F 
Diagnosis of acute hepatitis B infection relies on the detection of both H B s  
antigen and anti-Wc IgM. Current Anti-HBc IgM tests available on the 
market are most often quabtative tests. The cut-off range of these qualitative 
tests is roughly at 50 UPEVmL, which detect only high titres of IgM anti- 
HBc usually characterizing an acute hepatitis B episode. bioMtrieux has 
developed VIDAS HBc IgM 11, a quantitative ultra sensitive assay (10 
UPEI/nL) allowing patients with acute hepAtitis l3 to be monitored from 
the appearance of the H B s  Ag up to recovery. Because this assay reflects 
hepatic cytolysis, it can be used as an indirect specific marker of replication. 
During chronic infection, I t  helps to differentiate between active or non 
active viral replication. Titration of anti-HBc IgM with the VIDAS HBc 
IgM I1 enables the clinician the opportunity to monitor antiviral treatments 
of chronic hepatitis B. These potential applications were evaluated with two 
other assays (IMx Core-M Abbott and Core IGMK Sorin). A total of 719 
samples were tested including documented positive samples for anti-HBc 
IgM (n=97), follow up samples from 20 chronic HBV carriers ( ) I =  150), 
routine samples ( n  = 351) as well as potentially interfering samples ( n  = 121). 
When compared along with the two other EIA tests and clinical data, the 
VIDAS HBc IgM 11 test presented an overall sensitivity and specificity of 
100% and 98.1%, respectively. Moreover the VIDAS assay was able to 
detect 80.4% of the 112 samples which were HBV DNA positive whereas 
IMx Core-M and Core IGMK assays detected 50.9% and 63.4% 
respectively. It is interesting to note, within a portion of these 112 samples, 
that 55.4% were HBe Ag positive. 
Conclusion: These results show in addition to its routine use for acute HBV 
diagnosis, the VIDAS anti-HBc IgM I1 assay can be used as an indirect 
serological marker of viral replication. This is particulariy true when the 
classical HBe antigen marker is negative because of a precore mutation. This 
evaluation proves that there is an interest of a highly sensitive and 
quantitative anti-HBc IgM test, with possible clinical benefits. 
lp16251 Prevalence of hepatitis B viral markers among 
intravenous drug users from the Maribor region, Slovenia 
Z. Baklan, M. Poljak, K. Seme, A. Pisec 
Maribor, Ljubljana, SLO 
Objectives: Hepatitis B virus (HBV) infection is common among 
intravenous drug users (IVDU). Transmission of HBV infection can be 
prevented by vaccination. The a im of our study was to determine the 
prevalence of HBV markers among IVDU from Maribor region (north- 
eastern part of Slovenia) and to establish the proportion of IVDU who were 
effectively vaccinated against HBV infection. 
Methods: Fifty serum samples obtained from the same number of IVDU in 
January 2000 were included in the retrospective study. Serum samples were 
initially taken for the purpose of biochemical tests. All serum samples were 
tested for hepatitis B surface antigen (HBsAg), hepatitis B surface antibodies 
(antiHBs) and hepatitis B core antibodies (antiHBc). HBV markers were 
detected using Cobas Core I1 (Roche Diagnostic System) analyser. 
Results: Fifty IVDU from Maribor region, 14 (28%) female and 36 (72%) 
men, were included in the study. The average age was 26.4 years (range 17- 
48 years). 33 out of 50 (66%) were attending the methadone niaintenance 
treatment. IVDU were divided into four groups accordiug to the results of 
HBV markers detection: I, 37 (74%) without HBV markers; 11, 5 (10%) 
antiHBs positive(above 10 niIU/mL), antiHBc negative: vaccinated IVDU; 
111, 7 (14%) antiHBs positive, antiHBc positive; IVDU who resolved HBV 
infection; IV, 1 (2% HBsAG positive, antiHBc positive, antiHBcIgM 
negative; healthy carrier. 
Conclusion: The prevalence of markers of ongoing and resolved HBV 
infection among IVDU from Maribor region was 16%. The proportion of 
IVDU effectively vaccinated against HBV is quite low, resulting in relatively 
high proportion of IVDU (74%) who are still susceptible to HBV infection. 
rp1626 Detection of hepatitis B virus DNA in liver biopsy 
samples 
M.-Z. DO~IMZ,  A. Akbulut, Y.  Bulut, H. Yekeler, H.-H. Akbulut, S.-S. Kilic 
Elarig, TR 
The aim of the present study was to develop an assay procedure to detect 
the presence of Hepatitis B virus DNA in liver biopsy samples. For this 
purpose, we took advantage of the fact that dithiotretiol (DTT) stabilizes 
enzymes at digestion conditions’. Thus, by including DTT at  40 nlM 
concentrations into the proteinase K digestion buffer’, we were able to 
digest the liver biopsy samples adequately and then to detect HBV DNA 
fragments in the samples. For the detection, both polymerase chain reaction 
assay and hybridisation based assays were used. In the present study, liver 
biopsy samples were obtained from chronic HBV canien and the 
pathological analysis of the samples were also carried out. The results of 
this study show that determination of viral DNA was possible in Liver biopsy 
sampies obtained from HBV patients. 
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lp16271 Aetiologies of fulminant hepatitis in Tuzla, Bosnia 
and Herzegovina 
L. Mackovic, E. Jusufovic, S. Sabovic, D. Maric, J. Mesanovic, V. Stojic 
Tuzln, BJH 
Introduction: Fulrmnant hepatitis (FH) is characterized by rapid and 
progressive deterioration of liver function from massive hepatocellular necrosis, 
leading to encephalopathy and multisystem Mure. Various etiologic facton 
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have been associated with FH, such as hepatomopic viruses, toxins, vascular and 
ischaemic insults to the liver, rmscellaneous disorders, etc. 
Methods: The study included 39 patients with FH, who were admitted to 
the Clinic for lnfecnous Diseases, at the University Clinical Centar in Tuzla, 
between 1990 and 2000. 
Results: Of these cases, 23 were diagnosed as caused by mushroom 
poisoning. The aetiology of FH was viral in 13 cases: hepatitis B virus 
infecnon in 12 cases and hepatitis A virus infection in one. Two were 
diagnosed as being due to drugs. The remaining 5 were regarded as FH of 
unknown cause. The age of patients included in the study were from 21 
months to 60 years of age. Included were 25 males and 14 females. 22 
patients died. 
Conclusion: In this study, we attempted to identify aetiology of fulminant 
hepatic failure in our causes. Significant number of our cases was caused by 
ingestion of poisonous mushrooms. Despite intensive therapy, the prognosis 
of this disease was very poor. The mortality of FH significantly correlated 
with aetiology and age. 
lp16281 Assessment of immunity status of Imam Khomeini 
hospital healthcare workers to hepatitis B 
M. Rahbar, N. Shanfi, M. Ghiasi, M. Karamyar, R. Gharaaghaji 
Unnia, IR 
Health care workers (HCWs) are at risk for infectious diseases such as 
hepatitis B virus. The objective of this study was to determine immunity of 
HCWs of Imam Khomeini Hospital to hepatitis B virus (HBV). This study 
was camed out from 1 April to 30 July 1999 and all samples were sent to 
laboratory of blood banking and transfusion centre. The titre of antibody 
was assessed by Enzyme-Linked immunosorbent assay method. All data 
analysis was perfomied by using SPSS (version 6.1 Windows). Of the 299 
employees partlcipated in this study, there were 185 (61.9%)who had 
positive hepatitis B surface antibody serology. The remaining employees 
114 (38.1%)were hepatitis B surface antibody HBsAb negative. Evaluation 
of HBV vaccination was performed for all 299 employees. There were 223 
(74.6%) who had a prior history of vaccination, while 76 (25.4%) had not 
received any vaccination. In accordance with series of doses of vaccination 
32 (10.7%) had received one dose, 58 (19.4%) two doses, 102 (34.1%) three 
doses and 31(10.4%) eniployees more than three doses. According to this 
study protective efficacy of vaccination related to doses received by 
eniployees were as following: One dose 53.1% two doses 74.1%, three 
Vaccines 
doses 84.3% and more than three doses 83.9%. Of the 76 employees who 
had not received any vaccination 13 (17.1%) were HBsAb positive while 
remaining 63 (82.9%) were HBsAb negative. It is concluded that only about 
61.9% of employees have immunity to viral hepatitis B. We strongly 
recommend vaccination for all HCWs. 
lp1629/ Hepatitis B prevalence and epidemiological profile 
of seven hepatitis B outbreaks in Argentine dialysis units 
N. Grinberg, M. Pissano, C. Lavorato, M. Khoury, J .  Lercari, L. Gasparotti, 
M. Lopez 
Buenos Aim, RA 
Objectives: to investigate Hepatitis B (HVB) prevalence and profde of 
Dialysis Units (DU) with HVB seroconverted patients in Argentina. 
Methods: CADRA is constituted by 319 DU (among approximately 350 
surveyed units in the country), and it supervises dialysis treatment received 
by niore than 7000 patients (50% of dialysis patients in Argentina), 
according to agreements endorsed by Social Security institutions. Records 
from 2200 patients assisted at 52 units surveyed in the field by members of 
the Infectious Control Team at the Quality Program, from 7/1/98 to 12/ 
31 / 1999, were studied. Serologcal testing among haemodialysed patients IS 
compulsory under this Program. 
Results: In the field, it has been observed: HbsAg (f): 3.05% @revalence), 
HVB vaccine: 51%, annual seroconversion: 0.5% ofpatients HbsAg (-), 21/ 
51 (41.17%) DU dialysed 67 HbsAg (+) patients, 7/21 (33.33%) DU 
seroconverted in the last 2 years (23 new HbsAg + patients). 100% DU(7/ 
7): incorrect dialyser identification, inadequate deaddirty area delimitation, 
incorrect hypochlorine dilution use, not individualized clams and scissors; 
85.71%) DU(6/7): not dedicated staffin isolation room, HVB + reuse room 
shared by HCV + and negative, lack of facility cleamng instructions and 
incorrect blood spills management instructive, 71,42% DU (5/7): no hand 
washing staff sink in isolation room, clams and scissors were washed only 
between shifts and the machines were cleaned by the maid. 14.28% D U  (1/ 
7): reported one HVB seroconversion in a health care worker and one DU 
monitored HVB vaccine by HbsAc. Episodes of HBV seroconversion only 
occurred in centres where HbsAg + patients were dialysed. 
Conclusions: HVB is not an old problem in Argentina. It is essential to 
know the epidermological profiles in our DU in order to adjust programs of 
continuous improvement of quality in dialysis. Greater and continuous 
efforts are required to reduce the impact of this nosocomial infections. 
1 PI630 1 Early loss of HBV immunity acquired from previous 
vaccination in children with haematological malignancies 
G. Bassi, M. Parea, M. Aricb, A. Chiesa, A. Pagliaro 
Puwiu, I 
Background: Although drastically reduced, the nsk of Hepatitis B virus 
(HBV) infection in children with malignancies has not yet been eradicated 
and may lead to chronic liver disease. Impairment of HBV protection 
acquired by prior vaccination has been often postulated but specific studies 
have never been camed out. 
Aim: To assess the chemotherapy-induced loss of HBV immunity acquired 
by prior vaccination in children affected by Acute Lymphoblastic 
Leukaemia (ALL), with two main purposes: to identify groups of patients 
who deserve additional HBV prophylaxis during intensive chemotherapy 
(CT); to ameliorate the revaccination policy after C T  withdrawal. 
Patients and methods: 50 pts (26 males; median age 5 year, range 1-17), 
with ALL (43 intermediate risk, IR; 6 high risk, HR),  treated at our centre 
according to the AIEOP study ALL95. Pnor HBV vaccination or disease 
recorded and specific immunity assessed a t  diagnosis (before any treatment 
or blood supply), after intensive CT (inamtenance) and at the end of 
therapy. Anti-HBs titre < 10 mlU/mL accepted as protective. 
Results: At ALL diagnosis, 38/50 pts (76%) had protective anti-HBs (titre 
27-1000). The I2 unvaccinated pts were seronegative and HBsAg negative. 
While on treatment, 13 (8 males; 34%) lost HBV iinmunity: 8 (61%) were 
< 3 year and 10 (77%) had anti-HBs titres < 100 mlU/mL at ALL 
diagnosis. Loss of anti-HBs was early (maintenance) in 61% of pts. 
Impairment of previous HBV immunization was more evident among pts 
who received higher doses of CT (4/6 HR, 67%) than in IR group (9132, 
28%). Pts with unprotective anti-HBs titre were given active immunization 
(recombinant vaccine, 3 standard doses) 8-12 months after therapy 
withdrawal: all hut one seroconverted satisfactorily. During 5 years of 
follow-up, none was infected with HBV. 
Conclusions: Among children receiving immunosuppressive therapy for 
ALL, possible early loss of HBV immunity acquired from pnor vaccination 
must be considered. Pts more intensively treated, aged < 3 years and/or 
with anti-HBs titre < 100 mlU/mL at diagnosis, are at higher risk to loss 
H B V  immunity. Although responsiveness to HBV vaccine proved to be 
weaker in children undergoing antiblastic therapy, active immunization 
must be considered early after ALL diagnosis. Four doses or double dosage 
vaccination schedule should be needed. vaccination of off-therapy pts in 
complete remission is often required and always effective. 
p16311 High seroprotection rate induced by low doses of a 
recombinant hepatitis B vaccine in Iranian healthy neonates 
F. Shokri, A. Jafarzadeh 
Tehran, IR 
Universal vaccination of neonates with hepatitis B surface antigen (HBs Ag) 
has been recommended by W H O  for effective control of HBV infection, 
worldwide. Expense of the vaccine, however, limits implementation of this 
programme in many countries. Low dose vaccination has been proposed as 
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an alternative. Effectiveness of low vaccine doses, however, needs to he 
evaluated and verified in newborns from different ethnic backgrounds. I n  
this study a recornbinant H B  vaccine (Heberbiovac) was administered in 
three different doses, including the standard 10 nllcrogram, together with 5 
and 2.5 pg to three groups of healthy Iranian neonates. Each group, 
consisting of 230-260 subjects, received mple doses of vaccine given i.m. a t  
0, 1.5 and 9 months intervals. Serum samples were collected 2-4 weeks after 
completion of vaccination and anti-HBs antibody was quantitated by a 
sandwich ELISA. Sei-oprotection (anti-HBs > 10 IU/L) was detected in 
92.1% 97.4% and 96.1% of 2.5, 5, and 10 pg vaccine dose recipients, with 
geometric mean titre (GMT) of 4510, 5710 and 6104 IU/L, respectively. 
N o  significant differences were observed in seroprotection rate and GMT 
between the 10 and 5 pg dose recipients. Both parameters, however, were 
significantly lower in neonates vaccinated with 2.5 microgram vaccine dose 
( P  < 0.05 and P < 0.001, respectively). These findings indicate induction 
01 I ong protective iiiiinune response in healthy Iranian neonates by low 
doses of the recombinant HB vaccine. 
(p16321 Cost-efficiency of two different strategies for 
hepatitis A vaccination of hospital healthcare personnel 
J.-R. Juanes, M.-P. Arrazola, A. Garcia-Codes, F. Jabn, M.-I. Sam, 
A. Gonzilez 
Madrid, E 
Objectives: To assess the prevalence of antihepatitis A (HAV) antibodies in 
hospital health-care penonnel of an intermediate endemicity area, and to 
determine the cost-efficiency of two vaccination strategies for preventing 
HAV infection. 
Methods: Subjects are selected at one Umversity General Hospital of 
Madrid, Spain. Information was obtained on age, sex, occupation, previous 
vaccination against HAV idection and/or received inmiunoglobuh. Blood 
speciniens were obtained from each participant for anti-HAV antibody 
determination by an ELISA method. 
Results: A total of 423 hospital health-care workers were studied (mean age 
was 33.3 ( 5  9.7) years and 80% were female). The overall prevalence of 
anti-HAV antibody was 40% (95%CI: 35-45). Antibody prevalence was 
inversely correlated with age: only 4% of health-care workers 2&25 years 
in age were anti-HAV positive, whereas 92% of those 46-55 years in 
age were positive. Cost-efficiency analysis determined that the cntical 
value of prevalence for Vaccination with two doses of HAV vaccine was 
around 23%. 
Conclusions: In hospital health-care workers= < 30 years in age, 
vaccination with two doses of HAV vaccine (without screening) would 
he the less costly strategy. In those who are > 30 years in age, it would he 
less costly to screen for anti-HAV antibody first and vaccinate only those 
who are antibody negative. 
lp16331 Hepatitis B immunization of personnel employed in 
Ankara hospitals: are those at risk adequately protected? 
0. Senbil, K. Hizel 
Ankara, TR 
Objective: T o  examine the policies and practices in hospitals within Ankara, 
with respect to vaccination of staff against hepatitis B infection. 
Methods: A written questionnaire to he fdIed by the infection control 
o f h e r  within each hospital. Public (teaching and nonteaching), university 
and private hospitals, including metropolitan institutions in Ankara. Thirty- 
two Ankara hospitals were requested to participate in the survey. 
Results: There was no consistent hepatitis B prevention policy in hospitals 
within Ankara. Of the 32 hospitals, aU (100%) offered hepatitis B 
vaccination to sta& and; of these, 18 (56%) offered vaccination to all staff; 
14 (44%) offered vaccination based on job title. Twentyeight (87%) of 
these paid all costs of vaccination. Twenty-five (78%) of the 32 hospitals 
infomied staff on the need for, and availability of, hepatitis B vaccination. 
Numerous respondents indicated a need for dear guidelines on policy and 
clarification on practical matters of managements, such as acceptable 
immune levels, managements of nonresponders to the primary series, and 
the need for, and timing of, booster doses of vaccine. AU of the 32 hospitals 
offering hepatitis B vaccination to staff undertook routine prevaccination 
screening, a practice generally regarded as cost effective in Turkey. Twenty- 
six (81%) of these hospitals also undertook posmaccination tcreening. 
Conclusion: I t  is evident from this study that a considerable number of 
potentially susceptible healthcare personnel in Ankara hospitals remain 
unprotected against hepatitis B infection. A more reliable and consistent 
approach to preexposure hepatitis B vaccination is recommended. 
p1634/ Immunization of staff of a public hospital with a 
recombinant hepatitis B vaccine: safety, immunogenicity and 
factors that influence the immune response 
0. Senbil, H. Kurt, E. Tekeli, H. Yigit 
Anknra, TR 
The overall risk of hepatitis B to healthcare workers (HCWs) exposed to 
blood and body fluids is several times that of the general population. The 
Occupational Safety and Health Administration (OSHA) recorninends that 
all HCWs who have possible contact with blood or other potentially 
infectious body fluids be vaccinated against hepatitis B. We vaccinated 80 
hospital staK All staff were negative for HbsAg, anti-HBc and anti-HBs. A 
1-nL dose of recombinant hepatitis B (HB) vaccine (Engerix-B; 20 pg: 
Sinith Kline Beecham) was administered. Additional doses were g~ven 1 and 
6 months later. Anti-HBs was measured by ELISA, 6-8 weeks after the 
third dose. The rate of seroconversion to an anti-HBs titres 2 1 IU/L was 
75/80 (93.75%). Protective levels of teroconversion ( 2  10 IU/L) were 
achieved in 69/80 (86.25%) vaccinated. The geometric mean titre (GMT) 
was 2814.01 IU/L. The response rate was lower in older staff. The 
difference in response between the sexes was significant. Women had a 
higher rate of response and, among those persons responding, u.onien 
developed a higher concentranon of antibody. No serious adverse reactions 
occurred. Factors that affect antibody response such as sex, age, body-inass 
index (BMI), smoking and underlying disease were also examined, sex 
and age were found to he effective on vaccination response In the 
studies evaluated of HCWs, the Vaccination ratios for HB were determined 
as 5673% and employees who worked more than 20 yrars constituting 
the important part of unvaccinated staff were seen. Conseyueiitly, vaccine 
response and vaccine acceptance are better in the young group. Therefore, 
vaccination in the first years of occupation is considered at a choice 
of preference. 
lp16351 Side-eff ects following immunization with hepatitis B 
vaccine 
D. Dimmtrijevic, M. Kovacevic 
Bekrade, YU 
Introduction: Hepatitis B is a recognized occupational hazard among health 
care personnel. Those physicians, laboratory and technicians who regularly 
come in contact with blood products, other body fluids and of course. with 
camer patients, have the highest risk of exposure. Immunization wlth 
hepatitis B vaccine is the most powefiul tool to protect against hepatitis B 
virus infection and its consequences. 
Aim: The aim of this work is the surveillance of side-effects after 
immunization of health care workers with hepatitis €3 vaccine. 
Materials and methods: From 1996 till 2000, 102 health care workers have 
been immunized by the recombinant DNA vaccine-Engerix-B (20 pg). 
The stuff of both sexes was included, age from 21 to 62. The vaccine was 
administered intramuscularly in the deltoid muscle according to a 0, 1 and 6 
month schedule. The participants were asked to report local (soreness. 
redness, swelling and pain at injection site) and general (fever, fatigue. 
headache, nausea and vomiting) solicited symptoms and signs after each 
vaccine administration and to report any other syniptom and sign in the 
subsequent 5 days after immunization. 
Results: Number of persons with reported solicited local symptonls and 
signs was 27 (26.4%) after first, 22 (21.5%) after second and 38 (37.2%) after 
third dose. All local side-effects lasted less than one day. Only one person 
had after third dose pruritis at injection site with pain, swelling and redness 
which lasted more than five days. Soreness and pain at injection site were 
most irequently reported. Nunibei- of pevsonc with reported solicited 
general symptoms and signs was 10 (9.8%) after first, 3 (2.9%) after second 
and 3 (2.9%) after third dose. All reactions lasted less than one day. Fatigue 
and fever were most freyuently reported. 
Conclusion: In this group most general and local syniptonis and signs were 
categorized as mild and lasted less than one day. Hepatitis B vaccine is safe 
and well tolerated. This vaccine safeguards nllllions of health care workers 
from this life-threatening disease. 
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lp1636/ Genotypic characterization of isolates of Bordetella 
pertussis from Missouri, USA 
S. Neal, N. Fry, S .  Hanauer, E. Blank, T. Hamson 
Laridon, UK; Missouri', USA 
Objectives: To characterize epidemiologically related and unrelated isolates 
of Bordeklla pertussis submitted to the Missouri State Public Health 
Laboratory between 1984 and 1999 by examining genotypic variation in 
the genes coding for pertactin (pm), and the pertussis toxm S1 subunit 
(PtxSI), two important virulence factors of B.  ppriusris. 
Methods: A total of 33 5. p~rrussis clinical isolates submitted to the Missouri 
State Public Health Laboratory, USA were analysed; 14 from 1984 to 1988, 
and 19 from 1999, including 10 Gom a reported outbreak in Kansas City. 
Variable regions of the genes, pm and ptxSl were amplified by PCR and 
sequenced drectly. Sequence data were compared to those available from 
the GeilUank database. 
Results: Isolates froin the 14 isolates from 1984 to 1988 comprised four 
different pertactin gene (prn) types, including one novel type not previously 
reported; prnl, 9: pm2, 3; pm6, 1; novel prn, 1. Eighteen of the 19 isolates 
L?oni 1999 were pm2, and the remaining one was pml.  Only two pertussis 
toxin S1 subunit gene (ptxS1) variants, ptxSlA and ptxS1B were found in 
the Missouri B.  prftussiz isolates. There was a change in the frequency of the 
types from 1984 to 1988, ptxSlA, 11; ptxSlB, 3 ,  to that found in isolates 
from 1999, ptxSlA, 18; ptxSIB, 1. All 10 ofthese isolates froin Kansas City 
coniprised prn2 and ptxS1A. 
Conclusions: Variation m the pertactin and toxin genes has been reported in 
several European countries. This prehminary study on 33 isolates Gom one 
state in the USA shows similar variation in the B. pertussis toxin gene, but 
suggests a distinct composition of pertactin gene types compared to those 
described in Europe. This study has also identified a novel pertactin type, 
which has been fully sequenced 
p1-1 PCR, serology, and culture in the diagnosis of 
Bordetella pertussis infection in children and contacts in the UK 
N. K. Fry, Y. T. LI, 0. Tzivra, C.  Maple, E. Miller, N. Crowcroft, R.  C. 
George, T.  C. Harrison 
Lmzdivl, UK 
Background: DePpite high vaccination coverage against Bordeteila pertussis, 
there is evidence of an increase in the incidence of pertussis, from a number 
of countries. In contrast, the incidence of pertussis in the UK remains low. 
However, in the UK definitive diabmods is usually made by culture of the 
organism, which is infrequently attempted and may be insensitive. 
Objectives: The aim of this study was to compare the use of culture, PCR, 
and serology in the diagnoris of B.  perfussis infection in children (0-15 years) 
and their contacts (chddren and adults) in the UK using molecular and 
serological techniques in addition to culture. 
Methods: Two independent conventional PCR assays, targeting distinct 
regions on the B. pertussis genome were used together with an enzyme 
inimunoassay for antipemssis toxin IgG. Culture of B. pertussis was 
attempted by standard methods. 
Results: Of the 105 children and contacts studied, from whom appropnate 
specimens were received, 16 children had microbiological evidence of 
pertussis infection. Culture was attempted in 15 of these 16 cases, and was 
positive in four cases. Twelve out of 14 samples tested were positive by 
PCR and nine out of 13 tested had serological evidence of infection. 
Evidence of infection was found in 12 contacts of these children. B. pertussis 
way isolated from two of the 12 contacts. Five out of 12 were PCK positive, 
and X out of 9, from whom appropriate serological specimen$ were 
available, had serological evidence of infrction. 
Conclusion: This study clearly demonstrates that pertussis is under- 
diagnosed by culture in chddren and adults in the UK. The use of PCR 
for diagnosis in children, and serology for diagnosis in adult5 can greatly 
improve diagnostic sensitivity. 
lP1638) Long-term persistence of cell-mediated immune 
response to pertussis antigens at the age of 4-6 years after 
primary vaccination with DTPa 
M Knuf, I’ Habennehl, C U Mryer, P Schnndtke, R Clemens, F I’ Zepp 
hfmiiz, D, R i ~ e m a r / ,  B
Background Decreasing pertussis antibody concentrations after primary 
immunization supports the concept of a booster vaccination at 4-6 years. In 
previous studies we have demonstrated that CMI as a specific marker may 
help to charactenze efficiency of vaccines. Here we present serological and 
CMI data prior to and immediately after administration of two DTPa 
booster vaccinations at the age of 4-6 years. 
Materials and methods: 357 infants were primed with four doses of DTPa 
during the first two years of life. At the preschool age (4-6 years) these 
children received either a DTPa or a dTpa (reduced antigen content) 
booster vaccination (SB). Peripheral blood was drawn pre-and 30 days 
postvaccination. The specific T-cell response to pertussis antigens PT, FHA 
or P R N  was analysed for a subset of subjects ( i t =  172). Pertussis specific 
IgGl were measured. 
Results: Before the booster vaccination up to 80% of subjects showed a 
CMI-response to the pertussis antigens (PT 6796, FHA 80% PRN 60%). 
The antigen specific CMI-response after the booster exceeded the 
prebooster response (Table 1). Pre-booster, pertussis-specific antibody titres 
were low. However, booster vaccination induced a vigorous nse of 
antibody titres (Table 2). 
Tahle I Incrrdsc of ii1e.111~ prebooster v s .  podmocter 
PT FHA PKN 
d T p  i i h3 .8  71~!/763.7 5X.711118.7 
IlTI’a 4.xi79.2 59.hlHh2.2 54.6/1359.5 
Conclusion: After booster vaccination of children aged 4-6 years (2-4 years 
post 4th dose of DTPa-primary inmunization), high frequencies of pertussis 
specific periphereal blood T-cells can be demonstrated, in contrast to low 
levels of circulating antibodies. A major increase of the proliferative response 
postbooster was demonstrated for both (low and high dose) pertussis 
vaccines. The findings suggest that T-cell memory prebooster is of sufficient 
quality to mount immediate Pertussis specific immune responws. The 
presence of prebooster memory T-cells may have to be seen as still high 
enough for a sufficient cellular response. 
lp1639) Antibody response to MMR vaccination among 
children in northern Greece 
J. Kavaliotic, S. Petridou, E. Chatziagorou, D. Karabaxoglou, K. Kontouh, 
H.  Psilaki. A. Kansouzidou, H. Tsagaropoulou, C. Charitidou 
T/iessaloniki, GR 
Objective: The aim of this study was to evaluate the MMR vaccine 
coverage to a random population sample and to assets the seroprevalence of 
antibody against measles, rubella, and mumps in vaccinated children of 
Northern Greece. 
Material: Methods: A serosurvey of 562 children (304 boys), aged 13 
months to 14 years (median 5.5 years). was carried out between 5/1999 and 
6/2000. Vaccination against MMR was a prerequisite for all children 
included in the study. The children were hospitalized in our Deparhnent for 
other than measles-rubella-niuinps diseases. The 34/562 (6%) children had 
received two doses of MMR. Furthennore, 87 unvaccinated children were 
used as a control group. Serum samples were tested by enzymednked 
inmunosorbent assay (ELISA) for IgG antibodies to measles (Clonesystem) 
and mumps (Biochrm) and by an enzyliie-linked-fluorescent assay (ELFA) 
for IgG antibodies to rubella (VIDAS system-BioMerieux). 
Results: The vaccination rate in our study group was 86%. Prevalence of 
antibodies against measles, rubella, and mumps were 90%, 91% and 64%). 
respectively, for chddren having received a single dose of MMR, while 
administration of a second dose of MMR resulted in increase of anti 
measles, antirubella, and antimumps antibodies: 94.5%. 94.3% and 71% of 
them, respectively. The seroprevalence for measles, rubella, and mumps 
among unvaccinated children was 25%, 18% and 9%, respectively. 
Conclusions: (1) The vaccination rate for our study population was 
relatively sufficient. (2) The seroprevalence for measles and rubella was 90% 
and 91% among children vaccinated with one dose of MMR, while 
administration of a second dose increased the seroprevalence to 94.5%. (3) 
The seroprevalence for mumps was too low (7 1%). 4. A great effort should 
be made to increase the vaccination rate. 
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vl Immunization against measles, mumps and rubella- 
EPI program in Kosova 
A. Kalaveshi, L. Gashi, N. Ramadani, D. Salihu, P. Kreidl 
Piishfim, AL 
Introduction: Immunization can be the cheapest and most effective strategy 
to reduce the incidence of communicable diseases like measles, munips and 
rubella. Routine vaccination for M M R  in Kosovo is targeted to children 
12-18 months and, since 1999, administered simultaneously with DTP 
(fourth dose) and OPV (fourth dose). Booster doses should be given to 
children aged 12-13 years together with dT and OPV. Between 1993 and 
1998, measles vaccine was administered without mumps and rubella 
components. Before the war in 1999, 67 infectious diseases were reported 
on individually format through a statutory notification system. Since January 
2000, a syndrome based surveillance system has been implemented in 
Kosovo, reporting both individually and aggregated data. 
Objectives: To present routine vaccine coverage data of MMR together with 
recent epidemics of measles, mumps and rubella in Kosovo during the last 5 
years to underline the importance of strengthening imniunisation programmes. 
Methods: Desciiptive analysis of vaccine coverage and surveillance data. 
Results: The W H O  reconmiended vaccine coverage of 95% for measles by 
the end of the second year of life was never achieved since 1995. In 1997, a 
measles outbreak with a cumulative number of 3931 cases occurred in 
Kosovo. Between 1 January and 3 October 2000, a total of 1664 cases of 
suspected mumps and 7912 cases of suspected rubella were reported in 
Kosovo. In the same period 457 case of meningitis serosa were reported to 
have been admitted to Kosovan hospitals. 
Conclusions: The high number of meningitis serosa cases reported 111 2000 
are likely to be related to the mumps epidemic. All of the described 
outbreaks probably could have been prevented by effective vaccination 
strateges. Strengthening of routine EPI-vaccinations together with munips 
and rubella to reach sufficient vaccine coverage levels will hopefully 
decrease incidence and complications of these common observed childhood 
diseases in Kosovo. 
vl Pneumococcal serogroups causing the most invasive 
disease in Kayseri. Turkey 
I). Esel, B. Sunierkan 
Kayseri, TR 
Objective: The aim of this study was to compare the serogroups causing 
invasive pneuniococcal disease (IPD) with those represented m both currently 
available polysaccharide vaccine and conjugate vaccine formulations. 
Method: We evaluated 69 Streptococcus pneirtnorziae strains isolated &om 31 
chlldren and 38 adults in Erciyes University Hospital in the period from 
January 1998 to January 2000. The strains were isolated from cerebrospinal 
fluid (n=31), blood (n=28), and pleural fluid ( n =  10). Serotyping was 
pefiormed using Pneumotest kit (Statens Scruninstitute, Denmark). 
Results: Serogroups of 6 (8%) strains could not be defined. The remaining 
63 strains belonged to serogroup 19, 1, 6, 23, 3, 15, 14, and 7 by order of 
decreasing frequency. Serogroups in the 23-valent polysaccharide vaccine, 
7-valent, 9-valent, and 1 1-valent conjugate vaccine formulations caused 
91%, 68%, 81%, and 87% of IIW in our region, respectively. 
Conclusion: Although sever31 serogroups not found in these vaccine 
fomiulations are important causes of disease, each formulation can prevent a 
substantial IPD burden in this region. 
Ip16421 Immunization by inactivated whole cell 
Streptococcus pneumoniae and enhanced antibody response 
with live Bifidobacterium bifidum 
M. Vignjevic-Krastavcevic, D. Nikolic, L. Hegedis, G. Dakic 
Belgrade, W 
The aim of this study was to compare the antibody response following 
parental and oral immunization by Streptococcus piteurnoriiae, inactivated 
whole cells, and possibility of enhancing antibody response by adding the 
live Bjfidobacten'um bijdurn. Four heat-inactivated strains were used. Rabbits, 
weight 2-3 kg were inmunized in three different ways. First, parental by 
4 x 10" cells/dose, three injection per week for four weeks and after 30 days 
the same process were re eated for three weeks. Second group were 
inununized orally by 2 x 1(f cell/dose every day for 30 days, than pause 20 Y 
days. 10 days inmiunization, pause 20 days and 10 days iiiiniunizatioti. 
Third oup were immunized in the same schedule as the second group by 
2 x 10 cell/dose and 1.5 x 10" live B$dobacferiurn b!fiidum. The seruni was 
obtained from each rabbit, before inununizauon, 7 days after each pait of 
immunization, 3 weeks and 6 months after the inuiiuiization was 
completely finished. Titre of capsular antibodies and antibodier of the 
whole cell of Streptoroalrs pneumoniae were measured by agglutination. 
Parental and oral immunization led to the significant increase in antibody 
titre levels (4-32 tinies and 4-16 times) applying both to capsular antibody 
as well as to the whole cell. Titre antibodies produced after the oral 
immunization stayed longer in the circulation. Orally immunized rabbits 
with Streptococcus prieuitioriiae and B@fobacteriuin b$fidrmi had better aiitihody 
response (increase in antibody titre levels was more than 32 tiines) and 
retained in serum on the sanie level during the whole peiiod of 
exanination. Our study had shown that oral iinuiunizatio~i by the whole 
cell of Streptocorcuz prielrnioitiae resulted in a satisfactory aiinbody recponse that 
could be improved by addmg live Bjfidobamriuni b!fidum into the suspension. 
F 
/p1643/ Estimation of antigrippe vaccination application in 
adults and children in family practice in 1999/2000 
W. Lukas, 1. Szymczyk, P. Jedynak, J. Tomasik-Kr6tki 
Zabrze, PL 
Background: Reconmiendations dealing -7th antigrippe vaccination 
indicate reduction of age limit fkom 65 to 50 or even 45 years. Additionally, 
vaccination is reconimended in risk groups: health seivice employees, social 
help houses residents, patients with chronic heart, lung diseases and diabetes, 
taking iiimiunotherapy and patients with chronic kidney insufficieiicy. I t  
reduces the amount of visits m Fanllly Practice, decreases the frequency of 
hospitahsation and brings substantial savings. Criteria dealing with 
vaccination reconmendations in children aren't clear. Fanily doctor should 
actively participate in  prophylactic activities. Nevertheless the awareness of- 
antigrippe vaccination necessity in hidher patients isn't high. 
Objectives: The aini of this work has been to analyse antigrippe vaccination 
realisation in Group Fanlily Practice in 1999/2000. Practice iricluder 8660 
patients. 
Results: Among 4067 adults who visited Practice during the study 303 
persons have been vaccinated (7.4%). Among adults there have been 50.5% 
ofwomen and 4 9 9 6  ofnien. 88.5% ofvacciriated patients represent high or 
medium standard of education. 43.9% working patients, 11 2% $tudent\, 
40.3% pensioners and 4.6% unemployed. The source of infonriation about 
the need of Vaccination has been media (41.3'%$) medical ctaff (32.3'%), 
friends and family (26.4%). Among vaccinated adultc 37.950/;1 have had 
contact with large number of people. 44.88% represented cardiovascular 
diseases, 9.9% chronic respiratory diseases, 4.2% diabetes. Among 2043 
children and teenagerr up to 18 year 69 (3.4%) patients have been 
vaccinated. 36.2% of children have suffered from chronic respiratory rystem 
disease. What attracts our attention is low percentage of patients who gave 
permission to antigrippe vaccination. Particularly troubling is the fact that 
only 13 patients out of 180 with diabetes type 2 have undergone 
vaccin?tion. Makmg the decision dealing with antignppe Vaccination has 
been mainly influenced by media and other nonmedical factors (family 
friends)-67.7?'. Only in 32% vaccination depended on medical staE Patient 
education has represented main factor their decision. 
Conclusions: Results of perfomied studies the necessity of promotion 
strategy change as far antigrippe vaccination in Fanlily Practice is concenied. 
(p1644( Biological properties of escape mutant of influenza 
virus B/Panama/45/90 
E. V. Sorokin, A. A. Sonunina, J .  R. Komanova 
Sr. -Peterrbuug, RIJS 
The monoclonal antibodies, clone 4H7 (Mabs 4H7) to HA1 of influenza B/ 
Panaina/4S/90 virus which interacted in haemagglutination inhibition teqt 
(HIT) and in virus neutralizing reaction only with antigenic vari:~nts of U /  
Yarnagata/lh/RX-like viruses without any reaction with B/Victoria/2/87- 
like viruses were uted to select escape mutant (EM) of the virus. Selected 
EM was absolutely resistant to Mabs 4H7 in ELISA, HIT and plaque 
forming assay in MDCK cell. O n  the other hand, wild type (WT) of 
influenza 13/Panania/45/L10 virus and EM reacted sirmlarly with number of 
Mabs to conserved epitoprs of NP and H A  molecule of two distinct major 
HA lineages of influenza B virus. The HA genes of W T  and EM were 
